PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Whitney, SL; Eagle, SR; Marchetti, G; Mucha, A; Collins, MW; Kontos, AP				Whitney, Susan L.; Eagle, Shawn R.; Marchetti, Gregory; Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.		CARE Consortium Investigators	Association of acute vestibular/ocular motor screening scores to prolonged recovery in collegiate athletes following sport-related concussion	BRAIN INJURY			English	Article						Concussion; athlete; ocular; recovery; vestibular; VOMS	PREDICTORS; SYMPTOMS; REHABILITATION; DISORDERS; DURATION; VOMS	Introduction: Researchers have yet to explore the association of acute (i.e., within 3 days) post-injury VOMS scores and length of time until clearance to return to play in collegiate athletes. Objective: The purpose was to determine if individual Vestibular/Ocular Motor Screening (VOMS) component symptom scores (e.g., smooth pursuits, convergence, vestibular-ocular reflex) can predict clearance to return to activity from a sport-related concussion. Methods: Pre-season demographic and medical history and post-injury VOMS testing were collected (n = 79) on collegiate student-athletes following concussion. Impaired vestibulo-ocular function post-injury scores (>= 2) were compared to normal scores using survival analysis, with days to clearance to return to sport as the outcome. Results: Abnormal scores on smooth pursuits (p =.026), horizontal saccades (p =.025), vertical saccades (p =.028), and convergence (p =.031) were associated with lower probability of clearance in comparison with normal scores. Any score >= 2 predicted significantly greater days to clearance for return to play (13.1 days; 95% CI: 11.9-14.3; p = .025) compared with athletes with no abnormal test scores (9.6 days; 95% CI: 7.2-12.1, P =.014). Discussion: Post-injury symptoms with VOMS smooth pursuit, saccades, and convergence is associated with increased time-to-clearance for return to sport in collegiate athletes.	[Whitney, Susan L.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15203 USA; [Eagle, Shawn R.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Marchetti, Gregory] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15203 USA; [Mucha, Anne; Collins, Michael W.] Univ Pittsburgh, Ctr Rehabil Serv, Med Ctr, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Concuss Res Program, 3200 S Water Stree, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042	National Collegiate Athletic Association; U.S. Department of DefenseUnited States Department of Defense	This work was supported by the National Collegiate Athletic Association [CARE Consortium]; U.S. Department of Defense [CARE Consortium].	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Hall EE, 2015, CLIN J SPORT MED, V25, P291, DOI 10.1097/JSM.0000000000000133; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KLEINBAUM D.G, 1996, SURVIVAL ANAL; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2019, J ORTHOP SPORT PHYS, V49, P1; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	29	9	9	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					842	847		10.1080/02699052.2020.1755055		APR 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000528167800001	32315218				2022-02-06	
J	Meier, TB; Huber, DL; Bohorquez-Montoya, L; Nitta, ME; Savitz, J; Teague, TK; Bazarian, JJ; Hayes, RL; Nelson, LD; McCrea, MA				Meier, Timothy B.; Huber, Daniel L.; Bohorquez-Montoya, Luisa; Nitta, Morgan E.; Savitz, Jonathan; Teague, T. Kent; Bazarian, Jeffrey J.; Hayes, Ronald L.; Nelson, Lindsay D.; McCrea, Michael A.			A Prospective Study of Acute Blood-Based Biomarkers for Sport-Related Concussion	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SERUM; EXPRESSION; INCREASES; DIAGNOSIS; SEVERITY; PROTEIN; UTILITY; PLASMA; ALPHA	Objective Prospectively characterize changes in serum proteins following sport-related concussion and determine whether candidate biomarkers discriminate concussed athletes from controls and are associated with duration of symptoms following concussion. Methods High school and collegiate athletes were enrolled between 2015 and 2018. Blood was collected at preinjury baseline and within 6 hours (early acute) and at 24 to 48 hours (late acute) following concussion in football players (n = 106), matched uninjured football players (n = 84), and non-contact-sport athletes (n = 50). Glial fibrillary acidic protein, ubiquitin c-terminal hydrolase-L1, S100 calcium binding protein B, alpha-II-spectrin breakdown product 150, interleukin 6, interleukin 1 receptor antagonist, and c-reactive protein were measured in serum. Linear models assessed changes in protein concentrations over time. Receiver operating curves quantified the discrimination of concussed athletes from controls. A Cox proportional hazard model determined whether proteins were associated with symptom recovery. Results All proteins except glial fibrillary acidic protein and c-reactive protein were significantly elevated at the early acute phase postinjury relative to baseline and both control groups and discriminated concussed athletes from controls with areas under the curve of 0.68 to 0.84. The candidate biomarkers also significantly improved the discrimination of concussed athletes from noncontact controls compared to symptom severity alone. Glial fibrillary acidic protein was elevated postinjury relative to baseline in concussed athletes with a loss of consciousness or amnesia. Finally, early acute levels of interleukin 1 receptor antagonist were associated with the number of days to symptom recovery. Interpretation Brain injury and inflammatory proteins show promise as objective diagnostic biomarkers for sport-related concussion, and inflammatory markers may provide prognostic value. ANN NEUROL 2020	[Meier, Timothy B.; Huber, Daniel L.; Bohorquez-Montoya, Luisa; Nitta, Morgan E.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Nitta, Morgan E.] Marquette Univ, Dept Pathol, Milwaukee, WI 53233 USA; [Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Sch Community Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Oklahoma Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA; [Hayes, Ronald L.] Banyan Biomarkers, Banyan Labs, Alachua, FL USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Savitz, Jonathan/C-3088-2009; Teague, T. Kent/A-2527-2008	Savitz, Jonathan/0000-0001-8143-182X; Teague, T. Kent/0000-0002-4680-5440	Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099789]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NIH National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312]; NIH National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH113871]; NIH National Center for Advancing Translational Sciences [UL1TR001436]	This work was supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through award number W81XWH-14-1-0561. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. Support for this work was also provided by the NIH National Institute of Neurological Disorders and Stroke under award number R21NS099789. T.B.M. acknowledges additional support from the National Institute of Neurological Disorders and Stroke (R01NS102225) and through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. J.S. acknowledges support from the NIH National Institute of General Medical Sciences (P20GM121312) and the NIH National Institute of Mental Health (R21MH113871). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The REDCap electronic database and the Adult Translational Research Unit used for this project were supported by the NIH National Center for Advancing Translational Sciences, award number UL1TR001436.	Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bouvier D, 2017, SPORTS MED, V47, P781, DOI 10.1007/s40279-016-0579-9; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01367; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Metzger RR, 2018, J NEUROSURG-PEDIATR, V22, P369, DOI 10.3171/2018.4.PEDS17593; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Parkin GM, 2018, J NEUROTRAUM, V20, P20; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Venetsanou K, 2007, EUR CYTOKINE NETW, V18, P206, DOI 10.1684/ecn.2007.0112	33	9	9	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUN	2020	87	6					907	920		10.1002/ana.25725		APR 2020	14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP5TX	WOS:000527071300001	32215965	Bronze, Green Accepted			2022-02-06	
J	Picetti, E; Pelosi, P; Taccone, FS; Citerio, G; Mancebo, J; Robba, C				Picetti, Edoardo; Pelosi, Paolo; Taccone, Fabio Silvio; Citerio, Giuseppe; Mancebo, Jordi; Robba, Chiara		ESICM NIC ARF Sect	VENTILatOry strategies in patients with severe traumatic brain injury: the VENTILO Survey of the European Society of Intensive Care Medicine (ESICM)	CRITICAL CARE			English	Article						Traumatic brain injury; Mechanical ventilation; Respiratory failure	RESPIRATORY-DISTRESS-SYNDROME; EXTRACORPOREAL MEMBRANE-OXYGENATION; END-EXPIRATORY PRESSURE; ACUTE LUNG INJURY; PRONE POSITION; SUBARACHNOID HEMORRHAGE; MECHANICAL VENTILATION; INTRACRANIAL-PRESSURE; HEAD-INJURY; HYPEROXIA	Background Severe traumatic brain injury (TBI) patients often develop acute respiratory failure. Optimal ventilator strategies in this setting are not well established. We performed an international survey to investigate the practice in the ventilatory management of TBI patients with and without respiratory failure. Methods An electronic questionnaire, including 38 items and 3 different clinical scenarios [arterial partial pressure of oxygen (PaO2)/inspired fraction of oxygen (FiO(2)) > 300 (scenario 1), 150-300 (scenario 2), < 150 (scenario 3)], was available on the European Society of Intensive Care Medicine (ESICM) website between November 2018 and March 2019. The survey was endorsed by ESICM. Results There were 687 respondents [472 (69%) from Europe], mainly intensivists [328 (48%)] and anesthesiologists [206 (30%)]. A standard protocol for mechanical ventilation in TBI patients was utilized by 277 (40%) respondents and a specific weaning protocol by 198 (30%). The most common tidal volume (TV) applied was 6-8 ml/kg of predicted body weight (PBW) in scenarios 1-2 (72% PaO2/FIO2 > 300 and 61% PaO2/FiO(2) 150-300) and 4-6 ml/kg/PBW in scenario 3 (53% PaO2/FiO(2) < 150). The most common level of highest positive end-expiratory pressure (PEEP) used was 15 cmH(2)O in patients with a PaO2/FiO(2) <= 300 without intracranial hypertension (41% if PaO2/FiO(2) 150-300 and 50% if PaO2/FiO(2) < 150) and 10 cmH(2)O in patients with intracranial hypertension (32% if PaO2/FiO(2) 150-300 and 33% if PaO2/FiO(2) < 150). Regardless of the presence of intracranial hypertension, the most common carbon dioxide target remained 36-40 mmHg whereas the most common PaO2 target was 81-100 mmHg in all the 3 scenarios. The most frequent rescue strategies utilized in case of refractory respiratory failure despite conventional ventilator settings were neuromuscular blocking agents [406 (88%)], recruitment manoeuvres [319 (69%)] and prone position [292 (63%)]. Conclusions Ventilatory management, targets and practice of adult severe TBI patients with and without respiratory failure are widely different among centres. These findings may be helpful to define future investigations in this topic.	[Picetti, Edoardo] Parma Univ Hosp, Dept Anesthesia & Intens Care, Via Gramsci 14, I-43100 Parma, Italy; [Pelosi, Paolo; Robba, Chiara] IRCCS Oncol & Neurosci, Dept Anesthesia & Intens Care, Genoa, Italy; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Taccone, Fabio Silvio] Univ Libre Bruxelles, Dept Intens Care, Erasme Hosp, Brussels, Belgium; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Mancebo, Jordi] St Pau Hosp, Dept Intens Care, Barcelona, Spain		Picetti, E (corresponding author), Parma Univ Hosp, Dept Anesthesia & Intens Care, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Robba, Chiara/AAS-7421-2020				Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; Beuret P, 2002, INTENS CARE MED, V28, P564, DOI 10.1007/s00134-002-1266-x; Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Combes A, 2019, INTENS CARE MED, V45, P592, DOI 10.1007/s00134-019-05567-4; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; deBacker J, 2017, CHEST, V151, P697, DOI 10.1016/j.chest.2016.10.040; Della Torre V, 2019, CURR OPIN ANESTHESIO, V32, P234, DOI 10.1097/ACO.0000000000000698; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Frisvold SK, 2019, INTENS CARE MED, V45, P683, DOI 10.1007/s00134-019-05556-7; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Hardcastle TC, 2017, WORLD J SURG, V41, P1153, DOI 10.1007/s00268-016-3530-1; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Moss M, 2019, NEW ENGL J MED, V380, P1997, DOI 10.1056/NEJMoa1901686; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; Nekludov M, 2006, ACTA ANAESTH SCAND, V50, P932, DOI 10.1111/j.1399-6576.2006.01099.x; Oddo M, 2016, INTENS CARE MED, V42, P790, DOI 10.1007/s00134-016-4298-3; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pelosi P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1991-3; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; Robba C, 2017, J TRAUMA ACUTE CARE, V82, P165, DOI 10.1097/TA.0000000000001276; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Thelandersson A, 2006, ACTA ANAESTH SCAND, V50, P937, DOI 10.1111/j.1399-6576.2006.01037.x	45	9	11	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	APR 17	2020	24	1							158	10.1186/s13054-020-02875-w			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH2LI	WOS:000528618400002	32303255	Green Published, gold			2022-02-06	
J	Littlejohn, EL; Scott, D; Saatman, KE				Littlejohn, Erica L.; Scott, Danielle; Saatman, Kathryn E.			Insulin-like growth factor-1 overexpression increases long-term survival of posttrauma-born hippocampal neurons while inhibiting ectopic migration following traumatic brain injury	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Cognitive flexibility; Controlled cortical impact; Dentate gyrus; Gliogenesis; Granule cell layer; Neurogenesis; Reversal learning	CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; DENTATE GYRUS; GRANULE CELLS; NEWBORN NEURONS; COGNITIVE FLEXIBILITY; FUNCTIONAL RECOVERY; ADULT NEUROGENESIS; SPATIAL MEMORY; CA3 REGION	Cellular damage associated with traumatic brain injury (TBI) manifests in motor and cognitive dysfunction following injury. Experimental models of TBI reveal cell death in the granule cell layer (GCL) of the hippocampal dentate gyrus acutely after injury. Adult-born neurons residing in the neurogenic niche of the GCL, the subgranular zone, are particularly vulnerable. Injury-induced proliferation of neural progenitors in the subgranular zone supports recovery of the immature neuron population, but their development and localization may be altered, potentially affecting long-term survival. Here we show that increasing hippocampal levels of insulin-like growth factor-1 (IGF1) is sufficient to promote end-stage maturity of posttrauma-born neurons and improve cognition following TBI. Mice with conditional overexpression of astrocyte-specific IGF1 and wild-type mice received controlled cortical impact or sham injury and bromo-2 '-deoxyuridine injections for 7d after injury to label proliferating cells. IGF1 overexpression increased the number of GCL neurons born acutely after trauma that survived 6 weeks to maturity (NeuN+BrdU+), and enhanced their outward migration into the GCL while significantly reducing the proportion localized ectopically to the hilus and molecular layer. IGF1 selectively affected neurons, without increasing the persistence of posttrauma-proliferated glia in the dentate gyrus. IGF1 overexpressing animals performed better during radial arm water maze reversal testing, a neurogenesis-dependent cognitive test. These findings demonstrate the ability of IGF1 to promote the long-term survival and appropriate localization of granule neurons born acutely after a TBI, and suggest these new neurons contribute to improved cognitive function.	[Littlejohn, Erica L.; Scott, Danielle; Saatman, Kathryn E.] Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, B473 Biomed & Biol Sci Res Bldg BBSRB, Lexington, KY 40536 USA; [Littlejohn, Erica L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA		Saatman, KE (corresponding author), Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, B473 Biomed & Biol Sci Res Bldg BBSRB, Lexington, KY 40536 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA.	k.saatman@uky.edu		LITTLEJOHN, ERICA/0000-0003-3255-8546	National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS072302, NS077889]; Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 14-12A]	This work was supported by grants from the National Institutes of Health National Institute of Neurological Disorders and Stroke (NS072302 and NS077889) and the Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT 14-12A).	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Althaus AL, 2015, J NEUROPHYSIOL, V113, P1184, DOI 10.1152/jn.00835.2014; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Baker NL, 1999, DEV BRAIN RES, V118, P109, DOI 10.1016/S0165-3806(99)00136-4; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bromley-Brits Kelley, 2011, J Vis Exp, DOI 10.3791/2920; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.0.CO;2-N; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Han JJ, 2016, NEURON, V91, P79, DOI 10.1016/j.neuron.2016.05.034; Hayashi K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00135; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Horster H, 2017, STEM CELLS, V35, P787, DOI 10.1002/stem.2536; Huat TJ, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-91; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hurtado-Chong A, 2009, EUR J NEUROSCI, V30, P742, DOI 10.1111/j.1460-9568.2009.06870.x; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Idris N, 2010, PSYCHOPHARMACOLOGY, V208, P23, DOI 10.1007/s00213-009-1702-5; Ishikawa R, 2016, ELIFE, V5, DOI 10.7554/eLife.17464; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2002, DEV BRAIN RES, V134, P1, DOI 10.1016/S0165-3806(01)00224-3; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kim S, 2006, MOL REPROD DEV, V73, P1523, DOI 10.1002/mrd.20531; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Martin LA, 2002, J NEUROSCI, V22, P3520; Miller AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173167; Miltiadous P, 2011, EXP NEUROL, V231, P223, DOI 10.1016/j.expneurol.2011.06.014; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Muhic M, 2015, J BIOL CHEM, V290, P11167, DOI 10.1074/jbc.M114.629063; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Ng T, 2016, J BIOL CHEM, V291, P25088, DOI 10.1074/jbc.M116.755215; Ngwenya LB, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4209821; Nieto-Estevez V, 2016, STEM CELLS, V34, P2194, DOI 10.1002/stem.2397; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; OCRANT I, 1988, ENDOCRINOLOGY, V123, P1023, DOI 10.1210/endo-123-2-1023; Parent JM, 1997, J NEUROSCI, V17, P3727; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Popescu C, 2015, J Med Life, V8, P272; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rong ZH, 2015, INT J MOL MED, V36, P195, DOI 10.3892/ijmm.2015.2219; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Saha R, 2017, NEUROPSYCHOPHARMACOL, V42, P473, DOI 10.1038/npp.2016.205; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Scharfman HE, 2016, NAT REV NEUROSCI, V17, P562, DOI 10.1038/nrn.2016.87; Scharfman HE, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03480.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Selenica ML, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt241; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Sirbulescu RF, 2019, J NEUROTRAUM, V36, P2579, DOI 10.1089/neu.2018.6368; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villasana LE, 2019, J NEUROTRAUM, V36, P2454, DOI 10.1089/neu.2018.6162; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang JM, 1999, NEUROSCI LETT, V277, P17, DOI 10.1016/S0304-3940(99)00829-0; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Wu HJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00592; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	103	9	9	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 10	2020	8	1							46	10.1186/s40478-020-00925-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG3WY	WOS:000528036500001	32276671	Green Published, gold			2022-02-06	
J	Al Saiegh, F; Philipp, L; Mouchtouris, N; Chalouhi, N; Khanna, O; Shah, SO; Jallo, J				Al Saiegh, Fadi; Philipp, Lucas; Mouchtouris, Nikolaos; Chalouhi, Nohra; Khanna, Omaditya; Shah, Syed Omar; Jallo, Jack			Comparison of Outcomes of Severe Traumatic Brain Injury in 36,929 Patients Treated with or without Intracranial Pressure Monitoring in a Mature Trauma System	WORLD NEUROSURGERY			English	Article						Brain injury; ICP monitor; Intracranial pressure; Outcome; TBI	LENGTH-OF-STAY; GUIDELINES	BACKGROUND: Severe traumatic brain injury (TBI) remains a major cause of morbidity and mortality with mortality rates reaching 35%. Intracranial pressure (ICP) monitoring is used to prevent secondary brain injury and death. However, while the association of elevated ICP and worsened outcomes is accepted, routine ICP monitoring has been questioned after the publication of several studies including the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure trial. We examined whether severe TBI patients in the trauma system of Pennsylvania fared better with or without ICP monitoring. METHODS: We conducted a statewide retrospective analysis and included all TBI patients >18 years with an admission Glasgow Coma Scale (GCS) <9 from January 2000 through December 2017. The primary outcome was mortality. Secondary outcomes examined were intensive care unit length of stay (LOS) and discharge functional independence measure (FIM). RESULTS: A total of 36,929 patients matched our inclusion criteria and were included in the analysis. Of those, 6025 (16.3%) had ICP monitor placement. Mean ICU LOS was significantly higher in ICP-monitored patients (13.1 +/- 11.6 days vs. 6.0 +/- 10.8 days, P < 0.0001). Increasing age was a significant predictor of death (P < 0.0001). Mean FIM scores at discharge were significantly higher in patients without an ICP monitor (16.21 +/- 4.91 vs. 9.53 +/- 5.07, P < 0.0001). When controlling for injury severity score, GCS, age, and craniotomy, ICP monitoring conferred a hazard ratio of 0.85 (chi(2) = 32.63, P < 0. 0001), a 25% reduction of in-hospital mortality compared with non-ICPmonitored patients. CONCLUSION: We found that ICP-monitored patients had a lower risk of in-hospital mortality. Our findings support the use of ICP monitors in eligible patients.	[Al Saiegh, Fadi; Philipp, Lucas; Mouchtouris, Nikolaos; Chalouhi, Nohra; Khanna, Omaditya; Shah, Syed Omar; Jallo, Jack] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Al Saiegh, Fadi; Philipp, Lucas; Mouchtouris, Nikolaos; Chalouhi, Nohra; Khanna, Omaditya; Shah, Syed Omar; Jallo, Jack] Jefferson Hosp Neurosci, Philadelphia, PA USA		Jallo, J (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA.	jack.jallo@jefferson.edu	Philipp, Lucas/AAK-7896-2020	Philipp, Lucas/0000-0003-1179-7687; Mouchtouris, Nikolaos/0000-0001-9495-9391			Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Areas FZ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00432; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2002, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, TBI REL DEATHS; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czorlich P, 2020, NEUROSURG REV, V43, P1305, DOI 10.1007/s10143-019-01159-4; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Lazaridis C, 2015, J CRIT CARE, V30, P1258, DOI 10.1016/j.jcrc.2015.08.003; Lele A, 2019, NEUROSURGERY, V85, P231, DOI 10.1093/neuros/nyy247; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Melhem S, 2014, CRIT CARE, V18, DOI 10.1186/cc13713; Mouchtouris N, 2019, WORLD NEUROSURG, V130, pE166, DOI 10.1016/j.wneu.2019.06.025; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shaw M, 2018, ACTA NEUROCHIR SUPPL, V126, P205, DOI 10.1007/978-3-319-65798-1_42	18	9	9	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2020	136						E535	E541		10.1016/j.wneu.2020.01.070			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KW0BN	WOS:000520838600056	31954892				2022-02-06	
J	Hogg, FRA; Gallagher, MJ; Kearney, S; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Hogg, Florence R. A.; Gallagher, Mathew J.; Kearney, Siobhan; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Acute Spinal Cord Injury: Monitoring Lumbar Cerebrospinal Fluid Provides Limited Information about the Injury Site	JOURNAL OF NEUROTRAUMA			English	Article						clinical management of central nervous system injury; CSF; microdialysis; TSCI	PERFUSION-PRESSURE; INTRASPINAL PRESSURE; DRAINAGE; PARAPLEGIA; SURGERY; PROFILE; BRAIN	In some centers, monitoring lumbar cerebrospinal fluid (CSF) is used to guide management of patients with acute traumatic spinal cord injuries (TSCI) and draining lumbar CSF to improve spinal cord perfusion. Here, we investigate whether the lumbar CSF provides accurate information about the injury site and the effect of draining lumbar CSF on injury site perfusion. In 13 TSCI patients, we simultaneously monitored lumbar CSF pressure (CSFP) and intraspinal pressure (ISP) from the injury site. Using CSFP or ISP, we computed spinal cord perfusion pressure (SCPP), vascular pressure reactivity index (sPRx) and optimum SCPP (SCPPopt). We also assessed the effect on ISP of draining 10 mL CSF. Metabolites at the injury site were compared with metabolites in the lumbar CSF. We found that ISP was pulsatile, but CSFP had low pulse pressure and was non-pulsatile 21% of the time. There was weak or no correlation between CSFP versus ISP (R = -0.11), SCPP(csf) versus SCPP(ISP) (R = 0.39), and sPRx((csf)) versus sPRx((ISP)) (R = 0.45). CSF drainage caused no significant change in ISP in 7/12 patients and a significant drop of <5 mm Hg in 4/12 patients and of similar to 8 mm Hg in 1/12 patients. Metabolite concentrations in the CSF versus the injury site did not correlate for lactate (R = 0.00), pyruvate (R = -0.12) or lactate-to-pyruvate ratio (R = -0.05) with weak correlations noted for glucose (R = 0.31), glutamate (R = 0.61), and glycerol (R = 0.56). We conclude that, after a severe TSCI, monitoring from the lumbar CSF provides only limited information about the injury site and that lumbar CSF drainage does not effectively reduce ISP in most patients.	[Hogg, Florence R. A.; Gallagher, Mathew J.; Kearney, Siobhan; Papadopoulos, Marios C.; Saadoun, Samira] Univ London, St Georges Hosp, Acad Neurosurg Unit, London, England; [Zoumprouli, Argyro] Univ London, St Georges Hosp, Neurointens Care Unit, London, England		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, Mol & Clin Sci Inst, London SW17 0RE, England.	ssaadoun@sgul.ac.uk			Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation; National Institute for Health Research Clinical Research Network (NIHR CRN)	This study was supported by grants awarded to M.C.P. and S.S. from Wings for Life Spinal Cord Research Foundation and to M.C.P. from the Neurosciences Research Foundation (Fletcher Fund). F.R.A.H. is a Royal College of Surgeons of England research fellow. M.J.G. is supported by the Neurosciences Research Foundation (Fletcher Fund). S.K. is supported by the National Institute for Health Research Clinical Research Network (NIHR CRN).	Ackerman LL, 2002, NEUROSURGERY, V51, P1414, DOI 10.1097/00006123-200212000-00011; [Anonymous], 2014, J Spinal Cord Med, V37, P659, DOI 10.1179/1079026814Z.000000000341; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Coselli JS, 2002, J VASC SURG, V35, P631, DOI 10.1067/mva.2002.122024; CRAWFORD ES, 1991, J VASC SURG, V13, P36, DOI 10.1016/0741-5214(91)90010-R; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; Hogg FRA, 2019, NEUROCRIT CARE, V30, P421, DOI 10.1007/s12028-018-0616-7; Jones CF, 2012, SPINE, V37, pE1422, DOI 10.1097/BRS.0b013e31826ba7cd; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Martirosyan NL, 2015, NEUROSURGERY, V76, P461, DOI 10.1227/NEU.0000000000000638; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Saadoun S., 2020, NEUROTHERAPEUTICS; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Scott DA, 2016, BRIT J ANAESTH, V117, P26, DOI 10.1093/bja/aew217; Squair JW, 2017, NEUROLOGY, V89, P1660, DOI 10.1212/WNL.0000000000004519; Tamune H, 2014, AM J EMERG MED, V32, P263, DOI 10.1016/j.ajem.2013.11.030; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206	29	9	9	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2020	37	9					1156	1164		10.1089/neu.2019.6789		APR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LI7SL	WOS:000522971200001	32024422	Green Accepted			2022-02-06	
J	Katsigiannis, S; Hamisch, C; Krischek, B; Timmer, M; Mpotsaris, A; Goldbrunner, R; Stavrinou, P				Katsigiannis, Sotirios; Hamisch, Christina; Krischek, Boris; Timmer, Marco; Mpotsaris, Anastasios; Goldbrunner, Roland; Stavrinou, Pantelis			Independent predictors for functional outcome after drainage of chronic subdural hematoma identified using a logistic regression model	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Hematoma; subdural; chronic; Tomography; X-ray computed; Logistic models	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; SURGICAL-TREATMENT; NATURAL-HISTORY; RISK-FACTORS; RECURRENCE; MANAGEMENT	BACKGROUND: Chronic subdural hematoma (CSDH) is a common indication for undergoing neurosurgery, but the outcome may remain limited despite timely surgical treatment. The factors potentially associated with the functional outcome have not been sufficiently investigated. We set out to identify independent predictors associated with the functional outcome after surgical treatment of CSDH, avoiding arbitrary classifications and thresholds or subjective imaging assessment. METHODS: We retrospectively reviewed 197 consecutive surgical cases of CSDH. Univariate and multivariate analyses were performed to identify the relationship between clinical plus radiographic factors and outcome. Imaging analysis was performed using computer-assisted 3D-volumetric analysis. RESULTS: One-hundred and sixty-four (83.2%) patients had a favorable (GOS grade 5 and 4) and 33 (16.8%) an unfavorable clinical outcome (GOS grade 1-3). The multivariate logistic regression analysis determined 4 independent prognostic factors: age over or under 77 years, preoperative clinical condition (Markwalder Score), recurrence and surgical technique applied. Patients treated with mini-craniotomy procedures had worse outcomes than those treated with single or two burr-hole craniostomies. The percentage of the hematoma drained correlated strongly with recurrence and was by itself not an independent predictor for outcome. CONCLUSIONS: In our study age. preoperative neurological status. surgical technique and recurrence were found to be independent prognostic factors for the functional outcome in patients with CSDH.	[Katsigiannis, Sotirios; Hamisch, Christina; Krischek, Boris; Timmer, Marco; Goldbrunner, Roland; Stavrinou, Pantelis] Univ Hosp Cologne, Dept Neurosurg, Kerpener Str 62, D-50937 Cologne, Germany; [Mpotsaris, Anastasios] Univ Hosp Cologne, Dept Radiol & Neuroradiol, Cologne, Germany		Stavrinou, P (corresponding author), Univ Hosp Cologne, Dept Neurosurg, Kerpener Str 62, D-50937 Cologne, Germany.	pantelis.stavrinou@uk-koeln.de	Mpotsaris, Anastasios/O-2247-2016	Mpotsaris, Anastasios/0000-0002-1275-8164			Abouzari M, 2009, NEUROSURG REV, V32, P479, DOI 10.1007/s10143-009-0215-3; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232; Amirjamshidi A, 2007, J CLIN NEUROSCI, V14, P1240, DOI 10.1016/j.jocn.2006.03.030; Amirjamshidi A, 2007, CLIN NEUROL NEUROSUR, V109, P152, DOI 10.1016/j.clineuro.2006.07.007; ARIMITSU T, 1977, J COMPUT ASSIST TOMO, V1, P437, DOI 10.1097/00004728-197710000-00009; ASA Physical Status Classification System, AN ASO; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Brennan PM, 2017, J NEUROSURG, V11, P1; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Delgado PD, 2000, REV NEUROLOGIA, V30, P811, DOI 10.33588/rn.3009.99531; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Gastone P, 2004, NEUROL INDIA, V52, P475; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; JENNETT B, 1975, LANCET, V1, P480; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; Lee KS, 2004, BRAIN INJURY, V18, P351, DOI 10.1080/02699050310001645801; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Mellergard P, 1996, ACTA NEUROCHIR, V138, P708, DOI 10.1007/BF01411476; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mondorf Y, 2009, BRIT J NEUROSURG, V23, P612, DOI 10.3109/02688690903370297; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Phang I, 2015, ANN ROY COLL SURG, V97, P584, DOI 10.1308/rcsann.2015.0042; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Regan JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115085; Ro HW, 2016, ACTA NEUROCHIR, V158, P135, DOI 10.1007/s00701-015-2625-z; Rovlias Aristedis, 2015, Surg Neurol Int, V6, P127, DOI 10.4103/2152-7806.161788; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Sieber CC, 2007, INTERNIST, V48, P1190, DOI 10.1007/s00108-007-1945-3; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Sousa EB, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-5; Stavrinou P, 2017, WORLD NEUROSURG, V99, P465, DOI 10.1016/j.wneu.2016.12.058; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; White M, 2010, BRIT J NEUROSURG, V24, P257, DOI 10.3109/02688691003675218; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364	44	9	9	0	8	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	APR	2020	64	2					133	140		10.23736/S0390-5616.17.04056-5			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MA5SK	WOS:000541972700003	28707859				2022-02-06	
J	Robba, C; Donnelly, J; Cardim, D; Tajsic, T; Cabeleira, M; Citerio, G; Pelosi, P; Smielewski, P; Hutchinson, P; Menon, DK; Czosnyka, M				Robba, Chiara; Donnelly, Joseph; Cardim, Danilo; Tajsic, Tamara; Cabeleira, Manuel; Citerio, Giuseppe; Pelosi, Paolo; Smielewski, Peter; Hutchinson, Peter; Menon, David K.; Czosnyka, Marek			Optic nerve sheath diameter ultrasonography at admission as a predictor of intracranial hypertension in traumatic brain injured patients: a prospective observational study	JOURNAL OF NEUROSURGERY			English	Article						optic nerve sheath diameter; ultrasonography; traumatic brain injury; intracranial pressure	CEREBRAL PERFUSION-PRESSURE; COMPUTED-TOMOGRAPHY; AUTOREGULATION; MORTALITY; IMPACT	OBJECTIVE Intracranial hypertension and impaired cerebral autoregulation are common causes of secondary injuries in patients with traumatic brain injury (TBI). The primary outcome of this study was to assess whether a noninvasive method to estimate intracranial pressure (ICP) based on the ultrasonography of the optic nerve sheath diameter (ONSD) measured at the time of neurocritical care unit (NCCU) admission is correlated with the mean ICP during NCCU stay. Secondary outcomes were to assess whether ONSD is correlated with the dose of ICP > 20 mm Hg and impaired autoregulation during NCCU stay and with instantaneous ICP and whether ONSD is associated with NCCU mortality. METHODS This prospective observational monocentric study included adults with severe TBI. ONSD was measured at NCCU admission, immediately after invasive ICP insertion. ONSD-predicted noninvasive ICP (nICP(ONSD)) was calculated according the formula: nICP(ONSD) = 5 x ONSD - 14 (nICP(ONSD) in mm Hg, ONSD in mm). Autoregulation was measured using the pressure reactivity index (PRx). RESULTS In total, 100 patients were included in this study. ONSD was significantly correlated with mean ICP (r = 0.46, p < 0.0001), with mean PRx (r = 0.21, p = 0.04), and with the dose of ICP > 20 mm Hg during NCCU stay (r = 0.49, p < 0.0001). Admission nICP(ONSD) was shown to be significantly correlated with instantaneous ICP (r = 0.85, p < 0.001). ONSD at admission was significantly correlated with NCCU mortality (p = 0.02). CONCLUSIONS ONSD measured at NCCU admission can give important information about patients at risk of developing intracranial hypertension and impaired autoregulation. ONSD examination could be useful to screen patients at admission to determine who would benefit from further invasive ICP monitoring.	[Robba, Chiara; Pelosi, Paolo] Univ Genoa, San Martino Policlin Hosp, IRCCS Oncol & Neurosci, Anaesthesia & Intens Care, Genoa, Italy; [Robba, Chiara; Menon, David K.] Addenbrookes Hosp, Neurointens Care, Cambridge, England; [Donnelly, Joseph; Cardim, Danilo; Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Brain Phys Lab, Cambridge, England; [Donnelly, Joseph] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand; [Cardim, Danilo] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Tajsic, Tamara; Hutchinson, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge, England; [Citerio, Giuseppe] Univ Milan Bicocca Neurointens Care, San Gerardo Hosp, Sch Med & Surg, Dept Emergency & Intens Care,ASST Monza, Milan, Italy; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Robba, C (corresponding author), Univ Genoa, San Martino Policlin Hosp, IRCCS Oncol, Genoa, Italy.	kiarobba@gmail.com	Robba, Chiara/AAS-7421-2020; Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/E-9235-2018	Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069	NIHR Brain Injury Healthcare Technology Cooperative, Cambridge, United Kingdom; Woolf Fisher Scholarship (New Zealand); NIHR: Research Professorship, Neurotrauma	D.C. and M.C. are partially supported by the NIHR Brain Injury Healthcare Technology Cooperative, Cambridge, United Kingdom. J.D. is supported by a Woolf Fisher Scholarship (New Zealand). P.H. is supported by the NIHR: Research Professorship, Neurotrauma. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Robba C, 2016, BRIT J ANAESTH, V117, P783, DOI 10.1093/bja/aew356; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Robba C, 2018, J NEUROSCI RES, V96, P720, DOI 10.1002/jnr.24148; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	35	9	10	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2020	132	4					1279	1285		10.3171/2018.11.JNS182077			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KZ3SM	WOS:000523185100289	30849751				2022-02-06	
J	Sun, DD; Wang, JH; Liu, XL; Fan, YS; Yang, MC; Zhang, JN				Sun, Dongdong; Wang, Jianhao; Liu, Xilei; Fan, Yueshan; Yang, Mengchen; Zhang, Jianning			Dexmedetomidine attenuates endoplasmic reticulum stress-induced apoptosis and improves neuronal function after traumatic brain injury in mice	BRAIN RESEARCH			English	Article						Dexmedetomidine; Endoplasmic reticulum stress; Traumatic brain injury; Neuronal apoptosis; Neurological function	UNFOLDED PROTEIN RESPONSE; ER STRESS; EFFICACY; PATHWAY; ROLES	Traumatic brain injury (TBI) is one of the leading causes of mortality and disability worldwide. Emerging studies have shown that endoplasmic reticulum (ER) stress plays an important role in the pathophysiology of TBI. Dexmedetomidine (Dex), a highly selective alpha 2-adrenoreceptor agonist, has been shown to attenuate ER stress. However, there is no relevant research in the field of TBI. To study the effects of dexmedetomidine on TBI, we subjected mice to TBI with a controlled cortical impact (CCI) device. The expression levels of ER stress marker proteins and apoptosis-related proteins were evaluated by western blotting and immunofluorescence. Neuronal cell death was assessed by a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labelling (TUNEL) assay. Neurological and motor deficits were assessed by modified neurological severity scores (mNSSs) and beam balance and beam walking tests. Brain water content and EB leakage were also assessed. Our group found that ER stress was significantly activated 72 h after TBI. Dexmedetomidine significantly reduced ER stress and ER stress-related neuronal apoptosis induced by experimental TBI. In addition, dexmedetomidine significantly improved neurological function and alleviated brain oedema. These findings indicate that dexmedetomidine alleviates severe, post-traumatic ER stress and attenuates secondary brain damage.	[Sun, Dongdong; Wang, Jianhao; Liu, Xilei; Fan, Yueshan; Yang, Mengchen; Zhang, Jianning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Sun, Dongdong; Wang, Jianhao; Liu, Xilei; Fan, Yueshan; Yang, Mengchen; Zhang, Jianning] Minist Educ & Tianjin City, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China		Sun, DD; Zhang, JN (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	sundongdong0210@163.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501704, 81671902, 81370029]; Natural Science Foundation of TianjinNatural Science Foundation of Tianjin [17JCYBJC25200, 15JCQNJC44900]; Tianjin Medical University Excellent Teacher Teaching Research Fund	This work was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81501704, 81671902, and 81370029), the Natural Science Foundation of Tianjin (Grant Nos. 17JCYBJC25200 and 15JCQNJC44900) and the Tianjin Medical University Excellent Teacher Teaching Research Fund.	Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bejian S, 2009, CARDIOL YOUNG, V19, P98, DOI 10.1017/S1047951109003515; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.193; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Cuello-Carrion FD, 1999, J HISTOCHEM CYTOCHEM, V47, P837, DOI 10.1177/002215549904700614; Dash P.K., 2015, J NEUROTRAUM, V150; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Hetta DF, 2017, J PAIN RES, V10, P2621, DOI 10.2147/JPR.S145305; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Liu C, 2018, BRAIN RES, V1701, P246, DOI 10.1016/j.brainres.2018.09.007; Lucke-Wold BP, 2017, J NEUROTRAUM, V34, pS62, DOI 10.1089/neu.2016.4680; Mannelli LD, 2017, MINI-REV MED CHEM, V17, P95, DOI 10.2174/1389557516666160609065535; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Weerink MAS, 2017, CLIN PHARMACOKINET, V56, P893, DOI 10.1007/s40262-017-0507-7; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yin DP, 2018, BRAIN RES, V1698, P1, DOI 10.1016/j.brainres.2018.05.040; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang ZG, 2015, WORLD NEUROSURG, V83, DOI 10.1016/j.wneu.2014.12.036; Zhao ZL, 2016, J NEUROL SCI, V364, P12, DOI 10.1016/j.jns.2016.03.007	35	9	11	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 1	2020	1732								146682	10.1016/j.brainres.2020.146682			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB2IC	WOS:000524456200007	31991122				2022-02-06	
J	Wu, BW; Jazayeri, HE; Lee, KC; Khavanin, N; Dorafshar, AH; Peacock, ZS				Wu, Brendan W.; Jazayeri, Hossein E.; Lee, Kevin C.; Khavanin, Nima; Dorafshar, Amir H.; Peacock, Zachary S.			Characterizing Craniomaxillofacial Injuries in American Professional Sports Leagues	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							NATIONAL FOOTBALL LEAGUE; CONCUSSIONS; FRACTURES; BASEBALL; TRAUMA; GAMES	Purpose: The purpose of this study was to characterize the types of craniomaxillofacial (CMF) injuries that occur in professional sports leagues and the associated recovery times. Materials and Methods: A retrospective cohort study was designed and implemented using the Pro Sports Transaction Archive. The database was queried for all registered CMF injuries in the 4 main men's major professional sports leagues in the United States from 2013 to 2018. The sport, injury location, and season were the predictor variables, and the frequency and length of time on the injured list were the outcome variables. Descriptive statistics were computed, and Fisher's exact tests were used to determine the association between the predictor and outcome variables. Analysis of variance was used to compare the injury frequency and duration. Results: Of the 198 injuries that met the inclusion criteria, 60 were from Major League Baseball (MLB) (30%), 49 from the National Basketball Association (25%), 8 from the National Football League (4%), and 81 from the National Hockey League (NHL) (41%). Injuries to the midface were most common (mean, 25.2 +/- 3.6 injuries per season; P < .001) compared with the upper face (mean, 6.0 +/- 2.0 injuries per season) and lower face (mean, 8.4 +/- 2.3 injuries per season). The mean time on the injured list after CMF trauma was 8.4 +/- 10.4 days, with MLB injuries requiring the shortest duration (mean, 3.9 +/- 6.6 days; P = .001). A significant association was found between the injury location and sport (P < .001). However, no statistically significant difference was found in the number of injuries per season from 2013 to 2018 for each league (P = .818). Conclusions: Midface trauma was significantly more common than upper or lower face trauma in professional sports leagues during the past 5 seasons. The NHL had the greatest injury rate, even after adjustment for games played. (C) 2019 American Association of Oral and Maxillofacial Surgeons	[Wu, Brendan W.; Peacock, Zachary S.] Harvard Sch Dent Med, Boston, MA USA; [Jazayeri, Hossein E.] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Lee, Kevin C.] Columbia Univ, Irving Med Ctr, Div Oral & Maxillofacial Surg, New York Presbyterian, New York, NY USA; [Khavanin, Nima] Johns Hopkins Univ Hosp, Dept Plast & Reconstruct Surg, Baltimore, MD 21287 USA; [Dorafshar, Amir H.] Rush Univ, Div Plast & Reconstruct Surg, Med Ctr, Chicago, IL 60612 USA; [Peacock, Zachary S.] Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, 55 Fruit St,Warren 1201, Boston, MA 02114 USA		Peacock, ZS (corresponding author), Massachusetts Gen Hosp, Dept Oral & Maxillofacial Surg, 55 Fruit St,Warren 1201, Boston, MA 02114 USA.	zpeacock@partners.org	Dorafshar, Amir/AAP-2657-2021	Lee, Kevin/0000-0002-3079-1419			Azodo CC, 2011, INT DENT J, V61, P43, DOI 10.1111/j.1875-595X.2011.00009.x; Bak MJ, 2004, J ORAL MAXIL SURG, V62, P1209, DOI 10.1016/j.joms.2004.06.034; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; ENGELHARDT GM, 1995, PERCEPT MOTOR SKILL, V80, P416, DOI 10.2466/pms.1995.80.2.416; Ghosh R, 2018, J CRANIOFAC SURG, V29, pE334, DOI 10.1097/SCS.0000000000004269; Lee K, 2012, CRANIOMAX TRAUM REC, V5, P213, DOI 10.1055/s-0032-1322535; Leinhart J, 2017, CURR SPORT MED REP, V16, P23, DOI 10.1249/JSR.0000000000000329; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Manodh P, 2016, ORAL MAXILLOFAC SURG, V20, P377, DOI 10.1007/s10006-016-0576-z; Murphy C, 2015, J CRANIOFAC SURG, V26, P2120, DOI 10.1097/SCS.0000000000002109; Myrick KM, 2016, REHABIL NURS, V41, P197, DOI 10.1002/rnj.249; Rodriguez JO, 2003, AM FAM PHYSICIAN, V67, P1481; Samieirad S, 2017, MED ORAL PATOL ORAL, V22, pE616, DOI 10.4317/medoral.21809; Whatman C, 2018, PHYS THER SPORT, V32, P1, DOI 10.1016/j.ptsp.2018.01.011; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	18	9	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	APR	2020	78	4					588	593		10.1016/j.joms.2019.11.031			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KY5TT	WOS:000522636100025	31884077				2022-02-06	
J	Wu, M; Li, FL; Wu, YH; Zhang, TY; Gao, J; Xu, P; Luo, BY				Wu, Min; Li, Fali; Wu, Yuehao; Zhang, Tieying; Gao, Jian; Xu, Peng; Luo, Benyan			Impaired Frontoparietal Connectivity in Traumatic Individuals with Disorders of Consciousness: A Dynamic Brain Network Analysis	AGING AND DISEASE			English	Article						event-related potentials; consciousness; traumatic brain injury; frontoparietal network	EVENT-RELATED POTENTIALS; TOP-DOWN PROCESSES; FUNCTIONAL CONNECTIVITY; EMOTION REGULATION; RESTING STATE; NOVELTY P3; ATTENTION; STIMULI; SYSTEM; INJURY	Recent advances in neuroimaging have demonstrated that patients with disorders of consciousness (DOC) ma) retain residual consciousness through activation of a complex functional brain network. However, an understanding of the hierarch) of residual consciousness and dynamic network connectivity in DOC patients is lacking. This stud) aimed to investigate residual consciousness and the dynamics of neural processing in DOC patients. We included 42 patients with DOC, categorized b) aetiology. Event-related potentials combined with time-varying electroencephalograph) networks were used to probe affective consciousness in DOC and examine the related network mechanisms. The results showed an obvious frontal P3a component among patients in minimally conscious state (MCS), while a prominent N1 was observed in unresponsive wakefulness syndrome (UWS). No late positive potential (LPP) was detected in these patients. Next, we divided the results by aetiology. Patients with nontraumatic injury presented an obvious frontal P3a response compared to those with traumatic injury. With respect to the dynamic network mechanism, patients with UWS, both with and without trauma, exhibited impaired frontoparietal network connectivity during the middle to late emotion processing period (P3a and LPP). Surprisingly, unconscious post-traumatic patients had an evident deficit in top-down connectivity. This, it appears that earl) automatic sensor) identification is preserved in UWS and that exogenous attention was preserved even in MCS. However, high-level cognitive abilities were severe!) attenuated in unconscious patients. We also speculate that reduced frontoparietal connectivity ma) be useful as a biomarker to distinguish patients in an MCS from those with UWS given the same aetiology.	[Wu, Min; Wu, Yuehao; Zhang, Tieying; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Sch Med, Hangzhou, Peoples R China; [Wu, Min; Wu, Yuehao; Zhang, Tieying; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med, Hangzhou, Peoples R China; [Li, Fali; Xu, Peng] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Clin Hosp, Chengdu Brain Sci Inst, Chengdu, Peoples R China; [Gao, Jian] Hangzhou Hosp Zhejiang Armed Police Corps, Dept Rehabil, Hangzhou, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China.; Xu, P (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Chengdu, Peoples R China.	xupeng@uestc.edu.cn; luobenyan@zju.edu.cn			Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019-XZZX-001-01-02]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870817]	The authors thank all the patients and their families. The authors express appreciation to Professor Sun Yu in Zhejiang University for the helpful comments on revised versions of this manuscript. This work was supported by the Fundamental Research Funds for the Central Universities (2019-XZZX-001-01-02) and the National Natural Science Foundation of China (81870817).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Bayer M, 2018, BIOL PSYCHOL, V132, P133, DOI 10.1016/j.biopsycho.2017.12.002; Bodart O, 2018, BRAIN STIMUL, V11, P358, DOI 10.1016/j.brs.2017.11.006; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; Chennu S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00065; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Dennis TA, 2009, J CHILD PSYCHOL PSYC, V50, P1373, DOI 10.1111/j.1469-7610.2009.02168.x; Desatnik A, 2017, BIOL PSYCHOL, V129, P52, DOI 10.1016/j.biopsycho.2017.08.001; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Dien J, 2004, PSYCHOPHYSIOLOGY, V41, P665, DOI 10.1111/j.1469-8986.2004.00193.x; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Heitland I, 2013, BEHAV BRAIN RES, V249, P55, DOI 10.1016/j.bbr.2013.04.013; Huang ZR, 2014, HUM BRAIN MAPP, V35, P1997, DOI 10.1002/hbm.22308; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Iredale JM, 2013, INT J PSYCHOPHYSIOL, V89, P483, DOI 10.1016/j.ijpsycho.2013.06.025; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Law SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054396; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Li FL, 2016, IEEE T NEUR SYS REH, V24, P725, DOI 10.1109/TNSRE.2016.2523678; Machado C, 2002, NEUROLOGY, V59, P1473; MacNamara A, 2018, PSYCHOPHYSIOLOGY, V55; Moritz CH, 2005, NEUROLOGY, V65, P1843, DOI 10.1212/01.wnl.0000200030.64810.53; Morlet D, 2014, BRAIN TOPOGR, V27, P467, DOI 10.1007/s10548-013-0335-5; Morneau-Sevigny F, 2014, CAN J AGING, V33, P111, DOI 10.1017/S0714980814000063; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Omidvarnia A, 2014, IEEE T BIO-MED ENG, V61, P680, DOI 10.1109/TBME.2013.2286394; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Sanchez-Carmona AJ, 2016, NEUROIMAGE, V139, P279, DOI 10.1016/j.neuroimage.2016.06.043; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Si YJ, 2019, CEREB CORTEX, V29, P4119, DOI 10.1093/cercor/bhy294; Song M, 2018, ELIFE, V7, DOI 10.7554/eLife.36173; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tan XF, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101702; Vanhaudenhuyse A, 2008, NEUROCRIT CARE, V8, P262, DOI 10.1007/s12028-007-9016-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang Z, 2019, J NEUROTRAUM, P1557; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Wilke C, 2007, P ANN INT IEEE EMBS, P4949, DOI 10.1109/IEMBS.2007.4353451; Willis ML, 2010, NEUROIMAGE, V50, P329, DOI 10.1016/j.neuroimage.2009.11.071	58	9	10	3	9	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	APR	2020	11	2					301	314		10.14336/AD.2019.0606			14	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	KU9FE	WOS:000520029200007	32257543	Green Published, gold			2022-02-06	
J	Evans, LP; Woll, AW; Wu, S; Todd, BP; Hehr, N; Hedberg-Buenz, A; Anderson, MG; Newell, EA; Ferguson, PJ; Mahajan, VB; Harper, MM; Bassuk, AG				Evans, Lucy P.; Woll, Addison W.; Wu, Shu; Todd, Brittany P.; Hehr, Nicole; Hedberg-Buenz, Adam; Anderson, Michael G.; Newell, Elizabeth A.; Ferguson, Polly J.; Mahajan, Vinit B.; Harper, Matthew M.; Bassuk, Alexander G.			Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						anakinra; blast; IL-1; retina; visual function	TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; INDUCED OCULAR TRAUMA; MOUSE MODEL; HEAD-INJURY; PHASE-II; INTERLEUKIN-1; INFLAMMATION; DAMAGE; NEURODEGENERATION	The purpose of this study was to characterize acute changes in inflammatory pathways in the mouse eye after blast-mediated traumatic brain injury (bTBI) and to determine whether modulation of these pathways could protect the structure and function of retinal ganglion cells (RGC). The bTBI was induced in C57BL/6J male mice by exposure to three 20 psi blast waves directed toward the head with the body shielded, with an inter-blast interval of one hour. Acute cytokine expression in retinal tissue was measured through reverse transcription-quantitative polymerase chain reaction (RT-qPCR) four hours post-blast. Increased retinal expression of interleukin (lL)-1 beta, IL-1 alpha, IL-6, and tumor necrosis factor (TNF)alpha was observed in bTBI mice exposed to blast when compared with shams, which was associated with activation of microglia and macroglia reactivity, assessed via immunohistochemistry with ionized calcium binding adaptor molecule 1 and glial fibrillary acidic protein, respectively, one week post-blast. Blockade of the IL-1 pathway was accomplished using anakinra, an IL-1RI antagonist, administered intra-peritoneally for one week before injury and continuing for three weeks post-injury. Retinal function and RGC layer thickness were evaluated four weeks post-injury using pattern electroretinogram (PERG) and optical coherence tomography (OCT), respectively. After bTBI, anakinra treatment resulted in a preservation of RGC function and RGC structure when compared with saline treated bTBI mice. Optic nerve integrity analysis demonstrated a trend of decreased damage suggesting that IL-1 blockade also prevents axonal damage after blast. Blast exposure results in increased retinal inflammation including upregulation of pro-inflammatory cytokines and activation of resident microglia and macroglia. This may explain partially the RGC loss we observed in this model, as blockade of the acute inflammatory response after injury with the IL-1R1 antagonist anakinra resulted in preservation of RGC function and RGC layer thickness.	[Evans, Lucy P.; Wu, Shu; Todd, Brittany P.; Hehr, Nicole; Newell, Elizabeth A.; Ferguson, Polly J.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Evans, Lucy P.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Woll, Addison W.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Hedberg-Buenz, Adam; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Anderson, Michael G.; Harper, Matthew M.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Hedberg-Buenz, Adam; Anderson, Michael G.; Harper, Matthew M.] Iowa City Dept Vet Affairs Ctr Prevent & Treatmen, Iowa City, IA USA; [Mahajan, Vinit B.] Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst,Omics Lab, Palo Alto, CA 94304 USA; [Mahajan, Vinit B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA		Bassuk, AG (corresponding author), Univ Iowa, 200 Hawkins Dr, Iowa City, IA 52242 USA.; Harper, MM (corresponding author), Iowa City VA, Bldg 42 VAMC, Iowa City, IA 52242 USA.	matthew-harper@uiowa.edu; alexander-bassuk@uiowa.edu	; Anderson, Michael/B-4580-2009	Harper, Matthew/0000-0003-3395-2406; Anderson, Michael/0000-0001-5730-6105; Bassuk, Alexander/0000-0002-4067-2157	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY26682]; NIH/NIAMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR059703]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098590]; Department of Veterans AffairsUS Department of Veterans Affairs [RX000952]; Department of DefenseUnited States Department of Defense [W81XWH-14-1-0583]; Iowa City Center for the Prevention and Treatment of Visual Loss; NIH/NEI Center Support Grant [P30 EY025580];  [T32 DK112751-01]	AGB and VBM are supported by the NIH grant EY26682. PJF is funded by the NIH/NIAMS R01AR059703 and R01NS098590 NIH/NINDS. MMH is supported by the Department of Veterans Affairs grant RX000952, Department of Defense grant W81XWH-14-1-0583, and the Iowa City Center for the Prevention and Treatment of Visual Loss. AHB is supported by training grant T32 DK112751-01. Additional support was provided by NIH/NEI Center Support Grant to the University of Iowa (P30 EY025580).	Ahmad S, 2014, J NEUROIMMUNOL, V277, P96, DOI 10.1016/j.jneuroim.2014.10.006; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cho RI, 2009, J TRAUMA, V67, P516, DOI 10.1097/TA.0b013e3181a5f08d; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Clark SR, 2008, J CEREBR BLOOD F MET, V28, P387, DOI 10.1038/sj.jcbfm.9600537; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Crews FT, 2016, PSYCHOPHARMACOLOGY, V233, P1543, DOI 10.1007/s00213-015-3906-1; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; FAN L, 1995, MOL BRAIN RES, V30, P125; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Harder JM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0705-8; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P2716, DOI 10.1167/iovs.18-26353; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jha KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072016; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Mao M, 2011, INVEST OPHTH VIS SCI, V52, P2679, DOI 10.1167/iovs.10-5993; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mohan K, 2012, VET OPHTHALMOL, V15, P94, DOI 10.1111/j.1463-5224.2012.01034.x; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Scuderi S, 2015, J MOL NEUROSCI, V56, P431, DOI 10.1007/s12031-015-0505-x; Seibenhener ML, 2012, JOVE-J VIS EXP, DOI 10.3791/3634; Shedd DE, 2018, INVEST OPHTH VIS SCI, V59, P349, DOI 10.1167/iovs.17-21530; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	64	9	9	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1463	1480		10.1089/neu.2019.6725		MAR 2020	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525041300001	32056479	hybrid, Green Published			2022-02-06	
J	Di Battista, AP; Churchill, N; Rhind, SG; Richards, D; Hutchison, MG				Di Battista, Alex P.; Churchill, Nathan; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.			The relationship between symptom burden and systemic inflammation differs between male and female athletes following concussion	BMC IMMUNOLOGY			English	Article						Biomarkers; Inflammation; mTBI; Multivariate statistics; Immunity	TRAUMATIC BRAIN-INJURY; INDUCED SICKNESS BEHAVIOR; SPORTS-RELATED CONCUSSION; BASE-LINE; PITUITARY DYSFUNCTION; PERIPHERAL-BLOOD; SEX-DIFFERENCES; CYTOKINE; DEPRESSION; NEUROINFLAMMATION	Background Inflammation appears to be an important component of concussion pathophysiology. However, its relationship to symptom burden is unclear. Therefore, the purpose of this study was to evaluate the relationship between symptoms and inflammatory biomarkers measured in the blood of male and female athletes following a sport-related concussion (SRC). Results Forty athletes (n = 20 male, n = 20 female) from nine interuniversity sport teams at a single institution provided blood samples within one week of an SRC. Twenty inflammatory biomarkers were quantitated by immunoassay. The Sport Concussion Assessment Tool version 5 (SCAT-5) was used to evaluate symptoms. Partial least squares (PLS) analyses were used to evaluate the relationship(s) between biomarkers and symptoms. In males, a positive correlation between interferon (IFN)-gamma and symptom severity was observed following SRC. The relationship between IFN-gamma and symptoms was significant among all symptom clusters, with cognitive symptoms displaying the largest effect. In females, a significant negative relationship was observed between symptom severity and cytokines IFN-gamma, tumor necrosis factor (TNF)-alpha, and myeloperoxidase (MPO); a positive relationship was observed between symptom severity and MCP-4. Inflammatory mediators were significantly associated with all symptom clusters in females; the somatic symptom cluster displayed the largest effect. Conclusion These results provide supportive evidence of a divergent relationship between inflammation and symptom burden in male and female athletes following SRC. Future investigations should be cognizant of the potentially sex-specific pathophysiology underlying symptom presentation.	[Di Battista, Alex P.; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, 55 Harbord St, Toronto, ON M5S 2W6, Canada; [Di Battista, Alex P.; Rhind, Shawn G.] Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada; [Churchill, Nathan] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Program, Toronto, ON, Canada; [Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, Toronto, ON, Canada; [Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada		Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, 55 Harbord St, Toronto, ON M5S 2W6, Canada.; Di Battista, AP (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada.	dibattista.alex@gmail.com		Rhind, Shawn/0000-0003-2300-0620; Di Battista, Alex/0000-0002-3325-6833	Canadian Institute of Military and Veterans Health Research and Defence Research and Development Canada	This study was funded by the Canadian Institute of Military and Veterans Health Research and Defence Research and Development Canada.	Borrow AP, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12403; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chaireti R, 2016, SCAND J CLIN LAB INV, V76, P190, DOI 10.3109/00365513.2015.1129670; Chancellor SE, 2019, SEMIN PEDIATR NEUROL, V30, P14, DOI 10.1016/j.spen.2019.03.004; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Di Battista AP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54923-3; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Ebert SE, 2019, EUR J NEUROL, V26, P1426, DOI 10.1111/ene.13971; Elenkov IJ, 1999, BEST PRACT RES CL EN, V13, P583, DOI 10.1053/beem.1999.0045; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Engler H, BRAIN BEHAV IMMUN; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harrison NA, 2009, BIOL PSYCHIAT, V66, P415, DOI 10.1016/j.biopsych.2009.03.007; Heck AL, 2019, NEUROPSYCHOPHARMACOL, V44, P45, DOI 10.1038/s41386-018-0167-9; Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Kelley KW, 2007, BRAIN BEHAV IMMUN, V21, P384, DOI 10.1016/j.bbi.2006.11.010; Kim YK, 2016, PROG NEURO-PSYCHOPH, V64, P277, DOI 10.1016/j.pnpbp.2015.06.008; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA486, DOI 10.1016/j.autrev.2011.11.023; Oyola MG, 2016, SEX DIFFERENCES IN THE CENTRAL NERVOUS SYSTEM, P325, DOI 10.1016/B978-0-12-802114-9.00013-5; Qu P, 2018, PAIN PRACT, V18, P8, DOI 10.1111/papr.12574; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Sikora J, 2015, CYTOKINE, V76, P117, DOI 10.1016/j.cyto.2015.08.007; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Spennati A, 2013, PSYCHOL MED, V43, P1127, DOI 10.1017/S0033291712001808; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Vizi ES, 2002, ACTA BIOL HUNG, V53, P229, DOI 10.1556/ABiol.53.2002.1-2.21; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914	69	9	9	3	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2172		BMC IMMUNOL	BMC Immunol.	MAR 12	2020	21	1							11	10.1186/s12865-020-0339-3			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	KV4NB	WOS:000520457800001	32164571	Green Submitted, Green Published, gold			2022-02-06	
J	Ghai, V; Fallen, S; Baxter, D; Scherler, K; Kim, TK; Zhou, Y; Meabon, JS; Logsdon, AF; Banks, WA; Schindler, AG; Cook, DG; Peskind, ER; Lee, I; Wang, K				Ghai, Vikas; Fallen, Shannon; Baxter, David; Scherler, Kelsey; Kim, Taek-Kyun; Zhou, Yong; Meabon, James S.; Logsdon, Aric F.; Banks, William A.; Schindler, Abigail G.; Cook, David G.; Peskind, Elaine R.; Lee, Inyoul; Wang, Kai			Alterations in Plasma microRNA and Protein Levels in War Veterans with Chronic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; EVs; miRNAs; mTBI; veterans	POSTTRAUMATIC-STRESS-DISORDER; BLAST EXPOSURE; CIRCULATING MICRORNAS; APOLIPOPROTEIN-E; AMYLOID-BETA; BIOMARKERS; DIAGNOSIS; CELLS; RISK; PTSD	Blast-related mild traumatic brain injury (mTBI) is considered the "signature" injury of the wars in Iraq and Afghanistan. Identifying biomarkers that could aid in diagnosis and assessment of chronic mTBI are urgently needed, as little progress has been made toward identifying blood-based biomarkers of repetitive mTBI in the chronic state. Addressing this knowledge gap is especially important in the population of military veterans who are receiving assessment and care often years after their last exposure. Circulating microRNAs (miRNAs), especially those encapsulated in extracellular vesicles (EVs), have gained interest as a source of biomarkers for neurological conditions. To identify biomarkers for chronic mTBI, we used next generation sequencing (NGS) to analyze miRNAs in plasma and plasma-derived EVs from 27 Iraq and Afghanistan war veterans with blast-related chronic mTBI, 11 deployed veteran non-TBI controls, and 31 civilian controls. We identified 32 miRNAs in plasma and 45 miRNAs in EVs that significantly changed in the chronic mTBI cohort compared with control groups. These miRNAs were predominantly associated with pathways involved in neuronal function, vascular remodeling, blood-brain barrier integrity, and neuroinflammation. In addition, the plasma proteome was analyzed and showed that the concentrations of C-reactive protein (CRP) and membrane metalloendopeptidase (MME) were elevated in chronic mTBI samples. These plasma miRNAs and proteins could potentially be used as biomarkers and provide insights into the molecular processes associated with the long-term health outcomes associated with blast-related chronic mTBI.	[Ghai, Vikas; Fallen, Shannon; Baxter, David; Scherler, Kelsey; Kim, Taek-Kyun; Zhou, Yong; Lee, Inyoul; Wang, Kai] Inst Syst Biol, 401 Terry Ave North, Seattle, WA 98109 USA; [Meabon, James S.; Peskind, Elaine R.] VA Puget Sound Hlth Care Syst VAPSHCS, Vet Affairs Northwest Network Mental Illness, Res Educ & Clin Ctr, Seattle, WA USA; [Logsdon, Aric F.; Banks, William A.; Schindler, Abigail G.; Cook, David G.] VA Puget Sound Hlth Care Syst VAPSHCS, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Meabon, James S.; Schindler, Abigail G.; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Logsdon, Aric F.; Banks, William A.; Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA		Wang, K (corresponding author), Inst Syst Biol, 401 Terry Ave North, Seattle, WA 98109 USA.	Kai.wang@isbscience.org	Banks, William A/K-1330-2017; Ghai, Vikas/L-1734-2018	Banks, William A/0000-0002-0496-3619; Ghai, Vikas/0000-0003-1968-7060	Department of Defeuse (DoD)United States Department of Defense [W81XWH-16-1-0301, W911NF-17-2-0086]; Defense Threat Reduction Agency (DTRA)United States Department of DefenseDefense Threat Reduction Agency [HDTRA1-13-C-0055]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HL126496-02, R56HL133887, U01CA213330, R01DA040395]; Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review GrantUS Department of Veterans Affairs [B77421]; Department of Veterans Affairs Office of Research and Development Medical Research Service grant RDISUS Department of Veterans Affairs [0005]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service (BLRD) grantUS Department of Veterans Affairs [IK2 BX003258, R01AG046619, T32AG052354]; VA Puget Sound Health Care System Seed GrantUS Department of Veterans Affairs; Brain Injury Law of Seattle	This work is supported by research contracts from Department of Defeuse (DoD) W81XWH-16-1-0301 and W911NF-17-2-0086 (Dr. Wang) and Defense Threat Reduction Agency (DTRA) HDTRA1-13-C-0055 (Dr. Wang), and National Institutes of Health (NIH) grants U01HL126496-02, R56HL133887, U01CA213330, and R01DA040395 (Dr. Wang) as well as by Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review Grant #B77421 (Dr. Peskind), Department of Veterans Affairs Office of Research and Development Medical Research Service grant RDIS#0005 (Dr. Cook), Department of Veterans Affairs Biomedical Laboratory Research and Development Service (BLR&D) grant IK2 BX003258 (Dr. Schindler), R01AG046619 (Dr. Banks), T32AG052354 (Dr. Logsdon), and VA Puget Sound Health Care System Seed Grant (Dr. Meabon). We also thank Brain Injury Law of Seattle for their financial contributions.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Agoston D, 2017, J NEUROTRAUM, V34, pS6, DOI 10.1089/neu.2017.5220; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Alfano D, 2015, J CELL MOL MED, V19, P2262, DOI 10.1111/jcmm.12617; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cardo LF, 2013, J NEUROL, V260, P1420, DOI 10.1007/s00415-013-6900-8; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Cernak I, 1991, Vojnosanit Pregl, V48, P515; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Dean K.R., 2019, MOL PSYCHIAT; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Deslauriers J, 2017, CURR OPIN BEHAV SCI, V14, P123, DOI 10.1016/j.cobeha.2017.01.005; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Ghai V, 2016, ARCH TOXICOL, V90, P2959, DOI 10.1007/s00204-016-1828-2; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Hendrickson RC, 2018, NEUROBIOL STRESS, V8, P103, DOI 10.1016/j.ynstr.2018.03.001; Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428; HIXSON JE, 1990, J LIPID RES, V31, P545; Hsieh JY, 2013, NUCLEIC ACIDS RES, V41, P9753, DOI 10.1093/nar/gkt666; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lee MY, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070963; Li YF, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.09.004; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055108, 10.1371/journal.pone.0054369, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648]; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Long JT, 2016, TUMOR BIOL, V37, P5821, DOI 10.1007/s13277-015-4427-6; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Muller AH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1341-7; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Pagulayan K.F., 2018, BRAIN IMAGING BEHAV; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Papa L., 2015, BRAIN NEUROTRAUMA MO, P299; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sleddering MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112835; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Sun E, 2015, EXP NEUROL, V268, P46, DOI 10.1016/j.expneurol.2014.08.005; Tanriverdi F, 2015, J CLIN MED, V4, P847, DOI 10.3390/jcm4050847; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; VANNESTE Y, 1988, BIOCHEM J, V254, P531, DOI 10.1042/bj2540531; Wong KY, 2011, BRIT J HAEMATOL, V154, P569, DOI 10.1111/j.1365-2141.2011.08782.x; Wu DS, 2015, J CEREBR BLOOD F MET, V35, P412, DOI 10.1038/jcbfm.2014.207; Wu X, 2017, NUCLEIC ACIDS RES, V45, P12140, DOI 10.1093/nar/gkx999; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhu J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.361	93	9	9	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1418	1430		10.1089/neu.2019.6826		MAR 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525037700001	32024417	Green Published			2022-02-06	
J	Tensaouti, Y; Yu, TS; Kernie, SG				Tensaouti, Yacine; Yu, Tzong-Shiue; Kernie, Steven G.			Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury	PLOS ONE			English	Article							E KNOCKOUT MICE; ABERRANT NEUROGENESIS; ALZHEIMERS-DISEASE; APOE; ALLELE; MEMORY; SYNAPTOGENESIS; PROLIFERATION; ABNORMALITIES; ASSOCIATION	Various brain injuries lead to the activation of adult neural stem/progenitor cells in the mammalian hippocampus. Subsequent injury-induced neurogenesis appears to be essential for at least some aspects of the innate recovery in cognitive function observed following traumatic brain injury (TBI). It has previously been established that Apolipoprotein E (ApoE) plays a regulatory role in adult hippocampal neurogenesis, which is of particular interest as the presence of the human ApoE isoform ApoE4 leads to significant risk for the development of late-onset Alzheimer's disease, where impaired neurogenesis has been linked with disease progression. Moreover, genetically modified mice lacking ApoE or expressing the ApoE4 human isoform have been shown to impair adult hippocampal neurogenesis under normal conditions. Here, we investigate how controlled cortical impact (CCI) injury affects dentate gyrus development using hippocampal stereotactic injections of GFP-expressing retroviruses in wild-type (WT), ApoE-deficient and humanized (ApoE3 and ApoE4) mice. Infected adult-born hippocampal neurons were morphologically analyzed once fully mature, revealing significant attenuation of dendritic complexity and spine density in mice lacking ApoE or expressing the human ApoE4 allele, which may help inform how ApoE influences neurological diseases where neurogenesis is defective.	[Tensaouti, Yacine; Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Kernie, Steven G.] Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10027 USA		Kernie, SG (corresponding author), Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Kernie, SG (corresponding author), Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.	sk3516@cumc.columbia.edu	Kernie, Steven/AAT-9912-2020	Tensaouti, Yacine/0000-0001-6475-3245; Yu, Tzong-Shiue/0000-0003-4277-6213; Kernie, Steven/0000-0003-1371-0549	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS095803, R56NS089523]	This work was supported by the National Institutes of Health grants R01 NS095803 (sgk) and R56NS089523 (sgk) who played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Arredondo A, 2018, BRAIN STRUCT FUNCT, V223, P2859, DOI 10.1007/s00429-018-1664-7; Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Ceanga M, 2019, J NEUROSCI, V39, P1755, DOI 10.1523/JNEUROSCI.3303-17.2018; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Chung WS, 2016, P NATL ACAD SCI USA, V113, P10186, DOI 10.1073/pnas.1609896113; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Danzer Steve C, 2018, Brain Plast, V3, P169, DOI 10.3233/BPL-170056; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Dickstein DL, 2016, CURR PROTOC NEUROSCI, V77; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; East BS, 2018, NEUROSCIENCE, V380, P103, DOI 10.1016/j.neuroscience.2018.04.009; Fuentes D, 2018, BEHAV SCI, V8, DOI 10.3390/bs8030033; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Grootendorst J, 2001, NEUROSCIENCE, V108, P237, DOI 10.1016/S0306-4522(01)00412-2; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hollands C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00178; Hong S, 2016, J NEUROTRAUM, V33, P362, DOI 10.1089/neu.2014.3860; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059478; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim Hae-Young, 2015, Restor Dent Endod, V40, P172, DOI 10.5395/rde.2015.40.2.172; Koizumi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06301-2; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Mamotte CDS, 1999, AM J PHYSIOL-ENDOC M, V276, pE553, DOI 10.1152/ajpendo.1999.276.3.E553; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; Peister A, 2006, EXP NEUROL, V201, P266, DOI 10.1016/j.expneurol.2006.03.023; Peng KY, 2017, NEUROSCIENCE, V343, P364, DOI 10.1016/j.neuroscience.2016.12.004; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Pfrieger FW, 2002, CURR OPIN NEUROBIOL, V12, P486, DOI 10.1016/S0959-4388(02)00358-6; Pugh P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00045; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Salomon-Zimri Shiran, 2015, Alzheimers Dement (Amst), V1, P127, DOI 10.1016/j.dadm.2014.11.014; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tensaouti Y, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0155-18.2018; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Toni N., 2015, COLD SPRING HARB PER, V8, DOI 10.1101/cshperspect.a018903.; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang SB, 2018, J NEUROSCI, V38, P137, DOI 10.1523/JNEUROSCI.0988-17.2017; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583	71	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229240	10.1371/journal.pone.0229240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	WOS:000535245300017	32119690	Green Published, gold			2022-02-06	
J	Charek, DB; Elbin, RJ; Sufrinko, A; Schatz, P; D'Amico, NR; Collins, MW; Kontos, AP				Charek, Daniel B.; Elbin, R. J.; Sufrinko, Alicia; Schatz, Philip; D'Amico, Nathan R.; Collins, Michael W.; Kontos, Anthony P.			Preliminary Evidence of a Dose-Response for Continuing to Play on Recovery Time After Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; head injury; ImPACT; pediatric athletes; protracted recovery; risk factors; sport-related concussion	TEST-RETEST RELIABILITY; SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; ONLINE VERSION; UP-REGULATION; BASE-LINE; IMPACT; SPORTS; STATEMENT; SYMPTOMS	Objective: To investigate a dose-response relationship between continuing to play following concussion and outcomes. Participants: A total of 130 athletes (age 11-19 years). Design: Repeated-measures design comparing symptoms, neurocognitive performance, and recovery time between 52 athletes immediately removed from play (Removed), 24 who continued to play for 15 minutes or less (Short-Play), and 32 who continued to play for more than 15 minutes (Long-Play). Main Measures: Recovery was the number of days from injury to clearance. Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) measured neurocognitive outcomes and the Post-Concussion Symptom Scale (PCSS) measured symptom severity. Results: Long-Play (44.09 +/- 27.01 days) took longer to recover than Short-Play (28.42 +/- 12.74 days) and Removed (18.98 +/- 13.76 days). Short-Play was 5.43 times more likely, and Long-Play 11.76 times more likely, to experience protracted recovery relative to Removed. Both Play groups had worse neurocognitive performance and higher symptom scores than Removed at days 1 to 7, with Long-Play demonstrating worse reaction time than Short-Play. At days 8 to 30, both Play groups performed worse than Removed on visual memory and visual motor speed, while only Long-Play performed worse on verbal memory and reaction time. Conclusions: Results provide initial evidence of a dose-response effect for continuing to play on recovery from concussion, highlighting the importance of removal from play.	[Charek, Daniel B.; Sufrinko, Alicia; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA; [Elbin, R. J.; D'Amico, Nathan R.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu			National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]	This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Dr Kontos.	[Anonymous], 2006, IMM POSTC ASS COGN T; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; IBM Corp, 2012, IBM SPSS STAT WIND; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Youth CoS-RCi, 2013, SPORTS RELATED CONCU	35	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		85	91		10.1097/HTR.0000000000000476			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500002	31033740	Bronze, Green Accepted			2022-02-06	
J	Clark, JM; Adanty, K; Post, A; Hoshizaki, TB; Clissold, J; McGoldrick, A; Hill, J; Annaidh, AN; Gilchrist, MD				Clark, J. Michio; Adanty, Kevin; Post, Andrew; Hoshizaki, T. Blaine; Clissold, Jonathan; McGoldrick, Adrian; Hill, Jerry; Annaidh, Aisling Ni; Gilchrist, Michael D.			Proposed injury thresholds for concussion in equestrian sports	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head impact biomechanics; Brain injury; Accident reconstruction; Equestrian helmet	TRAUMATIC BRAIN-INJURY; VIDEO ANALYSIS; IMPACTS; RECONSTRUCTION; PREDICTORS; FOOTBALL; FRANCE	Objectives: Equestrian helmets are designed to pass certification standards based on linear drop tests onto rigid steel surfaces. However, concussions in equestrian sports occur most commonly when a rider is thrown off a horse and obliquely impacts a compliant surface such as turf or sand. This paper seeks to elucidate the mechanics of such impacts and thereby propose corresponding thresholds for the occurrence of concussion that can improve equestrian helmet standards and designs. Design: The present study examined the biomechanics of real-world equestrian accidents and developed thresholds for the occurrence of concussive injury. Methods: Twenty-five concussive and 25 non-concussive falls in equestrian sports were reconstructed using a combination of video analysis, computational and physical reconstruction methods. These represented male and female accidents from horse racing and the cross-country phase of eventing. Results: The resulting thresholds for concussion [59 g, 2700 rad/s(2), 28 rad/s, 0.24 (MPS), 6.6 kPa and 0.27 (CSMD10) for 50% risk] were consistent with those reported in the literature and represent a unique combination of head kinematic thresholds compared to other sports. Current equestrian helmet standards commonly use a threshold of 250 g and a linear drop to a steel anvil resulting in less than 15 ms impacts. This investigation found that concussive equestrian accidents occurred from oblique impacts to turf or sand with lower magnitude and longer duration impacts (<130 g and >20 ms). This suggests that current equestrian helmet standards may not adequately represent real-world concussive impact conditions and, consequently, there is an urgent need to assess the protective capacity of equestrian helmets under real-world conditions. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd.	[Clark, J. Michio; Post, Andrew; Annaidh, Aisling Ni; Gilchrist, Michael D.] Univ Coll Dublin Belfield, Sch Mech & Mat Engn, Dublin, Ireland; [Adanty, Kevin; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada; [Post, Andrew] St Michaels Hosp, Toronto, ON, Canada; [Clissold, Jonathan] British Eventing, Kenilworth, Warwick, England; [McGoldrick, Adrian] Irish Horseracing Regulatory Board, The Curragh, Kildare, Ireland; [Hill, Jerry] British Horseracing Author, London, England		Gilchrist, MD (corresponding author), Univ Coll Dublin Belfield, Sch Mech & Mat Engn, Dublin, Ireland.; Gilchrist, MD (corresponding author), Univ Ottawa, Sch Human Kinet, Fac Hlth Sci, Ottawa, ON, Canada.	michael.gilchrist@ucd.ie	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	European UnionEuropean Commission [642662]	This research received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642662. Helmets for this work were supplied by Charles Owen.	[Anonymous], 2016, 13842016 EN; [Anonymous], 2011, PAS0152011; ASTM F1163-15, 2015, F116315 ASTM; Bak K., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P148; BOND GR, 1995, PEDIATRICS, V95, P487; Bourdet N., 2015, P IRCOBI C LYON FRAN, P156; Clark JM, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1599062; Cullen S, 2016, J SCI MED SPORT, V19, P283, DOI 10.1016/j.jsams.2015.05.001; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Forero Rueda MA, 2007, STARSS C; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; O'Connor S., 2017, J SCI MED SPORT, V20, P20, DOI [10.1016/j.jsams.2017.09.228, DOI 10.1016/J.JSAMS.2017.09.228]; Oeur RA, 2019, INT J CRASHWORTHINES, V24, P326, DOI 10.1080/13588265.2018.1441617; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Smartt P, 2009, J SCI MED SPORT, V12, P376, DOI 10.1016/j.jsams.2008.04.001; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	30	9	9	2	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2020	23	3					222	236		10.1016/j.jsams.2019.10.006			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KR5OW	WOS:000517668700004	31690492	hybrid			2022-02-06	
J	Clement, T; Lee, JB; Ichkova, A; Rodriguez-Grande, B; Fournier, ML; Aussudre, J; Ogier, M; Haddad, E; Canini, F; Koehl, M; Abrous, DN; Obenaus, A; Badaut, J				Clement, Tifenn; Lee, Jeong B.; Ichkova, Aleksandra; Rodriguez-Grande, Beatriz; Fournier, Marie-Line; Aussudre, Justine; Ogier, Michael; Haddad, Elizabeth; Canini, Frederic; Koehl, Muriel; Abrous, Djoher Nora; Obenaus, Andre; Badaut, Jerome			Juvenile mild traumatic brain injury elicits distinct spatiotemporal astrocyte responses	GLIA			English	Article						histology; MRI; neuroinflammation; traumatic brain injury	DIFFUSION; SEGMENTATION; OPTIMIZATION; REGISTRATION; OUTCOMES; GLIOSIS; MODELS; SYSTEM; ROBUST	Mild-traumatic brain injury (mTBI) represents ~80% of all emergency room visits and increases the probability of developing long-term cognitive disorders in children. To date, molecular and cellular mechanisms underlying post-mTBI cognitive dysfunction are unknown. Astrogliosis has been shown to significantly alter astrocytes' properties following brain injury, potentially leading to significant brain dysfunction. However, such alterations have never been investigated in the context of juvenile mTBI (jmTBI). A closed-head injury model was used to study jmTBI on postnatal-day 17 mice. Astrogliosis was evaluated using glial fibrillary acidic protein (GFAP), vimentin, and nestin immunolabeling in somatosensory cortex (SSC), dentate gyrus (DG), amygdala (AMY), and infralimbic area (ILA) of prefrontal cortex in both hemispheres from 1 to 30 days postinjury (dpi). In vivo T2-weighted-imaging (T2WI) and diffusion tensor imaging (DTI) were performed at 7 and 30 dpi to examine tissue level structural alterations. Increased GFAP-labeling was observed up to 30 dpi in the ipsilateral SSC, the initial site of the impact. However, vimentin and nestin expression was not perturbed by jmTBI. The morphology of GFAP positive cells was significantly altered in the SSC, DG, AMY, and ILA up to 7 dpi that some correlated with magnetic resonance imaging changes. T2WI and DTI values were significantly altered at 30 dpi within these brain regions most prominently in regions distant from the impact site. Our data show that jmTBI triggers changes in astrocytic phenotype with a distinct spatiotemporal pattern. We speculate that the presence and time course of astrogliosis may contribute to pathophysiological processes and long-term structural alterations following jmTBI.	[Clement, Tifenn; Ichkova, Aleksandra; Rodriguez-Grande, Beatriz; Fournier, Marie-Line; Aussudre, Justine; Badaut, Jerome] Univ Bordeaux, CNRS, UMR5287, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Lee, Jeong B.; Obenaus, Andre; Badaut, Jerome] Loma Linda Univ, Sch Med, Dept Physiol, Basic Sci, Loma Linda, CA 92350 USA; [Ogier, Michael; Canini, Frederic] Inst Rech Biomed Armees, Dept Neurosci & Sci Cognit, Bretigny Sur Orge, France; [Koehl, Muriel; Abrous, Djoher Nora] INSERM, U1215, Neuroctr Magendie, Bordeaux, France; [Haddad, Elizabeth; Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA		Badaut, J (corresponding author), Univ Bordeaux, CNRS, UMR5287, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	jerome.badaut@u-bordeaux.fr	Koehl, Muriel/C-3698-2011; Koehl, Muriel/ABI-2043-2020	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Haddad, Elizabeth/0000-0002-7622-9085; abrous, nora/0000-0002-8589-305X; Clement, Tifenn/0000-0003-4634-5955; Fournier, Marie-Line/0000-0001-7183-8132			Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barry JM, 2015, EXP NEUROL, V269, P242, DOI 10.1016/j.expneurol.2015.04.015; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Blochet C, 2020, J CEREBR BLOOD F MET, V40, P163, DOI 10.1177/0271678X18806893; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; Choy M, 2014, J NEUROSCI, V34, P8672, DOI 10.1523/JNEUROSCI.4806-13.2014; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Garbuzova-Davis S, 2014, J COMP NEUROL, V522, P3120, DOI 10.1002/cne.23582; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Huang L, 2016, MED GAS RES, V6, P187, DOI 10.4103/2045-9912.196900; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jure I, 2017, NEUROCHEM RES, V42, P2178, DOI 10.1007/s11064-017-2225-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Richards K, 2011, NEUROIMAGE, V58, P732, DOI 10.1016/j.neuroimage.2011.06.025; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Rodriguez-Grande B, 2013, BRAIN BEHAV IMMUN, V29, P51, DOI 10.1016/j.bbi.2012.11.017; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Ullmann JFP, 2013, NEUROIMAGE, V78, P196, DOI 10.1016/j.neuroimage.2013.04.008; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wendel KM, 2019, J NEUROTRAUM, V36, P152, DOI 10.1089/neu.2018.5670; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	53	9	10	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAR	2020	68	3					528	542		10.1002/glia.23736			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KB7XI	WOS:000506703000005	31670865				2022-02-06	
J	Dandachi-FitzGerald, B; Duits, AA; Leentjens, AFG; Verhey, FRJ; Ponds, RWHM				Dandachi-FitzGerald, Brechje; Duits, Annelien A.; Leentjens, Albert F. G.; Verhey, Frans R. J.; Ponds, Rudolf W. H. M.			Performance and Symptom Validity Assessment in Patients with Apathy and Cognitive Impairment	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Symptom validity; Mild cognitive impairment; Dementia; Parkinson's disease; Test of Memory Malingering (TOMM); Structured Inventory of Malingered Symptomatology (SIMS); Dot Counting Test (DCT)	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; STRUCTURED-INVENTORY; ISSUES; TESTS; DEMENTIA; DISEASE; ADULTS; RATES; SIMS	Objective: Performance and symptom validity tests (PVTs and SVTs) measure the credibility of the assessment results. Cognitive impairment and apathy potentially interfere with validity test performance and may thus lead to an incorrect (i.e., false-positive) classification of the patient's scores as non-credible. The study aimed at examining the false-positive rate of three validity tests in patients with cognitive impairment and apathy. Methods: A cross-sectional, comparative study was performed in 56 patients with dementia, 41 patients with mild cognitive impairment, and 41 patients with Parkinson's disease. Two PVTs - the Test of Memory Malingering (TOMM) and the Dot Counting Test (DCT) - and one SVT - the Structured Inventory of Malingered Symptomatology (SIMS) - were administered. Apathy was measured with the Apathy Evaluation Scale, and severity of cognitive impairment with the Mini Mental State Examination. Results: The failure rate was 13.7% for the TOMM, 23.8% for the DCT, and 12.5% for the SIMS. Of the patients with data on all three tests (n = 105), 13.5% failed one test, 2.9% failed two tests, and none failed all three. Failing the PVTs was associated with cognitive impairment, but not with apathy. Failing the SVT was related to apathy, but not to cognitive impairment. Conclusions: In patients with cognitive impairment or apathy, failing one validity test is not uncommon. Validity tests are differentially sensitive to cognitive impairment and apathy. However, the rule that at least two validity tests should be failed to identify non-credibility seemed to ensure a high percentage of correct classification of credibility.	[Dandachi-FitzGerald, Brechje] Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol Sci, POB 616, NL-6200 MD Maastricht, Netherlands; [Duits, Annelien A.; Leentjens, Albert F. G.; Verhey, Frans R. J.; Ponds, Rudolf W. H. M.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol, POB 5800, NL-6202 AZ Maastricht, Netherlands		Dandachi-FitzGerald, B (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol Sci, POB 616, NL-6200 MD Maastricht, Netherlands.	b.fitzgerald@maastrichtuniversity.nl	Dandachi-FitzGerald, B/I-4918-2012	Dandachi-FitzGerald, B/0000-0002-8984-8192; ponds, rudolf/0000-0002-9748-4659			Aalten P, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0254-4; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2013, IEEE T POWER ELECTR, V28, P135, DOI DOI 10.1093/ARCLIN/ACS109; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Boone K.B., 2013, CLIN PRACTICE FORENS, P22; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Clarke DE, 2007, J NEUROPSYCH CLIN N, V19, P57, DOI 10.1176/appi.neuropsych.19.1.57; Dandachi-FitzGerald B, 2016, PSYCHIAT RES, V239, P47, DOI 10.1016/j.psychres.2016.02.061; Davis JJ, 2018, J CLIN EXP NEUROPSYC, V40, P1013, DOI 10.1080/13803395.2018.1472221; Dorociak KE, 2018, CLIN NEUROPSYCHOL, V32, P81, DOI 10.1080/13854046.2017.1339830; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hirst RB, 2017, ARCH CLIN NEUROPSYCH, V32, P456, DOI 10.1093/arclin/acx009; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2015, AM PSYCHOL, V70, P779, DOI 10.1037/a0039835; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2004, DOI 10.1002/mds.22229; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; McGuire C, 2019, ARCH CLIN NEUROPSYCH, V34, P114, DOI 10.1093/arclin/acy012; Merckelbach H, 2003, ARCH CLIN NEUROPSYCH, V18, P145, DOI 10.1016/S0887-6177(01)00191-3; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Merten Thomas, 2013, Clínica y Salud, V24, P129, DOI 10.5093/cl2013a14; Pluck GC, 2002, J NEUROL NEUROSUR PS, V73, P636, DOI 10.1136/jnnp.73.6.636; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Rossetti MA, 2018, ARCH CLIN NEUROPSYCH, V33, P508, DOI 10.1093/arclin/acx081; Tombaugh T.N., 2006, TEST MEMORY MALINGER; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682	36	9	9	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2020	26	3					314	321	PII S1355617719001139	10.1017/S1355617719001139			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	LC6YL	WOS:000525479400007	31658930	hybrid			2022-02-06	
J	Kroshus, E; Chrisman, SPD; Milroy, JJ; Baugh, CM				Kroshus, Emily; Chrisman, Sara P. D.; Milroy, Jeffrey J.; Baugh, Christine M.			History of Concussion Diagnosis, Differences in Concussion Reporting Behavior, and Self-Described Reasons for Non-Report	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						athlete; concussion; injury; reporting	TRAUMATIC BRAIN-INJURY; DECISION-MAKING; NORMS; RISK; MOTIVATIONS; KNOWLEDGE; EDUCATION; RATES	Purpose: Assess whether athletes with a prior concussion diagnosis are more likely to continue play with a possible concussion. Additionally, explore whether reasons for concussion under-reporting are different among athletes with a prior concussion when compared to other athletes. Methods: Cross-sectional survey of 328 collegiate athletes. Results: Athletes with a prior concussion diagnosis had significantly greater relative risk of continuing play while symptomatic of a possible concussion during their most recent season compared to athletes without prior concussion diagnosis. Significant differences exist in the reasons that athletes provided for not reporting by history of concussion. Conclusions: Findings suggest that learning may have occurred as a result of the prior diagnosis; however, this learning did not appear to result in safer reporting behavior. Additional research is necessary to clarify why athletes who have been previously diagnosed with a concussion are more likely to continue playing while experiencing concussion symptoms.	[Kroshus, Emily; Chrisman, Sara P. D.] Univ Washington, Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Dept Pediat,Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Milroy, Jeffrey J.] Univ North Carolina Greensboro, Dept Publ Hlth Educ, Inst Promote Athlete Hlth & Wellness, Greensboro, NC 27412 USA; [Baugh, Christine M.] Harvard Univ, Boston Childrens Hosp, Interfac Initiat Hlth Policy, Div Sports Med, Cambridge, MA 02138 USA		Milroy, JJ (corresponding author), Univ North Carolina Greensboro, Dept Publ Hlth Educ, Inst Promote Athlete Hlth & Wellness, Greensboro, NC 27412 USA.	jjmilroy@uncg.edu		Chrisman, Sara/0000-0001-5373-7223	National Institute of Mental Health of Award [T32MH019733]	C.M.B. is supported by the National Institute of Mental Health of Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Bandura A, 1986, SOCIAL FDN THOUGHT A; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bell JM, 2015, J HEAD TRAUMA REHAB, V30, P148, DOI 10.1097/HTR.0000000000000143; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Gerrard M, 2008, DEV REV, V28, P29, DOI 10.1016/j.dr.2007.10.001; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-157; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P., 2013, BRIT J SPORT MED, V47, P259, DOI DOI 10.1136/BJSPORTS-2013-092459.8; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; National Collegiate Athletic Association, 2013, 2013 2014 NCAA SPORT; National Collegiate Athletic Association, 2015, 2014 2015 NCAA SPORT; National Federation of High School Sports, 2013, 2013 2014 HIGH SCH A; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; StataCorp, 2017, STAT SOFTW REL 12; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Vogel DL, 2011, J COUNS PSYCHOL, V58, P368, DOI 10.1037/a0023688	37	9	9	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	MAR	2020	14	1					41	54		10.1123/jcsp.2017-0036			14	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	LY2AW	WOS:000540323900003					2022-02-06	
J	Lee, JS; Jeong, DW; Byun, YT				Lee, Jae-Sung; Jeong, Da-Woon; Byun, Young Tae			Porphyrin nanofiber/single-walled carbon nanotube nanocomposite-based sensors for monitoring hydrogen peroxide vapor	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Hydrogen peroxide vapor; Porphyrin nanofibers; Single-walled carbon nanotubes; Sub-ppm levels; Real-time monitoring	RAMAN-SPECTROSCOPY; FUNCTIONALIZATION; ADSORPTION; COMPLEX; REAGENT; GAS	Detection of hydrogen peroxide (H2O2) is particularly important in the field of clinical diagnosis for exhaled breath analysis, because H2O2 is closely related to diseases such as cancer, traumatic brain injury, chronic obstructive pulmonary disease, and asthma. Considering this, development of sensors for sensitive and selective real-time monitoring of H2O2 vapor (HPV) is required. In this study, we report the design and fabrication of a high-performance HPV sensor based on nanocomposites of nanofibers of a porphyrin derivative (oxo-[5,10,15,20-tetra(4-pyridyl)porphyrinato] titanium(IV) (TiOTPyP)) and single-walled carbon nanotubes (SWCNTs) at room temperature. Two types of HPV sensor transducers were fabricated using pristine SWCNTs only and TiOTPyP nanofiber/SWCNT nanocomposite and the sensor responses were compared. The significant differences in reproducibility and selectivity of the two sensors reflected the significant impact of the added TiOTPyP nanofibers on the device performance. The response of the TiOTPyP nanofiber/SWCNT nanocomposite-based sensor to 1 ppm of HPV is 9 times higher than that of the pristine SWCNT-based sensor. In addition, this sensor shows fast response/recovery times in the detection of HPV in the concentration range of 0.1-10 ppm, while showing a weak response to NH3 gas and negligible response to CO, toluene, acetone, hexane, NO, and NO2 gases.	[Lee, Jae-Sung] Gumi Elect & Informat Technol Res Inst GERI, Convergence Mat Res Ctr, Gumi 39171, South Korea; [Jeong, Da-Woon] Korea Inst Ind Technol KITECH, Korea Russia Innovat Ctr, Incheon 22004, South Korea; [Byun, Young Tae] KIST, Sensor Syst Res Ctr, Seoul 02792, South Korea		Byun, YT (corresponding author), KIST, Sensor Syst Res Ctr, Seoul 02792, South Korea.	byt427@kist.re.kr			National Research Council of Science & Technology (NST) - Korea government (MSIP) [QLT-CRC-18-02-KICT]	This research was supported by the National Research Council of Science & Technology (NST) funded by the Korea government (MSIP) (No. QLT-CRC-18-02-KICT).	Adamyan Z., 2019, SENS TRANSDUCERS, V229, P18; Anh DTV, 2005, SENSOR ACTUAT B-CHEM, V111, P494, DOI 10.1016/j.snb.2005.03.107; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995; Chen W, 2012, ANALYST, V137, P49, DOI 10.1039/c1an15738h; Choi SW, 2018, APPL SURF SCI, V433, P480, DOI 10.1016/j.apsusc.2017.09.245; Choi SW, 2017, SENSOR ACTUAT B-CHEM, V249, P414, DOI 10.1016/j.snb.2017.04.119; Choi SW, 2017, SENSOR ACTUAT B-CHEM, V238, P1032, DOI 10.1016/j.snb.2016.07.153; Cinke M, 2002, CHEM PHYS LETT, V365, P69, DOI 10.1016/S0009-2614(02)01420-3; Cui QH, 2014, CHEM SCI, V5, P52, DOI 10.1039/c3sc51798e; Das SK, 2012, CHEM-EUR J, V18, P11388, DOI 10.1002/chem.201200970; Dillon EP, 2008, ACS NANO, V2, P156, DOI 10.1021/nn7002713; Dresselhaus MS, 2002, CARBON, V40, P2043, DOI 10.1016/S0008-6223(02)00066-0; Drzewiecka-Matuszek A, 2013, CAN J CHEM, V91, P642, DOI 10.1139/cjc-2012-0513; Germain ME, 2009, CHEM SOC REV, V38, P2543, DOI 10.1039/b809631g; Guo PP, 2014, ACS NANO, V8, P3402, DOI 10.1021/nn406071f; Jeon JY, 2019, NANOSCALE, V11, P1587, DOI 10.1039/c8nr07393g; Karachevtsev VA, 2010, J PHYS CHEM C, V114, P16215, DOI 10.1021/jp104093q; Kim M, 2008, J PHARMACEUT BIOMED, V48, P592, DOI 10.1016/j.jpba.2008.05.029; Koshio A, 2001, NANO LETT, V1, P361, DOI 10.1021/nl0155431; Lee DJ, 2018, SENSOR ACTUAT B-CHEM, V256, P744, DOI 10.1016/j.snb.2017.10.001; Li J, 2003, NANO LETT, V3, P929, DOI 10.1021/nl034220x; Li JZ, 2003, ANAL SCI, V19, P517, DOI 10.2116/analsci.19.517; Liu SF, 2015, CHEM MATER, V27, P3560, DOI 10.1021/acs.chemmater.5b00153; Lu YJ, 2011, SMALL, V7, P1714, DOI 10.1002/smll.201100406; Manatt SL, 2004, CHEM-EUR J, V10, P6540, DOI 10.1002/chem.200400104; Manna AK, 2010, NANOSCALE, V2, P1190, DOI 10.1039/c0nr00124d; MATSUBARA C, 1992, ANALYST, V117, P1781, DOI 10.1039/an9921701781; Na PS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2032594; Pati R, 2002, APPL PHYS LETT, V81, P2638, DOI 10.1063/1.1510969; Qin SH, 2004, MACROMOLECULES, V37, P9963, DOI 10.1021/ma048692p; Riley CK, 2010, J PHYS CHEM C, V114, P19227, DOI 10.1021/jp1068494; Samarajeewa DR, 2013, CARBON, V57, P88, DOI 10.1016/j.carbon.2013.01.039; Sanchez JC, 2008, J MATER CHEM, V18, P5134, DOI 10.1039/b809674k; Schulte-Ladbeck R, 2006, ANAL BIOANAL CHEM, V386, P559, DOI 10.1007/s00216-006-0579-y; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Takamura K, 2008, ANAL BIOANAL CHEM, V391, P951, DOI 10.1007/s00216-008-1942-y; Takamura K, 2008, ANAL SCI, V24, P401, DOI 10.2116/analsci.24.401; Terrones M, 1998, APPL PHYS A-MATER, V66, P307, DOI 10.1007/s003390050671; Verma AL, 2011, THIN SOLID FILMS, V519, P8144, DOI 10.1016/j.tsf.2011.06.034; Wang AJ, 2019, DYES PIGMENTS, V161, P155, DOI 10.1016/j.dyepig.2018.09.057; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Wiedemair J, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.029; Xu MA, 2011, ACS APPL MATER INTER, V3, P642, DOI 10.1021/am1012535; Youdim KA, 2001, FREE RADICAL BIO MED, V30, P583, DOI 10.1016/S0891-5849(00)00510-4; Zahab A, 2000, PHYS REV B, V62, P10000, DOI 10.1103/PhysRevB.62.10000; Zhang YP, 2009, J ALLOY COMPD, V480, pL17, DOI 10.1016/j.jallcom.2009.01.114; Zhang YJ, 2004, J PHYS CHEM B, V108, P15343, DOI 10.1021/jp0471094; Zheng JY, 2012, ADV MATER, V24, pOP194, DOI 10.1002/adma.201200867	49	9	9	1	55	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND		0925-4005		SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	MAR 1	2020	306								127518	10.1016/j.snb.2019.127518			7	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry; Instruments & Instrumentation	KC8ZE	WOS:000507459500034					2022-02-06	
J	Garza, N; Toussi, A; Wilson, M; Shahlaie, K; Martin, R				Garza, Nicholas; Toussi, Atrin; Wilson, Machelle; Shahlaie, Kiarash; Martin, Ryan			The Increasing Age of TBI Patients at a Single Level 1 Trauma Center and the Discordance Between GCS and CT Rotterdam Scores in the Elderly	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; TBI; geriatrics; Glasgow Coma Scale; CT Rotterdam Score; geriatric TBI	QUALITY-OF-LIFE; BRAIN-INJURY; OLDER-ADULTS; OUTCOMES; ASSOCIATION; PREDICTION; DISABILITY; FRAILTY	Introduction: Traumatic brain injury (TBI) is frequently encountered in geriatric patients, but there is a paucity of data describing TBI in the elderly. Here, we show the age of patients with TBI is increasing at our medical center and discuss the relationship between age and injury severity with patient outcomes. Methods: This is a retrospective analysis of 3,179 adult patients with TBI treated at the University of California, Davis Level 1 Trauma Center between 2009 and 2016. Age, Glasgow Coma Scale (GCS), and CT Rotterdam Scores were recorded. Age was analyzed as both a continuous and categorical variable (18-34, 35-50, 51-65, >65 years-old). Extended Glasgow Outcome Scale was obtained at 3 and 6 months and dichotomized into favorable and unfavorable outcomes. Multivariable general linear regression models, chi-square, logistic regression analyses and ANOVA were used for statistical analyses; a p < 0.05 was considered significant. Results: The mean age of patients was 52.2 +/- 21.9 years with a male predominance (69%). There was a significant trend (p = 0.002) toward an increase in mean age each year, increasing by 4.4 years (p = 0.008) over the course of the analysis. Older patients had a higher mean GCS compared to younger patients with the same CT Rotterdam Score (p = 0.027), this becoming more pronounced with worse CT Rotterdam Scores. The >65 group had a 4-fold increased risk for unfavorable outcome when compared to the 18-34 group, this effect being most pronounced after mild TBI. Conclusions: The mean age of TBI patients is increasing at our trauma center. The largest disparity in outcomes across age was seen in patients with a mild GCS and low CT Rotterdam Scores, suggesting that these markers of injury severity may underestimate the severity of injury in the elderly population. This information highlights the need for clinical trials and validation of outcome markers in geriatric TBI.	[Garza, Nicholas; Toussi, Atrin] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Wilson, Machelle] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Sacramento, CA 95817 USA; [Shahlaie, Kiarash; Martin, Ryan] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; [Martin, Ryan] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA		Martin, R (corresponding author), Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA.; Martin, R (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.	rymartin@ucdavis.edu			National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001860]	Statistical support was provided by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant No. UL1 TR001860.	Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bureau USC, 2017, FACTS FEAT OLD AM MO; CDC, 2019, TBI REL EM DEP VIS H; CDC, 2019, TBI REL DEATHS; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Goulding MR, 2003, JAMA-J AM MED ASSOC, V289, P1371; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maxwell CA, 2015, J TRAUMA ACUTE CARE, V78, P844, DOI 10.1097/TA.0000000000000551; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	23	9	9	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 20	2020	11								112	10.3389/fneur.2020.00112			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT4JO	WOS:000518981200001	32153493	Green Published, gold			2022-02-06	
J	Chen, HS; Chen, MH				Chen, Hongshen; Chen, Muhu			The efficacy of tranexamic acid for brain injury: A meta-analysis of randomized controlled trials	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Tranexamic acid; Treatment efficacy; Traumatic brain injury; Mortality; Randomized controlled trials	GLASGOW COMA SCALE; HEAD-INJURY; HEMORRHAGE; MANAGEMENT; CHILDREN; TRAUMA; MILD	Background: Tranexamic acid shows some treatment efficacy for traumatic brain injury. This systematic review and meta-analysis is conducted to investigate the efficacy of tranexamic acid for traumatic brain injury. Methods: The databases including PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases are systematically searched for collecting the randomized controlled trials (RCTs) regarding the efficacy of tranexamic acid for traumatic brain injury. Results: This meta-analysis has included six RCTs. Compared with placebo group in patients with traumatic brain injury, tranexamic acid results in remarkably reduced mortality (risk ratio (RR) = 0.91; 95% confidence interval (CI) = 0.85 to 0.97; P = 0.004) and growth of hemorrhagic mass (RR = 0.78; 95% CI = 0.61 to 0.99; P = 0.04), but has no important impact on neurosurgery (RR = 0.99; 95% CI = 0.85 to 1.15; P = 0.92), extracranial surgery (RR = 1.00; 95% CI = 0.97 to 1.04; P = 0.99), unfavorable outcome (Glasgow Outcome Scale, GOS) (RR = 0.72; 95% CI = 0.47-1.11; P = 0.14), pulmonary embolism(RR = 1.86; 95% CI = 0.42-8.29; P = 0.42), and deep venous thrombosis (RR = 0.97; 95% CI = 0.64-1.47; P = 0.88). Conclusions: Tranexamic acid is associated with substantially reduced mortality and growth of hemorrhagic mass in patients with traumatic brain injury, but the need of neurosurgery and extracranial surgery, as well as the risk of unfavorable outcome (GOS) are similar between tranexamic acid and placebo. (C) 2019 Published by Elsevier Inc.	[Chen, Hongshen; Chen, Muhu] Southwest Med Univ, Affiliated Hosp, Dept Emergency Med, Luzhou, Sichuan, Peoples R China		Chen, MH (corresponding author), 104 Taiping St, Luzhou City 646000, Sichuan, Peoples R China.	409776268@qq.com					Al-Mufti F, 2018, WORLD NEUROSURG; Alen JF, 2003, J NEUROSURG, V98, P529, DOI 10.3171/jns.2003.98.3.0529; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Arumugam A, 2015, MALAYS J MED SCI, V22, P62; Boudreau RM, 2017, J SURG RES, V215, P47, DOI 10.1016/j.jss.2017.03.031; Chakroun-Walha O, 2018, EUR J TRAUMA EMERG S; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dorweiler MA, 2018, J KNEE SURG; Edwards P, 2005, LANCET, V365, P1957; Fakharian E, 2018, WORLD NEUROSURG, V109, pE748, DOI 10.1016/j.wneu.2017.10.075; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu HM, 2015, ARCH ORTHOP TRAUM SU, V135, P491, DOI 10.1007/s00402-015-2183-0; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kuo LT, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1972-3; Leiblich A, 2011, EMERG MED J, V28, P115, DOI 10.1136/emj.2009.079442; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Mahmood A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4814; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roos YB, 2003, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Shiraishi A, 2017, BRIT J SURG, V104, P710, DOI 10.1002/bjs.10497; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Xu CS, 2012, ARCH ORTHOP TRAUM SU, V132, P25, DOI 10.1007/s00402-011-1390-6; Xu DR, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0672-2; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	36	9	9	3	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2020	38	2					364	370		10.1016/j.ajem.2019.158499			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LR6PF	WOS:000535813900039	31706661				2022-02-06	
J	Cheng, PX; Li, RT; Schwebel, DC; Zhu, MT; Hu, GQ				Cheng, Peixia; Li, Ruotong; Schwebel, David C.; Zhu, Motao; Hu, Guoqing			Traumatic brain injury mortality among US children and adolescents ages 0-19 years, 1999-2017	JOURNAL OF SAFETY RESEARCH			English	Article						Traumatic brain injury; Mortality; Children and teenager; Intervention; The United States	UNITED-STATES; HEAD TRAUMA; EPIDEMIOLOGY; SURVEILLANCE; PREVENTION; CENTERS; PROGRAM; DEATHS; SPORTS; LAWS	Introduction: To examine recent traumatic brain injury (TBI) mortality changes among Americans aged 0-19 years by sex, age, urbanicity, state, and intent/causes of injury. Method: TBI mortality per 100,000 population and average annual percent changes (AAPCs), plus 95% confidence intervals (CIs) based on Joinpoint regression models. Results: Age-adjusted TBI mortality among Americans aged 0-19 years declined consistently, though at varying rates between 1999 and 2013 (AAPC = -4.8%, 95%CI: -6.3%, -3.2%), and then significantly increased from 4.42 per 100,000 population in 2013 to 5.17 per 100,000 population in 2017 (AAPC= 3.4%, 95% CI: 1.7%, 5.1%). During the study time period, boys, rural children, and youth aged 15-19 years had higher TBI mortality rates than girls, urban children, and younger children, respectively. TBI mortality from unintentional transport crashes decreased substantially in all age groups between 1999 and 2017, and especially from 1999 to 2010. TBI mortality from suicide increased significantly from 2008 to 2017 in the 10-14-year age group (AAPC= 14.6%, 95% CI: 12.6%, 16.6%) and from 2007 to 2017 in the 15-19-year age group (AAPC = 6.3%, 95% CI: 3.8%, 8.7%). Unintentional transport crashes were the leading cause of TBI-related mortality in 46 states in 1999, but by 2017, suicide became the first leading cause in 14 states. Conclusions: Pediatric TBI mortality declined consistently between 1999 and 2013 and increased significantly from 2013 to 2017, driven primarily by the mortality decrease from unintentional transport crashes and increase in suicide mortality. The spectrum of leading causes of pediatric TBI mortality changed across age groups and over time from 1999 to 2017. Practical Applications: TBI mortality increases in the United States since 2013 are driven primarily by increasing suicide rates, a trend that merits the attention of policy-makers and injury researchers. Action should be taken to curb growing TBI mortality rates among adolescents aged 10-19 years. (C) 2019 The Authors. Published by Elsevier Ltd.	[Cheng, Peixia; Li, Ruotong; Hu, Guoqing] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Zhu, Motao] Ohio State Univ, Dept Pediat, Ctr Injury Res & Policy, Res Inst,Nationwide Childrens Hosp, Columbus, OH 43210 USA		Hu, GQ (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China.	chengpeixia@csu.edu.cn; liruotong@csu.edu.cn; schwebel@uab.edu; motao.zhu@nationwidechildrens.org; huguoqing009@gmail.com					Bae JY, 2014, SOC SCI MED, V100, P30, DOI 10.1016/j.socscimed.2013.10.035; Baldwin G, 2016, NEUROREHABILITATION, V39, P345, DOI 10.3233/NRE-161366; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Breiding MJ, 2006, INJURY PREV, V12, P49, DOI 10.1136/ip.2006.012591; Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200; CDC/National Center for Health Statistics, NCHS URB RUR CLASS S; Charters KE, 2017, INJURY, V48, P1331, DOI 10.1016/j.injury.2017.05.021; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graves JM, 2019, HEALTH SERV RES, V54, P337, DOI 10.1111/1475-6773.13096; GunPolicy.org, US GUN FACTS FIG LAW; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; He MM, 2016, SOC SCI MED, V155, P1, DOI 10.1016/j.socscimed.2016.02.016; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Luxton DD, 2012, AM J PUBLIC HEALTH, V102, pS195, DOI 10.2105/AJPH.2011.300608; Maris RW, 2000, REV SUICIDOLOGY; National Association of State Head Injury Administrators, 2016, STAT PROGR; National Cancer Institute, 2019, APC AAPC TAU CONF IN; National Center for Injury Prevention and Control, 2015, CDC INJ CTR RES PRIO; National Center for Injury Prevention and Control, 2009, CDC INJ RES AG 2009; Ning PS, 2019, B WORLD HEALTH ORGAN, V97, P190, DOI [10.2471/BLT.18.215327, 10.2471/blt.18.215327]; Notrica DM, 2012, J TRAUMA ACUTE CARE, V73, P566, DOI 10.1097/TA.0b013e318265ca6f; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Reeping PM, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l542; Reidy DE, 2016, INJURY PREV, V22, P370, DOI 10.1136/injuryprev-2015-041599; Rice TM, 2009, AM J PUBLIC HEALTH, V99, P252, DOI 10.2105/AJPH.2007.131128; Safavi A, 2014, J TRAUMA ACUTE CARE, V76, P146, DOI 10.1097/TA.0b013e3182ab10fb; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Simons-Morton BG, 2006, ACCIDENT ANAL PREV, V38, P907, DOI 10.1016/j.aap.2006.03.001; Spies EL, 2016, MMWR-MORBID MORTAL W, V65, P505, DOI 10.15585/mmwr.mm6520a1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; U.S. Department of Health and Human Services (U.S. DHHS); Centers for Disease Control and Prevention (CDC); National Center for Health Statistics (NCHS), MULT CAUS DEATH CDC; U.S. Department of Transportation National Highway Traffic Safety Administration, 2015, TRAFF SAF FACTS DIST; United States Department of Health and Human Services (HHS) Office of the Surgeon General and National Action Alliance for Suicide Prevention, 2012, 2012 NAT STRAT SUIC; Viano DC, 2017, TRAFFIC INJ PREV, V18, P616, DOI 10.1080/15389588.2017.1285023; Williams AF, 2009, TRAFFIC INJ PREV, V10, P9, DOI 10.1080/15389580802500546; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791	42	9	9	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	FEB	2020	72						93	100		10.1016/j.jsr.2019.12.013			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	LG4AK	WOS:000528045600010	32199582	hybrid			2022-02-06	
J	Fellows, RP; Schmitter-Edgecombe, M				Fellows, Robert P.; Schmitter-Edgecombe, Maureen			Symbol Digit Modalities Test: Regression-Based Normative Data and Clinical Utility	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Norms; Assessment; Processing speed; Memory; Symbol substitution test; Mild cognitive impairment; Traumatic brain injury; Dementia; Norms calculator	COGNITIVE IMPAIRMENT; CONSTRUCT-VALIDITY; TEST-PERFORMANCE; AGE; SAMPLE; SPEED; NORMS	Objective: The purpose of this study was to provide regression-based normative data for the written, oral, and incidental recall trials of the Symbol Digit Modalities Test (SDMT). Method: Regression-based normative equations for the written and oral trials were derived from 536 healthy men and women between the ages of 18 and 91. Normative equations for the incidental recall trial are provided for a subset of the normative sample (age range = 60-91). The clinical utility of the newly developed norms was examined by comparing mean performance and rates of impaired scores for participants with traumatic brain injury (TBI), mild cognitive impairment (MCI), and dementia. Within-group analyses were used to compare the new norms to the original published norms. Results: Age, education, and sex were all significant predictors of written trial performance, age and education were significant predictors of oral trial performance, and only age predicted incidental recall trial performance. As expected, the TBI group demonstrated the highest rates of impaired performance on both written and oral trials. Participants with dementia showed the highest rate of impaired scores on the incidental recall trial, followed by participants with amnestic MCI. Compared to traditional norming methods, the regression-based norms classified more clinical participants as impaired on both the written and oral trials. Conclusions: Comprehensive regression-based normative equations with demonstrated clinical utility are provided to improve the detection of cerebral dysfunction using the SDMT. A calculator with the normative equations is provided so that raw scores can be easily converted to demographically-corrected standardized scores.	[Fellows, Robert P.; Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB009675]; Life Sciences Discovery Fund; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS047690]	NIBIB #R01 EB009675; Life Sciences Discovery Fund; NINDS #R01 NS047690.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Berrigan LI, 2014, CLIN NEUROPSYCHOL, V28, P281, DOI 10.1080/13854046.2013.871337; Blom G, 1958, STAT ESTIMATES TRANS; Burggraaff J, 2017, EUR NEUROL, V77, P246, DOI 10.1159/000464405; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Jorm AF, 2004, INTELLIGENCE, V32, P7, DOI 10.1016/j.intell.2003.08.001; Joy S, 2003, CLIN NEUROPSYCHOL, V17, P182, DOI 10.1076/clin.17.2.182.16495; Kiely KM, 2014, ARCH CLIN NEUROPSYCH, V29, P767, DOI 10.1093/arclin/acu055; Manly JJ, 2011, J CLIN EXP NEUROPSYC, V33, P853, DOI 10.1080/13803395.2010.547662; Oosterhuis HEM, 2016, ASSESSMENT, V23, P191, DOI 10.1177/1073191115580638; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SALTHOUSE TA, 1994, DEV PSYCHOL, V30, P240, DOI 10.1037/0012-1649.30.2.240; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Smith A., 1982, SYMBOL DIGIT MODALIT, P22; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TEASDALE G, 1974, LANCET, V2, P81; Testa SM, 2009, J INT NEUROPSYCH SOC, V15, P1012, DOI 10.1017/S1355617709990713; UCHIYAMA CL, 1994, CLIN NEUROPSYCHOL, V8, P209, DOI 10.1080/13854049408401558; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	24	9	9	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2020	35	1					105	115		10.1093/arclin/acz020			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN8GI	WOS:000569024700010	31329813	Bronze			2022-02-06	
J	Hwang, F; Pentakota, SR; Glass, NE; Berlin, A; Livingston, DH; Mosenthal, AC				Hwang, Franchesca; Pentakota, Sri Ram; Glass, Nina E.; Berlin, Ana; Livingston, David H.; Mosenthal, Anne C.			Older Patients With Severe Traumatic Brain Injury: National Variability in Palliative Care	JOURNAL OF SURGICAL RESEARCH			English	Article						Surgical palliative care; Traumatic brain injury; Geriatric trauma; Older patients; Intensity of treatment	OF-LIFE CARE; END; MORTALITY; CONSULTATION; INTENSITY; AGE	Background: Older patients with traumatic brain injury (TBI) have higher mortality and morbidity than their younger counterparts. Palliative care (PC) is recommended for all patients with a serious or life-limiting illness. However, its adoption for trauma patients has been variable across the nation. The goal of this study was to assess PC utilization and intensity of care in older patients with severe TBI. We hypothesized that PC is underutilized despite its positive effects. Materials and methods: The National Inpatient Sample database (2009-2013) was queried for patients aged >= 55 y with International Classification of Diseases, Ninth Revision codes for TBI with loss of consciousness >= 24 h. Outcome measures included PC rate, in-hospital mortality, discharge disposition, length of stay (LOS), and intensity of care represented by craniotomy and or craniectomy, ventilator use, tracheostomy, and percutaneous endoscopic gastrostomy. Results: Of 5733 patients, 78% died in hospital with a median LOS of 1 d, and 85% of the survivors were discharged to facilities. The overall PC rate was 35%. Almost 40% of deaths received PC, with nearly half within 48 h of admission. PC was used in 26% who had neurosurgical procedures, compared with 35% who were nonoperatively managed (P = 0.003). PC was associated with less intensity of care in the entire population. For survivors, those with PC had significantly shorter LOS, compared with those without PC. Conclusions: Despite high mortality, only one-third of older patients with severe TBI received PC. PC was associated with decreased use of life support and lower intensity of care. Significant efforts need to be made to bridge this quality gap and improve PC in this high-risk population. (C) 2019 Elsevier Inc. All rights reserved.	[Hwang, Franchesca; Pentakota, Sri Ram; Glass, Nina E.; Livingston, David H.; Mosenthal, Anne C.] Rutgers New Jersey Med Sch, Dept Surg, 185 South Orange Ave,Med Sci Bldg G-506, Newark, NJ 07103 USA; [Berlin, Ana] Columbia Univ, Dept Surg, Med Ctr, New York, NY USA		Hwang, F (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, 185 South Orange Ave,Med Sci Bldg G-506, Newark, NJ 07103 USA.	hwangjf@njms.rutgers.edu	Pentakota, Sri Ram/ABB-8001-2020; Berlin, Ana/M-1146-2016	Pentakota, Sri Ram/0000-0001-6872-1507; Glass, Nina/0000-0002-6821-4289	Patient Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [PCORI-1502-27462]; Auen Foundation [A16-88]	This work was supported by the Patient Centered Outcomes Research Institute through Grant PCORI-1502-27462 (Dr Mosenthal) and by the Auen Foundation through Grant #A16-88 (Dr Hwang).	American College of Surgeons Trauma Quality Improvement Program, ACS TQIP GER TRAUM M; Committee on Approaching Death: Addressing Key End of Life I Institute of M, 2015, DYING AM IMPR QUAL H; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Hua M, 2017, J PALLIAT MED, V20, P372, DOI 10.1089/jpm.2016.0363; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kupensky D, 2015, J TRAUMA NURS, V22, P261, DOI 10.1097/JTN.0000000000000151; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Lilley EJ, 2018, J TRAUMA ACUTE CARE, V85, P992, DOI 10.1097/TA.0000000000002000; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Lilley EJ, 2016, JAMA SURG, V151, P172, DOI 10.1001/jamasurg.2015.3625; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Murthy SB, 2016, CRIT CARE MED, V44, P575, DOI 10.1097/CCM.0000000000001391; Ortman JMVV, 2014, AGING NATION OLDER P; Ottochian M, 2009, INJURY, V40, P354, DOI 10.1016/j.injury.2008.10.015; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teno JM, 2005, J AM GERIATR SOC, V53, P1905, DOI 10.1111/j.1532-5415.2005.53563.x; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; World Health Organization, 2020, WHO DEF PALL CAR	25	9	9	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2020	246						224	230		10.1016/j.jss.2019.09.002			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JW1BS	WOS:000502794400028	31606512				2022-02-06	
J	Naguib, S; Bernardo-Colon, A; Cencer, C; Gandra, N; Rex, TS				Naguib, Sarah; Bernardo-Colon, Alexandra; Cencer, Caroline; Gandra, Neha; Rex, Tonia S.			Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma	NEUROBIOLOGY OF DISEASE			English	Article						Blast injury; Galantamine; Optic nerve; Electroretinogram; Visual evoked potential; Oxidative stress; Inflammation; Neurotrauma; Indirect traumatic optic neuropathy	TRAUMATIC OPTIC NEUROPATHY; MOUSE MODEL; OXIDATIVE STRESS; INJURY; RECEPTORS	Our goal was to investigate the neuroprotective effects of galantamine in a mouse model of blast-induced indirect traumatic optic neuropathy (bITON). Galantamine is an FDA-approved acetylcholinesterase inhibitor used to treat mild-moderate Alzheimer's disease. We exposed one eye of an anesthetized mouse to repeat bursts of over-pressurized air to induce traumatic optic neuropathy. Mice were given regular or galantamine-containing water (120 mg/L) ad libitum, beginning immediately after blast and continuing for one month. Electroretinograms and visual evoked potentials were performed just prior to endpoint collection. Histological and biochemical assessments were performed to assess activation of sterile inflammation, axon degeneration, and synaptic changes. Galantamine treatment mitigated visual function deficits induced by our bITON model via preservation of the b-wave of the electroretinogram and the N1 of the visual evoked potential. We also observed a reduction in axon degeneration in the optic nerve as well as decreased rod bipolar cell dendritic retraction. Galantamine also showed anti-inflammatory and antioxidant effects. Galantamine may be a promising treatment for blast-induced indirect traumatic optic neuropathy as well as other optic neuropathies.	[Naguib, Sarah; Cencer, Caroline; Gandra, Neha; Rex, Tonia S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, 11435 MRB 4,2213 Garland Ave, Nashville, TN 37232 USA; [Bernardo-Colon, Alexandra; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, 2311 Pierce Ave, Nashville, TN 37232 USA		Rex, TS (corresponding author), Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, 11435 MRB 4,2213 Garland Ave, Nashville, TN 37232 USA.	Sarah.naguib@vanderbilt.edu; Alexandra.bernardo@vumc.org; Caroline.s.cencer@vanderbilt.edu; Neha.gandra@vanderbilt.edu; Tonia.rex@vanderbilt.edu			DoDUnited States Department of Defense [W81XWH-15-1-0096, W81XWH-17-2-0055]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY022349, P30 EY008126, 5T32EY007135, U24 EY29893]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 NS094595]; Research to Prevent Blindness Unrestricted FundsResearch to Prevent Blindness (RPB); Ret. Maj. General Stephen L. Jones, MD Fund; Mark Pigott Fund; Potoscnak Family-CSC Research Fund; Ayers Research Fund in Regenerative Visual Neuroscience	DoD W81XWH-15-1-0096, W81XWH-17-2-0055, NEI R01 EY022349, NEI P30 EY008126, NIA R01 NS094595, (VEI) Research to Prevent Blindness Unrestricted Funds, Ret. Maj. General Stephen L. Jones, MD Fund, Mark Pigott Fund, Potoscnak Family-CSC Research Fund, Ayers Research Fund in Regenerative Visual Neuroscience, NEI 5T32EY007135 (VVRC) P30 grant number (S. Naguib), NEI U24 EY29893.	Aghadoost D, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.21639; Almasieh M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.23; Almasieh M, 2013, INVEST OPHTH VIS SCI, V54, P3171, DOI 10.1167/iovs.12-11481; Andreotti G, 2001, ARCH OPHTHALMOL-CHIC, V119, P1693; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Burke EG, 2019, NEURAL REGEN RES, V14, P593, DOI 10.4103/1673-5374.247463; Di Polo A., 2006, INVEST OPTHALMOL VIS, V47; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Duraes F, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020044; Ezoulin MJM, 2008, NEUROTOXICOLOGY, V29, P270, DOI 10.1016/j.neuro.2007.11.004; Faghih R., 2007, RECENT PAT CNS DRUG, V2; FEIST RM, 1989, ARCH OPHTHALMOL-CHIC, V107, P503, DOI 10.1001/archopht.1989.01070010517021; Francis PT, 2005, CNS SPECTRUMS, V10, P6, DOI 10.1017/S1092852900014164; Furukawa S, 2014, INT J DEV NEUROSCI, V37, P52, DOI 10.1016/j.ijdevneu.2014.06.011; GIACOBINI E, 1989, PROG BRAIN RES, V79, P335; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Kita Y, 2014, INT J NEUROPSYCHOPH, V17, P1957, DOI 10.1017/S1461145714000613; KUMARAN AM, 2014, CRANIOMAXILLOFAC TRA, V8, P31; Lilienfeld S, 2002, CNS DRUG REV, V8, P159; Lopes JP, 2013, BRAIN BEHAV, V3, P67, DOI 10.1002/brb3.118; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Melo JB, 2009, EUR J NEUROSCI, V29, P455, DOI 10.1111/j.1460-9568.2009.06612.x; Noda Y, 2010, INT J NEUROPSYCHOPH, V13, P1343, DOI 10.1017/S1461145710000222; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Romero A, 2010, J PINEAL RES, V49, P141, DOI 10.1111/j.1600-079X.2010.00778.x; Shimizu S, 2015, J PHARMACOL SCI, V127, P439, DOI 10.1016/j.jphs.2015.03.004; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; Texido L, 2005, BRIT J PHARMACOL, V145, P672, DOI 10.1038/sj.bjp.0706221; Volpe NJ, 2011, J NEURO-OPHTHALMOL, V31, P169, DOI 10.1097/WNO.0b013e31821c9b11; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; World Health Organization, 2018, PRIOR EYE DIS	39	9	9	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2020	134								104695	10.1016/j.nbd.2019.104695			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KG3BV	WOS:000509818400051	31778813	hybrid, Green Accepted, Green Published			2022-02-06	
J	Povolotskiy, R; Gupta, N; Leverant, AB; Kandinov, A; Paskhover, B				Povolotskiy, Roman; Gupta, Nakul; Leverant, Adam B.; Kandinov, Aron; Paskhover, Boris			Head and Neck Injuries Associated With Cell Phone Use	JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; COGNITIVE DISTRACTION; UNITED-STATES; DRIVERS; LACERATIONS; ADOLESCENT; FATALITIES; QUALITY	Importance As cell phones gain more influence in daily life, they also become potentially more hazardous. Injuries resulting from cell phone use have long been reported largely in the context of driving-related incidents, but other mechanisms of injury have been underreported. Objective To assess the incidence, types, and mechanisms of head and neck injuries associated with cell phone use. Design, Setting, and Participant Retrospective cross-sectional study using data from a national database of individuals with head and neck injuries related to cell phone use who presented to emergency departments in the United States between January 1998 and December 2017. Main Outcomes and Measures Incidence, types, and mechanisms of injury related to cell phone use in the US population. Results A reported total of 2501 patients (1129 [55.0%] female, 795 [38.8%] white, and 772 [37.6%] aged 13-29 years) presented with injuries of the head and neck related to cell phone use; the estimated weighted national total was 76 043 patients (42 846 females [56.3%], 34 894 [45.9%] white, and 29 956 [39.4%] aged 13-29 years). The most commonly reported subsites of injuries in the head and neck region included the head (33.1% of estimated total); face, including eyelid, eye area, and nose (32.7%); and neck (12.5%). The most common injury diagnoses included laceration (26.3% of estimated total), contusion/abrasion (24.5%), and internal organ injury (18.4%). Age group distributions showed that most injuries associated with cell phone user distraction occurred among individuals aged 13 to 29 years (60.3%; Cramer V = 0.29). In addition, those younger than 13 years were significantly more likely to sustain direct mechanical injury from a cell phone (82.1%) than to have a cell phone use-associated injury (17.9%) (Cramer V = 0.305), whereas a cell phone use-associated injury was more likely than a direct mechanical injury to occur among those aged 50 to 64 years (68.2% vs 31.8%; Cramer V = 0.11) and those older than 65 years (90.3% vs 9.7%; Cramer V = 0.29). Conclusions and Relevance Cell phone-related injuries to the head and neck have increased steeply over the recent 20-year period, with many cases resulting from distraction. Although the disposition of most cases is simple, some injuries bear a risk of long-term complications. Many of these injuries occurred among those aged 13 to 29 years and were associated with common activities, such as texting while walking. These findings suggest a need for patient education about injury prevention and the dangers of activity while using these devices.	[Povolotskiy, Roman; Gupta, Nakul; Leverant, Adam B.; Kandinov, Aron; Paskhover, Boris] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ USA		Paskhover, B (corresponding author), Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Doctors Off Ctr, 90 Bergen St,Room 8100, Newark, NJ 07101 USA.	boris.paskhover@njms.rutgers.edu					Ayers JW, 2016, JAMA INTERN MED, V176, P1865, DOI 10.1001/jamainternmed.2016.6274; Barbieri S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6596; Berry G, 1995, STATISTICIAN, V44, P417, DOI 10.2307/2348891; Bisson JI, 1997, J TRAUMA, V43, P496, DOI 10.1097/00005373-199709000-00018; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Cohen J., 2013, STAT POWER ANAL BEHA; Consumer Product Safety Commission, 2019, NEISS COD MAN; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Drolet BC, 2016, PLAST RECONSTR SURG, V137, P1927, DOI 10.1097/PRS.0000000000002147; Foss RD, 2014, J ADOLESCENT HEALTH, V54, pS50, DOI 10.1016/j.jadohealth.2014.01.005; Hanba C, 2016, JAMA FACIAL PLAST SU, V18, P441, DOI 10.1001/jamafacial.2016.0714; Harbluk JL, 2007, ACCIDENT ANAL PREV, V39, P372, DOI 10.1016/j.aap.2006.08.013; Jagoda A, 2000, EMERG MED CLIN N AM, V18, P355, DOI 10.1016/S0733-8627(05)70130-9; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kuwabara K, 2006, J EVAL CLIN PRACT, V12, P164, DOI 10.1111/j.1365-2753.2006.00597.x; Mankowski PJ, 2016, BURNS, V42, pE61, DOI 10.1016/j.burns.2015.10.012; Mirman JH, 2017, ACCIDENT ANAL PREV, V104, P18, DOI 10.1016/j.aap.2017.04.014; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; National Center for Injury Prevention and Control; Centers for Disease Control and Prevention, WISQARS NONF INJ DAT; National Highway Traffic Safety Administration, 2017, DISTR DRIV FAT CRASH; National Highway Traffic Safety Administration, 2017, TEEN DRIV RES; Nawar Eric W, 2007, Adv Data, P1; Overton TL, 2015, INT J INJ CONTROL SA, V22, P187, DOI 10.1080/17457300.2013.879482; Perelman VS, 2004, ANN EMERG MED, V43, P362, DOI 10.1016/j.annemergmed.2003.09.008; Povolotskiy R, 2019, ANN OTO RHINOL LARYN, V128, P516, DOI 10.1177/0003489419830114; Quinn JV, 2014, EMERG MED J, V31, P96, DOI 10.1136/emermed-2012-202143; Richards Kate Gemma, 2018, BMJ Case Rep, V11, DOI 10.1136/bcr-2017-224012; Sethi RKV, 2014, OTOLARYNG HEAD NECK, V151, P776, DOI 10.1177/0194599814546112; Singer AJ, 2000, AM J EMERG MED, V18, P683, DOI 10.1053/ajem.2000.16312; Smith DC, 2013, J SAFETY RES, V47, P19, DOI 10.1016/j.jsr.2013.08.003; Strayer DL, 2011, PSYCHOL LEARN MOTIV, V54, P29, DOI 10.1016/B978-0-12-385527-5.00002-4; Tebble NJ, 2006, BRIT J ORAL MAX SURG, V44, P520, DOI 10.1016/j.bjoms.2005.10.010; Truong LT, 2019, TRAFFIC INJ PREV, V20, P204, DOI 10.1080/15389588.2018.1546048; US Consumer Product Safety Commission, NEISS HIGHL DAT QUER; Wilson FA, 2010, AM J PUBLIC HEALTH, V100, P2213, DOI 10.2105/AJPH.2009.187179; Youssef P, 2018, J CRANIO MAXILL SURG, V46, P1539, DOI 10.1016/j.jcms.2018.05.054; Zatezalo N, 2018, J EMERG TRAUMA SHOCK, V11, P175, DOI 10.4103/JETS.JETS_24_18	37	9	9	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6181	2168-619X		JAMA OTOLARYNGOL	JAMA Otolaryngol-Head Neck Surg.	FEB	2020	146	2					122	127		10.1001/jamaoto.2019.3678			6	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology; Surgery	KS0QK	WOS:000518016400008	31804678	Green Published, Bronze			2022-02-06	
J	Shao, XF; Li, B; Shen, J; Wang, QF; Chen, SS; Jiang, XC; Qiang, D				Shao, Xue-Fei; Li, Bo; Shen, Jun; Wang, Qi-Fu; Chen, San-Song; Jiang, Xiao-Chun; Qiang, Di			Ghrelin alleviates traumatic brain injury-induced acute lung injury through pyroptosis/NF-kappa B pathway	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Traumatic brain injury; Acute lung injury; Pyroptosis; Inflammation; NF-kappa B pathway	ISCHEMIA/REPERFUSION INJURY; ORGAN DYSFUNCTION; MOUSE MODEL; EXPRESSION; PROTECTS; INFLAMMASOMES; PERMEABILITY; INFLAMMATION; INHIBITION; ACTIVATION	Acute lung injury (ALI) is one of the severe complications in patients with traumatic brain injury (TBI), contributing to the high mortality. Ghrelin has protective effects against various inflammatory diseases, but the effects of Ghrelin on TBI-induced ALI and its mechanisms remain unknown. In this study, Ghrelin administration was performed on the mice with TBI, then histological change in cortex and lung tissues, lung vascular permeability and macrophage number in bronchoalveolar lavage fluid (BALF) were examined, respectively. Simultaneously, the alterations of proinflammatory factors and pyroptosis-related proteins in lung tissues were detected. As a result, TBI-induced ALI was ameliorated after Ghrelin treatment, which was demonstrated by improved histology, reduced lung vascular permeability, and peripheral macrophage number. Furthermore, Ghrelin decreased the mRNA levels of proinflammatory factors (IL-1 beta, IL-6, TNF-alpha and IL-18), the protein levels of pyroptosis-related proteins (NLRP3, Caspasel-P20, HMGB1 and Gasdermin D), and the phosphorylation levels of NF-kappa B in lung tissues. These results showed that Ghrelin attenuating TBI-induced Ali might be via ameliorating inflammasome-induced pyroptosis by blocking NF-xB signal, which are important for the prevention and treatment of TBI-induced ALI.	[Shao, Xue-Fei; Shen, Jun; Wang, Qi-Fu; Chen, San-Song; Jiang, Xiao-Chun] Wannan Med Coll, Dept Neurosurg, Yi Ji Shan Hosp, 2 ZheShan West Rd, Wuhu 241000, Anhui, Peoples R China; [Li, Bo] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Qiang, Di] Wannan Med Coll, Dept Dermatol & STD, Yi Ji Shan Hosp, 2 ZheShan West Rd, Wuhu 241000, Anhui, Peoples R China		Shao, XF (corresponding author), Wannan Med Coll, Dept Neurosurg, Yi Ji Shan Hosp, 2 ZheShan West Rd, Wuhu 241000, Anhui, Peoples R China.; Qiang, D (corresponding author), Wannan Med Coll, Dept Dermatol & STD, Yi Ji Shan Hosp, 2 ZheShan West Rd, Wuhu 241000, Anhui, Peoples R China.	drshao@163.com; drqiangdi@163.com			Wannan Medical College [WK2017ZFO4, 2018jyxm58]; Yi-Ji Shan Hospital [Y1822]; Collegiate Major Natural Science Research Projects of Anhui Province [KJ2018ZD027, KJ2017A267]; Natural Science foundation of Anhui provinceNatural Science Foundation of Anhui Province [1908085QH362]	This study was funded by the priority of research funds of Wannan Medical College (WK2017ZFO4), the new project of Yi-Ji Shan Hospital (Y1822), the teaching quality and teaching reform project of Warman Medical College (2018jyxm58), the Collegiate Major Natural Science Research Projects (KJ2018ZD027, KJ2017A267) `of Anhui Province, and Natural Science foundation of Anhui province (1908085QH362).	Andrews ZB, 2011, TRENDS NEUROSCI, V34, P31, DOI 10.1016/j.tins.2010.10.001; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009; Chang LL, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116654; Chen J, 2008, MED SCI MONITOR, V14, pBR141; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eberhard LW, 2000, CRIT CARE MED, V28, P125, DOI 10.1097/00003246-200001000-00021; Ezquerro S, 2019, J CLIN ENDOCR METAB, V104, P21, DOI 10.1210/jc.2018-01171; Frago LM, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00023, 10.3389/fnmol.2011.00023]; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Grandjean-Laquerriere A, 2007, CYTOKINE, V37, P76, DOI 10.1016/j.cyto.2007.02.020; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Hsieh Chia-Jung, 2007, Clin Mol Allergy, V5, P5, DOI 10.1186/1476-7961-5-5; Imazu Y, 2011, EUR J PHARMACOL, V672, P153, DOI 10.1016/j.ejphar.2011.09.183; Jiao Q, 2017, NEUROSCI BIOBEHAV R, V73, P98, DOI 10.1016/j.neubiorev.2016.12.010; Jobin C, 1999, J IMMUNOL, V163, P3474; Kemp CD, 2008, AM SURGEON, V74, P866; Kim HM, 2018, IMMUNITY, V49, P582, DOI 10.1016/j.immuni.2018.09.021; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Li G, 2017, INT IMMUNOPHARMACOL, V52, P85, DOI 10.1016/j.intimp.2017.08.026; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; MASON JC, 1977, MICROVASC RES, V13, P185, DOI 10.1016/0026-2862(77)90084-X; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Peng ZY, 2012, INT IMMUNOPHARMACOL, V13, P440, DOI 10.1016/j.intimp.2012.04.006; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Ramtinfar S, 2016, INDIAN J CRIT CARE M, V20, P575, DOI 10.4103/0972-5229.192042; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SINCLAIR DG, 1994, CHEST, V106, P535, DOI 10.1378/chest.106.2.535; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun N, 2016, MOL MED REP, V14, P2764, DOI 10.3892/mmr.2016.5535; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian XL, 2018, LIFE SCI, V196, P1, DOI 10.1016/j.lfs.2017.07.023; Wang L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122024; Wang Q, 2017, LIFE SCI, V186, P50, DOI 10.1016/j.lfs.2017.08.004; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Zhang H, 2013, J CLIN INVEST, V123, P1019, DOI 10.1172/JCI64931; Zhou XL, 2010, AM J MED SCI, V339, P49, DOI 10.1097/MAJ.0b013e3181b9c3d3	49	9	16	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	FEB	2020	79								106175	10.1016/j.intimp.2019.106175			7	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	KN3PW	WOS:000514753800037	31918060				2022-02-06	
J	Stuart, S; Parrington, L; Morris, R; Martini, DN; Fino, PC; King, LA				Stuart, Samuel; Parrington, Lucy; Morris, Rosie; Martini, Douglas N.; Fino, Peter C.; King, Laurie A.			Gait measurement in chronic mild traumatic brain injury: A model approach	HUMAN MOVEMENT SCIENCE			English	Article						Gait; Mild traumatic brain injury; Principle component analysis; Inertial sensors	DUAL-TASK; INDEPENDENT DOMAINS; DETECTING GAIT; OLDER-ADULTS; SAMPLE-SIZE; CONCUSSION; DEFICITS; DYSFUNCTION; MOBILITY; SPEED	Introduction: Mild traumatic brain injury (mTBI) can impact gait, with deficits linked to underlying neural disturbances in cognitive, motor and sensory systems. Gait is complex as it is comprised of multiple characteristics that are sensitive to underlying neural deficits. However, there is currently no clear framework to guide selection of gait characteristics in mTBI. This study developed a model of gait in chronic mTBI and replicated this in a separate group of controls, to provide a comprehensive and structured methodology on which to base gait assessment and analysis. Methods: Fifty-two people with chronic mTBI and 59 controls completed a controlled laboratory gait assessment; walking for two minutes back and forth over a 13 m distance while wearing five wirelessly synchronized inertial sensors. Thirteen gait characteristics derived from the inertial sensors were selected for entry into the principle component analysis based on previous literature, robustness and novelty. Principle component analysis was then used to derive domains (components) of gait. Results: Four gait domains were derived for our chronic mTBI group (variability, rhythm, pace and turning) and this was replicated in a separate control cohort. Domains totaled 80.8% and 77.4% of variance in gait for chronic mTBI and controls, respectively. Gait characteristic loading was unambiguous for all features, with the exception of gait speed in controls that loaded on pace and rhythm domains. Conclusion: This study contributes a four component model of gait in chronic mTBI and controls that can be used to comprehensively assess and analyze gait and underlying mechanisms involved in impairment, or examine the influence of interventions.	[Stuart, Samuel; Parrington, Lucy; Morris, Rosie; Martini, Douglas N.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Stuart, Samuel; Parrington, Lucy; Morris, Rosie; Martini, Douglas N.; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Stuart, Samuel; Morris, Rosie] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Fino, Peter C.] Univ Utah, Salt Lake City, UT USA		Stuart, S; King, LA (corresponding author), Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	sam.stuart@northumbria.ac.uk	Morris, Rosie/ABA-4919-2021; Stuart, Samuel/I-6449-2019	Stuart, Samuel/0000-0001-6846-9372; Parrington, Lucy/0000-0001-8507-9974; Morris, Rosie/0000-0002-0290-6688	Defense for Health Affairs [W81XWH-15-1-0620]; Parkinson's Foundation [PF-FBS-1898]	This work was supported by the Assistant Secretary of Defense for Health Affairs [Award No. W81XWH-15-1-0620]. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Samuel Stuart is supported in part by a Postdoctoral Fellowship from the Parkinson's Foundation [Grant Number PF-FBS-1898].	Bandalos DL, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P61; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Brach JS, 2010, GAIT POSTURE, V31, P175, DOI 10.1016/j.gaitpost.2009.10.002; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2, P430; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Del Din S, 2019, ANN NEUROL, V86, P357, DOI 10.1002/ana.25548; Del Din S, 2016, IEEE J BIOMED HEALTH, V20, P838, DOI 10.1109/JBHI.2015.2419317; Dochtermann NA, 2011, ETHOLOGY, V117, P95, DOI 10.1111/j.1439-0310.2010.01846.x; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Grants L, 2017, INT J SPORTS PHYS TH, V12, P1011, DOI 10.26603/ijspt20171011; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Horak FB, 2016, PHYS THER, V96, P1364, DOI 10.2522/ptj.20150580; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lord S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00249; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Martini DN, 2016, GAIT POSTURE, V49, P264, DOI 10.1016/j.gaitpost.2016.06.028; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mc Ardle R, 2019, ALZHEIMERS DEMENT, V15, P1367, DOI 10.1016/j.jalz.2019.06.4953; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Morris R, 2019, PARKINSONISM RELAT D, V69, P104, DOI 10.1016/j.parkreldis.2019.06.014; Morris R, 2017, GAIT POSTURE, V52, P68, DOI 10.1016/j.gaitpost.2016.11.024; Morris R, 2016, NEUROSCI BIOBEHAV R, V64, P326, DOI 10.1016/j.neubiorev.2016.02.012; Osborne JW., 2004, PRACTICAL ASSESSMENT, P9; Paterson KL, 2008, ARCH PHYS MED REHAB, V89, P2360, DOI 10.1016/j.apmr.2008.06.018; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Schmitz-Hubsch T, 2016, GAIT POSTURE, V48, P194, DOI 10.1016/j.gaitpost.2016.05.014; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Velicer WF, 1998, PSYCHOL METHODS, V3, P231, DOI 10.1037/1082-989X.3.2.231; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Vienne A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00817; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	49	9	9	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	FEB	2020	69								102557	10.1016/j.humov.2019.102557			9	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	KG3BB	WOS:000509816400007	31783306	Green Accepted			2022-02-06	
J	von Steinbuchel, N; Meeuwsen, M; Zeldovich, M; Vester, JC; Maas, A; Koskinen, S; Covic, A				von Steinbuechel, Nicole; Meeuwsen, Mirjam; Zeldovich, Marina; Vester, Johannes C.; Maas, Andrew; Koskinen, Sanna; Covic, Amra			Differences in Health-Related Quality of Life after Traumatic Brain Injury between Varying Patient Groups: Sensitivity of a Disease-Specific (QOLIBRI) and a Generic (SF-36) Instrument	JOURNAL OF NEUROTRAUMA			English	Article						disease-specific; health-related quality of life; QOLIBRI; SF-36; traumatic brain injury	GLASGOW OUTCOME SCALE; PSYCHIATRIC-DISORDERS; SURVEY QUESTIONNAIRE; HOSPITAL ANXIETY; MODERATE; VALIDITY; INDIVIDUALS; DEPRESSION; MILD; PREVALENCE	Factors associated with health-related quality of life (HRQOL) in patients after traumatic brain injury (TBI) include severity of initial injury, different grades of trauma recovery, sociodemographic status, and psychological characteristics. Yet, sensitivity of HRQOL instruments to such effects is often underexplored. Thus, we aimed to compare the capacity of the disease-specific QOLIBRI (Quality of Life after Brain Injury) and the generic Medical Outcomes Study (MOS) 36-Item Short-Form Health Survey(SF-36) to detect significant differences in HRQOL between patients. Patients (n = 795) completed HRQOL, sociodemographic, clinical, psychological, and health status questionnaires. Univariate (Wilcoxon-Mann-Whitney) and multi-variate (Wei-Lachin) non-parametric analyses were conducted using the Wilcoxon-Mann-Whitney approach to compare the sensitivity of the QOLIBRI and the SF-36. For both instruments, HRQOL was particularly influenced by patients' reliance on others, depression, anxiety, and recovery status, whereas smaller effects were found for living arrangements and participation in leisure activities. Both HRQOL instruments were sensitive to group differences, but the QOLIBRI was able to detect a greater number of and finer differences between specific patient groups, which is particularly important in clinical and therapeutic contexts. This finding is likely explained by the QOLIBRI's greater specificity to disease-specific aspects of consequences of TBI. This head-to-head HRQOL instrument comparison resulted in a recommendation for the use of the QOLIBRI when detailed insight in the subjective consequences and impact of TBI on patients is required.	[von Steinbuechel, Nicole; Meeuwsen, Mirjam; Zeldovich, Marina; Covic, Amra] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany; [Vester, Johannes C.] IDV Datenanal & Versuchsplanung, Gauting, Germany; [Maas, Andrew] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; [Maas, Andrew] Univ Antwerp, Antwerp, Belgium; [Koskinen, Sanna] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland		von Steinbuchel, N (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37A, D-37073 Gottingen, Germany.	nvsteinbuechel@med.uni-goettingen.de		Koskinen, Sanna/0000-0002-3453-5084			Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Bandayrel K, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0110-7; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Lachin JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108784; Lamontagne ME, 2013, BRAIN INJURY, V27, P135, DOI 10.3109/02699052.2012.722253; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; McIntyre M, 2020, DISABIL REHABIL, V42, P754, DOI 10.1080/09638288.2018.1508511; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P87; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Perez Lori, 2007, J Neurosci Nurs, V39, P342; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Polinder S, 2010, INJURY PREV, V16, P147, DOI 10.1136/ip.2009.022418; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware J. E., 1996, SF 36 HLTH SURVEY VE; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; Ware Jr, 2000, SPINE, V25, P3130, DOI DOI 10.1097/00007632-200012150-00008; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	9	9	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1242	1254		10.1089/neu.2019.6627		JAN 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000512299300001	31801408				2022-02-06	
J	Caccese, JB; Bodt, BA; Iverson, GL; Kaminski, TW; Bryk, K; Oldham, J; Broglio, SP; McCrea, M; McAllister, T; Buckley, TA; Ortega, JD; Port, N; Goldman, JT; Giza, CC; Benjamin, HJ; Clugston, JR; Feigenbaum, LA; Eckner, JT; Mihalik, JP; Master, CL; Kontos, AP; Jackson, J; Susmarski, A; Duma, S; Miles, CM; Lintner, L				Caccese, Jaclyn B.; Bodt, Barry A.; Iverson, Grant L.; Kaminski, Thomas W.; Bryk, Kelsey; Oldham, Jessie; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas; Buckley, Thomas A.; Ortega, Justus D.; Port, Nicholas; Goldman, Joshua T.; Giza, Christopher C.; Benjamin, Holly J.; Clugston, James R.; Feigenbaum, Luis A.; Eckner, James T.; Mihalik, Jason P.; Master, Christina L.; Kontos, Anthony P.; Jackson, Jonathan; Susmarski, Adam; Duma, Stefan; Miles, Christopher M.; Lintner, Laura		CARE Consortium Investigators	Estimated Age of First Exposure to Contact Sports and Neurocognitive, Psychological, and Physical Outcomes in Healthy NCAA Collegiate Athletes: A Cohort Study	SPORTS MEDICINE			English	Article							HIGH-SCHOOL FOOTBALL; HEAD IMPACT EXPOSURE; LATER-LIFE; CONCUSSION; BRAIN; ASSOCIATION; COGNITION; AMERICAN; TRAINERS; PLAYERS	Background Collegiate football players who started playing tackle football before age 12 years did not show worse neuropsychological test performance than those who started playing tackle football after age 12 years. It is unknown if beginning other contact sports, such as lacrosse, at a younger age is associated with worse neurocognitive performance, greater psychological distress, or worse postural stability in collegiate student athletes. Objective The purpose of this study was to examine the association between estimated age of first exposure (eAFE) to repetitive head impacts (RHI) and these outcome measures in collegiate student athletes. Methods 1891 female and 4448 male collision/contact (i.e., football, ice hockey, lacrosse, wrestling, soccer) and non-contact (i.e., golf, rifle, rowing/crew, swimming, tennis) sport athletes completed baseline testing, including the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Brief Symptom Inventory 18 (BSI-18), and Balance Error Scoring System (BESS). Results For women, the eAFE-by-sport interaction was associated with ImPACT Verbal Memory and Visual Memory, whereby earlier eAFE to contact sports was associated with higher composite scores (B = - 0.397, B = - 0.485, respectively). For men, the eAFE-by-sport interaction was associated with BSI-18 Depression and Global Severity Index and symptom severity scores, whereby earlier eAFE to football was associated with lower psychological distress and symptom severity [Depression, Exp(B) = 1.057; Global Severity Index, Exp(B) = 1.047; Symptom Severity, Exp(B) = 1.046]. Parameter estimates were small suggesting these results may have minimal practical relevance. Conclusion Findings suggest that RHI during early adolescence is unrelated to brain health as measured by these specific outcome measures in collegiate student athletes.	[Caccese, Jaclyn B.] Ohio State Univ, Sch Hlth & Rehabil Sci, Coll Med, 453 W 10th Ave, Columbus, OH 43210 USA; [Bodt, Barry A.] Univ Delaware, Coll Hlth Sci, 540 S Coll Ave, Newark, DE 19713 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, MassGen Hosp Children Sports Concuss Program & Ho, Boston, MA 02115 USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Iverson, Grant L.] Ctr Hlth & Rehabil Res, 79 96 Thirteenth St, Charlestown, MA 20129 USA; [Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Interdisciplinary Biomech & Movement Sci Program, 541 S Coll Ave, Newark, DE 19716 USA; [Bryk, Kelsey; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Interdisciplinary Biomech & Movement Sci Program, 100 Discovery Blvd, Newark, DE 19713 USA; [Oldham, Jessie] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, 9 Hope Ave, Waltham, MA 02453 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48104 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [McAllister, Thomas] Indiana Univ Sch Med, 355 W 16th St,Suite 4800, Indianapolis, IN 46202 USA; [Ortega, Justus D.] Humboldt State Univ, Arcata, CA 95521 USA; [Port, Nicholas] Indiana Univ, Bloomington, IN 47405 USA; [Goldman, Joshua T.; Giza, Christopher C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Benjamin, Holly J.] Univ Chicago, Chicago, IL 60637 USA; [Clugston, James R.] Univ Florida, Gainesville, FL 32611 USA; [Feigenbaum, Luis A.] Univ Miami, Coral Gables, FL 33124 USA; [Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Mihalik, Jason P.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Master, Christina L.] Univ Penn, Philadelphia, PA 19104 USA; [Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Jackson, Jonathan] US Air Force Acad, Colorado Springs, CO 80840 USA; [Susmarski, Adam] US Naval Acad, Annapolis, MD 21402 USA; [Duma, Stefan] Virginia Tech, Blacksburg, VA USA; [Miles, Christopher M.] Wake Forest Univ, Winston Salem, NC 27101 USA; [Lintner, Laura] Winston Salem Univ, Winston Salem, NC USA		Caccese, JB (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, Coll Med, 453 W 10th Ave, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu; babodt@udel.edu; giverson@mgh.harvard.edu; kaminski@udel.edu; kbryk@udel.edu; Jessie.Oldham@childrens.harvard.edu; broglio@umich.edu; mmccrea@mcw.edu; twmcalli@iupui.edu; tbuckley@udel.edu	Caccese, Jaclyn B./AAH-4571-2020; Buckley, Thomas A/B-7525-2016	Caccese, Jaclyn B./0000-0003-2329-3603; Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110; Iverson, Grant/0000-0001-7348-9570; Susmarski, Adam/0000-0003-3698-4163; Kaminski, Thomas/0000-0003-0924-0978; Bodt, Barry/0000-0003-1086-9837; Ortega, Justus/0000-0002-9931-5605	Grand Alliance CARE Consortium - NCAA; DoDUnited States Department of Defense; USAMRAA, Ford Detrick, MD, USA; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded by the NCAA and the DoD. The USAMRAA, Ford Detrick, MD, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the DoD (DHP funds).	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco ML, 2019, SEMIN PEDIAT NEUROL; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brett BL, 2019, SPORTS HLTH; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2019, CLIN NEUROPSYCHOL; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stone Arthur A., 1999, SCI SELF REPORT IMPL	45	9	9	2	11	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	JUL	2020	50	7					1377	1392		10.1007/s40279-020-01261-4		JAN 2020	16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	LZ5CD	WOS:000510280100001	32002824				2022-02-06	
J	Takada, S; Sakakima, H; Matsuyama, T; Otsuka, S; Nakanishi, K; Norimatsu, K; Itashiki, Y; Tani, A; Kikuchi, K				Takada, Seiya; Sakakima, Harutoshi; Matsuyama, Takahiro; Otsuka, Shotaro; Nakanishi, Kazuki; Norimatsu, Kosuke; Itashiki, Yuki; Tani, Akira; Kikuchi, Kiyoshi			Disruption of Midkine gene reduces traumatic brain injury through the modulation of neuroinflammation	JOURNAL OF NEUROINFLAMMATION			English	Article						Midkine; Traumatic brain injury; Microglia; macrophages; M1; M2 phenotype; Neuroinflammation	MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; BINDING GROWTH-FACTOR; SPINAL-CORD; T-CELLS; INTRACEREBRAL HEMORRHAGE; DEGENERATION; REGENERATION; PLEIOTROPHIN; MACROPHAGES; DIFFERENTIATION	Background Midkine (MK) is a multifunctional cytokine found upregulated in the brain in the presence of different disorders characterized by neuroinflammation, including neurodegenerative disorders and ischemia. The neuroinflammatory response to traumatic brain injury (TBI) represents a key secondary injury factor that can result in further neuronal injury. In the present study, we investigated the role of endogenous MK in secondary injury, including neuroinflammation, immune response, and neuronal apoptosis activity, after TBI. Methods Wild type (Mdk(+/+)) and MK gene deficient (Mdk(-/-)) mice were subjected to fluid percussion injury for TBI models and compared at 3, 7, and 14 days after TBI, in terms of the following: brain tissue loss, neurological deficits, microglia response, astrocytosis, expression of proinflammatory M1 and anti-inflammatory M2 microglia/macrophage phenotype markers, and apoptotic activity. Results As opposed to Mdk(+/+) mice, Mdk(-/-) mice reported a significantly reduced area of brain tissue loss and an improvement in their neurological deficits. The ratios of the Iba1-immunoreactive microglia/macrophages in the perilesional site were significantly decreased in Mdk(-/-) than in the Mdk(+/+) mice at 3 days after TBI. However, the ratios of the glial fibrillary acidic protein immunoreactive area were similar between the two groups. The M1 phenotype marker (CD16/32) immunoreactive areas were significantly reduced in Mdk(-/-) than in the Mdk(+/+) mice. Likewise, the mRNA levels of the M1 phenotype markers (TNF-alpha, CD11b) were significantly decreased in Mdk(-/-) mice than in Mdk(+/+) mice. Furthermore, flow cytometry analysis identified the M2 markers, i.e., CD163(+) macrophages cells and arginase-1(+) microglia cells, to be significantly higher in Mdk(-/-) than in Mdk(+/+) mice. Finally, the ratios of apoptotic neurons were significantly decreased in the area surrounding the lesion in Mdk(-/-) than in Mdk(+/+) mice following TBI. Conclusion Our findings suggest that MK-deficiency reduced tissue infiltration of microglia/macrophages and altered their polarization status thereby reducing neuroinflammation, neuronal apoptosis, and tissue loss and improving neurological outcomes after TBI. Therefore, targeting MK to modulate neuroinflammation may represent a potential therapeutic strategy for TBI management.	[Takada, Seiya; Sakakima, Harutoshi; Otsuka, Shotaro; Nakanishi, Kazuki; Norimatsu, Kosuke; Itashiki, Yuki; Tani, Akira] Kagoshima Univ, Sch Hlth Sci, Fac Med, Dept Phys Therapy, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan; [Matsuyama, Takahiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan; [Kikuchi, Kiyoshi] Kurume Univ, Dept Physiol, Div Brain Sci, Sch Med, Kurume, Japan		Sakakima, H (corresponding author), Kagoshima Univ, Sch Hlth Sci, Fac Med, Dept Phys Therapy, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	sakaki@health.nop.kagoshima-u.ac.jp			JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP17K01459]	This work was supported by grant from the JSPS KAKENHI (grant No. JP17K01459 to Harutoshi Sakakima).	Aynacioglu AS, 2019, MOD RHEUMATOL, V29, P567, DOI 10.1080/14397595.2018.1523701; Clark W, 1998, STROKE, V29, P2136, DOI 10.1161/01.STR.29.10.2136; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Fernandez-Calle R, 2018, NEUROSCI LETT, V662, P213, DOI 10.1016/j.neulet.2017.10.038; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Herradon G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00377; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Ikutomo M, 2014, ACTA HISTOCHEM, V116, P319, DOI 10.1016/j.acthis.2013.08.009; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; Meng XQ, 2019, EBIOMEDICINE, V41, P185, DOI 10.1016/j.ebiom.2019.01.067; Muramatsu T, 2011, CURR PHARM DESIGN, V17, P410, DOI 10.2174/138161211795164167; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Muramoto A, 2013, NEUROSCI LETT, V550, P150, DOI 10.1016/j.neulet.2013.06.025; Nimmervoll B, 2013, CEREB CORTEX, V23, P1742, DOI 10.1093/cercor/bhs156; Ochiai K, 2004, LIVER INT, V24, P484, DOI 10.1111/j.1478-3231.2004.0990.x; Sakakima H, 2004, J NEUROTRAUM, V21, P471, DOI 10.1089/089771504323004610; Sakakima H, 2009, J NEUROSCI RES, V87, P2908, DOI 10.1002/jnr.22127; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Soares HD, 1995, J NEUROSCI, V15, P8223; Sonobe Y, 2012, J IMMUNOL, V188, P2602, DOI 10.4049/jimmunol.1102346; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; TSUTSUI J, 1993, CANCER RES, V53, P1281; Tucker LB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00509; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vicente-Rodriguez M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9894504; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Weckbach LT, 2014, BLOOD, V123, P1887, DOI 10.1182/blood-2013-06-510875; Xie LK, 2015, EUR J IMMUNOL, V45, P180, DOI 10.1002/eji.201444823; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; YASUHARA O, 1993, BIOCHEM BIOPH RES CO, V192, P246, DOI 10.1006/bbrc.1993.1406; YOSHIDA Y, 1995, DEV BRAIN RES, V85, P25, DOI 10.1016/0165-3806(94)00183-Z; Zhou K, 2017, J CEREBR BLOOD F MET, V37, P967, DOI 10.1177/0271678X16648712; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423	46	9	9	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 29	2020	17	1							40	10.1186/s12974-020-1709-8			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	KW6CA	WOS:000521251400001	31996236	gold, Green Published			2022-02-06	
J	Crespo-Castrillo, A; Garcia-Segura, LM; Arevalo, MA				Crespo-Castrillo, Andrea; Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles			The synthetic steroid tibolone exerts sex-specific regulation of astrocyte phagocytosis under basal conditions and after an inflammatory challenge	JOURNAL OF NEUROINFLAMMATION			English	Article						Astrocytes; Phagocytosis; Tibolone; Estrogen receptor; Androgen receptor; LPS; Sex differences; Cellular debris	ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; GENDER-DIFFERENCES; CELLS; EXPRESSION; MICROGLIA; ESTRADIOL; ACTIVATION; MECHANISM; ALPHA	Background Tibolone is a synthetic steroid used in clinical practice for the treatment of climacteric symptoms and osteoporosis. Active metabolites of tibolone, generated in target tissues, have an affinity for estrogen and androgen receptors. Astrocytes are direct targets for estrogenic compounds and previous studies have shown that tibolone protects brain cortical neurons in association with a reduction in reactive astrogliosis in a mouse model of traumatic brain injury. Since phagocytosis is a crucial component of the neuroprotective function exerted by astrocytes, in the present study, we have assessed whether tibolone regulates phagocytosis in primary astrocytes incubated with brain-derived cellular debris. Methods Male and female astrocyte cell cultures were obtained from newborn (P0-P2) female and male Wistar rats. Astrocytic phagocytosis was first characterized using carboxylate beads, Escherichia coli particles, or brain-derived cellular debris. Then, the effect of tibolone on the phagocytosis of Cy3-conjugated cellular debris was quantified by measuring the intensity of Cy3 dye-emitted fluorescence in a given GFAP immunoreactive area. Before the phagocytosis assays, astrocytes were incubated with tibolone in the presence or absence of estrogen or androgen receptor antagonists or an inhibitor of the enzyme that synthesizes estradiol. The effect of tibolone on phagocytosis was analyzed under basal conditions and after inflammatory stimulation with lipopolysaccharide. Results Tibolone stimulated phagocytosis of brain-derived cellular debris by male and female astrocytes, with the effect being more pronounced in females. The effect of tibolone in female astrocytes was blocked by a selective estrogen receptor beta antagonist and by an androgen receptor antagonist. None of these antagonists affected tibolone-induced phagocytosis in male astrocytes. In addition, the inhibition of estradiol synthesis in the cultures enhanced the stimulatory effect of tibolone on phagocytosis in male astrocytes but blocked the effect of the steroid in female cells under basal conditions. However, after inflammatory stimulation, the inhibition of estradiol synthesis highly potentiated the stimulation of phagocytosis by tibolone, particularly in female astrocytes. Conclusions Tibolone exerts sex-specific regulation of phagocytosis in astrocytes of both sexes, both under basal conditions and after inflammatory stimulation.	[Crespo-Castrillo, Andrea; Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles] CSIC, Inst Cajal, Madrid, Spain; [Garcia-Segura, Luis-Miguel; Arevalo, Maria-Angeles] Inst Salud Carlos III, CIBERFES, Madrid, Spain		Arevalo, MA (corresponding author), CSIC, Inst Cajal, Madrid, Spain.; Arevalo, MA (corresponding author), Inst Salud Carlos III, CIBERFES, Madrid, Spain.	arevalo@cajal.csic.es	Arevalo, Maria-Angeles/J-7000-2014	Arevalo, Maria-Angeles/0000-0002-4303-9576	Agencia Estatal de Investigacion (AEI); Fondo Europeo de Desarrollo Regional (FEDER)European Commission [BFU2017-82754-R]; CIBERFES [CB16/10/00383]	This study is supported by a grant from Agencia Estatal de Investigacion (AEI), co-funded by Fondo Europeo de Desarrollo Regional (FEDER): BFU2017-82754-R, and by CIBERFES: CB16/10/00383.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Albertazzi P, 2000, MATURITAS, V36, P223, DOI 10.1016/S0378-5122(00)00147-X; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X; Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; BERBEL P, 1988, J COMP NEUROL, V276, P132, DOI 10.1002/cne.902760109; Chisholm NC, 2016, NEUROBIOL DIS, V85, P245, DOI 10.1016/j.nbd.2015.03.028; Chistyakov DV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092793; Chowen JA, 2018, FRONT NEUROENDOCRIN, V48, P3, DOI 10.1016/j.yfrne.2017.05.003; Chung WS, 2016, P NATL ACAD SCI USA, V113, P10186, DOI 10.1073/pnas.1609896113; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Ciesielska A, 2009, INFLAMM RES, V58, P747, DOI 10.1007/s00011-009-0026-6; Couturier J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0477-y; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Duncan KA, 2013, J NEUROTRAUM, V30, P1919, DOI 10.1089/neu.2013.2951; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; Emanuelsson I, 2018, NEUROCHEM INT, V113, P46, DOI 10.1016/j.neuint.2017.11.007; Espinosa-Raya J, 2012, HORM BEHAV, V61, P76, DOI 10.1016/j.yhbeh.2011.10.005; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Figueira ML, 2010, CURR OPIN PSYCHIATR, V23, P369, DOI 10.1097/YCO.0b013e3283399b86; Fluck E, 2002, J CLIN PSYCHOPHARM, V22, P62, DOI 10.1097/00004714-200202000-00010; Genazzani Andrea Riccardo, 2006, Neuropsychiatr Dis Treat, V2, P299, DOI 10.2147/nedt.2006.2.3.299; Gomez-Arboledas A, 2018, GLIA, V66, P637, DOI 10.1002/glia.23270; Gonzalez-Giraldo Y, 2019, MOL CELL ENDOCRINOL, V486, P65, DOI 10.1016/j.mce.2019.02.017; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Grassi D, 2013, ENDOCRINOLOGY, V154, P2092, DOI 10.1210/en.2012-2137; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Jaber SM, 2018, NEUROCHEM INT, V117, P82, DOI 10.1016/j.neuint.2017.09.003; Jobin C, 2010, WOMENS HEALTH, V6, P797, DOI 10.2217/WHE.10.69; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Jung YJ, 2018, BIOMOL THER, V26, P350, DOI 10.4062/biomolther.2017.133; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Kalmar B, 2001, NEUROCHEM INT, V38, P453, DOI 10.1016/S0197-0186(00)00090-5; Kim S, 2015, COMPR PSYCHIAT, V62, P114, DOI 10.1016/j.comppsych.2015.07.002; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Li R, 2000, J NEUROCHEM, V75, P1447, DOI 10.1046/j.1471-4159.2000.0751447.x; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Loiola RA, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00420; Martin-Jimenez C, 2019, NEUROENDOCRINOLOGY, V108, P142, DOI 10.1159/000495078; Mecha M, 2011, PROTOC EXCHANGE, P218; Modelska K, 2002, J CLIN ENDOCR METAB, V87, P16, DOI 10.1210/jc.87.1.16; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Morizawa YM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00037-1; Morrison HW, 2016, NEUROSCIENCE, V339, P85, DOI 10.1016/j.neuroscience.2016.09.047; Nelson LH, 2017, BRAIN BEHAV IMMUN, V64, P11, DOI 10.1016/j.bbi.2017.03.010; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Palomba S, 2008, FERTIL STERIL, V90, P165, DOI 10.1016/j.fertnstert.2007.05.061; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Ponath G, 2017, BRAIN, V140, P399, DOI 10.1093/brain/aww298; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; RAINBOW TC, 1982, NATURE, V300, P648, DOI 10.1038/300648a0; Raven G, 2006, J CLIN ENDOCR METAB, V91, P3324, DOI 10.1210/jc.2006-0462; Rowan BG, 2000, STEROIDS, V65, P545, DOI 10.1016/S0039-128X(00)00112-4; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Santos-Galindo Maria, 2011, Biol Sex Differ, V2, P7, DOI 10.1186/2042-6410-2-7; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Villa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15224; Voskuhl Rhonda, 2011, Biol Sex Differ, V2, P1, DOI 10.1186/2042-6410-2-1; Yanguas-Casas N, 2018, GLIA, V66, P522, DOI 10.1002/glia.23263; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	71	9	9	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 28	2020	17	1							37	10.1186/s12974-020-1719-6			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	KW6WI	WOS:000521322800001	31992325	Green Published, gold			2022-02-06	
J	Kent, R; Forman, J; Bailey, AM; Funk, J; Sherwood, C; Crandall, J; Arbogast, KB; Myers, BS				Kent, Richard; Forman, Jason; Bailey, Ann M.; Funk, James; Sherwood, Chris; Crandall, Jeff; Arbogast, Kristy B.; Myers, Barry S.			The biomechanics of concussive helmet-to-ground impacts in the National Football league	JOURNAL OF BIOMECHANICS			English	Article						Concussion; Injury prevention; Helmets; Football	PROFESSIONAL FOOTBALL; STRAIN RESPONSES; INJURY RISK; HEAD; PERFORMANCE	This paper presents a detailed characterization of helmet-to-ground impacts in the National Football League. Video analysis was performed for 16 head-to-ground impacts that caused concussions. Average resultant closing velocity was 8.3 m/s at an angle nearly 45 degrees to the surface. Preimpact rotational velocity of the helmet ranged from negligible to as high as 54.1 rad/s. Helmet impacts were concentrated on the posterior and lateral aspects. To study the interaction in greater detail, a helmeted anthropomorphic test device (ATD) was launched over a football field and fell to the ground in various impact conditions. Substantial decoupling between the helmet and the head was observed, such that the head rebounded within the helmet and underwent changes in linear and rotational motion greater than those of the helmet. Vertical helmet rebound was also observed; the helmet underwent a change in vertical velocity on average 24% greater than the vertical component of its closing velocity. Frictional interaction between the helmet and the ground surface caused the helmet to undergo an average horizontal change in velocity of 57% of the horizontal component of its closing velocity. Finally, the duration of a helmet-to-ground impact was generally in the range of 15 - 30 ms, suggesting that the impact surface provides little ride-down. Lengthening this duration could be beneficial both by reducing the peak linear and rotational acceleration and by shifting the impact toward a time regime where brain strain is related to rotational acceleration rather than rotational velocity. (C) 2019 Elsevier Ltd. All rights reserved.	[Kent, Richard; Bailey, Ann M.; Funk, James; Sherwood, Chris; Crandall, Jeff] Biomech Consulting & Res LLC, Scottsdale, AZ USA; [Kent, Richard; Forman, Jason; Crandall, Jeff] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22903 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Myers, Barry S.] Duke Univ, Biomed Engn, Durham, NC USA		Kent, R (corresponding author), Biomech Consulting & Res Biocore LLC, 1627 Quail Run, Charlottesville, VA 22911 USA.	rwk3c@virginia.edu		Forman, Jason/0000-0001-8705-3997	Football Research, Inc. (FRI)	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). The views expressed are solely those of the authors and do not represent those of FRI any of its affiliates or funding sources.	Bailey A, 2020, SPORT BIOMECH, V19, P678, DOI 10.1080/14763141.2018.1513059; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Beusenberg M., 2001, P IRCOBI C ISL MAN; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Hoist H., 1999, U.S. Patent, Patent No. 665867161; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; Joodaki H., 2018, J BIOMECH ENG, V141, DOI [10.1115/1.4043038.081006-081006-16, DOI 10.1115/1.4043038.081006-081006-16]; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Kerrigan J., 2009, P 21 INT TECHN C ENH; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2015, 08712M15A NOCSAE; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; Neale W., 2016, SAE TECHNICAL PAPER; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Society of Automotive Engineers, 1995, J211 SAE; Stefanyshyn D.J., 2003, SPORTS SURFACES, P49; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Theobald P, 2010, SPORT BIOMECH, V9, P29, DOI 10.1080/14763141003690245; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4	27	9	9	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 23	2020	99								109551	10.1016/j.jbiomech.2019.109551			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KL2YN	WOS:000513294600035	31837745				2022-02-06	
J	Gerhartl, A; Hahn, K; Neuhoff, A; Friedl, HP; Forster, CY; Wunder, C; Schick, M; Burek, M; Neuhaus, W				Gerhartl, Anna; Hahn, Kathrin; Neuhoff, Anja; Friedl, Heinz-Peter; Foerster, Carola Y.; Wunder, Christian; Schick, Martin; Burek, Malgorzata; Neuhaus, Winfried			Hydroxyethylstarch (130/0.4) tightens the blood-brain barrier in vitro	BRAIN RESEARCH			English	Article						Brain endothelial cells; Claudin; Cerebral ischemia; Stroke; Traumatic brain injury	MICROVASCULAR ENDOTHELIAL-CELLS; STARCH; ASTROCYTES; MODEL; FLUID	In order to prevent cerebral vasospasm after a subarachnoid hemorrhage (SAH), the so-called triple H-therapy (hypertension, hypervolemia, hemodilution) could be applied. In these cases, colloidal solutions containing Hydroxyethylstarch (HES) are used to induce hypervolemia. The administration of HES is very much under debate for the mentioned use, because in general the application of HES for the treatment of critical ill patients has been reduced tremendously in the last years due to its nephrotoxic effects. In this context, there are limited data investigating the influence of HES on the blood-brain barrier. These data might help to assess if a transient administration of HES is possibly justifiable to prevent cerebral ischemia during vasospasm despite the risk of an acute kidney injury. To address this question, a mouse blood-brain barrier in vitro model based on cell line cerebEND was exposed to different HES concentrations and compared to NaCl-containing control solutions. In order to assess the effects of HES on blood-brain barrier properties, cell viability, transendothelial electrical resistance, permeability of carboxyfluorescein, mRNA and protein expression and localization of tight junction proteins were determined. In summary, 1.5-4% HES attenuated cell viability in a mild, concentration dependent manner compared to the NaCl control solution (0% HES). At the mRNA level 1% and 4% HES significantly increased the expression of tight junction associated proteins (ZO-1 and occludin) and the glucose transporter Glut-1 (Slc2a1). In correspondence to this, 4% HES inhibited breakdown of the paracellular barrier in comparison to the control NaCl group (0% HES) shown by transendothelial electrical resistance values and the permeability of the paracellular marker carboxyfluorescein. These effects at the functional level were confirmed by immunofluorescence microscopic images of junctional proteins. The obtained in vitro data showed a potential for HES to counteract blood-brain barrier damage. Future studies are needed to reveal the applicability of HES as a blood-brain barrier stabilizing agent.	[Gerhartl, Anna; Hahn, Kathrin; Friedl, Heinz-Peter; Neuhaus, Winfried] AIT Austrian Inst Technol GmbH, Ctr Hlth & Bioresources, Competence Unit Mol Diagnost, Giefinggasse 4, A-1210 Vienna, Austria; [Neuhoff, Anja; Foerster, Carola Y.; Burek, Malgorzata] Univ Wurzburg, Dept Anesthesia & Crit Care, Oberduerrbacherstr 6, D-97080 Wurzburg, Germany; [Wunder, Christian] Robert Bosch Krankenhaus, Anesthesiol & Intens Care Med, Auerbachstr 110, D-70376 Stuttgart, Germany; [Schick, Martin] Univ Freiburg, Med Ctr, Anesthesiol & Crit Care, Hugstetter Str 55, D-79106 Freiburg, Germany		Neuhaus, W (corresponding author), AIT Austrian Inst Technol GmbH, Ctr Hlth & Bioresources, Competence Unit Mol Diagnost, Giefinggasse 4, A-1210 Vienna, Austria.	winfried.neuhaus@ait.ac.at	Schick, Martin/ABH-6971-2020; Burek, Malgorzata/AAF-3283-2021	Burek, Malgorzata/0000-0001-6148-2195; Neuhaus, Winfried/0000-0002-6552-7183			Bercker S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192832; Bruno RR, 2014, ANESTH ANALG, V119, P570, DOI 10.1213/ANE.0000000000000325; Canfield SG, 2017, J NEUROCHEM, V140, P874, DOI 10.1111/jnc.13923; Chi OZ, 1996, ANESTH ANALG, V83, P336, DOI 10.1097/00000539-199608000-00023; Choi S, 2019, NITRIC OXIDE-BIOL CH, V83, P51, DOI 10.1016/j.niox.2018.12.007; Dieterich HJ, 2003, ANESTH ANALG, V96, P1150, DOI 10.1213/01.ANE.0000050771.72895.66; Dilling C, 2017, J CEREBR BLOOD F MET, V37, P3391, DOI 10.1177/0271678X16688706; Feng XM, 2010, INT IMMUNOPHARMACOL, V10, P859, DOI 10.1016/j.intimp.2010.04.020; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Gotsch U, 1997, J CELL SCI, V110, P583; Harazin A, 2018, PEERJ, V6, DOI 10.7717/peerj.4774; Kauffmann D.P.M., 2016, THESIS, P1; Liu YT, 2011, INT J CLIN EXP MED, V4, P276; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Neuhaus W, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00149; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Neuhaus W, 2012, DIFFERENTIATION, V84, P294, DOI 10.1016/j.diff.2012.08.006; Neuhaus W, 2012, ANESTH ANALG, V114, P371, DOI 10.1213/ANE.0b013e3182367a54; Neuhaus W, 2008, J PHARM SCI-US, V97, P5158, DOI 10.1002/jps.21371; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; Pemer A, 2012, NEW ENGL J MED, V367, P124, DOI DOI 10.1056/NEJMOA1204242; SCHELL RM, 1992, ANESTHESIOLOGY, V77, P86, DOI 10.1097/00000542-199207000-00013; Schick M.A., 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0137247.e0137247, DOI 10.1371/JOURNAL.PONE.0137247.E0137247]; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Silwedel C, 2006, J NEUROIMMUNOL, V179, P37, DOI 10.1016/j.jneuroim.2006.06.019; Somova LM, 2013, B EXP BIOL MED+, V155, P403, DOI 10.1007/s10517-013-2163-8; Stander S, 2002, CELL TISSUE RES, V310, P279, DOI 10.1007/s00441-002-0644-6; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006	28	9	9	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2020	1727								146560	10.1016/j.brainres.2019.146560			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE3ZH	WOS:000508497100034	31756307				2022-02-06	
J	Wu, MY; Gao, F; Yang, XM; Qin, X; Chen, GZ; Li, D; Dang, BQ; Chen, G				Wu, Mu-Yao; Gao, Fan; Yang, Xiao-Mei; Qin, Xia; Chen, Guo-Zhao; Li, Di; Dang, Bao-Qi; Chen, Gang			Matrix metalloproteinase-9 regulates the blood brain barrier via the hedgehog pathway in a rat model of traumatic brain injury	BRAIN RESEARCH			English	Article						MMP-9; Scube2; Shh; Traumatic brain injury; Blood brain barrier	MATRIX METALLOPROTEINASES; SONIC HEDGEHOG; PERMEABILITY; PROTEOLYSIS; INHIBITION; DISRUPTION; SIGNAL; TIMPS	The mechanisms of secondary brain injury after traumatic brain injury (TBI) are complex and are the result of multiple factors. Protecting the blood-brain barrier (BBB) and ameliorating cerebral edema are two key factors for improving the prognosis of TBI patients. The BBB is regulated by the hedgehog pathway through Scube2 and Shh protein. Matrix metalloproteinase-9 (MMP-9) influences the transport system and enzyme system of vascular endothelial cells, possibly via the hedgehog pathway. The present study aimed to investigate the role and mechanism of MMP-9 in TBI via the hedgehog pathway. Eighty male Sprague-Dawley rats were used to establish a murine model of TBI. Subsequently, the effect of SB-3CT-a specific inhibitor of MMP-9-was assessed via Western blotting, real-time PCR, immunofluorescence, apoptotic assays, and neurological scoring. The results showed that, compared with those of the sham-operation group, the mRNA and protein levels of MMP-9 were significantly increased after TBI, while the expressions of Scube2 and Shh were decreased. Application of SB-3CT at 24 h after TBI significantly reduced neuronal apoptosis and BBB permeability, while increasing expressions of Scube2 and Shh. In conclusion, these findings demonstrate an influence of TBI-induced MMP-9 upregulation in the induction of post-traumatic nerve and BBB injury, which may be partially mediated by Scube2 and Shh via the hedgehog pathway.	[Wu, Mu-Yao; Gao, Fan; Dang, Bao-Qi] Nanjing Univ Chinese Med, Zhangjiagang TCM Hosp, Dept Rehabil, Suzhou, Peoples R China; [Yang, Xiao-Mei] First Peoples Hosp Zhangjiagang, Dept Emergency, Suzhou, Peoples R China; [Qin, Xia] First Peoples Hosp Zhangjiagang, Dept Intens Care Unit, Suzhou, Peoples R China; [Chen, Guo-Zhao] First Peoples Hosp Zhangjiagang, Dept Orthoped, Suzhou, Peoples R China; [Li, Di] First Peoples Hosp Zhangjiagang, Dept Neurosurg, Suzhou, Peoples R China; [Li, Di] First Peoples Hosp Zhangjiagang, Translat Med Ctr, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China		Dang, BQ (corresponding author), Nanjing Univ Chinese Med, Zhangjiagang TCM Hosp, Dept Rehabil, Suzhou, Peoples R China.; Li, D (corresponding author), First Peoples Hosp Zhangjiagang, Dept Neurosurg, Suzhou, Peoples R China.; Li, D (corresponding author), First Peoples Hosp Zhangjiagang, Translat Med Ctr, Suzhou, Peoples R China.	lidilab@sina.com; zhenjiangdbq@163.com		Li, Di/0000-0003-3423-9047	Gusu Health Training Projects [GSWS2019076]; Suzhou "Science and Technology Xingwei" Youth Science and Technology Project [KJXW2018057]; Zhangjiagang Science and Technology Pillar Program [ZKS1712, ZKS1829]; Zhangjiagang Hospital of Traditional Chinese Medicine Youth Natural Science Foundation Project [ZZYQ1802]	This work was supported by the Gusu Health Training Projects (GSWS2019076); Suzhou "Science and Technology Xingwei" Youth Science and Technology Project (KJXW2018057); Zhangjiagang Science and Technology Pillar Program (ZKS1712, ZKS1829); and Zhangjiagang Hospital of Traditional Chinese Medicine Youth Natural Science Foundation Project (ZZYQ1802).	Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Boguszewska-Czubara A., 2018, CURR MED CHEM, V25; Brilha S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16250-3; Creanga A, 2012, GENE DEV, V26, P1312, DOI 10.1101/gad.191866.112; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Dang B. C., 2017, NEURAL PLAST, V2017, P1; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hao K, 2013, ONCOL REP, V29, P1124, DOI 10.3892/or.2012.2210; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Jakobs P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26435; Jakobs P, 2017, J CELL SCI, V130, P3261, DOI 10.1242/jcs.205872; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jin XC, 2015, J NEUROCHEM, V132, P724, DOI 10.1111/jnc.13065; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sehba FA, 2004, J NEUROSURG, V101, P633, DOI 10.3171/jns.2004.101.4.0633; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI [10.1089/neu.2009-0959, 10.1089/neu.2009.0959]; Tetsuhiro H., 2011, J NEUROSURG, V114, P92; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Wagner S, 1997, STROKE, V28, P858, DOI 10.1161/01.STR.28.4.858; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang Z., 2016, FIXED POINT THEORY A, V2016, DOI [DOI 10.1038/srep25385, DOI 10.1038/srep26818]; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang P, 2016, EXP NEUROL, V283, P157, DOI 10.1016/j.expneurol.2016.06.010; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; You WC, 2016, J NEUROL SCI, V367, P224, DOI 10.1016/j.jns.2016.06.021; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438	44	9	9	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2020	1727								146553	10.1016/j.brainres.2019.146553			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE3ZH	WOS:000508497100011	31734396				2022-02-06	
J	Martino, C; Russo, E; Santonastaso, DP; Gamberini, E; Bertoni, S; Padovani, E; Tosatto, L; Ansaloni, L; Agnoletti, V				Martino, Costanza; Russo, Emanuele; Santonastaso, Domenico Pietro; Gamberini, Emiliano; Bertoni, Silvia; Padovani, Emanuele; Tosatto, Luigino; Ansaloni, Luca; Agnoletti, Vanni			Long-term outcomes in major trauma patients and correlations with the acute phase	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Trauma; Trauma care; Outcomes; Long-term outcome; Disability; Quality of life	HEAD-INJURY; HYPOTENSION; MORTALITY; HYPOXIA	Background Major trauma patients experience a 20% mortality rate overall, and many survivors remain permanently disabled. In order to monitor the quality of trauma care in the Trauma System, outcomes assessment is essential. Quality indicators on outcome can be expressed as quality of life, functional outcome, and others. The trauma follow-up system was created within the Romagna Trauma System (Italy) in order to monitor the trauma network and assess its long-term outcomes. The aim of this paper is firstly to evaluate the existence of correlations between epidemiological data, severity of injury, and clinical assessment characterizing the acute phase and the long-term outcomes in trauma patients and secondly, to explore the association between outcome variables have been modified. Methods We conducted a cross-sectional study over a 10-year period, including patients with severe trauma who survived and were discharged from the intensive care unit. The outcome measures were assessed with the use of the Extended Glasgow Outcome Scale and the Euro Quality of Life scale 5 dimension. Demographic data and clinical severity descriptors versus functional outcome were tested in a binary logistic regression model. Results In all, 428 major trauma patients participated in the study. At 1 year, 50.8% of trauma patients included had a good recovery and 49.2% had some degree of disability. The median value of quality of life was 0.725. At the multivariate analysis, variables showing significant impact on functional outcome were age (p = 0.052, OR 1.025), injury severity score (p = 0.001, OR 1.025), and Glasgow coma scale <= 8 (p = 0.001, OR 3.509) The Spearman's Rank correlation coefficient showed a strong correlation between the global level of function variables and quality of life at one year (Spearman's Rho Correlation Coefficient 0.760 (p < 0.0001)). Conclusions Increased age, increased injury severity score, and severe traumatic brain injury are predictors of long-term disability. Most of these trauma patients show impairments that affect not only the level of functional state but also the quality of life. The degree of functional independence has the greatest positive impact on quality of life. According to our results, after the recovery a prompt recognition of physical and psychological problems with systematic follow-up screening programs can help patients and doctors in defining specific therapeutic-rehabilitation pathways tailored to meet individual requirements.	[Martino, Costanza; Russo, Emanuele; Santonastaso, Domenico Pietro; Gamberini, Emiliano; Agnoletti, Vanni] AUSL Romagna, M Bufalini Hosp, Anesthesia & Intens Care Unit, Viale Ghirotti 286, I-47521 Cesena, Italy; [Ansaloni, Luca] AUSL Romagna, M Bufalini Hosp, Gen & Emergency Surg Unit, Cesena, Italy; [Bertoni, Silvia] Univ Bologna, Bologna, Italy; [Padovani, Emanuele] Univ Bologna, Dept Management DiSA, Bologna, Italy; [Tosatto, Luigino] AUSL Romagna, M Bufalini Hosp, Dept Neurosurg, Cesena, Italy		Santonastaso, DP (corresponding author), AUSL Romagna, M Bufalini Hosp, Anesthesia & Intens Care Unit, Viale Ghirotti 286, I-47521 Cesena, Italy.	domenicopietro.santonastaso@auslromagna.it	Agnoletti, Vanni/AAC-9854-2022; Russo, Emanuele/AAP-5645-2020; Pisano, Michele/G-9348-2018; Ansaloni, Luca/AAP-9134-2020	Agnoletti, Vanni/0000-0002-7093-2749; Russo, Emanuele/0000-0002-6531-5527; Pisano, Michele/0000-0001-9237-3530; Ansaloni, Luca/0000-0001-6427-0307; Gamberini, Emiliano/0000-0001-9403-5244; santonastaso, domenico pietro/0000-0003-1304-7724			[Anonymous], 2015, PUBBLICATO NELLA GAZ, V127; Canadian Institute for Health Information, 2006, REP MAJ INJ CAN; Chieregato A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016415; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Di Bartolomeo S, 2011, ACCIDENT ANAL PREV, V43, P1955, DOI 10.1016/j.aap.2011.05.013; Durham R, 2006, ANN SURG, V243, P775, DOI 10.1097/01.sla.0000219644.52926.f1; Hoffman K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103082; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Montagna S, 2019, HLTH INFORM J, P1; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Taggi F, 2007, SALUTE SICUREZZA STR, P565; Ulvik A, 2008, ACTA ANAESTH SCAND, V52, P195, DOI 10.1111/j.1399-6576.2007.01533.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wisborg T, 2017, ACTA ANAESTH SCAND, V61, P362, DOI 10.1111/aas.12875	21	9	10	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	JAN 13	2020	15	1							6	10.1186/s13017-020-0289-3			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Surgery	KW5ZF	WOS:000521243700001	31956336	gold, Green Published			2022-02-06	
J	Qin, C; Feng, H; Zhang, C; Zhang, X; Liu, Y; Yang, DG; Du, LJ; Sun, YC; Yang, ML; Gao, F; Li, JJ				Qin, Chuan; Feng, Hao; Zhang, Chao; Zhang, Xin; Liu, Yi; Yang, De-Gang; Du, Liang-Jie; Sun, Ying-Chun; Yang, Ming-Liang; Gao, Feng; Li, Jian-Jun			Differential Expression Profiles and Functional Prediction of tRNA-Derived Small RNAs in Rats After Traumatic Spinal Cord Injury	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						tRNA-derived small RNA; spinal cord injury; sequencing; bioinformatics; BDNF	FRAGMENTS; TRANSLATION; PROLIFERATION; REGENERATION; METAANALYSIS; MUTATION; REVEALS	Spinal cord injury (SCI) is mostly caused by trauma. As the primary mechanical injury is unavoidable, a focus on the underlying molecular mechanisms of the SCI-induced secondary injury is necessary to develop promising treatments for patients with SCI. Transfer RNA-derived small RNA (tsRNA) is a novel class of short, non-coding RNA, possessing potential regulatory functions in various diseases. However, the functional roles of tsRNAs in traumatic SCI have not been determined yet. We used a combination of sequencing, quantitative reverse transcription-polymerase chain reaction (qRT-PCR), bioinformatics, and luciferase reporter assay to screen the expression profiles and identify the functional roles of tsRNAs after SCI. As a result, 297 differentially expressed tsRNAs were identified in rats' spinal cord 1 day after contusion. Of those, 155 tsRNAs were significantly differentially expressed: 91 were significantly up-regulated, whereas 64 were significantly down-regulated after SCI (fold change > 1.5; P < 0.05). Bioinformatics analyses revealed candidate tsRNAs (tiRNA-Gly-GCC-001, tRF-Gly-GCC-012, tRF-Gly-GCC-013, and tRF-Gly-GCC-016) that might play regulatory roles through the mitogen-activated protein kinase (MAPK) and neurotrophin signaling pathways by targeting brain-derived neurotrophic factor (BDNF). We validated the candidate tsRNAs and found opposite trends in the expression levels of the tsRNAs and BDNF after SCI. Finally, tiRNA-Gly-GCC-001 was identified to target BDNF using the luciferase reporter assay. In summary, we found an altered tsRNA expression pattern and predicted tiRNA-Gly-GCC-001 might be involved in the MAPK and neurotrophin pathways by targeting the BDNF, thus regulating the post-SCI pathophysiologic processes. This study provides novel insights for future investigations to explore the mechanisms and therapeutic targets for SCI.	[Qin, Chuan; Feng, Hao; Zhang, Chao; Zhang, Xin; Liu, Yi; Yang, De-Gang; Du, Liang-Jie; Sun, Ying-Chun; Yang, Ming-Liang; Gao, Feng; Li, Jian-Jun] Capital Med Univ, Sch Rehabil Med, Beijing, Peoples R China; [Qin, Chuan; Feng, Hao; Zhang, Chao; Zhang, Xin; Liu, Yi; Yang, De-Gang; Du, Liang-Jie; Yang, Ming-Liang; Gao, Feng; Li, Jian-Jun] China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, Beijing, Peoples R China; [Qin, Chuan; Feng, Hao; Zhang, Chao; Zhang, Xin; Liu, Yi; Yang, De-Gang; Du, Liang-Jie; Yang, Ming-Liang; Gao, Feng; Li, Jian-Jun] Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, Beijing, Peoples R China; [Qin, Chuan; Feng, Hao; Zhang, Chao; Zhang, Xin; Liu, Yi; Yang, De-Gang; Du, Liang-Jie; Yang, Ming-Liang; Gao, Feng; Li, Jian-Jun] Chinese Inst Rehabil Sci, Beijing, Peoples R China; [Qin, Chuan; Feng, Hao; Zhang, Chao; Zhang, Xin; Liu, Yi; Yang, De-Gang; Du, Liang-Jie; Yang, Ming-Liang; Gao, Feng; Li, Jian-Jun] Beijing Key Lab Neural Injury & Rehabil, Beijing, Peoples R China; [Sun, Ying-Chun] China Rehabil Res Ctr, TCM Treatment Ctr, Beijing, Peoples R China		Gao, F; Li, JJ (corresponding author), Capital Med Univ, Sch Rehabil Med, Beijing, Peoples R China.; Gao, F; Li, JJ (corresponding author), China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, Beijing, Peoples R China.; Gao, F; Li, JJ (corresponding author), Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, Beijing, Peoples R China.; Gao, F; Li, JJ (corresponding author), Chinese Inst Rehabil Sci, Beijing, Peoples R China.; Gao, F; Li, JJ (corresponding author), Beijing Key Lab Neural Injury & Rehabil, Beijing, Peoples R China.	gaofeng5960@126.com; crrclijj@163.com	qin, chuan/ABG-4508-2020	Liu, Yi/0000-0003-4641-7904	National Key R&D Program of China [2018YFF0301104]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870979]; Special Fund for Basic Scientific Research of Central Public Research Institutes [2018CZ1, 2019CZ-1]; Basic Scientific Research Foundation of China Rehabilitation Research Center [2018ZX-30]; Beijing Municipal Science and Technology CommissionBeijing Municipal Science & Technology Commission [Z181100004118004, Z171100001017076]; Beijing Science and Technology Major Project [D161100002816004]; Capital Health Research and Development of Special [2018-1-6011]	This work was supported by a grant from the National Key R&D Program of China (2018YFF0301104), the National Natural Science Foundation of China (General Program 81870979), the Special Fund for Basic Scientific Research of Central Public Research Institutes (2018CZ1; 2019CZ-1), the Basic Scientific Research Foundation of China Rehabilitation Research Center (2018ZX-30), the Beijing Municipal Science and Technology Commission (Z181100004118004; Z171100001017076), the Beijing Science and Technology Major Project (D161100002816004), and the Capital Health Research and Development of Special (2018-1-6011).	Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Arcaroli JJ, 2012, CLIN CANCER RES, V18, P2704, DOI 10.1158/1078-0432.CCR-11-3167; Carelli S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040329; Chen RS, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00061; Elkordy A, 2019, BRAIN RES, V1714, P8, DOI 10.1016/j.brainres.2019.02.019; Elkordy A, 2018, J NEUROCHEM, V146, P560, DOI 10.1111/jnc.14321; Fu XD, 2018, CLIN EXP PHARMACOL P, V45, P68, DOI 10.1111/1440-1681.12856; Gebetsberger J, 2017, RNA BIOL, V14, P1364, DOI 10.1080/15476286.2016.1257470; Hall OT, 2019, ARCH PHYS MED REHAB, V100, P95, DOI 10.1016/j.apmr.2018.08.179; Hodgetts SI, 2017, VITAM HORM, V104, P405, DOI 10.1016/bs.vh.2016.11.007; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Huang BQ, 2017, CANCER RES, V77, P3194, DOI 10.1158/0008-5472.CAN-16-3146; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jiang ZS, 2018, INT J BIOL MACROMOL, V120, P66, DOI 10.1016/j.ijbiomac.2018.08.002; Kang Y, 2018, J NEURORESTORATOLOGY, V6, P1, DOI 10.2147/JN.S143236; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Khuyagbaatar B, 2015, J NEUROTRAUM, V32, P1987, DOI 10.1089/neu.2015.3875; Kim HK, 2017, NATURE, V552, P57, DOI 10.1038/nature25005; Kumar P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0078-0; Kumar P, 2015, CURR PHARM DESIGN, V21, P1517, DOI 10.2174/1381612821666150115152323; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li PF, 2019, INT J BIOL SCI, V15, P895, DOI 10.7150/ijbs.29744; Li SQ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050246; Li XZ, 2019, SPINAL CORD, V57, P65, DOI 10.1038/s41393-018-0173-0; Liu RH, 2018, AGING-US, V10, P1474, DOI 10.18632/aging.101484; Liu S, 2019, NEURAL REGEN RES, V14, P1352, DOI 10.4103/1673-5374.253512; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Olvedy M, 2016, ONCOTARGET, V7, P24766, DOI 10.18632/oncotarget.8293; Pang XL, 2016, EXP THER MED, V12, P4121, DOI 10.3892/etm.2016.3900; Qin C, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00497; Qin C, 2018, NEURAL REGEN RES, V13, P1096, DOI 10.4103/1673-5374.233454; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Shakhbazau A, 2015, MACROMOL BIOSCI, V15, P1523, DOI 10.1002/mabi.201500150; Shao Y, 2017, CHEM BIOL DRUG DES, V90, P730, DOI 10.1111/cbdd.12994; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Vawda R, 2019, STEM CELL TRANSL MED, V8, P639, DOI 10.1002/sctm.18-0192; Wang Y, 2019, J CELL BIOCHEM, V120, P11582, DOI 10.1002/jcb.28438; Yang LX, 2019, NEURAL REGEN RES, V14, P632, DOI 10.4103/1673-5374.247467; Zhang HF, 2018, CELL CYCLE, V17, P1992, DOI 10.1080/15384101.2018.1509622; Zhang HF, 2018, RNA BIOL, V15, P1071, DOI 10.1080/15476286.2018.1493333; Zhang Y, 2018, INT J RHEUM DIS, V21, P1659, DOI 10.1111/1756-185X.13346; Zhang YF, 2014, J MOL CELL BIOL, V6, P172, DOI 10.1093/jmcb/mjt052; Zhang YQ, 2015, MOL NEUROBIOL, V51, P1144, DOI 10.1007/s12035-014-8785-7; Zhou K, 2017, ONCOTARGET, V8, P95377, DOI 10.18632/oncotarget.20709	48	9	10	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JAN 10	2020	12								326	10.3389/fnmol.2019.00326			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KF6JS	WOS:000509346600001	31998075	Green Published, gold			2022-02-06	
J	Sorensen, M; Sercy, E; Salottolo, K; Waxman, M; West, TA; Tanner, A; Bar-Or, D				Sorensen, Melissa; Sercy, Erica; Salottolo, Kristin; Waxman, Michael; West, Thomas A.; Tanner, Allen, II; Bar-Or, David			The effect of discharge destination and primary insurance provider on hospital discharge delays among patients with traumatic brain injury: a multicenter study of 1,543 patients	PATIENT SAFETY IN SURGERY			English	Article						Patient discharge; Traumatic brain injury; Insurance	LENGTH-OF-STAY; MORTALITY; INFECTIONS; SEVERITY; IMPACT	Background Hospital length of stay (HLOS) is a commonly used measure of hospital quality and is influenced by clinical and non-clinical factors. To reduce HLOS, it is key to identify factors placing patients at increased risk of lengthy HLOS and discharge delays. Methods This was a retrospective cohort study of patients age >= 18 admitted to four level 1 trauma centers between 1/1/2015 and 3/31/2018 with traumatic brain injury (TBI). The primary outcome was discharge delay, defined as discharge >= 24 h after case management notes indicated the patient was ready for discharge. The independent variables of interest were primary insurance provider and discharge destination. Chi-square, Fisher exact, and unadjusted and adjusted logistic regression analyses were used to assess associations between discharge delay and the two primary independent variables, as well as other patient demographic and clinical characteristics. Complications developing during the delay period were also examined. Results A total of 1543 patients with TBI were included. The median age was 61 years, and the median HLOS was 5 days. Approximately half of patients were discharged home (54%). The most common insurance providers were Medicare (35%) and commercial/private (35%). Two-hundred ten (14%) patients experienced a discharge delay. The median delay period was 3 days, and the most common reasons for delay were insurance authorization (52%) and lack of accepting bed (41%). Compared to being discharged home, patients discharged to a skilled nursing facility (adjusted odds ratio (AOR) = 10.35) or intermediate care facility (AOR = 10.64) had the highest odds of discharge delay. Compared to Medicare patients, uninsured/self-pay patients (AOR = 2.98) and those with Medicaid (AOR = 2.83) or commercial/private insurance (AOR = 2.22) had higher odds of delay. Thirty-two patients (15% of those delayed) experienced at least one complication during the delay, some of which were clinically severe. Conclusions A substantial portion of TBI patients in this study experienced discharge delays, and discharge destination and primary insurance provider were significant drivers of these delays. Evaluation of a facility's quality of care should consider the specific causes of these delays.	[Sorensen, Melissa] Swedish Med Ctr, Trauma Serv Dept, Englewood, CO 80110 USA; [Sercy, Erica; Salottolo, Kristin; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA; [Sercy, Erica; Salottolo, Kristin; Bar-Or, David] Med City Plano, Trauma Res Dept, Plano, TX 75075 USA; [Sercy, Erica; Salottolo, Kristin; Bar-Or, David] Med Res Ctr, Trauma Res Dept, Kansas City, MO USA; [Sercy, Erica; Salottolo, Kristin; Bar-Or, David] Penrose Community Hosp, Trauma Res Dept, Colorado Springs, CO USA; [Waxman, Michael] Med Res Ctr, Med Surg Intens Care Unit, Kansas City, MO USA; [West, Thomas A.] Med City Plano, Trauma Serv Dept, Plano, TX USA; [Tanner, Allen, II] Penrose Community Hosp, Trauma Serv Dept, Colorado Springs, CO USA; [Bar-Or, David] Injury Outcomes Network Res Grp, 501 E Hampden Ave, Englewood, CO 80113 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA.; Bar-Or, D (corresponding author), Med City Plano, Trauma Res Dept, Plano, TX 75075 USA.	davidbme49@gmail.com		Sercy, Erica/0000-0002-7975-8601			Agency for Healthcare Research and Quality, 2016, EX HOSP QUAL MEAS CO; Al-Tawfiq JA, 2014, J INFECT PUBLIC HEAL, V7, P339, DOI 10.1016/j.jiph.2014.04.003; American college of surgeons, 2010, ACS TRAUM QUAL IMPR; Boulanger L, 2007, AM SURGEON, V73, P1269; Brasel KJ, 2007, ARCH SURG-CHICAGO, V142, P461, DOI 10.1001/archsurg.142.5.461; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Cryer C, 2010, INJURY PREV, V16, P254, DOI 10.1136/ip.2009.023903; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; McDermott KW, 2017, TRENDS HOSP INPATIEN; Mitchell BG, 2016, J HOSP INFECT, V93, P92, DOI 10.1016/j.jhin.2016.01.012; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Salehi O, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.20349; Smith AL, 2017, J STROKE CEREBROVASC, V26, P711, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.037; Thomas SN, 2005, J TRAUMA, V58, P121, DOI 10.1097/01.TA.0000130611.64983.A7; WEISSERT WG, 1988, HEALTH SERV RES, V23, P619	17	9	9	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-9493			PATIENT SAF SURG	Patient Saf. Surg.	JAN 6	2020	14	1							2	10.1186/s13037-019-0227-z			10	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	KL8BT	WOS:000513643100001	31911820	Green Published, gold			2022-02-06	
J	Barletta, JF; Abdul-Rahman, D; Hall, ST; Mangram, AJ; Dzandu, JK; Frontera, JA; Zach, V				Barletta, Jeffrey F.; Abdul-Rahman, Diana; Hall, Scott T.; Mangram, Alicia J.; Dzandu, James K.; Frontera, Jennifer A.; Zach, Victor			The Role of Desmopressin on Hematoma Expansion in Patients with Mild Traumatic Brain Injury Prescribed Pre-injury Antiplatelet Medications	NEUROCRITICAL CARE			English	Article						Desmopressin; Aspirin; Platelet aggregation inhibitors; Traumatic brain injury; Hematoma; Intracerebral hemorrhage	REDUCED PLATELET ACTIVITY; PREINJURY WARFARIN USE; INTRACEREBRAL HEMORRHAGE; UNITED-STATES; THERAPY; MORTALITY; OUTCOMES; TRANSFUSION; IMPACT; ADULTS	Background/Objective Desmopressin (DDAVP) has been suggested for antiplatelet medication reversal in patients with traumatic brain injury (TBI) but there are limited data describing its effect on clinical outcomes. The purpose of this study was to evaluate the effect of DDAVP on hematoma expansion and thrombosis in patients with TBI who were prescribed pre-injury antiplatelet medications. Methods Consecutive adult patients who were admitted to our level I trauma center and prescribed pre-injury antiplatelet medications between July, 2012, and May, 2018, were retrospectively identified. Patients were excluded if their hospital length of stay was < 24 h, if DDAVP was administered by any route other than intravenous, if they received a DDAVP dose < 0.3 mcg/kg or there was no evidence of brain hemorrhage on computed tomography (CT) scan. Patients were stratified based on the use of DDAVP, and the incidence of hematoma expansion was compared between groups. Thrombotic events were reviewed as a secondary outcome. Multivariate analysis was utilized to control for confounding variables. Results Of 202 patients included in analysis, 158 (78%) received DDAVP. The mean age was 76 +/- 12 years; the most common injury mechanism was falls (76%); 69% had acute subdural hematoma, and 49% had multi-compartmental hemorrhage. Initial Glasgow coma score was between 13 and 15 for 91% of patients. Aspirin was the most common antiplatelet regimen prescribed (N = 151, 75%), followed by dual antiplatelet regimens (N = 26, 13%) and adenosine diphosphate (ADP)-receptor inhibitors (N = 25, 12%). The incidence of hematoma expansion was 14% and 30% for patients who did and did not receive DDAVP, respectively (p = 0.015). After controlling for age, injury severity score, multi-compartmental hemorrhage, and receipt of pre-injury high-dose aspirin (> 81 mg), ADP-receptor inhibitors, oral anticoagulants, prothrombin complex concentrates or platelets in a multivariate analysis, the association between DDAVP and hematoma expansion remained significant (adjusted OR 0.259 [95% CI 0.103-0.646], p = 0.004). Thrombotic events were similar between the two groups (DDAVP, 2.5%, no DDAVP, 4.5%; p = 0.613). Conclusions DDAVP was associated with a lower incidence of hematoma expansion in patients with mild TBI who were prescribed pre-injury antiplatelet medications. These results justify a randomized controlled trial to further evaluate the role of DDAVP for this indication.	[Barletta, Jeffrey F.] Midwestern Univ, Coll Pharm, 19555 N 59th Ave, Glendale, AZ 85308 USA; [Abdul-Rahman, Diana; Zach, Victor] Neurocrit Care Stroke Arizona, Phoenix, AZ USA; [Hall, Scott T.] HonorHlth John C Lincoln Med Ctr, Dept Pharm Serv, Phoenix, AZ USA; [Mangram, Alicia J.; Dzandu, James K.] HonorHlth John C Lincoln Med Ctr, Dept Trauma, Phoenix, AZ USA; [Frontera, Jennifer A.] NYU, Sch Med, New York, NY USA; [Zach, Victor] AT Still Univ, Sch Osteopath Med, Phoenix, AZ USA		Barletta, JF (corresponding author), Midwestern Univ, Coll Pharm, 19555 N 59th Ave, Glendale, AZ 85308 USA.	jbarle@midwestern.edu	Barletta, Jeffrey F./B-2644-2013	Barletta, Jeffrey/0000-0002-9054-8218			Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Ferraris VA, 2012, J TRAUMA ACUTE CARE, V73, P492, DOI 10.1097/TA.0b013e31825b85f1; Foreman PM, 2018, WORLD NEUROSURG, V116, pE649, DOI 10.1016/j.wneu.2018.05.064; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; LETHAGEN S, 1987, THROMB HAEMOSTASIS, V58, P1033; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; MANNUCCI PM, 1977, LANCET, V1, P869; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Naidech AM, 2009, NEUROSURGERY, V65, P684, DOI 10.1227/01.NEU.0000351769.39990.16; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Spahn DR, 2019, EUROPEAN GUIDELINE M, P98; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Toyoda K, 2009, CEREBROVASC DIS, V27, P151, DOI 10.1159/000177924; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6; Williams CD, 2015, AM J PREV MED, V48, P501, DOI 10.1016/j.amepre.2014.11.005; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809	31	9	9	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					405	413		10.1007/s12028-019-00899-x		JAN 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000505361100005	31898177				2022-02-06	
J	Bogner, J; Corrigan, JD; Yi, HG; Singichetti, B; Manchester, K; Huang, LH; Yang, JZ				Bogner, Jennifer; Corrigan, John D.; Yi, Honggang; Singichetti, Bhavna; Manchester, Kara; Huang, Lihong; Yang, Jingzhen			Lifetime History of Traumatic Brain Injury and Behavioral Health Problems in a Population-Based Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adults; disability; health surveillance data; traumatic brain injury	SUBSTANCE USE; RELIABILITY; OUTCOMES; DISORDERS; VALIDITY; RISK	Objective: To investigate the relationships between indices of lifetime history of traumatic brain injury (TBI) exposure and measures of behavioral health status among Ohioans. Participants: A random sample (n = 6996) of Ohioans contacted to complete the 2014 Ohio Behavioral Risk Factors Surveillance System (BRFSS). Design: A cross-sectional survey. Main measures: The Ohio State University TBI Identification Method adapted for BRFSS module and BRFSS behavioral indicators. Results: After demographic adjustment, lifetime history of TBI was found to be associated with increased odds of binge drinking, heavy drinking, smoking, a depressive disorder, or mental health not being good (>= 2 days and >= 14 days in last 30 days). Mixed findings across behavioral indicators were observed in regard to number and severity of injury. Age at first injury showed no remarkable associations with the behavioral health indicators. Conclusions: Ohioans who have sustained at least one TBI with loss of consciousness in their lifetime are at increased risk for poor behavioral health, including alcohol misuse, smoking, and depression. The findings underscore the need for community-based mental health treatment programs to screen for TBI history in their intake evaluations, and to train clinicians on the provisions of accommodations for cognitive and behavioral deficits.	[Bogner, Jennifer; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Yi, Honggang; Singichetti, Bhavna; Huang, Lihong; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Columbus, OH USA; [Yi, Honggang] Nanjing Med Univ, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Manchester, Kara] Ohio Dept Hlth, Ohio Violence & Injury Prevent Program, Columbus, OH 43266 USA; [Huang, Lihong] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghai, Peoples R China		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu		Singichetti, Bhavna/0000-0002-2188-3979	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0001]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17 CE924827]	Drs Corrigan's and Bogner's effort on this project were funded in part by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR #90DPTB0001). The NIDILRR is a center within the Administration for Community Living, Department of Health and Human Services. Ms Manchester's effort on this project was funded in part by the Centers for Disease Control and Prevention (U17 CE924827).	Allen S, 2016, SUBST USE MISUSE, V51, P1577, DOI 10.1080/10826084.2016.1188955; Bogner J, 2015, BRAIN INJURY, V29, P905, DOI 10.3109/02699052.2015.1005136; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Center for Behavioral Health Statistics and Quality, 2015, 2014 NAT SURV DRUG U; Center for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention Division of Population Health, 2015, BRFSS PREV TRENDS DA; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; NIH National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Osborn AJ, 2018, J HEAD TRAUMA REHAB, V33, P62, DOI 10.1097/HTR.0000000000000311; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141	22	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		E43	E50		10.1097/HTR.0000000000000488			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300009	31033748				2022-02-06	
J	Pattinson, CL; Shahim, P; Taylor, P; Dunbar, K; Guedes, VA; Motamedi, V; Lai, C; Devoto, C; Peyer, J; Roy, MJ; Gill, JM				Pattinson, Cassandra L.; Shahim, Pashtun; Taylor, Patricia; Dunbar, Kerri; Guedes, Vivian A.; Motamedi, Vida; Lai, Chen; Devoto, Christina; Peyer, Jordan; Roy, Michael J.; Gill, Jessica M.			Elevated Tau in Military Personnel Relates to Chronic Symptoms Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amyloid-beta; biomarkers; neurofilament light chain (NFL); postconcussive symptoms; posttraumatic stress disorder (PTSD); service members; veterans	NEUROFILAMENT LIGHT-CHAIN; COGNITIVE IMPAIRMENT; VALIDITY; BIOMARKER; RELIABILITY; SENSITIVITY; DEPRESSION; PATHOLOGY; SUSTAIN; RISK	Objective: To understand the relationships between traumatic brain injury (TBI), blood biomarkers, and symptoms of posttraumatic stress disorder (PTSD), depression, and postconcussive syndrome symptoms. Design: Cross-sectional cohort study using multivariate analyses. Participants: One hundred nine military personnel and veterans, both with and without a history of TBI. Main Measures: PTSD Checklist-Civilian Version (PCL-C); Neurobehavioral Symptom Inventory (NSI); Ohio State University TBI Identification Method; Patient Health Questionnaire-9 (PHQ-9); Simoa-measured concentrations of tau, amyloid-beta (A beta) 40, A beta 42, and neurofilament light (NFL). Results: Controlling for age, sex, time since last injury (TSLI), and antianxiety/depression medication use, NFL was trending toward being significantly elevated in participants who had sustained 3 or more TBIs compared with those who had sustained 1 or 2 TBIs. Within the TBI group, partial correlations that controlled for age, sex, TSLI, and antianxiety/depression medication use showed that tau concentrations were significantly correlated with greater symptom severity, as measured with the NSI, PCL, and PHQ-9. Conclusions: Elevations in tau are associated with symptom severity after TBI, while NFL levels are elevated in those with a history of repetitive TBIs and in military personnel and veterans. This study shows the utility of measuring biomarkers chronically postinjury. Furthermore, there is a critical need for studies of biomarkers longitudinally following TBI.	[Pattinson, Cassandra L.; Guedes, Vivian A.; Motamedi, Vida; Lai, Chen; Devoto, Christina; Peyer, Jordan; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Shahim, Pashtun; Taylor, Patricia; Dunbar, Kerri] Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Shahim, Pashtun] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Taylor, Patricia; Dunbar, Kerri; Roy, Michael J.] Henry M Jackson Fdn, Bethesda, MD USA; [Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA		Pattinson, CL (corresponding author), NINR, NIH, Bethesda, MD 20892 USA.	cassie.pattinson@nih.gov	Pattinson, Cassandra/AAY-5974-2020; Pattinson, Cassandra/A-5543-2019	de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Peyer, Jordan/0000-0002-4136-0315; Pattinson, Cassandra/0000-0002-5975-7935	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 NR999999] Funding Source: Medline		Akiki TJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0840-4; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Alwis DS, 2016, J NEUROTRAUM, V33, P1084, DOI 10.1089/neu.2014.3774; Averill Lynnette A, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017724714; Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Bejanin A, 2017, BRAIN, V140, P3286, DOI 10.1093/brain/awx243; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Clancy K, 2017, BRAIN, V140, P2041, DOI 10.1093/brain/awx116; Clark IA, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00104; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Denning L.A., 2014, PREVENTING PSYCHOL D, DOI [10.17226/18597, DOI 10.17226/18597]; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Fast CD, 2017, J NEUROSCI, V37, P3085, DOI 10.1523/JNEUROSCI.2797-16.2017; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jackowski MM, 1996, NEUROREHABILITATION, V6, P193, DOI 10.3233/NRE-1996-6305; Kevenaar JT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00044; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lau KM, 2016, BRAIN INJURY, V30, P287, DOI 10.3109/02699052.2015.1089601; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Weathers FW, 1993, ANN M INT SOC TRAUM, DOI [10.1101/gr.095406.109., DOI 10.1101/GR.095406.109]; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079; Zetterberg H, 2016, NEURON, V91, P1, DOI 10.1016/j.neuron.2016.06.030	53	9	9	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		66	73		10.1097/HTR.0000000000000485			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300014	31033745	Green Accepted			2022-02-06	
J	Rubiano, AM; Vera, DS; Montenegro, JH; Carney, N; Clavijo, A; Carreno, JN; Gutierrez, O; Mejia, J; Ciro, JD; Barrios, ND; Soto, AR; Tejada, PA; Zerpa, MC; Gomez, A; Navarrete, N; Echeverry, O; Umana, M; Restrepo, CM; Castillo, JL; Sanabria, OA; Bravo, MP; Gomez, CM; Godoy, DA; Orjuela, GD; Arias, AA; Echeverri, RA; Paranos, J				Rubiano, Andres M.; Vera, David S.; Montenegro, Jorge H.; Carney, Nancy; Clavijo, Angelica; Carreno, Jose N.; Gutierrez, Oscar; Mejia, Jorge; Ciro, Juan D.; Barrios, Ninel D.; Soto, Alvaro R.; Tejada, Paola A.; Zerpa, Maria C.; Gomez, Alejandro; Navarrete, Norberto; Echeverry, Oscar; Umana, Mauricio; Restrepo, Claudia M.; Castillo, Jose L.; Sanabria, Oscar A.; Bravo, Maria P.; Gomez, Claudia M.; Godoy, Daniel A.; Orjuela, German D.; Arias, Augusto A.; Echeverri, Raul A.; Paranos, Jorge			Recommendations of the Colombian Consensus Committee for the Management of Traumatic Brain Injury in Prehospital, Emergency Department, Surgery, and Intensive Care (Beyond One Option for Treatment of Traumatic Brain Injury: A Stratified Protocol [BOOTStraP])	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						traumatic brain injuries; intensive care; emergency care; prehospital care; critical care; intensive care; Colombia; guideline	GUIDELINES; STATEMENT; ADHERENCE; OUTCOMES; HEAD	Background Traumatic brain injury (TBI) is a global public health problem. In Colombia, it is estimated that 70% of deaths from violence and 90% of deaths from road traffic accidents are TBI related. In the year 2014, the Ministry of Health of Colombia funded the development of a clinical practice guideline (CPG) for the diagnosis and treatment of adult patients with severe TBI. A critical barrier to the widespread implementation was identified-that is, the lack of a specific protocol that spans various levels of resources and complexity across the four treatment phases. The objective of this article is to present the process and recommendations for the management of patients with TBI in various resource environments, across the treatment phases of prehospital care, emergency department (ED), surgery, and intensive care unit. Methods Using the Delphi methodology, a consensus of 20 experts in emergency medicine, neurosurgery, prehospital care, and intensive care nationwide developed recommendations based on 13 questions for the management of patients with TBI in Colombia. Discussion It is estimated that 80% of the global population live in developing economies where access to resources required for optimum treatment is limited. There is limitation for applications of CPGs recommendations in areas where there is low availability or absence of resources for integral care. Development of mixed methods consensus, including evidence review and expertise points of good clinical practices can fill gaps in application of CPGs. BOOTStraP (Beyond One Option for Treatment of Traumatic Brain Injury: A Stratified Protocol) is intended to be a practical handbook for care providers to use to treat TBI patients with whatever resources are available. Results Stratification of recommendations for interventions according to the availability of the resources on different stages of integral care is a proposed method for filling gaps in actual evidence, to organize a better strategy for interventions in different real-life scenarios. We develop 10 algorithms of management for building TBI protocols based on expert consensus to articulate treatment options in prehospital care, EDs, neurological surgery, and intensive care, independent of the level of availability of resources for care.	[Rubiano, Andres M.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Rubiano, Andres M.] Univ El Bosque, Neurosci Inst, Bogota, Colombia; [Rubiano, Andres M.] Meditech Fdn, Calle 7-A 44-95, Cali, Valle, Colombia; [Vera, David S.] Univ El Bosque, MEDITECH Fdn, Bogota, Colombia; [Montenegro, Jorge H.] Local Hosp Puerto Asis, Emergency Serv, Putumayo, Colombia; [Carney, Nancy] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA; [Clavijo, Angelica] Univ El Bosque, Clin Res, INUB MEDITECH, Bogota, Colombia; [Carreno, Jose N.] Fdn Santa Fe Univ Hosp, Dept Intens Care, Bogota, Colombia; [Gutierrez, Oscar] Hosp Occidente Kennedy, Neurosurg Serv, Bogota, Colombia; [Mejia, Jorge] Valle Lili Fdn, Dept Intens Care, Cali, Colombia; [Ciro, Juan D.] Las Amer Clin, Intens Care Serv, Medellin, Colombia; [Barrios, Ninel D.] Intens Care Serv, Clin Gen Norte, Barranquilla, Colombia; [Soto, Alvaro R.] San Antonio Departamental Hosp, Neurosurg Serv, Pitalito Huila, Colombia; [Tejada, Paola A.] Univ Bosque, Inst Neurosci, Clin Res, Bogota, Colombia; [Zerpa, Maria C.; Arias, Augusto A.] Clin Norte, Intens Care Serv, Cucuta, Colombia; [Gomez, Alejandro] Adventist Univ, Prehosp Care Program, Medellin, Colombia; [Navarrete, Norberto] Simon Bolivar Hosp, Burns Unit, Bogota, Colombia; [Echeverry, Oscar] MEDITECH Fdn, Clin Res, Cali, Colombia; [Umana, Mauricio] Clin Amiga, Intens Care Serv, Cali, Colombia; [Restrepo, Claudia M.] Hosp Mil Cent, Neurosurg Serv, Bogota, Colombia; [Castillo, Jose L.] Vallesalud Clin, Intens Care Serv, Cali, Colombia; [Sanabria, Oscar A.] Univ El Bosque, Fac Med, Bogota, Colombia; [Bravo, Maria P.] Univ Surcolombiana, Fac Med, Neiva, Colombia; [Gomez, Claudia M.] Uraba Clin, Neurosurg Serv, Apartado Antioquia, Antioquia, Colombia; [Godoy, Daniel A.] Sanat Pasteur, Intens Care Serv, Catamarca, Argentina; [Orjuela, German D.] Secretary Hlth, Prehosp Care Program, Bogota, Colombia; [Echeverri, Raul A.] Vallesalud Clin, Neurosurg Serv, Cali, Colombia; [Paranos, Jorge] Santa Casa Misericordia Hosp Sao Joao del Rei, Neurosurg & Intens Care Serv, Sao Joao Del Rei, MG, Brazil		Rubiano, AM (corresponding author), Meditech Fdn, Calle 7-A 44-95, Cali, Valle, Colombia.; Rubiano, AM (corresponding author), El Bosque Univ, Dept Neurosci & Neurosurg, Bogota, Colombia.	andresrubiano@aol.com	RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254	National Institute for Health Research (NIHR) Global Health Research Group on NeurotraumaNational Institute for Health Research (NIHR); NIHR using Official Development Assistance [16/137/105]	The National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma is supporting Dr. Rubiano research work. The group was commissioned by the NIHR using Official Development Assistance funding (project 16/137/105). The views expressed in this article are those of the authors and are not necessarily those of the UK National Health Service, NIHR, or the UK Department of Health.	Allen Jane, 2004, Br J Community Nurs, V9, P110; Alvis-Miranda H R, 2013, PANAM J TRAUMA CRIT, V2, P134; American College of Surgeons Committee on Trauma, ACS TQIP BEST PRACT; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Bullock R.M., 2006, NEUROSURGERY S2, V58, P1; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Colombia. Ministry of Health and Social Protection Colciencias MEDITECH Foundation, CLIN PRACT GUID DIAG; Colombian Institute of Forensic Sciences and Legal Medicine, 2018, FOR DAT LIF; Corley J, 2019, WORLD NEUROSURG, V123, P295, DOI 10.1016/j.wneu.2018.12.042; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Figaji A, 2014, NEUROCRIT CARE, V21, P239, DOI 10.1007/s12028-014-0019-3; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hirschi R, 2018, WORLD NEUROSURG, V116, pE399, DOI 10.1016/j.wneu.2018.04.215; Jaeschke R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a744; Jarman MP, 2016, SURGERY, V160, P1551, DOI 10.1016/j.surg.2016.06.020; Khormi YH, 2018, J NEUROTRAUM, V35, P1407, DOI 10.1089/neu.2017.5345; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Moscote LR, 2014, PANAM J TRAUMA CRIT, V3, P23, DOI [10.5005/jp-journals-10030-1081, DOI 10.5005/JP-JOURNALS-10030-1081]; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Park KB, 2019, J NEUROSURG, V130, P1053, DOI 10.3171/2019.2.JNS19295; Peden, 2004, GUIDELINES ESSENTIAL; Potapov A, 2015, ZH VOPR NEIROKHIR N, V79, P86; Potapov A A, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P93, DOI 10.17116/neiro201680293-101; Potapov A A, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P98, DOI 10.17116/neiro201680198-106; Ramesh A, 2014, CUREUS J MED SCIENCE, V5, pe179; Reynolds T A, 2017, DIS CONTROL PRIORITI; Srivastava A, 2017, TRAUMATIC BRAIN INJU, V1; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; United Nations Conference on Trade and Development (UNCTAD), 2018, UN HDB STAT 2018; Van Essen TA, 2016, J NEUROTRAUM, V33, pA20; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, WHO TRAUM CAR CHECKL; World Health Organization, VIOL INJ PREV GLOB S	47	9	9	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN	2020	11	1					7	22		10.1055/s-0040-1701370			16	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	KT7RL	WOS:000519210500005	32140001	Green Published, gold			2022-02-06	
S	Samfors, S; Fletcher, JS		Bohn, PW; Pemberton, JE		Samfors, Sanna; Fletcher, John S.			Lipid Diversity in Cells and Tissue Using Imaging SIMS	ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 13	Annual Review of Analytical Chemistry		English	Article; Book Chapter						secondary ion mass spectrometry; SIMS; imaging; lipids; cells; tissue	ION MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; TOF-SIMS; BRAIN-TISSUE; MEMBRANE-FLUIDITY; DROSOPHILA BRAIN; IN-SITU; TIME; RESOLUTION; C-60	Lipids are an important class of biomolecules with many roles within cells and tissue. As targets for study, they present several challenges. They are difficult to label, as many labels lack the specificity to the many different lipid species or the labels maybe larger than the lipids themselves, thus severely perturbing the natural chemical environment. Mass spectrometry provides exceptional specificity and is often used to examine lipid extracts from different samples. However, spatial information is lost during extraction. Of the different imaging mass spectrometry methods available, secondary ion mass spectrometry (SIMS) is unique in its ability to analyze very small features, with probe sizes <50 nm available. It also offers high surface sensitivity and 3D imaging capability on a subcellular scale. This article reviews the current capabilities and some remaining challenges associated with imaging the diverse lipids present in cell and tissue samples. We show how the technique has moved beyond show-and-tell, proof-of-principle analysis and is now being used to address real biological challenges. These include imaging the microenvironment of cancer tumors, probing the pathophysiology of traumatic brain injury, or tracking the lipid composition through bacterial membranes.	[Samfors, Sanna; Fletcher, John S.] Univ Gothenburg, Dept Chem & Mol Biol, S-41296 Gothenburg, Sweden; [Samfors, Sanna] Chalmers Univ Technol, Dept Chem & Chem Engn, Gothenburg, Sweden		Fletcher, JS (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, S-41296 Gothenburg, Sweden.	john.fletcher@chem.gu.se		fletcher, john/0000-0002-9418-8571	Swedish Research Council (VR)Swedish Research Council; University of Gothenburg	The authors gratefully acknowledge financial support from the Swedish Research Council (VR) and the University of Gothenburg.	Amaya KR, 2007, INT J MASS SPECTROM, V260, P121, DOI 10.1016/j.ijms.2006.09.032; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Angerer TB, 2019, BBA-MOL CELL BIOL L, V1864, P733, DOI 10.1016/j.bbalip.2019.01.011; Angerer TB, 2016, ANAL CHEM, V88, P11946, DOI 10.1021/acs.analchem.6b03884; Angerer TB, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4941064; Angerer TB, 2015, ANAL CHEM, V87, P4305, DOI 10.1021/ac504774y; Angerer TB, 2015, INT J MASS SPECTROM, V377, P591, DOI 10.1016/j.ijms.2014.05.015; Benabdellah F, 2010, ANAL BIOANAL CHEM, V396, P151, DOI 10.1007/s00216-009-3031-2; Bich C, 2013, ANAL CHEM, V85, P7745, DOI 10.1021/ac4009513; Breitenstein D, 2008, APPL SURF SCI, V255, P1249, DOI 10.1016/j.apsusc.2008.05.289; Bruinen AL, 2017, METHODS MOL BIOL, V1618, P165, DOI 10.1007/978-1-4939-7051-3_14; Carado A, 2008, ANAL CHEM, V80, P7921, DOI 10.1021/ac801712s; Chandra S, 2000, ANAL CHEM, V72, p104A, DOI 10.1021/ac002716i; CHANDRA S, 1987, J MICROSC-OXFORD, V148, P223, DOI 10.1111/j.1365-2818.1987.tb02869.x; Chandra S, 1997, J MICROSC-OXFORD, V186, P232, DOI 10.1046/j.1365-2818.1997.2030763.x; CHANDRA S, 1995, INT J MASS SPECTROM, V143, P161, DOI 10.1016/0168-1176(94)04134-S; CHRISTIE WW, 1985, J LIPID RES, V26, P507; Conlan XA, 2006, RAPID COMMUN MASS SP, V20, P1327, DOI 10.1002/rcm.2446; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Cullen P, 1997, J LIPID RES, V38, P401; Davies N, 2003, APPL SURF SCI, V203, P223, DOI 10.1016/S0169-4332(02)00631-1; Debois D, 2007, INT J MASS SPECTROM, V260, P115, DOI 10.1016/j.ijms.2006.09.026; Debois D, 2009, ANAL CHEM, V81, P2823, DOI 10.1021/ac900045m; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fisher GL, 2016, ANAL CHEM, V88, P6433, DOI 10.1021/acs.analchem.6b01022; Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u; Fletcher JS, 2006, APPL SURF SCI, V252, P6869, DOI 10.1016/j.apsusc.2006.02.153; Fletcher JS, 2013, METABOLOMICS, V9, P535, DOI 10.1007/s11306-012-0487-4; Fletcher JS, 2013, SURF INTERFACE ANAL, V45, P273, DOI 10.1002/sia.4874; Fletcher JS, 2011, RAPID COMMUN MASS SP, V25, P925, DOI 10.1002/rcm.4944; Fletcher JS, 2011, SURF INTERFACE ANAL, V43, P253, DOI 10.1002/sia.3488; Fletcher JS, 2008, ANAL CHEM, V80, P9058, DOI 10.1021/ac8015278; Frisz JF, 2013, J BIOL CHEM, V288, P16855, DOI 10.1074/jbc.M113.473207; Gunnarsson A, 2010, ANAL CHEM, V82, P2426, DOI 10.1021/ac902744u; Hannestad JK, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5019794; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Hill R, 2011, SURF INTERFACE ANAL, V43, P506, DOI 10.1002/sia.3562; Jones EA, 2006, APPL SURF SCI, V252, P6844, DOI 10.1016/j.apsusc.2006.02.145; Kezutyte T, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-3; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kurczy ME, 2010, P NATL ACAD SCI USA, V107, P2751, DOI 10.1073/pnas.0908101107; Lanekoff I, 2011, ANAL CHEM, V83, P5337, DOI 10.1021/ac200771g; Lanekoff I, 2010, ANAL CHEM, V82, P6652, DOI 10.1021/ac101243b; Le MUT, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5019597; Lee ES, 2013, ATHEROSCLEROSIS, V226, P378, DOI 10.1016/j.atherosclerosis.2012.11.003; Lehti S, 2015, AM J PATHOL, V185, P1216, DOI 10.1016/j.ajpath.2015.01.026; Levi-Setti R, 2006, APPL SURF SCI, V252, P6907, DOI 10.1016/j.apsusc.2006.02.176; MARTIN CE, 1976, BIOCHEMISTRY-US, V15, P5218, DOI 10.1021/bi00669a004; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; Morales-Soto N, 2018, J BIOL CHEM, V293, P9544, DOI 10.1074/jbc.RA118.002605; Morita SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11737; Mouhib T, 2010, J AM SOC MASS SPECTR, V21, P2005, DOI 10.1016/j.jasms.2010.08.013; Munem M, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5016254; Murata N, 1997, PLANT PHYSIOL, V115, P875, DOI 10.1104/pp.115.3.875; Nilsson KD, 2019, ANAL CHEM, V91, P11355, DOI 10.1021/acs.analchem.9b02533; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Parry S, 2005, ANAL CHEM, V77, P7950, DOI 10.1021/ac051263k; Passarelli MK, 2017, NAT METHODS, V14, P1175, DOI [10.1038/NMETH.4504, 10.1038/nmeth.4504]; Passarelli MK, 2013, ANAL CHEM, V85, P2231, DOI 10.1021/ac303038j; Phan NTN, 2017, ANAL BIOANAL CHEM, V409, P3923, DOI 10.1007/s00216-017-0336-4; Phan NTN, 2015, ANAL CHEM, V87, P4063, DOI 10.1021/acs.analchem.5b00555; Philipsen MH, 2018, J LIPID RES, V59, P2098, DOI [10.1194/jlr.M087734, 10.1194/jlr.m087734]; Piwowar AM, 2010, ANAL CHEM, V82, P8291, DOI 10.1021/ac101746h; Razo IB, 2015, RAPID COMMUN MASS SP, V29, P1851, DOI 10.1002/rcm.7285; Ren L, 2019, CHEM-EUR J, V25, P5406, DOI 10.1002/chem.201900010; Robinson MA, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4929633; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Samfors S, 2019, INT J MASS SPECTROM, V437, P77, DOI 10.1016/j.ijms.2017.09.012; Samfors S, 2018, RAPID COMMUN MASS SP, V32, P1473, DOI 10.1002/rcm.8181; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Sheraz S, 2014, SURF INTERFACE ANAL, V46, P51, DOI 10.1002/sia.5606; Sheraz S, 2013, ANAL CHEM, V85, P5654, DOI 10.1021/ac4013732; Sheraz S, 2019, ANAL CHEM, V91, P9058, DOI 10.1021/acs.analchem.9b01390; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shi YT, 2019, J PROTEOME RES, V18, P1669, DOI 10.1021/acs.jproteome.8b00941; Shon HK, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4941447; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sjovall P, 2003, ANAL CHEM, V75, P3429, DOI 10.1021/ac0207675; Sjovall P, 2006, APPL SURF SCI, V252, P6966, DOI 10.1016/j.apsusc.2006.02.126; Smith DF, 2011, ANAL CHEM, V83, P9552, DOI 10.1021/ac2023348; Szakal C, 2014, ANAL CHEM, V86, P3517, DOI 10.1021/ac404153q; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Thompson CE, 2006, APPL SURF SCI, V252, P6719, DOI 10.1016/j.apsusc.2006.02.237; Tian H., 2019, ANGEW CHEM, V131, P3188, DOI [10.1002/ange.201814256, DOI 10.1002/ange.201814256]; Tian H, 2017, ANAL CHEM, V89, P4611, DOI 10.1021/acs.analchem.7b00164; Tian H, 2014, J LIPID RES, V55, P1970, DOI 10.1194/jlr.D048660; Touboul D, 2005, J AM SOC MASS SPECTR, V16, P1608, DOI 10.1016/j.jasms.2005.06.005; Touboul D, 2005, J LIPID RES, V46, P1388, DOI 10.1194/jlr.M500058-JLR200; Touboul D, 2007, INT J MASS SPECTROM, V260, P158, DOI 10.1016/j.ijms.2006.09.027; Vaidyanathan S, 2008, ANAL CHEM, V80, P1942, DOI 10.1021/ac701921e; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wedlock LE, 2013, CHEM COMMUN, V49, P6944, DOI 10.1039/c3cc42098a; Wehrli PM, 2016, ANAL CHEM, V88, P8680, DOI 10.1021/acs.analchem.6b01981; Wong SCC, 2003, APPL SURF SCI, V203, P219, DOI 10.1016/S0169-4332(02)00629-3; Wu KJ, 1996, ANAL CHEM, V68, P873, DOI 10.1021/ac950717i; Yamada I, 2001, MAT SCI ENG R, V34, P231, DOI 10.1016/S0927-796X(01)00034-1; Yeager AN, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4939681; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	100	9	10	5	17	ANNUAL REVIEWS	PALO ALTO	4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA	1936-1327	1936-1335		ANNU REV ANAL CHEM	Annu. Rev. Anal. Chem.		2020	13						249	271		10.1146/annurev-anchem-091619-103512			23	Chemistry, Analytical; Spectroscopy	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Spectroscopy	BQ4OF	WOS:000591551900012	32212820				2022-02-06	
J	Wang, PC; Ma, HL; Zhang, YX; Zeng, R; Yu, JT; Liu, RN; Jin, XQ; Zhao, Y				Wang, Pengcheng; Ma, Haoli; Zhang, Yuxian; Zeng, Rong; Yu, Jiangtao; Liu, Ruining; Jin, Xiaoqing; Zhao, Yan			Plasma Exosome-derived MicroRNAs as Novel Biomarkers of Traumatic Brain Injury in Rats	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						Traumatic brain injury; exosomes; microRNA; plasma; biomarker; rat	CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; EXPRESSION; MILD; PROLIFERATION; DEGRADATION; DIAGNOSIS; AUTOPHAGY; NEUROINFLAMMATION; DIFFERENTIATION	Traumatic brain injury (TBI) is a widespread central nervous system (CNS) condition and a leading cause of death, disability, and long-term disability including seizures and emotional and behavioral issues. To date, applicable diagnostic biomarkers have not been elucidated. MicroRNAs (miRNAs) are enriched and stable in exosomes in plasma. Therefore, we speculated that miRNAs in plasma exosomes might serve as novel biomarkers for TBI diagnosis and are also involved in the pathogenesis of TBI. In this study, we first isolated exosomes from peripheral blood plasma in rats with TBI and then investigated the alterations in miRNA expression in exosomes by high-throughput RNA sequencing. As a result, we identified 50 significantly differentially expressed miRNAs, including 31 upregulated and 19 downregulated miRNAs. Then, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed that the most highly correlated pathways that were identified were the MAPK signaling pathway, regulation of actin cytoskeleton, Rapl signaling pathway and Ras signaling pathway. This study provides novel perspectives on miRNAs in peripheral blood plasma exosomes, which not only could be used as biomarkers of TBI diagnosis but could also be manipulated as therapeutic targets of TBI.	[Wang, Pengcheng; Ma, Haoli; Zhang, Yuxian; Zeng, Rong; Yu, Jiangtao; Liu, Ruining; Jin, Xiaoqing; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Peoples R China; [Wang, Pengcheng; Ma, Haoli; Zhang, Yuxian; Zeng, Rong; Yu, Jiangtao; Liu, Ruining; Jin, Xiaoqing; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Hubei Clin Res Ctr Emergency & Resuscitat, Wuhan 430071, Peoples R China		Jin, XQ; Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Emergency Ctr, Wuhan 430071, Peoples R China.; Jin, XQ; Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Hubei Clin Res Ctr Emergency & Resuscitat, Wuhan 430071, Peoples R China.	redjin@whu.edu.cn; doctoryanzhao@whu.edu.cn	Yu, Jiangtao/AAM-7143-2020		Emergency Diagnostic and Therapeutic Center of Central China (Wuhan, Hubei, China); Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2042019kf0149]; Science, Technology and Innovation Seed Fund of Zhongnan Hospital of Wuhan University [cxpy2017039, WJ2019H010/znpy2018043]	This study was supported by Emergency Diagnostic and Therapeutic Center of Central China (Wuhan, Hubei, China), Science, Technology and Innovation Seed Fund of Zhongnan Hospital of Wuhan University (cxpy2017039, WJ2019H010/znpy2018043), and the Fundamental Research Funds for the Central Universities (2042019kf0149).	Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Chen Shu, 2015, Zhonghua Bing Li Xue Za Zhi, V44, P905; Dai XP, 2019, BIOL CHEM, V400, P753, DOI 10.1515/hsz-2018-0340; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Ghanbari R, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp2329; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hu DL, 2019, GENE, V690, P81, DOI 10.1016/j.gene.2018.11.073; Hu XX, 2019, BIOCH BIOPHYS RES CO; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Ismail HM, 2015, ARTHRITIS RHEUMATOL, V67, P1826, DOI 10.1002/art.39099; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Jia AY, 2013, AM J PATHOL, V182, P1171, DOI 10.1016/j.ajpath.2013.01.006; Jia XP, 2018, CLIN LAB, V64, P915, DOI 10.7754/Clin.Lab.2017.171114; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Karnati HK, 2019, J NEUROTRAUM, V36, P975, DOI 10.1089/neu.2018.5898; Kichukova Tatyana M, 2015, Folia Med (Plovdiv), V57, P159, DOI 10.1515/folmed-2015-0035; Kleinsteuber K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061609; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Li PF, 2015, CELL MOL NEUROBIOL, V35, P433, DOI 10.1007/s10571-014-0139-5; Li WK, 2015, EXP CELL RES, V339, P367, DOI 10.1016/j.yexcr.2015.10.011; Makino K, 2012, CLIN EXP DERMATOL, V37, P34, DOI 10.1111/j.1365-2230.2011.04158.x; Mao G, 2017, CELL PHYSIOL BIOCHEM, V44, P38, DOI 10.1159/000484579; Mao ZK, 2018, INT IMMUNOPHARMACOL, V64, P308, DOI 10.1016/j.intimp.2018.09.018; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Rajarajan D, 2019, J CELL PHYSL; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shao N, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0325-8; Shen XH, 2018, INT J BIOL MACROMOL, V115, P509, DOI 10.1016/j.ijbiomac.2018.03.173; Shi YL, 2017, NEUROSCI LETT, V639, P68, DOI 10.1016/j.neulet.2016.12.052; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Sun Y, 2018, NEOPLASMA, V65, P505, DOI 10.4149/neo_2018_170705N462; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Tang LX, 2018, BIOCHEM BIOPH RES CO, V505, P578, DOI 10.1016/j.bbrc.2018.09.146; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; TE Stephanie M. J. Fliedner, 2014, PLOS ONE, P9; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Uhlen P, 2015, DEV NEUROBIOL, V75, P360, DOI 10.1002/dneu.22273; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Vuokila N, 2018, CELL MOL LIFE SCI, V75, P4557, DOI 10.1007/s00018-018-2911-z; Wang PC, 2018, INT J MOL MED, V41, P2117, DOI 10.3892/ijmm.2018.3410; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Xie JX, 2017, GENE, V627, P1, DOI 10.1016/j.gene.2017.06.003; Xiong Y, 2019, NEURAL REGEN RES, V14, P1477, DOI 10.4103/1673-5374.255957; Yan GL, 2019, AM J CANCER RES, V9, P585; Yang TX, 2019, IUBMB LIFE, V71, P134, DOI 10.1002/iub.1947; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; You YJ, 2019, ONCOTARGETS THER, V12, P2383, DOI 10.2147/OTT.S191158; Zhang XJ, 2018, CELL PHYSIOL BIOCHEM, V48, P1088, DOI 10.1159/000491975; Zhao LW, 2018, ANN CLIN LAB SCI, V48, P446; Zhao RT, 2018, J NEUROTRAUM, V35, P2056, DOI 10.1089/neu.2017.5502; Zhou YJ, 2019, J ALZHEIMERS DIS, V67, P571, DOI 10.3233/JAD-181053	72	9	9	2	8	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2020	17	4					437	448		10.7150/ijms.39667			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KN5BF	WOS:000514851600003	32174774	gold, Green Published			2022-02-06	
J	Salberg, S; Weerwardhena, H; Collins, R; Reimer, RA; Mychasiuk, R				Salberg, Sabrina; Weerwardhena, Himanthri; Collins, Reid; Reimer, Raylene A.; Mychasiuk, Richelle			The behavioural and pathophysiological effects of the ketogenic diet on mild traumatic brain injury in adolescent rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Prefrontal cortex; Hippocampus; Small intestine; Concussion; Neuroprotective	KETONE-BODIES; TELOMERE LENGTH; GENE-EXPRESSION; TIGHT JUNCTIONS; KETOSIS; MODEL; CONCUSSION; STRESS; NEURODEGENERATION; SYMPTOMOLOGY	Mild traumatic brain injury (mTBI), caused by an insult to the head, results in a cascade of molecular imbalance that includes altered glucose metabolism, mitochondrial dysfunction, and increases in reactive oxygen species. Although glucose is the primary energy source for the brain, it becomes an inefficient substrate following injury, and the brain is primed to use alternative substrates (such as ketones). The ketogenic diet (KD), a high-fat, low-carbohydrate diet, forces the brain to utilize ketones over glucose for energy. Given that mTBIs are commonly experienced during adolescence, our study sought to examine the effects of the KD on recovery from mTBI in adolescent rats. This was done via two experiments; the first of which animals were fed the KD prior to a mTBI in order to investigate the neuroprotective potential of the diet, and the second the animals were fed the KD following a mTBI to examine the therapeutic potential. Male and female Sprague Dawley rats were assigned to receive a control standard diet or the KD (either pre-injury or post-injury), then further randomized to receive a sham or mTBI. Animals were tested on 6 behavioural measures designed to examine post-concussive symptomology, and mRNA analysis of the brain and small intestine were performed. Pre-injury exposure to the KD offered some neuroprotection, reducing balance and motor impairments while increasing exploratory behaviour and telomere length. Consumption of the KD following the injury also provided some therapeutic benefit, reducing both anxiety- and depressive-like behaviours. The timing of KD administration also differentially modified expression of prefrontal cortex, hippocampus, and intestinal mRNA for our genes of interest (Fgf2, Iba1, Opa1, Sirt1, Claudin3, OCC, and ZO1) This study demonstrates the neuroprotective and therapeutic potential of the KD for mTBI and warrants further investigation.	[Salberg, Sabrina; Weerwardhena, Himanthri; Collins, Reid; Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp Res Inst, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Salberg, Sabrina; Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Richelle.mychasiuk@monash.edu			Alberta Children's Hospital Research Institute; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [PJT-153051]; National Scientific and Engineering Research Council [1304881]	The authors would like to thank the Alberta Children's Hospital Research Institute, Canadian Institute of Health Research (PJT-153051), and National Scientific and Engineering Research Council (1304881) for their financial contributions. In addition, we would like to thank Melinda Wang and Rose Tobias for their expertise and help with experimental design.	Alvis-Miranda Hernando Raphael, 2014, Bull Emerg Trauma, V2, P65; Amasheh S, 2011, ACTA PHYSIOL, V201, P133, DOI 10.1111/j.1748-1716.2010.02148.x; Ari C, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmal.2016.00137, 10.3389/fnmol.2016.00137]; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Benedek G, 2017, J NEUROIMMUNOL, V310, P51, DOI 10.1016/j.jneuroim.2017.06.007; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brownlow ML, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00129; Brownlow ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075713; Cassidy A., 2010, AM J CLIN NUTR, P28947; Chen KL, 2016, TRENDS ENDOCRIN MET, V27, P752, DOI 10.1016/j.tem.2016.08.001; Cheng BH, 2009, BRAIN RES, V1286, P25, DOI 10.1016/j.brainres.2009.06.060; Daisuke I, 1998, MOL BRAIN RES, V57, P1; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Hernandez AR, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00391; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Klein M., 2016, J PROTEOME RES; Kolb B., 2008, FUNDAMENTALS HUMAN N; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Likhodii SS, 2000, EPILEPSIA, V41, P1400, DOI 10.1111/j.1528-1157.2000.tb00115.x; Likhodii SS, 2002, CLIN CHEM, V48, P115; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; MacKay EM, 1941, J BIOL CHEM, V141, P889; Masino SA, 2012, MECH KETOGENIC DIET; Matsui S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07033-z; McCarty MF, 2015, MED HYPOTHESES, V85, P631, DOI 10.1016/j.mehy.2015.08.002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R., 2018, J NEUROTRAUM, V35, P1; Mychasiuk R, 2017, AUTISM RES, V10, P456, DOI 10.1002/aur.1682; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nicholson SE, 2018, SHOCK; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Patel JJ, 2016, CURR OPIN CRIT CARE, V22, P339, DOI 10.1097/MCC.0000000000000331; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Paul L, 2011, J NUTR BIOCHEM, V22, P895, DOI 10.1016/j.jnutbio.2010.12.001; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Rho JM, 1999, EPILEPSY RES, V37, P233, DOI 10.1016/S0920-1211(99)00068-6; Roberts M., 2017, CELL METAB, V26, pe5; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Silva MC, 2005, NUTR NEUROSCI, V8, P259, DOI 10.1080/10284150500475032; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Storoni M, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/681289; Sussman D, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.300; Suzuki H, 2017, ANN NY ACAD SCI, V1397, P25, DOI 10.1111/nyas.13371; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Van Itallie CM, 2014, SEMIN CELL DEV BIOL, V36, P157, DOI 10.1016/j.semcdb.2014.08.011; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Veech RL, 2017, IUBMB LIFE, V69, P305, DOI 10.1002/iub.1627; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042027; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xi L., 2009, NEUROCRIT CARE, V11, P151; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Ye F, 2015, J CLIN NEUROL, V11, P26, DOI 10.3988/jcn.2015.11.1.26; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	97	9	9	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	DEC 30	2019	376								112225	10.1016/j.bbr.2019.112225			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	LD5GC	WOS:000526056500043	31518660				2022-02-06	
J	Hristopulos, DT; Babul, A; Babul, S; Brucar, LR; Virji-Babul, N				Hristopulos, Dionissios T.; Babul, Arif; Babul, Shazia'Ayn; Brucar, Leyla R.; Virji-Babul, Naznin			Disrupted Information Flow in Resting-State in Adolescents With Sports Related Concussion	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						effective connectivity; concussion; mild traumatic brain injury; adolescents; EEG; resting state; information flow rate	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; NETWORKS; DIAGNOSIS; CHILDREN; TRENDS	Children and youths are at a greater risk of concussions than adults, and once injured, take longer to recover. A key feature of concussion is an increase in functional connectivity, yet it remains unclear how changes in functional connectivity relate to the patterns of information flow within resting state networks following concussion and how these relate to brain function. We applied a data-driven measure of directed effective brain connectivity to compare the patterns of information flow in healthy adolescents and adolescents with subacute concussion during the resting state condition. Data from 32 healthy adolescents (mean age =16 years) and 21 concussed adolescents (mean age = 15 years) within 1 week of injury were included in the study. Five minutes of resting state data EEG were collected while participants sat quietly with their eyes closed. We applied the information flow rate to measure the transfer of information between the EEG time series of each individual at different source locations, and therefore between different brain regions. Based on the ensemble means of the magnitude of normalized information flow rate, our analysis shows that the dominant nexus of information flow in healthy adolescents is primarily left lateralized and anterior-centric, characterized by strong bidirectional information exchange between the frontal regions, and between the frontal and the central/temporal regions. In contrast, adolescents with concussion show distinct differences in information flow marked by a more left-right symmetrical, albeit still primarily anterior-centric, pattern of connections, diminished activity along the central-parietal midline axis, and the emergence of inter-hemispheric connections between the left and right frontal and the left and right temporal regions of the brain. We also find that the statistical distribution of the normalized information flow rates in each group (control and concussed) is significantly different. This paper is the first to describe the characteristics of the source space information flow and the effective connectivity patterns between brain regions in healthy adolescents in juxtaposition with the altered spatial pattern of information flow in adolescents with concussion, statistically quantifying the differences in the distribution of the information flow rate between the two populations. We hypothesize that the observed changes in information flow in the concussed group indicate functional reorganization of resting state networks in response to brain injury.	[Hristopulos, Dionissios T.] Tech Univ Crete, Telecommun Syst Res Inst, Khania, Greece; [Hristopulos, Dionissios T.] Tech Univ Crete, Sch Mineral Resources Engn, Khania, Greece; [Babul, Arif] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Babul, Shazia'Ayn] Princeton Univ, Rockefeller Coll, Princeton, NJ 08544 USA; [Brucar, Leyla R.; Virji-Babul, Naznin] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Virji-Babul, Naznin] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada		Virji-Babul, N (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.; Virji-Babul, N (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada.	naznin.virji-babul@ubc.ca	Babul, Arif/E-2730-2010; Hristopulos, Dionisis/Q-4386-2019	Babul, Arif/0000-0003-1746-9529; Hristopulos, Dionisis/0000-0002-5189-5612; Virji-Babul, Naznin/0000-0002-8984-5848; Brucar, Leyla/0000-0002-5852-3088; Babul, Shelina/0000-0002-0227-2574			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bassett D.S., 2018, NONASSORTATIVE COMMU, DOI [10.1101/355016, DOI 10.1101/355016]; BESA Wiki, 2018, BES RES MONT ED; BLANCO S, 1995, IEEE ENG MED BIOL, V14, P395, DOI 10.1109/51.395321; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Bounova G., 2014, OCTAVE NETWORKS TOOL; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Durka PJ, 2004, IEEE T BIO-MED ENG, V51, P1167, DOI 10.1109/TBME.2004.827341; Efron B., 2016, COMPUTER AGE STAT IN; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Geier C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00462; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hristopulos D. T., 2019, 608299 BIORXIV, DOI [10.1101/608299, DOI 10.1101/608299]; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Keays G, 2018, CAN J PUBLIC HEALTH, V109, P52, DOI 10.17269/s41997-018-0037-6; Klonowski Wlodzimierz, 2009, Nonlinear Biomed Phys, V3, P2, DOI 10.1186/1753-4631-3-2; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liang X. S., 2018, CHAOS, V28, DOI 10.1063/1.501025330070535; Liang XS, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052201; Liang XS, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022126; Liang XS, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052150; Liang XS, 2013, ENTROPY-SWITZ, V15, P327, DOI 10.3390/e15010327; Liang XS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031113; Liang XS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.244101; Lim S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39243-w; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore RD, 2018, INT J PSYCHOPHYSIOL, V132, P14, DOI 10.1016/j.ijpsycho.2018.04.003; Muller AM, 2018, ASN NEURO, V10, DOI 10.1177/1759091417753802; Murdaugh DL, 2018, J INT NEUROPSYCH SOC, V24, P781, DOI 10.1017/S1355617718000413; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Noldus R, 2015, J COMPLEX NETW, V3, P507, DOI 10.1093/comnet/cnv005; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Porter S, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00373; Press W. H., 2007, NUMERICAL RECIPES, V3rd; Rotem-Kohavi N, 2017, NEUROSCI LETT, V650, P118, DOI 10.1016/j.neulet.2017.04.031; Rotem-Kohavi N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00209; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	63	9	9	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 12	2019	13								419	10.3389/fnhum.2019.00419			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	JY9NY	WOS:000504734000001	31920584	Green Published, Green Submitted, gold			2022-02-06	
J	Xie, XK; Xu, ZK; Xu, K; Xiao, YX				Xie, Xian-Kuan; Xu, Zheng-Kuan; Xu, Kan; Xiao, Yu-Xiang			DUSP19 mediates spinal cord injury-induced apoptosis and inflammation in mouse primary microglia cells via the NF-kB signaling pathway	NEUROLOGICAL RESEARCH			English	Article						DUSP19; spinal cord injury; NF-kappa B; Caspase-3; IL-6; IL-8	TRAUMATIC BRAIN; KAPPA-B; INHIBITION; ACTIVATION; CYTOKINES; RECOVERY; EXTRACT; STRESS	Objective: Spinal cord injury (SCI) is a common injury that seriously threatens human health. NF-kappa B may be involved in the secondary injury of SCI that is mediated by inflammation and aggravates damage. Our study was aimed to investigate the role of NF-kappa B signaling in DUSP19-mediated cleaved Caspase-3 expression and the release of inflammatory factors in vivo and in vitro. Materials and Methods: DUSP19 mRNA expression and the content of IL-6 and IL-8 in patients with traumatic SCI (TSCI) were measured by real-time PCR and ELISA, respectively. The levels of p-NF-kappa Bp65, NF-kappa Bp65 and cleaved Caspase-3 expression and the concentrations of IL-6 and IL-8 were measured by western blotting and ELISA, respectively. Results: Patients with TSCI showed lower DUSP19 expression and higher concentration of IL-6 and IL-8 compared with healthy controls. DUSP19 overexpression inhibited p-NF-kappa Bp65 level, cleaved Caspase-3 expression, and production of IL-8 and IL-6 in the mice induced by TSCI. DUSP19 silencing increased p-NF-kappa Bp65 level, cleaved Caspase-3 expression, and concentration of IL-6 and IL-8 in mouse primary microglia cells. DUSP19 overexpression had an inverse effect. Importantly, DUSP19 silencing and overexpression mediated p-NF-kappa Bp65 level, cleaved Caspase-3 expression, and concentration of IL-6 and IL-8 in mouse primary microglia cells were reversed by NF-kappa B inhibitor pyrrolidine dithiocarbamate (PDTC) and NF-kappa B activator 12-myristate 13-acetate (PMA), respectively. Conclusion: These results suggested that DUSP19-mediated SCI-induced apoptosis and inflammation via NF-kappa B signaling and might therefore serve as a potential therapeutic target for SCI.	[Xie, Xian-Kuan; Xu, Zheng-Kuan; Xu, Kan; Xiao, Yu-Xiang] Zhejiang Univ, Dept Orthoped, Affiliated Hosp 2, Sch Med, 1151 Binhong Rd, Hangzhou 310053, Zhejiang, Peoples R China		Xiao, YX (corresponding author), Zhejiang Univ, Dept Orthoped, Affiliated Hosp 2, Sch Med, 1151 Binhong Rd, Hangzhou 310053, Zhejiang, Peoples R China.	2306035@zju.edu.cn; xuzhengkuan@163.com; guukbj@163.com; 2309013@zju.edu.cn					Bakan A, 2008, CURR MED CHEM, V15, P2536, DOI 10.2174/092986708785909003; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Esposito E, 2009, J PINEAL RES, V46, P79, DOI 10.1111/j.1600-079X.2008.00633.x; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Feng NH, 2019, J NEUROIMMUNOL, V334, DOI 10.1016/j.jneuroim.2019.576996; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gangwani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135633; Guo J, 2014, INT J MOL MED, V34, P74, DOI 10.3892/ijmm.2014.1751; Jeon TJ, 2015, SPACE, V212121, P3121; Jiang J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00363; Jin W, 2014, ANN CLIN LAB SCI, V44, P151; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee JY, 2012, ENDOCRINOLOGY, V153, P3815, DOI 10.1210/en.2012-1068; Lee JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073948; Lee YS, 2019, SPINE J, V19, P2025, DOI 10.1016/j.spinee.2019.07.013; Li JJ, 2018, TOXICOL APPL PHARM, V360, P131, DOI 10.1016/j.taap.2018.10.007; Liao B, 2016, CELL PHYSIOL BIOCHEM, V38, P1129, DOI 10.1159/000443063; Liu G, 2017, CELL MOL NEUROBIOL, V37, P843, DOI 10.1007/s10571-016-0422-8; Luo JX, 2016, J ETHNOPHARMACOL, V183, P187, DOI 10.1016/j.jep.2016.01.020; Martini AC, 2016, NEUROSCI LETT, V621, P54, DOI 10.1016/j.neulet.2016.04.017; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; Moon YJ, 2012, J NEUROSCI RES, V90, P243, DOI 10.1002/jnr.22734; Ni HB, 2015, J SPINAL CORD MED, V38, P199, DOI 10.1179/2045772313Y.0000000179; Oudega M, 2013, EXP NEUROL, V250, P151, DOI 10.1016/j.expneurol.2013.09.013; Repici M, 2012, NEUROBIOL DIS, V46, P710, DOI 10.1016/j.nbd.2012.03.014; Shen Changxian, 2004, Methods Mol Biol, V252, P523; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wei CH, 2011, PROTEINS, V79, P3242, DOI 10.1002/prot.23156	33	9	9	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN 2	2020	42	1					31	38		10.1080/01616412.2019.1685068		DEC 2019	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KC5VS	WOS:000501103500001	31813339				2022-02-06	
J	Fallon, BA; Zubcevik, N; Bennett, C; Doshi, S; Rebman, AW; Kishon, R; Moeller, JR; Octavien, NR; Aucott, JN				Fallon, Brian A.; Zubcevik, Nevena; Bennett, Clair; Doshi, Shreya; Rebman, Alison W.; Kishon, Ronit; Moeller, James R.; Octavien, Nadlyne R.; Aucott, John N.			The General Symptom Questionnaire-30 (GSQ-30): A Brief Measure of Multi-System Symptom Burden in Lyme Disease	FRONTIERS IN MEDICINE			English	Article						Lyme disease; GSQ-30; PTLDS; multi-system illness; symptom burden	SCALE; DEPRESSION; SEVERITY; VALIDITY	Introduction: The multi-system symptoms accompanying acute and post-treatment Lyme disease syndrome pose a challenge for time-limited assessment. The General Symptom Questionnaire (GSQ-30) was developed to fill the need for a brief patient-reported measure of multi-system symptom burden. In this study we assess the psychometric properties and sensitivity to change of the GSQ-30. Materials and Methods: 342 adult participants comprised 4 diagnostic groups: Lyme disease (post-treatment Lyme disease syndrome, n = 124; erythema migrans, n = 94); depression, n = 36; traumatic brain injury, n = 51; healthy, n = 37. Participants were recruited from clinical research facilities in Massachusetts, Maryland, and New York. Validation measures for the GSQ-30 included the Patient Health Questionnaire-4 for depression and anxiety, visual analog scales for fatigue and pain, the Sheehan Disability Scale for functional impairment, and one global health question. To assess sensitivity to change, 53 patients with erythema migrans completed the GSQ-30 before treatment and 6 months after 3 weeks of treatment with doxycycline. Results: The GSQ-30 demonstrated excellent internal consistency (Cronbach alpha = 0.95). The factor structure reflects four core domains: pain/fatigue, neuropsychiatric, neurologic, and viral-like symptoms. Symptom burden was significantly associated with depression (r(s) = 0.60), anxiety (r(s) = 0.55), pain (r(s) = 0.75), fatigue (r(s) = 0.77), functional impairment (r(s) = 0.79), and general health (r(s) = -0.58). The GSQ-30 detected significant change in symptom burden before and after antibiotic therapy; this change correlated with change in functional impairment. The GSQ-30 total score significantly differed for erythema migrans vs. three other groups (post-treatment Lyme disease syndrome, depression, healthy controls). The GSQ-30 total scores for traumatic brain injury and depression were not significantly different from post-treatment Lyme disease syndrome. Conclusions and Relevance: The GSQ-30 is a valid and reliable instrument to assess symptom burden among patients with acute and post-treatment Lyme disease syndrome and is sensitive in the detection of change after treatment among patients with erythema migrans. The GSQ-30 should prove useful in clinical and research settings to assess multi-system symptom burden and to monitor change over time. The GSQ-30 may also prove useful in future precision medicine studies as a clinical measure to correlate with disease-relevant biomarkers.	[Fallon, Brian A.; Bennett, Clair; Doshi, Shreya; Kishon, Ronit; Moeller, James R.] Columbia Univ, Dept Psychiat, Irving Med Ctr, Lyme & TiCk Borne Dis Res Ctr, New York, NY 10032 USA; [Fallon, Brian A.; Bennett, Clair; Doshi, Shreya; Kishon, Ronit; Moeller, James R.] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA; [Zubcevik, Nevena; Octavien, Nadlyne R.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Dean Ctr Tick Borne Illness, Boston, MA 02115 USA; [Zubcevik, Nevena] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Rebman, Alison W.; Aucott, John N.] Johns Hopkins Sch Med, Lyme Dis Res Ctr, Dept Med, Div Rheumatol, Baltimore, MD USA		Fallon, BA (corresponding author), Columbia Univ, Dept Psychiat, Irving Med Ctr, Lyme & TiCk Borne Dis Res Ctr, New York, NY 10032 USA.; Fallon, BA (corresponding author), New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA.	baf1@cumc.columbia.edu			Oxford Immunotec, Inc.	Specific support for this project was provided by Oxford Immunotec, Inc. General support for research was provided by the Steven and Alexandra Cohen Foundation, Inc., the Global Lyme Alliance, Inc., the Lyme Disease Association, Inc., and the Cohen Foundation, Inc. NZ's work at the Spaulding site was supported by Mark and Eileen Lovell. The funding organizations and sponsors had no role in any of the following aspects of the study: design and conduct of the study; data collection, management, analysis, or interpretation; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Arbuckle R, 2009, PSYCHIAT RES, V165, P163, DOI 10.1016/j.psychres.2007.11.018; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Aucott JN, 2013, QUAL LIFE RES, V22, P75, DOI 10.1007/s11136-012-0126-6; Baglin J., 2014, PARE, V19, P1; Batheja S, 2013, J NEUROPSYCH CLIN N, V25, P176, DOI 10.1176/appi.neuropsych.12090223; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Caraceni A, 2002, J PAIN SYMPTOM MANAG, V23, P239, DOI 10.1016/S0885-3924(01)00409-2; Citera M, 2017, INT J GEN MED, V10, P249, DOI 10.2147/IJGM.S140224; Coles T, 2014, NEUROPSYCH DIS TREAT, V10, P887, DOI 10.2147/NDT.S55220; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Coughlin JM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1381-4; Derogatis LR., 2004, USE PSYCHOL TESTING, P1; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Lloret S, 2017, AN PSICOL-SPAIN, V33, P417, DOI 10.6018/analesps.33.2.270211; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Myers TA, 2011, COMMUN METHODS MEAS, V5, P297, DOI 10.1080/19312458.2011.624490; Newschaffer CJ., 1998, VALIDATION BEHAV RIS; R Core Team, 2018, R LANGUAGE ENV STAT; Rebman AW, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00224; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Watkins MW, 2018, J BLACK PSYCHOL, V44, P219, DOI 10.1177/0095798418771807; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	32	9	9	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	DEC 6	2019	6								283	10.3389/fmed.2019.00283			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JX9ZI	WOS:000504084700001	31867334	gold, Green Published			2022-02-06	
J	Fu, CY; Wu, Q; Zhang, ZM; Xia, ZA; Ji, HC; Lu, HM; Wang, Y				Fu, Chunyan; Wu, Qian; Zhang, Zhimin; Xia, Zian; Ji, Hongchao; Lu, Hongmei; Wang, Yang			UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Untargeted metabolomics; Traumatic brain injury; Xuefu Zhuyu decoction; UPLC-ESI-IT-TOF-MS	LIQUID-CHROMATOGRAPHY; GAS-CHROMATOGRAPHY; TIME-SERIES; IDENTIFICATION; BIOMARKERS	It has been widely reported that Xuefu Zhuyu decoction (XFZYD), a traditional Chinese medicine, is effective in the treatment of traumatic brain injury (TBI). However, the mechanism of the therapeutic process is still not fully understood. Metabolomic technique can be used to explore the mechanisms underlying the treatment of TBI with XFZYD. The purpose of this work was to investigate the metabolic characteristics of blood samples from rats with and without XFZYD treatment and the dynamic changes in metabolite profiles on days 1, 3, 7, 14 and 21 after injury (within the severe phase of TBI) based on untargeted UPLC-ESI-IT-TOF-MS analysis. Pattern recognition, clustering analysis and metabolic pathway analysis were used to analyse the metabolomic data of three groups (a sham-operated group, a TBI model, and an XFZYD-treated TBI model). The results showed that XFZYD reversed the abnormalities in the levels of small-molecule metabolites (such as L-acetylcarnitine, L-tryptophan, indoleacrylic acid, gamma-aminobutyric acid, hypotaurine, LysoPC(18:1)(11Z), creatine, L-phenylalanine and L-leucine) in TBI rats through six metabolic pathways (including phenylalanine, tyrosine and tryptophan biosynthesis; phenylalanine metabolism; valine, leucine and isoleucine biosynthesis; taurine and hypotaurine metabolism; tryptophan metabolism; and alanine, aspartate and glutamate metabolism) involved in the therapy process. XFZYD regulated the metabolic disorders of endogenous markers by the possible mechanisms of neuroprotection, energy metabolism, inflammatory response and oxidative stress. This study revealed the holistic and dynamic metabolic changes caused by XFZYD in rats with TBI and provided important research methods and approaches for exploring the multiple metabolites and metabolic pathways involved in the therapeutic effect of XFZYD on TBI.	[Fu, Chunyan; Wu, Qian; Zhang, Zhimin; Ji, Hongchao; Lu, Hongmei] Cent South Univ, Coll Chem & Chem Engn, Changsha, Hunan, Peoples R China; [Fu, Chunyan] Shaoyang Univ, Coll Pharm, Shaoyang, Hunan, Peoples R China; [Xia, Zian; Wang, Yang] Cent South Univ, Xiangya Hosp, Lab Ethnopharmacol, Inst Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China		Lu, HM (corresponding author), Cent South Univ, Coll Chem & Chem Engn, Changsha, Hunan, Peoples R China.; Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Lab Ethnopharmacol, Inst Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China.	hongmeilu@csu.edu.cn; wangyang_xy87@csu.edu.cn	ji, hongchao/I-3676-2019	ji, hongchao/0000-0002-7364-0741	National Natural Science Foundation of China of ChinaNational Natural Science Foundation of China (NSFC) [21675174, 21873116, 81673719]; Hunan Provincial Technology Innovation Guidance Plan, China [2018SK51902]; research foundation of the Education Bureau of Hunan Province, China [17C1420]; research foundation of Science and Technology Bureau of Shaoyang, China [2016ZD16]	This work was supported by the National Natural Science Foundation of China of China (Grant No. 21675174, 21873116, 81673719), Hunan Provincial Technology Innovation Guidance Plan, China (No. 2018SK51902), the research foundation of the Education Bureau of Hunan Province, China (No. 17C1420) and the research foundation of Science and Technology Bureau of Shaoyang, China (No. 2016ZD16).	Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0957-1; Bertrand S, 2014, MOL BIOSYST, V10, P2289, DOI 10.1039/c4mb00223g; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Emwas AHM, 2015, APPLICATIONS OF NMR SPECTROSCOPY, VOL 3, P4; Feng DD, 2017, ONCOTARGET, V8, P94692, DOI 10.18632/oncotarget.21876; Fievisohn EM, 2014, TRAFFIC INJ PREV, V15, pS81, DOI 10.1080/15389588.2014.929670; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gomez-Munoz A, 1999, J LIPID RES, V40, P988; Gu Y, 2012, MOL BIOSYST, V8, P1535, DOI 10.1039/c2mb25022e; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guo HM, 2016, RSC ADV, V6, P54471, DOI 10.1039/c6ra12641c; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Ji HC, 2017, ANAL CHEM, V89, P7631, DOI 10.1021/acs.analchem.7b01547; Ji HC, 2016, RSC ADV, V6, pS6977, DOI 10.1039/c6ra08409e; Jiang B, 2008, J CHIN I FOOD SCI TE, DOI [10.1016/S0301-0082(97)00002-6, DOI 10.1016/S0301-0082(97)00002-6]; Jin XY, 2008, J ETHNOPHARMACOL, V117, P473, DOI 10.1016/j.jep.2008.02.033; Kou K, 2014, WORLD J EMERG MED, V5, P245, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.001; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Mandal R, 2012, GENOME MED, V4, DOI 10.1186/gm337; Ming L. I, 2008, PARENTER ENTERAL NUT; Molinaro G, 2008, MOL CELL NEUROSCI, V37, P312, DOI 10.1016/j.mcn.2007.10.009; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; OLNEY JW, 1975, J NEUROPATH EXP NEUR, V34, P167, DOI 10.1097/00005072-197503000-00005; Pardridge WM, 1998, NEUROCHEM RES, V23, P635, DOI 10.1023/A:1022482604276; Partyka A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7279341; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Robert C, 2001, TOTAL HLTH; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; SCHURR A, 1987, FEBS LETT, V224, P4, DOI 10.1016/0014-5793(87)80411-8; Smilde AK, 2010, METABOLOMICS, V6, P3, DOI 10.1007/s11306-009-0191-1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Wang WB, 2018, J ETHNOPHARMACOL, V219, P299, DOI 10.1016/j.jep.2018.03.026; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang Y. H, 2009, MED J NATL DEFENDING; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30; Zhang Z, 2019, J NEUROTRAUM, V36, P74, DOI 10.1089/neu.2017.5450; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhou XY, 2016, TALANTA, V147, P82, DOI 10.1016/j.talanta.2015.09.040; Zhu CL, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1403-3; Zhu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17068	56	9	10	3	86	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741	1872-7573		J ETHNOPHARMACOL	J. Ethnopharmacol.	DEC 5	2019	245								112149	10.1016/j.jep.2019.112149			12	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	JB1OY	WOS:000488331300015	31401321				2022-02-06	
J	Yuan, JY; Botchway, BOA; Zhang, Y; Wang, XZ; Liu, XH				Yuan, Jiaying; Botchway, Benson O. A.; Zhang, Yong; Wang, Xizhi; Liu, Xuehong			Combined bioscaffold with stem cells and exosomes can improve traumatic brain injury	STEM CELL REVIEWS AND REPORTS			English	Article						Extracellular vesicles; Bioscaffold; Stem cell transportation; Nerve regeneration; Neuronal injury	COLLAGEN SCAFFOLDS; CEREBRAL-ISCHEMIA; FUNCTIONAL RECOVERY; DELIVERY VEHICLES; STROMAL CELLS; IN-VITRO; VESICLES; TRANSPLANTATION; REGENERATION; EXPRESSION	The intricacy of the brain, along with the existence of blood brain barrier (BBB) does complicate the delivery of effective therapeutics through simple intravascular injection. Hence, an effective delivery mechanism of therapeutics in the event of either traumatic brain injury (TBI) or other brain injuries is needed. Stem cells can promote regeneration and repair injury. The usage of biomaterials and exosomes in transporting stem cells to target lesion sites has been suggested as a potential option. The combination of biomaterials with modified exosomes can help in transporting stem cells to injury sites, whiles also increasing their survival and promoting effective treatment. Herein, we review the current researches pertinent to biological scaffolds and exosomes in repairing TBI and present the current progress and new direction in the clinical setting. We begin with the role of bioscaffold in treating neuronal conditions, the effect of exosomes in injury, and conclude with the improvement of TBI via the employment of combined exosomes, bioscaffold and stem cells.	[Yuan, Jiaying; Zhang, Yong; Wang, Xizhi; Liu, Xuehong] Shaoxing Univ, Med Coll, Dept Histol & Embryol, Shaoxing 312000, Zhejiang, Peoples R China; [Botchway, Benson O. A.] Zhejiang Univ, Inst Neurosci, Sch Med, Hangzhou, Zhejiang, Peoples R China		Liu, XH (corresponding author), Shaoxing Univ, Med Coll, Dept Histol & Embryol, Shaoxing 312000, Zhejiang, Peoples R China.	liuxueh6588@126.com	xuehong, liu/AAM-6326-2020; Botchway, Benson/ABD-3436-2021	Botchway, Benson/0000-0001-9732-7904; Liu, Xuehong/0000-0003-4325-6762	Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY19H170001]	This work was supported by the Natural Science Foundation of Zhejiang Province (no. LY19H170001).	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Allahverdiyev AM, 2018, ARTIF CELL NANOMED B, V46, pS755, DOI 10.1080/21691401.2018.1511573; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Arulmoli J, 2016, ACTA BIOMATER, V43, P122, DOI 10.1016/j.actbio.2016.07.043; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Bautista-Lopez NL, 2017, J CLIN MICROBIOL, V55, P744, DOI 10.1128/JCM.01649-16; Begum G, 2018, GLIA, V66, P126, DOI 10.1002/glia.23232; Horcajo CB, 2018, CYTOTHERAPY, V20, P314, DOI 10.1016/j.jcyt.2017.11.012; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bu N, 2011, J NEURO-ONCOL, V104, P659, DOI 10.1007/s11060-011-0537-1; Chen C, 2019, ACTA PHARM SIN B, V9, P557, DOI 10.1016/j.apsb.2019.03.004; Chen F, 2015, TRANSL STROKE RES, V6, P478, DOI 10.1007/s12975-015-0429-3; Chen X, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800315; Chen X, 2018, NEURAL REGEN RES, V13, P1231, DOI 10.4103/1673-5374.235061; Cho HJ, 2018, ANN BIOMED ENG, V46, P877, DOI 10.1007/s10439-018-2004-z; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.TEA.2012.0733, 10.1089/ten.tea.2012.0733]; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Curtin C, 2018, ACTA BIOMATER, V70, P84, DOI 10.1016/j.actbio.2018.02.004; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Dukhinova M, 2018, BRAIN BEHAV IMMUN, V74, P7, DOI 10.1016/j.bbi.2018.09.009; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fujimoto M, 2016, J NEUROSURG, V124, P1693, DOI 10.3171/2015.4.JNS15484; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Giunta M, 2016, HUM MOL GENET, V25, P2985, DOI 10.1093/hmg/ddw149; Goetzl EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00452; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang S, 2018, FASEB J, V32, P2315, DOI 10.1096/fj.201700673RERR; Huang X, 2018, EXP CELL RES, V371, P269, DOI 10.1016/j.yexcr.2018.08.021; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P9122, DOI 10.1007/s12035-018-1050-8; Janyou A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11181-5; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jia W, 2018, INT J ONCOL, V52, P1787, DOI 10.3892/ijo.2018.4330; Karunaratne DN, 2015, CURR PHARM DESIGN, V21, P4529, DOI 10.2174/138161282131151013185528; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Li D, 2019, NEUROCHEM RES, V44, P1903, DOI 10.1007/s11064-019-02825-1; Li D, 2019, MED SCI MONITOR, V25, P1871, DOI 10.12659/MSM.915727; Li JN, 2017, THROMB RES, V154, P96, DOI 10.1016/j.thromres.2017.04.016; Li X, 2017, BIOMATERIALS, V137, P73, DOI 10.1016/j.biomaterials.2017.05.027; Li Y, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0648-5; Liang YT, 2018, AM J TRANSL RES, V10, P352; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lubas M, 2015, CELL REP, V10, P178, DOI 10.1016/j.celrep.2014.12.026; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Manek R, 2018, MOL NEUROBIOL, V55, P6112, DOI 10.1007/s12035-017-0821-y; Martinez-Ramos C, 2015, NEUROSCI LETT, V598, P96, DOI 10.1016/j.neulet.2015.05.021; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Moisenovich MM, 2019, NEUROCHEM RES, V44, P2261, DOI 10.1007/s11064-018-2691-8; Moyron R. B., 2017, PROTEOMICS CLIN APPL, V11; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nedaeinia R, 2017, CANCER GENE THER, V24, P48, DOI 10.1038/cgt.2016.77; Negah SS, 2019, ACTA BIOMATER, V92, P132, DOI 10.1016/j.actbio.2019.05.010; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Quinsey C, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18281; Rajashekhar G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00059; Ranjit S, 2018, EXPERT OPIN THER TAR, V22, P703, DOI 10.1080/14728222.2018.1501473; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rocamonde B, 2016, BRAIN INJURY, V30, P208, DOI 10.3109/02699052.2015.1091505; Roohani-Esfahani SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19468; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shin SS, 2015, RESTOR NEUROL NEUROS, V33, P95, DOI 10.3233/RNN-140430; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skop NB, 2019, ASN NEURO, V11, DOI 10.1177/1759091419830186; Skop NB, 2016, J TISSUE ENG REGEN M, V10, pE419, DOI 10.1002/term.1832; Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068; Souza-Imberg A, 2017, TOXICON, V136, P27, DOI 10.1016/j.toxicon.2017.06.013; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Tatischeff I., 2011, J BIOMATER NANOBIOTE, V2, P494, DOI DOI 10.4236/jbnb.2011.225060; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tian T, 2018, BIOMATERIALS, V150, P137, DOI 10.1016/j.biomaterials.2017.10.012; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tseng CK, 2015, CELL REP, V13, P2232, DOI 10.1016/j.celrep.2015.10.075; Turtzo LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126551; Ucar B, 2018, NEURAL REGEN RES, V13, P595, DOI 10.4103/1673-5374.230273; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vashisht M, 2018, J CELL BIOCHEM, V119, P1488, DOI 10.1002/jcb.26309; Vining KH, 2017, NAT REV MOL CELL BIO, V18, P728, DOI 10.1038/nrm.2017.108; Wang B, 2018, MOL CELL NEUROSCI, V88, P158, DOI 10.1016/j.mcn.2018.02.002; Wang J, 2018, BIOCHEM BIOPH RES CO, V505, P677, DOI 10.1016/j.bbrc.2018.09.165; Wang JJ, 2018, BIOMED PHARMACOTHER, V108, P1451, DOI 10.1016/j.biopha.2018.09.174; Wang XZ, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00081; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Weiss OE, 2018, J BIOMED MATER RES B, V106, P2295, DOI 10.1002/jbm.b.34037; Wu Y, 2017, CELL TRANSPLANT, V26, P1224, DOI 10.1177/0963689717714090; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yan F, 2019, NEURAL REGEN RES, V14, P1780, DOI 10.4103/1673-5374.257533; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Yang YX, 2019, NEUROCHEM RES, V44, P811, DOI 10.1007/s11064-018-02714-z; Zamproni LN, 2019, NANOMED-NANOTECHNOL, V15, P98, DOI 10.1016/j.nano.2018.08.014; Zhang JC, 2014, BRAZ J MED BIOL RES, V47, P886, DOI 10.1590/1414-431X20143765; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang ZW, 2018, BRAIN RES, V1701, P112, DOI 10.1016/j.brainres.2018.09.012; Zhao RT, 2018, J NEUROTRAUM, V35, P2056, DOI 10.1089/neu.2017.5502; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231; Zhou YT, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1127-z	116	9	10	2	27	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2629-3269	2629-3277		STEM CELL REV REP	Stem Cell Rev. Rep.	APR	2020	16	2					323	334		10.1007/s12015-019-09927-x		DEC 2019	12	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	LC5FE	WOS:000501451100001	31808037				2022-02-06	
J	Bonow, RH; Young, CC; Bass, DI; Moore, A; Levitt, MR				Bonow, Robert H.; Young, Christopher C.; Bass, David, I; Moore, Anne; Levitt, Michael R.			Transcranial Doppler ultrasonography in neurological surgery and neurocritical care	NEUROSURGICAL FOCUS			English	Article						transcranial Doppler ultrasonography; vasospasm; stroke; traumatic brain injury; neurocritical care	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL-ISCHEMIA; BYPASS GRAFTS; ASYMPTOMATIC EMBOLIZATION; PRESSURE AUTOREGULATION; VASOSPASM DIAGNOSIS; ACUTE STROKE; CELL ANEMIA; BLOOD-FLOW; TCD	Transcranial Doppler (TCD) ultrasonography is an inexpensive, noninvasive means of measuring blood flow within the arteries of the brain. In this review, the authors outline the technology underlying TCD ultrasonography and describe its uses in patients with neurosurgical diseases. One of the most common uses of TCD ultrasonography is monitoring for vasospasm following subarachnoid hemorrhage. In this setting, elevated blood flow velocities serve as a proxy for vasospasm and can herald the onset of ischemia. TCD ultrasonography is also useful in the evaluation and management of occlusive cerebrovascular disease. Monitoring for microembolic signals enables stratification of stroke risk due to carotid stenosis and can also be used to clarify stroke etiology. TCD ultrasonography can identify patients with exhausted cerebrovascular reserve, and after extracranial-intracranial bypass procedures it can be used to assess adequacy of flow through the graft. Finally, assessment of cerebral autoregulation can be performed using TCD ultrasonography, providing data important to the management of patients with severe traumatic brain injury. As the clinical applications of TCD ultrasonography have expanded over time, so has their importance in the management of neurosurgical patients. Familiarity with this diagnostic tool is crucial for the modern neurological surgeon.	[Bonow, Robert H.; Young, Christopher C.; Bass, David, I; Moore, Anne; Levitt, Michael R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Levitt, Michael R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Levitt, Michael R.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Levitt, Michael R.] Univ Washington, Stroke & Appl Neurosci Ctr, Seattle, WA 98195 USA		Levitt, MR (corresponding author), Univ Washington, Neurosurg Publicat, Seattle, WA 98195 USA.	respub@uw.edu			Stryker; MedtronicMedtronic; Philips Volcano	Dr. Levitt: direct stock ownership in Cerebrotech, eLoupes Inc., and Corindus, and unrestricted educational grants from Stryker, Medtronic, and Philips Volcano.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; Alexandrov AV, 1999, STROKE, V30, P1604, DOI 10.1161/01.STR.30.8.1604; Almekhlafi MA, 2013, STROKE, V44, P1317, DOI 10.1161/STROKEAHA.111.000659; Bonow RH, 2017, CRIT CARE MED, V45, pE1011, DOI 10.1097/CCM.0000000000002549; Brunser AM, 2017, J NEUROIMAGING, V27, P232, DOI 10.1111/jon.12379; Brunser AM, 2016, J NEUROIMAGING, V26, P420, DOI 10.1111/jon.12334; Cho JH, 2015, NEURORADIOLOGY, V57, P189, DOI 10.1007/s00234-014-1451-y; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; D'Andrea A, 2016, WORLD J CARDIOL, V8, P383, DOI 10.4330/wjc.v8.i7.383; de la Cruz-Cosme C, 2018, J STROKE CEREBROVASC, V27, P3425, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.001; Demchuk AM, 2001, STROKE, V32, P89, DOI 10.1161/01.STR.32.1.89; Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Engelhardt M, 2004, ZBL CHIR, V129, P178, DOI 10.1055/s-2004-822798; Fisher C M, 1977, Neurosurgery, V1, P245; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fontanella M, 2008, NEUROL RES, V30, P256, DOI 10.1179/016164107X229939; Gao S, 2004, STROKE, V35, P2832, DOI 10.1161/01.STR.0000147035.31297.b6; Gathier CS, 2018, STROKE, V49, P76, DOI 10.1161/STROKEAHA.117.017956; GROSSET DG, 1993, J NEUROSURG, V78, P183; Guan JX, 2013, NEUROL RES, V35, P930, DOI 10.1179/1743132813Y.0000000230; Hart RG, 2017, STROKE, V48, P867, DOI 10.1161/STROKEAHA.116.016414; Hockel K, 2017, ACTA NEUROCHIR, V159, P2053, DOI 10.1007/s00701-017-3308-8; Inagawa T, 2014, NEUROL MED-CHIR, V54, P465, DOI 10.2176/nmc.oa.2013-0169; Katsanos AH, 2016, ANN NEUROL, V79, P625, DOI 10.1002/ana.24609; King A, 2009, STROKE, V40, P3711, DOI 10.1161/STROKEAHA.109.563056; Krejza J, 2013, MONITORING NEUROCRIT, P300; Krejza J, 2007, J NEUROIMAGING, V17, P311, DOI 10.1111/j.1552-6569.2007.00117.x; Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428; Lang EW, 2003, J CLIN NEUROSCI, V10, P670, DOI 10.1016/S0967-5868(03)00197-8; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LENNIHAN L, 1993, J NEUROL NEUROSUR PS, V56, P906, DOI 10.1136/jnnp.56.8.906; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Ma HY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01006; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Markus HS, 2005, STROKE, V36, P971, DOI 10.1161/01.STR.0000162717.62684.40; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Marshall SA, 2010, NEUROSURG CLIN N AM, V21, P291, DOI 10.1016/j.nec.2009.10.010; Mazzucco S, 2018, LANCET NEUROL, V17, P609, DOI 10.1016/S1474-4422(18)30167-4; Morton RP, 2017, J CLIN NEUROSCI, V40, P169, DOI 10.1016/j.jocn.2017.01.030; Morton RP, 2014, NEUROSURGERY, V74, P62, DOI 10.1227/NEU.0000000000000198; NELSON TR, 1988, AM J ROENTGENOL, V151, P439, DOI 10.2214/ajr.151.3.439; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; RINGELSTEIN EB, 1988, STROKE, V19, P963, DOI 10.1161/01.STR.19.8.963; Ritter MA, 2008, J NEUROL, V255, P953, DOI 10.1007/s00415-008-0638-8; RUSSELL MO, 1984, BLOOD, V63, P162; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Scott WW, 2015, J NEUROSURG, V122, P1202, DOI 10.3171/2014.9.JNS1461; Sekhar LN, 1999, NEUROSURGERY, V44, P1207, DOI 10.1097/00006123-199906000-00028; Sharma D, 2011, NEUROCRIT CARE, V14, P370, DOI 10.1007/s12028-010-9415-5; Soustiel JF, 2002, STROKE, V33, P72, DOI 10.1161/hs0102.100484; Spencer MP, 1992, TRANSCRANIAL DOPPLER, P215; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Stein SC, 2006, NEUROSURG FOCUS, V21, P2; Stolz E, 2008, STROKE, V39, P3255, DOI 10.1161/STROKEAHA.108.522714; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Suarez JI, 2002, CRIT CARE MED, V30, P1348, DOI 10.1097/00003246-200206000-00035; Thorpe SG, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00847; Tobe J, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.12.009; Tsivgoulis G, 2013, STROKE, V44, P394, DOI 10.1161/STROKEAHA.112.675074; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vora YY, 1999, NEUROSURGERY, V44, P1237, DOI 10.1097/00006123-199906000-00039; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Wozniak MA, 1996, J NEUROIMAGING, V6, P87, DOI 10.1111/jon19966287; Yamauchi H, 2012, BRAIN, V135, P2515, DOI 10.1093/brain/aws131	74	9	10	2	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2019	47	6							E2	10.3171/2019.9.FOCUS19611			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4IR	WOS:000500270900019	31786564	gold			2022-02-06	
J	Breck, J; Bohr, A; Poddar, S; McQueen, MB; Casault, T				Breck, John; Bohr, Adam; Poddar, Sourav; McQueen, Matthew B.; Casault, Tracy			Characteristics and Incidence of Concussion Among a US Collegiate Undergraduate Population	JAMA NETWORK OPEN			English	Article							TRAUMATIC BRAIN-INJURY; VISITS	IMPORTANCE Concussion on university campuses is a significant health problem. Characterizing the incidence of concussion on college campuses may inform education and resource allocation policy at student health care centers. OBJECTIVES To establish a measure of concussion incidence among collegiate undergraduate students and to describe characteristics associated with concussion incidence, including sex, cause, and month. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study included data from 3 academic years from August 2015 to April 2018 at a large, public university in the United States. Participants included any undergraduate student or varsity athlete who was diagnosed with at least 1 concussion during the academic year. EXPOSURES Sport- and non-sport-related activities of undergraduate students. MAIN OUTCOMES AND MEASURES Concussion diagnosis. RESULTS Among 954 undergraduate students from the general undergraduate population with at least 1 concussion, including 502 men and 452 women, 1020 concussions were diagnosed in 3 academic years. During 2 academic years, a total of 80 concussions occurred among the varsity athlete population, including 26 men and 54 women. Overall, concussion incidence among both the general undergraduate population and varsity athletes was 132.4 (95% CI, 123.2-142.0) concussions per 10 000 students. Men sustained concussions at a rate of 126.1 (95% CI, 114.1-139.0) concussions per 10 000 students and women sustained concussions at a rate of 140.0 (95% CI, 126.2-155.3) concussions per 10 000 students for the 2016 to 2017 and 2017 to 2018 academic years. Concussion incidence peaked in August at the start of the academic year and the rate of non-sport-related concussions (81.0 [95% CI, 73.9-88.7] concussions per 10 000 students for academic years 2016-2017 and 2017-2018) was higher than the rate of sport-related concussions (51.5 [95% CI, 49.5-57.7] concussions per 10 000 students for academic years 2016-2017 and 2017-2018). CONCLUSIONS AND RELEVANCE This cohort study found concussions to be common among this US collegiate population. While concussion is often associated with sport, the incidence of non-sport-related concussion was higher than that of sport-related concussion throughout the academic year. Additional research is warranted to determine if this incidence measure among undergraduate students is generalizable to other university populations.	[Breck, John; Casault, Tracy] Univ Colorado, Med Serv, 1900 Wardenburg Dr, Boulder, CO 80309 USA; [Bohr, Adam; McQueen, Matthew B.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Poddar, Sourav] Univ Colorado, Dept Family Med & Orthoped, Denver, CO 80309 USA		Breck, J (corresponding author), Univ Colorado, Med Serv, 1900 Wardenburg Dr, Boulder, CO 80309 USA.	john.breck@colorado.edu			Open Access Fund of the University of Colorado, Boulder	Publication of this article was funded by the Open Access Fund of the University of Colorado, Boulder.	Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	7	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	DEC	2019	2	12							e1917626	10.1001/jamanetworkopen.2019.17626			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KJ8TQ	WOS:000512329100012	31851345	gold, Green Published			2022-02-06	
J	Fabris, G; Suar, ZM; Kurt, M				Fabris, Gloria; Suar, Zeynep M.; Kurt, Mehmet			Micromechanical heterogeneity of the rat pia-arachnoid complex	ACTA BIOMATERIALIA			English	Article						Pia - arachnoid complex; Meninges; Atomic force microscopy; Traumatic brain injury; Brain mechanics	FETAL DURA-MATER; MECHANICAL-PROPERTIES; BRAIN-TISSUE; MENINGES; BEHAVIOR; INDENTATION; HEMORRHAGE; MICROSCOPY; STIFFNESS; MATTER	To better understand the onset of damage occurring in the brain upon traumatic events, it is essential to analyze how external mechanical loads propagate through the skull and meninges and down to the brain cortex. However, despite their crucial role as structural dampers protecting the brain, the mechanical properties and dynamic behavior of the meningeal layers are still poorly understood. Here, we characterized the local mechanical heterogeneity of rat pia-arachnoid complex (PAC) at the microscale via atomic force microscopy (AFM) indentation experiments to understand how microstructural variations at the tissue level can differentially affect load propagation. By coupling AFM mechanical testing with fresh tissue immunofluorescent staining, we could directly observe the effect of specific anatomical features on the local mechanical properties of tissue. We observed a two-fold stiffening of vascularized tissue when compared to non-vascularized PAC (with instantaneous Young's modulus distribution means of 1.32 +/- 0.03 kPa and 2.79 +/- 0.08 kPa, respectively), and statistically significant differences between regions of low- and high-vimentin density, reflecting trabecular density (with means of 0.67 +/- 0.05 kPa and 1.29 +/- 0.06 kPa, respectively). No significant differences were observed between cortical and cerebellar PAC. Additionally, by performing force relaxation experiments at the AFM, we identified the characteristic time constant tau(1) of PAC tissue to be in the range of 2.7 +/- 1.2 s to 3.1 +/- 0.9 s for the different PAC regions analyzed. Taken together, the results presented point at the complex biomechanical nature of the meningeal tissue, and underscore the need to account for its heterogeneity when modeling its behavior into finite element simulations or other computational methods enabling the prediction of load propagation during injury events. Statement of Significance The meningeal layers are pivotal in shielding the brain during injury events, yet the mechanical properties of this complex biological interface are still under investigation. Here, we present the first anatomically-informed micromechanical characterization of mammalian pia-arachnoid complex (PAC). We developed a protocol for the isolation and fresh immunostaining of rat PAC and subjected the tissue to AFM indentation and relaxation experiments, while visualizing the local anatomy via fluorescence microscopy. We found statistically significant variations in regional PAC stiffness according to the degree of vascularization and trabecular cell density, besides identifying the tissue's characteristic relaxation constant. In essence, this study captures the relationship between anatomy and mechanical heterogeneity in a key component of the brain-skull interface for the first time. (C) 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Fabris, Gloria; Suar, Zeynep M.; Kurt, Mehmet] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA; [Kurt, Mehmet] Mt Sinai Hosp, TMII, New York, NY 10029 USA		Kurt, M (corresponding author), Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA.	gfabris@stevens.edu; zsuar@stevens.edu; mkurt@stevens.edu	Kurt, Mehmet/AAX-3303-2021	Kurt, Mehmet/0000-0002-5618-0296	NSFNational Science Foundation (NSF) [1728186, 1826270]	We acknowledge funding from NSF grants no. 1728186 and no. 1826270. We thank Dr. Kevin Costa, (Icahn School of Medicine at Mount Sinai, New York, NY) for providing AFM access and Dr. Carrie Perlman's lab (Stevens Institute of Technology, Hoboken NJ) for providing brain and meningeal tissue.	Abderezaei J, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014058; Adeeb N, 2013, CHILD NERV SYST, V29, P17, DOI 10.1007/s00381-012-1910-x; Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Benitez R, 2013, MICROSC RES TECHNIQ, V76, P870, DOI 10.1002/jemt.22241; Bifari F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00383; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Bose A, 2018, MOL NEUROBIOL, V55, P6558, DOI 10.1007/s12035-017-0861-3; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; Coles JA, 2017, PROG NEUROBIOL, V156, P107, DOI 10.1016/j.pneurobio.2017.05.002; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Decimo I, 2012, AM J STEM CELLS, V1, P92; Dufrene YF, 2017, NAT NANOTECHNOL, V12, P295, DOI [10.1038/NNANO.2017.45, 10.1038/nnano.2017.45]; Ettmullero M.E., 1699, CEREBRI CORTICALI SU; Faul M., 2010, EMERG DEP VIS HOSP D; Fong KD, 2003, PLAST RECONSTR SURG, V112, P1312, DOI 10.1097/01.PRS.0000079860.14734.D6; Fratzl P., 2008, COLLAGEN STRUCTURE M; Fung Y.C, 1997, BIOMECHANICS CIRCULA, V2nd ed., DOI [10.1007/978-1-4757-2696-1, DOI 10.1007/978-1-4757-2696-1]; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gavara N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21267; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; Haimann MCJ, 1998, J ANAT, V192, P99; Halfter W, 2002, J NEUROSCI, V22, P6029; Hansen JT., 2017, NETTERS CLIN ANATOMY; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Holtzmann K, 2016, J NEUROSCI METH, V271, P50, DOI 10.1016/j.jneumeth.2016.07.002; Hoofien D., 2001, 189209 BRAIN INJ, V15, P10; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; KRIEWALL TJ, 1983, J BIOMECH ENG-T ASME, V105, P71, DOI 10.1115/1.3138388; KRISCH B, 1984, CELL TISSUE RES, V238, P459; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Lee Avione Y, 2010, Cardiovasc Eng, V1, P282, DOI 10.1007/s13239-010-0024-4; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Moreno-Flores S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/44/445101; Moreno-Flores S, 2010, J BIOMECH, V43, P349, DOI 10.1016/j.jbiomech.2009.07.037; Mortazavi MM, 2018, WORLD NEUROSURG, V111, P279, DOI 10.1016/j.wneu.2017.12.041; MURPHY M, 1991, J NEUROSCI RES, V30, P475, DOI 10.1002/jnr.490300304; ODA Y, 1984, J COMP NEUROL, V225, P448, DOI 10.1002/cne.902250310; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; PATIN DJ, 1993, ANESTH ANALG, V76, P535; Rouleau L, 2012, CARDIOVASC PATHOL, V21, P390, DOI 10.1016/j.carpath.2011.12.002; Runza M, 1999, ANESTH ANALG, V88, P1317, DOI 10.1097/00000539-199906000-00022; Saubamea B, 2012, J CEREBR BLOOD F MET, V32, P81, DOI 10.1038/jcbfm.2011.109; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Suar Zeynep M, 2019, Curr Protoc Neurosci, V89, pe83, DOI 10.1002/cpns.83; TENCER AF, 1985, SPINE, V10, P741, DOI 10.1097/00007632-198510000-00009; TUNTURI AR, 1978, J NEUROSURG, V48, P975, DOI 10.3171/jns.1978.48.6.0975; Walsh D.B., 2018, ACTA BIOMATER, DOI [10.1016/j.actbio.2018.09, DOI 10.1016/J.ACTBIO.2018.09]; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Weed LH, 1914, J MED RES, V31, P21; Wilcox Ruth K, 2003, J Orthop Sci, V8, P432, DOI 10.1007/s10776-003-0644-9	59	9	9	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	DEC	2019	100						29	37		10.1016/j.actbio.2019.09.044			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	JU4KQ	WOS:000501646900004	31585202				2022-02-06	
J	Ronning, P; Helseth, E; Skaga, NO; Stavem, K; Langmoen, IA				Ronning, Pal; Helseth, Eirik; Skaga, Nils-Oddvar; Stavem, Knut; Langmoen, Iver A.			The effect of ICP monitoring in severe traumatic brain injury: a propensity score-weighted and adjusted regression approach	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; Glasgow Coma Scale; ICP monitoring; intracranial pressure	MANAGEMENT; MORTALITY; IMPACT; IMPROVEMENT; GUIDELINES; OUTCOMES	OBJECTIVE The use of intracranial pressure (ICP) monitoring has been postulated to be beneficial in patients with severe traumatic brain injury (TBI), although studies investigating this hypothesis have reported conflicting results. The objective of this study was to evaluate the effect of inserting an ICP monitor on survival in patients with severe TBI. METHODS The Oslo University Hospital trauma registry was searched for the records of all patients admitted between January 1, 2002, and December 31, 2013, who fulfilled the Brain Trauma Foundation criteria for intracranial hypertension and who survived at least 24 hours after admission. The impact of ICP monitoring was investigated using both a logistic regression model and a multiple imputed, propensity score-weighted logistic regression analysis. RESULTS The study involved 1327 patients, in which 757 patients had an ICP monitor implanted. The use of ICP monitors significantly increased in the study period (p < 0.01). The 30-day overall mortality was 24.3% (322 patients), divided into 35.1% (200 patients, 95% confidence interval [CI] 31.3%-39.1%) in the group without an ICP monitor and 16.1% (122 patients, 95% CI 13.6%-18.9%) in the group with an ICP monitor. The impact of ICP monitors on 30-day mortality was found to be beneficial both in the complete case analysis logistic regression model (odds ratio [OR] 0.23, 95% CI 0.16-0.33) and in the adjusted, aggregated, propensity score-weighted imputed data sets (OR 0.22, 95% CI 0.15-0.35; both p < 0.001). The sensitivity analysis indicated that the findings are robust to unmeasured confounders. CONCLUSIONS The authors found that the use of an ICP monitor is significantly associated with improved survival in patients with severe head injury.	[Ronning, Pal; Helseth, Eirik; Langmoen, Iver A.] Univ Oslo, Dept Neurosurg, Oslo, Norway; [Skaga, Nils-Oddvar] Univ Oslo, Dept Anesthesiol, Oslo, Norway; [Skaga, Nils-Oddvar] Univ Oslo, Oslo Univ Hosp Trauma Registry, Oslo Univ Hosp, Oslo, Norway; [Ronning, Pal; Helseth, Eirik; Stavem, Knut; Langmoen, Iver A.] Univ Oslo, Fac Med, Oslo, Norway; [Stavem, Knut] Akershus Univ Hosp, Res Ctr, Dept Pulm Med, Lorenskog, Norway; [Stavem, Knut] Akershus Univ Hosp, Res Ctr, HOKH, Lorenskog, Norway		Ronning, P (corresponding author), Oslo Univ Hosp, Oslo, Norway.	palronning@gmail.com	Helseth, Eirik/AAH-2466-2020				Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Association for the Advancement of Automotive Medicine, 1998, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Harrell FE Jr, 2017, REGRESSION MODELING; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Jones JM, 2014, ACTA ANAESTH SCAND, V58, P303, DOI 10.1111/aas.12256; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Lane PL, 2000, CAN J SURG, V43, P442; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ronning P, 2015, BRAIN INJURY, V29, P1648, DOI 10.3109/02699052.2015.1075154; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050	31	9	9	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2019	131	6					1896	1904		10.3171/2018.7.JNS18270			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4CC	WOS:000500253800026	30579278	Bronze			2022-02-06	
J	Yao, M; Chen, Y; Zhang, J; Gao, F; Ma, S; Guan, F				Yao, M.; Chen, Y.; Zhang, J.; Gao, F.; Ma, S.; Guan, F.			Chitosan-based thermosensitive composite hydrogel enhances the therapeutic efficacy of human umbilical cord MSC in TBI rat model	MATERIALS TODAY CHEMISTRY			English	Article						Thermosensitive hydrogel; Human umbilical cord mesenchymal stem cells; Traumatic brain injury; Neurological function recovery	MESENCHYMAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; INJECTABLE HYDROGEL; IN-SITU; TRANSPLANTATION; BIOMATERIALS; SCAFFOLDS; PROTEIN; REPAIR	Recently, stem cell-based therapy shows great promise in treating traumatic brain injury. However, the low rate of cell engraftment and survival are two major barriers for efficacy. To improve the therapeutic effect, a new thermosensitive hydrogel based on chitosan, hydroxyethyl cellulose, hyaluronic acid, and beta-glycerophosphate (CS-HEC-HA/GP) was developed in this study. This CS-HEC-HA/GP hydrogel exhibits a faster gelation process and better biocompatibility to human umbilical cord mesenchymal stem cells (hUC-MSC) versus CS/GP or CS-HEC/GP hydrogels. The suitable rheological behavior similar to brain tissue supports that the CS-HEC-HA/GP hydrogel might be a preferable neural scaffold. In addition, CS-HEC-HA/GP hydrogel loaded with hUC-MSC could enhance the retention, survival, and migration of encapsulated hUC-MSC, improve survival and proliferation of endogenous neural cells probably by secreting neurotrophic factors and inhibiting apoptosis, and thereby accelerate remodeling of brain structure and neurological function recovery in TBI rats. Thus, this hydrogel shows enormous potentials in stem cell-based neural tissue repair and regeneration. (C) 2019 Elsevier Ltd. All rights reserved.	[Yao, M.; Chen, Y.; Zhang, J.; Gao, F.; Ma, S.; Guan, F.] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Yao, M.; Guan, F.] Zhengzhou Univ, Affiliated Hosp 1, Ctr Stem Cell & Regenerat Med, 40 Univ Rd, Zhengzhou 450052, Henan, Peoples R China; [Guan, F.] Henan Prov Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China		Yao, M; Ma, S; Guan, F (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China.; Yao, M; Guan, F (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Ctr Stem Cell & Regenerat Med, 40 Univ Rd, Zhengzhou 450052, Henan, Peoples R China.; Guan, F (corresponding author), Henan Prov Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.	yao453343550@126.com; mashanshan84@163.com; guanfangxia@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC 31700820, U1804198]; National Natural Science Foundation of Henan province [U1804198]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M612420]; Key Scientific Research Projects of higher education institutions in Henan province [18A180003]	The project was supported by the National Natural Science Foundation of China (NSFC 31700820), Joint Fund of the National Natural Science Foundation of China and Henan province (U1804198), China Postdoctoral Science Foundation (2017M612420), and Key Scientific Research Projects of higher education institutions in Henan province (18A180003).	Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Dimatteo R, 2018, ADV DRUG DELIVER REV, V127, P167, DOI 10.1016/j.addr.2018.03.007; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gnecchi M, 2016, METHODS MOL BIOL, V1416, P123, DOI 10.1007/978-1-4939-3584-0_7; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Ingavle GC, 2019, BIOMATERIALS, V197, P119, DOI 10.1016/j.biomaterials.2019.01.005; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim S, 2010, BIOMATERIALS, V31, P4157, DOI 10.1016/j.biomaterials.2010.01.139; Kozlowska J, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10040456; Leong WK, 2012, STEM CELL TRANSL MED, V1, P177, DOI 10.5966/sctm.2011-0039; Li JG, 2017, ACS APPL MATER INTER, V9, P30343, DOI 10.1021/acsami.7b07444; Li XM, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00499; Li Z, 2018, CARBOHYD POLYM, V184, P342, DOI 10.1016/j.carbpol.2018.01.006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mirahmadi F, 2013, MAT SCI ENG C-MATER, V33, P4786, DOI 10.1016/j.msec.2013.07.043; Morris DC, 2017, NEUROSCI LETT, V659, P7, DOI 10.1016/j.neulet.2017.08.064; Naderi-Meshkin H, 2014, CELL BIOL INT, V38, P72, DOI 10.1002/cbin.10181; O'Brien Fergal J., 2011, Materials Today, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Tang QM, 2017, ACTA BIOMATER, V61, P101, DOI 10.1016/j.actbio.2017.08.001; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Wang XX, 2016, MOL CELLS, V39, P418, DOI 10.14348/molcells.2016.2345; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wu J, 2006, INT J PHARMACEUT, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045; Xu BH, 2016, NEUROBIOL AGING, V39, P46, DOI 10.1016/j.neurobiolaging.2015.11.029; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yan JH, 2010, J BIOMATER APPL, V24, P625, DOI 10.1177/0885328208100536; Yao MH, 2014, J MATER CHEM B, V2, P3123, DOI 10.1039/c4tb00107a; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhou HY, 2015, CARBOHYD POLYM, V117, P524, DOI 10.1016/j.carbpol.2014.09.094; Zhuo FL, 2017, MAT SCI ENG C-MATER, V81, P1, DOI 10.1016/j.msec.2017.07.029	35	9	9	3	36	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2468-5194			MATER TODAY CHEM	Mater. Today Chem.	DEC	2019	14								100192	10.1016/j.mtchem.2019.08.011			12	Chemistry, Multidisciplinary; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Materials Science	JY8TQ	WOS:000504681200016					2022-02-06	
J	Fernandez, MP; Witte, F; Tozzi, G				Fernandez, M. Pena; Witte, F.; Tozzi, G.			Applications of X-ray computed tomography for the evaluation of biomaterial-mediated bone regeneration in critical-sized defects	JOURNAL OF MICROSCOPY			English	Article						Biomaterial; bone; digital volume correlation; in situ mechanics; osteoregeneration; X-ray computed tomography	DIGITAL VOLUME CORRELATION; TRAUMATIC BRAIN-INJURY; FLUID STEM-CELLS; IN-VIVO; TRABECULAR BONE; ANIMAL-MODELS; MECHANICAL-PROPERTIES; COLLAGEN SCAFFOLDS; IMAGE CORRELATION; GRAFT SUBSTITUTE	Bone as such displays an intrinsic regenerative potential following fracture; however, this capacity is limited with large bone defects that cannot heal spontaneously. The management of critical-sized bone defects remains a major clinical and socioeconomic need with osteoregenerative biomaterials constantly under development aiming at promoting and enhancing bone healing. X-ray computed tomography (XCT) has become a standard and essential tool for quantifying structure-function relationships in bone and biomaterials, facilitating the development of novel bone tissue engineering strategies. This paper presents recent advancements in XCT analysis of biomaterial-mediated bone regeneration. As a noninvasive and nondestructive technique, XCT allows for qualitative and quantitative evaluation of three-dimensional (3D) scaffolds and biomaterial microarchitecture, bone growth into the scaffold as well as the 3D characterisation of biomaterial degradation and bone regeneration in vitro and in vivo. Furthermore, in combination with in situ mechanical testing and digital volume correlation (DVC), XCT demonstrated its potential to better understand the bone-biomaterial interactions and local mechanics of bone regeneration during the healing process in relation to the regeneration achieved in vivo, which will likely provide valuable knowledge for the development and optimisation of novel osteoregenerative biomaterials. Lay Description Bone, being a dynamically adaptable material, displays excellent regenerative properties following fracture. However, the self-healing capacity of bone becomes more difficult with large bone defects. Those defects are common and occur in many clinical situations; hence, biomaterials are mostly used to restore both bone structure and function in the defect site. X-ray computed tomography (XCT) is a powerful tool to evaluate bone regeneration in critical-sized defects after the implantation of biomaterials, allowing to an improved understanding of the regeneration process following different bone tissue engineering approaches. This paper focuses on recent advancements in XCT analysis to characterise biomaterial-mediated bone regeneration in critical-sized defects. XCT supports three-dimensional (3D) analysis of biomaterials, scaffolds and regenerated bone microarchitecture, as well as bone ingrowth into the scaffold. As a nondestructive technique, XCT allows for a 3D characterisation of biomaterial degradation and bone regeneration over time. In addition, XCT combined with in situ mechanical experiments and digital volume correlation (DVC) provides a 3D evaluation and quantification of bone-biomaterial interactions and deformation mechanisms during the regeneration process. This remains essential for the development and enhancement of novel biomaterials able to produce bone that is comparable with the native tissue they aim to replace.	[Fernandez, M. Pena; Tozzi, G.] Univ Portsmouth, Zeiss Global Ctr, Sch Mech & Design Engn, Portsmouth PO1 2UP, Hants, England; [Witte, F.] Biotr Bioimplants GmbH, Berlin, Germany		Fernandez, MP (corresponding author), Univ Portsmouth, Zeiss Global Ctr, Sch Mech & Design Engn, Portsmouth PO1 2UP, Hants, England.	marta.pena-fernandez@port.ac.uk	; Witte, Frank/D-9294-2014	Pena Fernandez, Marta/0000-0002-3534-8838; Witte, Frank/0000-0001-9154-6217	Biotrics bioimplants GmbH (Berlin, Germany)	M.P.F. and G.T. would like to acknowledge Biotrics bioimplants GmbH (Berlin, Germany) for funding supporting this paper.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Arbez B, 2019, J BIOMED MATER RES B, V107, P415, DOI 10.1002/jbm.b.34133; Baas E, 2008, J BIOMECH, V41, P1374, DOI 10.1016/j.jbiomech.2008.01.018; Baas E, 2010, J BIOMECH, V43, P733, DOI 10.1016/j.jbiomech.2009.10.016; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31; Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Bay BK, 2008, J STRAIN ANAL ENG, V43, P745, DOI 10.1243/03093247JSA436; Bay BK, 1999, EXP MECH, V39, P217, DOI 10.1007/BF02323555; Berner A, 2017, J TISSUE ENG REGEN M, V11, P2081, DOI 10.1002/term.2104; Birkhold AI, 2015, BONE, V75, P210, DOI 10.1016/j.bone.2015.02.027; Birkhold AI, 2014, BIOMATERIALS, V35, P9290, DOI 10.1016/j.biomaterials.2014.07.051; Birkhold AI, 2014, BONE, V66, P15, DOI 10.1016/j.bone.2014.05.013; Bittner SM, 2019, ACTA BIOMATER, V90, P37, DOI 10.1016/j.actbio.2019.03.041; Bobe K, 2013, ACTA BIOMATER, V9, P8611, DOI 10.1016/j.actbio.2013.03.035; Boerckel JD, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt534; Boerckel JD, 2012, J ORTHOP RES, V30, P1067, DOI 10.1002/jor.22042; Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063; Bolland BJRF, 2008, BONE, V43, P195, DOI 10.1016/j.bone.2008.02.013; Bormann T, 2014, ACTA BIOMATER, V10, P1024, DOI 10.1016/j.actbio.2013.11.007; Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Carmignato, 2018, IND XRAY COMPUTED TO, P25; Castro APG, 2018, BIOMECH MODEL MECHAN, V17, P531, DOI 10.1007/s10237-017-0976-5; Castro NJ, 2015, NANOSCALE, V7, P14010, DOI 10.1039/c5nr03425f; Chappard D, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00161; Chen YX, 2015, APPL BIONICS BIOMECH, V2015, DOI [10.1155/2015/609132, 10.1016/j.arabjc.2015.10.001]; Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014; Choi JY, 2019, OR SURG OR MED OR PA, V128, P87, DOI 10.1016/j.oooo.2018.12.023; Christen D, 2012, J MECH BEHAV BIOMED, V8, P184, DOI 10.1016/j.jmbbm.2011.12.009; Coathup M, 2008, J BONE JOINT SURG BR, V90B, P246, DOI 10.1302/0301-620X.90B2.19675; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cristofolini, 2016, INT BIOMECH, V3, P1, DOI DOI 10.1080/23335432.2015.1117395; Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Dimitriou R, 2011, INJURY, V42, pS3, DOI 10.1016/j.injury.2011.06.015; EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015; El Haj AJ, 2005, PATHOL BIOL, V53, P581, DOI 10.1016/j.patbio.2004.12.002; El-Rashidy AA, 2017, ACTA BIOMATER, V62, P1, DOI 10.1016/j.actbio.2017.08.030; Farraro KE, 2014, J BIOMECH, V47, P1979, DOI 10.1016/j.jbiomech.2013.12.003; Fernandez MP, 2018, J MECH BEHAV BIOMED, V88, P109, DOI 10.1016/j.jmbbm.2018.08.012; Fernandez MP, 2019, ACS BIOMATER SCI ENG, V5, P2543, DOI 10.1021/acsbiomaterials.8b01044; Fernandez MP, 2018, MATERIALS, V11, DOI 10.3390/ma11112155; Fillingham Y, 2016, BONE JOINT J, V98B, P6, DOI [10.1302/0301-620X.98B1.36350, 10.1302/0301-620X.98B.36350]; Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040; Fu Q, 2011, TISSUE ENG PT A, V17, P3077, DOI 10.1089/ten.tea.2011.0068; Gao CD, 2014, INT J MOL SCI, V15, P4714, DOI 10.3390/ijms15034714; Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007; Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072; Geng H., 2016, J MATER SCI-MATER M, V27, P1; Georgiadis M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0088; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gillard F, 2014, J MECH BEHAV BIOMED, V29, P480, DOI 10.1016/j.jmbbm.2013.09.014; Ginebra MP, 2018, EFORT OPEN REV, V3, P173, DOI 10.1302/2058-5241.3.170056; Giorgio I, 2017, MATH MECH SOLIDS, V22, P1790, DOI 10.1177/1081286516644867; Giorgio I, 2016, BIOMECH MODEL MECHAN, V15, P1325, DOI 10.1007/s10237-016-0765-6; Giorgio I, 2016, CONTINUUM MECH THERM, V28, P21, DOI 10.1007/s00161-014-0397-y; Goggin PM, 2016, EUR CELLS MATER, V31, P264, DOI 10.22203/eCM.v031a18; Machado CPG, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0045; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Grover Vishakha, 2011, Indian J Dent Res, V22, P496, DOI 10.4103/0970-9290.87084; Gugala Z, 1999, J ORTHOP TRAUMA, V13, P187, DOI 10.1097/00005131-199903000-00006; Guldberg RE, 2003, IEEE ENG MED BIOL, V22, P77, DOI 10.1109/MEMB.2003.1256276; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hampel U, 2015, WOODH PUB SER ELECT, V71, P175, DOI 10.1016/B978-1-78242-118-4.00006-X; Hensley S, 2017, ACTA BIOENG BIOMECH, V19, P187, DOI 10.5277/ABB-00785-2016-04; Hild F, 2006, STRAIN, V42, P69, DOI 10.1111/j.1475-1305.2006.00258.x; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Howie RN, 2018, J TISSUE ENG REGEN M, V12, P2055, DOI 10.1002/term.2740; Hsieh J., 2003, COMPUT TOMOGR, P510; Hulsart-Billstrom G, 2016, EUR CELLS MATER, V31, P312, DOI 10.22203/eCM.v031a20; Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013; Ito M, 2002, BONE, V30, P594, DOI 10.1016/S8756-3282(02)00684-1; Jimbo R, 2011, ACTA BIOMATER, V7, P4229, DOI 10.1016/j.actbio.2011.07.017; Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046; Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014; Kaipel M, 2012, J ORTHOP RES, V30, P1563, DOI 10.1002/jor.22132; Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI 10.1016/j.biomaterials.2007.12.031; Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059; Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413; Kang MH, 2019, ACTA BIOMATER, V84, P453, DOI 10.1016/j.actbio.2018.11.045; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Katsamenis OL, 2019, AM J PATHOL, V189, P1608, DOI 10.1016/j.ajpath.2019.05.004; Keating JF, 2005, J BONE JOINT SURG BR, V87B, P142, DOI 10.1302/0301-620X.87B2.15874; Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023; Kerckhofs G, 2016, ACTA BIOMATER, V35, P330, DOI 10.1016/j.actbio.2016.02.037; Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010; Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074; Kwon S, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10080914; Kytyr D, 2017, MATER DESIGN, V134, P400, DOI 10.1016/j.matdes.2017.08.036; Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009; Lekszycki T, 2012, ZAMM-Z ANGEW MATH ME, V92, P426, DOI 10.1002/zamm.201100082; Li J.J., 2018, ADV HEALTHC MATER, V1800218, P1; Li Y, 2018, ACTA BIOMATER, V67, P378, DOI 10.1016/j.actbio.2017.12.008; Li Y, 2015, J ORTHOP TRANSL, V3, P95, DOI 10.1016/j.jot.2015.05.002; Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Malhotra A, 2014, FRONT SURG, V1, DOI 10.3389/fsurg.2014.00037; Mandal S., 2018, J MATER SCI-MATER M, V29, P1; MANKIN HJ, 2005, CLIN ORTHO RELAT RES, V432, P210, DOI DOI 10.1097/01.BLO.0000150371.77314.52; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Martin V, 2018, MAT SCI ENG C-MATER, V82, P363, DOI 10.1016/j.msec.2017.04.038; Matassi F, 2013, CLIN CASES MINER BON, V10, P111, DOI 10.11138/ccmbm/2013.10.2.111; Mehta M, 2012, EUR CELLS MATER, V24, P358, DOI 10.22203/eCM.v024a26; Miller GJ, 2015, BIOMECH MODEL MECHAN, V14, P1239, DOI 10.1007/s10237-015-0670-4; Morgan EF, 2010, J BIOMECH, V43, P2418, DOI 10.1016/j.jbiomech.2010.04.019; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Muller R, 1998, Technol Health Care, V6, P433; Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]; Nauth A, 2018, J ORTHOP TRAUMA, V32, pS7, DOI 10.1097/BOT.0000000000001115; Nauth A, 2011, J ORTHOP TRAUMA, V25, P462, DOI 10.1097/BOT.0b013e318224caf0; Nazarian A, 2004, J BIOMECH, V37, P55, DOI 10.1016/S0021-9290(03)00254-9; O'Neal JM, 2010, BONE, V47, P241, DOI 10.1016/j.bone.2010.05.016; Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006; Palmquist A, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6068-y; Pan B, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/062001; Parai R, 2019, J MECH BEHAV BIOMED, V96, P45, DOI 10.1016/j.jmbbm.2019.04.019; Park YS, 2005, CLIN ORAL IMPLAN RES, V16, P156, DOI 10.1111/j.1600-0501.2004.01083.x; Parrilli A, 2014, J MICROSC-OXFORD, V255, P20, DOI 10.1111/jmi.12132; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Peister A, 2009, TISSUE ENG PT A, V15, P3129, DOI [10.1089/ten.tea.2008.0536, 10.1089/ten.TEA.2008.0536]; Peister A, 2011, STEM CELL RES, V7, P17, DOI 10.1016/j.scr.2011.03.001; Pobloth AM, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0964-4; Pound JC, 2006, TISSUE ENG, V12, P2789, DOI 10.1089/ten.2006.12.2789; Qutachi O, 2014, ACTA BIOMATER, V10, P5090, DOI 10.1016/j.actbio.2014.08.015; Reznikov N, 2019, BIOMATERIALS, V194, P183, DOI 10.1016/j.biomaterials.2018.11.026; Roddy Erika, 2018, Eur J Orthop Surg Traumatol, V28, P351, DOI 10.1007/s00590-017-2063-0; Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519; Roseti L, 2017, MAT SCI ENG C-MATER, V78, P1246, DOI 10.1016/j.msec.2017.05.017; Saito E., 2015, EFFECTS DESIGNED PLL, V7, P99; Sandino C, 2011, BIOMECH MODEL MECHAN, V10, P565, DOI 10.1007/s10237-010-0256-0; Schemitsch EH, 2017, J ORTHOP TRAUMA, V31, pS20, DOI 10.1097/BOT.0000000000000978; Schmitz JP, 1986, CLIN ORTHOP RELAT R, V205, P299; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012; Shah FA, 2019, ACTA BIOMATER, V84, P1, DOI 10.1016/j.actbio.2018.11.018; Sharma S, 2019, BONE REP, V10, DOI 10.1016/j.bonr.2019.100205; Shkarina S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27097-7; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Stauber Martin, 2008, V455, P273, DOI 10.1007/978-1-59745-104-8_19; Stock S.R., 2009, METHODOLOGY APPL; Sweedy A, 2017, ACTA BIOMATER, V54, P441, DOI 10.1016/j.actbio.2017.03.001; Tayton E, 2014, J BIOMED MATER RES A, V102, P2613, DOI 10.1002/jbm.a.34926; Tayton E, 2015, J BIOMED MATER RES A, V103, P1346, DOI 10.1002/jbm.a.35279; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Torstrick FB, 2016, CLIN ORTHOP RELAT R, V474, P2373, DOI 10.1007/s11999-016-4833-0; Tourolle ne Betts D.C., 2019, 721365 BIORXIV, DOI [10.1101/721365, DOI 10.1101/721365]; Tozzi G, 2016, STRAIN, V52, P446, DOI 10.1111/str.12202; Tozzi G, 2012, J BIOMECH, V45, P356, DOI 10.1016/j.jbiomech.2011.10.011; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Ueng SWN, 2007, J ORTHOP RES, V25, P62, DOI 10.1002/jor.20286; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van der Stok J, 2015, EUR CELLS MATER, V29, P141, DOI 10.22203/eCM.v029a11; van Lenthe G.H., 2008, IBMS BONEKEY, V5, P410; Vila OF, 2014, ACTA BIOMATER, V10, P4377, DOI 10.1016/j.actbio.2014.05.028; Voide R, 2009, BONE, V45, P164, DOI 10.1016/j.bone.2009.04.248; Walsh WR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168883; Walsh WR, 2003, J ORTHOP RES, V21, P655, DOI 10.1016/S0736-0266(03)00012-3; Wang JL, 2015, ACTA BIOMATER, V21, P237, DOI 10.1016/j.actbio.2015.04.011; Wang P, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.17; Wang WH, 2017, BIOACT MATER, V2, P224, DOI 10.1016/j.bioactmat.2017.05.007; Wehrle E., 2019, 692343 BIORXIV, DOI [10.1101/692343, DOI 10.1101/692343]; Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005; Westhauser F, 2017, MATERIALS, V10, DOI 10.3390/ma10121341; Winkler T, 2018, BONE JOINT RES, V7, P232, DOI 10.1302/2046-3758.73.BJR-2017-0270.R1; Witek L, 2019, J ORTHOP RES, V37, P2499, DOI 10.1002/jor.24424; Wu YF, 2019, COLLOID SURFACE B, V181, P349, DOI 10.1016/j.colsurfb.2019.05.052; Wust S, 2015, J BIOMED MATER RES A, V103, P2558, DOI 10.1002/jbm.a.35393; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/ten.2004.10.1037; Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871; Yang Y, 2002, BIOMATERIALS, V23, P2119, DOI 10.1016/S0142-9612(01)00342-8; Yun YH, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70273-1; Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183; Zhang XY, 2015, CELL BIOCHEM BIOPHYS, V72, P777, DOI 10.1007/s12013-015-0531-x	179	9	9	7	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-2720	1365-2818		J MICROSC-OXFORD	J. Microsc.	MAR	2020	277	3			SI		179	196		10.1111/jmi.12844		NOV 2019	18	Microscopy	Science Citation Index Expanded (SCI-EXPANDED)	Microscopy	KZ8OG	WOS:000497222200001	31701530				2022-02-06	
J	Jing, Y; Yang, DX; Fu, YM; Wang, W; Yang, GY; Yuan, F; Chen, H; Ding, J; Chen, SW; Tian, HL				Jing, Yao; Yang, Dianxu; Fu, Yimu; Wang, Wei; Yang, Guoyuan; Yuan, Fang; Chen, Hao; Ding, Jun; Chen, Shiwen; Tian, Hengli			Neuroprotective Effects of Serpina3k in Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						serpina3k; traumatic brain injury; mouse model; SH-SY5Y cells; apoptosis; oxidative stress; neuroprotection	BARRIER DISRUPTION; CELL APOPTOSIS; INHIBITION; DEFICITS; MODERATE; STRESS	Traumatic brain injury (TBI) is a major cause of disability and mortality worldwide, in part resulting from secondary apoptosis of neurons in peri-contusion areas. Serpina3k, a serine protease inhibitor, has been shown to inhibit apoptosis in injury models. In this study, we investigated the anti-apoptotic function of serpina3k in vivo using a mouse model of TBI, as well as the underlying neuroprotective mechanism in vitro using the SH-SY5Y human neuroblastoma cell line. TBI was induced in adult male C57BL/6 mice using controlled cortical impact. Serpina3k protein was intravenously administered at a concentration of 0.5 mg/kg twice daily for up to 14 days. SH-SY5Y cells were subjected to biaxial stretch injury and then treated with different concentrations of serpina3k. We found that endogenous serpina3k protein levels were elevated in peri-contusion areas of the mouse brain following TBI. Serpina3k-treated mice had fewer apoptotic neurons, lower levels of oxidative stress, and showed greater recovery of neurological deficits relative to vehicle-treated mice. Meanwhile, in the SH-SY5Y cell injury model, serpina3k at an optimal concentration (150 nM) inhibited the generation of intracellular reactive oxygen species, abrogated changes of the mitochondrial membrane potential, and reduced the phospho-extracellular regulated protein kinases (p-ERK)/ERK, phospho-P38 (p-P38)/P38, B cell lymphoma (Bcl)-2-associated X protein/Bcl-2, and cleaved caspase-3/caspase-3 ratios, thereby reducing the apoptosis rate. These results demonstrate that serpina3k exerts a neuroprotective function following TBI and thus has therapeutic potential.	[Jing, Yao; Yang, Dianxu; Wang, Wei; Yuan, Fang; Chen, Hao; Ding, Jun; Chen, Shiwen; Tian, Hengli] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China; [Fu, Yimu] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Emergency, Shanghai, Peoples R China; [Yang, Guoyuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Yang, Guoyuan] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China		Ding, J; Chen, SW; Tian, HL (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China.	djdjdoc@126.com; chenshiwen@126.com; tianhlsh@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671207, 81701895]; Shanghai Jiao Tong University Medicine-Engineering Research Fund [YG2016QN20]	This work was supported by the National Natural Science Foundation of China (nos. 81671207 and 81701895) and Shanghai Jiao Tong University Medicine-Engineering Research Fund (no. YG2016QN20).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Batsaikhan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030502; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Cao GS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091418; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Chao JL, 2017, BIOL CHEM, V398, P1309, DOI 10.1515/hsz-2017-0180; Dong RF, 2019, GENE, V697, P152, DOI 10.1016/j.gene.2019.01.043; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Hu JN, 2019, J GINSENG RES, V43, P10, DOI 10.1016/j.jgr.2017.07.003; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jing Y, 2019, MED SCI MONITOR, V25, P1291, DOI 10.12659/MSM.912586; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kong L, 2019, IMMUNOPHARM IMMUNOT, V41, P349, DOI 10.1080/08923973.2019.1608560; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Li PF, 2016, EXP CELL RES, V340, P305, DOI 10.1016/j.yexcr.2016.01.004; Li QQ, 2019, INT J BIOCHEM CELL B, V107, P154, DOI 10.1016/j.biocel.2018.12.018; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Scipioni M, 2019, MEDCHEMCOMM, V10, P764, DOI 10.1039/c9md00048h; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Xu ZM, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0378-8; Yang DX, 2019, J NEUROTRAUM, V36, P1279, DOI 10.1089/neu.2018.5942; Yao YC, 2013, FEBS J, V280, P3244, DOI 10.1111/febs.12303; Yeo HJ, 2019, FREE RADICAL BIO MED, V135, P68, DOI 10.1016/j.freeradbiomed.2019.02.028; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhang L, 2019, J CELL MOL MED, V23, P2995, DOI 10.1111/jcmm.14206; Zhang L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00263; Zhu CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108859	40	9	9	4	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 15	2019	10								1215	10.3389/fneur.2019.01215			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JU6SE	WOS:000501803400001	31803133	Green Published, gold			2022-02-06	
J	Kowalski, EA; Chen, J; Hazy, A; Fritsch, LE; Gudenschwager-Basso, EK; Chen, M; Wang, X; Qian, Y; Zhou, MJ; Byerly, M; Pickrell, AM; Matson, JB; Allen, IC; Theus, MH				Kowalski, Elizabeth A.; Chen, Jiang; Hazy, Amanda; Fritsch, Lauren E.; Gudenschwager-Basso, Erwin Kristobal; Chen, Michael; Wang, Xia; Qian, Yun; Zhou, Mingjun; Byerly, Matthew; Pickrell, Alicia M.; Matson, John B.; Allen, Irving Coy; Theus, Michelle H.			Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage	JOURNAL OF NEUROINFLAMMATION			English	Article						Inflammation; Traumatic brain injury; Interleukin-6; Akt; Endothelial cells; Monocyte; macrophage polarization	TRAUMATIC BRAIN-INJURY; UP-REGULATION; STIMULATES MIGRATION; GENE-EXPRESSION; NERVOUS-SYSTEM; ACTIVATION; RECEPTORS; MONOCYTES; CELLS; PATHOPHYSIOLOGY	Background The continuum of pro- and anti-inflammatory response elicited by traumatic brain injury (TBI) is suggested to play a key role in the outcome of TBI; however, the underlying mechanisms remain ill -defined. Methods Here, we demonstrate that using bone marrow chimeric mice and systemic inhibition of EphA4 receptor shifts the pro-inflammatory milieu to pro-resolving following acute TBI. Results EphA4 expression is increased in the injured cortex as early as 2 h post-TBI and on CX3CR1(gfp)-positive cells in the peri-lesion. Systemic inhibition or genetic deletion of EphA4 significantly reduced cortical lesion volume and shifted the inflammatory profile of peripheral-derived immune cells to pro-resolving in the damaged cortex. These findings were consistent with in vitro studies showing EphA4 inhibition or deletion altered the inflammatory state of LPS-stimulated monocyte/macrophages towards anti-inflammatory. Phosphoarray analysis revealed that EphA4 may regulate pro-inflammatory gene expression by suppressing the mTOR, Akt, and NF-kappa B pathways. Our human metadata analysis further demonstrates increased EPHA4 and pro-inflammatory gene expression, which correlates with reduced AKT concurrent with increased brain injury severity in patients. Conclusions Overall, these findings implicate EphA4 as a novel mediator of cortical tissue damage and neuroinflammation following TBI.	[Kowalski, Elizabeth A.; Chen, Jiang; Hazy, Amanda; Gudenschwager-Basso, Erwin Kristobal; Chen, Michael; Wang, Xia; Byerly, Matthew; Allen, Irving Coy; Theus, Michelle H.] Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Fritsch, Lauren E.; Theus, Michelle H.] Virginia Tech, Grad Program Translat Biol Med & Hlth, Blacksburg, VA 24061 USA; [Qian, Yun; Zhou, Mingjun] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Qian, Yun; Zhou, Mingjun; Matson, John B.] Virginia Tech, Ctr Drug Discovery, Blacksburg, VA 24061 USA; [Pickrell, Alicia M.; Theus, Michelle H.] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA; [Matson, John B.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA; [Theus, Michelle H.] Virginia Maryland Coll Vet Med, Ctr Regenerat Med, Blacksburg, VA 24061 USA		Theus, MH (corresponding author), Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Grad Program Translat Biol Med & Hlth, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.; Theus, MH (corresponding author), Virginia Maryland Coll Vet Med, Ctr Regenerat Med, Blacksburg, VA 24061 USA.	mtheus@vt.edu	Qian, Yun/AAE-7462-2019; Pickrell, Alicia/B-8494-2018; Matson, John B/B-8347-2012	Qian, Yun/0000-0003-0660-2566; Pickrell, Alicia/0000-0002-8470-6056; Matson, John B/0000-0001-7984-5396; Fritsch, Lauren E./0000-0003-2904-8510	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, R01NS096281 (MHT).	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Brkovic A, 2007, J LEUKOCYTE BIOL, V81, P1093, DOI 10.1189/jlb.0906580; Bruno G, 1998, J NEUROSURG, V89, P431, DOI 10.3171/jns.1998.89.3.0431; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Chen Y, 2012, CELL SIGNAL, V24, P606, DOI 10.1016/j.cellsig.2011.11.016; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Coccia EM, 1999, INT IMMUNOL, V11, P1075, DOI 10.1093/intimm/11.7.1075; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Dumas E, 2012, BBA-MOL CELL RES, V1823, P358, DOI 10.1016/j.bbamcr.2011.12.002; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Garcia S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082088; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Gong M, 2017, MED SCI MONIT BASIC, V23, P240, DOI 10.12659/MSMBR.904014; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj/onc/1205181; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hashimoto T, 2004, ENDOTHELIUM-J ENDOTH, V11, P207, DOI 10.1080/10623320490512417; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hirayama D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010092; Hjorthaug HS, 2007, EUR J IMMUNOL, V37, P2326, DOI 10.1002/eji.200737111; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Jellinghaus S, 2013, BBA-MOL CELL RES, V1833, P2201, DOI 10.1016/j.bbamcr.2013.05.017; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kim SC, 1997, NEUROSURGERY, V41, P642, DOI 10.1097/00006123-199709000-00027; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Li L, 2015, CELL DEATH DIFFER, V22, P1081, DOI 10.1038/cdd.2014.212; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Nakaoka H, 2014, STROKE, V45, P2239, DOI 10.1161/STROKEAHA.114.005851; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Okyere B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159930; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Price L, 2015, FRONT NEUROSCI, V57, P85; Rahal OM, 2018, INT J RADIAT ONCOL, V100, P1034, DOI 10.1016/j.ijrobp.2017.11.043; Riedl SJ, 2015, CURR DRUG TARGETS, V16, P1031, DOI 10.2174/1389450116666150727115934; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Roberts DJ, 2013, J NEUROTRAUM, V30, P1717, DOI 10.1089/neu.2012.2841; Rocher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084009; Sanson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074676; Seok SH, 2013, MOL CELLS, V35, P550, DOI 10.1007/s10059-013-0088-8; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stanimirovic DB, 1997, ACT NEUR S, V70, P12; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wu BN, 2017, CELL CHEM BIOL, V24, P293, DOI 10.1016/j.chembiol.2017.01.006; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e	74	9	9	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	NOV 11	2019	16	1							210	10.1186/s12974-019-1605-2			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	JM8WL	WOS:000496488500001	31711546	Green Published, gold			2022-02-06	
J	Giarratana, AO; Teng, S; Reddi, S; Zheng, C; Adler, D; Thakker-Varia, S; Alder, J				Giarratana, Anna O.; Teng, Shavonne; Reddi, Sahithi; Zheng, Cynthia; Adler, Derek; Thakker-Varia, Smita; Alder, Janet			BDNF Val66Met Genetic Polymorphism Results in Poor Recovery Following Repeated Mild Traumatic Brain Injury in a Mouse Model and Treatment With AAV-BDNF Improves Outcomes	FRONTIERS IN NEUROLOGY			English	Article						BDNF; lateral fluid percussion; Val66Met; rmTBI; AAV-BDNF	ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; MESSENGER-RNA; RISK-FACTORS; FLUORO-JADE; VARIANT; ALTERS; EXPRESSION; MEMORY; NEURODEGENERATION	Clinicians have long noticed that some Traumatic Brain Injury (TBI) patients have worse symptoms and take a longer time to recover than others, for reasons unexplained by known factors. Identifying what makes some individuals more susceptible is critical to understanding the underlying mechanisms through which TBI causes deleterious effects. We have sought to determine the effect of a single nucleotide polymorphism (SNP) in Brain-derived neurotrophic factor (BDNF) at amino acid 66 (rs6265) on recovery after TBI. There is controversy from human studies as to whether the BDNF Val66Val or Val66Met allele is the risk factor for worse outcomes after brain trauma. We therefore investigated cellular and behavioral outcomes in genetically engineered mice following repeated mild TBI (rmTBI) using a lateral fluid percussion (LFP) injury model. We found that relative to injured Val66Val carriers, injured Val66Met carriers had a larger inflammation volume and increased levels of neurodegeneration, apoptosis, p-tau, activated microglia, and gliosis in the cortex and/or hippocampus at 1 and/or 21 days post-injury (DPI). We therefore concluded that the Val66Met genetic polymorphism is a risk factor for poor outcomes after rmTBI. In order to determine the mechanism for these differences, we investigated levels of the apoptotic-inducing pro BDNF and survival-inducing mature BDNF isoforms and found that Met carriers had less total BDNF in the cortex and a higher pro/mature ratio of BDNF in the hippocampus. We then developed a personalized approach to treating genetically susceptible individuals by overexpressing wildtype BDNF in injured Val66Met mice using an AAV-BDNF virus. This intervention improved cellular, motor, and cognitive behavior outcomes at 21 DPI and increased levels of mature BDNF and phosphorylation of mature BDNF's receptor trkB. This study lays the groundwork for further investigation into the genetics that play a role in the extent of injury after rmTBI and highlights how personalized therapeutics may be targeted for recovery in susceptible individuals.	[Giarratana, Anna O.; Teng, Shavonne; Reddi, Sahithi; Zheng, Cynthia; Adler, Derek; Thakker-Varia, Smita; Alder, Janet] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA		Alder, J (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	janet.alder@rutgers.edu			New Jersey Commission on Brain Injury Research [CBIR16FEL009]	Funding support for AG came from the New Jersey Commission on Brain Injury Research CBIR16FEL009.	Abode-Iyamah KO, 2016, J CLIN NEUROSCI, V24, P117, DOI 10.1016/j.jocn.2015.07.016; Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Anastasia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3490; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bagnato S, 2012, J NEUROTRAUM, V29, P2050, DOI 10.1089/neu.2011.2184; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carlino D, 2011, J PSYCHIATR RES, V45, P273, DOI 10.1016/j.jpsychires.2010.06.012; Chen T, 2017, NEUROCHEM RES, V42, P3073, DOI 10.1007/s11064-017-2340-7; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; DePalma RG, 2015, FRONTIERS NEUROENGIN, DOI [10.1201/b18126-3, DOI 10.1201/B18126-3]; Di Pino G, 2016, NEUROREHAB NEURAL RE, V30, P3, DOI 10.1177/1545968315583721; Dincheva I, 2012, NEUROSCIENTIST, V18, P439, DOI 10.1177/1073858411431646; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Eaton MJ, 2002, GENE THER, V9, P1387, DOI 10.1038/sj.gt.3301814; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Giza JI, 2018, NEURON, V99, P163, DOI 10.1016/j.neuron.2018.05.024; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jiao SS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.186; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Katerberg H, 2009, AM J MED GENET B, V150B, P1050, DOI 10.1002/ajmg.b.30930; Kim DY, 2016, PHYS THER, V96, P533, DOI 10.2522/ptj.20150135; Kim EJ, 2016, EUR J NEUROL, V23, P76, DOI 10.1111/ene.12791; Koliatsos VE, 2015, FRONTIERS NEUROENGIN, DOI [10.1201/b18126-55, DOI 10.1201/B18126-55]; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Kossel AH, 2001, P NATL ACAD SCI USA, V98, P14702, DOI 10.1073/pnas.251326998; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lagraoui M, 2017, BRAIN BEHAV IMMUN, V61, P96, DOI 10.1016/j.bbi.2016.12.005; Lamy JC, 2013, J NEUROPHYSIOL, V110, P109, DOI 10.1152/jn.00116.2013; Larson-Dupuis C, 2015, BRAIN INJURY, V29, P963, DOI 10.3109/02699052.2015.1016452; Leal G, 2017, VITAM HORM, V104, P153, DOI 10.1016/bs.vh.2016.10.004; Leech KA, 2017, J NEUROTRAUM, V34, P1240, DOI 10.1089/neu.2016.4532; Li XH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8460145; Lim YY, 2016, BRAIN, V139, P2766, DOI 10.1093/brain/aww200; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotrich F, 2012, CURR PHARM DESIGN, V18, P5920, DOI 10.2174/138161212803523680; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Ma XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22404; Mallei A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv069; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Marshall J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11316-8; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Mitroshina EV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082295; Mizui T, 2015, P NATL ACAD SCI USA, V112, pE3067, DOI 10.1073/pnas.1422336112; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Nicoll JAR, 1996, NEUROPATH APPL NEURO, V22, P515, DOI 10.1111/j.1365-2990.1996.tb01128.x; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Notaras M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.205; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Spencer-Segal JL, 2011, J NEUROSCI, V31, P6780, DOI 10.1523/JNEUROSCI.0910-11.2011; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Uegaki K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051042; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Westbroek EM, 2012, STROKE, V43, P2255, DOI 10.1161/STROKEAHA.112.663096; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Yu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081750; Ziebell JM, 2017, NEUROSCIENCE, V359, P209, DOI 10.1016/j.neuroscience.2017.07.027; Ziemlinska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088833; Zupanc GKH, 1998, EXP NEUROL, V152, P221, DOI 10.1006/exnr.1998.6853	102	9	9	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 7	2019	10								1175	10.3389/fneur.2019.01175			20	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JP9DM	WOS:000498557600001	31787925	gold, Green Published			2022-02-06	
J	Hohmann, U; Pelzer, M; Kleine, J; Hohmann, T; Ghadban, C; Dehghani, F				Hohmann, Urszula; Pelzer, Markus; Kleine, Joshua; Hohmann, Tim; Ghadban, Chalid; Dehghani, Faramarz			Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia	FRONTIERS IN NEUROSCIENCE			English	Article						2-arachidonoylglycerol; palmitoylethanolamide; peroxisome proliferator-activated receptor; neuroprotection; microglial cells	ACTIVATED-RECEPTOR-ALPHA; INHIBIT INFLAMMATORY RESPONSES; NITRIC-OXIDE PRODUCTION; TRAUMATIC BRAIN-INJURY; GYRUS GRANULE CELLS; ENDOCANNABINOID SYSTEM; NEURONAL DAMAGE; PPAR-ALPHA; SPINAL-CORD; CB2	Various studies performed in cultured cells and in in vivo models of neuronal damage showed that cannabinoids exert a neuroprotective effect. The increase in cannabinoids and cannabinoid like substances after stroke has been postulated to limit the content of neuronal injury. As well-accepted, inflammation, and neuronal damage are coupled processes and microglial cells as the main intrinsic immunological effector within the brain play a central role in their regulation. Treatment with the endocannabinoid, 2-arachidonoylglycerol (2-AG) or the endocannabinoid-like substance, palmitoylethanolamide (PEA) affected microglial cells and led to a decrease in the number of damaged neurons after excitotoxical lesion in organotypic hippocampal slice cultures (OHSC). 2-AG activated abnormal cannabidiol (abn-CBD) receptor, PEA was shown to mediate neuroprotection via peroxisome proliferator-activated receptor (PPAR)alpha. Despite the known neuroprotective and anti-inflammatory properties, the potential synergistic effect, namely possible entourage effect after treatment with the combination of these two protective cannabinoids has not been examined yet. After excitotoxical lesion OHSC were treated with PEA, 2-AG or a combination of both and the number of damaged neurons was evaluated. To investigate the role of microglial cells in PEA and 2-AG mediated protection, primary microglial cell cultures were treated with lipopolysaccharide (LPS) and 2-AG, PEA or a combination of those. Thereafter, we measured NO production, ramification index, proliferation and PPAR alpha distribution in microglial cells. While PEA or 2-AG alone were neuroprotective, their co-application vanished the protective effect. This behavior was independent of microglial cells. Furthermore, PEA and 2-AG had contrary effects on ramification index and on NO production. No significant changes were observed in the proliferation rate of microglial cells after treatment. The expression of PPAR alpha was not changed upon stimulation with PEA or 2-AG, but the distribution was significantly altered. 2-AG and PEA mediated neuroprotection was abolished when co-applied. Both cannabinoids exert contrary effects on morphology and function of microglial cells. Co-application of both cannabinoids with different targets did not lead to a positive additive effect as expected, presumably due to the contrary polarization of microglial cells.	[Hohmann, Urszula; Pelzer, Markus; Kleine, Joshua; Hohmann, Tim; Ghadban, Chalid; Dehghani, Faramarz] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Anat & Cell Biol, Halle, Seale, Germany		Dehghani, F (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Dept Anat & Cell Biol, Halle, Seale, Germany.	Faramarz.Dehghani@medizin.uni-halle.de	Hohmann, Urszula/ABB-7323-2020	Grabiec, Urszula/0000-0001-8376-4767	German Research Foundation (DFG)German Research Foundation (DFG)	We acknowledge the financial support within the funding program Open Access Publishing by the German Research Foundation (DFG).	Beggiato S, 2018, J ALZHEIMERS DIS, V61, P389, DOI 10.3233/JAD-170699; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; BRUCE AJ, 1995, EXP NEUROL, V132, P209, DOI 10.1016/0014-4886(95)90026-8; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cabral GA, 2001, ADV EXP MED BIOL, V493, P207; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Citraro R, 2013, NEUROPHARMACOLOGY, V69, P115, DOI 10.1016/j.neuropharm.2012.11.017; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; D'Agostino G, 2007, J PHARMACOL EXP THER, V322, P1137, DOI 10.1124/jpet.107.123265; D'Agostino G, 2012, NEUROPSYCHOPHARMACOL, V37, P1784, DOI 10.1038/npp.2012.25; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dubbelaar ML, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01753; Ebrahimi F, 2010, ANN ANAT, V192, P199, DOI 10.1016/j.aanat.2010.06.002; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Esposito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041880; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fernandez-Ruiz J, 2015, NEUROTHERAPEUTICS, V12, P793, DOI 10.1007/s13311-015-0381-7; Fernandez-Ruiz J, 2010, EXPERT OPIN THER TAR, V14, P387, DOI 10.1517/14728221003709792; Franklin A, 2003, J NEUROSCI, V23, P7767; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Grabiec U, 2017, JOVE-J VIS EXP, DOI 10.3791/55359; Grabiec U, 2012, NEUROPHARMACOLOGY, V62, P1797, DOI 10.1016/j.neuropharm.2011.11.023; Guida F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00342-1; Hagemann C, 2013, NEURO-ONCOLOGY, V15, P1696, DOI 10.1093/neuonc/not136; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Herrera MI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00145; Hezel M, 2012, MICRON, V43, P1031, DOI 10.1016/j.micron.2012.04.006; Ho WSV, 2008, BRIT J PHARMACOL, V155, P837, DOI 10.1038/bjp.2008.324; Hohmann T, 2019, CANCERS, V11, DOI 10.3390/cancers11020161; Hohmann T, 2017, CELL ADHES MIGR, V11, P54, DOI 10.1080/19336918.2016.1183867; Impellizzeri D, 2019, NEUROBIOL DIS, V125, P77, DOI 10.1016/j.nbd.2019.01.007; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jonsson KO, 2001, BRIT J PHARMACOL, V133, P1263, DOI 10.1038/sj.bjp.0704199; Kakizawa H, 2007, EARLY HUM DEV, V83, P535, DOI 10.1016/j.earlhumdev.2006.10.003; Kallendrusch S, 2013, GLIA, V61, P1822, DOI 10.1002/glia.22560; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koch M, 2011, HIPPOCAMPUS, V21, P554, DOI 10.1002/hipo.20772; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kohl A, 2003, EXP NEUROL, V181, P1, DOI 10.1016/S0014-4886(02)00049-3; Komuves LG, 2000, J INVEST DERMATOL, V115, P353, DOI 10.1046/j.1523-1747.2000.00073.x; Kondo S, 1998, FEBS LETT, V429, P152, DOI 10.1016/S0014-5793(98)00581-X; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Lipina C, 2017, J MOL CELL BIOL, V9, P91, DOI 10.1093/jmcb/mjx008; Lourbopoulos A, 2011, BRAIN RES, V1390, P126, DOI 10.1016/j.brainres.2011.03.020; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Luongo L, 2010, NEUROBIOL DIS, V37, P177, DOI 10.1016/j.nbd.2009.09.021; Ma L, 2015, BIOCHEM BIOPH RES CO, V458, P92, DOI 10.1016/j.bbrc.2015.01.073; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Mounsey RB, 2015, EXP NEUROL, V273, P36, DOI 10.1016/j.expneurol.2015.07.024; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Musella A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07519-8; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2014, P NUTR SOC, V73, P96, DOI 10.1017/S0029665113003649; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Portavella M, 2018, CANNABIS CANNABINOID, V3, P171, DOI 10.1089/can.2018.0013; RAI SC, 2015, ADV ELECTRON MATER, V1; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ross RA, 2000, EUR J PHARMACOL, V401, P121, DOI 10.1016/S0014-2999(00)00437-4; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Siracusa R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00233; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Smart D, 2002, BRIT J PHARMACOL, V136, P452, DOI 10.1038/sj.bjp.0704732; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Stefano GB, 2000, PHARMACOL RES, V42, P317, DOI 10.1006/phrs.2000.0702; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Vincent VAM, 1998, MEDIAT INFLAMM, V7, P239, DOI 10.1080/09629359890929; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wang SH, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1254-x; Warden A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27618; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Xu JH, 2006, J NEUROIMMUNOL, V176, P95, DOI 10.1016/j.jneuroim.2006.04.019; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200; Zhou T, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00077	95	9	9	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	NOV 7	2019	13								1180	10.3389/fnins.2019.01180			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JP9MU	WOS:000498582000001	31787870	Green Published, gold			2022-02-06	
J	Armstrong, E; Coffin, J; Hersh, D; Katzenellenbogen, JM; Thompson, SC; Ciccone, N; Flicker, L; Woods, D; Haywar, C; Dowell, C; McAllister, M				Armstrong, Elizabeth; Coffin, Juli; Hersh, Deborah; Katzenellenbogen, Judith M.; Thompson, Sandra C.; Ciccone, Natalie; Flicker, Leon; Woods, Deborah; Haywar, Colleen; Dowell, Catelyn; McAllister, Meaghan			"You felt like a prisoner in your own self, trapped": the experiences of Aboriginal people with acquired communication disorders	DISABILITY AND REHABILITATION			English	Article						Brain injury; acquired communication disorders; Aboriginal; Indigenous; aphasia; rehabilitation; cultural security	LOW-BACK-PAIN; HOSPITAL-CARE; HEALTH-CARE; INDIGENOUS AUSTRALIANS; WESTERN-AUSTRALIA; GROUP-THERAPY; APHASIA; STROKE; PARTICIPATION; INFORMATION	Purpose: Aboriginal Australians are under-represented in brain injury rehabilitation services despite a high incidence of both stroke and traumatic brain injury in this population. This study aimed to explore the experiences of Aboriginal Australian adults with acquired communication disorders (ACDs) after brain injury for the first time to inform the development of accessible and culturally secure service delivery models. Methods and materials: Semi-structured interviews were undertaken with 32 Aboriginal people who had experienced a brain injury resulting in ACDs (aged 35-79 years) and 18 family members/carers across Western Australia. Thematic analysis identified common themes across participants. Results: Overall themes related to communication (both related to the communication disorder and general healthcare interactions), health and social contexts, recovery, and support, being away from family and country, knowledge and beliefs about brain injury, and follow-up. Conclusions: An increase in healthcare staff's appreciation of the health and social contexts of Aboriginal people after brain injury is needed in order to improve communication with Aboriginal patients and the ability to offer accessible rehabilitation services. Ongoing support is required, with cultural identity noted as key to ensuring cultural security and ultimately recovery. Involvement of family and other Aboriginal people in recovery processes, as well as access to relevant Aboriginal languages and proximity to ancestral lands is central.	[Armstrong, Elizabeth; Hersh, Deborah; Ciccone, Natalie; Dowell, Catelyn; McAllister, Meaghan] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Coffin, Juli] Telethon Kids Inst, Broome, Australia; [Katzenellenbogen, Judith M.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Katzenellenbogen, Judith M.] Telethon Kids Inst, Perth, WA, Australia; [Thompson, Sandra C.] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, Australia; [Flicker, Leon] Univ Western Australia, Ctr Med Res, Perth, WA, Australia; [Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, Australia; [Haywar, Colleen] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Perth, WA, Australia		Armstrong, E (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, 270 Joondalup Dr, Joondalup, WA 6027, Australia.	b.armstrong@ecu.edu.au	; Thompson, Sandra/H-5955-2014	Ciccone, Natalie/0000-0002-1822-7217; Katzenellenbogen, Judith/0000-0001-5287-5819; Flicker, Leon/0000-0002-3650-0475; Armstrong, Elizabeth/0000-0003-4469-1117; Thompson, Sandra/0000-0003-0327-7155; Hersh, Deborah/0000-0003-2466-0225	National Health and Medical Research Foundation [1046228]	This work was supported by the National Health and Medical Research Foundation under Grant #1046228.	Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Armstrong E, 2012, INT J SPEECH-LANG PA, V14, P271, DOI 10.3109/17549507.2011.663790; Australian Bureau of Statistics, EST AB TORR STRAIT I; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Avery S., 2018, CULTURE IS INCLUSION; Avila AJ, 2017, DEV CULTURALLY APPRO; Bainbridge R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2052-3; Bessarab D., 2010, INT J CRIT INDIG STU, V3, P37; Bohanna I, 2013, ASSESSMENT ACQUIRED; Bohanna I, 2019, BRAIN IMPAIR, V20, P1; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Caffery LJ, 2017, AUST NZ J PUBL HEAL, V41, P48, DOI 10.1111/1753-6405.12600; Cass A, 2002, MED J AUSTRALIA, V176, P466, DOI 10.5694/j.1326-5377.2002.tb04517.x; Coffin J, 2018, POSITIONING ABORIGIN; Coffin Juli, 2007, ABORIGINAL ISLANDER, V31, P22; Department of Communications Information Technology and the Arts, 2005, NAT IND LANG SURV RE; Durey A, 2012, INTERN MED J, V42, P17, DOI 10.1111/j.1445-5994.2011.02628.x; Durey A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1497-0; Durey A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-151; Durey A, 2012, NURS INQ, V19, P144, DOI 10.1111/j.1440-1800.2011.00546.x; Elman RJ, 2016, TOP LANG DISORD, V36, P154, DOI 10.1097/TLD.0000000000000087; Fitts MS, 2019, BRAIN IMPAIR, V20, P137, DOI 10.1017/BrImp.2019.24; Foley D., 2003, SOC ALTERN, V22, P44, DOI DOI 10.3316/IELAPA.200305132; Freeman T, 2014, AUST NZ J PUBL HEAL, V38, P355, DOI 10.1111/1753-6405.12231; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Gilroy J., 2016, AUSTR INDIGENOUS HLT, V1, P1; Gilroy J, 2013, AUST ABORIG STUD, P42; Hersh D, 2019, PATIENT ED COUNS; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2014, INT J STROKE, V9, P61, DOI 10.1111/ijs.12278; Katzenellenbogen JM, 2010, INT J STROKE, V5, P269, DOI 10.1111/j.1747-4949.2010.00439.x; Kelly J., 2012, MANAGING 2 WORLDS TO; Kelly J, 2014, AUST J RURAL HEALTH, V22, P109, DOI 10.1111/ajr.12094; Kilkenny MF, 2013, INT J STROKE, V8, P164, DOI 10.1111/j.1747-4949.2011.00717.x; Lanyon LE, 2013, INT J SPEECH-LANG PA, V15, P359, DOI 10.3109/17549507.2012.752865; Laycock A., 2011, RES ABORIGINAL HLTH; Lin I, 2014, AUST FAM PHYSICIAN, V43, P320; Lin IB, 2017, PAIN MED, V18, P2070, DOI 10.1093/pm/pnw314; Marmion D, COMMUNITY IDENTITY W; McKenna B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2221-4; Nakata M, 2007, AUST J INDIG EDUC, V36, P7, DOI 10.1017/S1326011100004646; National Health and Medical Research Council, 2003, VAL ETH GUID ETH CON; O'Hara R, 2017, AUST J RURAL HEALTH, V25, P53, DOI 10.1111/ajr.12189; Penn C, 2017, APHASIOLOGY, V31, P563, DOI 10.1080/02687038.2016.1213788; Pilkington L, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4701-1; Porr M, 2018, CAMB ARCHAEOL J, V28, P395, DOI 10.1017/S0959774318000185; Purdy N, 2010, WORKING TOGETHER ABO; Rigney L., 1999, WICAZO SA REV, V14, P109, DOI [10.2307/1409555, DOI 10.2307/1409555]; Rose D.B., 1996, NOURISHING TERRAINS; Rose T, 2010, TOP STROKE REHABIL, V17, P79, DOI 10.1310/tsr1702-79; Shadden BB, 2005, APHASIOLOGY, V19, P211, DOI 10.1080/02687930444000697; Shahid S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-460; Shahid S, 2011, AUST HEALTH REV, V35, P235, DOI 10.1071/AH09835; Simmons-Mackie N, 2011, INT J LANG COMM DIS, V46, P312, DOI 10.3109/13682822.2010.507616; Simmons-Mackie Nina, 2009, Seminars in Speech and Language, V30, P18, DOI 10.1055/s-0028-1104531; Thompson Sandra C, 2011, BMC Res Notes, V4, P62, DOI 10.1186/1756-0500-4-62; You JQ, 2015, INT J STROKE, V10, P716, DOI 10.1111/ijs.12429	61	9	9	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUN 19	2021	43	13					1903	1916		10.1080/09638288.2019.1686073		NOV 2019	14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	SY0WN	WOS:000494716300001	31692386	Green Submitted			2022-02-06	
J	Brodsky, JR; Lipson, S; Bhattacharyya, N				Brodsky, Jacob R.; Lipson, Sophie; Bhattacharyya, Neil			Prevalence of Pediatric Dizziness and Imbalance in the United States	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						pediatric vestibular; dizziness; vertigo; imbalance; balance impairment	VESTIBULAR DISORDERS; BALANCE DISORDERS; CHILDREN; VERTIGO; EPIDEMIOLOGY; ADOLESCENTS; CHILDHOOD	Objectives Understand the prevalence of vestibular symptoms in US children. Study Design Cross-sectional analysis Setting 2016 National Health Interview Survey. Subjects and Methods Responses from the 2016 National Health Interview Survey for children ages 3 to 17 years were examined to determine the prevalence of vestibular symptoms and provider-assigned diagnoses. Results Dizziness or imbalance was reported in 3.5 (95% confidence interval, 3.1-3.9) million patients (5.6%) with a mean age of 11.5 years. Dizziness was reported in 1.2 million patients (2.0%) with a mean age of 12.7 years and balance impairment in 2.3 million patients (3.7%) with a mean age of 10.6 years. Prevalence of dizziness and imbalance did not vary by sex (P = .6, P = .2). Evaluation by a health professional was reported for 42% of patients with dizziness and 43% of patients with imbalance, with diagnoses reported in 45% and 48% of patients with dizziness and imbalance, respectively. The most common diagnoses reported for dizziness were depression or child psychiatric disorder (12%), side effects from medications (11%), head/neck injury or concussion (8.4%), and developmental motor coordination disorder (8.3%). The most common diagnoses reported for imbalance were blurred vision with head motion, "bouncing" or rapid eye movements (9.1%), depression or child psychiatric disorder (6.2%), head/neck injury or concussion (6.1%), and side effects from medications (5.9%). Conclusion The national prevalence of childhood vestibular symptoms is more common than previously thought. Reported diagnoses varied greatly from the literature, suggesting a need for increased awareness of causes of vestibular symptoms in children.	[Brodsky, Jacob R.; Lipson, Sophie] Boston Childrens Hosp, Boston, MA USA; [Brodsky, Jacob R.; Bhattacharyya, Neil] Harvard Med Sch, Boston, MA 02115 USA; [Bhattacharyya, Neil] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA		Brodsky, JR (corresponding author), Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA.	jacob.brodsky@childrens.harvard.edu		Lipson, Sophie/0000-0001-5609-8156			Sommerfleck PA, 2016, INT J PEDIATR OTORHI, V87, P148, DOI 10.1016/j.ijporl.2016.06.020; Bigelow RT, 2016, J NEUROL NEUROSUR PS, V87, P367, DOI 10.1136/jnnp-2015-310319; Brodsky JR, 2018, OTOLARYNG HEAD NECK, V159, P365, DOI 10.1177/0194599818770618; Brodsky JR, 2018, OTOL NEUROTOL, V39, P344, DOI 10.1097/MAO.0000000000001673; Brodsky JR, 2016, EUR J PAEDIATR NEURO, V20, P85, DOI 10.1016/j.ejpn.2015.09.011; Choung YH, 2003, INT J PEDIATR OTORHI, V67, P889, DOI 10.1016/S0165-5876(03)00136-8; DAgostino R, 1997, INT J PEDIATR OTORHI, V40, P133, DOI 10.1016/S0165-5876(97)00032-3; Erbek SH, 2006, INT J PEDIATR OTORHI, V70, P1547, DOI 10.1016/j.ijporl.2006.04.001; Gioacchini FM, 2014, INT J PEDIATR OTORHI, V78, P718, DOI 10.1016/j.ijporl.2014.02.009; Koo JW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008224; Lee JD, 2017, INT J PEDIATR OTORHI, V94, P36, DOI 10.1016/j.ijporl.2017.01.012; Li CM, 2016, J PEDIATR-US, V171, P240, DOI 10.1016/j.jpeds.2015.12.002; McCaslin DL, 2011, OTOLARYNG CLIN N AM, V44, P291, DOI 10.1016/j.otc.2011.01.003; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; National Center for Health Statistics, NAT HLTH INT SURV; National Center for Health Statistics Centers for Disease Control and Prevention, 2016, NAT HLTH INT SURV NH; National Health Interview Survey, 2017, 2016 DAT REL; Neuhauser HK, 2016, HAND CLINIC, V137, P67, DOI 10.1016/B978-0-444-63437-5.00005-4; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Niemensivu R, 2006, INT J PEDIATR OTORHI, V70, P259, DOI 10.1016/j.ijporl.2005.06.015; O'Reilly RC, 2011, OTOLARYNG HEAD NECK, V144, P142, DOI 10.1177/0194599810393679; O'Reilly RC, 2010, OTOL NEUROTOL, V31, P1441, DOI 10.1097/MAO.0b013e3181f20673; Roberts DS, 2013, LARYNGOSCOPE, V123, P2539, DOI 10.1002/lary.24087; Semenov YR, 2016, J GERONTOL A-BIOL, V71, P243, DOI 10.1093/gerona/glv069; Weiss AH, 2006, J CHILD NEUROL, V21, P572, DOI 10.1177/08830738060210071501; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358; Wiener-Vacher Sylvette R., 2018, Seminars in Hearing, V39, P229, DOI 10.1055/s-0038-1666815	27	9	9	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	FEB	2020	162	2					241	247	0194599819887375	10.1177/0194599819887375		NOV 2019	7	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	KH6SY	WOS:000497739100001	31689154				2022-02-06	
J	Bailey, C; Meyer, J; Briskin, S; Tangen, C; Hoffer, SA; Dundr, J; Brennan, B; Smith, P				Bailey, Christopher; Meyer, Jessica; Briskin, Susannah; Tangen, Christopher; Hoffer, S. Alan; Dundr, Jason; Brennan, Bethany; Smith, Paul			Multidisciplinary Concussion Management: A Model for Outpatient Concussion Management in the Acute and Post-Acute Settings	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; mild TBI; multidisciplinary management	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; RANDOMIZED-TRIAL; HIGH-SCHOOL; IMPACT; INTERVENTION; RECOVERY	Objective: To describe a model of multidisciplinary concussion management and explore management methods in the acute and post-acute settings. Setting: A multidisciplinary concussion management program within a large health system. Participants: Patients with sports and non-sports-related concussions aged 14 to 18 years with persisting concussion symptoms at 4 weeks postinjury or beyond. Design: Pilot randomized controlled trial comparing a subsymptom threshold exercise program with standard-of-care treatment in the post-acute setting. Main Measures: Beck Depression Inventory-II and the Post-Concussion Scale-Revised. Results: Across groups, 60% improvement in concussion symptoms was noted. After removing the influence of depression, the intervention showed a large effect on symptom reduction, with participants in the intervention group improving more than those in the control group. There was no difference in response to the intervention by the sports and nonsports groups. Conclusion: Results demonstrate that exercise intervention is effective in reducing symptoms in adolescents with persisting symptoms. The finding that participants in the control group who underwent education, light activity, and sophisticated monitoring still had meaningful recovery supports the utility of active engagement in a multidisciplinary management program. Finally, depression had a clinically meaningful effect on recovery, highlighting the need for targeted intervention of noninjury factors relevant to persisting symptoms.	[Bailey, Christopher; Meyer, Jessica] Univ Hosp Cleveland, Med Ctr, Dept Neurol, 11100 Euclid Ave,Mail Stop HAN 5040, Cleveland, OH 44106 USA; [Briskin, Susannah] Univ Hosp Cleveland, Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Tangen, Christopher] Univ Hosp Cleveland, Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Hoffer, S. Alan] Univ Hosp Cleveland, Med Ctr, Dept Neurosurg, Cleveland, OH 44106 USA; [Dundr, Jason; Brennan, Bethany; Smith, Paul] Univ Hosp Cleveland, Med Ctr, Dept Rehabil Serv, Cleveland, OH 44106 USA; [Bailey, Christopher; Meyer, Jessica; Briskin, Susannah; Hoffer, S. Alan] Case Western Reserve Univ, Sch Med, Cleveland, OH USA		Bailey, C (corresponding author), Univ Hosp Cleveland, Med Ctr, Dept Neurol, 11100 Euclid Ave,Mail Stop HAN 5040, Cleveland, OH 44106 USA.	Christopher.Bailey3@UHhospitals.org			Case Brain Health Collaborative Spitz Clinical Research Award	Funding for this study was provided by a Case Brain Health Collaborative Spitz Clinical Research Award.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carrick FR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00414; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hanks RA, 2019, J NEUROTRAUM, V36, P554, DOI 10.1089/neu.2018.5873; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrea MA, 2017, NEUROL CLIN, V35, P487, DOI 10.1016/j.ncl.2017.03.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Ott SD, 2018, ARCH CLIN NEUROPSYCH, V33, P319, DOI 10.1093/arclin/acx132; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Reynolds E, 2014, NEUROSURGERY S4, V75, P71; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	58	9	9	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					375	384		10.1097/HTR.0000000000000527			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200007	31479082				2022-02-06	
J	Broadway, JM; Rieger, RE; Campbell, RA; Quinn, DK; Mayer, AR; Yeo, RA; Wilson, JK; Gill, D; Fratzke, V; Cavanagh, JF				Broadway, James M.; Rieger, Rebecca E.; Campbell, Richard A.; Quinn, Davin K.; Mayer, Andrew R.; Yeo, Ronald A.; Wilson, J. Kevin; Gill, Darbi; Fratzke, Violet; Cavanagh, James F.			Executive function predictors of delayed memory deficits after mild traumatic brain injury	CORTEX			English	Article						Concussion; Delayed free recall; Delayed memory; Executive function; Mild traumatic brain injury; Semantic clustering	FRONTAL LOBES	Delayed memory deficits are common for patients with mild traumatic brain injury (mTBI), according to a recent systematic review of meta-analyses (Karr et al., 2014). However, there has been little work to identify different cognitive processes that may be underpinning these delayed memory deficits for mTBI. Frontal cortex is important for delayed memory, and is implicated in the pathophysiology of mTBI; moreover, frontal lobes are typically considered the locus of executive abilities. To further explore these relationships, we sought to partly explain delayed memory deficits after mTBI by examining behavioral indicators of executive function. Results showed that sub-acute as well as chronic mTBI patients performed worse than controls on the delayed memory trial of the Hopkins Verbal Learning Test-Revised (Brandt & Benedict, 2001), recalling approximately 18% and 15% fewer words, respectively. Furthermore, worse delayed memory performance was associated with less use of the cognitive strategy of semantic clustering, and with lower scores for the executive function composite from a standardized neuropsychological battery (NIH EXAMINER; Kramer et al., 2014). In contrast, serial clustering, a memory organizational strategy thought to be less dependent on executive function, did not show strong relationships to clinical status or delayed memory performance. This exploratory work suggests novel hypotheses to be tested in future, confirmatory studies, including that general executive functions and/or semantic clustering will mediate delayed memory deficits following mTBI. (C) 2019 Elsevier Ltd. All rights reserved.	[Broadway, James M.; Gill, Darbi] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA; [Rieger, Rebecca E.; Yeo, Ronald A.; Wilson, J. Kevin; Fratzke, Violet; Cavanagh, James F.] Univ New Mexico, Dept Psychol, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA; [Campbell, Richard A.; Quinn, Davin K.] Univ New Mexico, Dept Psychiat & Behav Sci, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA		Cavanagh, JF (corresponding author), Univ New Mexico, Dept Psychol, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA.	jcavanagh@unm.edu		Campbell, Richard/0000-0002-4305-4821	National Institute of General Medical Sciences (NIGMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1P20GM109089-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER	This study was a component of two larger studies supported by a grant from the National Institute of General Medical Sciences (NIGMS) 1P20GM109089-01A1. Details of these two projects can be found at the NIH Research Portfolio Online Reporting Tools (RePORTER; https://projectreporter.nih.gov/reporter.cfm).For the study referred to in the paper as Cavanagh et al., please use the following link. https://projectreporter.nih.gov/project_info_description.cfm?aid= 9525979&icde=45112451&ddparam=&ddvalue= &ddsub=&cr=1&csb=default&cs=ASC&pball=.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Benedict, 2001, HOPKINS VERBAL LEARN; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Hedges L.V., 1985, STAT METHODS META AN; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Nyberg L, 2003, NEUROPSYCHOLOGIA, V41, P371, DOI 10.1016/S0028-3932(02)00168-9; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wagner AD., 2002, NEUROPSYCHOL MEMORY, P174; Woods SP, 2005, NEUROPSYCHOLOGY, V19, P35, DOI 10.1037/0894-4105.19.1.35	26	9	10	0	1	ELSEVIER MASSON, CORP OFF	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	NOV	2019	120						240	248		10.1016/j.cortex.2019.06.011			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	JJ1CQ	WOS:000493898600018	31344589	Green Accepted			2022-02-06	
J	Lazzarino, G; Amorini, AM; Signoretti, S; Musumeci, G; Lazzarino, G; Caruso, G; Pastore, FS; Di Pietro, V; Tavazzi, B; Belli, A				Lazzarino, Giacomo; Amorini, Angela Maria; Signoretti, Stefano; Musumeci, Giuseppe; Lazzarino, Giuseppe; Caruso, Giuseppe; Pastore, Francesco Saverio; Di Pietro, Valentina; Tavazzi, Barbara; Belli, Antonio			Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle Enzymes Are Sensitive Targets of Traumatic Brain Injury Induced Metabolic Derangement	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; mitochondrial dysfunction; pyruvate dehydrogenase; tricarboxylic acid cycle; acetyl-CoA; concussion	MITOCHONDRIAL DYSFUNCTION; TEMPORAL WINDOW; CEREBRAL-CORTEX; MESSENGER-RNA; INBORN-ERRORS; COENZYME-A; GLUCOSE; EXPRESSION; VULNERABILITY; MODEL	Using a closed-head impact acceleration model of mild or severe traumatic brain injury (mTBI or sTBI, respectively) in rats, we evaluated the effects of graded head impacts on the gene and protein expressions of pyruvate dehydrogenase (PDH), as well as major enzymes of mitochondrial tricarboxylic acid cycle (TCA). TBI was induced in anaesthetized rats by dropping 450 g from 1 (mTBI) or 2 m height (sTBI). After 6 h, 12 h, 24 h, 48 h, and 120 h gene expressions of enzymes and subunits of PDH. PDH kinases and phosphatases (PDK1-4 and PDP1-2, respectively), citrate synthase (CS), isocitrate dehydrogenase (IDH), oxoglutarate dehydrogenase (OGDH), succinate dehydrogenase (SDH), succinyl-CoA synthase (SUCLG), and malate dehydrogenase (MDH) were determined in whole brain extracts (n = 6 rats at each time for both TBI levels). In the same samples, the high performance liquid chromatographic (HPLC) determination of acetyl-coenzyme A (acetyl-CoA) and free coenzyme A (CoA-SH) was performed. Sham-operated animals (n = 6) were used as controls. After mTBI, the results indicated a general transient decrease, followed by significant increases, in PDH and TCA gene expressions. Conversely, permanent PDH and TCA downregulation occurred following sTBI. The inhibitory conditions of PDH (caused by PDP1-2 downregulations and PDK1-4 overexpression) and SDH appeared to operate only after sTBI. This produced almost no change in acetyl-CoA and free CoA-SH following mTBI and a remarkable depletion of both compounds after sTBI. These results again demonstrated temporary or steady mitochondrial malfunctioning, causing minimal or profound modifications to energy-related metabolites, following mTBI or sTBI, respectively. Additionally, PDH and SDH appeared to be highly sensitive to traumatic insults and are deeply involved in mitochondrial-related energy metabolism imbalance.	[Lazzarino, Giacomo] UniCamillus St Camillus Int Univ Hlth Sci, Via St Alessandro 8, I-00131 Rome, Italy; [Amorini, Angela Maria; Lazzarino, Giuseppe] Univ Catania, Dept Biomed & Biotechnol Sci, Div Med Biochem, Viale A Doria 6, I-95125 Catania, Italy; [Signoretti, Stefano] S Eugenio Hosp, Div Emergency Urgency, UOC Neurosurg, Via Filippo Meda 35, I-00157 Rome, Italy; [Musumeci, Giuseppe] Sch Med, Dept Biomed & Biotechnol Sci, Human Anat & Histol Sect, Via S Sofia 97, I-95123 Catania, Italy; [Caruso, Giuseppe] Oasi Res Inst IRCCS, Via Conte Ruggero 73, I-94018 Troina, EN, Italy; [Pastore, Francesco Saverio] Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy; [Di Pietro, Valentina; Belli, Antonio] Univ Birmingham, Neurotrauma & Ophthalmol Res Grp, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Di Pietro, Valentina; Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Birmingham B15 2TT, W Midlands, England; [Tavazzi, Barbara] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy; [Tavazzi, Barbara] Fdn Policlin Univ A Gemelli IRCCS, Largo A Gemelli 8, I-00168 Rome, Italy		Lazzarino, G (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Div Med Biochem, Viale A Doria 6, I-95125 Catania, Italy.; Di Pietro, V (corresponding author), Univ Birmingham, Neurotrauma & Ophthalmol Res Grp, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.; Di Pietro, V (corresponding author), Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct & Microbiol R, Birmingham B15 2TT, W Midlands, England.; Tavazzi, B (corresponding author), Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy.; Tavazzi, B (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Largo A Gemelli 8, I-00168 Rome, Italy.	giacomo.lazzarino@unicamillus.org; amorini@unict.it; stefano.signoretti@aslroma2.it; g.musumeci@unict.it; lazzarig@unict.it; forgiuseppecaruso@gmail.com; pastore@uniroma2.it; dipietro@bham.ac.uk; barbara.tavazzi@unicatt.it; a.belli@bham.ac.uk	Belli, Antonio/I-3799-2015; TAVAZZI, BARBARA/AAB-9830-2019; Caruso, Giuseppe/C-1435-2018; Signoretti, stefano/AAL-5631-2020; pastore, francesco saverio/D-3827-2012; Musumeci, Giuseppe/K-9955-2016; lazzarino, giuseppe/K-2277-2015	Belli, Antonio/0000-0002-3211-9933; TAVAZZI, BARBARA/0000-0001-8743-0895; Caruso, Giuseppe/0000-0003-1571-5327; Signoretti, stefano/0000-0002-8086-1622; pastore, francesco saverio/0000-0002-2041-5161; Musumeci, Giuseppe/0000-0002-8260-8890; lazzarino, giuseppe/0000-0002-5917-7279; Lazzarino, Giacomo/0000-0003-1639-0966; AMORINI, Angela Maria/0000-0003-3525-9955	University of Birmingham; Catholic University of Rome	This research was funded in part by research funds of the University of Birmingham and of the Catholic University of Rome.	Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Caravas J, 2014, DIABETES OBES METAB, V16, P21, DOI 10.1111/dom.12333; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carteri RB, 2019, J NEUROTRAUM, V36, P2246, DOI 10.1089/neu.2018.6266; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Meo I, 2019, J INHERIT METAB DIS, V42, P49, DOI 10.1002/jimd.12026; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jiang XB, 1999, NEUROL MED-CHIR, V39, P649, DOI 10.2176/nmc.39.649; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lapel M, 2017, AM J PHYSIOL-CELL PH, V312, pC56, DOI 10.1152/ajpcell.00250.2016; Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013; Lazzarino G, 2017, MOL NEUROBIOL, V54, P7520, DOI 10.1007/s12035-016-0257-9; Lehmann S, 2013, J MOL MED, V91, P665, DOI 10.1007/s00109-013-1044-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Sen AK, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00175; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Shumar SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130013; Sibon OCM, 2016, NAT REV MOL CELL BIO, V17, P605, DOI 10.1038/nrm.2016.110; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Singh K, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3764; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088; Walczak J, 2019, FASEB J, V33, P4388, DOI 10.1096/fj.201801843R; Wu Q, 2017, HISTOL HISTOPATHOL, V32, P551, DOI 10.14670/HH-11-841; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Xing GQ, 2012, NEUROSCI LETT, V525, P140, DOI 10.1016/j.neulet.2012.07.055; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Xu Z, 2018, MOL NEUROBIOL, V55, P3499, DOI 10.1007/s12035-017-0576-5; Yang MY, 2019, MITOCHONDRION, V46, P380, DOI 10.1016/j.mito.2018.10.002; Ye CY, 2015, NEUROPHARMACOLOGY, V95, P29, DOI 10.1016/j.neuropharm.2015.02.020; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231	58	9	10	0	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2019	20	22							5774	10.3390/ijms20225774			22	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	JW0YW	WOS:000502786800256	31744143	Green Published, gold			2022-02-06	
J	Nagesh, M; Patel, KR; Mishra, A; Yeole, U; Prabhuraj, AR; Shukla, D				Nagesh, Madhusudhan; Patel, Kautilya Rajendrakumar; Mishra, Ajit; Yeole, Ujwal; Prabhuraj, Andiperumal R.; Shukla, Dhaval			Role of repeat CT in mild to moderate head injury: an institutional study	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; computed tomography; repeat imaging	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT; HEMORRHAGE; NEED	OBJECTIVE Patients with traumatic brain injury (TBI) often undergo repeat head CT scans to identify the possible progression of injury. The objective of this study is to evaluate the need for routine repeat head CT scans in patients with mild to moderate head injury and an initial positive abnormal CT scan. METHODS This is a retrospective study of patients presenting to the emergency department from January 2016 to December 2017 with Glasgow Coma Scale (GCS) scores > 8 and an initial abnormal CT scan, who underwent repeat CT during their in-hospital medical management. Patients who underwent surgery after the first CT scan, had a GCS score < 9, or had a normal initial CT scan were excluded. Demographic, medical history, and physical examination details were collected, and CT scans were reviewed. Radiological deterioration, neurological deterioration, and/or the need for neurosurgical intervention were the primary outcome variables. RESULTS A total of 1033 patients were included in this study. These patients underwent at least two CT scans on an inpatient basis. Of these 1033 patients, 54.1% had mild head injury and 45.9% had moderate head injury based on GCS score at admission. The most common diagnosis was contusion (43.8%), followed by extradural hematoma (28.8%) and subdural hematoma (26.6%). A total of 2636 CT scans were performed for 1033 patients, with a mean of 2.55 per patient. Of these, 25 (2.4%) had neurological deterioration, 90 (8.7%) had a progression of an existing lesion or appearance of a new lesion on repeat CT, and 101 (9.8%) required neurosurgical intervention. Seventy-five patients underwent surgery due to worsening of repeat CT without neurological deterioration, so the average number of repeat CT scans required to identify one such patient was 21.3. On multiple logistic regression, GCS score at admission (p = 0.024), abnormal international normalized ratio (INR; p < 0.001), midline shift (p = 0.005), effaced basal cisterns (p < 0.001), and multiple hemorrhagic lesions (p = 0.010) were associated with worsening of repeat CT, neurological deterioration, and/or need for neurosurgical intervention. CONCLUSIONS The role of routine repeat head CT in medically managed patients with head injury is controversial. The authors have tried to study the various factors that are associated with neurological deterioration, radiological deterioration, and/or need for neurosurgical intervention. In this study the authors found lower GCS score at admission, abnormal INR, presence of midline shift, effaced basal cisterns, and multiple lesions on initial CT to be significantly associated with the above outcomes.	[Nagesh, Madhusudhan; Patel, Kautilya Rajendrakumar; Mishra, Ajit; Yeole, Ujwal; Prabhuraj, Andiperumal R.; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bengaluru, Karnataka, India		Prabhuraj, AR (corresponding author), Natl Inst Mental Hlth & Neurosci, Bengaluru, Karnataka, India.	drprabhuraj@yahoo.co.in					Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Dharap SB, 2005, INJURY, V36, P412, DOI 10.1016/j.injury.2004.06.020; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Sharifuddin Ashraf, 2012, Med J Malaysia, V67, P305; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Van Ornam J, 2019, AM J EMERG MED, V37, P1694, DOI 10.1016/j.ajem.2018.12.012; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	18	9	11	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E2	10.3171/2019.8.FOCUS19527			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900002	31675712	gold			2022-02-06	
J	Opel, RA; Christy, A; Boespflug, EL; Weymann, KB; Case, B; Pollock, JM; Silbert, LC; Lim, MM				Opel, Ryan A.; Christy, Alison; Boespflug, Erin L.; Weymann, Kristianna B.; Case, Brendan; Pollock, Jeffery M.; Silbert, Lisa C.; Lim, Miranda M.			Effects of traumatic brain injury on sleep and enlarged perivascular spaces	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Alzheimer's disease; magnetic resonance imaging; brain trauma; sleep disorders; glymphatic system	VIRCHOW-ROBIN SPACES; ALZHEIMERS-DISEASE; HEAD-INJURY; RISK; PATHOLOGY; DEMENTIA; QUESTIONNAIRE; RELIABILITY; IMPAIRMENT; MARKER	Clearance of perivascular wastes in the brain may be critical to the pathogenesis of amyloidopathies. Enlarged perivascular spaces (ePVS) on MRI have also been associated with amyloidopathies, suggesting that there may be a mechanistic link between ePVS and impaired clearance. Sleep and traumatic brain injury (TBI) both modulate clearance of amyloid-beta through glymphatic function. Therefore, we sought to evaluate the relationship between sleep, TBI, and ePVS on brain MRI. A retrospective study was performed in individuals with overnight polysomnography and 3T brain MRI consented from a single site (n = 38). Thirteen of these individuals had a medically confirmed history of TBI. ePVS were visually assessed by blinded experimenters and analyzed in conjunction with sleep metrics and TBI status. Overall, individuals with shorter total sleep time had significantly higher ePVS burden. Furthermore, individuals with TBI showed a stronger relationship between sleep and ePVS compared to the non-TBI group. These results support the hypothesis that ePVS may be modulated by sleep and TBI, and may have implications for the role of the glymphatic system in ePVS.	[Opel, Ryan A.; Weymann, Kristianna B.; Silbert, Lisa C.; Lim, Miranda M.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mail Code P3-RD42, Portland, OR 97239 USA; [Christy, Alison] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Neurol, Portland, OR 97201 USA; [Boespflug, Erin L.; Silbert, Lisa C.] Oregon Hlth & Sci Univ, Dept Neurol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA; [Weymann, Kristianna B.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Case, Brendan; Pollock, Jeffery M.] Oregon Hlth & Sci Univ, Dept Diagnost Radiol, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Dept Behav Neurosci, Dept Med,Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mail Code P3-RD42, Portland, OR 97239 USA.	lmir@ohsu.edu		Christy, Alison/0000-0003-0995-8381	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG008017] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [UL1 GM118964] Funding Source: Medline		Achariyar TM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0138-8; Banerjee G, 2017, BRAIN, V140, P1107, DOI 10.1093/brain/awx003; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Berezuk C, 2015, SLEEP, V38, P853, DOI 10.5665/sleep.4726; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Boespflug EL, 2018, RADIOLOGY, V286, P632, DOI 10.1148/radiol.2017170205; Charidimou A, 2014, NEUROLOGY, V82, P57, DOI 10.1212/01.wnl.0000438225.02729.04; Charidimou A, 2013, J NEUROL NEUROSUR PS, V84, P624, DOI 10.1136/jnnp-2012-304434; Chen W, 2011, AM J NEURORADIOL, V32, P1490, DOI 10.3174/ajnr.A2541; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Ding J, 2017, JAMA NEUROL, V74, P1105, DOI 10.1001/jamaneurol.2017.1397; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gutierrez J, 2017, AM J NEURORADIOL, V38, P862, DOI 10.3174/ajnr.A5129; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lau KK, 2017, STROKE, V48, P1470, DOI 10.1161/STROKEAHA.117.016694; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lundgaard I, 2017, J CEREBR BLOOD F MET, V37, P2112, DOI 10.1177/0271678X16661202; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Potter GM, 2015, CEREBROVASC DIS, V39, P224, DOI 10.1159/000375153; R Core Team, 2017, R LANG ENV STAT COMP; Ramirez J, 2016, CELL MOL NEUROBIOL, V36, P289, DOI 10.1007/s10571-016-0343-6; Ramirez J, 2015, J ALZHEIMERS DIS, V43, P415, DOI 10.3233/JAD-132528; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Smith M. T., 2003, ARTHRITIS RHEUMATISM, V49, pS184, DOI DOI 10.1002/ART.11409; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers F.W., 1993, 9 ANN C ISTSS; Weaver TE, 1997, SLEEP, V20, P835; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang SN, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015719	44	9	10	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2019	39	11					2258	2267		10.1177/0271678X18791632			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	JR9MK	WOS:000499940200014	30092696	Bronze, Green Published			2022-02-06	
J	Schutz, A; Murek, M; Stieglitz, LH; Bernasconi, C; Vulcu, S; Beck, J; Raabe, A; Schucht, P				Schutz, Alessa; Murek, Michael; Stieglitz, Lennart Henning; Bernasconi, Corrado; Vulcu, Sonja; Beck, Jurgen; Raabe, Andreas; Schucht, Philippe			ACE-inhibitors: a preventive measure for bone flap resorption after autologous cranioplasty?	JOURNAL OF NEUROSURGERY			English	Article						bone flap resorption; aseptic osteolysis; craniectomy; autologous cranioplasty; ACE-inhibitors; bone preservation; surgical technique	TRAUMATIC BRAIN-INJURY; CONVERTING ENZYME-INHIBITOR; RISK-FACTORS; DECOMPRESSIVE CRANIECTOMY; HEMORRHAGIC STROKE; COMPLICATION RATE; BETA-BLOCKERS; OSTEOPOROSIS; REIMPLANTATION; WOMEN	OBJECTIVE Decompressive craniectomy (DC) is an established treatment for refractory intracranial hypertension. It is usually followed by autologous cranioplasty (AC), the reinsertion of a patient's explanted bone flap. A frequent long-term complication of AC is bone flap resorption (BFR), which results in disfigurement as well as loss of the protective covering of the brain. This study investigates risk factors for BFR after AC, including medical conditions and antihypertensive drug therapies, with a focus on angiotensin-converting enzyme inhibitors (ACEIs), which have been associated with a beneficial effect on bone healing and bone preservation in orthopedic, osteoporosis, and endocrinology research. METHODS In this single-center, retrospective study 183 consecutive cases were evaluated for bone flap resorption after AC. Information on patient demographics, medical conditions, antihypertensive therapy, and BFR-defined as an indication for revision surgery established by a neurosurgeon based on clinical or radiographic assessments-was collected. A Kaplan-Meier analysis of time from AC to diagnosis of BFR was performed, and factors associated with BFR were investigated using the log-rank test and Cox regression. RESULTS A total of 158 patients were considered eligible for inclusion in the data analysis. The median follow-up time for this group was 2.2 years (95% CI 1.9-2.5 years). BFR occurred in 47 patients (29.7%), with a median time to event of 3.7 years (95% CI 3.3-4.1 years). An ACEI prescription was recorded in 57 cases (36.1%). Univariate Kaplan-Meier analysis and the log-rank test revealed that ACEI therapy (2-year event free probability [EFP] 83.8% +/- 6.1% standard error vs 63.9% +/- 5.6%, p = 0.02) and ventriculoperitoneal (VP) shunt treatment (2-year EFP 86.9% +/- 7.1% vs 66% +/- 5.0%, p = 0.024) were associated with a lower probability of BFR. Multiple Cox regression analysis showed ACEI therapy (HR 0.29, p = 0.012), VP shunt treatment (HR 0.278, p = 0.009), and male sex (HR 0.500, p = 0.040) to be associated with a lower risk for BFR, whereas bone fragmentation (HR 1.92, p = 0.031) was associated with a higher risk for BFR. CONCLUSIONS Hypertensive patients treated with ACEIs demonstrate a lower rate of BFR than patients treated with other hypertensive medications and nonhypertensive patients. Our results are in line with previous reports on the positive influence of ACEIs on bone healing and preservation. Further analysis of the association between ACEI treatment and BFR development is needed and will be evaluated in a multicenter prospective trial.	[Schutz, Alessa; Murek, Michael; Vulcu, Sonja; Beck, Jurgen; Raabe, Andreas; Schucht, Philippe] Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurosurg, Bern, Switzerland; [Bernasconi, Corrado] Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland; [Stieglitz, Lennart Henning] Zurich Univ Hosp, Dept Neurosurg, Zurich, Switzerland		Schutz, A (corresponding author), Bern Univ Hosp, Bern, Switzerland.	alessa.schuetz@insel.ch	Stieglitz, Lennart Henning/AAM-2506-2020	Stieglitz, Lennart Henning/0000-0002-3744-5105; Bernasconi, Corrado/0000-0002-1019-5468			Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Cappuccio FP, 1999, LANCET, V354, P971, DOI 10.1016/S0140-6736(99)01437-3; Dontas I. A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P268; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Ewald C, 2014, NEUROCRIT CARE, V20, P91, DOI 10.1007/s12028-013-9892-4; Feroze AH, 2015, J NEUROSURG, V123, P1098, DOI 10.3171/2014.11.JNS14622; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Gebru Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/932691; GRANT FD, 1992, J CLIN ENDOCR METAB, V75, P988, DOI 10.1210/jc.75.4.988; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Honeybul S, 2016, BRIT J NEUROSURG, V30, P523, DOI 10.1080/02688697.2016.1187259; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lykissas M, 2017, WORLD J ORTHOP, V8, P531, DOI 10.5312/wjo.v8.i7.531; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Mracek J, 2015, ACTA NEUROCHIR, V157, P501, DOI 10.1007/s00701-014-2333-0; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb; Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359, DOI 10.2106/00004623-200407000-00002; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schlienger RG, 2004, JAMA-J AM MED ASSOC, V292, P1326, DOI 10.1001/jama.292.11.1326; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Shimizu H, 2009, HYPERTENS RES, V32, P786, DOI 10.1038/hr.2009.99; Stieglitz LH, 2015, ACTA NEUROCHIR, V157, P1001, DOI 10.1007/s00701-015-2414-8; Stieglitz LH, 2015, ACTA NEUROCHIR, V157, P275, DOI 10.1007/s00701-014-2310-7; Wiens M, 2006, J INTERN MED, V260, P350, DOI 10.1111/j.1365-2796.2006.01695.x; Yamamoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122691; Zhao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033228	39	9	9	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2019	131	5					1607	1614		10.3171/2018.6.JNS172605			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2EE	WOS:000493973300032	30497161	Bronze, Green Accepted			2022-02-06	
J	Tang, OY; Yoon, JS; Kimata, AR; Lawton, MT				Tang, Oliver Y.; Yoon, James S.; Kimata, Anna R.; Lawton, Michael T.			Volume-outcome relationship in pediatric neurotrauma care: analysis of two national databases	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; pediatric trauma; health policy; volume-outcome relationship; National Inpatient Sample; National Trauma Data Bank	TRAUMATIC BRAIN-INJURY; UNITED-STATES; HOSPITAL VOLUME; SUBARACHNOID HEMORRHAGE; CENTERS; SURGEON; REGIONALIZATION; CENTRALIZATION; DESIGNATION; CHILDREN	OBJECTIVE Previous research has demonstrated the association between increased hospital volume and improved outcomes for a wide range of neurosurgical conditions, including adult neurotrauma. The authors aimed to determine if such a relationship was also present in the care of pediatric neurotrauma patients. METHODS The authors identified 106,146 pediatric admissions for traumatic intracranial hemorrhage (tICH) in the National Inpatient Sample (NIS) for the period 2002-2014 and 34,017 admissions in the National Trauma Data Bank (NTDB) for 2012-2015. Hospitals were stratified as high volume (top 20%) or low volume (bottom 80%) according to their pediatric tICH volume. Then the association between high-volume status and favorable discharge disposition, inpatient mortality, complications, and length of stay (LOS) was assessed. Multivariate regression modeling was used to control for patient demographics, severity metrics, hospital characteristics, and performance of neurosurgical procedures. RESULTS In each database, high-volume hospitals treated over 60% of pediatric tICH admissions. In the NIS, patients at high-volume hospitals presented with worse severity metrics and more frequently underwent neurosurgical intervention over medical management (all p < 0.001). After multivariate adjustment, admission to a high-volume hospital was associated with increased odds of a favorable discharge (home or short-term facility) in both databases (both p < 0.001). However, there were no significant differences in inpatient mortality (p = 0.208). Moreover, high-volume hospital patients had lower total complications in the NIS and lower respiratory complications in both databases (all p < 0.001). Although patients at high-volume hospitals in the NTDB had longer hospital stays (beta-coefficient = 1.17, p < 0.001), they had shorter stays in the intensive care unit (beta-coefficient = 0.96, p = 0.024). To determine if these findings were attributable to the trauma center level rather than case volume, an analysis was conducted with only level I pediatric trauma centers (PTCs) in the NTDB. Similarly, treatment at a high-volume level I PTC was associated with increased odds of a favorable discharge (OR 1.28, p = 0.009), lower odds of pneumonia (OR 0.60, p = 0.007), and a shorter total LOS (beta-coefficient = 0.92, p = 0.024). CONCLUSIONS Pediatric tICH patients admitted to high-volume hospitals exhibited better outcomes, particularly in terms of discharge disposition and complications, in two independent national databases. This trend persisted when examining level I PTCs exclusively, suggesting that volume alone may have an impact on pediatric neurotrauma outcomes. These findings highlight the potential merits of centralizing neurosurgery and pursuing regionalization policies, such as interfacility transport networks and destination protocols, to optimize the care of children affected by traumatic brain injury.	[Tang, Oliver Y.; Kimata, Anna R.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Yoon, James S.] Yale Sch Med, New Haven, CT USA; [Lawton, Michael T.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol Surg, Phoenix, AZ USA		Lawton, MT (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA.	michael.lawton@barrowbrainandspine.com		Kimata, Anna/0000-0002-9983-7382			Alali AS, 2017, NEUROSURGERY, V80, P534, DOI 10.1093/neuros/nyw098; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bardach NS, 2004, CIRCULATION, V109, P2207, DOI 10.1161/01.CIR.0000126433.12527.E6; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; Bell TM, 2015, J SURG RES, V196, P350, DOI 10.1016/j.jss.2015.02.009; Bennett KM, 2011, J SURG RES, V167, P19, DOI 10.1016/j.jss.2010.05.020; Birkmeyer J D, 1999, Eff Clin Pract, V2, P277; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Clement RC, 2013, J NEUROSURG, V118, P687, DOI 10.3171/2012.10.JNS12682; Davies JM, 2017, J NEUROSURG, V127, P69, DOI 10.3171/2016.7.JNS15925; Davies JM, 2015, NEUROSURG CLIN N AM, V26, P207, DOI 10.1016/j.nec.2014.11.015; DeBehnke, 2019, RURAL HOSP SUSTAINAB; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Eskandar EN, 2003, J NEUROSURG, V99, P863, DOI 10.3171/jns.2003.99.5.0863; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goble S, 2009, J TRAUMA, V67, P637, DOI 10.1097/TA.0b013e3181b84294; Gologorsky Y, 2014, J NEUROSURG-SPINE, V21, P984, DOI 10.3171/2014.8.SPINE131113; Healthcare Cost Utilization Project, 2018, OV NAT NAT INP SAMPL; Hunter A, 2014, HEALTH CARE MANAG, V33, P128, DOI 10.1097/HCM.0000000000000006; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; Kirschen MP, 2019, JAMA PEDIATR, V173, P469, DOI 10.1001/jamapediatrics.2019.0249; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lorch SA, 2010, PEDIATRICS, V126, P1182, DOI 10.1542/peds.2010-1119; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mahesh B, 2012, ANN THORAC SURG, V94, P109, DOI 10.1016/j.athoracsur.2012.02.010; McAteer JP, 2013, JAMA PEDIATR, V167, P468, DOI 10.1001/jamapediatrics.2013.25; Moore L, 2012, CRIT CARE, V16, DOI 10.1186/cc11680; MULLINS RJ, 1999, J TRAUMA, V47, pS5; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nouraei SAR, 2015, ANN SURG, V261, P1096, DOI 10.1097/SLA.0000000000000851; Nuno M, 2012, ACTA NEUROCHIR, V154, P1343, DOI 10.1007/s00701-012-1358-5; Oyetunji TA, 2011, AM J SURG, V201, P445, DOI 10.1016/j.amjsurg.2010.10.006; Sakai-Bizmark R, 2019, HEALTH SERV RES, V54, P890, DOI 10.1111/1475-6773.13137; Schwartz TH, 2013, WORLD NEUROSURG, V80, P270, DOI 10.1016/j.wneu.2012.11.019; Sewalt CA, 2018, J TRAUMA ACUTE CARE, V85, P810, DOI 10.1097/TA.0000000000002043; Shen YC, 2009, MED CARE, V47, P968, DOI 10.1097/MLR.0b013e31819c9415; Smith ER, 2004, NEUROSURGERY, V54, P553, DOI 10.1227/01.NEU.0000108421.69822.67; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090	40	9	9	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E9	10.3171/2019.8.FOCUS19486			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900009	31675719	gold			2022-02-06	
J	Wade, SL; Cassedy, AE; McNally, KA; Kurowski, BG; Kirkwood, MW; Stancin, T; Taylor, HG				Wade, Shari L.; Cassedy, Amy E.; McNally, Kelly A.; Kurowski, Brad G.; Kirkwood, Michael W.; Stancin, Terry; Taylor, H. Gerry			A Randomized Comparative Effectiveness Trial of Family-Problem-Solving Treatment for Adolescent Brain Injury: Parent Outcomes From the Coping with Head Injury through Problem Solving (CHIPS) Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescents; family therapy; parental distress; randomized trial; traumatic brain injury	BEHAVIORAL OUTCOMES; COMPLICATED MILD; SELF-REGULATION; INTERVENTION; CHILD; TERM; EFFICACY; THERAPY	Objective: To examine changes in depression and distress in parents of adolescents receiving family-problem-solving therapy (F-PST) following traumatic brain injury. Method: Families of adolescents hospitalized for moderate to severe traumatic brain injury were randomized to face-to-face F-PST (34), therapist-guided online F-PST (56), or self-guided online F-PST (60). Outcomes were assessed pretreatment and 6 and 9 months later. Parents rated depression and distress on the Center for Epidemiological Studies Depression Scale and the Brief Symptom Inventory, respectively. Mixed modeling was used to examine changes over time and treatment moderators. Results: The therapist-guided online group had significant reductions in parental depression over time. Analyses of slopes of recovery revealed differential improvement on the Center for Epidemiological Studies Depression Scale between the 2 online groups, with no significant change in depressive symptoms following self-guided F-PST. On the Brief Symptom Inventory Global Severity Index, the therapist-guided online group reported significant improvement from baseline to 6 months that was maintained at 9 months. The face-to-face and self-guided online groups reported significant reductions in distress between 6 and 9 months with corresponding large effect sizes. Differences on the Center for Epidemiological Studies Depression Scale between therapist-guided and self-guided online groups at the 9-month follow-up were more pronounced in families of lower socioeconomic status, t(103) = -2.87; P = .005. Conclusions: Findings provide further support for the utility of therapist-guided online F-PST in reducing parental depression and distress following pediatric traumatic brain injury and offer limited evidence of the efficacy of self-guided online treatment for these outcomes. Families of lower socioeconomic status may benefit more from therapist involvement.	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, MLC 4009,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Wade, Shari L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Cassedy, Amy E.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [McNally, Kelly A.] Ohio State Univ, Div Psychiat & Behav Hlth, Columbus, OH 43210 USA; [McNally, Kelly A.] Ohio State Univ, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Rehabil Med, Cincinnati, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Rehabil Psychol Neuropsychol, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, MetroHealth Med Ctr, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp Res Inst, Ctr Biobehav Hlth, Columbus, OH 43210 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Div Dev Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Univ Hosp, Cleveland Med Ctr, Cleveland, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, MLC 4009,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Shari.Wade@cchmc.org		McNally, Kelly/0000-0001-9278-9413	Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [PCORI-CER-130602435]	Research reported in this work/publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCORI-CER-130602435). The views in this work/publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors, or Methodology Committee.	Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Carey JC, 2008, CYBERPSYCHOL BEHAV, V11, P188, DOI 10.1089/cpb.2007.0025; D'Zurilla T.J., 2007, PROBLEM SOLVING THER, V3rd ed.; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; Huebner ARS, 2018, PM&R, V10, P462, DOI 10.1016/j.pmrj.2017.10.004; Kurowski BG, 2018, CONT CLIN TRIAL COMM, V10, P111, DOI 10.1016/j.conctc.2018.04.001; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2019, J PEDIATR PSYCHOL, V44, P388, DOI 10.1093/jpepsy/jsy087; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, PEDIATRICS; Wade SL, 2018, COGNITIVE REHABILITA, P100; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	33	9	9	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					E1	E9		10.1097/HTR.0000000000000487			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200001	31033747	Bronze			2022-02-06	
J	Yuan, JW; Zhang, JH; Cao, J; Wang, GX; Bai, HS				Yuan, Jianwei; Zhang, Jinghua; Cao, Juan; Wang, Guangxing; Bai, Hansheng			Geniposide Alleviates Traumatic Brain Injury in Rats Via Anti-Inflammatory Effect and MAPK/NF-kB Inhibition	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Mitogen-activated protein kinase (MAPK); NF-kappaB (NF-kappa B); Traumatic brain injury (TBI); Geniposide	RECEPTOR; NEUROPROTECTION; PROGESTERONE; INFLAMMATION; ACTIVATION; CYTOKINES; MODEL	We aimed to investigate whether geniposide, a main component extracted from Gardenia jasminoides Ellis fruit, could exert neuroprotective functions against traumatic brain injury (TBI). Enzyme-linked immunosorbent assay (ELISA) was used for detection of plasma cytokines. Real-time polymerase chain reaction (RT-PCR) was employed for measurements of mRNA levels of cytokines. Neurological outcomes were evaluated by modified neurological severity score (mNSS) and Rota-Rod. Blood-brain barrier (BBB) integrity and brain edema were assessed. Protein expression was tested by Western blot. The plasma levels of interleukin (IL)-1 beta, IL-6, IL-8 and IL-10 were all elevated in patients with TBI compared to those of healthy controls. TBI rats treated with geniposide showed lower mNSS and longer fall latency time than untreated TBI rats. BBB integrity was maintained and brain edema was reduced by geniposide treatment in TBI rats. Plasma levels of IL-1 beta, IL-6 and IL-8 were significantly repressed by geniposide treatment in TBI rats, whereas IL-10 level was upregulated. mRNA expression levels of these cytokines in the brain tissues of TBI rats exhibited the same trends of changes. By testing p38 mitogen-activated protein kinase and NF-kappa B p65 activities, it was observed that phosphorylated (p)-p38 and p-p65 were dramatically inhibited by geniposide. In conclusion, geniposide exerts neuroprotective functions against TBI by inhibiting p-p38 and p-p65.	[Yuan, Jianwei; Wang, Guangxing; Bai, Hansheng] Heze Municipal Hosp Shandong Prov, 2888 Caozhou Rd, Heze 274000, Shandong, Peoples R China; [Zhang, Jinghua; Cao, Juan] Heze Med Coll, 1950 Univ Rd, Heze 274000, Shandong, Peoples R China		Bai, HS (corresponding author), Heze Municipal Hosp Shandong Prov, 2888 Caozhou Rd, Heze 274000, Shandong, Peoples R China.	2606057233@qq.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Chen YM, 2015, EUR J PHARMACOL, V768, P21, DOI 10.1016/j.ejphar.2015.09.029; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Li CX, 2019, EUR J PHARMACOL, V854, P224, DOI 10.1016/j.ejphar.2019.04.021; Li FH, 2016, J ETHNOPHARMACOL, V185, P77, DOI 10.1016/j.jep.2016.03.025; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lu W, 2018, CLIN EXP DERMATOL, V43, P667, DOI 10.1111/ced.13409; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Norden DM, 2016, NEUROBIOL AGING, V44, P22, DOI 10.1016/j.neurobiolaging.2016.04.014; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiong LL, 2016, INT IMMUNOPHARMACOL, V38, P54, DOI 10.1016/j.intimp.2016.03.036; Xu B, 2017, ACTA PHARMACOL SIN, V38, P688, DOI 10.1038/aps.2016.168; Zhao CH, 2017, NEUROPHARMACOLOGY, V116, P18, DOI 10.1016/j.neuropharm.2016.12.002; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	37	9	12	1	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2020	40	4					511	520		10.1007/s10571-019-00749-6		NOV 2019	10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	KY6DI	WOS:000493647200001	31677006				2022-02-06	
J	Liu, XY; Wei, MG; Liang, J; Xu, HH; Wang, JJ; Wang, J; Yang, XP; Lv, FF; Wang, KQ; Duan, JH; Tu, Y; Zhang, S; Chen, C; Li, XH				Liu, Xiao-Yin; Wei, Meng-Guang; Liang, Jun; Xu, Hai-Huan; Wang, Jing-Jing; Wang, Jing; Yang, Xi-Ping; Lv, Fang-Fang; Wang, Ke-Qiang; Duan, Jing-Hao; Tu, Yue; Zhang, Sai; Chen, Chong; Li, Xiao-Hong			Injury-preconditioning secretome of umbilical cord mesenchymal stem cells amplified the neurogenesis and cognitive recovery after severe traumatic brain injury in rats	JOURNAL OF NEUROCHEMISTRY			English	Article						brain extract; neurogenesis; preconditioning; secretome; traumatic brain injury	LONG-TERM SURVIVAL; ADULT NEUROGENESIS; DENTATE GYRUS; MILD HYPOTHERMIA; HIPPOCAMPUS; PROLIFERATION; NEURONS; EXPRESSION; IMPACT; DEATH	Traumatic brain injury (TBI) is a dominant cause of death and permanent disability worldwide. Although TBI could significantly increase the proliferation of adult neural stem cells in the hippocampus, the survival and maturation of newborn cells is markedly low. Increasing evidence suggests that the secretome derived from mesenchymal stem cells (MSCs) would be an ideal alternative to MSC transplantation. The successive and microenvironmentally responsive secretion in MSCs may be critical for the functional benefits provided by transplanted MSCs after TBI. Therefore, it is reasonable to hypothesize that the signaling molecules secreted in response to local tissue damage can further facilitate the therapeutic effect of the MSC secretome. To simulate the complex microenvironment in the injured brain well, we used traumatically injured brain tissue extracts to pretreat umbilical cord mesenchymal stem cells (UCMSCs) in vitro and stereotaxically injected the secretome from traumatic injury-preconditioned UCMSCs into the dentate gyrus of the hippocampus in a rat severe TBI model. The results revealed that compared with the normal secretome, the traumatic injury-preconditioned secretome could significantly further promote the differentiation, migration, and maturation of newborn cells in the dentate gyrus and ultimately improve cognitive function after TBI. Cytokine antibody array suggested that the increased benefits of secretome administration were attributable to the newly produced proteins and up-regulated molecules from the MSC secretome preconditioned by a traumatically injured microenvironment. Our study utilized the traumatic injury-preconditioned secretome to amplify neurogenesis and improve cognitive recovery, suggesting this method may be a novel and safer candidate for nerve repair. Open science badges This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at .	[Liu, Xiao-Yin; Liang, Jun; Xu, Hai-Huan; Wang, Ke-Qiang; Duan, Jing-Hao; Chen, Chong; Li, Xiao-Hong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin, Peoples R China; [Liu, Xiao-Yin; Wei, Meng-Guang; Xu, Hai-Huan; Wang, Jing-Jing; Wang, Jing; Yang, Xi-Ping; Lv, Fang-Fang; Tu, Yue; Zhang, Sai; Chen, Chong; Li, Xiao-Hong] Pingjin Hosp, Characterist Med Ctr Peoples Armed Police Forces, Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Liu, Xiao-Yin] Tianjin Med Univ, Tianjin, Peoples R China		Chen, C; Li, XH (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin, Peoples R China.	chongchen12@hotmail.com; lixiaohong12@hotmail.com		Liu, Xiao-yin/0000-0001-9409-4201	National Nature Scientific Fund of China [81771352, 81772018, 81671222, 81771350]; Nature Scientific Fund of Tianjin [18JCJQJC48500, 15ZXLCSY00040-7, 16ZXHLSY00120]	This work was supported by the National Nature Scientific Fund of China (81771352, 81772018, 81671222, 81771350) and the Nature Scientific Fund of Tianjin (18JCJQJC48500, 15ZXLCSY00040-7, 16ZXHLSY00120). There are no actual or potential conflicts of interest.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Dong HJ, 2018, NEUROSCIENCE, V377, P1, DOI 10.1016/j.neuroscience.2018.02.013; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Dumitru I, 2017, NEURON, V94, P125, DOI 10.1016/j.neuron.2017.03.003; Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Font-Belmonte E, 2019, J NEUROCHEM, V151, P777, DOI 10.1111/jnc.14789; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Kim DH, 2015, STEM CELLS DEV, V24, P2378, DOI 10.1089/scd.2014.0487; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33038; Li XH, 2013, MOL NEUROBIOL, V48, P490, DOI 10.1007/s12035-013-8437-3; Li XH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8460145; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Peredeny JV, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00017; Pilz GA, 2018, SCIENCE, V359, P658, DOI 10.1126/science.aao5056; Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Saraswati S, 2015, STEM CELLS, V33, P1333, DOI 10.1002/stem.1935; Sart S, 2014, TISSUE ENG PT A, V20, P2666, DOI [10.1089/ten.TEA.2013.0437, 10.1089/ten.tea.2013.0437]; Shinozaki Y, 2019, J NEUROCHEM, V151, P64, DOI 10.1111/jnc.14817; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Stastna M, 2012, CIRC-CARDIOVASC GENE, V5, pO8, DOI 10.1161/CIRCGENETICS.111.960187; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Sung HY, 2019, J NEUROCHEM, V150, P691, DOI 10.1111/jnc.14788; Tang JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13724; Teixeira FG, 2017, STEM CELL TRANSL MED, V6, P634, DOI 10.5966/sctm.2016-0071; Teixeira FG, 2015, STEM CELL REV REP, V11, P288, DOI 10.1007/s12015-014-9576-2; Tran C, 2015, ADV DRUG DELIVER REV, V82-83, P1, DOI 10.1016/j.addr.2014.10.007; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhao ML, 2018, J ALZHEIMERS DIS, V63, P303, DOI 10.3233/JAD-180002; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	63	9	10	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2020	153	2					230	251		10.1111/jnc.14859		OCT 2019	22	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LF1UD	WOS:000492392800001	31465551	Bronze			2022-02-06	
J	Miah, IP; Herklots, M; Roks, G; Peul, WC; Walchenbach, R; Dammers, R; Lingsma, HF; den Hertog, HM; Jellema, K; Van der Gaag, NA				Miah, Ishita P.; Herklots, Martin; Roks, Gerwin; Peul, Wilco C.; Walchenbach, Robert; Dammers, Ruben; Lingsma, Hester F.; den Hertog, Heleen M.; Jellema, Korne; Van der Gaag, Niels A.		Dutch Chronic Subdural Hematoma Re	Dexamethasone Therapy in Symptomatic Chronic Subdural Hematoma (DECSA-R): A Retrospective Evaluation of Initial Corticosteroid Therapy versus Primary Surgery	JOURNAL OF NEUROTRAUMA			English	Article						burr hole craniostomy; chronic subdural hematoma; corticosteroid therapy; CSDH; dexamethasone	NONSURGICAL TREATMENT; MANAGEMENT	Worldwide, different strategies are being applied for symptomatic chronic subdural hematoma (CSDH). The aim of this study was to evaluate the efficacy of two treatment strategies for symptomatic CSDH: initial dexamethasone (DXM) therapy versus primary surgery by burr hole craniostomy (BHC). We retrospectively collected data for 120 symptomatic CSDH patients in two neurotrauma centers between 2014 and 2016, each with their own treatment protocol. Sixty patients received primary BHC (center A), and another 60 initial DXM therapy (center B). Primary outcome was evaluated by dichotomized modified Rankin Scale (mRS) score (0-3 and 4-6) and Markwalder Grading Scale (MGS) score at 3 months. Secondary outcomes were additional interventions, CSDH recurrence, mortality, complications, and duration of hospital stay. Baseline characteristics were similar in both groups. At 3 months, a favorable mRS score (0-3) was observed in 70% and 76% of patients in cohort A and B, respectively (odds ratio [OR] 0.77, 95% CI 0.30-1.98; p = 0.59). A favorable MGS score (0-1) was observed in 96% of patients in both groups (OR 0.98, 95% CI 0.45-2.15; p = 0.95). CSDH recurrence was 12% in cohort A and 22% in cohort B (p = 0.15). Mortality was 10% in both cohorts. In cohort B, additional surgery was performed in 83% at a median of 6 days, and significantly more patients had complications (55% vs. 35%, p = 0.02), a prolonged hospitalization (10 vs. 5 days; p = 0.02), and one or more follow-up cranial CT's (85% vs. 48%; p < 0.001). To achieve a favorable clinical outcome, initial DXM therapy was associated with a high rate of crossover to surgery, significantly longer overall hospital stay, and more complications compared with primary surgery.	[Miah, Ishita P.; Peul, Wilco C.; Walchenbach, Robert; Jellema, Korne; Van der Gaag, Niels A.] Haaglanden Med Ctr, Dept Neurol & Neurosurg, The Hague, Netherlands; [Herklots, Martin; Roks, Gerwin] ETZ, Dept Neurol, Tilburg, Netherlands; [Miah, Ishita P.; Peul, Wilco C.; Van der Gaag, Niels A.] Leiden Univ, Med Ctr, Dept Neurol & Neurosurg, Leiden, Netherlands; [Dammers, Ruben] EMC, Dept Neurosurg, Rotterdam, Netherlands; [Lingsma, Hester F.] EMC, Dept Publ Hlth & Med Decis Making, Rotterdam, Netherlands; [Peul, Wilco C.; den Hertog, Heleen M.] Isala Hosp Zwolle, Dept Neurol, Zwolle, Netherlands; [Van der Gaag, Niels A.] Haga Teaching Hosp, Dept Neurol & Neurosurg, The Hague, Netherlands		Miah, IP (corresponding author), Leiden Univ, Med Ctr, Dept Neurol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	i.p.miah@lumc.nl	Dammers, Ruben/AAL-8391-2021; Dammers, Ruben/AAD-9095-2021	Dammers, Ruben/0000-0001-7033-0644; Miah, Ishita/0000-0003-4676-7955			Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; BENDER MB, 1974, ARCH NEUROL-CHICAGO, V31, P73, DOI 10.1001/archneur.1974.00490380021001; Berhauser Pont LME, 2012, EUR J NEUROL, V19, P1397, DOI [10.1111/j.1468-1331.2012.03768.x, DOI 10.1111/J.1468-1331.2012.03768.X]; Chandu  D., 2015, 21 NAT C COMM NCC, P1, DOI DOI 10.1109/FUZZ-IEEE.2015.7337877; Delgado-Lopez PD, 2009, NEUROCIRUGIA, V20, P346; Dran G, 2007, NEUROCHIRURGIE, V53, P477, DOI 10.1016/j.neuchi.2007.09.146; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; EDELMAN JD, 1980, ANESTHESIOLOGY, V52, P166; Holl DC, 2018, WORLD NEUROSURG, V116, P402, DOI 10.1016/j.wneu.2018.05.037; Ivamoto HS, 2016, WORLD NEUROSURG, V86, P399, DOI 10.1016/j.wneu.2015.10.025; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Kostas F, 2019, INTERDISCIP NEUROSUR, V16, P70, DOI 10.1016/j.inat.2018.12.011; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Miah IP, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2945-4; PICHERT G, 1987, SCHWEIZ MED WSCHR, V117, P1856; Pont LMEB, 2012, NEUROSURGERY, V70, P873, DOI 10.1227/NEU.0b013e31823672ad; Qian ZR, 2017, BRIT J NEUROSURG, V31, P84, DOI 10.1080/02688697.2016.1260686; RANKIN J, 1957, Scott Med J, V2, P200; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Sun TFD, 2005, BRIT J NEUROSURG, V19, P327, DOI 10.1080/02688690500305332; Surve RM, 2017, J NEUROSURG ANESTH, V29, P274, DOI 10.1097/ANA.0000000000000305; Thotakura AK, 2015, WORLD NEUROSURG, V84, P1968, DOI 10.1016/j.wneu.2015.08.044; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937	25	9	9	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					366	372		10.1089/neu.2019.6541		OCT 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489735300001	31452450				2022-02-06	
J	Bower, MM; Sweidan, AJ; Xu, JC; Stern-Neze, S; Yu, WG; Groysman, LI				Bower, Matthew M.; Sweidan, Alexander J.; Xu, Jordan C.; Stern-Neze, Sara; Yu, Wengui; Groysman, Leonid I.			Quantitative Pupillometry in the Intensive Care Unit	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						pupillometry; out of hospital; cardiac arrest; reflex; pupillary; brain injuries; traumatic; intracranial pressure	OCULOMOTOR NERVE PALSY; AUTOMATED PUPILLOMETRY; INFRARED PUPILLOMETRY; TRANSCRANIAL DOPPLER; BRAIN HERNIATION; CARDIAC-ARREST; LIGHT REFLEX; PREDICTION; DILATION; DIAZEPAM	Quantitative pupillometry provides a noninvasive and objective assessment within the neurological examination. This review details the physiology of the pupillary light response, the clinical significance of changes in pupillary reactivity, and the variables that compose the Neurological Pupil index or NPi are discussed. This article reviews the most recent applications and advances in quantitative pupillometry for noninvasive intracranial pressure monitoring, postcardiac arrest prognostication, and subarachnoid hemorrhage. Also discussed are the limitations and confounders of quantitative pupillometry in the modern neurological intensive care unit.	[Bower, Matthew M.; Sweidan, Alexander J.; Xu, Jordan C.; Stern-Neze, Sara; Yu, Wengui; Groysman, Leonid I.] Univ Calif Irvine, Dept Neurol, Orange, CA 92868 USA		Bower, MM (corresponding author), Univ Calif Irvine, Dept Neurol, Orange, CA 92868 USA.	bowerm1@uci.edu		Bower, Matthew/0000-0002-2753-8201			ALIO J, 1989, ANN OPHTHALMOL, V21, P132; Anderson M, 2018, J NEUROSCI NURS, V50, P30, DOI 10.1097/JNN.0000000000000333; Andrefsky JC, 1999, J NEUROSURG, V90, P644, DOI 10.3171/jns.1999.90.4.0644; Aoun SG, 2020, J NEUROSURG, V132, P27, DOI 10.3171/2018.9.JNS181928; Behrends M, 2012, RESUSCITATION, V83, P1223, DOI 10.1016/j.resuscitation.2012.05.013; Blumenfeld H, 2010, NEUROANATOMY THROUGH CLINICAL CASES, SECOND EDITION, P1; Cera SM, 2003, AM SURGEON, V69, P140; Chang LYL, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00006; Chaudhry P, 2014, INDIAN J CRIT CARE M, V18, P176, DOI 10.4103/0972-5229.128710; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Couret D, 2019, NEUROCRIT CARE, V30, P492, DOI 10.1007/s12028-018-0664-z; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Emelifeonwu JA, 2018, BRAIN INJURY, V32, P675, DOI 10.1080/02699052.2018.1429021; Fotiou DF, 2009, INT J PSYCHOPHYSIOL, V73, P143, DOI 10.1016/j.ijpsycho.2009.01.011; Frost S, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7935406; FUJIWARA S, 1989, NEUROSURG REV, V12, P123; GOETTING MG, 1991, ANN EMERG MED, V20, P55, DOI 10.1016/S0196-0644(05)81119-9; Granholm EL, 2017, J ALZHEIMERS DIS, V56, P1419, DOI 10.3233/JAD-161078; GRATTANSMITH PJ, 1993, ARCH DIS CHILD, V69, P151, DOI 10.1136/adc.69.1.151; Gray AT, 1997, ARCH NEUROL-CHICAGO, V54, P579, DOI 10.1001/archneur.1997.00550170055014; Haddock JH, 2017, OCHSNER J, V17, P250; Harthan JS., 2013, J OPTOM, V6, P60; Heimburger D, 2016, RESUSCITATION, V103, P88, DOI 10.1016/j.resuscitation.2016.02.026; Hou RH, 2007, PSYCHOPHARMACOLOGY, V195, P41, DOI 10.1007/s00213-007-0884-y; Hou RHH, 2006, BRIT J CLIN PHARMACO, V61, P752, DOI 10.1111/j.1365-2125.2006.02632.x; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Kassis SZ, 2010, WORLD NEUROSURG, V73, P11, DOI 10.1016/j.surneu.2009.03.042; Khan Z, 2018, HORNER SYNDROME; Kim HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208259; Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428; Kurokawa Y, 2005, NEUROL MED-CHIR, V45, P143, DOI 10.2176/nmc.45.143; Larson MD, 1997, ANESTHESIOLOGY, V87, P849, DOI 10.1097/00000542-199710000-00019; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Larson MD, 2003, ANESTH ANALG, V97, P1652, DOI 10.1213/01.ANE.0000090011.19809.93; Larson MD, 2008, CLIN NEUROPHYSIOL, V119, P1358, DOI 10.1016/j.clinph.2008.01.106; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; LONGSTRETH WT, 1983, NEW ENGL J MED, V308, P1378, DOI 10.1056/NEJM198306093082302; Manley GT, 2002, J NEUROSURG ANESTH, V14, P223, DOI 10.1097/00008506-200207000-00009; Martinez-Ricarte F, 2013, NEUROLOGIA, V28, P41, DOI 10.1016/j.nrl.2010.07.028; McAnany JJ, 2018, OPTOMETRY VISION SCI, V95, P953, DOI 10.1097/OPX.0000000000001289; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Mullaguri N, 2017, CUREUS, V9, DOI 10.7759/cureus.2004; Newman N, 2008, WALSH HOYTS CLIN NEU; Oddo M, 2018, INTENS CARE MED, V44, P2102, DOI 10.1007/s00134-018-5448-6; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Olson DM, 2016, CRIT CARE NURS CLIN, V28, P101, DOI 10.1016/j.cnc.2015.09.003; Ong C, 2019, NEUROCRIT CARE, V30, P307, DOI 10.1007/s12028-018-0620-y; Ong C, 2019, NEUROCRIT CARE, V30, P316, DOI 10.1007/s12028-018-0607-8; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; PICKWORTH WB, 1989, METHOD FIND EXP CLIN, V11, P759; Pretorius JL, 2001, BRIT J CLIN PHARMACO, V52, P322, DOI 10.1046/j.0306-5251.2001.01448.x; Radovanovic D, 2000, HUM EXP TOXICOL, V19, P489, DOI 10.1191/096032700671040438; Riker RR, 2020, NEUROCRIT CARE, V32, P152, DOI 10.1007/s12028-019-00717-4; Rollins MD, 2014, ANESTHESIOLOGY, V121, P1037, DOI 10.1097/ALN.0000000000000384; Shoyombo I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25477-7; Solari D, 2017, ANN NEUROL, V81, P804, DOI 10.1002/ana.24943; Suys T, 2014, NEUROCRIT CARE, V21, P300, DOI 10.1007/s12028-014-9981-z; Tamura T, 2018, RESUSCITATION, V131, P108, DOI 10.1016/j.resuscitation.2018.06.027; Taxini CL, 2017, NEUROSCIENCE, V354, P146, DOI 10.1016/j.neuroscience.2017.04.033; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; THOMPSON HS, 1991, EYE, V5, P36, DOI 10.1038/eye.1991.7; Yanaka K, 2003, NEUROSURGERY, V52, P553, DOI 10.1227/01.NEU.0000047816.02757.39	63	9	9	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	APR	2021	36	4					383	391	0885066619881124	10.1177/0885066619881124		OCT 2019	9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QU0TG	WOS:000490107600001	31601157	Green Submitted			2022-02-06	
J	Brant, JA; Johnson, B; Brou, L; Comstock, RD; Vu, T				Brant, Julia Aogaichi; Johnson, Bernadette; Brou, Lina; Comstock, R. Dawn; Vu, Tien			Rates and Patterns of Lower Extremity Sports Injuries in All Gender-Comparable US High School Sports	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						injury prevention; pediatric sports medicine; general sports trauma; female athlete; gender comparable; lower-extremity injury	EMERGENCY-DEPARTMENT VISITS; KNEE INJURIES; ANKLE INJURIES; UNITED-STATES; EPIDEMIOLOGY; CONCUSSION; COLLEGIATE; CHILDREN; GIRLS; BOYS	Background: High school athletes with lower extremity sports injuries (LESIs) frequently present to the emergency department in the United States. Previous epidemiological studies have presented rates and mechanisms of LESIs in these athletes. No studies, however, have looked at LESIs in gender-comparable sports in an attempt to evaluate what differences exist between LESIs in boys and girls. Purpose: To describe the epidemiology of LESIs among US high school athletes using a large national database of athletes in sports that could be considered gender comparable, given the rules of play and protective equipment. Study Design: Descriptive epidemiology study. Methods: Descriptive data from 2005 to 2016 were collected using the internet-based High School Reporting Information Online (High School RIO), a national high school sports injury surveillance system, for athletes participating in 8 gender-comparable sports (soccer, volleyball, basketball, baseball/softball, swimming and diving, track and field, cross-country, and tennis). Rates and patterns of injury were evaluated, with injury rates calculated as ratio of injuries per 10,000 athlete-exposures. Rate ratios (RRs) were calculated to compare the LESI rates in girls and boys. Results: In both genders, LESI rates (per 10,000 athlete-exposures) were highest in soccer (girls, 15.87; boys, 11.68) followed by basketball (girls, 11.51; boys, 9.35), and were lowest in swimming and diving (girls, 0.70; boys, 0.39). Although injury rates were significantly higher in girls compared with boys in all sports, only in tennis was the RR greater than 2 (RR, 2.03; 95% CI, 1.17-3.54). Girls had a greater proportion of severe LESIs and injuries that received radiographic evaluation, such as magnetic resonance imaging, compared with boys for all sports except volleyball. Consistency in the mechanism of injury was demonstrated between genders within each sport. Conclusion: This study demonstrated that LESIs are common among high school athletes and disproportionately affect girls more than boys, especially when looking at severe injuries and resource utilization. Further studies are needed to elucidate the cause of these findings. We hope that the awareness of gender-based differences in LESIs will lead to improvements in targeted efforts to decrease injury rates and injury severity.	[Brant, Julia Aogaichi; Johnson, Bernadette; Brou, Lina; Comstock, R. Dawn; Vu, Tien] Childrens Hosp Colorado, Sect Emergency Med, Dept Pediat, 13123 E 16th Ave,B251, Aurora, CO 80045 USA; [Brant, Julia Aogaichi; Johnson, Bernadette; Brou, Lina; Vu, Tien] Univ Colorado, Sect Emergency Med, Dept Pediat, Aurora, CO USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Brant, JA (corresponding author), Childrens Hosp Colorado, Sect Emergency Med, Dept Pediat, 13123 E 16th Ave,B251, Aurora, CO 80045 USA.	julia.brant@childrenscolorado.org					Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Cheung EC, 2015, CURR SPORT MED REP, V14, P368, DOI 10.1249/JSR.0000000000000188; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Fulstone D, 2016, INT J SPORTS MED, V37, P1150, DOI 10.1055/s-0042-112590; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Lin CY, 2018, PM&R, V10, P1073, DOI 10.1016/j.pmrj.2018.03.008; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pyle RP, 2003, CLIN PEDIATR, V42, P697, DOI 10.1177/000992280304200805; Rechel JA, 2011, J TRAUMA, V71, P982, DOI 10.1097/TA.0b013e318230e716; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Salvaterra G, 2016, SPORTS MED ARTHROSC, V24, pE34, DOI 10.1097/JSA.0000000000000122; Shanmugam C, 2008, BRIT MED BULL, V86, P33, DOI 10.1093/bmb/ldn001; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Shifrer D, 2015, YOUTH SOC, V47, P295, DOI 10.1177/0044118X12461656; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; Smyth EA, 2019, J SCI MED SPORT, V22, P887, DOI 10.1016/j.jsams.2019.03.002; Swenson DM, 2013, CLIN J SPORT MED, V23, P190, DOI 10.1097/JSM.0b013e31827d21fe; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Tenan MS, 2016, J ATHL TRAINING, V51, P309, DOI 10.4085/1062-6050-51.4.12; Tonnessen E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129014; Vanderlei FM, 2014, BRAZ J PHYS THER, V18, P530, DOI 10.1590/bjpt-rbf.2014.0059; Weiss AJ, 2006, SPORTS RELATED EMERG; Wild CY, 2012, SPORTS MED, V42, P733, DOI 10.2165/11632800-000000000-00000	26	9	10	2	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2019	7	10							2325967119873059	10.1177/2325967119873059			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JK8GD	WOS:000495077100001	31620485	Green Published, gold			2022-02-06	
J	Houck, ZM; Asken, BM; Bauer, RM; Kontos, AP; McCrea, MA; McAllister, TW; Broglio, SP; Clugston, JR				Houck, Zac M.; Asken, Breton M.; Bauer, Russell M.; Kontos, Anthony P.; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.; Clugston, James R.		Care Consortium Investigators	Multivariate Base Rates of Low Scores and Reliable Decline on ImPACT in Healthy Collegiate Athletes Using CARE Consortium Norms	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Cognitive functioning; Baseline testing; CARE; Reliable change; Race; Concussion	NEUROPSYCHOLOGICAL ASSESSMENT; CONCUSSION; SPORTS; PERFORMANCE	Objectives: To describe multivariate base rates (MBRs) of low scores and reliable change (decline) scores on Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) in college athletes at baseline, as well as to assess MBR differences among demographic and medical history subpopulations. Methods: Data were reported on 15,909 participants (46.5% female) from the NCAA/DoD CARE Consortium. MBRs of ImPACT composite scores were derived using published CARE normative data and reliability metrics. MBRs of sex-corrected low scores were reported at <25th percentile (Low Average), <10th percentile (Borderline), and <= 2nd percentile (Impaired). MBRs of reliable decline scores were reported at the 75%, 90%, 95%, and 99% confidence intervals. We analyzed subgroups by sex, race, attention-deficit/hyperactivity disorder and/or learning disability (ADHD/LD), anxiety/depression, and concussion history using chi-square analyses. Results: Base rates of low scores and reliable decline scores on individual composites approximated the normative distribution. Athletes obtained >= 1 low score with frequencies of 63.4% (Low Average), 32.0% (Borderline), and 9.1% (Impaired). Athletes obtained >= 1 reliable decline score with frequencies of 66.8%, 32.2%, 18%, and 3.8%, respectively. Comparatively few athletes had low scores or reliable decline on >= 2 composite scores. Black/African American athletes and athletes with ADHD/LD had higher rates of low scores, while greater concussion history was associated with lower MBRs (p < .01). MBRs of reliable decline were not associated with demographic or medical factors. Conclusions: Clinical interpretation of low scores and reliable decline on ImPACT depends on the strictness of the low score cutoff, the reliable change criterion, and the number of scores exceeding these cutoffs. Race and ADHD influence the frequency of low scores at all cutoffs cross-sectionally.	[Houck, Zac M.; Asken, Breton M.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Asken, Breton M.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02903 USA; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15213 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53266 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Broglio, Steven P.] Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Dept Kinesiol, Ann Arbor, MI 48109 USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL 32610 USA		Houck, ZM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	zhouck@phhp.ufl.edu		Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; U.S. Army Medical Research Acquisition Activity, Chandler Street, Ford Detrick MD	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense (DHP funds).	[Anonymous], 2010, MOV DISORD S1, V25, pS104; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Heaton R. K., 2004, REVISED COMPREHENSIV; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Lovell M, 2000, IMPACT IMMEDIATE POS; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mormile MEE, 2018, J SPORT REHABIL, V27, P16, DOI 10.1123/jsr.2016-0140; Therezo RB, 2018, RES PHENOMENOL, V48, P1, DOI 10.1163/15691640-12341382; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145	21	9	9	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2019	25	9					961	971	PII S1355617719000729	10.1017/S1355617719000729			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	JB3VM	WOS:000488484800007	31272517				2022-02-06	
J	Li, JR; Abe, K; Milanesi, A; Liu, YY; Brent, GA				Li, Jianrong; Abe, Kiyomi; Milanesi, Anna; Liu, Yan-Yun; Brent, Gregory A.			Thyroid Hormone Protects Primary Cortical Neurons Exposed to Hypoxia by Reducing DNA Methylation and Apoptosis	ENDOCRINOLOGY			English	Article							ELEMENT-BINDING PROTEIN; 3,5-DIIODOTHYROPROPIONIC ACID; GENE-EXPRESSION; TRANSPORTER; ANALOG; RISK; CONNECTIVITY; ASSOCIATION; RECEPTORS; MECHANISM	Traumatic brain injury (TBI) is associated with disruption of cerebral blood flow leading to localized brain hypoxia. Thyroid hormone (TH) treatment, administered shortly after injury, has been shown to promote neural protection in rodent TBI models. The mechanism of TH protection, however, is not established. We used mouse primary cortical neurons to investigate the effectiveness and possible pathways of T3-promoted cell survival after exposure to hypoxic injury. Cultured primary cortical neurons were exposed to hypoxia (0.2% oxygen) for 7 hours with or without T3 (5 nM). T3 treatment enhanced DNA 5-hydroxymethylcytosine levels and attenuated the hypoxia-induced increase in DNA 5-methylcytosine (5-mc). In the presence of T3, mRNA expression of Tet family genes was increased and DNA methyltransferase (Dnmt) 3a and Dnmt3b were downregulated, compared with conditions in the absence of T3. These T3-induced changes decreased hypoxia induced DNA de novo methylation, which reduced hypoxia-induced neuronal damage and apoptosis. We used RNA sequencing to characterize T3-regulated genes in cortical neurons under hypoxic conditions and identified 22 genes that were upregulated and 15 genes that were downregulated. KrCippel-like factor 9 (KLF9), a multifunctional transcription factor that plays a key role in central nervous system development, was highly upregulated by T3 treatment in hypoxic conditions. Knockdown of the KLF9 gene resulted in early apoptosis and abolished the beneficial role of T3 in neuronal survival. KLF9 mediates, in part, the neuronal protective role of T3. T3 treatment reduces hypoxic damage, although pathways that reduce DNA methylation and apoptosis remain to be elucidated.	[Li, Jianrong; Abe, Kiyomi; Milanesi, Anna; Liu, Yan-Yun; Brent, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Endocrinol Div,Mol Endocrinol Lab,Dept Med, Los Angeles, CA 90073 USA; [Li, Jianrong; Abe, Kiyomi; Milanesi, Anna; Liu, Yan-Yun; Brent, Gregory A.] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Endocrinol Div,Mol Endocrinol Lab,Dept Physiol, Los Angeles, CA 90073 USA		Liu, YY; Brent, GA (corresponding author), VA Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	yyl@ucla.edu; gbrent@mednet.ucla.edu	Abe, Kiyomi/AAM-6036-2021	Liu, Yan-Yun/0000-0003-1946-2275; Brent, Gregory/0000-0002-4638-6645	USDepartment of Veterans Affairs Merit Review Grant [BX001966]	This work was supported by USDepartment of Veterans Affairs Merit Review Grant BX001966 (to G.A.B.).	ADAN RAH, 1992, J BIOL CHEM, V267, P3771; Avci HX, 2012, P NATL ACAD SCI USA, V109, P14206, DOI 10.1073/pnas.1119853109; Begin ME, 2008, CURR GERONTOL GERIAT, V2008, P1, DOI [10.1155/2008/474868, DOI 10.1155/2008/474868]; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chatonnet F, 2015, BBA-GENE REGUL MECH, V1849, P122, DOI 10.1016/j.bbagrm.2014.05.023; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Crupi R, 2013, PHARMACOL RES, V70, P80, DOI 10.1016/j.phrs.2012.12.009; de Jong FJ, 2009, NEUROBIOL AGING, V30, P600, DOI 10.1016/j.neurobiolaging.2007.07.019; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Dugas JC, 2012, MOL CELL NEUROSCI, V50, P45, DOI 10.1016/j.mcn.2012.03.007; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Gil-Ibanez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091692; Gil-Ibanez P, 2013, ENDOCRINOLOGY, V154, P1940, DOI 10.1210/en.2012-2189; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Halder R, 2016, NAT NEUROSCI, V19, P102, DOI 10.1038/nn.4194; Hartley I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077859; Hofmeijer J, 2014, BRAIN RES, V1557, P180, DOI 10.1016/j.brainres.2014.02.027; Horn S, 2013, ENDOCRINOLOGY, V154, P968, DOI 10.1210/en.2012-1628; Jo SR, 2012, J NEUROSCI, V32, P8491, DOI 10.1523/JNEUROSCI.6514-11.2012; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Knoedler JR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3640-7; Kroiss M, 2006, AM J PHYSIOL-RENAL, V291, pF1201, DOI 10.1152/ajprenal.00067.2006; le Feber J, 2017, J NEUROPHYSIOL, V118, P394, DOI 10.1152/jn.00098.2017; Li J, 2019, DRYAD, DOI [10.5061/dryad.7b980d8, DOI 10.5061/DRYAD.7B980D8]; Li JR, 2017, MOL CELL ENDOCRINOL, V452, P120, DOI 10.1016/j.mce.2017.05.023; Liu YY, 2018, PHARMACOL THERAPEUT, V186, P176, DOI 10.1016/j.pharmthera.2018.01.007; Martinez L, 2009, P NATL ACAD SCI USA, V106, P20717, DOI 10.1073/pnas.0911024106; Mayer S, 2014, J CLIN INVEST, V124, P1987, DOI 10.1172/JCI70324; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Mousa SA, 2006, ENDOCRINOLOGY, V147, P1602, DOI 10.1210/en.2005-1390; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; PENNOCK GD, 1992, J PHARMACOL EXP THER, V263, P163; Potter GB, 2002, MOL ENDOCRINOL, V16, P2547, DOI 10.1210/me.2002-0115; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sadana P, 2015, J NEUROL SCI, V354, P37, DOI 10.1016/j.jns.2015.04.042; Santiago M, 2014, GENOMICS, V104, P334, DOI 10.1016/j.ygeno.2014.08.018; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Sermeus A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047519; Shoemaker TJ, 2012, ENDOCR PRACT, V18, P954, DOI 10.4158/EP12086.RA; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Thompson CC, 1997, P NATL ACAD SCI USA, V94, P8527, DOI 10.1073/pnas.94.16.8527; van Osch LADM, 2004, NEUROLOGY, V62, P1967, DOI 10.1212/01.WNL.0000128134.84230.9F; Vernaleken A, 2007, J BIOL CHEM, V282, P28501, DOI 10.1074/jbc.M705416200; Veyhl-Wichmann M, 2016, MOL PHARMACOL, V89, P118, DOI 10.1124/mol.115.101162	53	9	9	0	5	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2019	160	10					2243	2256		10.1210/en.2019-00125			14	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	KB9QY	WOS:000506823500004	31095291	Bronze			2022-02-06	
J	Li, LM; Violante, IR; Zimmerman, K; Leech, R; Hampshire, A; Patel, M; Opitz, A; McArthur, D; Jolly, A; Carmichael, DW; Sharp, DJ				Li, Lucia M.; Violante, Ines R.; Zimmerman, Karl; Leech, Rob; Hampshire, Adam; Patel, Maneesh; Opitz, Alexander; McArthur, David; Jolly, Amy; Carmichael, David W.; Sharp, David J.			Traumatic axonal injury influences the cognitive effect of non-invasive brain stimulation	BRAIN			English	Article						brain stimulation; response inhibition; traumatic brain injury; salience network; axonal injury	FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; SALIENCE NETWORK; ELECTRIC-FIELD; CORTEX; ATTENTION; TDCS; INTEGRITY; DAMAGE	Non-invasive brain stimulation has been widely investigated as a potential treatment for a range of neurological and psychiatric conditions, including brain injury. However, the behavioural effects of brain stimulation are variable, for reasons that are poorly understood. This is a particular challenge for traumatic brain injury, where patterns of damage and their clinical effects are heterogeneous. Here we test the hypothesis that the response to transcranial direct current stimulation following traumatic brain injury is dependent on white matter damage within the stimulated network. We used a novel simultaneous stimulation-MRI protocol applying anodal, cathodal and sham stimulation to 24 healthy control subjects and 35 patients with moderate/severe traumatic brain injury. Stimulation was applied to the right inferior frontal gyrus/anterior insula node of the salience network, which was targeted because our previous work had shown its importance to executive function. Stimulation was applied during performance of the Stop Signal Task, which assesses response inhibition, a key component of executive function. Structural MRI was used to assess the extent of brain injury, including diffusion MRI assessment of post-traumatic axonal injury. Functional MRI, which was simultaneously acquired to delivery of stimulation, assessed the effects of stimulation on cognitive network function. Anodal stimulation improved response inhibition in control participants, an effect that was not observed in the patient group. The extent of traumatic axonal injury within the salience network strongly influenced the behavioural response to stimulation. Increasing damage to the tract connecting the stimulated right inferior frontal gyrus/anterior insula to the rest of the salience network was associated with reduced beneficial effects of stimulation. In addition, anodal stimulation normalized default mode network activation in patients with poor response inhibition, suggesting that stimulation modulates communication between the networks involved in supporting cognitive control. These results demonstrate an important principle: that white matter structure of the connections within a stimulated brain network influences the behavioural response to stimulation. This suggests that a personalized approach to non-invasive brain stimulation is likely to be necessary, with structural integrity of the targeted brain networks an important criterion for patient selection and an individualized approach to the selection of stimulation parameters.	[Li, Lucia M.; Zimmerman, Karl; Hampshire, Adam; Jolly, Amy; Sharp, David J.] Imperial Coll London, Dept Med, Div Brain Sci, Computat Cognit & Clin Imaging Lab, London W12 0NN, England; [Li, Lucia M.; Hampshire, Adam; Sharp, David J.] Imperial Coll London, UK DRI Ctr Care Res & Technol, London W12 0NN, England; [Violante, Ines R.] Univ Surrey, Fac Hlth & Med Sci, Sch Psychol, Guildford GU2 7XH, Surrey, England; [Leech, Rob] Kings Coll London, Ctr Neuroimaging Sci, London SE5 8AF, England; [Patel, Maneesh] Charing Cross Hosp, Dept Imaging, London W6 8RF, England; [Opitz, Alexander] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [McArthur, David] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Carmichael, David W.] Kings Coll London, Dept Biomed Engn, London SE5 8AF, England		Sharp, DJ (corresponding author), Imperial Coll London, Cognit Computat & Clin Neuroimaging Lab, Du Cane Rd, London W12 0NN, England.	David.sharp@imperial.ac.uk	Zimmerman, Karl/AAL-4988-2020; Carmichael, David W/A-5391-2009	Zimmerman, Karl/0000-0003-1239-3414; Carmichael, David W/0000-0001-9972-0718; Jolly, Amy/0000-0002-7413-9772; Li, Lucia/0000-0001-7339-4854	Wellcome Trust Clinical Research Training FellowshipWellcome Trust [103429/Z/13/Z]; Sir Henry Wellcome Trust Fellowship [103045/Z/13/Z]; NIHR Imperial BRC; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [NIHR-RP-011-048]; NIHR CRF; Biomedical Research Centre (BRC); BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/S008314/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	L.M.L. is supported by a Wellcome Trust Clinical Research Training Fellowship (103429/Z/13/Z). I.R.V. is supported by a Sir Henry Wellcome Trust Fellowship (103045/Z/13/Z) and receives funding from the NIHR Imperial BRC. D.J.S. is supported by a National Institute for Health Research (NIHR) Professorship (NIHR-RP-011-048). This research was also supported by the NIHR CRF and Biomedical Research Centre (BRC).	Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Boorman ED, 2007, CURR BIOL, V17, P1426, DOI 10.1016/j.cub.2007.07.040; Bradnam LV, 2012, CEREB CORTEX, V22, P2662, DOI 10.1093/cercor/bhr344; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Chakraborty D, 2018, CEREB CORTEX, V28, P2786, DOI 10.1093/cercor/bhx158; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Delis DC., 2001, DELIS KAPLAN EXECUTI; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Grossman N, 2017, CELL, V169, P1029, DOI 10.1016/j.cell.2017.05.024; Hampshire A, 2015, TRENDS COGN SCI, V19, P445, DOI 10.1016/j.tics.2015.06.006; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Huizenga HM, 2007, NEUROPSYCHOLOGIA, V45, P2534, DOI 10.1016/j.neuropsychologia.2007.03.011; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kuo MF, 2012, CLIN EEG NEUROSCI, V43, P192, DOI 10.1177/1550059412444975; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Li L., 2018, HDB MAT MODELING MET, P1; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Liew SL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00378; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marquez J, 2015, INT J STROKE, V10, P306, DOI 10.1111/ijs.12169; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Metwally MK, 2012, IEEE ENG MED BIO, P5514, DOI 10.1109/EMBC.2012.6347243; Minjoli S, 2017, NEUROIMAGE-CLIN, V15, P106, DOI 10.1016/j.nicl.2017.04.014; O'Neil-Pirozzi TM, 2017, INT J NEUROSCI, V127, P592, DOI 10.1080/00207454.2016.1216415; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; O'Shea J, 2014, NEUROIMAGE, V85, P924, DOI 10.1016/j.neuroimage.2013.05.096; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; Rosso C, 2014, BRAIN STIMUL, V7, P122, DOI 10.1016/j.brs.2013.08.007; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, P1; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Shahid S, 2013, COMPUT METH PROG BIO, V109, P48, DOI 10.1016/j.cmpb.2012.09.001; Shahida S, 2014, J IRAN CHEM SOC, V11, P1, DOI 10.1007/s13738-013-0259-8; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Violante IR, 2017, ELIFE, V6, DOI [10.7554/elife.22001.001, 10.7554/eLife.22001]; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2010, LECT NOTES COMPUT SC, V6204, P83, DOI 10.1007/978-3-642-14366-3_8	60	9	9	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2019	142		10				3280	3293		10.1093/brain/awz252			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JY3MJ	WOS:000504322300035	31504237	Green Published, hybrid			2022-02-06	
J	Lu, M; Yan, XF; Si, Y; Chen, XZ				Lu, Ming; Yan, Xiao-Feng; Si, Yun; Chen, Xin-Zhi			CTGF Triggers Rat Astrocyte Activation and Astrocyte-Mediated Inflammatory Response in Culture Conditions	INFLAMMATION			English	Article						CTGF; astrocyte; traumatic brain injury; inflammation	TRAUMATIC BRAIN-INJURY; TISSUE GROWTH-FACTOR; NF-KAPPA-B; TGF-BETA; CELLS; EXPRESSION; APOPTOSIS; PATHWAY; PATHOGENESIS; INDUCTION	To improve clinical outcomes for patients with traumatic brain injury (TBI), it is necessary to explore the mechanism of traumatic brain injury (TBI)-induced neuroinflammation. Connective tissue growth factors (CTGF) have been reported to be involved in the process of inflammatory response or tissue repair, whereas whether and how CTGF participates in the astrocyte-mediated inflammation after TBI remains unclear. In the present study, the TBI-induced activation of astrocytes and augmentation of inflammatory response were simulated by stimulating rat astrocytes with TGF-beta 1 or CTGF in cultured conditions. TGF-beta 1 and CTGF both upregulated the expression of GFAP in astrocytes and facilitated the production of inflammatory cytokines and chemokines. Activation of astrocytes by CTGF is in an autocrine manner. According to the results of Boyden chamber assay, CTGF enhanced the recruitment of peripheral blood mononuclear cells (PBMCs) by reactive astrocytes. Besides, CTGF-mediated activation of astrocytes and augmentation of inflammatory response can be terminated by the inhibitor of ASK1 or p38 and JNK. Thus, our data suggested that CTGF could activate astrocytes in an autocrine manner and promote astrocyte-mediated inflammatory response by triggering the ASK1-p38/JNK-NF-kappa B/AP-1 pathways in astrocytes. Collectively, our study provided evidence that astrocyte-secreted CTGF serves as an amplifier of neuroinflammatory and could be a potential target for alleviating TBI-induced inflammation.	[Lu, Ming; Yan, Xiao-Feng; Si, Yun; Chen, Xin-Zhi] First Peoples Hosp Xiaoshan Dist Hangzhou City, Dept Neurosurg, 199 Shixin South Rd, Hangzhou 311200, Zhejiang, Peoples R China		Yan, XF (corresponding author), First Peoples Hosp Xiaoshan Dist Hangzhou City, Dept Neurosurg, 199 Shixin South Rd, Hangzhou 311200, Zhejiang, Peoples R China.	yan_xiao_f163@163.com			Hangzhou science and technology plan guidance project [20171226Y87]	This study was supported by the Hangzhou science and technology plan guidance project (Grant No. 20171226Y87).	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; BRUNNER A, 1991, DNA CELL BIOL, V10, P293, DOI 10.1089/dna.1991.10.293; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen HM, 2014, BBA-GEN SUBJECTS, V1840, P2162, DOI 10.1016/j.bbagen.2014.03.011; Chen YJ, 2001, EXP CELL RES, V271, P109, DOI 10.1006/excr.2001.5364; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Daniele S, 2015, CELL SIGNAL, V27, P1609, DOI 10.1016/j.cellsig.2015.04.006; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karger A, 2008, CELL SIGNAL, V20, P1865, DOI 10.1016/j.cellsig.2008.06.016; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051097; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Martin-Lopez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074039; Masuko Kayo, 2010, BMC Res Notes, V3, P5, DOI 10.1186/1756-0500-3-5; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Qu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0997-0; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Yu ZH, 2014, J NEUROCHEM, V130, P41, DOI 10.1111/jnc.12710	54	9	10	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	OCT	2019	42	5					1693	1704		10.1007/s10753-019-01029-7			12	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	IU5XG	WOS:000483660100017	31183597	Green Published, hybrid			2022-02-06	
J	Rass, V; Solari, D; Ianosi, B; Gaasch, M; Kofler, M; Schiefecker, AJ; Miroz, JP; Morelli, P; Thome, C; Beer, R; Pfausler, B; Oddo, M; Helbok, R				Rass, Verena; Solari, Daria; Ianosi, Bogdan; Gaasch, Max; Kofler, Mario; Schiefecker, Alois J.; Miroz, John-Paul; Morelli, Paola; Thome, Claudius; Beer, Ronny; Pfausler, Bettina; Oddo, Mauro; Helbok, Raimund			Protocolized Brain Oxygen Optimization in Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Aneurysmal subarachnoid hemorrhage; Brain; Critical care; Neurology	DELAYED CEREBRAL-ISCHEMIA; METABOLIC DISTRESS; HIGHER HEMOGLOBIN; TISSUE HYPOXIA; INJURY; IMPACT; HYPERVENTILATION; TRANSFUSION; FEVER	Background Brain tissue hypoxia (PbtO2 < 20 mmHg) is common after subarachnoid hemorrhage (SAH) and associated with poor outcome. Recent data suggest that brain oxygen optimization is feasible and reduces the time spent with PbtO2 < 20 mmHg from 45 to 16% in patients with severe traumatic brain injury. Here, we intended to quantify the brain tissue hypoxia burden despite implementation of a protocolized treatment approach in poor-grade SAH patients and to identify the simultaneous occurrence of pathologic values potentially amenable to treatment. Methods We present a bi-centric observational cohort study including 100 poor-grade SAH patients admitted to two tertiary care centers who underwent multimodal brain monitoring and were managed with a PbtO2-targeted protocolized approach. PbtO2 optimization (>= 20 mmHg) included a stepwise neuro-intensive care approach, aiming to prevent low cerebral perfusion pressure (CPP), and blood hemoglobin, and to keep normocapnia, normoxemia, and normothermia. Based on routine blood gas analysis, hemoglobin, PaCO2, and PaO2 data were matched to 2-h averaged data of continuous CPP, PbtO2, core temperature, and to hourly cerebral microdialysis (CMD) samples over the first 11 days. Results Patients had a Glasgow Coma Scale of 3 (IQR 3-4) and were 58 years old (IQR 48-66). Overall incidence of brain tissue hypoxia was 25%, which was not different between both sites despite differences in the treatment approach. During brain tissue hypoxia, episodes of CPP < 70 mmHg (27%), PaCO2 < 35 mmHg (19%), PaO2 < 80 mmHg (14%), Hb < 9 g/dL (11%), metabolic crisis (CMD-lactate/pyruvate ratio > 40, and CMD-glucose < 0.7 mmol/L; 7%), and temperature > 38.3 degrees C (4%) were common. Conclusions Our results demonstrate that brain tissue hypoxia remains common despite implementation of a PbtO2-targeted therapy in poor-grade SAH patients, suggesting room for further optimization.	[Rass, Verena; Ianosi, Bogdan; Gaasch, Max; Kofler, Mario; Schiefecker, Alois J.; Beer, Ronny; Pfausler, Bettina; Helbok, Raimund] Med Univ Innsbruck, Neurol Intens Care Unit, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria; [Solari, Daria; Miroz, John-Paul; Morelli, Paola; Oddo, Mauro] Univ Lausanne, CHUV, Dept Intens Care Med, Neurosci Crit Care Res Grp, Lausanne, Switzerland; [Ianosi, Bogdan] UMIT Univ Hlth Sci Med Informat & Technol, Inst Med Informat, Eduard Wallnoefer Zentrum 1, A-6060 Hall In Tirol, Austria; [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Neurol Intens Care Unit, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@tirol-kliniken.at	MIROZ, John-Paul/AAR-7445-2020; Rass, Verena/AAR-1731-2021; Helbok, Raimund/AAA-8361-2021	Rass, Verena/0000-0002-4241-5891	Austrian Science Fund (FWF)Austrian Science Fund (FWF) [KLI 375]	This study has received funding from the Austrian Science Fund (FWF) under project number KLI 375 (to RB).	Balbi M, 2017, J CEREBR BLOOD F MET, V37, P3625, DOI 10.1177/0271678X16686595; Chan JS, 2014, J DATA SCI, V12, P293; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dhar R, 2017, CRIT CARE MED, V45, P653, DOI 10.1097/CCM.0000000000002266; Douds GL, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/479865; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Helbok R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00565; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Kurtz P, 2010, NEUROCRIT CARE, V13, P10, DOI 10.1007/s12028-010-9357-y; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Naidech AM, 2006, NEUROSURGERY, V59, P775, DOI 10.1227/01.NEU.0000232662.86771.A9; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Westermaier T, 2016, NEUROCRIT CARE, V25, P205, DOI 10.1007/s12028-016-0246-x; Williamson CA, 2015, NEUROCRIT CARE, V23, P330, DOI 10.1007/s12028-015-0138-5	33	9	9	2	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2019	31	2					263	272		10.1007/s12028-019-00753-0			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JA0OX	WOS:000487511700007	31218640	Green Published, hybrid			2022-02-06	
J	Wrba, L; Ohmann, JJ; Eisele, P; Chakraborty, S; Braumuller, S; Braun, CK; Klohs, B; Schultze, A; von Baum, H; Palmer, A; Huber-Lang, M; Halbgebauer, R				Wrba, Lisa; Ohmann, Julia J.; Eisele, Philipp; Chakraborty, Shinjini; Braumueller, Sonja; Braun, Christian K.; Klohs, Bettina; Schultze, Anke; von Baum, Heike; Palmer, Annette; Huber-Lang, Markus; Halbgebauer, Rebecca			Remote Intestinal Injury Early After Experimental Polytrauma and Hemorrhagic Shock	SHOCK			English	Article						Barrier dysfunction; hemorrhagic shock; intestinal permeability; polytrauma; zonula occludens protein 1	MULTIPLE ORGAN FAILURE; TIGHT-JUNCTION; MESENTERIC LYMPH; BACTERIAL TRANSLOCATION; INDUCED GUT; TRAUMA; BARRIER; PERMEABILITY; DYSFUNCTION; INHIBITION	Dysfunction of the gut-blood barrier plays an important role in many diseases, such as inflammatory bowel disease, hemorrhagic shock (HS), or burn injury. However, little is known about gut barrier dysfunction after hemodynamically instable polytrauma (PT). Therefore, we aimed to evaluate the effects of PT and HS on remote intestinal damage and barrier dysfunction, especially regarding the role of zonula occludens protein 1 (ZO-1) as an important tight junction protein. Male C57BL/6 mice were subjected to either PT (thorax trauma, closed head injury, soft tissue injury, and distal femoral fracture), 60 min of pressure-controlled HS (30 +/- 5 mmHg), or PT+HS, or sham procedures. Animals of all trauma groups showed an increase in abdominal girth and dilation of the intestine during the experimental period, which was largest in the PT+HS group. Increased blood-tissue permeability to albumin (assessed by Evans blue dye) was found in the HS group. Experimental groups showed a slight increase in plasma concentration of intestinal fatty acid binding protein and some intestinal damage was histologically detectable. Of note, PT+HS animals revealed significantly reduced expression of ZO-1 in intestinal epithelial cells. In an in-vitro model, stimulation of human colon epithelial cells with peptidoglycan, but not with lipopolysaccharide, resulted in elevated secretion of pro-inflammatory cytokines, reflecting inflammatory activity of the intestinal epithelium. Taken together, PT and HS lead to increased permeability of the gut-blood barrier. Bacterial components may lead to production of inflammatory and chemotactic mediators by gut epithelial cells, underlining the role of the gut as an immunologically active organ.	[Wrba, Lisa; Ohmann, Julia J.; Eisele, Philipp; Chakraborty, Shinjini; Braumueller, Sonja; Braun, Christian K.; Klohs, Bettina; Schultze, Anke; Palmer, Annette; Huber-Lang, Markus; Halbgebauer, Rebecca] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Helmholtzstr 8-1, D-89081 Ulm, Germany; [von Baum, Heike] Univ Hosp Ulm, Inst Med Microbiol & Hyg, Ulm, Germany		Halbgebauer, R (corresponding author), Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Helmholtzstr 8-1, D-89081 Ulm, Germany.	rebecca.halbgebauer@uniklinik-ulm.de	Huber-Lang, Markus/AAJ-2209-2020; Braun, Christian Karl/I-5132-2018	Braun, Christian Karl/0000-0002-9854-3251			Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Chang ZG, 2016, J TRAUMA ACUTE CARE, V81, P512, DOI 10.1097/TA.0000000000001137; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; Davidson MT, 2004, ANN SURG, V240, P123, DOI 10.1097/01.sla.0000129341.94219.cf; Deitch EA, 2003, SHOCK, V19, P452, DOI 10.1097/01.shk.0000048899.46342.f6; DEITCH EA, 1987, J SURG RES, V42, P536, DOI 10.1016/0022-4804(87)90029-1; Denk S, 2018, SHOCK, V49, P154, DOI 10.1097/SHK.0000000000000925; Denk S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/463950; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hatano Kazuo, 1996, J Infect Chemother, V1, P193, DOI 10.1007/BF02350648; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kompan L, 1999, INTENS CARE MED, V25, P157, DOI 10.1007/s001340050809; LEVOYER T, 1992, ARCH SURG-CHICAGO, V127, P26; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; Relja B, 2010, ACAD EMERG MED, V17, P729, DOI 10.1111/j.1553-2712.2010.00792.x; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Sunderhauf A, 2017, MOL IMMUNOL, V90, P227, DOI 10.1016/j.molimm.2017.08.003; Thuijls G, 2009, SHOCK, V31, P164, DOI 10.1097/SHK.0b013e31817fc310; Timmermans K, 2015, SHOCK, V43, P117, DOI 10.1097/SHK.0000000000000284; Upperman JS, 1998, SHOCK, V10, P407, DOI 10.1097/00024382-199812000-00005; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; Wrba L, 2017, J TRAUMA ACUTE CARE, V83, P944, DOI 10.1097/TA.0000000000001654; Wu CY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1135-y; Wu XW, 2016, AM J PHYSIOL-REG I, V310, pR323, DOI 10.1152/ajpregu.00401.2015; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Zhao GJ, 2016, SHOCK, V45, P326, DOI 10.1097/SHK.0000000000000524	35	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	OCT	2019	52	4					e45	e51		10.1097/SHK.0000000000001271			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	KD9PM	WOS:000508193400004	30289852				2022-02-06	
J	Omelchenko, A; Shrirao, AB; Bhattiprolu, AK; Zahn, JD; Schloss, RS; Dickson, S; Meaney, DF; Boustany, NN; Yarmush, ML; Firestein, BL				Omelchenko, Anton; Shrirao, Anil B.; Bhattiprolu, Atul K.; Zahn, Jeffrey D.; Schloss, Rene S.; Dickson, Samantha; Meaney, David F.; Boustany, Nada N.; Yarmush, Martin L.; Firestein, Bonnie L.			Dynamin and reverse-mode sodium calcium exchanger blockade confers neuroprotection from diffuse axonal injury	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL FISSION; INHIBITOR; DYNASORE; DAMAGE; APOPTOSIS; MEMORY; HIPPOCAMPUS; MDIVI-1; RAT	Mild traumatic brain injury (mTBI) is a frequently overlooked public health concern that is difficult to diagnose and treat. Diffuse axonal injury (DAI) is a common mTBI neuropathology in which axonal shearing and stretching induces breakdown of the cytoskeleton, impaired axonal trafficking, axonal degeneration, and cognitive dysfunction. DAI is becoming recognized as a principal neuropathology of mTBI with supporting evidence from animal model, human pathology, and neuroimaging studies. As mitochondrial dysfunction and calcium overload are critical steps in secondary brain and axonal injury, we investigated changes in protein expression of potential targets following mTBI using an in vivo controlled cortical impact model. We show upregulated expression of sodium calcium exchanger1 (NCX1) in the hippocampus and cortex at distinct time points post-mTBI. Expression of dynamin-related protein1 (Drp1), a GTPase responsible for regulation of mitochondrial fission, also changes differently post-injury in the hippocampus and cortex. Using an in vitro model of DAI previously reported by our group, we tested whether pharmacological inhibition of NCX1 by SN-6 and of dynamin1, dynamin2, and Drp1 by dynasore mitigates secondary damage. Dynasore and SN-6 attenuate stretch injury-induced swelling of axonal varicosities and mitochondrial fragmentation. In addition, we show that dynasore, but not SN-6, protects against H2O2-induced damage in an organotypic oxidative stress model. As there is currently no standard treatment to mitigate cell damage induced by mTBI and DAI, this work highlights two potential therapeutic targets for treatment of DAI in multiple models of mTBI and DAI.	[Omelchenko, Anton; Bhattiprolu, Atul K.; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Omelchenko, Anton] Rutgers State Univ, Neurosci Grad Program, 604 Allison Rd, Piscataway, NJ 08854 USA; [Shrirao, Anil B.; Zahn, Jeffrey D.; Schloss, Rene S.; Boustany, Nada N.; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, 604 Allison Rd, Piscataway, NJ 08854 USA; [Dickson, Samantha; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu	Zahn, Jeffrey D/AAQ-7195-2020	Zahn, Jeffrey D/0000-0001-8712-752X; Yarmush, Martin/0000-0003-4986-8444; Firestein, Bonnie/0000-0002-1679-3565	National Science FoundationNational Science Foundation (NSF) [CBET 1512170]; New Jersey Commission on Brain Injury Research grant [CBIR14IRG019]; National Institutes of Health Biotechnology Training GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM008339-20]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	This work was funded by National Science Foundation CBET 1512170 (to M.L.Y., N.N.B., J.D.Z., and B.L.F.) and the New Jersey Commission on Brain Injury Research grant #CBIR14IRG019 (to B.L.F. and D.F.M.). A.O. was supported by National Institutes of Health Biotechnology Training Grant T32 GM008339-20.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Barsukova AG, 2012, J NEUROSCI, V32, P12028, DOI 10.1523/JNEUROSCI.0408-12.2012; Bastioli G, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1290-6; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chou AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138856; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Dolle JP, 2014, TECHNOLOGY, V2, P106, DOI 10.1142/S2339547814500095; Dolle JP, 2013, LAB CHIP, V13, P432, DOI 10.1039/c2lc41063j; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Keller JN, 1998, J NEUROSCI, V18, P687; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Li G, 2017, MOL NEUROBIOL, V54, P7471, DOI 10.1007/s12035-016-0252-1; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchetti P, 1996, J IMMUNOL, V157, P4830; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mu J, 2015, INT J CLIN EXP PATHO, V8, P4388; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Preta G, 2015, FASEB J, V29, P1516, DOI 10.1096/fj.14-265207; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tassew NG, 2014, CELL REP, V8, P1146, DOI 10.1016/j.celrep.2014.06.014; Thurneysen T, 2002, MOL BRAIN RES, V107, P145, DOI 10.1016/S0169-328X(02)00461-8; Tian L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00828; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep34330; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635; Zhou CF, 2016, ONCOTARGET, V7, P68314, DOI 10.18632/oncotarget.11599; Zhou QM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19923-9	63	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	SEP 27	2019	10								727	10.1038/s41419-019-1908-3			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	JB8VB	WOS:000488855200003	31562294	gold, Green Published			2022-02-06	
J	Zhang, B; Xu, XJ; Niu, F; Mao, X; Dong, JQ; Yang, MS; Gao, F; Liu, BY				Zhang, Bin; Xu, Xiaojian; Niu, Fei; Mao, Xiang; Dong, Jinqian; Yang, Mengshi; Gao, Fei; Liu, Baiyun			Corticosterone Replacement Alleviates Hippocampal Neuronal Apoptosis and Spatial Memory Impairment Induced by Dexamethasone via Promoting Brain Corticosteroid Receptor Rebalance after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; corticosteroid receptor balance; GR; MR; TBI	SEVERE HEAD-INJURY; CONTROLLED CORTICAL IMPACT; DOUBLE-BLIND; MINERALOCORTICOID RECEPTOR; GLUCOCORTICOID-RECEPTOR; CHRONIC STRESS; RAT HIPPOCAMPUS; DENTATE GYRUS; ACUTE-PHASE; DEATH	The balance of mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) is indispensable for maintaining the normal function and structure of the hippocampus. However, changes in GR/MR and their effect on the survival of hippocampal neurons after traumatic brain injury (TBI) are still unclear. Previous studies have indicated that high-dose glucocorticoids (GC) aggravate hippocampal neuronal damage after TBI. We hypothesize that the imbalance of GR/MR expression and activation caused by injury and irrational use of dexamethasone (DEX) aggravates post-traumatic hippocampal apoptosis and spatial memory dysfunction, but that restoration by refilling MR and inhibiting GR promotes the survival of neurons. Using rat controlled cortical impact model, we examined the plasma corticosterone (CORT), corticosteroid receptor expression, apoptosis, and cell loss in the hippocampus, and, accordingly, the spatial memory after TBI and GC treatment within 7 days. Plasma CORT, MR, and GR expression level were significantly reduced at 2 days after TBI. Accordingly, the number of apoptotic cells also peaked at 2 days. Compared with the TBI control group, DEX treatment (5 mg/kg) significantly reduced plasma CORT, upregulated GR expression, and increased the number of apoptotic cells and cell loss, whereas CORT replacement (0.3 mg/kg) upregulated MR expression, inhibited apoptosis, and improved spatial memory. The deleterious and protective effects of DEX and CORT were counteracted by spironolactone and mifepristone respectively. The results suggest that inhibition of GR by RU486 or the refilling of MR by CORT protects hippocampal neurons and alleviates spatial memory impairment via promoting GR/MR rebalancing after TBI.	[Xu, Xiaojian; Niu, Fei; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Zhang, Bin; Dong, Jinqian; Yang, Mengshi; Gao, Fei; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 119 Nan Si Huan W Rd, Beijing 100070, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Mao, Xiang] Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hefei, Anhui, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, 119 Nan Si Huan W Rd, Beijing 100070, Peoples R China.	liubaiyun1212@163.com	Dong, Jinqian/AAP-2298-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771327]	This work was supported by a research grant from the National Natural Science Foundation of China (No. 81771327).	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Andela CD, 2015, EUR J ENDOCRINOL, V173, pR1, DOI 10.1530/EJE-14-1101; Barik J, 2013, SCIENCE, V339, P332, DOI 10.1126/science.1226767; Bigio B, 2016, P NATL ACAD SCI USA, V113, P7906, DOI 10.1073/pnas.1603111113; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; CEMAK I, 2000, J NEUROTRAUM, V17, P53; Chen X, 2013, J PEDIAT ENDOCRINOL, V17, P1; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Christian KM, 2011, NEUROSCIENCE, V174, P26, DOI 10.1016/j.neuroscience.2010.11.033; Claessens SEF, 2012, BRAIN RES, V1482, P1, DOI 10.1016/j.brainres.2012.08.017; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; de Kloet ER, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12379; de Kloet ER, 2014, ENDOCRINOLOGY, V155, P2754, DOI 10.1210/en.2014-1048; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Edwards P, 2005, LANCET, V365, P1957; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gesmundo I, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00066; Gobiet W, 1976, INTRACRANIAL PRESSUR, P231; Gray JD, 2017, NAT REV ENDOCRINOL, V13, P661, DOI 10.1038/nrendo.2017.97; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Harris AP, 2013, PSYCHONEUROENDOCRINO, V38, P648, DOI 10.1016/j.psyneuen.2012.08.007; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Herman JP, 1999, ENDOCRINOLOGY, V140, P3981, DOI 10.1210/en.140.9.3981; Ikeda M, 2015, J ENDOCRINOL, V226, pM13, DOI 10.1530/JOE-15-0078; Joels M, 2004, STRESS, V7, P221, DOI 10.1080/10253890500070005; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meijer OC, 1998, ENDOCRINOLOGY, V139, P1789, DOI 10.1210/en.139.4.1789; Meijer OC, 2017, ENDOCRINOLOGY, V158, P448, DOI 10.1210/en.2016-1495; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Spiga F, 2007, J NEUROENDOCRINOL, V19, P891, DOI 10.1111/j.1365-2826.2007.01605.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Warris LT, 2016, J CLIN ONCOL, V34, P2287, DOI 10.1200/JCO.2015.66.0761; WEISS MH, 1970, J NEUROSURG, V32, P452, DOI 10.3171/jns.1970.32.4.0452; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	60	9	9	1	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					262	272		10.1089/neu.2019.6556		SEP 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000488044000001	31436134				2022-02-06	
J	Das, M; Mayilsamy, K; Tang, XL; Han, JY; Foran, E; Willing, AE; Mohapatra, SS; Mohapatra, S				Das, Mahasweta; Mayilsamy, Karthick; Tang, Xiaolan; Han, Jung Yeon; Foran, Elspeth; Willing, Alison E.; Mohapatra, Shyam S.; Mohapatra, Subhra			Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats	SCIENTIFIC REPORTS			English	Article							ACTIVATED RECEPTOR-GAMMA; STROMAL CELLS; NEUROTROPHIC FACTOR; CLINICAL-TRIAL; UP-REGULATION; FLUORO-JADE; SPINAL-CORD; BDNF; NEUROGENESIS; INHIBITION	Traumatic brain injury is a leading cause of death and disability around the world. So far, drugs are not available to repair brain damage. Human mesenchymal stem cell (hMSC) transplantation therapy is a promising approach, although the inflammatory microenvironment of the injured brain affects the efficacy of transplanted hMSCs. We hypothesize that reducing the inflammation in the cerebral microenvironment by reducing pro-inflammatory chemokines prior to hMSC administration will improve the efficacy of hMSC therapy. In a rat model of lateral fluid percussion injury, combined pioglitazone (PG) and hMSC (combination) treatment showed less anxiety-like behavior and improved sensorimotor responses to a noxious cold stimulus. Significant reduction in brain lesion volume, neurodegeneration, microgliosis and astrogliosis were observed after combination treatment. TBI induced expression of inflammatory chemokine CCL20 and IL1-beta were significantly decreased in the combination treatment group. Combination treatment significantly increased brain-derived neurotrophic factor (BDNF) level and subventricular zone (SVZ) neurogenesis. Taken together, reducing proinflammatory cytokine expression in the cerebral tissues after TBI by PG administration and prior to hMSC therapy improves the outcome of the therapy in which BDNF could have a role.	[Das, Mahasweta; Mayilsamy, Karthick; Tang, Xiaolan; Han, Jung Yeon; Foran, Elspeth; Mohapatra, Shyam S.; Mohapatra, Subhra] Univ S Florida, James A Haley Vet Hosp, Coll Med, Tampa, FL 33612 USA; [Das, Mahasweta; Mayilsamy, Karthick; Tang, Xiaolan; Han, Jung Yeon; Foran, Elspeth; Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33612 USA; [Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Coll Med, Tampa, FL 33612 USA; [Willing, Alison E.] Univ S Florida, Dept Neurosurg & Brain Repair, Coll Med, Tampa, FL 33612 USA		Mohapatra, S (corresponding author), Univ S Florida, James A Haley Vet Hosp, Coll Med, Tampa, FL 33612 USA.; Mohapatra, S (corresponding author), Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33612 USA.	smohapa2@health.usf.edu	Willing, Alison/AAP-7759-2021		Veterans AffairsUS Department of Veterans Affairs [BX002668, IK6BX004212, IK6 BX003778]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs	This work is supported by a Veterans Affairs Merit Review grant (BX002668) to Subhra Mohapatra, and Research Career Scientist Awards to Dr. Subhra Mohapatra (IK6BX004212) and Dr. Shyam Mohapatra (IK6 BX003778). Though this report is based upon work supported, in part, by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, the contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government. We acknowledge the extensive help of Dr. Edwin Weeber and Ms. Melinda Peters in behavioral testing of rats in this study.	Alexanian AR, 2011, NEUROREHAB NEURAL RE, V25, P873, DOI 10.1177/1545968311416823; [Anonymous], 2016, RAT TBI REL EM DEP V; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chamberlain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025663; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Cui GH, 2018, FASEB J, V32, P654, DOI 10.1096/fj.201700600R; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Doeppner TR, 2015, EXP NEUROL, V273, P45, DOI 10.1016/j.expneurol.2015.07.023; Duckworth EAM, 2005, BRAIN RES, V1042, P29, DOI 10.1016/j.brainres.2005.02.021; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Geesala R, 2017, CYTOTHERAPY, V19, P756, DOI 10.1016/j.jcyt.2017.03.072; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Glatz T, 2010, J HYPERTENS, V28, P1488, DOI 10.1097/HJH.0b013e3283396e4e; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; HEFTI F, 1986, J NEUROSCI, V6, P2155; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kalish H, 2010, J CHROMATOGR B, V878, P194, DOI 10.1016/j.jchromb.2009.10.022; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Khodeer DM, 2016, CAN J PHYSIOL PHARM, V94, P463, DOI 10.1139/cjpp-2015-0135; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leonardo CC, 2012, TRANSL STROKE RES, V3, P357, DOI 10.1007/s12975-012-0203-8; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Redondo-Castro E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0531-4; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Tsai HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104937; Vallee A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00745; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Vithlani M, 2013, J NEUROSCI, V33, P15567, DOI 10.1523/JNEUROSCI.1845-13.2013; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Wei L, 2017, PROG NEUROBIOL, V157, P49, DOI 10.1016/j.pneurobio.2017.03.003; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xu Z, 2018, MOL NEUROBIOL, V55, P3499, DOI 10.1007/s12035-017-0576-5; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687	69	9	9	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 20	2019	9								13646	10.1038/s41598-019-49428-y			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IZ3RD	WOS:000487002100041	31541141	Green Published, gold			2022-02-06	
J	McCarty, CA; Zatzick, D; Hoopes, T; Payne, K; Parrish, R; Rivara, FP				McCarty, Carolyn A.; Zatzick, Douglas; Hoopes, Teah; Payne, Katelyn; Parrish, Rebecca; Rivara, Frederick P.			Collaborative care model for treatment of persistent symptoms after concussion among youth (CARE4PCS-II): Study protocol for a randomized, controlled trial	TRIALS			English	Article						Collaborative care; Concussion; Cognitive-behavior therapy; Randomized trials; Adolescent health; Sports injury	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ANTIDEPRESSANT TREATMENT; ANXIETY DISORDERS; COMPLICATED MILD; ITEM BANKS; ADOLESCENTS; DEPRESSION	Background Currently, there is limited evidence to guide intervention and service delivery coordination for youth who suffer a concussion and subsequently experience persistent post-concussive symptoms (PCS) (Lumba-Brown et al. JAMA Pediatr 172(11):e182853, 2018; Lumba-Brown A et al. JAMA Pediatr 172(11):e182847, 2018). We have developed a collaborative care intervention with embedded cognitive-behavioral therapy, care management, and stepped-up psychotropic medication consultation to address persistent PCS and related psychological comorbidities. The CARE4PCS-II study was designed to assess whether adolescents with persistent symptoms after sports-related concussion will demonstrate better outcomes when receiving this collaborative care intervention compared to a usual care (control) condition. Methods/design This investigation is a randomized comparative effectiveness trial to receive intervention (collaborative care) or control (usual care). Two hundred sports-injured male and female adolescents aged 11-18 years with three or more post-concussive symptoms that persist for at least 1 month but less than 9 months after injury will be recruited and randomized into the study. The trial focuses on the effects of the intervention on post-concussive, depressive, and anxiety symptoms measured 3, 6, and 12 months after baseline. Discussion The CARE4PCS II study is a large comparative effectiveness trial targeting symptomatic improvements in sports injured adolescents after concussion. The study is unique in its adaptation of the collaborative care model to a broad spectrum of primary care, sports medicine, and school settings. The investigation incorporates novel elements such as the delivery of CBT through HIPAA complaint video conferenceing technology and has excellent widespread dissemination potential should effectiveness be demonstrated.	[McCarty, Carolyn A.; Hoopes, Teah; Payne, Katelyn; Parrish, Rebecca; Rivara, Frederick P.] Seattle Childrens Res Inst, POB 5371,M-S CW8-5, Seattle, WA 98145 USA; [McCarty, Carolyn A.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas] Univ Washington, Dept Psychiat & Behav Sci, Harborview Med Ctr 325 9th Ave,Box 359911, Seattle, WA 98104 USA		McCarty, CA (corresponding author), Seattle Childrens Res Inst, POB 5371,M-S CW8-5, Seattle, WA 98145 USA.; McCarty, CA (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	cari.mccarty@seattlechildrens.org		McCarty, Carolyn/0000-0002-9747-0927	National Institute of Child and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD090230]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD090230] Funding Source: NIH RePORTER	This study was supported by funding from the National Institute of Child and Human Development, R01 HD090230 (PIs: McCarty, Rivara, and Zatzick). The study funder is not playing a role in study design, data collection, or analyses.	[Anonymous], 2010, NEW YORK TIMES  1007, VZ, P1, DOI DOI 10.1109/IEEESTD.2010.5514475; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BERGMAN AB, 1990, AM J DIS CHILD, V144, P727, DOI 10.1001/archpedi.1990.02150300127033; Bertisch H, 2017, QUAL LIFE RES, V26, P1887, DOI 10.1007/s11136-017-1524-6; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Bridge JA, 2005, ANN MED, V37, P404, DOI 10.1080/07853890500284937; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Browner WS, 1988, DESIGNING CLIN RES E, P65; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Choe CJ, 2012, CHILD ADOL PSYCH CL, V21, P807, DOI 10.1016/j.chc.2012.07.002; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Cohen J., 2013, STAT POWER ANAL BEHA; Committee on the Assessment of Ongoing Effects in the Treatment of Posttraumatic Stress Disorder Institution of Medicine, 2012, TREATMENT POSTTRAUMA; Compton SN, 2007, PEDIATR ANN, V36, P586, DOI 10.3928/0090-4481-20070901-10; Connolly SD, 2011, CURR PSYCHIAT REP, V13, P99, DOI 10.1007/s11920-010-0173-z; Coventry PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108114; Donnelly CL, 2003, CHILD ADOL PSYCH CL, V12, P251, DOI 10.1016/S1056-4993(02)00102-5; Eiser C, 2013, EUR J PEDIATR, V172, P1299, DOI 10.1007/s00431-013-2049-9; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Foa EB, 2009, EFFECTIVE TREATMENTS, V2nd; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Garber J, 2009, JAMA-J AM MED ASSOC, V301, P2215, DOI 10.1001/jama.2009.788; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; GIBBONS RD, 1994, J CONSULT CLIN PSYCH, V62, P285, DOI 10.1037/0022-006X.62.2.285; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Giummarra MJ, 2018, CLIN PSYCHOL REV, V62, P11, DOI 10.1016/j.cpr.2018.05.001; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hilt RJ, 2013, JAMA PEDIATR, V167, P162, DOI 10.1001/2013.jamapediatrics.47; Hintze JL, 2000, PASS USERS GUIDE; Hopkins K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h824; Huemer J, 2010, CHILD PSYCHIAT HUM D, V41, P624, DOI 10.1007/s10578-010-0192-3; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kennard BD, 2009, J AM ACAD CHILD PSY, V48, P186, DOI 10.1097/CHI.0b013e31819176f9; Kessler R C, 1997, Epidemiol Psichiatr Soc, V6, P4; King DW, 2001, PTSD RES Q, V12, P1; Kolko DJ, 2014, PEDIATRICS, V133, pE981, DOI 10.1542/peds.2013-2516; Kolko DJ, 2012, ARCH PEDIAT ADOL MED, V166, P224, DOI 10.1001/archpediatrics.2011.201; Kolko DJ, 2010, J DEV BEHAV PEDIATR, V31, P393, DOI 10.1097/DBP.0b013e3181dff307; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P2425, DOI 10.1001/jama.2013.6494; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Little R. J., 2019, STAT ANAL MISSING DA, V793; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Mathyssek CM, 2013, INT J METH PSYCH RES, V22, P27, DOI 10.1002/mpr.1380; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCulloch CE, 2001, GEN LINEAR MIXED MOD; Mulrow C D, 1999, Evid Rep Technol Assess (Summ), P1; NRC) IoMIaNRC, 2013, SPORTS RELATED CONCU, P2013; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Roberts NP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006869.pub2; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; RUSH AJ, 1993, AM FAM PHYSICIAN, V47, P1776; Siddique J, 2008, PSYCHIAT ANN, V38, P793, DOI 10.3928/00485713-20081201-09; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Spence SH, 2011, J CONSULT CLIN PSYCH, V79, P629, DOI 10.1037/a0024512; Steinberg AM, 2013, J TRAUMA STRESS, V26, P1, DOI 10.1002/jts.21780; Strawn JR, 2012, CHILD ADOL PSYCH CL, V21, P527, DOI 10.1016/j.chc.2012.05.003; Sufrinko AM, 2015, SLEEP MED, V16, P1204, DOI 10.1016/j.sleep.2015.07.002; Trusz SG, 2011, PSYCHIATRY, V74, P207, DOI 10.1521/psyc.2011.74.3.207; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walkup JT, 2008, NEW ENGL J MED, V359, P2753, DOI 10.1056/NEJMoa0804633; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick D, 2015, J TRAUMA STRESS, V28, P391, DOI 10.1002/jts.22041; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zatzick DF, 2007, PSYCHIATRY, V70, P260, DOI 10.1521/psyc.2007.70.3.260; Zatzick DF, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0424-4; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	100	9	9	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	SEP 18	2019	20	1							567	10.1186/s13063-019-3662-3			14	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	IZ4HD	WOS:000487044000002	31533799	gold, Green Published			2022-02-06	
J	Tan, XL; Zheng, P; Wright, DK; Sun, MJ; Brady, RD; Liu, SJ; McDonald, SJ; Mychasiuk, R; Cenap, S; Jones, NC; O'Brien, TJ; Shultz, SR				Tan, Xin Lin; Zheng, Ping; Wright, David K.; Sun, Mujun; Brady, Rhys D.; Liu, Shijie; McDonald, Stuart J.; Mychasiuk, Richelle; Cenap, Sitare; Jones, Nigel C.; O'Brien, Terence J.; Shultz, Sandy R.			The genetic ablation of tau improves long-term, but not short-term, functional outcomes after experimental traumatic brain injury in mice	BRAIN INJURY			English	Article						Traumatic brain injury; animal model; mice; fluid percussion injury; MRI; behavior	PROTEIN PHOSPHATASE 2A; HYPERPHOSPHORYLATED TAU; ALZHEIMERS-DISEASE; SODIUM SELENATE; ACQUIRED EPILEPSY; ANIMAL-MODELS; NEUROINFLAMMATION; EPILEPTOGENESIS; DEMENTIA; DEFICITS	Primary Objective: This study characterized the acute and chronic effects of tau reduction in traumatic brain injury (TBI). Research Design: A fluid percussion injury (FPI) or a sham-injury was administered to wild type (WT) or tau knockout (Tau-/-) mice. Mice were assigned to a one-week or twelve-week recovery period before behavioral testing and analysis of brain tissue. Methods and Procedures: Mice were tested on the elevated-plus maze, the Y-maze, and rotarod. The twelve-week recovery mice underwent in vivo MRI. Phosphorylated tau in brain tissue was analyzed post-mortem using western blots. Main Outcomes and Results: FPI mice, regardless of genotype, had abnormalities on the elevated-plus maze (a task to assess anxiety-like behavior) at one-week post-injury. However, after twelve-weeks recovery, the Tau-/- mice that were given an FPI were less anxious and had improved motor function compared to their WT counterparts. MRI analysis found that while all FPI mice had brain damage, the Tau-/- mice had larger hippocampal volumes. The WT+FPI mice also had increased phosphorylated tau compared to WT+sham mice at both the one-week and twelve-week recovery times. Conclusion: These findings suggest that tau may play an important role in some of the consequences of TBI, particularly the long-term functional deficits.	[Tan, Xin Lin; Zheng, Ping; Sun, Mujun; Brady, Rhys D.; Liu, Shijie; Jones, Nigel C.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Wright, David K.; Sun, Mujun; Brady, Rhys D.; Liu, Shijie; McDonald, Stuart J.; Mychasiuk, Richelle; Jones, Nigel C.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [McDonald, Stuart J.; Cenap, Sitare] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179; Sun, Mujun/0000-0002-9923-9913	NHMRCNational Health and Medical Research Council of Australia; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1159645, 1141643]	This study was funded by an NHMRC project grant to SRS, NCJ, and TOB, as well as an NHMRC fellowship to SRS; National Health and Medical Research Council [1159645]; National Health and Medical Research Council [1141643].	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bortolato M, 2009, NEUROPSYCHOPHARMACOL, V34, P2746, DOI 10.1038/npp.2009.118; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Fan LW, 2008, EUR J NEUROSCI, V27, P1475, DOI 10.1111/j.1460-9568.2008.06121.x; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lindemann S, 2008, PHYSIOL BEHAV, V93, P415, DOI 10.1016/j.physbeh.2007.11.038; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Liu SJ, 2017, EPILEPSIA, V58, pE136, DOI 10.1111/epi.13847; Meyer JS, 2008, ANN NY ACAD SCI, V1139, P151, DOI 10.1196/annals.1432.029; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Shultz SR, 2020, J NEUROTRAUM, V37, P2381, DOI 10.1089/neu.2018.6149; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zheng P, 2014, MOL NEUROBIOL, V49, P1532, DOI 10.1007/s12035-013-8601-9	35	9	9	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					131	139		10.1080/02699052.2019.1667539		SEP 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000486959000001	31526028				2022-02-06	
J	Ghadiri, T; Vakilzadeh, G; Hajali, V; Khodagholi, F				Ghadiri, Tahereh; Vakilzadeh, Gelareh; Hajali, Vahid; Khodagholi, Fariba			Progesterone modulates post-traumatic epileptogenesis through regulation of BDNF-TrkB signaling and cell survival-related pathways in the rat hippocampus	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Progesterone; Pentylenetetrazole; Apoptosis; BDNF; Epileptogenesis	TRAUMATIC BRAIN-INJURY; KAPPA-B; ADULT; ACTIVATION; INDUCTION; EPILEPSY; SEIZURES; INSULTS; PROTEIN	Female sex hormone, progesterone, in addition to seizure modifying activity is also known as a potential protective agent against various brain injury conditions. Considering the predisposal role of traumatic brain injury (TBI) on developing post-traumatic epilepsy (PTE), the effect of progesterone on post-traumatic epileptogenesis is not investigated yet. Male Wistar rats were given a moderate focal weight drop injury (500 gr) or sham surgery and then progesterone (16 and 32mg/kg) was given daily for two consecutive weeks. On day 15 of injury, seizures were induced by administration of a GABAA receptor antagonist, pentylenetetrazole (PTZ, 30 mg/kg). Seizures were then assessed over a 1-h period using the Racine clinical rating scale. Traumatized animals that received 32 mg/kg progesterone had reduced score, duration of seizures and almost did not show tonic-clonic seizures during 60 min versus the untreated trauma group. In line with behavioral alterations, 32 mg/kg progesterone enhanced the amount of Nrf2 and HO-1 proteins and decreased the level of NF-kB, BDNF, Caspase 3 and ratio of Bax/Bcl-2 in the ipsilateral hippocampus. Additionally, the number of TUNEL-positive apoptotic cells, as well as injured dark neurons in the parietal cortex and hippocampal CA1 of 32 mg/kg-treated animals showed a significant reduction. Administration of 16 mg/kg progesterone elevated production of BDNF, Bax and Caspase 3 and decreased anti-apoptotic Bcl-2 protein. Taken together, an early administration of 32 mg/kg of progesterone after TBI for two weeks post-injury modified seizure activity. Our findings suggest that post-traumatic anti-epileptogenesis property of a high dose of progesterone partly occurs through the manipulation of BDNF-TrkB axis along with control of cell survival pathways.	[Ghadiri, Tahereh] Tabriz Univ Med Sci, Dept Neurosci, Fac Adv Med Sci, Tabriz, Iran; [Vakilzadeh, Gelareh] Khatamolanbia Hosp Tehran, Shefa Neurosci Res Ctr, Tehran, Iran; [Hajali, Vahid] Mashhad Univ Med Sci, Quchan Higher Hlth Educ Ctr, Mashhad, Razavi Khorasan, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran		Ghadiri, T (corresponding author), Tabriz Univ Med Sci, Dept Neurosci, Fac Adv Med Sci, Tabriz, Iran.	ghadirit@tbzmed.ac.ir	Khodagholi, Fariba/AAZ-4436-2020; Ghadiri, Tahereh/AAU-7811-2020	Ghadiri, Tahereh/0000-0002-3568-8699	Tehran University of Medical SciencesTehran University of Medical Sciences; Shefa Neuroscience Research Center [267258]	This study was funded by Tehran University of Medical Sciences and Shefa Neuroscience Research Center (Doctoral thesis 267258).	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Bao Y. H., 2010, J NEUROTRAUM, V28, P35; Behan LA, 2007, HORM RES, V68, P18, DOI 10.1159/000110466; Binder DK, 2004, ADV EXP MED BIOL, V548, P34; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bronnikov GE, 1999, J BIOL CHEM, V274, P37770, DOI 10.1074/jbc.274.53.37770; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Ebrahimzadeh Bideskan Ali Reza, 2015, Pathophysiology, V22, P125, DOI 10.1016/j.pathophys.2015.04.001; Edwards HE, 2001, BRAIN RES, V889, P260, DOI 10.1016/S0006-8993(00)03147-4; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Ghadiri T, 2014, J NEUROSCI METH, V233, P18, DOI 10.1016/j.jneumeth.2014.05.035; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ishida K, 2004, NEUROSCIENCE, V125, P633, DOI 10.1016/j.neuroscience.2004.02.002; Kaltschmidt B, 1999, ANTIOXID REDOX SIGN, V1, P129, DOI 10.1089/ars.1999.1.2-129; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kong SZ, 2010, BRAIN RES, V1355, P207, DOI 10.1016/j.brainres.2010.07.088; Koyama R, 2005, NEUROSCIENTIST, V11, P282, DOI 10.1177/1073858405278266; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; Otsuki Y, 2003, PROG HISTOCHEM CYTO, V38, P275, DOI 10.1016/S0079-6336(03)80002-5; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Prince D. A., 2012, TRAUMATIC BRAIN INJU; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Rong YQ, 1996, J NEUROCHEM, V67, P662; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; Sajadian A, 2015, NEUROPEPTIDES, V49, P15, DOI 10.1016/j.npep.2014.11.002; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Scharfman Helen, 2002, Epilepsy Curr, V2, P92, DOI 10.1046/j.1535-7597.2002.t01-1-00033.x; Scharfman Helen E, 2005, Epilepsy Curr, V5, P83, DOI 10.1111/j.1535-7511.2005.05312.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160	38	9	9	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 14	2019	709								134384	10.1016/j.neulet.2019.134384			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IZ6DY	WOS:000487173200010	31325580				2022-02-06	
J	Whiffin, CJ; Ellis-Hill, C; Bailey, C; Jarrett, N; Hutchinson, PJ				Whiffin, Charlotte Jane; Ellis-Hill, Caroline; Bailey, Christopher; Jarrett, Nikki; Hutchinson, Peter J.			We are not the same people we used to be: An exploration of family biographical narratives and identity change following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Family; Rehabilitation; Identity; Change	ADULT SIBLINGS; CHRONIC ILLNESS; SELF-CONCEPT; REHABILITATION; CAREGIVER; PERSPECTIVES; PREDICTORS; TRANSITION; DEPRESSION; STRESS	Subjective changes are increasingly recognised as important in recovery and rehabilitation following traumatic brain injury. Accumulation of subjective changes over time has led many to examine the question of "continuity of self" post-injury. Vacillation between feeling the same and different is common and often at odds with the medical narrative preparing families for permanent change. This position of ambiguity was examined in a qualitative narrative study. The aim of this paper is to describe the narrative structures used by uninjured members of a family to understand change. These changes relate primarily, to their perspective of whether and how the injured person had changed, but also secondarily to whether and why they themselves felt they had changed in the first year post-injury. Nine uninjured family members from three families took part in three unstructured interviews during the first twelve months post-injury. In-depth narrative analysis showed family members used biographical attendance; biographical disruption; biographical continuity; and biographical reconstruction to understand change. Drawing on these findings it is argued that concentrating on a narrative of change is too limiting and that engaging in biographical narratives may help humanise care provided to injured individuals and their families. Implications for research and practice are discussed.	[Whiffin, Charlotte Jane] Univ Derby, Coll Hlth & Social Care, Derby, England; [Ellis-Hill, Caroline] Bournemouth Univ, Fac Hlth & Social Sci, Bournemouth, Dorset, England; [Bailey, Christopher] Univ Nottingham, Queens Med Ctr, Sch Hlth Sci, Nottingham, England; [Jarrett, Nikki] Univ Southampton, Hlth Sci, Fac Hlth Sci, Southampton, Hants, England; [Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England		Whiffin, CJ (corresponding author), Univ Derby, Coll Hlth & Social Care, Derby, England.	c.whiffin@derby.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Whiffin, Charlotte/0000-0002-9767-2123; Jarrett, Nikki/0000-0003-2513-8113	NIHR Research Professorship; NIHR Cambridge BRC; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	PJH is supported by a NIHR Research Professorship and the NIHR Cambridge BRC. The Wellcome Trust Clinical Research Facility provided an appropriate environment for data collection.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Bingley AF, 2008, PALLIATIVE MED, V22, P653, DOI 10.1177/0269216308089842; Blake H, 2008, INT J THER REHABIL, V15, P263, DOI 10.12968/ijtr.2008.15.6.29878; Bowen C., 2009, HUMAN SYSTEMS J THER, V20, P62; Bruner Jerome S., 1990, ACTS MEANING; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Carter B, 2008, J CLIN NURS, V17, P1063, DOI 10.1111/j.1365-2702.2006.01942.x; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Couchman G, 2014, NEUROPSYCHOL REHABIL, V24, P809, DOI 10.1080/09602011.2014.912957; Creswell J.W., 2013, RES DESIGN QUALITATI; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2010, J REHABIL, V76, P27; Degeneffe CE, 2010, BRAIN INJURY, V24, P1416, DOI 10.3109/02699052.2010.514317; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Denzin N.K., 2011, SAGE HDB QUALITATIVE; Ellis-Hill C, 2008, DISABIL REHABIL, V30, P150, DOI 10.1080/09638280701195462; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Galvin KM, 2012, CARING WELL BEING LI; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Gosling J, 1999, BRAIN INJURY, V13, P785; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris D, 2006, HLTH SA GESONDHEID, V11, P46; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Holloway I, 2007, NARRATIVE RES NURSIN; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; JENNETT B, 1975, LANCET, V1, P480; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kosciulek JF, 1997, BRAIN INJURY, V11, P821, DOI 10.1080/026990597123034; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2016, J FAM THEOR REV, V8, P386, DOI 10.1111/jftr.12150; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; National Institute for Care and Clinical Excellence, 2014, HEAD INJ ASS EARL MA; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Riessman CK., 2005, QUALITATIVE SOCIAL W, V4, P391, DOI DOI 10.1177/1473325005058643; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Smith B., 2008, HDB CONSTRUCTIONIST, P295; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wengraf T., 2006, INTERVIEWING L UNPUB; Whiffin C. J., 2012, THESIS; Whiffin CJ, 2015, J ADV NURS, V71, P849, DOI 10.1111/jan.12551; Whiffin Charlotte Jane, 2014, Nurse Res, V21, P20, DOI 10.7748/nr2014.03.21.4.20.e1238; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191; World Health Organization, 2017, NEUROTRAUMA; Yeates G, 2007, NEUROPSYCHOL REHABIL, V17, P151, DOI 10.1080/09602010600696423; Zeigler E A, 1999, J Neurosci Nurs, V31, P106	71	9	9	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP 14	2019	29	8					1256	1272		10.1080/09602011.2017.1387577			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IF0HY	WOS:000472758600007	29070000	Green Submitted, Green Accepted			2022-02-06	
J	Caplain, S; Chenuc, G; Blancho, S; Marque, S; Aghakhani, N				Caplain, Sophie; Chenuc, Gaelle; Blancho, Sophie; Marque, Sebastien; Aghakhani, Nozar			Efficacy of Psychoeducation and Cognitive Rehabilitation After Mild Traumatic Brain Injury for Preventing Post-concussional Syndrome in Individuals With High Risk of Poor Prognosis: A Randomized Clinical Trial	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; post-concussion syndrome; rehabilitation; quality of life; human	POSTTRAUMATIC-STRESS-DISORDER; MINOR HEAD-INJURY; SYMPTOMS; PSYCHOGENESIS; PHYSIOGENESIS; VALIDATION; TASK	Unfavorable outcomes (UO) occur in 15-20% of patients with mild traumatic brain injury (mTBI). Early identification of patients at risk of UO is crucial for suitable management to be initiated, increasing the chances of full recovery. We previously developed a prognostic tool for early identification (8-21 days after the injury) of patients likely to develop UO. Patients whose initial risk factors indicate UO are at risk of developing post-concussion syndrome (PCS). In the present study, we examined the beneficial effects of early multidimensional management (MM) on prognosis. We used our prognostic tool to classify 221 mTBI patients into a UO (97) group or a favorable outcome (FO) group (124). We randomized the UO patients into two subgroups: a group that underwent MM (involving psychoeducation and cognitive rehabilitation) (34) and a control group with no specific treatment other than psychoeducation (46). At 6 months, these two groups were compared to assess the impact of MM. Among the followed-up patients initially classified as having FO (101), 95% had FO at 6 months and only five had PCS [as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV classification]. Among the followed-up MM patients, 94% did not have PCS 6 months after injury, whereas 52% of the control patients had PCS. The effect of MM on the recovery of patients at 6 months, once adjusted for the main confounding factors, was significant (p < 0.001). These results show that the initiation of MM after early identification of at-risk mTBI patients can considerably improve their outcomes.	[Caplain, Sophie] Univ Paris 08, Psychopathol & Neuropsychobgy Lab, St Denis, France; [Chenuc, Gaelle; Marque, Sebastien] Capionis Res, Bordeaux, France; [Blancho, Sophie] Inst Rech Moeile Epiniere & Encephaie, Paris, France; [Aghakhani, Nozar] Bicetre Univ Hosp, Dept Neurosurg, Paris, France		Aghakhani, N (corresponding author), Bicetre Univ Hosp, Dept Neurosurg, Paris, France.	nozar.aghakhani@aphp.fr	aghakhani, nozar/ABF-7908-2021	aghakhani, nozar/0000-0001-8389-8167	Paul Bennetot Foundation	This study was supported by Paul Bennetot Foundation.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; [Anonymous], 2002, LE GENERALISTE SUPPL; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Brickenkamp R, 1994, TEST D2 AUFMERKSAMKE; Bruchon-Schweitzer M., 1990, MANUEL STAI CD SPIEL; Bryant RA, 2011, J PSYCHIATR RES, V45, P842, DOI 10.1016/j.jpsychires.2010.11.012; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Caplain S, 2010, ACTA NEUROPSYCHOL, V8, P123; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Muller L, 2003, ENCEPHALE, V29, P507; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Palmese CA, 2000, BRAIN INJURY, V14, P535; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; RUTHERFORD WH, 1977, LANCET, V1, P1; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Thuillard F, 1983, Rev Med Suisse Romande, V103, P311; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	9	9	1	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 4	2019	10								929	10.3389/fneur.2019.00929			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IU7OQ	WOS:000483773600001	31551902	Green Published, gold			2022-02-06	
J	Horstemeyer, MF; Berthelson, PR; Moore, J; Persons, AK; Dobbins, A; Prabhu, RK				Horstemeyer, M. F.; Berthelson, P. R.; Moore, J.; Persons, A. K.; Dobbins, A.; Prabhu, R. K.			A Mechanical Brain Damage Framework Used to Model Abnormal Brain Tau Protein Accumulations of National Football League Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Damage nucleation; Damage growth; Damage coalescence; Internal state variable theory; Fatigue; Overloads; Creep	CHRONIC TRAUMATIC ENCEPHALOPATHY; FINITE-ELEMENT; CONCUSSION; FREQUENCY; INJURIES; GROWTH	A mechanics-based brain damage framework is used to model the abnormal accumulation of hyperphosphorylated p-tau associated with chronic traumatic encephalopathy within the brains of deceased National Football League (NFL) players studied at Boston University and to provide a framework for understanding the damage mechanisms. p-tau damage is formulated as the multiplicative decomposition of three independently evolving damage internal state variables (ISVs): nucleation related to number density, growth related to the average area, and coalescence related to the nearest neighbor distance. The ISVs evolve under different rates for three well known mechanical boundary conditions, which in themselves introduce three different rates making a total of nine scenarios, that we postulate are related to brain damage progression: (1) monotonic overloads, (2) cyclic fatigue which corresponds to repetitive impacts, and (3) creep which is correlated to damage accumulation over time. Different NFL player positions are described to capture the different types of damage progression. Skill position players, such as quarterbacks, are expected to exhibit a greater p-tau protein accumulation during low cycle fatigue (higher amplitude impacts with a lesser number), and linemen who exhibit a greater p-tau protein accumulation during high cycle fatigue (lower amplitude impacts with a greater number of impacts). This mechanics-based damage framework presents a foundation for developing a multiscale model for traumatic brain injury that combines mechanics with biology.	[Horstemeyer, M. F.; Moore, J.; Persons, A. K.] Mississippi State Univ, Dept Mech Engn, Starkville, MS 39762 USA; [Horstemeyer, M. F.; Berthelson, P. R.; Moore, J.; Persons, A. K.; Prabhu, R. K.] Mississippi State Univ, Ctr Adv Vehicular Syst, Starkville, MS 39759 USA; [Horstemeyer, M. F.] Liberty Univ, Sch Engn, 1971 Liberty Ave, Lynchburg, VA 24515 USA; [Berthelson, P. R.; Prabhu, R. K.] Mississippi State Univ, Dept Agr & Biol Engn, 130 Creelman St, Starkville, MS 39762 USA; [Dobbins, A.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA		Horstemeyer, MF (corresponding author), Mississippi State Univ, Dept Mech Engn, Starkville, MS 39762 USA.	mhorstemeyer@liberty.edu		Berthelson, Parker/0000-0002-2436-4218	Center for Advanced Vehicular Systems (CAVS) at Mississippi State University	MFH would like to acknowledge Jeff Crandall for conversations on this paper. MFH, PB, JM, AKP, and RKP would like to thank the Center for Advanced Vehicular Systems (CAVS) at Mississippi State University for supporting this effort.	Allison PG, 2013, J ENG MATER-T ASME, V135, DOI 10.1115/1.4025292; [Anonymous], 2018, ICME IMAGEJ; Bammann D. J., 1993, STRUCTURAL WORTHINES; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Brands D. W. A., 2002, SAE TECHNICAL PAPER; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; COCKS ACF, 1980, MET SCI, V14, P395, DOI 10.1179/030634580790441187; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Dick R, 2007, J ATHL TRAINING, V42, P221; Drapaca CS, 2006, J ELASTICITY, V85, P65, DOI 10.1007/s10659-006-9071-3; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Francis DK, 2014, INT J SOLIDS STRUCT, V51, P2765, DOI 10.1016/j.ijsolstr.2014.03.025; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; GARRISON WM, 1987, J PHYS CHEM SOLIDS, V48, P1035, DOI 10.1016/0022-3697(87)90118-1; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Horstemeyer M.F., 2012, INTEGRATED COMPUTATI; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Horstemeyer MF, 2000, INT J PLASTICITY, V16, P979, DOI 10.1016/S0749-6419(99)00076-5; Horstemeyer MF, 1999, INT J SOLIDS STRUCT, V36, P5029, DOI 10.1016/S0020-7683(98)00239-X; Kachanov M, 1999, INT J FRACTURE, V97, P1, DOI 10.1023/A:1018345702490; Kohandel M, 2006, MED ENG PHYS, V28, P449, DOI 10.1016/j.medengphy.2005.01.005; Kubota T., 2017, LIVE SCI CONTRIBUTOR; Lawrimore WB, 2016, MECH MATER, V96, P83, DOI 10.1016/j.mechmat.2016.02.002; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKee Ann C., 2018, PATHOLOGY CHRONIC TR, P19; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pihlajavaara S., 1974, CEMENT CONCRETE RES, V4, P761, DOI [https://doi.org/10.1016/0008-8846(74)90048-9, 10.1016/0008-8846(74)90048-9]; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Schaedel L, 2015, NAT MATER, V14, P1156, DOI [10.1038/NMAT4396, 10.1038/nmat4396]; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Suresh S, 1998, FATIGUE MAT, DOI [10.1017/CB09780511806575, DOI 10.1017/CB09780511806575, 10.1017/cbo9780511806575]; Ward J., 2017, 12111 N F L BRAINS A; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	48	9	9	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		1873	1888		10.1007/s10439-019-02294-1			16	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300004	31372858	Green Published, hybrid			2022-02-06	
J	Seo, DE; Shin, S; Song, KJ; Ro, YS; Hong, KJ; Park, JH				Seo, Dong Eun; Shin, Sang; Song, Kyoung Jun; Ro, Young Sun; Hong, Ki Jeong; Park, Jeong Ho			Effect of hypoxia on mortality and disability in traumatic brain injury according to shock status: A cross-sectional analysis	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Hypoxia; Shock; Survival; Disability	HOSPITAL CARDIAC-ARREST; BLOOD-PRESSURE; SLEEP-APNEA; HYPOTENSION; RESUSCITATION; ASSOCIATION; MULTICENTER; MODERATE	Objectives: This study aimed to test the association between hypoxia level and outcomes according to shock status in traumatic brain injury (TBI) patients. Methods: Adult TBI patients transported by emergency medical services in 10 provinces were enrolled. Hypoxia was a main exposure; three groups by oxygen saturation (SaO2, non-hypoxia (>= 94%), mild hypoxia (90 <= SaO2 < 94%)), and severe hypoxia (<90%). Shock status (<systolic blood pressure 90 mmHg) was an interactive exposure. The outcomes were hospital mortality and worsened disability (a 2-point increase of Glasgow Outcome Scale). Multivariable logistic regression was used to calculate the adjusted odds (AORs) with 95% Confidence intervals (CIs). Results: Of the 6125 patients, the mortality/disability rates were 49.4%/69.0% in severe hypoxia, 30.7%/46.9% in mild hypoxia, and 18.5%/27.5% in nomioxia (p < 0.0001). Mortality/disability rates were 47.1%/57.1% in shock status and 20.5%/31 A% in non-shock status (p < 0.0001). AORs (95% as) for worsened disability/mortality compared with normoxia (reference) were 3.23 (2.47-4.21)/2.24 (1.70-2.96) in patients with severe hypoxia and 2.11 (1.63-2.74)/1.84 (139-2.45) in those with mild hypoxia. AORs (95% CIs) for worsened disability/mortality was 1.58 (120-2.09)/133 (1.01-1.76) by severe hypoxia than normoxia in patient with only non-shock status in the interaction analysis. Conclusions: There was a trend toward worsened outcomes with mild and severe hypoxia in patient with and without shock, however, the only met statistical significance for patients with both severe hypoxia and non-shock status. (C) 2018 Elsevier Inc. All rights reserved.	[Seo, Dong Eun] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Shin, Sang] Seoul Natl Univ, Coll Med, Dept Emergency Med, 101 Daehak Ro, Seoul 110744, South Korea; [Song, Kyoung Jun; Park, Jeong Ho] Seoul Natl Univ, Boramae Med Ctr, Dept Emergency Med, Seoul, South Korea; [Song, Kyoung Jun; Ro, Young Sun; Hong, Ki Jeong] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea; [Hong, Ki Jeong] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea		Shin, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, 101 Daehak Ro, Seoul 110744, South Korea.	desotter@snu.ac.kr; sdshin@snu.ac.kr		Hong, Ki Jeong/0000-0003-3334-817X; Song, Kyoung Jun/0000-0002-0027-6352	Seoul Metropolitan Fire Department of Korea; Seoul Metropolitan Health Department of Korea; Korea Centers for Disease Control & Prevention (CDC)	This study was supported by the Seoul Metropolitan Fire Department and Seoul Metropolitan Health Department of Korea. The study was funded by the Korea Centers for Disease Control & Prevention (CDC) (2013-2014) (Grant for Private Support Program). The Korea CDC approved the use of the database in this study.	Avci AY, 2017, SLEEP BREATH, V21, P703, DOI 10.1007/s11325-017-1486-5; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cho EJ, 2016, RESUSCITATION, V109, P64, DOI 10.1016/j.resuscitation.2016.10.004; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; DODSON SR, 1988, CHEST, V94, P28, DOI 10.1378/chest.94.1.28; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Johansson P, 2015, EUR J CARDIOVASC NUR, V14, P222, DOI 10.1177/1474515114524072; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kong SY, 2017, PREHOSP EMERG CARE, P1; Leo P., 2016, FRONTIERS NEUROSCIEN; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Pakkanen T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0438-1; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Pimentel MAF, 2016, ACTA NEUROCHIR SUPPL, V122, P85, DOI 10.1007/978-3-319-22533-3_17; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Sun KM, 2017, PREHOSP EMERG CARE, V21, P242, DOI 10.1080/10903127.2016.1241325; Thelin EP, 2016, METHODS MOL BIOL, V1462, P459, DOI 10.1007/978-1-4939-3816-2_26; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	26	9	9	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2019	37	9					1709	1715		10.1016/j.ajem.2018.12.022			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IS5RZ	WOS:000482211500019	30583816				2022-02-06	
J	Townsend, MT; Alay, E; Skotak, M; Chandra, N				Townsend, Molly T.; Alay, Eren; Skotak, Maciej; Chandra, Namas			Effect of Tissue Material Properties in Blast Loading: Coupled Experimentation and Finite Element Simulation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Shock wave; Intracranial pressure; Brain properties	BRAIN-TISSUE; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; DEFORMATION; RESPONSES; MODELS; HELMET; RAT	Computational models of blast-induced traumatic brain injury (bTBI) require a robust definition of the material models of the brain. The mechanical constitutive models of these tissues are difficult to characterize, leading to a wide range of values reported in literature. Therefore, the sensitivity of the intracranial pressure (ICP) and maximum principal strain to variations in the material model of the brain was investigated through a combined computational and experimental approach. A finite element model of a rat was created to simulate a shock wave exposure, guided by the experimental measurements of rats subjected to shock loading conditions corresponding to that of mild traumatic brain injury in a field-validated shock tube. In the numerical model, the properties of the brain were parametrically varied. A comparison of the ICP measured at two locations revealed that experimental and simulated ICP were higher in the cerebellum (p < 0.0001), highlighting the significance of pressure sensor locations within the cranium. The ICP and strain were correlated with the long-term bulk (p < 0.0001) and shear moduli (p < 0.0001), with an 80 MPa effective bulk modulus value matching best with experimental measurements. In bTBI, the solution is sensitive to the brain material model, necessitating robust validation methods.	[Townsend, Molly T.; Alay, Eren; Skotak, Maciej; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294; Alay, Eren/0000-0003-2523-0366	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [14059001, W81XWH-15-1-0303]	This work was supported by Grant No. 14059001 (W81XWH-15-1-0303) under the U.S. Army Medical Research and Materiel Command. Authors acknowledge the assistance of Dr. Saikat Pal with proof reading, Debrina Roy in model development, and Dr. Raj Gupta in theoretical discussions.	Baumgartner D, 2009, IRCOBI C, P97; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN, P1; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Gadd CW, 1970, TOLERANCE PROPERTIES, DOI [10.4271/700910, DOI 10.4271/700910]; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Ganpule S, 2018, SHOCK WAVES, V28, P127, DOI 10.1007/s00193-017-0791-z; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Gupta RK, 2017, DEF LIFE SCI J, V2, P3, DOI DOI 10.14429/dlsj.2.10369; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Prange M T, 2000, Stapp Car Crash J, V44, P205; Przekwas A., 2009, ASME 2009 SUMM BIOEN, DOI [10.1115/sbc2009-206839, DOI 10.1115/SBC2009-206839]; Qian L, 2018, J MECH BEHAV BIOMED, V82, P210, DOI 10.1016/j.jmbbm.2018.03.031; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sarvghad-Moghaddam H, 2017, COMPUT METHOD BIOMEC, V20, P16, DOI 10.1080/10255842.2016.1193597; Singh D, 2017, SHOCK WAVES, V27, P905, DOI 10.1007/s00193-017-0732-x; Stalnaker RL, 1969, MECH PROPERTIES HEAD, P1; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; Zhang Jiangyue, 2009, Biomed Sci Instrum, V45, P119; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhu F, 2016, COMPUT METHOD BIOMEC, V19, P1053, DOI 10.1080/10255842.2015.1091887; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	45	9	9	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		2019	2032		10.1007/s10439-018-02178-w			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300014	30523466				2022-02-06	
J	Van Ornam, J; Pruitt, P; Borczuk, P				Van Ornam, Jonathan; Pruitt, Peter; Borczuk, Pierre			Is repeat head CT necessary in patients with mild traumatic intracranial hemorrhage	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 16-19, 2017	Orlando, FL	Soc Acad Emergency Med		Mild intracranial hemorrhage; Imaging utilization; Traumatic brain injury; Traumatic cranial computerized tomography	COMPUTED TOMOGRAPHIC SCANS; BRAIN-INJURY; LOW-RISK; UTILITY	Background: Patients with traumatic intracranial hemorrhage (TIH) frequently receive repeat head CT scans (RHCT) to assess for progression of TIH. The utility of this practice has been brought into question, with some studies suggesting that in the absence of progressive neurologic symptoms, the RHCT does not lead to clinical interventions. Methods: This was a retrospective review of consecutive patients with CT-documented TIH and GCS >= 13 presenting to an academic emergency department from 2009 to 2013. Demographic, historical, and physical exam variables, number of CT scans during admission were collected with primary outcomes of: neurological decline, worsening findings on repeat CT scan, and the need for neurosurgical intervention. Results: Of these 1126 patients with mild traumatic intracranial hemorrhage, 975 had RHCT. Of these, 54 (5.5% (4.2-7.2 95 CI) had neurological decline, 73 (7.5% 5.9-9.3 95 CI) had hemorrhage progression on repeat CT scan, and 58 (5.9% 4.5-7.6 95 CI) required neurosurgical intervention. Only 3 patients (0.3% 0.1-0.9% 95 CI) underwent neurosurgical intervention due to hemorrhage progression on repeat CT scan without neurological decline. In this scenario, the number of RHCT scans needed to be performed to identify this one patient is 305. Conclusions: RHCT after initial findings of TIH and GCS >= 13 leading to a change to operative management in the absence of neurologic progression is a rare event. A protocol that includes selective RHCT including larger subdural hematomas or patients with coagulopathy (vitamin K inhibitors and anti-platelet agents) may be a topic for further study. (C) 2018 Published by Elsevier Inc.	[Van Ornam, Jonathan; Borczuk, Pierre] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Van Ornam, Jonathan; Borczuk, Pierre] Harvard Affiliated Emergency Med Residency, Boston, MA 02114 USA; [Pruitt, Peter] Northwestern Univ, Chicago, IL 60611 USA		Van Ornam, J (corresponding author), Massachusetts Gen Hosp, Harvard Affiliated Emergency Med Residency, Five Emerson Pl, Boston, MA 02114 USA.	jvanornam@partners.org		Borczuk, Pierre/0000-0002-6242-7312			Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; BRUNETTI J, 1979, NEURORADIOLOGY, V18, P43, DOI 10.1007/BF00346211; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2011, MMWR SURVEILL SUMM, V60, P1; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Haider AA, 2015, AM J SURG, V210, P1088, DOI 10.1016/j.amjsurg.2015.07.004; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jeng TC, 2008, MALAYS J MED SCI, V15, P56; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kreitzer N, 2017, AM J EMERG MED, V35, P875, DOI 10.1016/j.ajem.2017.01.051; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Yun BJ, 2018, ACAD EMERG MED, V25, P769, DOI 10.1111/acem.13350	23	9	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2019	37	9					1694	1698		10.1016/j.ajem.2018.12.012			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	IS5RZ	WOS:000482211500016	30559018				2022-02-06	
J	Scott, LR; Bazargan-Hejazi, S; Shirazi, A; Pan, DY; Lee, S; Teruya, SA; Shaheen, M				Scott, Lagina R.; Bazargan-Hejazi, Shahrzad; Shirazi, Anaheed; Pan, Deyu; Lee, Steven; Teruya, Stacey A.; Shaheen, Magda			Helmet use and bicycle-related trauma injury outcomes	BRAIN INJURY			English	Article						Helmet use; traumatic brain injury; cycling	BRAIN-INJURY; ACCIDENTS; LAWS	Background: It is essential to identify factors that predict helmet use, so as to mitigate the injury and mortality from bicycle accidents. Objective: To examine the relationship between helmet use and the bicycle-related trauma injury outcomes among bicyclists with head/neck injury in the US. Methods: Data from the 2002-2012 National Trauma Data Bank were used, including all trauma bicycle riders involved in bicycle-related accidents whose primary reason for the hospital or Intensive Care Unit stay was head or neck injury. Using multiple logistic regression, the association between helmet use, Injury severity score (ISS), length of stay in hospital (HLOS) and Intensive Care Unit (ICULOS), and mortality was examined. Results: Of the 76,032 bicyclists with head/neck injury, 22% worn helmets. The lowest was among Blacks, Hispanics, and <17 years old. Wearing a helmet significantly reduces injury severity, HLOS, ICULOS, and mortality (i.e total and in-hospital). Males had a severe injury, longer HLOS, ICULOS, and higher mortality than female. Blacks and Hispanics had longer HLOS and ICULOS and higher total mortality than Whites, but had a similar chance for in-hospital mortality. Conclusions: More effort is needed to enhance helmet use among at-risk bicycle riders, which may reduce injury severity, HLOS, ICULOS, and mortality.	[Scott, Lagina R.; Bazargan-Hejazi, Shahrzad; Teruya, Stacey A.; Shaheen, Magda] Charles R Drew Univ Med & Sci, David Geffen Sch Med, 1621 E 120th St, Los Angeles, CA 90059 USA; [Shirazi, Anaheed] Charles Drew Univ Med & Sci, Psychiat, Los Angeles, CA USA; [Pan, Deyu] Charles Drew Univ Med & Sci, Prevent & Social Med, Los Angeles, CA USA; [Lee, Steven] Univ Calif Los Angeles, Harbor UCLA Div Pediat Surg, Gen Surg Residency, Los Angeles, CA USA; [Lee, Steven] Harbor UCLA Harbor UCLA Acad Off, Los Angeles, CA USA		Bazargan-Hejazi, S (corresponding author), Charles R Drew Univ Med & Sci CDU, Coll Med, Los Angeles, CA 90059 USA.; Bazargan-Hejazi, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA.	shahrzadbazargan@cdrewu.edu			University of California at Los Angeles (UCLA) Clinical and Translational Science Institute (CTSI) [UL1TR001881]; NIH Accelerated Excellence in Translational Sciences (AXIS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54MD007598]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001881] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007598] Funding Source: NIH RePORTER	This work was supported by the University of California at Los Angeles (UCLA) Clinical and Translational Science Institute (CTSI) [UL1TR001881]; NIH Accelerated Excellence in Translational Sciences (AXIS) [U54MD007598 (formerly U54RR026138)].	[Anonymous], 2015, 812151 DOT HS NAT HI; Baeseman Zachary J, 2014, WMJ, V113, P49; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; Dellinger AM, 2010, J SAFETY RES, V41, P375, DOI 10.1016/j.jsr.2010.05.003; Ebell MH, 2012, TRAFFIC INJ PREV, V13, P150, DOI 10.1080/15389588.2011.644255; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Forjuoh Samuel N, 2003, Med Sci Monit, V9, pCR436; Gulack BC, 2015, SURGERY, V158, P556, DOI 10.1016/j.surg.2015.02.025; Hofmann LJ, 2018, CUREUS, V10, DOI 10.7759/cureus.3610; Jewett A, 2016, J SAFETY RES, V59, P1, DOI 10.1016/j.jsr.2016.09.001; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Kraemer John D, 2016, Inj Epidemiol, V3, P21; Kraemer JD, 2016, J ADOLESCENT HEALTH, V59, P338, DOI 10.1016/j.jadohealth.2016.03.009; Kuo SCH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4649-1; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Meehan WP, 2013, J PEDIATR-US, V163, P726, DOI 10.1016/j.jpeds.2013.03.073; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; Olivier J, 2017, TRAFFIC INJ PREV, V18, P755, DOI 10.1080/15389588.2017.1298748; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Pierce SR, 2014, HEALTH PROMOT PRACT, V15, P406, DOI 10.1177/1524839913512329; Rezendes Jennifer L, 2006, J Pediatr Nurs, V21, P35, DOI 10.1016/j.pedn.2005.06.005; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Stranges E. (Thomson Reuters) Uscher-Pines L. (RAND) Stocks C. (Agency for Healthcare Research and Quality), 2009, HCUP STAT BRIEF 135; Thompson MP, 1999, MRS INTERNET J N S R, V4, part. no.; Williams C, 2018, J SURG RES, V222, P231, DOI 10.1016/j.jss.2017.11.006	25	9	9	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1597	1601		10.1080/02699052.2019.1650201		AUG 2019	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000486218500001	31514542				2022-02-06	
J	Rangaprakash, D; Dretsch, MN; Katz, JS; Denney, TS; Deshpande, G				Rangaprakash, D.; Dretsch, Michael N.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			Dynamics of Segregation and Integration in Directional Brain Networks: Illustration in Soldiers With PTSD and Neurotrauma	FRONTIERS IN NEUROSCIENCE			English	Article						functional MRI; network dynamics; complex network modeling; effective connectivity; dynamic connectivity; posttraumatic stress disorder; mild traumatic brain injury; machine learning	POSTTRAUMATIC-STRESS-DISORDER; RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; PREFRONTAL CORTEX; SPATIAL IMAGERY; INJURY; MRI; CLASSIFICATION; VARIABILITY	Brain functioning relies on various segregated/specialized neural regions functioning as an integrated-interconnected network (i.e., metastability). Various psychiatric and neurologic disorders are associated with aberrant functioning of these brain networks. In this study, we present a novel framework integrating the strength and temporal variability of metastability in brain networks. We demonstrate that this approach provides novel mechanistic insights which enables better imaging-based predictions. Using whole-brain resting-state fMRI and a graph-theoretic framework, we integrated strength and temporal-variability of complex-network properties derived from effective connectivity networks, obtained from 87 U.S. Army soldiers consisting of healthy combat controls (n = 28), posttraumatic stress disorder (PTSD; n = 17), and PTSD with comorbid mild-traumatic brain injury (mTBI; n = 42). We identified prefrontal dysregulation of key subcortical and visual regions in PTSD/mTBI, with all network properties exhibiting lower variability over time, indicative of poorer flexibility. Larger impairment in the prefrontal-subcortical pathway but not prefrontal-visual pathway differentiated comorbid PTSD/mTBI from the PTSD group. Network properties of the prefrontal-subcortical pathway also had significant association (R-2 = 0.56) with symptom severity and neurocognitive performance; and were also found to possess high predictive ability (81.4% accuracy in classifying the disorders, explaining 66-72% variance in symptoms), identified through machine learning. Our framework explained 13% more variance in behaviors compared to the conventional framework. These novel insights and better predictions were made possible by our novel framework using static and time-varying network properties in our three-group scenario, advancing the mechanistic understanding of PTSD and comorbid mTBI. Our contribution has wide-ranging applications for network-level characterization of healthy brains as well as mental disorders.	[Rangaprakash, D.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, AU MRI Res Ctr, Auburn, AL 36849 USA; [Rangaprakash, D.] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Rangaprakash, D.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] US Army Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis McChord, Joint Base Lewis Mcchord, WA USA; [Dretsch, Michael N.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Alabama Adv Imaging Consortium, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Ctr Neurosci, Auburn, AL 36849 USA; [Deshpande, Gopikrishna] Auburn Univ, Ctr Hlth Ecol & Equ Res, Auburn, AL 36849 USA; [Deshpande, Gopikrishna] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, India		Rangaprakash, D; Deshpande, G (corresponding author), Auburn Univ, AU MRI Res Ctr, Auburn, AL 36849 USA.; Rangaprakash, D (corresponding author), Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA.; Rangaprakash, D (corresponding author), Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA.; Deshpande, G (corresponding author), Auburn Univ, Dept Psychol, Auburn, AL 36849 USA.; Deshpande, G (corresponding author), Alabama Adv Imaging Consortium, Auburn, AL 36849 USA.; Deshpande, G (corresponding author), Auburn Univ, Ctr Neurosci, Auburn, AL 36849 USA.; Deshpande, G (corresponding author), Auburn Univ, Ctr Hlth Ecol & Equ Res, Auburn, AL 36849 USA.; Deshpande, G (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, India.	rzd0016@auburn.edu; gopi@auburn.edu			United States Army Medical Research and Materiel Command (MRMC) [00007218]	All authors acknowledge financial support for this work from the United States Army Medical Research and Materiel Command (MRMC) (Grant #00007218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Bellucci G, 2017, SOC NEUROSCI-UK, V12, P124, DOI 10.1080/17470919.2016.1153518; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Betzel RF, 2016, NEUROIMAGE, V127, P287, DOI 10.1016/j.neuroimage.2015.12.001; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Buchel C, 1998, HUM BRAIN MAPP, V6, P403; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Chen TW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002469; Chiang S, 2016, NEUROIMAGE, V125, P601, DOI 10.1016/j.neuroimage.2015.10.070; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deshpande G, 2009, P ISMRM 17 SCI M HON; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Deshpande G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00670; Deshpande G, 2012, BRAIN CONNECT, V2, P235, DOI 10.1089/brain.2012.0091; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Emmert K, 2016, NEUROIMAGE, V124, P806, DOI 10.1016/j.neuroimage.2015.09.042; Feng CL, 2016, HUM BRAIN MAPP, V37, P663, DOI 10.1002/hbm.23057; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P10, DOI 10.1016/B978-012372560-8/50002-4; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grant MM, 2015, NEUROPSYCHOPHARMACOL, V40, P1782, DOI 10.1038/npp.2015.28; Grant MM, 2014, HUM BRAIN MAPP, V35, P4815, DOI 10.1002/hbm.22514; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Gross J. J., 2014, HDB EMOTION REGULATI, V2nd, P3; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hall CN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0348; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hurlburt RT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01535; Hutcheson NL, 2015, HUM BRAIN MAPP, V36, P1442, DOI 10.1002/hbm.22714; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; Jin CF, 2017, HUM BRAIN MAPP, V38, P4479, DOI 10.1002/hbm.23676; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Katwal SB, 2013, NEUROIMAGE, V66, P436, DOI 10.1016/j.neuroimage.2012.10.052; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; King D. W., 2003, MANUAL DEPLOYMENT RI; Kirchgassner G, 2012, INTRO MODERN TIME SE; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lacey S, 2014, NEUROPSYCHOLOGIA, V60, P144, DOI 10.1016/j.neuropsychologia.2014.05.008; Lamichhane B, 2014, BRAIN CONNECT, V4, P619, DOI 10.1089/brain.2014.0243; Liao XH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00478, 10.3389/fnhum.7015.00478]; Libero LE, 2015, CORTEX, V66, P46, DOI 10.1016/j.cortex.2015.02.008; Lin P, 2014, BRAIN IMAGING BEHAV, V8, P558, DOI 10.1007/s11682-013-9279-3; Liu F, 2015, BRAIN TOPOGR, V28, P221, DOI 10.1007/s10548-014-0386-2; Marquand AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069237; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Preti MG, 2017, NEUROIMAGE, V160, P41, DOI 10.1016/j.neuroimage.2016.12.061; Rangaprakash D, 2018, DATA BRIEF, V17, P1175, DOI 10.1016/j.dib.2018.01.003; Rangaprakash D, 2018, MAGN RESON MED, V80, P1697, DOI 10.1002/mrm.27146; Rangaprakash D, 2018, HUM BRAIN MAPP, V39, P264, DOI 10.1002/hbm.23841; Rangaprakash D, 2017, NEUROIMAGE-CLIN, V16, P409, DOI 10.1016/j.nicl.2017.07.016; Rangaprakash D, 2017, DATA BRIEF, V14, P558, DOI 10.1016/j.dib.2017.07.072; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rangaprakash D, 2016, THESIS; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Rocca MA, 2016, BRAIN STRUCT FUNCT, V221, P115, DOI 10.1007/s00429-014-0896-4; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ryali S, 2016, NEUROIMAGE, V132, P398, DOI 10.1016/j.neuroimage.2016.02.067; Ryali S, 2012, NEUROIMAGE, V59, P3852, DOI 10.1016/j.neuroimage.2011.11.054; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sathian K, 2013, J NEUROSCI, V33, P5387, DOI 10.1523/JNEUROSCI.3482-12.2013; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thompson WL, 2009, PSYCHOL SCI, V20, P1245, DOI 10.1111/j.1467-9280.2009.02440.x; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Veterans, 2015, VET STAT PTSD DEPR T; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wang YZ, 2017, IEEE T NEUR SYS REH, V25, P539, DOI 10.1109/TNSRE.2016.2593655; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wheelock MD, 2014, NEUROIMAGE, V102, P904, DOI 10.1016/j.neuroimage.2014.08.005; White SF, 2015, NEUROIMAGE-CLIN, V7, P19, DOI 10.1016/j.nicl.2014.11.012; Woo CW, 2015, PAIN, V156, P1379, DOI 10.1097/j.pain.0000000000000223; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yu QB, 2013, SCHIZOPHR RES, V150, P450, DOI 10.1016/j.schres.2013.09.016; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zhang J, 2016, BRAIN, V139, P2307, DOI 10.1093/brain/aww143; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	109	9	11	2	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 23	2019	13								803	10.3389/fnins.2019.00803			23	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IS8VC	WOS:000482426600001	31507353	gold, Green Published			2022-02-06	
J	Han, K; Chapman, SB; Krawczyk, DC				Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.			Cognitive Training Reorganizes Network Modularity in Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain network; intervention; functional connectivity; graph theory; neuroplasticity; resting-state	FUNCTIONAL CONNECTIVITY; FMRI; NEUROPLASTICITY; REHABILITATION; ORGANIZATION; PLASTICITY; ATTENTION; DEFAULT	Background. Graph-theoretic approaches are increasingly popular for identifying the patterns of disrupted neural systems after traumatic brain injury (TBI). However, the patterns of neuroplasticity in brain organization after cognitive training in TBI are less well understood. Objective. We identified the patterns of training-induced neuroplasticity of the whole-brain network in TBI, using resting-state functional connectivity and graph theory. Methods. A total of 64 civilians and veterans with TBI were randomized into either a strategy-based cognitive training group (n = 33) or a knowledge-based training group (active control group; n = 31) for 8 weeks. The participants experienced mild to severe TBI without focal damage and persistent cognitive dysfunctions. A subset of participants complained of subclinical but residual psychiatric symptoms. We acquired their resting-state functional magnetic resonance imaging before training, immediately posttraining, and 3 months posttraining. From participants' resting-state networks, we obtained the modularity, participation coefficient, within-module connectivity, global efficiency, and local efficiency over multiple network densities. We next performed longitudinal analyses on those measures corrected for multiple comparisons across network densities using false discovery rate (FDR). Results. Relative to the knowledge-based training group, the strategy-based cognitive training group had reduced modularity and increased participation coefficient, global efficiency, and local efficiency over time (P-nodal < .05; q(FDR) < 0.05). Brain behavior analysis revealed that the participation coefficient and global efficiency within the strategy-based cognitive training group correlated with trail-making scores in the context of training (P-nodal < .05; q(FDR) < 0.05). Conclusions. Cognitive training reorganized modular networks in TBI over the whole brain. Graph-theoretic approaches may be useful in identifying a potential brain-based marker of training efficacy in TBI.	[Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Dallas, TX USA; [Krawczyk, Daniel C.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA		Han, K (corresponding author), Ctr BrainHlth, Sch Behav & Brain Sci, 2200 West Mockingbird Lane, Dallas, TX 75235 USA.	kihwan.han98@gmail.com		Han, Kihwan/0000-0002-4574-7306	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation; Sapphire Foundation Distinguished New Scientist Award; Friends of BrainHealth Distinguished New Scientist Award	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Department of Defense (W81XWH-11-2-0194 to DCK and W81XWH-11-2-0195 to SBC), the Meadows Foundation to DCK and SBC, and the Sapphire Foundation Distinguished New Scientist Award and the Friends of BrainHealth Distinguished New Scientist Award to KH. The views and opinions expressed in this article are those of the authors and do not reflect the official policy or position of the US Department of the Army, US Department of the Air Force, US Department of Defense, US Government, or the affiliated institutions.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alaverdashvili M, 2013, NEUROSCI BIOBEHAV R, V37, P950, DOI 10.1016/j.neubiorev.2013.03.026; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Binder D, 2008, BRAIN HLTH WORKSH; Birn RM, 2002, NEUROIMAGE, V15, P252, DOI 10.1006/nimg.2001.0964; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delis DC., 2001, DELIS KAPLAN EXECUTI; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Han K, 2018, NEUROIMAGE-CLIN, V18, P262, DOI 10.1016/j.nicl.2018.01.030; Han KW, 2018, HUM BRAIN MAPP, V39, P2955, DOI 10.1002/hbm.24052; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kolb B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00377; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vargas ER, 2016, MED BIOL ENG COMPUT, V54, P235, DOI 10.1007/s11517-015-1396-2; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Weathers F.W., 1993, ANN M INT SOC TRAUM; Wechsler D., 2011, WECHSLER ABBREVIATED; WechslerD, 2001, WECHSLER TEST ADULT	57	9	10	2	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2020	34	1					26	38	1545968319868710	10.1177/1545968319868710		AUG 2019	13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC9UZ	WOS:000483681300001	31434528	hybrid			2022-02-06	
J	Verhelst, H; Giraldo, D; Vander Linden, C; Vingerhoets, G; Jeurissen, B; Caeyenberghs, K				Verhelst, Helena; Giraldo, Diana; Vander Linden, Catharine; Vingerhoets, Guy; Jeurissen, Ben; Caeyenberghs, Karen			Cognitive Training in Young Patients With Traumatic Brain Injury: A Fixel-Based Analysis	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; cognitive training; diffusion weighted imaging; fixel-based analysis; neuroplasticity	WHITE-MATTER; DIFFUSION MRI; SPHERICAL-DECONVOLUTION; FIBER TRACTOGRAPHY; EXECUTIVE FUNCTION; PLASTICITY; REHABILITATION; CHILDREN; DENSITY; DTI	Background. Traumatic brain injury (TBI) is associated with altered white matter organization and impaired cognitive functioning. Objective. We aimed to investigate changes in white matter and cognitive functioning following computerized cognitive training. Methods. Sixteen adolescents with moderate-to-severe TBI (age 15.6 +/- 1.8 years, 1.2-4.6 years postinjury) completed the 8-week BrainGames program and diffusion weighted imaging (DWI) and cognitive assessment at time point 1 (before training) and time point 2 (after training). Sixteen healthy controls (HC) (age 15.6 +/- 1.8 years) completed DWI assessment at time point 1 and cognitive assessment at time point 1 and 2. Fixel-based analyses were used to examine fractional anisotropy (FA), mean diffusivity (MD), and fiber cross-section (FC) on a whole brain level and in tracts of interest. Results. Patients with TBI showed cognitive impairments and extensive areas with decreased FA and increased MD together with an increase in FC in the body of the corpus callosum and left superior longitudinal fasciculus (SLF) at time point 1. Patients improved significantly on the inhibition measure at time point 2, whereas the HC group remained unchanged. No training-induced changes were observed on the group level in diffusion metrics. Exploratory correlations were found between improvements on verbal working memory and reduced MD of the left SLF and between increased performance on an information processing speed task and increased FA of the right precentral gyrus. Conclusions. Results are indicative of positive effects of BrainGames on cognitive functioning and provide preliminary evidence for neuroplasticity associated with cognitive improvements following cognitive intervention in TBI.	[Verhelst, Helena; Vingerhoets, Guy] Univ Ghent, Ghent, Belgium; [Giraldo, Diana; Jeurissen, Ben] Univ Antwerp, Antwerp, Belgium; [Giraldo, Diana] Univ Nacl Colombia, Bogota, Colombia; [Vander Linden, Catharine] Ghent Univ Hosp, Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Melbourne, Vic, Australia		Verhelst, H (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Dunantlaan 2, B-9000 Ghent, Belgium.	helena.verhelst@ugent.be	Jeurissen, Ben/C-3246-2011	Jeurissen, Ben/0000-0002-3488-9819; Verhelst, Helena/0000-0002-6861-0249	Special Research Fund (BOF) from the University of Ghent [01N00214]; Research Foundation Flanders (FWO Vlaanderen)FWO [12M3116N]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a grant (#01N00214) from the Special Research Fund (BOF) from the University of Ghent. BJ is a postdoctoral fellow of the Research Foundation Flanders (FWO Vlaanderen) (grant #12M3116N).	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Colom R, 2012, INTELLIGENCE, V40, P479, DOI 10.1016/j.intell.2012.05.004; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Diez-Cirarda M, 2017, BRAIN IMAGING BEHAV, V11, P1640, DOI 10.1007/s11682-016-9639-x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dong GH, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00372; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fernandez E, 2012, MEDICC REV, V14, P32, DOI 10.37757/MR2012V14.N4.8; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huizinga M., 2009, BRIEF VRAGENLIJST EX; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jeurissen B, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3785; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kort W., 2005, WISC 3 NL WECHSLER I; Lampit A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00014; Lebel C, 2018, NEUROIMAGE, V182, P207, DOI 10.1016/j.neuroimage.2017.12.097; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Matthews PM, 2004, RESTOR NEUROL NEUROS, V22, P245; Metzler-Baddeley C, 2017, J COGNITIVE NEUROSCI, V29, P1509, DOI 10.1162/jocn_a_01127; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Perrone D, 2015, NEUROIMAGE, V120, P441, DOI 10.1016/j.neuroimage.2015.06.068; Prosperini L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/481574; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raffelt DA, 2015, NEUROIMAGE, V117, P40, DOI 10.1016/j.neuroimage.2015.05.039; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Vander Linden C, 2019, EUR J PHYS REHAB MED, V55, P585, DOI 10.23736/S1973-9087.18.05548-X; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Verhelst H, 2017, GAMES HEALTH J, V6, P28, DOI 10.1089/g4h.2016.0043; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	67	9	9	3	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	OCT	2019	33	10					813	824	1545968319868720	10.1177/1545968319868720		AUG 2019	12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IW0QP	WOS:000483188700001	31416407	Bronze			2022-02-06	
J	Jildeh, TR; Okoroha, KR; Taylor, KA; Buckley, P; Mehta, S; Mehran, N; Moutzouros, V				Jildeh, Toufic R.; Okoroha, Kelechi R.; Taylor, Kevin A.; Buckley, Patrick; Mehta, Samir; Mehran, Nima; Moutzouros, Vasilios			Effect of Concussions on the Performance of Running Backs and Wide Receivers in the National Football League	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; outcome; NFL; football; performance	COLLATERAL LIGAMENT RECONSTRUCTION; SPORT-RELATED CONCUSSION; INJURIES; RETURN; OUTCOMES; SURGERY; PLAYERS; DYSFUNCTION	Background: Concussion injuries are common in professional football players; however, their effect on player performance remains unclear. Purpose: To quantify the effect of concussions on the performance of running backs and wide receivers in professional football players. Study Design: Cohort study; Level of evidence, 3. Methods: Concussion data from the National Football League were collected for a period of 4 seasons (2012-2015) for running backs and wide receivers. Age, experience, position, time to return to play, yearly total yards, and touchdowns were recorded. A power rating (total yards divided by 10 plus touchdowns multiplied by 6) was calculated for each player's injury season as well as for the 3 seasons before and after their respective injury. A control group of running backs and wide receivers without an identified concussion injury who competed in the 2012 season was assembled for comparison. Player performance up to 3 seasons before and after the injury season was examined to assess acute and longitudinal changes in player performance. Results: A total of 38 eligible running backs and wide receivers sustained a concussion during the study period. Thirty-four (89%) players were able to return to competition in the same season, missing an average of 1.5 +/- 0.9 games; the remaining 4 players returned in the subsequent season. Power ratings for concussed players were similar to those of controls throughout the study period. Concussed players did not suffer an individual performance decline upon returning within the same season. Furthermore, no significant difference in change of power rating was observed in concussed players in the acute (+/- 1 year from injury; -1.2 +/- 4.8 vs -1.1 +/- 3.9, P = .199) or chronic (+/- 3 years from injury; -3.6 +/- 8.0 vs -3.0 +/- 4.5, P = .219) setting compared with controls. All concussed players successfully returned to competition in either the index or next season. Conclusion: A high rate of National Football League running backs and wide receivers are able to return to play after a concussion injury. These players were found to perform at a similar level in both the acute and long-term period after concussion.	[Jildeh, Toufic R.; Okoroha, Kelechi R.; Taylor, Kevin A.; Buckley, Patrick; Mehta, Samir; Mehran, Nima; Moutzouros, Vasilios] Henry Ford Hlth Syst, Detroit, MI USA; [Jildeh, Toufic R.; Okoroha, Kelechi R.; Taylor, Kevin A.; Moutzouros, Vasilios] Henry Ford Hlth Syst, Dept Orthopaed Surg, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Buckley, Patrick] Wayne State Univ, Sch Med, Detroit, MI USA; [Mehta, Samir] Hosp Univ Penn, Dept Orthopaed Surg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Mehran, Nima] Kaiser Permanente Los Angeles Med Ctr, Dept Orthoped, lSouthern Calif Permanente Med Grp, Los Angeles, CA USA		Jildeh, TR (corresponding author), Henry Ford Hlth Syst, Dept Orthopaed Surg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	touficjildeh@gmail.com					Barzilai P, 2014, US TODAY; Boublik M, 2013, AM J SPORT MED, V41, P1841, DOI 10.1177/0363546513490655; Boublik M, 2011, AM J SPORT MED, V39, P2436, DOI 10.1177/0363546511417083; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Carey JL, 2006, AM J SPORT MED, V34, P1911, DOI 10.1177/0363546506290186; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Erickson BJ, 2014, ORTHOPEDICS, V37, DOI 10.3928/01477447-20140728-59; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Jack RA, 2017, FOOT ANKLE INT, V38, P1092, DOI 10.1177/1071100717718131; Keller RA, 2017, J SHOULDER ELB SURG, V26, P288, DOI 10.1016/j.jse.2016.11.008; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Mai HT, 2016, AM J SPORT MED, V44, P2255, DOI 10.1177/0363546516651426; Marshall NE, 2018, ARTHROSCOPY, V34, P1809, DOI 10.1016/j.arthro.2018.01.008; Marshall NE, 2018, ARTHROSCOPY, V34, P473, DOI 10.1016/j.arthro.2017.08.298; McHale KJ, 2016, AM J SPORT MED, V44, P1810, DOI 10.1177/0363546516645082; National Football League, 2017, 2017 PERS INJ REP PO; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Nwachukwu BU, 2018, AM J SPORT MED, V46, P144, DOI 10.1177/0363546517729163; Okoroha KR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117698788; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Read CR, 2017, AM J SPORT MED, V45, P1815, DOI 10.1177/0363546517703361; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Yang J, 2017, J MATER CHEM B, V5	29	9	9	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2019	47	11					2717	2722	0363546519864581	10.1177/0363546519864581		AUG 2019	6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	IV8UI	WOS:000480352400001	31386551				2022-02-06	
J	Bobeff, EJ; Fortuniak, J; Bryszewski, B; Wisniewski, K; Bryl, M; Kwiecien, K; Stawiski, K; Jaskolski, DJ				Bobeff, Ernest J.; Fortuniak, Jan; Bryszewski, Bartosz; Wisniewski, Karol; Bryl, Maciej; Kwiecien, Katarzyna; Stawiski, Konrad; Jaskolski, Dariusz J.			Mortality After Traumatic Brain Injury in Elderly Patients: A New Scoring System	WORLD NEUROSURGERY			English	Article						Decision-making; Older adults; Prognosis; Scoring system; Traumatic brain injury	CELL DISTRIBUTION WIDTH; SELF-FULFILLING PROPHECY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; PROGNOSTIC MODELS; 28-DAY MORTALITY; IMPACT; ANTIPLATELET; PREDICTION; OUTCOMES	BACKGROUND: Traumatic brain injury (TBI) remains a life-threatening condition characterized by growing incidence worldwide, particularly in the aging population, in which the primary goal of treatment appears to be avoidance of chronic institutionalization. METHODS: To identify independent predictors of 30-day mortality or vegetative state in a geriatric population and calculate an intuitive scoring system, we screened 480 patients after TBI treated at a single department of neurosurgery over a 2-year period. We analyzed data of 214 consecutive patients aged >= 65 years, including demographics, medical history, cause and time of injury, neurologic state, radiologic reports, and laboratory results. A predictive model was developed using logistic regression modeling with a backward stepwise feature selection. RESULTS: The median Glasgow Coma Scale (GCS) score on admission was 14 (interquartile range, 12-15), whereas the 30-day mortality or vegetative state rate amounted to 23.4%. Starting with 20 predefined features, the final prediction model highlighted the importance of GCS motor score (odds ratio [OR], 0.17; 95% confidence interval [CI], 0.09-0.32); presence of comorbid cardiac, pulmonary, or renal dysfunction or malignancy (OR, 2.86; 9 5% CI, 1.08-7.61); platelets <= 100 x 10(9) cella (OR, 13.60; 95% CI, 3.33-55.49); and red blood cell distribution width coefficient of variation .14.5% (OR, 2.91; 95% CI, 1.09-7.78). The discovered coefficients were used for nomogram development. It was further simplified to facilitate clinical use. The proposed scoring system, Elderly Traumatic Brain Injury Score (eTBI Score), yielded similar performance metrics. CONCLUSIONS: The eTBI Score is the first scoring system designed specifically for older adults. It could constitute a framework for clinical decision-making and serve as an outcome predictor. Its capability to stratify risk provides reliable criteria for assessing efficacy of TBI management.	[Bobeff, Ernest J.; Fortuniak, Jan; Bryszewski, Bartosz; Wisniewski, Karol; Bryl, Maciej; Kwiecien, Katarzyna; Jaskolski, Dariusz J.] Med Univ Lodz, Barlicki Univ Hosp, Dept Neurosurg & Neurooncol, Lodz, Poland; [Stawiski, Konrad] Med Univ Lodz, Dept Biostat & Translat Med, Lodz, Poland		Fortuniak, J (corresponding author), Med Univ Lodz, Barlicki Univ Hosp, Dept Neurosurg & Neurooncol, Lodz, Poland.	jfort@tlen.pl	Stawiski, Konrad/O-6006-2019; Jaskolski, Dariusz/AAA-7656-2021; Jaskolski, Dariusz J/H-8051-2013	Stawiski, Konrad/0000-0002-6550-3384; Jaskolski, Dariusz/0000-0002-9971-9677; Bobeff, Ernest/0000-0003-1891-3791			Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Citerio G, 2007, INTENS CARE MED, V33, P45, DOI 10.1007/s00134-006-0381-5; Creutzfeldt CJ, 2011, CRIT CARE MED, V39, P158, DOI 10.1097/CCM.0b013e3181fb7b49; Cruise CM, 2006, CLIN GERIATR MED, V22, P257, DOI 10.1016/j.cger.2005.12.015; Dang Q, 2015, J SURG RES, V198, P482, DOI 10.1016/j.jss.2015.03.092; DAVIS CS, 1988, J AM GERIATR SOC, V36, P225, DOI 10.1111/j.1532-5415.1988.tb01805.x; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Downey DM, 2009, AM SURGEON, V75, P1100; Dukhinova M, 2018, BRAIN BEHAV IMMUN, V74, P7, DOI 10.1016/j.bbi.2018.09.009; East JM, 2018, CURR OPIN ANESTHESIO, V31, P219, DOI 10.1097/ACO.0000000000000566; Erdogan A, 2016, EUR J TRAUMA EMERG S, V42, P513, DOI 10.1007/s00068-015-0572-2; Estcourt LJ, 2017, BRIT J HAEMATOL, V176, P365, DOI 10.1111/bjh.14423; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Furay E, 2018, J TRAUMA ACUTE CARE, V85, P881, DOI 10.1097/TA.0000000000002047; Garbharran U, 2013, AGE AGEING, V42, P258, DOI 10.1093/ageing/afs176; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Havens J M, 2018, TRAUMA SURG ACUTE CA, V3, pe000147; Hemphill JC, 2019, WORLD NEUROSURG, V123, P157, DOI 10.1016/j.wneu.2018.12.060; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Jacobs BS, 2017, NEUROLOGY, V89, P417, DOI 10.1212/WNL.0000000000004195; Julien J, 2017, J CLIN NEUROSCI, V38, P122, DOI 10.1016/j.jocn.2016.12.032; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Kim SH, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0274-8; Kinoshita T, 2016, WORLD NEUROSURG, V89, P187, DOI 10.1016/j.wneu.2016.01.071; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kong T, 2017, AM J EMERG MED, V35, P1819, DOI 10.1016/j.ajem.2017.06.008; Kowalski RG, 2013, NEUROCRIT CARE, V19, P269, DOI 10.1007/s12028-013-9929-8; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lenell S, 2015, ACTA NEUROCHIR, V157, P417, DOI 10.1007/s00701-014-2329-9; Li N, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/7089493; Lippi G, 2017, ARCH MED SCI, V13, P606, DOI 10.5114/aoms.2017.67282; Liu ZH, 2018, AM J EMERG MED, V36, P1112, DOI 10.1016/j.ajem.2017.10.028; Majercik S, 2013, J TRAUMA ACUTE CARE, V74, P1021, DOI 10.1097/TA.0b013e3182826f02; McCracken DJ, 2019, NEUROSURGERY, V84, P741, DOI 10.1093/neuros/nyy193; McGuire C, 2017, CAN GERIATR J, V20, P2, DOI 10.5770/cgj.20.228; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Staples JA, 2016, BRAIN INJURY, V30, P899, DOI 10.3109/02699052.2016.1146964; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wan XY, 2017, WORLD NEUROSURG, V103, P584, DOI 10.1016/j.wneu.2017.04.069; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Weimer JM, 2016, CRIT CARE MED, V44, P1161, DOI 10.1097/CCM.0000000000001570; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Yin P, 2016, OSTEOPOROSIS INT, V27, P2077, DOI 10.1007/s00198-015-3357-x; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	68	9	9	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2019	128						E129	E147		10.1016/j.wneu.2019.04.060			19	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IJ4SX	WOS:000475895100016	30981800				2022-02-06	
J	Brickell, TA; French, LM; Gartner, RL; Driscoll, AE; Wright, MM; Lippa, SM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.; Wright, Megan M.; Lippa, Sara M.; Lange, Rael T.			Factors Related to Perceived Burden Among Caregivers of Service Members/Veterans Following TBI	REHABILITATION PSYCHOLOGY			English	Article						caregiver; burden; service member veteran; traumatic brain injury; posttraumatic stress	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CENTERED PREVENTIVE INTERVENTION; MENTAL-HEALTH PROBLEMS; MILITARY FAMILIES; COMBAT VETERANS; DEPLOYMENT; PARTNERS; BLAST; SYMPTOMS	Purpose/Objective: To examine factors related to perceived caregiving burden in a sample of caregivers assisting service members and veterans (SMVs) across four areas: SMV injury and health status; caregiver life circumstances; caregiver duty and responsibilities; and caregiver needs. Research Method/Design: Participants were 214 caregivers (95.8% female; 86.0% spouse/partner; Age: M = 38.6 years [SD = 10.4]) of SMVs who sustained a mild, moderate, severe, or penetrating traumatic brain injury (TBI). Caregivers were recruited from Walter Reed National Military Medical Center and via community outreach. Participants completed the Caregiver Appraisal Scale, Mayo-Portland Adaptability Inventory-4, and Caregiver Questionnaire. The sample was divided into 2 Caregiver Burden groups: High (n = 138) and Low Burden (n = 76). Results: Factors significantly related to higher levels of perceived burden were (a) experiencing a greater caregiving time commitment now and over time, (b) caring for activities of daily living/instrumental activities of daily living, (c) experiencing an impact of caregiving on employment, income, and out of pocket expenses. (d) parenting more than 1 child, (e) having less time to devote to one's self now and over time, (f) having caregiver needs, and/or (g) assisting a SMV who had incurred a mild TBI; was experiencing greater functional disability; had a posttraumatic stress disorder (PTSD) diagnosis; received mental health and rehabilitation treatment; and/or used an assistive device (all p < .05; odds ratios [ORs] = 1.13 to 14.57; ds = .02 to 1.30). Conclusions/Implications: Providing care for a SMV after a TBI can impose a heavy burden, particularly for caregivers who provide support to SMVs with comorbid mental health problems, such as PTSD.	[Brickell, Tracey A.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.; Wright, Megan M.; Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@dvbic.org	french, louis/AAB-2083-2020	Gartner, Rachel/0000-0001-8327-9737; french, louis/0000-0002-9451-0604			Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Beks T, 2016, QUAL REP, V21, P645; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Brickell TA, 2018, CLIN CHILD PSYCHOL P, V23, P425, DOI 10.1177/1359104517740405; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Caska CM, 2011, J ANXIETY DISORD, V25, P346, DOI 10.1016/j.janxdis.2010.10.008; Chandra A, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P175, DOI 10.1007/978-1-4419-7064-0_9; Chopin S. M, 2012, ROLE POSITIVE EMOTIO; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Easom LR, 2018, J CLIN PSYCHOL, V74, P536, DOI 10.1002/jclp.22536; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; French L. M., 2012, NEUROPSYCHOLOGICAL A, P127; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Huebner AJ, 2007, FAM RELAT, V56, P112, DOI 10.1111/j.1741-3729.2007.00445.x; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson G. L., 2016, BRAIN INJURY MED PRI, P470; Iverson G. L, 2013, BRAIN INJURY MED PRI, P333; Iverson G. L, 2016, MANUAL TRAUMATIC BRA, P470, DOI [10.1891/9781617052699.0008, DOI 10.1891/9781617052699.0008]; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2016, J AM ACAD CHILD PSY, V55, P14, DOI 10.1016/j.jaac.2015.10.009; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; Mansfield AJ, 2014, PROF PSYCHOL-RES PR, V45, P488, DOI 10.1037/a0038422; Monk JK, 2017, J MARITAL FAM THER, V43, P448, DOI 10.1111/jmft.12230; National Alliance for Caregiving (NAC), 2010, CAR VET SERV HOM; Nicosia N, 2017, PUBLIC HEALTH REP, V132, P93, DOI 10.1177/0033354916679995; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pinciotti CM, 2017, J NERV MENT DIS, V205, P106, DOI 10.1097/NMD.0000000000000560; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchand R., 2017, HIDDEN HEROES AMERIC, DOI [10.7249/rr499, DOI 10.7249/RR499]; Renshaw KD, 2011, J FAM PSYCHOL, V25, P953, DOI 10.1037/a0025871; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Tanielian T, 2013, MILITARY CAREGIVERS; The Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU, V2; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Uphold CR, 2014, ANNU REV NURS RES-SE, V32, P155, DOI 10.1891/0739-6686.32.155; Van Houtven CH., 2016, SHORT TERM IMPACTS V; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wadsworth SM, 2016, AM J COMMUN PSYCHOL, V57, P190, DOI 10.1002/ajcp.12025; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Yambo T, 2014, J AM PSYCHIAT NURSES, V20, P31, DOI 10.1177/1078390313516998; Yambo TW, 2016, J NURS SCHOLARSHIP, V48, P543, DOI 10.1111/jnu.12237	75	9	9	0	13	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2019	64	3					307	319		10.1037/rep0000272			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IE7MX	WOS:000472559200007	30896245				2022-02-06	
J	Czigler, A; Toth, L; Szarka, N; Berta, G; Amrein, K; Czeiter, E; Lendvai-Emmert, D; Bodo, K; Tarantini, S; Koller, A; Ungvari, Z; Buki, A; Toth, P				Czigler, Andras; Toth, Luca; Szarka, Nikolett; Berta, Gergely; Amrein, Kriszitina; Czeiter, Endre; Lendvai-Emmert, Dominika; Bodo, Kornelia; Tarantini, Stefano; Koller, Akos; Ungvari, Zoltan; Buki, Andras; Toth, Peter			Hypertension Exacerbates Cerebrovascular Oxidative Stress Induced by Mild Traumatic Brain Injury: Protective Effects of the Mitochondria-Targeted Antioxidative Peptide SS-31	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; free radicals; hypertension; MCA; mitochondrion	NADPH OXIDASE; ENDOTHELIAL FUNCTION; BLOOD-FLOW; DYSFUNCTION; MODEL; OLDER; NOX4	Traumatic brain injury (TBI) induces cerebrovascular oxidative stress, which is associated with neurovascular uncoupling, autoregulatory dysfunction, and persisting cognitive decline in both pre-clinical models and patients. However, single mild TBI (mTBI), the most frequent form of brain trauma, increases cerebral generation of reactive oxygen species (ROS) only transiently. We hypothesized that comorbid conditions might exacerbate long-term ROS generation in cerebral arteries after mTBI. Because hypertension is the most important cerebrovascular risk factor in populations prone to mild brain trauma, we induced mTBI in normotensive and spontaneously hypertensive rats (SHR) and assessed changes in cytoplasmic and mitochondrial superoxide (O-2-) production by confocal microscopy in isolated middle cerebral arteries (MCA) 2 weeks after mTBI using dihydroethidine (DHE) and the mitochondria-targeted redox-sensitive fluorescent indicator dye MitoSox. We found that mTBI induced a significant increase in long-term cytoplasmic and mitochondrial O-2- production in MCAs of SHRs and increased expression of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit Nox4, which were reversed to the normal level by treating the animals with the cell-permeable, mitochondria-targeted antioxidant peptide SS-31 (5.7 mg kg(-1) day(-1), i.p.). Persistent mTBI-induced oxidative stress in MCAs of SHRs was significantly decreased by inhibiting vascular NADPH oxidase (apocyinin). We propose that hypertension- and mTBI-induced cerebrovascular oxidative stress likely lead to persistent dysregulation of cerebral blood flow (CBF) and cognitive dysfunction, which might be reversed by SS-31 treatment.	[Czigler, Andras; Toth, Luca; Amrein, Kriszitina; Czeiter, Endre; Lendvai-Emmert, Dominika; Koller, Akos; Buki, Andras; Toth, Peter] Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary; [Czigler, Andras; Toth, Luca; Amrein, Kriszitina; Czeiter, Endre; Lendvai-Emmert, Dominika; Koller, Akos; Buki, Andras; Toth, Peter] Univ Pecs, Med Sch, Szentagothai Res Ctr, Pecs, Hungary; [Czigler, Andras; Toth, Luca; Szarka, Nikolett; Toth, Peter] Univ Pecs, Med Sch, Inst Translat Med, Pecs, Hungary; [Berta, Gergely] Univ Pecs, Dept Med Biol, Pecs, Hungary; [Czeiter, Endre; Bodo, Kornelia] Univ Pecs, Dept Immunol & Biotechnol, Pecs, Hungary; [Tarantini, Stefano; Ungvari, Zoltan] Univ Oklahoma, Hlth Sci Ctr, Donald W Reynolds Dept Geriatr Med, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Koller, Akos] Semmelweis Univ, Dept Morphol & Physiol, Budapest, Hungary; Univ Phys Educ, Sport Physiol Res Ctr, Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Toth, Peter] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary		Toth, P (corresponding author), Univ Pecs, Dept Neurosurg, 2 Ret St, H-7624 Pecs, Hungary.	toth.peter@pte.hu	Czigler, Andras/AAK-8425-2021; Lendvai-Emmert, Dominika/AAM-3250-2021	Lendvai-Emmert, Dominika/0000-0003-1439-6627; Czeiter, Endre/0000-0002-9578-6944; Czigler, Andras/0000-0001-6751-3298	National Research, Development, and Innovation Office [NKFI-FK123798, K108444]; Hungarian Academy of Sciences Bolyai Research Scholarship [BO/00634/15]; PTE [AOK-KA 3/2016 04.01/F]; UNKP-18-4-PTE-6 New National Excellence Program of the Ministry of Human Capacities, Higher Education Institutional Excellence Programme [207653/2018/FEKUTSTRAT, FIKP II/S, EFOP-3.6.2.-16-2017-00008, GINOP-2.3.2-15-2016-00048, GINOP-2.3.3-15-2016-00032]; Hungarian National Brain Research Program [2017-1.2.1-NKP-2017-00002]; Marie Curie Actions SMARTER 7th Framework Program of the European Union [606998]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG055395, R01-AG047879]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS056218, R01-NS100782]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100782, R01NS056218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG047879, R01AG055395] Funding Source: NIH RePORTER	This work was supported by grants from the National Research, Development, and Innovation Office to P.T. (NKFI-FK123798) and A.K. (K108444); the Hungarian Academy of Sciences Bolyai Research Scholarship BO/00634/15 to P.T.; the PTE AOK-KA 3/2016 04.01/F to P.T.; the UNKP-18-4-PTE-6 New National Excellence Program of the Ministry of Human Capacities, Higher Education Institutional Excellence Programme -Grant No. 207653/2018/FEKUTSTRAT, FIKP II/S, EFOP-3.6.2.-16-2017-00008, GINOP-2.3.2-15-2016-00048, and GINOP-2.3.3-15-2016-00032 to P.T. and A.B.; the Hungarian National Brain Research Program Grant No. 2017-1.2.1-NKP-2017-00002 to A.B.; the Marie Curie Actions SMARTER 7th Framework Program of the European Union 606998 to N.S. and A.K.; the National Institute on Aging (R01-AG055395, R01-AG047879); and the National Institute of Neurological Disorders and Stroke (NINDS) (R01-NS056218, R01-NS100782).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Ergul A, 2016, TRANSL STROKE RES, V7, P248, DOI 10.1007/s12975-016-0464-8; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Hortobagyi L, 2007, BRAIN RES, V1131, P129, DOI 10.1016/j.brainres.2006.11.009; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Ma MW, 2018, FREE RADICAL BIO MED, V117, P66, DOI 10.1016/j.freeradbiomed.2018.01.031; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Pinto CC, 2007, FREE RADICAL RES, V41, P1151, DOI 10.1080/10715760701632816; Springo Z, 2015, J GERONTOL A-BIOL, V70, P1355, DOI 10.1093/gerona/glu244; Szarka N., 2017, J NEUROTRAUMA; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Tarantini S, 2018, AGING CELL, V17, DOI 10.1111/acel.12731; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Toth P, 2014, AM J PHYSIOL-HEART C, V306, pH299, DOI 10.1152/ajpheart.00744.2013; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	35	9	10	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3309	3315		10.1089/neu.2019.6439		AUG 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479849200001	31266393	Green Published			2022-02-06	
J	Fernandez-Gayol, O; Sanchis, P; Aguilar, K; Navarro-Sempere, A; Comes, G; Molinero, A; Giralt, M; Hidalgo, J				Fernandez-Gayol, Olaya; Sanchis, Paula; Aguilar, Kevin; Navarro-Sempere, Alicia; Comes, Gemma; Molinero, Amalia; Giralt, Mercedes; Hidalgo, Juan			Different Responses to a High-Fat Diet in IL-6 Conditional Knockout Mice Driven by Constitutive GFAP-Cre and Synapsin 1-Cre Expression	NEUROENDOCRINOLOGY			English	Article						IL-6; GFAP-Cre; Synapsin 1-Cre; Body weight; High-fat diet; Insulin; Leptin; Growth hormone; RiboTag	VASOACTIVE-INTESTINAL-PEPTIDE; TRAUMATIC BRAIN-INJURY; BODY-WEIGHT; INTERLEUKIN-6 DELETION; INSULIN-RESISTANCE; INDUCED OBESITY; ADIPOSE-TISSUE; MESSENGER-RNA; GENE; NEURONS	Background/Aims: Interleukin-6 (IL-6) is a major cytokine controlling body weight and metabolism, at least in part through actions in the central nervous system (CNS) from local sources. Methods: We herewith report results obtained in conditional IL-6 KO mice for brain cells (Il6(Delta Gfap) and Il6(Delta Syn)). Results: The reporter RiboTag mouse line demonstrated specific astrocytic expression of GFAP-dependent Cre in the hypothalamus but not in other brain areas, whereas that of synapsin 1-dependent Cre was specific for neurons. Feeding a high-fat diet (HFD) or a control diet showed that Il6(Delta Gfap) and Il6(Delta Syn) mice were more prone and resistant, respectively, to HFD-induced obesity. Energy intake was not altered in HFD experiments, but it was reduced in Il6(Delta Syn) male mice following a 24-h fast. HFD increased circulating insulin, leptin, and cholesterol levels, decreased triglycerides, and caused impaired responses to the insulin and glucose tolerance tests. In Il6(Delta Gfap) mice, the only significant difference observed was an increase in insulin levels of females, whereas in Il6(Delta Syn) mice the effects of HFD were decreased. Hypothalamic Agrp expression was significantly decreased by HFD, further decreased in Il6(Delta Gfap), and increased in Il6(Delta Syn) female mice. Hypothalamic Il-6 mRNA levels were not decreased in Il6(Delta Syn) mice and even increased in Il6(Delta Gfap)male mice. Microarray analysis of hypothalamic RNA showed that female Il6(Delta Gfap) mice had increased interferon-related pathways and affected processes in behavior, modulation of chemical synaptic transmission, learning, and memory. Conclusion: The present results demonstrate that brain production of IL-6 regulates body weight in the context of caloric excess and that the cellular source is critical.	Univ Autonoma Barcelona, Fac Biosci, Inst Neurosci, Barcelona, Spain; Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, Anim Physiol Unit, ES-08193 Barcelona, Spain.	Juan.Hidalgo@uab.es	Sanchis, Paula/AAR-7500-2020; Hidalgo, Juan/C-9082-2011; Sanchis, Paula/K-2853-2017; Fernandez Gayol, Olaya/E-5635-2014	Sanchis, Paula/0000-0002-2729-4622; Hidalgo, Juan/0000-0003-0921-1122; Aguilar Ludwig, Kevin/0000-0002-1452-2841; Fernandez Gayol, Olaya/0000-0002-7649-3126; Navarro-Sempere, Alicia/0000-0003-2881-7568; COMES, GEMMA/0000-0002-4074-7665	Ministerio de Economia y Competitividad y Fondo Europeo de Desarrollo Regional [SAF2011-23272, SAF2014-56546-R]; Fundacio La Marato de TV3 [20142210];  [FPU2012-00365];  [BES-2015-071959];  [FPU17/02065]	Thanks are given to Dr. Richard Palmiter for valuable input on recombination issues, to Dr. Elisenda Sanz for providing the RiboTag mice and for useful discussions, to BioArray S.A. for carrying out the microarray, and to the Servei de Microscopia at UAB. O.F.-G., P.S., and K.A. acknowledge the support of fellowships FPU2012-00365, BES-2015-071959, and FPU17/02065, respectively. This study was supported by Ministerio de Economia y Competitividad y Fondo Europeo de Desarrollo Regional SAF2011-23272 and SAF2014-56546-R and Fundacio La Marato de TV3 20142210. These funding agencies had no role in the preparation or submission of the manuscript.	Baboota RK, 2014, J NUTR BIOCHEM, V25, P893, DOI 10.1016/j.jnutbio.2014.04.004; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Benrick A, 2009, J NEUROENDOCRINOL, V21, P620, DOI 10.1111/j.1365-2826.2009.01879.x; Bonda TA, 2016, INT J CARDIOL, V219, P1, DOI 10.1016/j.ijcard.2016.05.021; Camargo N, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002605; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Chen F, 2017, BBA-MOL BASIS DIS, V1863, P3128, DOI 10.1016/j.bbadis.2017.08.022; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EPELBAUM J, 1979, EUR J PHARMACOL, V58, P493, DOI 10.1016/0014-2999(79)90323-6; Erta M, 2015, HORM BEHAV, V73, P64, DOI 10.1016/j.yhbeh.2015.06.016; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Ferrer B, 2014, BRAIN BEHAV IMMUN, V40, P121, DOI 10.1016/j.bbi.2014.03.001; Ferris HA, 2017, P NATL ACAD SCI USA, V114, P1189, DOI 10.1073/pnas.1620506114; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Guo ZB, 2018, NEUROSCI BULL, V34, P769, DOI 10.1007/s12264-018-0228-4; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; Imura T, 2003, J NEUROSCI, V23, P2824; Ishii T, 2017, J BIOL CHEM, V292, P1240, DOI 10.1074/jbc.M116.748871; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; LARSSON LI, 1976, P NATL ACAD SCI USA, V73, P3197, DOI 10.1073/pnas.73.9.3197; Lau J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10058-x; Lehtonen A, 1997, J IMMUNOL, V159, P794; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; Matos M, 2015, BIOL PSYCHIAT, V78, P763, DOI 10.1016/j.biopsych.2015.02.026; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Navia B, 2014, ACTA PHYSIOL, V211, P585, DOI 10.1111/apha.12328; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmiter RD, 2017, NAT NEUROSCI, V20, P2, DOI 10.1038/nn.4456; Paxinos G., 2001, THE MOUSE BRAIN IN S; Pazos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072339; Pini M, 2011, CYTOKINE, V56, P708, DOI 10.1016/j.cyto.2011.09.015; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Quintana A, 2008, DEV NEUROBIOL, V68, P195, DOI 10.1002/dneu.20584; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; ROTHWELL NJ, 1991, CAN J PHYSIOL PHARM, V69, P1465, DOI 10.1139/y91-219; SAID SI, 1991, TRENDS ENDOCRIN MET, V2, P107, DOI 10.1016/S1043-2760(05)80006-2; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schele E, 2013, J NEUROENDOCRINOL, V25, P580, DOI 10.1111/jne.12033; Schele E, 2012, J NEUROENDOCRINOL, V24, P930, DOI 10.1111/j.1365-2826.2012.02286.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senaris RM, 2011, J NEUROENDOCRINOL, V23, P675, DOI 10.1111/j.1365-2826.2011.02158.x; SHIMADA M, 1973, EXP NEUROL, V41, P163, DOI 10.1016/0014-4886(73)90187-8; Song AJ, 2018, TRENDS GENET, V34, P333, DOI 10.1016/j.tig.2017.12.008; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; VIJAYAN E, 1979, ENDOCRINOLOGY, V104, P53, DOI 10.1210/endo-104-1-53; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang HQ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1352, DOI 10.1152/ajpendo.00230.2001; Wang Ren-Gang, 2012, Shengli Xuebao, V64, P577; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Zhang L, 2018, INT J BIOL SCI, V14, P398, DOI 10.7150/ijbs.23268; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	66	9	10	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology	AUG	2019	109	2					113	130		10.1159/000496845			18	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	JL6UD	WOS:000495664300003	30636247				2022-02-06	
J	Kroshus, E; Sonnen, AJ; Chrisman, SPD; Rivara, FP				Kroshus, Emily; Sonnen, Aly J.; Chrisman, Sara P. D.; Rivara, Frederick P.			Association between community socioeconomic characteristics and access to youth flag football	INJURY PREVENTION			English	Article						concussion; public health; recreation; sports; health disparities; sports; leisure facility; socioeconomic status	HEAD IMPACT EXPOSURE; TRAUMATIC BRAIN-INJURY; AMERICAN FOOTBALL; PHYSICAL-ACTIVITY; CONCUSSION; SPORTS; PERCEPTIONS; PARTICIPATION; INTERVENTIONS; KNOWLEDGE	Background The American Academy of Pediatrics has recommended that opportunities for non-tackling American football (e.g., flag football) be expanded, given concerns about the risks of brain trauma from tackle football. This study tested the hypothesis that flag football would be more accessible in communities characterised by higher socioeconomic status residents. Methods In July 2017, the locations of community-based organisations offering youth flag and tackle football for youth between the ages of 6 and 13 in two US states (Georgia and Washington) were aggregated (n=440). Organisations were coded in terms of the availability of tackle and/or flag football teams for youth at each year of age between 6 and 13. Multivariate logistic regression analyses were used to assess the odds of a community-based football organisation offering flag football, by community socioeconomic and demographic characteristics. Results In both states, communities with more educated residents were more likely to offer flag football for youth aged 6-12. For example, among 6 year-olds every 10% increase in the number of adult residents with a college education was associated with 1.51 times the odds of flag football availability (95% CI 1.22 to 1.86, P<0.001). Conclusion These results suggest that youth living in communities characterised by low educational attainment are less likely than other youth to have the option of a lower contact alternative to tackle football. Relying on voluntary community-level adoption of lower contact alternatives to tackle football may result in inequitable access to such sport options. This may contribute to an inequitable burden of brain trauma from youth sport.	[Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Sonnen, Aly J.] Univ Notre Dame, South Bend, IN USA; [Chrisman, Sara P. D.] Univ Washington, Div Adolescent Med, Seattle, WA 98195 USA; [Chrisman, Sara P. D.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	ekroshus@u.washington.edu		Chrisman, Sara/0000-0001-5373-7223			Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1796-0; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Geidne S, 2013, SCAND J PUBLIC HEALT, V41, P269, DOI 10.1177/1403494812473204; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Kaplan Y, 2013, CLIN J SPORT MED, V23, P39, DOI 10.1097/JSM.0b013e3182694870; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2017, ORTHOP J SPORTS MED, V3; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Morgan LJ, 2015, SOUTHEAST GEOGR, V55, P214, DOI 10.1353/sgo.2015.0008; Neuwirth K, 2004, COMMUN RES, V31, P669, DOI 10.1177/0093650204269388; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Physical Activity Council, 2017, 2017 PART REP PHYS A; Powell LM, 2006, AM J PUBLIC HEALTH, V96, P1676, DOI 10.2105/AJPH.2005.065573; Quarrie KL, 2017, BRIT J SPORT MED, V51, P1134, DOI 10.1136/bjsports-2017-098013; Romaine A, 2016, J CLIN SPORT PSYCHOL, V10, P253, DOI 10.1123/jcsp.2016-0018; Sabo D, 2014, HEALTH BEHAV POLICY, V1, P503, DOI 10.14485/HBPR.1.6.8; Santos MP, 2004, PEDIATR EXERC SCI, V16, P210, DOI 10.1123/pes.16.3.210; Shakib S, 2011, SOCIOL SPORT J, V28, P303, DOI 10.1123/ssj.28.3.303; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Sorek T, 2016, SOC SCI RES, V58, P266, DOI 10.1016/j.ssresearch.2016.03.006; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Sports & Fitness Industry Association , 2016, FOOTB FLAG PART REP; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; US Census Bureau, 2010, GEOGR TERMS CONC CEN; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weeks WB, 2004, AM J PUBLIC HEALTH, V94, P1762, DOI 10.2105/AJPH.94.10.1762; Wheeler S, 2014, LEISURE STUD, V33, P267, DOI 10.1080/02614367.2012.707227; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	40	9	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	AUG	2019	25	4					278	282		10.1136/injuryprev-2017-042677			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IN8GR	WOS:000478919100007	29330199				2022-02-06	
J	Mirzaeva, L; Gilhus, NE; Lobzin, S; Rekand, T				Mirzaeva, Lyudmilla; Gilhus, Nils Erik; Lobzin, Sergey; Rekand, Tiina			Incidence of adult traumatic spinal cord injury in Saint Petersburg, Russia	SPINAL CORD			English	Article							BRAIN-INJURY; EPIDEMIOLOGY; FINLAND; TIANJIN; PERIOD	Study design Retrospective population-based cohort study. Objectives To characterise the epidemiology of traumatic spinal cord injury (TSCI) among the inhabitants of Saint Petersburg, Russia. Setting All hospitals in Saint Petersburg. Methods Charts for all individuals admitted to city hospitals from 1st January 1 2012 to 31st December 2016 with acute TSCI were reviewed. Incidence rates were calculated for the whole period and for each year separately. Gender-specific and age-specific incidence rates were calculated, and epidemiological characteristics and possible risk factors were analysed. Results A total of 361 people were identified. The average annual incidence rate was 17.6 per million, varying from 21.2 (2013) to 13.6 (2016), and 70.9% were men. Mean age at injury was 42.1 years. Injuries from falls represented 49.8% of cases, and motor vehicle accidents 18.9%. The male:female ratio in the low-falls group was 1.2:1, and among the elderly patients, it was 0.5:1. Lesions at the cervical level were involved in 49.3%, thoracic in 24.7%, and lumbar/sacral in 23.5%. TSCI was complete in 16.9%. Concomitant injuries occurred in 47.2% of cases, and traumatic brain injuries in 37.7%. Conclusion TSCI incidence decreased during the observation period and was 2.4 times more common among men than women. In half of the cases, injuries involved the cervical level, and a fall was the most frequent injury cause. Elderly women more often had falls from a low height than men. Multiple injuries-most frequently traumatic brain injuries-were common.	[Mirzaeva, Lyudmilla; Lobzin, Sergey] North Western State Med Univ, Dept Neurol, St Petersburg, Russia; [Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Gilhus, Nils Erik; Rekand, Tiina] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Rekand, Tiina] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden		Rekand, T (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.; Rekand, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden.	tiina.rekand@helse-bergen.no	; Rekand, Tiina/A-6201-2008	Lobzin, Sergey/0000-0002-3272-7293; Mirzaeva, Liudmila/0000-0001-9392-1789; Rekand, Tiina/0000-0002-2506-9501	Norwegian Centre for International Cooperation in Education	The study was supported by a grant from the Norwegian Centre for International Cooperation in Education.	Ahoniemi E, 2008, SPINAL CORD, V46, P781, DOI 10.1038/sc.2008.53; Anghelescu Aurelian, 2017, Spinal Cord Ser Cases, V3, P17018, DOI 10.1038/scsandc.2017.18; Barinov AN, 2010, SPINE SURG, V4, P15; Biering-Sorensen F, 2017, SPINAL CORD, V55, P759, DOI 10.1038/sc.2017.59; Bombardier CH, 2016, ARCH PHYS MED REHAB, V97, P1628, DOI 10.1016/j.apmr.2016.03.008; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Ferro S, 2017, SPINAL CORD, V55, P1103, DOI 10.1038/sc.2017.88; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hagen EM, 2010, SPINAL CORD, V48, P313, DOI 10.1038/sc.2009.133; Hagen Ellen Merete, 2012, Tidsskr Nor Laegeforen, V132, P831, DOI 10.4045/tidsskr.10.0859; Juocevicius A, 2017, AM J PHYS MED REHAB, V96, pS86, DOI 10.1097/PHM.0000000000000658; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koskinen EA, 2014, SPINAL CORD, V52, P779, DOI 10.1038/sc.2014.131; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; Ning GZ, 2011, SPINAL CORD, V49, P386, DOI 10.1038/sc.2010.130; Ning GZ, 2012, J SPINAL CORD MED, V35, P229, DOI 10.1179/2045772312Y.0000000021; Noe BB, 2015, SPINAL CORD, V53, P436, DOI 10.1038/sc.2014.181; Sabre L, 2012, SPINAL CORD, V50, P755, DOI 10.1038/sc.2012.54; Schedrenok V, 2010, NEUROCHIR RUSS, V11, P458; [Щербук Ю.А. Shcherbuk Yu.A.], 2011, [Хирургия позвоночника, Khirurgiya pozvonochnika], P67; SILBERSTEIN B, 1995, PARAPLEGIA, V33, P322, DOI 10.1038/sc.1995.72; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yang SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058100	26	9	11	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	AUG	2019	57	8					692	699		10.1038/s41393-019-0266-4			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	IN4ZU	WOS:000478686500011	30842631	Bronze			2022-02-06	
J	Olczak, M; Poniatowski, LA; Niderla-Bielinska, J; Kwiatkowska, M; Chutoranski, D; Tarka, S; Wierzba-Bobrowicz, T				Olczak, Mieszko; Poniatowski, Lukasz A.; Niderla-Bielinska, Justyna; Kwiatkowska, Magdalena; Chutoranski, Dominik; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa			Concentration of microtubule associated protein tau (MAPT) in urine and saliva as a potential biomarker of traumatic brain injury in relationship with blood-brain barrier disruption in postmortem examination	FORENSIC SCIENCE INTERNATIONAL			English	Article						Microtubule associated protein tau; Traumatic brain injury; Urine; Saliva; Blood-brain barrier; Biomarker	CEREBROSPINAL-FLUID; SERUM; S100B; PATHOPHYSIOLOGY; BIOCHEMISTRY; MECHANISMS; DIAGNOSIS; AUTOPSY; DISEASE; RETINA	Traumatic brain injury (TBI) constitutes a frequent finding in medico-legal practice, including forensic autopsy and neuropathological examination. Despite clinico-scientific advances there is a need for identification of novel biomarkers considered for TBI diagnostics in ante- and postmortem cases. The role of MAPT protein as a biomarker in case of TBI was investigated in previous studies by examination of blood and cerebrospinal fluid obtained during forensic autopsies whereas less is known concerning its liberation and occurrence in other biofluids. The aim of this study was to elucidate and identify if elevated MAPT levels in other biofluids, such as urine, saliva, and vitreous body are also seen in TBI cases in population-based autopsy screening. The study was carried out using cases (n = 14) of severe head injury suspected as the cause of death and control cases (n= 13) of sudden death in the mechanism of cardiopulmonary failure. The biofluids, such as urine, saliva, and vitreous body were collected within similar to 24 h after death and compared using ELISA test. Tissue specimens including brain and kidney were similarly collected during forensic autopsies. Brain specimens were stained immunohistologically with anti-Vimentin (V9) antibody and histologically using Mallory's trichrome method (to assess structural damage to blood-brain barrier elements) whereas kidney specimens were stained immunohistologically with anti-MAPT antibody (to assess the suitability of such a study in the diagnosis of TBI). In our study, we observed the elevated concentration levels of MAPT in saliva and urine. These changes were accompanied by damage to the structural elements of the blood-brain barrier (damage to the vascular endothelium and vascular basement membrane). According to this elevated cencentration levels of MAPT in this biofluids should be considered as TBI marker in postmortem examination even in cases where the head injury was not supposed to consist the direct cause of death. (C) 2019 Elsevier B.V. All rights reserved.	[Olczak, Mieszko; Kwiatkowska, Magdalena; Tarka, Sylwia] Med Univ Warsaw, Ctr Biostruct Res, Dept Forens Med, Oczki 1, PL-02007 Warsaw, Poland; [Poniatowski, Lukasz A.] Med Univ Warsaw, Ctr Preclin Res & Technol CePT, Dept Expt & Clin Pharmacol, Banacha 1B, PL-02097 Warsaw, Poland; [Poniatowski, Lukasz A.] Maria Skiodowska Curie Mem Canc Ctr, Dept Neurosurg, WK Roentgena 5, PL-02781 Warsaw, Poland; [Poniatowski, Lukasz A.] Inst Oncol, WK Roentgena 5, PL-02781 Warsaw, Poland; [Niderla-Bielinska, Justyna] Med Univ Warsaw, Ctr Biostruct Res, Dept Histol & Embryol, Chalubinskiego 5, PL-02004 Warsaw, Poland; [Chutoranski, Dominik; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, Sobieskiego 9, PL-02957 Warsaw, Poland		Olczak, M (corresponding author), Med Univ Warsaw, Ctr Biostruct Res, Dept Forens Med, Oczki 1, PL-02007 Warsaw, Poland.	mieszkothe1st@hotmail.com; lukasz.poniatowski@gmail.com; jniderla@wum.edu.pl; magdalena.kwiatkowska@wum.edu.pl; chutoranski.dominik@gmail.com; sylwia.tarka@wum.edu.pl; bobrow@ipin.edu.pl	Poniatowski, Lukasz A./AAF-6980-2019	Poniatowski, Lukasz A./0000-0003-4202-7984; Wierzba-Bobrowicz, Teresa/0000-0003-2518-8321; , Dominik/0000-0001-5060-7423	Medical University of Warsaw [1MB/PM11/14]; European Union (EU) - The European Regional Development Fund (ERDF) within the "Infrastructure and Environment'' operational program	This study was supported by internal grant 1MB/PM11/14 conducted in the years 2014-2015 from the Medical University of Warsaw. The project was implemented with infrastructure financed by the European Union (EU) - The European Regional Development Fund (ERDF) within the "Infrastructure and Environment'' operational program for years 2007-2013. No additional external funding and support was received for this study.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Alali AS, 2017, J NEUROTRAUM, V34, P2760, DOI 10.1089/neu.2017.4997; An MX, 2015, GENOM PROTEOM BIOINF, V13, P345, DOI 10.1016/j.gpb.2015.08.005; Baniak N, 2015, J CLIN EXP PATHOL, V5, P199; Belsey SL, 2016, J FORENSIC LEG MED, V41, P49, DOI 10.1016/j.jflm.2016.04.011; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Blomberg M, 2001, DEMENT GERIATR COGN, V12, P127, DOI 10.1159/000051246; Caffrey TM, 2007, NEUROBIOL DIS, V27, P1, DOI 10.1016/j.nbd.2007.04.006; Caillet-Boudin ML, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0025-8; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cunha-Vaz JG, 1997, DOC OPHTHALMOL, V93, P149, DOI 10.1007/BF02569055; CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9; Dadas Aaron, 2018, Concussion, V3, pCNC53, DOI 10.2217/cnc-2017-0019; Davis NL, 2006, AM J FOREN MED PATH, V27, P1, DOI 10.1097/01.paf.0000201102.03778.65; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Erskine L, 2014, ASN NEURO, V6, DOI 10.1177/1759091414562107; Farah R, 2018, BIOMED J, V41, P63, DOI 10.1016/j.bj.2018.03.004; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Gamblin TC, 2005, BBA-MOL BASIS DIS, V1739, P140, DOI 10.1016/j.bbadis.2004.08.013; GUBETTA L, 1977, HISTOPATHOLOGY, V1, P277, DOI 10.1111/j.1365-2559.1977.tb01666.x; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Ho WL, 2012, MOL VIS, V18, P2700; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jashnani KD, 2010, J FORENSIC SCI, V55, P1523, DOI 10.1111/j.1556-4029.2010.01501.x; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Light TD, 2011, J SURG RES, V167, P121, DOI 10.1016/j.jss.2009.07.009; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; MacCormick IJC, 2015, BIOMARK MED, V9, P691, DOI [10.2217/BMM.15.17, 10.2217/bmm.15.17]; Madea B, 2007, FORENSIC SCI INT, V165, P165, DOI 10.1016/j.forsciint.2006.05.023; Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Occhiutto Marcelo L, 2012, Pharmaceutics, V4, P252, DOI 10.3390/pharmaceutics4020252; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Oliver J, 2015, J EXP NEUROSCI, V9, P67, DOI 10.4137/JEN.S27921; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Ottens AK, 2014, J NEUROTRAUM, V31, P782, DOI 10.1089/neu.2013.3116; Patowary A, 2010, AM J FOREN MED PATH, V31, P37, DOI 10.1097/PAF.0b013e3181c1e7e8; Pekeles H., 2018, ALZHEIMERS DEMENT AM, DOI [10.1016/j.dadm.2017.10.006, DOI 10.1016/J.DADM.2017.10.006]; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Sato C, 2018, NEURON, V98, P861, DOI 10.1016/j.neuron.2018.04.035; Saxena Susmita, 2015, J Oral Maxillofac Pathol, V19, P263, DOI 10.4103/0973-029X.164549; Scholz T, 2014, CELL MOL LIFE SCI, V71, P3139, DOI 10.1007/s00018-014-1610-7; Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sjogren M, 2001, CLIN CHEM, V47, P1776; Nunes LAS, 2015, BIOCHEM MEDICA, V25, P177, DOI 10.11613/BM.2015.018; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Thierauf A, 2009, FORENSIC SCI INT, V192, P78, DOI 10.1016/j.forsciint.2009.08.001; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tsitsopoulos PP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00599; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	79	9	9	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	AUG	2019	301						28	36		10.1016/j.forsciint.2019.05.010			9	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	IF7JY	WOS:000473261300014	31128406				2022-02-06	
J	Petrone, N; Candiotto, G; Marzella, E; Uriati, F; Carraro, G; Backstrom, M; Koptyug, A				Petrone, Nicola; Candiotto, Gianluca; Marzella, Edoardo; Uriati, Federico; Carraro, Giovanni; Backstrom, Mikael; Koptyug, Andrey			Feasibility of using a novel instrumented human head surrogate to measure helmet, head and brain kinematics and intracranial pressure during multidirectional impact tests	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article; Proceedings Paper	22nd International Congress on Snow Sports Trauma and Safety / Biennial Meeting of the International-Society-for-Skiing-Safety (ISSS)	APR 17-22, 2017	Univ Innsbruck, Innsbruck, AUSTRIA	Int Soc Skiing Safety	Univ Innsbruck	Human head; Surrogate; Accelerometers; Angular velocity; Intracranial pressure; Helmet evaluation	CONCUSSION; SPORTS; TRAUMA; SYSTEM; MODEL	Objectives: Aim of the work is to present the feasibility of using an Instrumented Human Head Surrogate (IHHS-1) during multidirectional impacts while wearing a modern ski helmet. The IHHS-1 is intended to provide reliable and repeatable data for the experimental validation of FE models and for the experimental evaluation of modern helmets designed to enhance the degree of protection against multidirectional impacts. Design: The new IHHS-1 includes 9 triaxial MEMS accelerometers embedded in a silicone rubber brain, independently molded and presenting lobes separation and cerebellum, placed into an ABS skull filled with surrogate cerebrospinal fluid. A triaxial MEMS gyroscope is placed at the brain center of mass. Intracranial pressure can be detected by eight pressure sensors applied to the skull internal surface along a transversal plane located at the brain center of mass and two at the apex. Additional MEMS sensors positioned over the skull and the helmet allow comparison between outer and inner structure kinematics and surrogate CSF pressure behavior. Methods: The IHHS-1 was mounted through a Hybrid III neck on a force platform and impacted with a striker connected to a pendulum tower, with the impact energies reaching 24J. Impact locations were aligned with the brain center of mass and located in the back (sagittal axis), right (90 degrees from sagittal axis), back/right (45 degrees), and front right (135 degrees) locations. Following dynamic data were collected: values of the linear accelerations and angular velocities of the brain, skull and helmet; intracranial pressures inside the skull. Results: Despite the relatively low intensity of impacts (HIC at skull max value 46), the skull rotational actions reached BrIC values of 0.33 and angular accelerations of 5216 rad/s(2), whereas brain angular acceleration resulted between 1,44 and 2,1 times lower with similar values of BrIC. Conclusions: The IHHS-1 is a physical head surrogate that can produce repeatable data for the interpretation of inner structures behavior during multidirectional impacts with or without helmets of different characteristics. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd.	[Petrone, Nicola; Candiotto, Gianluca; Marzella, Edoardo; Uriati, Federico; Carraro, Giovanni] Univ Padua, Dept Ind Engn, Padua, Italy; [Backstrom, Mikael; Koptyug, Andrey] Mid Sweden Univ, SportsTech Res Ctr, Ostersund, Sweden		Petrone, N (corresponding author), Univ Padua, Dept Ind Engn, Padua, Italy.	nicola.petrone@unipd.it		PETRONE, NICOLA/0000-0002-6638-484X; Uriati, Federico/0000-0003-1917-1267			Ahmadzadeh SMH, 2014, P I MECH ENG H, V228, P730, DOI 10.1177/0954411914540138; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Awad N, 2015, ARAB J SCI ENG, V40, P945, DOI 10.1007/s13369-015-1583-3; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Darvish K, 1998, AM SOC MECH ENG BIOE; Dickson TJ, 2013, PROCEDIA ENGINEER, V60, P220, DOI 10.1016/j.proeng.2013.07.079; Freitas CJ, 2014, INT J MED SCI, V11, P409, DOI 10.7150/ijms.8079; Hardy WN, 2001, STAPP CAR CRASH J; Hardy WN, 2007, STAPP CAR CRASH J, DOI [10.1016/j.bbi.2008.05.010, DOI 10.1016/J.BBI.2008.05.010]; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henn H.W., 1998, TEACH MATH APPL, V17, P162, DOI 10.1093/teamat/17.4.162.; Hodgson VR., 1972, P STAPP CAR CRASH C, P1; Hurst HT, 2018, J SCI MED SPORT; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kleiven S., 2005, P IRCOBI C PRAG CZEC; Kleiven S, 2002, STAPP CAR CRASH J; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Nahum AM, 1979, SAE TECH PAP, DOI [10.4271/791024, DOI 10.4271/791024]; Petrone N., 2018, PROC, V2, P269, DOI 10.3390/proceedings2060269; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Samaka H, 2013, INT J SCI TECHNOL RE; Taha Z, 2014, PROCEDIA ENGINEER, V72, P515, DOI 10.1016/j.proeng.2014.06.088; Takhounts EG, 2013, STAPP CAR CRASH J; Weber CD, 2016, EUR J TRAUMA EMERG S, V42, P741, DOI 10.1007/s00068-015-0596-7; Zhang J, 2009, STAPP CAR CRASH J, DOI [10.1089/neu.2009.1050, DOI 10.1089/NEU.2009.1050]; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	30	9	9	4	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2019	22			1			S78	S84		10.1016/j.jsams.2019.05.015			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Sport Sciences	JI6OQ	WOS:000493587000016	31272916	hybrid, Green Published			2022-02-06	
J	Stelmashook, EV; Genrikhs, EE; Mukhaleva, EV; Kapkaeva, MR; Kondratenko, RV; Skrebitsky, VG; Isaev, NK				Stelmashook, E., V; Genrikhs, E. E.; Mukhaleva, E., V; Kapkaeva, M. R.; Kondratenko, R., V; Skrebitsky, V. G.; Isaev, N. K.			Neuroprotective Effects of Methylene Blue In Vivo and In Vitro	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						traumatic brain injury; methylene blue; neurons; paraquat; zinc ions	TRAUMATIC BRAIN-INJURY	Focal unilateral traumatic brain injury in the sensorimotor cortical region disturbed the functions of contralateral limbs controlled by the damaged hemisphere. A single intravenous injection of methylene blue (1 mg/kg) immediately before or 30 min after the injury significantly weakened functional disorders in the affected extremities. In vitro experiments showed that methylene blue effectively reduced death of cultured neurons provoked by paraquat or zinc ions producing the toxic effects on mitochondrias.	[Stelmashook, E., V; Genrikhs, E. E.; Mukhaleva, E., V; Kapkaeva, M. R.; Kondratenko, R., V; Skrebitsky, V. G.; Isaev, N. K.] Res Ctr Neurol, Moscow, Russia; [Mukhaleva, E., V; Isaev, N. K.] Moscow MV Lomonosov State Univ, Moscow, Russia		Isaev, NK (corresponding author), Res Ctr Neurol, Moscow, Russia.; Isaev, NK (corresponding author), Moscow MV Lomonosov State Univ, Moscow, Russia.	isaev@genebee.msu.ru	Skrebitsky, Vladimir/C-5047-2012; Stelmashook, Elena V/B-4442-2012; Kondratenko, Rodion/B-4245-2012; Genrikhs, Elizaveta E/C-3854-2012; Isaev, Nikolay K/B-4194-2012; Kapkaeva, Marina/AAO-1646-2020	Skrebitsky, Vladimir/0000-0002-6594-9781; Kapkaeva, Marina/0000-0002-2833-2897; Mukhaleva, Elizaveta/0000-0002-9911-7625; Genrikhs, Elizaveta/0000-0002-3203-0250	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]	The experiments with paraquat were supported by the Russian Science Foundation (grant No. 16-1500235); other part of the study was also supported by the Russian Science Foundation (grant No. 16-15-10108).	Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; FUKUSHIMA T, 1993, EXP TOXICOL PATHOL, V45, P345, DOI 10.1016/S0940-2993(11)80424-0; Genrikhs EE, 2017, B EXP BIOL MED+, V164, P211, DOI 10.1007/s10517-017-3960-2; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Isaev NK, 2008, BIOCHEMISTRY-MOSCOW+, V73, P149, DOI 10.1134/S0006297908020053; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Sharpley MS, 2006, J BIOL CHEM, V281, P34803, DOI 10.1074/jbc.M607389200; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Wainwright M, 2005, TROP MED INT HEALTH, V10, P501, DOI 10.1111/j.1365-3156.2005.01417.x; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Wiklund L, 2016, CNS NEUROL DISORD-DR, V15, P1181, DOI 10.2174/1871527315666160915114516; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551	15	9	12	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	AUG	2019	167	4			SI		455	459		10.1007/s10517-019-04548-3			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JU7OP	WOS:000501862000009	31493258				2022-02-06	
J	Lizhnyak, PN; Muldoon, PP; Pilaka, PP; Povlishock, JT; Ottens, AK				Lizhnyak, Pavel N.; Muldoon, Pretal P.; Pilaka, Pallavi P.; Povlishock, John T.; Ottens, Andrew K.			Traumatic Brain Injury Temporal Proteome Guides KCC2-Targeted Therapy	JOURNAL OF NEUROTRAUMA			English	Article						CLP290; KCC2; proteomics; therapy; traumatic brain injury	EXPRESSION; COTRANSPORTERS; HIPPOCAMPUS; ACTIVATION; SHOCK; RATS	Advancing therapeutics for traumatic brain injury (TBI) remains a challenge, necessitating testable targets with interventions appropriately timed to intercede on evolving secondary insults. Neuroproteomics provides a global molecular approach to deduce the complex post-translational processes that underlie secondary events after TBI. Yet method advancement has outpaced approaches to interrogate neuroproteomic complexity, in particular when addressing the well-recognized temporal evolution of TBI pathobiology. Presented is a detailed account of the temporal neuroproteomic response to mild-moderate rat controlled cortical impact within perilesioned somatosensory neocortex across the first two weeks after injury. Further, this investigation assessed use of artificial neural network and functional enrichment analyses to discretize the temporal response across some 2047 significantly impacted proteins. Results were efficiently narrowed onto ion transporters with phenotypic relevance to abnormal GABAergic transmission and a delayed decline amenable to intervention under managed care conditions. The prototypical target potassium/chloride co-transporter 2 (KCC2 or SLC12A5) was investigated further with the KCC2-selective modulator CLP290. Guided by post-translational processing revealed one-day after insult to precede KCC2 protein loss a day after, CLP290 was highly effective at restoring up to 70% of lost KCC2 localization, which was significantly correlated with recovery of sham-level function in assessed somatosensory behavioral tasks. The timing of administration was important, with no significant improvement observed if given earlier, one-hour after insult, or later when KCC2 protein decline begins. Results portend importance for a detailed post-translational characterization when devising TBI treatments, and support the therapeutic promise of KCC2-targeted CLP290 intervention for positive functional recovery after brain injury.	[Lizhnyak, Pavel N.; Muldoon, Pretal P.; Pilaka, Pallavi P.; Povlishock, John T.; Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Box 980709, Richmond, VA 23298 USA		Ottens, AK (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Box 980709, Richmond, VA 23298 USA.	akottens@vcu.edu		Ottens, Andrew/0000-0002-2118-3796	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050606]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055012, NS100322]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS100322] Funding Source: NIH RePORTER	A monoclonal KCC2 antibody was provided through the UC Davis/NIH NeuroMAB Facility, supported by NIH grant NS050606 and maintained by the Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis. This research was supported by the National Institute of Neurological Disorders and Stroke grants NS055012 and NS100322.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Blaesse P, 2015, PFLUG ARCH EUR J PHY, V467, P615, DOI 10.1007/s00424-014-1547-6; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Bouet V., 2012, ADV PRECLINICAL STUD, P47, DOI 10.5772/32327; Chase Alex, 2015, Nat Rev Neurol, V11, P309, DOI 10.1038/nrneurol.2015.83; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Cortes DF, 2012, ELECTROPHORESIS, V33, P3712, DOI 10.1002/elps.201200341; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]; Evans Teresa M, 2014, Transl Proteom, V3, P10; Ferrini F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04209-3; Friedel P, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0055-17.2017; Gackiere F, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00102; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Hamidi S, 2015, NEUROBIOL DIS, V79, P51, DOI 10.1016/j.nbd.2015.04.006; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heap RE, 2017, BIOCHEM SOC T, V45, P1137, DOI 10.1042/BST20170091; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Hutchinson, 2018, SURGERY, V36, P613, DOI [10.1016/j.mpsur.2018.09.007, DOI 10.1016/J.MPSUR.2018.09.007]; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Kochanek PM, 2016, LANCET NEUROL, V15, P13, DOI 10.1016/S1474-4422(15)00339-7; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Leitner A, 2018, ANAL CHIM ACTA, V1000, P2, DOI 10.1016/j.aca.2017.08.026; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li X, 2017, SCI CHINA LIFE SCI, V60, P1093, DOI 10.1007/s11427-017-9175-2; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Souza GHMF, 2017, METHODS MOL BIOL, V1546, P57, DOI 10.1007/978-1-4939-6730-8_4; Mazzeo AT, 2018, J NEUROSURG SCI, V62, P549, DOI 10.23736/S0390-5616.18.04465-X; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Najafi Mohammad Reza, 2015, Adv Biomed Res, V4, P82, DOI 10.4103/2277-9175.156640; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391	54	9	9	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2019	36	22					3092	3102		10.1089/neu.2019.6415		JUL 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JI6MG	WOS:000479782700001	31122143	Green Published			2022-02-06	
J	Eglit, GML; Jurick, SM; Delis, DC; Filoteo, JV; Bondi, MW; Jak, AJ				Eglit, Graham M. L.; Jurick, Sarah M.; Delis, Dean C.; Filoteo, J. Vincent; Bondi, Mark W.; Jak, Amy J.			Utility of the D-KEFS Color Word Interference Test as an embedded measure of performance validity	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; D-KEFS color word interference test; traumatic brain injury; Parkinson's disease; processing speed	SYMPTOM VALIDITY; DIAGNOSTIC-CRITERIA; STROOP COLOR; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; AMERICAN ACADEMY; NEUROPSYCHOLOGY; DEMENTIA; DYSFUNCTION	Objective: The D-KEFS Color Word Interference Test (CWIT) is among the most commonly administered measures of verbally mediated processing speed and executive functioning. Previous research suggests that this test may also be sensitive to performance invalidity. We sought to develop new embedded measures of performance invalidity based on multi-condition performance on the CWIT and to evaluate previously proposed embedded measures for performance invalidity on this test. Method: Newly developed and previously proposed embedded measures were evaluated in three samples: a traumatic brain injury (TBI) sample (N = 224) classified into psychometrically-defined performance-valid and performance-invalid subgroups; the D-KEFS normative sample (N = 1,735); and a Parkinson's disease sample (N = 166). To explore the resilience of CWIT cutoffs to the effects of age and neurocognitive impairment, the D-KEFS normative sample was stratified into age groups of 8-19, 20-69, and 70-89 and the Parkinson's disease sample into normal cognition, mild cognitive impairment, and dementia groups. Results: Our newly developed embedded measures derived from within the TBI sample were largely resilient to the effects of age and neurocognitive impairment other than dementia. Overall, a cutoff of <= 18 on the sum of age-corrected scaled scores on all four conditions exhibited the strongest classification accuracy. In contrast, previously proposed cutoffs (Erdodi et al., 2018) produced unacceptable false-positive rates within the TBI sample and generally a high rate of potential false positives in the normative age and clinical groups. Conclusion: Scoring <= 18 on the sum of all conditions on the CWIT appears to be an optimal cutoff for performance invalidity detection in non-demented samples.	[Eglit, Graham M. L.; Jurick, Sarah M.; Filoteo, J. Vincent; Bondi, Mark W.; Jak, Amy J.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Jurick, Sarah M.; Jak, Amy J.] VASHDS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Delis, Dean C.; Filoteo, J. Vincent; Bondi, Mark W.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Filoteo, J. Vincent] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA		Jak, AJ (corresponding author), 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA.	ajak@ucsd.edu					Altemeier LE, 2008, J CLIN EXP NEUROPSYC, V30, P588, DOI 10.1080/13803390701562818; Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K. B., 2002, B TEST; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Golden CJ., 2002, STROOP COLOR WORD TE; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Latzman RD, 2010, ASSESSMENT, V17, P172, DOI 10.1177/1073191109356254; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mattson SN, 1999, ALCOHOL CLIN EXP RES, V23, P1808, DOI 10.1111/j.1530-0277.1999.tb04077.x; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Pagonabarraga J, 2012, NEUROBIOL DIS, V46, P590, DOI 10.1016/j.nbd.2012.03.029; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Pearson, 2009, ADV CLIN SOL WAIS 4; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Salmon DP, 2007, SEMIN NEUROL, V27, P7, DOI 10.1055/s-2006-956751; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	56	9	9	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2020	34	2					332	352		10.1080/13854046.2019.1643923		JUL 2019	21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KG3IM	WOS:000478147200001	31352854				2022-02-06	
J	Callahan, ML; Storzbach, D				Callahan, Megan L.; Storzbach, Daniel			Sensory sensitivity and posttraumatic stress disorder in blast exposed veterans with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Blast exposure; concussion; light sensitivity; noise sensitivity; posttraumatic stress; traumatic brain injury	CHRONIC PAIN; HEAD-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; MILITARY PERSONNEL; MISERABLE MINORITY; VISUAL FUNCTION; IRAQI FREEDOM; IMPAIRMENT; MECHANISMS	The purpose of this study was to examine the unique contribution of posttraumatic stress disorder (PTSD) symptoms on sensory sensitivity following mild traumatic brain injury (mTBI) in an Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) Veteran sample. We hypothesized that the effect of PTSD on noise and light sensitivity following mTBI would be largely driven by PTSD-related hyperarousal symptoms. We compared the relationships between PTSD, noise sensitivity, and light sensitivity of 49 OEF/OIF Veterans with mTBI to that of 23 OEF/OIF Veterans without mTBI. Results suggest that intrusive experiences were significantly related to noise sensitivity in the mTBI group, while light sensitivity was significantly associated with avoidance. Hyperarousal symptoms significantly accounted for noise sensitivity in the no-blast, non-TBI group, whereas PTSD did not affect light sensitivity in this group. These data suggest that PTSD symptoms may uniquely influence the experience of noise and light sensitivity. As such, treatment targeting specific PTSD symptoms may yield clinically significant improvement in sensory sensitivity.	[Callahan, Megan L.; Storzbach, Daniel] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Callahan, Megan L.; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA		Callahan, ML (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	megan.callahan@va.gov			VA Merit Review AwardUS Department of Veterans Affairs [B5060R]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and DevelopmentUS Department of Veterans Affairs	This work was supported by VA Merit Review Award #B5060R to D. Storzbach from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bengtzen R, 2008, NEUROLOGY, V70, P218, DOI 10.1212/01.wnl.0000287090.98555.56; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CONSTANS JI, 2005, NEUROPSYCHOLOGY PTSD, P00105; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Hallberg LRM, 2005, SCAND J CARING SCI, V19, P410, DOI 10.1111/j.1471-6712.2005.00361.x; Harvey AG, 2001, J TRAUMA STRESS, V14, P277, DOI 10.1023/A:1011108816888; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; IBM Corp, 2016, IBM SPSS STAT WINDOW; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Martenson ME, 2016, PAIN, V157, P868, DOI 10.1097/j.pain.0000000000000450; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; Tombaugh T.N., 1996, TEST MEMORY MALINGER; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weathers FW, 1996, MEASUREMENT STRESS T, P250; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	54	9	9	3	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 4	2019	26	4					365	373		10.1080/23279095.2018.1433179			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IL0AC	WOS:000476957400007	29465307				2022-02-06	
J	Merz, ZC; Zane, K; Emmert, NA; Lace, J; Grant, A				Merz, Zachary C.; Zane, Katherine; Emmert, Natalie A.; Lace, John; Grant, Alexandra			Examining the relationship between neuroticism and post-concussion syndrome in mild traumatic brain injury	BRAIN INJURY			English	Article						Post-concussion syndrome; mild traumatic brain injury; concussion; neuroticism; personality	SPORTS-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; PERSONALITY-CHARACTERISTICS; MECHANICAL TURK; HIGH-SCHOOL; BASE-LINE; SYMPTOMS; DEPRESSION; RECOVERY; RECOMMENDATIONS	Objective: We sought to examine the relationship between personality traits and post-concussion symptom reporting in individuals with and without a self-reported history of concussion.Methods: Data were collected via a cross-sectional electronic survey from 619 individuals via Amazon Mechanical Turk (mTurk). Participants completed a background demographic questionnaire, as well as both the Post-Concussion Symptom Scale (PCSS) and IPIP-NEO-120 personality inventory.Results: Significant relationships were seen between concussion symptom reporting and personality traits of neuroticism, extraversion, agreeableness, and conscientiousness, but not openness, among both groups. The positive concussion group reported more severe symptoms across nearly all PCSS items, despite being, on average, multiple years removed from their injury. Furthermore, broad personality traits did not differ between concussion groups.Discussion: The positive concussion group reported persisting symptoms many years post-injury, suggesting a small subset of individuals may not become fully asymptomatic following a concussion. While differences among personality traits, including neuroticism, were not seen, psychiatric distress, namely symptoms of depression, accounted for a significant degree of variance in symptom reporting and is likely a strong influencer in recovery trajectory. As such, an increased emphasis on psychotherapeutic treatment following a concussion, especially in cases with prolonged recovery, may be warranted.	[Merz, Zachary C.] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Zane, Katherine] West Virginia Univ, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA; [Emmert, Natalie A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Lace, John; Grant, Alexandra] St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA		Merz, ZC (corresponding author), Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA.	zachary_merz@med.unc.edu	Lace, John/AAF-7063-2020	Lace, John/0000-0003-3628-0334			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Bailes JE, 1999, SPORTS RELATED CONCU, P200; Barth JT, 1989, MILD HEAD INJURY, P257; Beidler E, 2017, SPORT EXERC PERFORM, V6, P252, DOI 10.1037/spy0000107; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Casler K, 2013, COMPUT HUM BEHAV, V29, P2156, DOI 10.1016/j.chb.2013.05.009; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Comijs HC, 2002, J AFFECT DISORDERS, V72, P157, DOI 10.1016/S0165-0327(01)00453-0; Costa Jr P.T., 1992, NEO PI R PROFESSIONA; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Difallah DE, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P238, DOI 10.1145/2736277.2741685; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Goldberg L.R., 1999, PERSONALITY PSYCHOL, VVol. 7, P7; Gripshover DL, 1997, ARCH CLIN NEUROPSYCH, V12, P328, DOI 10.1093/arclin/12.4.328; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; John P., 2008, HDB PERSONALITY THEO, V3, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson JA, 2014, J RES PERS, V51, P78, DOI 10.1016/j.jrp.2014.05.003; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kees J, 2017, J ADVERTISING, V46, P141, DOI 10.1080/00913367.2016.1269304; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; Maples JL, 2014, PSYCHOL ASSESSMENT, V26, P1070, DOI 10.1037/pas0000004; MARTIN M, 1985, PERS INDIV DIFFER, V6, P353, DOI 10.1016/0191-8869(85)90060-1; McAdams DP, 2006, AM PSYCHOL, V61, P204, DOI 10.1037/0003-066X.61.3.204; McAdams DP, 2006, PERSON NEW INTRO PER; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merritt VC, 2015, DEV NEUROPSYCHOL, V40, P45, DOI 10.1080/87565641.2014.979928; Miller JD, 2017, PERSONAL DISORD, V8, P26, DOI 10.1037/per0000191; Millon T., 1997, MILLON CLIN MULTIAXI, V2nd ed.; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murphy J.K., THESIS; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Stogner BL., THESIS; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	61	9	9	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1003	1011		10.1080/02699052.2019.1581949			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000478089800005	30810394				2022-02-06	
J	Baez-Jurado, E; Guio-Vega, G; Hidalgo-Lanussa, O; Gonzalez, J; Echeverria, V; Ashraf, GM; Sahebkar, A; Barreto, GE				Baez-Jurado, Eliana; Guio-Vega, Gina; Hidalgo-Lanussa, Oscar; Gonzalez, Janneth; Echeverria, Valentina; Ashraf, Ghulam Md; Sahebkar, Amirhossein; Barreto, George E.			Mitochondrial Neuroglobin Is Necessary for Protection Induced by Conditioned Medium from Human Adipose-Derived Mesenchymal Stem Cells in Astrocytic Cells Subjected to Scratch and Metabolic Injury	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Scratch assay; Mesenchymal stem cells; Inflammation; Conditioned medium; Neuroglobin	HUMAN BONE-MARROW; OXYGEN-GLUCOSE DEPRIVATION; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; IN-VITRO; OXIDATIVE STRESS; GROWTH-FACTOR; SIGNALING PATHWAY; STROMAL CELLS; GLUTAMATE EXCITOTOXICITY	Astrocytes are specialized cells capable of regulating inflammatory responses in neurodegenerative diseases or traumatic brain injury. In addition to playing an important role in neuroinflammation, these cells regulate essential functions for the preservation of brain tissue. Therefore, the search for therapeutic alternatives to preserve these cells and maintain their functions contributes in some way to counteract the progress of the injury and maintain neuronal survival in various brain pathologies. Among these strategies, the conditioned medium from human adipose-derived mesenchymal stem cells (CM-hMSCA) has been reported with a potential beneficial effect against several neuropathologies. In this study, we evaluated the potential effect of CM-hMSCA in a model of human astrocytes (T98G cells) subjected to scratch injury. Our findings demonstrated that CM-hMSCA regulates the cytokines IL2, IL-6, IL-8, IL-10, GM-CSF, and TNF-a, downregulates calcium at the cytoplasmic level, and regulates mitochondrial dynamics and the respiratory chain. These actions are accompanied by modulation of the expression of different proteins involved in signaling pathways such as AKT/pAKT and ERK1/2/pERK, and may mediate the localization of neuroglobin (Ngb) at the cellular level. We also confirmed that Ngb mediated the protective effects of CM-hMSCA through regulation of proteins involved in survival pathways and oxidative stress. In conclusion, regulation of brain inflammation combined with the recovery of fundamental cellular aspects in the face of injury makes CM-hMSCA a promising candidate for the protection of astrocytes in brain pathologies.	[Baez-Jurado, Eliana; Guio-Vega, Gina; Hidalgo-Lanussa, Oscar; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4080871, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL 33744 USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.	gsampaio@javeriana.edu.co	Sahebkar, Amirhossein/B-5124-2018; Ashraf, Ghulam Md/H-9485-2012; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; GONZALEZ, JANNETH/AAB-9948-2020	Ashraf, Ghulam Md/0000-0002-9820-2078; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; GONZALEZ, JANNETH/0000-0003-2009-3374; Hidalgo Lanussa, Oscar Alejandro/0000-0001-6028-922X	PUJ [6260, 7115, 6278]; Vicerrectoria Academica of PUJ	The authors thank Dr. Jorge Andres Afanador and the staff of the cosmetic surgery Clinic DHARA in Bogota, Colombia, for the adipose tissue samples. This work was supported in part by grants PUJ IDs 6260 and 7115 to GEB and 6278 to JG and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to EB.	Alarifi S, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S82050; Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Anderson CNG, 1999, J NEUROSCI, V19, P664; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P2285, DOI 10.1007/s12035-017-0481-y; Baez-Jurado E, 2018, MOL NEUROBIOL, V55, P5377, DOI 10.1007/s12035-017-0771-4; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Becerra-Calixto A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00088; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Bhela S, 2017, J IMMUNOL, V199, P1342, DOI 10.4049/jimmunol.1700520; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bravo-Sagua R, 2017, COMPR PHYSIOL, V7, P623, DOI 10.1002/cphy.c160013; Bruno V, 2000, EUR J PHARMACOL, V399, P117, DOI 10.1016/S0014-2999(00)00367-8; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Cabezas R, 2018, MOL NEUROBIOL, V55, P3085, DOI 10.1007/s12035-017-0567-6; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chaudhry H, 2013, IN VIVO, V27, P669; Chen WW, 2016, MOL MED REP, V13, P3391, DOI 10.3892/mmr.2016.4948; Chen XL, 2018, INT IMMUNOPHARMACOL, V59, P287, DOI 10.1016/j.intimp.2018.04.020; Chen YX, 2015, J RADIAT RES, V56, P700, DOI 10.1093/jrr/rrv026; CHENG B, 1995, J NEUROCHEM, V65, P2525; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Cunningham CJ, 2018, J CEREBR BLOOD F MET, V38, P1276, DOI 10.1177/0271678X18776802; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; de Oliveira MR, 2015, CHEM-BIOL INTERACT, V242, P396, DOI 10.1016/j.cbi.2015.11.003; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Dimitrov D.H., 2014, ADV PSYCHIAT, P1; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Eisner V, 2018, NAT CELL BIOL, V1; El-Sayed KMF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7154327; Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fiocchetti M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154959; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Gao F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.327; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; GIJBELS K, 1990, EUR J IMMUNOL, V20, P233, DOI 10.1002/eji.1830200134; Gimeno ML, 2017, STEM CELL TRANSL MED, V6, P161, DOI 10.5966/sctm.2016-0014; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; Gorgun FM, 2014, INHAL TOXICOL, V26, P361, DOI 10.3109/08958378.2014.902147; Guida E, 1998, CELL PHYSIOL BIOCHEM, V8, P75, DOI 10.1159/000016272; Guillen MI, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00661; Guo ZY, 2015, NEURAL REGEN RES, V10, P651, DOI 10.4103/1673-5374.155442; HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hao P, 2014, METAB BRAIN DIS, V29, P193, DOI 10.1007/s11011-014-9490-y; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Helleringer R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00349; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; HOLLIDAY J, 1993, BRAIN RES, V621, P233, DOI 10.1016/0006-8993(93)90111-Y; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeong SH, 2014, MAR DRUGS, V12, P4602, DOI 10.3390/md12084602; Jiang CL, 1998, BIOL SIGNAL RECEPT, V7, P148; Jiang T, 2014, AGING CELL, V13, P1059, DOI 10.1111/acel.12268; Jiang Y, 2008, NEUROBIOL DIS, V32, P125, DOI 10.1016/j.nbd.2008.06.017; Jin KL, 2012, NEUROSCI LETT, V519, P47, DOI 10.1016/j.neulet.2012.05.018; Johnson GG, 2014, NEURO-ONCOLOGY, V16, P1086, DOI 10.1093/neuonc/nou012; Kane MS, 2017, J CELL MOL MED, V21, P2284, DOI 10.1111/jcmm.13149; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kempuraj D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00216; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Le Thuc O, 2015, ANN NY ACAD SCI, V1351, P127, DOI 10.1111/nyas.12855; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Lotfinia M, 2016, STEM CELLS DEV, V25, P1898, DOI 10.1089/scd.2016.0244; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma WW, 2013, NEUROCHEM RES, V38, P1315, DOI 10.1007/s11064-013-1019-y; Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Mekhemar MK, 2018, CELL IMMUNOL, V326, P60, DOI 10.1016/j.cellimm.2017.01.007; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mita T, 2015, BEHAV BRAIN RES, V293, P189, DOI 10.1016/j.bbr.2015.07.043; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Morales AP, 2011, NEUROCHEM RES, V36, P829, DOI 10.1007/s11064-011-0411-8; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Ogunbileje JO, 2016, AM J PHYSIOL-ENDOC M, V311, pE436, DOI 10.1152/ajpendo.00535.2015; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Papazian I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030651; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Pedraza-Alva G, 2015, IMMUNOL REV, V265, P231, DOI 10.1111/imr.12294; Phuagkhaopong S, 2017, NEUROTOXICOLOGY, V60, P82, DOI 10.1016/j.neuro.2017.03.001; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pokrzywinski KL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45102; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Ranieri M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/293893; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Reyes RC, 2008, J NEUROSCI, V28, P9682, DOI 10.1523/JNEUROSCI.3484-08.2008; Rothhammer V, 2015, SEMIN IMMUNOPATHOL, V37, P625, DOI 10.1007/s00281-015-0515-3; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Shinotsuka T, 2014, BIOCHEM BIOPH RES CO, V444, P171, DOI 10.1016/j.bbrc.2014.01.035; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Stephenson J, 2018, IMMUNOLOGY, V154, P204, DOI 10.1111/imm.12922; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072926; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Trubiani O, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0253-4; Ulusoy C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0451-0; Valencia J, 2016, CYTOTHERAPY, V18, P1297, DOI 10.1016/j.jcyt.2016.07.006; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Voloboueva LA, 2010, J NEUROSCI, V30, P12242, DOI 10.1523/JNEUROSCI.1752-10.2010; Vomelova I, 2009, FOLIA BIOL-PRAGUE, V55, P243; Voulgari-Kokota A, 2012, EXP NEUROL, V236, P161, DOI 10.1016/j.expneurol.2012.04.011; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Xia W, 2015, NEURAL REGEN RES, V10, P610, DOI 10.4103/1673-5374.155436; Xie LK, 2015, EUR J IMMUNOL, V45, P180, DOI 10.1002/eji.201444823; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/756989; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zagoura DS, 2012, GUT, V61, P894, DOI 10.1136/gutjnl-2011-300908; Zhang Q, 2011, MOLECULES, V16, P10146, DOI 10.3390/molecules161210146; Zhao J, 2015, CNS NEUROSCI THER, V21, P61, DOI 10.1111/cns.12334; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zhu LH, 2017, NEUROSCI LETT, V650, P12, DOI 10.1016/j.neulet.2017.03.024	170	9	9	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2019	56	7					5167	5187		10.1007/s12035-018-1442-9			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT8VJ	WOS:000483159700044	30536184				2022-02-06	
J	Vu, HM; Tran, TT; Vu, GT; Nguyen, CT; Nguyen, CM; Vu, LG; Tran, TH; Tran, BX; Latkin, CA; Ho, CSH; Ho, RCM				Hai Minh Vu; Tung Thanh Tran; Giang Thu Vu; Cuong Tat Nguyen; Chau Minh Nguyen; Linh Gia Vu; Tung Hoang Tran; Bach Xuan Tran; Latkin, Carl A.; Ho, Cyrus S. H.; Ho, Roger C. M.			Alcohol Use Disorder among Patients Suffered from Road Collisions in a Vietnamese Delta Province	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traffic accidents; alcohol; drink-driving; Vietnam	RISK; CONSUMPTION; CHALLENGES; DISABILITY; COUNTRIES; DRINKING; INJURIES; TIME; LIFE	Traffic collisions have continuously been ranked amongst the top causes of deaths in Vietnam. In particular, drinking has been recognized as a major factor amplifying the likelihood of traffic collisions in various settings. This study aims to examine the relationship between alcohol use and traffic collisions in the current context of Vietnam. A cross-sectional study was conducted on 413 traffic collisions patients in six health facilities in the Thai Binh Province to investigate the level of alcohol consumption and identify factors influencing alcohol use among these patients. The Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) scale was used to determine the problematic drinking behavior of the participants. The percentage of patients having problematic drinking was more than 30%. Being male, having a high household income, and working as farmer/worker were risk factors for alcohol abuse. People causing accidents and patients with a traumatic brain injury had a higher likelihood of drinking alcohol before the accidents. This study highlights the necessity of more stringent laws on reducing drink-driving in Vietnam. In addition, more interventions, especially those utilizing mass media like educational campaign of good behavior on social networks, are necessary to reduce alcohol consumption in targeted populations in order to decrease the prevalence and burden of road injuries.	[Hai Minh Vu; Chau Minh Nguyen] Thai Binh Univ Med & Pharm, Dept Trauma, Thai Binh 410000, Vietnam; [Tung Thanh Tran; Giang Thu Vu; Linh Gia Vu] Nguyen Tat Thanh Univ, Ctr Excellence Evidence Based Med, Ho Chi Minh City 700000, Vietnam; [Cuong Tat Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang 550000, Vietnam; [Tung Hoang Tran] Vietnam Germany Hosp, Inst Orthopaed & Trauma Surg, Hanoi 100000, Vietnam; [Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100000, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Ho, Cyrus S. H.] Natl Univ Singapore Hosp, Dept Psychol Med, Singapore 119074, Singapore; [Ho, Roger C. M.] Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City 700000, Vietnam; [Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 119228, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Inst Hlth Innovat & Technol iHealthtech, Singapore 119077, Singapore		Nguyen, CT (corresponding author), Duy Tan Univ, Inst Global Hlth Innovat, Da Nang 550000, Vietnam.	cuong.ighi@gmail.com	Ho, Cyrus SH/AAN-9344-2020; Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021	Ho, Cyrus SH/0000-0002-7092-9566; Ho, Roger C./0000-0001-9629-4493; Latkin, Carl/0000-0002-7931-2116			Andreuccetti G, 2011, ADDICTION, V106, P2124, DOI 10.1111/j.1360-0443.2011.03521.x; Appota, 2018, VIETN MOB APP MARK R; Asefa NG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118675; Attwood S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4358-9; Tran BX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-27; Baruah A.M., 2015, J INDIAN ACAD FORENS, V37, P12, DOI [10.5958/0974-0848.2015.00002.0, DOI 10.5958/0974-0848.2015.00002.0]; Bates L., 2014, SULTAN QABOOS U MED, V14, P297; Braver ER, 2004, INJURY PREV, V10, P27, DOI 10.1136/ip.2003.002923; Clausen T, 2015, SUBST ABUS-RES TREAT, V9, P125, DOI 10.4137/SART.S23549; Cremonte M, 2014, MEDICINA-BUENOS AIRE, V74, P287; Diep PB, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070710; Dinesh Sethi F.M., 2012, REDUCING INJURIES DE; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; General statistics Office of Vietnam, SOC SIT 1 QUART 2019; Giang KB, 2008, SUBST USE MISUSE, V43, P481, DOI 10.1080/10826080701208111; Graham K, 2011, ADDICTION, V106, P1391, DOI 10.1111/j.1360-0443.2011.03425.x; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hendriks H, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9355; Giang KB, 2013, GLOBAL HEALTH ACTION, V6, P51, DOI 10.3402/gha.v6i0.18937; Lincoln M, 2016, DRUG ALCOHOL DEPEN, V159, P1, DOI 10.1016/j.drugalcdep.2015.10.030; Mann B, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/616323; Marinkovic M, 2015, VOJNOSANIT PREGL, V72, P155, DOI 10.2298/VSP1502155M; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Assembly of Vietnam, 2018, ROAD TRAFF LAW, V23/2008/QH12; National Assembly of Vietnam, 2008, LAW ROAD TRAFF; National Traffic Safety Committee, OBS TRAFF ACC DUE AL; Negussie Y., 2018, GETTING ZERO ALCOHOL; Odero W, 1998, E AFR MED J, V75, P708; Olson S., 1985, ALCOHOL AM TAKING AC, V3; Olson Z, 2016, INJURY PREV, V22, P233, DOI 10.1136/injuryprev-2015-041650; Peden M., 2004, WORLD REPORT ROAD TR; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sanna MB, 2015, TRAFFIC INJ PREV, V16, P104, DOI 10.1080/15389588.2014.926340; Steers Mai-Ly N, 2016, Curr Addict Rep, V3, P343, DOI 10.1007/s40429-016-0123-x; Stewart K, 2012, TRAFFIC INJ PREV, V13, P93, DOI 10.1080/15389588.2011.634464; Sutlovic D, 2014, TRAFFIC INJ PREV, V15, P222, DOI 10.1080/15389588.2013.804915; Bui TV, 2016, ALCOHOL ALCOHOLISM, V51, P186, DOI 10.1093/alcalc/agv082; Taylor B, 2012, ALCOHOL CLIN EXP RES, V36, P1827, DOI 10.1111/j.1530-0277.2012.01785.x; Vachal K, 2009, ACCIDENT ANAL PREV, V41, P617, DOI 10.1016/j.aap.2009.02.014; WHO, 2012, STAT ROAD SAF VIETN; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; World Bank, DAT VIETN LOW MIDDL; World Health Organization, 2014, GLOB ALC REP; World Health Organization, 2015, GLOB STAT REP ROAD S	45	9	9	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUL 1	2019	16	13							2423	10.3390/ijerph16132423			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	IL1DA	WOS:000477037900166	31288451	Green Published, Green Submitted			2022-02-06	
J	Huang, JH; Li, LH; Zhang, JY; Gao, C; Quan, W; Tian, Y; Sun, J; Tian, QL; Wang, D; Dong, JF; Zhang, JN; Jiang, RC				Huang, Jinhao; Li, Lihong; Zhang, Jingyi; Gao, Chuang; Quan, Wei; Tian, Ye; Sun, Jian; Tian, Qilong; Wang, Dong; Dong, Jingfei; Zhang, Jianning; Jiang, Rongcai			Treatment of Relapsed Chronic Subdural Hematoma in Four Young Children with Atorvastatin and Low-dose Dexamethasone	PHARMACOTHERAPY			English	Article						chronic subdural hematoma; child; atorvastatin; dexamethasone	TRAUMATIC BRAIN-INJURY; ANGIOGENESIS; EFFICACY; SAFETY; MULTICENTER; ADOLESCENTS; MANAGEMENT; DRAINAGE; CELLS; TRIAL	Chronic subdural hematoma (CSDH) can develop in children in rare cases. Burr-hole drainage (BHD) is the treatment of choice, but it is associated with a high rate of recurrence. This report describes four cases of pediatric patients (1-7 yrs of age) with post-BHD relapsed CSDH who were successfully treated with a drug regimen that included 2.5-5 mg atorvastatin daily combined with dexamethasone with stepwise-decreasing dosing for a total of 4 weeks. After 4 weeks of treatment, the hematoma was completely resolved in three patients and significantly reduced in one patient. During the treatment, no patient reported clinically significant adverse events. No patient experienced hematoma relapse during the follow-up period that lasted for up to 4 years. This case report suggests the need for a randomized placebo-controlled trial to evaluate this drug regimen for nonsurgical treatment of patients with relapsed CSDH.	[Huang, Jinhao; Gao, Chuang; Quan, Wei; Tian, Ye; Sun, Jian; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Huang, Jinhao; Gao, Chuang; Quan, Wei; Tian, Ye; Sun, Jian; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin Neurol Inst, Gen Hosp,Minist Educ, Tianjin, Peoples R China; [Li, Lihong; Tian, Qilong] Army Mil Univ, Tangdu Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Zhang, Jingyi] Yangquan 1st Peoples Hosp, Dept Neurosurg, Yangquan, Peoples R China; [Dong, Jingfei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA		Zhang, JN; Jiang, RC (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Zhang, JN; Jiang, RC (corresponding author), Minist Educ China & Tianjin, Tianjin Neurol Inst, Key Lab Postneurotrauma Neurorepair & Regenerat C, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com; jiang116216@163.com		Wang, Dong/0000-0002-5245-3074	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671221, 81271359, 81671380]	All phases of this study were supported by National Nature Science Foundation of China research grants (81671221, 81271359, and 81671380).	Araujo FA, 2010, BIOMED PHARMACOTHER, V64, P29, DOI 10.1016/j.biopha.2009.03.003; Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x; Carrascosa MF, 2015, J HEPATOL, V62, P751, DOI 10.1016/j.jhep.2014.11.019; Chan DYC, 2017, BRIT J NEUROSURG, V31, P72, DOI 10.1080/02688697.2016.1208806; Chin C, 2002, J HEART LUNG TRANSPL, V21, P1213, DOI 10.1016/S1053-2498(02)00455-2; Dias R, 2006, HORM RES, V65, P159, DOI 10.1159/000091830; Din BH, 2015, ACTA HAEMATOL-BASEL, V133, P124, DOI 10.1159/000362529; Doyle LW, 2007, PEDIATRICS, V119, P716, DOI 10.1542/peds.2006-2806; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Hohenstein A, 2005, J NEUROTRAUM, V22, P518, DOI 10.1089/neu.2005.22.518; Jaiswal SR, 2012, INDIAN J PHARMACOL, V44, P475, DOI 10.4103/0253-7613.99311; Jiang RC, 2018, JAMA NEUROL, V75, P1338, DOI 10.1001/jamaneurol.2018.2030; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Langslet G, 2016, J CLIN LIPIDOL, V10, P1153, DOI 10.1016/j.jacl.2016.05.010; Li T, 2014, J NEUROL SCI, V341, P88, DOI 10.1016/j.jns.2014.04.009; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Matsuo K, 2016, CHILD NERV SYST, V32, P2369, DOI 10.1007/s00381-016-3233-9; McCrindle BW, 2003, J PEDIATR-US, V143, P74, DOI 10.1016/S0022-3476(03)00186-0; Nagy JA, 2002, COLD SPRING HARB SYM, V67, P227, DOI 10.1101/sqb.2002.67.227; Prud'homme M, 2016, CAN J NEUROL SCI, V43, P284, DOI 10.1017/cjn.2015.393; Shofty B, 2016, WORLD NEUROSURG, V87, P529, DOI 10.1016/j.wneu.2015.09.035; Shrestha Rajendra, 2014, Asian J Neurosurg, V9, P168, DOI 10.4103/1793-5482.142739; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang D, 2016, J NEUROL SCI, V362, P91, DOI 10.1016/j.jns.2016.01.017; Wang D, 2014, J NEUROL SCI, V336, P237, DOI 10.1016/j.jns.2013.11.005; Wang D, 2010, J NEUROTRAUM, V27, P1489, DOI 10.1089/neu.2009.1057; Warris LT, 2016, PSYCHONEUROENDOCRINO, V72, P190, DOI 10.1016/j.psyneuen.2016.07.006; Wu XX, 2018, WORLD NEUROSURG, V109, pE118, DOI 10.1016/j.wneu.2017.09.115; Zhang Y, 2017, WORLD NEUROSURG, V105, P115, DOI 10.1016/j.wneu.2017.05.135	29	9	12	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	JUL	2019	39	7					783	789		10.1002/phar.2276			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IG7MU	WOS:000473983200008	31069819				2022-02-06	
J	Jamroziak, K; Bajkowski, M; Bocian, M; Polak, S; Magier, M; Kosobudzki, M; Stepien, R				Jamroziak, Krzysztof; Bajkowski, Marcin; Bocian, Miroslaw; Polak, Slawomir; Magier, Mariusz; Kosobudzki, Mariusz; Stepien, Radoslaw			Ballistic Head Protection in the Light of Injury Criteria in the Case of the Wz.93 Combat Helmet	APPLIED SCIENCES-BASEL			English	Article						ballistic impact; blunt trauma; ballistic protection; bulletproof helmet testing	TRAUMATIC BRAIN-INJURY; DEFORMATION; PERFORMANCE; WOUNDS; BLUNT	This paper discusses the general conditions relating to ballistic head protection, analyzing the risks that may occur on contemporary battlefields. A thorough literature review has enabled us to present development trends for helmets used in the largest armies in the world. The authors have focused on impacts to the helmet shell, overloading the entire helmet-protected head-neck system. The main objective of this study is to investigate the protective capability of a helmet shell when subjected to projectile-helmet contact, with contact curvature taken as being an indicator of the impact energy concentration. Blunt head trauma was estimated using backface deformation (BFD). The Wz.93 combat helmet was used for testing. Analytically, dependencies were derived to determine the scope of BFD. A five-parameter model of the helmet piercing process was adopted, thus obtaining the optimal BFD range. Verification of theoretical considerations was carried out on a specially developed research stand. In the ballistic tests, dynamic deflection of the helmet's body was registered using a speed camera. On the impact testing stand, a fragment of the helmet was pierced, producing results in the low impact velocity range. Data have been presented on the appropriate graph in order to compare them with values specified in the relevant standard and existing literature. Our results correlate well with the norm and literature values.	[Jamroziak, Krzysztof; Bocian, Miroslaw] Wroclaw Univ Sci & Technol, Dept Mech Mat Sci & Engn, Fac Mech Engn, Smoluchowskiego 25, PL-50370 Wroclaw, Poland; [Bajkowski, Marcin; Magier, Mariusz] Warsaw Univ Technol, Inst Mech & Printing, Fac Prod Engn, Narbutta 85, PL-02524 Warsaw, Poland; [Polak, Slawomir; Stepien, Radoslaw] Wroclaw Univ Sci & Technol, Dept Plast & Metrol, Fac Mech Engn, Lukasiewicza 5, PL-50371 Wroclaw, Poland; [Kosobudzki, Mariusz] Wroclaw Univ Sci & Technol, Dept Mech Engn Ind Machines & Vehicles, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland		Jamroziak, K (corresponding author), Wroclaw Univ Sci & Technol, Dept Mech Mat Sci & Engn, Fac Mech Engn, Smoluchowskiego 25, PL-50370 Wroclaw, Poland.	krzysztof.jamroziak@pwr.edu.pl	Kosobudzki, Mariusz/V-3615-2018; Jamroziak, Krzysztof/D-9552-2017; Magier, Mariusz/X-7528-2019	Kosobudzki, Mariusz/0000-0001-9602-926X; Jamroziak, Krzysztof/0000-0002-9887-0578; Magier, Mariusz/0000-0002-4431-9537; Marcin, Bajkowski/0000-0003-2517-5379; Bocian, Miroslaw/0000-0003-0638-6832			[Anonymous], 1981, 010601 NIJ LAW ENF S; Antolak-Dudka A, 2019, MATERIALS, V12, DOI 10.3390/ma12081225; Balandin DV, 2004, SHOCK VIB, V11, P547, DOI 10.1155/2004/182739; Baranowski P, 2015, ARCH CIV MECH ENG, V15, P361, DOI 10.1016/j.acme.2014.07.001; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BELLAMY RF, 1992, WORLD J SURG, V16, P888, DOI 10.1007/BF02066987; Bhatnagar A, 2016, LIGHTWEIGHT BALLISTI; Bin Tan L, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2884; Bir C, 2005, SOLID MECH APPL, V124, P25; Byers, 2011, INTRO FORENSIC ANTHR; Cai ZH, 2016, J VIBROENG, V18, P2495, DOI 10.21595/jve.2015.16497; Carey ME, 1998, MIL MED, V163, P581, DOI 10.1093/milmed/163.9.581; Civil Aviation Safety Authority, 2013, HUM INJ MOD SMALL UN; Clare V.R., 1975, BLUNT TRAUMA DATA CO; Committee on Review of Test Protocols Used by the Department of Defense to Test Combat Helmets, 2014, REV DEP DEF TEST PRO, DOI [10.17226/18621, DOI 10.17226/18621]; Cubano M.A., 2013, EMERGENCY WAR SURG, P213; DOT&E, 2012, STAND LOT ACC BALL T; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8; Gotts, 2005, BALLISTIC TRAUMA PRA, P67; Henn H.W., 1998, TEACH MATH APPL, V17, P162, DOI 10.1093/teamat/17.4.162.; Inspector General Department of Defense, 2013, DODIG2013079; Jamroziak K, 2018, ENGINEER MECHAN, P321, DOI 10.21495/91-8-321; Jamroziak K., 2016, AKTUAL PROBL BIOMECH, V11, P33; Jamroziak K., 2011, MODELOWANIE INYNIERS, V42, P179; Jones R.D., 2012, JANES INFANTRY WEAPO; Joszko K, 2016, ACTA BIOENG BIOMECH, V18, P159, DOI 10.5277/ABB-00633-2016-03; Kucewicz M, 2018, MATER DESIGN, V142, P177, DOI 10.1016/j.matdes.2018.01.028; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lankarani H., 2002, DOTFAAAR0299; Lim D.D., 2005, THESIS; Mazurkiewicz L, 2018, INT J ADV MANUF TECH, V97, P3925, DOI 10.1007/s00170-018-2236-y; NATO Unclassified Releasable to PFP and ZAF, 2012, TRHFM148 NATO UNCL R; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ptak M, 2017, INT J IMPACT ENG, V106, P238, DOI 10.1016/j.ijimpeng.2017.04.014; Ptak M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9051000; Ptak M, 2018, ACTA BIOENG BIOMECH, V20, P143, DOI 10.5277/ABB-01252-2018-03; Ptak M, 2017, LECT N MECH ENG, P431, DOI 10.1007/978-3-319-50938-9_45; Rafaels KA, 2015, J FORENSIC SCI, V60, P219, DOI 10.1111/1556-4029.12570; Raymond D, 2009, J BIOMECH, V42, P2479, DOI 10.1016/j.jbiomech.2009.07.018; Rezaei A., 2014, INT NEUROTRAUMA LETT, V35; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Sarvghad-Moghaddam H, 2017, COMPUT METHOD BIOMEC, V20, P16, DOI 10.1080/10255842.2016.1193597; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Sturdivan LM, 2004, J TRAUMA, V56, P651, DOI 10.1097/01.TA.0000074108.36517.D4; Viano DC, 1992, CLIN J SPORT MED, V2, P166; Walsh S.M., 2012, DEV INTEGRATED RATIO; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Weisenbach CA, 2018, MIL MED, V183, P287, DOI 10.1093/milmed/usx210; Wilber C.G., 1974, FORENSIC BIOL LAW EN; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014	53	9	9	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	JUL 1	2019	9	13							2702	10.3390/app9132702			16	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	IL1AS	WOS:000477031900121		gold, Green Submitted			2022-02-06	
J	Kyriazis, AD; Noroozizadeh, S; Refaee, A; Choi, W; Chu, LT; Bashir, A; Cheng, WH; Zhao, R; Namjoshi, DR; Salcudean, SE; Wellington, CL; Nir, G				Kyriazis, Alexander D.; Noroozizadeh, Shahriar; Refaee, Amir; Choi, Woongcheol; Chu, Lap-Tak; Bashir, Asma; Cheng, Wai Hang; Zhao, Rachel; Namjoshi, Dhananjay R.; Salcudean, Septimiu E.; Wellington, Cheryl L.; Nir, Guy			An End-to-end System for Automatic Characterization of Iba1 Immunopositive Microglia in Whole Slide Imaging	NEUROINFORMATICS			English	Article						Computer-aided detection and diagnosis; Whole slide imaging; Digital pathology; Image analysis; Classification; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; HEAD IMPACT MODEL; INFLAMMATION; PATHOLOGY; CLASSIFICATION; SEGMENTATION; LIMITATIONS; ACTIVATION; CANCER	Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Detailed studies of the microglial response after TBI require high throughput quantification of changes in microglial count and morphology in histological sections throughout the brain. In this paper, we present a fully automated end-to-end system that is capable of assessing microglial activation in white matter regions on whole slide images of Iba1 stained sections. Our approach involves the division of the full brain slides into smaller image patches that are subsequently automatically classified into white and grey matter sections. On the patches classified as white matter, we jointly apply functional minimization methods and deep learning classification to identify Iba1-immunopositive microglia. Detected cells are then automatically traced to preserve their complex branching structure after which fractal analysis is applied to determine the activation states of the cells. The resulting system detects white matter regions with 84% accuracy, detects microglia with a performance level of 0.70 (F1 score, the harmonic mean of precision and sensitivity) and performs binary microglia morphology classification with a 70% accuracy. This automated pipeline performs these analyses at a 20-fold increase in speed when compared to a human pathologist. Moreover, we have demonstrated robustness to variations in stain intensity common for Iba1 immunostaining. A preliminary analysis was conducted that indicated that this pipeline can identify differences in microglia response due to TBI. An automated solution to microglia cell analysis can greatly increase standardized analysis of brain slides, allowing pathologists and neuroscientists to focus on characterizing the associated underlying diseases and injuries.	[Kyriazis, Alexander D.; Noroozizadeh, Shahriar; Refaee, Amir; Choi, Woongcheol; Chu, Lap-Tak] Univ British Columbia, Engn Phys, 6224 Agr Rd, Vancouver, BC V6T 1Z1, Canada; [Bashir, Asma; Cheng, Wai Hang; Zhao, Rachel; Namjoshi, Dhananjay R.; Wellington, Cheryl L.] Univ British Columbia, Dept Pathol & Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Salcudean, Septimiu E.] Univ British Columbia, Dept Elect & Comp Engn, 2332 Main Mall, Vancouver, BC V6T 1Z4, Canada; [Nir, Guy] Univ British Columbia, Dept Urol Sci, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada		Nir, G (corresponding author), Univ British Columbia, Dept Urol Sci, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.	tims@ece.ubc.ca; wcheryl@mail.ubc.ca; guynir@ece.ubc.ca		Bashir, Asma/0000-0002-3616-9436	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); BC Innovation Council NRAS Program; Weston Brain Institute; Prostate Cancer Canada Post-Doctoral Research Fellowship Award [PDF2016-1338]	This work was supported in part by funding from Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Institutes of Health Research (CIHR), the BC Innovation Council NRAS Program, and the Weston Brain Institute. Support from Professor Salcudean's C. A. Laszlo Chair is gratefully acknowledged. Dr. Nir is a recipient of a Prostate Cancer Canada Post-Doctoral Research Fellowship Award #PDF2016-1338.	Abdolhoseini M, 2016, IEEE ENG MED BIO, P1208, DOI 10.1109/EMBC.2016.7590922; Bae MH, 2009, NEUROIMAGE, V46, P717, DOI 10.1016/j.neuroimage.2009.02.012; Bishop CM., 2006, PATTERN RECOGN; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Ciresan D., 2012, ADV NEURAL INF PROCE, V25, P2843; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Costa A., 2013, HAUSDORFF BOX COUNTI; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Cruz-Roa Angel, 2014, MED IMAGING 2014 DIG, V9041, DOI DOI 10.1117/12.2043872; Ding YC, 2017, IEEE ACM T COMPUT BI, V14, P1366, DOI 10.1109/TCBB.2016.2591520; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Duda RO, 2012, PATTERN CLASSIFICATI, V2; Ertosun Mehmet Gunhan, 2015, AMIA Annu Symp Proc, V2015, P1899; Farahani N, 2015, PATHOL LAB MED INT, V7, P23, DOI 10.2147/PLMI.S59826; Finkelstein E., 2006, INCIDENCE EC BURDEN; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gonzalez R. C, 2008, DIGITAL IMAGE PROCES, V3rd; Healy S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36410; Hipp Jason, 2011, J Pathol Inform, V2, P25, DOI 10.4103/2153-3539.82050; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Johnson SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10607; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaplan K.J., 2015, DIGITAL PATHOLOGY HI; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Karperien AL, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00051; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kollmannsberger P, 2009, SKELETON3D; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Li J, 2000, IEEE T SIGNAL PROCES, V48, P517, DOI 10.1109/78.823977; Li W, 2013, J SURG RES, V180, P133, DOI 10.1016/j.jss.2012.10.928; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Madabhushi A, 2016, IMAGE ANAL MACHINE L; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nir G, 2018, MED IMAGE ANAL, V50, P167, DOI 10.1016/j.media.2018.09.005; Petushi Sokol, 2006, BMC Med Imaging, V6, P14, DOI 10.1186/1471-2342-6-14; Popescu C, 2015, J Med Life, V8, P272; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rashid S, 2019, COMP M BIO BIO E-IV, V7, P336, DOI 10.1080/21681163.2018.1514280; Rouchdy Y, 2013, COMPUT VIS IMAGE UND, V117, P1453, DOI 10.1016/j.cviu.2013.06.001; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Steinwart I., 2008, SUPPORT VECTOR MACHI; Strekalovskiy E, 2014, LECT NOTES COMPUT SC, V8690, P127, DOI 10.1007/978-3-319-10605-2_9; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; The MathWorks, 2017, MATL REG MAX; The MathWorks, 2017, MATL DEEP LEARN; Vadakkan T., 2009, LACUNARITY BINARY IM; Valous NA, 2013, J NEUROSCI METH, V213, P250, DOI 10.1016/j.jneumeth.2012.12.017; Van Gool L., 2014, COMPUTER VISION; Wu T, 2012, NEUROIMAGE, V59, P2298, DOI 10.1016/j.neuroimage.2011.09.053	62	9	9	1	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics	JUL	2019	17	3					373	389		10.1007/s12021-018-9405-x			17	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	IF4VZ	WOS:000473081000004	30406865				2022-02-06	
J	Merritt, VC; Lapira, KM; Clark, AL; Sorg, SF; Werhane, ML; Jak, AJ; Bondi, MW; Schiehser, DM; Delano-Wood, L				Merritt, Victoria C.; Lapira, Kristina M.; Clark, Alexandra L.; Sorg, Scott F.; Werhane, Madeleine L.; Jak, Amy J.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			APOE-epsilon 4 Genotype is Associated with Elevated Post-Concussion Symptoms in Military Veterans with a Remote History of Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						APOE gene; Genetics; Post-concussion symptoms; Neurobehavioral Symptom Inventory; Military Veterans; mTBI; Head injury	APOLIPOPROTEIN-E; POSTCONCUSSIVE SYMPTOMS; ALLELE; EPSILON-4; MODERATE	Objective: We evaluated the influence of the APOE-epsilon 4 allele on post-concussive symptoms in military Veterans with a remote history of mild traumatic brain injury (mTBI). Method: Participants (N = 77) were administered neuropsychiatric measures, on average, approximately 5 years following their most recent mTBI and provided a DNA sample for APOE genotyping. Veterans were divided into two groups based on their epsilon 4 status (n = 14 epsilon 4+, n = 63 epsilon 4-). The Neurobehavioral Symptom Inventory (NSI) was the primary outcome measure, from which a total score was derived, as well as three symptom clusters (somatic, cognitive, and affective). Results: ANCOVAs showed a significant main effect of epsilon 4 genotype on the NSI total score and somatic symptom cluster after adjusting for posttraumatic stress symptoms and mTBI history (p = .019-.028, eta(2)(p) = .064-.073), such that epsilon 4+ Veterans endorsed significantly greater symptoms than epsilon 4- Veterans. Conclusions: Our findings suggest that genetic risk may help to explain the poorer long-term outcomes often observed in this population.	[Merritt, Victoria C.; Clark, Alexandra L.; Sorg, Scott F.; Werhane, Madeleine L.; Jak, Amy J.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Lapira, Kristina M.] UCSD, La Jolla, CA 92093 USA; [Clark, Alexandra L.; Werhane, Madeleine L.] SDSU UCSD, Joint Doctoral Program Clin Psychol, San Diego, CA 92120 USA; [Sorg, Scott F.; Jak, Amy J.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] UCSD, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Jak, Amy J.; Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu		Merritt, Victoria/0000-0001-5683-4168	Veterans AffairsUS Department of Veterans Affairs [829-MR-NB-25860, CDA-2-065-10S, CDA-2-CX001508]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31NS09870, K24 AG026431]	This work was supported by the Veterans Affairs [829-MR-NB-25860 to L.D.W., CDA-2-065-10S to D.M.S., CDA-2-CX001508 to S.F.S.], the Department of Defense [W81XWH-10-2-0169 to L.D.W.], and the National Institutes of Health [F31NS09870 to A.L.C. (National Institute of Neurological Disorders and Stroke), K24 AG026431 to M.W.B.].	Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Keane T.M., 1991, PCL M DSM 4; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Merritt VC, 2018, J NEUROTRAUM, V35, P2272, DOI 10.1089/neu.2017.5372; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558	20	9	9	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	2019	34	5					706	712		10.1093/arclin/acy082			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	IO3MG	WOS:000479283900011	30521018	Green Published, Bronze			2022-02-06	
J	Narad, ME; Moscato, E; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Narad, Megan E.; Moscato, Emily; Yeates, Keith Owen; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			Behavioral Health Service Utilization and Unmet Need After Traumatic Brain Injury in Childhood	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						behavioral health service utilization; pediatric TBI; unmet need	LONG-TERM; PSYCHIATRIC-DISORDERS; CHILDREN; OUTCOMES; AGE; PREDICTORS; CARE; BARRIERS; THERAPY; SCHOOLS	Objective: The need for behavioral health services, service utilization, and predictors of utilization was examined in children with moderate-to-severe traumatic brain injury (TBI) relative to a comparison group of children with orthopedic injury (OI) 6.8 years after injury. Methods: A total of 130 children hospitalized for moderate-to-severe TBI (16 severe and 42 moderate) or OI (72) between the ages of 3 and 7 years, who were enrolled at the time of injury at 3 tertiary care children's hospital and one general hospital in Ohio, and completed a long-term follow-up 6.8 years after injury were included in analyses. Results: Adolescents with TBI (moderate [38%] and severe [69%]) had significantly greater rates of need than those with OI (17%). Behavioral health services were utilized by 10% of the sample with no injury group differences (OI: 6%; moderate: 17%; severe: 13%). Early treatment and white race were associated with less service utilization; 77% had an unmet need, with no injury group differences (OI: 75%; moderate: 75%; severe: 82%). Rate of unmet need was greater among white than non-white children. Conclusion: Children who sustain a TBI in early childhood experience persistent and clinically significant impairments even years after injury. Rates of unmet need were high for all injury groups. Findings underscore the importance of long-term monitoring to identify developing needs and prevent significant complications/deficits.	[Narad, Megan E.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Narad, Megan E.; Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Moscato, Emily; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 3015, Cincinnati, OH 45229 USA; [Moscato, Emily] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp, Res Inst, Biobehav Hlth Ctr, Columbus, OH USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Psychiat, Div Child Psychiat & Psychol, 3395 Scranton Rd, Cleveland, OH 44109 USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 3015, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020		National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729, K02 HD44099, 1F32HD088011-1]; United States Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services trauma research grants; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011] Funding Source: NIH RePORTER	This project was supported by the National Institute of Child Health and Human Development (R01 HD42729, K02 HD44099, 1F32HD088011-1), United States Public Health Service National Institutes of Health (M01 RR 08084), State of Ohio Emergency Medical Services trauma research grants, National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (8 UL1 TR000077-04). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2012, DEV MED CHILD NEUROL, V54, P202, DOI 10.1111/j.1469-8749.2011.04212.x; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Glang A, 2008, NEUROREHABILITATION, V23, P477; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548; Kazdin AE, 1997, J CONSULT CLIN PSYCH, V65, P453, DOI 10.1037/0022-006X.65.3.453; Landsem IP, 2015, CHILD DEV, V86, P1063, DOI 10.1111/cdev.12368; Landsem IP, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0221-9; Langer DA, 2015, SCH MENT HEALTH, V7, P161, DOI 10.1007/s12310-015-9146-z; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; O'Donnell ML, 2008, CLIN PSYCHOL REV, V28, P387, DOI 10.1016/j.cpr.2007.07.008; Reback R, 2010, J POLICY ANAL MANAG, V29, P698, DOI 10.1002/pam.20528; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Snell-Johns J, 2004, J FAM PSYCHOL, V18, P19, DOI 10.1037/0893-3200.18.1.19; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Weisz JR, 2017, AM PSYCHOL, V72, P79, DOI 10.1037/a0040360; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20	39	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	JUL-AUG	2019	40	6					451	457		10.1097/DBP.0000000000000681			7	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	IQ4WQ	WOS:000480752600006	31107769	Green Accepted			2022-02-06	
J	Zhang, L; Jackson, WJ; Bentil, SA				Zhang, Ling; Jackson, William J.; Bentil, Sarah A.			The mechanical behavior of brain surrogates manufactured from silicone elastomers	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						TBI; Polydimethylsiloxane; PDMS; Brain surrogate; Brain simulant; Fractional zener	CONSTITUTIVE MODEL; VISCOELASTIC MODEL; TISSUE; COMPRESSION; STRAINS	The ongoing conflict against terrorism has resulted in an escalation of blast-induced traumatic brain injuries (bTBI) caused by improvised explosive devices (IEDs). The destructive IEDs create a blast wave that travels through the atmosphere. Blast-induced traumatic brain injuries, attributed to the blast wave, can cause life-threatening injuries and fatalities. This study aims to find a surrogate brain material for assessing the effectiveness of head protection systems designed to mitigate bTBI. Polydimethylsiloxane (PDMS) is considered as the surrogate brain material. The stiffness of PDMS (Sylgard 184, Dow Corning Corp.) can be controlled by varying the ratio of base and curing agent. Cylindrical PDMS specimen with ratios of 1:10, 1:70, and 1:80 were subjected to unconfined compression experiments at linear rates of 5 mm/min, 50 mm/min, and 500 mm/min. A ramp hold strain profile was used to simulate a stress relaxation experiment. The fractional Zener viscoelastic model was used to describe the stress relaxation response, after optimization of the material constants for the brain surrogate and shock wave exposure brain tissue. The results show that the low cost PDMS can be used as a surrogate brain material to study the dynamic brain response to blast wave exposure.	[Zhang, Ling; Jackson, William J.; Bentil, Sarah A.] Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA		Bentil, SA (corresponding author), Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA.	sbentil@iastate.edu		Bentil, Sarah/0000-0003-3983-0987	Roy J. Carver Charitable Trust [18-5021]; Iowa State University	This research was financially supported by the Roy J. Carver Charitable Trust under Grant #18-5021 and is acknowledged gratefully. The research is also financially supported by Iowa State University through start-up funds to S.A. Bentil, for which the authors are grateful.	Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; [Anonymous], 2007, SUPPL MAT ESI LAB CH; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bentil SA, 2016, EXP MECH, V56, P759, DOI 10.1007/s11340-015-0122-1; Bentil S.A, 2013, THESIS; Bentil SA, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aab990; Bentil SA, 2014, J MECH BEHAV BIOMED, V30, P83, DOI 10.1016/j.jmbbm.2013.10.020; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Carmichael B, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/046001; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Chanda A, 2018, MECH ADV MATER STRUC, V25, P1335, DOI 10.1080/15376494.2016.1143749; Chanda A, 2018, BIOMIMETICS-BASEL, V3, DOI 10.3390/biomimetics3030018; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; CLEMEDSON CJ, 1953, J APPL PHYSIOL, V6, P213, DOI 10.1152/jappl.1953.6.4.213; Corning D., 2018, SYLGARD 184 SILICONE; Courtney E, 2015, ARXIV150206112; Craiem D, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/013001; Davis GB, 2006, MED ENG PHYS, V28, P455, DOI 10.1016/j.medengphy.2005.07.023; Gu M, 2017, PROTECTION BLAST IND; Holzapfel GA, 1996, INT J SOLIDS STRUCT, V33, P3019, DOI 10.1016/0020-7683(95)00263-4; Holzapfel GA, 2001, COMPUT METHOD APPL M, V190, P4379, DOI 10.1016/S0045-7825(00)00323-6; Hossain SGM, 2010, THESIS; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Iwaskiw AS, 2018, SHOCK WAVES, V28, P63, DOI 10.1007/s00193-017-0759-z; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kohandel M, 2005, PHYS MED BIOL, V50, P2799, DOI 10.1088/0031-9155/50/12/005; Lai DW, 2005, MAT SCI ENG A-STRUCT, V405, P266, DOI 10.1016/j.msea.2005.06.011; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Lu T., 2016, J APPL MECH, V84; Mainardi, 2010, FRACTIONAL CALCULUS; Masoumi N, 2013, BASIC CLIN NEUROSCI, V4, P64; Mediavilla Varas J, 2011, FRONT NEURAL, V2; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miquelard-Garnier G, 2010, SOFT MATTER, V6, P5789, DOI 10.1039/c0sm00165a; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Payne T, 2015, J MECH BEHAV BIOMED, V41, P336, DOI 10.1016/j.jmbbm.2014.09.018; Ploch CC, 2016, WORLD NEUROSURG, V90, P668, DOI 10.1016/j.wneu.2016.02.081; Qi HJ, 2004, J MECH PHYS SOLIDS, V52, P2187, DOI 10.1016/j.jmps.2004.04.008; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Schiavone P, 2009, MED IMAGE ANAL, V13, P673, DOI 10.1016/j.media.2009.04.001; Selvan V, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024132; Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738; Sparrey CJ, 2011, J BIOMECH, V44, P1078, DOI 10.1016/j.jbiomech.2011.01.035; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; The MathWorks Inc, 2018, MATLAB; Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015; Wang Z, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40260; Xu HY, 2017, COMPUT MATH APPL, V73, P1377, DOI 10.1016/j.camwa.2016.05.002; 2017, BRAIN, V140, P333, DOI DOI 10.1093/BRAIN/AWW317; 2008, MICROELECTRON ENG, V85, P902, DOI DOI 10.1016/J.MEE.2008.01.018; 2008, J NEUROTRAUM, V25, P1397, DOI DOI 10.1089/NEU.2008.0602	55	9	9	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2019	95						180	190		10.1016/j.jmbbm.2019.04.005			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	HY6PB	WOS:000468251100020	31009902	Green Submitted			2022-02-06	
J	Pandamooz, S; Salehi, MS; Safari, A; Azarpira, N; Heravi, M; Ahmadiani, A; Dargahi, L				Pandamooz, Sareh; Salehi, Mohammad Saied; Safari, Anahid; Azarpira, Negar; Heravi, Mansooreh; Ahmadiani, Abolhassan; Dargahi, Leila			Enhancing the expression of neurotrophic factors in epidermal neural stem cells by valproic acid: A potential candidate for combinatorial treatment	NEUROSCIENCE LETTERS			English	Article						Epidermal neural crest stem cells; Neurotrophic factors; Valproic acid	MOUSE MODEL; PARKINSONS-DISEASE; GENE DELIVERY; GROWTH-FACTOR; DOUBLE-BLIND; BRAIN; BDNF; NEURONS; GDNF; RECEPTORS	Effective delivery of trophic factors to cure neurological disorders and traumatic injuries is a major challenge. With promising therapeutic effects of epidermal neural crest stem cells (EPI-NCSCs) in preclinical spinal cord injury, there is an implication that these stem cells might provide supportive role through releasing various trophic agents. Hence, the present study was designed to assess the influence of valproic acid (VPA), a well-known histone deacetylases inhibitor, on mRNA expression of selected trophic factors. In this study, following stem cell migration from explanted hair bulges, immunostaining against Nestin, SOX-10, DCX, beta-III tubulin and GFAP was carried out. Then, cells were treated with various clinically relevant concentrations of VPA and the survival rate was defined by MTT assay. Finally, stem cells were treated with 0.1 and 1 mM VPA and the drug impact on the transcription level of BDNF, GDNF, VEGF, NGF and NT3 at 6, 24, 72, 168 h was assessed by quantitative real-time PCR. The examined proteins expressions in the population of migrated cells confirmed the identity of stem cells as EPI-NCSCs. In addition, MTT assay showed that all three tested concentrations of VPA were suitable to treat these cells. Trophic factors assessment, following treatment revealed the mRNA expression level of BDNF, GDNF and VEGF could be significantly up- regulated at various time points, mainly by 1 mM VPA. However, NGF and NT3 transcripts were enhanced at few limited time points. Our findings showed that EPI-NCSCs due to secretion of various trophic factors are potential candidate to deliver the required trophic agents and their potential can be enhanced by 1 mM VPA, predominantly following 168 h treatment. Hence, these cells can be utilized to modulate destructive context of neurological disorders and injuries.	[Pandamooz, Sareh; Salehi, Mohammad Saied; Heravi, Mansooreh; Ahmadiani, Abolhassan] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Salehi, Mohammad Saied] Shiraz Univ Med Sci, Clin Neurol Res Ctr, Shiraz, Iran; [Safari, Anahid] Shiraz Univ Med Sci, Stem Cells Technol Res Ctr, Shiraz, Iran; [Azarpira, Negar] Shiraz Univ Med Sci, Transplant Res Ctr, Shiraz, Iran; [Dargahi, Leila] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran 196151178, Velenjak, Iran		Dargahi, L (corresponding author), Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran 196151178, Velenjak, Iran.	l.dargahi@sbmu.ac.ir	Salehi, Mohammad Saied/AAQ-5519-2021; Dargahi, Leila/K-4693-2017; Ahmadiani, Abolhassan/AAP-9004-2021; Safari, Anahid/Q-8432-2018; Azarpira, Negar/A-9421-2013; Pandamooz, Sareh/ABC-6229-2021	Dargahi, Leila/0000-0001-7777-5435; Safari, Anahid/0000-0001-8272-291X; Azarpira, Negar/0000-0002-5549-0057; Salehi, Mohammad Saied/0000-0002-3535-1578; pandamooz, sareh/0000-0002-6877-7102	Research Affairs, Shahid Beheshti University of Medical Sciences, Iran [15730-7]; Iran National Science Foundation (INSF)Iran National Science Foundation (INSF) [96017110]	This work was funded by Research Affairs (Grant Number: 15730-7), Shahid Beheshti University of Medical Sciences, Iran and also was supported by Iran National Science Foundation (INSF) (no: 96017110).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Almutawaa W, 2014, BASIC CLIN PHARMACOL, V115, P216, DOI 10.1111/bcpt.12201; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Castro LMR, 2005, J NEUROCHEM, V95, P1227, DOI 10.1111/j.1471-4159.2005.03457.x; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Deng P, 2016, EXPERT OPIN BIOL TH, V16, P1025, DOI 10.1080/14712598.2016.1183641; Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023; Gericota B, 2014, STEM CELL TRANSL MED, V3, P334, DOI 10.5966/sctm.2013-0129; Harvey AR, 2015, BRAIN RES, V1619, P36, DOI 10.1016/j.brainres.2014.10.049; Hu YF, 2010, STEM CELL REV REP, V6, P186, DOI 10.1007/s12015-010-9152-3; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Marsh SE, 2017, NEUROCHEM INT, V106, P94, DOI 10.1016/j.neuint.2017.02.006; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; Niles LP, 2012, INT J NEUROPSYCHOPH, V15, P1343, DOI 10.1017/S1461145711001969; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Olanow CW, 2015, ANN NEUROL, V78, P248, DOI 10.1002/ana.24436; Osuka S, 2012, NEUROL MED-CHIR, V52, P186, DOI 10.2176/nmc.52.186; Pandamooz S, 2018, J CELL BIOCHEM, V119, P3486, DOI 10.1002/jcb.26520; Pandamooz S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt235; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pollock K, 2016, MOL THER, V24, P965, DOI 10.1038/mt.2016.12; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; Sieber-Blum M, 2008, STEM CELL REV, V4, P256, DOI 10.1007/s12015-008-9042-0; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Uchida S, 2016, BIOMATERIALS, V109, P1, DOI 10.1016/j.biomaterials.2016.09.007; Wu CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27358; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Zhao Y, 2016, CLIN TRANSL ONCOL, V18, P1123, DOI 10.1007/s12094-016-1494-0; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	36	9	10	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 21	2019	704						8	14		10.1016/j.neulet.2019.03.033			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH4ZX	WOS:000474501800002	30904572				2022-02-06	
J	Ryan, NP; Reyes, J; Crossley, L; Beauchamp, MH; Catroppa, C; Anderson, VA				Ryan, Nicholas P.; Reyes, Jonathan; Crossley, Louise; Beauchamp, Miriam H.; Catroppa, Cathy; Anderson, Vicki A.			Unraveling the Association between Pediatric Traumatic Brain Injury and Social Dysfunction: the Mediating Role of Self-Regulation	JOURNAL OF NEUROTRAUMA			English	Article						childhood; outcome; predictors; social skills; traumatic brain injury	BEHAVIOR RATING INVENTORY; EXECUTIVE FUNCTIONS; INHIBITORY CONTROL; CHILDHOOD; CHILDREN; OUTCOMES; TBI; IMPULSIVITY; REHABILITATION; EMOTIONALITY	Social dysfunction is a common and disabling outcome of childhood traumatic brain injury (TBI); however, the mechanisms that link early brain injury to impaired social behavior are unclear. This longitudinal prospective study involved 129 children, including 86 children with TBI (53 mild, 33 moderate-severe TBI) and 43 age-matched typically developing control (TDC) children. Children with TBI were recruited via consecutive admissions to the emergency department of the Royal Children's Hospital, Melbourne Australia. At 6 months post-injury, all participants were assessed on measures of intellectual functioning, and parents provided ratings of children's self-regulation skills using gold standard measures of everyday executive function. At 12-month follow up, parents rated children's social adjustment using standardized measures of social skills, communication, and behavior. As expected, children with moderate-severe TBI were rated by parents as having greater self-regulation problems, worse social skills, and poorer communication than the mild TBI and TDC groups. In mediation models, greater self-regulation problems at 6 months post-injury were predictive of poorer social skills and worse overall social adjustment at 12-month follow-up. Moreover, self-regulation skills mediated the effect of moderate-severe TBI, but not mild TBI, on social skills and overall social adjustment. Our findings show that, while impaired social adjustment is common at 12 months following moderate-severe child TBI, the impact of TBI on these outcomes is likely mediated by its effect on self-regulation skills. Evidence for robust prospective associations between self-regulation deficits and later social adjustment difficulties have implications for early identification of children at high risk for chronic social problems.	[Ryan, Nicholas P.; Reyes, Jonathan; Crossley, Louise; Catroppa, Cathy; Anderson, Vicki A.] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Ryan, Nicholas P.] Deakin Univ, Cognit Neurosci Unit, Geelong, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Psychol, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada		Ryan, NP (corresponding author), Deakin Univ, Sch Psychol, Cognit Neurosci Unit, 221 Burwood Highway, Burwood, Vic 3125, Australia.	nicholas.ryan@deakin.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Reyes, Jonathan/0000-0002-6087-3159; Ryan, Nicholas/0000-0002-0878-8889; Reyes, Jonathan/0000-0002-2155-8797	Victorian Neurotrauma Initiative (VNI); Victorian Government Operational Infrastructure Support Program	We wish to acknowledge the support of the Victorian Neurotrauma Initiative (VNI), and the Victorian Government Operational Infrastructure Support Program.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Crothers IR, 2007, BRAIN INJURY, V21, P47, DOI 10.1080/02699050601149054; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eisenberg N, 2001, CHILD DEV, V72, P1112, DOI 10.1111/1467-8624.00337; Eisenberg N, 2009, DEV PSYCHOL, V45, P988, DOI 10.1037/a0016213; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heverly-Fitt S, 2016, J PEDIATR PSYCHOL, V41, P235, DOI 10.1093/jpepsy/jsv085; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Konrad KN, 2000, BRAIN INJURY, V14, P859; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lipszyc J, 2014, ARCH CLIN NEUROPSYCH, V29, P289, DOI 10.1093/arclin/acu004; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Olson SL, 1999, J ABNORM CHILD PSYCH, V27, P151, DOI 10.1023/A:1021915615677; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Ryan NP, 2017, BRAIN IMPAIR, V18, P88, DOI 10.1017/BrImp.2016.20; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Warnes ED, 2005, PSYCHOL SCHOOLS, V42, P173, DOI 10.1002/pits.20052; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	64	9	9	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2895	2903		10.1089/neu.2018.6308		JUN 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000472054900001	31038001				2022-02-06	
J	Gerbatin, RR; Silva, LFA; Hoffmann, MS; Della-Pace, ID; do Nascimento, PS; Kegler, A; de Zorzi, VN; Cunha, JM; Botelho, P; Neto, JBT; Furian, AF; Oliveira, MS; Fighera, MR; Royes, LFF				Gerbatin, Rogerio R.; Almeida Silva, Luiz Fernando; Hoffmann, Mauricio S.; Della-Pace, Iuri D.; do Nascimento, Patricia Severo; Kegler, Aline; de Zorzi, Viviane Nogueira; Cunha, Jane Marcal; Botelho, Priscilla; Torres Neto, Joao Bento; Furian, Ana Flavia; Oliveira, Mauro Schneider; Fighera, Michele R.; Freire Royes, Luiz Fernando			Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in rats	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						Fluid percussion injury; Epilepsy; Seizure; Creatine; Epileptiform discharge; GABA	POSTTRAUMATIC EPILEPSY; RECEPTOR SUBUNITS; OXIDATIVE STRESS; INTERNEURONS; HIPPOCAMPUS; INHIBITION; EXPRESSION; PREVENTION; THALAMUS; EXERCISE	Traumatic brain injury (TBI) is a devastating disease frequently followed by behavioral disabilities including post-traumatic epilepsy (PTE). Although reasonable progress in understanding its pathophysiology has been made, treatment of PTE is still limited. Several studies have shown the neuroprotective effect of creatine in different models of brain pathology, but its effects on PTE is not elucidated. Thus, we decided to investigate the impact of delayed and chronic creatine supplementation on susceptibility to epileptic seizures evoked by pentylenetetrazol (PTZ) after TBI. Our experimental data revealed that 4 weeks of creatine supplementation (300 mg/kg, p.o.) initiated 1 week after fluid percussion injury (FPI) notably increased the latency to first myoclonic and tonic-clonic seizures, decreased the time spent in tonic-clonic seizure, seizure intensity, epileptiform discharges and spindle oscillations induced by a sub-convulsant dose of PTZ (35 mg/kg, i.p.). Interestingly, this protective effect persists for 1 week even when creatine supplementation is discontinued. The anticonvulsant effect of creatine was associated with its ability to reduce cell loss including the number of parvalbumin positive (PARV+) cells in CA3 region of the hippocampus. Furthermore, creatine supplementation also protected against the reduction of GAD67 levels, GAD activity and specific [H-3] flunitrazepam binding in the hippocampus. These findings showed that chronic creatine supplementation may play a neuroprotective role on brain excitability by controlling the GABAergic function after TBI, providing a possible new strategy for the treatment of PTE.	[do Nascimento, Patricia Severo; Furian, Ana Flavia; Oliveira, Mauro Schneider; Fighera, Michele R.; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Ciencias Saude, Programa Posgrad Farmacol, Santa Maria, RS, Brazil; [Kegler, Aline; de Zorzi, Viviane Nogueira; Fighera, Michele R.; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil; [Gerbatin, Rogerio R.; Almeida Silva, Luiz Fernando; Della-Pace, Iuri D.; Fighera, Michele R.; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Lab Bioquim Exercicio, Programa Posgrad Educ Fis, Santa Maria, RS, Brazil; [Cunha, Jane Marcal; Botelho, Priscilla; Torres Neto, Joao Bento] Univ Fed Para, Inst Ciencias Biol, Ratorio Neurodegeneracao & Infeccao, Belem, Para, Brazil; [Hoffmann, Mauricio S.] Univ Fed Santa Maria, Dept Neuropsiquiatria, Santa Maria, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Hoffmann, Mauricio/AAM-9899-2020; NETO, JOAO BENTO TORRES/N-5458-2019; Fighera, Michele R/J-9576-2014; Nascimento, Patricia Severo do/I-6143-2012; Oliveira, Mauro/G-3437-2012	Hoffmann, Mauricio/0000-0003-4232-3169; NETO, JOAO BENTO TORRES/0000-0002-9155-9445; Nascimento, Patricia Severo do/0000-0001-5209-3761; Fighera, Michele/0000-0002-3111-7530; Oliveira, Mauro/0000-0002-5381-1208; Almeida Silva, Luiz Fernando/0000-0002-7621-4836	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [CNPq: 11/2082-4, CNPq 307382/2017-6]	This work was supported by the CNPq (grants: CNPq: 11/2082-4). Michele Fighera and L.F.F. Royes are recipients of CNPq fellowships (grants: CNPq 307382/2017-6).	Abdanipour A, 2011, NEUROL RES, V33, P625, DOI 10.1179/1743132810Y.0000000018; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dobrachinski F., 2018, MOL NEUROBIOL, V55, P1; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; DUNLOP DS, 1975, BRAIN RES, V99, P303, DOI 10.1016/0006-8993(75)90031-1; DUNLOP DS, 1975, J NEUROCHEM, V24, P337, DOI 10.1111/j.1471-4159.1975.tb11885.x; Royes LFF, 2016, AMINO ACIDS, V48, P1373, DOI 10.1007/s00726-015-2164-1; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Houser CR, 2012, JASPERS BASIC MECH E; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Koga Y, 2005, NEUROSCIENCE, V132, P65, DOI 10.1016/j.neuroscience.2005.01.004; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Lazarus MS, 2015, CEREB CORTEX, V25, P1290, DOI 10.1093/cercor/bht322; Lloyd K G, 1986, Adv Neurol, V44, P1033; Saraiva ALL, 2012, BRAIN RES BULL, V87, P180, DOI 10.1016/j.brainresbull.2011.10.010; Mackenzie L, 2010, EPILEPSY RES, V89, P194, DOI 10.1016/j.eplepsyres.2010.01.003; Magni DV, 2007, BRAIN RES, V1185, P336, DOI 10.1016/j.brainres.2007.09.023; Marcuzzo S, 2010, BRAIN DEV-JPN, V32, P323, DOI 10.1016/j.braindev.2009.04.016; Mohammad-Gharibani P, 2012, RESTOR NEUROL NEUROS, V30, P511, DOI 10.3233/RNN-2012-100155; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pazini F. L., 2018, BIOL PSYCHIAT, V89, P193; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rae CD, 2015, NEUROCHEM INT, V89, P249, DOI 10.1016/j.neuint.2015.08.010; Rambo LM, 2013, AMINO ACIDS, V44, P857, DOI 10.1007/s00726-012-1408-6; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tukker JJ, 2013, J NEUROSCI, V33, P6809, DOI 10.1523/JNEUROSCI.5052-12.2013; Zhang YF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06294-w	50	9	9	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	JUN 8	2019	92						328	338		10.1016/j.pnpbp.2019.02.004			11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	HW6YP	WOS:000466837000032	30742861				2022-02-06	
J	Baschera, D; Jager, D; Preda, R; Z'Graggen, WJ; Raabe, A; Exadaktylos, AK; Hasler, RM				Baschera, Dominik; Jaeger, Damian; Preda, Raluca; Z'Graggen, Werner J.; Raabe, Andreas; Exadaktylos, Aristomenis K.; Hasler, Rebecca M.			Comparison of the Incidence and Severity of Traumatic Brain Injury Caused by Electrical Bicycle and Bicycle Accidents-A Retrospective Cohort Study From a Swiss Level I Trauma Center	WORLD NEUROSURGERY			English	Article						Bicycle; E-bike; Head trauma; Helmet; TBI	HELMET USE; E-BIKE; CYCLISTS; SAFETY; RIDERS; SPEED; COSTS; CITY	BACKGROUND: Electrical bicycles (E-bikes) allow people of all ages to ride at high speeds but have an inherent risk of traumatic brain injury (TBI). Their sales have increased tremendously in recent years. METHODS: We performed a retrospective cohort study to compare the incidence and severity of TBI in E-bikers and conventional bicyclists. We included patients at a Swiss level 1 trauma center admitted from 2010 to 2015. The primary outcome was the association between TBI and the bicycle type. The secondary outcome was the association between helmet use and TBI severity. RESULTS: Of 557 patients injured riding an E-bike (n = 73) or a bicycle (n = 484), 60% sustained a TBI, most of which were mild (Glasgow coma scale [GCS] score, 13-15; E-bike, 78%; bicycle, 88%). TBI was more often moderate (GCS score, 9-12) or severe (GCS score, 3-8) in E-bikers than in bicyclists (P = 0.04). Intracranial hemorrhage, traumatic subarachnoid hemorrhage, and subdural hematoma occurred significantly more often in E-bikers than in bicyclists (P < 0.05). Neurosurgical intervention was necessary for 5 E-bikers (7%) and 25 (5%) bicyclists (P = 0.15). Wearing a helmet correlated with a lower risk of neurosurgical intervention in bicyclists (odds ratio [OR], 0.21; 95% confidence interval [CI], 0.06-0.73; P = 0.01) and a lower risk of calvarial fractures in both bicyclists (OR, 0.16; 95% CI, 0.06-0.42; P < 0.01) and E-bikers (OR, 0.21; 95% CI, 0.05-0.84; P = 0.03). CONCLUSIONS: E-bikers had a significantly greater risk of moderate to severe TBI compared with bicyclists. Helmet use was associated with decreased odds of severe TBI in bicyclists and a tendency toward a more favorable outcome for E-bikers.	[Baschera, Dominik] Kantonsspital Winterthur, Dept Neurosurg, Winterthur, Switzerland; [Jaeger, Damian; Exadaktylos, Aristomenis K.; Hasler, Rebecca M.] Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland; [Preda, Raluca; Z'Graggen, Werner J.; Raabe, Andreas] Bern Univ Hosp, Inselspital, Dept Neurosurg, Bern, Switzerland		Hasler, RM (corresponding author), Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland.	rebecca.hasler@insel.ch	Dominik, Baschera/AAI-1953-2021	Dominik, Baschera/0000-0002-9634-9922; Hasler, Rebecca Maria/0000-0002-0616-2313	"Furstlicher Kommerzienrat Guido Feger" Foundation	The present study was supported by the "Furstlicher Kommerzienrat Guido Feger" Foundation.	Airaksinen N., 2010, ANN ADV AUTOMOTIVE M, V54, P267; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Buffat M, 2014, DISTRIBUTION EFFECTS; Chen WS, 2013, ACAD EMERG MED, V20, P570, DOI 10.1111/acem.12146; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; Du W, 2014, INJURY PREV, V20, P128, DOI 10.1136/injuryprev-2012-040618; Du W, 2013, ACCIDENT ANAL PREV, V59, P319, DOI 10.1016/j.aap.2013.06.011; EilertPetersson E, 1997, ACCIDENT ANAL PREV, V29, P363, DOI 10.1016/S0001-4575(97)00002-X; Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1016/S0033-3506(01)00411-5; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Feng ZY, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.024646; Hefny AF, 2012, INJURY, V43, P1547, DOI 10.1016/j.injury.2011.05.016; Howick J, EXPLANATION 2011 OXF; Hu F, 2014, TRAFFIC INJ PREV, V15, P319, DOI 10.1080/15389588.2013.817669; Jellinek R, 2013, AUSWIRKUNGEN ENTWICK; JENNETT B, 1975, LANCET, V1, P480; Kim YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181362; Kubitzki J, 2013, NICHTMOTORISIERTE VE; Lawinger T., 2013, Z VERKEHRSSICHERHEIT, V59, P99; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Neumann MV, 2016, EMERG MED AUSTRALAS, V28, P90, DOI 10.1111/1742-6723.12495; Olds K, 2015, J FORENSIC LEG MED, V34, P99, DOI 10.1016/j.jflm.2015.05.018; Otte D, 2014, VKU VERKEHRSUNFALL F, V52, P48; Papoutsi S, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/850236; Petzoldt T, 2017, SAFETY SCI, V92, P283, DOI 10.1016/j.ssci.2015.07.021; R Core Team, 2014, R LANG ENV STAT COMP; Scheiman S, 2010, ACCIDENT ANAL PREV, V42, P758, DOI 10.1016/j.aap.2009.11.005; Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Swiss Council for Accident Prevention, 2017, SURV HELM WEAR RAT C; TEASDALE G, 1974, LANCET, V2, P81; Teschke K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008052; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Veisten K, 2007, ACCIDENT ANAL PREV, V39, P1162, DOI 10.1016/j.aap.2007.03.002; Vlakveld WP, 2015, ACCIDENT ANAL PREV, V74, P97, DOI 10.1016/j.aap.2014.10.018; Weber T, 2014, ACCIDENT ANAL PREV, V73, P47, DOI 10.1016/j.aap.2014.07.020; Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003902; Zhang X, 2015, ASIA-PAC J PUBLIC HE, V27; Zhou SA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007395; Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y	45	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E1023	E1034		10.1016/j.wneu.2019.03.032			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400129	30857998				2022-02-06	
J	Bijlenga, P; Morita, A; Ko, NU; Mocco, J; Morel, S; Murayama, Y; Wermer, MJH; Brown, RD; Suarez, JI; Macdonald, RL; Amin-Hanjani, S; Brown, RD; Manoel, ALD; Derdeyn, CP; Etminan, N; Keller, E; LeRoux, PD; Mayer, S; Morita, A; Rinkel, G; Rufennacht, D; Stienen, MN; Torner, J; Vergouwen, MDI; Wong, GKC; Bijlenga, P; Ko, N; McDougall, CG; Mocco, J; Murayama, Y; Werner, MJH; Suarez, JI; Damani, R; Broderick, J; Dhar, R; Jauch, EC; Kirkpatrick, PJ; Martin, RH; Mocco, J; Muehlschlegel, S; Mutoh, T; Nyquist, P; Olson, D; Mejia-Mantilla, JH; Amin-Hanjani, S; van der Jagt, M; Bambakidis, N; Brophy, G; Bulsara, K; Claassen, J; Connolly, ES; Hoffer, SA; Hoh, BL; Holloway, RG; Kelly, A; Nakaji, P; Rabinstein, A; Vajkoczy, P; Vergouwen, MDI; Woo, H; Zipfel, GJ; Keller, E; Chou, S; Dore, S; Dumont, AS; Gunel, M; Kasuya, H; Roederer, A; Ruigrok, Y; Vespa, PM; Sarrafzadeh-Khorrasani, AS; Derdeyn, CP; Etminan, N; Hackenberg, K; Huston, J; Krings, T; Lanzino, G; Meyers, PM; Rinkel, G; Rufennacht, D; Wintermark, M; Torner, J; Wong, GKC; Broderick, J; Daly, J; Ogilvy, C; Rhoney, DH; Roos, YB; Siddiqui, A; Etminan, N; Rinkel, G; Hackenberg, K; Algra, A; Frosen, J; Hasan, D; Juvela, S; Langer, DJ; Meyers, PM; Morita, A; Salman, RA; Stienen, MN; Vergouwen, MDI; Hanggi, D; Schweizer, T; Visser-Meily, J; Amos, L; Ludet, C; Moy, C; Odenkirchen, J; Ala'i, S; Esterlitz, J; Joseph, K; Sheikh, M				Bijlenga, Philippe; Morita, Akio; Ko, Nerissa U.; Mocco, J.; Morel, Sandrine; Murayama, Yuichi; Wermer, Marieke J. H.; Brown, Robert D.; Suarez, Jose I.; Macdonald, R. Loch; Amin-Hanjani, Sepideh; Brown, Robert D., Jr.; Manoel, Airton Leonardo de Oliveira; Derdeyn, Colin P.; Etminan, Nima; Keller, Emanuela; LeRoux, Peter D.; Mayer, Stephan; Morita, Akio; Rinkel, Gabriel; Rufennacht, Daniel; Stienen, Martin N.; Torner, James; Vergouwen, Mervyn D. I.; Wong, George K. C.; Bijlenga, Philippe; Ko, Nerissa; McDougall, Cameron G.; Mocco, J.; Murayama, Yuuichi; Werner, Marieke J. H.; Suarez, Jose I.; Damani, Rahul; Broderick, Joseph; Dhar, Raj; Jauch, Edward C.; Kirkpatrick, Peter J.; Martin, Renee H.; Mocco, J.; Muehlschlegel, Susanne; Mutoh, Tatsushi; Nyquist, Paul; Olson, Daiwai; Mejia-Mantilla, Jorge H.; Amin-Hanjani, Sepideh; van der Jagt, Mathieu; Bambakidis, Nicholas; Brophy, Gretchen; Bulsara, Ketan; Claassen, Jan; Connolly, E. Sander; Hoffer, S. Alan; Hoh, Brian L.; Holloway, Robert G.; Kelly, Adam; Nakaji, Peter; Rabinstein, Alejandro; Vajkoczy, Peter; Vergouwen, Mervyn D. I.; Woo, Henry; Zipfel, Gregory J.; Keller, Emanuela; Chou, Sherry; Dore, Sylvain; Dumont, Aaron S.; Gunel, Murat; Kasuya, Hidetoshi; Roederer, Alexander; Ruigrok, Ynte; Vespa, Paul M.; Sarrafzadeh-Khorrasani, Asita Simone; Derdeyn, Colin P.; Etminan, Nima; Hackenberg, Katharina; Huston, John, III; Krings, Timo; Lanzino, Giuseppe; Meyers, Philip M.; Rinkel, Gabriel; Rufennacht, Daniel; Wintermark, Max; Torner, James; Wong, George K. C.; Broderick, Joseph; Daly, Janis; Ogilvy, Christopher; Rhoney, Denise H.; Roos, Y. B.; Siddiqui, Adnan; Etminan, Nima; Rinkel, Gabriel; Hackenberg, Katharina; Algra, Ale; Frosen, Juhanna; Hasan, David; Juvela, Seppo; Langer, David J.; Meyers, Philip M.; Morita, Akio; Salman, Rustam Al-Shahi; Stienen, Martin N.; Vergouwen, Mervyn D. I.; Hanggi, Daniel; Schweizer, Tom; Visser-Meily, Johanna; Amos, Liz; Ludet, Christophe; Moy, Claudia; Odenkirchen, Joanne; Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza		Unruptured Cerebral Aneurysms SAH	Common Data Elements for Subarachnoid Hemorrhage and Unruptured Intracranial Aneurysms: Recommendations from the Working Group on Subject Characteristics	NEUROCRITICAL CARE			English	Article						Intracranial aneurysm; Subarachnoid Hemorrhage; Common Data Elements; Participant; Subject characteristics	MODIFIABLE RISK-FACTORS; CEREBRAL ANEURYSMS; ATTRIBUTABLE RISK; NATURAL-HISTORY; RUPTURE RISK; HYPERTENSION; PREDICTION; MORTALITY; SMOKING; DISEASE	BackgroundThe National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements (CDEs) have been generated to standardize and define terms used by the scientific community. The widespread use of these CDEs promotes harmonized data collection in clinical research. The aim of the NINDS Unruptured Intracranial Aneurysms (UIA) and Subarachnoid Hemorrhage (SAH), and Subject Characteristics working group (WG) was to identify, define, and classify CDEs describing the characteristics of patients diagnosed with an UIA and SAH. Thus, Participant/Subject characteristics is a set of factors defining a population of selected individuals and allowing comparisons with a reference population and overtime.MethodsBased on standard terms defined by the United States' Census Bureau, CDEs previously defined by several (Stroke, Epilepsy and Traumatic Brain Injury) NINDS CDE working groups literature and expert opinion of the WG, the Participant/Subject characteristics domain has been defined.ResultsA set of 192 CDEs divided in 7 subsections: demographics (8 CDEs), social status (8 CDEs), behavioral status (22 CDEs), family and medical history (144 CDEs), pregnancy and perinatal history (8 CDEs), history data source reliability (3 CDEs), and prior functional status (3 CDEs)was defined. SAH is characterized by 6 core elements, all classified in the Participant/Subject characteristics domain. Four exploratory elements out of the 39 for SAH overall are in the Participant/Subject characteristics domain, and all remaining 182 CDEs in the Participant/Subject characteristics domain are classified as Supplemental-Highly Recommended elements.ConclusionsThese CDEs would allow the development of best practice guidelines to standardize the assessment and reporting of observations concerning UIA and SAH.	[Bijlenga, Philippe; Morel, Sandrine] Univ Geneva, Fac Med, Dept Clin Neurosci, Neurosurg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Morita, Akio] Nippon Med Sch, Dept Neurol Surg, Tokyo, Japan; [Ko, Nerissa U.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mocco, J.] Mt Sinai Hlth Syst, Dept Neurosurg, New York, NY USA; [Murayama, Yuichi] Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Tokyo, Japan; [Wermer, Marieke J. H.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [LeRoux, Peter D.] Main Line Hlth, Wynnewood, PA USA; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Rufennacht, Daniel] Klin Hirslanden, Zurich, Switzerland; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Torner, James] Univ Iowa, Iowa City, IA USA; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Bijlenga, Philippe] Geneva Univ Hosp, Geneva, Switzerland; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Damani, Rahul] Baylor Coll Med, Houston, TX 77030 USA; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [van der Jagt, Mathieu] Erasmus MC, Rotterdam, Netherlands; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Torner, James] Univ Iowa, Iowa City, IA USA; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Amos, Liz] Natl Lib Med, Natl Informat Ctr Hlth Serv Res & Hlth Care Techn, Bethesda, MD USA; [Ludet, Christophe] Natl Lib Med, Bethesda, MD USA; [Moy, Claudia; Odenkirchen, Joanne] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza] Emmes Corp, Rockville, MD USA		Bijlenga, P (corresponding author), Univ Geneva, Fac Med, Dept Clin Neurosci, Neurosurg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	philippe.bijlenga@hcuge.ch	Wong, George Kwok Chu/L-4344-2016; de Oliveira Manoel, Airton Leonardo/C-4724-2018; Dore, Sylvain/AAG-1470-2020; Olson, DaiWai/I-5932-2019; Claassen, Jan/AAA-5451-2020; DAMANI, RAHUL/R-7012-2018; van der Jagt, Mathieu/G-1905-2017	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; Olson, DaiWai/0000-0002-9280-078X; DAMANI, RAHUL/0000-0001-7990-0965; Derdeyn, Colin/0000-0002-5932-2683; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574; van der Jagt, Mathieu/0000-0003-2566-8325; Morita, Akio/0000-0002-2497-5772; Al-Shahi Salman, Rustam/0000-0002-2108-9222	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN271201200034C]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002605] Funding Source: UKRI	Logistical support for this project was provided in part through NIH Contract HHSN271201200034C, the Intramural Research Program of the NIH, NLM, The Neurocritical Care Society and the CHI Baylor St Luke's Medical Center in Houston, TX. The development of the NINDS SAH CDEs was made possible thanks to the great investment of time and effort of WG members and the members of the NINDS CDE Project and NLM CDE project teams participating from 2015 to 2017.	Algra AM, 2012, NEUROLOGY, V79, P1230, DOI 10.1212/WNL.0b013e31826aace6; Andreasen TH, 2013, STROKE, V44, P3607, DOI 10.1161/STROKEAHA.113.001575; Broderick JP, 2003, STROKE, V34, P1375, DOI 10.1161/01.STR.0000074572.91827.F4; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; Damani R, 2019, NEUROCRIT CARE; Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150; Etminan N, 2015, NEUROLOGY, V85, P881, DOI 10.1212/WNL.0000000000001891; Etminan N, 2014, STROKE, V45, P1523, DOI 10.1161/STROKEAHA.114.004519; Etminan N, 2011, J NEUROL NEUROSUR PS, V82, P4, DOI 10.1136/jnnp.2009.199661; Fletcher G F, 1994, Health Rep, V6, P106; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hishikawa T, 2015, NEUROLOGY, V85, P1879, DOI 10.1212/WNL.0000000000002149; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Juvela S, 1996, ARCH NEUROL-CHICAGO, V53, P734, DOI 10.1001/archneur.1996.00550080048012; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Juvela S, 2015, NEUROLOGY, V84, P456, DOI 10.1212/WNL.0000000000001207; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Kissela BM, 2002, STROKE, V33, P1321, DOI 10.1161/01.STR.0000014773.57733.3E; KNEKT P, 1991, J CLIN EPIDEMIOL, V44, P933, DOI 10.1016/0895-4356(91)90056-F; Korja M, 2016, NEUROLOGY, V87, P1118, DOI 10.1212/WNL.0000000000003091; Korja M, 2014, STROKE, V45, P1958, DOI 10.1161/STROKEAHA.114.005318; Korja M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073760; Korja M, 2013, NEUROLOGY, V80, P481, DOI 10.1212/WNL.0b013e31827f0fb5; Koroknay-Pal P, 2012, STROKE, V43, P2091, DOI 10.1161/STROKEAHA.112.650077; Kruyt ND, 2010, J CEREBR BLOOD F MET, V30, P1577, DOI 10.1038/jcbfm.2010.102; Lindekleiv H, 2012, STROKE, V43, P1885, DOI 10.1161/STROKEAHA.112.651315; Lindgren AE, 2016, STROKE, V47, P1213, DOI 10.1161/STROKEAHA.115.012573; Lindgren AE, 2014, ANN MED, V46, P169, DOI 10.3109/07853890.2014.883168; Miller TD, 2012, J NEUROL NEUROSUR PS, V83, P86, DOI 10.1136/jnnp-2011-300789; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Rabinstein AA, 2013, NEUROLOGY, V80, pE56, DOI 10.1212/WNL.0b013e3182834b22; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Ruigrok YM, 2001, STROKE, V32, P1173, DOI 10.1161/01.STR.32.5.1173; Shiue I, 2012, J NEUROL SCI, V313, P92, DOI 10.1016/j.jns.2011.09.017; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; Tominari S, 2015, ANN NEUROL, V77, P1050, DOI 10.1002/ana.24400; Vlak MHM, 2011, STROKE, V42, P1878, DOI 10.1161/STROKEAHA.110.606558; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; WOO J, 1992, J AM GERIATR SOC, V40, P124, DOI 10.1111/j.1532-5415.1992.tb01931.x	40	9	9	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30			1			20	27		10.1007/s12028-019-00724-5			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF3IS	WOS:000472974700003	31077079				2022-02-06	
J	Chandrasekar, A; Heuvel, FO; Tar, L; Hagenston, AM; Palmer, A; Linkus, B; Ludolph, AC; Huber-Lang, M; Boeckers, T; Bading, H; Roselli, F				Chandrasekar, Akila; Heuvel, Florian Olde; Tar, Lilla; Hagenston, Anna M.; Palmer, Annette; Linkus, Birgit; Ludolph, Albert C.; Huber-Lang, Markus; Boeckers, Tobias; Bading, Hilmar; Roselli, Francesco			Parvalbumin Interneurons Shape Neuronal Vulnerability in Blunt TBI	CEREBRAL CORTEX			English	Article						chemogenetics; nuclear calcium; parvalbumin interneurons; traumatic brain injury	SYNAPTIC NMDA RECEPTORS; TRAUMATIC BRAIN-INJURY; CELL-DEATH; GENOMIC PROGRAM; INHIBITION; EXCITATION; MODEL; ROLES; TRANSCRIPTION; PROPAGATION	Excessive excitation has been hypothesized to subsume a significant part of the acute damage occurring after traumatic brain injury (TBI). However, reduced neuronal excitability, loss of neuronal firing, and a disturbed excitation/inhibition balance have been detected. Parvalbumin (PV) interneurons are major regulators of perisomatic inhibition, principal neurons firing, and overall cortical excitability. However, their role in acute TBI pathogenic cascades is unclear. We exploited the chemogenetic Pharmacologically Selective Activation Module and Pharmacologically Selective Effector Module control of PV-Cre(+) neurons and the Designer Receptors Exclusively Activated by Designer Drug (DREADD) control of principal neurons in a blunt model of TBI to explore the role of inhibition in shaping neuronal vulnerability to TBI. We demonstrated that inactivation of PV interneurons at the instance or soon after trauma enhances survival of principal neurons and reduces gliosis at 7 dpi whereas, activation of PV interneurons decreased neuronal survival. The protective effect of PV inactivation was suppressed by expressing the nuclear calcium buffer PV-nuclear localisation sequence in principal neurons, implying an activity-dependent neuroprotective signal. In fact, protective effects were obtained by increasing the excitability of principal neurons directly using DREADDs. Thus, we show that sustaining neuronal excitation in the early phases of TBI may reduce neuronal vulnerability by increasing activity-dependent survival, while excess activation of perisomatic inhibition is detrimental to neuronal integrity.	[Chandrasekar, Akila; Heuvel, Florian Olde; Tar, Lilla; Linkus, Birgit; Ludolph, Albert C.; Roselli, Francesco] Ulm Univ, Dept Neurol, DE-89081 Ulm, Germany; [Hagenston, Anna M.; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol IZN, DE-69120 Heidelberg, Germany; [Palmer, Annette; Huber-Lang, Markus; Roselli, Francesco] Ulm Univ, Inst Clin & Expt Trauma Immunol, Dept Orthoped Trauma Hand Plast & Reconstruct Sur, DE-89081 Ulm, Germany; [Boeckers, Tobias] Ulm Univ, Dept Anat & Cell Biol, DE-89081 Ulm, Germany; [Roselli, Francesco] Ulm Univ, Neurozentrum, DE-89081 Ulm, Germany		Roselli, F (corresponding author), Ulm Univ, Ctr Biomed Res ZBF, Dept Neurol, Helmholtzstr 8-2,R1-44, DE-89081 Ulm, Germany.	francesco.roselli@uni-ulm.de	Huber-Lang, Markus/AAJ-2209-2020; roselli, francesco/O-8847-2019	roselli, francesco/0000-0001-9935-6899	Deutsche Forschungsgemeinschaft (DFG) as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma"German Research Foundation (DFG) [SFB1149B05]; Collaborative Research Center 1158 [SFB 1158-A05]; ERANET-NEURON initiative "External Insults to the Nervous System"; BMBF as part of the MICRONET consortiumFederal Ministry of Education & Research (BMBF) [FKZ 01EW1705A]; Synapsis Foundation; Baustein program of the Medical Faculty of Ulm University	This work has been supported by the Deutsche Forschungsgemeinschaft (DFG) as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma" (SFB1149B05). H.B. is supported by the Collaborative Research Center 1158 (SFB 1158-A05). F.R. is also supported by the ERANET-NEURON initiative "External Insults to the Nervous System" and BMBF as part of the MICRONET consortium (FKZ 01EW1705A), by the Synapsis Foundation and by the Baustein program of the Medical Faculty of Ulm University.	Agetsuma Masakazu, 2018, Cereb Cortex, V28, P1831, DOI 10.1093/cercor/bhx169; Ahlgren H, 2014, J BIOL CHEM, V289, P9970, DOI 10.1074/jbc.M113.502914; Allitt BJ, 2017, CELL TRANSPLANT, V26, P1202, DOI 10.1177/0963689717714326; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bading H, 2017, J EXP MED, V214, P569, DOI 10.1084/jem.20161673; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Bas-Orth C, 2017, J BIOL CHEM, V292, P5183, DOI 10.1074/jbc.M116.761106; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Cammarota M, 2013, J PHYSIOL-LONDON, V591, P807, DOI 10.1113/jphysiol.2012.238154; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chovsepian A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00036; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; Depp C, 2018, ANTIOXID REDOX SIGN, V29, P1109, DOI 10.1089/ars.2017.7092; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donato F, 2015, NEURON, V85, P770, DOI 10.1016/j.neuron.2015.01.011; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hertle DN, 2016, J CLIN ANESTH, V35, P118, DOI 10.1016/j.jclinane.2016.07.006; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Karunakaran S, 2016, NAT NEUROSCI, V19, P454, DOI 10.1038/nn.4231; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khoshkhoo S, 2017, NEURON, V93, P291, DOI 10.1016/j.neuron.2016.11.043; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Lau D, 2015, CELL REP, V12, P1353, DOI 10.1016/j.celrep.2015.07.038; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Lu YS, 2014, NEURON, V84, P835, DOI 10.1016/j.neuron.2014.09.029; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Martin JL, 2001, J COMP NEUROL, V436, P127; Mauceri D, 2015, J BIOL CHEM, V290, P23039, DOI 10.1074/jbc.M115.654962; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Samson AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33746; Sawant-Pokam PM, 2017, CEREB CORTEX, V27, P1311, DOI 10.1093/cercor/bhv328; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Sun YJ, 2016, NEURON, V92, P160, DOI 10.1016/j.neuron.2016.08.033; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yang JW, 2017, CEREB CORTEX, V27, P5784, DOI 10.1093/cercor/bhx261; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	71	9	9	2	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUN	2019	29	6					2701	2715		10.1093/cercor/bhy139			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IS4OI	WOS:000482132400028	29982364				2022-02-06	
J	Lee, SW; Jang, MS; Jeong, SH; Kim, H				Lee, Suk-Woo; Jang, Mun-Sun; Jeong, Seong-Hae; Kim, Hoon			Exploratory, cognitive, and depressive-like behaviors in adult and pediatric mice exposed to controlled cortical impact	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Brain injuries; traumatic; Controlled cortical impact; Age difference; Neurobehavioral differences	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; WEIGHT-DROP; MOUSE MODEL; HEAD-INJURY; AGE; MAZE; IMPAIRMENT; HYPEROXIA; MEMORY	Objective Sequelae of behavioral impairments associated with human traumatic brain injury (TBI) include neurobehavioral problems. We compared exploratory, cognitive, and depressive-like behaviors in pediatric and adult male mice exposed to controlled cortical impact (CCI). Methods Pediatric (21 to 25 days old) and adult (8 to 12 weeks old) male C57Bl/6 mice underwent CCI at a 2-mm depth of deflection. Hematoxylin and eosin staining was performed 3 to 7 days after recovery from CCI, and injury volume was analyzed using ImageJ. Neurobehavioral characterization after CCI was performed using the Barnes maze test (BMT), passive avoidance test, open-field test, light/dark test, tail suspension test, and rotarod test. Acutely and subacutely (3 and 7 days after CCI, respectively), CCI mice showed graded injury compared to sham mice for all analyzed deflection depths. Results Time-dependent differences in injury volume were noted between 3 and 7 days following 2-mm TBI in adult mice. In the BMT, 2-mm TBI adults showed spatial memory deficits compared to sham adults (P<0.05). However, no difference in spatial learning and memory was found between sham and 2-mm CCI groups among pediatric mice. The open-field test, light/dark test, and tail suspension test did not reveal differences in anxiety-like behaviors in both age groups. Conclusion Our findings revealed a graded injury response in both age groups. The BMT was an efficient cognitive test for assessing spatial/non-spatial learning following CCI in adult mice; however, spatial learning impairments in pediatric mice could not be assessed.	[Lee, Suk-Woo; Kim, Hoon] Chungbuk Natl Univ Hosp, Dept Emergency Med, Cheongju, South Korea; [Lee, Suk-Woo; Jang, Mun-Sun; Kim, Hoon] Chungbuk Natl Univ, Dept Emergency Med, Coll Med, 1 Chungdae Ro, Cheongju 28644, South Korea; [Jang, Mun-Sun] Chungbuk Hlth & Sci Univ, Dept Emergency Med Technol, Cheongju, South Korea; [Jeong, Seong-Hae] Chungnam Natl Univ, Dept Neurol, Coll Med, Daejeon, South Korea		Kim, H (corresponding author), Chungbuk Natl Univ, Dept Emergency Med, Coll Med, 1 Chungdae Ro, Cheongju 28644, South Korea.	nichekh2000@chungbuk.ac.kr		Jeong, Seong-Hae/0000-0001-5055-9986	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2015R1A2A2A01002303, NRF-2016R1D1A1B04930247]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2015R1A2A2A01002303 & NRF-2016R1D1A1B04930247).	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Ashman TA, 2006, MT SINAI J MED, V73, P999; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Monsalve BC, 2014, NEUROREHABILITATION, V35, P67, DOI 10.3233/NRE-141103; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cheng J, 2009, J CEREBR BLOOD F MET, V29, P486, DOI 10.1038/jcbfm.2008.138; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; DAVIS M, 1994, ACT NEUR S, V60, P282; Deng G, 2014, J NEUROSCI METH, V222, P34, DOI 10.1016/j.jneumeth.2013.10.015; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Gacar N, 2011, PHARMACOL BIOCHEM BE, V99, P316, DOI 10.1016/j.pbb.2011.05.017; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Janz DR, 2012, CRIT CARE MED, V40, P3135, DOI 10.1097/CCM.0b013e3182656976; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Liu FD, 2012, NEUROCHEM INT, V61, P1255, DOI 10.1016/j.neuint.2012.10.003; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Popik P, 2017, NEUROTOX RES, V32, P544, DOI 10.1007/s12640-017-9759-0; Potts Mathew B, 2006, NeuroRx, V3, P143; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; VigilSewell J, 1996, ARCH PEDIAT ADOL MED, V150, P228, DOI 10.1001/archpedi.1996.02170270110022; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Whiting MD, 2006, ANIMAL MODELCOGNIT, P301; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	47	9	9	0	1	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	JUN	2019	6	2					125	137		10.15441/ceem.18.019			13	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	IF7ZN	WOS:000473306500005	31261483	Green Published, Green Submitted, gold			2022-02-06	
J	Morbitzer, KA; Jordan, JD; Dehne, KA; Durr, EA; Olm-Shipman, CM; Rhoney, DH				Morbitzer, Kathryn A.; Jordan, J. Dedrick; Dehne, Kelly A.; Durr, Emily A.; Olm-Shipman, Casey M.; Rhoney, Denise H.			Enhanced Renal Clearance in Patients With Hemorrhagic Stroke	CRITICAL CARE MEDICINE			English	Article						augmented renal clearance; creatinine clearance; intracerebral hemorrhage; subarachnoid hemorrhage	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; MEDICAL COMPLICATIONS; CREATININE CLEARANCE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; GLOMERULAR-FILTRATION; 30-DAY READMISSION; VANCOMYCIN; MANAGEMENT	Objectives: To evaluate enhanced renal clearance over time in patients with aneurysmal subarachnoid hemorrhage or intracerebral hemorrhage via measured creatinine clearance and to compare measured creatinine clearance to creatinine clearance calculated by the Cockcroft-Gault equation and estimated glomerular filtration rate calculated by the Modification of Diet in Renal Diseases equation. Design: Prospective, observational study. Setting: Neurosciences ICU in a tertiary care academic medical center. Patients: Study participants had an admission diagnosis of aneurysmal subarachnoid hemorrhage or intracerebral hemorrhage, an expected neurosciences ICU length of stay greater than 48 hours, no evidence of renal dysfunction (admission serum creatinine < 1.5 mg/dL), and no history of chronic kidney disease. Interventions: Eight-hour urine collections to measure creatinine clearance were collected daily as the primary method of measuring renal function. Creatinine clearance was also calculated using the Cockcroft-Gault equation and estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease equation. Enhanced renal clearance was defined as a measured creatinine clearance greater than the calculated creatinine clearance via Cockcroft-Gault and estimated glomerular filtration rate via Modification of Diet in Renal Disease. Augmented renal clearance was defined by a measured creatinine clearance greater than or equal to 130 mL/min/1.73 m(2). Relevant demographic, clinical, and outcome data were recorded. Measurements and Main Results: Fifty aneurysmal subarachnoid hemorrhage patients and 30 intracerebral hemorrhage patients were enrolled, contributing 590 individual measurements. Patients with aneurysmal subarachnoid hemorrhage had a higher mean measured creatinine clearance compared with the mean calculated creatinine clearance based on the Cockcroft-Gault equation (147.9 +/- 50.2 vs 109.1 +/- 32.7 mL/min/1.73 m(2); p < 0.0001) and higher mean measured creatinine clearance compared with the mean calculated estimated glomerular filtration rate based on the Modification of Diet in Renal Disease equation (147.9 +/- 50.2 vs 126.0 +/- 41.9 mL/min/1.73 m(2); p = 0.04). Ninety-four percent of participants with aneurysmal subarachnoid hemorrhage experienced augmented renal clearance on at least 1 day. In patients with intracerebral hemorrhage, there was a higher mean measured creatinine clearance over the study period compared with the mean calculated creatinine clearance (119.5 +/- 57.2 vs 77.8 +/- 27.6 mL/min/1.73 m(2); p < 0.0001) and higher mean measured creatinine clearance compared with the mean calculated estimated glomerular filtration rate based on the Modification of Diet in Renal Disease equation (119.5 +/- 57.2 vs 93.0.0 +/- 32.8 mL/min/1.73 m(2); p = 0.02). Fifty percent of participants with intracerebral hemorrhage experienced augmented renal clearance on at least 1 day. Conclusions: A substantial group of patients with aneurysmal subarachnoid hemorrhage or intracerebral hemorrhage experienced enhanced renal clearance, which may be otherwise unknown to clinicians. Enhanced renal clearance may lead to increased renal solute elimination over what is expected, resulting in subtherapeutic renally eliminated drug concentrations. This may result in underexposure to critical medications, leading to treatment failure and other medical complications.	[Morbitzer, Kathryn A.; Rhoney, Denise H.] Univ N Carolina, Div Practice Adv & Clin Educ, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA; [Jordan, J. Dedrick; Olm-Shipman, Casey M.] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA; [Jordan, J. Dedrick; Olm-Shipman, Casey M.] Univ N Carolina, Sch Med, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Dehne, Kelly A.] UNC Hlth Care, Dept Pharm, Chapel Hill, NC USA; [Durr, Emily A.] Grady Mem Hosp, Dept Pharm, Atlanta, GA USA		Rhoney, DH (corresponding author), Univ N Carolina, Div Practice Adv & Clin Educ, UNC Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.	drhoney@unc.edu		Jordan, Dedrick/0000-0002-0706-9583	Department of Neurology at the University of North Carolina School of Medicine; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002489]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002489] Funding Source: NIH RePORTER	The study was funded through the Department of Neurology at the University of North Carolina School of Medicine (to Drs. Morbitzer and Rhoney). We would also like to acknowledge the statistical assistance of the North Carolina Translational and Clinical Sciences Institute, which is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number UL1TR002489. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Andaluz N, 2009, J NEUROSURG, V110, P403, DOI 10.3171/2008.5.17559; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Baptista JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10262; BAUMANN TJ, 1987, CLIN PHARMACY, V6, P393; Bilbao-Meseguer I, 2018, CLIN PHARMACOKINET, V57, P1107, DOI 10.1007/s40262-018-0636-7; Campassi María Luz, 2014, Rev. bras. ter. intensiva, V26, P13, DOI 10.5935/0103-507X.20140003; Carlier M, 2015, INTENS CARE MED, V41, P427, DOI 10.1007/s00134-014-3641-9; Carrie C, 2018, ANAESTH CRIT CARE PA, V37, P35, DOI 10.1016/j.accpm.2017.06.006; Cherry RA, 2002, J TRAUMA, V53, P267, DOI 10.1097/00005373-200208000-00013; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; Fugate JE, 2012, CURR NEUROL NEUROSCI, V12, P1, DOI 10.1007/s11910-011-0230-y; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Just A, 2007, AM J PHYSIOL-REG I, V292, pR1, DOI 10.1152/ajpregu.00332.2006; Kassel LE, 2018, PHARMACOTHERAPY, V38, P921, DOI 10.1002/phar.2156; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liotta EM, 2013, CRIT CARE MED, V41, P2762, DOI 10.1097/CCM.0b013e318298a10f; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; McKinnon PS, 2008, INT J ANTIMICROB AG, V31, P345, DOI 10.1016/j.ijantimicag.2007.12.009; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/306189; Morbitzer KA, 2016, NEUROCRIT CARE, V25, P250, DOI 10.1007/s12028-016-0264-8; Naidech AM, 2009, NEUROCRIT CARE, V10, P11, DOI 10.1007/s12028-008-9148-x; Ohshima K, 2013, CURR HYPERTENS REV, V9, P99, DOI 10.2174/15734021113099990004; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; Parker Dennis Jr, 2010, J Pharm Pract, V23, P398, DOI 10.1177/0897190010372320; Rhoney Denise H, 2010, J Pharm Pract, V23, P408, DOI 10.1177/0897190010372334; Schiller A, 2010, NEPHROL DIAL TRANSPL, V25, P1370, DOI 10.1093/ndt/gfq068; Singh M, 2013, NEUROCRIT CARE, V19, P306, DOI 10.1007/s12028-013-9908-0; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Sunder S, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-31; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Udy AA, 2010, CLIN PHARMACOKINET, V49, P1, DOI 10.2165/11318140-000000000-00000; Wartenberg KE, 2006, CURR OPIN CRIT CARE, V12, P78, DOI 10.1097/01.ccx.0000216571.80944.65; Wartenberg KE, 2010, NEUROSURG CLIN N AM, V21, P325, DOI 10.1016/j.nec.2009.10.012; Wu FLL, 2015, THER DRUG MONIT, V37, P609, DOI 10.1097/FTD.0000000000000187; 2013, J INTENSIVE CARE MED, V28, P341	46	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2019	47	6					800	808		10.1097/CCM.0000000000003716			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY2TK	WOS:000467975600028	30870191				2022-02-06	
J	Siddiqi, SH; Trapp, NT; Shahim, P; Hacker, CD; Laumann, TO; Kandala, S; Carter, AR; Brody, DL				Siddiqi, Shan H.; Trapp, Nicholas T.; Shahim, Pashtun; Hacker, Carl D.; Laumann, Timothy O.; Kandala, Sridhar; Carter, Alexandre R.; Brody, David L.			Individualized Connectome-Targeted Transcranial Magnetic Stimulation for Neuropsychiatric Sequelae of Repetitive Traumatic Brain Injury in a Retired NFL Player	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							FUNCTIONAL CONNECTIVITY; CORTICAL EXCITABILITY; NETWORK DYSFUNCTION; DEPRESSION; DISORDER; ORGANIZATION; MECHANISMS; DEFAULT	Objective: The recent advent of individualized resting-state network mapping (RSNM) has revealed substantial inter-individual variability in anatomical localization of brain networks identified by using resting-state functional MRI (rsfMRI). RSNM enables personalized targeting of focal neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS). rTMS is believed to exert antidepressant efficacy by modulating connectivity between the stimulation site, the default mode network (DMN), and the subgenual anterior cingulate cortex (sgACC). Personalized rTMS may be particularly useful after repetitive traumatic brain injury (TBI), which is associated with neurodegenerative tauopathy inmedial temporal limbic structures. These degenerative changes are believed to be related to treatment-resistant neurobehavioral disturbances observed in many retired athletes. Methods: The authors describe a case in which RSNM was successfully used to target rTMS to treat these neuropsychiatric disturbances in a retired NFL defensive lineman whose symptoms were not responsive to conventional treatments. RSNM was used to identify left-right dorsolateral prefrontal rTMS targets with maximal difference between dorsal attention network and DMN correlations. These targets were spatially distinct from those identified by prior methods. Twenty sessions of left-sided excitatory and right-sided inhibitory rTMS were administered at these targets. Results: Treatment led to improvement in Montgomery-Asberg Depression Rating Scale (72%), cognitive testing, and headache scales scores. Compared with healthy individuals and subjects with TBI-associated depression, baseline rsfMRI revealed substantially elevated DMN connectivity with the medial temporal lobe (MTL). Serial rsfMRI scans revealed gradual improvement in MTL-DMN connectivity and stimulation site connectivity with sgACC. Conclusions: These results highlight the possibility of individualized neuromodulation and biomarker-based monitoring for neuropsychiatric sequelae of repetitive TBI.	[Siddiqi, Shan H.; Trapp, Nicholas T.; Shahim, Pashtun; Hacker, Carl D.; Laumann, Timothy O.; Kandala, Sridhar; Carter, Alexandre R.; Brody, David L.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Siddiqi, Shan H.; Trapp, Nicholas T.; Shahim, Pashtun; Hacker, Carl D.; Laumann, Timothy O.; Kandala, Sridhar; Carter, Alexandre R.; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Siddiqi, Shan H.; Trapp, Nicholas T.; Shahim, Pashtun; Hacker, Carl D.; Laumann, Timothy O.; Kandala, Sridhar; Carter, Alexandre R.; Brody, David L.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Siddiqi, Shan H.] Harvard Med Sch, Dept Neurol, McLean Hosp, Boston, MA 02115 USA; [Siddiqi, Shan H.; Shahim, Pashtun] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Trapp, Nicholas T.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA		Siddiqi, SH (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Siddiqi, SH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Siddiqi, SH (corresponding author), Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA.; Siddiqi, SH (corresponding author), Harvard Med Sch, Dept Neurol, McLean Hosp, Boston, MA 02115 USA.; Siddiqi, SH (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	shan.siddiqi@mgh.harvard.edu	Siddiqi, Shan/ABA-6482-2020	Siddiqi, Shan/0000-0002-0967-9289; Trapp, Nicholas/0000-0003-0287-2964; Laumann, Timothy/0000-0002-0428-427X	McDonnell Center for Systems Neuroscience; Mallinckrodt Institute of Radiology at Washington University, St. Louis; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University	Supported by pilot funds from the McDonnell Center for Systems Neuroscience and the Mallinckrodt Institute of Radiology at Washington University, St. Louis. Data were provided in part by the Human Connectome Project, Washington University-University of Minnesota Consortium (principal investigators, David Van Essen, Ph.D., and Kamil Ugurbil, Ph.D. [1U54MH091657]), funded by NIH, and the McDonnell Center for Systems Neuroscience at Washington University.	Awiszus F, 2011, BRAIN STIMUL, V4, P58, DOI 10.1016/j.brs.2010.09.004; Blumberger DM, 2018, LANCET, V391, P1683, DOI 10.1016/S0140-6736(18)30295-2; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Choi KS, 2015, JAMA NEUROL, V72, P1252, DOI 10.1001/jamaneurol.2015.2564; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Diefenbach GJ, 2016, BRIT J PSYCHIAT, V209, P222, DOI 10.1192/bjp.bp.115.168203; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fecteau S, 2015, NEUROREHAB NEURAL RE, V29, P548, DOI 10.1177/1545968314558603; Fitzgerald PB, 2009, NEUROPSYCHOPHARMACOL, V34, P1255, DOI 10.1038/npp.2008.233; Fox MD, 2014, P NATL ACAD SCI USA, V111, pE4367, DOI 10.1073/pnas.1405003111; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; Gordon EM, 2017, NEUROIMAGE, V146, P918, DOI 10.1016/j.neuroimage.2016.08.032; Gordon EM, 2017, CEREB CORTEX, V27, P386, DOI 10.1093/cercor/bhv239; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Klomjai W, 2015, ANN PHYS REHABIL MED, V58, P220, DOI 10.1016/j.rehab.2015.05.006; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Lee Megan H, 2016, Top Magn Reson Imaging, V25, P11, DOI 10.1097/RMR.0000000000000075; Liston C, 2014, BIOL PSYCHIAT, V76, P517, DOI 10.1016/j.biopsych.2014.01.023; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nobler MS, 2001, AM J PSYCHIAT, V158, P305, DOI 10.1176/appi.ajp.158.2.305; Opitz A, 2016, NEUROIMAGE, V127, P86, DOI 10.1016/j.neuroimage.2015.11.040; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Philip NS, 2018, BIOL PSYCHIAT, V83, P263, DOI 10.1016/j.biopsych.2017.07.021; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Reti IM, 2015, BRAIN INJURY, V29, P789, DOI 10.3109/02699052.2015.1009168; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Siddiqi SH, 2017, 2 EUR C BRAIN STIM P; Siddiqi SH, 2016, J PSYCHIATR PRACT, V22, P193, DOI 10.1097/PRA.0000000000000150; Sollmann N, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0305-4; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Wassermann EM, 2012, PHARMACOL THERAPEUT, V133, P98, DOI 10.1016/j.pharmthera.2011.09.003; Weigand A, 2018, BIOL PSYCHIAT, V84, P28, DOI 10.1016/j.biopsych.2017.10.028	50	9	9	2	12	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2019	31	3					254	263		10.1176/appi.neuropsych.18100230			10	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	IK5IW	WOS:000476619900011	30945588	Green Submitted			2022-02-06	
J	Kurowski, BG; Treble-Barna, A; Pilipenko, V; Wade, SL; Yeates, KO; Taylor, HG; Martin, LJ; Jegga, AG				Kurowski, Brad G.; Treble-Barna, Amery; Pilipenko, Valentina; Wade, Shari L.; Yeates, Keith Owen; Taylor, H. Gerry; Martin, Lisa J.; Jegga, Anil G.			Genetic Influences on Behavioral Outcomes After Childhood TBI: A Novel Systems Biology-Informed Approach	FRONTIERS IN GENETICS			English	Article						traumatic brain injury; genetics; systems biology; pediatrics; behavioral outcomes	TRAUMATIC BRAIN-INJURY; FAMILY ENVIRONMENT; RECOVERY; ASSOCIATION; MODERATE; POLYMORPHISMS; INFLAMMATION; PERFORMANCE; DEPRESSION; CHILDREN	Objectives: To test whether genetic associations with behavioral outcomes after early childhood traumatic brain injury (TBI) are enriched for biologic pathways underpinning neurocognitive and behavioral networks. Design: Cross-sectional evaluation of the association of genetic factors with early (similar to 6 months) and long-term (similar to 7 years) post-TBI behavioral outcomes. We combined systems biology and genetic association testing methodologies to identify biologic pathways associated with neurocognitive and behavior outcomes after TBI. We then evaluated whether genes/single nucleotide polymorphism (SNPs) associated with these biologic pathways were more likely to demonstrate a relationship (i.e., enrichment) with short and long-term behavioral outcomes after early childhood TBI compared to genes/SNPs not associated with these biologic pathways. Setting: Outpatient research setting. Participants: 140 children, ages 3-6:11 years at time of injury, admitted for a TBI or orthopedic injury (OI). Interventions: Not Applicable. Main Outcome Measures: Child behavior checklist total problems T score. Results: Systems biology methodology identified neuronal systems and neurotransmitter signaling (Glutamate receptor, dopamine, serotonin, and calcium signaling), inflammatory response, cell death, immune systems, and brain development as important biologic pathways to neurocognitive and behavioral outcomes after TBI. At 6 months post injury, the group (TBI versus OI) by polymorphism interaction was significant when the aggregate signal from the highest ranked 40% of case gene associations was compared to the control set of genes. At similar to 7 years post injury, the selected polymorphisms had a significant main effect after controlling for injury type when the aggregate signal from the highest ranked 10% of the case genes were compared to the control set of genes Conclusions: Findings demonstrate the promise of applying a genomics approach, informed by systems biology, to understanding behavioral recovery after pediatric TBI. A mixture of biologic pathways and processes are associated with behavioral recovery, specifically genes associated with cell death, inflammatory response, neurotransmitter signaling, and brain development. These results provide insights into the complex biology of TBI recovery.	[Kurowski, Brad G.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45221 USA; [Kurowski, Brad G.; Jegga, Anil G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Pilipenko, Valentina] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Pilipenko, Valentina; Wade, Shari L.; Martin, Lisa J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Abigail Wexner Res Inst, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43210 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp Med Ctr, Div Bioinformat, Cincinnati, OH 45229 USA		Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45221 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA.	brad.kurowski@cchmc.org	Martin, Lisa/E-2425-2016; Yeates, Keith/AAJ-4223-2020; Jegga, Anil/H-6140-2011	Martin, Lisa/0000-0001-8702-9946; Jegga, Anil/0000-0002-4881-7752	Rehabilitation Medicine Scientist Training Program (RMSTP) [K-12 HD001097-16]; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1, R01 HD42729]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096053-01A1]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]	Funding for this study was supported in part by the Rehabilitation Medicine Scientist Training Program (RMSTP) K-12 HD001097-16, National Institute for Child Health and Human Development K23HD074683-01A1, and R01 HD42729, National Institute of Neurological Disorders and Stroke 1R01NS096053-01A1, and Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adams SM, 2017, PHARMACOGENOMICS, V18, P1427, DOI 10.2217/pgs-2017-0073; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bookman EB, 2011, GENET EPIDEMIOL, V35, P217, DOI 10.1002/gepi.20571; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Cotter D, 2017, SEIZURE-EUR J EPILEP, V46, P53, DOI 10.1016/j.seizure.2017.02.002; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gelernter J, 2015, BIOL PSYCHIAT, V77, P36, DOI 10.1016/j.biopsych.2014.08.005; Hirschhorn JN, 2005, PEDIATR RES, V57, p74R, DOI 10.1203/01.PDR.0000159574.98964.87; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kennedy E, 2017, J HEAD TRAUMA REHAB, V32, P425, DOI 10.1097/HTR.0000000000000289; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P404, DOI 10.1097/HTR.0000000000000281; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Lagraoui M, 2017, BRAIN BEHAV IMMUN, V61, P96, DOI 10.1016/j.bbi.2016.12.005; Lipsky Robert H, 2015, Handb Clin Neurol, V127, P23, DOI 10.1016/B978-0-444-52892-6.00003-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Smith-Paine J, 2018, J NEUROTRAUM, V35, P2796, DOI 10.1089/neu.2017.5388; Tandon A, 2011, GENET EPIDEMIOL, V35, P80, DOI 10.1002/gepi.20550; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	59	9	9	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-8021		FRONT GENET	Front. Genet.	MAY 22	2019	10								481	10.3389/fgene.2019.00481			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HZ1BT	WOS:000468581600001	31191606	Green Published, gold			2022-02-06	
J	Liu, Y; Zhang, TY; Wang, YB; Wu, P; Li, YC; Wang, CL; Xu, SC; Shi, HZ				Liu, Yao; Zhang, Tongyu; Wang, Yanbin; Wu, Pei; Li, Yuchen; Wang, Chunlei; Xu, Shancai; Shi, Huaizhang			Apelin-13 attenuates early brain injury following subarachnoid hemorrhage via suppressing neuronal apoptosis through the GLP-1R/PI3K/Akt signaling	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Subarachnoid hemorrhage; Early brain injury; Apelin-13; GLP-1R; Apoptosis; PI3K/Akt signaling	CEREBRAL-ISCHEMIA; GLUCAGON; SURVIVAL; PATHWAY; RECEPTOR; MECHANISMS; EXPRESSION; EXENDIN-4; PROTECTS; AKT	Apelin, an endogenous ligand for the orphan G-protein-coupled receptor APJ, possesses anti-apoptotic and neuroprotective properties. It has been shown to be a protective factor for different types of central nervous system insults, such as ischemia and traumatic brain injury. Here, we investigated the effects of apelin-13 on early brain injury (EBI) following subarachnoid hemorrhage (SAH), and the underlying molecular mechanisms involved. Apelin-13 was delivered to rats via intracerebroventricular administration. Neurological scores, brain water content and neuronal apoptosis were measured 24 h after SAH. The PI3K/Akt inhibitor LY294002 or GLP-1R siRNA were injected into the lateral cerebral ventricle before induction of SAH. Changes in the expression of p-Akt, GLP-1R and apoptosis-associated proteins (Bax, Bcl-2, cleaved caspase-3) were then investigated. Results showed that the levels of GLP-1R in neurons increased significantly, reaching a peak at 24 h after the induction of SAH. Treatment with apelin-13 improved neurological deficits, as well as alleviated brain edema and apoptotic cell death. Apelin-13 was also able to increase the levels of p-Akt, GLP-1R and Bcl-2, while inhibiting the expression levels of Bax and cleaved caspase-3. The anti-apoptotic and neuroprotective effects of apelin-13 were partially reversed by addition of LY294002 or GLP-1R siRNA. These results provide evidence that apelin-13 attenuates EBI following SAH via suppressing neuronal apoptosis, and that this effect may act partially via the activation of the GLP-1R/PI3K/Akt signaling pathway. (C) 2019 Elsevier Inc. All rights reserved.	[Liu, Yao; Zhang, Tongyu; Wang, Yanbin; Wu, Pei; Li, Yuchen; Wang, Chunlei; Xu, Shancai; Shi, Huaizhang] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China		Shi, HZ (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, 23 Youzheng St, Harbin 150001, Heilongjiang, Peoples R China.	liuyao7891@126.com; huaizhangshi@126.com			Natural Science Foundation of Heilongjiang Province of ChinaNatural Science Foundation of Heilongjiang Province [ZD2018018]; Postgraduate Innovation Research Project (Sino-Russia Special Fund) of Harbin Medical University [YJSCX2017-58HYD]	This work was supported by grant from Natural Science Foundation of Heilongjiang Province of China [ZD2018018]; and Postgraduate Innovation Research Project (Sino-Russia Special Fund) of Harbin Medical University [YJSCX2017-58HYD].	Alvarez E, 1996, J NEUROCHEM, V66, P920; Boal F, 2016, BRIT J PHARMACOL, V173, P1850, DOI 10.1111/bph.13485; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Cassidy JM, 2017, TRANSL STROKE RES, V8, P33, DOI 10.1007/s12975-016-0467-5; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Liu QF, 2015, BIOCHEM BIOPH RES CO, V468, P617, DOI 10.1016/j.bbrc.2015.10.171; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; O'Harte FPM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202350; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Parthsarathy V, 2018, DIABETES OBES METAB, V20, P319, DOI 10.1111/dom.13068; Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Wattez JS, 2013, PEPTIDES, V48, P134, DOI 10.1016/j.peptides.2013.08.005; Xie ZY, 2018, NEUROPHARMACOLOGY, V128, P142, DOI 10.1016/j.neuropharm.2017.09.040; Xu WL, 2018, NEUROSCIENCE, V388, P284, DOI 10.1016/j.neuroscience.2018.07.023; Zhang DD, 2016, ACS CHEM NEUROSCI, V7, P710, DOI 10.1021/acschemneuro.5b00306; Zhuang Z, 2011, ANN CLIN LAB SCI, V41, P364	24	9	11	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 21	2019	513	1					105	111		10.1016/j.bbrc.2019.03.151			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	HY6RL	WOS:000468257300016	30935689				2022-02-06	
J	Davies, CL; Patir, A; McColl, BW				Davies, Claire L.; Patir, Anirudh; McColl, Barry W.			Myeloid Cell and Transcriptome Signatures Associated With Inflammation Resolution in a Model of Self-Limiting Acute Brain Inflammation	FRONTIERS IN IMMUNOLOGY			English	Article						brain; inflammation; macrophage; microglia; neuroinflammation; neutrophil; resolution; transcriptome	CENTRAL-NERVOUS-SYSTEM; INTERLEUKIN-1 RECEPTOR ANTAGONIST; LIPID MEDIATORS; TRAUMATIC BRAIN; SPINAL-CORD; CEREBRAL-ISCHEMIA; ACUTE STROKE; MACROPHAGES; MICROGLIA; MECHANISMS	Inflammation contributes to tissue repair and restoration of function after infection or injury. However, some forms of inflammation can cause tissue damage and disease, particularly if inappropriately activated, excessive, or not resolved adequately. The mechanisms that prevent excessive or chronic inflammation are therefore important to understand. This is particularly important in the central nervous system where some effects of inflammation can have particularly harmful consequences, including irreversible damage. An increasing number of neurological disorders, both acute and chronic, and their complications are associated with aberrant neuroinflammatory activity. Here we describe a model of self-limiting acute brain inflammation optimized to study mechanisms underlying inflammation resolution. Inflammation was induced by intracerebral injection of lipopolysaccharide (LPS) and the temporal profile of key cellular and molecular changes were defined during the progression of the inflammatory response. The kinetics of accumulation and loss of neutrophils in the brain enabled well-demarcated phases of inflammation to be operatively defined, including induction and resolution phases. Microglial reactivity and accumulation of monocyte-derived macrophages were maximal at the onset of and during the resolution phase. We profiled the transcriptome-wide gene expression changes at representative induction and resolution timepoints and used gene coexpression network analysis to identify gene clusters. This revealed a distinct cluster of genes associated with inflammation resolution that were induced selectively or maximally during this phase and indicated an active programming of gene expression that may drive resolution as has been described in other tissues. Induction of gene networks involved in lysosomal function, lipid metabolism, and a comparative switch to MHC-II antigen presentation (relative to MHC-I during induction) were prominent during the resolution phase. The restoration and/or further induction of microglial homeostatic signature genes was notable during the resolution phase. We propose the current model as a tractable reductionist system to complement more complex models for further understanding how inflammation resolution in the brain is regulated and as a platform for in vivo testing/screening of candidate resolution-modifying interventions. Our data highlight how resolution involves active cellular and transcriptome reprogramming and identify candidate gene networks associated with resolution-phase adaptations that warrant further study.	[Davies, Claire L.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Patir, Anirudh] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [McColl, Barry W.] Univ Edinburgh, UK Dementia Res Inst, Ctr Discovery Brain Sci, Edinburgh BioQuarter, Chancellors Bldg, Edinburgh, Midlothian, Scotland		McColl, BW (corresponding author), Univ Edinburgh, UK Dementia Res Inst, Ctr Discovery Brain Sci, Edinburgh BioQuarter, Chancellors Bldg, Edinburgh, Midlothian, Scotland.	barry.mccoll@ed.ac.uk			BBSRC Doctoral Training GrantUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004332/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L003384/1, MR/R001316/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-4005] Funding Source: UKRI	This work was funded by a BBSRC Doctoral Training Grant to CD and grants from BBSRC (BB/J004332/1) and MRC (MR/L003384/1, MR/R001316/1) to BM.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Banwell V, 2009, J STROKE CEREBROVASC, V18, P269, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.009; Bottcher C, 2016, BBA-MOL BASIS DIS, V1862, P323, DOI 10.1016/j.bbadis.2015.10.003; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chang CF, 2018, J CLIN INVEST, V128, P607, DOI 10.1172/JCI95612; Chen AQ, 2016, NEUROBIOL AGING, V38, P56, DOI 10.1016/j.neurobiolaging.2015.10.021; Chitnis T, 2017, J CLIN INVEST, V127, P3577, DOI 10.1172/JCI90609; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cuevas VD, 2017, J IMMUNOL, V198, P2070, DOI 10.4049/jimmunol.1601667; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Drieu A, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418789854; Edwards P, 2005, LANCET, V365, P1957; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8; Giles JA, 2015, EUR J IMMUNOL, V45, P525, DOI 10.1002/eji.201444748; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lampron A, 2015, J EXP MED, V212, P481, DOI 10.1084/jem.20141656; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Prieto P, 2015, AUTOPHAGY, V11, P1729, DOI 10.1080/15548627.2015.1078958; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sanjurjo L, 2015, J LEUKOCYTE BIOL, V98, P173, DOI 10.1189/jlb.3RU0215-074R; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Schwab JM, 2006, CURR OPIN PHARMACOL, V6, P414, DOI 10.1016/j.coph.2006.02.006; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Sobowale OA, 2016, STROKE, V47, P2160, DOI 10.1161/STROKEAHA.115.010001; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Strecker JK, 2017, NEUROCHEM INT, V107, P117, DOI 10.1016/j.neuint.2016.11.006; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Vedantam S., 2015, J NEUROL STROKE, V2, P73, DOI DOI 10.15406/JNSK.2015.02.00073; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Veltkamp R, 2016, NEUROTHERAPEUTICS, V13, P791, DOI 10.1007/s13311-016-0458-y; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yu T, 2017, BLOOD, V129, P509, DOI 10.1182/blood-2016-07-727651	75	9	9	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	MAY 17	2019	10								1048	10.3389/fimmu.2019.01048			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY5IT	WOS:000468162200001	31156629	Green Published, Green Submitted, gold			2022-02-06	
J	Achar, S; Yamanaka, J				Achar, Suraj; Yamanaka, Jarrod			Apophysitis and Osteochondrosis: Common Causes of Pain in Growing Bones	AMERICAN FAMILY PHYSICIAN			English	Article							CALCANEAL APOPHYSITIS; INJURIES; DISEASE	Apophysitis and osteochondrosis are common causes of pain in growing bones but have differing etiologies and required management. Apophysitis results from a traction injury to the cartilage and bony attachment of tendons in children and adolescents. Most often it is an overuse injury in children who are growing and have tight or inflexible muscle tendon units. Although apophysitis occurs in upper and lower extremities, it occurs more often in the lower extremities, with common locations including the patellar tendon attachment at the patella or tibia (i.e., Larsen-Johansson and Osgood-Schlatter diseases), the calcaneus (i.e., Sever disease), and multiple locations around the hip, including the anterior inferior iliac spine. Other locations include the medial epicondyle, which is common in patients who throw or participate in racket sports, and more rarely at the base of the fifth metatarsal (i.e., Iselin disease). Radiography can be helpful in evaluating for other pathologies but is usually not necessary. Treatment includes stretching the affected muscle groups, relative rest, offloading the affected tendon, icing after activity, and limited use of non steroidal anti-inflammatory drugs. Osteochondrosis presents less commonly and refers to degenerative changes in the epiphyseal ossification centers of growing bones. Unlike apophysitis, the etiology of osteochondrosis is unknown. Multiple possible etiologies have been explored, including genetic causes, hormonal imbalances, mechanical factors, repetitive trauma, and vascular abnormalities Other locations of osteochondrosis include the second metatarsal head (i.e., Freiberg disease), the navicular bone (i.e., K8hler bone disease), the femoral head (i.e., Legg-Calve-Perthes disease), and the capitellum (i.e., Panner disease). Radiography results may be normal initially; magnetic resonance imaging is more sensitive to early changes. Osteochondrosis generally resolves with relative rest, but close monitoring is needed to ensure resolution. Surgery is rarely needed for either apophysitis or osteochondrosis. Copyright (C) 2019 American Academy of Family Physicians.)	[Achar, Suraj] Univ Calif San Diego, Rady Childrens Sports Med 360, Sch Med, San Diego, CA 92103 USA; [Yamanaka, Jarrod] Fairview Sports & Orthoped Care, Blaine, MN USA		Achar, S (corresponding author), 9500 Gilman Dr, La Jolla, CA 92023 USA.	sachar@ucsd.edu					Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Arnaiz J, 2011, AM J ROENTGENOL, V196, pW316, DOI 10.2214/AJR.10.5308; Atanda A, 2011, AM FAM PHYSICIAN, V83, P285; Circi E, 2017, Musculoskelet Surg, V101, P195, DOI 10.1007/s12306-017-0479-7; De Inocencio J, 2004, ARCH DIS CHILD, V89, P431, DOI 10.1136/adc.2003.028860; de Lucena GL, 2011, AM J SPORT MED, V39, P415, DOI 10.1177/0363546510383835; Elengard T, 2010, OPEN ACCESS J SPORTS, V1, P223, DOI [10.2147/OAJSM.S413, 10.2147/OAJSM.S15413]; Forrester RA, 2017, J FOOT ANKLE SURG, V56, P1065, DOI 10.1053/j.jfas.2017.04.030; Frush TJ, 2009, SPORTS HEALTH, V1, P201, DOI 10.1177/1941738109334214; Haws BE, 2018, J ISAKOS JOINT DISOR, V3, P38; Ibrahim T, 2016, JBJS REV, V4, DOI 10.2106/JBJS.RVW.15.00063; Ishikawa Susan N, 2005, Foot Ankle Clin, V10, P503, DOI 10.1016/j.fcl.2005.03.001; James AM, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-16; Longo UG, 2016, BRIT MED BULL, V120, P139, DOI 10.1093/bmb/ldw041; Norton R, AM J SPORTS MED, DOI [10.1177/036354651876, DOI 10.1177/036354651876]; Otoshi K, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117707703; Sakata Ryosuke, 2015, Kobe J Med Sci, V61, pE36; Sunilkumar M, 2014, ANN PAEDIAT RHEUM, V3, P135; Talusan Paul G, 2014, Foot Ankle Spec, V7, P52, DOI 10.1177/1938640013510314; Tiwari V, 2018, Musculoskelet Surg, V102, P153, DOI 10.1007/s12306-017-0513-9; Tok F, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-25; Vaishya R, 2016, CUREUS, V8, DOI 10.7759/cureus.780; Valentino M, 2012, J Ultrasound, V15, P127, DOI 10.1016/j.jus.2012.03.001; Wiegerinck JI, 2014, EUR J PEDIATR, V173, P677, DOI 10.1007/s00431-013-2219-9; Wilk KE, 2011, PHYSICIAN SPORTSMED, V39, P90, DOI 10.3810/psm.2011.11.1943; Yanagisawa S, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114542084; Yen YM, 2014, PEDIATR CLIN N AM, V61, P1155, DOI 10.1016/j.pcl.2014.08.003; Zucker EJ, 2013, AM J ROENTGENOL, V201, pW776, DOI 10.2214/AJR.13.10623; 2009, FOOT ANKLE INT, V30, P167, DOI DOI 10.3113/FAI.2009.0167; 2015, J CHILD ORTHOP, V9, P9, DOI DOI 10.1007/S11832-015-0635-2; 2017, ARCH DIS CHILD, V102, P109, DOI DOI 10.1136/ARCHDISCHILD-2016-311402; 2010, SKELETAL RADIOL, V39, P359, DOI DOI 10.1007/S00256-009-0774-Y; 2011, CLIN J SPORT MED, V21, P144, DOI DOI 10.1097/JSM.0B013E31820EBCEF	33	9	9	0	10	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	MAY 15	2019	99	10					610	618					9	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY0ED	WOS:000467782700003	31083875				2022-02-06	
J	Ryan-Gonzalez, C; Kimbrel, NA; Meyer, EC; Gordon, EM; DeBeer, BB; Gulliver, SB; Elliott, TR; Morissette, SB				Ryan-Gonzalez, Clark; Kimbrel, Nathan A.; Meyer, Eric C.; Gordon, Evan M.; DeBeer, Bryann B.; Gulliver, Suzy Bird; Elliott, Timothy R.; Morissette, Sandra B.			Differences in Post-Traumatic Stress Disorder Symptoms among Post-9/11 Veterans with Blast- and Non-Blast Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast injury; mild traumatic brain injury; post-traumatic stress disorder; veterans	MILITARY SEXUAL TRAUMA; MENTAL-HEALTH PROBLEMS; FUNCTIONAL CONNECTIVITY; AFGHANISTAN VETERANS; PTSD; IRAQ; ASSOCIATION; EXPOSURE; RISK; METAANALYSIS	The relationship between traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) has been difficult to disentangle, in part due to the commonality of incidents that can cause both conditions, as well as high rates of comorbidity between the two conditions. Inconsistent findings may be related to different study characteristics and types of mild TBI (mTBI) sustained (e.g., blast, non-blast). The objective of this study was to determine the association of blast- versus non-blast-related TBIs with long-term PTSD symptoms after controlling for demographic variables and trauma exposure. The sample included 230 post-9/11 veterans who experienced a blast-related mTBI (n = 29), non-blast mTBI (n = 74), combined blast and non-blast mTBI (n = 40), or no TBI (n = 87). As hypothesized, a between-groups analysis of covariance (ANCOVA) revealed that, after controlling for demographics, combat exposure, and prior trauma, PTSD symptoms among individuals with blast-related mTBI and combined blast and non-blast mTBI were significantly higher compared with non-blast-related mTBI and no TBI. These data suggest that blast-related mTBI is associated with more severe long-term PTSD symptoms.	[Ryan-Gonzalez, Clark; Morissette, Sandra B.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Kimbrel, Nathan A.] Mid Atlantic Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC USA; [Meyer, Eric C.] Texas A&M Univ, Hlth Sci Ctr, Cent Texas Vet Healthcare Syst, Dept Vet Affairs,VISN 17 Ctr Excellence Res Retur, Waco, TX USA; [Meyer, Eric C.; Gulliver, Suzy Bird] Baylor Scott & White Hlth, Warriors Res Inst, Waco, TX USA; [Gordon, Evan M.] Cent Texas Vet Healthcare Syst, VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Dallas, TX USA; [Gordon, Evan M.] Univ Texas Dallas, Dallas, TX USA; [DeBeer, Bryann B.] Cent Texas Vet Healthcare Syst, VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, College Stn, TX USA; [DeBeer, Bryann B.; Gulliver, Suzy Bird] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX USA; [Elliott, Timothy R.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA		Meyer, EC (corresponding author), Cent Texas Vet Healthcare Syst, VA VISN 17 Ctr Excellence Res Returning War Vetjj, 4800 Mem Dr,151-C, Waco, TX 76711 USA.	Eric.Meyer2@va.go	Gordon, Evan/J-5672-2019; Elliott, Timothy R./I-5301-2012; Gulliver, Suzy/X-9776-2019	Gordon, Evan/0000-0002-2276-5237; Elliott, Timothy R./0000-0002-6608-7714; 	Veterans AffairsUS Department of Veterans Affairs [IK2CX001680, I01RX000304] Funding Source: NIH RePORTER; CSRD VA [IK2 CX001680] Funding Source: Medline; RRD VA [I01 RX000304] Funding Source: Medline		Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; American Psychiatric Association , 2000, DSM 4 TR DIAGN STAT, Vtext revision; [Anonymous], 2016, VA DOD CLIN PRACT GU; ANTONY MM, 2001, PRACTITIONERS GUIDE; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bernat JA, 1998, J TRAUMA STRESS, V11, P645, DOI 10.1023/A:1024485130934; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Epstein JN, 1997, J TRAUMA STRESS, V10, P573, DOI 10.1023/A:1024841718677; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kimbrel NA, 2014, PSYCHIAT RES, V220, P1118, DOI 10.1016/j.psychres.2014.08.053; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Maguen S, 2012, WOMEN HEALTH ISS, V22, pE61, DOI 10.1016/j.whi.2011.07.010; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; US Department of Defense Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TRAU; Van der Kolk BA, 2007, TRAUMATIC STRESS EFF; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilson LC, 2015, PSYCHIAT RES, V229, P596, DOI 10.1016/j.psychres.2015.07.023; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	50	9	10	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1584	1590		10.1089/neu.2017.5590			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900010	30511882				2022-02-06	
J	Song, HL; Chen, M; Chen, C; Cui, JK; Johnson, CE; Cheng, JL; Wang, XW; Swerdlow, RH; DePalma, RG; Xia, WM; Gu, ZZ				Song, Hailong; Chen, Mei; Chen, Chen; Cui, Jiankun; Johnson, Catherine E.; Cheng, Jianlin; Wang, Xiaowan; Swerdlow, Russell H.; DePalma, Ralph G.; Xia, Weiming; Gu, Zezong			Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction after Low-Intensity Primary Blast Exposure	JOURNAL OF NEUROTRAUMA			English	Article						mitochondrial dysfunction; open-field LIB; oxidative stress; quantitative proteomics	TRAUMATIC BRAIN-INJURY; R PACKAGE; EXPRESSION; FISSION; MODEL; AUTOPHAGY; NEURODEGENERATION; PHOSPHORYLATION; MECHANISMS; PROTEINS	Service members during military actions or combat training are frequently exposed to primary blasts by weaponry. Most studies have investigated moderate or severe brain injuries from blasts generating overpressures >100 kPa, whereas understanding the pathophysiology of low-intensity blast (LIB)-induced mild traumatic brain injury (mTBI) leading to neurological deficits remains elusive. Our recent studies, using an open-field LIB-induced mTBI mouse model with a peak overpressure at 46.6 kPa, demonstrated behavioral impairments and brain nanoscale damages, notably mitochondrial and axonal ultrastructural changes. In this study, we used tandem mass tagged (TMT) quantitative proteomics and bioinformatics analysis to seek insights into the molecular mechanisms underlying ultrastructural pathology. Changes in global- and phospho-proteomes were determined at 3 and 24 h and at 7 and 30 days post injury (DPI), in order to investigate the biochemical and molecular correlates of mitochondrial dysfunction. Results showed striking dynamic changes in a total of 2216 proteins and 459 phosphorylated proteins at vary time points after blast. Disruption of key canonical pathways included evidence of mitochondrial dysfunction, oxidative stress, axonal/cytoskeletal/synaptic dysregulation, and neurodegeneration. Bioinformatic analysis identified blast-induced trends in networks related to cellular growth/development/movement/assembly and cell-to-cell signaling interactions. With observations of proteomic changes, we found LIB-induced oxidative stress associated with mitochondrial dysfunction mainly at 7 and 30 DPI. These dysfunctions included impaired fission-fusion dynamics, diminished mitophagy, decreased oxidative phosphorylation, and compensated respiration-relevant enzyme activities. Insights on the early pathogenesis of primary LIB-induced brain damage provide a template for further characterization of its chronic effects, identification of potential biomarkers, and targets for intervention.	[Song, Hailong; Cui, Jiankun; Gu, Zezong] Univ Missouri, Dept Pathol & Anat Sci, Sch Med, Columbia, MO 65212 USA; [Chen, Mei; Xia, Weiming] Bedford VA Med Ctr, Bedford, MA USA; [Chen, Chen; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65212 USA; [Cui, Jiankun; Gu, Zezong] Truman VA Hosp Res Serv, Columbia, MO USA; [Johnson, Catherine E.] Missouri Univ Sci & Technol, Dept Min & Nucl Engn, Rolla, MO USA; [Wang, Xiaowan; Swerdlow, Russell H.] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Dept Neurol, Kansas City, KS 66103 USA; [DePalma, Ralph G.] Dept Vet Affairs, Off Res & Dev, Washington, DC USA; [DePalma, Ralph G.] Uniformed Serv Univ Hlth Sci, Norman Rich Dept Surg, Bethesda, MD 20814 USA		Gu, ZZ (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Sch Med, Columbia, MO 65212 USA.	guze@health.missouri.edu	Cheng, Jianlin/N-8209-2013; Wang, Xiaowan/AAD-2780-2019; Song, Hailong/I-9418-2018	Song, Hailong/0000-0002-4204-6459; Cheng, Jianlin/0000-0003-0305-2853	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG035982] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003527, I21BX003807, I21BX002215] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG035982] Funding Source: Medline; BLRD VA [I01 BX003527, I21 BX003807, I21 BX002215] Funding Source: Medline		Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Dai W, 2009, BRAIN RES, V1251, P287, DOI 10.1016/j.brainres.2008.11.034; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huang FK, 2017, J PROTEOME RES, V16, P1121, DOI 10.1021/acs.jproteome.6b00374; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Kim DK, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-017-0234-4; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Ning MM, 2011, STROKE, V42, P37, DOI 10.1161/STROKEAHA.110.585703; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Qu Z, 2014, J PROTEOME RES, V13, P3200, DOI 10.1021/pr401179v; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sarkis GA, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0736-z; Selfridge JE, 2013, NEUROBIOL DIS, V51, P3, DOI 10.1016/j.nbd.2011.12.057; Song H, 2018, J PROTEOME RES, V17, P858, DOI 10.1021/acs.jproteome.7b00618; Song HL, 2018, NEURAL REGEN RES, V13, P1516, DOI 10.4103/1673-5374.237110; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Song HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35323; Swan AL, 2013, OMICS, V17, P595, DOI 10.1089/omi.2013.0017; Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang XW, 2017, CELL REP, V20, P2184, DOI 10.1016/j.celrep.2017.08.022; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Xiao MQ, 2017, FREE RADICAL BIO MED, V111, P316, DOI 10.1016/j.freeradbiomed.2017.04.363; Yap YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176997; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang JH, 2013, REDOX BIOL, V1, P19, DOI 10.1016/j.redox.2012.11.008; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014	57	9	9	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1591	1605		10.1089/neu.2018.6114			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900011	30484371	Green Published			2022-02-06	
J	Cecchi, NJ; Monroe, DC; Fote, GM; Small, SL; Hicks, JW				Cecchi, Nicholas J.; Monroe, Derek C.; Fote, Gianna M.; Small, Steven L.; Hicks, James W.			Head impacts sustained by male collegiate water polo athletes	PLOS ONE			English	Article							HIGH-SCHOOL; CONCUSSIONS; FOOTBALL; EPIDEMIOLOGY	Water polo is a contact sport that is gaining popularity in the United States and carries a risk of repeated head impacts and concussion. The frequency and magnitude of sport-related head impacts have not been described for water polo. We aimed to compare patterns of empirically measured head impact exposure of male collegiate water polo players to patterns previously reported by a survey of current and former water polo athletes. Participants wore water polo caps instrumented with head impact sensors during three seasons of collegiate water polo. Peak linear acceleration (PLA) and peak rotational acceleration (PRA) were recorded for head impacts. Athlete positions were recorded by research staff at the occurrence of each head impact. Head impacts were sustained by athletes in offensive positions more frequently than in defensive and transition positions (246, 59.9% vs. 93, 22.6% vs. 72, 17.5%). 37% of all head impacts during gameplay were sustained by athletes playing the offensive center position. Impact magnitude (means +/- SD: PLA = 36.1 +/- 12.3g, PRA = 5.0 +/- 2.9 krads/sec(2)) did not differ between position or game scenario. Among goalies, impact frequency and magnitude were similar between games (means +/- SD: 0.54 +/-.51 hits/game, PLA = 36.9 +/- 14.2g, PRA = 4.3 +/- 4.2 krads/sec(2)) and practices (means +/- SD: 0.96 +/- 1.11 hits/practice, PLA = 43.7 +/- 14.5g, PRA = 3.9 +/- 2.5 krads/sec(2)). We report that collegiate water polo athletes are at risk for sport-related head impacts and impact frequency is dependent on game scenario and player position. In contrast, magnitude does not differ between scenarios or across positions.	[Cecchi, Nicholas J.; Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Monroe, Derek C.; Small, Steven L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Fote, Gianna M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA		Hicks, JW (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	jhicks@uci.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163; Monroe, Derek/0000-0003-3885-6878; Small, Steven/0000-0002-5293-6172	Center for Exercise Medicine and Sport Sciences, School of Bio Sci, UC Irvine; NIH T32 grant: "UCI Multidisciplinary Training program in Exercise Science"	NJC received financial support from the Center for Exercise Medicine and Sport Sciences, School of Bio Sci, UC Irvine; http://emssi.uci.edu/. DCM received postdoctoral support from an NIH T32 grant: "UCI Multidisciplinary Training program in Exercise Science." GMF, SLS and JWH received salary support from the University of California Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, WAT POL FAST GROW SP; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2003, J ATHL TRAINING, V38, P238; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Karton C, 2016, ISBS C P ARCH, V34; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mountjoy M, 2019, BRIT J SPORT MED, V53, P25, DOI 10.1136/bjsports-2018-099349; Mountjoy M, 2010, BRIT J SPORT MED, V44, P522, DOI 10.1136/bjsm.2010.071720; Oeur RA, 2016, ISBS C P ARCH, V34; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2019	14	5							e0216369	10.1371/journal.pone.0216369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2JY	WOS:000466511200077	31048869	Green Published, Green Submitted, gold			2022-02-06	
J	Chrisman, SPD; Whitlock, KB; Kroshus, E; Schwien, C; Herring, SA; Rivara, FP				Chrisman, Sara P. D.; Whitlock, Kathryn B.; Kroshus, Emily; Schwien, Christina; Herring, Stanley A.; Rivara, Frederick P.			Parents' Perspectives Regarding Age Restrictions for Tackling in Youth Football	PEDIATRICS			English	Article							HIGH-SCHOOL FOOTBALL; HEAD-IMPACT EXPOSURE; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; BODY CHECKING; RISK-FACTORS; INJURY; CONCUSSION; SPORT; EPIDEMIOLOGY	Investigators conducted a nationally representative survey of parents to determine popular support for instituting age restrictions on tackling in youth football. BACKGROUND:In ice hockey and soccer, age restrictions exist for body checking and heading because of injury risk. There are currently no age restrictions for tackling in youth football.METHODS:We surveyed a nationally representative sample of US parents regarding their support for age restrictions on tackling in football with responses of yes, no, and maybe. We then generated regression models, attempting to predict support for age restrictions in tackling using demographic variables, parent perceptions of the risk of concussion in youth football, and the intensity of football support. All analyses were stratified by sex given effect modification.RESULTS:There were 1025 parents who completed the survey (52% response rate; 56% female sex). The majority (61%) supported age restrictions for tackling, and an additional 24% indicated they maybe would support age restrictions. For female respondents, a greater perceived risk of tackle football (odds ratio [OR] 3.83; 95% confidence interval [CI] 1.06-13.83) and greater educational attainment (OR 3.97; 95% CI 1.61-9.80) were associated with greater odds of supporting age restrictions for tackling. For male respondents, having a child 6 to 12 years old was associated with greater odds of maybe supporting age restrictions for tackling (OR 2.34; 95% CI 1.19-4.62).CONCLUSIONS:A majority of US parents across sexes would support age restrictions for tackling in football. This information should inform discussions when guidelines about tackling in youth football are revisited.	[Chrisman, Sara P. D.; Whitlock, Kathryn B.; Kroshus, Emily; Schwien, Christina; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, 2001 Eighth Ave,POB 5371,CW 8-6, Seattle, WA 98145 USA; [Chrisman, Sara P. D.; Kroshus, Emily; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med Orthoped & Sports Med & Neurol S, Seattle, WA 98195 USA; [Chrisman, Sara P. D.; Kroshus, Emily; Herring, Stanley A.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, 2001 Eighth Ave,POB 5371,CW 8-6, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	Seattle Children's Hospital Academic Enrichment Fund at the University of Washington School of Medicine; Seattle Pediatric Concussion Research Collaborative at the University of Washington School of Medicine; Sports Institute at the University of Washington School of Medicine	Funded by the Seattle Children's Hospital Academic Enrichment Fund, the Seattle Pediatric Concussion Research Collaborative, and the Sports Institute at the University of Washington School of Medicine.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Bailey AP, 2018, PSYCHOL MED, V48, P1068, DOI 10.1017/S0033291717002653; Bartley JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740887; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Borghans L, 2009, J EUR ECON ASSOC, V7, P649, DOI 10.1162/JEEA.2009.7.2-3.649; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Eckel C.C., 2008, HDB EXPT EC RESULTS, V1, P1061, DOI DOI 10.1016/S1574-0722(07)00113-8; Eibach RP, 2011, J EXP SOC PSYCHOL, V47, P694, DOI 10.1016/j.jesp.2010.12.009; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Emahiser D, INTRO BODY CONTACT; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Galligan KM, 2011, ACCIDENT ANAL PREV, V43, P1316, DOI 10.1016/j.aap.2011.02.001; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Gorlitz K, 2015, SSRN ELECT J; Hagan LK, 2007, J APPL DEV PSYCHOL, V28, P2, DOI 10.1016/j.appdev.2006.10.007; Halek M, 2001, J RISK INSUR, V68, P1, DOI 10.2307/2678130; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Krill MK, 2017, PHYSICIAN SPORTSMED, V45, P26, DOI 10.1080/00913847.2017.1279520; Kroshus E, 2019, INJURY PREV, V25, P278, DOI 10.1136/injuryprev-2017-042677; Kurnianingsih YA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00280; Langhorst P, 2016, ENGAGE SPORTS   0308; Lawler M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4677-x; Macpherson A, 2006, PEDIATRICS, V117; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martin A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009728.pub4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Quarrie KL, 2017, BRIT J SPORT MED, V51, P1134, DOI 10.1136/bjsports-2017-098013; Rodriguez-Ayllon M, 2018, J SCI MED SPORT, V21, P179, DOI 10.1016/j.jsams.2017.09.019; Rohrmann B, RISK PERCEPTION RISK; Rosen AB, 2003, MED DECIS MAKING, V23, P511, DOI 10.1177/0272989X03258431; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; US Soccer, 2016, IMPL GUID US SOCC PL; USA Hockey, SECT 6 PLAYING RUL R; Warshawsky-Livne L, 2014, ADV HEALTH ECON HEAL, V24, P123, DOI 10.1108/S0731-219920140000024003; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; 2015, PLAST RECONSTR SURG, V0136	59	9	9	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAY	2019	143	5							e20182402	10.1542/peds.2018-2402			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	II0VQ	WOS:000474923900010	30936250	Bronze			2022-02-06	
J	Dassa, Y; Crosnier, H; Chevignard, M; Viaud, M; Personnier, C; Flechtner, I; Meyer, P; Puget, S; Boddaert, N; Breton, S; Polak, M				Dassa, Yamina; Crosnier, Helene; Chevignard, Mathilde; Viaud, Magali; Personnier, Claire; Flechtner, Isabelle; Meyer, Philippe; Puget, Stephanie; Boddaert, Nathalie; Breton, Sylvain; Polak, Michel			Pituitary deficiency and precocious puberty after childhood severe traumatic brain injury: a long-term follow-up prospective study	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							GROWTH-HORMONE GH; QUALITY-OF-LIFE; HYPOTHALAMOHYPOPHYSEAL DYSFUNCTION; CONSENSUS GUIDELINES; PEDIATRIC SURVIVORS; HEIGHT VELOCITY; CHILDREN; HYPOPITUITARISM; ADOLESCENTS; RECOVERY	Objectives: Childhood traumatic brain injury (TBI) is a public health issue. Our objectives were to determine the prevalence of permanent pituitary hormone deficiency and to detect the emergence of other pituitary dysfunctions or central precocious puberty several years after severe TBI. Design: Follow-up at least 5 years post severe TBI of a prospective longitudinal study. Patients: Overall, 66/87 children, who had endocrine evaluation 1 year post severe TBI, were included (24 with pituitary dysfunction 1 year post TBI). Main outcome measures: In all children, the pituitary hormones basal levels were assessed at least 5 years post TBI. Growth hormone (GH) stimulation tests were performed 3-4 years post TBI in children with GH deficiency (GHD) 1 year post TBI and in all children with low height velocity (<-1 DS) or low IGF-1 (<-2 DS). Central precocious puberty (CPP) was confirmed by GnRH stimulation test. Results: Overall, 61/66 children were followed up 7 (5-10) years post TBI (median; (range)); 17/61 children had GHD 1 year post TBI, and GHD was confirmed in 5/17 patients. For one boy, with normal pituitary function 1 year post TBI, GHD was diagnosed 6.5 years post TBI. 4/61 patients developed CPP, 5.7 (2.4-6.1) years post-TBI. Having a pituitary dysfunction 1 year post TBI was significantly associated with pituitary dysfunction or CPP more than 5 years post TBI. Conclusion: Severe TBI in childhood can lead to permanent pituitary dysfunction; GHD and CPP may appear after many years. We recommend systematic hormonal assessment in children 1 year after severe TBI and a prolonged monitoring of growth and pubertal maturation. Recommendations should be elaborated for the families and treating physicians.	[Dassa, Yamina; Crosnier, Helene; Viaud, Magali; Flechtner, Isabelle; Polak, Michel] Necker Enfants Malades Univ Hosp, AP HP, Paediat Endocrinol Gynaecol & Diabetol Unit, Paris, France; [Chevignard, Mathilde] St Maurice Hosp, Rehabil Dept Children & Adolescents Acquired Neur, St Maurice, France; [Chevignard, Mathilde] Sorbonne Univ, Lab Imagerie Biomed, Paris, France; [Chevignard, Mathilde] Sorbonne Univ, GRC HanCRe, Paris, France; [Personnier, Claire] CHI Poissy St Germain, Poissy, France; [Meyer, Philippe] Necker Enfants Malades Univ Hosp, AP HP, Paediat Anaesthesiol Unit, Paris, France; [Meyer, Philippe; Puget, Stephanie; Boddaert, Nathalie; Polak, Michel] Paris Descartes Univ, Paris, France; [Puget, Stephanie] Necker Enfants Malades Univ Hosp, AP HP, Paediat Neurosurg Unit, Paris, France; [Boddaert, Nathalie; Breton, Sylvain] Necker Enfants Malades Univ Hosp, AP HP, Radiol Unit, Paris, France; [Polak, Michel] IMAGINE Inst, Paris, France		Crosnier, H (corresponding author), Necker Enfants Malades Univ Hosp, AP HP, Paediat Endocrinol Gynaecol & Diabetol Unit, Paris, France.	h.savajol-crosnier@orange.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631	Pfizer SAS grant [8501577006]	This work was partially supported by an educational grant from Pfizer SAS grant (number 8501577006). The sponsor was not involved in data collection, manuscript preparation, or publishing decisions.	Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Auble BA, 2014, J NEUROTRAUM, V31, P321, DOI 10.1089/neu.2013.2916; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bellone S, 2013, PITUITARY, V16, P499, DOI 10.1007/s11102-012-0446-0; Carel JC, 1997, J CLIN ENDOCR METAB, V82, P2117, DOI 10.1210/jc.82.7.2117; Casano-Sancho P, 2017, ARCH DIS CHILD, V102, P572, DOI 10.1136/archdischild-2016-311609; Casano-Sancho P, 2013, CLIN ENDOCRINOL, V79, P853, DOI 10.1111/cen.12237; Cole TJ, 2000, ANN HUM BIOL, V27, P401, DOI 10.1080/03014460050044874; De Sanctis V, 2015, PEDIATR ENDOCR REV P, V13, P458; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Devesa J, 2011, THER CLIN RISK MANAG, V7, P199, DOI 10.2147/TCRM.S21403; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Heather NL, 2016, CLIN ENDOCRINOL, V84, P463, DOI [10.1111/cen.12953, DOI 10.1111/CEN.12953]; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2015, EUR J ENDOCRINOL, V172, P753, DOI 10.1530/EJE-14-1069; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krahulik D, 2017, BIOMED PAP, V161, P80, DOI 10.5507/bp.2016.047; Le Moal J, 2018, EUR J ENDOCRINOL, V178, P33, DOI 10.1530/EJE-17-0379; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Quinn M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00008; Ranke MB, 2011, DIAGNOSTICS OF ENDOCRINE FUNCTION IN CHILDREN AND ADOLESCENTS, 4TH EDITION, P102; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sempe M., 1979, AUXOLOGIE METHODES S; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Siemensma EPC, 2012, J CLIN ENDOCR METAB, V97, P2307, DOI 10.1210/jc.2012-1182; Sorensen K, 2012, HORM RES PAEDIAT, V77, P137, DOI 10.1159/000336325; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; TEASDALE G, 1974, LANCET, V2, P81; Thomas M, 2004, EUR J ENDOCRINOL, V151, P67, DOI 10.1530/eje.0.1510067; van Pareren YK, 2004, J CLIN ENDOCR METAB, V89, P5295, DOI 10.1210/jc.2003-031187; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786	60	9	9	0	4	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	MAY	2019	180	5					283	+		10.1530/EJE-19-0034			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	HU0YF	WOS:000464997600004	30884465	Bronze			2022-02-06	
J	Fortress, AM; Avcu, P; Wagner, AK; Dixon, CE; Pang, KCH				Fortress, Ashley M.; Avcu, Pelin; Wagner, Amy K.; Dixon, C. Edward; Pang, Kevin C. H.			Experimental traumatic brain injury results in estrous cycle disruption, neurobehavioral deficits, and impaired GSK3 beta/beta-catenin signaling in female rats	EXPERIMENTAL NEUROLOGY			English	Article						Acoustic startle response; Brainstem; Estrous cycle; Female; Hippocampus; Hypogonadism; Lateral fluid percussion; Memory; Neurobehavioral	OBJECT MEMORY CONSOLIDATION; GLYCOGEN-SYNTHASE KINASE-3; HORMONE PROFILES; NERVOUS-SYSTEM; NEURONAL LOSS; SEX-HORMONES; PROGESTERONE; MILD; OUTCOMES; RISK	An estimated 2.8 million traumatic brain injuries (TBI) occur within the United States each year. Approximately 40% of new TEE cases are female, however few studies have investigated the effects of TBI on female subjects. In addition to typical neurobehavioral sequelae observed after TBI, such as poor cognition, impaired behavior, and somatic symptoms, women with TBI report amenorrhea or irregular menstrual cycles suggestive of disruptions in the hypothalamic-pituitary-gonadal (HPG) axis. HPG dysfunction following TBI has been linked to poor functional outcome in men and women, but the mechanisms by which this may occur or relate to behavior has not been fully developed or ascertained. The present study determined if TBI resulted in HPG axis perturbations in young adult female Sprague Dawley rats, and whether TBI was associated with cognitive and sensorimotor deficits. Following lateral fluid percussion injury, injured females spent significantly more time in diestrus compared to sham females, consistent with a persistent low sex-steroid hormone state. Injured females displayed significantly reduced 17 beta-estradiol (E2) and luteinizing hormone levels. Concomitantly, injured females were impaired in spatial working memory compared to shams. Impaired GSK3 beta/beta-catenin signaling related to synaptic changes was evident one-week post-injury in the hippocampus among injured females compared to sham females, and this impairment paralleled the deficits in spatial working memory. Sensorimotor function, as evidenced by suppression of the acoustic startle response, was chronically impaired even after normal estrous cycling resumed. These data demonstrate that TBI results in estrous cycle impairments, memory dysfunction, and perturbations in GSK3 beta/beta-catenin signaling, suggesting a potential mechanism for HPG-mediated cognitive impairment following TBI.	[Fortress, Ashley M.; Pang, Kevin C. H.] New Jersey Hlth Care Syst, NeuroBehav Res Lab, Dept Vet Affairs, E Orange, NJ USA; [Avcu, Pelin; Pang, Kevin C. H.] Rutgers Biomed & Hlth Sci, Grad Sch Biomed Sci, 65 Bergen St, Newark, NJ 07103 USA; [Pang, Kevin C. H.] Univ Med & Dent New Jersey, Rutgers Biomed & Hlth Sci, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Fortress, Ashley M.; Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Mailstop 151,Univ Dr C, Pittsburgh, PA 15240 USA; [Wagner, Amy K.; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Ctr Neurosci, 3471 Fifth Ave Suite 202,Kaufman Bldg, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Fortress, AM (corresponding author), VA Pittsburgh Healthcare Syst, Mailstop 151,Univ Dr C, Pittsburgh, PA 15240 USA.	Ashley.fortress@va.gov; wagnerak@upmc.edu; dixonec@upmc.edu; Kevin.Pang@va.gov			Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [IK2 BX-003196, I01BX000132]; Veterans AffairsUS Department of Veterans Affairs [I01BX000132, IK2BX003196] Funding Source: NIH RePORTER	This project was supported by Career Development Award Number IK2 BX-003196 from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development to AMF and Biomedical Laboratory Research & Development Service of the VA Office of Research and DevelopmentI01BX000132 to KCHP.	Aponte M., 2017, WOMEN VETERANS REPOR, P72; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barrera-Ocampo A, 2012, J NEUROSCI RES, V90, P1078, DOI 10.1002/jnr.22816; Barton DJ, 2016, J HEAD TRAUMA REHAB, V31, P277, DOI 10.1097/HTR.0000000000000188; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Becker J. B., 2007, SEX DIFFERENCES BRAI; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Carlson SW, 2018, J NEUROTRAUM, V35, P2827, DOI 10.1089/neu.2017.5509; CDC, 2016, RAT TBI REL EM DEP V; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339; Daniel JM, 1997, HORM BEHAV, V32, P217, DOI 10.1006/hbeh.1997.1433; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Fernandez SM, 2008, J NEUROSCI, V28, P8660, DOI 10.1523/JNEUROSCI.1968-08.2008; Fortress AM, 2015, HIPPOCAMPUS, V25, P616, DOI 10.1002/hipo.22398; Fortress AM, 2013, J NEUROSCI, V33, P12619, DOI 10.1523/JNEUROSCI.0659-13.2013; Frick KM, 2015, LEARN MEMORY, V22, P472, DOI 10.1101/lm.037267.114; Frieden T. R., 2015, TRAUMATIC BRAIN INJU, P65; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Gomez-Nieto R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00216; Gresack JE, 2006, PHARMACOL BIOCHEM BE, V84, P112, DOI 10.1016/j.pbb.2006.04.013; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Jacome LF, 2016, ENDOCRINOLOGY, V157, P1357, DOI 10.1210/en.2015-1959; Kato A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00149; Kermath BA, 2012, NEUROENDOCRINOLOGY, V96, P1, DOI 10.1159/000335994; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; MAEDA K, 2000, LAB RAT; Mahmoud R, 2016, FRONT NEUROENDOCRIN, V41, P129, DOI 10.1016/j.yfrne.2016.03.002; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; McLeod F, 2018, CURR OPIN NEUROBIOL, V53, P90, DOI 10.1016/j.conb.2018.06.003; Melcangi RC, 2016, NEUROSCI BIOBEHAV R, V67, P25, DOI 10.1016/j.neubiorev.2015.09.023; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P172, DOI 10.1006/nlme.1997.3785; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Pedersen AL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1040-1; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Rocca WA, 2012, NEURODEGENER DIS, V10, P175, DOI 10.1159/000334764; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Ryan J, 2014, BJOG-INT J OBSTET GY, V121, P1729, DOI 10.1111/1471-0528.12828; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schuster A, 2017, J NEUROTRAUM, V34, pA7; Scott EL, 2013, STEROIDS, V78, P624, DOI 10.1016/j.steroids.2012.11.004; Servatius RJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00379; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Siddiqui AN, 2016, CNS NEUROSCI THER, V22, P342, DOI 10.1111/cns.12538; Sinha SP, 2017, BRAIN BEHAV IMMUN, V61, P353, DOI 10.1016/j.bbi.2017.01.006; Smillie Karen Janet, 2011, Int J Alzheimers Dis, V2011, P263673, DOI 10.4061/2011/263673; Soni M, 2014, MINERVA ENDOCRINOL, V39, P189; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Treip C S, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P178; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright WG, 2018, MIL MED, V183, P313, DOI 10.1093/milmed/usx182	78	9	9	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2019	315						42	51		10.1016/j.expneurol.2019.01.017			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ0RG	WOS:000462102100006	30710530				2022-02-06	
J	Harvey, MM; Petersen, TJ; Sager, JC; Makhija-Graham, NJ; Wright, EC; Clark, EL; Laifer, LM; Richards, LK; Chow, LK; Sylvia, LG; Lento, RM; Harward, LK; Clowes, J; Brathwaite, V; Lakin, LK; Silverberg, ND; Iverson, GL; Bui, E; Simon, NM				Harvey, Margaret M.; Petersen, Timothy J.; Sager, Julia C.; Makhija-Graham, Nita J.; Wright, Edward C.; Clark, Erika L.; Laifer, Lauren M.; Richards, Lauren K.; Chow, Louis K.; Sylvia, Louisa G.; Lento, Rene M.; Harward, Laura K.; Clowes, Joan; Brathwaite, Valerie; Lakin, Laura K.; Silverberg, Noah D.; Iverson, Grant L.; Bui, Eric; Simon, Naomi M.			An Intensive Outpatient Program for Veterans With Posttraumatic Stress Disorder and Traumatic Brain Injury	COGNITIVE AND BEHAVIORAL PRACTICE			English	Article						posttraumatic stress; traumatic brain injury; intensive treatment; veteran; service member	QUALITY-OF-LIFE; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MENTAL-HEALTH PROBLEMS; COMBAT-RELATED PTSD; PROLONGED EXPOSURE; SERVICE MEMBERS; THERAPY; AFGHANISTAN; DEPRESSION; SOLDIERS	Post-9/11 service members may return from military service with a complicated set of symptoms and conditions, such as posttraumatic stress disorder (PTSD), depression, substance misuse, and traumatic brain injury (TBI), that interfere with reintegration and impair functioning. Although evidence-based treatments that facilitate recovery exist, their successful delivery at a sufficient dose is limited. Barriers to accessing treatment combined with challenges compiling a comprehensive treatment team further delay delivery of effective evidence-based care for PTSD, TBI, and co-occurring mental health conditions. This paper describes the development of a comprehensive, multidisciplinary, 2-week intensive day program for post-9/11 veterans with complex mental health concerns. The treatment program combines skill building groups, family education, and integrative health approaches with evidence-based individual PTSD or TBI care. Initial results from the first 132 participants were notable for a 97% completion rate, as well as statistically significant and clinically meaningful reductions in PTSD, neurobehavioral, and depression symptom severity for the 107 veterans who completed the PTSD track and the 21 who completed the TBI track. These data suggest the intensive program approach is an effective, well-tolerated model of treatment for post-9/11 veterans with PTSD and/or 7731 Future controlled studies should examine the effectiveness of this intensive model compared to standard evidence-based therapy delivery, as well as longitudinal outcomes.	[Harvey, Margaret M.; Petersen, Timothy J.; Sager, Julia C.; Makhija-Graham, Nita J.; Wright, Edward C.; Clark, Erika L.; Laifer, Lauren M.; Richards, Lauren K.; Chow, Louis K.; Sylvia, Louisa G.; Lento, Rene M.; Harward, Laura K.; Clowes, Joan; Brathwaite, Valerie; Lakin, Laura K.; Iverson, Grant L.; Bui, Eric; Simon, Naomi M.] Home Base, Boston, MA USA; [Harvey, Margaret M.; Petersen, Timothy J.; Sager, Julia C.; Makhija-Graham, Nita J.; Wright, Edward C.; Clark, Erika L.; Laifer, Lauren M.; Richards, Lauren K.; Chow, Louis K.; Sylvia, Louisa G.; Lento, Rene M.; Harward, Laura K.; Clowes, Joan; Brathwaite, Valerie; Lakin, Laura K.; Silverberg, Noah D.; Iverson, Grant L.; Bui, Eric; Simon, Naomi M.] Massachusetts Gen Hosp Program, Boston, MA USA; [Harvey, Margaret M.; Petersen, Timothy J.; Makhija-Graham, Nita J.; Wright, Edward C.; Clark, Erika L.; Richards, Lauren K.; Chow, Louis K.; Sylvia, Louisa G.; Lento, Rene M.; Iverson, Grant L.; Bui, Eric; Simon, Naomi M.] Harvard Med Sch, Boston, MA 02115 USA; [Harvey, Margaret M.] Univ Massachusetts, Med Sch, Amherst, MA 01003 USA; [Silverberg, Noah D.] Univ British Columbia, Vancouver, BC, Canada; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Simon, Naomi M.] NYU Langone Hlth, New York, NY USA		Harvey, MM (corresponding author), One Ashburton Pl,10th Floor, Boston, MA 02180 USA.	Margaret.Harvey@umassmed.edu	Laifer, Lauren/AAU-1704-2020	Laifer, Lauren/0000-0001-5473-7882			Back SE, 2010, AM J PSYCHIAT, V167, P11, DOI 10.1176/appi.ajp.2009.09111602; Barrera TL, 2013, CLIN PSYCHOL REV, V33, P24, DOI 10.1016/j.cpr.2012.09.005; Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Blount TH, 2014, COGN BEHAV PRACT, V21, P89, DOI 10.1016/j.cbpra.2013.05.004; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Cahill S.P., 2008, EFFECTIVE TREATMENTS, P139; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carter AC, 2011, J DUAL DIAGN, V7, P285, DOI 10.1080/15504263.2011.620453; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Descilo T, 2010, ACTA PSYCHIAT SCAND, V121, P289, DOI 10.1111/j.1600-0447.2009.01466.x; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Foa E.B., 2007, PROLONGED EXPOSURE T; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Goetter EM, 2018, PSYCHOL SERV, V15, P453, DOI 10.1037/ser0000151; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Grodin MA, 2008, J ALTERN COMPLEM MED, V14, P801, DOI 10.1089/acm.2007.0736; Harpaz-Rotem I, 2011, PSYCHIAT SERV, V62, P22, DOI 10.1176/ps.62.1.pss6201_0022; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Institute of Medicine, 2008, TREATM POSTTR STRESS; Jain S, 2012, MIL MED, V177, P481, DOI 10.7205/MILMED-D-11-00401; Khaylis A, 2011, MIL MED, V176, P126, DOI 10.7205/MILMED-D-10-00094; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Meis LA, 2013, PSYCHOL TRAUMA-US, V5, P334, DOI 10.1037/a0028366; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Murdoch M, 2011, ARCH GEN PSYCHIAT, V68, P1072, DOI 10.1001/archgenpsychiatry.2011.105; Nanda U, 2010, ENVIRON BEHAV, V42, P376, DOI 10.1177/0013916510361874; Norman SB, 2010, J PSYCHOACTIVE DRUGS, V42, P83, DOI 10.1080/02791072.2010.10399788; Ohye BY, 2015, PROF PSYCHOL-RES PR, V46, P97, DOI 10.1037/a0037735; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Park ER, 2013, PSYCHOSOMATICS, V54, P165, DOI 10.1016/j.psym.2012.09.001; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Richards LK, 2017, COMMUNITY MENT HLT J, V53, P215, DOI 10.1007/s10597-016-0013-7; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Silverberg ND, 2017, J TRAUMA STRESS, V30, P318, DOI 10.1002/jts.22184; Simon NM, 2008, J CLIN PSYCHIAT, V69, P400, DOI 10.4088/JCP.v69n0309; Sloan DM, 2012, J REHABIL RES DEV, V49, P689, DOI 10.1682/JRRD.2011.07.0123; Smith ER, 2015, J ANXIETY DISORD, V30, P23, DOI 10.1016/j.janxdis.2014.12.008; Smith-Marek EN, 2016, AM J FAM THER, V44, P53, DOI 10.1080/01926187.2016.1145080; Steenkamp MM, 2013, CLIN PSYCHOL REV, V33, P45, DOI 10.1016/j.cpr.2012.10.002; Sylvia Louisa G, 2015, Glob Adv Health Med, V4, P38, DOI 10.7453/gahmj.2015.080; Tanielian T, 2016, PSYCHIAT SERV, V67, P718, DOI 10.1176/appi.ps.201500237; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Volkow N. D, 2014, DRUGS BRAIN BEHAV SC; Vranceanu AM, 2014, PSYCHOSOMATICS, V55, P386, DOI 10.1016/j.psym.2014.01.005; Vujanovic AA, 2011, PROF PSYCHOL-RES PR, V42, P24, DOI 10.1037/a0022272; Wagner A. W., 2006, COGNITIVE BEHAV THER, V2nd, P117, DOI DOI 10.1002/JTS.20268; Walter KH, 2014, J CONSULT CLIN PSYCH, V82, P551, DOI 10.1037/a0037075; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260	74	9	9	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1077-7229	1878-187X		COGN BEHAV PRACT	Cogn. Behav. Pract.	MAY	2019	26	2					323	334					12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HW6UO	WOS:000466826300008					2022-02-06	
J	Iyer, KK; Barlow, KM; Brooks, B; Ofoghi, Z; Zalesky, A; Cocchi, L				Iyer, Kartik K.; Barlow, Karen M.; Brooks, Brian; Ofoghi, Zahra; Zalesky, Andrew; Cocchi, Luca			Relating brain connectivity with persistent symptoms in pediatric concussion	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							DEFAULT-MODE NETWORK; STRUCTURAL CONNECTIVITY; CHILDREN; INJURY; PSYCHOPATHOLOGY; DISRUPTION; ADULTS	Persistent post-concussion symptoms (PCS) in children following a mild traumatic brain injury (mTBI) are a growing public health concern. There is a pressing need to understand the neural underpinning of PCS. Here, we examined whole-brain functional connectivity from resting-state fMRI with behavioral assessments in a cohort of 110 children with mTBI. Children with mTBI and controls had similar levels of connectivity. PCS symptoms and behaviors including poor cognition and sleep were associated with connectivity within functional brain networks. The identification of a single "positive-negative" dimension linking connectivity with behaviors enables better prognosis and stratification toward personalized therapeutic interventions.	[Iyer, Kartik K.; Barlow, Karen M.] Univ Queensland, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia; [Barlow, Karen M.] Queensland Childrens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Barlow, Karen M.; Ofoghi, Zahra] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Barlow, Karen M.; Brooks, Brian; Ofoghi, Zahra] Univ Calgary, Calgary, AB, Canada; [Zalesky, Andrew] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Zalesky, Andrew] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Cocchi, Luca] QIMR Berghofer Med Res Inst, Clin Brain Networks Grp, Brisbane, Qld, Australia		Iyer, KK (corresponding author), Univ Queensland, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia.	k.iyer@uq.edu.au	Cocchi, Luca/AAC-3337-2019; Barlow, Karen/I-6492-2019	Cocchi, Luca/0000-0003-3651-2676; Barlow, Karen/0000-0003-2612-8507; ZALESKY, ANDREW/0000-0003-2298-9908	Brain Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1099082, 1138711]	K.K.I acknowledges funding support from the Brain Foundation. K.M.B. acknowledges funding support from the Canadian Institutes of Health Research (grant number: 293375). L.C. is supported by the Australian National Health and Medical Research Council (L.C. 1099082 and 1138711).The authors also thank Dr Luke Hearne for feedback regarding the interpretation of the findings.	[Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gioia GA., 1996, BEHAV RATING INVENTO; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hearne LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32328; Kamphaus R., 2004, BEHAV ASSESSMENT SYS, V4201, P55014; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lin HY, 2018, PSYCHOL MED, V48, P2399, DOI 10.1017/S0033291718000028; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tashjian SM, 2018, SOC COGN AFFECT NEUR, V13, P290, DOI 10.1093/scan/nsy009; Xia CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05317-y; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	30	9	9	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	MAY	2019	6	5					954	961		10.1002/acn3.764			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HZ1SZ	WOS:000468630000014	31139693	Green Published, gold, Green Submitted			2022-02-06	
J	Karlsen, RH; Einarsen, C; Moe, HK; Haberg, AK; Vik, A; Skandsen, T; Eikenes, L				Karlsen, Rune Hatlestad; Einarsen, Cathrine; Moe, Hans Kristian; Haberg, Asta Kristine; Vik, Anne; Skandsen, Toril; Eikenes, Live			Diffusion kurtosis imaging in mild traumatic brain injury and postconcussional syndrome	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain concussion; diffusion tensor imaging; magnetic resonance imaging; postconcussion syndrome	POST-CONCUSSION SYMPTOMS; TENSOR	Aims of this study were to investigate white matter (WM) and thalamus microstructure 72 hr and 3 months after mild traumatic brain injury (TBI) with diffusion kurtosis imaging (DKI) and diffusion tensor imaging (DTI), and to relate DKI and DTI findings to postconcussional syndrome (PCS). Twenty-five patients (72 hr = 24; 3 months = 23) and 22 healthy controls were recruited, and DKI and DTI data were analyzed with Tract-Based Spatial Statistics (TBSS) and a region-of-interest (ROI) approach. Patients were categorized into PCS or non-PCS 3 months after injury according to the ICD-10 research criteria for PCS. In TBSS analysis, significant differences between patients and controls were seen in WM, both in the acute stage and 3 months after injury. Fractional anisotropy (FA) reductions were more widespread than kurtosis fractional anisotropy (KFA) reductions in the acute stage, while KFA reductions were more widespread than the FA reductions at 3 months, indicating the complementary roles of DKI and DTI. When comparing patients with PCS (n = 9), without PCS (n = 16), and healthy controls, in the ROI analyses, no differences were found in the acute DKI and DTI metrics. However, near-significant differences were observed for several DKI metrics obtained in WM and thalamus concurrently with symptom assessment (3 months after injury). Our findings indicate a combined utility of DKI and DTI in detecting WM microstructural alterations after mild TBI. Moreover, PCS may be associated with evolving alterations in brain microstructure, and DKI may be a promising tool to detect such changes.	[Karlsen, Rune Hatlestad; Einarsen, Cathrine; Moe, Hans Kristian; Haberg, Asta Kristine; Vik, Anne; Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, N-7491 Trondheim, Norway; [Einarsen, Cathrine; Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Haberg, Asta Kristine] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Haberg, Asta Kristine; Eikenes, Live] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway		Skandsen, T (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no	; Skandsen, Toril/P-6767-2014	Moe, Hans Kristian/0000-0002-1699-6848; Karlsen, Rune Hatlestad/0000-0002-3435-9156; Skandsen, Toril/0000-0001-5495-9338	Liaison Committee	This work was supported by funding from the Liaison Committee between the Central Norway Regional Health Authority (RHA), the Norwegian University of Science and Technology (NTNU), and the National Norwegian Advisory Unit for functional MRI	Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Fakhran S, 2014, PROG NEUROL SURG, V28, P234, DOI 10.1159/000358787; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hansen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23999; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; IBM Corp, 2016, IBM SPSS STAT WINDOW; Irie R, 2018, MAGN RESON MED SCI, V17, P138, DOI 10.2463/mrms.mp.2017-0031; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McCormick DA, 1999, NAT MED, V5, P1349, DOI 10.1038/70911; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MOSER BK, 1992, AM STAT, V46, P19, DOI 10.2307/2684403; Naess-Schmidt ET, 2018, BRAIN INJURY, V32, P91, DOI 10.1080/02699052.2017.1377352; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; R Core Team, 2018, R LANGUAGE ENV STAT; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; World Health Organization, 1993, ICD 10 CLASS MENT BE; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	56	9	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY	2019	97	5					568	581		10.1002/jnr.24383			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP7TA	WOS:000461891200005	30675907	Green Published, hybrid, Green Submitted			2022-02-06	
J	Su, TM; Lan, CM; Lee, TH; Hsu, SW; Tsai, NW; Lu, CH				Su, Tsung-Ming; Lan, Chu-Mei; Lee, Tsung-Han; Hsu, Shih-Wei; Tsai, Nai-Wen; Lu, Cheng-Hsien			Risk factors for the development of posttraumatic hydrocephalus after unilateral decompressive craniectomy in patients with traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Decompressive craniectomy; Posttraumatic hydrocephalus; Subdural hygroma; Traumatic brain injury	SUBDURAL HYGROMA; INTRACRANIAL HYPERTENSION; INTERHEMISPHERIC HYGROMA; SUBARACHNOID HEMORRHAGE; CLINICAL-FEATURES; COMPLICATIONS	Decompressive craniectomy (DC) has been performed increasingly to control medically refractory intracranial hypertension in patients with traumatic brain injury (TBI). Although DC is a potentially life-saving procedure and technically straightforward, it is associated with some significant complications that include subdural hygroma (SDG) and posttraumatic hydrocephalus (PTH). A retrospective analysis of 143 TBI patients who underwent unilateral DC was undertaken to investigate the incidence and risk factors of PTH and investigate the relationship between the types of SDG and PTH. Among these patients, the incidence of PTH was 30.1%. SDG was noted in 25 patients (58.1%) who developed PTH. SDG was noted in 27 patients (27%) without PTH. The patients with PTH had a significantly unfavorable outcome (p < 0.0001). After stepwise logistic regression analyses, only age (p = 0.004, odds ratio [OR] = 1.036, 95% confidence interval [CI] = 1.011-1.061) and contralateral SDG (p < 0.0001, OR = 5.613, 95% Cl = 2.232-14.115) remained independently associated with PTH development, and PTH development rate increased by 3.6% with every 1-year increase in age. Close surveillance is indicated in older TBI patients with contralateral SDG after unilateral DC to prompt early detection and timely management of PTH. (C) 2019 Elsevier Ltd. All rights reserved.	[Su, Tsung-Ming; Lee, Tsung-Han] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Dapi Rd, Kaohsiung 83301, Taiwan; [Su, Tsung-Ming; Lee, Tsung-Han; Hsu, Shih-Wei; Tsai, Nai-Wen; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, 123 Dapi Rd, Kaohsiung 83301, Taiwan; [Lan, Chu-Mei] Chang Jung Christian Univ, Dept Hlth Psychol, 1 Changda Rd, Tainan 71101, Taiwan; [Hsu, Shih-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, 123 Dapi Rd, Kaohsiung 83301, Taiwan; [Tsai, Nai-Wen; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, 123 Dapi Rd, Kaohsiung 83301, Taiwan; [Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Xiamen Chang Gung Mem Hosp, Dept Neurol, Xiamen, Fujian, Peoples R China		Lu, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, 123 Ta Pei Rd, Kaohsiung 833, Taiwan.	tm.su@msa.hinet.net; cmlan@mail.cjcu.edu.tw; hsusw@adm.cgmh.org.tw; chlu99@ms44.url.com.tw					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di G, 2018, WORLD NEUROSURG, V116; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GRAFFRADFORD NR, 1989, ARCH NEUROL-CHICAGO, V46, P744, DOI 10.1001/archneur.1989.00520430038014; Hammes EM, 1944, ARCH NEURO PSYCHIATR, V52, P505, DOI 10.1001/archneurpsyc.1944.02290360077006; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; JENNETT B, 1975, LANCET, V1, P480; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mehta V, 1996, CAN J NEUROL SCI, V23, P40, DOI 10.1017/S0317167100039160; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2018, TURK NEUROSURG, V28, P582, DOI 10.5137/1019-5149.JTN.20761-17.1; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Yoshioka H, 2000, SURG NEUROL, V53, P119, DOI 10.1016/S0090-3019(99)00185-8; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760	31	9	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2019	63						62	67		10.1016/j.jocn.2019.02.006			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV8QW	WOS:000466249000012	30827885				2022-02-06	
J	Sullivan, DR				Sullivan, Danielle R.			A Cerebrovascular Hypothesis of Neurodegeneration in mTBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cerebral blood flow; cerebrovascular; mTBI; neural integrity; neurodegeneration; neuroinflammation	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CEREBRAL-BLOOD-FLOW; WHITE-MATTER ABNORMALITIES; NATIONAL EPIDEMIOLOGIC SURVEY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; COGNITIVE DECLINE; WAVE 2	Objectives: Mild traumatic brain injury (mTBI) is a major public health concern that has generated considerable scientific interest as a complex brain disorder that is associated with long-term neural consequences. This article reviews the literature on cerebrovascular dysfunction in chronic mTBI, with a focus on the long-term neural implications of such dysfunction. Methods and Results: Evidence is presented from human neuroimaging studies to support cerebrovascular involvement in long-term mTBI pathology. In addition, a pathway between mTBI and neurodegeneration via cerebrovascular dysfunction is explored. Conclusions: Future work focused on identifying the neurobiological mechanisms underlying the neural consequences of mTBI will be important to guide therapeutic interventions and long-term care for patients with mTBI.	[Sullivan, Danielle R.] VA Boston Healthcare Syst, Natl Ctr PTSD, 116B-2,150 S Huntington Ave, Boston, MA 02130 USA; [Sullivan, Danielle R.] Boston Univ, Sch Med, Boston, MA 02215 USA		Sullivan, DR (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, 116B-2,150 S Huntington Ave, Boston, MA 02130 USA.	drsulliv@bu.edu		Sullivan, Danielle R./0000-0002-0141-5887	VA Clinical Science Research and Development Career Development Award [1IK2CX001772-01]; National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019836-01]; National Center for PTSD; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019836] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX001772] Funding Source: NIH RePORTER	This work was supported by VA Clinical Science Research and Development Career Development Award (1IK2CX001772-01) awarded to D.R.S., National Institutes of Mental Health training grant (T32MH019836-01) awarded to Terence Keane, PhD, supporting D.R.S., and the National Center for PTSD.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Badaut J, 2000, NEUROSCI LETT, V292, P75, DOI 10.1016/S0304-3940(00)01364-1; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Benedictus MR, 2017, EUR RADIOL, V27, P1169, DOI 10.1007/s00330-016-4450-z; Bernbaum M, 2015, J CEREBR BLOOD F MET, V35, P1610, DOI 10.1038/jcbfm.2015.92; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Ceprnja M, 2011, COLLEGIUM ANTROPOL, V35, P1155; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056733; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez-Ramos A, 2003, J NEUROSCI RES, V71, P863, DOI 10.1002/jnr.10525; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Logue MW, 2013, MOL PSYCHIATR, V18, P937, DOI 10.1038/mp.2012.113; Lohr JB, 2015, AM J GERIAT PSYCHIAT, V23, P709, DOI 10.1016/j.jagp.2015.04.001; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Peng SP, 2016, NEURAL REGEN RES, V11, P257, DOI 10.4103/1673-5374.177733; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Pietrzak RH, 2011, PSYCHOSOM MED, V73, P697, DOI 10.1097/PSY.0b013e3182303775; Ponto L.L., 2015, J NEUROPSYCHIATRY CL, V28, P89, DOI DOI 10.1053/APMR.2002.28802; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Promjunyakul N, 2015, NEUROIMAGE-CLIN, V8, P224, DOI 10.1016/j.nicl.2015.04.012; Promjunyakul NO, 2016, J CEREBR BLOOD F MET, V36, P1528, DOI 10.1177/0271678X16651268; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Roy SS, 2015, AM J PUBLIC HEALTH, V105, P757, DOI 10.2105/AJPH.2014.302342; Salat DH, 2014, NEUROSCIENCE, V276, P174, DOI 10.1016/j.neuroscience.2013.11.041; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schlenger WE, 2015, AM J EPIDEMIOL, V182, P980, DOI 10.1093/aje/kwv217; Shi YL, 2016, J CEREBR BLOOD F MET, V36, P1653, DOI 10.1177/0271678X16662891; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Steketee RME, 2016, NEUROBIOL AGING, V43, P119, DOI 10.1016/j.neurobiolaging.2016.03.031; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Vaccarino V, 2013, J AM COLL CARDIOL, V62, P970, DOI 10.1016/j.jacc.2013.04.085; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Z, 2013, NEUROIMAGE-CLIN, V2, P630, DOI 10.1016/j.nicl.2013.04.014; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf EJ, 2016, PSYCHIAT ANN, V46, P527, DOI 10.3928/00485713-20160729-01; Wolf EJ, 2016, BIOL PSYCHIAT, V80, P363, DOI 10.1016/j.biopsych.2015.11.023; Wolf EJ, 2016, PSYCHONEUROENDOCRINO, V63, P155, DOI 10.1016/j.psyneuen.2015.09.020; Xekardaki A, 2015, RADIOLOGY, V274, P490, DOI 10.1148/radiol.14140680; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	91	9	9	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E18	E27		10.1097/HTR.0000000000000449			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100003	30499930	Green Accepted			2022-02-06	
J	Volovici, V; Ercole, A; Citerio, G; Stocchetti, N; Haitsma, IK; Huijben, JA; Dirven, CMF; van der Jagt, M; Steyerberg, EW; Nelson, D; Cnossen, MC; Maas, AIR; Polinder, S; Menon, DK; Lingsma, HF				Volovici, Victor; Ercole, Ari; Citerio, Giuseppe; Stocchetti, Nino; Haitsma, Iain K.; Huijben, Jilske A.; Dirven, Clemens M. F.; van der Jagt, Mathieu; Steyerberg, Ewout W.; Nelson, David; Cnossen, Maryse C.; Maas, Andrew I. R.; Polinder, Suzanne; Menon, David K.; Lingsma, Hester F.		CENTER-TBI Collaborators	Variation in Guideline Implementation and Adherence Regarding Severe Traumatic Brain Injury Treatment: A CENTER-TBI Survey Study in Europe	WORLD NEUROSURGERY			English	Article						CENTER-TBI; European; Guidelines; Guideline adherence; Implementation; Implementation barriers; Severe TBI	MANAGEMENT	OBJECTIVE: Guidelines may reduce practice variation and optimize patient care. We aimed to study differences in guideline use in the management of traumatic brain injury (TBI) patients and analyze reasons for guideline nonadherence. METHODS: As part of a prospective, observational, multicenter European cohort study, participants from 68 centers in 20 countries were asked to complete 72-item questionnaires regarding their management of severe TBI. Six questions with multiple sub-questions focused on guideline use and implementation. RESULTS: Questionnaires were completed by 65 centers. Of these, 49 (75%) reported use of the Brain Trauma Foundation guidelines for the medical management of TBI or related institutional protocols, 11 (17%) used no guidelines, and 5 used other guidelines (8%). Of 54 centers reporting use of any guidelines, 41 (75%) relied on written guidelines. Four centers of the 54 (7%) reported no formal implementation efforts. Structural attention to the guidelines during daily clinical rounds was reported by 21 centers (38%). The most often reported reasons for nonadherence were "every patient is unique" and the presence of extracranial injuries, both for centers that did and did not report the use of guidelines. CONCLUSIONS: There is substantial variability in the use and implementation of guidelines in neurotrauma centers in Europe. Further research is needed to strengthen the evidence underlying guidelines and to overcome implementation barriers.	[Volovici, Victor; Haitsma, Iain K.; Dirven, Clemens M. F.] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Volovici, Victor; Huijben, Jilske A.; Steyerberg, Ewout W.; Cnossen, Maryse C.; Polinder, Suzanne; Lingsma, Hester F.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [van der Jagt, Mathieu] Erasmus MC, Dept Intens Care Adults, Rotterdam, Netherlands; [Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] San Gerardo Hosp, ASST Monza, Neurointens Care Unit, Monza, Italy; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Nelson, David] Karolinska Inst, Sect Perioperat Med & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Volovici, V (corresponding author), Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands.; Volovici, V (corresponding author), Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands.	v.volovici@erasmusmc.nl	Ercole, Ari/B-6288-2009; Maas, Andrew IR/C-5584-2013; Citerio, Giuseppe/B-1839-2015; Posti, Jussi P./Y-2908-2019; Volovici, Victor/AAZ-8901-2020; van der Jagt, Mathieu/G-1905-2017	Ercole, Ari/0000-0001-8350-8093; Maas, Andrew IR/0000-0003-1612-1264; Citerio, Giuseppe/0000-0002-5374-3161; Posti, Jussi P./0000-0002-5925-5193; Volovici, Victor/0000-0002-5798-5360; van der Jagt, Mathieu/0000-0003-2566-8325; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Rossi, Sandra/0000-0002-9963-8121; Nelson, David/0000-0003-2530-8207; Radoi, Andreea/0000-0002-0677-3544	European Commission, Seventh Framework Programme [602150]	All authors report funding from the European Commission, Seventh Framework Programme, grant number 602150.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cnossen MC, 2016, J NEUROTRAUM; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Lyseng-Williamson KA, 2011, DRUGS, V71, P489, DOI 10.2165/11204490-000000000-00000; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Thomas LH, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000349; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Volovici V, 2017, NEUROSURGERY, V81, pE21, DOI 10.1093/neuros/nyx183; 2007, J TRAUMA, V63, P841, DOI DOI 10.1097/TA.0B013E318123FC21	15	9	9	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E515	E520		10.1016/j.wneu.2019.01.116			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700068	30710717	Green Submitted			2022-02-06	
J	Wu, AG; Samadani, U; Slusher, TM; Zhang, L; Kiragu, AW				Wu, Andrew G.; Samadani, Uzma; Slusher, Tina M.; Zhang, Lei; Kiragu, Andrew W.			23.4% Hypertonic Saline and Intracranial Pressure in Severe Traumatic Brain Injury Among Children: A 10-Year Retrospective Analysis	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hypertonic saline; intracranial pressure; neurocritical care; pediatrics; traumatic brain injury; 23.4% saline	ACUTE KIDNEY INJURY; CRITICALLY-ILL CHILDREN; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; RESUSCITATION; HYPERTENSION; GUIDELINES; MANAGEMENT; MANNITOL	Objective: To explore the effect of 23.4% hypertonic saline for management of elevated intracranial pressure in children admitted to our institution for severe traumatic brain injury. Design: Single-center, retrospective medical chart analysis. Setting: A PICU at a level 1 pediatric trauma center in the United States. Patients: Children admitted for severe traumatic brain injury from 2006 to 2016 who received 23.4% hypertonic saline and whose intracranial pressures were measured within 5 hours of receiving 23.4% hypertonic saline. Interventions: None. Measurements and Main Results: Over the 10-year period, 1,587 children were admitted for traumatic brain injury, 155 of whom were deemed severe per this study's criteria. Forty of these children received at least one dose of hypertonic saline, but 14 were excluded for insufficient intracranial pressure data. Among the remaining 26 children, one hundred one 23.4% hypertonic saline boluses were used in the analysis. Use of 23.4% hypertonic saline was associated with a decrease in intracranial pressure of approximately 7 mm Hg at both within 1 hour after the bolus (p < 0.01) and 4 hours after the bolus (p < 0.01) when compared with the intracranial pressure measured within 1 hour before the hypertonic saline bolus. These effects remained significant after adjusting for Functional Status Scale score and CT Marshall scores. There was no statistically significant association between adjunctive therapies, such as antiepileptics and analgesics, and changes in intracranial pressure. There was no laboratory evidence of hyperkalemia or renal injury after use of 23.4% hypertonic saline. Across all hospitalizations, 65% of the study population demonstrated an abnormally elevated creatinine at least once, but only three episodes of acute kidney injury occurred in total, all before hypertonic saline administration. Eight of the 26 children in this analysis died during their hospitalization. The Functional Status Scale scores ranged from 6 to 26 with a mean of 12.2 and sd of 5.7. Conclusions: Use of 23.4% hypertonic saline with children admitted for severe traumatic brain injury is associated with a statistically significant decrease in intracranial pressure within 1 hour of use.	[Wu, Andrew G.; Slusher, Tina M.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Samadani, Uzma] Hennepin Healthcare, Dept Neurosurg, Minneapolis, MN USA; [Slusher, Tina M.; Kiragu, Andrew W.] Hennepin Healthcare, Dept Pediat, Minneapolis, MN USA; [Zhang, Lei] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA		Wu, AG (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	andrewwu@umn.edu	Kiragu, Andrew/G-1978-2019	Kiragu, Andrew/0000-0002-1067-2922	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002494]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002494] Funding Source: NIH RePORTER	Supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR002494.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Arikan AA, 2012, PEDIATR CRIT CARE ME, V13, P253, DOI 10.1097/PCC.0b013e31822882a3; Bailey D, 2007, PEDIATR CRIT CARE ME, V8, P29, DOI 10.1097/01.pcc.0000256612.40265.67; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 10 LEAD CAUS DEATH I; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention (CDC), TBI GET THE FACTS; Centers of Disease Control and Prevention, CDC CHILDH INJ REP; Ceriotti F, 2008, CLIN CHEM, V54, P559, DOI 10.1373/clinchem.2007.099648; Chen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160093; Chiwane S, 2016, CRIT CARE MED, V44; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Guardenier A, 2015, CRIT CARE MED, V43, P294; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002032; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Nakagawa K, 2012, J CLIN ANESTH, V24, P318, DOI 10.1016/j.jclinane.2011.10.011; Piper BJ, 2015, ANAESTH INTENS CARE, V43, P204, DOI 10.1177/0310057X1504300210; Prodhan P, 2012, J TRAUMA ACUTE CARE, V73, P832, DOI 10.1097/TA.0b013e31825ab14f; ProTECT III Clinical Standardization Team AANS/CNS Joint Section of Neurotrauma and Critical Care Neurocritical Care Society American College of Emergency Medicine, 2015, TRAUM QUAL IMPR PROG, P3; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Schell RM, 1996, J NEUROSURG ANESTH, V8, P178, DOI 10.1097/00008506-199604000-00022; Selewski DT, 2014, PEDIATR REV, V35, P30, DOI 10.1542/pir.35-1-30; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Welch TP, 2016, CRIT CARE MED, V44, P809, DOI 10.1097/CCM.0000000000001558; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011	46	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2019	20	5					466	473		10.1097/PCC.0000000000001867			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	HX7NX	WOS:000467593400010	30664588				2022-02-06	
J	Finkel, AM; Bieniek, KF				Finkel, Adam M.; Bieniek, Kevin F.			A quantitative risk assessment for chronic traumatic encephalopathy (CTE) in football: How public health science evaluates evidence	HUMAN AND ECOLOGICAL RISK ASSESSMENT			English	Article						epidemiology; OSHA; quantitative risk assessment; head trauma; science-policy; chronic traumatic encephalopathy (CTE)	BRAIN-INJURY; TAU; POLLUTION; DISEASE	How should science and policy interpret the recent finding that 110 of 111 former National Football League (NFL) players had brain pathology known as chronic traumatic encephalopathy (CTE) at autopsy? Some physicians view this (and related epidemiologic and mechanistic evidence) skeptically, emphasizing that the association between repeated head trauma (RHT) and CTE may be artifactual, that this "incidence" is biased by self-selection of players with cognitive or emotional symptoms, and that even if RHT causes CTE, the lesions themselves may be inconsequential. Public health scientists look at this emerging evidence quite differently; in particular, they tend not to fall prey to certain illogical arguments justifying inaction. We present a quantitative risk assessment showing that even accounting for the non-representativeness of the 110 cases, the risk of CTE in the NFL workforce amply meets both parts of the test for "a significant risk of material impairment of health" that would permit the U.S. Occupational Safety and Health Administration to intervene to reduce RHT exposure. We further conclude that according to available evidence, CTE is a public health problem, and that lawyers and physicians need to understand that this conclusion is based on standards of evidence at least as long-standing and robust as their own.	[Finkel, Adam M.] Univ Michigan, Sch Publ Hlth, Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Finkel, Adam M.] Univ Penn, Wharton Risk Management & Decis Proc Ctr, Philadelphia, PA 19104 USA; [Bieniek, Kevin F.] Mayo Clin, Coll Med & Sci, Neurosci, Jacksonville, FL USA		Finkel, AM (corresponding author), Univ Michigan, Sch Publ Hlth, Environm Hlth Sci, Ann Arbor, MI 48109 USA.; Finkel, AM (corresponding author), Univ Penn, Wharton Risk Management & Decis Proc Ctr, Philadelphia, PA 19104 USA.	afinkel@upenn.edu		Bieniek, Kevin/0000-0003-4922-864X; Finkel, Adam M./0000-0001-6259-9387	Florida Department of Health; Ed and Ethel Moore Alzheimer's Disease Biomedical Research Program [7AZ08]; Mayo Clinic Younkin Scholars Program on Synaptic Biology and Memory; National Center for Advancing Translational Sciences (NCATS), a component of the NIH [UL1 TR002377]	Dr. Bieniek is supported by the Florida Department of Health, Ed and Ethel Moore Alzheimer's Disease Biomedical Research Program (7AZ08) and the Mayo Clinic Younkin Scholars Program on Synaptic Biology and Memory. This publication was in part made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	ALLEN BC, 1988, RISK ANAL, V8, P531, DOI 10.1111/j.1539-6924.1988.tb01193.x; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bailes Julian E, 2015, Neurosurgery, V62 Suppl 1, P15, DOI 10.1227/NEU.0000000000000811; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Belson K, 2016, NEW YORK TIMES  0205, pD2; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bingham E, 2013, LATE LESSONS EARLY W, P235; Carey B., 2016, NY TIMES; Carpenter R, 2017, REQUIEM RUNNING BACK; Castellani RJ, 2015, LAB INVEST, V95, P576, DOI 10.1038/labinvest.2015.54; Coggins CRE, 2007, INT J TOXICOL, V26, P331, DOI 10.1080/10915810701490190; Conway E.M, 2010, MERCHANTS DOUBT HAND; Cox LA, 2016, ANN AM THORAC SOC, V13, P2280; Dwass E, 2015, NY TIMES, pD4; EPA, 2005, GUIDELINES CARCINOGE; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Finkel AM, 2018, DOUBTING HLTH HARMS; Finkel AM, 1994, INSIGHT, V50, P20; Finkel AM, 2009, I POL INT NYU LAW SC; Finkel AM, 2018, ARIZ LAW REV, V60, P291; Fischhoff B, 1983, ACCEPTABLE RISK; Gantt D, 2017, R GOODELL FOOTBALL P; Gao A. F., 2017, INT J PATHOLOGICAL C, V3, P50, DOI [10.23937/2469-5807/1510050, DOI 10.23937/2469-5807/1510050]; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Haidt J., 2012, RIGHTEOUS MIND WHY G; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Kelly E, 2018, NY TIMES, pSR1; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; Li Y, 2010, SCI TOTAL ENVIRON, V408, P1226, DOI 10.1016/j.scitotenv.2009.11.035; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Michaels D., 2008, DOUBT IS THEIR PRODU; Mitts DL, 1998, SAN JOAQUIN AGR L RE, V8, P187; Montenigro P. H., 2016, J NEUROTRAUMA, V33, P1; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; National Football League, EXC SPREADSH GIV NUM; National Research Council, 1994, SCI JUDGM RISK ASS; National Research Council, 1983, RISK ASS FED GOV MAN; National Research Council Committee on Improving Risk Analysis Approaches used by the US Environmental Protection Agency, 2008, SCI DEC IMPR RISK AS; Neutra RR., 2018, JURIMETRICS, V58, P127; NFLlaborwordpresscom, 2011, WHAT IS AV NFL PLAY; Nierenberg AA, 2017, PSYCHIAT ANN, V47, P571, DOI 10.3928/00485713-20171108-01; Nixon J, 2014, LIST ALL PROFOOTBAL; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Occupational Safety and Health Administration US, 2014, OSHA B; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Peto R, 1977, NEW SCI, V73, P480; Rhomberg LR, 1997, HUM ECOL RISK ASSESS, V3, P1029, DOI 10.1080/10807039709383746; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Schnabel J, 2016, REAL IS CTE; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Sunstein Cass, 2008, NUDGE IMPROVING DECI; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; *US DEP HLTH ED WE, 1964, PHS PUBL, V1103; Utecht B, 2017, COUNTING DAYS MY MIN; Ward J., 2017, NY TIMES; Willborn S. L., 2014, U MIAMI LAW REV, V69, P65; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113	79	9	9	19	38	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1080-7039	1549-7860		HUM ECOL RISK ASSESS	Hum. Ecol. Risk Assess.	APR 3	2019	25	3					564	589		10.1080/10807039.2018.1456899			26	Biodiversity Conservation; Environmental Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biodiversity & Conservation; Environmental Sciences & Ecology	IE0VZ	WOS:000472106200004					2022-02-06	
J	Harriss, A; Johnson, AM; Walton, DM; Dickey, JP				Harriss, Alexandra; Johnson, Andrew M.; Walton, David M.; Dickey, James P.			The number of purposeful headers female youth soccer players experience during games depends on player age but not player position	SCIENCE AND MEDICINE IN FOOTBALL			English	Article						Repetitive; sports; adolescent; prevention; coaching; football	IMPACT EXPOSURE; FOOTBALL; BIOMECHANICS; CONCUSSIONS; FREQUENCY; BRAIN; BALL	Purpose: The aim of this study was to describe the frequency and characteristics of purposeful soccer heading in youth players based on age, position, and head impact location.Methods: Game video was recorded for three female youth teams [under-13 (U13), under-14 (U14), and under-15 (U15)] for an entire season. Purposeful headers were categorized for these three teams and their opposition.Results: The median number of headers experienced during games was one, and the minimum number of headers was zero. The maximum number of headers performed during a game by a U13 player was eight, and nine for U14 and U15 players. There were statistically significant differences in the number of headers performed in the different age groups (p < 0.05), but no significant differences between player position (p > 0.05). There was no significant association between head impact location and game scenario (p > 0.05).Conclusions: Our study shows that youth players frequently head the ball during games. This information may guide data-driven approaches regarding heading restrictions in youth soccer.	[Harriss, Alexandra; Dickey, James P.] Univ Western Ontario, Sch Kinesiol, London, ON, Canada; [Johnson, Andrew M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Walton, David M.] Univ Western Ontario, Sch Phys Therapy, London, ON, Canada; [Harriss, Alexandra; Walton, David M.] Univ Western Ontario, Hlth & Rehabil Sci, London, ON, Canada		Dickey, JP (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON, Canada.	jdickey@uwo.ca	Dickey, James P/K-6776-2013; Johnson, Andrew M/B-2048-2012; Walton, David M/C-9902-2015	Dickey, James P/0000-0002-4101-835X; Walton, David M/0000-0001-9155-3337; Johnson, Andrew M./0000-0002-7269-3016			Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Chiampas GT, 2018, SCI MED FOOTBALL, V2, P80, DOI 10.1080/24733938.2017.1421771; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Gallant C, 2017, CURR PSYCHOL, V36, P286, DOI 10.1007/s12144-016-9414-6; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Kerr Z, 2017, J NEUROTRAUMA; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kuznetsov BL, 2016, Upravlenets, P2; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meyer T, 2018, SCI MED FOOTBALL, V2, P1, DOI 10.1080/24733938.2017.1416950; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Schaalje GB, 2002, J AGRIC BIOL ENVIR S, V7, P512, DOI 10.1198/108571102726; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Tarnutzer AA, 2018, SCI MED FOOTBALL, V2, P75, DOI 10.1080/24733938.2017.1386793; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; USAClubSoccer, 2016, REC REC IMPL GUID US; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	35	9	9	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football	APR 3	2019	3	2					109	114		10.1080/24733938.2018.1506591			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OH6DH	WOS:000582678500005					2022-02-06	
J	Chelly, H; Bahloul, M; Ammar, R; Dhouib, A; Ben Mahfoudh, K; Boudawara, MZ; Chakroun, O; Chabchoub, I; Chaari, A; Bouaziz, M				Chelly, Hedi; Bahloul, Mabrouk; Ammar, Rania; Dhouib, Ahmed; Ben Mahfoudh, Khaireddine; Boudawara, Mohamed Zaher; Chakroun, Olfa; Chabchoub, Imen; Chaari, Anis; Bouaziz, Mounir			Clinical characteristics and prognosis of traumatic head injury following road traffic accidents admitted in ICU "analysis of 694 cases"	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Trauma; Head injury; Road traffic accident; Intensive care unit; Multivariate analysis; Prognosis	BRAIN-INJURY; MORTALITY; CHILDREN; EPIDEMIOLOGY; SCALE	BackgroundThe aim of the present study is to analyze the clinical and epidemiological characteristics of Traumatic Brain Injury (TBI) following Road Traffic Accidents (RTAs). Moreover, we aim to evaluate the outcome of the TBI victims referred to our medico-surgical Intensive Care Unit (ICU), and to define predictive factors associated with poor prognosis.MethodsA retrospective study over a 4-year period (2009 to 2012) of 694 patients with head injuries, incurred during road traffic accidents, admitted to the Intensive Care Unit (ICU) of a university hospital (Sfax-Tunisia). Basic demographic, clinical, biological, and radiological data were recorded on admission and during the ICU stay.ResultsThere were 592 males (85.3%), and 102 female patients. The mean age was at 31.817.8years (range 1-91). The mechanism of the accident was detailed in 666 patients (96%). The majority of the victims were motorcycle riders and/or passengers (40.5%), followed by pedestrians (29.1%). Extra-cranial pathology was present in 452 patients (65%). A total of 677 patients (97.6%) required intubation, mechanical ventilation, and sedation. Mean ICU stay was 16 +/- 17.4days. A total of 187 patients (26.9%) died during their hospital stay. The GOS performed within a mean delay of 6months after hospital discharge was as follows: 198 deaths (28.5%), 13 vegetative state (1.9%), and 349 (50.3%) good recovery and/or moderate disability. A multivariate analysis showed that the factors which correlated with a poor prognosis (mortality and severe disability) were: age>38 years, Glasgow coma scale score<8, subdural hematoma, and development of secondary systemic insults (respiratory, circulatory, and metabolic).ConclusionIn Tunisia, traumatic brain injury due to RTAs is a frequent cause of ICU admission, especially among young adults, and is associated with high mortality and morbidity rates. The majority of the victims were motorcycle riders and/or passengers and pedestrians. The factors associated with a poor outcome were: age>38 years, Glasgow Coma Scale score<8, subdural hematoma, and development of secondary systemic insults (respiratory, circulatory, and metabolic). As a consequence, prevention is highly warranted.	[Chelly, Hedi; Bahloul, Mabrouk; Ammar, Rania; Dhouib, Ahmed; Chaari, Anis; Bouaziz, Mounir] Habib Bourguiba Univ Hosp, Dept Intens Care, Sfax 3029, Tunisia; [Ben Mahfoudh, Khaireddine] Habib Bourguiba Univ Hosp, Dept Radiol, Sfax, Tunisia; [Boudawara, Mohamed Zaher] Habib Bourguiba Univ Hosp, Dept Neurosurg, Sfax, Tunisia; [Chakroun, Olfa] Habib Bourguiba Univ Hosp, Dept Emergency Med, Sfax, Tunisia; [Chabchoub, Imen] Hedi Chaker Univ Hosp, Dept Pediat, Sfax, Tunisia		Bahloul, M (corresponding author), Habib Bourguiba Univ Hosp, Dept Intens Care, Sfax 3029, Tunisia.	bahloulmab@yahoo.fr		Bahloul, Mabrouk/0000-0002-6488-8294			Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P198, DOI 10.4103/0974-2700.82206; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P29, DOI 10.4103/0974-2700.76831; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Benham EC, 2016, AM J SURG; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Castello FV, 1999, CRIT CARE MED, V27, P985, DOI 10.1097/00003246-199905000-00041; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Deepika A, 2017, NEUROL INDIA, V65, P83, DOI 10.4103/0028-3886.198228; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Granry JC, 2002, ANN FR ANESTH, V21, P148, DOI 10.1016/S0750-7658(01)00521-4; GREGER NG, 1986, AM J DIS CHILD, V140, P551, DOI 10.1001/archpedi.1986.02140200061028; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Jackisch J, 2015, EUROPEAN FACTS GLOBA; JENNETT B, 1975, LANCET, V1, P480; Lee JJ, 2017, J NEUROSURG; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Yokobori S, 2016, BEHAV BRAIN RES	28	9	9	1	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2019	45	2					245	253		10.1007/s00068-017-0885-4			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HS2US	WOS:000463718800009	29234838				2022-02-06	
J	Cochrane, GD; Christy, JB; Almutairi, A; Busettini, C; Swanson, MW; Weise, KK				Cochrane, Graham D.; Christy, Jennifer B.; Almutairi, Anwar; Busettini, Claudio; Swanson, Mark W.; Weise, Katherine K.			Visuo-oculomotor Function and Reaction Times in Athletes with and without Concussion	OPTOMETRY AND VISION SCIENCE			English	Article							POST-CONCUSSION; RELIABILITY; TESTS	SIGNIFICANCE: Oculomotor tests in concussion commonly show impairment in smooth pursuit and saccadic function. Honing in on the systems likely to be affected by concussion will streamline use of oculomotor function as a supplemental diagnostic and prognostic tool, as well as improve our understanding of the pathophysiology of concussion. PURPOSE This study investigates oculomotor function between concussed and healthy collegiate athletes and determines measurement test-retest reliability of those tools. METHODS Eighty-seven healthy athletes were recruited from a U.S. Division 1 sports university and completed a 30-minute vestibular ocular testing battery in an enclosed rotary chair system equipped with 100-Hz eye-tracking goggles. Forty-three individuals completed the battery twice. Twenty-eight individuals with a current diagnosis of concussion also completed the battery. All participants were aged 18 to 24 years. Bivariate statistical tests examined differences in scores across groups, and intraclass coefficients were computed to test reliability. RESULTS Concussed individuals had significantly longer saccadic, visual, and dual-task reaction times and reduced saccadic accuracy. There was no difference in optokinetic reflex gain, but few concussed individuals tolerated the task. Reaction time latencies and optokinetic gain show moderate test-retest reliability. Smooth pursuit tasks and saccadic accuracies showed poor test-retest reliability. CONCLUSIONS Saccadic latency was the most sensitive oculomotor function to change after concussion and was reliable over time. Saccadic accuracy was significantly lower in the concussed group but had poor retest reliability. Optokinetic gain may warrant more investigation because of its high test-retest reliability and symptom provocation in concussion, despite not showing a significant difference between groups.	[Cochrane, Graham D.; Christy, Jennifer B.; Almutairi, Anwar] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA; [Busettini, Claudio; Swanson, Mark W.; Weise, Katherine K.] Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA; [Busettini, Claudio] Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL USA		Cochrane, GD (corresponding author), Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA.	gcoch@uab.edu		Cochrane, Graham/0000-0003-1548-9382	National Institutes of Health-National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30 EY-03039]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY003039] Funding Source: NIH RePORTER	This research was funded by a grant from the National Institutes of Health-National Eye Institute (P30 EY-03039 Vision Science Research Center Core grant).	Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Bialunska A, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.874; Bin Zahid A, 2018, CLIN J SPORT MED; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Iverson GL, 2007, J CLIN EXP NEUROPSYC, V27, P683; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Pillai C, 2017, SEMIN OPHTHALMOL, V32, P144, DOI 10.1080/08820538.2016.1228412; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Taghdiri F, 2018, J NEUROTRAUM, V35, P719, DOI 10.1089/neu.2017.5274; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Vera J, 2017, J SPORT HLTH SCI; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wetzel PA, 2018, INVEST OPHTH VIS SCI, V59, P4011, DOI 10.1167/iovs.18-23815; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y; Zaki R, 2013, IRAN J BASIC MED SCI, V16, P803	28	9	9	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	APR	2019	96	4					256	265		10.1097/OPX.0000000000001364			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	HR5PB	WOS:000463198100004	30907863	Green Accepted			2022-02-06	
J	Curvello, V; Pastor, P; Hekierski, H; Armstead, WM				Curvello, Victor; Pastor, Philip; Hekierski, Hugh; Armstead, William M.			Inhaled Nitric Oxide Protects Cerebral Autoregulation and Reduces Hippocampal Necrosis After Traumatic Brain Injury Through Inhibition of ET-1, ERK MAPK and IL-6 Upregulation in Pigs	NEUROCRITICAL CARE			English	Article						Cerebral autoregulation; Endothelin; Nitric oxide IL-6; Signal transduction; Traumatic brain injury	PHENYLEPHRINE; ENDOTHELIN-1; HYPOTENSION; HYPOXIA; DAMAGE; MALES; AGE	ObjectiveTraumatic brain injury (TBI) is an important contributor to morbidity and mortality. Cerebral autoregulation is impaired after TBI, contributing to poor outcome. Extracellular signal-related kinase (ERK) mitogen activated protein kinase (MAPK) and ET-1 are upregulated and contribute to impairment of cerebral autoregulation and histopathology after porcine fluid percussion brain injury (FPI). Recent studies show that inhaled nitric oxide (iNO) prevents impairment of cerebral autoregulation and histopathology after FPI in pigs. Unrelated studies indicated an association between ERK and increased IL-6 after FPI. However, the role of IL-6 in central nervous system (CNS) pathology is not well understood. We investigated whether iNO protects autoregulation and limits histopathology after FPI in pigs due to modulation of brain injury associated upregulation of ET-1, ERK MAPK, and IL-6.MethodsLateral FPI was produced in anesthetized pigs equipped with a closed cranial window and iNO administered at 30min or 2h post injury.ResultsCSF ET-1, ERK MAPK, and IL-6 were increased by FPI, but release was blocked by iNO administered at 30min or 2h after TBI. The IL-6 antagonist LMT-28 prevented impairment of cerebral autoregulation and hippocampal CA1 and CA3 neuronal necrosis after FPI. Papaverine induced dilation was unchanged by FPI and LMT-28. Protection lasted for at least 2h after iNO administration was stopped.ConclusionsThese data indicate that iNO protects cerebral autoregulation and reduces hippocampal necrosis after traumatic brain injury through inhibition of ET-1, ERK MAPK, and IL-6 upregulation in pigs.	[Curvello, Victor; Pastor, Philip; Hekierski, Hugh; Armstead, William M.] Univ Penn, Dept Anesthesia & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			Mallinckrodt Pharmaceuticals	This investigator initiated research was funded by Mallinckrodt Pharmaceuticals.	Armstead W.M., 2014, VASCULAR MECH CNS TR, P269; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Curvello V, 2017, BRAIN RES, V1670, P118, DOI 10.1016/j.brainres.2017.06.010; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Hekierski H, 2019, J NEUROTRAUM, V36, P630, DOI 10.1089/neu.2018.5824; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Nakamura M, 2005, CLIN REV ALLERG IMMU, V28, P197, DOI 10.1385/CRIAI:28:3:197; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Ross J, 2005, BRAIN RES, V1054, P95, DOI 10.1016/j.brainres.2005.06.065; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zhu CL, 2013, TRANSL STROKE RES, V4, P201, DOI 10.1007/s12975-012-0217-2	23	9	9	2	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					467	477		10.1007/s12028-018-0638-1			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900030	30386963				2022-02-06	
J	Duceppe, MA; Williamson, DR; Elliott, A; Para, M; Poirier, MC; Delisle, MS; Deckelbaum, D; Razek, T; Desjardins, M; Bertrand, JC; Bernard, F; Rico, P; Burry, L; Frenette, AJ; Perreault, M				Duceppe, Marc-Alexandre; Williamson, David R.; Elliott, Audree; Para, Melissa; Poirier, Marie-Christine; Delisle, Marie-Soleil; Deckelbaum, Dan; Razek, Tarek; Desjardins, Monique; Bertrand, Jean-Claude; Bernard, Francis; Rico, Philippe; Burry, Lisa; Frenette, Anne Julie; Perreault, Marc			Modifiable Risk Factors for Delirium in Critically Ill Trauma Patients: A Multicenter Prospective Study	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						delirium; trauma; intensive care unit; risk factors	INTENSIVE-CARE-UNIT; MECHANICALLY-VENTILATED PATIENTS; TERM COGNITIVE IMPAIRMENT; CAM-ICU; PREVALENCE; IMPACT; MORTALITY; OUTCOMES; SEPSIS; MUSIC	Objective: Intensive care unit (ICU)-acquired delirium has been associated with increased morbidity and mortality. Prevention strategies including modification of delirium risk factors are emphasized by practice guidelines. No study has specifically evaluated modifiable delirium risk factors in trauma ICU patients. Our goal was to evaluate modifiable risk factors for delirium among trauma patients admitted to the ICU. Design: Prospective observational study. Setting: Two level 1 trauma ICU centers. Patients: Patients 18 years of age or older admitted for trauma including mild to moderate traumatic brain injury were eligible for the study. Interventions and Measurements: Delirium was assessed daily using the confusion assessment method for the ICU (CAM-ICU). The effect of modifiable risk factors was assessed using multivariate Cox regression analysis adjusting for severity of illness and significant nonmodifiable risk factors. Main Results: A total of 58 of 150 recruited patients (38.7%; 95% confidence interval [CI] 30.9-46.5) screened positive for delirium during ICU stay. When adjusting for significant nonmodifiable risk factors, physical restraints (hazard ratio [HR]: 2.13; 95% CI: 1.07-4.24) and active infection or sepsis (HR: 2.12; 95% CI: 1.18-3.81) significantly increased the risk of delirium, whereas opioids (HR: 0.35; 95% CI: 0.13-0.98), episodes of hypoxia (HR: 0.55; 95% CI: 0.31-0.95), access to a television/radio in the room (HR: 0.26; 95% CI: 0.11-0.62), and number of hours mobilized per day (HR: 0.77; 95% CI: 0.68-0.88) were associated with significantly less risk of delirium. Conclusion: We have identified modifiable risk factors for delirium. Future studies should aim at implementing strategies to modify these risk factors and evaluate their impact on the risk of delirium.	[Duceppe, Marc-Alexandre; Elliott, Audree; Para, Melissa; Poirier, Marie-Christine; Delisle, Marie-Soleil; Perreault, Marc] McGill Univ, Ctr Hlth, Dept Pharm, Montreal, PQ, Canada; [Williamson, David R.; Frenette, Anne Julie] Hop Sacre Coeur Montreal, Dept Pharm, 5400 Gouin W, Montreal, PQ H4J 1C5, Canada; [Williamson, David R.; Frenette, Anne Julie; Perreault, Marc] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Deckelbaum, Dan; Razek, Tarek] McGill Univ, Ctr Hlth, Dept Traumatol, Montreal, PQ, Canada; [Desjardins, Monique; Bertrand, Jean-Claude] Hop Sacre Coeur Montreal, Dept Psychiat, Montreal, PQ, Canada; [Desjardins, Monique; Bertrand, Jean-Claude; Bernard, Francis; Rico, Philippe] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Bernard, Francis; Rico, Philippe] Hop Sacre Coeur Montreal, Dept Crit Care, Montreal, PQ, Canada; [Bernard, Francis; Rico, Philippe] Hop Sacre Coeur Montreal, Dept Crit Care, Montreal, PQ, Canada; [Burry, Lisa] Mt Sinai Hosp, Dept Pharm, Toronto, ON, Canada; [Burry, Lisa] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada		Williamson, DR (corresponding author), Hop Sacre Coeur Montreal, Dept Pharm, 5400 Gouin W, Montreal, PQ H4J 1C5, Canada.; Williamson, DR (corresponding author), Hop Sacre Coeur Montreal, Res Ctr, 5400 Gouin W, Montreal, PQ H4J 1C5, Canada.	david.williamson@umontreal.ca	Burry, Lisa D/C-6546-2017	Burry, Lisa D/0000-0002-6545-3890; Duceppe, Marc-Alexandre/0000-0001-5211-2600			Agarwal V, 2010, J BURN CARE RES, V31, P706, DOI 10.1097/BCR.0b013e3181eebee9; Al-Qadheeb NS, 2014, CRIT CARE MED, V42, P1442, DOI 10.1097/CCM.0000000000000224; Angles EM, 2008, AM J SURG, V196, P864, DOI 10.1016/j.amjsurg.2008.07.037; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Beaulieu-Boire G, 2013, J CRIT CARE, V28, P442, DOI 10.1016/j.jcrc.2013.01.007; Bigatello LM, 2013, J TRAUMA ACUTE CARE, V74, P876, DOI 10.1097/TA.0b013e31827e1b69; Blondell RD, 2004, AM J SURG, V187, P332, DOI 10.1016/j.amjsurg.2003.12.027; Celis-Rodriguez E, 2013, MED INTENSIVA, V37, P519, DOI 10.1016/j.medin.2013.04.001; Chlan L L, 1995, Am J Crit Care, V4, P233; Dijkstra BM, 2010, J CLIN NURS, V19, P1030, DOI 10.1111/j.1365-2702.2009.02968.x; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Frenette AJ, 2016, INTENS CARE MED, V42, P122, DOI 10.1007/s00134-015-3964-1; Guillamondegui OD, 2011, J TRAUMA, V70, P910, DOI 10.1097/TA.0b013e3182114f18; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Jackson P, 2015, CRIT CARE CLIN, V31, P589, DOI 10.1016/j.ccc.2015.03.011; Klein PMC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6652; Lat I, 2009, CRIT CARE MED, V37, P1898, DOI 10.1097/CCM.0b013e31819ffe38; Liu Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009413.pub2; Martin Jorg, 2010, Ger Med Sci, V8, pDoc02, DOI 10.3205/000091; Mehta S, 2015, CRIT CARE MED, V43, P557, DOI 10.1097/CCM.0000000000000727; Micek ST, 2005, CRIT CARE MED, V33, P1260, DOI 10.1097/01.CCM.0000164540.58515.BF; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Pandharipande P, 2007, INTENS CARE MED, V33, P1726, DOI 10.1007/s00134-007-0687-y; Price R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2197; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sundararajan K, 2014, ANAESTH INTENS CARE, V42, P473, DOI 10.1177/0310057X1404200408; Tsuruta R, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0145-4; van den Boogaard M, 2012, INT J NURS STUD, V49, P775, DOI 10.1016/j.ijnurstu.2011.11.016; van den Boogaard M, 2011, CRIT CARE, V15, DOI 10.1186/cc10598; Zaal IJ, 2015, CRIT CARE MED, V43, P40, DOI 10.1097/CCM.0000000000000625	36	9	12	2	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	APR	2019	34	4					330	336		10.1177/0885066617698646			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5LJ	WOS:000461718300007	28335673				2022-02-06	
J	Garcia-Gonzalez, D; Jerusalem, A				Garcia-Gonzalez, D.; Jerusalem, A.			Energy based mechano-electrophysiological model of CNS damage at the tissue scale	JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS			English	Article						Mechano-electrophysiological model; Spinal cord injury; Constitutive modelling; Blast injury	SPINAL-CORD-INJURY; IN-VITRO; STRAIN; NERVE; THERMODYNAMICS; DEFORMATION; PROPAGATION; FORMULATION; CONDUCTION; AXONS	Injuries to the central nervous system (CNS) have become a major health challenge in our society. Such injuries can affect the electrophysiological properties, and thus functional behaviour of the nervous system. Most of the related computational studies to date have mainly been focussed on the cellular, subcellular or axonal scales. Although essential for understanding the characteristics of spinal cord injury and traumatic brain injury at the cellular level, these approaches suffer from a lack of scalability to meso- and macroscopic scenarios. To this end, this work presents a tissue level framework describing the coupled mechanical and electrophysiological behaviour of CNS tissue. The proposed mechanical large deformation constitutive model accounts for strain rate dependency, viscous effects and mechanical damage within a thermodynamically consistent framework. Coupled to it, a FitzHugh-Nagumo based model that includes axonal fibre informed anisotropic conduction describes the electrophysiological behaviour. The mechanical model is first calibrated against experimental deformation measurements of spinal cord white matter. The complete framework is then calibrated and used to study the mechano-electrophysiological coupling in spinal cord samples subjected to tension-free relaxation tests by considering electrophysiological damage as a function of mechanical energetic terms. The flexibility of the proposed model is illustrated with the case of mechano-electrophysiological coupling in spinal cord subjected to blast loading, After validation of the coupled model, the mechanical parameters are identified for white matter and an analysis of the influence of axonal dispersion on anisotropic AP conduction in an in silico rat model is presented. This work provides a novel mechano-electrophysiological framework able to model the mechanics of spinal cord and brain tissue and its translation into electrophysiological dysfunction through energetic terms at the tissue level. (C) 2019 The Authors. Published by Elsevier Ltd.	[Garcia-Gonzalez, D.; Jerusalem, A.] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	danigarc@ing.uc3m.es; antoine.jerusalem@eng.ox.ac.uk	Garcia-Gonzalez, Daniel/K-7349-2017	Garcia-Gonzalez, Daniel/0000-0003-4692-3508; Jerusalem, Antoine/0000-0001-5026-8038	European Union Seventh Framework Programme (FP7 2007-2013) ERC Grant [306587]; EPSRC Healthcare Technologies Challenge AwardUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/l]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/1] Funding Source: UKRI	The authors acknowledge funding from the European Union Seventh Framework Programme (FP7 2007-2013) ERC Grant Agreement No. 306587 and funding from the EPSRC Healthcare Technologies Challenge Award EP/N020987/l. DGG would like to thank Dr. Damian Aranda-Iglesias at Luxembourg Institute of Science and Technology for his comments regarding the mechanical modelling.	Aliev RR, 1996, CHAOS SOLITON FRACT, V7, P293, DOI 10.1016/0960-0779(95)00089-5; Alvarez VS, 2018, J BIOMECH, V71, P76, DOI 10.1016/j.jbiomech.2018.01.038; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; BOYCE MC, 1988, MECH MATER, V7, P15, DOI 10.1016/0167-6636(88)90003-8; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Cinelli I, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2942; Cinelli I, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.3118; Cinelli I, 2018, IEEE T BIO-MED ENG, V65, P1373, DOI 10.1109/TBME.2017.2752258; COLEMAN BD, 1963, ARCH RATION MECH AN, V13, P167, DOI 10.1007/BF01262690; COLEMAN BD, 1967, J CHEM PHYS, V47, P597, DOI 10.1063/1.1711937; Connell S, 2011, J MED SYST, V35, P765, DOI 10.1007/s10916-010-9464-5; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Coppieters MW, 2007, J ORTHOP RES, V25, P972, DOI 10.1002/jor.20310; Costabal FS, 2017, COMPUT METHOD APPL M, V320, P352, DOI 10.1016/j.cma.2017.03.015; Dassault Systemes Abaqus v6. 14 Documentation, 2014, AB AN US MAN; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Engelbrecht J, 2018, P EST ACAD SCI, V67, P28, DOI 10.3176/proc.2017.4.28; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Fradet L, 2016, P I MECH ENG H, V230, P858, DOI 10.1177/0954411916655373; Garcia-Gonzalez D, 2018, J MECH PHYS SOLIDS, V112, P209, DOI 10.1016/j.jmps.2017.12.001; Garcia-Gonzalez D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28271-7; Garcia-Martin JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137859; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Honmou Osamu, 1995, P480; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jannesar S, 2018, ACTA BIOMATER, V74, P260, DOI 10.1016/j.actbio.2018.05.002; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Kachanov LM, 1958, IZV ACAD NAUK USSR O, V8, P26, DOI DOI 10.1023/A:1018671022008; Kang WH, 2015, J NEUROTRAUM, V32, P1011, DOI 10.1089/neu.2014.3667; Karimi A, 2017, J CHEM NEUROANAT, V86, P15, DOI 10.1016/j.jchemneu.2017.07.004; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kwong MT, 2019, COMPUT METHOD APPL M, V346, P1025, DOI 10.1016/j.cma.2018.09.006; LaPlaca M. C., 2018, CLIN BIOMECH; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Ng LJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00269; Ogden RW, 2004, COMPUT MECH, V34, P484, DOI 10.1007/s00466-004-0593-y; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prevost T. P., 2011, ACTA BIOMATER, V7; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; SIMO JC, 1987, COMPUT METHOD APPL M, V60, P153, DOI 10.1016/0045-7825(87)90107-1; Tagge CA., 2018, BRAIN, P1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810	57	9	9	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-5096	1873-4782		J MECH PHYS SOLIDS	J. Mech. Phys. Solids	APR	2019	125						22	37		10.1016/j.jmps.2018.12.009			16	Materials Science, Multidisciplinary; Mechanics; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics; Physics	HP5PI	WOS:000461728600002		hybrid, Green Published			2022-02-06	
J	Jure, I; De Nicola, AF; Labombarda, F				Jure, Ignacio; De Nicola, Alejandro F.; Labombarda, Florencia			Progesterone effects on oligodendrocyte differentiation in injured spinal cord	BRAIN RESEARCH			English	Article						Progesterone; Oligodendrocytes precursor cells; TGF beta 1; Microglial cells; Remyelination; Spinal cord injury	CUPRIZONE-INDUCED DEMYELINATION; TRAUMATIC BRAIN-INJURY; MYELIN BASIC-PROTEIN; PROGENITOR CELLS; TGF-BETA; REMYELINATION FAILURE; CLINICAL-TRIAL; WHITE-MATTER; GLIAL-CELLS; EXPRESSION	Spinal cord lesions result in chronic demyelination as a consequence of secondary injury. Although oligodendrocyte precursor cells proliferate the differentiation program fails. Successful differentiation implies progressive decrease of transcriptional inhibitors followed by upregulation of activators. Progesterone emerges as an anti-inflammatory and pro-myelinating agent which improves locomotor outcome after spinal cord injury. In this study, we have demonstrated that spinal cord injury enhanced oligodendrocyte precursor cell number and decreased mRNA expression of transcriptional inhibitors (Id2, Id4, hes5). However, mRNA expression of transcriptional activators (Olig2, Nkx2.2, Sox10 and Mash1) was down-regulated 3 days post injury. Interestingly, a differentiation factor such as progesterone increased transcriptional activator mRNA levels and the density of Olig2-expressing oligodendrocyte precursor cells. The differentiation program is regulated by extracellular signals which modify transcriptional factors and epigenetic players. As TGF beta 1 is a known oligodendrocyte differentiation factor which is regulated by progesterone in reproductive tissues, we assessed whether TGF beta 1 could mediate progesterone remyelinating actions after the lesion. Notwithstanding that astrocyte, oligodendrocyte precursor and microglial cell density increased after spinal cord injury, the number of these cells which expressed TGF beta 1 remained unchanged regarding sham operated rats. However, progesterone treatment increased TGF beta 1 mRNA expression and the number of astrocytes and microglial TGF beta 1 expressing cells which would indirectly enhance oligodendrocyte differentiation. Therefore, TGF beta 1 arises as a potential mediator of progesterone differentiating effects on oligodendrocyte linage.	[Jure, Ignacio; De Nicola, Alejandro F.; Labombarda, Florencia] Inst Biol & Med Expt, Lab Neuroendocrine Biochem, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina; [De Nicola, Alejandro F.; Labombarda, Florencia] Univ Buenos Aires, Fac Med, Dept Human Biochem, Paraguay 2155 C1121, Buenos Aires, DF, Argentina		Labombarda, F (corresponding author), Inst Biol & Med Expt, Vuelta Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.	florlabombarda@gmail.com			Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [PICT 2012-0009]; National Research Council of ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 112 20120100016]; University of Buenos AiresUniversity of Buenos Aires [Ubacyt 20020100100089]	This work was supported by grants from the Ministry of Science and Technology (PICT 2012-0009), the National Research Council of Argentina (PIP 112 20120100016), the University of Buenos Aires (Ubacyt 20020100100089). These funding sources did not have a role either in the collection, analysis, and interpretation of data or in the writing of the report and in the decision to submit the paper for publication.	Allen RS, 2016, RESTOR NEUROL NEUROS, V34, P947, DOI 10.3233/RNN-160672; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aryanpour R, 2017, INT IMMUNOPHARMACOL, V51, P131, DOI 10.1016/j.intimp.2017.08.007; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Nicola AF, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12502; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dutta DJ, 2014, DEVELOPMENT, V141, P2414, DOI 10.1242/dev.106492; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Gago N, 2001, GLIA, V36, P295, DOI 10.1002/glia.1117; Garay L, 2011, NEUROSCIENCE, V192, P588, DOI 10.1016/j.neuroscience.2011.06.065; Garay LI, 2012, NEUROSCIENCE, V226, P40, DOI 10.1016/j.neuroscience.2012.09.032; Garay L, 2014, J NEUROIMMUNOL, V276, P89, DOI 10.1016/j.jneuroim.2014.08.619; Garcia-Ovejero D, 2014, J NEUROTRAUM, V31, P857, DOI 10.1089/neu.2013.3162; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Hornig J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003907; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang H, 2013, NEUROSCI BULL, V29, P155, DOI 10.1007/s12264-013-1314-2; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Ishii K, 2001, J NEUROSCI RES, V65, P500, DOI 10.1002/jnr.1180; JUNGTESTAS I, 1994, J STEROID BIOCHEM, V48, P145, DOI 10.1016/0960-0760(94)90261-5; Jurynczyk M, 2008, J NEUROL SCI, V265, P5, DOI 10.1016/j.jns.2007.09.007; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2000, NEUROSCI LETT, V288, P29, DOI 10.1016/S0304-3940(00)01191-5; Labombarda F, 2015, J STEROID BIOCHEM, V154, P274, DOI 10.1016/j.jsbmb.2015.09.011; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Liu AX, 2006, EMBO J, V25, P4833, DOI 10.1038/sj.emboj.7601352; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Maurya VK, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106542; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Misumi S, 2008, EUR J NEUROSCI, V28, P1049, DOI 10.1111/j.1460-9568.2008.06420.x; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Palazuelos J, 2014, J NEUROSCI, V34, P7917, DOI 10.1523/JNEUROSCI.0363-14.2014; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Roche SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165197; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Siegenthaler MM, 2007, J NEUROTRAUM, V24, P1631, DOI 10.1089/neu.2007.0302; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	74	9	9	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 1	2019	1708						36	46		10.1016/j.brainres.2018.12.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO1ZX	WOS:000460712300005	30527678				2022-02-06	
J	La Fountaine, MF; Hohn, AN; Testa, AJ; Weir, JP				La Fountaine, Michael F.; Hohn, Asante N.; Testa, Anthony J.; Weir, Joseph P.			Attenuation of Spontaneous Baroreceptor Sensitivity after Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; SYMPATHETIC NERVOUS SYSTEM; BAROREFLEX; PHASE-RECTIFIED SIGNAL AVERAGING	HEART-RATE-VARIABILITY; SPONTANEOUS BAROREFLEX; CARDIOVASCULAR MORTALITY; AUTONOMIC DYSFUNCTION; FOOTBALL; FREQUENCY; RECOVERY; IMPACT	Introduction Cardiovascular autonomic nervous system (CV-ANS) function is negatively impacted after concussion. The arterial baroreflex buffers pressor and depressor challenges through efferent modulation of cardiac chronotropism and inotropism, and peripheral vascular tone. Baroreceptor sensitivity (BRS) reflects the capacity of the CV-ANS to accommodate dynamic metabolic demands in the periphery. The impact of concussion on BRS has yet to be defined. Methods Cardiovascular autonomic nervous system assessment (e.g., electrocardiogram and beat-to-beat systolic blood pressure [SBP]) was performed the seated upright position at rest within 48 h (V1) of concussion and 1 wk later (V2) in 10 intercollegiate male athletes with concussion and 10 noninjured male athletes. Changes in HR, SBP, high- and low-frequency HR variabilities (HF-HRV and LF-HRV, respectively), LF-SBP variability and BRS for increasing (BRSn-Up) and decreasing (BRSn-Dn) SBP excursions, and overall BRS (BRSn-Avg) were assessed for differences at V1 and V2. Results The concussion (age, 20 +/- 1 yr; height, 1.79 +/- 0.14 m; weight, 83 +/- 10 kg) and control (age, 20 +/- 1 yr; height, 1.78 +/- 0.10 m; weight, 79 +/- 13 kg) groups were matched for demographics. Concussed athletes had a significantly reduced BRSn-Up, BRSn-Dn, and BRSn-Avg compared with controls at V1 or V2; these changes occurred without differences in conventional markers of CV-ANS function (e.g., HF-HRV, LF-HRV, LF-SBP), HR, or SBP at either visit. Conclusions Reduced BRS is a postconcussive consequence of CV-ANS dysfunction during the first postinjury week. Because SBP was similar between groups, it may be speculated that reduced BRS was not afferent in origin, but represents a postinjury consequence of the central nervous system after injury.	[La Fountaine, Michael F.; Hohn, Asante N.] Seton Hall Univ, Sch Hlth & Med Sci, S Orange, NJ 07079 USA; [La Fountaine, Michael F.] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, S Orange, NJ 07079 USA; [La Fountaine, Michael F.] Seton Hall Univ, Hackensack Meridian Sch Med, Dept Med Sci, Nutley, NJ USA; [La Fountaine, Michael F.] Seton Hall Univ, Hackensack Meridian Sch Med, Dept Neurol, Nutley, NJ USA; [Testa, Anthony J.] Seton Hall Univ, Ctr Sports Med, S Orange, NJ 07079 USA; [Weir, Joseph P.] Univ Kansas, Dept Hlth Sport & Exercise Sci, Lawrence, KS 66045 USA		La Fountaine, MF (corresponding author), Seton Hall Univ, Interprofess Hlth Sci IHS Campus, Nutley, NJ 07110 USA.	lafounmi@shu.edu	La Fountaine, Michael/Q-6769-2019		New Jersey Commission for Brain Injury Research Individual Research grant [CBIR16IRG025]	The preparation of this article was partially supported by the New Jersey Commission for Brain Injury Research Individual Research grant CBIR16IRG025. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation, and statement that results of the present study do not constitute endorsement by the ACSM.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Barons S, 1994, HLTH HAZARD EVALUATI; Bauer A, 2010, J ELECTROCARDIOL, V43, P649, DOI 10.1016/j.jelectrocard.2010.05.012; Bauer A, 2009, J ELECTROCARDIOL, V42, P602, DOI 10.1016/j.jelectrocard.2009.06.023; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Chapleau MW, 2001, ANN NY ACAD SCI, V940, P1; CHEN RYZ, 1982, AM J PHYSIOL, V243, pR18, DOI 10.1152/ajpregu.1982.243.1.R18; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DEBOER RW, 1987, AM J PHYSIOL, V253, pH680, DOI 10.1152/ajpheart.1987.253.3.H680; DeKosky ST, 2018, JAMA-J AM MED ASSOC, V319, P773, DOI 10.1001/jama.2017.20885; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Hamilton WF, 1936, J AMER MED ASSOC, V107, P853, DOI 10.1001/jama.1936.02770370017005; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; HUGHSON RL, 1993, CLIN PHYSIOL, V13, P663, DOI 10.1111/j.1475-097X.1993.tb00481.x; KIRCHHEIM HR, 1976, PHYSIOL REV, V56, P100, DOI 10.1152/physrev.1976.56.1.100; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; La Fountaine MF, 2018, INT J PSYCHOPHYSIOL, V132, P155, DOI 10.1016/j.ijpsycho.2017.11.016; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; La Fountaine MF, 2014, INT J CARDIOL, V172, pE511, DOI 10.1016/j.ijcard.2014.01.095; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Muller A, 2012, J ELECTROCARDIOL, V45, P77, DOI 10.1016/j.jelectrocard.2011.07.010; Prabhakar H, 2007, MINIM INVAS NEUROSUR, V50, P98, DOI 10.1055/s-2007-982505; Riley DO, 2015, BRAIN INJURY, V29, P154, DOI 10.3109/02699052.2014.965215; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Selden MA, 2009, AM J MED, V122, P811, DOI 10.1016/j.amjmed.2009.03.027; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Skrapari I, 2006, CURR DIABETES REV, V2, P329, DOI 10.2174/157339906777950589; Venkataramani AS, 2018, JAMA-J AM MED ASSOC, V319, P800, DOI 10.1001/jama.2018.0140; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072	39	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	APR	2019	51	4					792	797		10.1249/MSS.0000000000001833			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HP1TF	WOS:000461449700022	30407273				2022-02-06	
J	Parrington, L; Fino, PC; Swanson, CW; Murchison, CF; Chesnutt, J; King, LA				Parrington, Lucy; Fino, Peter C.; Swanson, Clayton W.; Murchison, Charles F.; Chesnutt, James; King, Laurie A.			Longitudinal Assessment of Balance and Gait After Concussion and Return to Play in Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						return to sport; wearable; inertial sensors; mild traumatic brain injury; postural control	TRAUMATIC BRAIN-INJURY; INTER-JOINT COORDINATION; ERROR SCORING SYSTEM; DUAL-TASK; DIVIDED-ATTENTION; EXECUTIVE DYSFUNCTION; POSTURAL STABILITY; RECOVERY-TIME; HIGH-SCHOOL; ABNORMALITIES	Context: In longitudinal studies tracking recovery after concussion, researchers often have not considered the timing of return to play (RTP) as a factor in their designs, which can limit the understanding of how RTP may affect the analysis and resulting conclusions. Objective: To evaluate the recovery of balance and gait in concussed athletes using a novel linear mixed-model design that allows an inflection point to account for changes in trend that may occur after RTP. Design: Cohort study. Setting: University athletics departments, applied field setting. Patients or Other Participants: Twenty-three concussed (5 women, 18 men; age = 20.1 +/- 1.3 years) and 25 healthy control (6 women, 19 men; age = 20.9 +/- 1.4 years) participants were studied. Participants were referred by their team athletic trainers. Main Outcome Measure(s): Measures consisted of the Balance Error Scoring System (BESS) total score, sway (instrumented root mean square of mediolateral sway), single-task gait speed, gait speed while simultaneously reading a handheld article (dual-task gait speed), dual-task cost of reading on gait speed, and dual-task cost of walking on reading. Results: We observed no significant effects or interactions for the BESS. Instrumented sway was worse in concussed participants, and a change in the recovery trend occurred after RTP. We observed group and time effects and group x time and group x RTP change interactions (P <= .046). No initial between-groups differences were found for single-task or dual-task gait. Both groups increased gait speed initially and then leveled off after the average RTP date. We noted time and RTP change effects and positive group x time interactions for both conditions (P <= .042) and a group x RTP change interaction for single-task gait speed (P= .005). No significant effects or interactions were present for the dual-task cost of reading on gait speed or the dual-task cost of walking on reading. Conclusions: Changes in the rate of recovery were coincident with the timing of RTP. Although we cannot suggest these changes were a result of the athletes returning to play, these findings demonstrate the need for further research to evaluate the effects of RTP on concussion recovery.	[Parrington, Lucy; Fino, Peter C.; Murchison, Charles F.; Chesnutt, James; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 Southwest Sam Jackson Pk Rd,L226, Portland, OR 97239 USA; [Swanson, Clayton W.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA		Parrington, L (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 Southwest Sam Jackson Pk Rd,L226, Portland, OR 97239 USA.	parringt@ohsu.edu	Swanson, Clayton W./AAU-1280-2020	Parrington, Lucy/0000-0001-8507-9974; Fino, Peter/0000-0002-8621-3706; Swanson, Clayton/0000-0002-2163-610X	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R21HD080398]	This study was supported by research grant R21HD080398 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (Dr King). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bleiberg Joseph, 2005, Neurosurgery, V56, pE1166; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Chen HL, 2015, J MED BIOL ENG, V35, P28, DOI 10.1007/s40846-015-0002-2; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Clark DJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00246; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00045; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Parrington L, 2018, SCAND J MED SCI SPOR, V28, P2436, DOI 10.1111/sms.13239; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; Schildbach B., 2010, P 12 INT C HUM COMP, P93, DOI [DOI 10.1145/1851600.1851619, 10.1145/1851600.1851619]; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	53	9	9	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2019	54	4					429	438		10.4085/1062-6050-46-18			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HY0LT	WOS:000467804100009	30933608	gold, Green Published			2022-02-06	
J	Wang, JT; Lin, J; Chen, Y; Welle, CG; Pfefer, TJ				Wang, Jianting; Lin, Jonathan; Chen, Yu; Welle, Cristin G.; Pfefer, T. Joshua			Phantom-based evaluation of near-infrared intracranial hematoma detector performance	JOURNAL OF BIOMEDICAL OPTICS			English	Article						near-infrared spectroscopy; standardization; hematoma detection; traumatic brain injury; light-tissue interaction; tissue phantoms	SUBARACHNOID HEMORRHAGE; OPTICAL-PROPERTIES; SPECTROSCOPY; BRAIN; DEVICE	Near-infrared spectroscopy (NIRS) is emerging as a rapid, low-cost approach for point-of-care triage of hematomas resulting from traumatic brain injury. However, there remains a lack of standardized test methods for benchtop performance assessment of these devices and incomplete understanding of relevant light-tissue interactions. We propose a phantom-based test method for systems operating near the 800-nm oxy-/deoxyhemoglobin isosbestic point and implement it to evaluate a clinical system. Semi-idealized phantom geometries are designed to represent epidural/subdural, subarachnoid, and intracerebral hemorrhages. Measurements of these phantoms are made with a commercial NIRS-based hematoma detector to quantify the effect of hematoma type, depth, and size, as well as measurement repeatability and detector positioning relative to the hematoma. Results indicated high sensitivity to epidural/subdural and subarachnoid hematomas. Intracerebral hematomas are detectable to a maximum depth of similar to 2.5 cm, depending on thickness and diameter. The maximum lateral detection area for the single-emitter/single-collector device studied here appears elliptical and decreases strongly with inclusion depth. Overall, this study provides unique insights into hematoma detector function and indicates the utility of modular polymer tissue phantoms in performance tests for emerging NIRS-based cerebral diagnostic technology. (C) The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License.	[Wang, Jianting; Lin, Jonathan; Welle, Cristin G.; Pfefer, T. Joshua] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Chen, Yu] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Welle, Cristin G.] Univ Colorado, Dept Neurosurg & Bioengn, Aurora, CO USA		Wang, JT (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	jianting.wang@fda.hhs.gov			FDA's Medical Countermeasures Initiative Regulatory Science Program [MCM 301]; Oak Ridge Institute for Science and Education (ORISE) program by Oak Ridge Associated Universities (ORAU)	The authors gratefully acknowledge support for this research from FDA's Medical Countermeasures Initiative Regulatory Science Program (MCM 301). The authors also acknowledge the support through Oak Ridge Institute for Science and Education (ORISE) program by Oak Ridge Associated Universities (ORAU).	Agrawal A, 2013, BIOMED OPT EXPRESS, V4, P1166, DOI 10.1364/BOE.4.001166; Bir SC, 2015, CLIN NEUROL NEUROSUR, V138, P99, DOI 10.1016/j.clineuro.2015.07.021; Boers AM, 2014, AM J NEURORADIOL, V35, P2279, DOI 10.3174/ajnr.A4042; BRADLEY WG, 1985, RADIOLOGY, V156, P99, DOI 10.1148/radiology.156.1.4001427; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Choi J, 2004, J BIOMED OPT, V9, P221, DOI 10.1117/1.1628242; Francis SV, 2005, J CLIN NEUROSCI, V12, P291, DOI 10.1016/j.jocn.2004.06.009; Goodsitt MM, 1998, MED PHYS, V25, P1385, DOI 10.1118/1.598404; HAYMAN LA, 1989, AM J ROENTGENOL, V153, P135, DOI 10.2214/ajr.153.1.135; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kessel B, 2007, INJURY, V38, P1065, DOI 10.1016/j.injury.2007.05.009; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Liu Y, 2018, BIOMED OPT EXPRESS, V9, P2810, DOI 10.1364/BOE.9.002810; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; McCollough CH, 2004, MED PHYS, V31, P2423, DOI 10.1118/1.1769632; Moffitt T, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2240972; Nahman D., 2015, U.S. Patent, Patent No. [US20150099980A1, 20150099980]; Prahl S.A., 1999, TABULATED MOLAR EXTI; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; Rao MG, 2016, J CLIN DIAGN RES, V10, pHC1, DOI 10.7860/JCDR/2016/19783.8141; Riley JD, 2012, BIOMED OPT EXPRESS, V3, P192, DOI 10.1364/BOE.3.000192; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wabnitz H, 2013, PROC SPIE, V8583, DOI 10.1117/12.2002438; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988; [No title captured]	28	9	10	0	2	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	APR	2019	24	4							045001	10.1117/1.JBO.24.4.045001			10	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	IS0YR	WOS:000481879600004	30989838	Green Published, gold			2022-02-06	
J	Hawkins, BE; Huie, JR; Almeida, C; Chen, JP; Ferguson, AR				Hawkins, Bridget E.; Huie, J. Russell; Almeida, Carlos; Chen, Jiapei; Ferguson, Adam R.			Data Dissemination: Shortening the Long Tail of Traumatic Brain Injury Dark Data	JOURNAL OF NEUROTRAUMA			English	Article						analytics; big data; data sharing; FAIR principles; traumatic brain injury	SPINAL-CORD-INJURY; COMMON DATA ELEMENTS; BIG-DATA; INCREASING VALUE; REDUCING WASTE; THERAPY; TBI; INFORMATICS; NEUROTRAUMA; KNOWLEDGE	Translation of traumatic brain injury (TBI) research findings from bench to bedside involves aligning multi-species data across diverse data types including imaging and molecular biomarkers, histopathology, behavior, and functional outcomes. In this review we argue that TBI translation should be acknowledged for what it is: a problem of big data that can be addressed using modern data science approaches. We review the history of the term big data, tracing its origins in Internet technology as data that are "big" according to the "4Vs" of volume, velocity, variety, veracity and discuss how the term has transitioned into the mainstream of biomedical research. We argue that the problem of TBI translation fundamentally centers around data variety and that solutions to this problem can be found in modern machine learning and other cutting-edge analytical approaches. Throughout our discussion we highlight the need to pull data from diverse sources including unpublished data ("dark data") and "long-tail data" (small, specialty TBI datasets undergirding the published literature). We review a few early examples of published articles in both the pre-clinical and clinical TBI research literature to demonstrate how data reuse can drive new discoveries leading into translational therapies. Making TBI data resources more Findable, Accessible, Interoperable, and Reusable (FAIR) through better data stewardship has great potential to accelerate discovery and translation for the silent epidemic of TBI.	[Hawkins, Bridget E.] Univ Texas Med Branch, Dept Anesthesiol, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA; [Huie, J. Russell; Almeida, Carlos; Chen, Jiapei; Ferguson, Adam R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Weill Inst Neurosci, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ferguson, Adam R.] SFVAHCS, San Francisco, CA USA		Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Neurol Surg, Box 0899,1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94143 USA.	adam.ferguson@ucsf.edu	; Hawkins, Bridget/H-4933-2015	Ferguson, Adam/0000-0001-7102-1608; Hawkins, Bridget/0000-0002-1887-3657	Darrell K. Royal Research Fund for Alzheimer's Disease; Mission Connect, a program of the TIRR Foundation; Moody Project for Translational TBI Research; NIH BD2K TCC Data Science RoAD-Trip Fellowship; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UG3NS106899, R01NS088475]; Department of Veterans AffairsUS Department of Veterans Affairs [1I01RX002245, I01RX002787]; Wings for Life Foundation; Craig H. Neilsen Foundation	We thank the Moody Project for Translational Traumatic Brain Injury Research Team for thoughtful discussions and sharing data. Supported in part by the Darrell K. Royal Research Fund for Alzheimer's Disease (BEH); Mission Connect, a program of the TIRR Foundation (BEH); Moody Project for Translational TBI Research (BEH); NIH BD2K TCC Data Science RoAD-Trip Fellowship (BEH); NIH/NINDS: UG3NS106899 (ARF), R01NS088475 (ARF); Department of Veterans Affairs: 1I01RX002245 (ARF), I01RX002787 (ARF); Wings for Life Foundation (ARF); and Craig H. Neilsen Foundation (ARF).	Adam NR, 2017, ANN NY ACAD SCI, V1387, P5, DOI 10.1111/nyas.13309; [Anonymous], 2017, J Neurotrauma, V34, pA1, DOI 10.1089/neu.2017.29011.abstracts; [Anonymous], 2019, NATURE, V565, P134, DOI 10.1038/d41586-019-00075-3; [Anonymous], 2017, Hosp Case Manag, V25, P1; [Anonymous], 2016, SPINAL CORD INJURY P; [Anonymous], 2018, J NEUROTRAUM, V35, pA2; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Bierer BE, 2017, NEW ENGL J MED, V376, P1684, DOI 10.1056/NEJMsb1616595; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Butte AJ, 2017, NAT BIOTECHNOL, V35, P720, DOI 10.1038/nbt.3934; Callahan A, 2017, EXP NEUROL, V295, P135, DOI 10.1016/j.expneurol.2017.05.012; Callahan A, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw040; Carroll HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186472; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chen B, 2016, CLIN PHARMACOL THER, V99, P285, DOI 10.1002/cpt.318; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Ferguson AR, 2014, NAT NEUROSCI, V17, P1442, DOI 10.1038/nn.3838; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Figueiredo AS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00327; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Grechkin M, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002477; Haas M, 2016, ALZHEIMERS DEMENT, V12, P1022, DOI 10.1016/j.jalz.2016.05.005; Haefeli J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42474; HAINES CJ, 1983, AUST NZ J OBSTET GYN, V23, P114, DOI 10.1111/j.1479-828X.1983.tb00177.x; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hemingway H, 2018, EUR HEART J, V39, P1481, DOI 10.1093/eurheartj/ehx487; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirst T.C., 2016, EVID BASED PRECLIN M, V3; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Hopewell S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000011.pub2; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Huie JR, 2018, CURR OPIN NEUROL, V31, P702, DOI 10.1097/WCO.0000000000000614; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Ioannidis JPA, 2017, JAMA-J AM MED ASSOC, V317, P1019, DOI 10.1001/jama.2017.0549; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Jagodnik KM, 2017, J BIOMED INFORM, V71, P49, DOI 10.1016/j.jbi.2017.05.006; Johnson G., 2009, VETS VIEW ANIMAL RES; Kepler CK, 2015, SPINAL CORD, V53, P763, DOI 10.1038/sc.2015.76; Khachaturian AS, 2013, ALZHEIMERS DEMENT, V9, P619, DOI [10.1016/j.jalz.2013.10.001, 10.1016/j.jalz.2013.09.001]; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2016, LANCET NEUROL, V15, P13, DOI 10.1016/S1474-4422(15)00339-7; Kordower JH, 2009, J NEUROSCI, V29, P11419, DOI 10.1523/JNEUROSCI.3764-09.2009; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Laney D, 2001, 3D DATA MANAGEMENT C; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mabray MC, 2016, J NEUROTRAUM, V33, P954, DOI 10.1089/neu.2015.4093; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Markel H, 2013, NEW ENGL J MED, V369, P794, DOI 10.1056/NEJMp1306553; Mayer-Schonberger V, 2018, J INTERN MED, V283, P418, DOI 10.1111/joim.12721; Mlinari A., 2017, BIOCHEM MEDICA, V27, P92; Neff EP, 2018, LAB ANIMAL, V47, P45, DOI 10.1038/laban.1405; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; Oldenburg H., 1665, PHILOS T ROY SOC LON, V1, P2, DOI [10.1098/rstl.1665.0002, DOI 10.1098/RSTL.1665.0001]; Payakachat N, 2016, PHARMACOECONOMICS, V34, P127, DOI 10.1007/s40273-015-0331-6; Rasmussen TE, 2016, J NEUROTRAUM, V33, P511, DOI 10.1089/neu.2016.29007.ter; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SEABURY S, 2018, OPEN, V1, DOI DOI 10.1001/JAMANETWORKOPEN.2018.0210; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Thompson HJ, 2015, ANNU REV NURS RES-SE, V33, P1, DOI 10.1891/0739-6686.33.1; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Watzlawick R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002468; Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zakrasek EC, 2017, SPINAL CORD, V55, P559, DOI 10.1038/sc.2017.10; ZWETSLOOT P, 2017, P P, V6, DOI DOI 10.7554/ELIFE.24260	89	9	9	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2020	37	22					2414	2423		10.1089/neu.2018.6192		MAR 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OP2MH	WOS:000462762300001	30794049	Green Published, hybrid			2022-02-06	
J	Lai, XL; Deng, ZF; Zhu, XG; Chen, ZH				Lai, Xian-Liang; Deng, Zhi-Feng; Zhu, Xin-Gen; Chen, Zhi-Hua			Apc gene suppresses intracranial aneurysm formation and rupture through inhibiting the NF-kappa B signaling pathway mediated inflammatory response	BIOSCIENCE REPORTS			English	Article							CEREBRAL ANEURYSM; EXPRESSION; CATENIN; PROGRESSION; ACTIVATION; PROTEIN; GROWTH; MCP-1	Background: Intracranial aneurysm (IA) is a critical acquired cerebrovascular disease that may cause subarachnoid hemorrhage, and nuclear factor-kappa B (NF-kappa B)-mediated inflammation is involved in the pathogenesis of IA. Adenomatous polyposis coli (Apc) gene is a tumor suppressor gene associated with both familial and sporadic cancer. Herein, the purpose of our study is to validate effect of Apc gene on IA formation and rupture by regulating the NF-kappa B signaling pathway mediated inflammatory response. Methods: We collected IA specimens (from incarceration of IA) and normal cerebral arteries (from surgery of traumatic brain injury) to examine expression of Apc and the NF-kappa B signaling pathway related factors (NF-kappa B p65 and I kappa B alpha). ELISA was used to determine levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta (IL-1 beta), and IL-6. IA model was established in rats, and Apc-siRNA was treated to verify effect of Apc on IA formation and rupture. Next, regulation of Apc on the NF-kappa B signaling pathway was investigated. Results: Reduced expression of Apc and I kappa B alpha, and increased expression of NF-kappa B p65 were found in IA tissues. MCP-1, TNF-alpha, IL-1 beta, and IL-6 exhibited higher levels in unruptured and ruptured IA, which suggested facilitated inflammatory responses. In addition, the IA rats injected with Apc-siRNA showed further enhanced activation of NF-kappa B signaling pathway, and up-regulated levels ofMCP-1, TNF-alpha, IL-1 beta, IL-6, MMP-2, and MMP-9 as well as extent of p65 phosphorylation in IA. Conclusion: Above all, Apc has the potential role to attenuate IA formation and rupture by inhibiting inflammatory response through repressing the activation of the NF-kappa B signaling pathway.	[Lai, Xian-Liang; Deng, Zhi-Feng; Zhu, Xin-Gen; Chen, Zhi-Hua] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China		Lai, XL (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China.	laixianliang_lxl@163.com					Aguera-Gonzalez S, 2017, CELL REP, V21, P181, DOI 10.1016/j.celrep.2017.09.020; Aoki T, 2010, GENE THER, V17, P1117, DOI 10.1038/gt.2010.60; Aoki T, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-34; Aoki T, 2012, NEUROSURGERY, V70, P1534, DOI 10.1227/NEU.0b013e318246a390; Benaissa A, 2015, J NEURORADIOLOGY, V42, P80, DOI 10.1016/j.neurad.2014.04.003; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Caranci F, 2013, EUR J RADIOL, V82, P1598, DOI 10.1016/j.ejrad.2012.12.026; Catrysse L, 2017, TRENDS CELL BIOL, V27, P417, DOI 10.1016/j.tcb.2017.01.006; Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274; Chalouhi N, 2012, J CEREBR BLOOD F MET, V32, P1659, DOI 10.1038/jcbfm.2012.84; Chang YS, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0297-2; Cheng WT, 2013, ASIAN PAC J TROP MED, V6, P570, DOI 10.1016/S1995-7645(13)60098-X; Dey A, 2008, CELL CYCLE, V7, P3759, DOI 10.4161/cc.7.23.7213; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Guo RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049701; Huang GL, 2013, MOL CELL BIOL, V33, P3416, DOI 10.1128/MCB.00384-13; Jayaraman T, 2008, VASC HEALTH RISK MAN, V4, P805, DOI 10.2147/VHRM.S2700; Johnston SC, 2008, STROKE, V39, P120, DOI 10.1161/STROKEAHA.107.495747; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Kim B, 2010, PATHOLOGY, V42, P58, DOI 10.3109/00313020903356392; Kurki MI, 2011, NEUROSURGERY, V68, P1667, DOI 10.1227/NEU.0b013e318210f001; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li Y, 2016, ONCOGENE, V35, P4558, DOI 10.1038/onc.2015.522; Liu W, 2016, ONCOGENE, V35, P5237, DOI 10.1038/onc.2016.58; Liu YF, 2014, CAN J NEUROL SCI, V41, P200, DOI 10.1017/S0317167100016589; Loewenstein JE, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/898052; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Makino H, 2012, STROKE, V43, P2450, DOI 10.1161/STROKEAHA.112.659821; Nishihara M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185923; Pawlowska E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041245; Pecina-Slaus N, 2011, BRAIN TUMOR PATHOL, V28, P223, DOI 10.1007/s10014-011-0030-8; Pecina-Slaus N, 2010, J NEURO-ONCOL, V97, P143, DOI 10.1007/s11060-009-0001-7; Sawyer DM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0654-z; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; Tulu S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1102-6; Tuo YL, 2015, EUR REV MED PHARMACO, V19, P3403; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Yamamoto R, 2017, BRIT J PHARMACOL, V174, P2085, DOI 10.1111/bph.13820; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhang HF, 2016, DNA CELL BIOL, V35, P96, DOI 10.1089/dna.2015.3105	42	9	9	0	3	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	MAR 29	2019	39		3						BSR20181909	10.1042/BSR20181909			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HU7IE	WOS:000465453700026	30808715	Green Published, gold, Green Submitted			2022-02-06	
J	Keegan, LC; Murdock, M; Suger, C; Togher, L				Keegan, Louise C.; Murdock, Macy; Suger, Caitlin; Togher, Leanne			Improving natural social interaction: Group rehabilitation after Traumatic Brain Injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic Brain Injury; Speech-language pathology; Group treatment; Social communication; Cognitive communication	COMMUNICATION PARTNERS; APHASIA; TBI; INTERVENTIONS; CONVERSATIONS; INDIVIDUALS; MANAGEMENT; EFFICACY	This pilot study investigates the outcomes of a group treatment approach for communication difficulties after Traumatic Brain Injury (TBI). This programme, entitled INSIGHT, focuses on group interactions and is designed to manage the various behaviours and impulses that may manifest with this injury. Additionally, INSIGHT promotes natural and authentic communication, encourages flexibility in interaction, and is client-centred. While group treatment services were provided through an outpatient University clinic, treatment occurred in authentic, contextualized everyday community environments. Participants in the treatment programme included six individuals who experienced chronic communication difficulties as a result of moderate to severe TBI. Three trained student clinicians provided the treatment, under the supervision of the principal investigator. Outcomes were examined at four intervals over one year. Goal Attainment Scaling (GAS) scores served as the primary quantitative outcome measure and a discourse analysis procedure, called Exchange Structure Analysis, served as a secondary qualitative outcome measure. Significant improvements in GAS scores and qualitative evidence of enhanced social communication skills indicated that the clients demonstrated improvements over this one-year period. This research indicates that the INSIGHT programme, a client-centred contextualized approach that promotes positive identity construction, shows promise as an effective model for treating chronic communication difficulties in individuals with TBI.	[Keegan, Louise C.] Moravian Coll, Dept Rehabil Sci, 1200 Main St, Bethlehem, PA 18018 USA; [Murdock, Macy] Atrium Hlth, Carolinas Rehabil, Charlotte, NC USA; [Suger, Caitlin] RehabCare, Westwood Hills Nursing & Rehabil Ctr, Wilkesboro, NC USA; [Togher, Leanne] Univ Sydney, Speech Pathol, Sydney, NSW, Australia		Keegan, LC (corresponding author), Moravian Coll, Dept Rehabil Sci, 1200 Main St, Bethlehem, PA 18018 USA.	keeganl@moravian.edu	Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748	Appalachian State University; American Speech-Language-Hearing Association	This work was supported by Appalachian State University: [Graduate Research Mentorship Award]; American Speech-Language-Hearing Association: [Advancing Academic Research Careers].	Adamovich B. B., 1992, SCALES COGNITIVE ABI; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2013, US ICF PRACT MAN US; Baines KA., 1999, ASSESSMENT LANGUAGE; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brain Injury Association of Pennsylvania (BIAPA), 2017, SUPP GROUP LIST; Braverman SE, 1999, BRAIN INJURY, V13, P405; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico J, 2015, APHASIOLOGY, V29, P400, DOI 10.1080/02687038.2014.945388; Dijkers MP, 2014, ARCH PHYS MED REHAB, V95, pS1, DOI 10.1016/j.apmr.2013.09.023; Eckert P., 2000, LINGUISTIC VARIATION; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Fadie H., 2017, CREATING CONVERSATIO; Halliday M., 2004, INTRO FUNCTIONAL GRA; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; Hoofien D, 2001, BRAIN INJURY, V15, P189; IBM Corp Released, 2016, IBM SPSS STAT WIND V; Kagan A, 2008, APHASIOLOGY, V22, P258, DOI 10.1080/02687030701282595; Keegan L. C., 2018, PERSPECTIVES AM SPEE, V3, P21, DOI [10.1044/persp3.SIG2.21, DOI 10.1044/PERSP3.SIG2.21]; Keegan LC, 2016, J INTERACT RES COM D, V7, P101, DOI 10.1558/jircd.v7i1.21570; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kovarsky Dana, 2007, Commun Med, V4, P53, DOI 10.1515/CAM.2007.029; Lanyon L, 2019, DISABIL REHABIL, V41, P1024, DOI 10.1080/09638288.2017.1419290; Lanyon LE, 2013, INT J SPEECH-LANG PA, V15, P359, DOI 10.3109/17549507.2012.752865; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Ownsworth T., 2014, NEUROPSYCHOLOGICAL R; Ownsworth T, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P340; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; Simmons-Mackie N, 2007, TOP LANG DISORD, V27, P5, DOI 10.1097/00011363-200701000-00003; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sykes CR, 2014, ARCH PHYS MED REHAB, V95, pS91, DOI 10.1016/j.apmr.2013.10.008; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Tregea S, 2013, APHASIOLOGY, V27, P581, DOI 10.1080/02687038.2013.796506; Turkstra LS, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-15-0060; Whyte J., 2017, M AM C REH MED ATL G; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	47	9	9	1	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP 13	2020	30	8					1497	1522		10.1080/09602011.2019.1591464		MAR 2019	26	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MT6UM	WOS:000463455100001	30905263				2022-02-06	
J	Houze-Cerfon, CH; Bounes, V; Guemon, J; Le Gourrierec, T; Geeraerts, T				Houze-Cerfon, Charles-Henri; Bounes, Vincent; Guemon, Johanna; Le Gourrierec, Thibault; Geeraerts, Thomas			Quality And Feasibility of Sonographic Measurement of the Optic Nerve Sheath Diameter to Estimate the Risk of Raised Intracranial Pressure After Traumatic Brain Injury in Prehospital Setting	PREHOSPITAL EMERGENCY CARE			English	Article						sonographic; traumatic brain injury; prehospital	ULTRASOUND; MANAGEMENT; ULTRASONOGRAPHY; EPIDEMIOLOGY	Objective: In patients with traumatic brain injury (TBI), early detection and subsequent prompt treatment of elevated intracranial pressure (ICP) is a challenge in the prehospital setting, because physical examination is limited in comatose patients and invasive device placement is not possible. The aim of this study was to evaluate the quality and feasibility of optic nerve sheath diameter (ONSD) measurements obtained during the prehospital management of patients with TBI. Methods: This study was a prospective, observational study of 23 patients with moderate and severe TBI during prehospital medical care. The primary endpoint was the quality of ONSD measurements expressed as the percentage of ONSD validated by the experts. Secondary endpoints included the feasibility of ONSD measurements as the percentage of ONSD performed and assessment by operators of ease and duration to perform. Results: Ultrasound ONSD was performed in 19 (82%) patients and 80% of ONSD measurements were validated by the experts. The ONSD measurements were possible in 15 (79%) cases. The physicians have assessed the ease of use at 8 (interquartile range [IQR] = 2.5-8) on 10 for and the median time to obtain ONSD measurement was 4 min (IQR = 3-5). ONSD measurement was performed in 12 (63%) cases during the transport and in 7 (37%) cases on scene, with 58% (n = 7) and 71% (n = 5) validated ONSD, respectively. The success rate in the helicopter was 43% compared to 80% in the ambulance. Conclusion: This study shows that it is feasible to obtain high-quality ONSD measurements in the management of patients with TBI in a prehospital setting. A randomized study evaluating the usefulness of ONSD to guide management of TBI in the prehospital phase may be of great interest.	[Houze-Cerfon, Charles-Henri; Bounes, Vincent; Le Gourrierec, Thibault] Univ Hosp Toulouse, Emergency Dept, SAMU 31, Toulouse, France; [Bounes, Vincent] Univ Paul Sabatier Toulouse 3, Lab Clin & Med Pharmacol, Toulouse, France; [Guemon, Johanna] Hosp Ctr Montauban, Emergency Dept, Montauban, France; [Geeraerts, Thomas] Univ Hosp Toulouse, Dept Anaesthesia & Intens Care, Toulouse, France; [Geeraerts, Thomas] INSERM, Toulouse NeuroImaging Ctr, UMR 1214, UPS,ToNIC, Toulouse, France		Houze-Cerfon, CH (corresponding author), Univ Hosp Toulouse, 7Emergency Dept, SAMU 31, Pavillon Louis Lareng,Pl Dr Baylac, F-31059 Toulouse 9, France.	houze-cerfon.ch@chu-toulouse.fr					Azema O, 2017, PANORAMA OCCITANIE A, P22; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Busch M, 2006, ACTA ANAESTH SCAND, V50, P754, DOI 10.1111/j.1399-6576.2006.01030.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dubourg J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-62; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Goldberg SA, 2015, PREHOSPITAL MANAGEME, V127; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Heegaard W, 2010, ACAD EMERG MED, V17, P624, DOI 10.1111/j.1553-2712.2010.00755.x; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; O'Dochartaigh D, 2015, INJURY, V46, P2093, DOI 10.1016/j.injury.2015.07.007; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; Qayyum H, 2013, EUR J EMERG MED, V20, P91, DOI 10.1097/MEJ.0b013e32835105c8; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rajajee V, 2011, OPTIC NERVE ULTRASOU; Roline Chad E, 2013, Air Med J, V32, P153, DOI 10.1016/j.amj.2012.10.013; Romagnuolo L, 2005, AM J EMERG MED, V23, P686, DOI 10.1016/j.ajem.2004.11.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schlachetzki F, 2012, CEREBROVASC DIS, V33, P262, DOI 10.1159/000334667; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x; Thotakura AK, 2017, NEUROCHIRURGIE, V63, P444, DOI 10.1016/j.neuchi.2017.06.001; Walcher F, 2006, BRIT J SURG, V93, P238, DOI 10.1002/bjs.5213	30	9	9	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	MAR 4	2019	23	2					277	283		10.1080/10903127.2018.1501444			7	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	HN8VL	WOS:000460474800016	30118380				2022-02-06	
J	Medlej, Y; Asdikian, R; Wadi, L; Salah, H; Dosh, L; Hashash, R; Karnib, N; Medlej, M; Darwish, H; Kobeissy, F; Obeid, M				Medlej, Yasser; Asdikian, Rita; Wadi, Lara; Salah, Houssein; Dosh, Laura; Hashash, Rabih; Karnib, Nabil; Medlej, Mohammad; Darwish, Hala; Kobeissy, Firas; Obeid, Makram			Enhanced setup for wired continuous long-term EEG monitoring in juvenile and adult rats: application for epilepsy and other disorders	BMC NEUROSCIENCE			English	Article						Electroencephalogram; Long-term; Continuous monitoring; Juvenile rats; Wired EEG; Swivel; Balance	BRAIN-INJURY; SEIZURES; MODELS	BackgroundThe electroencephalogram (EEG) is a widely used laboratory technique in rodent models of epilepsy, traumatic brain injury (TBI), and other neurological diseases accompanied by seizures. Obtaining prolonged continuous EEG tracings over weeks to months is essential to adequately answer research questions related to the chronobiology of seizure emergence, and to the effect of potential novel treatment strategies. Current EEG recording methods include wired and the more recent but very costly wireless technologies. Wired continuous long-term EEG in rodents remains the mainstay approach but is often technically challenging due to the notorious frequent EEG cable disconnections from the rodent's head, and to poor signal-to-noise ratio especially when simultaneously monitoring multiple animals. Premature EEG cable disconnections and cable movement-related artifacts result from the animal's natural mobility, and subsequent tension on the EEG wires, as well as from potential vigorous and frequent seizures. These challenges are often accompanied by injuries to the scalp, and result in early terminations of costly experiments.ResultsHere we describe an enhanced customized swivel-balance EEG-cage system that allows tension-free rat mobility. The cage setup markedly improves the safety and longevity of current existing wired continuous long-term EEG. Prevention of EEG cable detachments is further enhanced by a special attention to surgical electrode anchoring to the skull. In addition to mechanically preventing premature disconnections, the detailed stepwise approach to the electrical shielding, wiring and grounding required for artifact-free high signal-to-noise ratio recordings is also included. The successful application of our EEG cage system in various rat models of brain insults and epilepsy is described with illustrative high quality tracings of seizures and electrographic patterns obtained during continuous and simultaneous monitoring of multiple rats early and up to 3months post-brain insult.ConclusionOur simple-to-implement key modifications to the EEG cage setup allow the safe acquisition of substantial high quality wired EEG data without resorting to the still costly wireless technologies.	[Medlej, Yasser; Asdikian, Rita; Salah, Houssein; Karnib, Nabil; Darwish, Hala; Obeid, Makram] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Diana Tamari Sabbagh DTS Bldg,First Floor,117b, Beirut 11072020, Lebanon; [Wadi, Lara] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Dosh, Laura; Hashash, Rabih] Amer Univ Beirut, Anim Care Facil, Beirut, Lebanon; [Karnib, Nabil] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon; [Medlej, Mohammad] Lebanese Univ, Fac Fine Arts, Beirut, Lebanon; [Darwish, Hala] Amer Univ Beirut, Rafic Hariri Sch Nursing, Beirut, Lebanon; [Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Obeid, Makram] Amer Univ Beirut, Div Child Neurol, Dept Pediat & Adolescent Med, Med Ctr, Beirut, Lebanon		Obeid, M (corresponding author), Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Diana Tamari Sabbagh DTS Bldg,First Floor,117b, Beirut 11072020, Lebanon.; Obeid, M (corresponding author), Amer Univ Beirut, Div Child Neurol, Dept Pediat & Adolescent Med, Med Ctr, Beirut, Lebanon.	ym22@aub.edu.lb; mo21@aub.edu.lb	Wadi, Lara/AAQ-9903-2021; Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Darwish, Hala/0000-0001-5744-6466; Obeid, Makram/0000-0003-4349-674X	American University of Beirut, Beirut, Lebanon [MPP 320150]	This research project was funded by the American University of Beirut, Beirut, Lebanon, MPP 320150 to MO.	Appavu B, 2017, NEUROLOGIST, V22, P196, DOI 10.1097/NRL.0000000000000138; Assi L, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0467-0; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Bertram EH, 1997, BRAIN RES PROTOC, V2, P85, DOI 10.1016/S1385-299X(97)00033-0; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Leiser SC, 2011, BIOCHEM PHARMACOL, V81, P1408, DOI 10.1016/j.bcp.2010.10.002; Loscher W, 2002, EPILEPSY RES, V50, P1, DOI 10.1016/S0920-1211(02)00062-1; Lu XCM, 2015, J NEUROTRAUM, V32, P1621, DOI 10.1089/neu.2014.3766; Medlej Y, 2019, EPILEPSY BEHAV, V92, P332, DOI 10.1016/j.yebeh.2019.01.023; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Obeid M, 2014, EPILEPSY RES, V108, P806, DOI 10.1016/j.eplepsyres.2014.01.019; Obeid M, 2010, EPILEPSY BEHAV, V19, P278, DOI 10.1016/j.yebeh.2010.07.023; Pitkanen A, 2015, COLD SPRING HARB PER, V5, P10, DOI DOI 10.1101/CSHPERSPECT.A022822; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; van Luijtelaar G, 2016, J NEUROSCI METH, V260, P144, DOI 10.1016/j.jneumeth.2015.07.010; Williams PA, 2004, EPILEPSIA, V45, P1210, DOI 10.1111/j.0013-9580.2004.60403.x; Williams P, 2006, J NEUROSCI METH, V155, P39, DOI 10.1016/j.jneumeth.2005.12.035; Yang Z, 2016, JOVE-J VIS EXP, V116; Zayachkivsky A, 2015, JOVE-J VIS EXP, DOI 10.3791/52554	22	9	10	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	MAR 4	2019	20								8	10.1186/s12868-019-0490-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN9LU	WOS:000460521700001	30832562	Green Published, gold			2022-02-06	
J	Henry, JA; Thielman, EJ; Zaugg, TL; Kaelin, C; McMillan, GP; Schmidt, CJ; Myers, PJ; Carlson, KF				Henry, James A.; Thielman, Emily J.; Zaugg, Tara L.; Kaelin, Christine; McMillan, Garnett P.; Schmidt, Caroline J.; Myers, Paula J.; Carlson, Kathleen F.			Telephone-Based Progressive Tinnitus Management for Persons With and Without Traumatic Brain Injury: A Randomized Controlled Trial	EAR AND HEARING			English	Article						Clinical trial; Hearing disorders; Military Veterans; Rehabilitation; Telehealth; Tinnitus; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PSYCHOMETRIC PROPERTIES; HOSPITAL ANXIETY; HEARING-LOSS; SOLDIERS; QUESTIONNAIRE; DISTRESS; CONTACT; HEAD	Objectives: This randomized controlled trial evaluated the efficacy of delivering coping skills education from Progressive Tinnitus Management (PTM) by telephone (Tele-PTM). The trial followed a previous pilot study that showed positive results for Tele-PTM. Design: Participants included individuals with bothersome tinnitus (N = 205) located anywhere within the United States. A special emphasis was given to including individuals who had experienced one or more traumatic brain injuries (TBIs). Participants were randomized to either Tele-PTM intervention or 6-month wait-list control (WLC). The Tele-PTM intervention involved five telephone appointments-two led by an audiologist (teaching how to use therapeutic sound) and three by a psychologist (teaching coping skills derived from cognitive-behavioral therapy). It was hypothesized that Tele-PTM would be more effective than WLC in reducing functional effects of tinnitus as measured with the Tinnitus Functional Index. Additional outcome measures included the Self-Efficacy for Managing Reactions to Tinnitus questionnaire and the Hospital Anxiety and Depression Scale. The effect of Tele-PTM on outcomes was estimated using linear mixed models. Results: Overall results showed convincingly that the Tele-PTM group had significantly better outcomes than the WLC group. These results were consistent across all outcome measures, indicating not only a reduction of tinnitus functional distress but also increased self-efficacy. Improvements in measures of anxiety and depression were also observed. Tele-PTM participants in all TBI categories showed significant improvement. Conclusions: Results provide strong support for use of Tele-PTM methodology for persons with bothersome tinnitus, regardless of whether the person also has TBI symptoms. The effect size for Tele-PTM was high for the primary outcome measure, the Tinnitus Functional Index, and all other outcome measures showed significant improvement. Combined with our previous pilot study, the Tele-PTM method is validated for potential nationwide provision of tinnitus services.	[Henry, James A.; Thielman, Emily J.; Zaugg, Tara L.; Kaelin, Christine; McMillan, Garnett P.; Carlson, Kathleen F.] VA Portland Hlth Care Syst, Natl Ctr Rehabilitat Auditory Res, VA Rehabil Res & Dev, Portland, OR USA; [Henry, James A.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Schmidt, Caroline J.] VA Connecticut Healthcare Syst, Psychol Serv, West Haven, CT USA; [Schmidt, Caroline J.] VA Connecticut Healthcare Syst, Audiol Serv, West Haven, CT USA; [Schmidt, Caroline J.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Myers, Paula J.] James A Haley Vet Hosp, Dept Audiol, Tampa, FL USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, VA Hlth Serv Res & Dev Ctr Innovat, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA		Henry, JA (corresponding author), VA Portland Hlth Care Syst, NCRAR, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	james.henry@va.gov			VA Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [C7452I, C9247S]	This study was funded by VA Rehabilitation Research and Development Service (C7452I and C9247S).	Altman D.G., 1990, PRACTICAL STAT MED R; Andersson G, 2005, INT J AUDIOL, V44, P671, DOI 10.1080/14992020500266720; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; dos Santos GM, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514542657; Fitzmaurice G.M., 2004, APPL LONGITUDINAL AN, Ved; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Henry, 1996, Int Tinnitus J, V2, P9; Henry J. A., 2010, MANAGE YOUR TINNITUS; Henry JA, 2010, PROGRESSIVE TINNITUS; Henry JA, 2017, J SPEECH LANG HEAR R, V60, P1378, DOI 10.1044/2016_JSLHR-H-16-0126; Henry JA, 2016, EAR HEARING, V37, pE346, DOI 10.1097/AUD.0000000000000330; Henry JA, 2015, AM J AUDIOL, V24, P66, DOI 10.1044/2014_AJA-14-0042; Henry JA, 2012, J REHABIL RES DEV, V49, P1025, DOI 10.1682/JRRD.2010.07.0125; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaldo V, 2007, J PSYCHOSOM RES, V63, P195, DOI 10.1016/j.jpsychores.2007.04.007; Kroner-Herwig B, 2003, J PSYCHOSOM RES, V54, P381, DOI 10.1016/S0022-3999(02)00400-2; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2012, J REHABIL RES DEV, V49, pVII, DOI 10.1682/JRRD.2012.07.0126; Lipsey M. W., 2012, 20133000 NCSER; Lorig K R, 2001, Eff Clin Pract, V4, P256; Martinez-Devesa P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub3; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; Newman C W, 1998, J Am Acad Audiol, V9, P153; NEWMAN CW, 1988, EAR HEARING, V9, P81, DOI 10.1097/00003446-198804000-00006; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Ratnayake SAB, 2009, NOISE HEALTH, V11, P156, DOI 10.4103/1463-1741.53362; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; ROBINSON P, 1995, J FAM PRACTICE, V40, P352; Snow J, 2004, TINNITUS THEORY MANA, P16; VERNON JA, 1994, ARCH OTOLARYNGOL, V120, P547; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; WILSON PH, 1991, J SPEECH HEAR RES, V34, P197, DOI 10.1044/jshr.3401.197; Zaugg T. L., 2002, P 7 INT TINN SEM, P226; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	9	9	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	MAR-APR	2019	40	2					227	242		10.1097/AUD.0000000000000609			16	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	HM8YQ	WOS:000459769700002	29847413				2022-02-06	
J	Kennedy, JE; Lu, LH; Reid, MW; Leal, FO; Cooper, DB				Kennedy, Jan E.; Lu, Lisa H.; Reid, Matthew W.; Leal, Felix O.; Cooper, Douglas B.			Correlates of Depression in US Military Service Members With a History of Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			depression; mild TBI; PTSD; Military	POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSION; SUICIDE RISK; MENTAL-DISORDERS; PERSONNEL; DEPLOYMENT; SAMPLE; ASSOCIATION; AFGHANISTAN; PREVALENCE	Objectives Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) are identified as signature injuries of the Wars in Iraq and Afghanistan. Statistics have confirmed a high incidence of PTSD among military personnel with mild TBI (mTBI) who served in these conflicts. Although receiving less attention, individuals with a history of mTBI are also at increased risk for depressive disorders. This study examines the incidence and correlates of depression in service members with a history of mTBI received an average of 4-1/2 years prior to evaluation. Methods Retrospective analysis of 184 service members with a history of mTBI extracted from a data repository maintained at a military medical center. Results One-third of the sample (34.2%) was clinically diagnosed with a depressive disorder in the month preceding evaluation. Of those with depression, 81% (51 of 63) were also diagnosed with PTSD. Proportionately more women than men had depression. Depression was more common among those who were undergoing a Military Evaluation Board and those who served in more than three combat deployments. Conclusions Results confirm chronically elevated the rates of depressive disorders and PTSD comorbidity among service members with a history of mTBI. Depression screening and treatment within the Military Health System should remain a priority for service members reporting a remote history of mTBI. Individuals with chronic PTSD, women, service members undergoing MEB and those who served in greater than three combat deployments are at particular risk.	[Kennedy, Jan E.; Lu, Lisa H.; Reid, Matthew W.; Leal, Felix O.] Brooke Army Med Ctr, Dept Neurol, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA; [Cooper, Douglas B.] Audie L Murphy Mem VA Hosp, South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, Def & Vet Brain Injury Ctr, 7400 Merton Minter, San Antonio, TX 78229 USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA		Kennedy, JE (corresponding author), Brooke Army Med Ctr, Dept Neurol, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.				Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [W91YTZ-13-C-0015 20DEC18]; Office of the Secretary of Defense for Health Affairs	Defense and Veterans Brain Injury Center. Contract #W91YTZ-13-C-0015 20DEC18. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Brief DJ, 2011, J CONTEMP PSYCHOTHER, V41, P237, DOI 10.1007/s10879-011-9173-5; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Cohen GH, 2016, WOMEN HEALTH ISS, V26, P268, DOI 10.1016/j.whi.2016.01.001; Cole W. R., 2016, TRANSLATIONAL RES TR; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Greenberg J, 2012, MIL MED, V177, P60, DOI 10.7205/MILMED-D-12-00102; Gros DF, 2011, CONTEMP CLIN TRIALS, V32, P122, DOI 10.1016/j.cct.2010.10.003; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hasin DS, 2018, JAMA PSYCHIAT, V75, P336, DOI 10.1001/jamapsychiatry.2017.4602; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Kansagara D., 2013, COMPLICATIONS MILD T; Kantor V, 2017, CLIN PSYCHOL REV, V52, P52, DOI 10.1016/j.cpr.2016.12.001; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Leo P, 2016, TRANSLATIONAL RES TR; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Martinez P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011249; Mota NP, 2012, J PSYCHIATR RES, V46, P159, DOI 10.1016/j.jpsychires.2011.09.014; Obenaus A, 2016, ENCY MENTAL HLTH, P329; Office of the Under Secretary of Defense, 2009, DIR TYP MEM DTM 08 0; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Price M, 2015, J AFFECT DISORDERS, V186, P149, DOI 10.1016/j.jad.2015.06.012; Rusu C, 2016, CAN J PSYCHIAT, V61, p46S, DOI 10.1177/0706743716628856; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shen YC, 2012, AM J PUBLIC HEALTH, V102, pS80, DOI 10.2105/AJPH.2011.300425; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Swanson TM, 2017, PUBLIC HLTH REP, V21, P1; Vanderploeg RD, 2018, REHABIL PSYCHOL, V63, P194, DOI 10.1037/rep0000215	37	9	9	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			148	154		10.1093/milmed/usy321			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100025	30901404	Bronze			2022-02-06	
J	Stojanovski, S; Felsky, D; Viviano, JD; Shahab, S; Bangali, R; Burton, CL; Devenyi, GA; O'Donnell, LJ; Szatmari, P; Chakravarty, MM; Ameis, S; Schachar, R; Voineskos, AN; Wheeler, AL				Stojanovski, Sonja; Felsky, Daniel; Viviano, Joseph D.; Shahab, Saba; Bangali, Rutwik; Burton, Christie L.; Devenyi, Gabriel A.; O'Donnell, Lauren J.; Szatmari, Peter; Chakravarty, M. Mallar; Ameis, Stephanie; Schachar, Russell; Voineskos, Aristotle N.; Wheeler, Anne L.			Polygenic Risk and Neural Substrates of Attention-Deficit/Hyperactivity Disorder Symptoms in Youths With a History of Mild Traumatic Brain Injury	BIOLOGICAL PSYCHIATRY			English	Article						Attention-deficit/hyperactivity disorder; Diffusion tensor imaging; Magnetic resonance imaging; Polygenic score; Traumatic brain injury; Youths	PHILADELPHIA NEURODEVELOPMENTAL COHORT; DEFICIT HYPERACTIVITY DISORDER; DIFFUSION TENSOR; CHILDREN; ADOLESCENTS; PREVALENCE; ADHD; SECONDARY; DIAGNOSIS; ADULTS	BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a major sequela of traumatic brain injury (TBI) in youths. The objective of this study was to examine whether ADHD symptoms are differentially associated with genetic risk and brain structure in youths with and without a history of TBI. METHODS: Medical history, ADHD symptoms, genetic data, and neuroimaging data were obtained from a community sample of youths. ADHD symptom severity was compared between those with and without TBI (TBI n = 418, no TBI n = 3193). The relationship of TBI history, genetic vulnerability, brain structure, and ADHD symptoms was examined by assessing 1) ADHD polygenic score (discovery sample ADHD n = 19,099, control sample n = 34,194), 2) basal ganglia volumes, and 3) fractional anisotropy in the corpus callosum and corona radiata. RESULTS: Youths with TBI reported greater ADHD symptom severity compared with those without TBI. Polygenic score was positively associated with ADHD symptoms in youths without TBI but not in youths with TBI. The negative association between the caudate volume and ADHD symptoms was not moderated by a history of TBI. However, the relationship between ADHD symptoms and structure of the genu of the corpus callosum was negative in youths with TBI and positive in youths without TBI. CONCLUSIONS: The identification of distinct ADHD etiology in youths with TBI provides neurobiological insight into the clinical heterogeneity in the disorder. Results indicate that genetic predisposition to ADHD does not increase the risk for ADHD symptoms associated with TBI. ADHD symptoms associated with TBI may be a result of a mechanical insult rather than neurodevelopmental factors.	[Stojanovski, Sonja; Burton, Christie L.; Szatmari, Peter; Ameis, Stephanie; Schachar, Russell; Wheeler, Anne L.] Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Stojanovski, Sonja; Wheeler, Anne L.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Shahab, Saba; Voineskos, Aristotle N.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Szatmari, Peter; Ameis, Stephanie; Schachar, Russell; Voineskos, Aristotle N.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Felsky, Daniel; Viviano, Joseph D.; Shahab, Saba; Bangali, Rutwik; Voineskos, Aristotle N.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Inst, Toronto, ON, Canada; [Szatmari, Peter; Ameis, Stephanie] Ctr Addict & Mental Hlth, Margaret & Wallace McCain Ctr Child Youth & Famil, Toronto, ON, Canada; [Devenyi, Gabriel A.; Chakravarty, M. Mallar] McGill Univ, Douglas Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Devenyi, Gabriel A.; Chakravarty, M. Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Felsky, Daniel] Columbia Univ, Med Ctr, Dept Neurol, Ctr Translat & Computat Neuroimmunol, New York, NY USA; [Felsky, Daniel] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [O'Donnell, Lauren J.] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [O'Donnell, Lauren J.] Harvard Med Sch, Boston, MA USA		Wheeler, AL (corresponding author), Hosp Sick Children, SickKids Res Inst, 686 Bay St, Toronto, ON M5G 0A4, Canada.	anne.wheeler@sickkids.ca	Devenyi, Gabriel A/B-7819-2009; Voineskos, Aristotle/J-5014-2013; Ameis, Stephanie H./Q-4822-2018; O'Donnell, Lauren J./ABA-7546-2020; Hassan, Randa/AAW-3624-2021; Wheeler, Anne/V-1215-2019	Devenyi, Gabriel A/0000-0002-7766-1187; O'Donnell, Lauren J./0000-0003-0197-7801; Burton, Christie/0000-0002-8955-6528; Voineskos, Aristotle/0000-0003-0156-0395	SickKids Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH099167, U01CA199459, R03NS088301, P41 EB015898, P41 EB015902]; Centre for Addiction and Mental Health Foundation via the O'Brien Scholarship Fund; Academic Scholars Award from the Department of Psychiatry, University of Toronto;  [RC2MH089983];  [RC2MH089924]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U01CA199459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015898, P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH099167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS088301] Funding Source: NIH RePORTER	Support for the collection of the data sets was provided by Grant No. RC2MH089983 awarded to Raquel Gur and Grant No. RC2MH089924 awarded to Hakon Hakonarson. Funding was provided by the SickKids Foundation and the following National Institutes of Health grants: Grant No. R01MH099167 (to AV), Grant No. U01CA199459 (to LJO), Grant No. R03NS088301 (to LJO), Grant No. P41 EB015898 (National Center for Image-Guided Therapy), and Grant No. P41 EB015902 (Neuroimaging Analysis Center).; SA receives financial support from the Centre for Addiction and Mental Health Foundation via the O'Brien Scholarship Fund, and the Academic Scholars Award from the Department of Psychiatry, University of Toronto. All other authors report no biomedical financial interests or potential conflicts of interest.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ameis SH, 2016, AM J PSYCHIAT, V173, P1213, DOI 10.1176/appi.ajp.2016.15111435; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Calkins ME, 2015, J CHILD PSYCHOL PSYC, V56, P1356, DOI 10.1111/jcpp.12416; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chakravarty MM, 2006, NEUROIMAGE, V30, P359, DOI 10.1016/j.neuroimage.2005.09.041; Chen LZ, 2016, NEUROSCI BIOBEHAV R, V68, P838, DOI 10.1016/j.neubiorev.2016.07.022; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Hawi Z, 2015, MOL PSYCHIATR, V20, P289, DOI 10.1038/mp.2014.183; Hoogman M, 2017, LANCET PSYCHIAT, V4, P310, DOI 10.1016/S2215-0366(17)30049-4; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Merikangas KR, 2009, J AM ACAD CHILD PSY, V48, P367, DOI 10.1097/CHI.0b013e31819996f1; Miller G, 2010, SCIENCE, V327, P1437, DOI 10.1126/science.327.5972.1437; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Norton I, 2017, CANCER RES, V77, pE101, DOI 10.1158/0008-5472.CAN-17-0332; Oguz I, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00004; Onnink AMH, 2015, PROG NEURO-PSYCHOPH, V63, P14, DOI 10.1016/j.pnpbp.2015.04.008; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polimanti R, 2017, J NEUROTRAUM, V34, P781, DOI 10.1089/neu.2016.4550; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Purper-Ouakil D, 2011, PEDIATR RES, V69, p69R, DOI 10.1203/PDR.0b013e318212b40f; Ripley DL, 2014, BRAIN INJURY, V28, P1514, DOI 10.3109/02699052.2014.919530; Satterthwaite TD, 2016, NEUROIMAGE, V124, P1115, DOI 10.1016/j.neuroimage.2015.03.056; Satterthwaite TD, 2014, NEUROIMAGE, V86, P544, DOI 10.1016/j.neuroimage.2013.07.064; Shaw P, 2014, J AM ACAD CHILD PSY, V53, P780, DOI 10.1016/j.jaac.2014.05.003; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Stave EA, 2017, J CHILD NEUROL, V32, P458, DOI 10.1177/0883073816685652; Swanson James M, 2012, Int J Educ Psychol Assess, V10, P51; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; van Ewijk H, 2014, J AM ACAD CHILD PSY, V53, P790, DOI 10.1016/j.jaac.2014.05.001; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Wu ZM, 2017, NEUROPSYCHOPHARMACOL, V42, P572, DOI 10.1038/npp.2016.223; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	58	9	9	2	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0006-3223	1873-2402		BIOL PSYCHIAT	Biol. Psychiatry	MAR 1	2019	85	5					408	416		10.1016/j.biopsych.2018.06.024			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	HJ9UD	WOS:000457543700006	30119875	Green Accepted			2022-02-06	
J	Hlavac, N; VandeVord, PJ				Hlavac, Nora; VandeVord, Pamela J.			Astrocyte Mechano-Activation by High-Rate Overpressure Involves Alterations in Structural and Junctional Proteins	FRONTIERS IN NEUROLOGY			English	Article						astrocyte; overpressure; reactivity; cadherin; connexin; integrin; ICAM-1	TRAUMATIC BRAIN-INJURY; STRETCH-INDUCED INJURY; FOCAL ADHESION KINASE; REACTIVE ASTROGLIOSIS; CELL-PROLIFERATION; UP-REGULATION; CULTURED ASTROCYTES; GAP-JUNCTIONS; EXPRESSION; CONNEXIN43	Primary blast neurotrauma represents a unique injury paradigm characterized by high-rate overpressure effects on brain tissue. One major hallmark of blast neurotrauma is glial reactivity, notably prolonged astrocyte activation. This cellular response has been mainly defined in primary blast neurotrauma by increased intermediate filament expression. Because the intermediate filament networks physically interface with transmembrane proteins for junctional support, it was hypothesized that cell junction regulation is altered in the reactive phenotype as well. This would have implications for downstream transcriptional regulation via signal transduction pathways like nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B). Therefore, a custom high-rate overpressure simulator was built for in vitro testing using mechanical conditions based on intracranial pressure measurements in a rat model of blast neurotrauma. Primary rat astrocytes were exposed to isolated high-rate mechanical stimulation to study cell junction dynamics in relation to their mechano-activation. First, a time course for "classical" features of reactivity was devised by evaluation of glial fibrillary acidic protein (GFAP) and proliferating cell nuclear antigen (PCNA) expression. This was followed by gene and protein expression for both gap junction (connexins) and anchoring junction proteins (integrins and cadherins). Signal transduction analysis was carried out by nuclear localization of two molecules, NF-kappa B p65 and mitogen-activated protein kinase (MAPK) p38. Results indicated significant increases in connexin-43 expression and PCNA first at 24 h post-overpressure (p < 0.05), followed by structural reactivity (via increased GFAP, p < 0.05) corresponding to increased anchoring junction dynamics at 48 h post-overpressure (p < 0.05). Moreover, increased phosphorylation of focal adhesion kinase (FAK) was observed in addition to increased nuclear localization of both p65 and p38 (p < 0.05) during the period of structural reactivity. To evaluate the transcriptional activity of p65 in the nucleus, electrophoretic mobility shift assay was conducted for a binding site on the promoter region for intracellular adhesion molecule-1 (ICAM-1), an antagonist of tight junctions. A significant increase in the interaction of nuclear proteins with the NF-kappa B site on the ICAM-1 corresponded to increased gene and protein expression of ICAM-1 (p < 0.05). Altogether, these results indicate multiple targets and corresponding signaling pathways which involve cell junction dynamics in the mechano-activation of astrocytes following high-rate overpressure.	[Hlavac, Nora; VandeVord, Pamela J.] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [VandeVord, Pamela J.] Salem Vet Affairs Med Ctr, Dept Res, Salem, VA 24153 USA		VandeVord, PJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.; VandeVord, PJ (corresponding author), Salem Vet Affairs Med Ctr, Dept Res, Salem, VA 24153 USA.	pvord@vt.edu					Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; AKIYAMA H, 1993, ACTA NEUROPATHOL, V85, P628, DOI 10.1007/BF00334673; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Bailey ZS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00064; Bailey ZS, 2015, NEUROSCI LETT, V604, P119, DOI 10.1016/j.neulet.2015.07.035; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bauman RA, 1997, TOXICOLOGY, V121, P65, DOI 10.1016/S0300-483X(97)03656-1; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen J, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.44; Chi Y, 2016, REDOX BIOL, V9, P198, DOI 10.1016/j.redox.2016.08.008; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Floyd CL, 2004, J NEUROTRAUM, V21, P205, DOI 10.1089/089771504322778668; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Golubovskaya VM, 2013, MOL CANCER THER, V12, P162, DOI 10.1158/1535-7163.MCT-12-0701; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hampton Carolyn E, 2013, Biomed Sci Instrum, V49, P312; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Hlavac Nora, 2015, Biomed Sci Instrum, V51, P439; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Johnson KM, 2015, NEUROSCI LETT, V600, P104, DOI 10.1016/j.neulet.2015.06.013; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Lafrenaye AD, 2010, J NEUROCHEM, V115, P269, DOI 10.1111/j.1471-4159.2010.06926.x; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x; Liu B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07008; Logan NJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55618; Lutton EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03309-4; Malric L, 2017, ONCOTARGET, V8, P86947, DOI 10.18632/oncotarget.20372; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Mattern Ralph-Heiko, 2005, Cancer Ther, V3A, P325; Melotti P, 2001, GENE THER, V8, P1436, DOI 10.1038/sj.gt.3301533; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mui KL, 2016, J CELL SCI, V129, P1093, DOI 10.1242/jcs.183699; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nathan FM, 2017, NEURAL REGEN RES, V12, P1964, DOI 10.4103/1673-5374.221144; Nayak A, 2013, BIOANALYSIS-ADV MAT, V2, P77, DOI 10.1007/978-1-4614-4376-6_6; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nishio T, 2005, NEUROSCIENCE, V132, P87, DOI 10.1016/j.neuroscience.2004.12.028; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Pan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104335; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Peng H, 2008, DEV NEUROBIOL, V68, P559, DOI 10.1002/dneu.20593; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prochnow N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00031; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; Renault-Mihara F, 2011, EMBO MOL MED, V3, P682, DOI 10.1002/emmm.201100179; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Rovegno M, 2015, GLIA, V63, P1185, DOI 10.1002/glia.22808; Russell-Puleri S, 2017, AM J PHYSIOL-HEART C, V312, pH485, DOI 10.1152/ajpheart.00035.2016; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030; Sawai H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-37; Schwartz MA, 2001, J CELL SCI, V114, P2553; SHRIKANT P, 1994, J NEUROIMMUNOL, V51, P209, DOI 10.1016/0165-5728(94)90083-3; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song DL, 2010, ACTA BIOCH BIOPH SIN, V42, P472, DOI 10.1093/abbs/gmq047; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Theodoric N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047311; Tittarelli A, 2015, BRIT J CANCER, V113, P259, DOI 10.1038/bjc.2015.162; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Wang JHC, 2008, INT REV CEL MOL BIO, V271, P301, DOI 10.1016/S1937-6448(08)01207-0; Wang LQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04269-7; Weaver LC, 2015, EXP NEUROL, V271, P409, DOI 10.1016/j.expneurol.2015.07.003; WEBER F, 1994, BRAIN, V117, P59, DOI 10.1093/brain/117.1.59; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu XH, 2013, MOL CELL BIOCHEM, V384, P155, DOI 10.1007/s11010-013-1793-5; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Xia YF, 2001, BIOCHEM BIOPH RES CO, V289, P851, DOI 10.1006/bbrc.2001.6067; Xie X, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-38; Yamada K, 2005, HEART RHYTHM, V2, pS139, DOI [10.1016/j.hrthm.2005.02.433, DOI 10.1016/J.HRTHM.2005.02.433]; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Young SRL, 2010, BONE, V47, P74, DOI 10.1016/j.bone.2010.03.014; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422; Zhu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27983; Zou J, 2011, NEUROCHEM INT, V58, P404, DOI 10.1016/j.neuint.2010.12.018	131	9	9	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 22	2019	10								99	10.3389/fneur.2019.00099			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM3MO	WOS:000459378000001	30853931	Green Published, gold			2022-02-06	
J	Yang, WC; Wang, Q; Chi, LT; Wang, YZ; Cao, HL; Li, WZ				Yang, Wan-Chao; Wang, Qi; Chi, Lai-Ting; Wang, Yue-Zhen; Cao, Hong-Ling; Li, Wen-Zhi			Therapeutic hypercapnia reduces blood-brain barrier damage possibly via protein kinase C epsilon in rats with lateral fluid percussion injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Hypercapnia; Traumatic brain injury; Protein kinases; Blood-brain barrier	CEREBRAL-ISCHEMIA; PERMISSIVE HYPERCAPNIA; ENDOTHELIAL-CELLS; FAMILY-MEMBERS; CARBON-DIOXIDE; HYPOXIA; PKC; ACTIVATION; APOPTOSIS; PRESSURE	Background: This study investigated whether therapeutic hypercapnia (TH) ameliorated blood-brain barrier (BBB) damage and improved the neurologic outcome in a rat model of lateral fluid percussion injury (FPI), and explored the possible underlying mechanism. Methods: Rats underwent lateral FPI and received inhalation of 30%O-2-70%N-2 or 30%O-2-N-2 plus CO2 to maintain arterial blood CO2 tension (PaCO2) between 80 and 100 mmHg for 3 h. To further explore the possible mechanisms for the protective effects of TH, a PKC inhibitor staurosporine or PKC alpha beta inhibitor GO6976 was administered via intracerebral ventricular injection. Results: TH significantly improved neurological function 24 h, 48 h, 7 d, and 14 d after FPI. The wet/dry ratio, computed tomography values, Evans blue content, and histological lesion volume were significantly reduced by TH. Moreover, numbers of survived neurons and the expression of tight junction proteins (ZO-1, occludin, and claudin-5) were significantly elevated after TH treatment at 48-h post-FPI. TH significantly increased the expression of protein kinase C epsilon (PKC epsilon) at 48-h post-FPI, but did not significantly change the expression of PKC alpha and PKC beta II. PKC inhibitor staurosporine (but not the selective PKC alpha beta inhibitor-GO6976) inhibited the protective effect of TH. Conclusions: Therapeutic hypercapnia is a promising candidate that should be further evaluated for clinical treatment. It not only protects the traumatic penumbra from secondary injury and improves histological structure but also maintains the integrity of BBB and reduces neurologic deficits after trauma in a rat model of FPI.	[Yang, Wan-Chao; Wang, Qi; Chi, Lai-Ting; Wang, Yue-Zhen; Cao, Hong-Ling; Li, Wen-Zhi] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Li, Wen-Zhi] Harbin Med Univ, Anesthesiol Key Lab, Dept Educ, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China		Li, WZ (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China.; Li, WZ (corresponding author), Harbin Med Univ, Anesthesiol Key Lab, Dept Educ, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.	Dachao_1980@126.com; Wenzhili9@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400989]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015 M581474]	This study was supported by the National Natural Science Foundation of China (grant no. 81400989) and China Postdoctoral Science Foundation Grant (grant no. 2015 M581474).	Abdullah Z, 2016, BBA-MOL BASIS DIS, V1862, P1354, DOI 10.1016/j.bbadis.2016.03.014; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Bright R, 2008, NEUROSCI LETT, V441, P120, DOI 10.1016/j.neulet.2008.05.080; Capuani B, 2016, PHARMACOL RES, V111, P659, DOI 10.1016/j.phrs.2016.07.029; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Fleegal MA, 2005, AM J PHYSIOL-HEART C, V289, pH2012, DOI 10.1152/ajpheart.00495.2005; Gao W, 2015, ANESTHESIOLOGY, V122, P1235, DOI 10.1097/ALN.0000000000000627; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jia J, 2007, J NEUROSURG ANESTH, V19, P18, DOI 10.1097/01.ana.0000211020.88431.e2; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim YA, 2010, NEUROSCI LETT, V468, P254, DOI 10.1016/j.neulet.2009.11.007; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Lange-Asschenfeldt C, 2004, J CEREBR BLOOD F MET, V24, P636, DOI 10.1097/01.WCB.0000121235.42748.BF; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mylroie H, 2015, CARDIOVASC RES, V106, P509, DOI 10.1093/cvr/cvv131; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; Petridis AK, 2010, ACTA NEUROCHIR, V152, P2143, DOI 10.1007/s00701-010-0761-z; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sonobe Y, 2016, J BIOL CHEM, V291, P12573, DOI 10.1074/jbc.A109.025940; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Swannie Helen C, 2002, Curr Oncol Rep, V4, P37, DOI 10.1007/s11912-002-0046-7; Tao T, 2013, BRAIN RES, V1533, P52, DOI 10.1016/j.brainres.2013.08.014; Teshima Y, 2003, STROKE, V34, P1796, DOI 10.1161/01.STR.0000077017.60947.AE; Tregub P, 2015, J STROKE CEREBROVASC, V24, P381, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.003; Urwin L, 2004, EMERG MED J, V21, P119, DOI 10.1136/emj.2003.005009; VANNUCCI RC, 1995, PEDIATRICS, V95, P868; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang LL, 2012, ANTIVIR RES, V93, P270, DOI 10.1016/j.antiviral.2011.12.004; Yang TZ, 2006, PHARM RES-DORDR, V23, P291, DOI 10.1007/s11095-005-9143-2; Yang WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167359; Yang ZG, 2012, BBA-MOL CELL RES, V1823, P950, DOI 10.1016/j.bbamcr.2011.12.012; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	57	9	10	1	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 13	2019	16								36	10.1186/s12974-019-1427-2			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	HL4AZ	WOS:000458658800002	30760300	gold, Green Published			2022-02-06	
J	Lin, WJ; Harnod, T; Lin, CL; Kao, CH				Lin, Wei-Jun; Harnod, Tomor; Lin, Cheng-Li; Kao, Chia-Hung			Mortality Risk and Risk Factors in Patients with Posttraumatic Epilepsy: A Population-Based Cohort Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						cohort study; mortality; National Health Insurance; posttraumatic epilepsy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEALTH-INSURANCE; LONG-TERM; EPILEPTOGENESIS; COUNTRIES; SEIZURES	Aim: Use the National Health Insurance Research Database of Taiwan to determine whether patients with posttraumatic epilepsy (PTE) have an increased risk of mortality. Methods: Patients 20 years old ever admitted because of head injury (per International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 850-854 and 959.01) during 2000-2012 were enrolled into a traumatic brain injury (TBI) cohort. The TBI cohort was divided into with PTE (ICD-9-CM code 345) and posttraumatic nonepilepsy (PTN) cohorts. We compared the PTE and PTN cohorts in terms of age, sex, and comorbidities. We calculated adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of all-cause mortality risk in these cohorts. Results: Patients with PTE had a higher incidence rate (IR) of mortality than did patients with TBI alone (IR per 1000 person-years: 71.8 vs. 27.6), with an aHR 2.31 (95% CI = 1.96-2.73). Patients with PTE aged 20-49, 50-64, and 65 years had, respectively, 2.78, 4.14, and 2.48 times the mortality risk of the PTN cohort. Patients with any comorbidity and PTE had 2.71 times the mortality risk as patients in the PTN cohort. Furthermore, patients with PTE had 28.2 increased hospital days and 7.85 times as frequent medical visits per year compared with the PTN cohort. Conclusion: Taiwanese patients with PTE had approximately 2 times the mortality risk and an increased medical burden compared to patients with TBI only. Our findings provide crucial information for clinicians and the government to improve TBI outcomes.	[Lin, Wei-Jun] China Med Univ Hosp, Dept Emergency, Taichung 404, Taiwan; [Harnod, Tomor] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Gen Hosp, Dept Neurosurg, Hualien 970, Taiwan; [Harnod, Tomor] Tzu Chi Univ, Coll Med, Hualien 970, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung 404, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung 404, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung 413, Taiwan		Kao, CH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung 404, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung 404, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung 404, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung 404, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung 413, Taiwan.	bbgun1208@gmail.com; tomorha@yahoo.com.tw; orangechengli@gmail.com; d10040@mail.cmuh.org.tw		Kao, Chia-Hung/0000-0002-6368-3676	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW108-TDU-B-212-133004]; China Medical University Hospital [CMU106-ASIA-12, DMR-107-192]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133004); China Medical University Hospital (CMU106-ASIA-12, DMR-107-192); Academia Sinica Stroke Biosignature Project (BM10701010021); MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-); Tseng-Lien Lin Foundation, Taichung, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2015, TRAUM BRAIN INJ US E; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Huang N, 2006, PUBLIC HEALTH, V120, P1055, DOI 10.1016/j.puhe.2006.06.011; Institute of Medicine, 2009, LONG TERM CONS TRAUM; Keezer MR, 2016, NEUROLOGY, V86, P704, DOI 10.1212/WNL.0000000000002390; Levira F, 2017, EPILEPSIA, V58, P6, DOI 10.1111/epi.13603; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Lusardi TA, 2015, NEUROPHARMACOLOGY, V99, P500, DOI 10.1016/j.neuropharm.2015.08.007; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Rao VR, 2015, SEMIN NEUROL, V35, P57, DOI 10.1055/s-0035-1544239; Shu CC, 2011, J HOSP MED, V6, P378, DOI [10.1002/Thm.896, 10.1002/jhm.896]; Uski J, 2018, NEUROLOGY, V91, pE878, DOI 10.1212/WNL.0000000000006077; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Ying YW, 2008, CULT DIVERS ETHN MIN, V14, P29, DOI 10.1037/1099-9809.14.1.29	21	9	9	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB 2	2019	16	4							589	10.3390/ijerph16040589			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	HO3FK	WOS:000460804900068	30781634	gold, Green Submitted, Green Published			2022-02-06	
J	Tierney, GJ; Simms, C				Tierney, Gregory J.; Simms, Ciaran			Predictive Capacity of the MADYMO Multibody Human Body Model Applied to Head Kinematics during Rugby Union Tackles	APPLIED SCIENCES-BASEL			English	Article						concussion; sport; computational modelling	HUMAN MOTION; TIME; RECONSTRUCTION; ACCELERATION; PLAYERS	Multibody models have not yet been evaluated for reconstructing head kinematics during sports impacts. Accordingly, the goal of this study was to utilise whole-body motion data from twenty upper and mid/lower trunk rugby shoulder tackles recorded in a marker-based 3D motion analysis laboratory to assess the MADYMO human body passive ellipsoid model for head kinematic reconstruction. Head linear and angular velocity during the tackle for the multibody model predictions and 3D motion laboratory measures were recorded for the ball carrier. Examined were the linear and angular velocity, as well as the absolute and percentage differences. For upper trunk tackles, the median percentage error (with quartiles) for the MADYMO predictions were 10% (6% to 45%) and 23% (16% to 39%) for change in head linear and angular velocity, respectively. For mid/lower trunk tackles, the median percentage error (with quartiles) for the MADYMO predictions were 46% (33% to 63%) and 60% (53% to 123%) for change in head linear and angular velocity, respectively. In conclusion, the model is currently unsuitable for reconstruction of head kinematics during individual rugby union tackle cases.	[Tierney, Gregory J.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9NL, W Yorkshire, England; [Tierney, Gregory J.; Simms, Ciaran] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin D02 PN40, Ireland		Tierney, GJ (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9NL, W Yorkshire, England.; Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin D02 PN40, Ireland.	g.tierney@leeds.ac.uk; csimms@tcd.ie		Tierney, Gregory/0000-0002-4666-4473; Simms, Ciaran/0000-0001-5564-1620	Irish Research CouncilIrish Research Council for Science, Engineering and Technology [202835]	This research was funded by the Irish Research Council (Grant NO: 202835).	Bonnoit J, 1994, MEMOIRE DEA U PARIS; Bonnoit J., 1995, SAE TECHNICAL PAPER; BOUQUET R, 1994, FOURTEENTH INTERNATIONAL TECHNICAL CONFERENCE ON ENHANCED SAFETY OF VEHICLES, PROCEEDINGS, VOLS 1 AND 2, P100; Cazzola D., 2015, P ISBS C P ARCH POIT, P1406; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Elliott JR, 2012, P I MECH ENG K-J MUL, V226, P266, DOI 10.1177/1464419311430176; Forman Jason L, 2015, Stapp Car Crash J, V59, P401; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Ghanouchi S., 1993, P 1993 INT C BIOM IM; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; McIntosh A., 2007, P ENH SAF VEH C; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Parent DP, 2011, INT J CRASHWORTHINES, V16, P633, DOI 10.1080/13588265.2011.616114; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Richards JG, 1999, HUM MOVEMENT SCI, V18, P589, DOI 10.1016/S0167-9457(99)00023-8; Simms C.K., 2015, P INT RES COUNC BIOM, P180, DOI DOI 10.1002/NET.21589; Simms CK., 2016, ISBS C P ARCH, DOI DOI 10.1016/J.PUHE.2015.10.038; Talantikite Y., 1998, P C ENH SAF VEH WIND; Tierney G.J., 2017, IRCOBI C ANTW BELG, P703; Tierney G.J., 2016, P IRCOBI C P MAL SPA, P381; Tierney GJ, 2019, J SPORT SCI, V37, P262, DOI 10.1080/02640414.2018.1494952; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P16, DOI 10.1177/1747954117711866; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney GJ, 2018, J SCI MED SPORT, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; TNO, 2015, MAD HUM BOD MOD MAN, P103; Van Hooijdonk, 2012, IRCOBI C SEPT 12 14, P622; Viano D. C, 1989, SAE TECHNICAL PAPER; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	37	9	9	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	FEB 2	2019	9	4							726	10.3390/app9040726			9	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	HO1UL	WOS:000460696500112		gold, Green Published			2022-02-06	
J	Kroshus, E; Qu, PP; Chrisman, SPD; Schwien, C; Herring, SA; Rivara, FP				Kroshus, Emily; Qu, Pingping; Chrisman, Sara P. D.; Schwien, Christina; Herring, Stanley A.; Rivara, Frederick P.			Parental concern about concussion risk for their children	SOCIAL SCIENCE & MEDICINE			English	Article						concussion; Parents; Health threat; Socioeconomic status	SOCIOECONOMIC-STATUS; UNITED-STATES; HIGH-SCHOOL; PEDIATRIC CONCUSSION; HEALTH; PARTICIPATION; SPORT; TIME	Purpose: Assess demographic patterns of parental concern or worry about concussion for their children; compare parent worry about concussion to worry about other health threats. Methods: Survey data were obtained using a probability-based nationally representative cross-sectional online survey of parents (n = 1025, 52% response rate). The association between family demographic characteristics and parent worry about concussion was assessed using multivariate logistic regression. The extent to which parents were worried about concussion was compared to worry about 14 other pediatric health threats. Patterns of worry about all measured health threats were modeled using latent class analyses, with comparisons made by parent demographic characteristics. Results: Around half of parents (51%) were worried about child's risk of concussion (responses of "very worried" or "somewhat worried"), statistically indistinguishable to the amount worried about risk of car crashes (55%) and anxiety (54%). Parents were more worried about screen time (71%) and bullying (57%) than concussion. In a multivariate logistic regression model with step-wise variable selection, there was statistically significantly greater worry about concussion among parents who were less educated, less affluent and who identified as Hispanic or Black. The latent class analysis resulted in three groups: high, moderate, and low worry about all health threats. There were significantly higher odds of being in the high worry group as compared to the moderate or low worry group among parents who were less educated and of Hispanic ethnicity. Conclusions: Many parents are worried about concussion, and this worry is greatest among the most socio-economically disadvantaged parents. Further research is needed to determine the cause of this difference. Such work can identify whether there are appropriate individual or community-level targets for intervention to improve the ability of parents to understand and address the potential threat of concussion to their child.	[Kroshus, Emily; Qu, Pingping; Chrisman, Sara P. D.; Schwien, Christina; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily; Rivara, Frederick P.] Univ Washington, Seattle, WA 98195 USA; [Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Chrisman, Sara P. D.] Univ Washington, Div Adolescent Med, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Kroshus, E (corresponding author), 2001 8th Ave, Seattle, WA 98105 USA.	ekroshus@u.washington.edu		Kroshus, Emily/0000-0002-7484-2601; Chrisman, Sara/0000-0001-5373-7223	Seattle Children's Hospital Academic Enrichment Fund; Seattle Pediatric Concussion Research Collaborative; The Sports Institute at UW Medicine	Funding for this project was provided by the Seattle Children's Hospital Academic Enrichment Fund, the Seattle Pediatric Concussion Research Collaborative, and the The Sports Institute at UW Medicine.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Agyemang, 2017, J MULTIDISCIPLINARY, V9, P45; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Aust CF, 1996, JOURNALISM MASS COMM, V73, P787, DOI 10.1177/107769909607300403; Bardeen JR, 2013, BEHAV THER, V44, P459, DOI 10.1016/j.beth.2013.04.001; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Curtin Sally C, 2018, Natl Vital Stat Rep, V67, P1; D'Amico N, 2017, INT J EXERC SCI, V11, pe35; Dentro KN, 2014, J PHYS ACT HEALTH, V11, pS105, DOI 10.1123/jpah.2014-0184; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Fields B, 2018, SYSTEMS HLTH FAMILIE; Fitzgerald S, 2016, NEUROL TODAY, V16, P10; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Friedman SM, 2012, COMMUNICATING UNCERT; Guthrie LC, 2009, SOC SCI MED, V68, P2145, DOI 10.1016/j.socscimed.2009.04.004; Hinnant A, 2013, JOURNALISM STUD, V14, P539, DOI 10.1080/1461670X.2012.721633; Hwang V, 2014, J TRAUMA ACUTE CARE, V77, P117, DOI 10.1097/TA.0000000000000275; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Keeley B, 2009, SOCIOL HEALTH ILL, V31, P734, DOI 10.1111/j.1467-9566.2009.01164.x; Kroshus E, 2018, CLIN J SPORT MED; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; O'Hagan F, 2015, J EXERCI MOVE SPORT, V47, P108; Perloff RM, 2006, AM BEHAV SCI, V49, P835, DOI 10.1177/0002764205283804; R Development Core Team, 2012, R LANG ENV STAT COMP; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Romaine A, 2016, J CLIN SPORT PSYCHOL, V10, P253, DOI 10.1123/jcsp.2016-0018; Slovic P, 1980, SOC RISK ASSESSMENT, P181, DOI 10.1007/978-1-4899-0445-4_9; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; United States Census, 2018, POV THRESH; United States Department of Agriculture, 2018, SCH MEALS INC EL GUI; Ursache A, 2017, PSYCHONEUROENDOCRINO, V78, P142, DOI 10.1016/j.psyneuen.2017.01.020; von Wagner C, 2011, EPIDEMIOL REV, V33, P135, DOI 10.1093/epirev/mxq018; Wahlberg AAF., 2000, J RISK RES, V3, P31, DOI [10.1080/136698700376699, DOI 10.1080/136698700376699]; Wallace DJ, 2018, BMJ QUAL SAF, V27, P437, DOI 10.1136/bmjqs-2017-007168; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	45	9	9	5	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536	1873-5347		SOC SCI MED	Soc. Sci. Med.	FEB	2019	222						359	366		10.1016/j.socscimed.2018.12.037			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	HM9XS	WOS:000459838900039	30674437				2022-02-06	
J	Nikolian, VC; Dennahy, IS; Weykamp, M; Williams, AM; Bhatti, UF; Eidy, H; Ghandour, MH; Chtraklin, K; Li, YQ; Alam, HB				Nikolian, Vahagn C.; Dennahy, Isabel S.; Weykamp, Michael; Williams, Aaron M.; Bhatti, Umar F.; Eidy, Hassan; Ghandour, Mohamed H.; Chtraklin, Kiril; Li, Yongqing; Alam, Hasan B.			Isoform 6-selective histone deacetylase inhibition reduces lesion size and brain swelling following traumatic brain injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Isoform selective; histone deacetylase inhibitor; traumatic brain injury; hemorrhagic shock; neuroprotection	GENE-EXPRESSION PROFILES; LONG-TERM SURVIVAL; VALPROIC ACID; PHARMACOLOGICAL RESUSCITATION; TRANSCRIPTOMIC CHANGES; VOLUME RESUSCITATION; PORCINE MODEL; SWINE MODEL; ACETYLATION; MODULATION	BACKGROUND: Nonselective histone deacetylase (pan-HDAC) inhibitors, such as valproic acid (VPA), have demonstrated neuroprotective properties in trauma models. However, isoform-specific HDAC inhibitors may provide opportunity for more effective drug administration with fewer adverse effects. We investigated HDAC6 inhibition with ACY-1083 in an in vitro and an in vivo large animal model of injury. METHODS: Mouse hippocampal cells were subjected to oxygen-glucose deprivation (0% O-2, glucose-free and serum-free medium, 18 hours) and reoxygenation (21% O-2, normal culture media, 4 hours) with/without VPA (4 mmol/L) or ACY-1083 (30 nmol/L, 300 nmol/L). Cell viability was measured by methylthiazolyl tetrazolium assay. Expression of hypoxia-inducible factor-1 alpha, heat shock protein 70, and effectors in the phosphoinositide-3 kinase/mammalian target of rapamycin pathway were measured by Western blot analysis. Additionally, swine were subjected to combined traumatic brain injury and hemorrhagic shock and randomized to three treatment groups (n = 5/group): (i) normal saline (NS; 3 x hemorrhage volume); (ii) NS + VPA (NS; 3 x hemorrhage volume, VPA; 150 mg/kg), and (iii) NS + ACY-1083 (NS; 3 x hemorrhage volume, ACY-1083; 30 mg/kg). After 6 hours, brain tissue was harvested to assess lesion size and brain swelling. RESULTS: Significant improvement in cell viability was seen with both HDAC inhibitors in the in vitro study. ACY-1083 suppressed hypoxiainducible factor-1 alpha expression and up-regulated phosphorylated mammalian target of rapamycin and heat shock protein 70 in a dosedependent manner. Lesion size and brain swelling in animals treated with pharmacologic agents (VPA and ACY-1083) were both smaller than in the NS group. No differences were observed between the VPA and ACY-1083 treatment groups. CONCLUSIONS: In conclusion, selective inhibition of HDAC6 is as neuroprotective as nonselective HDAC inhibition in large animal models of traumatic brain injury and hemorrhagic shock. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved.	[Nikolian, Vahagn C.; Dennahy, Isabel S.; Weykamp, Michael; Williams, Aaron M.; Bhatti, Umar F.; Eidy, Hassan; Ghandour, Mohamed H.; Chtraklin, Kiril; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, 2920 Taubman Ctr,5331 Univ Michigan Hosp, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan, Dept Surg, 2920 Taubman Ctr,5331 Univ Michigan Hosp, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			US Army Materiel and Research Command [W81XWH-09-1-0520]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2 R01 GM084127]; Massey Foundation Severe TBI Grand Challenge Initiative	This work was supported by the US Army Materiel and Research Command, Contract W81XWH-09-1-0520, NIH grant 2 R01 GM084127, and funding from the Massey Foundation Severe TBI Grand Challenge Initiative.	Alam HB, 2011, J TRAUMA, V70, P636, DOI 10.1097/TA.0b013e31820d0dcc; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Burns JW, 2012, INT J BURNS TRAUMA, V2, P59; Chang PP, 2018, J TRAUMA ACUTE CARE, V84, P795, DOI 10.1097/TA.0000000000001824; Chang ZG, 2016, J TRAUMA ACUTE CARE, V81, P512, DOI 10.1097/TA.0000000000001137; Chang ZG, 2015, J TRAUMA ACUTE CARE, V79, P905, DOI 10.1097/TA.0000000000000784; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2010, TRANSL STROKE RES, V1, P65, DOI 10.1007/s12975-009-0009-5; Jochems J, 2014, NEUROPSYCHOPHARMACOL, V39, P389, DOI 10.1038/npp.2013.207; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; LEE HB, 1985, J NUCL MED, V26, P72; Li YQ, 2015, J TRAUMA ACUTE CARE, V78, P378, DOI 10.1097/TA.0000000000000510; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Maier RV, 2014, J TRAUMA ACUTE CARE, V77, P912; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2017, INFLAMMATION, V40, P1264, DOI 10.1007/s10753-017-0569-6; Patel J, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-12; Rasmussen Todd E, 2015, J Trauma Acute Care Surg, V79, pS61, DOI 10.1097/TA.0000000000000795; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Sailhamer EA, 2008, SURGERY, V144, P204, DOI 10.1016/j.surg.2008.03.034; Scholpa NE, 2019, J NEUROTRAUM, V36, P962, DOI 10.1089/neu.2018.5669; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691; Weykamp M, 2018, J SURG RES, V228, P84, DOI 10.1016/j.jss.2018.02.046	41	9	9	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2019	86	2					232	239		10.1097/TA.0000000000002119			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HK0GN	WOS:000457577100009	30399139				2022-02-06	
J	Niu, F; Dong, JQ; Xu, XJ; Zhang, B; Liu, BY				Niu, Fei; Dong, Jinqian; Xu, Xiaojian; Zhang, Bin; Liu, Baiyun			Mitochondrial Division Inhibitor 1 Prevents Early-Stage Induction of Mitophagy and Accelerated Cell Death in a Rat Model of Moderate Controlled Cortical Impact Brain Injury	WORLD NEUROSURGERY			English	Article						Drp1; Mitochondrial fission; Mitophagy; TBI	CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NEURONAL INJURY; AUTOPHAGY; DYSFUNCTION; DEFICITS; INFLAMMATION; DEGRADATION; APOPTOSIS; DYNAMICS	BACKGROUND: Increasing evidence has implicated dysfunctional mitochondria in the pathophysiology of neurodegenerative disorders. Selective degradation of dysfunctional mitochondria has been termed mitophagy and constitutes a pivotal component of mitochondrial quality control to maintain cellular homeostasis. Mitochondrial fission plays a prominent role in controlling mitochondrial shape and function. However, it is unclear whether mitochondrial fission in the context of eliminating damaged mitochondria is involved in traumatic brain injury (TBI). We examined the role of mitochondrial division inhibitor 1 (Mdivi1), a small-molecule inhibitor of dynamin-related protein (Drp1), in general autophagy and mitophagy after controlled cortical impact (CCI). METHODS: Mitophagy and the role of Drp1 in this process after CCI were examined using Western blotting, electron microscopy, double immunofluorescence staining, neurological severity scores, and hematoxylin and eosin staining. Statistical analysis was performed using 1-way analysis of variance, followed by the least significant difference test or the Games-Howell test. RESULTS: The rats exposed to CCI exhibited induction of mitophagy and fragmentation of mitochondria. When fission was blocked with Mdivi1, the mitochondria became excessively long and interconnected. Inhibition of Drp1 blocked the induction of mitophagy specifically, which aggravated neurological manifestations and neuronal apoptosis. Mdivi1 activated caspase-3 and caspase-9, implying that selective degradation of damaged mitochondria by autophagy markedly decreased cell apoptosis induced by TBI and, thus, promoted cell survival. CONCLUSIONS: The findings from the present study support the hypothesis that Drp1-dependent mitochondrial fission contributes to mitophagy in TBI, and further understanding of the regulatory mechanisms of Drp1 will provide opportunities to develop novel strategies against TBI.	[Niu, Fei; Xu, Xiaojian; Liu, Baiyun] Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China; [Dong, Jinqian; Zhang, Bin; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China		Liu, BY (corresponding author), Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.	liubaiyun1212@163.com	Dong, Jinqian/AAP-2298-2021		Beijing Neurosurgical Institute Youth Programme [2016002]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471238, 81771327]	This study was supported by the Beijing Neurosurgical Institute Youth Programme (grant 2016002) and the National Natural Science Foundation of China (grants 81471238 and 81771327).	Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fimia GM, 2013, CELL DEATH DIFFER, V20, P1, DOI 10.1038/cdd.2012.97; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Goemans CG, 2008, CELL DEATH DIFFER, V15, P545, DOI 10.1038/sj.cdd.4402290; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu K, 2016, AUTOPHAGY, V12, P2000, DOI 10.1080/15548627.2016.1212786; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI 10.1089/ARS.2008.2263; Purnell PR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-86; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Santos RX, 2010, J ALZHEIMERS DIS, V20, pS401, DOI 10.3233/JAD-2010-100666; Shi J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.278; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Yu SS, 2016, NEUROSCI LETT, V628, P24, DOI 10.1016/j.neulet.2016.06.012; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zuo W, 2014, NEUROPHARMACOLOGY, V86, P103, DOI 10.1016/j.neuropharm.2014.07.002	44	9	9	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2019	122						E1090	E1101		10.1016/j.wneu.2018.10.236			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HJ6UM	WOS:000457328100134	30439527				2022-02-06	
J	van Eijck, MM; Sprengers, MOP; Oldenbeuving, AW; de Vries, J; Schoonman, GG; Roks, G				van Eijck, Marleen M.; Sprengers, Marlou O. P.; Oldenbeuving, Annemarie W.; de Vries, Jolanda; Schoonman, Guus G.; Roks, Gerwin			The use of the PSH-AM in patients with diffuse axonal injury and autonomic dysregulation: A cohort study and review	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Diffuse axonal injury; Paroxysmal sympathetic hyperactivity; Autonomic dysregulation	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; TRAUMATIC BRAIN-INJURY; DYSAUTONOMIA; INSTABILITY; MANAGEMENT; PROGNOSIS; RISK	Purpose: 1) To determine the clinical expression and consequences of autonomic dysregulation in patients with diffuse axonal injury (DAI), and 2) to study the use of the "paroxysmal sympathetic hyperactivity assessment measure" (PSH-AM). Methods: Patients clinically diagnosed with autonomic dysregulation were selected from a cohort involving 116 patients with DAI We studied the incidence of autonomic features, treatment, and outcome. In addition a systematic review was performed. Results: Autonomic dysregulation was diagnosed in 19 of 116 (16.4%). Lower age (OR 0.95) and higher DAI grade (OR 7 2) were risk factors for autonomic dysregulation. Autonomic dysregulation was associated with an unfavourable outcome (OR 5.6) and a longer ICU and hospital stay. On the PSH-AM 57.9% (n = 11) scored a probable paroxysmal sympathetic hyperactivity (PSH), 36.8% (n = 7) scored possible, and 5.2% (n = 1) scored unlikely. The review yielded 30 articles. The incidence of autonomic dysregulation after TBI varied from 7.7-32.6% (mean 13.5%). TBI patients with autonomic dysregulation had a longer ICU stay and poorer outcome. Conclusion: Patients with DAI and autonomic dysregulation had a longer ICU stay and a poorer outcome compared to patients without autonomic dysregulation. The PSH-AM is a potential valuable tool to determine the likelihood of autonomic dysregulation. (C) 2018 Elsevier Inc. All rights reserved.	[van Eijck, Marleen M.; Sprengers, Marlou O. P.; Schoonman, Guus G.; Roks, Gerwin] Flisabeth TweeSteden Hosp, Dept Neurol, Tilburg, Netherlands; [van Eijck, Marleen M.; de Vries, Jolanda; Schoonman, Guus G.; Roks, Gerwin] Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Tilbuig, Netherlands; [Oldenbeuving, Annemarie W.] Elisabeth TweeSteden Hosp, Dept Intens Care Med, Tilburg, Netherlands; [de Vries, Jolanda] Elisabeth TweeSteden Hosp, Dept Med Psychol, Tilburg, Netherlands; [de Vries, Jolanda] Tilburg Univ, CoRPS, Dept Med & Clin Psychol, Tilburg, Netherlands		van Eijck, MM (corresponding author), ElisabethTweeSteden Ziekenhuis, Secretariat Neurol, Hilyarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands.	in.vaneijck@etz.nl		Roks, Gerwin/0000-0002-1393-9848	Dutch Organization for Health Research and Care Innovation (ZonMw) [842004002]	This work resulted from the TopCare Experiment which is supported by a grant of the Dutch Organization for Health Research and Care Innovation (ZonMw), grant number 842004002. The authors alone are responsible for the content and writing of the article.	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Gonzalez AMB, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-752; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hinson HE, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000271; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Kishner S, 2006, EMED J, P7; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2011, ARCH PHYS MED REHAB, V92, P1515, DOI 10.1016/j.apmr.2011.01.014; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Rabinstein AA, 2004, ARCH NEUROL-CHICAGO, V61, P1625, DOI 10.1001/archneur.61.10.1625-a; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Tang QL, 2017, PEERJ, V5, DOI 10.7717/peerj.2986; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	45	9	9	1	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2019	49						110	117		10.1016/j.jcrc.2018.10.018			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC3UQ	WOS:000451728600018	30415180				2022-02-06	
J	Minney, MJ; Roberts, RM; Mathias, JL; Raftos, J; Kochar, A				Minney, M. J.; Roberts, R. M.; Mathias, J. L.; Raftos, J.; Kochar, A.			Service and support needs following pediatric brain injury: perspectives of children with mild traumatic brain injury and their parents	BRAIN INJURY			English	Article						Health services; rehabilitation; families; unmet needs; unrecognized needs	QUALITY-OF-LIFE; FAMILY INTERVENTION; PRELIMINARY EFFICACY; OUTCOMES; REHABILITATION; MANAGEMENT; TERM; ADOLESCENTS; CHILDHOOD; CARE	Objective: To provide a qualitative examination of the service and support needs of children who have had a mild traumatic brain injury (mTBI), and their parents, in order to improve clinical services. Methods: Semi-structured interviews were conducted with 9 children (8-12 years; M = 10.6 years, SD = 0.8) and their parents (n = 9) 29-55 days (M = 34 days; SD = 9.3) after presenting to an Australian Paediatric Emergency Department (PED) for mTBI. Children's post-concussive symptoms (PCS) were additionally measured using the Post-Concussive Symptom Inventory (PCSI). Audio recordings were transcribed, and a thematic analysis was conducted. Results: Post-injury needs were reflected in four main themes: Communication; Family Burden; Continuity of Care; and Social and Community Support. These themes reflected children's and parents' needs for information, emotional/social/community support, and follow-up care. Both the children's and parents' needs, and the extent to which they were met, appeared to be related to the severity and duration of the child's PCS. Conclusions: Dedicated pediatric mTBI follow-up services that build on family's resources and meet their individual needs for information, emotional support, and referral may assist in optimizing post-injury outcomes.	[Minney, M. J.; Roberts, R. M.; Mathias, J. L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5006, Australia; [Raftos, J.; Kochar, A.] Womens & Childrens Hosp, Pediat Emergency Dept, Adelaide, SA, Australia		Roberts, RM (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5006, Australia.	rachel.roberts@adelaide.edu.au	Roberts, Rachel Margaret/AAE-5712-2020	Roberts, Rachel Margaret/0000-0002-9547-9995			Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Aitken ME, 2005, ARCH PHYS MED REHAB, V86, P175, DOI 10.1016/j.apmr.2004.02.026; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Balaban T, 2009, PHYS OCCUP THER PEDI, V29, P367, DOI 10.3109/01942630903245333; Ball H, 2013, EDUC PSYCHOL PRACT, V29, P69, DOI 10.1080/02667363.2012.755460; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Buck PW, 2012, REHABIL RES PRACT, V3, P11; Butera-Prinzi F, 2010, NEUROREHABILITATION, V27, P31, DOI 10.3233/NRE-2010-0579; Canto AI, 2014, EDUC PSYCHOL PRACT, V30, P88, DOI 10.1080/02667363.2014.883498; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Cox CM, 2010, J PEDIATR PSYCHOL, V35, P581, DOI 10.1093/jpepsy/jsp095; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Falk AC, 2008, PATIENT EDUC COUNS, V70, P251, DOI 10.1016/j.pec.2007.10.001; Falk AC, 2009, SCAND J CARING SCI, V23, P125, DOI 10.1111/j.1471-6712.2008.00598.x; Fereday J., 2006, INT J QUAL METHODS, V5, P80, DOI [10.1177/160940690600500107, DOI 10.1177/160940690600500107]; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Katia S., 2014, OPEN J THERAPY REHAB, V2, P11, DOI [10.4236/ojtr.2014.21009, DOI 10.4236/OJTR.2014.21009]; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kool B, 2014, EMERG MED AUSTRALAS, V26, P376, DOI 10.1111/1742-6723.12255; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; Marks DF, 2004, CLIN HLTH PSYCHOL; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCubbin H. I., 1997, J FAMILY CONSUMER SC, V89, P2; McCubbin M., 1993, FAMILIES HLTH ILLNES, P21, DOI 10.4135/9781452274720.n8; McDougall J, 2006, BRAIN INJURY, V20, P1189, DOI 10.1080/02699050600975541; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Miller R. L., 2003, A Z SOCIAL RES; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Morse JM, 2002, INT J QUAL METH, V1, P13, DOI DOI 10.1177/160940690200100202; Muenchberger H, 2011, J PRIM CARE COMMUNIT, V2, P60, DOI 10.1177/2150131910383578; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Petersen DJ, 2001, NEEDS ASSESSMENT PUB; Piccenna L, 2016, BRAIN INJURY, V30, P241, DOI 10.3109/02699052.2015.1113569; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, INPSYCH, V34; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; QSR International Pty Ltd, 2015, NVIVO VERS 11; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Robson T., 2005, BRAIN IMPAIR, V6, P45, DOI [10.1375/brim.6.1.45.65477, DOI 10.1375/BRIM.6.1.45.65477]; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Roscigno CI, 2011, BRAIN INJURY, V25, P882, DOI 10.3109/02699052.2011.581638; Rossi P. H., 2004, EVALUATION SYSTEMATI; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Russo RN, 2012, DEV NEUROREHABIL, V15, P13, DOI 10.3109/17518423.2011.625558; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Smith JA, 2007, RES METHODS PSYCHOL, P322; Smith Jonathan, 2007, QUALITATIVE PSYCHOL, P24; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; Swaine BR, 2008, BRAIN INJURY, V22, P581, DOI 10.1080/02699050802189701; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Terry L, 2001, Br J Nurs, V10, P384; Vassallo G, 2014, DEV MED CHILD NEUROL, V56, P34; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WHO, 1992, INT STAT CLASS DIS R; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	116	9	9	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					168	182		10.1080/02699052.2018.1540794			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300007	30396278				2022-02-06	
J	Hussmann, B; Schoeneberg, C; Jungbluth, P; Heuer, M; Lefering, R; Maek, T; Hildebrand, F; Lendemans, S; Pape, HC				Hussmann, Bjoern; Schoeneberg, Carsten; Jungbluth, Pascal; Heuer, Matthias; Lefering, Rolf; Maek, Teresa; Hildebrand, Frank; Lendemans, Sven; Pape, Hans-Christoph			Enhanced prehospital volume therapy does not lead to improved outcomes in severely injured patients with severe traumatic brain injury	BMC EMERGENCY MEDICINE			English	Article						Trauma; Prehospital replacement volume; Severe traumatic brain injury; Trauma registry; Hemorrhagic shock; emergency medicine	HYPOTENSIVE RESUSCITATION; FLUID RESUSCITATION; CLINICAL-COURSE; MANAGEMENT; MORTALITY; EPIDEMIOLOGY; PATTERNS; DEATHS; IMPACT	Background: Whether enhanced prehospital volume therapy leads to outcome improvements in severely injured patients with severe traumatic brain injury (TBI) remains controversial. The aim of this study was to investigate the influence of prehospital volume therapy on the clinical course of severely injured patients with severe TBI. Methods: Data for 122,672 patients from TraumaRegister DGU (R) (TR-DGU) was analyzed. Inclusion criteria were defined as follows: Injury Severety Score (ISS) >= 16, primary admission, age >= 16 years, Abbreviated Injury Scale (AIS) head >= 3, administration of at least one unit of packed red blood cells (pRBCs), and available volume and blood pressure data. Stratification based on the following matched-pair criteria was performed: group 1: prehospital volumes of 0-1000 ml; group 2: prehospital volumes of >= 1501 ml; AIS head (3, 4, 5 + 6 and higher than for other body regions); age (16-54, 55-69, >= 70 years); gender; prehospital intubation (yes/no); emergency treatment time +/-30 min.; rescue resources (rescue helicopter, emergency ambulance); blood pressure (20-60, 61-90, >= 91mmHg); year of accident (2002-2005, 2006-2009, 2010-2012); AIS thorax, abdomen, and extremities plus pelvis. Results: A total of 169 patients per group fulfilled the inclusion criteria. Increasing volume administration was associated with reduced coagulation capability and reduced hemoglobin (Hb) levels (prothrombin ratio: group 1: 68%, group 2: 63.7%; p <= 0.04; Hb: group 1: 11.2 mg/dl, group 2: 10.2 mg/dl; p <= 0.001). It was not possible to show a significant reduction in the mortality rate with increasing volumes (group 1: 45.6, group 2: 45.6; p = 1). Conclusions: The data presented in this study demonstrates that prehospital volume administration of more than 1500 ml does not improve severely injured patients with severe traumatic brain injury (TBI).	[Hussmann, Bjoern; Schoeneberg, Carsten; Maek, Teresa; Lendemans, Sven] Alfried Krupp Hosp, Trauma Surg Dept, Alfried Krupp Str 21, D-45131 Essen, Germany; [Jungbluth, Pascal] Univ Hosp, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Heuer, Matthias] Philippusstift, Surg Dept, Essen, Germany; [Lefering, Rolf] Witten Herdecke Univ, Inst Res Operat Med IFOM, Witten, Germany; [Hildebrand, Frank] Univ Hosp RWTH, Clin Trauma & Reconstruct Surg, Aachen, Germany; [Pape, Hans-Christoph] Univ Hosp, Dept Trauma, Zurich, Switzerland; [Pape, Hans-Christoph] Univ Zurich, Zurich, Switzerland		Hussmann, B (corresponding author), Alfried Krupp Hosp, Trauma Surg Dept, Alfried Krupp Str 21, D-45131 Essen, Germany.	bjoern.hussmann@krupp-krankenhaus.de	Schoeneberg, Carsten/AAS-9274-2021	Schoeneberg, Carsten/0000-0001-5633-1616; Pape, Hans-Christoph/0000-0002-2059-4980			Albreiki M, 2018, EUR J TRAUMA EMERG S, V44, P191, DOI 10.1007/s00068-017-0862-y; American College of Surgeons Committee on Trauma, 2012, ATLS STUD COURS MAN, V9th ed; Bickell W H, 1998, Curr Opin Anaesthesiol, V11, P177, DOI 10.1097/00001503-199804000-00010; BICKELL WH, 1993, ANN EMERG MED, V22, P225, DOI 10.1016/S0196-0644(05)80208-2; BICKELL WH, 1994, AM J EMERG MED, V12, P36, DOI 10.1016/0735-6757(94)90194-5; Christensen EF, 2007, TRAUMA EMERGENCY RES, P43; Curry N, 2012, INJURY, V43, P1021, DOI 10.1016/j.injury.2012.03.014; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Dula David J, 2002, Prehosp Emerg Care, V6, P417, DOI 10.1080/10903120290938058; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Geeraedts LMG, 2015, INJURY, V46, P4, DOI 10.1016/j.injury.2014.08.001; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hubetamann Bjorn, 2011, J Emerg Trauma Shock, V4, P465, DOI 10.4103/0974-2700.86630; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; Hussmann B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354367; Hussmann B, 2012, CRIT CARE, V16, DOI 10.1186/cc11809; Hussmann B, 2013, INJURY, V44, P611, DOI 10.1016/j.injury.2012.02.004; Jagoda A, 2006, STUD NEUROPSYCH DEV, P1; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Lendemans S, 2004, UNFALLCHIRURG, V107, P203, DOI 10.1007/s00113-004-0729-7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Pepe Paul E, 2002, Prehosp Emerg Care, V6, P81, DOI 10.1080/10903120290938887; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Soudry E, 2004, ISR MED ASSOC J, V6, P485; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Talving P, 2005, PREHOSP DISASTER MED, V20, P228, DOI 10.1017/S1049023X00002582; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Trunkey D D, 2001, Emerg Med Serv, V30, P93; Turner J, 2000, Health Technol Assess, V4, P1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	37	9	9	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	JAN 23	2019	19								13	10.1186/s12873-019-0221-x			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HQ2JS	WOS:000462227600002	30674281	Green Accepted, Green Published, gold			2022-02-06	
J	Sussman, ZW; Peterson, RL; Connery, AK; Baker, DA; Kirkwood, MW				Sussman, Zachary W.; Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			Utility of matrix reasoning as an embedded performance validity indicator in pediatric mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Concussion; Matrix Reasoning; mTBI; Performance Validity Test	VERBAL-LEARNING TEST; SYMPTOM VALIDITY; NONCREDIBLE EFFORT; DIGIT SPAN; CHILDREN; ABILITY; EXAM; BIAS; TBI	The present study examined the utility of the Wechsler Abbreviated Scale of Intelligence, Second Edition (WASI-II) Matrix Reasoning (MR) subtest in detecting suspect effort among a pediatric mild traumatic brain injury (mTBI) sample. The sample consisted of 526 clinically referred patients aged 8-16 years. Sixteen percent of participants failed the Medical Symptom Validity Test, which was used to categorize the sample into adequate and suspect effort groups. No background or injury-related variables differentiated the two groups. Comparisons between the adequate and suspect effort groups revealed significant differences in MR performance (p < .001; d = 1.46). A subsample (n = 206) where first item missed data were available was also analyzed; suspect effort participants missed their first item significantly earlier than adequate effort participants. In the entire sample, a MR cutoff T-score of 43 resulted in sensitivity of 57% and specificity of 90%. Receiver operating characteristic area under the curve for MR T-score was .804. Within this relatively high-functioning pediatric population with mTBI, MR appeared to have good utility as an embedded validity indicator, with classification statistics comparable to many of the most commonly used embedded indices used with adults.	[Sussman, Zachary W.] Independent Practice, Boulder, CO USA; [Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Rehabil, Aurora, CO USA; [Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Dept Phys Med & Rehabil, Denver Sch Med, Aurora, CO USA		Sussman, ZW (corresponding author), 5243 Willow Way, Denver, CO 80238 USA.	sussman.zach@gmail.com					BABIKIAN T, 2007, ASSESSMENT FEIGNED C, P00103; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green CM, 2014, J CLIN EXP NEUROPSYC, V36, P261, DOI 10.1080/13803395.2013.879096; Green P., 2003, GREENS MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kirkwood M. W., 2015, VALIDITY TESTING CHI; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; McKinzey RK, 2003, BRIT J CLIN PSYCHOL, V42, P95, DOI 10.1348/014466503762842048; McKinzey RK, 1999, BRIT J CLIN PSYCHOL, V38, P435, DOI 10.1348/014466599162935; Rambo PL, 2015, APPL NEUROPSYCH-CHIL, V4, P1, DOI 10.1080/21622965.2013.780238; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	31	9	9	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2019	8	1					70	75		10.1080/21622965.2017.1382359			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HS3VU	WOS:000463791400007	29058467				2022-02-06	
J	Champagne, AA; Peponoulas, E; Terem, I; Ross, A; Tayebi, M; Chen, YN; Coverdale, NS; Nielsen, PMF; Wang, A; Shim, V; Holdsworth, SJ; Cook, DJ				Champagne, Allen A.; Peponoulas, Emile; Terem, Itamar; Ross, Andrew; Tayebi, Maryam; Chen, Yining; Coverdale, Nicole S.; Nielsen, Poul M. F.; Wang, Alan; Shim, Vickie; Holdsworth, Samantha J.; Cook, Douglas J.			Novel strain analysis informs about injury susceptibility of the corpus callosum to repeated impacts	BRAIN COMMUNICATIONS			English	Article						sub-concussive impacts; amplified magnetic resonance imaging; diffusion tensor imaging; helmet accelerometers; tissue biomechanics	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; DIFFUSION; FOOTBALL; CONCUSSION; REPRODUCIBILITY; OPTIMIZATION; REGISTRATION; EXPOSURES; PLAYERS	Increasing evidence for the cumulative effects of head trauma on structural integrity of the brain has emphasized the need to understand the relationship between tissue mechanic properties and injury susceptibility. Here, diffusion tensor imaging, helmet accelerometers and amplified magnetic resonance imaging were combined to gather insight about the region-specific vulnerability of the corpus callosum to microstructural changes in white-matter integrity upon exposure to sub-concussive impacts. A total of 33 male Canadian football players (mean(age) = 20.3 +/- 1.4 years) were assessed at three time points during a football season (baseline pre-season, mid-season and post-season). The athletes were split into a LOW (N = 16) and HIGH (N = 17) exposure group based on the frequency of sub-concussive impacts sustained on a per-session basis, measured using the helmet-mounted accelerometers. Longitudinal decreases in fractional anisotropy were observed in anterior and posterior regions of the corpus callosum (average cluster size = 40.0 +/- 4.4 voxels; P < 0.05, corrected) for athletes from the HIGH exposure group. These results suggest that the white-matter tract may be vulnerable to repetitive sub-concussive collisions sustained over the course of a football season. Using these findings as a basis for further investigation, a novel exploratory analysis of strain derived from sub-voxel motion of brain tissues in response to cardiac impulses was developed using amplified magnetic resonance imaging. This approach revealed specific differences in strain (and thus possibly stiffness) along the white-matter tract (P < 0.0001) suggesting a possible signature relationship between changes in white-matter integrity and tissue mechanical properties. In light of these findings, additional information about the viscoelastic behaviour of white-matter tissues may be imperative in elucidating the mechanisms responsible for region-specific differences in injury susceptibility observed, for instance, through changes in microstructural integrity following exposure to sub-concussive head impacts.	[Champagne, Allen A.; Peponoulas, Emile; Chen, Yining; Coverdale, Nicole S.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Room 260, Kingston, ON K7L 3N6, Canada; [Terem, Itamar] Stanford Univ, Dept Elect Engn, 350 Serra Mall, Stanford, CA 94305 USA; [Ross, Andrew] Performance Phen, Toronto, ON, Canada; [Tayebi, Maryam; Nielsen, Poul M. F.; Wang, Alan; Shim, Vickie] Univ Auckland, Auckland Bioengn Inst, Auckland Bioengn House L6,70 Symonds St, Auckland 1010, New Zealand; [Nielsen, Poul M. F.] Univ Auckland, Fac Engn, Dept Engn Sci, Auckland 1010, New Zealand; [Holdsworth, Samantha J.] Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Med Imaging, Auckland 1023, New Zealand; [Holdsworth, Samantha J.] Univ Auckland, Fac Med & Hlth Sci, Ctr Brain Res, Auckland 1023, New Zealand; [Cook, Douglas J.] Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada		Cook, DJ (corresponding author), Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada.	dj.cook@queensu.ca	Tayebi, Maryam/D-9633-2017	Tayebi, Maryam/0000-0003-4911-3885; Holdsworth, Samantha/0000-0002-2929-1169; Shim, Vickie Bo Kyung/0000-0002-1680-4287	Southeastern Ontario Academic Medical Organization (SEAMO); University of Auckland Faculty Research Development Fund strategic initiative fund; Ontario Graduate scholarshipOntario Graduate Scholarship; Globalink Research Award from Mitacs (ON, Canada)	This work was supported by the Southeastern Ontario Academic Medical Organization (SEAMO) and The University of Auckland Faculty Research Development Fund strategic initiative fund. A.A.C would also like to acknowledge funding from the Ontario Graduate scholarship and the Globalink Research Award from Mitacs (ON, Canada).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Adams AL, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4050; Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BAZARIAN J, 2014, PLOS ONE, V0009, P00001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Champagne AA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101753; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Cookinham B, 2018, NEUROLOGY, V91, pS5; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hernandez F, 2019, BIOMECH MODEL MECHAN, P1; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Holdsworth SJ, 2016, MAGN RESON MED, V75, P2245, DOI 10.1002/mrm.26142; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeppesen MA, 2005, AM J PHYS, V23, P300; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Kuriyama Andrew M, 2017, Hawaii J Med Public Health, V76, P77; Ling CL, 2006, CONCEPT MAGN RESON A, V28, P181; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Murphy MC, 2019, NEUROIMAGE, V187, P176, DOI 10.1016/j.neuroimage.2017.10.008; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stamm J. M., 2015, J NEUROTRAUM, V1776, P1, DOI [10.1164/rccm.2012091583CI, DOI 10.1164/RCCM.2012091583CI]; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Terem I, 2018, MAGN RESON MED, V80, P2549, DOI 10.1002/mrm.27236; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Wadhwa N, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461966; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010; Zhang L, 2006, AM J NEURORADIOL; Zhao W, 2016, J NEUROTRAUMA	63	9	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2019	1	1							21	10.1093/braincomms/fcz021			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3RF	WOS:000574927100021	32954264	Green Published, gold			2022-02-06	
J	Crocker, LD; Keller, AV; Jurick, SM; Bomyea, J; Hays, CC; Twamley, EW; Jak, AJ				Crocker, Laura D.; Keller, Amber, V; Jurick, Sarah M.; Bomyea, Jessica; Hays, Chelsea C.; Twamley, Elizabeth W.; Jak, Amy J.			Mild Traumatic Brain Injury Burden Moderates the Relationship Between Cognitive Functioning and Suicidality in Iraq/Afghanistan-Era Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Suicidal ideation; Neuropsychology; Cognition; Memory; Operation Iraqi Freedom; Operation Enduring Freedom	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; FOOTBALL PLAYERS; ACTIVE-DUTY; PSYCHIATRIC-DISORDERS; MULTIPLE CONCUSSIONS; RECURRENT CONCUSSION; RISK-FACTORS; US VETERANS; BEHAVIOR	Objectives: Suicidal ideation (SI) is highly prevalent in Iraq/Afghanistan-era veterans with a history of mild traumatic brain injury (mTBI), and multiple mTBIs impart even greater risk for poorer neuropsychological functioning and suicidality. However, little is known about the cognitive mechanisms that may confer increased risk of suicidality in this population. Thus, we examined relationships between neuropsychological functioning and suicidality and specifically whether lifetime mTBI burden would moderate relationships between cognitive functioning and suicidal ideation. Methods: Iraq/Afghanistan-era Veterans with a history of mTBI seeking outpatient services (N = 282) completed a clinical neuropsychological assessment and psychiatric and postconcussive symptom questionnaires. Results: Individuals who endorsed SI reported more severe post-traumatic stress disorder (PTSD), depression, and postconcussive symptoms and exhibited significantly worse memory performance compared to those who denied SI. Furthermore, mTBI burden interacted with both attention/processing speed and memory, such that poorer performance in these domains was associated with greater likelihood of SI in individuals with a history of three or more mTBIs. The pattern of results remained consistent when controlling for PTSD, depression, and postconcussive symptoms. Conclusions: Slowed processing speed and/or memory difficulties may make it challenging to access and use past experiences to solve current problems and imagine future outcomes, leading to increases in hopelessness and SI in veterans with three or more mTBIs. Results have the potential to better inform treatment decisions for veterans with history of multiple mTBIs. (JINS, 2019, 25, 79-89)	[Crocker, Laura D.; Keller, Amber, V; Bomyea, Jessica; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Crocker, Laura D.; Bomyea, Jessica; Twamley, Elizabeth W.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jurick, Sarah M.; Hays, Chelsea C.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Bomyea, Jessica; Twamley, Elizabeth W.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA		Crocker, LD (corresponding author), 3350 La Jolla Village Dr,MC 151B, San Diego, CA 92161 USA.	laura.crocker@va.gov		Keller, Amber/0000-0002-2972-784X	VA Interprofessional Polytrauma; TBI; VA Rehabilitation RD Service [IK2 RX002459]; VA Clinical Science RD Service [CX001647]; Veterans AffairsUS Department of Veterans Affairs [IK2RX002459] Funding Source: NIH RePORTER	Laura Crocker received salary support during this work from the VA Interprofessional Polytrauma and TBI Fellowship and Career Development Award Number IK2 RX002459 from the VA Rehabilitation R&D Service. The authors declare no conflicts of interest. Jessica Bomyea received salary support during this work from Career Development Award Number CX001647 From the VA Clinical Science R&D Service.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bredemeier K, 2015, CLIN PSYCHOL REV, V40, P170, DOI 10.1016/j.cpr.2015.06.005; Brenner LA, 2015, ARCH PHYS MED REHAB, V96, P1411, DOI 10.1016/j.apmr.2015.04.010; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Burton CZ, 2011, J NEUROPSYCH CLIN N, V23, P173, DOI 10.1176/appi.neuropsych.23.2.173; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conner KR, 2013, J ABNORM PSYCHOL, V122, P256, DOI 10.1037/a0030163; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TRAU; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haller M, 2016, SUICIDE LIFE-THREAT, V46, P160, DOI 10.1111/sltb.12181; Hayes, 2018, INTRO MEDIATION MODE; Heaton R., 2000, WISCONSIN CARD SORTI; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Ilgen MA, 2010, ARCH GEN PSYCHIAT, V67, P1152, DOI 10.1001/archgenpsychiatry.2010.129; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Jurick SM, 2018, J HEAD TRAUMA REHAB, V33, pE41, DOI 10.1097/HTR.0000000000000313; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Keilp JG, 2014, PSYCHOL MED, V44, P2965, DOI 10.1017/S0033291714000786; Keilp JG, 2013, PSYCHOL MED, V43, P539, DOI 10.1017/S0033291712001419; Keilp JG, 2001, AM J PSYCHIAT, V158, P735, DOI 10.1176/appi.ajp.158.5.735; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mann JJ, 2008, J CLIN PSYCHIAT, V69, P23, DOI 10.4088/JCP.v69n0104; Meyers JE., 1995, REY COMPLEX FIGURE T; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Office of Suicide Prevention Department of Veterans Affairs, 2016, SUIC VET OTH AM; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Pu SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12142-8; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Richard-Devantoy S, 2015, WORLD J BIOL PSYCHIA, V16, P544, DOI 10.3109/15622975.2014.925584; Richard-Devantoy S, 2012, CAN J PSYCHIAT, V57, P254, DOI 10.1177/070674371205700409; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Weathers F.W., 1993, 9 ANN C ISTSS; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Zimmerman Lindsey, 2015, Mil Behav Health, V3, P296	79	9	9	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2019	25	1					79	89		10.1017/S1355617718000851			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HL2DV	WOS:000458514600009	30444208	Green Accepted			2022-02-06	
J	Ferdosi, H; Schwab, KA; Metti, A; Brenner, LA; Terrio, H; Pazdan, RM; Cole, WR; Scher, AI				Ferdosi, Hamid; Schwab, Karen A.; Metti, Andrea; Brenner, Lisa A.; Terrio, Heidi; Pazdan, Renee M.; Cole, Wesley R.; Scher, Ann I.			Trajectory of Postconcussive Symptoms 12 Months After Deployment in Soldiers With and Without Mild Traumatic Brain Injury: Warrior Strong Study	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						concussion; deployment; epidemiology; mild traumatic brain injury; military; postconcussive symptoms; prospective study	POSTTRAUMATIC-STRESS-DISORDER; US MILITARY; AFGHANISTAN; MANAGEMENT; DIAGNOSIS; PROGNOSIS; VALIDITY; IRAQ	We analyzed data from a cohort of recently deployed soldiers from 2 US Army bases, Fort Carson and Fort Bragg (2009 to 2015). Soldiers with and without a recent history of mild traumatic brain injury (mTBI) on deployment were evaluated within days of return and at 3, 6, and 12 months. Those with mTBI were more likely than those without to endorse 1 postconcussive symptom as severe and/or very severe (47% vs. 21%, baseline; adjusted relative risk (RR) = 1.71, 95% confidence interval: 1.51, 1.93, all time points), which remained significant after adjusting for posttraumatic stress disorder (adjusted RR = 1.34, 95% confidence interval: 1.20, 1.50). Prevalence and relative risks for 3 of the most common baseline symptoms remained constant over time: sleep problems (RR = 2.19), forgetfulness (RR = 2.56), and irritability (RR = 2.73). The pattern was slightly different for headache (baseline, RR = 3.44; 12 months, RR = 3.26), due to increased prevalence of headache in those without mTBI. The prevalence of clinically relevant postconcussive symptoms remained relatively constant over 1 year of follow-up, whether or not symptoms were associated with concussion. Service members with recent mTBI reported more symptoms than those without at all time points.	[Ferdosi, Hamid; Schwab, Karen A.] TBI Ctr Excellence, Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Ferdosi, Hamid] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Metti, Andrea] Metti Consulting Co, Pittsburgh, PA USA; [Brenner, Lisa A.] Rocky Mt Mental Illness Res Educ & Clin Ctr, Vet Hlth Adm, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado, Marcus Inst Brain Hlth, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Terrio, Heidi; Pazdan, Renee M.] Evans Army Community Hosp, Def & Vet Brain Injury Ctr, Colorado Springs, CO USA; [Cole, Wesley R.] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Schwab, Karen A.; Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Ferdosi, H (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA.	hamidferdosi@gwu.edu	Brenner, Lisa A./AAG-2442-2019; Ferdosi, Hamid/K-2510-2015	Scher, Ann/0000-0003-4599-9834; Ferdosi, Hamid/0000-0003-2941-2394	Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W81XWH-08-2-0105]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; Defense Medical Research and Development Program; Military Clinical Neuroscience Center of Excellence	Primary funding for the Warrior Strong study was provided by the Congressionally Directed Medical Research Programs (grant W81XWH-08-2-0105), with additional support from the Center for Neuroscience and Regenerative Medicine, Defense Medical Research and Development Program, and the Defense and Veterans Brain Injury Center. Funding specifically for this analysis was provided by the Military Clinical Neuroscience Center of Excellence.	Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Miller MA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00224; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Veterans Affairs, DEP DEF CLIN PRACT G; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Weathers FW, 1991, PCL C FOR DSM 4; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	33	9	9	1	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JAN	2019	188	1					77	86		10.1093/aje/kwy199			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HU6AB	WOS:000465359900010	30203085				2022-02-06	
J	Gabel, NM; Waldron-Perrine, B; Spencer, RJ; Pangilinan, PH; Hale, AC; Bieliauskas, LA				Gabel, Nicolette M.; Waldron-Perrine, Brigid; Spencer, Robert J.; Pangilinan, Percival H.; Hale, Andrew C.; Bieliauskas, Linas A.			Suspiciously slow: timed digit span as an embedded performance validity measure in a sample of veterans with mTBI	BRAIN INJURY			English	Article						Neuropsychology; malingering; assessment	ADULT INTELLIGENCE SCALE; SYMPTOM; EFFICIENCY; INDEXES; INJURY; RATES; TOMM; BIAS	Objective: To explore the utility of Timed Digit Span (TDS) as an embedded performance validity test (PVT) in a sample of veterans with mild traumatic brain injury (mTBI). We hypothesize that TDS will predict PVT failure on an established stand-alone measure (Trial 1 of the Test of Memory Malingering; TOMM).Methods: TDS was compared to Digit Span accuracy (DS), using TOMM as a criterion measure, in a sample of 99 veterans with mTBI. Correlation and regression were used to characterize associations between PVTs. Logistic regression was utilized to examine the relationship between embedded PVTs and the odds of TOMM failure. Classification accuracy of TDS was examined using receiver operating characteristic (ROC) curves. Predictive power of TDS to estimate TOMM failure was calculated for the current sample and for hypothetical populations with common base rates (BRs).Outcomes: TDS significantly predicted failure on the TOMM and added greater incremental predictive value to the model compared to DS accuracy. Estimates of the predictive power of TDS were calculated using observed and hypothetical BRs. Sensitivity to stand-alone PVT, failure was 38% when specificity was set at 90%.Conclusion: TDS offers a promising embedded PVT method, given its strong convergence with an established stand-alone PVT.	[Gabel, Nicolette M.] Michigan Med, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Waldron-Perrine, Brigid] Detroit Med Ctr, Rehabil Inst Michigan, Detroit, MI USA; [Spencer, Robert J.; Hale, Andrew C.] VA Ann Arbor Healthcare Syst, Mental Hlth Serv, Ann Arbor, MI USA; [Pangilinan, Percival H.] Michigan Med, VA Ann Arbor Healthcare Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Neuropsychol, Ann Arbor, MI USA		Gabel, NM (corresponding author), Michigan Med, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA.	jonesnm@med.umich.edu		Gabel, Nicolette/0000-0002-0239-6403			Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bieliauskas LA, 2014, NEUROPSYCHOL REV SCI, V2, P26; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P., 1996, WORD MEMORY TEST USE; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Millis S.R., 2008, NEUROPSYCHOLOGY MALI, P39; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; R Core Team, 2017, R LANG ENV STAT COMP; Rey A., 1964, EXAMEN CLIN PSYCHOL; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 2008, WECHSLER ADULT INTEL; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	31	9	9	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					377	382		10.1080/02699052.2018.1553311			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400014	30526120				2022-02-06	
J	Heller, RA; Seelig, J; Boc, T; Haubruck, P; Grutzner, PA; Schomburg, L; Moghaddam, A; Biglari, B				Heller, Raban Arved; Seelig, Julian; Boc, Tobias; Haubruck, Patrick; Gruetzner, Paul Alfred; Schomburg, Lutz; Moghaddam, Arash; Biglari, Bahram			Relation of selenium status to neuro-regeneration after traumatic spinal cord injury	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Zinc; Selenoprotein P; Inflammation; Trace element; ELISA; Brain; Neuron; Biomarker; Injury; Prediction; Precision medicine; Profile; Neurodegeneration; Supplementation; Recovery; Paraplegia; Surgery	INFLAMMATORY RESPONSE SYNDROME; NEUROLOGICAL DYSFUNCTION; FUNCTIONAL RECOVERY; CEREBROSPINAL-FLUID; SELENOPROTEIN-P; TRACE-ELEMENTS; SUPPLEMENT; ZINC; METHYLPREDNISOLONE; NEUROPROTECTION	Introduction: The trace element selenium (Se) is crucial for the biosynthesis of selenoproteins. Both neurodevelopment and the survival of neurons that are subject to stress depend on a regular selenoprotein biosynthesis and sufficient Se supply by selenoprotein P (SELENOP). Hypothesis: Neuro-regeneration after traumatic spinal cord injury (TSCI) is related to the Se status. Study design: Single-centre prospective observational study. Patients and methods: Three groups of patients with comparable injuries were studied; vertebral fractures without neurological impairment (n = 10, group C), patients with TSCI showing no remission (n = 9, group GO), and patients with remission developing positive abbreviated injury score (AIS) conversion within 3 months (n = 10, group G1). Serum samples were available from different time points (upon admission, and after 4, 9 and 12 h, 1 and 3 days, 1 and 2 weeks, and 1, 2 and 3 months). Serum trace element concentrations were determined by total reflection X-ray fluorescence, SELENOP by ELISA, and further parameters by laboratory routine. Results: Serum Se and SELENOP concentrations were higher on admission in the remission group (G1) as compared to GO. During the first week, both parameters remained constant in C and GO, whereas they declined significantly in the remission group. Similarly, the concentration changes between admission and 24 h were most pronounced in this group of recovering patients (G1). Binary logistic regression analysis including the delta of Se and SELENOP within the first 24 h indicated an AUC of 90.0% (CI: 67.4%-100.0%) with regards to predicting the outcome after TSCI. Conclusion: A Se deficit might constitute a risk factor for poor outcome after TSCI. A dynamic decline of serum Se and SELENOP concentrations after admission may reflect ongoing repair processes that are associated with higher odds for a positive clinical outcome.	[Heller, Raban Arved; Boc, Tobias; Haubruck, Patrick; Moghaddam, Arash] Heidelberg Univ Hosp, Dept Trauma & Reconstruct Surg, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Heidelberg Trauma Res Grp, Heidelberg, Germany; [Seelig, Julian; Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; [Gruetzner, Paul Alfred] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped, Ludwigshafen, Germany; [Biglari, Bahram] BG Trauma Ctr Ludwigshafen, Dept Paraplegiol, Ludwigshafen, Germany		Schomburg, L (corresponding author), Charite Univ Med Sch Berlin, Inst Expt Endocrinol, Sudring 10, D-13353 Berlin, Germany.	lutz.schomburg@charite.de	Seelig, Julian/AAU-6678-2021; Haubruck, Patrick/U-4442-2019; Heller, Raban/P-4152-2019	Haubruck, Patrick/0000-0002-7045-0387; Heller, Raban/0000-0001-8006-9742; Schomburg, Lutz/0000-0001-9445-1555	Deutsche Forschungsgemeinschaft (DFG Research Unit 2558 TraceAge)German Research Foundation (DFG) [Scho 849/6-1]	This work was supported by the Deutsche Forschungsgemeinschaft (DFG Research Unit 2558 TraceAge, Scho 849/6-1 to LS).	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; ANDERSON DK, 1985, ANN EMERG MED, V14, P816, DOI 10.1016/S0196-0644(85)80064-0; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Angstwurm MWA, 1999, CRIT CARE MED, V27, P1807, DOI 10.1097/00003246-199909000-00017; Audige L, 2009, SPINE CLASSIFICATION, P503; Auguie B., 2017, MISCELLANEOUS FUNCTI; Benstoem C, 2015, NUTRIENTS, V7, P3094, DOI 10.3390/nu7053094; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Chen XB, 2015, EUR REV MED PHARMACO, V19, P4434; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Estevez AO, 2014, NEUROTOXICOLOGY, V41, P28, DOI 10.1016/j.neuro.2013.12.012; Evaniew N, 2016, J NEUROTRAUM, V33, P468, DOI 10.1089/neu.2015.4192; Ferbert T, 2017, J NEUROTRAUM, V34, P607, DOI 10.1089/neu.2015.4294; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Gomez-Rubio V, 2017, J STAT SOFTW, V77, P1, DOI DOI 10.18637/JSS.V077.B02; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; Heller RA, 2017, SPINAL CORD, V55, P1002, DOI 10.1038/sc.2017.69; Heyland DK, 2005, INTENS CARE MED, V31, P327, DOI 10.1007/s00134-004-2522-z; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hughes DJ, 2016, AM J CLIN NUTR, V104, P406, DOI 10.3945/ajcn.116.131672; Ito Y, 2009, SPINE, V34, P2121, DOI 10.1097/BRS.0b013e3181b613c7; Janssen K, 2016, MOL NEUROBIOL, V53, P1551, DOI 10.1007/s12035-015-9113-6; Kasaikina M. V., 2016, BIOCHIM BIOPHYS ACTA, V1823; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2011, J NEUROTRAUM, V28, P1589, DOI 10.1089/neu.2009.1150; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; MITCHELL JD, 1986, J NEUROL NEUROSUR PS, V49, P211, DOI 10.1136/jnnp.49.2.211; Moghaddam A, 2016, SPINAL CORD, V54, P957, DOI 10.1038/sc.2016.44; Moghaddam  A., 2012, PLOS ONE, V11; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweizer U, 2005, IUBMB LIFE, V57, P737, DOI 10.1080/15216540500364255; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Tetreault LA, 2017, GLOB SPINE J, V7, p28S, DOI 10.1177/2192568217700396; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Vinceti M, 2013, NEUROTOXICOLOGY, V38, P25, DOI 10.1016/j.neuro.2013.05.016; Wang YS, 2014, BRAIN RES, V1545, P45, DOI 10.1016/j.brainres.2013.12.015; Wang YS, 2011, MED HYPOTHESES, V77, P589, DOI 10.1016/j.mehy.2011.06.037; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438	52	9	9	0	6	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0946-672X			J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.		2019	51						141	149		10.1016/j.jtemb.2018.10.006			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	HR4LZ	WOS:000463119100022	30466924				2022-02-06	
J	Huang, M; Frantz, J; Moralez, G; Sabo, T; Davis, PF; Davis, SL; Bell, KR; Purkayastha, S				Huang, Mu; Frantz, Justin; Moralez, Gilbert; Sabo, Tonia; Davis, Peter F.; Davis, Scott L.; Bell, Kathleen R.; Purkayastha, Sushmita			Reduced Resting and Increased Elevation of Heart Rate Variability With Cognitive Task Performance in Concussed Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						autonomic nervous system; cardiac vagal tone; cognition; concussion; heart rate variability; traumatic brain injury	PHYSICAL-ACTIVITY; RECOVERY	Objective: To examine heart rate variability (HRV) at rest and with a 2-Back cognitive task involving executive function and sustained attention in athletes during the acute phase following concussion and compare them with the controls. Participants: Twenty-three male and female collegiate athletes (20 +/- 1 years) following (4 +/- 1 days) a sports-related concussion and 23 sports-and sex-matched noninjured controls. Procedure: Continuous R-R interval was acquired using 3-lead electrocardiogram for 3 minutes each at rest and during the 2-Back task. HRV was quantified as percent high-frequency (HF) power. Results: At rest, lower percent HF power was observed in the concussed athletes (23 +/- 11) compared with the controls (38 +/- 14; P =.0027). However, with the 2-Back task, an increase in HF power was observed in the concussed group (39 +/- 12; P =.0008) from rest and was comparable with the controls (36 +/- 15). No difference in HF power between rest and 2-Back task was observed in the controls. Conclusion: Lower HRV was observed at rest following concussion. An increase in HRV, suggestive of enhanced prefrontal cortex (PFC) functioning, was observed during a cognitive task in the concussed athletes. Therefore, cognitive tasks as early as 4 days after injury may increase PFC functioning from rest and expedite return to learn in collegiate athletes.	[Huang, Mu; Frantz, Justin; Davis, Scott L.; Purkayastha, Sushmita] Southern Methodist Univ, Simmons Sch Educ & Human Dev, Dept Appl Physiol & Wellness, 3101 Univ Blvd, Dallas, TX 75205 USA; [Davis, Peter F.] Southern Methodist Univ, Dr Bob Smith Hlth Ctr, Dallas, TX 75275 USA; [Moralez, Gilbert] Texas Hlth Presbyterian Hosp, Inst Exercise & Environm Med, Dallas, TX USA; [Sabo, Tonia] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Pediat Neurol & Pain Management, Dallas, TX 75390 USA; [Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Purkayastha, S (corresponding author), Southern Methodist Univ, Simmons Sch Educ & Human Dev, Dept Appl Physiol & Wellness, 3101 Univ Blvd, Dallas, TX 75205 USA.	spurkayastha@smu.edu	Moralez, Gilbert/AAT-4029-2020; Purkaysastha, Sushmita/Y-8908-2019	Moralez, Gilbert/0000-0002-0654-2383; Bell, Kathleen/0000-0002-0928-2046; Sabo, Tonia/0000-0002-7293-4764; Huang, Mu/0000-0001-9526-7944			Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; [Anonymous], 2016, DIAGNOSIS MANAGEMENT; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Camm AJ, 1996, EUR HEART J, V17, P354; Chrisman SPD, 2016, JAMA-J AM MED ASSOC, V316, P2491, DOI 10.1001/jama.2016.17562; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Draghici AE, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0113-7; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; Eastman A, 2015, NEUROREHABILITATION, V37, P235, DOI 10.3233/NRE-151256; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hilz MJ, 2015, J NEUROTRAUM, V32, P1796, DOI 10.1089/neu.2014.3842; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Quintana DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.73; Saus ER, 2006, MIL PSYCHOL, V18, pS3, DOI 10.1207/s15327876mp1803s_2; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375, DOI 10.1002/j.1552-4604.1994.tb04977.x; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Sung CW, 2016, PSYCHOPHYSIOLOGY, V53, P455, DOI 10.1111/psyp.12575; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152	34	9	9	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		45	51		10.1097/HTR.0000000000000409			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600012	29863622				2022-02-06	
J	Mac Donald, CL; Barber, J; Wright, J; Coppel, D; De Lacy, N; Ottinger, S; Peck, S; Panks, C; Sun, S; Zalewski, K; Temkin, N				Mac Donald, Christine L.; Barber, Jason; Wright, Jason; Coppel, David; De Lacy, Nina; Ottinger, Steve; Peck, Suzanne; Panks, Chris; Sun, Samantha; Zalewski, Kody; Temkin, Nancy			Longitudinal Clinical and Neuroimaging Evaluation of Symptomatic Concussion in 10-to 14-year-old Youth Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; longitudinal study; MRI; pediatrics	WHITE-MATTER MICROSTRUCTURE; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; DIFFUSION TENSOR; DISTORTION CORRECTION; ROBUST ESTIMATION; BLOOD-FLOW; DEPRESSION; CHILDREN; HISTORY	This study longitudinally assessed 10- to 14-year-old patients with sports and recreational concussion (n=22) who remained symptomatic 3 to 4weeks post-injury compared with typically developing controls (n=24). Examination by multi-modal magnetic resonance imaging (MRI) and multi-domain clinical outcome measures was completed at 1-month and 6-months post-injury. Concussion patients showed evidence of improvement by 6-month follow-up in domains of cognitive function, whereas measures of psychological health were less resolved with patients exhibiting sustained symptoms of depression, behavior impairment, and concussion symptoms. Quantitative neuroimaging measures identified measures indicative of chronic injury with regional reductions observed by both volumetric segmentation and white matter fractional anisotropy (FA) from diffusion tensor imaging (DTI). Volumetric reductions (p<0.01) were observed in the middle anterior and posterior portions of the corpus callosum, and right caudal anterior cingulate cortex of patients, although none held after strict correction. Examination of the FA data identified significant reductions in the left middle frontal gyrus white matter (p=0.0003). Linear regression analysis on the 6-month depression outcome variable using the initial clinical, demographic, and imaging measures identified the top predictive models to include concussion diagnosis, and initial symptoms of depression, concussion symptoms, and sleep impairment with additional contribution from other measures of mental health, behavior impairment, and quality of life depending on the model (adjusted r-squared=0.69 indicating strong predictive ability). This study supports further inclusion of mental health rehabilitation and imaging supplementing traditional cognitive rehabilitation strategies employed in these young athletes.	[Mac Donald, Christine L.; Barber, Jason; Coppel, David; Ottinger, Steve; Panks, Chris; Sun, Samantha; Zalewski, Kody; Temkin, Nancy] Univ Washington, Dept Neurol Surg, 352 9th Ave,Box 359924, Seattle, WA 98104 USA; [De Lacy, Nina] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Mac Donald, Christine L.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Wright, Jason] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA; [Peck, Suzanne] Seattle Childrens Res Inst, Seattle, WA USA		Mac Donald, CL (corresponding author), Univ Washington, Dept Neurol Surg, 352 9th Ave,Box 359924, Seattle, WA 98104 USA.	cmacd@uw.edu		Sun, Samantha/0000-0002-5971-066X	Seattle Pediatric Concussion Research Collaborative	We would like to thank the families, patients, and participants without whom this study would not be possible. We are grateful for the assistance of the University of Washington Diagnostic Imaging Sciences team including Serena Bennett, Tim Wilbur, and Liza Young for their support with the imaging acquisition and logistical planning. Funding for this research was provided by the Seattle Pediatric Concussion Research Collaborative.	Akaike H, 1973, 2 INT S INF THEOR BU, P267; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bracht T, 2015, J AFFECT DISORDERS, V187, P45, DOI 10.1016/j.jad.2015.06.041; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burnham KP., 2002, MODEL SELECTION MULT; Cavanaugh JE, 1997, STAT PROBABIL LETT, V33, P201, DOI 10.1016/S0167-7152(96)00128-9; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Genc S, 2017, NEUROIMAGE, V156, P286, DOI 10.1016/j.neuroimage.2017.05.017; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hoy AR, 2014, NEUROIMAGE, V103, P323, DOI 10.1016/j.neuroimage.2014.09.053; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Janusz JA, 2012, MILD TRAUMATIC BRAIN; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Koay CG, 2009, J MAGN RESON, V197, P108, DOI 10.1016/j.jmr.2008.11.015; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mac Donald CL, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000381; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayo Foundation, 2017, KING DEV TEST; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Oishi K., 2011, MRI ATLAS HUMAN WHIT, V2nd Edn.; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Pierpaoli C., 2010, INT SOC MAGN RESON M; Pierpaoli C., 2010, P 18 ANN M INT SOC M; PsychCorp, 2017, WECHSL INT SCAL CHIL; Rohde GK, 2005, NEUROIMAGE, V26, P673, DOI 10.1016/j.neuroimage.2005.02.023; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Smith A., 1982, SYMBOL DIGITS MODALI; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Varni JW, 2017, THE PEDSQL; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39; Wu T., 2017, BRAIN IMAGING BEHAV; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	58	9	9	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					264	274		10.1089/neu.2018.5629			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800009	29901414				2022-02-06	
J	Manning, KY; Llera, A; Dekaban, GA; Bartha, R; Barreira, C; Brown, A; Fischer, L; Jevremovic, T; Blackney, K; Doherty, TJ; Fraser, DD; Holmes, J; Beckmann, CF; Menon, RS				Manning, Kathryn Y.; Llera, Alberto; Dekaban, Gregory A.; Bartha, Robert; Barreira, Christy; Brown, Arthur; Fischer, Lisa; Jevremovic, Tatiana; Blackney, Kevin; Doherty, Timothy J.; Fraser, Douglas D.; Holmes, Jeff; Beckmann, Christian F.; Menon, Ravi S.			Linked MRI signatures of the brain's acute and persistent response to concussion in female varsity rugby players	NEUROIMAGE-CLINICAL			English	Article						Functional MRI; Resting state connectivity; Diffusion weighted imaging; Concussion; Linked independent component analysis; Mild traumatic brain injury	MULTIMODAL FUSION; CORPUS-CALLOSUM; HEAD IMPACTS; 1ST EXPOSURE; INJURY; FOOTBALL; SEASON; ABNORMALITIES; INTEGRITY; NETWORK	Acute brain changes are expected after concussion, yet there is growing evidence of persistent abnormalities well beyond clinical recovery and clearance to return to play. Multiparametric MRI is a powerful approach to non-invasively study structure-function relationships in the brain, however it remains challenging to interpret the complex and heterogeneous cascade of brain changes that manifest after concussion. Emerging conjunctive, data-driven analysis approaches like linked independent component analysis can integrate structural and functional imaging data to produce linked components that describe the shared inter-subject variance across images. These linked components not only offer the potential of a more comprehensive understanding of the underlying neurobiology of concussion, but can also provide reliable information at the level of an individual athlete. In this study, we analyzed resting-state functional MRI (rs-fMRI) and diffusion tensor imaging (DTI) within a cohort of female varsity rugby players (n = 52) through the in-and off-season, including concussed athletes (n = 21) who were studied longitudinally at three days, three months and six months after a diagnosed concussion. Linked components representing co-varying white matter microstructure and functional network connectivity characterized (a) the brain's acute response to concussion and (b) persistent alterations beyond clinical recovery. Furthermore, we demonstrate that these long-term brain changes related to specific aspects of a concussion history and allowed us to monitor individual athletes before and longitudinally after a diagnosed concussion.	[Manning, Kathryn Y.; Bartha, Robert; Menon, Ravi S.] Western Univ, Med Biophys, London, ON, Canada; [Manning, Kathryn Y.; Bartha, Robert; Menon, Ravi S.] Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada; [Llera, Alberto; Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Dekaban, Gregory A.; Barreira, Christy; Brown, Arthur; Blackney, Kevin] Robarts Res Inst, Mol Med Res Labs, London, ON, Canada; [Dekaban, Gregory A.; Blackney, Kevin] Western Univ, Microbiol & Immunol, London, ON, Canada; [Brown, Arthur] Western Univ, Anat & Cell Biol, London, ON, Canada; [Fischer, Lisa; Jevremovic, Tatiana] Fowler Kennedy Sport Med, Primary Care Sport Med, London, ON, Canada; [Doherty, Timothy J.] Western Univ, Phys Med & Rehabil, London, ON, Canada; [Fraser, Douglas D.] London Hlth Sci Ctr, Paediat Crit Care Med, London, ON, Canada; [Holmes, Jeff] Western Univ, Occupat Therapy, London, ON, Canada; [Beckmann, Christian F.] Radboud Univ Nijmegen, Med Ctr, Cognit Neurosci, Nijmegen, Netherlands; [Beckmann, Christian F.] Univ Oxford, Ctr Funct MRI Brain FMRIB, Oxford, England		Menon, RS (corresponding author), Univ Western Ontario, Robarts Res Inst, Ctr Funct & Metab Mapping, 1151 Richmond St, North London, ON N6A 5B7, Canada.	kmanning@robarts.ca; a.llera@donders.ru.nl; dekaban@robarts.ca; rbartha@robarts.ca; cbarreira@robarts.ca; abrown@robarts.ca; lfischer@uwo.ca; tjevremo@uwo.ca; kblackne@uwo.ca; tim.doherty@lhsc.on.ca; douglas.fraser@lhsc.on.ca; jholme@uwo.ca; c.beckmann@donders.ru.nl; rmenon@robarts.ca	Beckmann, Christian F./E-6374-2012; Fischer, Lisa K/H-3999-2015; Menon, Ravi S/K-5500-2013; Bartha, Robert/K-3611-2013; Brown, Arthur/K-8328-2013; Dekaban, Gregory/L-1987-2013	Beckmann, Christian F./0000-0002-3373-3193; Fischer, Lisa K/0000-0001-5992-0176; Menon, Ravi S/0000-0002-7916-0263; Bartha, Robert/0000-0002-7118-9096; Brown, Arthur/0000-0002-8725-3195; Dekaban, Gregory/0000-0002-3087-4660; Llera Arenas, Alberto/0000-0002-8358-8625	Schulich School of Medicine and Dentistry, Western University; Brain Canada; Canada First Research Excellence Fund; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	The authors would to thank the athletes who participated in this longitudinal study and the coaching staff. We would also like to acknowledge the support provided by the MRI technicians and staff at the Centre for Functional and Metabolic Mapping. We acknowledge funding through the Schulich School of Medicine and Dentistry, Western University; Brain Canada; Canada First Research Excellence Fund; and the Natural Sciences and Engineering Research Council of Canada.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Groves AR, 2012, NEUROIMAGE, V63, P365, DOI 10.1016/j.neuroimage.2012.06.038; Groves AR, 2011, NEUROIMAGE, V54, P2198, DOI 10.1016/j.neuroimage.2010.09.073; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; Schranz AL, 2018, HUM BRAIN MAPP, V39, P1489, DOI 10.1002/hbm.23919; Shinmura S., 2017, BRAIN IMAGING BEHAV, V2017, P1; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Sui J, 2012, J NEUROSCI METH, V204, P68, DOI 10.1016/j.jneumeth.2011.10.031; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thomas AG, 2011, RADIOGRAPHICS, V31, P1107, DOI 10.1148/rg.314105729; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wolfers T, 2017, J PSYCHIATR NEUROSCI, V42, P386, DOI 10.1503/jpn.160240; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	35	9	9	2	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	21									10.1016/j.nicl.2018.101627			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN6ZP	WOS:000460337700040	30528959	Green Published, gold			2022-02-06	
J	Prieto-Fernandez, E; Aransay, AM; Royo, F; Gonzalez, E; Lozano, JJ; Santos-Zorrozua, B; Macias-Camara, N; Gonzalez, M; Garay, RP; Benito, J; Garcia-Orad, A; Falcon-Perez, JM				Prieto-Fernandez, Endika; Maria Aransay, Ana; Royo, Felix; Gonzalez, Esperanza; Jose Lozano, Juan; Santos-Zorrozua, Borja; Macias-Camara, Nuria; Gonzalez, Monika; Perez Garay, Raquel; Benito, Javier; Garcia-Orad, Africa; Manuel Falcon-Perez, Juan			A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice	THERANOSTICS			English	Article						CSF miRNAs; CSF exosomes; microRNA profiling; infants; clinical samples	TRAUMATIC BRAIN-INJURY; DIFFERENTIAL EXPRESSION; EXTRACELLULAR VESICLES; MICRORNA; BIOMARKER; DISEASE; EXOSOME; VISUALIZATION; GLIOBLASTOMA; DIAGNOSIS	Cerebrospinal fluid (CSF) microRNAs (miRNAs) have emerged as potential biomarkers for minimally invasive diagnosis of central nervous system malignancies. However, despite significant advances in recent years, this field still suffers from poor data reproducibility. This is especially true in cases of infants, considered a new subject group. Implementing efficient methods to study miRNAs from clinically realistic CSF volumes is necessary for the identification of new biomarkers. Methods: We compared six protocols for characterizing miRNAs, using 200-mu L CSF from infants (aged 0-7). Four of the methods employed extracellular vesicle (EV) enrichment step and the other two obtained the miRNAs directly from cleared CSF. The efficiency of each method was assessed using real-time PCR and small RNA sequencing. We also determined the distribution of miRNAs among different CSF shuttles, using size-exclusion chromatography. Results: We identified 281 CSF miRNAs from infants. We demonstrated that the miRNAs could be efficiently detected using only 200 mu L of biofluid in case of at least two of the six methods. In the exosomal fraction, we found 12 miRNAs that might be involved in neurodevelopment. Conclusion: The Norgen and Invitrogen protocols appear suitable for the analysis of a large number of miRNAs using small CSF samples.	[Prieto-Fernandez, Endika; Santos-Zorrozua, Borja; Garcia-Orad, Africa] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Fac Med & Nursing, Leioa 48940, Bizkaia, Spain; [Maria Aransay, Ana; Macias-Camara, Nuria; Gonzalez, Monika] CIC bioGUNE, Genome Anal Platform, Derio, Bizkaia, Spain; [Maria Aransay, Ana; Manuel Falcon-Perez, Juan] Inst Salud Carlos III, CIBERehd, Madrid 28029, Spain; [Royo, Felix; Gonzalez, Esperanza; Manuel Falcon-Perez, Juan] CIBERehd, CIC bioGUNE, Exosomes Lab, Derio 48980, Bizkaia, Spain; [Jose Lozano, Juan] CIBERehd, Bioinformat Unit, CEK, Barcelona 08036, Spain; [Perez Garay, Raquel] Cruces Univ Hosp, Serv Biochem, Baracaldo 48903, Bizkaia, Spain; [Benito, Javier] Cruces Univ Hosp, Dept Pediat Emergency, Baracaldo 48940, Bizkaia, Spain; [Benito, Javier] Univ Basque Country UPV EHU, Dept Pediat, Leioa 48940, Bizkaia, Spain; [Garcia-Orad, Africa] BioCruces Hlth Res Inst, Baracaldo 48903, Bizkaia, Spain; [Manuel Falcon-Perez, Juan] Basque Fdn Sci, IKERBASQUE, Bilbao 48015, Bizkaia, Spain		Prieto-Fernandez, E; Garcia-Orad, A (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Fac Med & Nursing, Leioa 48940, Bizkaia, Spain.; Falcon-Perez, JM (corresponding author), Inst Salud Carlos III, CIBERehd, Madrid 28029, Spain.; Falcon-Perez, JM (corresponding author), CIBERehd, CIC bioGUNE, Exosomes Lab, Derio 48980, Bizkaia, Spain.; Garcia-Orad, A (corresponding author), BioCruces Hlth Res Inst, Baracaldo 48903, Bizkaia, Spain.; Falcon-Perez, JM (corresponding author), Basque Fdn Sci, IKERBASQUE, Bilbao 48015, Bizkaia, Spain.	endika.prieto@ehu.eus; africa.garciaorad@ehu.eus; jfalcon@cicbiogune.es	Gonzalez, Monika/AAF-1636-2020; Falcon-Perez, Juan M/F-5920-2011; Gonzalez, Esperanza/AAK-4097-2020; Fernandez, Endika Prieto/AAE-9488-2019; Gonzalez, Monika/F-9339-2016; Royo, Felix/ABE-8064-2021; Gonzalez, Esperanza/H-5450-2015; Aransay, Ana M./F-8086-2011	Gonzalez, Monika/0000-0003-1506-0332; Gonzalez, Esperanza/0000-0002-3831-4596; Fernandez, Endika Prieto/0000-0001-8378-1495; Gonzalez, Monika/0000-0003-1506-0332; Royo, Felix/0000-0001-9769-4165; Gonzalez, Esperanza/0000-0002-3831-4596; Aransay, Ana M./0000-0002-8271-612X	Basque GovernmentBasque Government [IT989-16]; Spanish Ministry of Economy and Competitiveness MINECOSpanish Government [SAF2015066312]; Ramon Areces Foundation [FRA-17-JMF]; Severo Ochoa Excellence Accreditation [SEV-2016-0644]	This work was supported by the Basque Government [IT989-16], the Spanish Ministry of Economy and Competitiveness MINECO [SAF2015066312], and the Ramon Areces Foundation [FRA-17-JMF]. We thank MINECO for the REDIEX (Spanish Excellence Network in Exosomes) and the Severo Ochoa Excellence Accreditation (SEV-2016-0644). Funding for open access charge: Severo Ochoa Excellence Accreditation (SEV-2016-0644).	Akers JC, 2017, ONCOTARGET, V8, P68769, DOI 10.18632/oncotarget.18332; Akers JC, 2015, J NEURO-ONCOL, V123, P205, DOI 10.1007/s11060-015-1784-3; Anckar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117076; Bache S, 2017, STROKE, V48, P2391, DOI 10.1161/STROKEAHA.117.017804; Baraniskin A, 2012, NEURO-ONCOLOGY, V14, P29, DOI 10.1093/neuonc/nor169; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergman P, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000219; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cunha BA, 2012, J CLIN MICROBIOL, V50, P211, DOI 10.1128/JCM.06072-11; Denk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126423; Drusco A, 2015, ONCOTARGET, V6, P20829, DOI 10.18632/oncotarget.4096; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; El Kadmiri N, 2018, NEUROSCIENCE, V370, P181, DOI 10.1016/j.neuroscience.2017.07.017; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Gamez-Valero A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33641; Goswami S, 2017, MOL NEUROBIOL, V54, P1541, DOI 10.1007/s12035-016-9764-y; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Haque A, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020033; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Johanson TM, 2014, INT J HEMATOL, V100, P246, DOI 10.1007/s12185-014-1606-y; Jung KO, 2017, ONCOTARGET, V8, P9899, DOI 10.18632/oncotarget.14247; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kopkova A, 2018, CLIN CHEM LAB MED, V56, P869, DOI 10.1515/cclm-2017-0958; Kumar D, 2018, MOL NEUROBIOL, V55, P2112, DOI 10.1007/s12035-017-0474-x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liu CG, 2014, MOL MED REP, V10, P2395, DOI 10.3892/mmr.2014.2484; Lobb RJ, 2017, SEMIN CELL DEV BIOL, V67, P3, DOI 10.1016/j.semcdb.2017.01.004; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Monguio-Tortajada M, 2017, THERANOSTICS, V7, P270, DOI 10.7150/thno.16154; Nagaraj S, 2019, AGEING RES REV, V49, P125, DOI 10.1016/j.arr.2018.10.008; Nevel KS, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0706-x; Quintana E, 2017, MULT SCLER J, V23, P1716, DOI 10.1177/1352458516684213; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Riancho J, 2017, J ALZHEIMERS DIS, V57, P483, DOI 10.3233/JAD-161179; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Royo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068693; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Shi R, 2015, ONCOTARGET, V6, P26971, DOI 10.18632/oncotarget.4699; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Sorensen SS, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0104-9; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Tietje A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113116; van Harten AC, 2015, J ALZHEIMERS DIS, V47, P243, DOI 10.3233/JAD-140075; Verheul C, 2018, HAND CLINIC, V146, P139, DOI 10.1016/B978-0-12-804279-3.00010-1; Wang YX, 2015, P NATL ACAD SCI USA, V112, P9704, DOI 10.1073/pnas.1511694112; Welton JL, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1369805; Yagi Y, 2017, NEUROSCI LETT, V636, P48, DOI 10.1016/j.neulet.2016.10.042; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004	57	9	9	3	11	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2019	9	16					4567	4579		10.7150/thno.31502			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IG4JH	WOS:000473769400001	31367240	gold, Green Published, Green Submitted			2022-02-06	
J	Seidman, AJ; Wade, NG; Vogel, DL; Armistead-Jehle, P				Seidman, Andrew J.; Wade, Nathaniel G.; Vogel, David L.; Armistead-Jehle, Patrick			The impact of stigma on behavioral health care utilization among active duty service members	MILITARY PSYCHOLOGY			English	Article						Self-stigma; public stigma; mental health care; military; help-seeking	SELF-STIGMA; MILITARY PERSONNEL; TREATMENT SEEKING; VETERANS; INTENTIONS; ATTITUDES; BARRIERS; DEPRESSION; BELIEFS; DROPOUT	This study assessed the relationship between the stigma of seeking psychological help and use of outpatient behavioral health services over a 2-year period among active duty military service members initially referred for neuropsychological evaluation secondary to their histories of mild traumatic brain injury. Although research has examined how stigma predicts proxies for help-seeking (i.e., attitudes towards/intentions to use services), very little research has looked at actual behavior, and studies that do have largely focused on previous use. In this study, we examined the relationship between participants' stigma and subsequent behavioral health use. Our results indicated that whereas greater self-stigma (i.e., negative self-judgments for seeking psychological help) was associated with attending fewer behavioral health care sessions, public stigma (i.e., perceptions of public attitudes towards people who seek psychological help) was not associated with service use. These findings support the need for addressing the self-stigma associated with seeking behavioral health care.	[Seidman, Andrew J.; Wade, Nathaniel G.; Vogel, David L.] Iowa State Univ, Dept Psychol, W-112 Lagomarcino Hall,901 Stange Rd, Ames, IA 50011 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Dept Behav Hlth, Ft Leavenworth, KS USA		Seidman, AJ (corresponding author), Iowa State Univ, Dept Psychol, W-112 Lagomarcino Hall,901 Stange Rd, Ames, IA 50011 USA.	aseidman@iastate.edu	Armistead-Jehle, Patrick/AAU-5741-2020				Adler AB, 2015, BRIT J PSYCHIAT, V207, P346, DOI 10.1192/bjp.bp.114.146506; Ben-Zeev D, 2012, J MENT HEALTH, V21, P264, DOI 10.3109/09638237.2011.621468; Blais RK, 2014, MIL PSYCHOL, V26, P114, DOI 10.1037/mil0000036; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Britt TW, 2016, WORK STRESS, V30, P318, DOI 10.1080/02678373.2016.1246490; Britt TW, 2015, PSYCHIATR REHABIL J, V38, P142, DOI 10.1037/prj0000120; Defense Manpower Data Center, 2017, ARM FORC STRENGTH FI; Dickstein BD, 2010, MIL PSYCHOL, V22, P224, DOI 10.1080/08995600903417399; Dingfelder S., 2009, MONITOR PSYCHOL, V40, P56; Elnitsky CA, 2013, MIL MED, V178, P775, DOI 10.7205/MILMED-D-13-00012; Engel CC, 2008, MIL MED, V173, P935, DOI 10.7205/MILMED.173.10.935; Held P, 2013, TRAUMATOLOGY, V19, P136, DOI DOI 10.1177/1534765612455227; Jennings KS, 2016, PSYCHOL SERV, V13, P356, DOI 10.1037/ser0000082; Kendra MS, 2014, PSYCHOTHERAPY, V51, P563, DOI 10.1037/a0036586; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Komiya N, 2000, J COUNS PSYCHOL, V47, P138, DOI 10.1037/0022-0167.47.1.138; Lannin DG, 2015, COUNS PSYCHOL, V43, P64, DOI 10.1177/0011000014541550; Michalopoulou LE, 2017, MIL BEHAV HLTH, V5, P12, DOI [10.1080/21635781.2016.1200504, DOI 10.1080/21635781.2016.1200504]; Momen N, 2012, MIL MED, V177, P1143, DOI 10.7205/MILMED-D-11-00286; Ribisl KM, 1996, EVAL PROGRAM PLANN, V19, P1, DOI 10.1016/0149-7189(95)00037-2; Seidman AJ, 2018, J COUNS PSYCHOL, V65, P653, DOI 10.1037/cou0000289; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Skopp NA, 2012, J CLIN PSYCHOL, V68, P1036, DOI 10.1002/jclp.21889; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Vogel DL, 2006, J COUNS PSYCHOL, V53, P325, DOI 10.1037/0022-0167.53.3.325; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wade NG, 2015, PSYCHIATR REHABIL J, V38, P135, DOI 10.1037/prj0000131; Wade NG, 2011, J COUNS PSYCHOL, V58, P170, DOI 10.1037/a0022630; Zinzow HM, 2012, CLIN PSYCHOL REV, V32, P741, DOI 10.1016/j.cpr.2012.09.002	29	9	9	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.		2019	31	1					11	17		10.1080/08995605.2018.1522927			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	IB3ZS	WOS:000470208400002					2022-02-06	
J	Servia, L; Badia, M; Montserrat, N; Trujillano, J				Servia, L.; Badia, M.; Montserrat, N.; Trujillano, J.			Severity scores in trauma patients admitted to ICU. Physiological and anatomic models	MEDICINA INTENSIVA			Spanish	Article						Trauma; Scoring; Mortality prediction	APACHE-II; OUTCOME PREDICTION; RISK ADJUSTMENT; TRISS; MORTALITY; CARE; CLASSIFICATION; REGISTRY	Introduction: The goals of this project were to compare both the anatomic and physiologic severity scores in trauma patients admitted to intensive care unit (ICU), and to elaborate mixed statistical models to improve the precision of the scores. Methods: A prospective study of cohorts. The combined medical/surgical ICU in a secondary university hospital. Seven hundred and eighty trauma patients admitted to ICU older than 16 years of age. Anatomic models (ISS and HISS) were compared and combined with physiological models (T-RTS, APACHE II [APII], and MPM II). The probability of death was calculated following the TRISS method. The discrimination was assessed using ROC curves (ABC [CI 95%]), and the calibration using the Hosmer-Lemeshowis H test. The mixed models were elaborated with the tree classification method type Chi Square Automatic Interaction Detection. Results: A 14% global mortality was recorded. The physiological models presented the best discrimination values (APII of 0.87 [0.84-0.90]). All models were affected by bad calibration (P< .01). The best mixed model resulted from the combination of APII and ISS (0.88 [0.83-0.90]). This model was able to differentiate between a 7.5% mortality for elderly patients with pathological antecedents and a 25% mortality in patients presenting traumatic brain injury, from a pool of patients with APII values ranging from 10 to 17 and an ISS threshold of 22. Conclusions: The physiological models perform better than the anatomical models in traumatic patients admitted to the ICU. Patients with low scores in the physiological models require an anatomic analysis of the injuries to determine their severity. (C) 2017 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.	[Servia, L.; Badia, M.; Montserrat, N.] Hosp Arnau Vilanova, Serv Med Intens, Lleida, Spain; [Trujillano, J.] Univ Lleida, IRBLLEIDA, Lleida, Spain		Trujillano, J (corresponding author), Univ Lleida, IRBLLEIDA, Lleida, Spain.	jtruji@cmb.udl.es	Trujillano, Javier/A-4325-2010; Castello, Maria Badia/C-7234-2011; Badia, Mariona/AAB-5513-2020; Goixart, Lluis Servia/C-6561-2011	Trujillano, Javier/0000-0001-8071-7711; Badia, Mariona/0000-0002-0923-1417; Goixart, Lluis Servia/0000-0001-9513-1465			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brockamp T, 2013, CRIT CARE, V17, DOI 10.1186/cc12813; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P395, DOI 10.1016/j.medin.2015.11.003; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P327, DOI 10.1016/j.medin.2015.07.011; de Munter L, 2017, INJURY, V48, P221, DOI 10.1016/j.injury.2016.12.009; Dossett LA, 2009, INJURY, V40, P993, DOI 10.1016/j.injury.2009.03.004; Gabbe BJ, 2003, ANZ J SURG, V73, P944, DOI 10.1046/j.1445-1433.2003.02833.x; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kahloul M, 2014, EUR J EMERG MED, V21, P125, DOI 10.1097/MEJ.0b013e32836188ce; Kilgo PD, 2004, J TRAUMA, V57, P479, DOI 10.1097/01.TA.0000141024.96440.7C; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lefering R, 2012, CURR OPIN CRIT CARE, V18, P637, DOI 10.1097/MCC.0b013e3283585356; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; MCANENA OJ, 1992, J TRAUMA, V33, P504, DOI 10.1097/00005373-199210000-00003; Moore L, 2009, ANN SURG, V249, P1040, DOI 10.1097/SLA.0b013e3181a6cd97; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Paffrath T, 2014, INJURY S3, V45, P564; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Reiter A, 2004, J TRAUMA, V57, P375, DOI 10.1097/01.TA.0000104016.78539.94; RHEE KJ, 1990, CRIT CARE MED, V18, P827, DOI 10.1097/00003246-199008000-00006; Ringdal KG, 2013, INJURY, V44, P29, DOI 10.1016/j.injury.2011.12.024; Rozenfeld M, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041042; Trujillano J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-83; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204	34	9	9	0	2	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JAN-FEB	2019	43	1					26	34		10.1016/j.medin.2017.11.008			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HG8NX	WOS:000455260400005	29398167				2022-02-06	
J	Shen, XT; Yeung, HT; Lai, KO				Shen, Xuting; Yeung, Hoi Ting; Lai, Kwok-On			Application of Human-Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders	DEVELOPMENTAL NEUROBIOLOGY			English	Article						Synaptognenesis; Human-induced pluripotent stem cells (hiPSCs); autism spectrum disorder (ASD); schizophrenia (SCZ)	SCAFFOLDING PROTEIN SHANK3; NEURAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; DE-NOVO MUTATIONS; RETT-SYNDROME; MOUSE MODEL; SYNAPTIC PLASTICITY; DIRECTED DIFFERENTIATION; SCHIZOPHRENIA-PATIENTS; FUNCTIONAL MATURATION	Synapses are the basic structural and functional units for information processing and storage in the brain. Their diverse properties and functions ultimately underlie the complexity of human behavior. Proper development and maintenance of synapses are essential for normal functioning of the nervous system. Disruption in synaptogenesis and the consequent alteration in synaptic function have been strongly implicated to cause neurodevelopmental disorders such as autism spectrum disorders (ASDs) and schizophrenia (SCZ). The introduction of human-induced pluripotent stem cells (hiPSCs) provides a new path to elucidate disease mechanisms and potential therapies. In this review, we will discuss the advantages and limitations of using hiPSC-derived neurons to study synaptic disorders. Many mutations in genes encoding for proteins that regulate synaptogenesis have been identified in patients with ASDs and SCZ. We use Methyl-CpG binding protein 2 (MECP2), SH3 and multiple ankyrin repeat domains 3 (SHANK3) and Disrupted in schizophrenia 1 (DISC1) as examples to illustrate the promise of using hiPSCs as cellular models to elucidate the mechanisms underlying disease-related synaptopathy. (c) 2018 Wiley Periodicals, Inc.	[Shen, Xuting; Yeung, Hoi Ting; Lai, Kwok-On] Univ Hong Kong, Sch Biomed Sci, Fac Med, 21 Sassoon Rd, Hong Kong, Peoples R China; [Lai, Kwok-On] Univ Hong Kong, State Key Lab Brain & Cognit Sci, 21 Sassoon Rd, Hong Kong, Peoples R China		Lai, KO (corresponding author), Univ Hong Kong, Sch Biomed Sci, Fac Med, 21 Sassoon Rd, Hong Kong, Peoples R China.; Lai, KO (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, 21 Sassoon Rd, Hong Kong, Peoples R China.	laiko@hku.hk	Lai, Kwok-On/L-7468-2019; Lai, Kwok On/ABC-8046-2021	Lai, Kwok-On/0000-0002-4069-054X; 	Area of Excellence Scheme of the University Grants Committee of Hong Kong [AoE/M-604/16]; Research Grant Council Hong KongHong Kong Research Grants Council [GRF16100814, ECS 27119715, GRF 17135816]; Liu Po Shan/Dr. Vincent Liu Endowment Fund for Motor Neurone Disease	Contract grant sponsor: The Area of Excellence Scheme of the University Grants Committee of Hong Kong; contract grant AoE/M-604/16.; Contract grant sponsor: Research Grant Council Hong Kong; contract grant GRF16100814, ECS 27119715, GRF 17135816.; Contract grant sponsor: Liu Po Shan/Dr. Vincent Liu Endowment Fund for Motor Neurone Disease	Alam MP, 2010, EPIGENETICS-US, V5, P241, DOI 10.4161/epi.5.3.11417; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Alhebshi AH, 2014, NEUROSCI LETT, V570, P126, DOI 10.1016/j.neulet.2013.09.049; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Bayes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046683; Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Brouwer JR, 2007, EXP CELL RES, V313, P244, DOI 10.1016/j.yexcr.2006.10.002; Castro H, 2017, HUM MOL GENET, V26, P2133, DOI 10.1093/hmg/ddx108; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chandran JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108088; Chandrasekaran A, 2017, STEM CELL RES, V25, P139, DOI 10.1016/j.scr.2017.10.010; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chaste Pauline, 2012, Dialogues Clin Neurosci, V14, P281; Chen L, 2018, COMPR PSYCHIAT, V80, P155, DOI 10.1016/j.comppsych.2017.09.009; Chen M, 2018, J PROTEOMICS, V182, P21, DOI 10.1016/j.jprot.2018.04.032; Cheng J, 2014, J NEUROCHEM, V128, P798, DOI 10.1111/jnc.12523; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; CORNFORD ME, 1994, J CHILD NEUROL, V9, P424, DOI 10.1177/088307389400900419; Cortabitarte AD, 2017, AM J MED GENET B, V174, P390, DOI 10.1002/ajmg.b.32528; Costales JL, 2015, NEUROTHERAPEUTICS, V12, P620, DOI 10.1007/s13311-015-0352-z; Costas J, 2015, MOL PSYCHIATR, V20, P1486, DOI 10.1038/mp.2015.119; Crabtree GW, 2017, J NEUROSCI, V37, P4158, DOI 10.1523/JNEUROSCI.4345-15.2017; Dahlhaus R, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00041; Deans PJM, 2017, BIOL PSYCHIAT, V82, P49, DOI 10.1016/j.biopsych.2016.08.038; Devine MJ, 2016, J PHYSIOL-LONDON, V594, P5459, DOI 10.1113/JP272187; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Edgar JM, 2017, ACTA BIOMATER, V51, P237, DOI 10.1016/j.actbio.2017.01.040; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Entezam A, 2007, GENE, V395, P125, DOI 10.1016/j.gene.2007.02.026; Fang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31462; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gomez-Sintes R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00253; Gouder L, 2015, JOVE-J VIS EXP, DOI 10.3791/53197; Grabrucker S, 2014, EXP NEUROL, V253, P126, DOI 10.1016/j.expneurol.2013.12.015; Grobarczyk B, 2015, STEM CELL REV REP, V11, P774, DOI 10.1007/s12015-015-9600-1; Gu Q, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700175; Gunhanlar N, 2018, MOL PSYCHIATR, V23, P1336, DOI 10.1038/mp.2017.56; Haapaniemi E., 2018, NATURE MED, V1; Hashimoto-Torii K, 2014, NEURON, V82, P560, DOI 10.1016/j.neuron.2014.03.002; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hofrichter M, 2017, STEM CELL RES, V25, P72, DOI 10.1016/j.scr.2017.10.013; Hogberg HT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt365; Hookway TA, 2016, METHODS, V101, P11, DOI 10.1016/j.ymeth.2015.11.027; Hoveizi E, 2017, MOL NEUROBIOL, V54, P601, DOI 10.1007/s12035-015-9663-7; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Hunsaker MR, 2010, BEHAV BRAIN RES, V213, P263, DOI 10.1016/j.bbr.2010.05.010; Ihry R.J., 2018, NATURE MED, V1; Ishikawa M, 2017, J TISSUE ENG REGEN M, V11, P1766, DOI 10.1002/term.2072; Johnstone M, 2011, SCHIZOPHRENIA BULL, V37, P14, DOI 10.1093/schbul/sbq135; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Karimi P, 2017, J RES MED SCI, V22, DOI 10.4103/1735-1995.200272; Kathuria A, 2018, MOL PSYCHIATR, V23, P735, DOI 10.1038/mp.2017.185; Kazdoba TM, 2014, INTRACTABLE RARE DIS, V3, P118, DOI 10.5582/irdr.2014.01024; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kira J, 2017, MULT SCLER J, V23, P1300, DOI 10.1177/1352458517703803; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Krencik R, 2017, STEM CELL REP, V9, P1745, DOI 10.1016/j.stemcr.2017.10.026; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110; Lennertz L, 2012, EUR ARCH PSY CLIN N, V262, P117, DOI 10.1007/s00406-011-0233-3; Leong MF, 2016, ACTA BIOMATER, V46, P266, DOI 10.1016/j.actbio.2016.09.032; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li KJ, 2017, ACTA BIOMATER, V54, P117, DOI 10.1016/j.actbio.2017.02.032; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Lu HF, 2012, BIOMATERIALS, V33, P9179, DOI 10.1016/j.biomaterials.2012.09.006; Ludwig AL, 2014, HUM MOL GENET, V23, P3228, DOI 10.1093/hmg/ddu032; Ma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057865; Maher BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034053; Maki P, 2005, BRIT MED BULL, V73-74, P1, DOI 10.1093/bmb/ldh046; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Medda X, 2016, J BIOMOL SCREEN, V21, P804, DOI 10.1177/1087057116638029; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Muratore CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105807; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Norlelawati AT, 2015, PSYCHIAT INVEST, V12, P103, DOI 10.4306/pi.2015.12.1.103; Ohashi M, 2018, STEM CELL REP, V10, P1453, DOI 10.1016/j.stemcr.2018.04.001; Onay H, 2016, BALK J MED GENET, V19, P17, DOI 10.1515/bjmg-2016-0031; Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pedrosa E, 2011, J NEUROGENET, V25, P88, DOI 10.3109/01677063.2011.597908; Pellett S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14566; Peykov S, 2015, MOL PSYCHIATR, V20, P1489, DOI 10.1038/mp.2014.172; Pfrieger FW, 2009, CELL MOL LIFE SCI, V66, P2037, DOI 10.1007/s00018-009-0005-7; Pre D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103418; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roberts B, 2017, MOL BIOL CELL, V28, P2854, DOI 10.1091/mbc.E17-03-0209; Saetre P, 2008, SCHIZOPHR RES, V106, P237, DOI 10.1016/j.schres.2008.08.024; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schutte RJ, 2018, J NEUROSCI METH, V294, P91, DOI 10.1016/j.jneumeth.2017.07.019; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun AX, 2016, CELL REP, V16, P1942, DOI 10.1016/j.celrep.2016.07.035; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Tanaka Y, 2014, HUM MOL GENET, V23, P1045, DOI 10.1093/hmg/ddt500; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Uemura T, 2011, BIO-MED MATER ENG, V21, P333, DOI 10.3233/BME-2012-0680; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang Q, 2011, MOL CELL NEUROSCI, V48, P359, DOI 10.1016/j.mcn.2011.06.004; Washbourne P, 2015, NEUROPSYCHOPHARMACOL, V40, P4, DOI 10.1038/npp.2014.163; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Xu J., 2016, MOL PSYCHIAT; Yi F, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2669; Yu DY, 2006, BIOL CHEM, V387, P977, DOI 10.1515/BC.2006.121; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059685; Zhang F, 2006, AM J MED GENET B, V141B, P155, DOI 10.1002/ajmg.b.30274; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhang ZN, 2016, P NATL ACAD SCI USA, V113, P3185, DOI 10.1073/pnas.1521255113; Zhou Y, 2016, NEURON, V89, P147, DOI 10.1016/j.neuron.2015.11.023; Zhou YF, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0105-9	149	9	9	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451	1932-846X		DEV NEUROBIOL	Dev. Neurobiol.	JAN	2019	79	1			SI		20	35		10.1002/dneu.22644			16	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	HI6XV	WOS:000456599600003	30304570				2022-02-06	
J	Snyder, CW; Kauffman, JD; Pracht, EE; Danielson, PD; Ciesla, DJ; Chandler, NM				Snyder, Christopher W.; Kauffman, Jeremy D.; Pracht, Etienne E.; Danielson, Paul D.; Ciesla, David J.; Chandler, Nicole M.			Risk factors for avoidable transfer to a pediatric trauma center among patients 2 years and older	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Secondary overtriage; avoidable transfer; preventable transfer; pediatric trauma; traumatic brain injury	BRAIN-INJURY; TELEMEDICINE; MORTALITY; ADMISSION; CHILDREN; FLORIDA; SYSTEM; IMPACT; CARE	BACKGROUND Effective and sustainable pediatric trauma care requires systems of regionalization and interfacility transfer. Avoidable transfer, also known as secondary overtriage, occurs when a patient is transferred to a regional trauma center after initial evaluation at another facility that is capable of providing definitive care. The purpose of this study was to identify risk factors for avoidable transfer among pediatric trauma patients in southwest Florida. METHODS All pediatric trauma patients 2 years and older transferred from outlying hospitals to the emergency department of a single state-designated pediatric trauma center between 2009 and 2017 were obtained from the institutional registry. Transfers were classified as avoidable if the patient suffered only minor injuries (International Classification of Diseases-9th Rev. Injury Severity Score > 0.9), did not require invasive procedures or intensive care unit monitoring, and was discharged within 48 hours. Demographics and injury characteristics were compared for avoidable and nonavoidable transfers. Logistic regression was used to estimate the independent effects of age, sex, insurance type, mechanism of injury, diagnosis, within region versus out-of-region residence, suspected nonaccidental trauma, and abnormal Glasgow Coma Scale score on the risk of avoidable transfer. RESULTS A total of 3,876 transfer patients met inclusion criteria, of whom 1,628 (42%) were classified as avoidable. Among avoidable transfers, 29% had minor head injuries (isolated skull fractures, concussions, and mild traumatic brain injury not otherwise specified), and 58% received neurosurgery consultation. On multivariable analysis, the strongest risk factors for avoidable transfer were diagnoses of isolated skull fracture or concussion. Suspected nonaccidental trauma was predictive of nonavoidable transfer. CONCLUSION Among injured children 2 years and older, those with minor head injuries were at greatest risk for avoidable transfer. Many were transferred because of a perceived need for evaluation by a pediatric neurosurgeon. Future projects seeking to reduce avoidable transfers should focus on children with isolated skull fractures and concussions, in whom there is no suspicion of nonaccidental trauma.	[Snyder, Christopher W.; Kauffman, Jeremy D.; Danielson, Paul D.; Chandler, Nicole M.] Johns Hopkins All Childrens Hosp, Div Pediat Surg, St Petersburg, FL USA; [Pracht, Etienne E.] Univ S Florida, Coll Publ Hlth, Tampa, FL USA; [Ciesla, David J.] Univ S Florida, Div Trauma & Acute Care Surg, Tampa, FL USA		Snyder, CW (corresponding author), Suite 306,601 5th St South, St Petersburg, FL 33701 USA.	csnyde21@jhmi.edu	Kauffman, Jeremy D./K-2113-2019				Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Boulanger B, 2001, J AM COLL SURGEONS, V192, P447, DOI 10.1016/S1072-7515(01)00796-7; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Falcone RA, 2016, J TRAUMA ACUTE CARE, V80, P433, DOI 10.1097/TA.0000000000000945; Farach SM, 2015, J SURG RES, V198, P13, DOI 10.1016/j.jss.2015.05.031; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Gagne M, 2016, J TRAUMA ACUTE CARE, V80, P419, DOI 10.1097/TA.0000000000000944; Goldstein SD, 2015, J PEDIATR SURG, V50, P1028, DOI 10.1016/j.jpedsurg.2015.03.028; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Halaweish I, 2018, J PEDIATR SURG, V53, P748, DOI 10.1016/j.jpedsurg.2017.07.008; HARRIS BH, 1989, J PEDIATR SURG, V24, P149, DOI 10.1016/S0022-3468(89)80235-0; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Kim PT, 2017, SEMIN PEDIATR SURG, V26, P47, DOI 10.1053/j.sempedsurg.2017.01.008; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LaBarbera JM, 2013, TELEMED E-HEALTH, V19, P760, DOI 10.1089/tmj.2012.0303; Larimer EL, 2013, J PEDIATR SURG, V48, P1357, DOI 10.1016/j.jpedsurg.2013.03.035; Leung ST, 2009, HUM PATHOL, V40, P1137, DOI 10.1016/j.humpath.2009.01.009; Lorch SA, 2010, PEDIATRICS, V126, P1182, DOI 10.1542/peds.2010-1119; Murphy EEK, 2015, J TRAUMA ACUTE CARE, V78, P930, DOI 10.1097/TA.0000000000000610; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Pracht EE, 2008, J PEDIATR SURG, V43, P212, DOI 10.1016/j.jpedsurg.2007.09.047; Schulman CI, 2013, TELEMED E-HEALTH, V19, P248, DOI 10.1089/tmj.2012.0102; Sharp NE, 2014, J PEDIATR SURG, V49, P1843, DOI 10.1016/j.jpedsurg.2014.09.035; Snyder CW, 2017, J TRAUMA ACUTE CARE, V83, P711, DOI 10.1097/TA.0000000000001580; Soundappan SVS, 2007, J TRAUMA, V62, P1229, DOI 10.1097/01.ta.0000219893.99386.fc; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	30	9	9	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2019	86	1					92	96		10.1097/TA.0000000000002087			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HG4HW	WOS:000454937100012	30312251				2022-02-06	
J	Sun, Y; Xiong, Y; Yan, CC; Chen, L; Chen, D; Mi, BB; Liu, GH				Sun, Yun; Xiong, Yuan; Yan, Chenchen; Chen, Lang; Chen, Dong; Mi, Bobin; Liu, Guohui			Downregulation of microRNA-16-5p accelerates fracture healing by promoting proliferation and inhibiting apoptosis of osteoblasts in patients with traumatic brain injury	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Traumatic brain injury; fracture; miRNA	MESENCHYMAL STEM-CELLS; BONE-FORMATION; HEAD-INJURY; DIFFERENTIATION; GROWTH; REGENERATION; OSTEOGENESIS; DEFICIENCY; FIBROBLAST; GENE	Patients who suffered a traumatic brain injury (TBI) show a faster fracture healing than patients with isolated fractures. Prior studies have suggested that this process may be accelerated through the inhibition of key microRNAs. In this study, we aimed to explore the mechanisms underlying this phenomenon, with a special focus on miR-16-5p, which is markedly decreased in patients with TBI. In vitro, miR-16-5p over-expression significantly inhibited cell proliferation in MC3T3-E1 cells transfected with agomiR-16-5p. Flow cytometry analysis further demonstrated that the overexpression of miR-16-5p induced cell cycle G1/S phase arrest and apoptosis. Moreover, target prediction and luciferase reporter assay demonstrated that miR-16-5p could negatively regulate Bcl-2 and Cyclin-D1 expression. Meanwhile, Bcl-2 and Cyclin-D1 were up-regulated after osteogenic differentiation while the down-regulation of endogenous Bcl-2 and Cyclin-D suppressed the osteogenic differentiation of MC3T3-E1 cells. In vivo, PBS, agomiR-16-5p and antagomiR-16-5p were injected into fracture sites to assess any improvements in fracture healing, which further confirmed the negative effect of miR-16-5p on fracture healing. Together, these results demonstrate miR-16-5p downregulation may accelerate fracture healing by enhancing the proliferation and inhibiting the apoptosis of osteoblasts in patients with both fractures and TBI. These phenomena may be exploited in the treatment of fractures.	[Xiong, Yuan; Yan, Chenchen; Chen, Lang; Chen, Dong; Mi, Bobin; Liu, Guohui] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Orthopaed, Union Hosp, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Sun, Yun] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurosurg, Union Hosp, Wuhan 430022, Hubei, Peoples R China		Mi, BB; Liu, GH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Orthopaed, Union Hosp, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	mi19882@163.com; liuguohui@hust.edu.cn	Xiong, Yuan/AAQ-3642-2021		Funds of Wuhan Union Hospital [02.03.2017-13]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772345]; Healthy Commission Key Project of Hubei Province [WJ2019Z009]; Science and Technology Department of Hubei Province [2016CFB424]; Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China [ZX-01-C2016024]	Our work was supported by the Funds of Wuhan Union Hospital (02.03.2017-13), the National Science Foundation of China (No. 81772345), Healthy Commission Key Project of Hubei Province (No. WJ2019Z009), Science and Technology Department of Hubei Province (No. 2016CFB424), Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China (ZX-01-C2016024).	Andermahr J, 2006, J NEUROTRAUM, V23, P708, DOI 10.1089/neu.2006.23.708; Aquino-Martinez R, 2019, J BONE MINER RES, V34, P135, DOI 10.1002/jbmr.3586; Arfat Y, 2018, MOL THER-NUCL ACIDS, V11, P323, DOI 10.1016/j.omtn.2017.11.009; Baek D, 2018, MOL THER-NUCL ACIDS, V13, P322, DOI 10.1016/j.omtn.2018.09.015; Cai PS, 2019, AM J TRANSL RES, V11, P865; Cheng YL, 2019, J BIOL CHEM, V294, P5890, DOI 10.1074/jbc.RA119.007516; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fan TT, 2018, CANCER SCI, V109, P2897, DOI 10.1111/cas.13725; Fernandez AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fushimi S, 2018, GENES CELLS, V23, P517, DOI 10.1111/gtc.12591; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Greenhough J, 2016, SCI REP, V6, P115; Gu ZY, 2019, AM J TRANSL RES, V11, P2603; Hadjiargyrou M, 2014, J BONE MINER RES, V29, P2307, DOI 10.1002/jbmr.2373; Iwamoto N, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1703-z; Jia HL, 2018, J CELL BIOCH; Lee E, 2016, J CELL BIOCHEM, V117, P2815, DOI 10.1002/jcb.25582; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Liu H, 2018, J CELL BIOCH; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Luo FT, 2018, MOL THER-NUCL ACIDS, V13, P291, DOI 10.1016/j.omtn.2018.09.012; Morgan EF, 2012, BONE, V51, P535, DOI 10.1016/j.bone.2012.05.008; Moriishi T, 2016, J BONE MINER RES, V31, P1366, DOI 10.1002/jbmr.2808; Nugent M, 2017, CALCIFIED TISSUE INT, V101, P355, DOI 10.1007/s00223-017-0296-x; Ru Y, 2017, ONCOTARGET, V8, P73860, DOI 10.18632/oncotarget.18008; Sabarimurugan S, 2018, MOL DIAGN THER, V22, P653, DOI 10.1007/s40291-018-0357-5; Seeliger C, 2016, STEM CELLS DEV, V25, P1261, DOI 10.1089/scd.2016.0133; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Seenprachawong K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00543; Song DH, 2019, AM J TRANSL RES, V11, P832; Song Y, 2017, EUR REV MED PHARMACO, V21, P1522; Strassburg S, 2017, J CELL BIOCHEM, V118, P1756, DOI 10.1002/jcb.25838; Tanaka T, 2003, CELL STRUCT FUNCT, V28, P165; Tuncer SB, 2019, MOL BIOL REP, V46, P975, DOI 10.1007/s11033-018-4554-4; Vi L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07666-0; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wang YX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1153-1; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yao CJ, 2018, BIOCHEM BIOPH RES CO, V501, P55, DOI 10.1016/j.bbrc.2018.04.138; Ye J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5311-3; Zha XL, 2018, J ORTHOP RES, V36, P417, DOI 10.1002/jor.23613; Zhan XH, 2017, ONCOTARGET, V8, P54788, DOI 10.18632/oncotarget.18510; Zhang J, 2018, AM J TRANSL RES, V10, P2796; Zhang R, 2018, THER CLIN RISK MANAG, V14, P2315, DOI 10.2147/TCRM.S182325; Zhang R, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0926-7; Zhang XH, 2016, GENET MOL RES, V15; Zhu XB, 2018, J CELL BIOCHEM, V119, P8346, DOI 10.1002/jcb.26910	50	9	10	4	16	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2019	11	8					4746	4760					15	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	IV0IV	WOS:000483963700011	31497196				2022-02-06	
J	Terry, DP; Huebschmann, NA; Maxwell, BA; Cook, NE; Mannix, R; Zafonte, R; Seifert, T; Berkner, PD; Iverson, GL				Terry, Douglas P.; Huebschmann, Nathan A.; Maxwell, Bruce A.; Cook, Nathan E.; Mannix, Rebekah; Zafonte, Ross; Seifert, Tad; Berkner, Paul D.; Iverson, Grant L.			Preinjury Migraine History as a Risk Factor for Prolonged Return to School and Sports following Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; migraine; mild traumatic brain injury; outcome; sport-related concussion	POSTCONCUSSION SYNDROME; POSTTRAUMATIC MIGRAINE; COGNITIVE IMPAIRMENT; RECOVERY; TIME; CHILDREN; EPIDEMIOLOGY; PATHOGENESIS; ASSOCIATION; PREDICTORS	Having a preexisting migraine disorder might be a risk factor for a prolonged recovery following a sport-related concussion. We examined whether having a migraine history was associated with a prolonged return to academics and athletics following a concussion. High school and collegiate athletes (n = 1265; 42% female) who sustained a sport-related concussion were monitored by athletic trainers using a web-based surveillance system that collects information about concussion recovery. Nonparametric Kolmogorov-Smirnov tests (KS) were used to compare days to return to academics/athletics across groups due to non-normally distributed outcome variables and unequal distributions of scores between groups. Chi-squared tests were used to examine the proportion of players who had not returned to academics/athletics at 7, 14, and 21 days post-injury stratified by self-reported migraine history. There were 117 athletes (9.2%) who reported a preinjury migraine history. Athletes with a history of migraine took a median of 6 days to return to academics (mean [M] = 10.6, standard deviation [SD] = 14.2) and 15.5 days to return to athletics (M = 23.8, SD = 30.8), while those with no migraine history took a median of 5 days to return to academics (M = 7.5, SD = 10.9) and 14 days to return to athletics (M = 19.4, SD = 19.4). There were no statistically significant differences in days to return to school or athletics between the groups (KS p > 0.05). However, a lower percentage of athletes with a history of migraine had returned to school after 7 days (57% vs. 68%, chi(2) = 5.53, p = 0.02), 14 days (75% vs. 88%, chi(2) = 14.21, p < 0.001), and 21 days post-injury (89% vs. 94%, chi(2) = 4.90, p = 0.03). Stratifying the analyses by sex showed that this effect was significant in girls and women with preexisting migraines, but not boys and men with preexisting migraines. There were no group differences in recovery rates when examining return to athletics. Athletes with a preinjury migraine history may be at an elevated risk for a protracted return to school after concussion, especially girls and women.	[Terry, Douglas P.; Cook, Nathan E.; Zafonte, Ross; Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Mannix, Rebekah] Harvard Med Sch, Div Emergency Med, Boston Childrens Hosp, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Brigham & Womens Hosp, Boston, MA USA; [Terry, Douglas P.; Zafonte, Ross; Iverson, Grant L.] Home Base, Boston, MA USA; [Terry, Douglas P.; Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children TM, Sport Concuss Program, Charlestown, MA USA; [Huebschmann, Nathan A.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Seifert, Tad] Norton Healthcare, Sports Neurol Program, Kentucky Boxing & Wrestling Commiss, Louisville, KY USA; [Mannix, Rebekah] Harvard Med Sch, Dept Pediat, Boston, MA USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Iverson, Grant/0000-0001-7348-9570			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; IBM Corp, 2012, IBM SPSS STAT MAC; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; TAYLOR AR, 1966, LANCET, V2, P178; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	44	9	9	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					142	151		10.1089/neu.2017.5443			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000453863000014	29732944				2022-02-06	
J	Ullucci, PA; Tudini, F; Moran, MF				Ullucci, Paul A.; Tudini, Frank; Moran, Matthew F.			Reliability of Smartphone Inclinometry to Measure Upper Cervical Range of Motion	JOURNAL OF SPORT REHABILITATION			English	Article						upper cervical spine; inclinometer; atlanto-axial joint; atlanto-occipital joint	FLEXION-ROTATION TEST; CONCUSSION; DIZZINESS; VALIDITY	Context: Assessment of upper cervical range of motion (UCROM) and mobility is commonly performed in the clinical setting for patients suffering from headache, neck pain, and vestibular dysfunction. Reliable and reproducible measurement of this motion is often difficult or too expensive to perform in the clinical setting. Smartphone applications using the device's internal gyroscope offer an easy and inexpensive means of measuring UCROM, but their reliability has not been reported in the literature. Objective: To assess the reliability of an inclinometer application installed on 2 different devices (iPhone 6 [IP] and android [AN]) and to measure UCROM in a healthy population. Design: Two examiners assessed passive UCROM. Each examiner was assigned to a specific smartphone, and a repeated-measures design consisting of 3 trials for each examiner-phone was performed. The order of testing was randomized, and the examiners were blinded to UCROM measures. Setting: Laboratory. Participants: A total of 38 subjects (19 females and 19 males; age: 23.8 [1.2] y) without pain or injury to the neck or spine for at least 3 months. Intervention: Each examiner passively flexed the head fully, rotated the head fully in 1 direction, and then in another. Peak rotation measures were recorded from each smartphone. Three trials were performed for each phone, with a 2-minute break between examiners/phones. Main Outcome Measures: Intraclass correlation coefficient using a 2-way mixed, absolute agreement model was obtained (1) between each examiner-phone and (2) within each examiner-phone for the measurements in each rotation direction. Results: Interphone/examiner reliability comparing average peak and total UCROM for each device was excellent (.87, .81). Intraphone/examiner reliability, determined across 3 trials, was also excellent (AN right rot. = .91, AN left rot. = .96; IP right rot. = .98, IP left rot. = .95). Conclusion: UCROM can be reliably measured using a smartphone inclinometer application.	[Ullucci, Paul A.; Moran, Matthew F.] Sacred Heart Univ, Dept Phys Therapy & Human Movement Sci, Fairfield, CT 06825 USA; [Tudini, Frank] Campbell Univ, Buies Creek, NC 27506 USA		Ullucci, PA (corresponding author), Sacred Heart Univ, Dept Phys Therapy & Human Movement Sci, Fairfield, CT 06825 USA.	ulluccip@sacredheart.edu	Tudini, Frank/ABG-8099-2021; Ullucci, Paul A./AAR-1570-2021	Tudini, Frank/0000-0003-4192-4595; Ullucci, Paul A./0000-0003-1930-6520; Moran, Matthew/0000-0002-7909-4083			Amiri M, 2003, MANUAL THER, V8, P176, DOI 10.1016/S1356-689X(03)00009-2; Blanpied Peter R, 2017, J Orthop Sports Phys Ther, V47, pA1, DOI 10.2519/jospt.2017.0302; Endo K, 2006, EUR SPINE J, V15, P886, DOI 10.1007/s00586-005-0970-y; Ernst MJ, 2015, MANUAL THER, V20, P547, DOI 10.1016/j.math.2014.12.005; Hall T, 2004, MANUAL THER, V9, P197, DOI 10.1016/j.math.2004.04.004; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Ogince M, 2007, MANUAL THER, V12, P256, DOI 10.1016/j.math.2006.06.016; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Tousignant-Laflamme Y, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-69; Wellmon RH, 2016, J SPORT REHABIL, V25, P371, DOI 10.1123/jsr.2015-0041	10	9	9	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2019	28	1								10.1123/jsr.2018-0048			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HI8SR	WOS:000456726700002	30040023	Green Published			2022-02-06	
J	Urban, JE; Kelley, ME; Espeland, MA; Davenport, EM; Whitlow, CT; Powers, AK; Maldjian, JA; Stitzel, JD				Urban, Jillian E.; Kelley, Mireille E.; Espeland, Mark A.; Davenport, Elizabeth M.; Whitlow, Christopher T.; Powers, Alexander K.; Maldjian, Joseph A.; Stitzel, Joel D.			In-Season Variations in Head Impact Exposure among Youth Football Players	JOURNAL OF NEUROTRAUMA			English	Article						biomechanics; football; head impact exposure; impact magnitude; pediatric	HIGH-SCHOOL FOOTBALL; PROFESSIONAL FOOTBALL; WHITE-MATTER; BIOMECHANICS; CONCUSSION; SPORT; INJURY; PARTICIPATION; EPIDEMIOLOGY; ADOLESCENCE	Head impact exposure (HIE) is often summarized by the total exposure measured during the season and does not indicate how the exposure was accumulated, or how it varied during the season. Therefore, the objective of this study was to compare HIE during pre-season, the first and second halves of the regular season, and playoffs in a sample of youth football players (n=119, aged 9-13 years). Athletes were divided into one of four exposure groups based on quartiles computed from the distribution of risk-weighted cumulative exposure (RWECP). Mean impacts per session and mean 95th percentile linear and rotational acceleration in practices and games were compared across the four exposure groups and time frames using mixed effects models. Within games, the mean 95th percentile accelerations for the entire sample ranged from 47.2g and 2331.3rad/sec(2) during pre-season to 52.1g and 2533.4rad/sec(2) during the second half of regular season. Mean impacts per practice increased from pre-season to the second half of regular season and declined into playoffs among all exposure groups; however, the variation between time frames was not greater than two impacts per practice. Time of season had a significant relationship with mean 95th percentile linear and rotational acceleration in games (both, p=0.01) but not with practice accelerations or impacts per session. The in-practice mean levels of 95th percentile linear and rotational acceleration remained fairly constant across the four time frames, but in games these changed over time depending on exposure group (interactions, p0.05). The results of this study improve our understanding of in-season variations in HIE in youth football and may inform important opportunities for future interventions.	[Urban, Jillian E.; Kelley, Mireille E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Clin & Translat Sci Inst, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA; [Urban, Jillian E.; Kelley, Mireille E.; Whitlow, Christopher T.; Stitzel, Joel D.] Virginia Tech, Wake Forest Sch Biomed Engn & Sci, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA; [Davenport, Elizabeth M.; Maldjian, Joseph A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA		Urban, JE (corresponding author), Virginia Tech, Wake Forest Sch Biomed Engn & Sci, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	jurban@wakehealth.edu			National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421]; Childress Institute for Pediatric Trauma at Wake Forest BaptistMedical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under award numbers R01NS094410 and R01NS082453. The National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR001421 supported Dr. Jillian Urban. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Special thanks to the Childress Institute for Pediatric Trauma at Wake Forest BaptistMedical Center for providing support for this study. The authors would like to thank the leaders, coaches, parents, athletes, and athletic trainers (Mary Kopacki, LAT, ATC and Erica Cheramie, LAT, ATC) of the youth football organization for their continued support for our efforts. The authors would also like to thank Kamah Woelfel, Amanda Dunn, Matt Bennett, Meghan Thompson, Eliza Szuch, Danielle Rocheleau, Joeline Kane, Katie Fabian, Ana Katsafanas, Megan Anderson, and Leslie Hoyt for their valuable assistance in data collection.	Agel J, 2013, CLIN J SPORT MED, V23, P33, DOI 10.1097/JSM.0b013e3182717983; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dawes NP, 2014, J YOUTH ADOLESCENCE, V43, P1374, DOI 10.1007/s10964-013-9980-y; Gabbett TJ, 2007, J SPORT SCI, V25, P1507, DOI 10.1080/02640410701215066; Gunnoe Aimee J., 2001, J Athl Train, V36, P150; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kay MC, 2017, J ATHL TRAINING, V52, P117, DOI 10.4085/1062-6050-52.1.01; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Oudejans RRD, 2011, ANXIETY STRESS COPIN, V24, P59, DOI 10.1080/10615806.2010.481331; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Steiner ME, 2016, SPORTS HEALTH, V8, P217, DOI 10.1177/1941738115626689; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; THEEBOOM M, 1995, J SPORT EXERCISE PSY, V17, P294, DOI 10.1123/jsep.17.3.294; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wagnsson S, 2014, J SPORT EXERCISE PSY, V36, P584, DOI 10.1123/jsep.2013-0137	41	9	9	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					275	281		10.1089/neu.2018.5699			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800010	29921164	Green Published			2022-02-06	
J	Wicker, E; Benton, L; George, K; Furlow, W; Villapol, S				Wicker, Evan; Benton, Leah; George, Kershina; Furlow, William; Villapol, Sonia			Serum Amyloid A Protein as a Potential Biomarker for Severity and Acute Outcome in Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article								Traumatic brain injury (TBI) causes a wide variety of neuroinflammatory events. These neuroinflammatory events depend, to a greater extent, on the severity of the damage. Our previous studies have shown that the liver produces serum amyloid A (SAA) at high levels in the initial hours after controlled cortical impact (CCI) injury in mice. Clinical studies have reported detectable SAA in the plasma of brain injury patients, but it is not clear if SAA levels depend on TBI severity. To evaluate this question, we performed a mild to severe CCI injury in wild-type mice. We collected blood samples and brains at 1, 3, and 7 days after injury for protein detection by western blotting, enzyme-linked immunosorbent assay, or immunohistochemical analysis. Our results showed that severe CCI injury compared to mild CCI injury or sham mice caused an increased neuronal death, larger lesion volume, increased microglia/macrophage density, and augmented neutrophil infiltration. Furthermore, we found that the serum levels of SAA protein ascended in the blood in correlation with high neuroinflammatory and neurodegenerative responses. Altogether, these results suggest that serum SAA may be a novel neuroinflammation-based, and severity-dependent, biomarker for acute TBI.	[Wicker, Evan] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Benton, Leah; George, Kershina; Furlow, William] Georgetown Univ, MS Biochem & Mol Biol Program, Washington, DC USA; [Villapol, Sonia] Houston Methodist Res Inst, Ctr Neuroregenerat, Houston, TX 77030 USA; [Villapol, Sonia] Houston Methodist Res Inst, Dept Neurosurg, Houston, TX 77030 USA		Villapol, S (corresponding author), Houston Methodist Res Inst, Ctr Neuroregenerat, Houston, TX 77030 USA.; Villapol, S (corresponding author), Houston Methodist Res Inst, Dept Neurosurg, Houston, TX 77030 USA.	ew521@georgetown.edu; ju17ben@gmail.com; kershina@gmail.com; wfurlow@emory.edu; svillapol@houstonmethodist.org		Villapol, Sonia/0000-0002-6174-4113; Wicker, Evan/0000-0003-4242-7849	National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS095038]; Master's Degree in Biochemistry and Molecular Biology Program at Georgetown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS095038] Funding Source: NIH RePORTER	This work was supported by R03NS095038 (Sonia Villapol) Grant from the National Institute for Neurological Disorders and Stroke (NINDS). We thank the Master's Degree in Biochemistry and Molecular Biology Program at Georgetown University for the support.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Aly H, 2011, J PERINATOL, V31, P263, DOI 10.1038/jp.2010.130; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; BERGER R, 2002, THE JOURNAL OF HEAD, V21, P315; CHUNG T, 2002, AMYLOID, V7, P105; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Hardardottir I, 1997, BBA-LIPID LIPID MET, V1344, P210, DOI 10.1016/S0005-2760(96)00143-9; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; LEVITON A, 2002, JOURNAL OF PEDIATRIC, V158, P897, DOI DOI 10.1016/J.JPEDS.2010.11.059; Leviton A, 2013, J CHILD NEUROL, V28, P1637, DOI 10.1177/0883073812463068; LIANG J, 2002, NEUROSCIENCE LETTERS, V225, P73; MEEK R, 2002, THE AMERICAN JOURNAL, V135, P411; PAPA L, 2002, JSA, V24, P108, DOI DOI 10.1097/JSA.0000000000000117; Pascrell Jr B., 2001, SOCIETY, V98, P47; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; de Castro MRT, 2017, J PHYSIOL-LONDON, V595, P6023, DOI 10.1113/JP273933; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Yamada T, 2006, THE JAPANESE, V54, P509	35	9	9	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2019	2019								5967816	10.1155/2019/5967816			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	HV9QH	WOS:000466316800001	31119176	Green Submitted, Green Published, gold			2022-02-06	
J	Zysk, M; Clausen, F; Aguilar, X; Sehlin, D; Syvanen, S; Erlandsson, A				Zysk, Marlena; Clausen, Fredrik; Aguilar, Ximena; Sehlin, Dag; Syvanen, Stina; Erlandsson, Anna			Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid-beta; inflammation; Morris water maze; neurodegeneration astrocytes; PET; traumatic brain injury	AMYLOID-BETA; POSTTRAUMATIC SEIZURES; ANIMAL-MODELS; DEPOSITION; INFLAMMATION; NEUROGENESIS; AGGREGATION; ACTIVATION; HYPOTHESIS; ASTROCYTES	Alzheimer's disease (AD) is the leading cause of dementia worldwide, affecting over 10% of the elderly population. Epidemiological evidence indicates that traumatic brain injury (TBI) is an important risk factor for developing AD later in life. However, which injury-induced processes that contribute to the disease onset remains unclear. The aim with the present study was to identify cellular processes that could link TBI to AD development, by investigating the chronic impact of two different injury models, controlled cortical impact (CCI) and midline fluid percussion injury (mFPI). The trauma was induced in 3-month-old tg-ArcSwe mice, carrying the Arctic mutation along with the Swedish mutation, and the influence of TBI on AD progression was analyzed at 12- and 24-weeks post-injury. The long-term effect of the TBI on memory deficiency, amyloid-beta (A beta) pathology, neurodegeneration and inflammation was investigated by Morris water maze, PET imaging, immunohistochemistry, and biochemical analyses. Morris water maze analysis demonstrated that mice subjected to CCI or mFPI performed significantly worse than uninjured tg-ArcSwe mice, especially at the later time point. Moreover, the injured mice showed a late upregulation of reactive gliosis, which concurred with a more pronounced A beta pathology, compared to uninjured AD mice. Our results suggest that the delayed glial activation following TBI may be an important link between the two diseases. However, further studies in both experimental models and human TBI patients will be required to fully elucidate the reasons why TBI increases the risk of neurodegeneration.	[Zysk, Marlena; Aguilar, Ximena; Sehlin, Dag; Syvanen, Stina; Erlandsson, Anna] Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab, Uppsala, Sweden; [Clausen, Fredrik] Uppsala Univ, Dept Neurosci, Rudbeck Lab, Uppsala, Sweden		Erlandsson, A (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Mol Geriatr, Rudbeck Lab, SE-75185 Uppsala, Sweden.			Zysk, Marlena/0000-0002-0270-2503; Clausen, Fredrik/0000-0003-3592-4417; Syvanen, Stina/0000-0002-8196-4041	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Alzheimer Foundation; Ahlen Foundation; Hedlund's Foundation; Swedish Brain Foundation; Uppsala Berzelii Center; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	This study was supported by grants from the Swedish Research Council, the Swedish Alzheimer Foundation, Ahlen Foundation, Hedlund's Foundation, the Swedish Brain Foundation, and the Uppsala Berzelii Center. We are grateful to Lars N.G. Nilsson, who developed and characterized the mouse model. The molecular imaging work in this study was performed at SciLifeLab Pilot Facility for Preclinical PET-MRI, a Swedish nationally available imaging platform at Uppsala University, Sweden, financed by the Knut and Alice Wallenberg Foundation.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Chun H, 2018, NEUROSCI RES, V126, P44, DOI 10.1016/j.neures.2017.11.012; Collins JM, 2019, J NEUROTRAUM, V36, P1876, DOI 10.1089/neu.2018.5982; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Filley CM, 2018, J ALZHEIMERS DIS, V65, P345, DOI 10.3233/JAD-180287; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hartman RE, 2002, J NEUROSCI, V22, P10083; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Hultqvist G, 2017, THERANOSTICS, V7, P308, DOI 10.7150/thno.17155; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Laforce R, 2018, ALZHEIMERS DEMENT, V14, P1522, DOI 10.1016/j.jalz.2018.06.2855; Lannfelt L, 2010, NUTR REV, V68, pS128, DOI 10.1111/j.1753-4887.2010.00347.x; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lopez-Toledano MA, 2010, J ALZHEIMERS DIS, V20, P395, DOI 10.3233/JAD-2010-1388; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meier SR, 2018, J NUCL MED, V59, P1885, DOI 10.2967/jnumed.118.213140; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nikitidou E, 2017, J ALZHEIMERS DIS, V60, P305, DOI 10.3233/JAD-170278; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Olsen M, 2018, MOL IMAGING BIOL, V20, P605, DOI 10.1007/s11307-017-1153-z; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Philipson O, 2010, FEBS J, V277, P1389, DOI 10.1111/j.1742-4658.2010.07564.x; Powell MA, 2018, NEUROSCIENCE, V371, P106, DOI 10.1016/j.neuroscience.2017.11.045; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; RAMSAY RR, 1991, BIOCHEMISTRY-US, V30, P4624, DOI 10.1021/bi00232a038; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Sehlin D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10759; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sollvander S, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0098-z; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Verkhratsky A, 2015, NEUROCHEM RES, V40, P389, DOI 10.1007/s11064-014-1403-2; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387	60	9	9	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	72	1					161	180		10.3233/JAD-190572			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT1TQ	WOS:000500780700014	31561367	Green Published			2022-02-06	
J	Dai, JB; Li, AY; Haider, SF; Tomaselli, R; Gometz, A; Sobotka, S; Post, AF; Adams, R; Maniya, AY; Lau, GK; Kaye-Kauderer, HP; Lovell, MR; Choudhri, TF				Dai, Jennifer B.; Li, Adam Y.; Haider, Syed F.; Tomaselli, Raechel; Gometz, Alex; Sobotka, Stanislaw; Post, Alexander F.; Adams, Ryan; Maniya, Akbar Y.; Lau, George K.; Kaye-Kauderer, Halley P.; Lovell, Mark R.; Choudhri, Tanvir F.			Effects of Game Characteristics and Player Positions on Concussion Incidence and Severity in Professional Football	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; epidemiology; American football; home versus away; games missed	LONG-TERM; SPORTS; HOME	Background: Increasing efforts have been made to reduce the incidence and severity of concussion in high-contact sports. Despite these efforts, a relative lack of knowledge is available regarding modulating factors affecting concussion injury. Purpose: To analyze the potential influence of game characteristics and outcomes on concussion incidence and severity in professional football. Study Design: Descriptive epidemiology study. Methods: PBS Frontline Concussion Watch was used to collect concussion injury data from regular-season games of 32 National Football League (NFL) teams from 2012 to 2015. Game characteristic variables such as rushing and passing attempts, turnovers, and margin of victory were collected from ESPN. Analysis included descriptive statistics, analysis of variance, t tests, and correlation tests. Results: Away teams demonstrated a significantly greater concussion incidence per game than home teams. Losing teams had a significantly greater concussion incidence per game than winning teams. Being both the away team and the losing team appeared to have an additive effect. The home-versus-away and win-versus-loss effects were significant for offensive but not defensive positions. Within individual positions, significantly greater concussion incidence was associated with tight ends, running backs, wide receivers, and cornerbacks. When running versus passing positions were compared, passing positions (wide receiver, tight end, cornerback, safety) had significantly greater concussion incidence. A total of 626 games were missed as a result of reported concussions. Away teams had significantly more games missed due to concussion when they lost. Play time did not significantly differ before or after concussion injury. Other game characteristic variables did not significantly affect concussion frequency or intensity. Conclusion: Position, game location, and game outcome affect concussion incidence for professional football players. In a subset of analyses, the number of games missed aligned with concussion incidence, but this appeared to be an imperfect measure. These findings highlight new factors that may modulate concussion incidence and merit further study on how they may influence concussion evaluation.	[Dai, Jennifer B.; Li, Adam Y.; Haider, Syed F.; Tomaselli, Raechel; Gometz, Alex; Sobotka, Stanislaw; Post, Alexander F.; Adams, Ryan; Maniya, Akbar Y.; Lau, George K.; Kaye-Kauderer, Halley P.; Lovell, Mark R.; Choudhri, Tanvir F.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Choudhri, Tanvir F.] 1468 Madison Ave,Annenberg Bldg,8th Floor,Room 88, New York, NY 10029 USA; [Dai, Jennifer B.; Li, Adam Y.; Haider, Syed F.; Maniya, Akbar Y.; Kaye-Kauderer, Halley P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Tomaselli, Raechel; Gometz, Alex] Concuss Management New York, New York, NY USA; [Lau, George K.] Touro Coll Osteopath Med, New York, NY USA; [Lovell, Mark R.] ImPACT Applicat Inc, Pittsburgh, PA USA		Choudhri, TF (corresponding author), 1468 Madison Ave,Annenberg Bldg,8th Floor,Room 88, New York, NY 10029 USA.	tanvir.choudhri@mountsinai.org	Li, Adam Y./AAS-6860-2020	Li, Adam Y./0000-0001-7654-1469; Kaye-Kauderer, Halley/0000-0003-1387-9336			Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Carre JM, 2009, AM J HUM BIOL, V21, P392, DOI 10.1002/ajhb.20867; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Diamond AB, 2014, PHYSICIAN SPORTSMED, V42, P20, DOI 10.3810/psm.2014.09.2071; Jones MB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3432-6; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McClincy MP, 2009, BRAIN INJURY, V20, P33; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nevill AM, 2002, PSYCHOL SPORT EXERC, V3, P261, DOI 10.1016/S1469-0292(01)00033-4; Nevill AM, 1999, SPORTS MED, V28, P221, DOI 10.2165/00007256-199928040-00001; NFL Football Operations, HLTH SAF RUL CHANG; NFL Football Operations, 2018, 2018 RUL CHANG POINT; NFL Play Smart Play Safe, 2017, 2017 INJ DAT; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Ribeiro HV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152440; Teramoto M, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740862; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Valerio J, 2012, J HEAD TRAUMA REHAB, V27, P216, DOI 10.1097/HTR.0b013e3182229b6c	22	9	9	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 28	2018	6	12							2325967118815448	10.1177/2325967118815448			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HF8MU	WOS:000454497200001	30627588	Green Published, gold			2022-02-06	
J	Materne, M; Strandberg, T; Lundqvist, LO				Materne, Marie; Strandberg, Thomas; Lundqvist, Lars-Olov			Change in quality of life in relation to returning to work after acquired brain injury: a population-based register study	BRAIN INJURY			English	Article						Stroke; traumatic brain injury; vocational rehabilitation; rehabilitation; life satisfaction	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; COMMUNITY INTEGRATION; PARTICIPATION; EUROQOL; STROKE; SATISFACTION; DISABILITY; SUPPORT	Purpose: This study investigated changes in quality of life (QoL) in relation to return to work among patients with acquired brain injury (ABI). Method: The sample consisted of 1487 patients with ABI (63% men) aged 18-66 years (mean age 52) from the WebRehab Sweden national quality register database. Only patients who worked at least 50% at admission to hospital and were on full sick leave at discharge from hospital were included. QoL was measured by the EuroQol EQ-5D questionnaire. Results: Patients who returned to work perceived a larger improvement in QoL from discharge to follow-up one year after injury compared to patients who had not returned to work. This difference remained after adjustment for other factors associated with improved QoL, such as having a university education, increased Extended Glasgow Outcome Scale scores and getting one's driving licence reinstated. Conclusion: Return to work is an important factor for change in QoL among patients with ABI, even after adjusting for other factors related to QoL. This is consistent with the hypothesis that having employment is meaningful, increases self-esteem and fosters participation in society. Thus, helping patients with ABI return to work has a positive influence on QoL.	[Materne, Marie; Lundqvist, Lars-Olov] Reg Orebro Cty, Univ Hlth Care Res Ctr, Orebro, Sweden; [Strandberg, Thomas; Lundqvist, Lars-Olov] Orebro Univ, Sch Law Psychol & Social Work, Orebro, Sweden; [Materne, Marie; Strandberg, Thomas; Lundqvist, Lars-Olov] Orebro Univ, Swedish Inst Disabil Res, Orebro, Sweden		Materne, M (corresponding author), Orebro Univ, Univ Hlth Care Res Ctr, Fac Med & Hlth, Box 1613, S-70116 Orebro, Sweden.	marie.materne@regionorebrolan.se	Lundqvist, Lars-Olov/M-8547-2014	Lundqvist, Lars-Olov/0000-0002-6703-7575; Materne, Marie/0000-0002-7048-1925	University Health Care Research Centre, Region Orebro County, Sweden	The authors report no conflict of interest. This study was supported by grants from the University Health Care Research Centre, Region Orebro County, Sweden.	Vieira RDA, 2013, REV LAT-AM ENFERM, V21, P868, DOI 10.1590/S0104-11692013000400006; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arwert HJ, 2017, J OCCUP REHABIL, V27, P239, DOI 10.1007/s10926-016-9651-4; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Campbell M., 2000, REHABILITATION TRAUM; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Edwards Dorothy F, 2006, J Stroke Cerebrovasc Dis, V15, P151, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.001; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Ferrans C E, 1990, Oncol Nurs Forum, V17, P15; FORTUNE N, 1999, DEFINITION INCIDENCE; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Franzen-Dahlin A, 2012, J CLIN NURS, V21, P2386, DOI 10.1111/j.1365-2702.2011.04064.x; Fride Y, 2015, TOP STROKE REHABIL, V22, P317, DOI 10.1179/1074935714Z.0000000013; Gabriele W, 2009, DISABIL REHABIL, V31, P1487, DOI 10.1080/09638280802621432; Gerber GJ, 2016, BRAIN INJURY, V30, P1552, DOI 10.1080/02699052.2016.1199896; Gould KR, 2015, BRAIN INJURY, V29, P283, DOI 10.3109/02699052.2014.974671; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hilari K, 2003, APHASIOLOGY, V17, P365, DOI 10.1080/02687030244000725; Jae-Hyun K, 2015, HEALTH QUAL LIFE OUT, V12, P1; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Kumar KS, 2017, COCHRANE DB SYST REV, V6; Mar J, 2011, BMC NEUROL, V11, P1, DOI [10.1186/1471-2377-11-1, DOI 10.1186/1471-2377-11-1]; Martin Bland Bland M., 2015, INTRO MED STAT, V4th; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Materne M, 2016, J SOC WORK DISABIL R, V15, P351, DOI 10.1080/1536710X.2016.1220880; McDowell I., 1996, MEASURING HLTH GUIDE; Norrving B., 2010, FOREKOMST BEFOLKNING; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Socialstyrelsen, 2007, TERMB; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization Quality of Life Group, 1993, QUAL LIFE RES, V2, P6; Zafonte RD, 2007, BRAIN INJURY MED PRI	45	9	9	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1731	1739		10.1080/02699052.2018.1517224			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600016	30296173	hybrid, Green Published			2022-02-06	
J	El-Menyar, A; Asim, M; Latifi, R; Bangdiwala, SI; Al-Thani, H				El-Menyar, Ayman; Asim, Mohammad; Latifi, Rifat; Bangdiwala, Shrikant I.; Al-Thani, Hassan			Predictive value of positive high-sensitivity troponin T in intubated traumatic brain injury patients	JOURNAL OF NEUROSURGERY			English	Article						cardiac troponin; high-sensitivity troponin T; traumatic brain injury; intubation; head; vascular disorders	ELEVATED TROPONIN; MYOCARDIAL-INFARCTION; CARDIAC TROPONINS; BETA-BLOCKADE; DIAGNOSIS; MORTALITY; BIOMARKERS; PROGNOSIS; SURVIVAL; BLOCKERS	OBJECTIVE The clinical relevance of high-sensitivity troponin T (HsTnT) in trauma patients is not well explored. In this study, the authors aimed to study the predictive value of serum HsTnT in intubated patients who had sustained traumatic brain injury (TBI). METHODS A retrospective analysis was conducted for all intubated TBI patients between 2010 and 2014 at a national level 1 trauma center. Data were analyzed and compared based on the HsTnT status on admission (group 1, negative results; and group 2, positive results). Receiver operating characteristic curves were used to determine sensitivity, specificity, and cutoff level of HsTnT to predict mortality. Time to earlier discharge from hospital or death was modeled using Cox proportional hazard models to describe the relationship between HsTnT and in-hospital mortality. RESULTS Of the 826 intubated TBI patients, 490 underwent HsTnT testing; 65.7% had positive HsTnT results. Patients in group 2 had a higher Injury Severity Score (p = 0.001) and head Abbreviated Injury Scale (AIS) score (p = 0.004) than those in group 1. In addition, group 2 patients were more likely to have lower Glasgow Coma Scale scores (p = 0.001) and more likely to experience intraventricular hemorrhage, brain edema, pneumonia, and sepsis (p = 0.001). HsTnT values positively correlated with head AIS score (r = 0.19, p = 0.001) and varied by the type of lesion and time to death. Ventilator days and length of hospital stay were more prolonged in group 2 patients (p = 0.001). Area under the curve (AUC) analysis showed that HsTnT = 26.5 ng/L predicted all-cause mortality (AUC 0.75, 95% CI 0.699-0.801) with 80% sensitivity. Positive HsTnT was an independent predictor of mortality in multivariate models (adjusted OR 3.10, 95% CI 1.308-7.351) even after excluding chest injury (adjusted OR 4.18, 95% CI 1.320-13.231). CONCLUSIONS Positive HsTnT results are associated with poor outcomes in intubated patients with TBI. In this subset of patients, measuring serum HsTnT on admission is a useful tool for early risk stratification and expedited care; however, further prospective studies are warranted.	[El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Clin Res, Trauma Surg Sect, Dept Surg, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Sch Qatar, Dept Clin Med, Doha, Qatar; [Latifi, Rifat] Westchester Med Ctr, Dept Surg, Valhalla, NY USA; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA; [Bangdiwala, Shrikant I.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA; [Al-Thani, Hassan] Hamad Gen Hosp, Trauma Surg Sect, Dept Surg, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Bangdiwala, Shrikant/0000-0002-3111-0689; Latifi, Rifat/0000-0003-1091-3682			Ahmed AN, 2014, ANN MED, V46, P653, DOI 10.3109/07853890.2014.959558; Al-Otaiby MA, 2011, J SAUDI HEART ASSOC, V23, P3, DOI 10.1016/j.jsha.2010.10.001; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Bakshi TK, 2002, INTERN MED J, V32, P520, DOI 10.1046/j.1445-5994.2002.00270.x; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; Carlton EW, 2015, HEART, V101, P1041, DOI 10.1136/heartjnl-2014-307288; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; de Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262, DOI 10.1001/jama.2013.5809; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; El-Menyar AA, 2007, SAUDI MED J, V28, P1763; Garrett MC, 2010, NEUROCRIT CARE, V12, P199, DOI 10.1007/s12028-009-9245-5; Giannitsis E, 2013, NAT REV CARDIOL, V10, P623, DOI 10.1038/nrcardio.2013.129; Gorgun E, 2016, ANN SURG, V264, P605, DOI 10.1097/SLA.0000000000001854; Hays A, 2006, NEUROLOGY, V66, P1330, DOI 10.1212/01.wnl.0000210523.22944.9b; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Korley Frederick K, 2016, EJIFCC, V27, P217; Lippi G, 2013, INT J CARDIOL, V168, P1617, DOI 10.1016/j.ijcard.2013.01.018; Mahmood I, 2016, N AM J MED SCI, V8, P17, DOI 10.4103/1947-2714.175188; Mannu GS, 2014, SCOT MED J, V59, P172, DOI 10.1177/0036933014540090; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; Miketic JK, 2010, AM J CRIT CARE, V19, P522, DOI 10.4037/ajcc2010156; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Nagele P, 2013, AM HEART J, V166, P325, DOI 10.1016/j.ahj.2013.04.018; Poe S, 2015, J INVEST MED, V63, P905, DOI 10.1097/JIM.0000000000000239; Ramappa P, 2008, NEUROCRIT CARE, V8, P398, DOI 10.1007/s12028-007-9038-7; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Schuiling WJ, 2005, J NEUROL NEUROSUR PS, V76, P1565, DOI 10.1136/jnnp.2004.060913; Smith Andria, 2009, W V Med J, V105, P29; Soufer Robert, 2009, Curr Cardiol Rep, V11, P133; Tanindi A, 2011, VASC HEALTH RISK MAN, V7, P597, DOI 10.2147/VHRM.S24509; White HD, 2011, J AM COLL CARDIOL, V57, P2406, DOI 10.1016/j.jacc.2011.01.029; Xu B, 2013, AUST FAM PHYSICIAN, V42, P554; Xu RY, 2013, J GERIATR CARDIOL, V10, P102, DOI [10.3724/SP.J.1263.2012.11101, 10.3969/j.issn.1671-5411.2013.01.015]; Zhelev Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h15	41	9	9	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2018	129	6					1541	1549		10.3171/2017.7.JNS17675			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE4YU	WOS:000453376800018	29303440	Bronze			2022-02-06	
J	Ghorbani, M; Shahabi, P; Ebrahimi-kalan, A; Soltani-Zangbar, H; Mahmoudi, J; Bani, S; Sadeghzadeh-Oskouei, B; Rafiee-Byraami, Y; Salimi, O				Ghorbani, Meysam; Shahabi, Parviz; Ebrahimi-kalan, Abass; Soltani-Zangbar, Hamid; Mahmoudi, Javad; Bani, Soheila; Sadeghzadeh-Oskouei, Behnaz; Rafiee-Byraami, Yusef; Salimi, Omid			Induction of traumatic brain and spinal cord injury models in rat using a modified impactor device	PHYSIOLOGY AND PHARMACOLOGY			English	Article						Spinal cord injury; Traumatic brain injury; Modified impactor	CONTROLLED CORTICAL IMPACT; CONTUSION MODEL; RESPONSES	Introduction: The use of standard rodent model, allows for the understanding of neuronal injury physiopathology and helping development of therapeutic strategies. Because of eliminating technical problems, we designed a modified impactor device with ability to induce different degrees according to kilodyne from very mild to very severe of spinal cord injury (SCI) and traumatic brain injury (TBI) models in rat. Methods: For standardization and determining of optimal performance of the device to induce varying injuries, 47 adult male Wistar rats were used, and 8 different forces were applied in spinal cord and brain tissues. Results: The hematoxylin and eosin and 2, 3, 5-triphenyltetrazolium chloride (TTC) results demonstrated that by increasing the level of forces, histological changes in the spinal cord and brain were significantly enhanced. Different injuries had significant effect on the Basso-Beattie-Brenham and elevated body swing test outcomes, and there were significant differences between groups in comparison with control group. Conclusion: Our results showed that the modified device could be valid to produce precise SCI and TBI models, goal to replicate SCI and TBI in humans as much as possible. However, it might be considered that aspects of SCI and TBI models are complicate and more examination is necessary.	[Ghorbani, Meysam; Shahabi, Parviz; Ebrahimi-kalan, Abass; Soltani-Zangbar, Hamid; Mahmoudi, Javad; Bani, Soheila; Rafiee-Byraami, Yusef; Salimi, Omid] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Ebrahimi-kalan, Abass] Tabriz Univ Med Sci, Fac Adv Med Sci, Neurosci Dept, Tabriz, Iran; [Sadeghzadeh-Oskouei, Behnaz] Tabriz Univ Med Sci, Fac Nursing & Midwifery, Tabriz, Iran		Shahabi, P (corresponding author), Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran.	shahabip@tbzmed.ac.ir	Mahmoudi, Javad/M-4680-2017		Neuroscience Research Center at Tabriz University of Medical Sciences; Tabriz University of Medical Sciences [5/4/11472]	We would like to thank from Saeid Feyzizadeh for technical assistant. We would also like to thank from Neuroscience Research Center at Tabriz University of Medical Sciences technical and financial supports. This work has supported by Tabriz University of Medical Sciences (Grant number: 5/4/11472).	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dunham KA, 2010, J NEUROTRAUM, V27, P2091, DOI 10.1089/neu.2010.1424; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Khuyagbaatar B, 2015, J NEUROTRAUM, V32, P1987, DOI 10.1089/neu.2015.3875; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JHT, 2012, JOVE-J VIS EXP, DOI 10.3791/3313; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin YP, 2015, NEURAL REGEN RES, V10, P1088, DOI 10.4103/1673-5374.160100; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NOYES DH, 1987, MED BIOL ENG COMPUT, V25, P335, DOI 10.1007/BF02447434; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Rabchevsky AG, 2003, J NEUROTRAUM, V20, P659, DOI 10.1089/089771503322144572; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; STOKES BT, 1992, J NEUROTRAUM, V9, P129, DOI 10.1089/neu.1992.9.129; STOKES BT, 1992, J NEUROTRAUM, V9, P187, DOI 10.1089/neu.1992.9.187; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; van Gorp S, 2014, SPINAL CORD, V52, P524, DOI 10.1038/sc.2014.72; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu GL, 2004, BRAIN RES, V1015, P50, DOI 10.1016/j.brainres.2004.04.055; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	43	9	9	1	1	IRANIAN SOC PHYSIOLOGY & PHARMACOLOGY	TEHRAN	PO BOX 19615-1178, TEHRAN, 00000, IRAN	2476-5236	2476-5244		PHYSIOL PHARMACOL	Physiol. Pharmacol.	DEC	2018	22	4					228	239					12	Physiology	Emerging Sources Citation Index (ESCI)	Physiology	HL7OO	WOS:000458931100003					2022-02-06	
J	Moran, RN; Covassin, T				Moran, Ryan N.; Covassin, Tracey			King-Devick test normative reference values and internal consistency in youth football and soccer athletes	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						concussion; head injury; neurology; vision screening; youth	TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; AMATEUR RUGBY UNION; BASE-LINE; CONCUSSION; MANAGEMENT; LEAGUE	The King-Devick (K-D) test has gained popularity as a sideline concussion assessment tool, comprising of visual tracking and saccadic eye movements. However, limited normative data exist for youth athletes under the age of 13. The purpose of this study was to establish normative reference values and examine the internal consistency of the K-D test in youth athletes. The K-D test was administered to 422 youth football and soccer athletes prior to their respective season. The average K-D score was 54.29 +/- 11.5 seconds. Across the two trials, 55% of participants committed at least one error. Overall, the K-D test demonstrated a high internal consistency (Cronbach alpha = 0.92) when administered at baseline. Inter-item correlations revealed a moderate-to-strong relationship between test cards and trials (r range = 0.71 to 0.95; P < 0.001), along with test cards and baseline K-D time (r range = 0.85 to 0.94; P < 0.001). Although the K-D test was consistent during baseline testing, the high percentage of errors at baseline makes the K-D test questionable for post-concussion comparisons.	[Moran, Ryan N.] Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, Tuscaloosa, AL 35487 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, Sports Injury Res Lab, E Lansing, MI 48824 USA		Moran, RN (corresponding author), Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, Tuscaloosa, AL 35487 USA.	rnmoran@ches.ua.edu			Michigan State University College of Education; Michigan State University Graduate School	Michigan State University College of Education and the Graduate School; Michigan State University's College of Education and the Graduate School	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Baumgartner T. A., 1999, MEASUREMENT EVALUATI; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750	17	9	9	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2018	28	12					2686	2690		10.1111/sms.13286			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GZ9ST	WOS:000449842400025	30153344				2022-02-06	
J	Snoeck, F; Szymanska, KJ; Sarrazin, S; Ortiz-Escribano, N; Leybaert, L; Van Soom, A				Snoeck, Feline; Szymanska, Katarzyna Joanna; Sarrazin, Steven; Ortiz-Escribano, Nerea; Leybaert, Luc; Van Soom, Ann			Blocking connexin channels during vitrification of immature cat oocytes improves maturation capacity after warming	THERIOGENOLOGY			English	Article						Connexins; Vitrification; Cryopreservation; Felids; Parthenogenesis	GAP-JUNCTION CHANNELS; IN-VITRO MATURATION; DOMESTIC CAT; INTERCELLULAR COMMUNICATION; EMBRYO DEVELOPMENT; MIMETIC PEPTIDES; CUMULUS CELLS; CRYOPRESERVATION; HEMICHANNELS; BLASTOCYSTS	In the domestic cat, nuclear maturation and embryo development after vitrification of immature oocytes have been obtained but developmental competence after warming remains low. It has been reported that during folliculogenesis, the association and communication between the oocyte and the surrounding cumulus cells through connexin-based gap junctions is essential for normal oocyte and follicular development. Gap junctions result from the head-to-head interaction of two hemichannels; however, there is always a population of hemichannels not incorporated into gap junctions. These unopposed hemichannels are normally closed but may open under certain stress conditions, potentially also during vitrification and warming, turning them into toxic pores inducing cell injury and cell death. The aim of our study was to test whether inhibiting connexin 37 (Cx37) and connexin 43 (Cx43) channels with the connexin-targeting peptide Gap26 during vitrification and warming of cat immature cumulusoocyte-complexes (COCs) could improve oocyte maturation and competence of resultant blastocysts derived by parthenogenetic activation. In the first experiment, our immunostainings confirmed the presence of Cx43 protein in the cytoplasm of immature cat oocytes and in the plasma membranes of cumulus cells. In the second experiment, COCs were randomly divided in three different groups: a control group (control), a group vitrified without Gap26 (vitrified) and a group vitrified with Gap26 (vitrified-peptide). The maturation rate was checked and oocytes from all three different experimental groups were parthenogenetically activated and cultured in vitro until day 8. After vitrification and warming, 49% of the oocytes in the control group matured, while this was 8% and 19% in the vitrified and vitrified-peptide groups, respectively. Compared to the vitrified group, oocytes in the vitrified-peptide group had significantly larger maturation rates. No blastocysts were detected at day 8 in the vitrified group, while 2% and 13% of the oocytes further developed to blastocyst at day 8 in the vitrified-peptide and control non-vitrified group, respectively. We conclude that the use of Gap26 in vitrification and warming media to vitrify immature cat oocytes improves maturation success and allows such oocytes to reach the blastocyst stage (2%) at day 8 after parthenogenetic activation. (C) 2018 Elsevier Inc. All rights reserved.	[Snoeck, Feline; Sarrazin, Steven; Ortiz-Escribano, Nerea; Van Soom, Ann] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, Merelbeke, Belgium; [Szymanska, Katarzyna Joanna; Leybaert, Luc] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, Physiol Grp, Ghent, Belgium		Snoeck, F (corresponding author), Salisburylaan 133, B-9820 Merelbeke, Belgium.	feline.snoeck@ugent.be			'Agentschap voor Innovatie door Wetenschap en Technologie' grant [131495]	The authors would like to thank Petra Van Damme and Isabel Lemahieu for their excellent technical assistance. All collaborating veterinarians are acknowledged for collection of the cat ovaries. This work was funded by the 'Agentschap voor Innovatie door Wetenschap en Technologie' grant 131495.	Ackert CL, 2001, DEV BIOL, V233, P258, DOI 10.1006/dbio.2001.0216; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Alves AE, 2012, REPROD DOMEST ANIM, V47, P1003, DOI 10.1111/j.1439-0531.2012.02006.x; Bol M, 2013, EUR J VASC ENDOVASC, V45, P382, DOI 10.1016/j.ejvs.2012.12.012; Brambillasca F, 2013, J ASSIST REPROD GEN, V30, P1531, DOI 10.1007/s10815-013-0112-0; Cocchia N, 2010, CRYOBIOLOGY, V60, P229, DOI 10.1016/j.cryobiol.2010.01.003; Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P269, DOI 10.1111/j.1439-0531.2009.01372.x; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; Du Y, 2008, REPRODUCTION, V135, P13, DOI 10.1530/REP-07-0362; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Filliers M, 2012, REPROD FERT DEVELOP, V24, P691, DOI 10.1071/RD11068; Galiguis J, 2014, CRYOBIOLOGY, V68, P459, DOI 10.1016/j.cryobiol.2014.02.012; Gittens JEI, 2003, AM J PHYSIOL-CELL PH, V284, pC880, DOI 10.1152/ajpcell.00277.2002; Gu RH, 2017, CRYOBIOLOGY, V75, P144, DOI 10.1016/j.cryobiol.2016.12.009; Hansen DB, 2014, FEBS LETT, V588, P1446, DOI 10.1016/j.febslet.2014.01.036; Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008; Luciano AM, 2009, CRYOBIOLOGY, V59, P90, DOI 10.1016/j.cryobiol.2009.05.002; Luvoni GC, 2006, THERIOGENOLOGY, V66, P101, DOI 10.1016/j.theriogenology.2006.03.012; Luvoni GC, 2000, THERIOGENOLOGY, V53, P1529, DOI 10.1016/S0093-691X(00)00295-8; Martins L, 2007, BIOL REPROD, P142; Merlo B, 2008, THERIOGENOLOGY, V70, P126, DOI 10.1016/j.theriogenology.2008.03.009; Murakami M, 2004, CRYOBIOLOGY, V48, P341, DOI 10.1016/j.crybiol.2004.02.012; Nuttinck F, 2000, MOL REPROD DEV, V57, P60, DOI 10.1002/1098-2795(200009)57:1&lt;60::AID-MRD9&gt;3.0.CO;2-6; Ortiz-Escribano N, 2018, EQUINE VET J, V50, P391, DOI 10.1111/evj.12747; Ortiz-Escribano N, 2016, THERIOGENOLOGY, V86, P635, DOI 10.1016/j.theriogenology.2016.02.015; Ortiz-Escribano N, 2017, BIOL REPROD, V96, P288, DOI 10.1095/biolreprod.116.144121; Pope CE, 2012, THERIOGENOLOGY, V77, P531, DOI 10.1016/j.theriogenology.2011.08.028; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Santos ECS, 2018, REPROD DOMEST ANIM, V53, P304, DOI 10.1111/rda.13105; Snoeck F, 2017, REPROD DOMEST ANIM, V52, P98, DOI 10.1111/rda.12827; Sowinska N, 2017, REPROD DOMEST ANIM, V52, P108, DOI 10.1111/rda.12895; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Tharasanit T, 2011, THERIOGENOLOGY, V76, P1442, DOI 10.1016/j.theriogenology.2011.06.014; Veitch GI, 2004, J CELL SCI, V117, P2699, DOI 10.1242/jcs.01124; Wood TC, 1997, J REPROD FERTIL, V110, P355, DOI 10.1530/jrf.0.1100355; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	39	9	9	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0093-691X	1879-3231		THERIOGENOLOGY	Theriogenology	DEC	2018	122						144	149		10.1016/j.theriogenology.2018.09.011			6	Reproductive Biology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Reproductive Biology; Veterinary Sciences	GY5PM	WOS:000448632900022	30268031				2022-02-06	
J	Sullivan, L; Pursell, L; Molcho, M				Sullivan, L.; Pursell, L.; Molcho, M.			Evaluation of a theory-based concussion education program for secondary school student-athletes in Ireland	HEALTH EDUCATION RESEARCH			English	Article							SPORT-RELATED CONCUSSION; RECURRENT CONCUSSION; FOOTBALL PLAYERS; HOCKEY PLAYERS; KNOWLEDGE; INTERVENTION; PREVENTION; BEHAVIOR; DEPRESSION; BRAIN	Concussion education is an important aspect of concussion prevention. The purpose of this study was to investigate the effect of a novel, theory of planned behavior (TPB)-driven concussion education program on secondary school athletes' concussion-reporting relevant cognitions immediately post-intervention and at 3 months follow-up. Data were collected from 428 secondary school athletes during the 2016-2017 academic year: 229 were assigned to an intervention group of which 59 (25.76%) completed assessments at all timepoints; 199 were assigned to a control group of which 153 (76.88%) completed assessments at all timepoints. Using repeated measures ANOVAs, we examined differences in athletes' concussion-reporting cognitions, by group and gender. The program had a significant positive effect on athletes' knowledge (P < 0.01), perceived behavioral control over concussion recognition and reporting (P < 0.01), and reporting intention (P < 0.01). These results were maintained at 3 months follow-up, with the exception of perceived behavioral control. The program did not have a significant effect on athletes' attitudes toward concussion reporting and subjective reporting norms. Results suggest that the TPB may be a useful framework to inform the development of more effective educational programs. There is a need for multi-layered interventions that aim to create sporting environments that encourage positive concussion care seeking behaviors.	[Sullivan, L.; Pursell, L.] Natl Univ Ireland Galway, Coll Arts Social Sci & Celt Studies, Sch Hlth Sci, Discipline Hlth Promot,Languages,Cultures, Univ Rd, Galway, Ireland; [Molcho, M.] Natl Univ Ireland Galway, Coll Arts Social Sci & Celt Studies, Childrens Studies Programme, Languages,Cultures,Sch Languages, Univ Rd, Galway, Ireland		Sullivan, L (corresponding author), Natl Univ Ireland Galway, Coll Arts Social Sci & Celt Studies, Sch Hlth Sci, Discipline Hlth Promot,Languages,Cultures, Univ Rd, Galway, Ireland.	l.sullivan2@nuigalway.ie	Pursell, Lisa/AAU-7978-2020	Pursell, Lisa/0000-0002-2894-6303	Government of Ireland Postgraduate Scholarship Scheme [GOIPG/2014/914]	This work was supported by the Government of Ireland Postgraduate Scholarship Scheme [Grant number GOIPG/2014/914].	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2015, HEALTH PSYCHOL REV, V9, P131, DOI 10.1080/17437199.2014.883474; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bartholomew LK, 1998, HEALTH EDUC BEHAV, V25, P545, DOI 10.1177/109019819802500502; Blake C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-74; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Eaton LA, 2008, AM J PUBLIC HEALTH, V13, P141; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kok G, 2004, J HEALTH PSYCHOL, V9, P85, DOI 10.1177/1359105304038379; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Leppink J, 2016, PERSPECT MED EDUC, V5, P347, DOI 10.1007/s40037-016-0308-y; Lipsey M.W., 2001, PRACTICAL META ANAL; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Mrazik M, 2015, BRIT J SPORT MED; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schwarzer R, 2008, EUR PSYCHOL, V13, P141, DOI 10.1027/1016-9040.13.2.141; Sniehotta FF, 2014, HEALTH PSYCHOL REV, V8, P1, DOI 10.1080/17437199.2013.869710; Sullivan L, 2016, INT J ADOLESC MED HL, V29; Sullivan L, 2018, J SPORT HEALTH SCI, V7, P102, DOI 10.1016/j.jshs.2017.05.003; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280	50	9	9	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1153	1465-3648		HEALTH EDUC RES	Health Educ. Res.	DEC	2018	33	6					492	504		10.1093/her/cyy034			13	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	HI8EN	WOS:000456688200008	30346610	Bronze			2022-02-06	
J	Taylor, BN; Rasnake, N; McNutt, K; McKnight, CL; Daley, BJ				Taylor, Bryce N.; Rasnake, Niki; McNutt, Kelly; McKnight, Catherine Lindsay; Daley, Brian J.			Rapid Ground Transport of Trauma Patients: A Moderate Distance From Trauma Center Improves Survival	JOURNAL OF SURGICAL RESEARCH			English	Article						Blunt trauma; Emergency medical services; Aeromedical transportation	UNITED-STATES; BRAIN-INJURY; GOLDEN HOUR; HELICOPTER; MORTALITY; TIME	Background: There is debate within the emergency medical services (EMS) community over the value of calling a helicopter for trauma patients within a moderate distance/<45 min, of a trauma center. Helicopter EMS (HEMS) generally have a wider scope and more advanced training than the ground EMS (GEMS). GEMS, on the other hand, have the benefit of being able to immediately initiate rapid transport to the trauma center without the delay involved with HEMS flying to the scene, landing, and assuming patient care. Methods: We retrospectively analyzed patients brought to a level I trauma center who were admitted with blunt traumatic injuries between 2010 and 2015 in the Trauma Quality Improvement Program database. Two analyses were performed, one in which the patient's reported initial scene vitals met criteria for step one of the Centers for Disease Control's 2011 National Field Triage Guidelines (NFTG) and the other in which the patient's initial scene vitals met those same guidelines and/or had a pulse greater than 110 beats per minute. Patients were categorized on scene to emergency department (ED) transport mode, either HEMS or GEMS. Inclusion criteria were a HEMS response time to the scene that was between 15 and 45 min with a transport time from the scene to the ED that was between 10 and 35 min or a GEMS transport time from the scene to the ED that was between 15 and 45 min. Statistical significance (P < 0.05) was established through logit regression. Mortality rates were then calculated within each transport mode-based population. Results: Four hundred subjects were included in the analysis of patients meeting the first step of the NFTG, with 212 HEMS patients and 188 in the GEMS group. HEMS had a higher mortality rate at 0.184 and GEMS at 0.101, which was statistically significant (P = 0.019). When 606 subjects meeting the first step of the NFTG or with a pulse greater than 110 beats per minute were analyzed, the results were statistically significant (P < 0.001), with the HEMS category having a higher mortality rate at 0.154 and the GEMS category having a lower mortality at 0.056. Conclusions: Our data demonstrate that scene-to-ED time is paramount, and rapid ground transport should be used in blunt trauma patients when the scene is up to a moderate ground distance away from the trauma center and there would be a moderate-to-prolonged HEMS response time. In both analyses, hemodynamically unstable trauma patients had lower rates of mortality following ground transport. We recognize that there may be a subset of patients at these distances who could benefit from HEMS response, particularly if the flight crew can offer more advanced and specialized techniques; however, every effort should be made to minimize the scene-to-ED time, and HEMS response, scene, and transport time must be considered. This study only analyzed the patients within a moderate distance of the trauma center and at longer distances or in different environments; HEMS transport may indeed minimize the scene to ED time. (C) 2018 Elsevier Inc. All rights reserved.	[Taylor, Bryce N.; Rasnake, Niki; McNutt, Kelly; McKnight, Catherine Lindsay; Daley, Brian J.] Univ Tennessee, Med Ctr Knoxville, 1924 Alcoa Highway, Knoxville, TN USA; [Taylor, Bryce N.] Lincoln Mem Univ, DeBusk Coll Osteopath Med, 6965 Cumberland Gap Pkwy, Harrogate, TN 37752 USA		Taylor, BN (corresponding author), 350 North Wesley Dr Apartment 1234, League City, TX 77571 USA.; Taylor, BN (corresponding author), Lincoln Mem Univ, DeBusk Coll Osteopath Med, 6965 Cumberland Gap Pkwy, Harrogate, TN 37752 USA.	bryce.taylor@lmunet.edu					Alarhayem AQ, 2016, AM J SURG, V212, P1101, DOI 10.1016/j.amjsurg.2016.08.018; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brown JB, 2016, J TRAUMA ACUTE CARE, V81, P93, DOI 10.1097/TA.0000000000000999; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Cheung BH, 2014, ACAD EMERG MED, V21, P1232, DOI 10.1111/acem.12512; Gaieski DF, 2016, DEFINITION CLASSIFIC; Galvagno SM, 2013, CRIT CARE, V17, DOI 10.1186/cc12779; Galvagno SM, 2013, SURV ANESTHESIOL, V57, P12; Garwe T, 2017, PREHOSP EMERG CARE, V21, P734, DOI 10.1080/10903127.2017.1332123; Gerecht R, 2014, J EMERG MED SERV; Hannay RS, 2014, CAN J SURG, V57, P49, DOI 10.1503/cjs.000113; Howard JT, 2018, J TRAUMA ACUTE CARE, V84, P11, DOI 10.1097/TA.0000000000001727; MedEvac Facts, 2015, LEARN HEL SPEED FUEL; Michailidou M, J PEDIAT SURG; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; NOLAN JP, 2014, BR MED J, V348; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Petrie David A, 2007, Air Med J, V26, P50, DOI 10.1016/j.amj.2006.10.005; Pham Hannah, 2017, Trauma Surg Acute Care Open, V2, pe000122, DOI 10.1136/tsaco-2017-000122; Rhinehart ZJ, 2013, ANN SURG, V257, P1147, DOI 10.1097/SLA.0b013e31827ee6b0; Rose MK, 2012, AM SURGEON, V78, P794; Sasser SM, 2011, MMWR-MORBID MORTAL W, V61, P1; Talving P, 2010, WORLD J SURG, V34, P1731, DOI 10.1007/s00268-010-0511-7; Thomas SH, 2014, PREHOSP EMERG CARE, V18, P35, DOI 10.3109/10903127.2013.844872	25	9	9	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2018	232						318	324		10.1016/j.jss.2018.06.055			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GY1YP	WOS:000448333700044	30463735				2022-02-06	
J	Williams, CN; Piantino, J; McEvoy, C; Fino, N; Eriksson, CO				Williams, Cydni N.; Piantino, Juan; McEvoy, Cynthia; Fino, Nora; Eriksson, Carl O.			The Burden of Pediatric Neurocritical Care in the United States	PEDIATRIC NEUROLOGY			English	Article						Pediatric; Critical care; Neurology; Traumatic brain injury; Stroke	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; CONVULSIVE STATUS EPILEPTICUS; ARTERIAL ISCHEMIC-STROKE; FUNCTIONAL STATUS SCALE; INTENSIVE-CARE; SEVERE SEPSIS; RISK-FACTORS; CHILDREN; OUTCOMES	BACKGROUND: Disorders requiring pediatric neurocritical care (PNCC) affect thousands of children annually. We aimed to quantify the burden of PNCC through generation of national estimates of disease incidence, utilization of critical care interventions (CCI), and hospital outcomes. METHODS: We performed a retrospective cohort analysis of the Kids Inpatient Database over three years to evaluate pediatric traumatic brain injury, neuro-infection or inflammatory diseases, status epilepticus, stroke, hypoxic ischemic injury after cardiac arrest, and spinal cord injury. We evaluated use of CCI, death, length of stay, hospital charges, and poor functional outcome defined as receipt of tracheostomy or gastrostomy or discharge to a medical care facility. RESULTS: At least one CCI was recorded in 67,058 (23%) children with a primary neurological diagnosis, and considered a PNCC admission. Over half of PNCC admissions had at least one chronic condition, and 23% were treated in children's hospitals. Mechanical ventilation was the most common CCI, but utilization of CCIs varied significantly by diagnosis. Among PNCC admissions, 8110 (12%) children died during hospitalization and 14,067 (21%) children had poor functional outcomes. PNCC admissions cumulatively accounted for over 1.5 million hospital days and over $4 billion in hospital costs in the study years. Most PNCC admissions, across all diagnoses, had prolonged hospitalizations (more than one week) with an average cost of $39.9 thousand per admission. CONCLUSIONS: This large, nationally representative study shows PNCC diseases are a significant public health burden with substantial risk to children's health. More research is needed to improve outcomes in these vulnerable children. (C) 2018 Elsevier Inc. All rights reserved.	[Williams, Cydni N.; Eriksson, Carl O.] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Piantino, Juan] Div Pediat Neurol, Portland, OR USA; [McEvoy, Cynthia] Div Neonatol, Portland, OR USA; [Fino, Nora] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA		Williams, CN (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, CDRC P, 707 SW Gaines St, Portland, OR 97239 USA.	willicyd@ohsu.edu	Piantino, Juan/AAI-2184-2019	Piantino, Juan/0000-0002-8861-5709; Eriksson, Carl/0000-0002-1885-4800; Williams, Cydni/0000-0002-2049-7662	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL105447]; Office of Dietary SupplementsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01H L129060, UG3OD023288]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL105447, K12HL133115, R01HL129060] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UG3OD023288, UH3OD023288] Funding Source: NIH RePORTER	Dr. Williams is supported by the Agency for Healthcare Research and Quality (grant number K12HS022981). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. Dr. Piantino is supported by the National Heart, Lung and Blood Institute (grant number K12HL133115). Dr. McEvoy is supported by the National Heart, Lung and Blood Institute, R01 HL105447 with cofunding from the Office of Dietary Supplements, R01H L129060 and UG3OD023288.	Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Alievi PT, 2007, J PEDIAT-BRAZIL, V83, P505, DOI [10.1590/S0021-75572007000800005, 10.2223/JPED.1693]; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Ambuehl J, 2007, SWISS MED WKLY, V137, P312; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bardes JM, 2018, J PEDIATR SURG, V53, P1523, DOI 10.1016/j.jpedsurg.2017.09.017; Bell MJ, 2012, NEUROCRIT CARE, V17, P468, DOI 10.1007/s12028-012-9731-z; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bennett TD, 2017, PEDIATR CRIT CARE ME, V18, P442, DOI 10.1097/PCC.0000000000001120; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Buysse CMP, 2007, QUAL LIFE RES, V16, P1567, DOI 10.1007/s11136-007-9271-8; Cappell J, 2013, PEDIATR CLIN N AM, V60, P709, DOI 10.1016/j.pcl.2013.02.008; Centers for Disease Control, 2018, ACT BACT COR SURV; Chandee T, 2017, PEDIATR CRIT CARE ME, V18, P1166, DOI 10.1097/PCC.0000000000001350; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, pE85, DOI 10.1097/PCC.0b013e3182712997; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Cunha F, 2013, PEDIATR CRIT CARE ME, V14, pE8, DOI 10.1097/PCC.0b013e31826012b4; deVeber GA, 2017, PEDIATR NEUROL, V69, P58, DOI 10.1016/j.pediatrneurol.2017.01.016; Doucette A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152208; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Elliott D, 2014, CRIT CARE MED, V42, P2518, DOI 10.1097/CCM.0000000000000525; Farris RWD, 2013, PEDIATR CRIT CARE ME, V14, P835, DOI 10.1097/PCC.0b013e3182a551c8; Faul M, 2010, TRAUMATIC BRAIN INJU; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fink EL, 2016, RESUSCITATION, V107, P121, DOI 10.1016/j.resuscitation.2016.07.244; Fink EL, 2012, PEDIATR CRIT CARE ME, V13, P80, DOI 10.1097/PCC.0b013e3181fe27c7; Galgano MA, 2015, CUREUS, V7, DOI 10.7759/cureus.385; Hasegawa K, 2013, J PEDIATR-US, V163, P1127, DOI 10.1016/j.jpeds.2013.05.002; Hopkins RO, 2015, J PEDIATR INTENSIVE, V4, P204, DOI 10.1055/s-0035-1563547; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Knoester H, 2008, INTENS CARE MED, V34, P1076, DOI 10.1007/s00134-008-1061-4; Knoester H, 2007, EUR J PEDIATR, V166, P1119, DOI 10.1007/s00431-007-0573-1; Lanthier S, 2000, NEUROLOGY, V54, P371, DOI 10.1212/WNL.54.2.371; Larsen GY, 2016, NEUROCRIT CARE, V24, P353, DOI 10.1007/s12028-015-0218-6; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Nasr DM, 2014, PEDIATR NEUROL, V51, P624, DOI 10.1016/j.pediatrneurol.2014.07.030; Odetola FO, 2006, PEDIATRICS, V117, P1893, DOI 10.1542/peds.2005-2179; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Polic B, 2013, EUR J PEDIATR, V172, P85, DOI 10.1007/s00431-012-1843-0; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Sahin S, 2016, J TROP PEDIATRICS, V62, P94, DOI 10.1093/tropej/fmv076; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Statler KD, 2011, CHILD NERV SYST, V27, P565, DOI 10.1007/s00381-010-1292-x; Tasker RC, 2014, PEDIATR ANESTH, V24, P717, DOI 10.1111/pan.12398; Tijssen JA, 2015, RESUSCITATION, V94, P1, DOI 10.1016/j.resuscitation.2015.06.012; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Tully I, 2015, SEIZURE-EUR J EPILEP, V29, P153, DOI 10.1016/j.seizure.2015.04.002; Wainwright MS, 2016, CURR OPIN CRIT CARE, V22, P106, DOI 10.1097/MCC.0000000000000288; Wainwright MS, 2014, SEMIN PEDIATR NEUROL, V21, P248, DOI 10.1016/j.spen.2014.10.006; Williams C, 2012, J NEUROSURG-PEDIATR, V9, P524, DOI 10.3171/2012.1.PEDS11465; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083; Wilson JL, 2017, PEDIATR NEUROL, V69, P87, DOI 10.1016/j.pediatrneurol.2017.01.013	63	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	DEC	2018	89						31	38		10.1016/j.pediatrneurol.2018.07.013			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	HH6QP	WOS:000455856400006	30327237	Green Accepted			2022-02-06	
J	Zhao, H; Pan, WL; Chen, LH; Luo, YC; Xu, RX				Zhao, Hao; Pan, Wenlong; Chen, Lihua; Luo, Yongchun; Xu, Ruxiang			Nur77 promotes cerebral ischemia-reperfusion injury via activating INF2-mediated mitochondrial fragmentation	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Stroke; Nur77; Cerebral IR injury; Wnt; -catenin; INF2 axis; Mitochondrial fragmentation	TARGETED ANTIOXIDANT MITOQ; TRAUMATIC BRAIN-INJURY; APOPTOSIS; FISSION; MITOPHAGY; CATENIN; NR4A1; DRP1	Mitochondrial fragmentation drastically regulates mitochondrial homeostasis in brain illness. However, the role of mitochondrial fragmentation in cerebral ischemia-reperfusion (IR) injury remains unclear. Nur77, a regulator of mitochondrial homeostasis, is associated with heart and liver IR injury, but its effects on mitochondrial function in cerebral IR injury has not been studied intensively. The aim of our study is to explore whether cerebral IR injury is modulated by Nur77 via modification of mitochondrial homeostasis. Our results indicated that Nur77 was upregulated in reperfused brain tissues. Genetic ablation of Nur77 reduced infarction area and promoted neuron survival under IR burden. Biochemical analysis demonstrated that Nur77 deletion protected mitochondrial function, attenuated mitochondrial oxidative stress, preserved mitochondrial potential, and blocked mitochondria-related cell apoptosis. In addition, we illustrated that Nur77 mediated mitochondrial damage via evoking mitochondrial fragmentation that occurred through increased mitochondrial fission and decreased fusion. Besides, our results also demonstrated that Nur77 controlled mitochondrial fragmentation via upregulating INF2 in a manner dependent on the Wnt/-catenin pathway; inhibition of the Wnt pathway abrogated the protective effect of Nur77 deletion on reperfused-mediated neurons. Altogether, our study highlights that the pathogenesis of cerebral IR injury is associated with Nur77 activation followed by augmented mitochondrial fragmentation via an abnormal Wnt/-catenin/INF2 pathway. Accordingly, Nur77-dependent mitochondrial fragmentation and the Wnt/-catenin/INF2 axis may represent novel therapeutic targets to reduce cerebral IR injury.	[Zhao, Hao; Pan, Wenlong; Chen, Lihua; Luo, Yongchun; Xu, Ruxiang] PLA Army Gen Hosp, Dept Neurosurg, 5 Nanmencang Hutong, Beijing 100730, Peoples R China		Xu, RX (corresponding author), PLA Army Gen Hosp, Dept Neurosurg, 5 Nanmencang Hutong, Beijing 100730, Peoples R China.	xuruxiangzj@163.com	Zhao, Hao/AAE-5052-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100917]; Beijing Nova programBeijing Municipal Science & Technology Commission [Z171100001117096]	This study was supported by a grant from the National Natural Science Foundation of China (Grant No. 81100917) and Beijing Nova program (Z171100001117096).	Banta KL, 2018, J BIOL CHEM, V293, P4724, DOI 10.1074/jbc.RA117.001101; Bavarsad K, 2019, MOL NEUROBIOL, V56, P1391, DOI 10.1007/s12035-018-1169-7; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Chenn Anjen, 2008, Organogenesis, V4, P76; Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761; Fan JJ, 2017, NEUROSCI LETT, V647, P45, DOI 10.1016/j.neulet.2017.02.065; Gan L, 2018, TOXICOL APPL PHARM, V341, P1, DOI 10.1016/j.taap.2018.01.003; Garcia-Ruiz JM, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0605-6; Geng C., 2018, ACTA NEUROL BELG, DOI [10.1007/s13760-018-0944-6, DOI 10.1007/S13760-018-0944-6]; Ho DH, 2018, EXP NEUROBIOL, V27, P171, DOI 10.5607/en.2018.27.3.171; Hong H, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0649-7; Hu MJ, 2017, MOL CELL, V66, P141, DOI 10.1016/j.molcel.2017.03.008; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Jin QH, 2018, REDOX BIOL, V14, P576, DOI 10.1016/j.redox.2017.11.004; Jin XF, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006748; Jokinen R, 2017, REDOX BIOL, V12, P246, DOI 10.1016/j.redox.2017.02.011; Jovancevic N, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0600-y; Kang Z, 2014, NEUROSCIENCE, V267, P232, DOI 10.1016/j.neuroscience.2014.02.050; Lan R, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/4147502; Lee HY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12379; Lee K, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12392; Li RB, 2018, REDOX BIOL, V18, P229, DOI 10.1016/j.redox.2018.07.011; Martin JL, 2019, PEDIATR NEPHROL, V34, P1167, DOI 10.1007/s00467-018-3984-5; Nauta TD, 2017, ANGIOGENESIS, V20, P39, DOI 10.1007/s10456-016-9527-4; Park H, 2018, YONSEI MED J, V59, P736, DOI 10.3349/ymj.2018.59.6.736; Perez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00441; Reynolds MS, 2016, AM J PHYSIOL-ENDOC M, V311, pE186, DOI 10.1152/ajpendo.00022.2016; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Shen YQ, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12461; Shi ZY, 2017, INT J MOL MED, V40, P1699, DOI 10.3892/ijmm.2017.3158; Singh Varinder, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P403, DOI 10.1515/jbcpp-2017-0070; Steffen J, 2018, J CELL BIOL, V217, P15, DOI 10.1083/jcb.201711075; Stepanova A, 2017, J CEREBR BLOOD F MET, V37, P3649, DOI 10.1177/0271678X17730242; Tang YY, 2016, BRAIN RES, V1646, P73, DOI 10.1016/j.brainres.2016.05.042; Wei Z, 2015, INT J CLIN EXP PATHO, V8, P15599; Xing XS, 2015, MOL MED REP, V11, P3122, DOI 10.3892/mmr.2014.3000; Yu W, 2018, NEUROCHEM RES, V43, P420, DOI 10.1007/s11064-017-2437-z; Zhao H, 2018, CELL STRESS CHAPERON, V23, P1079, DOI 10.1007/s12192-018-0917-y; Zhou H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00755; Zhou H, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0682-1; Zhou H, 2018, ANGIOGENESIS, V21, P599, DOI 10.1007/s10456-018-9611-z; Zhou H, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12471; Zhou H, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12450; Zhou H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005328; Zhou J, 2018, AM J TRANSL RES, V10, P1887	46	9	9	2	22	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	DEC	2018	49	6					599	613		10.1007/s10735-018-9798-8			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GY7YQ	WOS:000448834400005	30298449				2022-02-06	
J	al-Dahhak, R; Khoury, R; Qazi, E; Grossberg, GT				al-Dahhak, Roula; Khoury, Rita; Qazi, Erum; Grossberg, George T.			Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer Disease	CLINICS IN GERIATRIC MEDICINE			English	Article						Traumatic brain injury; Concussion; Neurodegenerative disorders; Dementia; Chronic traumatic encephalopathy	ENVIRONMENTAL RISK-FACTORS; HEAD-INJURY; APOLIPOPROTEIN-E; UNITED-STATES; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; FRONTOTEMPORAL DEMENTIA; LEWY BODIES; DISABILITY; MANAGEMENT	Traumatic brain injury (TBI) is a major health and economic burden. With increasing aging population, this issue is expected to continue to increase. Neurodegenerative disorders are more common with aging population in general regardless of history of TBI. Recent evidence continues to support a relation between a TBI and neurocognitive decline later in life (such as in athletes and military). This article summarizes the pathologic and clinical effects of TBI (regardless of severity) on the later development of dementia in individuals 65 years or older.	[al-Dahhak, Roula] St Louis Univ, Dept Neurol, 1438 South Grand Blvd,Suite 105, St Louis, MO 63104 USA; [Khoury, Rita; Qazi, Erum; Grossberg, George T.] St Louis Univ, Dept Psychiat & Behav Neurosci, 1438 South Grand Blvd, St Louis, MO 63104 USA		al-Dahhak, R (corresponding author), St Louis Univ, Dept Neurol, 1438 South Grand Blvd,Suite 105, St Louis, MO 63104 USA.	roula.aldahhak@health.slu.edu		KHOURY, RITA/0000-0003-2481-6816			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Boot BP, 2013, NEUROLOGY, V81, P833, DOI 10.1212/WNL.0b013e3182a2cbd1; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Formisano R, 2014, J HEAD TRAUMA REHAB, V29, P387, DOI 10.1097/HTR.0000000000000027; Frank C, 2014, CAN MED ASSOC J, V186, P1369, DOI 10.1503/cmaj.131873; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123743; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; ICD-10, 2016, ICD 10; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Luz C, 2017, GERONTOLOGIST, V57, P211, DOI 10.1093/geront/gnv096; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mark Mather, 2015, POPULATION B, V70, P2; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; O'Neil ME, 2013, CLASSIFICATION TBI S; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rabin LA, 2017, ANNU REV CLIN PSYCHO, V13, P369, DOI 10.1146/annurev-clinpsy-032816-045136; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith Karen, 2012, JBI Libr Syst Rev, V10, P4610; Soble JR, 2017, PHYS MED REH CLIN N, V28, P339, DOI 10.1016/j.pmr.2016.12.009; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Straus LB., 2013, NEUROCOGNITIVE TESTI; Suhanov AV, 2006, EUR J NEUROL, V13, P990, DOI 10.1111/j.1468-1331.2006.01391.x; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	133	9	11	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0690	1879-8853		CLIN GERIATR MED	Clin. Geriatr. Med.	NOV	2018	34	4					617	+		10.1016/j.cger.2018.06.008			20	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	HC6VK	WOS:000451939600008	30336991				2022-02-06	
J	Barry, LC; Steffens, DC; Covinsky, KE; Conwell, Y; Li, YX; Byers, AL				Barry, Lisa C.; Steffens, David C.; Covinsky, Kenneth E.; Conwell, Yeates; Li, Yixia; Byers, Amy L.			Increased Risk of Suicide Attempts and Unintended Death Among Those Transitioning From Prison to Community in Later Life	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Suicide; suicide attempt; overdose; prisoners; veterans; late-life	POPULATION-BASED COHORT; RELEASE; MORTALITY; SYSTEM; ADULTS	Objective: The number of individuals transitioning from correctional facilities to community in later life (age >= 50 ) is increasing. We sought to determine if later-life prison release is a risk factor for suicidal behavior and death by accidental injury, including drug overdose. Design: Retrospective cohort study. Setting: U.S. Department of Veterans Affairs and Medicare healthcare systems, 2012-2014. Participants: Veterans age >= 50 released from correctional facilities (N = 7,671 re-entry veterans) and those never incarcerated (N = 7,671). Methods: Dates of suicide attempt and cause-specific mortality defined using the National Suicide Prevention Applications Network and the National Suicide Data Repository, respectively. Results: Later-life prison release was associated with increased risk of suicide attempt (599.7 versus 134.7 per 100,000 per year; adjusted hazard ratio [HR] 3.45; 95% confidence interval [CI] 2.24-5.32; p < 0.001, Wald chi(2) = 31.58, degrees of freedom [df] = 1), death by drug overdose (121.7 versus 43.5; adjusted HR 3.45; 95% CI 1.37-8.73; p = 0.009, Wald chi(2) = 6.86, df = 1), and other accidental injury (126.0 versus 39.1; adjusted HR 3.13; 95% CI 1.28-7.69; p = 0.013, Wald chi(2) = 6.25, df = 1), adjusting for homelessness, traumatic brain injury, medical and psychiatric conditions, and accounting for competing risk of other deaths. Suicide mortality rates were observed as nonsignificant between re-entry veterans and those never incarcerated (30.4 versus 17.4, respectively; adjusted HR 2.40; 95% CI 0.51-11.24; p = 0.266, Wald chi(2) = 1.23, df = 1). Conclusion: Older re-entry veterans are at considerable risk of attempting suicide and dying by drug overdose or other accidental injury. This study highlights importance of prevention and intervention efforts targeting later-life prison-to-community care transitions.	[Barry, Lisa C.] UCONN Hlth, Dept Psychiat, 263 Farmington Ave, Farmington, CT 06030 USA; UCONN Ctr Aging, Farmington, CT USA; San Francisco VA Hlth Care Syst, San Francisco, CA USA; Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; Univ Rochester, Sch Med, Dept Psychiat, Rochester, NY USA; Northern Calif Inst Res & Educ, San Francisco, CA USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA		Barry, LC (corresponding author), UCONN Hlth, Dept Psychiat, 263 Farmington Ave, Farmington, CT 06030 USA.	libarry@uchc.edu		BARRY, LISA/0000-0002-2639-906X	Clinical Science Research & Development Service of the Office of Research and Development, U.S. Department of Veterans Affairs [I01 CX001119]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH106529]; Center of Excellence for Suicide Prevention, U.S. Department of Veterans Affairs; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center [SDR 02-237, 98-004]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH106529] Funding Source: NIH RePORTER	This work was supported by I01 CX001119 from the Clinical Science Research & Development Service of the Office of Research and Development, U.S. Department of Veterans Affairs (principal investigator: Amy L. Byers, Ph.D., M.P.H.), and by R01 MH106529 from NIMH (principal investigator: Lisa C. Barry, Ph.D., M.P.H.). Support for SDR and SPAN is provided by the Center of Excellence for Suicide Prevention, U.S. Department of Veterans Affairs. Support for VA/CMS data is provided by the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (SDR 02-237 and 98-004).	Alex B, 2017, J CORRECT HEALTH CAR, V23, P83, DOI 10.1177/1078345816685311; Andersen UA, 2000, ACTA PSYCHIAT SCAND, V102, P126, DOI 10.1034/j.1600-0447.2000.102002126.x; [Anonymous], 2016, SURV CAS DEF; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Carson EA, 1991, TRENDS ADMISSIONS RE; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Center of Excellence for Suicide Prevention, SUIC DAT REP NAT DEA; Chen Li Hui, 2014, NCHS Data Brief, P1; Chock MM, 2015, MAYO CLIN PROC, V90, P1475, DOI 10.1016/j.mayocp.2015.07.023; Conner KR, INJURY HOSPITALIZATI; Dombrovski AY, 2013, JAMA PSYCHIAT, V70, P1020, DOI 10.1001/jamapsychiatry.2013.75; Gujral S, 2014, AM J GERIATR PSYCHIA; Haglund A, 2014, J CLIN PSYCHIAT, V75, P1047, DOI 10.4088/JCP.13m08967; Hayes AJ, 2013, AGE AGEING, V42, P589, DOI 10.1093/ageing/aft066; Hoffmire C, 2016, PUBLIC HEALTH REP, V131, P816, DOI 10.1177/0033354916670133; Jenkins R, 2005, PSYCHOL MED, V35, P257, DOI 10.1017/S0033291704002958; Kariminia A, 2007, MED J AUST; Kemp J, 2012, SUICIDE DATA REPORT; Kemp J, 2012, AM J PUBLIC HLTH; Lim S, 2001, RISKS DRUG RELATED D; Luallen J, 2015, J GERONTOL B; Meijers J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00043; National Violent Death Reporting System, 2014, SUIC RAT ALL MECH AL; Peterson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132664; Pratt D, 2006, LANCET, V368, P119, DOI 10.1016/S0140-6736(06)69002-8; Rockett IRH, 2014, JAMA PSYCHIAT, V71, P231, DOI 10.1001/jamapsychiatry.2013.3738; Rosen DL, 1980, ALL CAUSE CAUSE SPEC; Rudd RA, 2010, INCREASES DRUG OPIOI; Spittal MJ, 2014, J EPIDEMIOL COMMUN H, V68, P993, DOI 10.1136/jech-2014-204295; Stone DM, DECIPHERING SUICIDE; Vadini F, 2018, J AFFECT DISORD; Wang EA, 2013, JAMA INTERN MED, V173, P1621, DOI 10.1001/jamainternmed.2013.9008; Williams BA, 2010, J GEN INTERN MED; Yu SSV, 2014, PSYCHIAT SERV, V65, P381, DOI 10.1176/appi.ps.201300062; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	36	9	10	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	NOV	2018	26	11					1165	1174		10.1016/j.jagp.2018.07.004			10	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	HA5JK	WOS:000450306600010	30146371	Green Accepted			2022-02-06	
J	Condron, M; Rowell, S; Dewey, E; Anderson, T; Lealiiee, L; Farrell, D; Hinson, H				Condron, Mary; Rowell, Susan; Dewey, Elizabeth; Anderson, Taylor; Lealiiee, Lelani; Farrell, David; Hinson, Holly			The procoagulant molecule plasminogen activator inhibitor-1 is associated with injury severity and shock in patients with and without traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		PAI-1; injury severity; coagulopathy	PROTEIN-C PATHWAY; EARLY COAGULOPATHY; PAI-1; HYPERFIBRINOLYSIS; HYPOPERFUSION; COAGULATION; INFLAMMATION; SCORE; CARE	BACKGROUND Traumatic injury is associated with an increased risk of coagulopathy and venous thrombosis. plasminogen activator inhibitor-1 (PAI-1) is a procoagulant molecule that inhibits tPA/uPA, thrombomodulin, and activated protein C. We hypothesized that elevated PAI-1 levels would be associated with increased Injury Severity Score (ISS) in injured patients with and without traumatic brain injury and that PAI-1 levels would vary with injury type. METHODS We retrospectively analyzed demographic, ISS, and hemodynamic data from a prospectively collected database. Patients with traumatic injury requiring intensive care unit admission (n = 268) were classified as multiple injuries, isolated body, or isolated head based on Abbreviated Injury Severity score. Admission PAI-1 levels were quantified using a Luminex analyte platform. Univariate tests for association informed the construction of a multivariate model of the relationship between PAI-1 and ISS. RESULTS Plasminogen activator inhibitor-1 positively associated with ISS (p < 0.0001) and was highest in patients with ISS greater than 35 (p < 0.0001). Plasminogen activator inhibitor-1 was significantly different between multiple injuries, isolated body, and isolated head patients (p < 0.0001). On univariate analysis, age (p = 0.0011), hypotension (p = 0.0076), and alcohol intoxication (p = 0.0024) were all positively associated with PAI-1 level. Admission international normalized ratio was not associated with PAI-1 level (p = 0.638). After adjusting for age, sex, hypotension, and alcohol intoxication, higher PAI-1 levels were associated with higher ISS (p < 0.0001). CONCLUSION Elevated PAI-1 at admission is associated with higher ISS. This association is more pronounced in patients with hypotension. These findings suggest that PAI-1 levels may reflect the burden of endothelial damage and platelet activation after injury. LEVEL OF EVIDENCE Prognostic, level III.	[Condron, Mary; Rowell, Susan; Dewey, Elizabeth; Anderson, Taylor; Lealiiee, Lelani; Farrell, David; Hinson, Holly] Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, 3181 SW Sam Jackson Pk Rd,L611, Portland, OR 97239 USA		Condron, M (corresponding author), Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, 3181 SW Sam Jackson Pk Rd,L611, Portland, OR 97239 USA.	condron@ohsu.edu	Rowell, Susan/S-7480-2019; Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782; Condron, Mary/0000-0003-4792-2160; Anderson, Taylor/0000-0002-8608-8343	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K12HL108974-03]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [TL4GM118965, UL1GM118964, RL5GM118963] Funding Source: NIH RePORTER	The project described was supported in part by Award Number 5K12HL108974-03 from the National Heart, Lung, and Blood Institute. This publication was supported by Oregon Clinical and Translational Research Institute (OCTRI); grant number (UL1TR000128) from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).	Aoki K, 2001, BURNS, V27, P569, DOI 10.1016/S0305-4179(01)00011-0; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hinson HE, 2018, J TRAUMA ACUTE CARE, V84, P19, DOI 10.1097/TA.0000000000001627; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; McCully SP, 2013, J TRAUMA ACUTE CARE, V75, P947, DOI 10.1097/TA.0b013e3182a9676c; Mertens I, 2006, INT J OBESITY, V30, P1308, DOI 10.1038/sj.ijo.0803189; Moore HB, 2015, SURGERY, V158, P386, DOI 10.1016/j.surg.2015.04.008; Rutledge R, 1996, J TRAUMA, V40, P944, DOI 10.1097/00005373-199606000-00013; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schrieber M, 2007, J TRAUMA, V63, P1261; Toker Serdar, 2011, Thrombosis, V2011, P505373, DOI 10.1155/2011/505373; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364	23	9	9	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					888	893		10.1097/TA.0000000000002040			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100009	30086072	Green Accepted			2022-02-06	
J	Dickens, AM; Posti, JP; Takala, RSK; Ala-Seppala, H; Mattila, I; Coles, JP; Frantzen, J; Hutchinson, PJ; Katila, AJ; Kyllonen, A; Maanpaa, HR; Newcombe, V; Outtrim, J; Tallus, J; Carpenter, KLH; Menon, DK; Hyotylainen, T; Tenovuo, O; Oresic, M				Dickens, Alex M.; Posti, Jussi P.; Takala, Riikka S. K.; Ala-Seppala, Henna; Mattila, Ismo; Coles, Jonathan P.; Frantzen, Janek; Hutchinson, Peter J.; Katila, Ari J.; Kyllonen, Anna; Maanpaa, Henna-Riikka; Newcombe, Virginia; Outtrim, Joanne; Tallus, Jussi; Carpenter, Keri L. H.; Menon, David K.; Hyotylainen, Tuulia; Tenovuo, Olli; Oresic, Matej			Serum Metabolites Associated with Computed Tomography Findings after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; CT scanning; human studies; metabolism; TBI	FIBRILLARY ACIDIC PROTEIN; FLIGHT MASS-SPECTROMETRY; C-TERMINAL HYDROLASE-L1; MINOR HEAD-INJURY; INTRACRANIAL LESIONS; CEREBROSPINAL-FLUID; BARRIER DISRUPTION; OXIDATIVE STRESS; BIOMARKER; GFAP	There is a need to rapidly detect patients with traumatic brain injury (TBI) who require head computed tomography (CT). Given the energy crisis in the brain following TBI, we hypothesized that serum metabolomics would be a useful tool for developing a set of biomarkers to determine the need for CT and to distinguish among different types of injuries observed. Logistical regression models using metabolite data from the discovery cohort (n=144, Turku, Finland) were used to distinguish between patients with traumatic intracranial findings and those with negative findings on head CT. The resultant models were then tested in the validation cohort (n=66, Cambridge, United Kingdom). The levels of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 were also quantified in the serum from the same patients. Despite there being significant differences in the protein biomarkers in patients with TBI, the model that determined the need for a CT scan validated poorly (area under the curve [AUC]=0.64: Cambridge patients). However, using a combination of six metabolites (two amino acids, three sugar derivatives, and one ketoacid) it was possible to discriminate patients with intracranial abnormalities on CT and patients with a normal CT (AUC=0.77 in Turku patients and AUC=0.73 in Cambridge patients). Further, a combination of three metabolites could distinguish between diffuse brain injuries and mass lesions (AUC=0.87 in Turku patients and AUC=0.68 in Cambridge patients). This study identifies a set of validated serum polar metabolites, which associate with the need for a CT scan. Additionally, serum metabolites can also predict the nature of the brain injury. These metabolite markers may prevent unnecessary CT scans, thus reducing the cost of diagnostics and radiation load.	[Dickens, Alex M.; Oresic, Matej] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Posti, Jussi P.; Ala-Seppala, Henna; Frantzen, Janek; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Dept Neurol, Turku, Finland; [Posti, Jussi P.; Frantzen, Janek; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Frantzen, Janek] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Univ Turku, Turku, Finland; [Mattila, Ismo] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Coles, Jonathan P.; Newcombe, Virginia; Outtrim, Joanne; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England; [Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Hyotylainen, Tuulia] Orebro Univ, Dept Chem, Orebro, Sweden; [Oresic, Matej] Orebro Univ, Sch Med Sci, Orebro, Sweden		Dickens, AM (corresponding author), Turku Ctr Biotechnol, Tykistokatu 6, Turku 20520, Finland.	alex.dickens@utu.fi	Hyotylainen, Tuulia/AAP-6266-2020; Oresic, Matej/K-7673-2016; Posti, Jussi P./Y-2908-2019; Oresic, Matej/AAV-3978-2020; Dickens, Alex/F-8566-2013	Oresic, Matej/0000-0002-2856-9165; Posti, Jussi P./0000-0002-5925-5193; Mattila, Ismo/0000-0001-9597-7831; Hutchinson, Peter/0000-0002-2796-1835; Newcombe, Virginia/0000-0001-6044-9035; Coles, Jonathan/0000-0003-4013-679X; Hyotylainen, Tuulia/0000-0002-1389-8302; Ala-Seppala, Henna/0000-0002-1577-3028; Dickens, Alex/0000-0002-3178-8449	EU FP7 project TBIcare [270259]; GE-NFL Head Health Challenge I Award [7620]; Goverment's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation; Finnish Brain Foundation; National Institute for Health ResearchNational Institute for Health Research (NIHR); National Institute for Health Research and Biomedical Research Centre, Cambridge; National Institute for Health Research Biomedical Research Center, Cambridge (Neuroscience Theme); National Institute for Health Research Biomedical Research Center, Cambridge (Brain Injury and Repair Theme); NIHR Biomedical Research Centre in Cambridge; Academy of Medical Sciences/The Health Foundation Fellowship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277, G0601025, G0600986, G0502030, G9439390] Funding Source: UKRI	The work was supported by the EU FP7 project TBIcare (Project ref. 270259 to M.O., D.K.M., and O.T.), by the GE-NFL Head Health Challenge I Award (grant no. 7620 to M.O. and T.H.), by Goverment's Special Financial Transfer tied to academic research in Health Sciences (Finland) (to J.P.P. and R.S.K.T.), and by a personal grant from Emil Aaltonen Foundation and Finnish Brain Foundation (to J.P.P.). P.J.H. received support from a National Institute for Health Research, Research Professorship, an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship, and the National Institute for Health Research and Biomedical Research Centre, Cambridge. K.L.H.C. received support from the National Institute for Health Research Biomedical Research Center, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). This work was supported by the NIHR Biomedical Research Centre in Cambridge. V.N. is supported by an Academy of Medical Sciences/The Health Foundation Fellowship. The authors thank all the study participants of TBI care for providing the samples used in this study. The authors also thank Mark Van Gils who coordinated the TBI care project. Further, the authors thank Anna-Liisa Ruuskepaa for technical assistance in metabolomics analysis, as well as research nurses Patricia Bertenyi and Satu Timlin for their valuable contribution to this study.	Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Antila K, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0072; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Dickens AM, 2014, NEUROLOGY, V83, P1492, DOI 10.1212/WNL.0000000000000905; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hartonen M, 2013, J CHROMATOGR A, V1293, P142, DOI 10.1016/j.chroma.2013.04.005; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; Hsieh SY, 2006, PROTEOMICS, V6, P3189, DOI 10.1002/pmic.200500535; Jorgenrud B, 2015, BIOANALYSIS, V7, P991, DOI 10.4155/bio.15.16; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; MANCARDI GL, 1991, J NEUROL SCI, V102, P177, DOI 10.1016/0022-510X(91)90066-G; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mitchell BL, 2005, CANCER INFORM, V1, P98; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Posti JP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00398; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Price L., 2016, TRANSLATIONAL RES TR; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suvitaival T, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.222; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Tebani A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071167; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Torabian S, 2005, CURR OPIN ONCOL, V17, P167, DOI 10.1097/01.cco.0000154039.07466.5d; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Wolahan SM, 2016, NEUROSURG CLIN N AM, V27, P465, DOI 10.1016/j.nec.2016.05.006	52	9	9	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2673	2683		10.1089/neu.2017.5272			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000449057900007	29947291	Green Submitted			2022-02-06	
J	Lemaire, JJ; Sontheimer, A; Pereira, B; Coste, J; Rosenberg, S; Sarret, C; Coll, G; Gabrillargues, J; Jean, B; Gillart, T; Coste, A; Roche, B; Kelly, A; Pontier, B; Feschet, F				Lemaire, Jean-Jacques; Sontheimer, Anna; Pereira, Bruno; Coste, Jerome; Rosenberg, Sarah; Sarret, Catherine; Coll, Guillaume; Gabrillargues, Jean; Jean, Betty; Gillart, Thierry; Coste, Aurelien; Roche, Basile; Kelly, Antony; Pontier, Benedicte; Feschet, Fabien			Deep brain stimulation in five patients with severe disorders of consciousness	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							VEGETATIVE STATE; FOLLOW-UP; INPATIENT REHABILITATION; PEDUNCULOPONTINE NUCLEUS; SQUIRREL-MONKEY; BASAL GANGLIA; LATE RECOVERY; INJURY; COMA; SYSTEMS	Objective The efficacy of deep brain stimulation in disorders of consciousness remains inconclusive. We investigated bilateral 30-Hz low-frequency stimulation designed to overdrive neuronal activity by dual pallido-thalamic targeting, using the Coma Recovery Scale Revised (CRS-R) to assess conscious behavior. Methods We conducted a prospective, single center, observational 11-month pilot study comprising four phases: baseline (2 months); surgery and titration (1 month); blind, random, crossover, 1.5-month ON and OFF periods; and unblinded, 5-month stimulation ON. Five adult patients were included: one unresponsive-wakefulness-syndrome male (traumatic brain injury); and four patients in a minimally conscious state, one male (traumatic brain injury) and three females (two hemorrhagic strokes and one traumatic brain injury). Primary outcome measures focused on CRS-R scores. Secondary outcome measures focused notably on baseline brain metabolism and variation in activity (stimulation ON - baseline) using normalized fluorodeoxyglucose positron emission tomography maps. Statistical analysis used random-effect models. Results The two male patients (one minimally conscious and one unresponsive wakefulness syndrome) showed improved mean CRS-R scores (stimulation ON vs. baseline), in auditory, visual and oromotor/verbal subscores, and visual subscores respectively. The metabolism of the medial cortices (low at baseline in all five patients) increased specifically in the two responders. Interpretation Our findings show there were robust but limited individual clinical benefits, mainly in visual and auditory processes. Overall modifications seem linked to the modulation of thalamo-cortico-basal and tegmental loops activating default mode network cortices. Specifically, in the two responders there was an increase in medial cortex activity related to internal awareness.	[Lemaire, Jean-Jacques; Sontheimer, Anna; Coste, Jerome; Coll, Guillaume; Coste, Aurelien; Pontier, Benedicte] CHU Clermont Ferrand, Serv Neurochirurg, 58 Rue Montalembert, F-63000 Clermont Ferrand, France; [Lemaire, Jean-Jacques; Sontheimer, Anna; Coste, Jerome; Rosenberg, Sarah; Sarret, Catherine; Coll, Guillaume; Gabrillargues, Jean; Roche, Basile; Pontier, Benedicte; Feschet, Fabien] Univ Clermont Auvergne, CNRS, SIGMA Clermont, Inst Pascal, F-63000 Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Unite Biostat, Delegat Rech Clin & Innovat, F-63000 Clermont Ferrand, France; [Gabrillargues, Jean; Jean, Betty] CHU Clermont Ferrand, Serv Radiol, F-63000 Clermont Ferrand, France; [Gillart, Thierry] CHU Clermont Ferrand, Dept Anesthesie Reanimat, F-63000 Clermont Ferrand, France; [Kelly, Antony] Ctr Jean Perrin, Serv Med Nucl, F-63000 Clermont Ferrand, France		Lemaire, JJ (corresponding author), CHU Clermont Ferrand, Serv Neurochirurg, 58 Rue Montalembert, F-63000 Clermont Ferrand, France.	jjlemaire@chu-clermontferrand.fr	Coste, Jerome/D-2070-2013	Coste, Jerome/0000-0002-3262-0867	Fondation de l'Avenir (Paris, France) [BO4-001, ET1-615 2011]; University Hospital of Clermont-Ferrand; Fondation de l'Avenir; Medtronic FranceMedtronic; Saint-Jude Medical	This study was funded by the Fondation de l'Avenir (Paris, France; ET1-615 2011; "Deroche Legacy" Grant BO4-001; wages of AS; patient transportation and MRI costs) and the University Hospital of Clermont-Ferrand (waived hospital inpatient expenses, endorsed study insurance, trial promoter). Medtronic France supplied DBS devices (without charge), and the Centre Jean Perrin provided FDG Pet-Scan exams (without charge). JJL declares grant from the Fondation de l'Avenir and Medtronic France. BeP declares grants from the Fondation de l'Avenir. JJL declares non-financial support from Saint-Jude Medical (grant awarded to the academic entity; travel expenses) and Medtronic (travel expenses).	[Anonymous], 2015, PROL DIS CONSC NAT C; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; COHADON F, 1985, NEUROSTIMULATION OVE, P247; Cohadon F, 1984, ADV STEREOTACTIC FUN, P535; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Crone JS, 2017, CEREB CORTEX, V27, P2727, DOI 10.1093/cercor/bhw112; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; DIECKMANN G, 1968, J NEUROL SCI, V7, P385, DOI 10.1016/0022-510X(68)90157-3; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Garcia-Rill E, 2011, J NEURAL TRANSM, V118, P1397, DOI 10.1007/s00702-010-0500-x; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; JONES BE, 1993, PROG BRAIN RES, V98, P61; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; LAVOIE B, 1994, J COMP NEUROL, V344, P210, DOI 10.1002/cne.903440204; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Magrassi L, 2016, J NEUROSURG, V8, P1; McLardy T, 1968, Trans Am Neurol Assoc, V93, P25; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Shink E, 1997, J COMP NEUROL, V382, P348; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Steriade M, 1993, Curr Opin Neurobiol, V3, P619, DOI 10.1016/0959-4388(93)90064-6; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; Tsubokawa T, 1990, Brain Inj, V4, P315; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x	48	9	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	NOV	2018	5	11					1372	1384		10.1002/acn3.648			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA9RZ	WOS:000450644900006	30480031	Green Published, gold			2022-02-06	
J	Maddux, AB; Cox-Martin, M; Dichiaro, M; Bennett, TD				Maddux, Aline B.; Cox-Martin, Matthew; Dichiaro, Michael; Bennett, Tellen D.			The Association Between the Functional Status Scale and the Pediatric Functional Independence Measure in Children Who Survive Traumatic Brain Injury*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; critical care; critical care outcomes; patient outcome assessment; pediatric; traumatic	RECEIVING INPATIENT REHABILITATION; YOUNG-CHILDREN; INTENSIVE-CARE; UNITED-STATES; OUTCOMES; WEEFIM; POPULATION; SCORES; SAMPLE	Objectives: To determine the association between the Functional Status Scale and Pediatric Functional Independence Measure scores during the rehabilitation stay in children who survive traumatic brain injury. Design: Secondary analysis of a prospective observational cohort study. Setting: Tertiary care children's hospital with a level 1 trauma center and inpatient rehabilitation service. Patients: Sixty-five children less than 18 years old admitted to an ICU with acute traumatic brain injury and subsequently transferred to the inpatient rehabilitation service. Interventions: Not applicable. Measurements and Main Results: Functional Status Scale and Pediatric Functional Independence Measure at transfer to rehabilitation and Pediatric Functional Independence Measure at discharge from rehabilitation. The median age of the cohort was 7.1 years (interquartile range, 0.8-12.3 yr), and 29% were female. Nearly all of the children were healthy prior to the traumatic brain injury: six patients (9.2%) had a baseline Functional Status Scale score greater than 6. At the time of transfer to inpatient rehabilitation, total Functional Status Scale and Pediatric Functional Independence Measure scores had the expected negative correlation due to increasing disability resulting in lower scores in Pediatric Functional Independence Measure and higher scores in Functional Status Scale (r = -0.49; 95% CI, -0.62 to -0.35). Among subjects with less disability as measured by lower total Functional Status Scale scores, we found substantial variability in the total Pediatric Functional Independence Measure scores. In contrast, Pediatric Functional Independence Measure scores were consistently low among subjects with a wide range of higher total Functional Status Scale scores (more disability). Conclusions: Although proprietary and more time-intensive, the Pediatric Functional Independence Measure has advantages relative to the Functional Status Scale for less severely injured patients and task-specific measurements. The Functional Status Scale may have advantages relative to the Pediatric Functional Independence Measure for more severely injured patients. Further investigations are needed to characterize changes in the Functional Status Scale during the rehabilitation stay and after discharge.	[Maddux, Aline B.; Bennett, Tellen D.] Univ Colorado, Sch Med, Pediat Crit Care Med, Aurora, CO 80045 USA; [Maddux, Aline B.; Cox-Martin, Matthew; Dichiaro, Michael; Bennett, Tellen D.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Cox-Martin, Matthew] Univ Colorado, Sch Med, Dept Family Med, Aurora, CO USA; [Cox-Martin, Matthew; Bennett, Tellen D.] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA; [Dichiaro, Michael] Univ Colorado, Sch Med, Phys Med & Rehabil, Aurora, CO USA; Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat Crit Care Med, Aurora, CO USA; Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA		Maddux, AB (corresponding author), Univ Colorado, Sch Med, Pediat Crit Care Med, Aurora, CO 80045 USA.; Maddux, AB (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.	aline.maddux@childrenscolorado.org		Bennett, Tellen/0000-0003-1483-4236; Maddux, Aline/0000-0002-0949-4284	Eunice Kennedy Shriver National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Colorado Department of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	Drs. Maddux's and Bennett's institutions received funding from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (grant K23HD074620 to Dr. Bennett), and they received support for article research from the National Institutes of Health. Dr. Bennett's institution also received funding from the Colorado Department of Public Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bennett TD, 2015, PEDIATR CRIT CARE ME, V16, P377, DOI 10.1097/PCC.0000000000000380; Cashen K, 2017, PEDIATR CRIT CARE ME, V18, P561, DOI 10.1097/PCC.0000000000001155; Estroff JM, 2015, J EMERG MED, V48, P274, DOI 10.1016/j.jemermed.2014.07.030; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; KRAUS JF, 1987, PEDIATRICS, V79, P501; Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325; McBride T, 2015, BRAIN INJURY, V29, P951, DOI 10.3109/02699052.2015.1022881; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Risen SR, 2014, J PEDIATR-US, V164, P613, DOI 10.1016/j.jpeds.2013.10.075; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Trovato MK, 2013, ARCH PHYS MED REHAB, V94, P1335, DOI 10.1016/j.apmr.2012.12.004; Zinter MS, 2018, BIOL BLOOD MARROW TR, V24, P330, DOI 10.1016/j.bbmt.2017.10.036; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	30	9	9	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	NOV	2018	19	11					1046	1053		10.1097/PCC.0000000000001710			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pediatrics	GY9FL	WOS:000448945200014	30119094	Green Accepted			2022-02-06	
J	McAllister, BB; Wright, DK; Wortman, RC; Shultz, SR; Dyck, RH				McAllister, Brendan B.; Wright, David K.; Wortman, Ryan C.; Shultz, Sandy R.; Dyck, Richard H.			Elimination of vesicular zinc alters the behavioural and neuroanatomical effects of social defeat stress in mice	NEUROBIOLOGY OF STRESS			English	Article						Synaptic zinc; SLC30A3; Chronic stress; Depression; Fear memory; Magnetic resonance imaging (MRI)	DEPRESSION-LIKE BEHAVIOR; TRAUMATIC BRAIN-INJURY; ANXIETY-LIKE BEHAVIOR; TRANSPORTER 3 ZNT3; LIFE EVENTS; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT TREATMENT; NEUROTROPHIC FACTOR; SYNAPTIC VESICLES; MAJOR DEPRESSION	Chronic stress can have deleterious effects on mental health, increasing the risk of developing depression or anxiety. But not all individuals are equally affected by stress; some are susceptible while others are more resilient. Understanding the mechanisms that lead to these differing outcomes has been a focus of considerable research. One unexplored mechanism is vesicular zinc - zinc that is released by neurons as a neuromodulator. We examined how chronic stress, induced by repeated social defeat, affects mice that lack vesicular zinc due to genetic deletion of zinc transporter 3 (ZnT3). These mice, unlike wild type mice, did not become socially avoidant of a novel conspecific, suggesting resilience to stress. However, they showed enhanced sensitivity to the potentiating effect of stress on cued fear memory. Thus, the contribution of vesicular zinc to stress susceptibility is not straightforward. Stress also increased anxiety-like behaviour but produced no deficits in a spatial Y-maze test. We found no evidence that microglial activation or hippocampal neurogenesis accounted for the differences in behavioural outcome. Volumetric analysis revealed that ZnT3 KO mice have larger corpus callosum and parietal cortex volumes, and that corpus callosum volume was decreased by stress in ZnT3 KO, but not wild type, mice.	[McAllister, Brendan B.; Dyck, Richard H.] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [McAllister, Brendan B.; Dyck, Richard H.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Wright, David K.; Wortman, Ryan C.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3010, Australia		Dyck, RH (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	rdyck@ucalgary.ca		Dyck, Richard/0000-0002-3254-8332; Shultz, Sandy/0000-0002-2525-8775; Wright, David/0000-0002-7535-8651	NSERC Discovery GrantNatural Sciences and Engineering Research Council of Canada (NSERC) [217322]; University of Calgary Seed Grant (URGC) [F1031033642]; NHMRC FellowshipNational Health and Medical Research Council of Australia [1087172, 1141643]	This research was supported by a NSERC Discovery Grant (217322) awarded to RHD, a University of Calgary Seed Grant (URGC, F1031033642) awarded to BBM and RHD, and a NHMRC Fellowship (1087172) and Project Grant (1141643) awarded to SRS. The funding sources had no involvement in the design or conduct of this research, the writing of this report, or the decision to submit this report for publication.	Alboni S, 2016, BRAIN BEHAV IMMUN, V58, P261, DOI 10.1016/j.bbi.2016.07.155; Anacker C, 2016, BIOL PSYCHIAT, V79, P840, DOI 10.1016/j.biopsych.2015.08.009; Anderson CT, 2015, P NATL ACAD SCI USA, V112, pE2705, DOI 10.1073/pnas.1503348112; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; BEAULIEU C, 1992, NEUROREPORT, V3, P861, DOI 10.1097/00001756-199210000-00010; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Chou DL, 2014, EXP NEUROL, V255, P19, DOI 10.1016/j.expneurol.2014.02.016; Christensen MK, 1998, J COMP NEUROL, V400, P375, DOI 10.1002/(SICI)1096-9861(19981026)400:3<375::AID-CNE7>3.0.CO;2-5; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cole TB, 2001, BRAIN RES, V891, P253, DOI 10.1016/S0006-8993(00)03220-0; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Conrad CD, 2003, NEUROBIOL LEARN MEM, V79, P32, DOI 10.1016/S1074-7427(02)00018-7; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; Cunningham MG, 2007, NEUROREPORT, V18, P531, DOI 10.1097/WNR.0b013e328091c212; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Ding Q, 2016, J AFFECT DISORDERS, V197, P100, DOI 10.1016/j.jad.2016.03.017; Dou X, 2014, BEHAV BRAIN RES, V273, P133, DOI 10.1016/j.bbr.2014.07.040; Dubreucq S, 2012, NEUROSCIENCE, V204, P230, DOI 10.1016/j.neuroscience.2011.08.049; FREDERICKSON CJ, 1992, J CHEM NEUROANAT, V5, P521, DOI 10.1016/0891-0618(92)90007-D; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; GARRETT B, 1991, ANAT EMBRYOL, V184, P461, DOI 10.1007/BF01236052; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Han MH, 2017, NEUROTHERAPEUTICS, V14, P677, DOI 10.1007/s13311-017-0527-x; Higashi Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43778; Jo SM, 2000, BRAIN RES, V865, P227, DOI 10.1016/S0006-8993(00)02227-7; Jo SM, 2002, BRAIN RES, V956, P230, DOI 10.1016/S0006-8993(02)03544-8; Kalappa BI, 2015, P NATL ACAD SCI USA, V112, P15749, DOI 10.1073/pnas.1512296112; Kendler KS, 2016, PSYCHOL MED, V46, P1865, DOI 10.1017/S0033291716000349; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lisboa SF, 2018, NEUROPSYCHOPHARMACOL, V43, P1924, DOI 10.1038/s41386-018-0064-2; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Martel G, 2011, BEHAV BRAIN RES, V223, P233, DOI 10.1016/j.bbr.2011.04.020; Martel G, 2010, LEARN MEMORY, V17, P582, DOI 10.1101/lm.1962010; McAllister BB, 2017, NEUROSCI BIOBEHAV R, V80, P329, DOI 10.1016/j.neubiorev.2017.06.006; McAllister BB, 2015, BEHAV BRAIN RES, V290, P102, DOI 10.1016/j.bbr.2015.04.049; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; McKim DB, 2016, J NEUROSCI, V36, P2590, DOI 10.1523/JNEUROSCI.2394-15.2016; MICZEK KA, 1978, SCIENCE, V199, P1459, DOI 10.1126/science.415367; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Ranjbar E, 2014, NUTR NEUROSCI, V17, P65, DOI 10.1179/1476830513Y.0000000066; Redenti S, 2004, VISION RES, V44, P3317, DOI 10.1016/j.visres.2004.07.038; Samuels B.A., 2011, MOOD ANXIETY RELATED, VII, P107; Sela H, 2017, METALLOMICS, V9, P323, DOI 10.1039/c6mt00207b; Sheerin CM, 2018, DEPRESS ANXIETY, V35, P140, DOI 10.1002/da.22700; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Smidt K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005684; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suvrathan A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0151; Takeda A, 2007, BEHAV BRAIN RES, V177, P1, DOI 10.1016/j.bbr.2006.11.023; Takeda A, 2012, BEHAV BRAIN RES, V226, P259, DOI 10.1016/j.bbr.2011.09.026; Tao LP, 2013, BIOL TRACE ELEM RES, V155, P65, DOI 10.1007/s12011-013-9762-0; Thackray SE, 2017, BEHAV BRAIN RES, V321, P36, DOI 10.1016/j.bbr.2016.12.028; THURMOND JB, 1975, PHYSIOL BEHAV, V14, P879, DOI 10.1016/0031-9384(75)90086-4; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Ugarte M, 1999, EXP EYE RES, V69, P459, DOI 10.1006/exer.1999.0727; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Venzala E, 2012, PSYCHOPHARMACOLOGY, V224, P313, DOI 10.1007/s00213-012-2754-5; Vergnano AM, 2014, NEURON, V82, P1101, DOI 10.1016/j.neuron.2014.04.034; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Watanabe M, 2010, NEUROCHEM INT, V56, P410, DOI 10.1016/j.neuint.2009.11.014; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Whittle N, 2009, AMINO ACIDS, V36, P147, DOI 10.1007/s00726-008-0195-6; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wu HPP, 2018, NEUROSCIENCE, V369, P242, DOI 10.1016/j.neuroscience.2017.11.020; Yeh YW, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu065; Yoo MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28548	83	9	9	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	2352-2895			NEUROBIOL STRESS	Neurobiol. Stress	NOV	2018	9						199	213		10.1016/j.ynstr.2018.10.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ9CN	WOS:000449794300020	30450385	Green Published, Green Submitted, gold			2022-02-06	
J	Savarraj, JPJ; McGuire, MF; Parsha, K; Hergenroeder, G; Bajgur, S; Ahn, S; Zhu, L; Espino, E; Chang, T; Blackburn, S; Kim, DH; Dash, P; Choi, HA				Savarraj, Jude P. J.; McGuire, Mary F.; Parsha, Kaushik; Hergenroeder, Georgene; Bajgur, Suhas; Ahn, Sungho; Zhu, Liang; Espino, Elena; Chang, Tiffany; Blackburn, Spiros; Kim, Dong H.; Dash, Pramod; Choi, Huimahn A.			Disruption of thrombo-inflammatory response and activation of a distinct cytokine cluster after subarachnoid hemorrhage	CYTOKINE			English	Article						Early brain injury; Subarachnoid hemorrhage; Neuroinflammation; Cytokine cluster; Clustering analysis; Correlation networks	DELAYED CEREBRAL-ISCHEMIA; ENDOTHELIAL GROWTH-FACTOR; EARLY BRAIN-INJURY; PLATELET ACTIVATION; INDUCIBLE PROTEIN-10; CSF; SYSTEM; ALPHA; EDEMA; IP-10	Background: Unregulated inflammatory and thrombotic responses have been proposed to be important causes of early brain injury and worse clinical outcomes after subarachnoid hemorrhage (SAH). Objective: We hypothesize that SAH is characterized by an increased inflammatory and thrombotic state and disruption of associations between these states. Methods: This is a retrospective cohort study of 60 patients with SAH. 23 patients with unruptured aneurysms (UA) and 77 patients with traumatic brain injury (TBI) were chosen as controls. Plasma cytokine levels were measured using a 41-plex human immunoassay kit, and cytokine patterns associated with SAH, UA and TBI were identified using statistical and informatics methods. Results: SAH was characterized by an increase in several cytokines and chemokines, platelet-derived factors, and growth factors. Cluster analysis identified several cytokine clusters common in SAH, UA and TBI groups - generally grouped as platelet-derived, vascular and pro-inflammatory clusters. In the UA group, the platelet derived cluster had an inverse relationship with the inflammatory cluster which was absent in SAH. Additionally, a cluster comprising of growth and colony stimulating factors was unique to SAH. Conclusions: A cluster of cytokines involved in growth and colony stimulation was unique to SAH. Negative associations between the thrombotic and inflammatory molecules were observed in UA but not in SAH. Further studies to examine the pathophysiology behind the cluster unique to SAH and the associations between the thrombotic and inflammatory cytokines are required.	[Savarraj, Jude P. J.; McGuire, Mary F.; Parsha, Kaushik; Hergenroeder, Georgene; Bajgur, Suhas; Ahn, Sungho; Zhu, Liang; Espino, Elena; Chang, Tiffany; Blackburn, Spiros; Kim, Dong H.; Dash, Pramod; Choi, Huimahn A.] Univ Texas Houston, McGovern Med Sch, Houston, TX USA		Choi, HA (corresponding author), 6431 Fannin St, Houston, TX 77030 USA.	Huimahn.A.Choi@uth.tmc.edu	Parsha, Kaushik/AAY-8159-2020; Savarraj, Jude/AAJ-4969-2021; Ahn, Sungho/AAC-9241-2022	Parsha, Kaushik/0000-0001-5230-3095; Savarraj, Jude/0000-0003-0194-0734; Ahn, Sungho/0000-0002-8376-545X; Dash, Pramod/0000-0001-6746-1002; BLACKBURN, SPIROS/0000-0003-2902-5079	Joe Niekro Foundation; CCTS Scholar Program at the McGovern Medical School	We are grateful for the support of the Joe Niekro Foundation and the CCTS Scholar Program at the McGovern Medical School.	Ahn SH, 2018, NEUROSURGERY, V83, P137, DOI 10.1093/neuros/nyx364; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Beaulieu LM, 2014, ARTERIOSCL THROM VAS, V34, P552, DOI 10.1161/ATVBAHA.113.302700; Bester J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32188; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Choi HA, 2016, NEUROCRIT CARE, V25, P64, DOI 10.1007/s12028-015-0229-3; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Dorhout MSM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006184.pub2; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Gao C, 2009, AUTON NEUROSCI-BASIC, V147, P70, DOI 10.1016/j.autneu.2009.01.010; GEISER T, 1993, J BIOL CHEM, V268, P15419; Gomis P, 2010, J NEUROSURG, V112, P681, DOI 10.3171/2009.4.JNS081377; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hartz S, 2003, CYTOM PART A, V52A, P117, DOI 10.1002/cyto.a.10026; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kang MH, 2016, IRAN J VET RES, V17, P62; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu L, 2016, ACTA NEUROCHIR SUPPL, V121, P173, DOI 10.1007/978-3-319-18497-5_31; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; McBride DW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00555; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Monfils MH, 2005, NEUROSCIENCE, V134, P1, DOI 10.1016/j.neuroscience.2005.04.006; Ornitz DM, 2001, GENOME BIOL, V2; Osuka K, 1998, ACTA NEUROCHIR, V140, P943, DOI 10.1007/s007010050197; Regnault V, 2003, BLOOD, V101, P1419, DOI 10.1182/blood-2002-02-0620; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Salgado Roberto, 2001, Angiogenesis, V4, P37, DOI 10.1023/A:1016611230747; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Savarraj J, 2018, NEUROCRIT CARE, V28, P203, DOI 10.1007/s12028-017-0471-y; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiraha H, 1999, J CELL BIOL, V146, P243; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; Subramanian N, 2015, WIRES SYST BIOL MED, V7, P13, DOI 10.1002/wsbm.1288; SUZUKI S, 1990, Neurologia Medico-Chirurgica, V30, P309, DOI 10.2176/nmc.30.309; Swystun LL, 2016, BLOOD, V128, P753, DOI 10.1182/blood-2016-05-718114; Veldeman M, 2016, BRIT J ANAESTH, V117, P17, DOI 10.1093/bja/aew095; Young AMH, 2012, CURR DRUG SAF, V7, P190, DOI 10.2174/157488612803251315; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	46	9	9	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	NOV	2018	111						334	341		10.1016/j.cyto.2018.09.003			8	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	HG1XG	WOS:000454753800045	30269030				2022-02-06	
J	Taylor, KM; Kioumourtzoglou, MA; Clover, J; Coull, BA; Dennerlein, JT; Bellinger, DC; Weisskopf, MG				Taylor, Kathryn M.; Kioumourtzoglou, Marianthi-Anna; Clover, Jim; Coull, Brent A.; Dennerlein, Jack T.; Bellinger, David C.; Weisskopf, Marc G.			Concussion History and Cognitive Function in a Large Cohort of Adolescent Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						neurocognitive testing; adolescents; concussion; duration of effects; mTBI	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; CONSTRUCT-VALIDITY; MISSING DATA; RECOVERY; PLASTICITY; FOOTBALL; IMPACT; PLAYERS	Background: The incidence of reported concussions in the adolescent population is increasing, yet research on the effects of concussions in this population is minimal and inconclusive. Purpose: To assess the association between concussion and performance on a cognitive test battery. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Using multivariate models, the authors assessed the association between concussion and performance on a cognitive test battery among 5616 high school and junior high school athletes. The researchers utilized a global cognitive score and scores for 5 domains: verbal memory, visual memory, visual motor, reaction time, and impulse control. Each cognitive score was converted to a z score with the mean and SD of the nonconcussed population. Results from each model were then interpreted as change in the standardized unit score. In the models, concussion was evaluated as ever having a concussion, number of concussions, time since last concussion, and age at first concussion. Results: Ever having a concussion was associated with a mean decrease of 0.11 standardized units (95% CI, -0.20 to -0.01) on the global cognitive score and lower scores in all cognitive domains. Each additional concussion was associated with lower scores on global cognitive function (effect estimate, -0.06; 95% CI, -0.11 to -0.02), verbal memory, visual memory, and impulse control. Concussion in early childhood was associated with lower global cognition (effect estimate, -0.05; 95% CI, -0.08 to -0.01), visual memory, and motor visual scores as compared with concussions in later childhood. The associations between time since last concussion and cognitive test scores were nonlinear, and on all tests, lower scores were observed even >= 1 year after the concussion. Conclusion: On the basis of objective performance metrics for cognitive function, concussions had a more persistent effect on cognitive function than previously thought. The age at which an individual has his or her first concussion may be an important factor in determining long-lasting cognitive effects.	[Taylor, Kathryn M.; Kioumourtzoglou, Marianthi-Anna; Clover, Jim; Coull, Brent A.; Dennerlein, Jack T.; Bellinger, David C.; Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Taylor, Kathryn M.; Coull, Brent A.; Dennerlein, Jack T.; Bellinger, David C.; Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Taylor, Kathryn M.] US Army, Inst Environm Med, Mil Performance Div, Natick, MA 01760 USA; [Kioumourtzoglou, Marianthi-Anna] Columbia Univ, Dept Environm Hlth Sci, Joseph L Mailman Sch Publ Hlth, New York, NY USA; [Clover, Jim] Sport Fdn, Riverside, CA USA; [Coull, Brent A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Dennerlein, Jack T.] Northeastern Univ, Dept Phys Therapy Movement & Rehabil Sci, Boston, MA 02115 USA; [Bellinger, David C.] Harvard Med Sch, Childrens Hosp, Boston, MA USA; [Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA		Taylor, KM (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	kmt691@mail.harvard.edu		Dennerlein, Jack/0000-0001-7703-643X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25 GM055353, T32 ES007069]; National Institute for Occupational Safety and HealthUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [T42 OH008416, P30 ES000002]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [T42OH008416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES000002, T32ES007069] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health (R25 GM055353 and T32 ES007069) and the National Institute for Occupational Safety and Health (T42 OH008416 and P30 ES000002). AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; [Anonymous], 2012, BYL 503; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bellinger DC, 2012, ENVIRON HEALTH PERSP, V120, P501, DOI 10.1289/ehp.1104170; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comstock D, 2014, NATL HIGH SCH SPORTS; Coull BA, 2001, J AM STAT ASSOC, V96, P1194, DOI 10.1198/016214501753381841; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fischer K. W., 1996, DEV NEUROIMAGING MAP, P263; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Lanphear BP, 2015, ANNU REV PUBL HEALTH, V36, P211, DOI 10.1146/annurev-publhealth-031912-114413; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 2013, J PEDIAT, V163; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Menon V, 2013, TRENDS COGN SCI, V17, P627, DOI 10.1016/j.tics.2013.09.015; National Public Radio Robert Wood Johnson Foundation Harvard T.H. Chan School of Public Health, 2015, SPORTS HLTH AM; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Solomon GS, 2014, AM J SPORT MED, V42, P934, DOI 10.1177/0363546513518742; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stamm JM, 2015, NEUROLOGY, V32, P1768; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tsushima WT, 2013, APPL NEUROPSYCH-CHIL, V2, P13, DOI 10.1080/09084282.2011.643967; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	64	9	9	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2018	46	13					3262	3270		10.1177/0363546518798801			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	HA5WM	WOS:000450350300022	30230912	Green Accepted			2022-02-06	
J	Urosevich, TG; Boscarino, JJ; Hoffman, SN; Kirchner, HL; Figley, CR; Adams, RE; Withey, CA; Boscarino, JA				Urosevich, Thomas G.; Boscarino, Joseph J.; Hoffman, Stuart N.; Kirchner, H. Lester; Figley, Charles R.; Adams, Richard E.; Withey, Carrie A.; Boscarino, Joseph A.			Visual Dysfunction and Associated Co-morbidities as Predictors of Mild Traumatic Brain Injury Seen Among Veterans in Non-VA Facilities: Implications for Clinical Practice	MILITARY MEDICINE			English	Article							SYMPTOMS; MILITARY; TBI	Introduction: Traumatic brain injury (TBI) and post-traumatic stress disorder are considered the signature injuries of the Iraq and Afghanistan conflicts. With the extensive use of improvised explosive devices by the enemy, the concussive effects from blast have a greater potential to cause mild TBI (mTBI) in military Service Members. These mTBI can be associated with other physical and psychological health problems, including mTBI-induced visual processing and eye movement dysfunctions. Our study assessed if any visual dysfunctions existed in those surveyed in non-Veterans Administration (VA) facilities who had suffered mTBI (concussive effect), in addition to the presence of concussion-related co-morbidities. Materials and Methods: As part of a larger study involving veterans from different service eras, we surveyed 235 Veterans who had served during the Iraq and/or Afghanistan conflict era. Data for the study were collected using diagnostic telephone interviews of these veterans who were outpatients of the Geisinger Health System. We assess visual dysfunction in this sample and compare visual dysfunctions of those who had suffered a mTBI (concussive effect), as well as co-morbidities, with those in the cohort who had not suffered concussion effects. Results: Of those veterans who experienced visual dysfunctions, our results reflected that the visual symptoms were significant for concussion with the subjects surveyed, even though all had experienced a mTBI event greater than five years ago. Although we did find an association with concussion and visual symptoms, the association for concussion was strongest with the finding of greater than or equal to three current TBI symptoms, therefore we found this to be the best predictor of previous concussion among the veterans. Conclusions: Veterans from the Iraq/ Afghanistan era who had suffered concussive blast effects (mTBI) can present with covert visual dysfunction as well as additional physical and psychological health problems. The primary eye care providers, especially those in a nonmilitary/VA facility, who encounter these veterans need to be aware of the predictors of mTBI, with the aim of uncovering visual dysfunctions and other associated co-morbidities.	[Urosevich, Thomas G.] Geisinger Med Clin, Ophthalmol Serv, 126 Market Way, Mt Pocono, PA 18344 USA; [Boscarino, Joseph J.] William James Coll, Dept Clin Psychol, 1 Wells Ave, Newton, MA 02459 USA; [Hoffman, Stuart N.] Geisinger Med Clin, Dept Sleep Med, 100 N Acad Ave, Danville, PA 17822 USA; [Kirchner, H. Lester] Geisinger Med Clin, Biomed & Translat Informat, 100 N Acad Ave, Danville, PA 17822 USA; [Figley, Charles R.] Tulane Univ, Sch Social Work, 127 Elk Pl, New Orleans, LA 70112 USA; [Adams, Richard E.] Kent State Univ, Dept Sociol, 215 Merrill Hall, Kent, OH 44242 USA; [Withey, Carrie A.; Boscarino, Joseph A.] Geisinger Med Clin, Dept Epidemiol & Hlth Serv Res, 100 N Acad Ave,MC 44-00, Danville, PA 17822 USA		Urosevich, TG (corresponding author), Geisinger Med Clin, Ophthalmol Serv, 126 Market Way, Mt Pocono, PA 18344 USA.				Geisinger Auxiliary Fund; Kline & Ditty Health Fund; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21-MH-086317]; Department of DefenseUnited States Department of Defense [W81XWH-15-1-0506]	Support for this research was provided by: Geisinger Auxiliary Fund, the Kline & Ditty Health Fund, the National Institute of Mental Health (Grant No. R21-MH-086317), the Wounded Warrior Project, and the Department of Defense (Contract No. W81XWH-15-1-0506) to Dr Joseph A. Boscarino	[Anonymous], 2010, TRAUMATIC BRAIN INJU; [Anonymous], DOD WORLDW NUMB TBI; [Anonymous], 2017, RET TO DUT TOOLK ASS; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Boscarino Joseph A, 2015, Mil Behav Health, V3, P244; Boscarino JA, 2016, SUBST ABUSE REHABIL, V7, P131, DOI 10.2147/SAR.S108302; Boscarino Joseph A, 2010, Int J Emerg Ment Health, V12, P161; Capo-Aponte J.E., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-004, DOI 10.4172/2165-7939.S4-004]; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Goodman B, 2013, P NEUR C; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Magone MT, 2012, AM AC OPHTH M CHIC I; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; ONeil ME, 2014, 05225 VA ESP; Pepe M S, 2003, STAT EVALUATION MED; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Schwab KA, 2006, NEUROLOGY, V66, pA235; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sutter P., 1995, TRAUMATIC BRAIN INJU, P187; Urosevich TG, 2017, AM OPT ASS WASH DC; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	28	9	10	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2018	183	11-12					E564	E570		10.1093/milmed/usy102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4ZP	WOS:000451813600031	29800265	Green Published, Bronze			2022-02-06	
J	Park, HK; Joo, W; Gu, BK; Ha, MY; You, SJ; Chun, HJ				Park, Hae Kwan; Joo, Wonil; Gu, Bon Kang; Ha, Mi Yeon; You, Su Jung; Chun, Heung Jae			Collagen/poly(D,L-lactic-co-glycolic acid) composite fibrous scaffold prepared by independent nozzle control multi-electrospinning apparatus for dura repair	JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY			English	Article						Collagen; PLGA; Fibrous scaffold; Dura repair; Macrophage	HUMAN-BLOOD MONOCYTES; IN-VITRO; COLLAGEN; SUBSTITUTE; ADHESION; BIOCOMPATIBILITY; BIOMATERIALS; REGENERATION; FIBERS; BRAIN	The objective of the present study was to evaluate non-woven collagen/poly(lactic-co-glycolic acid) fibrous scaffold (Col/PLGA FS) prepared by a co-electrospinning process using a novel multi syringe electrospinning system for dura repair. The morphological and mechanical properties of the fibrous scaffolds (FSs) were assessed by scanning electron microscopy (SEM) and a universal testing machine (UTM). The changes in chemical composition due to the incorporation of collagen into PLGA were determined by Fourier transform infrared spectroscopy-attenuated total reflection mode (FTIR-ATR). The biocompatibility of the FSs was also evaluated in vitro in cultures of mouse fibroblasts and in vivo by subcutaneous implantation studies in rats. SEM images of the samples showed that the fiber size distribution of Col/PLGA FS became narrow compared to that of PLGA FS due to the incorporation of collagen with small fiber diameter. The FTIR-ATR spectrum of Col/PLGA FS revealed the characteristic bands of collagen and PLGA, indicating the co-existence of two fibrous structures. The poor mechanical properties of collagen FS were improved by co-electrospinning with PLGA. In vitro L929 cell proliferation assay revealed that the cyto-compatibility of Col/PLGA FS was increased compared to that of PLGA FS. In addition, Col/PLGA FS showed increased hydrophilic properties sufficient to absorb the exudates at the interface with mild foreign body reactions. In animal studies using a traumatic brain injury (TBI) model, the incorporation of collagen induced increased macrophage chemotaxis, and the post-inflammatory reaction of these cells led to remarkable brain tissue regeneration. (C) 2018 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.	[Park, Hae Kwan; Joo, Wonil] Catholic Univ Korea, Coll Med, Neurosci Ctr, Dept Neurosurg,Yeouido St Marys Hosp, Seoul 07345, South Korea; [Gu, Bon Kang] Korea Inst Radiol & Med Sci, Lab Tissue Engn, Seoul 01812, South Korea; [Ha, Mi Yeon; You, Su Jung; Chun, Heung Jae] Catholic Univ Korea, Coll Med, Inst Cell & Tissue Engn, Seoul 06591, South Korea; [Chun, Heung Jae] Catholic Univ Korea, Coll Med, Dept Biomed Sci, Seoul 06591, South Korea		Chun, HJ (corresponding author), Catholic Univ Korea, Coll Med, Inst Cell & Tissue Engn, Seoul 06591, South Korea.	chunhj@catholic.ac.kr		Chun, Heung Jae/0000-0002-0446-9901	Ministry of Trade, Industry and Energy [10047811]	This research was supported by the grant from Ministry of Trade, Industry and Energy (grant no. 10047811).	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Azzam D, 2018, WORLD NEUROSURG, V113, P244, DOI 10.1016/j.wneu.2018.01.115; Conn P. Michael, 2008, NEUROSCIENCE MED, P25; Epstein NE, 2010, SPINE J, V10, P1065, DOI 10.1016/j.spinee.2010.09.017; Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3; Freitas CJ, 2014, INT J MED SCI, V11, P409, DOI 10.7150/ijms.8079; Garnotel R, 2000, J IMMUNOL, V164, P5928, DOI 10.4049/jimmunol.164.11.5928; Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; Sandoval-Sanchez JH, 2012, WORLD NEUROSURG, V77, P577, DOI [10.1016/J.WNEU.2011.07.007, 10.1016/j.wneu.2011.07.007]; Jeon DW, 2012, APPL SURF SCI, V262, P134, DOI 10.1016/j.apsusc.2012.03.078; Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007; Lewis KM, 2018, NEUROSURGERY, V82, P397, DOI 10.1093/neuros/nyx216; Lv D, 2017, EUR J NEUROSCI, V45, P1258, DOI 10.1111/ejn.13558; MAURER PK, 1985, J NEUROSURG, V63, P448, DOI 10.3171/jns.1985.63.3.0448; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Norouzi M, 2015, J BIOMED MATER RES A, V103, P2225, DOI 10.1002/jbm.a.35355; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Paxinos G., 2014, RAT BRAIN STEREOTAXI; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; SANGALLI F, 1992, NEUROSURGERY, V30, P396, DOI 10.1227/00006123-199203000-00014; Sawyer AJ, 2014, BIOMATERIALS, V35, P6698, DOI 10.1016/j.biomaterials.2014.05.008; Seo NM, 2011, TISSUE ENG REGEN MED, V8, P16; Standring S., 2016, GRAYS ANATOMY ANATOM, V41st Edn; Stratton-Powell AA, 2015, J NEUROSURG, V123, P153, DOI 10.3171/2014.12.JNS14917; Terasaka S, 2006, NEUROSURGERY, V58, P134, DOI 10.1227/01.NEU.0000193515.95039.49; VALLFORS B, 1981, NEUROSURGERY, V9, P407, DOI 10.1227/00006123-198110000-00011; Waring MJ, 2001, BIOMATERIALS, V22, P903, DOI 10.1016/S0142-9612(00)00254-4; Zhou YY, 2015, INT J NANOMED, V10, P3203, DOI 10.2147/IJN.S79241	31	9	9	4	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1226-086X	1876-794X		J IND ENG CHEM	J. Ind. Eng. Chem.	OCT 25	2018	66						430	437		10.1016/j.jiec.2018.06.010			8	Chemistry, Multidisciplinary; Engineering, Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering	GV5LT	WOS:000446144400045					2022-02-06	
J	Mustafa, AG; Al-Shboul, O; Alfaqih, MA; Al-Qudah, MA; Al-Dwairi, AN				Mustafa, Ayman G.; Al-Shboul, Othman; Alfaqih, Mahmoud A.; Al-Qudah, Mohammad A.; Al-Dwairi, Ahmed N.			Phenelzine reduces the oxidative damage induced by peroxynitrite in plasma lipids and proteins	ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Peroxynitrite; oxidative stress; ageing; phenelzine; thiobarbituric acid reactive substances; hydrazine	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; PEROXIDATION; STRESS; SUPEROXIDE; PROTECTION; MALONDIALDEHYDE; ANTIOXIDANTS; METABOLISM; GENERATION	Peroxynitrite is a reactive nitrogen species produced in the intravascular compartment from superoxide anion and nitric oxide. Peroxynitrite destroys blood plasma proteins and membranes of red blood cells and of platelets. This explains why excessive production of peroxynitrite contributes to diseases and to ageing. Therapeutics that antagonize peroxynitrite may delay ageing and the progression of disease. We developed an in vitro assay that allows the investigation of the oxidative damage caused by peroxynitrite in the intravascular compartment. This assay correlates the damage with the rate of formation of protein carbonyl groups, 3-nitrotyrosine (3-NT) and thiobarbituric acid reactive substances. Using this assay, we evaluated the ability of phenelzine, a scavenger of reactive aldehydes, to antagonize the effects of peroxynitrite. Herein, we showed that phenelzine significantly decreased the lipid peroxidative damage caused by peroxynitirite in blood plasma and platelets. Moreover, it inhibited carbonyl group and 3-NT formation in blood plasma and platelet proteins.	[Mustafa, Ayman G.; Al-Shboul, Othman; Al-Qudah, Mohammad A.; Al-Dwairi, Ahmed N.] Jordan Univ Sci & Technol, Sch Med, Irbid, Jordan; [Alfaqih, Mahmoud A.] Jordan Univ Sci & Technol, Fac Med, Dept Physiol & Biochem, Irbid 22110, Jordan		Alfaqih, MA (corresponding author), Jordan Univ Sci & Technol, Fac Med, Dept Physiol & Biochem, Irbid 22110, Jordan.	maalfaqih@just.edu.jo	Alqudah, Mohammad/AAR-5917-2020	Al-Dwairi, Ahmed/0000-0002-8909-9275; Alfaqih, Mahmoud/0000-0002-6383-7014; mustafa, ayman/0000-0002-0341-7149			Amorati R, 2015, FREE RADICAL RES, V49, P633, DOI 10.3109/10715762.2014.996146; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Berry C, 2001, CURR OPIN NEPHROL HY, V10, P247, DOI 10.1097/00041552-200103000-00014; Birlouez-Aragon I, 2003, J Nutr Health Aging, V7, P103; Denicola A, 1998, P NATL ACAD SCI USA, V95, P3566, DOI 10.1073/pnas.95.7.3566; El-Shafey Mostafa M, 2015, Pathophysiology, V22, P49, DOI 10.1016/j.pathophys.2014.12.002; Fernando N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156085; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Graham PM, 2013, MOL CELL BIOCHEM, V378, P291, DOI 10.1007/s11010-013-1620-z; Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032; GUTTERIDGE JMC, 1984, FEBS LETT, V172, P245, DOI 10.1016/0014-5793(84)81134-5; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; He K, 1999, NEUROSCIENCE, V94, P909, DOI 10.1016/S0306-4522(99)00350-4; Hou AQ, 2015, ACS APPL MATER INTER, V7, P27918, DOI 10.1021/acsami.5b09993; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Kalsi SS, 2011, OPEN ACCESS EMERG M, V3, P87, DOI 10.2147/OAEM.S24963; Kim S, 2017, RADIAT RES, V187, P32, DOI 10.1667/RR14346.1; Leong XF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/528757; Mustafa AG, 2015, EXP BIOL MED, V240, P109, DOI 10.1177/1535370214546291; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Niemann B, 2017, J AM COLL CARDIOL, V70, P230, DOI 10.1016/j.jacc.2017.05.043; Ohta Y, 2004, J PINEAL RES, V36, P10, DOI 10.1046/j.1600-079X.2003.00091.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Papandreou C, 2012, SLEEP BREATH, V16, P873, DOI 10.1007/s11325-011-0589-7; Prieto-Bermejo R, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020032; Sadowska-Bartosz I, 2014, FOOD CHEM, V164, P228, DOI 10.1016/j.foodchem.2014.04.105; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Stadler K, 2011, CURR MED CHEM, V18, P280, DOI 10.2174/092986711794088317; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Teixeira D, 2017, J CHROMATOGR B, V1046, P48, DOI 10.1016/j.jchromb.2017.01.035; Tulen JHM, 2006, J CLIN PSYCHOPHARM, V26, P542, DOI 10.1097/01.jcp.0000236657.08663.ae; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Weber D, 2015, REDOX BIOL, V5, P367, DOI 10.1016/j.redox.2015.06.005; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Yermilov V, 1996, FEBS LETT, V399, P67, DOI 10.1016/S0014-5793(96)01288-4; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011	42	9	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1381-3455	1744-4160		ARCH PHYSIOL BIOCHEM	Arch. Physiol. Biochem.	OCT 20	2018	124	5					418	423		10.1080/13813455.2017.1415939			6	Biochemistry & Molecular Biology; Biophysics; Endocrinology & Metabolism; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Endocrinology & Metabolism; Physiology	GW9KQ	WOS:000447305900006	29256275				2022-02-06	
J	Li, XG; Kleiven, S				Li, Xiaogai; Kleiven, Svein			Improved safety standards are needed to better protect younger children at playgrounds	SCIENTIFIC REPORTS			English	Article							BRAIN-INJURY; HEAD; STRAIN; FALLS; MODEL	Playground-related traumatic brain injuries (TBIs) in children remain a considerable problem world-wide and current safety standards are being questioned due to historical reasons where the injury thresholds had been perpetuated from automobile industry. Here we investigated head injury mechanisms due to falls on playgrounds using a previously developed and validated age-scalable and positionable whole body child model impacted at front, back and side of the head simulating head-first falls from 1.59 meters (m). The results show that a playground material passing the current testing standards (HIC < 1000 and resultant linear acceleration <200g) resulted in maximum strain in the brain higher than known injury thresholds, thus not offering sufficient protection especially for younger children. The analysis highlights the age dependence of head injuries in children due to playground falls and the youngest have a higher risk of brain injury and skull fracture. Further, the results provide the first biomechanical evidence guiding age-dependent injury thresholds for playground testing standards. The results also have direct implications for novel designs of playground materials for a better protection of children from TBIs. Only making the playground material thicker and more compliant is not sufficient. This study represents the first initiative of using full body human body models of children as a new tool to improve playground testing standards and to better protect the children at playgrounds.	[Li, Xiaogai; Kleiven, Svein] KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, S-14152 Huddinge, Sweden		Kleiven, S (corresponding author), KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, S-14152 Huddinge, Sweden.	sveink@kth.se		Li, Xiaogai/0000-0001-8522-4705; Kleiven, Svein/0000-0003-0125-0784	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2016-04203]; KTH (Stockholm, Sweden)	This study was supported by the Swedish Research Council grants 2016-04203, and by research funds from KTH (Stockholm, Sweden). Acknowledgements go to the PIPER development team who have developed PIPER model and the PIPER tool which were fundamental for the study.	Alvarez V., 2017, THESIS; Alvarez VS, 2018, J BIOMECH, V71, P76, DOI 10.1016/j.jbiomech.2018.01.038; Alvarez Victor S, 2014, Stapp Car Crash J, V58, P63; American Society for Testing and Materials International, 2017, F129299 ASTM; [Anonymous], 2018, 1177 CEN EUR COMM ST; Ball D. J, 2002, PLAYGROUNDS RISKS BE; Bandak, 1999, DEV IMPROVED INJURY; Beillas P., 2016, 14 INT C PROT CHILDR; Beillas P, 2017, PIPER EU PROJECT FIN; Bierbaum M, 2018, J PAEDIATR CHILD H, V54, P556, DOI 10.1111/jpc.13777; Cheng H., 1994, ALCFTR19940051 WRIGH; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Eager D, 2019, ASCE-ASME J RISK U B, V5, DOI 10.1115/1.4039999; Eager D, 2017, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2016, VOL. 14; Euro-NCAP, 2017, PED TEST PROT VERS 8; Fahlstedt M., 2016, P 2016 IRCOBI C INT, P459; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Giordano C., 2016, IRCOBI C, P288; Giordano C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187916; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Huang TJ, 2009, MATER DESIGN, V30, P3819, DOI 10.1016/j.matdes.2008.12.024; Huber R., 2011, IMPACT ATTENUATION V; Huber R., 2015, PREVENTING CHILDHOOD; Janiskangas T, 2018, INJURY PREV, V24, P224, DOI 10.1136/injuryprev-2017-042335; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Loyd A.M., 2011, THESIS; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Osth J, 2015, TRAFFIC INJ PREV, V16, P304, DOI 10.1080/15389588.2014.931949; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Schwartz D, 2015, TRAFFIC INJ PREV, V16, pS49, DOI 10.1080/15389588.2015.1021418; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; The Swedish National Board of Health and Welfare, 2015, INJ CHILDR SWED ACC; Thompson A, 2013, ACCIDENT ANAL PREV, V50, P16, DOI 10.1016/j.aap.2012.09.011; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Thompson AK, 2009, J TRAUMA, V66, P1019, DOI 10.1097/TA.0b013e31817dac8b; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	43	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 10	2018	8								15061	10.1038/s41598-018-33393-z			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4BQ	WOS:000446856000009	30305685	Green Published, gold			2022-02-06	
J	Papesh, MA; Elliott, JE; Callahan, ML; Storzbach, D; Lim, MM; Gallun, FJ				Papesh, Melissa A.; Elliott, Jonathan E.; Callahan, Megan L.; Storzbach, Daniel; Lim, Miranda M.; Gallun, Frederick J.			Blast Exposure Impairs Sensory Gating: Evidence from Measures of Acoustic Startle and Auditory Event-Related Potentials	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; hearing; post-traumatic stress; TBI; veteran	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; AUTONOMIC NERVOUS-SYSTEM; P50; VETERANS; SEQUELAE; SCHIZOPHRENIA; HABITUATION; DYSFUNCTION; MECHANISMS	Many military service members and veterans who have been exposed to high-intensity blast waves experience traumatic brain injury (TBI), resulting in chronic auditory deficits despite normal hearing sensitivity. The current study sought to examine the neurological cause of this chronic dysfunction by testing the hypothesis that blast exposure leads to impaired filtering of sensory information at brainstem and early cortical levels. Groups of blast-exposed and non-blast-exposed participants completed self-report measures of auditory and neurobehavioral status, auditory perceptual tasks involving degraded and competing speech stimuli, and physiological measures of sensory gating, including pre-pulse inhibition and habituation of the acoustic startle reflex and electrophysiological assessment of a paired-click sensory gating paradigm. Blast-exposed participants showed significantly reduced habituation to acoustic startle stimuli and impaired filtering of redundant sensory information at the level the auditory cortex. Multiple linear regression analyses revealed that poorer sensory gating at the cortical level was primarily influenced by a diagnosis of TBI, whereas reduced habituation was primarily influenced by a diagnosis of post-traumatic stress disorder. A statistical model was created including cortical sensory gating and habituation to acoustic startle, which strongly predicted performance on a degraded speech task. These results support the hypothesis that blast exposure impairs central auditory processing via impairment of neural mechanisms underlying habituation and sensory gating.	[Papesh, Melissa A.; Elliott, Jonathan E.; Callahan, Megan L.; Storzbach, Daniel; Lim, Miranda M.; Gallun, Frederick J.] VA Portland Hlth Care Syst, Natl Ctr Rehabilitat Auditory Res, Portland, OR USA; [Papesh, Melissa A.; Gallun, Frederick J.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Elliott, Jonathan E.; Storzbach, Daniel; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Callahan, Megan L.; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Inst Occupat Hlth Sci, Portland, OR 97201 USA		Papesh, MA (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P5-NCRAR, Portland, OR 97239 USA.	Melissa.Papesh@va.gov	Gallun, Frederick J./G-3792-2012	Gallun, Frederick J./0000-0002-4145-2199	VA Portland Health Care SystemUS Department of Veterans Affairs; VA Office of Academic Affiliations (OAA) Advanced Research Fellowship in Polytrauma/TBI Rehabilitation; VA Career Development Award [IK1RX001820, IK2 BX002712]; VA Rehabilitation Research and Development (RRD) Merit Award [C7755I]; National Institutes of Health (N.I.H.)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AT 002688]; Portland VA Research Foundation; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT002688] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000536, IK1RX001820, IK2BX002712] Funding Source: NIH RePORTER	The authors express their sincere appreciation and gratitude for the participation of all subjects, and thank the staff at the VA Portland Health Care System and the National Center for Rehabilitative Auditory Research and Drs. Mary Beth Duncan and Curtis Billings for support with establishing protocols and initial data analysis. This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, VA Office of Academic Affiliations (OAA) Advanced Research Fellowship in Polytrauma/TBI Rehabilitation, and VA Career Development Award IK1RX001820 to M.A.P.; VA Rehabilitation Research and Development (RR&D) Merit Award #C7755I to F.J.G; National Institutes of Health (N.I.H.) T32 AT 002688 to J.E.E.; and VA Career Development Award #IK2 BX002712, and the Portland VA Research Foundation to M.M.L. The contents do not represent the views of the United States Department of Veterans Affairs or the United States Government.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Boutros NN, 2004, SCHIZOPHR RES, V70, P303, DOI 10.1016/j.schres.2003.12.009; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Callahan M.L., 2018, APPL NEUROPSYCH-ADUL, P1; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen H, 2007, EUR NEUROPSYCHOPHARM, V17, P464, DOI 10.1016/j.euroneuro.2006.11.003; Cromwell HC, 2008, CLIN EEG NEUROSCI, V39, P69, DOI 10.1177/155005940803900209; Croux C, 2010, STAT METHOD APPL-GER, V19, P497, DOI 10.1007/s10260-010-0142-z; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; Ghisolfi ES, 2006, EUR NEUROPSYCHOPHARM, V16, P204, DOI 10.1016/j.euroneuro.2005.09.001; Gjini K, 2010, SCHIZOPHR RES, V121, P139, DOI 10.1016/j.schres.2010.04.020; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer N, 2016, PREVALENCE EPIDEMIOL; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grunwald T, 2003, BIOL PSYCHIAT, V53, P511, DOI 10.1016/S0006-3223(02)01673-6; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Hoover EC, 2015, SIG 6 PERSPECT HEAR, V19, P12; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; JERGER K, 1992, BIOL PSYCHIAT, V31, P365, DOI 10.1016/0006-3223(92)90230-W; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; KATZ J, 1962, J AUD RES, V2, P327; Kisley MA, 2004, PSYCHOPHYSIOLOGY, V41, P604, DOI 10.1111/j.1469-8986.2004.00191.x; Knott V, 2013, J PSYCHOPHARMACOL, V27, P790, DOI 10.1177/0269881113490449; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Luxford WM, 2001, OTOLARYNG HEAD NECK, V124, P125, DOI 10.1067/mhn.2001.113035; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Newson R., 2001, STATA J, V1, P1; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; PETERSON GE, 1962, J SPEECH HEAR DISORD, V27, P62, DOI 10.1044/jshd.2701.62; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prins Annabel, 1995, P291; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Spahr AJ, 2012, EAR HEARING, V33, P112, DOI 10.1097/AUD.0b013e31822c2549; Streeter CC, 2012, MED HYPOTHESES, V78, P571, DOI 10.1016/j.mehy.2012.01.021; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Van der Kolk BA, 2006, ANN NY ACAD SCI, V1071, P277, DOI 10.1196/annals.1364.022; Wan L, 2008, INT J PSYCHOPHYSIOL, V67, P91, DOI 10.1016/j.ijpsycho.2007.10.008; Wilson R H, 1994, J Am Acad Audiol, V5, P269; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	80	9	9	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					702	712		10.1089/neu.2018.5801		OCT 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446276200001	30113267	Green Published, hybrid, Green Submitted			2022-02-06	
J	Bigler, ED; Finuf, C; Abildskov, TJ; Goodrich-Hunsaker, NJ; Petrie, JA; Wood, DM; Hesselink, JR; Wilde, EA; Max, JE				Bigler, Erin D.; Finuf, Chris; Abildskov, Tracy J.; Goodrich-Hunsaker, Naomi J.; Petrie, Jo Ann; Wood, Dawn-Marie; Hesselink, John R.; Wilde, Elisabeth A.; Max, Jeffrey E.			Cortical thickness in pediatric mild traumatic brain injury including sports-related concussion	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Mild traumatic brain injury (mTBI); Concussion; Cortical thickness; Brain development; Free-surfer; Post-concussion symptoms	LONGITUDINAL CHANGES; DEVELOPING-CHILDREN; IMAGING ANALYSIS; CEREBRAL-CORTEX; NEUROPATHOLOGY; ABNORMALITIES; METAANALYSIS; ADOLESCENTS; MODERATE; HISTORY	This investigation explored whether differences in cortical thickness could be detected in children who sustained a mild traumatic brain injury (mTBI) compared to those with orthopedic injury (OD and whether cortical thickness related parental reporting of symptoms. To achieve this objective, FreeSurfe (R)-based cortical thickness measures were obtained in 330 children, 8 to 15 years of age, with either a history of mTBI or OI. Imaging was performed in all participants with the same 3 Tesla MRI scanner at six-months post-injury, where a parent-rated Post-Concussion Symptom Inventory (PCSI) was also obtained. Robust age-mediated reductions in cortical thickness were observed, but no consistent group-based differences between the mTBI and OI groups were observed. Also, the relation between mechanism of injury (i.e., sports-related, recreational, fall, motor vehicle accident or other) and cortical thickness was examined. Injuries associated with any type of abuse were excluded and children with OI could not have experienced a MVA. Mechanism of injury did not differentially relate to cortical thickness, although in the fall group, parental rating using the PCSI showed increased symptom reporting to be associated with reduced cortical thickness in the left interior frontal, temporal pole and lateral temporal lobe as well as in the right temporal pole. Results from these preliminary findings are discussed in terms of injury variables and developmental factors associated with mTBI in childhood.	[Bigler, Erin D.; Finuf, Chris; Abildskov, Tracy J.; Goodrich-Hunsaker, Naomi J.; Petrie, Jo Ann; Wood, Dawn-Marie] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Bigler, Erin D.; Finuf, Chris] Brigham Young Univ, Neurosci Ctr, 1001 SWKT, Provo, UT 84602 USA; [Hesselink, John R.; Max, Jeffrey E.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Hesselink, John R.; Max, Jeffrey E.] Rady Childrens Hosp, San Diego, CA USA; [Wilde, Elisabeth A.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.] Baylor Coll Med, Houston, TX 77030 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.; Bigler, ED (corresponding author), Brigham Young Univ, Neurosci Ctr, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R01 HD068432-01A1]	The NIH funding for the 'Pediatric mild traumatic brain injury study' was supported by grant 1 R01 HD068432-01A1. Drs. Bigler, Hesselink and Max have provided expert testimony involving TBI cases. No other conflicts of interest are reported for other authors.	Adolfi F, 2017, CORTEX, V88, P124, DOI 10.1016/j.cortex.2016.12.019; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bernard CO, 2017, J HEAD TRAUMA REHAB, V32, P413, DOI 10.1097/HTR.0000000000000298; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Bigler ED, 2016, J CHILD NEUROL, V31, P1302, DOI 10.1177/0883073816654143; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bigler ED, 2015, BRAIN INJURY, V29, P1062, DOI 10.3109/02699052.2015.1011234; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Brito NH, 2017, BRAIN COGNITION, V116, P54, DOI 10.1016/j.bandc.2017.03.007; Brown TT, 2012, NEUROPSYCHOL REV, V22, P313, DOI 10.1007/s11065-012-9214-1; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cannon TD, 2016, SCHIZOPHRENIA BULL, V42, pS127, DOI 10.1093/schbul/sbv173; Chua CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183960; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; de Kruijf M, 2016, AM J NEURORADIOL, V37, P430, DOI 10.3174/ajnr.A4556; Dennis Emily L, 2013, Dialogues Clin Neurosci, V15, P359; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; EPSTEIN HT, 1986, DEV BRAIN RES, V30, P114, DOI 10.1016/0165-3806(86)90139-2; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Helms G, 2016, MAGN RESON MATER PHY, V29, P111, DOI 10.1007/s10334-015-0518-z; Herting MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119774; Higger M, 2018, LECT NOTES COMPUT SC, V10670, P100, DOI 10.1007/978-3-319-75238-9_9; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Khundrakpam BS, 2016, NEUROIMAGE, V134, P192, DOI 10.1016/j.neuroimage.2016.03.062; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kucyi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035589; Levan A, 2016, BRAIN IMAGING BEHAV, V10, P1090, DOI 10.1007/s11682-015-9472-7; LeWinn KZ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00908-7; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Moeskops P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131552; Newman E, 2016, BRAIN STRUCT FUNCT, V221, P3013, DOI 10.1007/s00429-015-1085-9; Newsome M. R, 2018, BRAIN INJ; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Piccolo LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162511; Plourde V, 2018, CHILD NEUROPSYCHOL, P1, DOI [10.1080/09297049.2018, DOI 10.1080/09297049.2018]; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Selemon LD, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.115; Shapiro LP, 2017, J NEUROSCI RES, V95, P1123, DOI 10.1002/jnr.23960; Silk TJ, 2011, J DEV BEHAV PEDIATR, V32, P158, DOI 10.1097/DBP.0b013e318206d58f; Squier W, 2010, J ANAT, V217, P312, DOI 10.1111/j.1469-7580.2010.01288.x; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Tamnes CK, 2017, J NEUROSCI, V37, P3402, DOI 10.1523/JNEUROSCI.3302-16.2017; Thomas MSC, 2016, DEVELOPMENTAL SCI, V19, P284, DOI 10.1111/desc.12303; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Wang Y, 2018, PAIN, V159, P507, DOI 10.1097/j.pain.0000000000001120; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Woodworth DC, 2019, NEUROSURGERY, V84, P588, DOI 10.1093/neuros/nyy066	66	9	10	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		99	104		10.1016/j.ijpsycho.2018.07.474			6	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000014	30040986				2022-02-06	
J	Davey, K; Saul, T; Russel, G; Wassermann, J; Quaas, J				Davey, Kevin; Saul, Turandot; Russel, Geoffrey; Wassermann, Jonathan; Quaas, Joshua			Application of the Canadian Computed Tomography Head Rule to Patients With Minimal Head Injury	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; EMERGENCY-DEPARTMENT; DEFENSIVE MEDICINE; DECISION-MAKING; CLINICAL POLICY; UNITED-STATES; SCANS; RELIABILITY; PHYSICIANS	Study objective: Two clinical decision rules, the Canadian CT Head Rule and the New Orleans Criteria, set the standard to guide clinicians in determining which patients with minor head trauma need computed tomography (CT) imaging. Both rules were derived with patients with minor head injury who had had a loss of consciousness or witnessed disorientation. No evidence exists for evaluating patients and need for CT imaging with minimal head injury; that is, patients who had a head injury but no loss of consciousness or disorientation and therefore would have been excluded from the Canadian CT Head Rule and New Orleans Criteria trials. We evaluate the Canadian CT Head Rule in patients with head injury without loss of consciousness or witnessed disorientation (minimal head injury). Methods: We studied a prospective convenience sample of patients with minimal head injury who received head CTs as part of their evaluations in the emergency department (ED). Participants were enrolled after head CT was ordered, but before the physician received the imaging results. Physicians were surveyed on their clinical reasoning for ordering imaging in this low-risk cohort of patients. Physicians surveyed consisted of ED attending physicians and senior-level emergency medicine residents. Final patient disposition was recorded when it became available. Patients with positive CT findings had their medical records reviewed for specific disposition, admission length of stay, ICU stay, and any operative or procedural interventions. Results: Two hundred forty patients with minimal head injury were enrolled. Five patients (2.1%) had head CTs that were positive for intracranial hemorrhage. All instances of intracranial hemorrhage occurred in patients who were at high or moderate risk by the Canadian CT Head Rule (2 high risk [age], 3 moderate risk [mechanism]). No patient with intracranial hemorrhage went to the ICU or underwent any intervention; the average hospital length of stay was 1.25 days. The Canadian CT Head Rule was 100% sensitive (95% confidence interval 40% to 100%) and 29% specific (95% confidence interval 23% to 35%) for the presence of intracranial hemorrhage. Physicians listed their own reassurance (24.6%), patient reassurance (24.2%), patient expectation (14.6%), and reduction of legal liability (11.7%) as the rationale for ordering head CT in patients with minimal head injury. Shared decision making was used in 51% of cases. Conclusion: Risk of intracranial hemorrhage in patients with minimal head injury was very low, and even in patients found to have an intracranial hemorrhage, none had any serious adverse outcome (eg, death, intubation, prolonged hospitalization, surgical procedure). The Canadian CT Head Rule was 100% sensitive in this small cohort of patients with minimal head injury. Among our study cohort, which specifically included only patients who had CT scanning, applying the Canadian CT Head Rule may have reduced the need for CT, potentially saving costs and resources. However, because many patients with minimal head injury who present to the ED may not have CTs, it is unclear what effect the broad application of this rule would have on overall CT use. Providers' rationale for obtaining CT was multifactorial. These represent barriers that may need to be overcome before physicians are comfortable changing CT ordering patterns in this group of head injury patients.	[Davey, Kevin] George Washington Univ, Dept Emergency Med, Washington, DC 20052 USA; [Saul, Turandot; Russel, Geoffrey; Wassermann, Jonathan; Quaas, Joshua] Mt Sinai Roosevelt Hosp, Mt Sinai St Lukes Hosp, Dept Emergency Med, New York, NY USA		Davey, K (corresponding author), George Washington Univ, Dept Emergency Med, Washington, DC 20052 USA.	kdavey0210@gmail.com					af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Bishop TF, 2010, ARCH INTERN MED, V170, P1081, DOI 10.1001/archinternmed.2010.155; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huff JS, 2017, AM J EMERG MED, V35, P1777, DOI 10.1016/j.ajem.2017.05.027; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Lee J, 2013, EMERG RADIOL, V20, P219, DOI 10.1007/s10140-012-1098-0; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; MCMICKEN DB, 1986, ANN EMERG MED, V15, P274, DOI 10.1016/S0196-0644(86)80565-0; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Parma C, 2014, AM SURGEON, V80, P664; PricewaterhouseCoopers, 2010, PRIC EXC ID WAST HEA; Salottolo K, 2009, CRIT CARE MED, V37, P1336, DOI 10.1097/CCM.0b013e31819d6739; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609	25	9	9	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	OCT	2018	72	4					342	350		10.1016/j.annemergmed.2018.03.034			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GU9RW	WOS:000445689400005	29753518				2022-02-06	
J	Hilkman, DMW; van Mook, WNKA; Mess, WH; van Kranen-Mastenbroek, VHJM				Hilkman, Danny M. W.; van Mook, Walther N. K. A.; Mess, Werner H.; van Kranen-Mastenbroek, Vivianne H. J. M.			The Use of Continuous EEG Monitoring in Intensive Care Units in The Netherlands: A National Survey	NEUROCRITICAL CARE			English	Article						Continuous EEG monitoring; Non-convulsive seizures; Critical illness; Intensive care; Neuromonitoring	NONCONVULSIVE STATUS EPILEPTICUS; CRITICALLY-ILL PATIENTS; CONSENSUS STATEMENT; CARDIAC-ARREST; ADULTS; HYPOTHERMIA; MANAGEMENT; CHILDREN; TIME; ICU	Background: Currently, continuous electroencephalographic monitoring (cEEG) is the only available diagnostic tool for continuous monitoring of brain function in intensive care unit (ICU) patients. Yet, the exact relevance of routinely applied ICU cEEG remains unclear, and information on the implementation of cEEG, especially in Europe, is scarce. This study explores current practices of cEEG in adult Dutch ICU departments focusing on organizational and operational factors, development over time and factors perceived relevant for abstaining its use. Methods: A national survey on cEEG in adults among the neurology and adult intensive care departments of all Dutch hospitals (n=82) was performed. Results: The overall institutional response rate was 78%. ICU cEEG is increasingly used in the Netherlands (in 37% of all hospitals in 2016 versus in 21% in 2008). Currently in 88% of university, 55% of teaching and 14% of general hospitals use ICU cEEG. Reasons for not performing cEEG are diverse, including perceived non-feasibility and lack of data on the effect of cEEG use on patient outcome. Mostly, ICU cEEG is used for non-convulsive seizures or status epilepticus and prognostication. However, cEEG is never or rarely used for monitoring cerebral ischemia and raised intracranial pressure in traumatic brain injury. Review and reporting practices differ considerably between hospitals. Nearly all hospitals perform non-continuous review of cEEG traces. Methods for moving toward continuous review of cEEG traces are available but infrequently used in practice. Conclusions: cEEG is increasingly used in Dutch ICUs. However, cEEG practices vastly differ between hospitals. Future research should focus on uniform cEEG practices including unambiguous EEG interpretation to facilitate collaborative research on cEEG, aiming to provide improved standard patient care and robust data on the impact of cEEG use on patient outcome.	[Hilkman, Danny M. W.; Mess, Werner H.; van Kranen-Mastenbroek, Vivianne H. J. M.] MUMC, Dept Clin Neurophysiol, POB 5800, NL-6202 Maastricht, Netherlands; [van Mook, Walther N. K. A.] MUMC, Dept Intens Care Med, Maastricht, Netherlands		Hilkman, DMW (corresponding author), MUMC, Dept Clin Neurophysiol, POB 5800, NL-6202 Maastricht, Netherlands.	d.hilkman@mumc.nl	Mess, Werner/AAB-9527-2020	Hilkman, Danny/0000-0002-7687-9037			Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Beniczky S, 2017, CLIN NEUROPHYSIOL, V128, P2334, DOI 10.1016/j.clinph.2017.07.418; Chen JWY, 2006, LANCET NEUROL, V5, P246, DOI 10.1016/S1474-4422(06)70374-X; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Dericioglu N, 2015, EPILEPSY RES, V109, P48, DOI 10.1016/j.eplepsyres.2014.10.013; Friberg H, 2013, CRIT CARE, V17, DOI 10.1186/cc12699; Gaspard N, 2016, J CLIN NEUROPHYSIOL, V33, P211, DOI 10.1097/WNP.0000000000000279; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hilkman DMW, 2017, CURR OPIN ANESTHESIO, V30, P192, DOI 10.1097/ACO.0000000000000443; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Hofmeijer J, 2016, CLIN NEUROPHYSIOL, V127, P2047, DOI 10.1016/j.clinph.2016.02.002; Kinney MO, 2017, EXPERT REV NEUROTHER, V17, P987, DOI 10.1080/14737175.2017.1369880; Kowoll CM, 2014, NEUROCRIT CARE, V20, P176, DOI 10.1007/s12028-013-9893-3; Kurtz P, 2014, INTENS CARE MED, V40, P228, DOI 10.1007/s00134-013-3149-8; Kurtz P, 2009, CURR OPIN CRIT CARE, V15, P99, DOI 10.1097/MCC.0b013e3283294947; Laccheo I, 2015, NEUROCRIT CARE, V22, P202, DOI 10.1007/s12028-014-0070-0; Lemesle M, 2015, NEUROPHYSIOL CLIN, V45, P121, DOI 10.1016/j.neucli.2014.12.001; Moura LMVR, 2014, NEUROLOGY, V83, P56, DOI 10.1212/WNL.0000000000000537; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; Oddo M, 2014, CRIT CARE MED, V42, P1340, DOI 10.1097/CCM.0000000000000211; Ponten SC, 2009, TIJDSCHR NEUROL NEUR, V110, P29; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; Rossetti AO, 2011, LANCET NEUROL, V10, P922, DOI 10.1016/S1474-4422(11)70187-9; Rubinos C, 2017, NEUROCRIT CARE; Ruijter BJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-433; Sivaraju A, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-015-0391-0; Spalletti M, 2016, CLIN NEUROPHYSIOL, V127, P2610, DOI 10.1016/j.clinph.2016.04.008; Sutter R, 2016, J CLIN NEUROPHYSIOL, V33, P25, DOI 10.1097/WNP.0000000000000216; Taccone FS, 2014, CRIT CARE, V18, DOI 10.1186/cc13696; Thomke F, 2013, DTSCH ARZTEBL INT, V110, P137, DOI 10.3238/arztebl.2013.0137; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Tsetsou S, 2013, NEUROCRIT CARE, V19, P283, DOI 10.1007/s12028-013-9883-5; Tsuchida TN, 2013, J CLIN NEUROPHYSIOL, V30, P161, DOI 10.1097/WNP.0b013e3182872b24	35	9	10	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2018	29	2					195	202		10.1007/s12028-018-0525-9			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GY3QG	WOS:000448467900008	29589330	hybrid, Green Published			2022-02-06	
J	Howland, J; Hackman, H; Taylor, A; Brown, L; Gapinski, MA; Mills, JK; Thornton, K				Howland, Jonathan; Hackman, Holly; Taylor, Alyssa; Brown, Linda; Gapinski, Mary Ann; Mills, Julie Kautz; Thornton, Kathleen			Evaluation of Implementation of Massachusetts Sports Concussion Regulations: Results of Focus Groups With School Nurses and Athletic Trainers	JOURNAL OF SCHOOL NURSING			English	Article						concussion; students; athletes; school nurses; athletic trainers; regulations; focus groups	LAW	In 2015, the Massachusetts Department of Public Health conducted focus groups with school nurses (SNs) and athletic trainers (ATs) from Massachusetts middle and high schools to assess implementation of legislated regulations relative to the management of students' head injuries incurred during extracurricular sports. Four tape-recorded focus groups were conducted by experienced facilitators. Lists of themes were synthesized by investigators for each focus group. Participating SNs and ATs supported the sports concussion legislation, felt that implementation had gone well, indicated that the law empowered them in managing return-to-school/play for students with concussion, and experienced support from their school administrators. Some SNs reported that they had applied relevant procedures to all students with head injuries, regardless of how or where the injury occurred. Challenges identified included protocols for away games, inconsistent concussion care by physicians, and a need for teacher education. Further research is required to quantify these findings.	[Howland, Jonathan; Hackman, Holly; Taylor, Alyssa] Boston Univ, Sch Med, Dept Emergency Med, Boston Med Ctr, One Boston Med Ctr Pl,Dowling 1 South, Boston, MA 02118 USA; [Howland, Jonathan; Hackman, Holly; Taylor, Alyssa] Boston Med Ctr, Injury Prevent Ctr, Boston, MA USA; [Brown, Linda; Gapinski, Mary Ann; Mills, Julie Kautz] Massachusetts Dept Publ Hlth, Boston, MA USA; [Thornton, Kathleen] Athlet Trainers Massachusetts, Boston, MA USA		Howland, J (corresponding author), Boston Univ, Sch Med, Dept Emergency Med, Boston Med Ctr, One Boston Med Ctr Pl,Dowling 1 South, Boston, MA 02118 USA.	jhowl@bu.edu					Blackwell LS, 2017, J CHILD NEUROL, V32, P327, DOI 10.1177/0883073816681351; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Flaherty MR, 2016, J PEDIATR-US, V178, P268, DOI 10.1016/j.jpeds.2016.08.025; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Massachusetts Department of Elementary and Secondary Education and Department of Public Health, 2015, HLTH RISK BEH MASS Y; National Association of School Nurses, 2016, CONC ROL SCH NURS PO; The Network for Public Health Law, 2016, SUMM MATR STAT LAWS	9	9	9	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	OCT	2018	34	5					344	349		10.1177/1059840517702697			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	GT3VV	WOS:000444432900004	28378627				2022-02-06	
J	Jiang, HJ; Guo, YS; Wu, ZL; Zhang, C; Jia, W; Wang, ZH				Jiang, Hanjun; Guo, Yanshu; Wu, Zeliang; Zhang, Chun; Jia, Wen; Wang, Zhihua			Implantable Wireless Intracranial Pressure Monitoring Based on Air Pressure Sensing	IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS			English	Article; Proceedings Paper	IEEE Biomedical Circuits and Systems Conference (BioCAS)	OCT 19-21, 2017	Torino, ITALY	IEEE Circuits & Syst Soc, IEEE Engn Med & Biol Soc		Air pressure sensor; implantable device; intracranial pressure (ICP); system-on-a-chip (SoC); wireless monitoring	TRAUMATIC BRAIN-INJURY; SENSOR	A wireless intracranial pressure (ICP) monitoring system based on the air pressure sensing is proposed in this work. The proposed system is composed of an implantable ICP sensing device and a portable wireless data recorder. The ICP sensing device consists of an air pressure sensor, an ultra-thin air pouch for pressure sensing, and a low-power dedicated system-on-a-chip (SoC) for the data acquisition control and wireless transmission. The SoC consists of a power management unit, a wake-up controller, the sensor interface, a wireless transmitter, and the workflow control logic. The SoC is fabricated in 0.18 mu m CMOS technology with a die area of 3.04 mm x 2 mm. Experimental results show that the prototype implantable ICP device has achieved a resolution of 0.2 mmHg and a battery lifetime of 1 week with a 3 V 50 mAh battery. The ICP device has been tested in the liquid environment. The nonlinearity error is less than +/- 0.4 mmHg for the full measurement range of -20 to +150 mmHg. Compared to the other implantable wireless ICP solutions in the literature, the proposed system alleviates the biocompatibility issue and increases the measurement accuracy.	[Jiang, Hanjun; Guo, Yanshu; Wu, Zeliang; Zhang, Chun; Wang, Zhihua] Tsinghua Univ, Inst Microelect, Beijing 10084, Peoples R China; [Jia, Wen] Tsinghua Univ, Res Inst, Guangdong Engn Res Ctr ICs Wireless Healthcare, Shenzhen 518057, Peoples R China		Jiang, HJ (corresponding author), Tsinghua Univ, Inst Microelect, Beijing 10084, Peoples R China.	jianghanjun@tsinghua.edu.cn; guoys@tsinghua-sz.org; wzl15@mails.tsinghua.edu.cn; zhangchun@tsinghua.edu.cn; jiaw@tsinghua-sz.org; zhihua@tsinghua.edu.cn	Guo, Yanshu/AAU-8674-2021	Guo, Yanshu/0000-0002-5800-8799; zhang, chun/0000-0001-9791-4500	Science, Technology and Innovation Commission of Shenzhen Municipality [JCYJ20170307145728497]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61474070, 61431166002]; Beijing Engineering Research Center [BG0149]	This work was supported in part by the Science, Technology and Innovation Commission of Shenzhen Municipality under Grant JCYJ20170307145728497, in part by the National Natural Science Foundation of China under Grants 61474070 and 61431166002, and in part by Beijing Engineering Research Center under Grant BG0149. This paper was recommended by Associate Editor M. Martina. (Corresponding author: Hanjun Jiang.)	AHUJA BK, 1983, IEEE J SOLID-ST CIRC, V18, P629, DOI 10.1109/JSSC.1983.1052012; Behfar MH, 2016, IEEE ENG MED BIO, P1950, DOI 10.1109/EMBC.2016.7591105; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Ghanbari MM, 2017, IEEE J SOLID-ST CIRC, V52, P720, DOI 10.1109/JSSC.2016.2633510; Iliut M, 2016, CARBON, V106, P228, DOI 10.1016/j.carbon.2016.05.032; Jiang H, 2010, ADV EXP MED BIOL, P1; Kawoos U, 2015, IEEE MICROW MAG, V16, P39, DOI 10.1109/MMM.2014.2377585; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Khan MWA, 2017, 2017 INTERNATIONAL WORKSHOP ON ANTENNA TECHNOLOGY: SMALL ANTENNAS, INNOVATIVE STRUCTURES, AND APPLICATIONS (IWAT), P122, DOI 10.1109/IWAT.2017.7915334; Khan MWA, 2016, IEEE ANTENNAS PROP, P997, DOI 10.1109/APS.2016.7696207; Khan MWA, 2016, IEEE MICROW WIREL CO, V26, P549, DOI 10.1109/LMWC.2016.2574836; Kiefer M, 2011, IEEE ENG MED BIO, P2246, DOI 10.1109/IEMBS.2011.6090426; Meng XL, 2011, PHIL MAG LETT, V91, P344, DOI 10.1080/09500839.2011.559912; Meng X, 2013, IEEE T MICROW THEORY, V61, P316, DOI 10.1109/TMTT.2012.2224361; Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480; Nancy C., 2007, J NEUROTRAUM, V24, pS45; Petkus V, 2014, COMP MED SY, P427, DOI 10.1109/CBMS.2014.44; Rincon-Mora GA, 1998, IEEE J SOLID-ST CIRC, V33, P36, DOI 10.1109/4.654935; Waqas M, 2017, IEEE SENS J, V17, P2191, DOI 10.1109/JSEN.2017.2661324; Wu ZD, 2018, PHYSICA B, V551, P60, DOI 10.1016/j.physb.2017.12.030	20	9	9	1	11	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4545	1940-9990		IEEE T BIOMED CIRC S	IEEE Trans. Biomed. Circuits Syst.	OCT	2018	12	5					1076	1087		10.1109/TBCAS.2018.2845462			12	Engineering, Biomedical; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering	GX8JU	WOS:000448032000012	30010593				2022-02-06	
J	Saha, P; Gupta, R; Sen, T; Sen, N				Saha, Pampa; Gupta, Rajaneesh; Sen, Tanusree; Sen, Nilkantha			Activation of cyclin D1 affects mitochondrial mass following traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						TBI; Mitochondria; Cyclin D1; NRF1	CENTRAL-NERVOUS-SYSTEM; CELL-CYCLE; INTRANASAL DELIVERY; PROVIDES NEUROPROTECTION; OXIDATIVE STRESS; BIOGENESIS; SIRNA; DAMAGE; INACTIVATION; DEGRADATION	Cell cycle activation has been associated with varying types of neurological disorders including brain injury. Cyclin D1 is a critical modulator of cell cycle activation and upregulation of Cyclin D1 in neurons contributes to the pathology associated with traumatic brain injury (TBI). Mitochondrial mass is a critical factor to maintain the mitochondrial function, and it can be regulated by different signaling cascades and transcription factors including NRF1. However, the underlying mechanism of how TBI leads to impairment of mitochondrial mass following TBI remains obscure. Our results indicate that augmentation of CyclinD1 attenuates mitochondrial mass formation following TBI. To elucidate the molecular mechanism, we found that Cyclin D1 interacts with a transcription factor NRF1 in the nucleus and prevents NRF1's interaction with p300 in the pericontusional cortex following TBI. As a result, the acetylation level of NRF1 was decreased, and its transcriptional activity was attenuated. This event leads to a loss of mitochondrial mass in the pericontusional cortex following TBI. Intranasal delivery of Cyclin D1 RNAi immediately after TBI rescues transcriptional activation of NRF1 and recovers mitochondrial mass after TBI.	[Saha, Pampa; Gupta, Rajaneesh; Sen, Tanusree; Sen, Nilkantha] Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,Scaife Hall, Pittsburgh, PA 15213 USA		Sen, N (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,Scaife Hall, Pittsburgh, PA 15213 USA.	senn@pitt.edu	Sen, Nilkantha/AAW-9788-2020; Gupta, Rajaneesh/AAD-5893-2019	Gupta, Rajaneesh/0000-0003-0212-6478; Sen, Nilkantha/0000-0002-8383-8209	National Institutes of Health - University of Pittsburgh [RO1NS094516, RO1EY025622, 29470]; Pittsburgh Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094516] Funding Source: NIH RePORTER	This work was partly supported by the National Institutes of Health (Grants RO1NS094516 and RO1EY025622 to N.S., R.G., P.S and T.S.), funding from University of Pittsburgh (29470) and 2018 Walter L. Copeland Fund of the Pittsburgh Foundation to R.G, T.S, and N.S.	Aigner A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71659; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Ballista-Hernandez J, 2017, MOL CANCER RES, V15, P831, DOI 10.1158/1541-7786.MCR-16-0218; Bitko Vira, 2008, V442, P75, DOI 10.1007/978-1-59745-191-8_6; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; Chauhan M.B., 2015, J NEUROL NEUROSURG, V2; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Corona JC, 2015, J BIOENERG BIOMEMBR, V47, P89, DOI 10.1007/s10863-014-9576-6; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Danielyan L, 2010, REJUV RES, V13, P195, DOI 10.1089/rej.2009.0944; de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Djupesland PG, 2013, J CEREBR BLOOD F MET, V33, P793, DOI 10.1038/jcbfm.2013.41; Dominy JE, 2013, COLD SPRING HARB PER, V5; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Femandez-Marcos P. J., 2011, AM J CLIN NUTR, V93, P8845; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Frade JM, 2015, CELL CYCLE, V14, P712, DOI 10.1080/15384101.2015.1004937; Fukuda AM, 2013, GENES-BASEL, V4, P435, DOI 10.3390/genes4030435; Gonzalez-Hunt C. P., 2016, CURR PROTOC TOXICOL, V67; Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/h11-070, 10.1139/H11-070]; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Kim ID, 2012, MOL THER, V20, P829, DOI 10.1038/mt.2011.291; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li Y, 1997, J CEREBR BLOOD F MET, V17, P846, DOI 10.1097/00004647-199708000-00003; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lien LM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006157; Liu TF, 2015, J BIOL CHEM, V290, P396, DOI 10.1074/jbc.M114.566349; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mathison S, 1998, J DRUG TARGET, V5, P415, DOI 10.3109/10611869808997870; Mathupala SP, 2009, EXPERT OPIN THER PAT, V19, P137, DOI 10.1517/13543770802680195; May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-65; Mir S, 2014, MOL CELL, V56, P786, DOI 10.1016/j.molcel.2014.10.019; Pardridge WM, 2007, ADV DRUG DELIVER REV, V59, P141, DOI 10.1016/j.addr.2007.03.008; Raina AK, 2000, J NEUROSCI RES, V61, P128, DOI 10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.3.CO;2-8; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Rodriguez M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01819-9; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sen T, 2007, NEUROCHEM INT, V50, P719, DOI 10.1016/j.neuint.2007.01.007; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Small DL, 2001, BRAIN RES, V900, P26, DOI 10.1016/S0006-8993(01)02102-3; Tayebati SK, 2013, CURR PHARM DESIGN, V19, P510; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Upadhyay RK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869269; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang B, 2017, CAN J PHYSIOL PHARM, V95, P667, DOI 10.1139/cjpp-2016-0611; Wang Z, 2017, INT REV CEL MOL BIO, V331, P245, DOI 10.1016/bs.ircmb.2016.09.010; Wei GW, 2007, FRONT BIOSCI-LANDMRK, V12, P4986, DOI 10.2741/2443; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; Yin W, 2008, STROKE, V39, P3057, DOI 10.1161/STROKEAHA.108.520114; Zhang SM, 2014, J IMMUNOL, V193, P5973, DOI 10.4049/jimmunol.1400839	77	9	9	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2018	118						108	116		10.1016/j.nbd.2018.07.010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR0GW	WOS:000442193400009	30010002	Green Accepted			2022-02-06	
J	Shavit, I; Aviram, E; Hoffmann, Y; Biton, O; Glassberg, E				Shavit, Itai; Aviram, Eliad; Hoffmann, Yoav; Biton, Oded; Glassberg, Elon			Laryngeal mask airway as a rescue device for failed endotracheal intubation during scene-to-hospital air transport of combat casualties	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						airway; casualties; combat; intubation; laryngeal mask airway	SUCCESS RATES; BATTLEFIELD; HELICOPTERS; SERVICE; INJURY	BackgroundAdvanced airway management of combat casualties during scene-to-hospital air transport is challenging. Because of the short transport time, flight physicians of the Israeli military airborne combat evacuation unit are approved for the use of a laryngeal mask airway (LMA) in the event of failed endotracheal intubation (ETI). The aim of this study was to assess the effectiveness of LMA use during scene-to-hospital transport of combat casualties in Israel.Patients and methodsA retrospective cohort analysis of all combat casualties treated with ETI during scene-to-hospital transport over a 3-year period was carried out. Successful LMA insertion was defined as satisfactory placement of the device on the basis of adequate chest expansion with bag-mask ventilation.ResultsThe median flight time from scene to hospital was 13min [interquartile range (IQR): 9-15min]. Sixty-five casualties underwent ETI attempts, 47 successful and 18 failed. All 18 casualties who had failed ETI underwent LMA insertion as a rescue treatment. Six casualties suffered from traumatic brain injury, six had firearm injuries, two had blast injuries, and two had inhalational injuries. LMA insertion was successful in 16/18 (88.9%) casualties, 14 survived to hospital discharge, whereas two were declared dead upon hospital arrival. Two cases of LMA insertion were unsuccessful, but patients survived to hospital discharge. Among the 16 successful cases, the median oxygen saturation on scene-pickup before LMA insertion and on hospital-handover with LMA in place were 90% (IQR: 84-96%) and 98% (IQR: 96-99%), respectively (P<0.0001, the 95% confidence interval for difference between medians was 4-11).ConclusionThe findings of this study suggest that in the event of failed ETI, combat casualties can be treated effectively with LMA during a short scene-to-hospital transport time.	[Shavit, Itai] Rambam Hlth Care Campus, Pediat Emergency Dept, Haifa, Israel; [Aviram, Eliad; Biton, Oded; Glassberg, Elon] Israel Def Forces Med Corps, Ramat Gan, Israel; [Hoffmann, Yoav] Western Galilee Hosp, Pediat Intens Care Unit, Nahariyya, Israel; [Hoffmann, Yoav; Glassberg, Elon] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Glassberg, Elon] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Shavit, I (corresponding author), Rambam Hlth Care Campus, Pediat Emergency Dept, Haifa, Israel.	itai@pem-database.iorg					Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Calkins MD, 1999, J TRAUMA, V46, P927, DOI 10.1097/00005373-199905000-00025; Germann C, 2009, PREHOSP EMERG CARE, V13, P44, DOI 10.1080/10903120802474505; Hilton MT, 2016, PREHOSP EMERG CARE, V20, P570, DOI 10.3109/10903127.2016.1163446; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P515, DOI 10.3109/10903127.2010.497903; Katzenell U, 2013, J TRAUMA ACUTE CARE, V75, pS178, DOI 10.1097/TA.0b013e318299d650; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Kyle T, 2016, J ROY ARMY MED CORPS, V162, P460, DOI 10.1136/jramc-2016-000637; Le Cong M, 2012, EMERG MED J, V29, P249, DOI 10.1136/emj.2010.100651; Mabry Robert L, 2011, J Spec Oper Med, V11, P16; Mabry Robert L, 2012, J Spec Oper Med, V12, P17; Mabry RL, 2010, PREHOSP EMERG CARE, V14, P272, DOI 10.3109/10903120903537205; Martin SE, 1999, J TRAUMA, V47, P352, DOI 10.1097/00005373-199908000-00023; Samuel N, 2013, J EMERG MED, V44, P641, DOI 10.1016/j.jemermed.2012.07.082; Schwartz D, 2009, MIL MED, V174, P551, DOI 10.7205/MILMED-D-03-0008; Studer NM, 2013, MIL MED, V178, P1202, DOI 10.7205/MILMED-D-13-00250	16	9	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	OCT	2018	25	5					368	371		10.1097/MEJ.0000000000000480			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GU8YJ	WOS:000445629800011	28657971				2022-02-06	
J	Simani, L; Elmi, M; Asadollahi, M				Simani, Leila; Elmi, Mahboubeh; Asadollahi, Marjan			Serum GFAP level: A novel adjunctive diagnostic test in differentiate epileptic seizures from psychogenic attacks	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Epilep; Tic seizure; PNES; Serum GFAP level; Biomarker	FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; NONEPILEPTIC SEIZURES; CREATINE-KINASE; LACTIC-ACIDOSIS; PROLACTIN; MARKER; BIOMARKERS	Purpose: There has been increasing interest in the use of different biomarkers to help distinguish psychogenic from epileptic seizures, in patients presenting acutely with seizure-like events. In the present study, we measured serum glial fibrillary astrocytic protein (GFAP) levels in patients presenting with such events who were subsequently diagnosed as epileptic seizures (ESs) or psychogenic non-epileptic seizures (PNESs) and compared GFAP levels obtained with those found in healthy subjects. Methods: Sixty-three patients with seizures (43 with ES and 20 with PNES), and 19 healthy subjects participated in the study. Venous blood samples were obtained within the first 6 h after seizures and serum GFAP levels were measured by protein quantification (ELIZA kit) with an electrochemical luminescence immunoassay. Results: Serum GFAP levels were significantly higher in patients with ES compared to PNES or healthy controls. A cut-off point of 2.71 ng/ml was found optimally to differentiate ES from PNES (sensitivity 72%, specificity 59%). Conclusion: Our study suggests that post-seizure serum GFAP levels could be used in future studies better to understand the underlying mechanism of seizures and may offer as an adjunctive diagnostic test in differentiating ES from PNES.	[Simani, Leila] Shaheed Beheshti Univ Med Sci, Loghman Hakim Hosp, Skull Base Res Ctr, Tehran, Iran; [Elmi, Mahboubeh; Asadollahi, Marjan] Shaheed Beheshti Univ Med Sci, Loghman Hakim Hosp, Dept Epilepsy, South Kargar Ave,Kamali St, Tehran, Iran		Asadollahi, M (corresponding author), Loghman Hakim Hosp, Epilepsy Monitoring Unit, Clin Neurophysiol & Epilepsy, Kamali St,South Kargar Ave, Tehran 1333635445, Iran.	marjanasadollahi54@gmail.com		simani, leila/0000-0002-1349-4252	Clinical Research Development Unit (CRDU) of Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran	The authors would like to thank the Clinical Research Development Unit (CRDU) of Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran for their support, cooperation and assistance throughout the study.	Alper K, 1997, EPILEPSIA, V38, P991, DOI 10.1111/j.1528-1157.1997.tb01481.x; ANZOLA GP, 1993, EPILEPSIA, V34, P1044, DOI 10.1111/j.1528-1157.1993.tb02132.x; Aydin S, 2011, PEPTIDES, V32, P1276, DOI 10.1016/j.peptides.2011.04.021; Bakvis P, 2010, EPILEPSIA, V51, P752, DOI 10.1111/j.1528-1167.2009.02394.x; BALLOUGH GPH, 1995, J NEUROSCI METH, V61, P23, DOI 10.1016/0165-0270(95)00019-Q; BAUER J, 1992, EUR ARCH PSY CLIN N, V241, P365, DOI 10.1007/BF02191962; Bodde NMG, 2009, SEIZURE-EUR J EPILEP, V18, P543, DOI 10.1016/j.seizure.2009.06.006; Brigo F, 2015, J NEUROL, V262, P251, DOI 10.1007/s00415-014-7369-9; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Buttner T, 1999, J NEUROL, V246, P459, DOI 10.1007/s004150050383; Calik M, 2013, SEIZURE-EUR J EPILEP, V22, P99, DOI 10.1016/j.seizure.2012.10.012; Chen DK, 2005, NEUROLOGY, V65, P668, DOI 10.1212/01.wnl.0000178391.96957.d0; Chmielewska N, 2018, NEUROL NEUROCHIR POL, V52, P318, DOI 10.1016/j.pjnns.2018.02.002; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Dogan EA, 2017, EPILEPSY BEHAV, V75, P13, DOI 10.1016/j.yebeh.2017.07.003; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Ehsan T, 1996, J EPILEPSY, V9, P101, DOI 10.1016/0896-6974(96)00006-0; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Gurnett CA, 2003, EPILEPSIA, V44, P1455, DOI 10.1046/j.1528-1157.2003.21603.x; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Kyriakides T, 2010, EUR J NEUROL, V17, P767, DOI 10.1111/j.1468-1331.2010.03012.x; LaFrance WC, 2010, NEUROLOGY, V75, P1285, DOI 10.1212/WNL.0b013e3181f612bb; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; Lange RP, 2014, CANCER INVEST, V32, P423, DOI 10.3109/07357907.2014.933237; Lee SY, 2010, J NEUROL, V257, P1708, DOI 10.1007/s00415-010-5608-2; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Li YJ, 2013, EPILEPSY RES, V103, P205, DOI 10.1016/j.eplepsyres.2012.08.001; Lipka K, 2003, ACTA ANAESTH SCAND, V47, P616, DOI 10.1034/j.1399-6576.2003.00115.x; Liu RSN, 2005, EPILEPSIA, V46, P1482, DOI 10.1111/j.1528-1167.2005.51603.x; Lu CF, 2010, NEUROSCI LETT, V484, P139, DOI 10.1016/j.neulet.2010.08.036; Matz O, 2016, SEIZURE-EUR J EPILEP, V40, P71, DOI 10.1016/j.seizure.2016.06.014; Missler U, 1999, CLIN CHEM, V45, P138; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nass RD, 2017, SEIZURE-EUR J EPILEP, V47, P51, DOI 10.1016/j.seizure.2017.02.013; ORRINGER CE, 1977, NEW ENGL J MED, V297, P796, DOI 10.1056/NEJM197710132971502; Palmio J, 2008, EPILEPSY RES, V81, P155, DOI 10.1016/j.eplepsyres.2008.05.006; Palmio J, 2009, SEIZURE-EUR J EPILEP, V18, P474, DOI 10.1016/j.seizure.2009.04.006; PRITCHARD PB, 1985, ANN NEUROL, V18, P87, DOI 10.1002/ana.410180115; Rabinowicz AL, 1996, EPILEPSIA, V37, P122, DOI 10.1111/j.1528-1157.1996.tb00002.x; Rejdak K, 2012, EPILEPSIA, V53, P922, DOI 10.1111/j.1528-1167.2012.03459.x; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Silvestri NJ, 2013, MUSCLE NERVE, V47, P805, DOI 10.1002/mus.23755; SIMON RP, 1985, EPILEPSIA, V26, pS58, DOI 10.1111/j.1528-1157.1985.tb05725.x; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Sundararajan T, 2016, SEIZURE-EUR J EPILEP, V35, P11, DOI 10.1016/j.seizure.2015.12.011; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Tunca Z, 2000, PSYCHOSOMATICS, V41, P152, DOI 10.1176/appi.psy.41.2.152; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Willert C, 2004, ACTA NEUROL SCAND, V109, P318, DOI 10.1046/j.1600-0404.2003.00232.x; Witgert ME, 2005, EPILEPSY BEHAV, V6, P174, DOI 10.1016/j.yebeh.2004.11.005; Young G Bryan, 2006, Adv Neurol, V97, P217	53	9	10	0	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	OCT	2018	61						41	44		10.1016/j.seizure.2018.07.010			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX1KZ	WOS:000447477500008	30077862				2022-02-06	
J	Lajud, N; Diaz-Chavez, A; Radabaugh, HL; Cheng, JP; Rojo-Soto, G; Valdez-Alarcon, JJ; Bondi, CO; Kline, AE				Lajud, Naima; Diaz-Chavez, Arturo; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Rojo-Soto, Georgina; Valdez-Alarcon, Juan J.; Bondi, Corina O.; Kline, Anthony E.			Delayed and Abbreviated Environmental Enrichment after Brain Trauma Promotes Motor and Cognitive Recovery That Is Not Contingent on Increased Neurogenesis	JOURNAL OF NEUROTRAUMA			English	Article						behavioral outcome; controlled cortical impact; environmental enrichment; functional recovery; learning and memory; Morris water maze; traumatic brain injury	MORRIS WATER MAZE; MEDIATED FUNCTIONAL IMPROVEMENT; ADULT HIPPOCAMPAL NEUROGENESIS; HISTOLOGICAL BENEFITS; VOLUNTARY EXERCISE; MEMORY DEFICITS; CELL-SURVIVAL; MOUSE MODEL; INJURY; RAT	Environmental enrichment (EE) confers motor and cognitive recovery in pre-clinical models of traumatic brain injury (TBI), and neurogenesis has been attributed to mediating the benefits. Whether that ascription is correct has not been fully investigated. Hence, the goal of the current study is to further clarify the possible role of learning-induced hippocampal neurogenesis on functional recovery after cortical impact or sham injury by utilizing two EE paradigms (i.e., early + continuous, initiated immediately after TBI and presented 24h/day; and delayed + abbreviated, initiated 4 days after TBI for 6h/day) and comparing them to one another as well as to standard (STD) housed controls. Motor and cognitive performance was assessed on post-operative Days 1-5 and 14-19, respectively, for the STD and early + continuous EE groups and on Days 4-8 and 17-22, for the delayed + abbreviated EE groups. Rats were injected with bromodeoxyuridine (BrdU, 500mg/ kg; intraperitoneally) for 3 days (12h apart) before cognitive training and sacrificed 1 week later for quantification of BrdU+ and doublecortin (DCX+) labeled cells. Both early + continuous and delayed + abbreviated EE promoted motor and cognitive recovery after TBI, relative to STD (p<0.05), and did not differ from one another (p>0.05). However, only early + continuous EE increased DCX+ cells beyond the level of STD-housed controls (p<0.05). No effect of EE on non-injured controls was observed. Based on these data, two novel conclusions emerged. First, EE does not need to be provided early and continuously after TBI to confer benefits, which lends credence to the delayed + abbreviated EE paradigm as a relevant pre-clinical model of neurorehabilitation. Second, the functional recovery observed after TBI in the delayed + abbreviated EE paradigm is not contingent on increased hippocampal neurogenesis. Future studies will elucidate alternate viable mechanisms mediating the benefits induced by EE.	[Lajud, Naima; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Lajud, Naima; Radabaugh, Hannah L.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Lajud, Naima; Diaz-Chavez, Arturo; Rojo-Soto, Georgina] Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico; [Valdez-Alarcon, Juan J.] Univ Michoacana, Ctr Estudios Multidisciplinarios Biotecnol Beneme, Morelia, Michoacan, Mexico		Kline, AE (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Childrens Hosp Pittsburgh, Sch Med,Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute; Programa de Cooperacion Internacional (PCI)-Instituto Mexicano del Seguro Social; Fondo de Investigacion en Salud [FIS/IMSS/PROT/G16/1593]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967, R03NS094950, R21NS099683] Funding Source: NIH RePORTER	This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB), Programa de Cooperacion Internacional (PCI)-Instituto Mexicano del Seguro Social (NL) and Fondo de Investigacion en Salud (FIS/IMSS/PROT/G16/1593) (NL). We would like to thank the international collaboration program at the Instituto Mexicano del Seguro Social and M.C. Carla Martinez Castuera for her valuable help.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Ambrogini P, 2004, NEUROSCI LETT, V359, P13, DOI 10.1016/j.neulet.2003.12.123; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Berardi N, 2007, J ALZHEIMERS DIS, V11, P359; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; de la Tremblaye P.B., 2018, NEUROPHARMACOLOGY; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gregoire CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086237; Hairston IS, 2001, NEUROSCI LETT, V315, P29, DOI 10.1016/S0304-3940(01)02309-6; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hase Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0850-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hullinger R, 2015, NEUROBIOL LEARN MEM, V125, P126, DOI 10.1016/j.nlm.2015.08.006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Mala H, 2017, RESTOR NEUROL NEUROS, V35, P25, DOI 10.3233/RNN-160682; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Miki Takanori, 2005, Anatomical Science International, V80, P153, DOI 10.1111/j.1447-073x.2005.00121.x; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Nicolas S, 2015, PSYCHONEUROENDOCRINO, V57, P72, DOI 10.1016/j.psyneuen.2015.03.017; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wang SH, 2010, PHARMACOL BIOCHEM BE, V95, P129, DOI 10.1016/j.pbb.2009.12.017; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	71	9	9	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					756	767		10.1089/neu.2018.5866		SEP 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000445769100001	30051757	Green Published			2022-02-06	
J	Cramer, A; Hecla, J; Wu, DF; Lai, XC; Boers, T; Yang, K; Moulton, T; Kenyon, S; Arzoumanian, Z; Krull, W; Gendreau, K; Gupta, R				Cramer, Avilash; Hecla, Jake; Wu, Dufan; Lai, Xiaochun; Boers, Tim; Yang, Kai; Moulton, Tim; Kenyon, Steven; Arzoumanian, Zaven; Krull, Wolfgang; Gendreau, Keith; Gupta, Rajiv			Stationary Computed Tomography for Space and other Resource-constrained Environments	SCIENTIFIC REPORTS			English	Article							ACUTE STROKE; PHOTOCATHODES; EXPERIENCE; HEMORRHAGE; BRAIN; TIME; CT	Computed tomography (CT) is used to diagnose many emergent medical conditions, including stroke and traumatic brain injuries. Unfortunately, the size, weight, and expense of CT systems make them largely inaccessible for patients outside of major hospitals. We have designed a module containing multiple miniature x-ray sources that could allow for CT systems to be significantly lighter, smaller, and cheaper, and to operate without any moving parts. We have developed a novel photocathode-based x-ray source, created by depositing a thin film of magnesium on an electron multiplier. When illuminated by a UV LED, this photocathode emits a beam of electrons, with a beam current of up to 1 mA. The produced electrons are accelerated through a high voltage to a tungsten target. These sources are individually addressable and can be pulsed rapidly, through electronic control of the LEDs. Seven of these sources are housed together in a 17.5 degree arc within a custom vacuum manifold. A full ring of these modules could be used for CT imaging. By pulsing the sources in series, we are able to demonstrate x-ray tomosynthesis without any moving parts. With a clinical flat-panel detector, we demonstrate 3D acquisition and reconstructions of a cadaver swine lung.	[Cramer, Avilash; Hecla, Jake] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cramer, Avilash; Wu, Dufan; Lai, Xiaochun; Yang, Kai; Gupta, Rajiv] Harvard Med Sch, Boston, MA 20115 USA; [Wu, Dufan; Lai, Xiaochun; Yang, Kai; Moulton, Tim; Krull, Wolfgang; Gupta, Rajiv] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Moulton, Tim; Krull, Wolfgang; Gupta, Rajiv] Consortia Improving Med Innovat Technol, Boston, MA 02114 USA; [Boers, Tim] Univ Twente, NL-7522 NB Enschede, Netherlands; [Kenyon, Steven; Arzoumanian, Zaven; Gendreau, Keith] NASA, Goddard Space Flight Ctr, Greenbelt, MD 02771 USA		Cramer, A (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Cramer, A (corresponding author), Harvard Med Sch, Boston, MA 20115 USA.	avilash@mit.edu	Lai, Xiaochun/AAY-7784-2020		National Institute of Biomedical Imaging and Bioengineering (NIBIB), of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [5T32EB1680]; US Army Medical Research Contract Acquisition Activity [W81XWH-15-C-0052]; Eran Broshy Fellowship in Medical Engineering and Science; DoDUnited States Department of Defense [W81XWH-13-2-0067]; DoD CDMRP Air Force [FA8650-17-C-9113]; USAMRAA [W81XWH-15-C-0052, W81XWH-17-C-0068]; Consortia for Improving Medicine with Innovation and Technology (CIMIT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001680] Funding Source: NIH RePORTER	A.C. supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), of the National Institutes of Health under award number 5T32EB1680; by the US Army Medical Research Contract Acquisition Activity under award number W81XWH-15-C-0052; and by the Eran Broshy Fellowship in Medical Engineering and Science. R.G. was supported in part by the following contracts: (a) DoD W81XWH-13-2-0067, (b) DoD CDMRP Air Force Contract FA8650-17-C-9113, (c) USAMRAA W81XWH-15-C-0052, and (d) USAMRAA W81XWH-17-C-0068. We received additional support from the Consortia for Improving Medicine with Innovation and Technology (CIMIT). We would like to thank Varex Imaging for providing us with the flat-panel detector. We would also like to thank Cody Dennett, Leigh Ann Kesler, Pete Stahl, Dr. Richard Lanza, and Dr. Michael Short at MIT Nuclear Science and Engineering for all of their advice and help with the photocathode design, and Richard Koenecke of Beta Systems, Inc. for his help with the mechanical design and fabrication.	Bagg Mark R, 2006, J Am Acad Orthop Surg, V14, pS7; Bonard JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115406; Bowry R, 2015, STROKE, V46, P3370, DOI 10.1161/STROKEAHA.115.011093; Foale CM, 2005, AVIAT SPACE ENVIR MD, V76, P594; Folio LR, 2010, COMBAT RADIOLOGY: DIAGNOSTIC IMAGING OF BLAST AND BALLISTIC INJURIES, P1, DOI 10.1007/978-1-4419-5854-9; Gonzalez RG, 2013, J NEUROINTERV SURG, V5, P7, DOI 10.1136/neurintsurg-2013-010715; Hart R, 2002, AVIAT SPACE ENVIR MD, V73, P601; John S, 2016, J NEUROIMAGING, V26, P391, DOI 10.1111/jon.12346; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; Kirmani A, 2014, SCIENCE, V343, P58, DOI 10.1126/science.1246775; Lee Bruce, 2005, NeuroRx, V2, P372; Loch R. A., 2005, THESIS; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Michelato P, 1997, NUCL INSTRUM METH A, V393, P455, DOI 10.1016/S0168-9002(97)00545-7; Neurologica Corporation, 2018, CER PORT CT; Nie HQ, 2016, J PHYS CHEM C, V120, P974, DOI 10.1021/acs.jpcc.5b08848; OECD, 2021, COMP TOM CT EX IND, DOI [10.1787/3c994537-en, DOI 10.1787/3C994537-EN]; Palmer D. T., 2005, SLACTN05080; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Parmee R, 2014, NANOCONVERGENCE, V1; Ribaya BP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/18/185201; Roentgen W, 1896, NATURE; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Schellinger PD, 1999, STROKE, V30, P765, DOI 10.1161/01.STR.30.4.765; Shan J, 2015, THESIS; Shan J, 2015, PHYS MED BIOL, V60, P81, DOI 10.1088/0031-9155/60/1/81; Southerland AM, 2016, STROKE, V47, P1965, DOI 10.1161/STROKEAHA.115.011149; Sprawls P, 1995, PHYS PRINCIPLES MED; STEVENSON J, 1961, J APPL PHYS, V32, P166, DOI 10.1063/1.1735972; Sugie H, 2001, APPL PHYS LETT, V78, P2578, DOI 10.1063/1.1367278; Williams D. R, 2011, MCGILL J MED MJM, V13; Williams LT, 2010, IEEE T ELECTRON DEV, V57, P3163, DOI 10.1109/TED.2010.2069563; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707; Yuan Q, 2003, J VAC SCI TECHNOL B, V21, P2830, DOI 10.1116/1.1624265	34	9	9	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 21	2018	8								14195	10.1038/s41598-018-32505-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU4SY	WOS:000445276000039	30242169	Green Published, gold			2022-02-06	
J	Zhang, WJ; Liu, XG; Li, QY				Zhang, Weijing; Liu, Xiaogang; Li, Qiuyue			Protective Effects of Oleuropein Against Cerebral Ischemia/Reperfusion by Inhibiting Neuronal Apoptosis	MEDICAL SCIENCE MONITOR			English	Article						Apoptosis; Brain Ischemia; Olea; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt	AKT/GSK3-BETA SIGNALING PATHWAY; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; OLIVE OIL; RAT MODEL; INTRACEREBRAL HEMORRHAGE; MOUSE-BRAIN; ISCHEMIA; NEUROPROTECTION; ACTIVATION	Background: In this study, we investigated the potential neuroprotective effect of oleuropein (OLE) on apoptotic changes via modulating Akt/glycogen synthase kinase 3 beta (Akt/GSK-3b) signaling in a rat model of cerebral ischemia/reperfusion injury (IRI). Material/Methods: Sprague-Dawley male rats (12 weeks, n=200) were randomly assigned to 5 groups: sham group, vehicle (IRI+vehicle) group, OLE (IRI+OLE) group, OLE+LY294002 (IRI+OLE+LY294002) group, and LY294002(IRI+LY294002) group. The rats were subjected to cerebral ischemia/reperfusion injury (IRI) model and treated once daily for 5 days with vehicle and OLE (100 mg/kg via intraperitoneal injection) after IRI injury. LY294002 (0.3 mg/kg) was intraperitoneally injected once at 30 min after IRI injury. Brain edema, neurological deficit, rotarod latencies, and Morris water maze (MWM) performance were evaluated after IRI. The number of dead cells were assayed by TUNEL staining. Western blot was used to detect the expression of Bcl-2, Bax, cleaved caspase-3 (CC3), neurotrophic factors, and the phosphorylation levels of Akt and GSK-3b. Results: Compared with the vehicle group, brain water content, neurological deficits, rotarod latencies, and escape latency following IRI were reduced in the OLE group. Cell apoptosis and reduced neurotrophic factor caused by IRI was also attenuated by OLE. Furthermore, increased p-Akt and decreased p-GSK-3b were caused by OLE, which were associated with decrease of Bax/Bcl-2 ratio and the suppression of Caspase-3 activity after IRI. Importantly, all the beneficial effects of OLE in the vehicle group were abrogated by PI3K inhibitor LY294002. Conclusions: Cerebral ischemia was protected by OLE via suppressing apoptosis through the Akt/GSK-3b pathway and upregulating neurotrophic factor after IRI.	[Zhang, Weijing; Li, Qiuyue] Tangshan Gongren Hosp, Dept Nursing, Tangshan, Hebei, Peoples R China; [Liu, Xiaogang] Tangshan Gongren Hosp, Dept Hepatobiliary Surg, Tangshan, Hebei, Peoples R China		Liu, XG (corresponding author), Tangshan Gongren Hosp, Dept Hepatobiliary Surg, Tangshan, Hebei, Peoples R China.	chensits@163.com					Angeloni C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112230; Carito V, 2014, NAT PROD RES, V28, P1970, DOI 10.1080/14786419.2014.918977; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chiang KL, 2018, QJM, V1, P10; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Efentakis P, 2015, PLANTA MED, V81, P648, DOI 10.1055/s-0035-1546017; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Feng FB, 2018, BIOMED PHARMACOTHER, V102, P1209, DOI 10.1016/j.biopha.2018.03.142; Gao C, 2014, BRAIN PATHOL, V24, P261, DOI 10.1111/bpa.12116; Garwood ER, 2010, BREAST CANCER RES TR, V119, P137, DOI 10.1007/s10549-009-0507-x; Goldsmith CD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071937; Gonzalez-Correa JA, 2007, LIPIDS, V42, P921, DOI 10.1007/s11745-007-3097-6; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Gursoy-Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI 10.1111/j.1471-4159.2012.07938.x; Hu Q, 2014, INT J CLIN EXP PATHO, V7, P5057; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Impellizzeri D, 2012, BIOCHEM PHARMACOL, V83, P1413, DOI 10.1016/j.bcp.2012.02.001; Janahmadi Z, 2017, N-S ARCH PHARMACOL, V390, P245, DOI 10.1007/s00210-016-1323-6; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P164, DOI 10.6091/IBJ.1026.2012; Khalatbary AR, 2012, NEUROL RES, V34, P44, DOI 10.1179/1743132811Y.0000000058; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li HL, 2018, FREE RADICAL BIO MED, V120, P228, DOI 10.1016/j.freeradbiomed.2018.03.014; Li P, 2016, INT J NEUROSCI, V126, P552, DOI 10.3109/00207454.2015.1042973; Li R, 2017, INT J BIOL SCI, V13, P640, DOI 10.7150/ijbs.18636; Li ZW, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.897689; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu XX, 2017, MED SCI MONITOR, V23, P6072, DOI 10.12659/MSM.907628; Luo TF, 2014, INT J MOL SCI, V15, P15426, DOI 10.3390/ijms150915426; Ma XD, 2015, INT J NEUROSCI, V125, P161, DOI 10.3109/00207454.2014.917413; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mohagheghi F, 2010, THESCIENTIFICWORLDJO, V10, P1180, DOI 10.1100/tsw.2010.128; Nogami-Hara A, 2018, J ETHNOPHARMACOL, V214, P190, DOI 10.1016/j.jep.2017.12.025; Romorini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35660; Ryan F, 2018, NEUROTOX RES, V34, P79, DOI 10.1007/s12640-017-9861-3; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sherif IO, 2016, INT J BIOCHEM CELL B, V74, P12, DOI 10.1016/j.biocel.2016.02.012; Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Visioli F, 2002, MED RES REV, V22, P65, DOI 10.1002/med.1028; Yu HL, 2016, EUR J PHARMACOL, V775, P113, DOI 10.1016/j.ejphar.2016.02.027; Yu Z, 2013, MOL MED REP, V8, P1315, DOI 10.3892/mmr.2013.1666; Zaidi HA, 2015, WORLD NEUROSURG, V84, P1191, DOI 10.1016/j.wneu.2015.06.015; Zamani M, 2013, J Neurosci Rural Pract, V4, P164, DOI 10.4103/0976-3147.112753; Zhang DD, 2018, EXP THER MED, V15, P5100, DOI 10.3892/etm.2018.6016; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zhang XM, 2018, INT J MOL MED, V41, P3185, DOI 10.3892/ijmm.2018.3517; Zhao Q, 2017, EVID-BASED COMPL ALT, V2017	50	9	11	1	13	INT SCIENTIFIC LITERATURE, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	SEP 19	2018	24						6587	6598		10.12659/MSM.912336			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GU2LF	WOS:000445100500002	30230477	Green Published, Green Submitted			2022-02-06	
J	Chang, C; Hinze, A; Bowen, J; Gilbert, L; Starkey, N				Chang, Carole; Hinze, Annika; Bowen, Judy; Gilbert, Leah; Starkey, Nicola			Mymemory: A mobile memory assistant for people with traumatic brain injury	INTERNATIONAL JOURNAL OF HUMAN-COMPUTER STUDIES			English	Article						Traumatic brain injury; Mobile memory aid; Autobiographic memory; Cue-based memory retrieval	AUTOBIOGRAPHICAL MEMORY; NEW-ZEALAND; ALZHEIMERS-DISEASE; WEARABLE CAMERA; REHABILITATION; SENSECAM; SYSTEM; ROBOTS; CARE	Traumatic Brain Injury (TBI) is a major cause of disability in young people in New Zealand, and has long-term effects on memory and other cognitive functions. This article introduces MyMemory, a mobile augmented memory system that aims to assist TBI survivors in coping with their memory impairments. We here present an exploration of design requirements for mobile memory aids for people with TBI, the MyMemory conceptual design and high-level details of the prototype implementation. We report on the results of our A-B-A-B study with six TBI survivors and three caregivers. The participants with TBI all reported improvements when using MyMemory with regards to their well-being, memory function and autobiographical memory. The caregivers confirmed these observations of TBI participants, however, the results regarding possible reductions of caregiver burden are mixed.	[Chang, Carole; Hinze, Annika; Bowen, Judy; Gilbert, Leah; Starkey, Nicola] Univ Waikato, Hamilton, Waikato, New Zealand		Hinze, A (corresponding author), Univ Waikato, Hamilton, Waikato, New Zealand.	cchang@waikato.ac.nz; hinze@waikato.ac.nz; jbowen@waikato.ac.nz; nicola.starkey@waikato.ac.nz	Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Bowen, Judy/0000-0003-2815-8267			Acampora G, 2013, P IEEE, V101, P2470, DOI 10.1109/JPROC.2013.2262913; Adam H., 2016, 2016 IEEE MTT S INT, P1; Adami AM, 2010, IEEE T INF TECHNOL B, V14, P481, DOI 10.1109/TITB.2008.2010701; Andreadis S, 2016, LECT NOTES COMPUT SC, V9989, P357, DOI 10.1007/978-3-319-47602-5_49; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Barkow K, 2001, EUR ARCH PSY CLIN N, V251, P21, DOI 10.1007/BF03035122; Barthel R, 2013, PERS UBIQUIT COMPUT, V17, P321, DOI 10.1007/s00779-011-0496-8; Beer JM, 2012, ACMIEEE INT CONF HUM, P335, DOI 10.1145/2157689.2157806; BrainLine, 2013, LIF CHANG MOB APPS P; Bright Focus Foundation, 2011, ALZH DIS RES; Broekens Joost, 2009, Gerontechnology, V8, P94; Browne G, 2011, MEMORY, V19, P713, DOI 10.1080/09658211.2011.614622; Canzian L, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P1293, DOI 10.1145/2750858.2805845; Cardinale A. M., 2016, TRAUMATIC BRAIN INJU; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CAVALLO MM, 2005, TXB TRAUMATIC BRAIN, P533; Chang C.C., 2011, DICT PSYCHOL; Chang C.-H., 2017, THESIS; Chen TL, 2013, IEEE ROBOT AUTOM MAG, V20, P30, DOI 10.1109/MRA.2012.2229950; Chen TL, 2011, ACMIEEE INT CONF HUM, P457, DOI 10.1145/1957656.1957818; Costa A, 2012, EXPERT SYST APPL, V39, P12192, DOI 10.1016/j.eswa.2012.04.058; De Leo G, 2011, APPL NEUROPSYCHOL, V18, P69, DOI 10.1080/09084282.2011.545730; Dobbins C, 2014, 2014 28TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS (WAINA), P922, DOI 10.1109/WAINA.2014.142; Doherty AR, 2012, HUM-COMPUT INTERACT, V27, P151, DOI 10.1080/07370024.2012.656050; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Ebling MR, 2016, IEEE PERVAS COMPUT, V15, P4, DOI 10.1109/MPRV.2016.41; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Feng V. W., 2014, THESIS; Ferguson S., 2015, BARTHES STUDIES, V29, P1; Fitzgerald JM, 2013, MEMORY, V21, P230, DOI 10.1080/09658211.2012.725736; Gilbert L., 2017, P ICCAE C, P51; Gravenhorst F, 2015, PERS UBIQUIT COMPUT, V19, P335, DOI 10.1007/s00779-014-0829-5; Grunerbl A, 2015, IEEE J BIOMED HEALTH, V19, P140, DOI 10.1109/JBHI.2014.2343154; Gurrin Cathal, 2014, Foundations and Trends in Information Retrieval, V8, P5, DOI 10.1561/1500000033; Hao Y, 2008, PHYSIOL MEAS, V29, pR27, DOI 10.1088/0967-3334/29/11/R01; Harbouche A, 2013, IEEE ENABL TECHNOL, P44, DOI 10.1109/WETICE.2013.17; Hardy RM, 2006, NEUROPSYCHOL REHABIL, V16, P178, DOI 10.1080/09602010500145646; Haux R, 2016, IMIA YB; Health Care POV, 2012, SPEAK APPS INTR MEM; Heffner C.L., 2004, ALL PSYCH ONLINE; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hodges S, 2011, MEMORY, V19, P685, DOI 10.1080/09658211.2011.605591; IWAMURA M, 2014, P AH 14, DOI DOI 10.1145/2582051.2582083; Jahr D., 2017, CAMPAIGN FIGHT HIDDE; Khong E.B.-Y., 2016, THESIS; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Lee M, 2006, WORKSH DES TECHN PEO; Lee ML, 2007, ASSETS'07: PROCEEDINGS OF THE NINTH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P131; Lee ML, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P44, DOI 10.1145/1409635.1409643; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Masel B.E., 2010, J NEUROTRAUMA, V27; McCullagh S., 2011, COGNITIVE CHANGES 2, P279; Mordoch E, 2013, MATURITAS, V74, P14, DOI 10.1016/j.maturitas.2012.10.015; Nelson LA, 2013, NEUROPSYCHOLOGY, V27, P666, DOI 10.1037/a0034117; Neumann Stephanie, 2017, P 2017 CHI C EXT ABS, P884, DOI 10.1145/3027063.3052756; Nielsen J., 2012, THINKING ALOUD 1 USA; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Petrelli D, 2010, PERS UBIQUIT COMPUT, V14, P153, DOI 10.1007/s00779-009-0279-7; Pollack ME, 2003, ROBOT AUTON SYST, V44, P273, DOI 10.1016/S0921-8890(03)00077-0; Rantz M. J., 2011, 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services (Healthcom 2011), P142, DOI 10.1109/HEALTH.2011.6026731; Rashidi P, 2013, IEEE J BIOMED HEALTH, V17, P579, DOI 10.1109/JBHI.2012.2234129; Rashidi P, 2009, IEEE T SYST MAN CY A, V39, P949, DOI 10.1109/TSMCA.2009.2025137; Richmond J., 2012, DIGITAL PARROT ANDRO; Rodriguez-Sanchez MC, 2014, EXPERT SYST APPL, V41, P7210, DOI 10.1016/j.eswa.2014.05.031; Schweer A., 2009, P CHINZ, P105; Schweer A., 2011, THESIS; Sellen A, 2010, COMMUN ACM, V53, P70, DOI 10.1145/1735223.1735243; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P217, DOI 10.1016/j.jarmac.2012.07.009; Smarr C.-A., 2011, TECHNICAL REPORT; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Starkey N.J., 2013, PSYCHOL AOTEAROA, V5, P18; Stevens R., 2017, HIDDEN EPIDEMIC TRAU; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thompson C. P., 2013, AUTOBIOGRAPHICAL MEM; van den Hoven E., 2015, Z PSYCHOL; van den Hoven E, 2008, PERS UBIQUIT COMPUT, V12, P433, DOI 10.1007/s00779-007-0177-9; Van Erp J. B., 2015, FRONTIERS DIGIT HUM, V2, P2, DOI 10.3389/fdigh.2015.00002; Vemuri S, 2004, BT TECHNOL J, V22, P125, DOI 10.1023/B:BTTJ.0000047591.29175.89; Wada K, 2010, 2010 IEEE RO-MAN, P533, DOI 10.1109/ROMAN.2010.5598615; WAGENAAR WA, 1986, COGNITIVE PSYCHOL, V18, P225, DOI 10.1016/0010-0285(86)90013-7; Wood A., 2015, THESIS; Woodberry E, 2015, MEMORY, V23, P340, DOI 10.1080/09658211.2014.886703	85	9	9	1	15	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1071-5819	1095-9300		INT J HUM-COMPUT ST	Int. J. Hum.-Comput. Stud.	SEP	2018	117						4	19		10.1016/j.ijhcs.2018.02.006			16	Computer Science, Cybernetics; Ergonomics; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering; Psychology	GL2BD	WOS:000436917100002					2022-02-06	
J	Davies, S; Coxe, K; Harvey, HH; Singichetti, B; Guo, JH; Yang, JZ				Davies, Susan; Coxe, Kathryn; Harvey, Hosea H.; Singichetti, Bhavna; Guo, Jinhong; Yang, Jingzhen			Qualitative Evaluation of High School Implementation Strategies for Youth Sports Concussion Laws	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; adolescents; return to play	TRAUMATIC BRAIN-INJURY; MANAGEMENT; COACHES; STATE; EDUCATION; HEADS	Context: All 50 states and the District of Columbia have enacted laws governing concussion management and education. These concussion laws, featuring common tenets regarding removal from play, return to play, and concussion education, have shaped school and district policies. Objective: To evaluate the strategies commonly used to implement concussion laws at the school and district levels, as reported by certified athletic trainers (ATs). Design: Qualitative study. Setting: High schools. Patients or Other Participants: We interviewed 64 ATs from high schools (1 per school) participating in High School Reporting Information Online. Data Collection and Analysis: Interviews were conducted with participants between April and October 2015 regarding implementation of the 3 core tenets of concussion laws. Research team members independently evaluated the interview transcripts and field notes to identify common themes in implementation strategies. Results: Of the 64 schools represented, 90.6% were public schools, 89.1% sponsored more than 15 sports, and all schools employed at least 1 AT and had a written concussion policy. Four commonly used strategies to implement removal from play were reliance on coaches, immediate response, referral and guidance after injury, and notification of key individuals. Use of assessment or baseline tests, communication among parties involved, reliance on AT assessments, and return-to-learn policies were 4 frequent strategies to implement return to play. Finally, 3 major implementation strategies to effectuate concussion education were use of existing educational tools, timing of education, and concussion training for school professionals. Conclusions: Although concussion laws were passed at different times and varied in content across states, common themes in implementation strategies emerged across jurisdictions. The identification of strategic approaches to implementation will help ensure proper concussion management and education, reducing negative health outcomes among youths with concussions.	[Davies, Susan] Univ Dayton, Dept Counselor Educ & Human Serv, Dayton, OH 45469 USA; [Coxe, Kathryn] Ohio Dept Mental Hlth & Addict Serv, Dept Qual Planning & Res, Columbus, OH USA; [Harvey, Hosea H.] Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; [Singichetti, Bhavna; Guo, Jinhong; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr,RB3-WB5403, Columbus, OH 43205 USA.	ginger.yang@nationwidechildrens.org	Coxe, Kathryn/AAJ-8041-2021	Coxe, Kathryn/0000-0002-7813-1081; Singichetti, Bhavna/0000-0002-2188-3979	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [30822]	This work was supported by the Robert Wood Johnson Foundation grant 30822. The interpretations and conclusions in this article do not necessarily represent those of the funding organization. We express our appreciation to HS RIO and to the athletic directors and athletic trainers who participated in this project.	[Anonymous], INT CONS DIAGN MAN S; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Davies SC, 2016, PSYCHOL SCHOOLS, V53, P567, DOI 10.1002/pits.21927; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glanz K., 2008, HLTH BEHAV HLTH ED T; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Lowrey Kerri McGowan, 2016, J Health Care Law Policy, V19, P99; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	21	9	9	0	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2018	53	9					873	879		10.4085/1062-6050-529-17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GY4NU	WOS:000448540500007	30284457	gold, Green Published			2022-02-06	
J	Fiandaca, MS; Gross, TJ; Johnson, TM; Hu, MT; Evetts, S; Wade-Martins, R; Merchant-Borna, K; Bazarian, J; Cheema, AK; Mapstone, M; Federoff, HJ				Fiandaca, Massimo S.; Gross, Thomas J.; Johnson, Thomas M.; Hu, Michele T.; Evetts, Samuel; Wade-Martins, Richard; Merchant-Borna, Kian; Bazarian, Jeffrey; Cheema, Amrita K.; Mapstone, Mark; Federoff, Howard J.			Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury	METABOLITES			English	Article						Parkinson's disease; Parkinson's disease dementia; subacute mild traumatic brain injury; glutamic acid; excitotoxicity; metabolomics	SLEEP BEHAVIOR DISORDER; FREE FATTY-ACIDS; MITOCHONDRIAL ENERGY-METABOLISM; EXCITATORY AMINO-ACIDS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; CEREBROSPINAL-FLUID; MASS-SPECTROMETRY; HEAD-INJURY	The etiologic basis for sporadic forms of neurodegenerative diseases has been elusive but likely represents the product of genetic predisposition and various environmental factors. Specific gene-environment interactions have become more salient owing, in part, to the elucidation of epigenetic mechanisms and their impact on health and disease. The linkage between traumatic brain injury (TBI) and Parkinson's disease (PD) is one such association that currently lacks a mechanistic basis. Herein, we present preliminary blood-based metabolomic evidence in support of potential association between TBI and PD. Using untargeted and targeted high-performance liquid chromatography-mass spectrometry we identified metabolomic biomarker profiles in a cohort of symptomatic mild TBI (mTBI) subjects (n = 75) 3-12 months following injury (subacute) and TBI controls (n = 20), and a PD cohort with known PD (n = 20) or PD dementia (PDD) (n = 20) and PD controls (n = 20). Surprisingly, blood glutamic acid levels in both the subacute mTBI (increased) and PD/PDD (decreased) groups were notably altered from control levels. The observed changes in blood glutamic acid levels in mTBI and PD/PDD are discussed in relation to other metabolite profiling studies. Should our preliminary results be replicated in comparable metabolomic investigations of TBI and PD cohorts, they may contribute to an "excitotoxic" linkage between TBI and PD/PDD.	[Fiandaca, Massimo S.; Gross, Thomas J.; Mapstone, Mark; Federoff, Howard J.] Univ Calif Irvine, Sch Med, Translat Lab & Biorepository, Dept Neurol, Irvine, CA 92697 USA; [Fiandaca, Massimo S.] Univ Calif Irvine, Sch Med, Dept Neurol Surg, Irvine, CA 92697 USA; [Fiandaca, Massimo S.; Gross, Thomas J.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Johnson, Thomas M.] Naval Med Ctr Camp Lejeune, Intrepid Spirit Concuss Recovery Ctr, Jacksonville, NC 28540 USA; [Hu, Michele T.; Evetts, Samuel] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford 01865, England; [Hu, Michele T.] Oxford Univ Hosp Trust, John Radcliffe Hosp, Dept Neurol, Oxford 01865, England; [Wade-Martins, Richard] Univ Oxford, Oxford Parkinsons Dis Ctr, Dept Physiol Anat & Genet, Oxford 01865, England; [Merchant-Borna, Kian; Bazarian, Jeffrey] Univ Rochester, Dept Emergency Med, Sch Med & Dent, Rochester, NY 14604 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20001 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20001 USA		Fiandaca, MS; Federoff, HJ (corresponding author), Univ Calif Irvine, Sch Med, Translat Lab & Biorepository, Dept Neurol, Irvine, CA 92697 USA.; Fiandaca, MS (corresponding author), Univ Calif Irvine, Sch Med, Dept Neurol Surg, Irvine, CA 92697 USA.; Fiandaca, MS (corresponding author), Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	mfiandac@uci.edu; tjgross@uci.edu; thomas.m.johnson74.mil@mail.mil; michele.hu@ndcn.ox.ac.uk; samuel.evetts@ndcn.ox.ac.uk; richard.wade-martins@dpag.ox.ac.uk; Kian_Merchant-Borna@URMC.Rochester.edu; jeff_bazarian@urmc.rochester.edu; amrita.cheema@georgetown.edu; mark.mapstone@uci.edu; federoff@uci.edu		Wade-Martins, Richard/0000-0001-6691-580X; Fiandaca, Massimo/0000-0002-8376-1934; Hu, Michele/0000-0001-6382-5841; Merchant-Borna, Kian/0000-0002-6643-1597	U.S. Army Medical Research Acquisition Act (USAMRAA) [W81XWH-09-1-0103, W81XWH-09-1-0107, W81XWH-16-1-0148]; U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0103, W81XWH-09-1-0107, W81XWH-16-1-0148]	This research was funded through the U.S. Army Medical Research Acquisition Act (USAMRAA) and the U.S. Army Medical Research and Materiel Command (USAMRMC) grant numbers W81XWH-09-1-0103 and W81XWH-09-1-0107 to Howard Federoff, and W81XWH-16-1-0148 to Howard Federoff and Massimo Fiandaca.	Adachi Junko, 2006, Kobe Journal of Medical Sciences, V52, P127; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; AlSarraf H, 1997, DEV BRAIN RES, V102, P47, DOI 10.1016/S0165-3806(97)00075-8; AlSarraf H, 1997, DEV BRAIN RES, V102, P127, DOI 10.1016/S0165-3806(97)00089-8; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Blandini F, 1996, FUNCT NEUROL, V11, P3; Chen TL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/298183; Chong J, 2018, NUCL ACIDS RES; Contreras MA, 1999, NEUROCHEM RES, V24, P833, DOI 10.1023/A:1020997728511; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; Dromerick AW, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00231; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; ERECINSKA M, 1990, J GEN PHYSIOL, V95, P591, DOI 10.1085/jgp.95.4.591; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Feng Y, 2015, J NEUROL SCI, V349, P3, DOI 10.1016/j.jns.2014.12.017; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Fiandaca MS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00237; Gao JJ, 2015, PARKINSONISM RELAT D, V21, P292, DOI 10.1016/j.parkreldis.2014.12.033; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GREENE JG, 1995, J NEUROCHEM, V64, P2332; Gross T, 2018, CURR TOP MED CHEM, V18, P883, DOI 10.2174/1568026618666180711144323; Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042; Hawkins RA, 2009, AM J CLIN NUTR, V90, p867S, DOI 10.3945/ajcn.2009.27462BB; Helms HC, 2012, GLIA, V60, P882, DOI 10.1002/glia.22321; Holtbernd F, 2014, NEUROLOGY, V82, P620, DOI 10.1212/WNL.0000000000000130; Huan T, 2017, NAT METHODS, V14, P461, DOI 10.1038/nmeth.4260; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; IWASAKI Y, 1992, NEUROSCI LETT, V145, P175, DOI 10.1016/0304-3940(92)90015-Y; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Klavins Kristaps, 1800, Alzheimers Dement (Amst), V1, P295; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lawton M, 2015, J PARKINSON DIS, V5, P269, DOI 10.3233/JPD-140523; Lei S, 2014, ACS CHEM BIOL, V9, P2032, DOI 10.1021/cb400894a; Liu LS, 2010, ANAL BIOCHEM, V406, P105, DOI 10.1016/j.ab.2010.07.015; Mapstone M, 2017, ALZHEIMERS DEMENT, V13, P608, DOI 10.1016/j.jalz.2016.11.004; Mapstone M, 2017, NEUROBIOL AGING, V51, P148, DOI 10.1016/j.neurobiolaging.2016.11.007; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Messina SA, 2000, ADV EXP MED BIOL, V483, P355; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; NEWKIRK JD, 1971, BIOCHIM BIOPHYS ACTA, V225, P224, DOI 10.1016/0005-2736(71)90215-X; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Postuma RB, 2012, MOVEMENT DISORD, V27, P720, DOI 10.1002/mds.24939; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI DOI 10.1007/S11306-011-0293-4; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Salminen A, 2015, PROG NEUROBIOL, V131, P1, DOI 10.1016/j.pneurobio.2015.05.001; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Su XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144724; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Wang G, 2014, J PROTEOME RES, V13, P2649, DOI 10.1021/pr5000895; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xie WJ, 2016, CHEM CENT J, V10, DOI 10.1186/s13065-016-0187-7; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yudkoff M, 2017, NEUROCHEM RES, V42, P10, DOI 10.1007/s11064-016-2057-z; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	88	9	11	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2218-1989			METABOLITES	Metabolites	SEP	2018	8	3							50	10.3390/metabo8030050			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GU3CN	WOS:000445152200011	30205491	Green Published, Green Submitted, gold			2022-02-06	
J	Luaute, J; Villeneuve, L; Roux, A; Nash, S; Bar, JY; Chabanat, E; Cotton, F; Ciancia, S; Sancho, PO; Hovantruc, P; Quelard, F; Sarraf, T; Cojan, Y; Hadj-Bouziane, F; Farne, A; Janoly-Dumenil, A; Boisson, D; Jacquin-Courtois, S; Rode, G; Rossetti, Y				Luaute, Jacques; Villeneuve, Laurent; Roux, Adeline; Nash, Stuart; Bar, Jean-Yves; Chabanat, Eric; Cotton, Francois; Ciancia, Sophie; Sancho, Pierre-Olivier; Hovantruc, Patrick; Quelard, Francois; Sarraf, Thierry; Cojan, Yann; Hadj-Bouziane, Fadila; Farne, Alessandro; Janoly-Dumenil, Audrey; Boisson, Dominique; Jacquin-Courtois, Sophie; Rode, Gilles; Rossetti, Yves			Adding methylphenidate to prism-adaptation improves outcome in neglect patients. A randomized clinical trial	CORTEX			English	Article						Neglect; Randomised trials; Stroke; Rehabilitation; Attention; Prim adaptation; Methylphenidate	UNILATERAL SPATIAL NEGLECT; TRAUMATIC BRAIN-INJURY; VISUOSPATIAL NEGLECT; DOUBLE-BLIND; HEMISPATIAL NEGLECT; VISUAL NEGLECT; RECOVERY; REHABILITATION; COGNITION; SENSORIMOTOR	Spatial neglect is one of the main predictors of poor functional recovery after stroke. Many therapeutic interventions have been developed to alleviate this condition, but to date the evidence of their effectiveness is still scarce. Objective: The purpose of this study was to test whether combining prism adaptation (PA) and methylphenidate (MP) could enhance the recovery of neglect patients at a functional level. Methods: RITAPRISM is a multicentre, randomized, double-blind, placebo-controlled study comparing PA plus placebo (control) versus PA plus MP. 24 patients were prospectively enrolled (10 in the placebo group and 14 in the MP group). Results: The main result is a long-term functional improvement (on the functional independence measure (FIM) and on Bergego's scale) induced by MP combined with PA. No serious adverse event occurred. Conclusions: The long-term benefit on activities of daily living (ADL) obtained in this randomized controlled trial set this intervention apart from previous attempts and supports with a high level of evidence the value of combining PA and MP in order to improve the autonomy of neglect patients. Further studies will be needed to clarify the mechanism of this improvement. Although not specifically assessed at this stage, a part of the improvement in ADL might be related to the collateral effect of MP on mood, executive functions or fatigue, and/or the combined effect of PA and MP on motor intentional bias of neglect patients. Classification of evidence: This study provides Class I evidence that adding MP to PA improves the functional outcome of neglect patients. (C) 2018 Elsevier Ltd. All rights reserved.	[Luaute, Jacques; Nash, Stuart; Bar, Jean-Yves; Cotton, Francois; Ciancia, Sophie; Sancho, Pierre-Olivier; Janoly-Dumenil, Audrey; Boisson, Dominique; Jacquin-Courtois, Sophie; Rode, Gilles; Rossetti, Yves] Hosp Civils Lyon, Hop Henry Gabrielle, Pharm Clin, Mouvement & Handicap, St Genis Laval, France; [Luaute, Jacques; Chabanat, Eric; Hadj-Bouziane, Fadila; Farne, Alessandro; Boisson, Dominique; Jacquin-Courtois, Sophie; Rode, Gilles; Rossetti, Yves] Lyon Neurosci Res Ctr, Inserm CNRS U1028 UMR5292, Integrat Multisensory Percept Act & Cognit Team, Lyon, France; [Luaute, Jacques; Chabanat, Eric; Hadj-Bouziane, Fadila; Farne, Alessandro; Boisson, Dominique; Jacquin-Courtois, Sophie; Rode, Gilles; Rossetti, Yves] Univ Lyon 1, Villeurbanne, France; [Villeneuve, Laurent; Roux, Adeline] Hosp Civils Lyon, Unite Rech Clin, Pole IMER, Lyon, France; [Cotton, Francois] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Imaging Dept, Pierre Benite, France; [Cotton, Francois] Univ Lyon 1, INSA Lyon, INSERM U1044, CNRS UMR 5220,CREATIS, Villeurbanne, France; [Hovantruc, Patrick] Ctr Med Phys & Readaptat ORCET, Hauteville, France; [Quelard, Francois] Ctr Med Mangini, Hauteville Lompnes, France; [Sarraf, Thierry] Ctr Med LArgentiere, St Foy Largentiere, France; [Cojan, Yann] Univ Geneva, Dept Neurosci Fondamentales, Lab Neurol & Imagerie Cognit, Geneva, Switzerland		Luaute, J (corresponding author), Hop Henry Gabrielle, 20 Route Vourles, F-69230 St Genis Laval, France.	jacques.luaute@chu-lyon.fr	Villeneuve, Laurent/V-4513-2019; Rossetti, Yves/H-3693-2017; Hadj-Bouziane, Fadila/AAC-7147-2020; cojan, yann/AAK-2383-2020; FARNE, ALESSANDRO/G-1238-2015; cotton, francois/F-4762-2013; Hadj-Bouziane, Fadila/F-6309-2016	Villeneuve, Laurent/0000-0002-8713-7821; Rossetti, Yves/0000-0001-8867-4496; FARNE, ALESSANDRO/0000-0001-5769-3491; cotton, francois/0000-0003-0046-2478; Chabanat, Eric/0000-0001-6069-7346; Hadj-Bouziane, Fadila/0000-0002-5415-7949	Programme Hospitalier de Recherche Clinique (PHRC 2007); Labex/Idex [ANR-11-LABX-0042]; IHU CeSaMe [ANR-10-IBHU-0003]	This work was supported by institutional grant from the Programme Hospitalier de Recherche Clinique (PHRC 2007). This work also benefited from institutional supports from Inserm, CNRS, UCBL, HCL, the Labex/Idex ANR-11-LABX-0042 and IHU CeSaMe ANR-10-IBHU-0003 and the James McDonnell Foundation.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Bergego C., 1995, Annales de Readaptation et de Medecine Physique, V38, P183, DOI 10.1016/0168-6054(96)89317-2; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Delbari A, 2011, EUR NEUROL, V66, P7, DOI 10.1159/000329275; Edgeworth J., 1998, BALLOONS TEST THAMES; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; Fimm B., 1994, TEST BATTERIE AUFMER; Fortis P, 2011, NEUROREPORT, V22, P700, DOI 10.1097/WNR.0b013e32834a3e20; Fortis P, 2010, NEUROPSYCHOLOGY, V24, P681, DOI 10.1037/a0019476; Frassinetti F, 2002, BRAIN, V125, P608, DOI 10.1093/brain/awf056; GAINOTTI G, 1972, J NEUROL NEUROSUR PS, V35, P545, DOI 10.1136/jnnp.35.4.545; Geminiani G, 1998, J NEUROL NEUROSUR PS, V65, P344, DOI 10.1136/jnnp.65.3.344; Goedert KM, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/jnhum.2015.00243, 10.3389/fnhum.2015.00243]; Goedert KM, 2014, NEUROREHAB NEURAL RE, V28, P483, DOI 10.1177/1545968313516872; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Jacquin-Courtois S, 2013, NEUROSCI BIOBEHAV R, V37, P594, DOI 10.1016/j.neubiorev.2013.02.007; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; Malhotra PA, 2006, ANN NEUROL, V59, P186, DOI 10.1002/ana.20701; Mizuno K, 2011, NEUROREHAB NEURAL RE, V25, P711, DOI 10.1177/1545968311407516; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Nissen SE, 2006, NEW ENGL J MED, V354, P1445, DOI 10.1056/NEJMp068049; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Provinciali L, 2002, NEUROL SCI, V22, P417, DOI 10.1007/s100720200000; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; Rode G, 2015, ANN PHYS REHABIL MED, V58, P40, DOI 10.1016/j.rehab.2014.10.004; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Salo A. A., 1987, SOC NEUR; Samuelsson H, 1998, J CLIN EXP NEUROPSYC, V20, P73, DOI 10.1076/jcen.20.1.73.1481; Schelleman H, 2012, AM J PSYCHIAT, V169, P178, DOI 10.1176/appi.ajp.2011.11010125; Tenenbaum YS, 2015, J MOL NEUROSCI, V57, P231, DOI 10.1007/s12031-015-0611-9; Van Vleet TM, 2003, BEHAV BRAIN RES, V143, P147, DOI 10.1016/S0166-4328(03)00040-8; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Westover AN, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-41; Wiart L, 1997, ARCH PHYS MED REHAB, V78, P424, DOI 10.1016/S0003-9993(97)90236-7; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187	44	9	10	0	6	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	SEP	2018	106						288	298		10.1016/j.cortex.2018.03.028			11	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	GV3HO	WOS:000445985200022	29703446				2022-02-06	
J	Parvaresh, KC; Upasani, VV; Bomar, JD; Pennock, AT				Parvaresh, Kevin C.; Upasani, Vidyadhar V.; Bomar, James D.; Pennock, Andrew T.			Secondary Ossification Center Appearance and Closure in the Pelvis and Proximal Femur	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						pelvic secondary ossification centers; pelvic growth plates; iliac crest; triradiate	AVULSION FRACTURES; SKELETAL MATURITY; HEIGHT VELOCITY; AGE ESTIMATION; APOPHYSIS; ADOLESCENTS; CHILDREN; PROGRESSION; SCOLIOSIS; INJURIES	Introduction: Variable ossification patterns of the pelvis in skeletally immature patients can make the interpretation of pelvic radiographs challenging. Inconsistencies among prior studies and lack of sex comparisons underscore the need for a more comprehensive characterization of the secondary ossification centers. This study evaluates the chronology and sex differences for appearance and closure of pelvic and proximal femoral secondary ossification centers using computed tomography (CT). Methods: Patients who underwent abdominal and pelvic CT scans between January 2009 and December 2014 at 2 tertiary level 1 trauma centers were retrospectively reviewed. Patients between the ages of 2 and 32 years with adequate imaging of the pelvis and proximal femurs were included. Patients with a history of orthopaedic trauma or pathology affecting ossification were excluded. CT scans were assessed for the appearance and closure of the following secondary ossification centers: anterior inferior iliac spine (AIIS), anterior superior iliac spine (ASIS), femoral head (FH), greater trochanter (GT), iliac crest (IC), ischial tuberosity (IT), lesser trochanter (LT), posterior superior iliac spine (PSIS), symphysis pubis (SP), and triradiate cartilage (TRC). Basic descriptive statistics are reported. Results: A total of 496 CT scans met inclusion criteria (240 males and 256 females). The order of appearance of the secondary ossification centers was: (male) GT, LT, AIIS, IT, ASIS, PSIS, IC, and SP; (female) GT, LT, IT, AIIS, PSIS, IC, ASIS, and SP. The order of closure was similar: (male) TRC, LT, FH, AIIS, GT, ASIS, PSIS, IT, IC, and SP; (female) LT, TRC, AIIS, FH, GT, ASIS, PSIS, IT, IC, and SP. Female ossification centers appeared similar to 1 to 2 years before males in all locations. Female ossification centers closed similar to 1 to 2 years before males in all locations except TRC, IC, and SP. Conclusions: The appearance and closure of the pelvis and proximal femur secondary ossification centers follow a predictable pattern of development, occurring slightly earlier in females than males. Knowledge of more precise ages of development and sex differences better characterize this complex skeletal development. Future studies may use secondary ossification centers to further evaluate skeletal maturity, assess pediatric pathology, and aid surgical management.	[Parvaresh, Kevin C.; Upasani, Vidyadhar V.; Pennock, Andrew T.] Univ Calif San Diego, Dept Orthopaed Surg, San Diego, CA 92103 USA; [Upasani, Vidyadhar V.; Bomar, James D.; Pennock, Andrew T.] Rady Childrens Hosp, Dept Orthopaed Surg, San Diego, CA USA		Pennock, AT (corresponding author), Rady Childrens Hosp, 3030 Childrens Way,Suite 410, San Diego, CA 92123 USA.	apennock@rchsd.org	Upasani, Vidyadhar/AAY-6332-2020	Upasani, Vidyadhar/0000-0003-2635-9823			ACHESON ROY M., 1957, CLIN ORTHOPAED, V10, P19; Camp JD, 1931, AM J ROENTGENOL RADI, V26, P905; Cox LA, 1996, HORM RES, V45, P53, DOI 10.1159/000184848; CUNDY P, 1988, J PEDIATR ORTHOPED, V8, P513, DOI 10.1097/01241398-198809000-00002; EICH GF, 1992, RADIOGRAPHICS, V12, P467, DOI 10.1148/radiographics.12.3.1609139; Flecker H, 1932, J ANAT, V67, P118; Flory CD, 1935, CHILD DEV, V6, P205, DOI 10.2307/1125863; GIRDANY BR, 1952, AM J ROENTGENOL, V68, P922; Greulich WW., 1959, RADIOGRAPHIC ATLAS S; Hans SD, 2008, J PEDIATR ORTHOPED, V28, P836, DOI 10.1097/BPO.0b013e31818ee3c4; Hearty T, 2011, J ORTHOP TRAUMA, V25, pE68, DOI 10.1097/BOT.0b013e3181f9a7ba; KAUFMANN HJ, 1964, RONTGENBEFUNDE KINDL; Kautzner J, 2014, INT ORTHOP, V38, P1495, DOI 10.1007/s00264-014-2323-0; Kenawey M, 2015, BONE JOINT J, V97B, P696, DOI 10.1302/0301-620X.97B5.35162; Li XG, 2014, INJURY, V45, P721, DOI 10.1016/j.injury.2013.10.005; MAGID D, 1992, J PEDIATR ORTHOPED, V12, P621; Matsuda DK, 2012, ORTHOPEDICS, V35, pE460, DOI 10.3928/01477447-20120222-44; METZMAKER JN, 1985, AM J SPORT MED, V13, P349, DOI 10.1177/036354658501300510; O'Rourke MR, 2003, J BONE JOINT SURG AM, V85A, P2000, DOI 10.2106/00004623-200310000-00022; Pattamapaspong N, 2015, FORENSIC SCI INT, V246, DOI 10.1016/j.forsciint.2014.10.044; PONSETI IV, 1978, J BONE JOINT SURG AM, V60, P575, DOI 10.2106/00004623-197860050-00001; RISSER J C, 1958, Clin Orthop, V11, P111; Sanders JO, 2008, J BONE JOINT SURG AM, V90A, P540, DOI 10.2106/JBJS.G.00004; Sanders JO, 2007, J BONE JOINT SURG AM, V89A, P64, DOI 10.2106/JBJS.F.00067; Schuett DJ, 2015, J PEDIATR ORTHOPED, V35, P617, DOI 10.1097/BPO.0000000000000328; Schulze D, 2006, FORENSIC SCI INT, V158, P184, DOI 10.1016/j.forsciint.2005.05.033; Servant CTJ, 1998, BRIT J SPORT MED, V32, P255, DOI 10.1136/bjsm.32.3.255; Singer G, 2014, SEMIN MUSCULOSKEL R, V18, P498, DOI 10.1055/s-0034-1389267; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; Wittschieber D, 2014, FORENSIC SCI MED PAT, V10, P198, DOI 10.1007/s12024-014-9548-5	30	9	10	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	SEP	2018	38	8					418	423		10.1097/BPO.0000000000000836			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	GQ7KE	WOS:000441918500006	27442214				2022-02-06	
J	Trevena-Peters, J; Ponsford, J; McKay, A				Trevena-Peters, Jessica; Ponsford, Jennie; McKay, Adam			Agitated Behavior and Activities of Daily Living Retraining During Posttraumatic Amnesia	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living; agitation; posttraumatic amnesia; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ACUTE CONFUSION; SCALE; DISTURBANCES; RELIABILITY; MANAGEMENT; SEVERITY; OUTCOMES; PATIENT	Background: Patients in posttraumatic amnesia (PTA) may receive limited rehabilitation due to the risk of overstimulation and agitation. This assumption has not been tested. Objective: To examine the relationship between agitated behavior and participation in therapy for retraining of activities of daily living (ADL) while in PTA. Setting: Inpatient rehabilitation center. Participants: A total of 104 participants with severe traumatic brain injury, admitted to rehabilitation, in PTA of more than 7 days. Intervention: ADL retraining during PTA followed errorless and procedural learning principles. Design: Group comparison and regression modeling of patient agitation data from a randomized controlled trial comparing ADL retraining in PTA (treatment) versus no ADL retraining in PTA (treatment as usual, TAU). Outcome Measures: Agitation using the Agitated Behavior Scale. Therapy participation measured in minutes and missed sessions. Results: There were no group differences in agitated behavior (average scores, peak scores, or number of clinically agitated days) between the treatment and TAU groups. For treated patients, there was no significant relationship between agitation and therapy participation (therapy minutes or missed ADL treatment sessions). Conclusions: This study demonstrated that agitation is not increased by delivery of structured ADL retraining during PTA and agitation did not limit therapy participation. This supports the consideration of active therapy during PTA.	[Trevena-Peters, Jessica; Ponsford, Jennie; McKay, Adam] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; Ponsford, Jennie; McKay, Adam] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; Ponsford, Jennie; McKay, Adam] Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia; [McKay, Adam] Epworth Healthcare, Richmond, Vic, Australia		Trevena-Peters, J (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	jessica.trevena-peters@monash.edu			Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research; Epworth Research Institute grant; William Buckland Foundation grant; Institute for Safety, Compensation and Recovery Research grant [N-13-089]	This project was funded by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research. Financial support was provided by Epworth Research Institute grant, William Buckland Foundation grant, and Institute for Safety, Compensation and Recovery Research grant (no. N-13-089), but parties did not participate in design or write-up of the study. The authors thank the occupational therapists, neuropsychologists, and nursing staff working in the Brain Injury Unit at Epworth Healthcare.	Amato S, 2012, REHABIL NURS, V37, P19, DOI 10.1002/RNJ.00001; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Bayley M., 2007, ABIKUS EVIDENCE BASE; Bogner J, 2015, ARCH PHYS MED REHAB, V96; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Eisenberg M.E., 2009, CRITICAL REV PHYS RE, V21, P215; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; GILES GM, 1993, BRAIN INJURY REHABIL; Hagen C, 1972, RANCHO LOS AMIGOS LE; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Lee KJ, 2015, BMC MED RES METHODOL, V15, P1; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Montgomery P, 1997, Rehabil Nurs, V22, P20; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Rebeiro K L, 1999, Can J Occup Ther, V66, P14; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds CP, 1943, LANCET, V1, P7; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wolffbrandt MM, 2013, REHABIL NURS, V38, P133, DOI 10.1002/rnj.82	40	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					317	325		10.1097/HTR.0000000000000363			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500014	29194180				2022-02-06	
J	Park, J; Choi, E; Shin, S; Lim, S; Kim, D; Baek, S; Lee, KP; Lee, JJ; Lee, BH; Kim, B; Jeong, K; Baik, JH; Kim, YK; Kim, S				Park, Jeongmin; Choi, Eunshil; Shin, Seulgi; Lim, Sungsu; Kim, Dohee; Baek, Suji; Lee, Kang Pa; Lee, Jae Jun; Lee, Byeong Han; Kim, Bokyung; Jeong, Keunsoo; Baik, Ja-Hyun; Kim, Yun Kyung; Kim, Sehoon			Nootropic nanocomplex with enhanced blood-brain barrier permeability for treatment of traumatic brain injury-associated neurodegeneration	JOURNAL OF CONTROLLED RELEASE			English	Article						Methylene blue; Pluronic block copolymer; Blood-brain barrier; Neuroprotection; Traumatic brain injury	PLURONIC BLOCK-COPOLYMERS; METHYLENE-BLUE; DRUG; NANOPARTICLES; DELIVERY; THERAPY; CELLS	Traumatic brain injury (TBI) is an intracranial injury which can induce immediate neuroinflammation and long-term neurological deficits. Methylene blue (MB) as a nootropic has a great potential to treat neurodegeneration after TBI because of its anti-inflmmatory and neuroprotective functions. However, its limited accumulation to the brain across the blood-brain barrier (BBB) remains a major hurdle to be overcome. In this paper, we present a polymer surfactant-encapsulated nanocomplex of MB as a delivery system with high BBB permeability for efficacious treatment of TBI-induced neurodegeneration. MB was formulated via electrostatically/hydrophobically directed assembly with fatty acid and Pluronic surfactant (F-127 or F-68) to construct nanocomplexes of two different colloidal sizes (< 10 nm and similar to 108 nm in hydrodynamic diameter for NanoMB-127 and NanoMB-68, respectively). Compared to uncomplexed free MB, formulation into the ultrasmall nanocomplex (NanoMB-127) significantly enhanced the uptake of MB by blood-brain vascular endothelial bEnd3 cells in vitro, and indeed improved its BBB penetration upon systemic administration to normal mice in vivo. However, large-size NanoMB-68 showed negligible BBB crossing despite the efficient bEnd3 cell internalization in vitro, probably due to the unfavorable pharmacokinetic profile associated with its large particle size. By virtue of the efficient BBB penetration and cellular uptake, ultrasmall NanoMB-127 was shown to distinctively reduce the expression level of an inflammatory cytokine with no notable toxicity in vitro and also considerably prevent the neurodegeneration after TBI in mice at much lower doses than free MB. Overall, the Pluronic-supported nanocomplexation method allows efficient brain delivery of MB, offering a novel way of enhancing the efficacy of neurotherapeutics to treat brain diseases.	[Park, Jeongmin; Choi, Eunshil; Jeong, Keunsoo; Kim, Sehoon] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul 02792, South Korea; [Shin, Seulgi; Lim, Sungsu; Kim, Dohee; Kim, Yun Kyung] Korea Inst Sci & Technol, Convergence Res Ctr Diag Treatment & Care Syst De, Seoul 02792, South Korea; [Kim, Yun Kyung; Kim, Sehoon] Korea Univ Sci & Technol UST, Div Biomed Sci & Technol, KIST Sch, Seoul 02792, South Korea; [Kim, Sehoon] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 02841, South Korea; [Park, Jeongmin; Baik, Ja-Hyun] Korea Univ, Dept Life Sci, Sch Life Sci & Biotechnol, Seoul 02841, South Korea; [Baek, Suji; Lee, Kang Pa; Kim, Bokyung] Konkuk Univ, Sch Med, Dept Physiol, 120 Neungdong Ro, Seoul 05029, South Korea; [Lee, Jae Jun; Lee, Byeong Han] Osong Med Innovat Fdn, Lab Anim Ctr, 123 Osongsaengmyeong Ro, Chungbuk 28160, South Korea		Jeong, K; Kim, S (corresponding author), Korea Inst Sci & Technol, Ctr Theragnosis, Seoul 02792, South Korea.; Kim, YK (corresponding author), Korea Inst Sci & Technol, Convergence Res Ctr Diag Treatment & Care Syst De, Seoul 02792, South Korea.	jkeunsoo1@gmail.com; yunkyungkim@kist.re.kr; sehoonkim@kist.re.kr	Lee, Kang-Pa/AAJ-9550-2020	Lee, Kang-Pa/0000-0002-6136-4970	National Research Foundation of KoreaNational Research Foundation of Korea [2017M3A9D8029942, 2017M2A2A7A02019610]; Korea Health Industry Development InstituteKorea Health Industry Development Institute (KHIDI) [HI15C1540]; Korea Research Institute of Standards and Science [KRISS-2017-GP2017-0020]; KISTKorea Institute of Science & Technology Information (KISTI)	This work was supported by the grants from the National Research Foundation of Korea (2017M3A9D8029942 and 2017M2A2A7A02019610), the Korea Health Industry Development Institute (HI15C1540), the Development of Platform Technology for Innovative Medical Measurements Program from Korea Research Institute of Standards and Science (KRISS-2017-GP2017-0020), and the Intramural Research Program of KIST.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahn H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12635-6; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Choi BY, 2016, AMINO ACIDS, V48, P1619, DOI 10.1007/s00726-016-2221-4; Dibaj P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043963; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Ginimuge Prashant R, 2010, J Anaesthesiol Clin Pharmacol, V26, P517; Herman MI, 1999, ANN EMERG MED, V33, P111, DOI 10.1016/S0196-0644(99)70427-0; Jeong K, 2016, COLLOID SURFACE B, V144, P303, DOI 10.1016/j.colsurfb.2016.04.029; Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3; Kabanov AV, 2003, ADV DRUG DELIVER REV, V55, P151, DOI 10.1016/S0169-409X(02)00176-X; Kim SH, 2009, CANCER RES, V69, P5860, DOI 10.1158/0008-5472.CAN-08-4855; Lee E, 2015, J CONTROL RELEASE, V210, P105, DOI 10.1016/j.jconrel.2015.05.262; Lee YD, 2015, J CONTROL RELEASE, V209, P12, DOI 10.1016/j.jconrel.2015.04.011; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lim CK, 2012, THERANOSTICS, V2, P871, DOI 10.7150/thno.4133; Lim CK, 2011, SMALL, V7, P112, DOI 10.1002/smll.201001358; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Miller DW, 1997, BIOCONJUGATE CHEM, V8, P649, DOI 10.1021/bc970118d; Nam M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16984; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Pitto-Barry A, 2014, POLYM CHEM-UK, V5, P3291, DOI 10.1039/c4py00039k; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Schirmer R. H., 2011, MICROBIOL AGING, V2325, pe7, DOI DOI 10.1016/J.NEUR0BI0LAGING.2010.12.012; Singh A, 2016, ADV FUNCT MATER, V26, P7057, DOI 10.1002/adfm.201602808; Sun WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34784; Tucker D, 2018, MOL NEUROBIOL, V55, P5137, DOI 10.1007/s12035-017-0712-2; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Vutskits L, 2008, ANESTHESIOLOGY, V108, P684, DOI 10.1097/ALN.0b013e3181684be4; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017	35	9	10	3	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	AUG 28	2018	284						152	159		10.1016/j.jconrel.2018.06.021			8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	GP7CE	WOS:000441048900014	29913220				2022-02-06	
J	Deleglise, B; Lassus, B; Soubeyre, V; Doulazmi, M; Brugg, B; Vanhoutte, P; Peyrin, JM				Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vanessa; Doulazmi, Mohamed; Brugg, Bernard; Vanhoutte, Peter; Peyrin, Jean-Michel			Dysregulated Neurotransmission induces Trans-synaptic degeneration in reconstructed Neuronal Networks	SCIENTIFIC REPORTS			English	Article							EXTRASYNAPTIC NMDA RECEPTORS; GLUTAMATE TRANSPORTERS; DISEASE; MECHANISMS; APOPTOSIS; HOMEOSTASIS; INCREASES; MEMANTINE; CALCIUM; PATHWAY	Increasing evidence suggests that pathological hallmarks of chronic degenerative syndromes progressively spread among interconnected brain areas in a disease-specific stereotyped pattern. Functional brain imaging from patients affected by various neurological syndromes such as traumatic brain injury and stroke indicates that the progression of such diseases follows functional connections, rather than simply spreading to structurally adjacent areas. Indeed, initial damage to a given brain area was shown to disrupt the communication in related brain networks. Using cortico-striatal neuronal networks reconstructed in a microfluidic environment, we investigated the role of glutamate signaling in activity-dependent neuronal survival and trans-synaptic degeneration processes. Using a variety of neuronal insults applied on cortical neurons, we demonstrate that acute injuries such as axonal trauma, focal ischemia, or alteration of neuronal rhythms, lead to glutamate-dependent striatal neuron dysfunction. Interestingly, focal pro-oxidant insults or chronic alteration of spontaneous cortical rhythms provoked dysfunction of distant striatal neurons through abnormal glutamate GluN2B-NMDAR- mediated signaling at cortico-striatal synapses. These results indicate that focal alteration of cortical functions can initiate spreading of dysfunction along neuronal pathways in the brain, reminiscent of diaschisis-like processes.	[Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vanessa; Doulazmi, Mohamed; Brugg, Bernard; Peyrin, Jean-Michel] CNRS, UMR 8256, Biol Adaptat & Ageing, F-75005 Paris, France; [Deleglise, Berangere; Lassus, Benjamin; Soubeyre, Vanessa; Doulazmi, Mohamed; Brugg, Bernard; Peyrin, Jean-Michel] UPMC Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, CNRS,UMR 8256, F-75005 Paris, France; [Vanhoutte, Peter; Peyrin, Jean-Michel] UPMC Univ Paris 06, Sorbonne Univ, Neurosci Paris Seine,Inst Biol Paris Seine, CNRS,UMR8246,INSERM,UMR S1130, F-75005 Paris, France		Peyrin, JM (corresponding author), CNRS, UMR 8256, Biol Adaptat & Ageing, F-75005 Paris, France.; Peyrin, JM (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, CNRS,UMR 8256, F-75005 Paris, France.; Peyrin, JM (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Neurosci Paris Seine,Inst Biol Paris Seine, CNRS,UMR8246,INSERM,UMR S1130, F-75005 Paris, France.	jean-michel.peyrin@upmc.fr		Peyrin, Jean-Michel/0000-0002-8705-8672; Doulazmi, Mohamed/0000-0002-0313-1490; Peyrin, Jean-Michel/0000-0002-0108-1266	European Commission: MicroDEG, ERA-NET Neuron JTC2012 "Novel Methods", ANR Neuroscreen [2011-RPIB-008-01]; MNRT fellowship; ANR Neuroscreen	This work was supported by grants from the European Commission: MicroDEG, ERA-NET Neuron JTC2012 "Novel Methods", http://www.neuron-eranet.eu/en/317.php (J-M.P) ANR Neuroscreen: 2011-RPIB-008-01". B.D. was funded by an MNRT fellowship and the ANR Neuroscreen. We thanks Ysander von Boxberg and Stephanie Fowler for carefull editing of the paper.	Ahmed I, 2011, BRAIN, V134, P979, DOI 10.1093/brain/awr028; Aizenman E, 2000, J PHARMACOL EXP THER, V295, P572; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Chapman AG, 2000, NEUROPHARMACOLOGY, V39, P1567, DOI 10.1016/S0028-3908(99)00242-7; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; Deleglise B, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0145-3; Deleglise B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071103; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; Finger S, 2004, ARCH NEUROL-CHICAGO, V61, P283, DOI 10.1001/archneur.61.2.283; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Kovac AD, 2004, BRAIN PATHOL, V14, P249; Lado FA, 2002, EPILEPTIC DISORD, V4, P83; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Lim DH, 2014, J NEUROSCI, V34, P16455, DOI 10.1523/JNEUROSCI.3384-14.2014; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Molnar E, 2011, SEMIN CELL DEV BIOL, V22, P506, DOI 10.1016/j.semcdb.2011.07.017; Muller CM, 2010, CELL CALCIUM, V47, P242, DOI 10.1016/j.ceca.2009.12.006; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Paul D, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3569946; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Voigt T, 2001, J NEUROSCI, V21, P8895, DOI 10.1523/JNEUROSCI.21-22-08895.2001; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yuan HJ, 2015, NEURON, V85, P1305, DOI 10.1016/j.neuron.2015.02.008; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	48	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 2	2018	8								11596	10.1038/s41598-018-29918-1			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP2AN	WOS:000440621000013	30072750	gold, Green Published			2022-02-06	
J	Adams, WM; Scarneo, SE; Casa, DJ				Adams, William M.; Scarneo, Samantha E.; Casa, Douglas J.			Assessment of Evidence-Based Health and Safety Policies on Sudden Death and Concussion Management in Secondary School Athletics: A Benchmark Study	JOURNAL OF ATHLETIC TRAINING			English	Article						emergency action plan; heat acclimatization; automated external defibrillators; concussion	ASSOCIATION POSITION STATEMENT; AUTOMATED EXTERNAL DEFIBRILLATORS; EXERTIONAL HEAT-STROKE; CARDIAC-ARREST; EMERGENCY PREPAREDNESS; CONSENSUS STATEMENT; FOOTBALL PLAYERS; UNITED-STATES; TASK-FORCE; TRAINERS	Context: Implementation of best-practice health and safety policies has been shown to be effective at reducing the risk of sudden death in sport; however, little is known about the extent to which these policies are required within secondary school athletics. Objective: To examine best-practice health and safety policies pertaining to the leading causes of sudden death and to concussion management in sport mandated at the state level for secondary school athletics. Design: Descriptive observational study. Setting: State high school athletic associations (SHSAAs), state departments of education, and enacted legislation. Patients or Other Participants: United States (including the District of Columbia) SHSAAs. Main Outcome Measure(s): A review of SHSAA health and safety policies for the 2016-2017 academic year, state department of education policies, and enacted legislation was undertaken to assess the polices related to the leading causes of sudden death and concussion management in sport. Current best-practice recommendations used to assess health and safety policies were specific to emergency action plans, automated external defibrillators, heat acclimatization, environmental monitoring and modification, and concussion management. The total number of best-practice recommendations required for each SHSAA's member schools for the aforementioned areas was quantified and presented as total number and percentage of recommendations required. Results: Four of 51 SHSAA member schools were required to follow best practices for emergency action plans, 7 of 51 for access to automated external defibrillators, 8 of 51 for heat acclimatization, and 3 of 51 for management of concussion. Conclusions: At the time of this study, SHSAA member schools were not required to follow all best-practice recommendations for preventing the leading causes of sudden death and for concussion management in sport. Continued advocacy for the development and implementation of best practices at the state level to be required of all secondary schools is needed to appropriately serve the health and well-being of our young student-athletes.	[Adams, William M.] Univ North Carolina Greensboro, Dept Kinesiol, 1408 Walker Ave,Coleman Bldg,Room 237L, Greensboro, NC 27412 USA; [Scarneo, Samantha E.; Casa, Douglas J.] Univ Connecticut, Dept Kinesiol, Korey Stringer Inst, Storrs, CT USA		Adams, WM (corresponding author), Univ North Carolina Greensboro, Dept Kinesiol, 1408 Walker Ave,Coleman Bldg,Room 237L, Greensboro, NC 27412 USA.	wmadams@uncg.edu					Adams WM, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117752129; Adams WM, 2015, CURR SPORT MED REP, V14, P273, DOI 10.1249/JSR.0000000000000166; Adams WM, 2014, J ATHL TRAINING, V49, P469, DOI 10.4085/1062-6050-49.3.01; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; Andersen JC, 2002, J ATHL TRAINING, V37, P99; [Anonymous], 2016, CAT SPORTS INJ RES; Attanasio SM, 2016, J ATHL TRAIN S6, V51, pS; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Casa DJ, 2009, J ATHL TRAINING, V44, P332, DOI 10.4085/1062-6050-44.3.332; Cooper ER, 2016, J ATHL TRAINING, V51, P593, DOI 10.4085/1062-6050-51.8.08; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Drezner JA, 2007, PREHOSP EMERG CARE, V11, P253, DOI 10.1080/10903120701204839; Drezner JA, 2013, BRIT J SPORT MED, V47, P1179, DOI 10.1136/bjsports-2013-092786; Drezner JA, 2009, CIRCULATION, V120, P518, DOI 10.1161/CIRCULATIONAHA.109.855890; Harer Matthew W, 2014, WMJ, V113, P144; Johnson ST, 2017, SPORTS HEALTH, V9, P181, DOI 10.1177/1941738116686782; Kaeding CC, 2017, CLIN SPORT MED, V36, P1, DOI 10.1016/j.csm.2016.08.001; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Kujawa R, 2000, APPL RES COACH ATHLE, V15, P14; Lear A, 2015, J ATHL TRAINING, V50, P1054, DOI 10.4085/1062-6050-50.8.01; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mensch J, 2005, J ATHL TRAINING, V40, P333; Monroe Anna, 2009, N C Med J, V70, P198; National Federation of State High School Associations, 2016, 2014 15 HIGH SCH ATH; Olympia RP, 2007, PEDIATR EMERG CARE, V23, P703, DOI 10.1097/PEC.0b013e318155adfc; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Ransone J, 1999, J ATHL TRAINING, V34, P267; Schneider K, 2017, RURAL REMOTE HEALTH, V17; Sherrid MV, 2017, J AM COLL CARDIOL, V69, P1735, DOI 10.1016/j.jacc.2017.01.033; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Toresdahl BG, 2013, J ATHL TRAINING, V48, P242, DOI 10.4085/1062-6050-48.1.20; Wasilko SM, 2013, SPORTS HEALTH, V5, P548, DOI 10.1177/1941738113484250	38	9	9	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2018	53	8					756	767		10.4085/1062-6050-220-17			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GW7OJ	WOS:000447157700007	30212234	Green Published, gold			2022-02-06	
J	Brodsky, JR; Shoshany, TN; Lipson, S; Zhou, GW				Brodsky, Jacob R.; Shoshany, Talia N.; Lipson, Sophie; Zhou, Guangwei			Peripheral Vestibular Disorders in Children and Adolescents with Concussion	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article; Proceedings Paper	149th Annual Meeting of the American-Otological-Society at the Combined Otolaryngology Spring Meetings (COSM) / 137th Annual Meeting of the American-Laryngological-Association / Meeting of the American-Society-for-Pediatric-Otolaryngology (ASPO)	MAY 18-22, 2016	Chicago, IL	Amer Otol Soc, Amer Laryngol Assoc, Amer Soc Pediat Otolaryngol		concussion; postconcussion syndrome; vertigo; benign paroxysmal positional vertigo; BPPV; pediatric	TRAUMATIC BRAIN-INJURY; 4TH INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; CONSENSUS STATEMENT; NOVEMBER 2012; SPORT; DIZZINESS; SYMPTOMS; ZURICH	Objective To review peripheral vestibular disorders in pediatric patients with dizziness following concussion. Study Design Case series with chart review. Setting Pediatric vestibular clinic and pediatric multidisciplinary concussion clinic at a tertiary level pediatric hospital. Subjects and Methods We retrospectively reviewed 109 patients seen for dizziness following a concussion between September 2012 and July 2015. Patients were 20 years of age at the time of concussion. Incidences of specific peripheral vestibular disorders were assessed along with timing of diagnosis relative to the date of injury, diagnostic test findings, and treatment interventions associated with those diagnoses. Results Twenty-eight patients (25.7%) were diagnosed with peripheral vestibular disorders. None of these disorders were diagnosed prior to evaluation in our pediatric vestibular clinic or our multidisciplinary concussion clinic, which occurred a mean of 133 days (95% confidence interval, 89.2-177.3) after injury. Benign paroxysmal positioning vertigo was diagnosed in 19 patients, all of whom underwent successful canalith repositioning maneuvers. Other diagnoses included temporal bone fracture (n = 3), labyrinthine concussion (n = 2), perilymphatic fistula (n = 2), and superior semicircular canal dehiscence (n = 2). Both patients with perilymphatic fistula and 1 patient with superior semicircular canal dehiscence underwent successful surgical management, while 1 patient with superior semicircular canal dehiscence was managed nonsurgically. Conclusion Peripheral vestibular disorders may occur in pediatric patients with dizziness following concussion, but these disorders may not be recognized until symptoms have persisted for several weeks. An algorithm is proposed to guide the diagnosis and management of peripheral vestibular disorders in pediatric patients with concussion.	[Brodsky, Jacob R.; Shoshany, Talia N.; Lipson, Sophie; Zhou, Guangwei] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA; [Brodsky, Jacob R.; Shoshany, Talia N.; Lipson, Sophie; Zhou, Guangwei] Harvard Med Sch, Boston, MA USA		Brodsky, JR (corresponding author), Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, 300 Longwood Ave, Boston, MA 02115 USA.	jacob.brodsky@childrens.harvard.edu		Brodsky, Jacob/0000-0001-9656-5855; Shoshany, Talia/0000-0002-9106-6966; Lipson, Sophie/0000-0001-5609-8156			Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gerberding JL, 2003, STEPS PREVENTING SER; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Minor LB, 2005, LARYNGOSCOPE, V115, P1717, DOI 10.1097/01.mlg.0000178324.55729.b7; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; World Health Organization, 2012, INT STAT CLASS DIS R; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	18	9	9	0	10	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	AUG	2018	159	2					365	370		10.1177/0194599818770618			6	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Otorhinolaryngology; Surgery	GP2OV	WOS:000440675600026	29685082				2022-02-06	
J	Jacobsen, JS; Bolvig, L; Holmich, P; Thorborg, K; Jakobsen, SS; Soballe, K; Mechlenburg, I				Jacobsen, Julie Sandell; Bolvig, Lars; Holmich, Per; Thorborg, Kristian; Jakobsen, Stig Storgaard; Soballe, Kjeld; Mechlenburg, Inger			Muscle-tendon-related abnormalities detected by ultrasonography are common in symptomatic hip dysplasia	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Hip dysplasia; Hip dislocation; congenital; Ultrasound; Ultrasonography; Muscle; Tendon	LABRAL TEAR DIAGNOSTICS; STANDING GROIN PAIN; PERIACETABULAR OSTEOTOMY; CLINICAL PRESENTATION; ACETABULAR DYSPLASIA; ULTRASOUND; STABILITY; MORPHOLOGY; PATTERNS; STRENGTH	Hip dysplasia is characterized by reduced acetabular coverage of the femoral head leading to an increased mechanical load on the hip joint and the acting hip muscles. Potentially, the muscles and tendons functioning close to the hip joint may present with overuse-related ultrasonography findings. The primary aim was to report the prevalence of muscle-tendon-related abnormalities detected by ultrasonography in 100 patients with symptomatic hip dysplasia. The secondary aim was to investigate correlations between muscle-tendon-related abnormalities detected by ultrasonography and clinically identified pain related to muscles and tendons. One hundred patients (17 men) with a mean age of 29 +/- 9 years were included. Muscle-tendon-related abnormalities were detected with a standardized ultrasound examination. Correlations between muscle-tendon-related abnormalities detected by ultrasonography and clinically identified pain related to muscles and tendons were tested with Spearman's rank correlation coefficient. The most prevalent ultrasonography findings were identified in the iliopsoas tendon [50% (95% CI 40; 60)], the adductor longus tendon [31% (95% 22; 40)] and the gluteus medius/minimus tendons [27% (18; 36)]. Significant correlations between ultrasonography findings and pain related to muscles and tendons were only found for the iliopsoas tendon (rho = 0.24 and p = 0.02) and the gluteus medius/minimus tendons (rho = 0.35 and p < 0.001). Muscle-tendon-related abnormalities detected by ultrasonography in the hip and groin region are common in patients with symptomatic hip dysplasia, and the ultrasonography findings of the iliopsoas and gluteus medius/minimus tendons are weakly to moderately correlated to pain related to muscles and tendons in these structures. Both the iliopsoas and the gluteus medius/minimus have a pronounced stabilizing role in the dysplastic hip joint, and the common muscle-tendon-related abnormalities in these patients may be caused by injuries related to excessive use or degenerative changes in the muscle-tendon tissue.	[Jacobsen, Julie Sandell] VIA Univ Coll, Fac Hlth Sci, Dept Physiotherapy, Hedeager 2, DK-8200 Aarhus N, Denmark; [Jacobsen, Julie Sandell] Aarhus Univ Hosp, Dept Physiotherapy & Occupat Therapy, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark; [Bolvig, Lars] Aarhus Univ Hosp, Dept Radiol, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark; [Holmich, Per; Thorborg, Kristian] Copenhagen Univ Hosp, SORC C, Dept Orthopaed Surg, Italiensvej 1, DK-2300 Copenhagen S, Denmark; [Jakobsen, Stig Storgaard; Soballe, Kjeld; Mechlenburg, Inger] Aarhus Univ Hosp, Dept Orthopaed Surg, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark; [Mechlenburg, Inger] Aarhus Univ, Inst Clin Med, Ctr Res Rehabil CORIR, Blvd 82,Bldg 2, DK-8200 Aarhus N, Denmark		Jacobsen, JS (corresponding author), VIA Univ Coll, Fac Hlth Sci, Dept Physiotherapy, Hedeager 2, DK-8200 Aarhus N, Denmark.; Jacobsen, JS (corresponding author), Aarhus Univ Hosp, Dept Physiotherapy & Occupat Therapy, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark.	jsaj@via.dk	Mechlenburg, Inger/AAP-8454-2021	Mechlenburg, Inger/0000-0001-5432-8691; Holmich, Per/0000-0003-2098-0272; Jakobsen, Stig Storgaard/0000-0002-1890-3617; Jacobsen, Julie Sandell/0000-0002-3323-3631	Danish Rheumatism Association [A3280]; Aase and Ejnar Danielsen Fund [10-000761/LPJ]	This work was funded by the Danish Rheumatism Association (Grant number A3280) and the Aase and Ejnar Danielsen Fund (Grant number 10-000761/LPJ).	Alpert JM, 2009, AM J SPORT MED, V37, P1594, DOI 10.1177/0363546509332817; Babst D, 2011, CLIN ORTHOP RELAT R, V469, P1728, DOI 10.1007/s11999-010-1705-x; Bancroft LW, 2007, SEMIN MUSCULOSKEL R, V11, P126, DOI 10.1055/s-2007-1001878; Bass CJ, 2002, SKELETAL RADIOL, V31, P143, DOI 10.1007/s00256-001-0459-7; Branci S, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-093710; Domb BG, 2014, CLIN ORTHOP RELAT R, V472, P674, DOI 10.1007/s11999-013-3140-2; Fabricant PD, 2012, ARTHROSCOPY, V28, P965, DOI 10.1016/j.arthro.2011.11.028; Finnoff JT, 2015, CLIN J SPORT MED, V25, P6, DOI 10.1097/JSM.0000000000000175; Grimaldi A, 2011, MANUAL THER, V16, P26, DOI 10.1016/j.math.2010.08.005; Gupta A, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115572573; Henak CR, 2011, J BIOMECH, V44, P2201, DOI 10.1016/j.jbiomech.2011.06.011; Holmich P, 2004, BRIT J SPORT MED, V38, P446, DOI 10.1136/bjsm.2003.004754; Holmich P, 2007, BRIT J SPORT MED, V41, P247, DOI 10.1136/bjsm.2006.033373; Ingwersen KG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011746; Jacobsen JS, 2018, J HIP PRESERV SURG, V5, P39, DOI 10.1093/jhps/hnx041; Jansen JACG, 2008, SCAND J MED SCI SPOR, V18, P679, DOI 10.1111/j.1600-0838.2008.00848.x; KALEBO P, 1992, AM J SPORT MED, V20, P634, DOI 10.1177/036354659202000603; KLAUE K, 1991, J BONE JOINT SURG BR, V73, P423, DOI 10.1302/0301-620X.73B3.1670443; Kuroda D, 2013, ISOKINET EXERC SCI, V21, P95, DOI 10.3233/IES-130480; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Long SS, 2013, AM J ROENTGENOL, V201, P1083, DOI 10.2214/AJR.12.10038; Martin HD, 2010, ARTHROSCOPY, V26, P161, DOI 10.1016/j.arthro.2009.07.015; McCarthy JC, 2001, CLIN ORTHOP RELAT R, P25; Mechlenburg I, 2004, ACTA ORTHOP SCAND, V75, P147, DOI 10.1080/00016470412331294395; Mendis MD, 2009, GAIT POSTURE, V30, P533, DOI 10.1016/j.gaitpost.2009.08.002; Nakahara I, 2014, BONE JOINT J, V96B, P580, DOI 10.1302/0301-620X.96B5.32503; Nestorova R, 2012, MED ULTRASON, V14, P217; Nunley RM, 2011, J BONE JOINT SURG AM, V93A, P17, DOI 10.2106/JBJS.J.01735; O'Connor PJ, 2004, EUR RADIOL, V14, P1968, DOI 10.1007/s00330-004-2448-4; Retchford TH, 2013, J MUSCULOSKEL NEURON, V13, P1; Robinson P, 2015, BRIT J SPORT MED, V49, P176, DOI 10.1136/bjsports-2013-092932; Ross JR, 2011, AM J SPORT MED, V39, p72S, DOI 10.1177/0363546511412320; Skalshoi O, 2015, GAIT POSTURE, V42, P529, DOI 10.1016/j.gaitpost.2015.08.008; Thorborg K, 2011, BRIT J SPORT MED, V45, P478, DOI 10.1136/bjsm.2010.080937; Tibor LM, 2008, ARTHROSCOPY, V24, P1407, DOI 10.1016/j.arthro.2008.06.019; Tonnis D., 1987, CONGENITAL DYSPLASIA; Troelsen A, 2008, J BONE JOINT SURG AM, V90A, P493, DOI 10.2106/JBJS.F.01399; Troelsen A, 2007, ACTA RADIOL, V48, P1004, DOI 10.1080/02841850701545839; Troelsen A, 2009, ACTA ORTHOP, V80, P314, DOI 10.3109/17453670902988402; Weir A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094869; Wells J, 2017, CLIN ORTHOP RELAT R, V475, P1045, DOI 10.1007/s11999-016-5119-2; Whittaker JL, 2014, J ORTHOP SPORT PHYS, V44, P627, DOI 10.2519/jospt.2014.5315; Wiberg G., 1939, ACTA CHIR SCAND S, V58, P1	43	9	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	AUG	2018	138	8					1059	1067		10.1007/s00402-018-2947-4			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	GM9LM	WOS:000438570000004	29728835				2022-02-06	
J	Jonasson, A; Levin, C; Renfors, M; Strandberg, S; Johansson, B				Jonasson, Axel; Levin, Christopher; Renfors, Marielle; Strandberg, Sara; Johansson, Birgitta			Mental fatigue and impaired cognitive function after an acquired brain injury	BRAIN AND BEHAVIOR			English	Article						acquired brain injury; cognitive performance; mental fatigue	DIVIDED ATTENTION; MILD; DEFICITS	Objective: Mental fatigue is a common subjective symptom following an acquired brain injury. In many cases, this is long-lasting with a considerable negative impact on work, studies, social activities, and quality of life. No objective test for mental fatigue exists today. The aim of this study was to investigate whether mental fatigue can be objectively measured. Materials and Methods: This study included 32 controls with no mental fatigue and 42 well-rehabilitated participants who suffered from long-term mental fatigue following stroke, traumatic brain injury, encephalitis or meningitis, and late effects after brain tumor. Attention, processing speed and working memory were assessed using a test and retest design following a demanding reading exercise. Results: Significant interactions were found for tests measuring processing speed, working memory, and attention. The control group improved at the second test, while those who suffered from mental fatigue did not. Conclusions: This study indicates impaired cognitive performance over time after cognitive activity for individuals suffering from mental fatigue after an acquired brain injury.	[Jonasson, Axel] Neuropsykiatrin, Molndal, Sweden; [Levin, Christopher] Resursctr Karnhuset, Halmstad, Sweden; [Renfors, Marielle] Rehabiliteringskliniken, Vaxjo, Sweden; [Strandberg, Sara] Lanssjukhuset, Rehabiliteringsmottagningen, Kalmar, Sweden; [Johansson, Birgitta] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		Johansson, Birgitta/0000-0002-8942-5771			Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Claros-Salinas D, 2010, J NEUROL SCI, V295, P75, DOI 10.1016/j.jns.2010.04.018; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Penner IK, 2017, NAT REV NEUROL, V13, P662, DOI [10.1038/nmeurol.2017.117, 10.1038/nrneurol.2017.117]; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Veje M, 2016, ACTA NEUROL SCAND, V134, P434, DOI 10.1111/ane.12561; Wechsler D., 2010, WECHSLER ADULT INTEL; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	27	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	AUG	2018	8	8							e01056	10.1002/brb3.1056			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GZ0QW	WOS:000449070600018	29956894	Green Published, gold			2022-02-06	
J	Levadnyi, I; Awrejcewicz, J; Zhang, Y; Goethel, MF; Gu, YD				Levadnyi, Ievgen; Awrejcewicz, Jan; Zhang, Yan; Goethel, Marcio Fagundes; Gu, Yaodong			Finite Element Analysis of Impact for Helmeted and Non-helmeted Head	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Head injury; Impact severity; Protective helmet; FEM	TRAUMATIC BRAIN-INJURY; MOTORCYCLE HELMET; BICYCLE HELMETS; BIOMECHANICS; EQUIPMENT	This study investigated the influence of human head impact on the severity of traumatic brain injury. Simulation of the dynamic impact of a human head was performed using FEM (finite element method) and employing HIC (Head Injury Criterion). The study of traumatic brain injury included impacts with the occiput, temporal, forehead, and parietal part of the head, and the impact velocity at the surface ranged from 1 to 7 m/s. The following characteristics were considered and analyzed in the simulation: duration of the impact, intracranial pressure, HIC, and change in accelerations at the center of gravity of the brain. The computed distribution of pressure values in the brain during an impact confirmed the theory of inertial intracranial brain displacement. The effect of a protective helmet aimed at reducing the severity of traumatic brain injury was investigated, and a method to determine rational helmet parameters was developed. In the case of the protected head, impact acceleration occurred over a longer period of time, which yielded a reduction in the brain load compared to the unprotected head. The developed method allows us to predict the severity of traumatic brain injury (TBI) in the protected/unprotected human head and to provide recommendations for the determination of rational parameters for manufacturing personal protective equipment for the head.	[Levadnyi, Ievgen; Awrejcewicz, Jan; Zhang, Yan; Goethel, Marcio Fagundes] Lodz Univ Technol, Dept Automat Biomech & Mechatron, 1-15 Stefanowski Str, PL-90924 Lodz, Poland; [Awrejcewicz, Jan] Warsaw Univ Technol, Inst Vehicles, 84 Narbutta Str, PL-02524 Warsaw, Poland; [Gu, Yaodong] Ningbo Univ, Fac Sports Sci, Ningbo, Zhejiang, Peoples R China; [Gu, Yaodong] Ningbo Univ, Res Acad Grand Hlth Interdisciplinary, 818 Fenghua Rd, Ningbo 315211, Zhejiang, Peoples R China		Levadnyi, I (corresponding author), Lodz Univ Technol, Dept Automat Biomech & Mechatron, 1-15 Stefanowski Str, PL-90924 Lodz, Poland.	evgenabaqus@gmail.com	Gu, Yaodong/AAJ-4148-2020; Awrejcewicz, Jan/G-9123-2018; Gu, Yaodong/AAH-7551-2020; Goethel, Marcio F./C-5693-2013	Awrejcewicz, Jan/0000-0003-0387-921X; Goethel, Marcio F./0000-0003-4382-0159; Zhang, Yan/0000-0001-8945-3361	National Science Center of Poland under the grant OPUS 9 [2015/17/B/ST8/01700]	The work was supported by the National Science Center of Poland under the grant OPUS 9 No. 2015/17/B/ST8/01700 for years 2016-2018.	Allsop D., 1988, SAE TECHNICAL PAPER; Belingardi G., 2005, P 19 INT TECHN C ENH, P1; Chang LT, 2003, J CHIN INST ENG, V26, P835, DOI 10.1080/02533839.2003.9670838; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Ebel E., 2014, RAPID TECHNOLOGY; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Fung IWH, 2014, SAFETY SCI, V65, P70, DOI 10.1016/j.ssci.2013.12.014; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; KING AI, 2002, 4 WORLD C BIOM CALG; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Li Z., 2010, ADV THEOR APPL MECH, V3, P139; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; Moss W. C., 2011, LLNLSR464951, P1; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Nyquist G.W, 1986, SAE TECHNICAL PAPER; Pearson WS, 2012, W J EMERG MED, V13, P289; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Sawacha E., 1999, INT J PROJECT MANAGE, V17, P309, DOI [DOI 10.1016/S0263-7863(98)00042-8, 10.1016/S0263-7863(98)00042-8]; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Silver J, 2005, TXB TRAUMATIC BRAIN, P27; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trojian TH, 2012, CURR SPORT MED REP, V11, P304, DOI 10.1249/JSR.0b013e31827558c8; Trosseille X, 1992, STAPP CAR CRASH C, DOI [10.4271/922527, DOI 10.4271/922527]; Willinger R, 2000, INT J CRASHWORTHINES, V5, P249; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou YJ, 2015, MATER DESIGN, V88, P162, DOI 10.1016/j.matdes.2015.08.120	40	9	9	2	14	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	AUG	2018	38	4					587	595		10.1007/s40846-017-0324-3			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GN4NZ	WOS:000439005300006	30100828	Green Published, hybrid			2022-02-06	
J	Lin, SJ; Cao, LX; Cheng, SB; Dai, QF; Lin, JH; Pu, L; Chen, WH; Zhang, YJ; Chen, SL; Zhang, YM				Lin, Shu-jun; Cao, Lu-xi; Cheng, Shao-bing; Dai, Qiu-fu; Lin, Ji-huan; Pu, Liu; Chen, Wei-hao; Zhang, Yu-juan; Chen, Shu-lian; Zhang, Yi-min			Effect of acupuncture on the TLR2/4-NF-kappa B signalling pathway in a rat model of traumatic brain injury	ACUPUNCTURE IN MEDICINE			English	Article							FOCAL CEREBRAL-ISCHEMIA; TOLL-LIKE RECEPTORS; UNITED-STATES; SPINAL-CORD; EXPRESSION; ELECTROACUPUNCTURE; STROKE; NEUROPROTECTION; DIFFERENTIATION; PROLIFERATION	Objective To study the effect of acupuncture on the TLR2/4-NF-kappa B signalling pathway in the cortex of Sprague-Dawley rats following traumatic brain injury (TBI), and investigate the possible mechanism underlying the effects of acupuncture on scar repair. Methods TBI was established using Feeney's free-falling epidural percussion model. In total, 108 rats were randomly divided into a normal group (n=18), untreated TBI model group (TBI group, n=36) and manual acupuncture-treated TBI group (TBI+MA, n=36). Each group of rats was subdivided into three time groups: 3-day (3d), 7-day (7d) and 14-day (14d). No treatment was given to rats in the normal and TBI groups. The TBI+MA group received manual acupuncture at GV20, GV26, GV16 through GV15, and bilateral LI4. mRNA expression of TLR2, TLR4, NF-kappa B and protein in the rat cortices was quantified using real-time fluorescence quantitative polymerase chain reaction (qPCR) and Western blot analyses. Results The modified neurological severity score (mNSS) scores of the TBI+MA group were improved compared with baseline scores 12 hours after modelling, and improved at 7d and 14d compared with the TBI group (P<0.05), while the score of the TBI group did not improve until 14d compared to baseline. mRNA and protein expression of TLR2, TLR4 and NF-kappa B in the TBI group were higher than the normal group at 3d (P<0.05), reached a peak at 7d, then began to decrease at 14d. mRNA and protein expression of TLR2, TLR4 and NF-kappa B were higher in the TBI+MA group compared with the TBI group at 3d (P<0.05), were significantly down-regulated at 7d (P<0.01), and decreased to normal levels at 14d. Conclusions Acupuncture has a bidirectional regulatory effect on the TLR2/4-NF-kappa B signalling pathway-related genes TLR2, TLR4 and NF-kappa B in the TBI rat cortex, promoting their expression in the early stage and inhibiting it in the later stage.	[Lin, Shu-jun; Cao, Lu-xi; Cheng, Shao-bing; Lin, Ji-huan; Pu, Liu; Chen, Wei-hao; Zhang, Yu-juan; Chen, Shu-lian; Zhang, Yi-min] Jinan Univ, Tradit Chinese Med Coll, Guangzhou 510632, Guangdong, Peoples R China; [Dai, Qiu-fu] China Acad Chinese Med Sci, Beijing, Peoples R China		Zhang, YM (corresponding author), Jinan Univ, Tradit Chinese Med Coll, Guangzhou 510632, Guangdong, Peoples R China.	zhangymjnu@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81574066]; Fundamental Research Funds for the Central Universities, ChinaFundamental Research Funds for the Central Universities [21615427]; Foundation of Guangdong Province Traditional Chinese Medicine Scientific Research Project [20151184]	Supported by the Natural Science Foundation of China (grant no. 81574066), the Fundamental Research Funds for the Central Universities, China (grant no. 21615427) and the Foundation of Guangdong Province Traditional Chinese Medicine Scientific Research Project (grant no. 20151184).	Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Chunlei D, 1998, EXPT ACUPUNCTURE; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27; Fawu Z, 2005, EFFECT ACUPUNCTURE T; Jiang ST, 2016, EVID-BASED COMPL ALT, V4, P1; Jing-hong C, 2012, MED RECAPITULATE, V18, P297; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lee Hyun-Ho, 2015, Korean J Neurotrauma, V11, P44, DOI 10.13004/kjnt.2015.11.2.44; Li X, 2017, EVID-BASED COMPL ALT, V2017, P1; Li Z, 2012, ACTA U MED ANHUI, V47, P518; Liang WU, 2010, CHINESE J REHABI THE, V16, P201; Liang Y, 2016, ACUPUNCT MED, V34, P40, DOI 10.1136/acupmed-2015-010773; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Ryazantseva NV, 2010, B EXP BIOL MED+, V149, P50, DOI 10.1007/s10517-010-0873-8; Schmidt C, 2006, NAT BIOTECHNOL, V24, P230, DOI 10.1038/nbt0306-230; Sheng XH, 2011, CHEM LIFE, V2, P272; Tieshan S, 2008, CHINESEJ PHYS MED RE, V30, P244; Tu XK, 2014, INFLAMMATION, V37, P1544, DOI 10.1007/s10753-014-9881-6; Tu XK, 2011, INFLAMMATION, V34, P463, DOI 10.1007/s10753-010-9254-8; Wang J, 2009, BRAIN RES BULL, V80, P89, DOI 10.1016/j.brainresbull.2009.04.020; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Winters L, 2013, NEUROSCIENCE, V238, P87, DOI 10.1016/j.neuroscience.2013.02.001; Wong V, 2013, COCHRANE DB SYST REV, V3, P100; Xu Q, 2015, NEUROSCI LETT, V588, P88, DOI 10.1016/j.neulet.2014.12.057; Yang XH, 2017, ACUPUNCT MED, V35, P122, DOI 10.1136/acupmed-2016-011134; Ye LB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010037; Yimin Z, 2014, CHINESE J GERONTO, V21, P6100; Yimin Z, 2010, J TRADIT CHIN MED, V51, P528; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang YM, 2016, ACUPUNCT MED, V34, P48, DOI 10.1136/acupmed-2014-010742; Zhang Yi-Min, 2013, Zhen Ci Yan Jiu, V38, P158; Zhang YM, 2013, CHIN J INTEGR MED, V19, P132, DOI 10.1007/s11655-013-1353-6; Zhang Yun-Ge, 2008, Fa Yi Xue Za Zhi, V24, P453; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914; Zwagerman N, 2010, NEUROL RES, V32, P123, DOI 10.1179/016164109X12464612122812	45	9	12	3	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0964-5284	1759-9873		ACUPUNCT MED	Acupunct. Med.	AUG	2018	36	4					247	253		10.1136/acupmed-2017-011472			7	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	GU1TU	WOS:000445050200006	29550760	hybrid, Green Published			2022-02-06	
J	Takahashi, DK; Jin, S; Prince, DA				Takahashi, D. K.; Jin, Sha; Prince, D. A.			Gabapentin Prevents Progressive Increases in Excitatory Connectivity and Epileptogenesis Following Neocortical Trauma	CEREBRAL CORTEX			English	Article						excitatory networks; laser-scanning photostimulation; neocortex; post-traumatic epilepsy; prophylaxis	V PYRAMIDAL NEURONS; CALCIUM-CHANNEL SUBUNIT; RAT BARREL CORTEX; PARTIAL CORTICAL DEAFFERENTATION; FAST-SPIKING INTERNEURONS; TEMPORAL-LOBE EPILEPSY; HIPPOCAMPUS IN-VITRO; FREEZE-LESION MODEL; NEUROPATHIC PAIN; POSTTRAUMATIC EPILEPSY	Neocortical injury initiates a cascade of events, some of which result in maladaptive epileptogenic reorganization of surviving neural circuits. Research focused on molecular and organizational changes that occur following trauma may reveal processes that underlie human post-traumatic epilepsy (PTE), a common and unfortunate consequence of traumatic brain injury. The latency between injury and development of PTE provides an opportunity for prophylactic intervention, once the key underlying mechanisms are understood. In rodent neocortex, injury to pyramidal neurons promotes axonal sprouting, resulting in increased excitatory circuitry that is one important factor promoting epileptogenesis. We used laserscanning photostimulation of caged glutamate and whole-cell recordings in in vitro slices from injured neocortex to assess formation of new excitatory synapses, a process known to rely on astrocyte-secreted thrombospondins (TSPs), and to map the distribution of maladaptive circuit reorganization. We show that this reorganization is centered principally in layer V and associated with development of epileptiform activity. Short-term blockade of the synaptogenic effects of astrocytesecreted TSPs with gabapentin (GBP) after injury suppresses the new excitatory connectivity and epileptogenesis for at least 2 weeks. Results reveal that aberrant circuit rewiring is progressive in vivo and provide further rationale for prophylactic anti-epileptogenic use of gabapentinoids following cortical trauma.	[Takahashi, D. K.; Jin, Sha; Prince, D. A.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Room M016,300 Pasteur Dr, Stanford, CA 94305 USA		Prince, DA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Room M016,300 Pasteur Dr, Stanford, CA 94305 USA.	daprince@stanford.edu			Neurological Institute of Neurological Disorders and Stroke at the National Institutes of Health [NS12151, NS090076, NS077623]; Edward F. and Irene Thiele Pimley Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090076] Funding Source: NIH RePORTER	The Neurological Institute of Neurological Disorders and Stroke at the National Institutes of Health (Grant numbers NS12151 and NS090076 to D.A.P.); (F32) (NS077623 to D.K.T.) and the Edward F. and Irene Thiele Pimley Research Fund.	Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Avoli M, 2005, PROG NEUROBIOL, V77, P166, DOI 10.1016/j.pneurobio.2005.09.006; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Barrueto F, 2002, J TOXICOL-CLIN TOXIC, V40, P925, DOI 10.1081/CLT-120016965; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; Brill J, 2009, J NEUROSCI, V29, P7413, DOI 10.1523/JNEUROSCI.6098-08.2009; Brown JT, 2005, SYNAPSE, V55, P262, DOI 10.1002/syn.20115; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Bureau I, 2008, J NEUROSCI, V28, P5178, DOI 10.1523/JNEUROSCI.1076-08.2008; Carmichael ST, 2002, J NEUROSCI, V22, P6062; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Chauvette S, 2016, J NEUROSCI METH, V260, P185, DOI 10.1016/j.jneumeth.2015.08.030; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Cunningham MO, 2004, EUR J NEUROSCI, V20, P1566, DOI 10.1111/j.1460-9568.2004.03625.x; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DAVENPORT CJ, 1990, EXP NEUROL, V109, P180, DOI 10.1016/0014-4886(90)90072-Z; DeFelipe J., 1991, CAJALS DEGENERATION; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Deleuze C, 2006, J NEUROSCI, V26, P8633, DOI 10.1523/JNEUROSCI.2333-06.2006; Dolphin AC, 2012, JASPERS BASIC MECH E; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Dudek FE, 2012, JASPERS BASIC MECH E; Eckstein-Ludwig U, 1999, BRIT J PHARMACOL, V128, P92, DOI 10.1038/sj.bjp.0702794; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Faria LC, 2012, NEUROBIOL DIS, V45, P821, DOI 10.1016/j.nbd.2011.11.006; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Fijalkowski L, 2017, EUR J PHARM SCI, V96, P362, DOI 10.1016/j.ejps.2016.10.004; Finch Christopher K, 2010, J Pain Palliat Care Pharmacother, V24, P236, DOI 10.3109/15360288.2010.493927; FISHMAN PS, 1993, J NEUROTRAUM, V10, P457, DOI 10.1089/neu.1993.10.457; Galvan CD, 2003, EUR J NEUROSCI, V18, P1861, DOI 10.1046/j.1460-9568.2003.02920.x; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hellwig TR, 2010, AM J HEALTH-SYST PH, V67, P910, DOI 10.2146/ajhp090313; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Jin XM, 2014, J NEUROPHYSIOL, V112, P1703, DOI 10.1152/jn.00854.2013; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li Z, 2011, EUR J PHARMACOL, V667, P80, DOI 10.1016/j.ejphar.2011.05.054; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lillis KP, 2015, J NEUROSCI, V35, P9920, DOI 10.1523/JNEUROSCI.4007-14.2015; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; Norton JW, 2001, CLIN NEUROPHARMACOL, V24, P245, DOI 10.1097/00002826-200107000-00011; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Prince D A, 1971, Trans Am Neurol Assoc, V96, P88; Prince D. A., 2012, JASPERS BASIC MECH E, V4, P315; PRINCE DA, 1965, ELECTROEN CLIN NEURO, V19, P139, DOI 10.1016/0013-4694(65)90224-5; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Rossi AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078516; RINK A, 1995, AM J PATHOL, V147, P1575; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salin P, 1995, J NEUROSCI, V15, P8234; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Shao LR, 2005, EPILEPSIA, V46, P100, DOI 10.1111/j.1528-1167.2005.01018.x; Shao LR, 2004, J NEUROPHYSIOL, V92, P1366, DOI 10.1152/jn.00131.2004; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Takahashi DK, 2016, NEUROBIOL DIS, V91, P166, DOI 10.1016/j.nbd.2016.03.003; Takahashi DK, 2012, SOC NEUR ABSTR; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; Tseng GF, 1996, J NEUROPHYSIOL, V75, P248, DOI 10.1152/jn.1996.75.1.248; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Hooft JA, 2002, EUR J PHARMACOL, V449, P221, DOI 10.1016/S0014-2999(02)02044-7; VOLLMER KO, 1986, ARZNEIMITTEL-FORSCH, V36-1, P830; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yu JN, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.006.2008	118	9	10	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	AUG	2018	28	8					2725	2740		10.1093/cercor/bhx152			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP6DH	WOS:000440966600005	28981586	Green Published, Bronze			2022-02-06	
J	Theadom, A; Barker-Collo, S; Jones, KM; Parmar, P; Bhattacharjee, R; Feigin, VL				Theadom, A.; Barker-Collo, S.; Jones, K. M.; Parmar, P.; Bhattacharjee, R.; Feigin, V. L.			MLC901 (NeuroAiD II) for cognition after traumatic brain injury: a pilot randomized clinical trial	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cognitive deficits; concussion; MLC901; NeuroAiD II; quality of life; traumatic brain injury	FATIGUE IMPACT SCALE; CONCUSSION SYMPTOMS QUESTIONNAIRE; QUALITY-OF-LIFE; DEPRESSION SCALE; HOSPITAL ANXIETY; ANTIOXIDANT THERAPY; CHINESE MEDICINE; MILD; VALIDITY; RELIABILITY	Background and purposeTreatments to facilitate recovery after traumatic brain injury (TBI) are urgently needed. We conducted a 9-month pilot, randomized placebo-controlled clinical trial to examine the safety and potential effects of the herbal supplement MLC901 (NeuroAiD II) on cognitive functioning following TBI. MethodsAdults aged 18-65 years at 1-12 months after mild or moderate TBI were randomized to receive MLC901 (0.8 g capsules 3 times daily) or placebo for 6 months. The primary outcome was cognitive functioning as assessed by the CNS Vital Signs online neuropsychological test. Secondary outcomes included the Cognitive Failures Questionnaire, the Rivermead Post-concussion Symptom Questionnaire (neurobehavioral sequelae), Quality of Life after Brain Injury, Hospital Anxiety and Depression Scale, Modified Fatigue Impact Scale and extended Glasgow Outcome Scale (physical disability). Assessments were completed at baseline and at 3-, 6- and 9-month follow-up. Linear mixed-effects models were conducted, with the primary outcome time-point of 6 months. ResultsA total of 78 participants [mean age 37.5 14.8 years, 39 (50%) female] were included in the analysis. Baseline variables were similar between groups (treatment group, n = 36; control group, n = 42). Linear mixed-effects models controlling for time, group allocation, repeated measurements, adherence and baseline assessment scores revealed significant improvements in complex attention (P = 0.04, d = 0.6) and executive functioning (P = 0.04, d = 0.4) at 6 months in the MLC901 group compared with controls. There were no significant differences between the groups for neurobehavioral sequelae, mood, fatigue, physical disability or overall quality of life at 6 months. No serious adverse events were reported. ConclusionsMLC901 was safe and well tolerated post-TBI. This study provided Class I/II evidence that, for patients with mild to moderate TBI, 6 months of MLC901 improved cognitive functioning.	[Theadom, A.; Jones, K. M.; Parmar, P.; Bhattacharjee, R.; Feigin, V. L.] Auckland Univ Technol, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Barker-Collo, S.] Univ Auckland, Dept Psychol, Auckland, New Zealand		Feigin, VL (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	valery.feigin@aut.ac.nz	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019	Feigin, Valery L./0000-0002-6372-1740; Theadom, Alice/0000-0003-0351-6216	Moleac Pte Ltd, Singapore	We would like to acknowledge the financial support of Moleac Pte Ltd, Singapore. We thank the participants for their time and interest in taking part in this study and the service providers for their support with patient recruitment and discussion of the implications of the study findings.	Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Atreja Ashish, 2005, MedGenMed, V7, P4; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bejot Y, 2008, J NEUROL NEUROSUR PS, V79, P1344, DOI 10.1136/jnnp.2008.150318; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Gualtieri CT, 2004, PSYCHOMETRIC CLIN PR; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Hopkins WG, 2002, SCALE MAGNITUDES EFF; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Osterberg K, 2009, STRESS, V12, P70, DOI 10.1080/10253890802049699; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pocock, 1983, CLIN TRIALS PRACTICA; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Rigg JL, 2005, J HEAD TRAUMA REHAB, V20, P389, DOI 10.1097/00001199-200507000-00010; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	39	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	AUG	2018	25	8					1055	+		10.1111/ene.13653			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GM1MO	WOS:000437832600017	29611892	Green Published, hybrid			2022-02-06	
J	Wade, SL; Bedell, G; King, JA; Jacquin, M; Turkstra, LS; Haarbauer-Krupa, J; Johnson, J; Salloum, R; Narad, ME				Wade, Shari L.; Bedell, Gary; King, Jessica A.; Jacquin, Michele; Turkstra, Lyn S.; Haarbauer-Krupa, Juliet; Johnson, Jeremy; Salloum, Ralph; Narad, Megan E.			Social Participation and Navigation (SPAN) Program for Adolescents With Acquired Brain Injury: Pilot Findings	REHABILITATION PSYCHOLOGY			English	Article						brain injury; brain tumor; adolescence; social participation; peer coaching intervention	MENTORING PROGRAM; CHILDREN; OUTCOMES; SCHOOL; SURVIVORS; TERM; TUMORS; INTERVENTION; COMPETENCE; COMMUNITY	Purpose/Objective: Our goal was to examine the feasibility and preliminary efficacy of an app-based coaching intervention (Social Paiticipation and Navigation; SPAN) to help survivors of acquired brain injury attain social participation goals. Research Method/Design: This is a nonrandomized pilot trial of SPAN, including 15 adolescents (9 with traumatic brain injury, 6 with brain tumor) between the ages ol 14-22. The SPAN intervention consisted of a mobile app to support the development and implementation of social participation goals, weekly video-conference coaching sessions to identify goals and step-by-step action plans and online didactic materials Assessments were completed pre- and postintervention. Satisfaction with the intervention. confidence in the adolescents' ability to participate in and plan social activities and manage then emotions and behaviors and frequency and satisfaction with social participation were assessed via self- and parent-report questionnaries developed for This project. Behavior problems, social competence, and social problems were measured by using the Child Behavior Checklist and the Youth Self-Report. Results: High levels of participant and parent satisfaction were reported. Increases in parent-reported frequency of social participation and teen-reported confidence in their ability to participate and develop social participation goals and plans were observed. A decline in parent-reported total problems internalizing problems, externalizing problems and social problems was noted. Conclusion/Implications: Results support the feasibility of the program because participants were able to successfully meet with then coaches and use the app to develop and accomplish social participation goals. Further research will be needed to refine the app and program, particularly when reaching out to populations beyond traumatic brain injury.	[Wade, Shari L.; King, Jessica A.; Narad, Megan E.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Bedell, Gary; Jacquin, Michele] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Turkstra, Lyn S.] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI USA; [Turkstra, Lyn S.] Univ Wisconsin Madison, Dept Surg, Neurosci Training Program, Madison, WI USA; [Haarbauer-Krupa, Juliet] Childrens Healthcare Atlanta, Div Rehabil Serv, Atlanta, GA USA; [Johnson, Jeremy] Georgia Tech Univ, Interact Media Technol Ctr, Atlanta, GA USA; [Salloum, Ralph] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH 45229 USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Turkstra, Lyn/ABC-5831-2021	Bedell, Gary/0000-0002-9555-8861; Turkstra, Lyn/0000-0002-6948-6921	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G130272]	The contents of this article were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant H133G130272). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Bedell G, 2012, DEV SOCIAL NEUROSCIE, P185; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2017, DEV NEUROREHABIL, V20, P408, DOI 10.1080/17518423.2016.1237584; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; Braga LW, 2012, NEUROREHABILITATION, V30, P205, DOI 10.3233/NRE-2012-0746; CARPENTIERI SC, 1993, ARCH CLIN NEUROPSYCH, V8, P345, DOI 10.1016/0887-6177(93)90024-U; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Cooley E, 1997, ACQUIRED BRAIN INJUR; DeMatteo CA, 2008, ARCH PHYS MED REHAB, V89, P1803, DOI 10.1016/j.apmr.2008.02.025; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Foley B, 2000, CHILD HEALTH CARE, V29, P209, DOI 10.1207/S15326888CHC2903_5; Fraas M, 2010, BRAIN INJURY, V24, P50, DOI 10.3109/02699050903446781; Fuemmeler BF, 2002, CLIN PSYCHOL REV, V22, P547, DOI 10.1016/S0272-7358(01)00120-9; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Gresham FM, 2001, EXCEPT CHILDREN, V67, P331, DOI 10.1177/001440290106700303; Haarbauer-Krupa J, 2010, J HEAD TRAUMA REHAB, V25, P396; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Mahoney JL, 2003, J EDUC PSYCHOL, V95, P409, DOI 10.1037/0022-0663.95.2.409; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Mitchell Alex J, 2013, Lancet Oncol, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Narad M. E, 2017, ADV ONLINE PUBLICATI, DOI [10.1080/17518423.2017.1354092, DOI 10.1080/17518423.2017.1354092]; Pollock N, 1998, CANADIAN OCCUPATIONA; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; SELMAN RL, 1997, FOSTERING FRIENDSHIP; SELMAN RL, 1990, MAKING FRIEND YOUTH; Shah SS, 2015, CHILD NERV SYST, V31, P653, DOI 10.1007/s00381-015-2669-7; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TEASDALE G, 1974, LANCET, V2, P81; TURKSTRA L, 2007, NEUROPHYSIOLOGY NEUR, V17, P15, DOI DOI 10.1044/NNSLD17.3.15; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Vannatta K, 1998, J PEDIATR PSYCHOL, V23, P279, DOI 10.1093/jpepsy/23.5.279; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2017, ARCH PHYS MED REHAB, V98, P1614, DOI 10.1016/j.apmr.2017.03.006; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148	57	9	9	1	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2018	63	3					327	337		10.1037/rep0000187			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GQ4ZS	WOS:000441685700001	30024207	Green Accepted			2022-02-06	
J	Zhang, LJ; Cui, X; Jauregui, R; Park, KS; Justus, S; Tsai, YT; Duong, JK; Hsu, CW; Wu, WH; Xu, CL; Lin, CS; Tsang, SH				Zhang, Lijuan; Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia; Justus, Sally; Tsai, Yi-Ting; Duong, Jimmy K.; Hsu, Chun-Wei; Wu, Wen-Hsuan; Xu, Christine L.; Lin, Chyuan-Sheng; Tsang, Stephen H.			Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa	MOLECULAR THERAPY			English	Article							ROD CELL-DEATH; RETINAL DEGENERATION; CGMP-PHOSPHODIESTERASE; TRAUMATIC BRAIN; MOUSE MODEL; MICE; DISEASE; CX3CR1; DEFICIENCY; INJURY	Microglia cells (MGCs) play a key role in scavenging pathogens and phagocytosing cellular debris in the central nervous system and retina. Their activation, however, contributes to the progression of multiple degenerative diseases. Given the potential damage created by MGCs, it is important to better understand their mechanism of activation. Here, we explored the role of MGCs in the context of retinitis pigmentosa (RP) by using four independent preclinical mouse models. For therapeutic modeling, tamoxifen-inducible CreER was introduced to explore changes in MGCs when RP progression halted. The phenotypes of the MGCs were observed using live optical coherence tomography, live autofluorescence, and immunohistochemistry. We found that, regardless of genetic background, MGCs were activated in neurodegenerative conditions and migrated beyond the layers where they are typically found to the inner and outer segments, where degeneration was ongoing. Genetic rescue not only halted degeneration but also deactivated MGCs, regardless of whether the intervention occurred at the early, middle, or late stage of the disease. These findings suggest that halting long-term disease progression may be more successful by downregulating MGC activity while co-administering the therapeutic intervention.	[Zhang, Lijuan] Shanxi Med Univ, Shanxi Eye Hosp, 100 Fudong St, Taiyuan, Shanxi, Peoples R China; [Cui, Xuan] Tianjin Med Univ, Hosp Eye, Inst Eye, Tianjin 300384, Peoples R China; [Cui, Xuan] Tianjin Med Univ, Sch Optometry & Ophthalmol, Tianjin 300384, Peoples R China; [Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia; Justus, Sally; Tsai, Yi-Ting; Hsu, Chun-Wei; Wu, Wen-Hsuan; Xu, Christine L.; Tsang, Stephen H.] Columbia Univ, Jonas Childrens Vis Care, New York, NY USA; [Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia; Justus, Sally; Tsai, Yi-Ting; Hsu, Chun-Wei; Wu, Wen-Hsuan; Xu, Christine L.; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Bernard & Shirlee Brown Glaucoma Lab, Columbia Stem Cell Initiat, New York, NY 10027 USA; [Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia; Justus, Sally; Tsai, Yi-Ting; Hsu, Chun-Wei; Wu, Wen-Hsuan; Xu, Christine L.; Tsang, Stephen H.] New York Presbyterian Hosp, Edward S Harkness Eye Inst, 635 West 165th St,Box 112, New York, NY 10032 USA; [Cui, Xuan] Tianjin Med Univ, Hosp Eye, Tianjin, Peoples R China; [Jauregui, Ruben] Weill Cornell Med Coll, New York, NY USA; [Justus, Sally] Harvard Med Sch, Boston, MA USA; [Duong, Jimmy K.] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Lin, Chyuan-Sheng] Columbia Univ, Dept Pathol & Cell Biol, Herbert Irving Comprehens Canc Ctr, Coll Phys & Surg,Med Ctr, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, Inst Human Nutr,Stem Cell Initiat CSCI, New York, NY USA		Zhang, LJ (corresponding author), Shanxi Med Univ, Shanxi Eye Hosp, 100 Fudong St, Taiyuan, Shanxi, Peoples R China.; Tsang, SH (corresponding author), New York Presbyterian Hosp, Edward S Harkness Eye Inst, 635 West 165th St,Box 112, New York, NY 10032 USA.; Tsang, SH (corresponding author), Columbia Univ, Irving Med Ctr, 635 West 165th St,Box 112, New York, NY 10032 USA.	zhanglj2004@163.com; sht2@columbia.edu		Park, Karen/0000-0002-1605-3110; Jauregui, Ruben/0000-0002-2367-7298; Xu, Christine/0000-0002-7679-7189	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81500750]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30EY019007, R01EY018213, R01EY024698, R01EY026682, R21AG050437]; National Cancer Institute CoreUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5P30CA013696]; Research to Prevent Blindness (RPB) Physician-Scientist AwardResearch to Prevent Blindness (RPB); RPB, New York, NY, USA; Tistou and Charlotte Kerstan Foundation; Schneeweiss Stem Cell Fund, New York State [C029572]; Foundation Fighting BlindnessEuropean Commission [TA-NMT-0116-06-COLU]; Gebroe Family Foundation; RPB Medical Student Eye Research Fellowship; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA013696] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY024698, R01EY018213, R01EY026682, P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG050437] Funding Source: NIH RePORTER	L.Z. is supported by the National Natural Science Foundation of China (81500750). The Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory are supported by the NIH (P30EY019007, R01EY018213, R01EY024698, R01EY026682, R21AG050437), National Cancer Institute Core (5P30CA013696), the Research to Prevent Blindness (RPB) Physician-Scientist Award, and unrestricted funds from the RPB, New York, NY, USA. S.H.T. is a member of the RD-CURE Consortium and is supported by the Tistou and Charlotte Kerstan Foundation, the Schneeweiss Stem Cell Fund, New York State (C029572), the Foundation Fighting Blindness (TA-NMT-0116-06-COLU), and the Gebroe Family Foundation. R.J. is supported by the RPB Medical Student Eye Research Fellowship.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Arroba AI, 2017, ACTA DIABETOL, V54, P527, DOI 10.1007/s00592-017-0984-z; Beli E, 2016, J MOL MED, V94, P1255, DOI 10.1007/s00109-016-1433-0; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BLANKS JC, 1993, EXP EYE RES, V57, P265, DOI 10.1006/exer.1993.1124; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Cai ZY, 2014, INT J NEUROSCI, V124, P307, DOI 10.3109/00207454.2013.833510; Chen CW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-142; Chen PQ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8090918; Daiger S. P., 2014, COLD SPRING HARB PER, V5; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Davis RJ, 2013, J NEUROSCI, V33, P13475, DOI 10.1523/JNEUROSCI.0419-13.2013; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; FARBER DB, 1995, INVEST OPHTH VIS SCI, V36, P263; Feng X, 2015, ONCOTARGET, V6, P15077, DOI 10.18632/oncotarget.3730; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hart AW, 2005, INVEST OPHTH VIS SCI, V46, P3443, DOI 10.1167/iovs.05-0254; HIRATE J, 1984, J PHARMACOBIO-DYNAM, V7, P883; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koch SF, 2017, P NATL ACAD SCI USA, V114, P5259, DOI 10.1073/pnas.1615394114; Koch SF, 2015, J CLIN INVEST, V125, P3704, DOI 10.1172/JCI82462; Kohno H, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0408-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Liu S, 2012, INVEST OPHTH VIS SCI, V53, P6254, DOI 10.1167/iovs.12-9450; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luna G, 2016, EXP EYE RES, V150, P4, DOI 10.1016/j.exer.2016.03.027; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; Man AL, 2017, J IMMUNOL, V198, P335, DOI 10.4049/jimmunol.1502559; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Narayan DS, 2016, ACTA OPHTHALMOL, V94, P748, DOI 10.1111/aos.13141; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sengillo JD, 2016, AM J MED GENET C, V172, P349, DOI 10.1002/ajmg.c.31534; SILVA M, 1979, REV ESP FISIOL, V35, P85; Sutti S, 2017, CLIN SCI, V131, P2289, DOI 10.1042/CS20171025; Tristao FSM, 2016, NEUROTOX RES, V29, P364, DOI 10.1007/s12640-015-9557-5; Tsang Stephen H, 2014, Trans Am Ophthalmol Soc, V112, P103; Wambach JA, 2014, AM J RESP CRIT CARE, V189, P1538, DOI 10.1164/rccm.201402-0342OC; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JP, 2013, INT J MOL MED, V31, P172, DOI 10.3892/ijmm.2012.1179; Wensel TG, 2016, PROG RETIN EYE RES, V55, P32, DOI 10.1016/j.preteyeres.2016.06.002; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zeng H, 2014, NEUROSCIENCE, V275, P54, DOI 10.1016/j.neuroscience.2014.05.065; Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090	56	9	9	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	AUG 1	2018	26	8					1953	1964		10.1016/j.ymthe.2018.06.014			12	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	GQ3FR	WOS:000441547500013	30001913	Green Published, hybrid			2022-02-06	
J	Castro, L; Noelia, M; Vidal-Jorge, M; Sanchez-Ortiz, D; Gandara, D; Martinez-Saez, E; Cicuendez, M; Poca, MA; Simard, JM; Sahuquillo, J				Castro, Lidia; Noelia, Montoya; Vidal-Jorge, Marian; Sanchez-Ortiz, David; Gandara, Dario; Martinez-Saez, Elena; Cicuendez, Marta; Poca, Maria-Antonia; Simard, J. Marc; Sahuquillo, Juan			Kir6.2, the Pore-Forming Subunit of ATP-Sensitive K+ Channels, Is Overexpressed in Human Posttraumatic Brain Contusions	JOURNAL OF NEUROTRAUMA			English	Article						brain contusion; brain edema; human; Kir6.2; SUR1	SULFONYLUREA RECEPTOR 1; GLIBENCLAMIDE; INJURY; ISCHEMIA; BLOCKADE; MODEL; NEUROPROTECTION; PROGRESSION; INHIBITION; EXPRESSION	Brain contusions (BCs) are one of the most frequent lesions in patients with moderate and severe traumatic brain injury (TBI). BCs increase their volume due to peri-lesional edema formation and/or hemorrhagic transformation. This may have deleterious consequences and its mechanisms are still poorly understood. We previously identified de novo upregulation sulfonylurea receptor (SUR) 1, the regulatory subunit of adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channels and other channels, in human BCs. Our aim here was to study the expression of the pore-forming subunit of K-ATP, Kir6.2, in human BCs, and identify its localization in different cell types. Protein levels of Kir6.2 were detected by western blot (WB) from 33 contusion specimens obtained from 32 TBI patients aged 14-74 years. The evaluation of Kir6.2 expression in different cell types was performed by immunofluorescence in 29 contusion samples obtained from 28 patients with a median age of 42 years. Control samples were obtained from limited brain resections performed to access extra-axial skull base tumors or intraventricular lesions. Contusion specimens showed an increase of Kir6.2 expression in comparison with controls. Regarding cellular location of Kir6.2, there was no expression of this channel subunit in blood vessels, either in control samples or in contusions. The expression of Kir6.2 in neurons and microglia was also analyzed, but the observed differences were not statistically significant. However, a significant increase of Kir6.2 was found in glial fibrillary acidic protein (GFAP)-positive cells in contusion specimens. Our data suggest that further research on SUR1-regulated ionic channels may lead to a better understanding of key mechanisms involved in the pathogenesis of BCs, and may identify novel targeted therapeutic strategies.	[Castro, Lidia; Noelia, Montoya; Vidal-Jorge, Marian; Sanchez-Ortiz, David; Gandara, Dario; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ, Neurotraumatol & Neurosurg Res Unit UNINN, Paseo Vall dHebron 119-129, Barcelona 08035, Spain; [Martinez-Saez, Elena] Univ Autonoma Barcelona, Vall dHebron Univ, Dept Pathol, Barcelona, Spain; [Gandara, Dario; Cicuendez, Marta; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ, Dept Neurosurg, Paseo Vall dHebron 119-129, Barcelona 08035, Spain; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ, Neurotraumatol & Neurosurg Res Unit UNINN, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.; Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ, Dept Neurosurg, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Martinez-Saez, Elena/E-9097-2018; Montoya, Noelia/AAB-7839-2019; Sabatini, Dario Fabian Gandara/AAB-6699-2019; Sanchez-Ortiz, David/AAF-5020-2019; Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008	Martinez-Saez, Elena/0000-0001-6004-5364; Montoya, Noelia/0000-0002-8634-5303; Sabatini, Dario Fabian Gandara/0000-0003-1303-9847; Sanchez-Ortiz, David/0000-0001-9160-6777; Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) - European Regional Development [PI10/00302, PI11/00700, PI15/01228]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102589] Funding Source: NIH RePORTER	This work was supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grants PI10/00302, PI11/00700, and PI15/01228, which were co-financed by the European Regional Development and awarded to Dr. M.-A. Poca and Dr. J. Sahuquillo, respectively. We also thank Dr. T. Martinez-Valverde, former PhD of the Neurotraumatology and Neurosurgery Research Unit (UNINN), for her advice and help during the setting up of the initial experiments. Also, we would like to thank Dr. F. Elortza (Proteomics Platform Manager of CIC bioGUNE) and Dr. J.M. Estanyol (Proteomics Unit Supervisor of the University of Barcelona) for their support and advice in immunoprecipitation and recombinant protein experiments. Finally, we thank Dr. H. Peluffo (PI of the Neuroinflammation and Gene Therapy Laboratory of the Institut Pasteur of Montevideo) for his advice on the treatment and processing of tissue samples.	Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.ne.11.030188.000525; Benarroch EE, 2017, NEUROLOGY, V88, P314, DOI 10.1212/WNL.0000000000003523; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Clancy B, 1998, J NEUROSCI METH, V83, P97, DOI 10.1016/S0165-0270(98)00066-1; Flagg TP, 2011, CIRC-ARRHYTHMIA ELEC, V4, P796, DOI 10.1161/CIRCEP.111.968081; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Guerrero CRL, 2016, NEUROLOGY, V87, P270, DOI 10.1212/WNL.0000000000002861; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Insuk SO, 2003, INT J IMPOT RES, V15, P258, DOI 10.1038/sj.ijir.3901013; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Katayama Y., 1994, INTRACRANIAL PRESSUR, P324; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kunte H, 2012, ANN NEUROL, V72, P799, DOI 10.1002/ana.23680; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lybaert P, 2013, PLACENTA, V34, P467, DOI 10.1016/j.placenta.2013.03.006; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nistico R, 2007, INT REV NEUROBIOL, V82, P383, DOI 10.1016/S0074-7742(07)82021-6; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ortega FJ, 2014, GLIA, V62, P247, DOI 10.1002/glia.22603; Ortega FJ, 2013, J CEREBR BLOOD F MET, V33, P1138, DOI 10.1038/jcbfm.2013.72; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Principalli MA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12533; Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9; RStudio Team, 2020, RSTUDIO INT DEV R; Seino S, 2003, J DIABETES COMPLICAT, V17, P2, DOI 10.1016/S1056-8727(02)00274-X; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard JM, 2004, J NEUROSURG ANESTH, V16, P98, DOI 10.1097/00008506-200401000-00021; Sola D, 2015, ARCH MED SCI, V11, P840, DOI 10.5114/aoms.2015.53304; Stoller DA, 2010, AM J PHYSIOL-HEART C, V299, pH1100, DOI 10.1152/ajpheart.00084.2010; Sun XL, 2008, NEUROPSYCHOPHARMACOL, V33, P1336, DOI 10.1038/sj.npp.1301501; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/NMETH.3995, 10.1038/nmeth.3995]; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yamada K, 2005, J MOL CELL CARDIOL, V38, P945, DOI 10.1016/j.yjmcc.2004.11.020	53	9	9	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					165	175		10.1089/neu.2017.5619		JUL 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439668700001	29737232	Green Published			2022-02-06	
J	Cnossen, MC; van der Brande, R; Lingsma, HF; Polinder, S; Lecky, F; Maas, AIR				Cnossen, Maryse C.; van der Brande, Ruben; Lingsma, Hester F.; Polinder, Suzanne; Lecky, Fiona; Maas, Andrew I. R.		CENTER TBI Investigators Participa	Prehospital Trauma Care among 68 European Neurotrauma Centers: Results of the CENTER-TBI Provider Profiling Questionnaires	JOURNAL OF NEUROTRAUMA			English	Article						comparative effectiveness research; Europe; prehospital trauma care; survey; traumatic brain injury	SYSTEMS	The first hour following traumatic brain injury (TBI) is considered crucial to prevent death and disability. It is, however, not established yet how the prehospital care should be organized to optimize recovery during the first hour. The objective of the current study was to examine variation in prehospital trauma care across Europe aiming to inform comparative effectiveness analyses on care for neurotrauma patients. A survey on prehospital trauma care was sent to 68 neurotrauma centers from 20 European countries participating in the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study. The survey was developed using literature review and expert opinion and was pilot tested in 16 centers. All participants completed the questionnaire. Advanced life support was used in half of the centers (n=35; 52%), whereas the other centers used mainly basic life support (n=26; 38%). A mobile medical team (MMT) could be dispatched 24/7 in most centers (n=66; 97%). Helicopters were used in approximately half of the centers to transport the MMT to the scene (n=39; 57%) and the patient to the hospital (n=31, 46%). Half of the centers used a stay-and-play approach at the scene (n=37; 55%), while the others used a scoop-and-run approach or another policy. We found wide variation in prehospital trauma care across Europe. This may reflect differences in socio-economic situations, geographic differences, and a general lack of strong evidence for some aspects of prehospital care. The current variation provides the opportunity to study the effectiveness of prehospital interventions and systems of care in comparative effectiveness research.	[Cnossen, Maryse C.; Lingsma, Hester F.; Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van der Brande, Ruben; Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [van der Brande, Ruben; Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res SCHARR, Hlth Serv Res Sect, Ctr Urgent & Emergency Care Res CURE, Sheffield, S Yorkshire, England		Cnossen, MC (corresponding author), Erasmus MC, Dept Publ Hlth, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl	Posti, Jussi P./Y-2908-2019; Badenes, Rafael/K-6628-2019; Maas, Andrew IR/AAF-5683-2019; Maas, Andrew IR/C-5584-2013	Posti, Jussi P./0000-0002-5925-5193; Badenes, Rafael/0000-0001-7017-0150; Maas, Andrew IR/0000-0003-1612-1264; Maas, Andrew IR/0000-0003-1612-1264	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework program (602150).	Bakalos G, 2011, RESUSCITATION, V82, P1130, DOI 10.1016/j.resuscitation.2011.04.006; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; BOYD DR, 1983, WORLD J SURG, V7, P149, DOI 10.1007/BF01655923; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Dijkink S, 2017, J TRAUMA ACUTE CARE, V83, P917, DOI 10.1097/TA.0000000000001633; European Defence Agency, 2007, SOC SIT EUR UN 2007, p[1, 3]; Galvagno SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub3; Jayaraman S., 2014, COCHRANE DB SYST REV, V8; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; World Health Organization, 2014, INJ VIOL FACTS	12	9	9	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					176	181		10.1089/neu.2018.5712		JUL 2018	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439667000001	29732946	Green Submitted, Green Accepted			2022-02-06	
J	Scrimgeour, AG; Carrigan, CT; Condlin, ML; Urso, ML; van den Berg, RM; van Helden, HPM; Montain, SJ; Joosen, MJA				Scrimgeour, Angus G.; Carrigan, Christopher T.; Condlin, Michelle L.; Urso, Maria L.; van den Berg, Roland M.; van Helden, Herman P. M.; Montain, Scott J.; Joosen, Marloes J. A.			Dietary Zinc Modulates Matrix Metalloproteinases in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast; matrix metalloproteinase; mild traumatic brain injury; neuroinflammation; zinc	SKELETAL-MUSCLE; RAT MODEL; CEREBROSPINAL-FLUID; GENE-EXPRESSION; PROTEIN-LEVELS; BARRIER DISRUPTION; TISSUE INHIBITOR; MESSENGER-RNA; BLAST; MATRIX-METALLOPROTEINASE-9	Animal models of mild traumatic brain injury (mTBI) provide opportunity to examine the extent to which dietary interventions can be used to improve recovery after injury. Animal studies also suggest that matrix metalloproteinases (MMPs) play a role in tissue remodeling post-TBI. Because dietary zinc (Zn) improved recovery in nonblast mTBI models, and the MMPs are Zn-requiring enzymes, we evaluated the effects of low- (LoZn) and adequate-Zn (AdZn) diets on MMP expression and behavioral responses, subsequent to exposure to a single blast. MMP messenger RNA expression in soleus muscle and frontal cortex tissues were quantified at 48h and 14 days post-blast. In muscle, blast resulted in significant upregulation of membrane-type (MT)-MMP, MMP-2, tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 at 48h post-injury in rats consuming AdZn. At 14 days post-blast, there were no blast or dietary effects observed on MMP levels in muscle, supporting the existence of a Zn-responsive, functional repair and remodeling mechanism. In contrast, blast resulted in a significant downregulation of MT-MMP, TIMP-1, and TIMP-2 and a significant upregulation of MMP-3 levels at 48h post-injury in cortex tissue, whereas at 14 days post-blast, MT-MMP, MMP-2, and TIMP-2 were all downregulated in response to blast, independent of diet, and TIMP-1 were significantly increased in rats fed AdZn diets despite the absence of elevated MMPs. Because the blast injuries occurred while animals were under general anesthesia, the increased immobility observed post-injury in rats consuming LoZn diets suggest that blast mTBI can, in the absence of any psychological stressor, induce post-traumatic stress disorder-related traits that are chronic, but responsive to diet. Taken together, our results support a relationship between marginally Zn-deficient status and a compromised regenerative response post-injury in muscle, likely through the MMP pathway. However, in neuronal tissue, changes in MMP/TIMP levels after blast indicate a variable response to marginally Zn-deficient diets that may help explain compromised repair mechanism(s) previously associated with the systemic hypozincemia that develops in patients with TBI.	[Scrimgeour, Angus G.; Carrigan, Christopher T.; Condlin, Michelle L.; Montain, Scott J.] USARIEM, Mil Nutr Div, 10 Gen Greene Ave, Natick, MA 01760 USA; [Urso, Maria L.] USARIEM, Mil Performance Div, Natick, MA USA; [van den Berg, Roland M.; van Helden, Herman P. M.; Joosen, Marloes J. A.] TNO CBRN Protect, Rijswijk, Netherlands		Scrimgeour, AG (corresponding author), USARIEM, Mil Nutr Div, 10 Gen Greene Ave, Natick, MA 01760 USA.	angus.g.scrimgeour.civ@mail.mil	Joosen, Marloes/ABD-5619-2021	Joosen, Marloes/0000-0002-0626-6980			Agoston D.V., 2015, BRAIN NEUROTRAUMA MO; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Barnes BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1501, DOI 10.1152/ajpcell.00217.2009; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Campestre C, 2015, CURR DRUG TARGETS, V16, P1634, DOI 10.2174/1389450116666150113121733; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Geerse GJ, 2006, BEHAV BRAIN RES, V175, P9, DOI 10.1016/j.bbr.2006.07.011; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Gurney KJ, 2006, NEUROBIOL DIS, V23, P87, DOI 10.1016/j.nbd.2006.02.006; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Jadhav V, 2008, ACTA NEUROCHIR SUPPL, V102, P357, DOI 10.1007/978-3-211-85578-2_68; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mukherjee R, 2005, J MOL CELL CARDIOL, V39, P259, DOI 10.1016/j.yjmcc.2005.03.012; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; National Research Council, 2011, GUIDE CARE USE LAB A; Nishimura T, 2008, J MUSCLE RES CELL M, V29, P37, DOI 10.1007/s10974-008-9140-2; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Scrimgeour AG, 2010, J NUTR BIOCHEM, V21, P653, DOI 10.1016/j.jnutbio.2009.03.015; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Silva DD, 2011, ACTA CIR BRAS, V26, P94, DOI 10.1590/S0102-86502011000200004; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Urso ML, 2010, EUR J APPL PHYSIOL, V109, P963, DOI 10.1007/s00421-010-1435-5; Vandooren J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174853; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	9	10	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2495	2506		10.1089/neu.2017.5614		JUL 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000438824000001	29774825				2022-02-06	
J	Beebe, DW; Powers, SW; Slattery, EW; Gubanich, PJ				Beebe, Dean W.; Powers, Scott W.; Slattery, Eric W.; Gubanich, Paul J.			Short Sleep and Adolescents' Performance on a Concussion Assessment Battery: An Experimental Sleep Manipulation Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sleep restriction; adolescents; concussion		Objective: Correlational studies have linked short sleep to adolescents' report of postconcussion symptoms and cognitive performance during concussion assessments. This study tested whether those are cause-effect relationships. Design: Three-week randomly counterbalanced, within-subjects, crossover experiment. Setting: Adolescents slept at home with weekly visits to an outpatient clinic for sleep monitor uploads and outcome assessments. Participants: Twenty-four healthy 14- to 17.9-year-olds. Conditions: After an initial sleep-stabilization period, adolescents experienced 5-night spans of short sleep (SS; 6.5 hours/night in bed) versus Healthy Sleep Opportunity (HS; 9.5 hours/night in bed). Main Outcome Measures: Cognitive indexes and the postconcussion symptom scale (PCSS) from the Immediate PostConcussion Assessment and Cognitive Testing. Results: Adolescents reported significantly worse symptoms on the PCSS after SS than HS, even after excluding items manifestly related to sleep. Verbal memory was also worse after SS than HS, though the effect was small. The manipulation did not significantly affect other cognitive indexes. Conclusions: A realistic "dose" of short sleep, similar to what many adolescents experience regularly on school nights, can cause or contribute to symptom reports during concussion assessments. Consistent with previous sleep research, one-on-one cognitive tests seem to he less sensitive than measures of emotional and behavioral functioning to the effects of short sleep.	[Beebe, Dean W.; Powers, Scott W.; Gubanich, Paul J.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Beebe, Dean W.; Powers, Scott W.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Slattery, Eric W.; Gubanich, Paul J.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA		Beebe, DW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	dean.beebe@cchmc.org		Powers, Scott/0000-0002-5348-9650	United States National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HL120879]; Division of Sports Medicine at Cincinnati Children's Hospital Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL120879] Funding Source: NIH RePORTER	Supported by the United States National Institutes of Health (NIH; R01HL120879) and the Division of Sports Medicine at Cincinnati Children's Hospital Medical Center.	Baum KT, 2014, J CHILD PSYCHOL PSYC, V55, P180, DOI 10.1111/jcpp.12125; Beebe DW, 2012, CHILD NEUROPSYCHOL, V18, P313, DOI 10.1080/09297049.2011.602014; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; National Sleep Foundation, 2006, SUMM FIND 2006 SLEEP; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pS311, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]	9	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2018	28	4					395	397		10.1097/JSM.0000000000000454			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	GP1IO	WOS:000440569000015	28742612	Green Accepted			2022-02-06	
J	Budde, MD; Skinner, NP				Budde, Matthew D.; Skinner, Nathan P.			Diffusion MRI in acute nervous system injury	JOURNAL OF MAGNETIC RESONANCE			English	Article						Diffusion tensor imaging; Acute neurological injury; Cerebral ischemia; Traumatic brain injury; Spinal cord injury; Magnetic resonance imaging; Double diffusion encoding	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; WHITE-MATTER CHANGES; TENSOR IMAGING PARAMETERS; ACUTE ISCHEMIC-STROKE; WATER DIFFUSION; CEREBRAL-ISCHEMIA; AXONAL INJURY; APPARENT DIFFUSION; WEIGHTED MRI	Diffusion weighted magnetic resonance imaging (DWI) and related techniques such as diffusion tensor imaging (DTI) are uniquely sensitive to the microstructure of the brain and spinal cord. In the acute aftermath of nervous system injury, for example, DWI reveals changes caused by injury that remains invisible on other MRI contrasts such as T-2-weighted imaging. This ability has led to a demonstrated clinical utility in cerebral ischemia. However, despite strong promise in preclinical models and research settings, DWI has not been as readily adopted for other acute injuries such as traumatic spinal cord, brain, or peripheral nerve injury. Furthermore, the precise biophysical mechanisms that underlie DWI and DTI changes are not fully understood. In this report, we review the DWI and DTI changes that occur in acute neurological injury of cerebral ischemia, spinal cord injury, traumatic brain injury, and peripheral nerve injury. Their associations with the underlying biology are examined with an emphasis on the role of acute axon and dendrite beading. Lastly, emerging DWI techniques to overcome the limitations of DTI are discussed as these may offer the needed improvements to translate to clinical settings. (C) 2018 Elsevier Inc. All rights reserved.	[Budde, Matthew D.; Skinner, Nathan P.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Skinner, Nathan P.] Med Coll Wisconsin, Med Scientist Training Program, Milwaukee, WI 53226 USA		Budde, MD (corresponding author), 9000 W Natl Ave,VA Res 151, Milwaukee, WI 53295 USA.	mdbudde@mcw.edu			Craig H. Neilsen Foundation; U.S. Department of Veterans AffairsUS Department of Veterans Affairs; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Medical Scientist Training ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS096958] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001497] Funding Source: NIH RePORTER	MDB acknowledges support from the Craig H. Neilsen Foundation and the U.S. Department of Veterans Affairs. NPS acknowledges support from the National Institutes of Health and the Medical Scientist Training Program. All animal procedures were approved by the Institutional Animal Care and Use Committees at the Medical College of Wisconsin and Clement J Zablocki VA Medical Center and were performed in accordance with the relevant guidelines and regulations.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Andre JB, 2012, AM J NEURORADIOL, V33, P1860, DOI 10.3174/ajnr.A3134; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Baron CA, 2015, STROKE, V46, P2136, DOI 10.1161/STROKEAHA.115.008815; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boyer RB, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.6.FOCUS1590; Brennan FH, 2013, NEUROIMAGE, V82, P574, DOI 10.1016/j.neuroimage.2013.06.019; Brugieres P, 2004, AM J NEURORADIOL, V25, P692; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Cain SM, 2017, P NATL ACAD SCI USA, V114, P2401, DOI 10.1073/pnas.1614447114; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chen YY, 2014, ACAD RADIOL, V21, P338, DOI 10.1016/j.acra.2013.11.005; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Conklin CJ, 2016, NEUROIMAGE-CLIN, V11, P61, DOI 10.1016/j.nicl.2016.01.009; D'souza MM, 2017, INJURY, V48, P880, DOI 10.1016/j.injury.2017.02.016; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341, DOI 10.1097/00004647-199903000-00012; Dijkstra K, 2016, J NEUROSCI, V36, P11881, DOI 10.1523/JNEUROSCI.1934-16.2016; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Dreier J. P., 2017, NEUROPHARMACOLOGY; Dreier JP, 2017, P NATL ACAD SCI USA, V114, P2112, DOI 10.1073/pnas.1700760114; Duong TQ, 1998, MAGN RESON MED, V40, P1, DOI 10.1002/mrm.1910400102; Elkin BS, 2010, PHILOS T R SOC A, V368, P585, DOI 10.1098/rsta.2009.0223; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; Espy MA, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2365473; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; Finsterbusch J, 2009, J MAGN RESON IMAGING, V29, P987, DOI 10.1002/jmri.21717; FORD JC, 1994, MAGNET RESON MED, V31, P488, DOI 10.1002/mrm.1910310504; Goodman JA, 2008, MAGN RESON MED, V59, P65, DOI 10.1002/mrm.21418; Grinberg F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089225; Guggenberger R, 2012, RADIOLOGY, V265, P194, DOI 10.1148/radiol.12111403; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Homola A, 2006, NEUROSCI LETT, V404, P137, DOI 10.1016/j.neulet.2006.05.028; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jelescu IO, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00061; Jengojan S, 2015, EUR RADIOL, V25, P1678, DOI 10.1007/s00330-014-3562-6; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jeurissen B., 2012, HUMAN BRAIN MAPP; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Kaden E, 2016, MAGN RESON MED, V75, P1752, DOI 10.1002/mrm.25734; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kim JH, 2012, EXP NEUROL, V235, P188, DOI 10.1016/j.expneurol.2011.11.015; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Landman BA, 2010, NMR BIOMED, V23, P152, DOI 10.1002/nbm.1437; LATOUR LL, 1994, P NATL ACAD SCI USA, V91, P1229, DOI 10.1073/pnas.91.4.1229; Li L, 2016, CHINESE MED J-PEKING, V129, P1091, DOI 10.4103/0366-6999.180518; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Li XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12639; Li XC, 2013, EUR J RADIOL, V82, pE707, DOI 10.1016/j.ejrad.2013.07.018; Lin M, 2016, MAGN RESON MED, V76, P290, DOI 10.1002/mrm.25816; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; Mondragon-Lozano R, 2013, SPINE, V38, pE1242, DOI 10.1097/BRS.0b013e31829ef69c; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Mussel M, 2017, MAGN RESON MED, V78, P746, DOI 10.1002/mrm.26375; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Neil JJ, 1996, MAGNET RESON MED, V35, P329, DOI 10.1002/mrm.1910350310; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Nicholson C, 2005, J NEURAL TRANSM, V112, P29, DOI 10.1007/s00702-004-0204-1; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Novikov D., 2016, QUANTIFYING BRAIN MI; Pan YA, 2003, J NEUROSCI, V23, P11479; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373; Pouw MH, 2012, SPINAL CORD, V50, P426, DOI 10.1038/sc.2011.168; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Sagiuchi T, 2002, J COMPUT ASSIST TOMO, V26, P654, DOI 10.1097/00004728-200207000-00032; Samson RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155557; Saritas EU, 2008, MAGN RESON MED, V60, P468, DOI 10.1002/mrm.21640; Sarracanie M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15177; Schellinger PD, 2010, NEUROLOGY, V75, P177, DOI 10.1212/WNL.0b013e3181e7c9dd; Shanmuganathan K, 2008, AM J NEURORADIOL, V29, P655, DOI 10.3174/ajnr.A0916; Shanmuganathan K, 2017, J NEUROTRAUM, V34, P2964, DOI 10.1089/neu.2016.4901; Shen HY, 2007, INT ORTHOP, V31, P375, DOI 10.1007/s00264-006-0175-y; Silva MD, 2002, MAGN RESON MED, V48, P826, DOI 10.1002/mrm.10296; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Skinner N. P., 2016, MAGN RESON MED; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Skinner NP, 2015, NMR BIOMED, V28, P1489, DOI 10.1002/nbm.3405; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Stein D, 2009, J MAGN RESON IMAGING, V29, P657, DOI 10.1002/jmri.21553; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Sun CP, 2014, J COMPUT ASSIST TOMO, V38, P790, DOI 10.1097/RCT.0000000000000118; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Tamura H, 2009, MAGN RESON MED SCI, V8, P121, DOI 10.2463/mrms.8.121; Thomas AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178360; Thuen M, 2009, J MAGN RESON IMAGING, V29, P39, DOI 10.1002/jmri.21606; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Wang-Leandro A, 2017, SPINAL CORD, V55, P1108, DOI 10.1038/sc.2017.83; Wang-Leandro A, 2017, J VET INTERN MED, V31, P842, DOI 10.1111/jvim.14715; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Williams PR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6683; Wilm BJ, 2009, NMR BIOMED, V22, P174, DOI 10.1002/nbm.1298; Yin B, 2010, J CLIN NEUROSCI, V17, P1173, DOI 10.1016/j.jocn.2010.02.020; Zaharchuk G, 2011, AM J NEURORADIOL, V32, P813, DOI 10.3174/ajnr.A2418; Zhang JS, 2014, EUR RADIOL, V24, P685, DOI 10.1007/s00330-013-3051-3; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	126	9	11	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1090-7807	1096-0856		J MAGN RESON	J. Magn. Reson.	JUL	2018	292						137	148		10.1016/j.jmr.2018.04.016			12	Biochemical Research Methods; Physics, Atomic, Molecular & Chemical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Physics; Spectroscopy	GJ9UP	WOS:000435750700017	29773299				2022-02-06	
J	Camp, CL; Wang, D; Sinatro, AS; D'Angelo, J; Coleman, SH; Dines, JS; Fealy, S; Conte, S				Camp, Christopher L.; Wang, Dean; Sinatro, Alec S.; D'Angelo, John; Coleman, Struan H.; Dines, Joshua S.; Fealy, Stephen; Conte, Stan			Getting Hit by Pitch in Professional Baseball: Analysis of Injury Patterns, Risk Factors, Concussions, and Days Missed for Batters	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						hit by pitch; professional baseball; concussion; batters	MAJOR-LEAGUE BASEBALL; EPIDEMIOLOGY; SYSTEM	Background: Although batters are frequently hit by pitch (HBP) in baseball, the effect of HBP injuries remains undefined in the literature. Purpose: To determine the effect of HBP injuries in terms of time out of play, injury patterns resulting in the greatest time out of play, and the value of protective gear such as helmets and elbow pads. Study Design: Descriptive laboratory study. Methods: Based on the Major League Baseball (MLB) Health and Injury Tracking System, all injuries to batters HBP during the 2011-2015 MLB and Minor League Baseball (MiLB) seasons were identified and analyzed. Video analysis was performed on all HBP events from the 2015 MLB season. Multivariate stepwise regression analysis was utilized to determine the predictive capacity of multiple variables (velocity, pitch type, location, etc) on injury status and severity. Results: A total of 2920 HBP injuries resulted in 24,624 days missed (DM) over the 5 seasons. MLB HBP injuries occurred at a rate of 1 per 2554 plate appearances (1 per 9780 pitches thrown). Mean DM per injury were 8.4 (11.7 for MLB vs 8.0 for MiLB, P < .001). Surgery was required for 3.1% of MLB injuries and 1.2% of MiLB injuries (P = .005). The most common body regions injured were the hand/fingers (n = 638, 21.8%), head/face (n = 497, 17.0%), and elbow (n = 440, 15.7%), and there were 146 (5.0%) concussions. Injury rates and mean DM correlated with velocity in a near linear fashion. Players hit in the head/face (odds ratio, 28.7) or distal upper extremity (odds ratio, 6.4) were more likely to be injured than players HBP in other locations. Players with an unprotected elbow missed 1.7 more days (95% CI, -4.1 to 7.6) than those with an elbow protector (P = .554) when injured after being HBP. Conclusion/Clinical Relevance: Although HBP injuries occur infrequently in the course of normal play, they collectively represent a significant source of time out of play. The most common body regions injured include the hands/fingers and head/face, and batters hit in these locations are significantly more likely to be injured. After contusions, concussions were the most common injury diagnosis.	[Camp, Christopher L.; Wang, Dean; Sinatro, Alec S.; D'Angelo, John; Coleman, Struan H.; Dines, Joshua S.; Fealy, Stephen; Conte, Stan] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Camp, Christopher L.] Mayo Clin, Dept Orthoped Surg & Sports Med, Rochester, MN 55905 USA; [Wang, Dean; Sinatro, Alec S.; Coleman, Struan H.; Dines, Joshua S.; Fealy, Stephen] Hosp Special Surg, Dept Orthopaed Surg, 535 E 70th St, New York, NY 10021 USA; [D'Angelo, John] Major League Baseball, Off Commissioner, New York, NY USA; [Conte, Stan] Santa Clara Univ, Santa Clara, CA 95053 USA		Camp, CL (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.; Camp, CL (corresponding author), Mayo Clin, Dept Orthoped Surg & Sports Med, Rochester, MN 55905 USA.	camp.christopher@mayo.edu			Arthrex; Zimmer Biomet; Stryker Corp.; StrykerPivot Medical; Biomet Sports Medicine; MAKO Surgical; Smith Nephew; Trice; Wright Medical; Linvatec; DePuy; Enocre	C.L.C. reports education and hospitality payments from Arthrex and hospitality payments from Zimmer Biomet and Stryker Corp. S.H.C. reports intellectual property royalties from Blue Belt Technologies; stock or stock options from Blue Belt Technologies and Cymedica Orthopedics; consulting fees from StrykerPivot Medical, Biomet Sports Medicine, and MAKO Surgical; and education payments from Smith & Nephew. J.S.D. reports consulting fees from Arthrex, Trice, Wright Medical, Linvatec, and DePuy; research support from Arthrex; and intellectual property royalties from Linvatec. S.F. reports intellectual property royalties from DJ Orthopaedics and other payments from Enocre.	Ahmad CS, 2014, AM J SPORT MED, V42, P1464, DOI 10.1177/0363546514529083; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Camp CL, 2018, AM J SPORT MED, V46, P1727, DOI 10.1177/0363546518765158; Camp CL, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117694025; Conte S, 2001, AM J SPORT MED, V29, P431, DOI 10.1177/03635465010290040801; Conte Stan, 2016, Am J Orthop (Belle Mead NJ), V45, P116; Dahm Diane L, 2016, Am J Orthop (Belle Mead NJ), V45, pE54; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Kilcoyne KG, 2015, AM J SPORT MED, V43, P2496, DOI 10.1177/0363546515597684; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Posner M, 2011, AM J SPORT MED, V39, P1676, DOI 10.1177/0363546511411700	12	9	9	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2018	46	8					1997	2003		10.1177/0363546518773048			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GN0AK	WOS:000438619500030	29768041				2022-02-06	
J	Martin, PK; Schroeder, RW; Wyman-Chick, KA; Hunter, BP; Heinrichs, RJ; Baade, LE				Martin, Phillip K.; Schroeder, Ryan W.; Wyman-Chick, Kathryn A.; Hunter, Ben P.; Heinrichs, Robin J.; Baade, Lyle E.			Rates of Abnormally Low TOPF Word Reading Scores in Individuals Failing Versus Passing Performance Validity Testing	ASSESSMENT			English	Article						Test of Premorbid Functioning (TOPF); malingering; effort; validity; neuropsychology; word reading	TRAUMATIC BRAIN-INJURY; ALBANY CONSISTENCY INDEX; WECHSLER TEST; NEUROCOGNITIVE DYSFUNCTION; NEUROPSYCHOLOGICAL TESTS; SYMPTOM EXAGGERATION; PREMORBID ABILITY; LIKELIHOOD RATIOS; SUSPECT EFFORT; TEST FAILURE	The present study examined the impact of performance validity test (PVT) failure on the Test of Premorbid Functioning (TOPF) in a sample of 252 neuropsychological patients. Word reading performance differed significantly according to PVT failure status, and number of PVTs failed accounted for 7.4% of the variance in word reading performance, even after controlling for education. Furthermore, individuals failing 2 PVTs were twice as likely as individuals passing all PVTs (33% vs. 16%) to have abnormally low obtained word reading scores relative to demographically predicted scores when using a normative base rate of 10% to define abnormality. When compared with standardization study clinical groups, those failing 2 PVTs were twice as likely as patients with moderate to severe traumatic brain injury and as likely as patients with Alzheimer's dementia to obtain abnormally low TOPF word reading scores. Findings indicate that TOPF word reading based estimates of premorbid functioning should not be interpreted in individuals invalidating cognitive testing.	[Martin, Phillip K.; Schroeder, Ryan W.; Wyman-Chick, Kathryn A.; Hunter, Ben P.; Heinrichs, Robin J.; Baade, Lyle E.] Univ Kansas, Sch Med, 7829 E,Rockhill,Suite 105, Wichita, KS 67206 USA; [Wyman-Chick, Kathryn A.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA		Martin, PK (corresponding author), Univ Kansas, Sch Med, 7829 E,Rockhill,Suite 105, Wichita, KS 67206 USA.	pmartin820@gmail.com		Wyman-Chick, Kathryn/0000-0002-5057-5094			Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Boone K., 2002, DOT COUNTING TEST; Buddin WH, 2014, CLIN NEUROPSYCHOL, V28, P525, DOI 10.1080/13854046.2014.906658; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2005, MANUAL WORD MEMORY T; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Johnstone B, 2002, ARCH CLIN NEUROPSYCH, V17, P273, DOI 10.1016/S0887-6177(01)00112-3; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P14; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lemeshow S, 2000, APPL LOGISTIC REGRES; Leritz EC, 2008, NEUROPSYCHOLOGY, V22, P687, DOI 10.1037/a0013319; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martin PK, 2015, ARCH CLIN NEUROPSYCH, V30, P377, DOI 10.1093/arclin/acv032; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McFarlane J, 2006, BRIT J CLIN PSYCHOL, V45, P453, DOI 10.1348/014466505X71245; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mossman D, 2015, PSYCHOL ASSESSMENT, V27, P763, DOI 10.1037/pas0000085; Nelson H.E., 1982, NATL ADULT READING T; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Patterson K., 1994, NEUROPSYCHOLOGY, V8, P395, DOI DOI 10.1037/0894-4105.8.3.395; Pearson, 2009, ADV CLIN SOL WAIS IV; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Sawyer RJ, 2014, CLIN NEUROPSYCHOL, V28, P756, DOI 10.1080/13854046.2014.920922; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schroeder RW, 2012, COGN BEHAV NEUROL, V25, P139, DOI 10.1097/WNN.0b013e31826b71c1; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van Egmond J, 2002, EUR PSYCHIAT, V17, P46, DOI 10.1016/S0924-9338(02)00622-3; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	56	9	9	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUL	2018	25	5					640	652		10.1177/1073191116656796			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GI4BO	WOS:000434316100009	27364003				2022-02-06	
J	Rowe, RK; Harrison, JL; Ellis, TW; Adelson, PD; Lifshitz, J				Rowe, Rachel K.; Harrison, Jordan L.; Ellis, Timothy W.; Adelson, P. David; Lifshitz, Jonathan			Midline (central) fluid percussion model of traumatic brain injury in pediatric and adolescent rats	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; TBI; fluid percussion; pediatric; adolescent; aging; development; trauma	AGE; DYSFUNCTION; IMMATURE; FEMALE; IMPACT; HYPOPITUITARISM; MORPHOLOGY; JUVENILE	OBJECTIVE Experimental traumatic brain injury (TBI) models hold significant validity to the human condition, with each model replicating a subset of clinical features and symptoms. TBI is the leading cause of mortality and morbidity in children and teenagers; thus, it is critical to develop preclinical models of these ages to test emerging treatments. Midline fluid percussion injury (FPI) might best represent mild and diffuse clinical brain injury because of the acute behavioral deficits, the late onset of behavioral morbidities, and the absence of gross histopathology. In this study, the authors sought to adapt a midline FPI to postnatal day (PND) 17 and 35 rats. The authors hypothesized that scaling the craniectomy size based on skull dimensions would result in a reproducible injury comparable to the standard midline FPI in adult rats. METHODS PND17 and PND35 rat skulls were measured, and trephines were scaled based on skull size. Custom trephines were made. Rats arrived on PND10 and were randomly assigned to one of 3 cohorts: PND17, PND35, and 2 months old. Rats were subjected to midline FPI, and the acute injury was characterized. The right reflex was recorded, injury-induced apnea was measured, injury-induced seizure was noted, and the brains were immediately examined for hematoma. RESULTS The authors' hypothesis was supported; scaling the trephines based on skull size led to a reproducible injury in the PND17 and PND35 rats that was comparable to the injury in a standard 2-month-old adult rat. The midline FPI suppressed the righting reflex in both the PND17 and PND35 rats. The injury induced apnea in PND17 rats that lasted significantly longer than that in PND35 and 2-month-old rats. The injury also induced seizures in 73% of PND17 rats compared with 9% of PND35 rats and 0% of 2-month-old rats. There was also a significant relationship between the righting reflex time and presence of seizure. Both PND17 and PND35 rats had visible hematomas with an intact dura, indicative of diffuse injury comparable to the injury observed in 2-month-old rats. CONCLUSIONS With these procedures, it becomes possible to generate brain-injured juvenile rats (pediatric [PND17] and adolescent [PND35]) for studies of injury induced pathophysiology and behavioral deficits, for which rational therapeutic interventions can be implemented.	[Rowe, Rachel K.; Harrison, Jordan L.; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Coll Med, Barrow Neurol Inst, Phoenix Childrens Hosp, Phoenix, AZ USA; [Rowe, Rachel K.; Harrison, Jordan L.; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA; [Ellis, Timothy W.] Midwestern Univ, Sch Osteopath Med, Glendale, AZ USA; [Harrison, Jordan L.] Univ Arizona, Coll Med, Basic Med Sci, Phoenix, AZ USA; [Ellis, Timothy W.] Midwestern Univ, Coll Dent Med, Glendale, AZ USA		Rowe, RK (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA.	rkro222@email.arizona.edu	Adelson, David/W-2083-2019	Rowe, Rachel/0000-0002-9034-3159	Phoenix Children's Hospital Mission Support Funds; Science Foundation Arizona; Diane and Bruce Halle Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS09092]	This work was supported in part by Phoenix Children's Hospital Mission Support Funds. Dr. Rowe is funded by a Bisgrove Scholar Award from Science Foundation Arizona. Dr. Harrison was partially supported by the Diane and Bruce Halle Foundation and NIH grant no. F31 NS09092. We thank Dr. Sean Murphy for contribution to the statistical analyses of data.	Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DOHLER KD, 1974, ENDOCRINOLOGY, V94, P1003; Eakin K, 2015, BRAIN NEUROTRAUMA MO; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Gurkoff GG, 2009, NEUROSCIENCE, V164, P862, DOI 10.1016/j.neuroscience.2009.08.021; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRELL MJ, 1993, NEUROL CLIN, V11, P737, DOI 10.1016/S0733-8619(18)30121-X; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Rowe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066955; Schwartzkroin PA, 2004, ADV EXP MED BIOL, V548, P145; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; URBANSKI HF, 1985, ENDOCRINOLOGY, V117, P644, DOI 10.1210/endo-117-2-644; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Zemunik T, 2003, BRAZ J MED BIOL RES, V36, P871, DOI 10.1590/S0100-879X2003000700007	43	9	10	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2018	22	1					22	30		10.3171/2018.1.PEDS17449			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GL7YL	WOS:000437425100004	29676680	Bronze			2022-02-06	
J	Walton, SR; Broshek, DK; Freeman, JR; Cullum, CM; Resch, JE				Walton, Samuel R.; Broshek, Donna K.; Freeman, Jason R.; Cullum, C. Munro; Resch, Jacob E.			Valid but Invalid: Suboptimal ImPACT Baseline Performance in University Athletes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; MILD TRAUMATIC BRAIN INJURY; COMPUTERIZED NEUROCOGNITIVE TESTING	TEST-RETEST RELIABILITY; SPORTS-RELATED CONCUSSION; NEUROCOGNITIVE TEST-PERFORMANCE; HIGH-SCHOOL; TEST BATTERY; ONLINE VERSION; TEST-SCORES; MANAGEMENT; SENSITIVITY; TRAINERS	Purpose This study aimed to investigate the frequency of valid yet suboptimal Immediate Postconcussion Assessment and Cognitive Test (ImPACT) performance in university athletes and to explore the benefit of subsequent ImPACT administrations. Methods This descriptive laboratory study involved baseline administration of ImPACT to 769 university athletes per the institution's concussion management protocol. Testing was proctored in groups of 2 participants. Participants who scored below the 16th percentile according to ImPACT normative data were readministered the ImPACT test up to two additional times because these scores were thought to be potentially indicative of suboptimal effort or poor understanding of instructions. Descriptive analyses were used to examine validity indicators and individual Verbal and Visual Memory, Visual Motor Speed, and Reaction Time ImPACT composite scores in initial and subsequent administrations. Results On the basis of ImPACT's validity criteria, 1% (9/769) of administrations were invalid and 14.6% (112/769) had one or more composite score of <16th percentile but were considered valid. After one readministration, 71.4% (80/112) achieved scores of 16th percentile and an additional 18 of 32 scored 16th percentile after a third administration. Verbal Memory was most commonly <16th percentile on the first administration (43%), Verbal Memory and Visual Motor Speed on the second administration (44% each), and Visual Motor Speed alone on the third administration (50%). Conclusions Approximately 16% of ImPACT records were flagged as invalid or had one or more composite scores of <16th percentile, potentially indicative of suboptimal performance. Upon readministration, 88% of those participants scored >16th percentile. Clinicians must be aware of suboptimal ImPACT performance as it limits the clinical utility of the baseline assessment. Further research is needed to address factors leading to valid but invalid baseline performance.	[Walton, Samuel R.; Resch, Jacob E.] Univ Virginia, Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22904 USA; [Broshek, Donna K.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA; [Freeman, Jason R.] Univ Virginia, McCue Ctr, Charlottesville, VA USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Neuropsychol Sect, Dallas, TX 75390 USA		Walton, SR (corresponding author), Univ Virginia, Dept Kinesiol, 210 Emmet St S, Charlottesville, VA 22904 USA.	srw2rf@virginia.edu	Cullum, C. Munro/AAC-2496-2019; Broshek, Donna/ABA-4208-2021	Cullum, C. Munro/0000-0001-9706-5465; Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701			Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Heaton R. K., 2004, REVISED COMPREHENSIV; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell M. R., 2016, IMPACT ADM INTERPRET; Lovell MR, 2003, IMPACT USER MANUAL; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	40	9	9	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2018	50	7					1377	1384		10.1249/MSS.0000000000001592			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GJ4KB	WOS:000435348900005	29485429	Bronze			2022-02-06	
J	Yun, BJ; Borczuk, P; Wang, LL; Dorner, S; White, BA; Raja, AS				Yun, Brian J.; Borczuk, Pierre; Wang, Lulu; Dorner, Stephen; White, Benjamin A.; Raja, Ali S.			Evaluation of a Low-risk Mild Traumatic Brain Injury and Intracranial Hemorrhage Emergency Department Observation Protocol	ACADEMIC EMERGENCY MEDICINE			English	Article							MINIMAL HEAD-INJURY; NEUROSURGICAL INTERVENTION; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; CT; SCORE; DETERIORATION	Objectives: Among emergency physicians, there is wide variation in admitting practices for patients who suffered a mild traumatic brain injury (TBI) with an intracranial hemorrhage (ICH). The purpose of this study was to evaluate the effects of implementing a protocol in the emergency department (ED) observation unit for patients with mild TBI and ICH. Methods: This retrospective cohort study was approved by the institutional review board. Study subjects were patients >= 18 years of age with an International Classification of Diseases code corresponding to a traumatic ICH and admitted to an ED observation unit (EDOU) of an urban, academic LevelI trauma center between February 1, 2015, and January 31, 2017. Patient data and discharge disposition were abstracted from the electronic health record, and imaging data, from the final neuroradiologist report. To measure kappa, two abstractors independently collected data for presence of neuro deficit from a 10% random sample of the medical charts. Using a multivariable logistic regression model with a propensity score of the probability of placement in the EDOU before and after protocol implementation as a covariate, we sought to determine the pre-post effects of implementing a protocol on the composite outcome of admission to the floor, intensive care unit, or operating room from the EDOU and the proportion of patients with worsening findings on repeat computed tomography (CT) head scan in the EDOU. Results: A total of 379 patients were identified during the study period; 83 were excluded as they were found to have no ICH on chart review. Inter-rater reliability kappa statistic was 0.63 for 30 charts. Among the 296 patients who remained eligible and comprised the study population, 143 were in the preprotocol period and 153 after protocol implementation. The EDOU protocol was associated with an independently statistically significant decreased odds ratio (OR) for admission or worsening ICH on repeat CT scan (OR=0.45, 95% confidence interval [CI]=0.25-0.82, p=0.009) in the observation unit. After a stay in the EDOU, 26% (37/143) of patients required an inpatient admission before implementation of the protocol and 13% (20/153) of patients required an inpatient admission after protocol implementation. There was no statistically significant difference in log transformed EDOU length of stay (LOS) between the groups after adjusting for propensity score (p=0.34). Conclusions: While there was no difference in EDOU LOS, implementing a low-risk mild TBI and ICH protocol in the EDOU may decrease the rate of inpatient admissions from the EDOU. A protocol-driven observation unit may help physicians by standardizing eligibility criteria and by providing guidance on management. As the propensity score method limits our ability to create a straightforward predictive model, a future larger study should validate the results.	[Yun, Brian J.; Borczuk, Pierre; Wang, Lulu; Dorner, Stephen; White, Benjamin A.; Raja, Ali S.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Yun, Brian J.; White, Benjamin A.; Raja, Ali S.] Massachusetts Gen Hosp, Dept Emergency Med, CREDO, Boston, MA 02114 USA; [Wang, Lulu; Dorner, Stephen] Brigham & Womens Hosp, Massachusetts Gen Hosp, Harvard Affiliated Emergency Med Residency Progra, 75 Francis St, Boston, MA 02115 USA		Yun, BJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA.; Yun, BJ (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, CREDO, Boston, MA 02114 USA.	byun@mgh.harvard.edu	Raja, Ali S./AAE-5103-2019	Yun, Brian/0000-0002-3842-420X			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Bellew SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002984; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Elze MC, 2017, J AM COLL CARDIOL, V69, P345, DOI 10.1016/j.jacc.2016.10.060; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Nahab F, 2012, J STROKE CEREBROVASC, V21, P673, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.017; Nayak NV, 2013, J TRAUMA ACUTE CARE, V75, P273, DOI 10.1097/TA.0b013e3182905eb4; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Ross MA, 2013, HEALTH AFFAIR, V32, P2149, DOI 10.1377/hlthaff.2013.0662; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Sing RF, 2006, J TRAUMA, V60, P499; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	25	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2018	25	7					769	775		10.1111/acem.13350			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GO4PD	WOS:000439992800006	29159958	Bronze			2022-02-06	
J	Zheng, F; Xu, H; von Spreckelsen, N; Stavrinou, P; Timmer, M; Goldbrunner, R; Cao, F; Ran, QS; Li, G; Fan, RM; Zhang, Q; Chen, W; Yao, ST; Krischek, B				Zheng, Feng; Xu, Hao; von Spreckelsen, Niklas; Stavrinou, Pantelis; Timmer, Marco; Goldbrunner, Roland; Cao, Fang; Ran, Qishan; Li, Gang; Fan, Ruiming; Zhang, Qiang; Chen, Wei; Yao, Shengtao; Krischek, Boris			Early or late cranioplasty following decompressive craniotomy for traumatic brain injury: A systematic review and meta-analysis	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Cranioplasty; decompressive craniotomy; complications; traumatic brain injury	SEVERE HEAD-INJURY; CRANIAL DEFECT; CRANIECTOMY; HEMICRANIECTOMY; MULTICENTER; EFFICACY; SURGERY; IMPACT; GRAFT	Objective To evaluate the effectiveness of early (<3 months) cranioplasty (CP) and late CP (>3 months) on post-operative complications in patients receiving decompressive craniotomy (DC) for traumatic brain injury (TBI). Methods The Cochrane Library, PubMed and EMBASE databases were systematically searched for studies published prior to May 21, 2017. A meta-analysis examined post-operative overall complication rates, infection rates, subdural fluid collection and operating times according to early and late CP. Results Of the initial 1675 references, five studies, all cohort, involving a total of 413 patients, were selected for the review. There was no difference between early and late CP in post-operative overall complication rate (RR=0.68, 95%CI [0.36, 1.29]) and the post-operative infection rate (RR=0.50, 95%CI [0.20, 1.24]) in patients receiving DC for TBI. However, there was a significant difference in post-operative subdural effusion (RR=0.24, 95%CI [0.07, 0.78]) and mean operative time (mean difference=-33.02 min, 95%CI [-48.19, -17.84]) both in favour of early CP. Conclusions No differences were found between early and late CP in post-operative overall complications and procedural related infections in patients receiving DC for TBI, but early CP reduced the complication of subdural effusion and the mean operating time. These findings need to be confirmed by large, randomised controlled trials.	[Zheng, Feng] Gannan Med Univ, Dept Neurosurg, Affiliated Hosp 1, Qingnian Rd 23, Ganzhou 341000, Jiangxi, Peoples R China; [Zheng, Feng; von Spreckelsen, Niklas; Stavrinou, Pantelis; Timmer, Marco; Goldbrunner, Roland; Krischek, Boris] Univ Hosp Cologne, Dept Neurosurg, Kerpener St 62, D-50937 Cologne, Germany; [Xu, Hao] Univ Sci & Technol China, Dept Neurosurg, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Cao, Fang; Ran, Qishan; Li, Gang; Fan, Ruiming; Zhang, Qiang; Chen, Wei; Yao, Shengtao] Zunyi Med Coll, Dept Cerebrovasc Dis, Affiliated Hosp 1, Zunyi, Guizhou, Peoples R China		Zheng, F (corresponding author), Gannan Med Univ, Dept Neurosurg, Affiliated Hosp 1, Qingnian Rd 23, Ganzhou 341000, Jiangxi, Peoples R China.; Krischek, B (corresponding author), Univ Hosp Cologne, Dept Neurosurg, Kerpener St 62, D-50937 Cologne, Germany.	dr.feng.zheng@gmail.com; boris.krischek@uk-koeln.de	von Spreckelsen, Niklas/X-3054-2019; Stavrinou, Pantelis/R-9115-2019	von Spreckelsen, Niklas/0000-0002-9873-1711; Stavrinou, Pantelis/0000-0001-8653-1395	Affiliated Hospital of Guangdong Medical University; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660211]	This work was supported by Affiliated Hospital of Guangdong Medical University and the National Natural Science Foundation of China (81660211).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Coulter IC, 2014, ACTA NEUROCHIR, V156, P1361, DOI 10.1007/s00701-014-2081-1; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; FOSTER R.D., 2000, SCHMIDEK SWEET OPERA, P29; Gadde Judith, 2012, Del Med J, V84, P213; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Honeybul S, 2016, NEUROSURGERY, V79, P231, DOI 10.1227/NEU.0000000000001115; Hutchinson P, 2007, NEUROSURG FOCUS, V22, P1; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820; Marion DW, 2011, LANCET NEUROL, V10, P497, DOI 10.1016/S1474-4422(11)70098-9; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Mokri B, 2010, HEADACHE, V50, P1206, DOI 10.1111/j.1526-4610.2010.01715.x; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; PROLO D.J, 1996, NEUROSURGERY, V2nd, P2783; RIFKINSONMANN S, 1988, NEUROSURGERY, V23, P411, DOI 10.1227/00006123-198810000-00001; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Song F, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/hta4100; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; WANG R, 2015, MEDICINE, V94; Wells G, 2000, THYC 10 GREATER NEWC; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001; Zheng F, 2016, CLIN NEUROL NEUROSUR, V143, P162, DOI 10.1016/j.clineuro.2015.11.021	45	9	11	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	JUL	2018	46	7					2503	2512		10.1177/0300060518755148			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GN5NF	WOS:000439106300001	29779445	Green Published, gold			2022-02-06	
J	Chen, SL; Gallagher, MJ; Papadopoulos, MC; Saadoun, S				Chen, Suliang; Gallagher, Mathew J.; Papadopoulos, Marios C.; Saadoun, Samira			Non-linear Dynamical Analysis of Intraspinal Pressure Signal Predicts Outcome After Spinal Cord Injury	FRONTIERS IN NEUROLOGY			English	Article						chaos theory; complexity theory; critical care unit; detrended fluctuation analysis; entropy; Lyapunov; monitoring; spinal cord injury	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; TIME-SERIES; COMPLEXITY; MICRODIALYSIS; VARIABILITY; EXPONENTS; PROFILE; FUTURE	The injured spinal cord is a complex system influenced by many local and systemic factors that interact over many timescales. To help guide clinical management, we developed a technique that monitors intraspinal pressure from the injury site in patients with acute, severe traumatic spinal cord injuries. Here, we hypothesize that spinal cord injury alters the complex dynamics of the intraspinal pressure signal quantified by computing hourly the detrended fluctuation exponent alpha, multiscale entropy, and maximal Lyapunov exponent lambda. 49 patients with severe traumatic spinal cord injuries were monitored within 72 h of injury for 5 days on average to produce 5,941 h of intraspinal pressure data. We computed the spinal cord perfusion pressure as mean arterial pressure minus intraspinal pressure and the vascular pressure reactivity index as the running correlation coefficient between intraspinal pressure and arterial blood pressure. Mean patient follow-up was 17 months. We show that alpha values are greater than 0.5, which indicates that the intraspinal pressure signal is fractal. As alpha increases, intraspinal pressure decreases and spinal cord perfusion pressure increases with negative correlation between the vascular pressure reactivity index vs. alpha. Thus, secondary insults to the injured cord disrupt intraspinal pressure fractality. Our analysis shows that high intraspinal pressure, low spinal cord perfusion pressure, and impaired pressure reactivity strongly correlate with reduced multi-scale entropy, supporting the notion that secondary insults to the injured cord cause de-complexification of the intraspinal pressure signal, which may render the cord less adaptable to external changes. Healthy physiological systems are characterized by edge of chaos dynamics. We found negative correlations between the percentage of hours with edge of chaos dynamics (-0.01 <= lambda <= 0.01) vs. high intraspinal pressure and vs. low spinal cord perfusion pressure; these findings suggest that secondary insults render the intraspinal pressure more regular or chaotic. In a multivariate logistic regression model, better neurological status on admission, higher intraspinal pressure multi-scale entropy and more frequent edge of chaos intraspinal pressure dynamics predict long-term functional improvement. We conclude that spinal cord injury is associated with marked changes in non-linear intraspinal pressure metrics that carry prognostic information.	[Chen, Suliang; Gallagher, Mathew J.; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Mol & Clin Sci Res Inst, Acad Neurosurg Unit, London, England		Saadoun, S (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Acad Neurosurg Unit, London, England.	ssaadoun@sgul.ac.uk		Papadopoulos, Marios/0000-0001-9174-4176; Saadoun, Samira/0000-0002-5480-5678	Wings for Life Spinal Cord Research Foundation; Fletcher Fund; Neurosciences Research Foundation; London Deanery	This work was supported by the Wings for Life Spinal Cord Research Foundation, the Fletcher Fund, the Neurosciences Research Foundation and the London Deanery.	Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; da Costa CS, 2017, J CEREBR BLOOD F MET, V37, P3368, DOI 10.1177/0271678X16687314; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lu CW, 2016, ACTA NEUROCHIR SUPPL, V122, P33, DOI 10.1007/978-3-319-22533-3_6; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Papadopoulos MC, 2015, NEUROSURGERY, V77, pE500, DOI 10.1227/NEU.0000000000000862; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Sejdic E, 2013, COMPUT METH PROG BIO, V111, P459, DOI 10.1016/j.cmpb.2013.03.014; Soehle M, 2013, J CLIN MONIT COMPUT, V27, P395, DOI 10.1007/s10877-012-9427-0; van Middendorp JJ, 2011, GLOB SPINE J, V1, P1, DOI 10.1055/s-0031-1296049; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	33	9	9	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 26	2018	9								493	10.3389/fneur.2018.00493			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK6PF	WOS:000436309900001	29997566	Green Published, Green Accepted, gold			2022-02-06	
J	Hashimoto, K; Nakashima, M; Hamano, A; Gotoh, M; Ikeshima-Kataoka, H; Murakami-Murofushi, K; Miyamoto, Y				Hashimoto, Kei; Nakashima, Mari; Hamano, Ayana; Gotoh, Mari; Ikeshima-Kataoka, Hiroko; Murakami-Murofushi, Kimiko; Miyamoto, Yasunori			2-carba cyclic phosphatidic acid suppresses inflammation via regulation of microglial polarisation in the stab-wounded mouse cerebral cortex	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EXTRACELLULAR-MATRIX; BIOLOGICAL FUNCTIONS; LIPID MEDIATOR; ACTIVATION; RECEPTOR; CYTOKINES; LIPOPOLYSACCHARIDE; AUTOTAXIN	Traumatic brain injury (TBI) is caused by physical damage to the brain and it induces blood-brain barrier (BBB) breakdown and inflammation. To diminish the sequelae ofTBI, it is important to decrease haemorrhage and alleviate inflammation. In this study, we aimed to determine the effects of 2-carbacyclic phosphatidic acid (2ccPA) on the repair mechanisms after a stab wound injury as a murine TBI model. The administration of 2ccPA suppressed serum immunoglobulin extravasation after the injury. To elucidate the effects of 2ccPA on inflammation resulting from TBI, we analysed the mRNA expression of inflammatory cytokines. We found that 2ccPA prevents a TBI-induced increase in the mRNA expression of Il-1 beta, Il-6, Tnf-alpha and Tgf-beta 1. In addition, 2ccPA reduces the elevation of Iba1 levels. These data suggest that 2ccPA attenuates the inflammation after a stab wound injury via the modulation of pro-inflammatory cytokines release from microglial cells. Therefore, we focused on the function of 2ccPA in microglial polarisation towards M1 or M2 phenotypes. The administration of 2ccPA decreased the number of M1 and increased the number of M2 type microglial cells, indicating that 2ccPA modulates the microglial polarisation and shifts them towards M2 phenotype. These data suggest that 2ccPA treatment suppresses the extent of BBB breakdown and inflammation after TBI.	[Hashimoto, Kei; Nakashima, Mari; Hamano, Ayana; Miyamoto, Yasunori] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan; [Hashimoto, Kei; Nakashima, Mari; Hamano, Ayana; Gotoh, Mari; Miyamoto, Yasunori] Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan; [Gotoh, Mari; Murakami-Murofushi, Kimiko] Ochanomizu Univ, Res Div Human Welf Sci, Bunkyo Ku, Tokyo, Japan; [Hashimoto, Kei] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Ikeshima-Kataoka, Hiroko] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Ikeshima-Kataoka, Hiroko] Keio Univ, Sch Med, Dept Pharmacol & Neurosci, Shinjuku Ku, Tokyo, Japan		Miyamoto, Y (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan.; Miyamoto, Y (corresponding author), Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan.	miyamoto.yasunori@ocha.ac.jp	Miyamoto, Yasunori/M-4825-2019; GOTOH, Mari/AAX-4457-2020	Miyamoto, Yasunori/0000-0001-9192-4281; GOTOH, Mari/0000-0002-8052-4247	Institute for Human Life Innovation, Ochanomizu University	The authors gratefully acknowledge the work of past and present members of Miyamoto laboratory and Murofushi laboratory. This work was supported by grant from Institute for Human Life Innovation, Ochanomizu University.	Amin DN, 2010, AM J TROP MED HYG, V82, P983, DOI 10.4269/ajtmh.2010.09-0770; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Gotoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051093; Gotoh M, 2010, EUR J PHARMACOL, V649, P206, DOI 10.1016/j.ejphar.2010.09.052; Hashimoto K, 2017, J NEUROTRAUM, V34, P3183, DOI 10.1089/neu.2017.5008; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Jiang JX, 2015, NEUROBIOL DIS, V76, P126, DOI 10.1016/j.nbd.2014.12.032; Konakazawa M, 2015, BRAIN RES, V1614, P28, DOI 10.1016/j.brainres.2015.04.013; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/297241; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Ma L, 2010, J NEUROCHEM, V115, P643, DOI 10.1111/j.1471-4159.2010.06955.x; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Murakami-Murofushi K, 2000, ANN NY ACAD SCI, V905, P319; Murakami-Murofushi K, 2002, BBA-MOL CELL BIOL L, V1582, P1, DOI 10.1016/S1388-1981(02)00131-2; MURAKAMIMUROFUSHI K, 1992, J BIOL CHEM, V267, P21512; Nakajima S, 2018, BRAIN RES, V1681, P44, DOI 10.1016/j.brainres.2017.12.031; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Santos-Nogueira E, 2015, J NEUROSCI, V35, P10224, DOI 10.1523/JNEUROSCI.4703-14.2015; Tsuda S, 2006, J BIOL CHEM, V281, P26081, DOI 10.1074/jbc.M602925200; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wei J, 2015, PARASITOL RES, V114, P3247, DOI 10.1007/s00436-015-4541-9; Welser-Alves JV, 2013, NEUROCHEM INT, V63, P47, DOI 10.1016/j.neuint.2013.04.007; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Yamamoto S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0923-5; Yamamoto S, 2014, EUR J PHARMACOL, V741, P17, DOI 10.1016/j.ejphar.2014.07.040; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yu Y, 2014, INT J MOL MED, V33, P661, DOI 10.3892/ijmm.2014.1618; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhao XR, 2015, J NEUROSCI, V35, P11281, DOI 10.1523/JNEUROSCI.1685-15.2015	44	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 26	2018	8								9715	10.1038/s41598-018-27990-1			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK5RK	WOS:000436234000012	29946114	Green Published, gold			2022-02-06	
J	Kawa, L; Kamnaksh, A; Long, JB; Arborelius, UP; Hokfelt, T; Agoston, DV; Risling, M				Kawa, Lizan; Kamnaksh, Alaa; Long, Joseph B.; Arborelius, Ulf P.; Hokfelt, Tomas; Agoston, Denes V.; Risling, Marten			A Comparative Study of Two Blast-Induced Traumatic Brain Injury Models: Changes in Monoamine and Galanin Systems Following Single and Repeated Exposure	FRONTIERS IN NEUROLOGY			English	Article						anxiety; catecholamines; dorsal raphe nucleus; locus coeruleus; animal models; neuropeptide; post-traumatic stress disorder; transmitter coexistence	PREPROGALANIN MESSENGER-RNA; LOCUS-COERULEUS; LABORATORY ENVIRONMENT; STRESS; RATS; CONSEQUENCES; TBI; CONCUSSION; MECHANISMS; SYMPTOMS	Repeated mild blast-induced traumatic brain injury (rmb TBI), caused by recurrent exposure to low levels of explosive blast, is a significant concern for military health systems. However, the pathobiology of rmbTBI is currently poorly understood. Animal models are important tools to identify the molecular changes of rmbTBI, but comparisons across different models can present their own challenges. In this study, we compared two well-established rodent models of mb TBI, the "KI model" and the "USU/WRAIR model." These two models create different pulse forms, in terms of peak pressure and duration. Following single and double exposures to mild levels of blast, we used in situ hybridization (ISH) to assess changes in mRNA levels of tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH2), and galanin in the locus coeruleus (LC) and dorsal raphe nucleus (DRN). These systems and their transmitters are known to mediate responses to stress and anxiety. We found increased mRNA levels of TH, TPH2 and galanin in the LC and DRN of single-exposed rats relative to sham rats in the KI but not the USU/WRAIR model. Sham mRNA values measured in the USU/WRAIR model were substantially higher than their KI counterparts. Double exposure caused similarly significant increases in mRNA values in the KI model but not the USU/WRAIR model, except TPH2 and galanin levels in the DRN. We detected no cumulative effect of injury in either model at the used inter-injury interval (30 min), and there were no detectable neuropathological changes in any experimental group at 1 day post-injury. The apparent lack of early response to injury as compared to sham in the USU/WRAIR model is likely caused by stressors (e.g., transportation and noise), associated with the experimental execution, that were absent in the KI model. This study is the first to directly compare two established rodent models of rmbTBI, and to highlight the challenges of comparing findings from different animal models. Additional studies are needed to understand the role of stress, dissect the effects of psychological and physical injuries and to identify the window of increased cerebral vulnerability, i.e., the inter-injury interval that results in a cumulative effect following repeated blast exposure.	[Kawa, Lizan; Arborelius, Ulf P.; Hokfelt, Tomas; Agoston, Denes V.; Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Kamnaksh, Alaa; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA; [Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD USA		Kawa, L (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	lizan.kawa@ki.se			Swedish Armed Forces RD; Swedish Research CouncilSwedish Research CouncilEuropean Commission [04X-2887]; Karolinska Institutet Funds; United States Army Medical Research Acquisition Activity (USAMRAA) grant [G1702174]	The work at KI was supported by the Swedish Armed Forces R&D (MR), the Swedish Research Council (04X-2887) (TH) and Karolinska Institutet Funds (TH and MR). The work at USU was supported by the United States Army Medical Research Acquisition Activity (USAMRAA), grant number G1702174. The valuable contributions of Maria Angeria and Jenny Gustavsson are gratefully acknowledged.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Barde S, 2016, P NATL ACAD SCI USA, V113, pE8472, DOI 10.1073/pnas.1617824113; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Davenport ND, 2015, BRAIN IMAGING BEHAV, V9, P472, DOI 10.1007/s11682-015-9371-y; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HOLMES PV, 1995, PHARMACOL BIOCHEM BE, V50, P655, DOI 10.1016/0091-3057(94)00334-3; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kawa L, 2016, EXP NEUROL, V279, P159, DOI 10.1016/j.expneurol.2016.02.019; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; KORF J, 1973, NEUROPHARMACOLOGY, V12, P933, DOI 10.1016/0028-3908(73)90024-5; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; MELANDER T, 1986, J NEUROSCI, V6, P3640; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ritzel DV, 2011, HFM207 NATO RTO; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rusnak M, 1998, MOL CHEM NEUROPATHOL, V33, P249, DOI 10.1007/BF02815186; Sciolino NR, 2015, NEUROPHARMACOLOGY, V89, P255, DOI 10.1016/j.neuropharm.2014.09.029; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; SVENSSON T H, 1987, Journal of Cardiovascular Pharmacology, V10, pS88, DOI 10.1097/00005344-198710012-00012; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Vermeiren Y, 2017, NEUROCHEM INT, V102, P22, DOI 10.1016/j.neuint.2016.11.009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weinshenker D, 2016, BRAIN RES, V1641, P320, DOI 10.1016/j.brainres.2015.11.025	55	9	9	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 20	2018	9								479	10.3389/fneur.2018.00479			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GK0UW	WOS:000435828500001	29973912	Green Published, gold			2022-02-06	
J	Falnikar, A; Stratton, J; Lin, RH; Andrews, CE; Tyburski, A; Trovillion, VA; Gottschalk, C; Ghosh, B; Iacovitti, L; Elliott, MB; Lepore, AC				Falnikar, Aditi; Stratton, Jarred; Lin, Ruihe; Andrews, Carrie E.; Tyburski, Ashley; Trovillion, Victoria A.; Gottschalk, Chelsea; Ghosh, Biswarup; Iacovitti, Lorraine; Elliott, Melanie B.; Lepore, Angelo C.			Differential Response in Novel Stem Cell Niches of the Brain after Cervical Spinal Cord Injury and Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						circumventricular organs; controlled cortical impact; contusion; SCI; TBI	MOTOR-NEURON DEGENERATION; ADULT NEUROGENESIS; SYSTEM; MODEL; TRANSPLANTATION; PROLIFERATION; REGENERATION; ALLODYNIA; RECOVERY; WINDOWS	Populations of neural stem cells (NSCs) reside in a number of defined niches in the adult central nervous system (CNS) where they continually give rise to mature cell types throughout life, including newly born neurons. In addition to the prototypical niches of the subventricular zone (SVZ) and subgranular zone (SGZ) of the hippocampal dentate gyrus, novel stem cell niches that are also neurogenic have recently been identified in multiple midline structures, including circumventricular organs (CVOs) of the brain. These resident NSCs serve as a homeostatic source of new neurons and glial cells under intact physiological conditions. Importantly, they may also have the potential for reparative processes in pathological states such as traumatic spinal cord injury (SCI) and traumatic brain injury (TBI). As the response in these novel CVO stem cell niches has been characterized after stroke but not following SCI or TBI, we quantitatively assessed cell proliferation and the neuronal and glial lineage fate of resident NSCs in three CVO nucleiarea postrema (AP), median eminence (ME), and subfornical organ (SFO)-in rat models of cervical contusion-type SCI and controlled cortical impact (CCI)-induced TBI. Using bromodeoxyuridine (BrdU) labeling of proliferating cells, we find that TBI significantly enhanced proliferation in AP, ME, and SFO, whereas cervical SCI had no effects at early or chronic time-points post-injury. In addition, SCI did not alter NSC differentiation profile into doublecortin-positive neuroblasts, GFAP-expressing astrocytes, or Olig2-labeled cells of the oligodendrocyte lineage within AP, ME, or SFO at both time-points. In contrast, CCI induced a pronounced increase in Sox2- and doublecortin-labeled cells in the AP and Iba1-labeled microglia in the SFO. Lastly, plasma derived from CCI animals significantly increased NSC expansion in an in vitro neurosphere assay, whereas plasma from SCI animals did not exert such an effect, suggesting that signaling factors present in blood may be relevant to stimulating CVO niches after CNS injury and may explain the differential in vivo effects of SCI and TBI on the novel stem cell niches.	[Falnikar, Aditi; Lin, Ruihe; Andrews, Carrie E.; Trovillion, Victoria A.; Gottschalk, Chelsea; Ghosh, Biswarup; Iacovitti, Lorraine; Elliott, Melanie B.; Lepore, Angelo C.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurosci, 900 Walnut St,JHN 469, Philadelphia, PA 19107 USA; [Stratton, Jarred; Tyburski, Ashley; Elliott, Melanie B.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurol Surg, 1020 Locust St,JAH 236, Philadelphia, PA 19107 USA		Lepore, AC (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurosci, 900 Walnut St,JHN 469, Philadelphia, PA 19107 USA.; Elliott, MB (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurol Surg, 1020 Locust St,JAH 236, Philadelphia, PA 19107 USA.; Elliott, MB (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Vickie & Jack Farber Inst Neurosci, Dept Neurosci, 1020 Locust St,JAH 236, Philadelphia, PA 19107 USA.	Melanie.Elliottt@jefferson.edu; Angelo.Lepore@jefferson.edu			Dean's Programmatic Science Grant;  [NS079702]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079702] Funding Source: NIH RePORTER	This work was supported by the Dean's Programmatic Science Grant (to L.I., M.B.E., and A.C.L.) and NS079702 (to A.C.L.). We thank Brittany Daiutolo for technical support in the early stages of these experiments.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bennett L, 2009, MOL CELL NEUROSCI, V41, P337, DOI 10.1016/j.mcn.2009.04.007; Bennett LB, 2010, NEUROSCI LETT, V475, P1, DOI 10.1016/j.neulet.2010.03.019; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Carreira BP, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00343; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Elliott M.B., 2007, NEUROSCI METHODS, V168, P320; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Franz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102896; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; GROSS PM, 1987, J CEREBR BLOOD F MET, V7, P663, DOI 10.1038/jcbfm.1987.120; Gu N, 2016, CELL REP, V16, P605, DOI 10.1016/j.celrep.2016.06.018; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Heo HR, 2015, INT J STEM CELLS, V8, P18, DOI 10.15283/ijsc.2015.8.1.18; HIMES BT, 1994, J COMP NEUROL, V339, P117, DOI 10.1002/cne.903390111; Hutton S.R., 2008, CSH PROTOC; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Joly JS, 2007, SEMIN CELL DEV BIOL, V18, P512, DOI 10.1016/j.semcdb.2007.06.001; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Li K, 2015, EXP NEUROL, V271, P479, DOI 10.1016/j.expneurol.2015.07.020; Li K, 2015, MOL THER, V23, P533, DOI 10.1038/mt.2014.236; Li K, 2014, J NEUROSCI, V34, P7622, DOI 10.1523/JNEUROSCI.4690-13.2014; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lin RH, 2015, BRAIN RES, V1628, P327, DOI 10.1016/j.brainres.2015.04.029; Lin RH, 2015, NEUROBIOL DIS, V74, P229, DOI 10.1016/j.nbd.2014.11.016; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mouton P. R., 2002, PRINCIPLES PRACTICES; Moyse E, 2006, AUTON NEUROSCI-BASIC, V126, P50, DOI 10.1016/j.autneu.2006.03.006; Nicaise C, 2013, J NEUROTRAUM, V30, P1092, DOI 10.1089/neu.2012.2728; Nicaise C, 2012, EXP NEUROL, V235, P539, DOI 10.1016/j.expneurol.2012.03.007; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Park JH, 2006, NEUROSCIENCE, V140, P673, DOI 10.1016/j.neuroscience.2006.02.076; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Warren PM, 2014, PROG BRAIN RES, V212, P173, DOI 10.1016/B978-0-444-63488-7.00010-0; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	9	9	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	18					2195	2207		10.1089/neu.2017.5497		JUN 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GT2EF	WOS:000434868600001	29471717	Green Published			2022-02-06	
J	Haber, M; Amyot, F; Kenney, K; Meredith-Duliba, T; Moore, C; Silverman, E; Podell, J; Chou, YY; Pham, DL; Butman, J; Lu, HZ; Diaz-Arrastia, R; Sandsmark, D				Haber, Margalit; Amyot, Franck; Kenney, Kimbra; Meredith-Duliba, Tawny; Moore, Carol; Silverman, Erika; Podell, Jamie; Chou, Yi-Yu; Pham, Dzung L.; Butman, John; Lu, Hanzhang; Diaz-Arrastia, Ramon; Sandsmark, Danielle			Vascular Abnormalities within Normal Appearing Tissue in Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						erebral blood flow; cerebral vascular reactivity; diffusion tensor imaging; FLAIR; traumatic brain injury	CEREBRAL-BLOOD-FLOW; AXONAL INJURY; HEAD-INJURY; CEREBROVASCULAR REACTIVITY; EMBOLIC STROKE; ANGIOGENESIS; MRI; SILDENAFIL; RAT; ATORVASTATIN	Magnetic resonance imaging (MRI) is a powerful tool for visualizing traumatic brain injury(TBI)-related lesions. Trauma-induced encephalomalacia is frequently identified by its hyperintense appearance on fluid-attenuated inversion recovery (FLAIR) sequences. In addition to parenchymal lesions, TBI commonly results in cerebral microvascular injury, but its anatomical relationship to parenchymal encephalomalacia is not well characterized. The current study utilized a multi-modal MRI protocol to assess microstructural tissue integrity (by mean diffusivity [MD] and fractional aniosotropy [FA]) and altered vascular function (by cerebral blood flow [CBF] and cerebral vascular reactivity [CVR]) within regions of visible encephalomalacia and normal appearing tissue in 27 chronic TBI (minimum 6 months post-injury) subjects. Fifteen subjects had visible encephalomalacias whereas 12 did not have evident lesions on MRI. Imaging from 14 age-matched healthy volunteers were used as controls. CBF was assessed by arterial spin labeling (ASL) and CVR by measuring the change in blood-oxygen-level-dependent (BOLD) MRI during a hypercapnia challenge. There was a significant reduction in FA, CBF, and CVR with a complementary increase in MD within regions of FLAIR-visible encephalomalacia (p < 0.05 for all comparisons). In normal-appearing brain regions, only CVR was significantly reduced relative to controls (p < 0.05). These findings indicate that vascular dysfunction represents a TBI endophenotype that is distinct from structural injury detected using conventional MRI, may be present even in the absence of visible structural injury, and persists long after trauma. CVR may serve as a useful diagnostic and pharmacodynamic imaging biomarker of traumatic microvascular injury.	[Haber, Margalit; Meredith-Duliba, Tawny; Silverman, Erika; Podell, Jamie; Diaz-Arrastia, Ramon; Sandsmark, Danielle] Univ Penn, Dept Neurol, Perelman Sch Med, 51 North 39th St, Philadelphia, PA 19104 USA; [Kenney, Kimbra; Moore, Carol] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Chou, Yi-Yu; Pham, Dzung L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Butman, John] NIH, Ctr Clin, Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Lu, Hanzhang] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Amyot, Franck] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA		Haber, M (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, 51 North 39th St, Philadelphia, PA 19104 USA.	Margalit.Haber@uphs.upenn.edu	Butman, John A/A-2694-2008; Pham, Dzung/AAR-8263-2020; Butman, John/J-2780-2013	Butman, John/0000-0002-1547-9195	Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS; Bethesda, MD); Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS; Intramural Research Program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; TBI Endpoints Development (TED) Project [DoD W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS104239] Funding Source: NIH RePORTER	Work in the authors' laboratory was supported by the Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS; Bethesda, MD) by the Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS, and by the Intramural Research Program of the National Institutes of Health. Support from the TBI Endpoints Development (TED) Project (DoD W81XWH-14-2-0176) is also acknowledged.	Akbik OS, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0672-3; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bouma G J, 1995, New Horiz, V3, P384; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cechetti F, 2012, BRAIN RES BULL, V87, P109, DOI 10.1016/j.brainresbull.2011.10.006; Centers for Disease Control and Prevention, 2010, RAT TBI REL EM DEP V; CHANG H, 1992, IEEE T MED IMAGING, V11, P319, DOI 10.1109/42.158935; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Landman BA, 2013, NEUROINFORMATICS, V11, P91, DOI 10.1007/s12021-012-9159-9; Lee Bruce, 2005, NeuroRx, V2, P372; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Lu HZ, 2014, JOVE-J VIS EXP, DOI 10.3791/52306; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Matsumura M, 2009, J ATHEROSCLER THROMB, V16, P319, DOI 10.5551/jat.No026; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; O'Neil M E., 2013, COMPLICATIONS MILD T, P1; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Promjunyakul NO, 2016, J CEREBR BLOOD F MET, V36, P1528, DOI 10.1177/0271678X16651268; Ravi H, 2016, J MAGN RESON IMAGING, V43, P661, DOI 10.1002/jmri.25028; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shaker M, 2017, MED IMAGE ANAL, V37, P56, DOI 10.1016/j.media.2017.01.005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang J.Y., 2008, ARCH NEUROL-CHICAGO, V65, P1; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	9	9	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2250	2258		10.1089/neu.2018.5684		JUN 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000434867000001	29609518	Green Published			2022-02-06	
J	Becker, A; Peleg, K; Olsha, O; Givon, A; Kessel, B				Becker, Alexander; Peleg, Kobi; Olsha, Oded; Givon, Adi; Kessel, Boris		Israeli Trauma Grp	Analysis of incidence of traumatic brain injury in blunt trauma patients with Glasgow Coma Scale of 12 or less	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Multiple trauma; Transfer; Glasgow Coma Scale	SECONDARY OVERTRIAGE; EPIDEMIOLOGY; MODERATE; SYSTEM; IMPACT; TIME	Purpose: Early diagnosis of traumatic brain injury (TBI) is important for improving survival and neurologic outcome in trauma victims. The purpose of this study was to assess whether Glasgow Coma Scale (GCS) of 12 or less can predict the presence of TBI and the severity of associated injuries in blunt trauma patients. Methods: A retrospective cohort study including 303,435 blunt trauma patients who were transferred from the scene to hospital from 1998 to 2013. The data was obtained from the records of the National Trauma Registry maintained by Israel's National Center for Trauma and Emergency Medicine Research, in the Gertner Institute for Epidemiology and Health Policy Research. All blunt trauma patients with GCS 12 or less were included in this study. Data collected in the registry include age, gender, mechanism of injury, GCS, initial blood pressure, presence of TBI and incidence of associated injuries. Patients younger than 14 years old and trauma victims with GCS 13-15 were excluded from the study. Statistical analysis was performed by using Statistical Analysis Software Version 9.2. Statistical tests performed included Chi-square tests. A p-value less than 0.05 was considered statistically significant. Results: There were 303,435 blunt trauma patients, 8731 (2.9%) of them with GCS of 3-12 that including 6351 (72%) patients with GCS of 3-8 and 2380 (28%) patient with GCS of 9-12. In these 8731 patients with GCS of 3-12, 5372 (61.5%) patients had TBI. There were total 1404 unstable patients in all the blunt trauma patients with GCS of 3-12, 1256 (89%) patients with GCS 3-8, 148 (11%) patients with GCS 9-12. In the 5095 stable blunt trauma patients with GCS 3-8, 32.4% of them had no TBI. The rate in the 2232 stable blunt trauma patients with GCS 9-12 was 50.1%. In the unstable patients with GCS 3-8, 60.5% of them had TBI, and in subgroup of patients with GCS 9-12, only 37.2% suffered from TBI. Conclusion: The utility of a GCS 12 and less is limited in prediction of brain injury in multiple trauma patients. Significant proportion of trauma victims with low GCS had no TBI and their impaired neurological status is related to severe extra-cranial injuries. The findings of this study showed that using of GCS in initial triage and decision making processes in blunt trauma patients needs to be re-evaluated. (C) 2018 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.	[Becker, Alexander] Emek Med Ctr, Dept Surg A, Afula, Israel; [Peleg, Kobi; Givon, Adi] Natl Ctr Trauma & Emergency Med Res, Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Olsha, Oded] Shaare Zedek Med Ctr, Dept Surg, Jerusalem, Israel; [Kessel, Boris] Hillel Yaffe Med Ctr, Trauma Unit, Hadera, Israel; [Peleg, Kobi] Tel Aviv Univ, Fac Med, Sch Publ Hlth, Disaster Med Dept, Tel Aviv, Israel; [Becker, Alexander; Kessel, Boris] Technion, Rappoport Med Sch, Haifa, Israel		Becker, A (corresponding author), Emek Med Ctr, Dept Surg A, Afula, Israel.	alexb20042000@yahoo.com		Olsha, Oded/0000-0002-8805-7794			American College of Surgeons, 2012, ADV TRAUM LIF SUPP P, P161; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Billeter AT, 2014, AM J SURG, V207, P459, DOI 10.1016/j.amjsurg.2013.04.015; CDC, 2011, MMWR-MORBID MORTAL W, V2012, P61; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Demetriades D, 1996, ARCH SURG-CHICAGO, V131, P133; Fatovich DM, 2011, RESUSCITATION, V82, P560, DOI 10.1016/j.resuscitation.2011.01.016; Gonzalez RP, 2009, AM J SURG, V197, P30, DOI 10.1016/j.amjsurg.2007.11.018; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rosenbaum BP, 2014, J CLIN NEUROSCI, V21, P1874, DOI 10.1016/j.jocn.2014.05.006; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	19	9	11	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2018	21	3					152	155		10.1016/j.cjtee.2018.01.004			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GK2IQ	WOS:000435952400003	29776836	Green Published			2022-02-06	
J	Boutin, A; Moore, L; Green, RS; Zarychanski, R; Erdogan, M; Lauzier, F; English, S; Fergusson, DA; Butler, M; McIntyre, L; Chasse, M; Bonaventure, PL; Leger, C; Desjardins, P; Griesdale, D; Lacroix, J; Turgeon, AF				Boutin, Amelie; Moore, Lynne; Green, Robert S.; Zarychanski, Ryan; Erdogan, Mete; Lauzier, Francois; English, Shane; Fergusson, Dean A.; Butler, Michael; McIntyre, Lauralyn; Chasse, Michael; Bonaventure, Paule Lessard; Leger, Caroline; Desjardins, Philippe; Griesdale, Donald; Lacroix, Jacques; Turgeon, Alexis F.			Hemoglobin thresholds and red blood cell transfusion in adult patients with moderate or severe traumatic brain injuries: A retrospective cohort study	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Red blood cell; Transfusion; Hemoglobin; Mortality; Complications	CLINICAL-PRACTICE GUIDELINE; CRITICALLY-ILL PATIENTS; MULTICENTER-COHORT; CRITICAL-CARE; HEAD-INJURY; ANEMIA; OUTCOMES; MORTALITY; INFORMATION; ADMISSION	Purpose: We aimed to evaluate the association between transfusion practices and clinical outcomes in patients with traumatic brain injury. Material and methods: We conducted a retrospective cohort study of adult patients with moderate or severe traumatic brain injury admitted to the intensive care unit (ICU) of a level I trauma center between 2009 and 2013. The associations between hemoglobin (Hb) level, red blood cell (RBC) transfusion and clinical outcomes were estimated using robust Poisson models and proportional hazard models with time-dependent variables, adjusted for confounders. Results: We included 215 patients. Sixty-six patients (30.7%) were transfused during ICU stay. The median pre-transfusion Hb among transfused patients was 81 g/L (IQR 67-100), while median nadir Hb among non-transfused patients was 110 g/L (IQR 93-123). Poor outcomes were significantly more frequent in patients who were transfused (mortality risk ratio [RR]: 2.15 [95% CI 1.37-3.38] and hazard ratio: 3.06 [95% CI 1.57-5.97]; neurological complications RR: 3.40 [95% CI 1.35-8.561; trauma complications RR: 1.65 [95% CI 131-2.08]; ICU length of stay geometric mean ratio: 1.42 [95% CI 1.06-1.92]). Conclusions: During ICU stay, transfused patients tended to have lower Hb levels and worse outcomes than patients who did not receive RBCs, after adjustment for confounders. (C) 2017 Elsevier Inc. All rights reserved.	[Boutin, Amelie; Moore, Lynne; Lauzier, Francois; Bonaventure, Paule Lessard; Leger, Caroline; Desjardins, Philippe; Turgeon, Alexis F.] Univ Laval, CHU Quebec, Populat Hlth & Optimal Hlth Practices Res Unit Tr, Res Ctr, Z-207,1401,18E rue, Quebec City, PQ G1J 1Z4, Canada; [Boutin, Amelie; Moore, Lynne] Univ Laval, Dept Social & Prevent Med, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Green, Robert S.; Erdogan, Mete; Butler, Michael] Dalhousie Univ, Dept Crit Care, Suite 377,Bethune Bldg,1276 South Pk St, Halifax, NS B3H 2Y9, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Crit Care Med, Room GC430,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Haematol, Room GC430,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Med Oncol, Room GC430,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Lauzier, Francois; Desjardins, Philippe; Turgeon, Alexis F.] Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Lauzier, Francois] Univ Laval, Dept Med, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [English, Shane; McIntyre, Lauralyn] Ottawa Hosp, Dept Crit Care Med, 206-501 Smyth Rd, Ottawa, ON K1H 8L6, Canada; [English, Shane; Fergusson, Dean A.; McIntyre, Lauralyn] Ottawa Hosp Res Inst, Clin Epidemiol Unit, 511-501 Smyth Rd, Ottawa, ON K1H 8L6, Canada; [Bonaventure, Paule Lessard] Univ Laval, Dept Surg, Div Neurosurg, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Griesdale, Donald] Univ British Columbia, Dept Anesthesia, 217-2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Lacroix, Jacques] Univ Montreal, Crit Care Med, Dept Pediat, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada; [Chasse, Michael] Ctr Hosp Univ Montreal, Dept Med, 3840 Rue St Urbain, Montreal, PQ H2W 1T8, Canada		Turgeon, AF (corresponding author), Univ Laval, CHU Quebec, Populat Hlth & Optimal Hlth Practices Res Unit Tr, Res Ctr, Z-207,1401,18E rue, Quebec City, PQ G1J 1Z4, Canada.	amelie.boutin.2@ulaval.ca; lynne.moore@fmed.ulaval.ca; dr.robert.green@dal.ca; ryan.zarychanski@cancercare.mb.ca; mete.erdogan@nshealth.ca; francois.lauzier@med.ulaval.ca; senglish@toh.ca; dafergusson@ohri.ca; michaelb.butler@nshealth.ca; lmcintyre@ohri.ca; paule.lessard-bonaventure.1@ulaval.ca; caroline.leger@crchudequebec.ulaval.ca; philippe.desjardins.1@ulaval.ca; donald.griesdale@vch.ca; jacques_lacroix@ssss.gouv.qc.ca; alexis.turgeon@fmed.ulaval.ca	Chasse, Michael/Y-7820-2019; Zarychanski, Ryan/AAB-6369-2022; McIntyre, Lauralyn/AAR-7710-2021; English, Shane/P-9187-2019; Lauzier, Francois/B-9237-2015	McIntyre, Lauralyn/0000-0001-7421-1407; English, Shane/0000-0002-9477-6146; Chasse, Michael/0000-0001-7075-1924; Lauzier, Francois/0000-0002-6530-5513; Fergusson, Dean/0000-0002-3389-2485; Boutin, Amelie/0000-0003-1907-2920	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Traumatology Research Consortium of the Fonds de Recherche du Quebec - Sante (FRQS); FRQS	Dr. Boutin is a recipient of a Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award from the Canadian Institutes of Health Research (CIHR). Drs Moore, Turgeon and Zarychanski are/were recipients of New Investigator Awards from the Canadian Institutes of Health Research (CIHR). Drs Turgeon and Lauzier are supported by the Traumatology Research Consortium of the Fonds de Recherche du Quebec - Sante (FRQS). Drs Lauzier and Chasse are recipients of a salary support Award from the FRQS. Dr. Turgeon is the Canada Research Chair in Critical Care Neurology and Trauma.	American College of Surgeons, 2015, ACS TQIP BEST PRACT; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Brain Trauma Foundation, 2007, J NEUROTRAUMA S1, V24, pi; Brock GN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-144; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Griesdale DE, 2015, NEUROCRIT CARE, V23, P78, DOI 10.1007/s12028-014-0096-3; Halpern SD, 2012, ICU LENGTH STAY NEW; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Korn EL, 2006, STAT SCI, V21, P310, DOI 10.1214/088342306000000286; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; Moore L, 2014, ANN SURG, V260, P179, DOI 10.1097/SLA.0000000000000624; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Omar M, 2017, J CRIT CARE, V41, P1, DOI 10.1016/j.jcrc.2017.04.031; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vespa PM, 2006, CURR OPIN CRIT CARE, V12, P119, DOI 10.1097/01.ccx.0000216577.57180.bd; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499	36	9	10	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2018	45						133	139		10.1016/j.jcrc.2018.01.023			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4VX	WOS:000432695500022	29459342				2022-02-06	
J	Coelli, S; Barbieri, R; Reni, G; Zucca, C; Bianchi, AM				Coelli, Stefania; Barbieri, Riccardo; Reni, Gianluigi; Zucca, Claudio; Bianchi, Anna Maria			EEG indices correlate with sustained attention performance in patients affected by diffuse axonal injury	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						EEG; Engagement; Sustained attention; Traumatic brain injury	ADAPTIVE AUTOMATION SYSTEM; ENGAGEMENT; ALERTNESS; VIGILANCE; DEFICITS; LOAD	The aim of this study is to assess the ability of EEG-based indices in providing relevant information about cognitive engagement level during the execution of a clinical sustained attention (SA) test in healthy volunteers and DAI (diffused axonal injury)-affected patients. We computed three continuous power-based engagement indices (P (beta) /P (alpha) , 1/P (alpha) , and P (beta) / (P (alpha) + P (theta) )) from EEG recordings in a control group (n = 7) and seven DAI-affected patients executing a 10-min Conners' "not-X" continuous performance test (CPT). A correlation analysis was performed in order to investigate the existence of relations between the EEG metrics and behavioral parameters in both the populations. P (beta) /P (alpha) and 1/P (alpha) indices were found to be correlated with reaction times in both groups while P (beta) / (P (alpha) + P (theta) ) and P (beta) /P (alpha) also correlated with the errors rate for DAI patients. In line with previous studies, time course fluctuations revealed a first strong decrease of attention after 2 min from the beginning of the test and a final fading at the end. Our results provide evidence that EEG-derived indices extraction and evaluation during SA tasks are helpful in the assessment of attention level in healthy subjects and DAI patients, offering motivations for including EEG monitoring in cognitive rehabilitation practice.	[Coelli, Stefania; Barbieri, Riccardo; Bianchi, Anna Maria] Politecn Milan, Dept Elect Informat & Bioengn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy; [Reni, Gianluigi; Zucca, Claudio] IRCCS E Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy		Coelli, S (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	stefania.coelli@polimi.it	Bianchi, Anna M./AAA-4258-2020; Zucca, Claudio/AAV-2162-2020; Barbieri, Riccardo/AAC-5310-2022; Coelli, Stefania/Y-8837-2019; Reni, Gianluigi/L-7781-2015	Zucca, Claudio/0000-0001-7621-2542; Coelli, Stefania/0000-0003-4104-4790; Reni, Gianluigi/0000-0003-0822-3287; Bianchi, Anna M./0000-0002-8290-7460; Barbieri, Riccardo/0000-0001-9381-3833	THINK&GO (POR FSE) project; ARTE - Regione Lombardia and Fondazione Cariplo	The present research was partially funded by the THINK&GO (POR FSE 2007/2013) project and ARTE project supported by Regione Lombardia and Fondazione Cariplo.	Andujar M., 2013, CHI 13 HUM FACT COMP, P703, DOI DOI 10.1145/2468356.2468480; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; Bazanova OM, 2014, NEUROSCI BIOBEHAV R, V44, P94, DOI 10.1016/j.neubiorev.2013.05.007; Benjamini Y, 2001, ANN STAT, V29, P1165; Berka C, 2007, AVIAT SPACE ENVIR MD, V78, pB231; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Butti Michele, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1040; Chaouachi M, 2010, LECT NOTES COMPUT SC, V6095, P291; Chuang SW, 2012, NEUROIMAGE, V62, P1469, DOI 10.1016/j.neuroimage.2012.05.035; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dissanayaka C, 2015, MED BIOL ENG COMPUT, V53, P599, DOI 10.1007/s11517-015-1272-0; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Fairclough S. H., 2009, 2009 3 INT C AFF COM 2009 3 INT C AFF COM, P1, DOI DOI 10.1109/ACII.2009.5349483; Freeman FG, 1999, BIOL PSYCHOL, V50, P61, DOI 10.1016/S0301-0511(99)00002-2; Freeman FG, 2000, APPL PSYCHOPHYS BIOF, V25, P103, DOI 10.1023/A:1009566809021; Galan Federico Cirett, 2012, User Modeling, Adaptation, and Personalization. Proceedings 20th International Conference, UMAP 2012, P51, DOI 10.1007/978-3-642-31454-4_5; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gevins A, 1998, HUM FACTORS, V40, P79, DOI 10.1518/001872098779480578; Gola M, 2013, INT J PSYCHOPHYSIOL, V89, P334, DOI 10.1016/j.ijpsycho.2013.05.007; Gola M, 2012, INT J PSYCHOPHYSIOL, V85, P62, DOI 10.1016/j.ijpsycho.2011.09.001; Gomez-Pilar J, 2016, MED BIOL ENG COMPUT, V54, P1655, DOI 10.1007/s11517-016-1454-4; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Holm A, 2009, THESCIENTIFICWORLDJO, V9, P639, DOI 10.1100/tsw.2009.83; Homack Susan, 2006, J Atten Disord, V9, P556, DOI 10.1177/1087054705283578; Huang J., 2014, P CHI 14, P1905, DOI DOI 10.1145/2556288.2557339; ISAKSSON A, 1981, P IEEE, V69, P451, DOI 10.1109/PROC.1981.11988; Keller I, 2001, J NEUROTHERAPY, V5, P19; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Molteni E, 2007, P ANN INT IEEE EMBS, P1298, DOI 10.1109/IEMBS.2007.4352535; Molteni E, 2008, ANN BIOMED ENG, V36, P1216, DOI 10.1007/s10439-008-9506-z; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; POPE AT, 1995, BIOL PSYCHOL, V40, P187, DOI 10.1016/0301-0511(95)05116-3; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Stathopoulou S., 2004, Journal of Neurotherapy, V8, P21, DOI 10.1300/J184v08n02_03; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Szafir D, 2012, P SIGCHI C HUM FACT, DOI [DOI 10.1145/2207676.2207679, 10.1145/2207676.2207679]; Szafir D, 2013, P SIGCHI C HUM FACT, P1001, DOI DOI 10.1145/2470654.2466128; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Vecchiato G, 2011, MED BIOL ENG COMPUT, V49, P579, DOI 10.1007/s11517-011-0747-x; Warraich Z, 2010, PM&R, V2, pS208, DOI 10.1016/j.pmrj.2010.10.016; Zetterberg LH, 1979, MATH BIOSCI, V5, P227, DOI [DOI 10.1016/0025-5564(69)90044-3, 10.1016/0025-5564(69)90044-3]; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	51	9	9	1	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	JUN	2018	56	6					991	1001		10.1007/s11517-017-1744-5			11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	GG9UA	WOS:000433045400006	29124529				2022-02-06	
J	Cranmer, GA; LaBelle, S				Cranmer, Gregory A.; LaBelle, Sara			Using the Disclosure Decision-Making Model to Understand High School Football Players' Disclosures of Concussion Symptoms	INTERNATIONAL JOURNAL OF SPORT COMMUNICATION			English	Article						athlete-coach communication; athlete well-being; sport concussions	COACH; PREDICTORS; COMMUNICATION; INFORMATION; PERSPECTIVE; BEHAVIORS; EDUCATION; SUPPORT; SPORTS; ZURICH	Despite advancements in concussion treatment and management, health and sports professionals largely depend on athletes' self-reporting of symptoms to begin the process of diagnosis. With this in mind, recent scholarly attention has focused on understanding the barriers and processes of athletes' self-disclosure of symptoms. The current study applied the disclosure decision-making model to understand high school football players' disclosure decisions after experiencing symptoms of a concussion. Data obtained from 184 high school football players from across the United States demonstrated 2 significant paths by which players' disclosures of concussion symptoms during a game can be understood. First, the perceived severity of these symptoms predicted athletes' self-efficacy to disclose concussions, which subsequently predicted their intentions to disclose concussion symptoms during a game. Second, the felt stigma around disclosing concussion symptoms predicted athletes' anticipated responses from coaches to such disclosures, which subsequently predicted their intentions to disclose concussion symptoms during a game. Furthermore, the effect of perceived stigma on the anticipated responses from coaches was moderated by the quality of athletes' relationships with their coaches. These results highlight the importance of convincing athletes to take concussion symptoms seriously and the role of athlete-coach relationships in combatting stigma around concussion disclosures. These findings suggest that scholars and practitioners should acknowledge the social contexts surrounding disclosure of concussion symptom and shift educational efforts to focus on the dangers of concussions and the process by which athletes should report potential symptoms.	[Cranmer, Gregory A.] Clemson Univ, Dept Commun, Clemson, SC 29634 USA; [LaBelle, Sara] Chapman Univ, Dept Commun Studies, Orange, CA USA		Cranmer, GA (corresponding author), Clemson Univ, Dept Commun, Clemson, SC 29634 USA.	gcranme@Clemson.edu			Robert H. Brooks Sports Science Institute	The authors thank Robert H. Brooks Sports Science Institute for providing the funding for the incentives. They also recognize Grady M. Austin, Caitlin Barber, Clelin Ferrell, Katie Fortner, Christian H. Groomes, Laura Millard, Lilly A. Schweickhardt, Chad Smith, Peyton Swancy, and Christian Wilkins for helping collect the data used in this study.	Afifi WA, 2004, COMMUN THEOR, V14, P167, DOI 10.1111/j.1468-2885.2004.tb00310.x; Ajzen I, 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brashers DE, 2001, J COMMUN, V51, P477, DOI 10.1111/j.1460-2466.2001.tb02892.x; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Centers for Disease Control and Prevention, 2016, WHAT AR SIGNS SYMPT; Choi SY, 2016, J PSYCHOL, V150, P1004, DOI 10.1080/00223980.2016.1226742; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Connell R.W., 1990, SOCIOLOGICAL PERSPEC, P141; Cranmer G. A., 2015, International Journal of Sport Communication, V8, P193, DOI 10.1123/IJSC.2014-0078; Cranmer GA, 2017, COMMUN SPORT, V5, P751, DOI 10.1177/2167479516660037; Cranmer GA, 2018, COMMUN SPORT, V6, P239, DOI 10.1177/2167479516684755; Cranmer GA, 2015, COMMUN SPORT, V3, P100, DOI 10.1177/2167479513520487; Cranmer GA, 2015, WESTERN J COMM, V79, P614, DOI 10.1080/10570314.2015.1069389; Cranmer GA, 2016, COMMUN SPORT, V4, P43, DOI 10.1177/2167479514542151; Cranmer GA, 2015, COMMUN RES REP, V32, P253, DOI 10.1080/08824096.2015.1052900; Cranmer GA, 2017, COMMUN STUD, V68, P37, DOI 10.1080/10510974.2016.1254096; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; FINCH J, 1987, SOCIOLOGY, V21, P105, DOI 10.1177/0038038587021001008; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gerdy J.R., 1997, SUCCESSFUL COLL ATHL; Greene K., 2009, UNCERTAINTY INFORM M, P226; Greene K, 2012, HEALTH COMMUN, V27, P356, DOI 10.1080/10410236.2011.586988; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jowett S, 2004, SCAND J MED SCI SPOR, V14, P245, DOI 10.1111/j.1600-0838.2003.00338.x; KASSING JW, 2004, ANN INT COMMUNICATIO, V28, P373, DOI DOI 10.1080/23808985.2004.11679040; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mak WWS, 2008, J APPL RES INTELLECT, V21, P532, DOI 10.1111/j.1468-3148.2008.00426.x; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Messner Michael A., 1992, POWER PLAY SPORTS PR; National Athletic Trainers' Association, 2015, NEW STUD SHOWS 37 PE; National Federation of State High School Associations, 2017, 2016 2017 HIGH SCH A; Petronio S., 2004, J FAMILY COMMUNICATI, V4, P193, DOI [10.1207/s15327698jfc0403&4_6, DOI 10.1080/15267431.2004.9670131]; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Silk K. J., 2003, ROUTLEDGE HDB HLTH C, P203; Steiger J. H., 1980, ANN SPRING M PSYCHOM; TRUJILLO N, 1995, SOCIOL SPORT J, V12, P403, DOI 10.1123/ssj.12.4.403; Turman P. D., 2003, Journal of Sport Behavior, V26, P86; Turman PD, 2008, WESTERN J COMM, V72, P162, DOI 10.1080/10570310802038424; Venetis MK, 2018, HEALTH COMMUN, V33, P653, DOI 10.1080/10410236.2017.1294231; Venetis MK, 2015, J HEALTH COMMUN, V20, P306, DOI 10.1080/10810730.2014.965364; Wenner LA, 2015, COMMUN SPORT, V3, P247, DOI 10.1177/2167479515584781; Wheeless LR., 1976, HUM, V2, P338, DOI [10.1111/j.1468-2958.1976.tb00494.x, DOI 10.1111/J.1468-2958.1976.TB00494.X]; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Winston FK, 2010, INJURY PREV, V16, P107, DOI 10.1136/ip.2009.021972; Young, 2004, SPORTING BODIES DAMA, P59	60	9	9	0	8	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1936-3915	1936-3907		INT J SPORT COMMUN	Int. J. Sport Commun.	JUN	2018	11	2					241	260		10.1123/ijsc.2017-0120			20	Communication	Emerging Sources Citation Index (ESCI)	Communication	GL2XH	WOS:000436989700007					2022-02-06	
J	Li, D; Ni, HB; Rui, Q; Gao, R; Chen, G				Li, Di; Ni, Haibo; Rui, Qin; Gao, Rong; Chen, Gang			Deletion of Mst1 attenuates neuronal loss and improves neurological impairment in a rat model of traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Mst1; p-Mst1; Neuronal cell death	CELL PROLIFERATION; IN-VITRO; APOPTOSIS; INHIBITION; AUTOPHAGY; PATHWAY; STRESS; KINASE; XENON	Neuronal cell death following traumatic brain injury (TBI) is a considerable contributor to neurological deficits. In our work, we explored the functions of Mammalian STE20-like kinase-1 (Mstl), a apoptosis-promoting kinase and also a pivotal bridgebuilder of apoptotic signaling, in the etiopathogenesis of an experimental rat model of TBI. We found that the phosphorylation level of Mst1 in injured area was significantly increased after TBI. Furthermore, we discovered that inhibition of Mst1 phosphorylation can effectively reduce neuronal cell death by inhibiting the activation of caspase 3 and suppressing the damage of DNA during TBI. In addition, the decreased of Mst1 phosphorylation level, not only reduced brain edema and blood-brain barrier (BBB) damage in injured region but also weakened the impairment of neurologic behavior during TBI. In conclusion, our work demonstrates that Mstl plays an important role in TBI-induced neuronal cell death, suggesting that Mstl is expected to be a potential therapeutic target for TBI. (C) 2017 Published by Elsevier B.V.	[Li, Di; Ni, Haibo; Gao, Rong] Soochow Univ, Peoples Hosp Zhangjiagang 1, Dept Neurosurg, Suzhou, Peoples R China; [Li, Di] Soochow Univ, Peoples Hosp Zhangjiagang 1, Translat Med Ctr, Suzhou, Peoples R China; [Rui, Qin] Soochow Univ, Peoples Hosp Zhangjiagang 1, Clin Lab, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China		Li, D (corresponding author), First Peoples Hosp Zhangjiagang, Dept Neurosurg, 68 Jiyang Western Rd, Suzhou, Peoples R China.	lidi715@163.com					Babel I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001784; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Chao YW, 2015, J NEURO-ONCOL, V121, P279, DOI 10.1007/s11060-014-1654-4; Chase Alex, 2014, Nat Rev Neurol, V10, P547, DOI 10.1038/nrneurol.2014.169; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Khalafian Andrey, 2015, J Okla State Med Assoc, V108, P358; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Matsuda T, 2016, CIRC RES, V119, P596, DOI 10.1161/CIRCRESAHA.116.308586; Mia MM, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.85; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Nakamura M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86217; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sciarretta S, 2015, CELL REP, V11, P125, DOI 10.1016/j.celrep.2015.03.010; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang PF, 2017, MOL CELL BIOCHEM, V431, P11, DOI 10.1007/s11010-017-2969-1; Wang Y., 2017, J NEUROTRAUM, DOI DOI 10.1089/neu.2016.4953; Wen ZJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4296075; Weng LH, 2016, NEUROL RES, V38, P342, DOI 10.1080/01616412.2016.1174423; Xiao L, 2011, J NEUROSCI, V31, P9611, DOI 10.1523/JNEUROSCI.0035-11.2011; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yin C, 2017, NEUROBIOL DIS, V103, P133, DOI 10.1016/j.nbd.2017.04.006; Zhang MM, 2016, DIABETOLOGIA, V59, P2435, DOI 10.1007/s00125-016-4070-9; Zhao SQ, 2016, BRAIN BEHAV IMMUN, V55, P236, DOI 10.1016/j.bbi.2015.12.016; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	31	9	9	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 1	2018	1688						15	21		10.1016/j.brainres.2017.10.018			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE4BT	WOS:000431160000003	29054447				2022-02-06	
J	Nilsson, MKL; Zachrisson, O; Gottfries, CG; Matousek, M; Peilot, B; Forsmark, S; Schuit, RC; Carlsson, ML; Kloberg, A; Carlsson, A				Nilsson, Marie Karin Lena; Zachrisson, Olof; Gottfries, Carl-Gerhard; Matousek, Michael; Peilot, Birgitta; Forsmark, Sara; Schuit, Robert Christiaan; Carlsson, Maria Lizzie; Kloberg, Angelica; Carlsson, Arvid			A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome	ACTA NEUROPSYCHIATRICA			English	Article						(-)-OSU6162; fatigue; monoaminergic stabiliser; myalgic encephalomyelitis	SEROTONIN REUPTAKE INHIBITORS; 5-HT2A SEROTONIN; MENTAL FATIGUE; CROSS-OVER; PLACEBO; RECEPTORS; ANTIDEPRESSANTS; (+)-OSU6162; SYMPTOMS; DISEASE	Objective: The monoaminergic stabiliser (-)-OSU6162 has in previous studies shown promising effects on mental fatigue after stroke and traumatic brain injury. This study investigated the safety and effectiveness of (-)-OSU6162 in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Methods: A total of 62 patients were randomly assigned to placebo or (-)-OSU6162. Primary outcomes were assessment on the mental fatigue scale (MFS) and the clinical global impression of change (CGI-C) scale. Secondary outcomes were results on the FibroFatigue scale (FF), the Beck Depression Inventory (BDI), the pain visual analogue scale and neuropsychological tests. Assessments were performed at baseline, after 1 and 2 weeks of treatment and at follow-up after 6 weeks. Results: MFS and CGI-C showed significant improvements for both treatment groups after treatment but not at follow-up; a similar pattern was seen for FF and BDI. However, significant differences between groups could not be demonstrated. On the other hand, correlation analyses showed a significant correlation between (-)-OSU6162 concentration and change in MFS, FF, and BDI score within the concentration interval 0.1-0.7 mu M. Exploratory subgroup analyses showed a larger treatment effect with (-)-OSU6162 in improving MFS and FF symptoms in patients on antidepressant therapy compared to those without antidepressant treatment. Conclusion: (-)-OSU6162 was found to be safe and well tolerated. When analysing the entire material (-)-OSU6162 was not found to differ significantly from placebo in alleviating fatigue in ME patients but was superior to placebo in counteracting fatigue in a subgroup of ME patients who received concomitant pharmacological treatment for depression.	[Nilsson, Marie Karin Lena; Carlsson, Maria Lizzie; Carlsson, Arvid] Univ Gothenburg, Dept Clin Neurosci, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Zachrisson, Olof; Gottfries, Carl-Gerhard; Matousek, Michael; Peilot, Birgitta; Forsmark, Sara; Carlsson, Maria Lizzie] Univ Gothenburg, Gottfries Clin, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Schuit, Robert Christiaan] Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands; [Kloberg, Angelica] Carlsson Res AB, Sahlgrenska Sci Pk, Gothenburg, Sweden		Nilsson, MKL (corresponding author), Univ Gothenburg, Inst Neurosci & Phyisol, Sahlgrenska Acad, Sahlgrenska Sci Pk,Medicinaregatan 8 A, S-41390 Gothenburg, Sweden.	marie.nilsson@gu.se			Arvid Carlsson Foundation; Foundation for Neuropharmacological Research and Education; Vastra Gotalandsregionen	This study was supported by the Arvid Carlsson Foundation, The Foundation for Neuropharmacological Research and Education, and Vastra Gotalandsregionen.	Barnhart W Jason, 2004, J Psychiatr Pract, V10, P196, DOI 10.1097/00131746-200405000-00010; Burstein ES, 2011, J NEURAL TRANSM, V118, P1523, DOI 10.1007/s00702-011-0701-y; Carlsson ML, 2011, J NEURAL TRANSM, V118, P1511, DOI 10.1007/s00702-011-0704-8; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Damsa C, 2004, J CLIN PSYCHIAT, V65, P1064; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hawthorne JM, 2015, ANN PHARMACOTHER, V49, P1136, DOI 10.1177/1060028015594812; Jakobsen JC, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1173-2; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Kloberg A, 2014, ACTA NEUROPSYCHIATR, V26, P298, DOI 10.1017/neu.2014.16; Madhusoodanan S, 2010, ANN CLIN PSYCHIATRY, V22, P148; Price J, 2009, BRIT J PSYCHIAT, V195, P211, DOI 10.1192/bjp.bp.108.051110; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Tolboom N, 2015, NEUROPSYCHOPHARMACOL, V40, P472, DOI 10.1038/npp.2014.195; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4; ZACHRISSON O, 2002, THESIS	19	9	10	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1601-5215			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	JUN	2018	30	3					148	157		10.1017/neu.2017.35			10	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	GN2DP	WOS:000438808000004	29212562				2022-02-06	
J	Page, PS; Wei, ZK; Brooks, NP				Page, Paul S.; Wei, Zhikui; Brooks, Nathaniel P.			Motorcycle helmets and cervical spine injuries: a 5-year experience at a Level 1 trauma center	JOURNAL OF NEUROSURGERY-SPINE			English	Article						cervical spine; motorcycle; craniocerebral trauma; neck injuries	LAWS; FATALITY; IMPACT; NECK	OBJECTIVE Motorcycle helmets have been shown to decrease the incidence and severity of traumatic brain injury due to motorcycle crashes. Despite this proven efficacy, some previous reports and speculation suggest that helmet use is associated with a higher likelihood of cervical spine injury (CSI). In this study, the authors examine 1061 cases of motorcycle crash victims who were treated during a 5-year period at a Level 1 trauma center to investigate the association of helmet use with the incidence and severity of CSI. The authors hypothesized that wearing a motorcycle helmet during a motorcycle crash is not associated with an increased risk of CSI and may provide some protective advantage to the wearer. METHODS The authors performed a retrospective review of all cases in which the patient had been involved in a motorcycle crash and was evaluated at a single Level 1 trauma center in Wisconsin between January 1, 2010, and January 1, 2015. Biometric, clinical, and imaging data were obtained from a trauma registry database. The patients were then divided into 2 distinct groups based on whether or not they were wearing helmets at the time of the accident. Baseline and functional characteristics were compared between the 2 groups. The Student t-test was used for continuous variables, and Pearson's chi-square analysis was used for categorical variables. RESULTS In total, 1061 patient charts were examined containing data on 738 unhelmeted (69.6%) and 323 helmeted (30.4%) motorcycle riders. On average, helmeted riders had a much lower Injury Severity Score (p < 0.001). Cervical spine injury occurred in 114 unhelmeted riders (15.4%) compared with only 24 helmeted riders (7.4%) (p < 0.001), with an adjusted odds ratio of 2.3 (95% CI 1.44-3.61, p = 0.0005). In the unhelmeted group, 10.8% of patients were found to have a cervical spine fracture compared with only 4.6% of patients in the helmeted group (p = 0.001). Additionally, ligamentous injury occurred more frequently in unhelmeted riders (1.9% vs 0.3%, p = 0.04). No difference was found in the occurrence of cervical strain, cord contusion, or nerve root injury (all p > 0.05). CONCLUSIONS The results of this study demonstrate a statistically significant lower likelihood of suffering a CSI among helmeted motorcyclists. Unhelmeted riders sustained a statistically significant higher number of vertebral fractures and ligamentous injuries. The study findings reported here confirm the authors' hypothesis that helmet use does not increase the risk of developing a cervical spine fracture and may provide some protective advantage.	[Page, Paul S.; Wei, Zhikui; Brooks, Nathaniel P.] Univ Wisconsin Hosp & Clin, Dept Neurol Surg, Madison, WI 53792 USA		Brooks, NP (corresponding author), Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA.	brooks@neurosurgery.wisc.edu		Wei, Zhikui/0000-0002-2311-9800			Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Dao H, 2012, J TRAUMA ACUTE CARE, V72, P638, DOI 10.1097/TA.0b013e318243d9ca; Eastridge BJ, 2006, J TRAUMA, V60, P978, DOI 10.1097/01.ta.0000215582.86115.01; Eltorai AEM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2914-3; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Jones MM, 2007, AM J PUBLIC HEALTH, V97, P208, DOI 10.2105/AJPH.2005.083204; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; Lin MR, 2004, NEUROEPIDEMIOLOGY, V23, P269, DOI 10.1159/000080091; Moskal A, 2008, INJURY PREV, V14, P238, DOI 10.1136/ip.2007.018093; Muller A, 2004, AM J PUBLIC HEALTH, V94, P556, DOI 10.2105/AJPH.94.4.556; National Highway Traffic Safety Administration, 2016, TRAFF SAF FACTS 2015; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; Ooi SS, 2011, ASIA-PAC J PUBLIC HE, V23, P608, DOI 10.1177/1010539511413750; Ouellet JV, 2013, INT MOT SAF C ORL FL	16	9	9	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUN	2018	28	6					607	611		10.3171/2017.7.SPINE17540			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GO5BS	WOS:000440033500007	29506463	Bronze			2022-02-06	
J	Portbury, SD; Hare, DJ; Bishop, DP; Finkelstein, DI; Doble, PA; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Bishop, David P.; Finkelstein, David I.; Doble, Philip A.; Adlard, Paul A.			Trehalose elevates brain zinc levels following controlled cortical impact in a mouse model of traumatic brain injury	METALLOMICS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; HEAD-INJURY; AUTOPHAGY; MICE; AGE; SUPPLEMENTATION; ENHANCEMENT; DEPRESSION	Zinc (Zn) deficiency is a clinical consequence of brain injury that can result in neuropathological outcomes that are exacerbated with age. Here, we present laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) imaging data showing modulation of brain Zn levels by the disaccharide trehalose in aged mice following a controlled cortical impact model of traumatic brain injury. In this proof-of-concept study, trehalose induced an increase in brain zinc levels, providing important preliminary data for larger studies using this simple carbohydrate as a modulator of this essential micronutrient in traumatic brain injury. Our results may have further implications for the treatment of a variety of neurodegenerative diseases and other disorders of the nervous system.	[Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hare, Dominic J.; Bishop, David P.; Doble, Philip A.] Univ Technol, Elemental Bioimaging Facil, Broadway, NSW, Australia		Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	paul.adlard@florey.edu.au	Doble, Philip/A-8812-2012; Finkelstein, David/B-9617-2009; Hare, Dominic/H-2481-2011; Bishop, David P/F-2891-2019	Doble, Philip/0000-0002-8472-1301; Finkelstein, David/0000-0002-8167-4917; Hare, Dominic/0000-0002-5922-7643; Bishop, David P/0000-0002-6533-4410	Australian National Health and Medical Research Council Career Development FellowshipNational Health and Medical Research Council of Australia [APP1120582]; Agilent Technologies; Australian Research Council Linkage ProjectAustralian Research Council [LP120200081]; ESI Ltd.; Australian Research Council Future FellowshipAustralian Research Council [FT120100030]; Operational Infrastructure Support Grant	DJH is supported by an Australian National Health and Medical Research Council Career Development Fellowship (APP1120582) with Agilent Technologies. DJH and PAD are supported by an Australian Research Council Linkage Project (LP120200081) with Agilent Technologies and ESI Ltd. PAA was supported by an Australian Research Council Future Fellowship (FT120100030). In addition, the Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and the funding from the Operational Infrastructure Support Grant. The Elemental Bio-imaging Facility receives material support from Agilent Technologies. We would like to acknowledge the excellent technical assistance provided by Charlotte J. Sgambelloni during the surgical procedures undertaken for these experiments.	Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Adlard PA, 2014, AGING CELL, V13, P351, DOI 10.1111/acel.12178; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frederickson CJ, 2005, J ALZHEIMERS DIS, V8, P155; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gronli O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082793; Hellmich HL, 2004, NEUROSCI LETT, V355, P221, DOI 10.1016/j.neulet.2003.10.074; Holler CJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0114-3; James SA, 2017, ACS CHEM NEUROSCI, V8, P629, DOI 10.1021/acschemneuro.6b00362; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Kara NZ, 2013, PSYCHOPHARMACOLOGY, V229, P367, DOI 10.1007/s00213-013-3119-4; Khazdouz Maryam, 2018, Journal of Dietary Supplements, V15, P1, DOI 10.1080/19390211.2017.1304486; Liuzzi JP, 2014, BIOMETALS, V27, P1087, DOI 10.1007/s10534-014-9773-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Ni H, 2011, BIOL TRACE ELEM RES, V143, P1607, DOI 10.1007/s12011-011-8982-4; Nuttall JR, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0379-x; Portbury SD, 2017, J ALZHEIMERS DIS, V60, P549, DOI 10.3233/JAD-170322; Portbury SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183683; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Ranjbar Elham, 2013, Iran J Psychiatry, V8, P73; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Vashum KP, 2014, J AFFECT DISORDERS, V166, P249, DOI 10.1016/j.jad.2014.05.016; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Zhao YM, 2014, STROKE, V45, P1139, DOI 10.1161/STROKEAHA.113.004296	45	9	9	2	13	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics	JUN 1	2018	10	6					846	853		10.1039/c8mt00068a			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK3GQ	WOS:000436031100007	29872801	hybrid			2022-02-06	
J	Zhao, X; Zhou, KS; Li, ZH; Nan, W; Wang, J; Xia, YY; Zhang, HH				Zhao, Xin; Zhou, Kai-Sheng; Li, Zhong-Hao; Nan, Wei; Wang, Jing; Xia, Ya-Yi; Zhang, Hai-Hong			Knockdown of Ski decreased the reactive astrocytes proliferation in vitro induced by oxygen-glucose deprivation/reoxygenation	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						astrocyte; cell cycle; central nervous system (CNS); ischemia; proliferation; Ski	SPINAL-CORD-INJURY; CELL-CYCLE PROGRESSION; TRAUMATIC BRAIN-INJURY; SCAR FORMATION; GLIAL SCAR; CEREBRAL-ISCHEMIA; SMAD PROTEINS; C-SKI; EXPRESSION; REGENERATION	Glia scar is a pathological marker in late phase of brain ischemia disease, which constitutes a major physical biochemical barrier to impede axonal regrowth. Astrocytes are known to be critically involved in the formation of glial scar. However, their response to ischemia and their role in neuroprotection after central nervous system (CNS) injury are not completely clear. Recently, we have demonstrated for the first time that Ski was up-regulated in reactive astrocytes after spinal cord injury in vivo and in vitro, which indicates Ski may be a new molecule that control astrocytes biologic properties after CNS injury. However, its role in the process of reactive astrogliosis after cerebral ischemia and its definite mechanism still remains unknown. This study is to elucidate the role of Ski in reactive astrocytes induced by oxygen-glucose deprivation/reoxygenation (OGD/R) model in vitro. The expression of Ski was proved to be up-regulated in OGD/R model. Meanwhile, Up-regulation of Ski was accompanied with high ratio of EdU (+) cells and up-expression of related proteins including GFAP, PCNA, CDK4, and CyclinD1, which demonstrated the distinct activation and proliferation of astrocytes after stimulation by OGD/R. Astrocytes were transfected with Ski-specific siRNA to knockdown Ski expression and subsequently attenuated OGD-induced astrocyte proliferation. Our results also showed that Ski down-regulation could suppress the activity of the Ras-Raf-ERK1/2 signaling pathway. Together, knockdown of Ski can effectively inhibit the proliferation of reactive astrogliosis via suppressing the Ras-Raf-ERK1/2 pathway. These findings indicated that maybe Ski is a promising therapeutic target for cerebral ischemic injury.	[Zhao, Xin; Zhou, Kai-Sheng; Li, Zhong-Hao; Nan, Wei; Xia, Ya-Yi; Zhang, Hai-Hong] Lanzhou Univ, Clin Med Coll 2, Lanzhou, Gansu, Peoples R China; [Zhao, Xin; Zhou, Kai-Sheng; Li, Zhong-Hao; Nan, Wei; Wang, Jing] Orthopaed Key Lab Gansu Prov, Lanzhou, Gansu, Peoples R China		Zhang, HH (corresponding author), Lanzhou Univ, Dept Orthoped, Hosp 2, 82 Cuiying Men, Lanzhou 730000, Gansu, Peoples R China.	zhanghaih1968@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772299, 81672207]; Second Hospital Research Foundation of Lanzhou University [sdkyjj-04]	National Natural Science Foundation of China, Grant numbers: 30772299, 81672207; The Second Hospital Research Foundation of Lanzhou University, Grant number: sdkyjj-04	Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z; Boone B, 2009, J DERMATOL SCI, V53, P26, DOI 10.1016/j.jdermsci.2008.07.010; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Chen DH, 2003, CANCER RES, V63, P6626; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Chu LF, 2008, BRAIN RES, V1239, P24, DOI 10.1016/j.brainres.2008.08.087; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diaz M, 2012, OBESITY, V20, P2157, DOI 10.1038/oby.2012.101; Ding SH, 2009, GLIA, V57, P767, DOI 10.1002/glia.20804; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Grusch M, 2010, CURR CANCER DRUG TAR, V10, P849, DOI 10.2174/156800910793357943; He KY, 2009, GENE THER, V16, P840, DOI 10.1038/gt.2009.48; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Komitova M, 2002, J CEREBR BLOOD F MET, V22, P852, DOI 10.1097/00004647-200207000-00010; Li CY, 2015, NEUROCHEM INT, V83-84, P9, DOI 10.1016/j.neuint.2015.03.001; Liu X, 2010, CLIN EXP DERMATOL, V35, P417, DOI 10.1111/j.1365-2230.2009.03606.x; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lukovic D, 2015, STEM CELLS, V33, P1036, DOI 10.1002/stem.1959; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Macias-Silva M, 2002, J BIOL CHEM, V277, P28483, DOI 10.1074/jbc.M202403200; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McCluggage WG, 2006, INT J GYNECOL PATHOL, V25, P101, DOI 10.1097/01.pgp.0000192269.14666.68; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pivonkova H, 2017, CURR PHARM DESIGN, V23, P5056, DOI 10.2174/1381612823666170710161858; Qiu J, 2013, NEUROCHEM INT, V63, P87, DOI 10.1016/j.neuint.2013.05.009; Shi YL, 2017, NEUROSCI LETT, V639, P68, DOI 10.1016/j.neulet.2016.12.052; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sukhorukova E G, 2015, Zh Evol Biokhim Fiziol, V51, P3; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wang CF, 2014, REV NEUROSCIENCE, V25, P255, DOI 10.1515/revneuro-2013-0055; Xia RX, 2017, CELL PHYSIOL BIOCHEM, V42, P987, DOI 10.1159/000478681; Yang Q, 2011, J NEUROCHEM, V119, P644, DOI 10.1111/j.1471-4159.2011.07446.x; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Zhan JS, 2017, NEUROCHEM RES, V42, P272, DOI 10.1007/s11064-016-2089-4; Zhao X, 2017, NEUROSCIENCE, V362, P1, DOI 10.1016/j.neuroscience.2017.08.027; Zhou KS, 2017, NEUROREPORT, V28, P149, DOI 10.1097/WNR.0000000000000729; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	48	9	11	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	JUN	2018	119	6					4548	4558		10.1002/jcb.26597			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GD7CP	WOS:000430667200031	29236326				2022-02-06	
J	Masri, S; Zhang, LS; Luo, H; Pace, E; Zhang, JS; Bao, SW				Masri, Samer; Zhang, Li S.; Luo, Hao; Pace, Edward; Zhang, Jinsheng; Bao, Shaowen			Blast Exposure Disrupts the Tonotopic Frequency Map in the Primary Auditory Cortex	NEUROSCIENCE			English	Article						blast; auditory cortex; frequency map; central auditory processing disorder; rat	TRAUMATIC BRAIN-INJURY; GLIAL TNF-ALPHA; INDUCED TINNITUS; HEARING-LOSS; INFERIOR COLLICULUS; INDUCED NEUROTRAUMA; NEURAL ACTIVITY; ANIMAL-MODEL; RATS; OVERPRESSURE	Blast exposure can cause various auditory disorders including tinnitus, hyperacusis, and other central auditory processing disorders. While this is suggestive of pathologies in the central auditory system, the impact of blast exposure on central auditory processing remains poorly understood. Here we examined the effects of blast shockwaves on acoustic response properties and the tonotopic frequency map in the auditory cortex. We found that multiunits recorded from the auditory cortex exhibited higher acoustic thresholds and broader frequency tuning in blast-exposed animals. Furthermore, the frequency map in the primary auditory cortex was distorted. These changes may contribute to central auditory processing disorders. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Masri, Samer; Bao, Shaowen] Univ Arizona, Neurosci Grad Program, Tucson, AZ 85724 USA; [Zhang, Li S.; Bao, Shaowen] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; [Luo, Hao; Pace, Edward; Zhang, Jinsheng] Wayne State Univ, Dept Otolaryngol, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Dept Commun Sci & Disorders, Detroit, MI 48201 USA		Bao, SW (corresponding author), Univ Arizona, Coll Med, Dept Physiol, Tucson, AZ 85724 USA.	sbao@email.arizona.edu		Bao, Shengyong/0000-0001-5368-167X; Masri, Samer/0000-0002-5448-7446	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	The research was supported by Department of Defense (W81XWH-11-2-0031). We thank Alexander K. Zinsmaier for comments on the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Argyros GJ, 1997, TOXICOLOGY, V121, P105, DOI 10.1016/S0300-483X(97)03659-7; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen W, 2013, INT J CLIN EXP PATHO, V6, P375; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; GALLO R, 1964, Am Ind Hyg Assoc J, V25, P237; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Guo W, 2012, J NEUROSCI, V32, P9159, DOI 10.1523/JNEUROSCI.0065-12.2012; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kim H, 2009, J NEUROSCI, V29, P5163, DOI 10.1523/JNEUROSCI.0365-09.2009; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Niwa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31754; Nondahl David M, 2002, J Am Acad Audiol, V13, P323; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Ouyang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04941-w; Race N, 2017, J NEUROPHYSIOL; Remenschneider AK, 2014, OTOL NEUROTOL, V35, P1825, DOI 10.1097/MAO.0000000000000616; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2003, J NEUROTRAUM, V20, P787, DOI 10.1089/089771503767870014; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Syka J, 2000, HEARING RES, V139, P59, DOI 10.1016/S0378-5955(99)00175-6; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; VERNON JA, 1994, ARCH OTOLARYNGOL, V120, P547; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yang S, 2014, CEREB CORTEX, V24, P1956, DOI 10.1093/cercor/bht053; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108	57	9	9	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 21	2018	379						428	434		10.1016/j.neuroscience.2018.03.041			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GE0DK	WOS:000430884100037	29625214	Green Published			2022-02-06	
J	Hu, QX; Di, GF; Shao, XF; Zhou, W; Jiang, XC				Hu, Qianxin; Di, Guangfu; Shao, Xuefei; Zhou, Wei; Jiang, Xiaochun			Predictors Associated With Post-Traumatic Hydrocephalus in Patients With Head Injury Undergoing Unilateral Decompressive Craniectomy	FRONTIERS IN NEUROLOGY			English	Article						post-traumatic hydrocephalus; decompressive craniectomy; traumatic brain injury; risk factor; unilateral	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; HEMORRHAGE; HYGROMA	Objective: Post-traumatic hydrocephalus (PTH) makes recovery from head trauma after decompression more complicated and is associated with high risks of clinical deterioration and poor outcomes. The aim of this study was to verify the predictors associated with the development of PTH in patients with head injury undergoing unilateral decompressive craniectomy (DC). Methods: Among traumatic brain injury (TBI) patients who underwent unilateral DC between January 2013 and December 2016, the clinical medical records, radiological information, and changes of patients' conditions in the 3-month after injury were reviewed retrospectively. Results: 183 TBI patients after unilateral DC were analyzed, and 50 (27.32%) of them suffered PTH based on head CT scans. Univariate and multivariable analyses revealed that older age (p = 0.002), the Glasgow Coma Scale (GCS) score at admission (p < 0.001), intraventricular hemorrhage (IVH; p = 0.008), post-traumatic cerebral infarction (PCI; p = 0.007), and postoperative meningitis (p = 0.016) were independent predictors for the hydrocephalus after DC. Receiver operating characteristic curves were created and the area under the curve (AUC) were calculated to further assess the accuracy of the variables for predicting PTH. The AUC was 0.836 for the combined all five independent factors (95% confidence interval: 0.775-0.887). Conclusion: TBI patients who undergo unilateral DC with advanced age, lower GCS score at admission, coexisting IVH, PCI, and/or postoperative meningitis should be closely monitored at follow-up assessments for earlier prediction of PTH.	[Hu, Qianxin; Di, Guangfu; Shao, Xuefei; Zhou, Wei; Jiang, Xiaochun] Wannan Med Coll, Yijishan Hosp, Dept Neurosurg, Wuhu, Peoples R China		Jiang, XC (corresponding author), Wannan Med Coll, Yijishan Hosp, Dept Neurosurg, Wuhu, Peoples R China.	jiangxiaochun2001@hotmail.com			Anhui University Natural Science Fund Project [KJ2015ZD40]	This study was supported by Anhui University Natural Science Fund Project (KJ2015ZD40).	[Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101961; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; FOROGLOU G, 1972, Acta Radiologica Diagnosis, V13, P524; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Haubrich C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158506; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kim H, 2017, J KOREAN NEUROSURG S, V60, P730, DOI 10.3340/jkns.2017.0210; Licata C, 2001, J Neurosurg Sci, V45, P141; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Pena A, 2002, ACT NEUR S, V81, P59; Quah BL, 2016, WORLD NEUROSURG, V94, P13, DOI 10.1016/j.wneu.2016.06.081; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Symss NP, 2013, J NEUROSURG-PEDIATR, V11, P170, DOI 10.3171/2012.3.PEDS0934; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Yang XT, 2016, WORLD NEUROSURG, V89, P93, DOI 10.1016/j.wneu.2015.12.040; Yoshioka H, 2000, SURG NEUROL, V53, P119, DOI 10.1016/S0090-3019(99)00185-8	26	9	10	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 14	2018	9								337	10.3389/fneur.2018.00337			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF4ZC	WOS:000431972500001	29867743	Green Published, gold			2022-02-06	
J	Combs, MA; Critchfield, EA; Soble, JR				Combs, Martha A.; Critchfield, Edan A.; Soble, Jason R.			Relax While You Rehabilitate: A Pilot Study Integrating a Novel, Yoga-Based Mindfulness Group Intervention Into a Residential Military Brain Injury Rehabilitation Program	REHABILITATION PSYCHOLOGY			English	Article						TBI; rehabilitation; mindfulness; yoga; veterans	FALSE DISCOVERY RATE; STRESS REDUCTION; COGNITIVE THERAPY; SYMPTOMS; PEOPLE; HEALTH; PAIN; METAANALYSIS; MEDITATION; DEPRESSION	Objective: This preliminary, pilot study assessed the effectiveness of a group-based, mindfulness intervention in a residential, rehabilitation setting with specific focus on assessing participants' self-report of perceived benefit of the intervention on overall health, pain, sleep. mood/anxiety, attention. and self-awareness, as well as implementing modifications needed for successful intervention application among a diverse, clinical military population. Method/Design: Participants were 19 veterans and active duty service members with a history of traumatic brain injury (FBI; 63% severe) who completed a mindfulness-based group intervention during inpatient admission at a Veterans Affairs Polytrauma Transitional Rehabilitation Program (PTRP). Mindfulness and yoga skills were taught in a required, weekly group incorporated into participants' rehabilitation schedule. Opinions and attitudes about mindfulness, as well as pertinent self-report outcome measures, were obtained pre- and postgroup participation. Results: Results suggested that participation in the group was positively associated with individuals' self-reported belief about the benefit of mindfulness in the areas of overall health. physical health. mood, focus, and self-awareness. The more groups attended, the more positive the participants' beliefs about potential impact on overall health and mood became. even while controlling for length of rehabilitation stay. Additionally, several specific group modifications relevant to this population (e.g., physical/environmental modifications, repetition, ignoring/reorienting) were implemented to support successful participation. Conclusions/Implications: These preliminary and exploratory findings suggest that it may be worthwhile for psychologists, clinicians, and other health care providers working with a mixed TBI population, and more specifically a military population with TBI, to consider introducing mindfulness skills as pan of multidisciplinary rehabilitation.	[Combs, Martha A.; Critchfield, Edan A.; Soble, Jason R.] South Texas Vet Hlth Care Syst, Psychol Serv, San Antonio, TX USA; [Critchfield, Edan A.] South Texas Vet Hlth Care Syst, Polytrauma Transit Rehabil Program, San Antonio, TX 78229 USA		Combs, MA (corresponding author), South Texas Vet Hlth Care Syst, Psychol Serv 116B, 7400 Merton Minter, San Antonio, TX 78229 USA.	martha.combs@va.gov					Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bussing A, 2012, J PAIN, V13, P1, DOI 10.1016/j.jpain.2011.10.001; Buffart LM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-559; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cole MA, 2015, MIL MED, V180, P956, DOI 10.7205/MILMED-D-14-00581; Defense and Veterans Brain Injury Center, 2016, DOD WORLDWNUMB TBI; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Johansson B, 2015, MINDFULNESS, V6, P227, DOI 10.1007/s12671-013-0249-z; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Marchand WR, 2012, J PSYCHIATR PRACT, V18, P233, DOI 10.1097/01.pra.0000416014.53215.86; McPherson F, 2004, MIL MED, V169, P354, DOI 10.7205/MILMED.169.5.354; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Ross A, 2010, J ALTERN COMPLEM MED, V16, P3, DOI 10.1089/acm.2009.0044; Schmid AA, 2016, DISABIL REHABIL, V38, P914, DOI 10.3109/09638288.2015.1062927; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Sohl Stephanie J, 2011, Int J Yoga Therap, P85; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x	26	9	9	1	13	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2018	63	2					182	193		10.1037/rep0000179			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GI5ON	WOS:000434420400003	29528664				2022-02-06	
J	Dams-O'Connor, K; Sy, KTL; Landau, A; Bodien, Y; Dikmen, S; Felix, ER; Giacino, JT; Gibbons, L; Hammond, FM; Hart, T; Johnson-Greene, D; Lengenfelder, J; Lequerica, A; Newman, J; Novack, T; O'Neil-Pirozzi, TM; Whiteneck, G				Dams-O'Connor, Kristen; Sy, Karla Therese L.; Landau, Alexandra; Bodien, Yelena; Dikmen, Sureyya; Felix, Elizabeth R.; Giacino, Joseph T.; Gibbons, Laura; Hammond, Flora M.; Hart, Tessa; Johnson-Greene, Doug; Lengenfelder, Jeannie; Lequerica, Anthony; Newman, Jody; Novack, Thomas; O'Neil-Pirozzi, Therese M.; Whiteneck, Gale			The Feasibility of Telephone-Administered Cognitive Testing in Individuals 1 and 2 Years after Inpatient Rehabilitation for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; cognitive function; neuropsychology; rehabilitation; traumatic brain injury	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; NATIONAL INSTITUTE; ADULT COGNITION; DISABILITY; VALIDITY; MODERATE; HEALTH	Traumatic brain injury (TBI) often results in cognitive impairment, and trajectories of cognitive functioning can vary tremendously over time across survivors. Traditional approaches to measuring cognitive performance require face-to-face administration of a battery of objective neuropsychological tests, which can be time- and labor-intensive. There are numerous clinical and research contexts in which in-person testing is undesirable or unfeasible, including clinical monitoring of older adults or individuals with disability for whom travel is challenging, and epidemiological studies of geographically dispersed participants. A telephone-based method for measuring cognition could conserve resources and improve efficiency. The objective of this study is to examine the feasibility and usefulness of the Brief Test of Adult Cognition by Telephone (BTACT) among individuals who are 1 and 2 years post-moderate-to-severe TBI. A total of 463 individuals participated in the study at Year 1 post-injury, and 386 participated at Year 2. The sample was mostly male (73%) and white (59%), with an average age of (mean +/- standard deviation) 47.9 +/- 20.9 years, and 73% experienced a duration of post-traumatic amnesia (PTA) greater than 7 days. A majority of participants were able to complete the BTACT subtests (61-69% and 56-64% for Years 1 and 2 respectively); score imputation for those unable to complete a test due to severity of cognitive impairment yields complete data for 74-79% of the sample. BTACT subtests showed expected changes between Years 1-2, and summary scores demonstrated expected associations with injury severity, employment status, and cognitive status as measured by the Functional Independence Measure. Results indicate it is feasible, efficient, and useful to measure cognition over the telephone among individuals with moderate-severe TBI.	[Dams-O'Connor, Kristen; Sy, Karla Therese L.; Landau, Alexandra] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Bodien, Yelena; Giacino, Joseph T.; O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Bodien, Yelena; Giacino, Joseph T.; O'Neil-Pirozzi, Therese M.] Harvard Med Sch, Boston, MA USA; [Bodien, Yelena] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Gibbons, Laura] Univ Washington, Dept Gen Internal Med, Seattle, WA 98195 USA; [Felix, Elizabeth R.; Johnson-Greene, Doug] Univ Miami, Dept Phys Med & Rehabil, Miami, FL USA; [Felix, Elizabeth R.] Miami Vet Adm Med Ctr, Res Serv, Miami, FL USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Lengenfelder, Jeannie; Lequerica, Anthony] Kessler Fdn Res Ctr, W Orange, NJ USA; [Newman, Jody; Whiteneck, Gale] Craig Hosp, Englewood, CO USA; [Novack, Thomas] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org	Felix, Elizabeth/AAD-6356-2021; Sy, Karla Therese/AAV-3945-2021; Giacino, Joseph/AAF-1952-2021	Sy, Karla Therese/0000-0003-0608-9811; Giacino, Joseph/0000-0002-7916-9698; Felix, Elizabeth/0000-0002-6239-715X; Bodien, Yelena/0000-0003-4858-2903	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0010]; New York TBI Model System [90DP0038]; Indiana University/Rehabilitation Hospital of Indiana TBI Model System [90DP0036]; University of Washington Traumatic Brain Injury Model System [90DP0031]; Spaulding-Harvard TBI Model System [90DP0039]; University of Alabama at Birmingham Traumatic Brain Injury Care System [90DP0044]; Moss TBI Model System [90DP0037]; Rocky Mountain Regional Brain Injury System [90DP0034]; Northern New Jersey Traumatic Brain Injury System [90DP0032]; South Florida TBI Model System [90DP0046]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005136] Funding Source: NIH RePORTER	This work was funded by Grants from the National Institute on Disability, Independent Living, and Rehabilitation Research to the Traumatic Brain Injury Model Systems National Data and Statistical Center (Grant Number is 90DP0010), the New York TBI Model System (Grant Number 90DP0038), Indiana University/Rehabilitation Hospital of Indiana TBI Model System (Grant Number 90DP0036), University of Washington Traumatic Brain Injury Model System (Grant Number 90DP0031), Spaulding-Harvard TBI Model System (Grant Number 90DP0039), University of Alabama at Birmingham Traumatic Brain Injury Care System (Grant Number 90DP0044), Moss TBI Model System (Grant Number 90DP0037), Rocky Mountain Regional Brain Injury System (Grant Number 90DP0034), Northern New Jersey Traumatic Brain Injury System (Grant Number 90DP0032), South Florida TBI Model System (Grant Number 90DP0046).	Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Brim OG, 2004, MAC FDN MEN, P1; Castanho TC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00016; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crane PK, 2016, ALZHEIMERS DEMENT, V12, P419, DOI 10.1016/j.jalz.2015.10.007; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; IBM Corp, 2016, IBM SPSS STAT WINDOW; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lachman M.E., 2011, BRIEF TEST ADULT COG; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; National Institute of Neurological Disorders and Stroke, 2012, COMM DAT EL TRAUM BR; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rezaei S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.25363; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; StataCorp, 2017, STATA STAT SOFTWARE; Taylor E., 1959, PSYCHOL APPRAISAL CH; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; *UN DAT SYST MED R, 1997, GUID UN DAT SET MED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	9	9	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1138	1145		10.1089/neu.2017.5347			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000432198500005	29648959	Green Published			2022-02-06	
J	Ioannou, L; Cameron, PA; Gibson, SJ; Ponsford, J; Jennings, PA; Georgiou-Karistianis, N; Giummarra, MJ				Ioannou, L.; Cameron, P. A.; Gibson, S. J.; Ponsford, J.; Jennings, P. A.; Georgiou-Karistianis, N.; Giummarra, M. J.			Financial and recovery worry one year after traumatic injury: A prognostic, registry-based cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Worry; Stress; Finances; Recovery; Trauma; Compensation; Mental health; Affect	WHIPLASH-ASSOCIATED DISORDERS; BRAIN-INJURY; PERCEIVED INJUSTICE; SCALE DEVELOPMENT; STRESS SYMPTOMS; HEALTH OUTCOMES; COMPENSATION; PAIN; DISABILITY; ANXIETY	Background: Levels of stress post-injury, especially after compensable injury, are known to be associated with worse long-term recovery. It is therefore important to identify how, and in whom, worry and stress manifest post-injury. This study aimed to identify demographic, injury, and compensation factors associated with worry about financial and recovery outcomes 12 months after traumatic injury. Methods: Participants (n = 433) were recruited from the Victorian Orthopaedic Trauma Outcomes Registry and Victorian State Trauma Registry after admission to a major trauma hospital in Melbourne, Australia. Participants completed questionnaires about pain, compensation experience and psychological wellbeing as part of a registry-based observational study. Results: Linear regressions showed that demographic and injury factors accounted for 11% and 13% of variance in financial and recovery worry, respectively. Specifically, lower education, discharge to inpatient rehabilitation, attributing fault to another and having a compensation claim predicted financial worry. Worry about recovery was only predicted by longer hospital stay and attributing fault to another. In all participants, financial and recovery worry were associated with worse pain (severity, interference, catastrophizing, kinesiophobia, self-efficacy), physical (disability, functioning) and psychological (anxiety, depression, PTSD, perceived injustice) outcomes 12 months post-injury. In participants who had transport (n = 135) or work (n = 22) injury compensation claims, both financial and recovery worry were associated with sustaining permanent impairments, and reporting negative compensation system experience 12 months post-injury. Financial worry 12 months post-injury was associated with not returning to work by 3-6 months post-injury, whereas recovery worry was associated with attributing fault to another, and higher healthcare use at 6-12 months post-injury. Conclusions: These findings highlight the important contribution of factors other than injury severity, to worry about finances and recovery post-injury. Having a compensation claim, failure to return to work and experiencing pain and psychological symptoms also contribute to elevated worry. As these factors explained less than half of the variance in worry, however, other factors not measured in this study must play a role. As worry may increase the risk of developing secondary mental health conditions, timely access to financial, rehabilitation and psychological supports should be provided to people who are not coping after injury. (C) 2018 Elsevier Ltd. All rights reserved.	[Ioannou, L.; Ponsford, J.; Georgiou-Karistianis, N.] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol Sci, Clayton, Vic, Australia; [Ioannou, L.; Ponsford, J.; Georgiou-Karistianis, N.] Monash Univ, Fac Med Nursing & Hlth Sci, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Cameron, P. A.; Giummarra, M. J.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Gibson, S. J.; Giummarra, M. J.] Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia; [Gibson, S. J.] Univ Melbourne, Natl Ageing Res Inst, Parkville, Vic, Australia; [Ponsford, J.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Jennings, P. A.] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Frankston, Vic, Australia; [Jennings, P. A.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic, Australia		Giummarra, MJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic, Australia.	melita.giummarra@monash.edu	Georgiou-Karistianis, Nellie/ABC-5623-2020; Ioannou, Liane/M-6012-2017; Giummarra, Melita/H-8387-2012; Jennings, Paul/AAF-2016-2019	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Ioannou, Liane/0000-0002-8988-8370; Giummarra, Melita/0000-0001-7839-6058; Jennings, Paul/0000-0002-5605-7589; Cameron, Peter/0000-0002-1443-557X	Australian Research Council (ARC) Linkage GrantAustralian Research Council [LP120200033]; Transport Accident Commission (TAC); Monash UniversityMonash University; National Health & Medical Research Council of Australia (NHMRC) Early Career FellowshipNational Health and Medical Research Council of Australia [APP1036124]; Australian Research Council Discovery Early Career Researcher AwardAustralian Research Council [DE170100726]; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia [APP545926]; Department of Health and Human Services, State Government of Victoria; TAC; TAC via the Institute for Safety, Compensation and Recovery Research (ISCRR)	This research was funded by an Australian Research Council (ARC) Linkage Grant (LP120200033) in collaboration with the Transport Accident Commission (TAC), and a Platform Access Grant from Monash University. MJG was supported by a National Health & Medical Research Council of Australia (NHMRC) Early Career Fellowship (APP1036124) and Australian Research Council Discovery Early Career Researcher Award (DE170100726) and PC by a NHMRC Practitioner Fellowship (APP545926). The VSTR is a Department of Health and Human Services, State Government of Victoria and TAC funded project. The Victorian State Trauma Outcome Registry and Monitoring (VSTORM) group is thanked for the provision of VSTR data. VOTOR is funded by the TAC via the Institute for Safety, Compensation and Recovery Research (ISCRR). We acknowledge the contribution of Melissa Hart and Mimi Morgan for recruitment; Susan McLellan, Behrooz Hassani-Mahmooei and David Atwood for data linkage and extraction; and Katharine Baker, Amy Allen, Jessica Frisina and Samantha Finan for data collection.	Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Australia Bureau of Statistics, 2008, INFORM PAPER INTRO S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belzer KD, 2002, PERS INDIV DIFFER, V33, P573, DOI 10.1016/S0191-8869(01)00173-8; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Borkovec TD., 1994, WORRYING PERSPECTIVE, P5; Brosschot J.F., 2004, ADV THEORY ASSESSMEN, P99; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Brosschot JF, 2002, SCAND J PSYCHOL, V43, P113, DOI 10.1111/1467-9450.00276; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Casey PP, 2015, INJURY, V46, P2118, DOI 10.1016/j.injury.2015.08.038; Cleeland C. S., 1989, MEASUREMENT PAIN SUB, P391; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Davey GC, 1994, WORRYING PERSPECTIVE; DAVEY GCL, 1992, PERS INDIV DIFFER, V13, P133, DOI 10.1016/0191-8869(92)90036-O; Davey GCL, 1996, COGNITIVE THER RES, V20, P499, DOI 10.1007/BF02227910; Elbers NA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3331-3; Elbers NA, 2013, INJURY, V44, P1431, DOI 10.1016/j.injury.2012.08.034; Elbers NA, 2013, ACCIDENT ANAL PREV, V53, P121, DOI 10.1016/j.aap.2013.01.007; Franche RL, 2009, PSYCHOL INJ LAW, V2, P225, DOI 10.1007/s12207-009-9053-4; Gabbe BJ, 2014, INJURY, V45, P1445, DOI 10.1016/j.injury.2014.01.019; Giummarra MJ, 2015, CLIN J PAIN; Giummarra MJ, 2016, J OCCUP REHABIL; Giummarra MJ, 2017, EPIDEMIOLOGICAL CHAR; Grant G, 2013, ISCRR RES S; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hepburn CG, 2010, J OCCUP HEALTH PSYCH, V15, P409, DOI 10.1037/a0021001; Hinton DE, 2011, SOC SCI MED, V72, P1817, DOI 10.1016/j.socscimed.2011.03.045; Hu JM, 2016, PAIN, V157, P438, DOI 10.1097/j.pain.0000000000000388; Ioannou L, 2016, PSYCHOL INJURY LAW; Keogh E, 1998, ANXIETY STRESS COPIN, V11, P67, DOI 10.1080/10615809808249314; Kilgour E, 2015, PSYCHOL INJ LAW, V8, P153, DOI 10.1007/s12207-015-9222-6; Lippel K, 2007, INT J LAW PSYCHIAT, V30, P427, DOI 10.1016/j.ijlp.2007.06.013; Miller RP, 1991, CLIN J PAIN, V7, P51, DOI DOI 10.1097/00002508-199103000-00053; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; O'Donnell ML, 2015, J CLIN PSYCHIAT, V76, pE1000, DOI 10.4088/JCP.14m09211; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Prang Khic-Houy, 2016, BMC Res Notes, V9, P456; Rios R, 2011, HEALTH PSYCHOL, V30, P58, DOI 10.1037/a0022025; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roussis P, 2008, ANXIETY STRESS COPIN, V21, P213, DOI 10.1080/10615800801889600; Scott SL, 2010, J LOSS TRAUMA, V15, P123, DOI 10.1080/15325020902925985; Spearing NM, 2012, J CLIN EPIDEMIOL, V65, P1219, DOI 10.1016/j.jclinepi.2012.05.012; Spinhoven P, 2015, BEHAV RES THER, V2015; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Sullivan M., 2013, HDB WORK DISABILITY, P107; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th; Urquhart DM, 2006, INJURY, V37, P120, DOI 10.1016/j.injury.2005.10.016; Weathers FW, 1991, PCL C FOR DSM 4; Wells A, 2004, J BEHAV THER EXP PSY, V35, P307, DOI 10.1016/j.jbtep.2004.07.001; WHO Collaborating Centre for Drug Statistics Methodology, 2015, GUID ATC CLASS DDD A; Yancura L.A., 2004, TRAUMA HLTH PHYS HLT, P2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	63	9	9	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2018	49	5					990	1000		10.1016/j.injury.2018.03.013			11	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GG0LO	WOS:000432370300018	29653676				2022-02-06	
J	Kubli, LR; Brungart, D; Northern, J				Kubli, Lina R.; Brungart, Douglas; Northern, Jerry			Effect of Blast Injury on Auditory Localization in Military Service Members	EAR AND HEARING			English	Article						Auditory localization; Blast exposure; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; SOUND LOCALIZATION; SPEECH-INTELLIGIBILITY; SPATIAL SEPARATION; HEARING-IMPAIRMENT; NOISE; CORTEX; LISTENERS; RESPONSES; PRESSURE	Objectives: Among the many advantages of binaural hearing are the abilities to localize sounds in space and to attend to one sound in the presence of many sounds. Binaural hearing provides benefits for all listeners, but it may be especially critical for military personnel who must maintain situational awareness in complex tactical environments with multiple speech and noise sources. There is concern that Military Service Members who have been exposed to one or more high-intensity blasts during their tour of duty may have difficulty with binaural and spatial ability due to degradation in auditory and cognitive processes. The primary objective of this study was to assess the ability of blast-exposed Military Service Members to localize speech sounds in quiet and in multisource environments with one or two competing talkers. Design: Participants were presented with one, two, or three topic-related (e.g., sports, food, travel) sentences under headphones and required to attend to, and then locate the source of, the sentence pertaining to a prespecified target topic within a virtual space. The listener's head position was monitored by a head-mounted tracking device that continuously updated the apparent spatial location of the target and competing speech sounds as the subject turned within the virtual space. Measurements of auditory localization ability included mean absolute error in locating the source of the target sentence, the time it took to locate the target sentence within 30 degrees, target/competitor confusion errors, response time, and cumulative head motion. Twenty-one blast-exposed Active-Duty or Veteran Military Service Members (blast-exposed group) and 33 non-blast-exposed Service Members and beneficiaries (control group) were evaluated. Results: In general, the blast-exposed group performed as well as the control group if the task involved localizing the source of a single speech target. However, if the task involved two or three simultaneous talkers, localization ability was compromised for some participants in the blast-exposed group. Blast-exposed participants were less accurate in their localization responses and required more exploratory head movements to find the location of the target talker. Conclusions: Results suggest that blast-exposed participants have more difficulty than non-blast-exposed participants in localizing sounds in complex acoustic environments. This apparent deficit in spatial hearing ability highlights the need to develop new diagnostic tests using complex listening tasks that involve multiple sound sources that require speech segregation and comprehension.	[Kubli, Lina R.; Brungart, Douglas] Walter Reed Natl Mil Med Ctr, Audiol & Speech Pathol Ctr, Bethesda, MD USA; [Kubli, Lina R.] US Dept Vet Affairs, Rehabil Res & Dev Serv, Off Res & Dev, Washington, DC USA; [Northern, Jerry] Univ Colorado, Sch Med, Colorado Sch Med, Denver, CO USA		Kubli, LR (corresponding author), 810 Vermont Ave NW 10P9R, Washington, DC 20420 USA.	lina.kubli@va.gov			Defense Medical Research and Development Program [D61I10J826]	The research was supported by a grant (D61I10J826) from the Defense Medical Research and Development Program.	Andeol G, 2011, J NEUROSCI, V31, P6759, DOI 10.1523/JNEUROSCI.0248-11.2011; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Boothroyd A., 1985, 10 RCI CIT U NEW YOR; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Brimijoin WO, 2010, J ACOUST SOC AM, V127, P3678, DOI 10.1121/1.3409488; Bronkhorst AW, 2015, ATTEN PERCEPT PSYCHO, V77, P1465, DOI 10.3758/s13414-015-0882-9; BRONKHORST AW, 1989, J ACOUST SOC AM, V86, P1374, DOI 10.1121/1.398697; Brungart DS, 2002, J ACOUST SOC AM, V112, P664, DOI 10.1121/1.1490592; Cameron S, 2009, J AM ACAD AUDIOL, V20, P128, DOI 10.3766/jaaa.20.2.6; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Drullman R, 2000, J ACOUST SOC AM, V107, P2224, DOI 10.1121/1.428503; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; French L., 2009, CARE COMBAT AMPUTEE, P399; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gatehouse S, 2004, INT J AUDIOL, V43, P85, DOI 10.1080/14992020400050014; HEFFNER H, 1975, J NEUROPHYSIOL, V38, P1340, DOI 10.1152/jn.1975.38.6.1340; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P191, DOI 10.1152/jn.1990.64.1.191; Iverson G, 2006, MILD TRAUMATIC BRAIN; Katz J., 1998, SSW TEST MANUAL, Vfifth; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Lister Jennifer J, 2006, Am J Audiol, V15, P133, DOI 10.1044/1059-0889(2006/017); Livingston I., 2010, AFGHANISTAN INDEX; Livingston I, 2010, IRAQ INDEX REPORT; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marrone N, 2008, J ACOUST SOC AM, V124, P3064, DOI 10.1121/1.2980441; May BJ, 2004, ARCH OTOLARYNGOL, V130, P660, DOI 10.1001/archotol.130.5.660; Miller J. D., 2002, P 2002 INT C AUD DIS, P403; Musiek F.E., 2006, AUDITORY SYSTEM ANAT; NOBLE W, 1994, J ACOUST SOC AM, V95, P992, DOI 10.1121/1.408404; POIRIER P, 1995, EXP BRAIN RES, V104, P30; Romigh G, 2009, IEEE WORKSH WASPAA N; Romigh GD, 2015, IEEE J-STSP, V9, P921, DOI 10.1109/JSTSP.2015.2421876; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Saunders GH, 2012, J REHABIL RES DEV, V49, P1043, DOI 10.1682/JRRD.2010.08.0157; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Vaughan N, 2006, J AM ACAD AUDIOL, V17, P506, DOI 10.3766/jaaa.17.7.6; Warren JD, 2003, J NEUROSCI, V23, P5799	45	9	9	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	MAY-JUN	2018	39	3					457	469		10.1097/AUD.0000000000000517			13	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	GQ9WT	WOS:000442150400007	29287039				2022-02-06	
J	Lu, LY; Wang, ML; Yuan, F; Wei, XE; Li, WB				Lu, Liyan; Wang, Mingliang; Yuan, Fang; Wei, Xiaoer; Li, Wenbin			Roles of elevated 20-HETE in the breakdown of blood brain barrier and the severity of brain edema in experimental traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						20-hydroxyeicosatetraenoic acid; blood brain barrier; brain edema; traumatic brain injury	CEREBRAL ISCHEMIA/REPERFUSION; OXIDATIVE STRESS; ARACHIDONIC-ACID; ISCHEMIA; DISRUPTION; INHIBITOR; MATRIX-METALLOPROTEINASE-9; HEMORRHAGE; HET0016	Breakdown of the blood brain barrier (BBB) is a secondary injury following traumatic brain injury (TBI) and can lead to the development of brain edema. However, the factors that contribute to the disruption of the BBB and increase the severity of brain edema in TBI remain to be elucidated. 20-hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid. The inhibition of 20-HETEsynthesis by HET0016 has been suggested as a strategy to decrease brain edema. The present study aimed to investigate whether the elevated production of 20-HETE in cerebral tissue may contribute to BBB breakdown and increase the severity of brain edema in rats with TBI. BBB permeability was quantified using dynamic contrast-enhanced magnetic resonance imaging and brain edema was measured according to brain water content. Superoxide production in injured tissue was also assessed. Liquid chromatography-mass spectrometry was used to evaluate 20-HETE production in injured tissue. Western blot analysis was used to assess the expression of occludin, zonula occludens (ZO)-1, matrix metalloproteinase (MMP)-9, and proteins of the c-Jun N-terminal kinase (JNK) pathway. A total of 3, 24 and 72 h following the induction of TBI, 20-HETE levels, BBB permeability and brain edema were identified to be increased, accompanied by an increase in superoxide production. Conversely, superoxide dismutase levels, in addition to the total antioxidative capability were decreased. In addition, the expression of MMP-9 and proteins of the JNK pathway was upregulated, whereas the expression of occludin and ZO-1 was observed to be suppressed. These results suggested that 20-HETE may aggravate BBB disruption following TBI, via enhancing the expression of MMP-9 and tight junction proteins. Furthermore, oxidative stress and the JNK signaling pathway may be involved in BBB dysregulation. In conclusion, the results of the present demonstrated that the production of 20-HETE was increased in cerebral tissue following traumatic injury, thus suggesting that it may contribute to the compromise of BBB integrity and the development of brain edema.	[Lu, Liyan] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing 210006, Jiangsu, Peoples R China; [Lu, Liyan; Wang, Mingliang; Wei, Xiaoer; Li, Wenbin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China; [Yuan, Fang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China; [Li, Wenbin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar 844000, Xinjiang, Peoples R China		Li, WB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301213, 81271540]	The present study was supported by the National Natural Science Foundation of China (grant nos. 81271540 and 81301213).	Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Cai HX, 2015, NEUROSCI BULL, V31, P550, DOI 10.1007/s12264-015-1533-1; Fordsmann JC, 2013, J NEUROSCI, V33, P2562, DOI 10.1523/JNEUROSCI.2308-12.2013; Garcia V, 2015, PROSTAG OTH LIPID M, V116, P124, DOI 10.1016/j.prostaglandins.2014.12.001; Gasche Y, 2001, J CEREBR BLOOD F MET, V21, P1393, DOI 10.1097/00004647-200112000-00003; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Hanrahan F, 2016, TRANSLATIONAL RES TR; Harder David R., 1994, American Journal of Physiology, V266, pH2098; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Kim JY, 2015, NEUROSCIENCE, V304, P355, DOI 10.1016/j.neuroscience.2015.07.065; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Liu Y, 2012, BRAIN RES, V1445, P73, DOI 10.1016/j.brainres.2012.01.031; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Toth P, 2013, BRIT J PHARMACOL, V168, P1878, DOI 10.1111/bph.12079; Urrutia A, 2013, NEUROBIOL DIS, V50, P49, DOI 10.1016/j.nbd.2012.10.006; Wang GY, 2015, CELL MOL NEUROBIOL, V35, P1105, DOI 10.1007/s10571-015-0204-8; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wu GF, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0287-3; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zhu JC, 2015, DEV NEUROSCI-BASEL, V37, P376, DOI 10.1159/000369007	25	9	9	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2018	17	5					7339	7345		10.3892/mmr.2018.8780			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GD5OR	WOS:000430556800142	29568904	Bronze			2022-02-06	
J	Lubillo, ST; Parrilla, DM; Blanco, J; Morera, J; Dominguez, J; Belmonte, F; Lopez, P; Molina, I; Ruiz, C; Clemente, FJ; Godoy, DA				Lubillo, Santiago T.; Parrilla, Dacil M.; Blanco, Jose; Morera, Jesus; Dominguez, Jaime; Belmonte, Felipe; Lopez, Patricia; Molina, Ismael; Ruiz, Candelaria; Clemente, Francisco J.; Godoy, Daniel A.			Prognostic value of changes in brain tissue oxygen pressure before and after decompressive craniectomy following severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; brain tissue oxygen pressure; decompressive craniectomy; outcome	CEREBRAL HEMODYNAMIC-CHANGES; SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; PERFUSION-PRESSURE; ACUTE MANAGEMENT; ICP; DELIVERY; TENSION; HEMICRANIECTOMY; HYPOTHERMIA	OBJECTIVE In severe traumatic brain injury (TBI), the effects of decompressive craniectomy (DC) on brain tissue oxygen pressure (PbtO(2)) and outcome are unclear. The authors aimed to investigate whether changes in PbtO(2) after DC could be used as an independent prognostic factor. METHODS The authors conducted a retrospective, observational study at 2 university hospital ICUs. The study included 42 patients who were admitted with isolated moderate or severe TBI and underwent intracranial pressure (ICP) and PbtO(2) monitoring before and after DC. The indication for DC was an ICP higher than 25 mm Hg refractory to first-tier medical treatment. Patients who underwent primary DC for mass lesion evacuation were excluded. However, patients were included who had undergone previous surgery as long as it was not a craniectomy. ICP/PbtO(2) monitoring probes were located in an apparently normal area of the most damaged hemisphere based on cranial CT scanning findings. PbtO(2) values were routinely recorded hourly before and after DC, but for comparisons the authors used the first PbtO(2) value on ICU admission and the number of hours with PbtO(2) < 15 mm Hg before DC, as well as the mean PbtO(2) every 6 hours during 24 hours pre-and post-DC. The end point of the study was the 6-month Glasgow Outcome Scale; a score of 4 or 5 was considered a favorable outcome, whereas a score of 1-3 was considered an unfavorable outcome. RESULTS Of the 42 patients included, 26 underwent unilateral DC and 16 bilateral DC. The median Glasgow Coma Scale score at the scene of the accident or at the initial hospital before the patient was transferred to one of the 2 ICUs was 7 (interquartile range [IQR] 4-14). The median time from admission to DC was 49 hours (IQR 7-301 hours). Before DC, the median ICP and PbtO(2) at 6 hours were 35 mm Hg (IQR 28-51 mm Hg) and 11.4 mm Hg (IQR 3-26 mm Hg), respectively. In patients with favorable outcome, PbtO(2) at ICU admission was higher and the percentage of time that pre-DC PbtO(2) was < 15 mm Hg was lower (19 +/- 4.5 mm Hg and 18.25% +/- 21.9%, respectively; n = 28) than in those with unfavorable outcome (12.8 +/- 5.2 mm Hg [p < 0.001] and 59.58% +/- 38.8% [p < 0.001], respectively; n = 14). There were no significant differences in outcomes according to the mean PbtO(2) values only during the last 12 hours before DC, the hours of refractory intracranial hypertension, the timing of DC from admission, or the presence/absence of previous surgery. In contrast, there were significant differences in PbtO(2) values during the 12-to 24-hour period before DC. In most patients, PbtO(2) increased during the 24 hours after DC but these changes were more pronounced in patients with favorable outcome than in those with unfavorable outcome (28.6 +/- 8.5 mm Hg vs 17.2 +/- 5.9 mm Hg, p < 0.0001; respectively). The areas under the curve for the mean PbtO(2) values at 12 and 24 hours after DC were 0.878 (95% CI 0.75-1, p < 0.0001) and 0.865 (95% CI 0.73-1, p < 0.0001), respectively. CONCLUSIONS The authors' findings suggest that changes in PbtO(2) before and after DC, measured with probes in healthy-appearing areas of the most damaged hemisphere, have independent prognostic value for the 6-month outcome in TBI patients.	[Lubillo, Santiago T.; Parrilla, Dacil M.; Belmonte, Felipe; Lopez, Patricia; Molina, Ismael; Ruiz, Candelaria; Clemente, Francisco J.] Hosp Univ NS de Candelaria, ICU, Tenerife, Spain; [Dominguez, Jaime] Hosp Univ NS de Candelaria, Dept Neurosurg, Tenerife, Spain; [Lubillo, Santiago T.; Parrilla, Dacil M.; Blanco, Jose] Hosp Univ Dr Negrin, ICU, Las Palmas Gran Canaria, Spain; [Morera, Jesus] Hosp Univ Dr Negrin, Dept Neurosurg, Las Palmas Gran Canaria, Spain; [Godoy, Daniel A.] NeuroICU Sanatorio Pasteur, Catamarca, Argentina		Lubillo, ST (corresponding author), Hosp Univ NS de Candelaria, ICU Dept, Carretera Rosario 145, Santa Cruz De Tenerife 38010, Spain.	lubimon@gmail.com					Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Jaeger M, 2005, ACT NEUR S, V95, P117; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Le Roux PD, 2013, NEUROSURG CLIN N AM, V24, P427, DOI 10.1016/j.nec.2013.03.001; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Lubillo S, 2011, MED INTENSIVA, V35, P166, DOI 10.1016/j.medin.2010.09.011; Lubillo S, 2002, INTENS CARE MED, V28, pS191; Lubillo S, 2009, MED INTENSIVA, V33, P74, DOI 10.1016/S0210-5691(09)70685-0; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meier U, 2008, ACTA NEUROCHIR SUPPL, V102, P29, DOI 10.1007/978-3-211-85578-2_6; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Walcott BP, 2013, WORLD NEUROSURG, V79, P80, DOI 10.1016/j.wneu.2012.11.014; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	51	9	10	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2018	128	5					1538	1546		10.3171/2017.1.JNS161840			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2HQ	WOS:000440650000033	28665250	Bronze			2022-02-06	
J	Mikkonen, J; Moustgaard, H; Remes, H; Martikainen, P				Mikkonen, Janne; Moustgaard, Heta; Remes, Hanna; Martikainen, Pekka			The Population Impact of Childhood Health Conditions on Dropout from Upper-Secondary Education	JOURNAL OF PEDIATRICS			English	Article							POISSON REGRESSION APPROACH; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; YOUNG-ADULTS; ADOLESCENT HEALTH; ACADEMIC-PERFORMANCE; CANCER SURVIVORS; SCHOOL DROPOUT; FOLLOW-UP; ATTAINMENT	Objectives To quantify how large a part of educational dropout is due to adverse childhood health conditions and to estimate the risk of dropout across various physical and mental health conditions. Study design A registry-based cohort study was conducted on a 20% random sample of Finns born in 1988-1995 (n = 101 284) followed for school dropout at ages 17 and 21. Four broad groups of health conditions (any, somatic, mental, and injury) and 25 specific health conditions were assessed from inpatient and outpatient care records at ages 10-16 years. We estimated the immediate and more persistent risks of dropout due to health conditions and calculated population-attributable fractions to quantify the population impact of childhood health on educational dropout, while accounting for a wide array of sociodemographic confounders and comorbidity. Results Children with any health condition requiring inpatient or outpatient care at ages 10-16 years were more likely to be dropouts at ages 17 years (risk ratio 1.71, 95% CI 1.61-1.81) and 21 years (1.46, 1.37-1.54) following adjustment for individual and family sociodemographic factors. A total of 30% of school dropout was attributable to health conditions at age 17 years and 21% at age 21 years. Mental disorders alone had an attributable fraction of 11% at age 21 years, compared with 5% for both somatic conditions and injuries. Adjusting for the presence of mental disorders reduced the effects of somatic conditions. Conclusions More than one fifth of educational dropout is attributable to childhood health conditions. Early-onset mental disorders emerge as key targets in reducing dropout.	[Mikkonen, Janne; Moustgaard, Heta; Remes, Hanna; Martikainen, Pekka] Univ Helsinki, Fac Social Sci, Populat Res Unit, POB 18, FIN-00014 Helsinki, Finland; [Martikainen, Pekka] Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies CHESS, Stockholm, Sweden; [Martikainen, Pekka] Max Planck Inst Demog Res, Rostock, Germany		Mikkonen, J (corresponding author), Univ Helsinki, Fac Social Sci, Populat Res Unit, POB 18, FIN-00014 Helsinki, Finland.	janne.mk.mikkonen@helsinki.fi		Mikkonen, Janne/0000-0002-9410-9335; Martikainen, Pekka/0000-0001-9374-1438; Moustgaard, Heta/0000-0001-6632-4727	Academy of FinlandAcademy of FinlandEuropean Commission [294861]; Strategic Research Council of Finland [303615]	Supported by the Academy of Finland (294861) and the Strategic Research Council of Finland (303615). The authors declare no conflicts of interest.	Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Barbaresi WJ, 2007, J DEV BEHAV PEDIATR, V28, P265, DOI 10.1097/DBP.0b013e31811ff87d; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; BIEDERMAN J, 1995, J AM ACAD CHILD PSY, V34, P579, DOI 10.1097/00004583-199505000-00010; Boardman JD, 2015, SOC SCI MED, V127, P171, DOI 10.1016/j.socscimed.2014.08.001; Boman KK, 2010, CANCER-AM CANCER SOC, V116, P1385, DOI 10.1002/cncr.24840; Breslau J, 2011, J PSYCHIATR RES, V45, P295, DOI 10.1016/j.jpsychires.2010.06.014; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Champaloux SW, 2015, J ADOLESCENT HEALTH, V56, P98, DOI 10.1016/j.jadohealth.2014.07.016; Currie J, 2010, J HUM RESOUR, V45, P517; De Ridder KAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074954; De Ridder KAA, 2012, J EPIDEMIOL COMMUN H, V66, P995, DOI 10.1136/jech-2011-200047; Ding W, 2009, J HEALTH ECON, V28, P578, DOI 10.1016/j.jhealeco.2008.11.006; Evensen M, 2016, EUR SOCIOL REV, V32, P552, DOI 10.1093/esr/jcw001; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Finnish National Agency for Education , 2018, ED SYST; Fletcher JM, 2008, HEALTH ECON, V17, P1215, DOI 10.1002/hec.1319; Fletcher JM, 2012, HEALTH AFFAIR, V31, P27, DOI 10.1377/hlthaff.2011.0862; Fletcher JM, 2010, HEALTH ECON, V19, P855, DOI 10.1002/hec.1526; Flouri E, 2007, EDUC PSYCHOL-UK, V27, P737, DOI 10.1080/01443410701309282; Freudenberg Nicholas, 2007, Prev Chronic Dis, V4, pA107; Fried R, 2016, J ATTEN DISORD, V20, P383, DOI 10.1177/1087054712473180; Frissen A, 2015, SOC PSYCH PSYCH EPID, V50, P1511, DOI 10.1007/s00127-015-1082-6; Ghaderi S, 2016, J CANCER SURVIV, V10, P87, DOI 10.1007/s11764-015-0453-z; Goodman A, 2011, P NATL ACAD SCI USA, V108, P6032, DOI 10.1073/pnas.1016970108; Goulding SM, 2010, SCHIZOPHR RES, V116, P228, DOI 10.1016/j.schres.2009.09.006; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Haas SA, 2008, J HEALTH SOC BEHAV, V49, P178, DOI 10.1177/002214650804900205; Hale DR, 2015, PEDIATRICS, V136, P128, DOI 10.1542/peds.2014-2105; Isohanni I, 2001, PSYCHOL MED, V31, P339, DOI 10.1017/S003329170100304X; Jackson MI, 2009, DEMOGRAPHY, V46, P671, DOI 10.1353/dem.0.0078; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koch SV, 2004, BRIT J CANCER, V91, P923, DOI 10.1038/sj.bjc.6602085; Kokkonen J, 1997, J NEUROL NEUROSUR PS, V62, P265, DOI 10.1136/jnnp.62.3.265; Kroger H, 2015, EUR J PUBLIC HEALTH, V25, P951, DOI 10.1093/eurpub/ckv111; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Lancashire ER, 2010, J NATL CANCER I, V102, P254, DOI 10.1093/jnci/djp498; Layte R, 2013, SOC PSYCH PSYCH EPID, V48, P1307, DOI 10.1007/s00127-012-0609-3; Lewinsohn PM, 2000, AM J PSYCHIAT, V157, P1584, DOI 10.1176/appi.ajp.157.10.1584; LLOYD CE, 1992, DIABETIC MED, V9, P661, DOI 10.1111/j.1464-5491.1992.tb01863.x; Lynch JL, 2016, SOC SCI MED, V154, P18, DOI 10.1016/j.socscimed.2016.02.029; Malmgren K, 1998, BEHAV DISORDERS, V23, P257; Maslow GR, 2011, J ADOLESCENT HEALTH, V49, P206, DOI 10.1016/j.jadohealth.2010.12.001; MAYBERRY MK, 1992, GUT, V33, P312, DOI 10.1136/gut.33.3.312; Maynard BR, 2015, COMMUNITY MENT HLT J, V51, P289, DOI 10.1007/s10597-014-9760-5; Mazurek JM, 2012, AM J EPIDEMIOL, V175, P279, DOI 10.1093/aje/kwr300; McLeod JD, 2012, J HEALTH SOC BEHAV, V53, P482, DOI 10.1177/0022146512462888; Melkevik O, 2016, ADOLESC RES REV, V1, P245, DOI 10.1007/s40894-016-0024-1; Ministry of Social Affairs and Health, 2013, HLTH CAR FINL; Needham BL, 2009, J ADOLESCENT HEALTH, V45, P179, DOI 10.1016/j.jadohealth.2008.12.015; Organisation for Economic Co-operation and Development, 2012, EQ QUAL ED SUPP DIS; Palloni A, 2006, DEMOGRAPHY, V43, P587, DOI 10.1353/dem.2006.0036; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; Ristikari T., 2016, SUOMI NUORTEN KASVUY; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; ROSS S, 1992, BRIT MED J, V305, P545, DOI 10.1136/bmj.305.6853.545; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Singh H, 2015, J PEDIATR-US, V166, P1128, DOI 10.1016/j.jpeds.2014.12.010; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Statistics Finland, 2016, DISC ED; Statistics Finland, 2017, FAMILIES; Suhrcke M., 2011, IMPACT HLTH HLTH BEH; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Uiters E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1104; van der Heide I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168110; van Heesch MMJ, 2012, EUR J PUBLIC HEALTH, V22, P550, DOI 10.1093/eurpub/ckr129; Vander Stoep A, 2003, J BEHAV HEALTH SER R, V30, P119, DOI 10.1007/BF02287817; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wennick A, 2011, PEDIATR DIABETES, V12, P619, DOI 10.1111/j.1399-5448.2011.00757.x; WEST P, 1991, SOC SCI MED, V32, P373, DOI 10.1016/0277-9536(91)90338-D; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	73	9	9	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2018	196						283	+		10.1016/j.jpeds.2018.01.034			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GG1MY	WOS:000432452300051	29551321	Green Published, hybrid			2022-02-06	
J	Vanderploeg, RD; Cooper, DB; Curtiss, G; Kennedy, JE; Tate, DF; Bowles, AO				Vanderploeg, Rodney D.; Cooper, Douglas B.; Curtiss, Glenn; Kennedy, Jan E.; Tate, David F.; Bowles, Amy O.			Predicting Treatment Response to Cognitive Rehabilitation in Military Service Members With Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						mild traumatic brain injury; cognitive rehabilitation; clinical trial; postconcussive syndrome; posttraumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; OF-THE-LITERATURE; RESIDENTIAL-TREATMENT; COMMITMENT THERAPY; PROLONGED EXPOSURE; SYMPTOMS; VETERANS; PTSD; POSTCONCUSSION; ACCEPTANCE	Objective: Determine factors that affect responsiveness to cognitive rehabilitation (CR) interventions in service members (SMs) who sustained mild traumatic brain injury (mTBI). Method: 126 SMs with a history of mTBI 3 to 24 months postinjury participated in a randomized clinical trial of one of four, 6-week treatment arms: (a) psychoeducation, (b) computer-based CR, (c) therapist-directed manualized CR, and (d) therapist-directed CR integrated with cognitive-behavioral psychotherapy. Practice-adjusted reliable change scores (RCS) were calculated for the three primary outcome measures: Paced Auditory Serial Addition Test (PASAT), Symptom Checklist-90 Revised (SCL-90-R) Global Severity Index (GSI), and Key Behaviors Change Inventory (KBCI). Hierarchical logistic regression was used to predict RCS. Variables considered were: (a) demographic, (b) injury characteristics, (c) comorbid mental health conditions, (d) nonspecific treatment variables (i.e., team vs. no-team milieu), and (e) specific treatment elements. Results: No predictor variables were associated with RCS improvements on the PASAT or the SCL-90-R. Comorbid depression (p < .02) and team-treatment milieu (p < .02) were associated with RCS improvement on the KBCI. Specific CR (ps > .65) and psychotherapy treatments (p > .26) were not associated with improvements on any outcome. There was evidence that self-administered computer CR was not only not beneficial, but negatively associated with cognitive and neurobehavioral improvement. Conclusions: Although reliable improvements were found on the PASAT and KBCI, no specific treatment intervention effects were found. Rather, comorbid depression and team-milieu treatment environment were associated with improvement, but only on the KBCI. Comorbid depression was associated with higher rates of improvement.	[Vanderploeg, Rodney D.] James A Haley Vet Hosp, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Cooper, Douglas B.] San Antonio VA Polytrauma Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Curtiss, Glenn] James A Haley Vet Affairs Med Ctr, Tampa, FL USA; [Curtiss, Glenn] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Kennedy, Jan E.] Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Kennedy, Jan E.] Brooke Army Med Ctr, Dept Neurol, San Antonio, TX USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA; [Bowles, Amy O.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, San Antonio, TX USA		Vanderploeg, RD (corresponding author), ABPP CN, 5322 Primrose Lake Circle,Sutie G D Vande, Tampa, FL 33647 USA.	rdv53@aol.com	Tate, David F/I-3963-2013; Curtiss, Glenn/ABB-5566-2020	Tate, David F/0000-0003-0213-1920; 	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [VA HSRD IIR 13-196-1]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs [VA CSRD W81XWH-13-2-0095]; Telemedicine and Advanced Technology Research Center [ERMS 12286030]; Brooke Army Medical Center, Joint Base San Antonio	Psychoeducational materials were based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service (VA HSR&D IIR 13-196-1), and Clinical Sciences Research and Development (VA CSRD W81XWH-13-2-0095). Data management was supported by the Telemedicine and Advanced Technology Research Center (Grant ERMS 12286030) to David F. Tate. This work is the result of work supported with resources and the use of the facilities at Brooke Army Medical Center, Joint Base San Antonio. Research staff and resources were provided in part by the Defense and Veterans Brain Injury Center (DVBIC) and the TATRC. Individuals providing the interventions were Department of the Army civilian employees.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; EGAN V, 1988, PERS INDIV DIFFER, V9, P179, DOI 10.1016/0191-8869(88)90046-3; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hayes SC., 1999, ACCEPTANCE COMMITMEN; HEITJAN DF, 1991, J R STAT SOC C-APPL, V40, P13; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Institute of Medicine, 2011, COGN REH THER TRAUM; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MCCAFFREY RJ, 1995, ARCH CLIN NEUROPSYCH, V10, P241, DOI 10.1016/0887-6177(94)00048-U; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nelson LA, 2013, NEUROPSYCHOLOGY, V27, P666, DOI 10.1037/a0034117; Ost LG, 2014, BEHAV RES THER, V61, P105, DOI 10.1016/j.brat.2014.07.018; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Powers MB, 2009, PSYCHOTHER PSYCHOSOM, V78, P73, DOI 10.1159/000190790; Ruiz F. J., 2012, INT J PSYCHOL, DOI DOI 10.1016/J.BETH.2011.07.004; Schenker N, 1996, COMPUT STAT DATA AN, V22, P425, DOI 10.1016/0167-9473(95)00057-7; Schmitt JS, 2004, J CLIN EPIDEMIOL, V57, P1008, DOI 10.1016/j.jclinepi.2004.02.007; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Walter KH, 2012, J TRAUMA STRESS, V25, P426, DOI 10.1002/jts.21722; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029	50	9	9	1	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2018	63	2					194	204		10.1037/rep0000215			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GI5ON	WOS:000434420400004	29878826				2022-02-06	
J	Wang, JP; Zhang, YM				Wang, Jianping; Zhang, Yamin			Neuroprotective effect of berberine agonist against impairment of learning and memory skills in severe traumatic brain injury via Sirt1/p38 MAPK expression	MOLECULAR MEDICINE REPORTS			English	Article						berberine; severe traumatic brain injury; learning and memory; p38 mitogen-activated protein kinase	CRITICALLY-ILL PATIENTS; CEREBRAL-BLOOD-FLOW; CONTROLLED-TRIAL; RAT MODEL; DISEASE; APOPTOSIS; BARRIER	Berberine has multiple clinical applications, including the treatment of tumors, diabetes, cardiovascular diseases, hyperlipidemia, inflammation, bacterial and viral infections, cerebral ischemic injuries, mental diseases, Alzheimer's disease and osteoporosis. In the present study, the neuroprotective effect of berberine agonist rescue learning and memory in severe traumatic brain injury (TBI), and the possible mechanism underlying these observations was explored. The protective effect of berberine agonist significantly recovered learning and memory skills, attenuated brain edema and inhibited matrix metalloproteinase-3 and -9 protein expression in mice with severe TBI. Berberine agonist significantly reduced inflammation, oxidative stress and apoptosis levels in mice with severe TBI. Berberine agonist promoted choline acetyltransferase activity and inhibited the activity of acetylcholinesterase. Collectively, results of the present study revealed that the neuroprotective effect of berberine agonist rescues learning and memory skills in severe TBI.	[Wang, Jianping] Gansu Prov Hosp, Dept Emergency, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China; [Zhang, Yamin] Gansu Prov Hosp, Dept Neurol Rehabil, Lanzhou 730000, Gansu, Peoples R China		Wang, JP (corresponding author), Gansu Prov Hosp, Dept Emergency, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China.	wzekyr2926206@126.com					Bentz K, 2010, CELL PHYSIOL BIOCHEM, V26, P821, DOI 10.1159/000323991; Cha Y, 2017, TOXICOL APPL PHARM, V314, P48, DOI 10.1016/j.taap.2016.11.008; Chuang CH, 2013, ACUPUNCT MED, V31, P395, DOI 10.1136/acupmed-2013-010406; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Du GL, 2016, NEUROL RES, V38, P1012, DOI 10.1080/01616412.2016.1240393; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Habtemariam S, 2016, PHARMACOL RES, V113, P592, DOI 10.1016/j.phrs.2016.09.041; Hammond FM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0609-0; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Ma L, 2015, EUR J PHARMACOL, V755, P102, DOI 10.1016/j.ejphar.2015.02.039; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Nageli M, 2014, CRIT CARE, V18, DOI 10.1186/cc13962; Pineda RG, 2014, J PEDIATR-US, V164, P52, DOI 10.1016/j.jpeds.2013.08.047; Reinhard SM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00280; Saxena MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144740; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wiggins-Dohlvik K, 2014, AM J SURG, V208, P954, DOI 10.1016/j.amjsurg.2014.08.014; Yang Y, 2017, MOL MED REP, V15, P97, DOI 10.3892/mmr.2016.5980; Zhang J, 2009, SAUDI MED J, V30, P760	25	9	9	3	17	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2018	17	5					6881	6886		10.3892/mmr.2018.8674			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GD5OR	WOS:000430556800084	29512719	Bronze			2022-02-06	
J	Wennberg, R; Hiploylee, C; Tai, P; Tator, CH				Wennberg, Richard; Hiploylee, Carmen; Tai, Peter; Tator, Charles H.			Is Concussion a Risk Factor for Epilepsy?	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Convulsion; Incidence; Mild traumatic brain injury (mTBI); Prevalence; Seizure	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC EPILEPSY; HEAD-INJURY; SEIZURES; CONVULSIONS; SPORT; EPIDEMIOLOGY; STATEMENT	Background: Epidemiologic studies have suggested that concussion, or mild traumatic brain injury (mTBI), is associated with a twofold or greater increase in relative risk for the development of post-traumatic epilepsy. To assess the clinical validity of these findings, we analyzed the incidence of epilepsy in a large cohort of post-concussion patients in whom concussion was strictly defined according to international guidelines. Methods: A retrospective cohort study of 330 consecutive post-concussion patients followed by a single concussion specialist. Exclusion criteria: abnormal brain CT/MRI, Glasgow Coma Scale < 13 more than 1-hour post-injury, hospitalization >48 hours. Independent variable: concussion. Outcome measure: epilepsy incidence (dependent variable). Results: The mean number of concussions/patient was 3.3 (+/- 2.5), mean age at first clinic visit 28 years (+/- 14.7), and mean follow-up after first concussion 7.6 years (+/- 10.8). Eight patients were identified whose medical records included mention of seizures or convulsions or epilepsy. Upon review by an epileptologist none met criteria for a definite diagnosis of epilepsy: four had episodic symptoms incompatible with epileptic seizures (e.g., multifocal paraesthesiae, multimodality hallucinations, classic migraine) and normal EEG/MRI investigations; four had syncopal (n = 2) or concussive (n = 2) convulsions. Compared with annual incidence (0.5/1000 individuals) in the general population, there was no difference in this post-concussion cohort (p = 0.49). Conclusion: In this large cohort of post-concussion patients we found no increased incidence of epilepsy. For at least the first 5-10 years post-injury, concussion/mTBI should not be considered a significant risk factor for epilepsy. In patients with epilepsy and a past history of concussion, the epilepsy should not be presumed to be post-traumatic.	[Wennberg, Richard; Hiploylee, Carmen; Tator, Charles H.] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Wennberg, Richard; Tai, Peter] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurol, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada		Wennberg, R (corresponding author), Toronto Western Hosp, 399 Bathurst St,Suite 5W444, Toronto, ON M5T 2S8, Canada.	richard.wennberg@uhn.ca					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; Chadwick D, 1997, BRIT MED J, V314, P1283; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ellis MJ, 2016, CAN MED ASSOC J, V188, P443, DOI 10.1503/cmaj.150124; Elvidge A, 1939, T AM NEUROL ASSOC, V65, P125; Epilepsy Foundation, EP BAS WHAT AR RISK; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jennet B, 1975, EPILEPSY NONMISSILE; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McGinty RN, 2016, EPILEPSIA, V57, P1009, DOI 10.1111/epi.13393; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Pickett William, 2004, Chronic Dis Can, V25, P32; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Shorvon S, 2009, LANCET, V373, P1060, DOI 10.1016/S0140-6736(09)60215-4; Tai PC, 2004, CAN J NEUROL SCI, V31, P394, DOI 10.1017/S0317167100003516; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039	43	9	10	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2018	45	3					275	282		10.1017/cjn.2017.300			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF8MQ	WOS:000432227200005	29557322	hybrid			2022-02-06	
J	Mang, CS; Whitten, TA; Cosh, MS; Scott, SH; Wiley, JP; Debert, CT; Dukelow, SP; Benson, BW				Mang, Cameron S.; Whitten, Tara A.; Cosh, Madeline S.; Scott, Stephen H.; Wiley, J. Preston; Debert, Chantel T.; Dukelow, Sean P.; Benson, Brian W.			Test-retest reliability of the KINARM end-point robot for assessment of sensory, motor and neurocognitive function in young adult athletes	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ICE HOCKEY PLAYERS; CONCUSSION ASSESSMENT; VALIDITY; STROKE; SENSORIMOTOR; SYMPTOMS; SPORTS; TRAIL; AGE	Background Current assessment tools for sport-related concussion are limited by a reliance on subjective interpretation and patient symptom reporting. Robotic assessments may provide more objective and precise measures of neurological function than traditional clinical tests. Objective To determine the reliability of assessments of sensory, motor and cognitive function conducted with the KINARM end-point robotic device in young adult elite athletes. Methods Sixty-four randomly selected healthy, young adult elite athletes participated. Twenty-five individuals (25 M, mean age +/- SD, 20.2 +/- 2.1 years) participated in a within-season study, where three assessments were conducted within a single season (assessments labeled by session: S1, S2, S3). An additional 39 individuals (28M; 22.8 +/- 6.0 years) participated in a year-to-year study, where annual pre-season assessments were conducted for three consecutive seasons (assessments labeled by year: Y1, Y2, Y3). Forty-four parameters from five robotic tasks (Visually Guided Reaching, Position Matching, Object Hit, Object Hit and Avoid, and Trail Making B) and overall Task Scores describing performance on each task were quantified. Results Test-retest reliability was determined by intra-class correlation coefficients (ICCs) between the first and second, and second and third assessments. In the within-season study, ICCs were >= 0.50 for 68% of parameters between S1 and S2, 80% of parameters between S2 and S3, and for three of the five Task Scores both between S1 and S2, and S2 and S3. In the year-to-year study, ICCs were >= 0.50 for 64% of parameters between Y1 and Y2, 82% of parameters between Y2 and Y3, and for four of the five Task Scores both between Y1 and Y2, and Y2 and Y3. Conclusions Overall, the results suggest moderate-to-good test-retest reliability for the majority of parameters measured by the KINARM robot in healthy young adult elite athletes. Future work will consider the potential use of this information for clinical assessment of concussion-related neurological deficits.	[Mang, Cameron S.; Whitten, Tara A.; Debert, Chantel T.; Dukelow, Sean P.; Benson, Brian W.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Mang, Cameron S.; Whitten, Tara A.; Debert, Chantel T.; Dukelow, Sean P.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Cosh, Madeline S.; Benson, Brian W.] Winter Sport Inst, WinSport Med Clin, Calgary, AB, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Wiley, J. Preston; Dukelow, Sean P.; Benson, Brian W.] Univ Calgary, Sport Med Ctr, Fac Kinesiol, Calgary, AB, Canada; [Benson, Brian W.] Canadian Sport Inst Calgary, Calgary, AB, Canada		Mang, CS (corresponding author), Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada.; Mang, CS (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	cameron.mang@ucalgary.ca		Mang, Cameron/0000-0002-3376-5355; Debert, Chantel/0000-0002-2704-0438; Dukelow, Sean/0000-0002-0609-981X	Own the Podium Canada; Canadian Academy of Sport and Exercise Medicine Research Fund; Canadian Sport Institute Calgary; Calgary, Alberta; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Mitacs fellowship; Alberta Innovates [201500083] Funding Source: researchfish	This work was funded by Own the Podium Canada, the Canadian Academy of Sport and Exercise Medicine Research Fund, the Canadian Sport Institute Calgary and Jim Smith of Calgary, Alberta (BWB). CSM was funded by post-doctoral fellowships from the Canadian Institutes of Health Research and Alberta Innovates Health Solutions. TAW was funded by a Mitacs fellowship in partnership with Own the Podium Canada.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; BLEECKER ML, 1987, DEV NEUROPSYCHOL, V3, P165, DOI 10.1080/87565648709540372; Bourke TC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0201-2; Brett B. L., 2016, ARCH CLIN NEUROPSYCH; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Cohen J., 2013, STAT POWER ANAL BEHA; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dukelow SP, 2017, INT J STROKE, V12, P7, DOI 10.1177/1747493016654483; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kane M, 2004, APPL MEAS EDUC, V17, P221, DOI 10.1207/s15324818ame1703_1; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kenzie JM, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0329-8; Little CE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0195-9; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, DOI [10.1109/JTEHM.2015.2424224, DOI 10.1109/JTEHM.2015.2424224]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean D, 2016, DEXTERIT E 3 6 USER; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Otaka E, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0059-8; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Salarian A., 2008, MATLAB CENTRAL FILE; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Simmatis L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188786; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Subbian V, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2424224; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	47	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196205	10.1371/journal.pone.0196205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7GN	WOS:000430678800031	29689075	Green Published, Green Submitted, gold			2022-02-06	
J	Zhang, L; Zhang, L; Liu, HX; Jiang, F; Wang, HJ; Li, D; Gao, R				Zhang, Ling; Zhang, Li; Liu, Huixiang; Jiang, Feng; Wang, Huanjing; Li, Di; Gao, Rong			Inhibition of Epac2 Attenuates Neural Cell Apoptosis and Improves Neurological Deficits in a Rat Model of Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; Epac2; P38; apoptosis; neuroprotection	ACTIVATED PROTEIN-KINASE; CEREBRAL ISCHEMIA/REPERFUSION; NEURONAL DEATH; MAP KINASES; P38; NEUROPROTECTION; MECHANISM; STRESS; TARGET; GROWTH	Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. TBI-induced neuronal apoptosis is one of the main contributors to the secondary injury process. The aim of this study is to investigate the involvement of Exchange protein directly activated by cAMP 2 (Epac2) on TBI. We found that the expression level of Epac2 surrounding the injured area of brain in rats of TBI model was significantly increased at 12 h after TBI. The role of Epac2 in TBI was further explored by using a selective Epac2 antagonist ESI-05 to decrease the Epac2 expression. We discovered that inhibition of Epac2 could improve the neurological impairment and attenuate brain edema following TBI. The Epac2 inhibition effectively reduced neuronal cell death and P38 MAPK signaling pathway may be involved in this process. Our results suggest that inhibition of Epac2 may be a potential therapy for TBI by reducing the neural cell death, alleviating brain edema and improving neurologic deficits.	[Zhang, Ling; Li, Di] First Peoples Hosp Zhangjiagang, Translat Med Ctr, Zhangjiagang, Peoples R China; [Zhang, Ling; Zhang, Li; Liu, Huixiang; Jiang, Feng; Gao, Rong] First Peoples Hosp Zhangjiagang, Dept Neurosurg, Zhangjiagang, Peoples R China; [Wang, Huanjing] Zhangjiagang Hosp Tradit Chinese Med, Dept Neurosurg, Zhangjiagang, Peoples R China		Li, D (corresponding author), First Peoples Hosp Zhangjiagang, Translat Med Ctr, Zhangjiagang, Peoples R China.; Gao, R (corresponding author), First Peoples Hosp Zhangjiagang, Dept Neurosurg, Zhangjiagang, Peoples R China.	lidilab@sina.com; lidi715@163.com					Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Calderon-Sanchez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147375; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Emery AC, 2017, J BIOL CHEM, V292, P12220, DOI 10.1074/jbc.M117.790329; Fernandes HB, 2015, J NEUROSCI, V35, P6544, DOI 10.1523/JNEUROSCI.0314-14.2015; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gutierrez-Uzquiza A, 2010, CELL SIGNAL, V22, P533, DOI 10.1016/j.cellsig.2009.11.008; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Harada J, 1999, JPN J PHARMACOL, V79, P369, DOI 10.1254/jjp.79.369; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Lee K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0130-1; Li D, 2017, BRAIN RES, V1654, P1, DOI 10.1016/j.brainres.2016.10.013; Li H, 2015, J NEUROL SCI, V357, P270, DOI 10.1016/j.jns.2015.08.004; Liu XW, 2014, MOL MED REP, V10, P1942, DOI 10.3892/mmr.2014.2402; Lu L, 2016, CANCER MED-US, V5, P3544, DOI 10.1002/cam4.946; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Matsuda M, 2017, ANESTHESIOLOGY, V126, P150, DOI 10.1097/ALN.0000000000001401; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Oldenburger A, 2014, FASEB J, V28, P4617, DOI 10.1096/fj.13-248930; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Park JY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.152; Parnell E, 2015, TRENDS PHARMACOL SCI, V36, P203, DOI 10.1016/j.tips.2015.02.003; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Priego N, 2016, ONCOTARGET, V7, P45060, DOI 10.18632/oncotarget.9911; Rehmann H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03032; Seo H, 2016, BMB REP, V49, P128, DOI 10.5483/BMBRep.2016.49.2.202; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Strassburger M, 2008, EUR J PHARMACOL, V592, P55, DOI 10.1016/j.ejphar.2008.06.099; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Takeda K, 2002, GENES CELLS, V7, P1099, DOI 10.1046/j.1365-2443.2002.00591.x; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Wang WB, 2015, J NEUROL SCI, V348, P121, DOI 10.1016/j.jns.2014.11.018; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143777; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yang ZK, 2017, ANTIOXID REDOX SIGN, V27, P117, DOI 10.1089/ars.2015.6485; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256	45	9	9	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 23	2018	12								263	10.3389/fnins.2018.00263			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD5VP	WOS:000430575400001	29740274	Green Published, gold			2022-02-06	
J	Akhand, O; Galetta, MS; Cobbs, L; Hasanaj, L; Webb, N; Drattell, J; Amorapanth, P; Rizzo, JR; Nolan, R; Serrano, L; Rucker, JC; Cardone, D; Jordan, BD; Silverio, A; Galetta, SL; Balcer, LJ				Akhand, Omar; Galetta, Matthew S.; Cobbs, Lucy; Hasanaj, Lisena; Webb, Nikki; Drattell, Julia; Amorapanth, Prin; Rizzo, John-Ross; Nolan, Rachel; Serrano, Liliana; Rucker, Janet C.; Cardone, Dennis; Jordan, Barry D.; Silverio, Arlene; Galetta, Steven L.; Balcer, Laura J.			The new Mobile Universal Lexicon Evaluation System (MULES): A test of rapid picture naming for concussion sized for the sidelines	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Sports; Picture naming; Mobile Universal Lexicon Evaluation System (MULES); Saccades; Vision	CEREBRAL-DYSFUNCTION; EXECUTIVE FUNCTIONS; PERIRHINAL CORTEX; ADOLESCENT BRAIN; HEAD-INJURY; MATURATION; CHILDREN; DISABILITIES; RECOGNITION; PERFORMANCE	Objective: Measures of rapid automatized naming (RAN) have been used for over 50 years to capture vision based aspects of cognition. The Mobile Universal Lexicon Evaluation System (MULES) is a test of rapid picture naming under investigation for detection of concussion and other neurological disorders. MULES was designed as a series of 54 grouped color photographs (fruits, random objects, animals) that integrates saccades, color perception and contextual object identification. Recent changes to the MULES test have been made to improve ease of use on the athletic sidelines. Originally an 11 x 17-inch single-sided paper, the test has been reduced to a laminated 8.5 x 11-inch double-sided version. We identified performance changes associated with transition to the new, MULES, now sized for the sidelines, and examined MULES on the sideline for sports-related concussion. Methods: We administered the new laminated MULES to a group of adult office volunteers as well as youth and collegiate athletes during pre-season baseline testing. Athletes with concussion underwent sideline testing after injury. Time scores for the new laminated MULES were compared to those for the larger version (big MULES). Results: Among 501 athletes and office volunteers (age 16 7 years, range 6-59, 29% female), average test times at baseline were 44.4 14.4 s for the new laminated MULES (n = 196) and 46.5 16.3 s for big MULES (n = 248). Both versions were completed by 57 participants, with excellent agreement (p < 0.001, linear regression, accounting for age). Age was a predictor of test times for both MULES versions, with longer times noted for younger participants (p < 0.001). Among 6 athletes with concussion thus far during the fall sports season (median age 15 years, range 11-21) all showed worsening of MULES scores from pre-season baseline (median 4.0 s, range 2.1-16.4). Conclusion: The MULES test has been converted to an 11 x 8.5-inch laminated version, with excellent agreement between versions across age groups. Feasibly administered at pre-season and in an office setting, the MULES test shows preliminary evidence of capacity to identify athletes with sports-related concussion.	[Akhand, Omar; Galetta, Matthew S.; Cobbs, Lucy; Hasanaj, Lisena; Rizzo, John-Ross; Nolan, Rachel; Serrano, Liliana; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Amorapanth, Prin; Rizzo, John-Ross] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Silverio, Arlene] NYU, Sch Med, Dept Orthopaed, Primary Care Sports Med, New York, NY USA; [Webb, Nikki; Cardone, Dennis] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Drattell, Julia] NYU, Dept Recreat & Athlet, New York, NY USA; [Jordan, Barry D.] Burke Rehabil Hosp, White Plains, NY USA		Balcer, LJ (corresponding author), NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.	omar.akhand@nyumc.org; matthew.galetta@nyumc.org; lucy.cobbs@nyumc.org; lisena.hasanaj@nyumc.org; nikki.webb@nyu.edu; julia.drattell@nyumc.org; prin.amorapanth@nyumc.org; johnross.rizzo@nyumc.org; rachel.nolan@nyumc.org; liliana.serrano2@nyumc.org; janet.rucker@nyumc.org; dennis.cardone@nyumc.org; bjordan@burke.org; steven.galetta@nyumc.org; laura.balcer@nyumc.org		Drattell, Julia/0000-0003-2982-4890; Amorapanth, Prin/0000-0002-4260-7826; Rizzo, John-Ross/0000-0002-4084-0085; Rucker, Janet/0000-0002-0397-0999	NYU School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER	This study was supported in part by the NYU School of Medicine.	Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Balcer LJ, 2017, MULT SCLER J, V23, P734, DOI 10.1177/1352458517690822; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Denckla M.B., 1974, CORTEX, V10, P185; DENCKLA MB, 1976, BRAIN LANG, V3, P1, DOI 10.1016/0093-934X(76)90001-8; Denckla MB, 1999, ANN DYSLEXIA, V49, P29, DOI 10.1007/s11881-999-0018-9; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K. M., 2016, KING DEVICK TEST RAP, V2; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GESCHWIND N, 1966, ARCH NEUROL-CHICAGO, V15, P137, DOI 10.1001/archneur.1966.00470140027004; Gilbert L. C., 1953, U CALIFORNIA PUBLICA, V11; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Kandel Eric R, 2012, THE AGE OF INSIGHT; Kellenbach ML, 2005, CORTEX, V41, P121, DOI 10.1016/S0010-9452(08)70887-6; Klenberg L, 2001, DEV NEUROPSYCHOL, V20, P407, DOI 10.1207/S15326942DN2001_6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRocca NG, 2018, MULT SCLER J, V24, P1469, DOI 10.1177/1352458517723718; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Norman Geschwind, 1967, CORTEX, V3, P97; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roy JE, 2014, J COGNITIVE NEUROSCI, V26, P1283, DOI 10.1162/jocn_a_00568; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Seymour KJ, 2016, CEREB CORTEX, V26, P1997, DOI 10.1093/cercor/bhv021; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Watson HC, 2013, J NEUROSCI, V33, P4192, DOI 10.1523/JNEUROSCI.2075-12.2013; Wells F.L., 1945, MENTAL EXAMINERS HDB; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230	43	9	9	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	APR 15	2018	387						199	204		10.1016/j.jns.2018.02.031			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GD8PX	WOS:000430775700037	29571863	Green Accepted			2022-02-06	
J	Alsalaheen, B; Bean, R; Almeida, A; Eckner, J; Lorincz, M				Alsalaheen, Bara; Bean, Ryan; Almeida, Andrea; Eckner, James; Lorincz, Matthew			Characterization of cervical neuromuscular response to head-neck perturbation in active young adults	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Sternocleidomastoid; Anticipation; Preload; EMG; Concussion	SEGMENT DYNAMIC STABILIZATION; FALSE DISCOVERY RATE; PROFESSIONAL FOOTBALL; MUSCLE-ACTIVATION; DISABILITY INDEX; INJURY RISK; CONCUSSION; STRENGTH; PERFORMANCE; BIOMECHANICS	Background: The majority of studies examining the role of cervical muscles on head-neck kinematics focused on musculoskeletal attributes (e.g. strength). Cervical neuromuscular response to perturbation may represent a divergent construct that has not been examined under various perturbation conditions. This study examined the association between cervical musculoskeletal attributes and cervical neuromuscular response of the sternocleidomastoid (SCM) to perturbation. Furthermore, this study examined the effect of anticipation and preload on the SCM neuromuscular response. Methods: Nineteen participants completed measurement of SCM muscle size, cervical flexion maximal voluntary isometric contraction, and the neuromuscular response of the SCM to cervical perturbation. Cervical perturbation was delivered by dropping a 1.59 kg mass from a loading apparatus. The impulsive load was delivered under four conditions: (1) Anticipated perturbation with no preload (A-NP), (2) Unanticipated perturbation with no preload (U-NP), (3) Anticipated perturbation with preload (A-P), and (4) Unanticipated perturbation with preload (U-P). Results: None of the cervical musculoskeletal attributes were correlated with the SCM cervical neuromuscular response. This study demonstrated significant effect of preloading and anticipation on baseline EMG amplitude and EMG onset latency for the SCM. Furthermore, there was a significant effect of preloading on average EMG response amplitude for the SCM. Discussion: The findings of this study indicate that cervical neuromuscular response of the SCM is different from musculoskeletal attributes and is influenced by perturbation conditions. These findings provide conceptual support to examine the neuromuscular response of the SCM in mitigating head-neck kinematics.	[Alsalaheen, Bara; Bean, Ryan] Univ Michigan, Dept Phys Therapy, Flint, MI 48503 USA; [Alsalaheen, Bara; Almeida, Andrea; Lorincz, Matthew] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara; Almeida, Andrea; Eckner, James; Lorincz, Matthew] Michigan Med, Michigan NeuroSport, Ann Arbor, MI USA; [Eckner, James] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Alsalaheen, B (corresponding author), 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umflint.edu	Lorincz, Matthew Thomas/P-7785-2019		Dr. Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity (RCA) Award	We would like to acknowledge Katherine S. Rudolph, PT, PhD for her assistance during various parts of the project. We would like to thank Hassan Khalife and Leor Giladi for their technical help throughout this project. This work was supported by Dr. Ben F. Bryer Foundation Medical Research Fund and by the University of Michigan-Flint's Research and Creative Activity (RCA) Award.	Alkjaer T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.99; Almosnino S, 2009, BMC SPORTS SCI MED R, V1, DOI 10.1186/1758-2555-1-22; Arts IMP, 2010, MUSCLE NERVE, V41, P32, DOI 10.1002/mus.21458; Avela J, 1998, EUR J APPL PHYSIOL O, V78, P403, DOI 10.1007/s004210050438; BEDINGHAM W, 1984, CAN J NEUROL SCI, V11, P272, DOI 10.1017/S0317167100045534; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chimera NJ, 2004, J ATHL TRAINING, V39, P24; Cohen J., 2013, STAT POWER ANAL BEHA; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Debison-Larabie, 2016, EXAMINING RELATIONSH; Dupeyron A, 2010, J ELECTROMYOGR KINES, V20, P426, DOI 10.1016/j.jelekin.2009.05.004; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Falla D, 2002, EUR J APPL PHYSIOL, V87, P542, DOI 10.1007/s00421-002-0661-x; Falla D, 2004, EXP BRAIN RES, V157, P43, DOI 10.1007/s00221-003-1814-9; Falla D, 2004, SPINE, V29, P1436, DOI 10.1097/01.BRS.0000128759.02487.BF; Falla D, 2011, CLIN J PAIN, V27, P309, DOI 10.1097/AJP.0b013e31820212cf; FELLOWS SJ, 1989, EXP BRAIN RES, V77, P135; Gilchrist I, 2017, J ATHLET ENHANCEMENT, V4; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; He J, 1998, IEEE Trans Rehabil Eng, V6, P182, DOI 10.1109/86.681184; Hernandez IA, 2006, EUR SPINE J, V15, P876, DOI 10.1007/s00586-005-0956-9; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; Keshwani N, 2015, J ORTHOP SPORT PHYS, V45, P808, DOI 10.2519/jospt.2015.6143; Kuramochi R, 2004, NEUROSCI LETT, V366, P206, DOI 10.1016/j.neulet.2004.05.040; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Milosevic M, 2016, J ELECTROMYOGR KINES, V26, P94, DOI 10.1016/j.jelekin.2015.12.003; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; REID SE, 1981, AVIAT SPACE ENVIR MD, V52, P78; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Shinya M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00029; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Solnik S, 2008, ACTA BIOENG BIOMECH, V10, P65; Sugimoto D, 2015, SPORTS MED, V45, P809, DOI 10.1007/s40279-015-0311-1; Swanik KA, 2002, J SHOULDER ELB SURG, V11, P579, DOI 10.1067/mse.2002.127303; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	51	9	9	2	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	APR	2018	39						70	76		10.1016/j.jelekin.2018.01.011			7	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	GC7AC	WOS:000429943200009	29413455				2022-02-06	
J	El Haj, M; Nandrino, JL				El Haj, Mohamad; Nandrino, Jean Louis			Seeing life through rose-colored spectacles: Autobiographical memory as experienced in Korsakoff's syndrome	CONSCIOUSNESS AND COGNITION			English	Article						Autobiographical memory; Consciousness; Korsakoff's syndrome; Subjective experience	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RETROGRADE-AMNESIA; SPATIAL-MEMORY; CONTEXT MEMORY; EPISODIC MEMORY; SELF-AWARENESS; TEMPORAL-LOBE; DEFICITS; RECALL	We investigated whether patients with Korsakjoff's Sybdrome (KS) would demonstrate a discrepancy between (low) autobiographical specificity and (high) sense of reliving. We invited 20 KS patients and 24 controls to retrieve personal memories. After memory retrieval, they were invited to rate subjective characteristics of their recall (e.g., reliving, travel in time, remembering, realness). Besides this rating, we analyzed memories objectively with regard to specificity. Analysis demonstrated poorer sense of reliving and memory specificity in KS patients than in controls. Critically, a discrepancy (i.e., higher level of sense of reliving than of specificity) was observed in KS participants but not in controls. We propose a hypothesis of "genuine consciousness experience" in which the discrepancy between sense of reliving and specificity mirrors how KS patients can benefit from an authentic experience of the past despite compromise in their autobiographical recall.	[El Haj, Mohamad; Nandrino, Jean Louis] Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab Sci Cognit & Sci Affect, F-59000 Lille, France; [El Haj, Mohamad] Ctr Hosp Tourcoing, Unite Geriatrie, Tourcoing, France		El Haj, M (corresponding author), Univ Lille, Lab SCALab UMR CNRS 9193, F-59653 Villeneuve Dascq, France.	mohamad.elhaj@univ-lille3.fr	; Nandrino, Jean-Louis/O-8900-2017	el haj, mohamad/0000-0001-7635-7557; Nandrino, Jean-Louis/0000-0003-2339-9432			Aalten P, 2005, AGING MENT HEALTH, V9, P414, DOI 10.1080/13607860500143075; ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; Association A. P., 2000, TASK FORC DSM 4 DIAG; BADDELEY AD, 1986, AUTOBIOGRAPHICAL MEM, P225; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Borsutzky S, 2008, NEUROPSYCHOLOGIA, V46, P3133, DOI 10.1016/j.neuropsychologia.2008.07.005; Brand M, 2003, NEUROPSYCHOLOGIA, V41, P575, DOI 10.1016/S0028-3932(02)00183-5; Brion M, 2017, ALCOHOL CLIN EXP RES, V41, P596, DOI 10.1111/acer.13318; Butters N., 1986, AUTOBIOGRAPHICAL MEM, P253, DOI [10.1017/CBO9780511558313.021, DOI 10.1017/CBO9780511558313.021]; Clare L, 2011, AGING MENT HEALTH, V15, P936, DOI 10.1080/13607863.2011.583630; Cohen J., 2013, STAT POWER ANAL BEHA; COHEN NJ, 1981, NEUROPSYCHOLOGIA, V19, P337, DOI 10.1016/0028-3932(81)90064-6; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; CROVITZ HF, 1986, AUTOBIOGRAPHICAL MEM, P273; D'Argembeau A, 2012, CONSCIOUS COGN, V21, P1198, DOI 10.1016/j.concog.2012.05.004; DALLABARBA G, 1990, CORTEX, V26, P525, DOI 10.1016/S0010-9452(13)80356-5; El Haj M., 2017, J SYSTEMS INTEGRATIV, V3, P1, DOI DOI 10.15761/JSIN.1000152; El Haj M, 2017, J NEUROPSYCH CLIN N, V29, P319, DOI 10.1176/appi.neuropsych.16100206; El Haj M, 2017, CONSCIOUS COGN, V55, P188, DOI 10.1016/j.concog.2017.08.011; El Haj M, 2017, CORTEX, V91, P262, DOI 10.1016/j.cortex.2017.02.006; El Haj M, 2017, CONSCIOUS COGN, V49, P110, DOI 10.1016/j.concog.2017.01.009; El Haj M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005448; El Haj M, 2016, ALCOHOL CLIN EXP RES, V40, P1321, DOI 10.1111/acer.13070; El Haj M, 2016, J ALZHEIMERS DIS, V52, P421, DOI 10.3233/JAD-151122; El Haj M, 2015, AGEING RES REV, V23, P183, DOI 10.1016/j.arr.2015.07.001; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Fama R, 2004, J INT NEUROPSYCH SOC, V10, P427, DOI 10.1017/S135561770410310X; Fama R, 2012, NEUROPSYCHOL REV, V22, P93, DOI 10.1007/s11065-012-9207-0; Gandolphe MC, 2017, SCAND J PSYCHOL, V58, P199, DOI 10.1111/sjop.12364; Gandolphe MC, 2016, J PSYCHOL COGN, V1, P20; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Holdstock JS, 1999, CORTEX, V35, P479, DOI 10.1016/S0010-9452(08)70814-1; Janssen SMJ, 2011, MEM COGNITION, V39, P1, DOI 10.3758/s13421-010-0003-x; Kessels RPC, 2012, NEUROPSYCHOL REV, V22, P117, DOI 10.1007/s11065-012-9202-5; Kinsbourne M., 1990, NEUROPSYCHOLOGICAL I, P319, DOI DOI 10.1017/CBO9780511665547.017; Kopelman M D, 1994, Memory, V2, P211, DOI 10.1080/09658219408258945; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; Kopelman MD, 2010, COGN NEUROPSYCHIATRY, V15, P14, DOI 10.1080/13546800902732830; Korsakoff S., 1889, REV PHILOS, V5, P501; KOVNER R, 1988, CORTEX, V24, P477, DOI 10.1016/S0010-9452(88)80012-1; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Maki Y, 2013, MEMORY, V21, P286, DOI 10.1080/09658211.2012.725739; MAYES AR, 1991, NEUROPSYCHOLOGIA, V29, P771, DOI 10.1016/0028-3932(91)90071-F; Mimura M, 2000, J INT NEUROPSYCH SOC, V6, P517, DOI 10.1017/S1355617700655017; Mograbi DC, 2013, COGN NEUROSCI-UK, V4, P181, DOI 10.1080/17588928.2013.833899; Mograbi DC, 2012, NEUROPSYCHOLOGIA, V50, P2075, DOI 10.1016/j.neuropsychologia.2012.05.008; Mograbi DC, 2009, CONSCIOUS COGN, V18, P989, DOI 10.1016/j.concog.2009.07.005; Morris RG, 2013, CORTEX, V49, P1553, DOI 10.1016/j.cortex.2012.09.006; Oslin D, 1998, INT J GERIATR PSYCH, V13, P203, DOI 10.1002/(SICI)1099-1166(199804)13:4<203::AID-GPS734>3.0.CO;2-B; PARKIN AJ, 1988, CORTEX, V24, P143, DOI 10.1016/S0010-9452(88)80023-6; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2003, COGN NEUROPSYCHOL, V20, P619, DOI 10.1080/02643290242000899; Pitel AL, 2008, ALCOHOL CLIN EXP RES, V32, P1229, DOI 10.1111/j.1530-0277.2008.00677.x; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rubin DC, 2005, CURR DIR PSYCHOL SCI, V14, P79, DOI 10.1111/j.0963-7214.2005.00339.x; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; SHOQEIRAT MA, 1991, NEUROPSYCHOLOGIA, V29, P749, DOI 10.1016/0028-3932(91)90070-O; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Talland G.A., 1965, DERANGED MEMORY; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Zangwill L., 1966, AMNESIA, P104	67	9	9	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	APR	2018	60						9	16		10.1016/j.concog.2018.02.007			8	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	GC2RP	WOS:000429630600002	29501971				2022-02-06	
J	Ellis, M; Krisko, C; Selci, E; Russell, K				Ellis, Michael; Krisko, Cameron; Selci, Erin; Russell, Kelly			Effect of concussion history on symptom burden and recovery following pediatric sports-related concussion	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						sports-related concussion; concussion history; pediatric; symptoms; predictors; recovery; outcomes; trauma	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL PLAYERS; RECURRENT CONCUSSION; HIGH-SCHOOL; HOCKEY PLAYERS; HEAD-INJURY; BASE-LINE; ASSOCIATION; MANAGEMENT; MODIFIERS	OBJECTIVE The aim of this study was to examine differences in symptom burden and duration until physician-documented clinical recovery among pediatric patients with sports-related concussion (SRC) with and without a history of concussion. METHODS A retrospective chart review was performed for all pediatric patients (7-19 years old) referred to the Pan Am Concussion Program in Winnipeg, Canada, with an SRC and evaluated < 30 days postinjury between September 1, 2013, and August 1, 2015. RESULTS A total of 322 patients with SRC (64.91% male, mean age 13.96 years) who were evaluated a median of 7 days (interquartile range [IQR] 5-11 days) postinjury were included. Patients without a history of concussion endorsed significantly fewer concussion symptoms at initial assessment (median 5.5 symptoms, IQR 1-10 symptoms) than those with a previous concussion (median 7 symptoms, IQR 2-13.25 symptoms; p = 0.036). The median Post-Concussion Symptom Scale scores were 9 (IQR 1-23) for patients with no concussion history and 13 (IQR 3-33) for those with a history of concussion (p = 0.032). For patients with no previous concussion, the median number of days until physician-documented clinical recovery was 23 (IQR 15-44 days) compared with 25 days (IQR 18-43 days) for those with a history of concussion (p = 0.281). There was no significant difference in the proportion of patients who experienced delayed time until physician-documented clinical recovery (> 1 month postinjury) between the groups (p = 0.584). CONCLUSIONS Although a history of concussion may be associated with increased symptom burden following pediatric SRC, there was no difference in the time until physician-documented clinical recovery. Pediatric patients with SRC who have a history of concussion should be managed on an individualized basis. Future work is needed to examine the short-and long-term effects of multiple concussions in children and adolescents.	[Ellis, Michael] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael; Selci, Erin; Russell, Kelly] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Krisko, Cameron] Univ Manitoba, Phys Assistant Studies, Winnipeg, MB, Canada; [Ellis, Michael] Pan Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael; Selci, Erin; Russell, Kelly] Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael; Russell, Kelly] Canada North Concuss Network, Winnipeg, MB, Canada		Russell, K (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	krussell@chrim.ca		Russell, Kelly/0000-0002-9159-9201	Pan Am Clinic Foundation; Research Manitoba Establishment Grant	This study was funded by the Pan Am Clinic Foundation and a Research Manitoba (formally Manitoba Health Research Council) Establishment Grant.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haider MN, 2017, BR J SPORTS MED; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	44	9	9	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2018	21	4					401	408		10.3171/2017.9.PEDS17392			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GB4EO	WOS:000429013500010	29393810				2022-02-06	
J	Kutty, RK; Sreemathyamma, SB; Sivanandapanicker, J; Asher, P; Prabhakar, RB; Peethambaran, A; Libu, GK				Kutty, Raja K.; Sreemathyamma, Sunilkumar Balakrishnan; Sivanandapanicker, Jyothish; Asher, Prasanth; Prabhakar, Rajmohan Bhanu; Peethambaran, Anilkumar; Libu, Gnanaseelan Kanakamma			The Conundrum of Ventricular Dilatations Following Decompressive Craniectomy: Is Ventriculoperitoneal Shunt, The Only Panacea?	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Decompressive craniectomy; hydrocephalus; ventriculoperitoneal shunt; ventriculostomy	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; CEREBRAL INFARCTION; RISK-FACTORS; CRANIOPLASTY; HEMORRHAGE; EVACUATION; MANAGEMENT; PRESSURE	Introduction: Ventriculomegaly and hydrocephalus (HCP) are sometimes a bewildering sequela of decompressive craniectomy (DC). The distinguishing criteria between both are less well defined. Majority of the studies quoted in the literature have defined HCP radiologically, rather than considering the clinical status of the patient. Accordingly, these patients have been treated with permanent cerebrospinal fluid (CSF) diversion procedures. We hypothesize that asymptomatic ventriculomegaly following DC should undergo aspiration with cranioplasty and be followed up regularly. Materials and Methods: All patients with post-DC who were scheduled for cranioplasty and satisfied the radiological criteria for HCP were included. These patients were categorized into two groups. Group 1 included ventriculomegaly with clinical signs attributable to HCP and Group 2 constituted ventriculomegaly but no clinical signs attributable to HCP. All patients in Group 1 underwent ventriculoperitoneal shunt followed by cranioplasty, whereas all patients in Group 2 underwent cranioplasty along with simultaneous ventriculostomy and temporary aspiration of the lateral ventricle. All patients were regularly followed as the outpatient basis. Results: There were 21 patients who developed ventriculomegaly following DC. There were 10 patients in Group 1 and 11 patients in Group 2. The average duration of follow-up was from 6 months to 2 years. Two patients in the shunt group - (group 1) had over drainage and required revision. One patient in aspiration group - (group 2) required permanent CSF diversion. Conclusions: Cranioplasty with aspiration is a viable option in selected group of patients in whom there is ventriculomegaly but no signs or symptoms attributable to HCP.	[Kutty, Raja K.; Sreemathyamma, Sunilkumar Balakrishnan; Sivanandapanicker, Jyothish; Asher, Prasanth; Prabhakar, Rajmohan Bhanu; Peethambaran, Anilkumar] Govt Med Coll, Dept Neurosurg, Thiruvananthapuram, Kerala, India; [Libu, Gnanaseelan Kanakamma] Govt Med Coll, Dept Community Med, Thiruvananthapuram, Kerala, India		Sreemathyamma, SB (corresponding author), Govt Med Coll, Dept Neurosurg, Thiruvananthapuram, Kerala, India.	sunilkumarbs2017@gmail.com		Gnanaseelan, Libu Kanakamma/0000-0001-5147-2591			Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Erdogan E, 2003, NEUROL INDIA, V51, P479; Fraioli MF, 2016, OPEN ACCESS LIB J, V3, pe2346, DOI [10.4236/oalib.1102346, DOI 10.4236/OALIB.1102346]; Ghritlaharey RK, 2016, J CLIN DIAGN RES, V10, pPE1, DOI 10.7860/JCDR/2016/23372.8920; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Iglesias S, 2016, CHILD NERV SYST, V32, P2377, DOI 10.1007/s00381-016-3206-z; Jabbarli R, 2017, WORLD NEUROSURG, V98, P689, DOI 10.1016/j.wneu.2016.12.012; Joshua SP, 2011, CLIN NEUROL NEUROSUR, V113, P635, DOI 10.1016/j.clineuro.2011.05.012; Jung Young Taek, 2015, Korean J Neurotrauma, V11, P93, DOI 10.13004/kjnt.2015.11.2.93; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kapapa T, 2016, WORLD NEUROSURG, V93, P389, DOI 10.1016/j.wneu.2016.06.075; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lee MH, 2012, CLIN NEUROL NEUROSUR, V114, P555, DOI 10.1016/j.clineuro.2011.11.027; Li G, 2008, BRAIN INJURY, V22, P333, DOI 10.1080/02699050801958353; Lin BJ, 2015, TURK NEUROSURG, V25, P742, DOI 10.5137/1019-5149.JTN.11345-14.1; Manet R, 2016, ACTA NEUROCHIR SUPPL, V122, P55, DOI 10.1007/978-3-319-22533-3_11; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Neiter E, 2016, NEUROCHIRURGIE, V62, P53, DOI 10.1016/j.neuchi.2015.10.005; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Pachatouridis D, 2014, TURK NEUROSURG, V24, P855, DOI 10.5137/1019-5149.JTN.8871-13.1; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Takeuchi S, 2013, J CLIN NEUROSCI, V20, P377, DOI 10.1016/j.jocn.2012.03.035; Takeuchi S, 2013, CLIN NEUROL NEUROSUR, V115, P317, DOI 10.1016/j.clineuro.2012.05.026; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; [王雷平 Wang Leiping], 2014, [中华创伤杂志, Chinese Journal of Trauma], V30, P307; Wang QP, 2016, INT J NEUROSCI, V126, P707, DOI 10.3109/00207454.2015.1055357; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang VXD, 2016, BRIT J NEUROSURG, V30, P269, DOI 10.3109/02688697.2015.1063587; Zhang S, 2017, J NEUROSURG, V127, P709, DOI 10.3171/2016.8.JNS161112	39	9	9	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	APR-JUN	2018	9	2					232	239		10.4103/jnrp.jnrp_395_17			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GD2CQ	WOS:000430308100012	29725175	Green Published, gold			2022-02-06	
J	Lim, SW; Nyam, TTE; Hu, CY; Chio, CC; Wang, CC; Kuo, JR				Lim, Sher-Wei; Nyam, Eric T. T.; Hu, Cho-Ya; Chio, Chung-Ching; Wang, Che-Chuan; Kuo, Jinn-Rung			Estrogen Receptor-alpha is Involved in Tamoxifen Neuroprotective Effects in a Traumatic Brain Injury Male Rat Model	WORLD NEUROSURGERY			English	Article						Apoptosis; Estrogen receptor alpha; Neuroinflammation; Tamoxifen; Traumatic brain injury; Tumor necrosis factor-alpha	BREAST-CANCER PATIENTS; TUMOR-NECROSIS-FACTOR; SIGNALING PATHWAYS; CEREBRAL-ISCHEMIA; POTENTIAL ROLE; TNF-ALPHA; BETA; MODULATORS; MICROGLIA; TISSUE	OBJECTIVE: To determine the neuroprotective mechanisms of tamoxifen (TMX) during traumatic brain injury (TBI), especially the effects on estrogen receptor-alpha (ER alpha) expression, as well as neuroinflammatory associations. MATERIALS AND METHODS: Anesthetized male Sprague-Dawley rats were divided into 4 groups: sham-operated controls, sham-operated controls given TMX (1 mg/kg/per day) for 3 days, those given a vehicle solution immediately after TBI, and those given TMX (1 mg/kg/per day) for 3 days. The functional outcome was evaluated by assessments of body weight and proprioception. The total ER alpha expression in the cortex also was investigated by Western blotting, and ER alpha expression in neurons, microglia, and astroglia were each detected via immunofluorescence staining. Neuronal apoptosis (marker caspase-3), activated microglia (marker 0X42), astroglia (marker glial fibrillary acidic protein), and tumor necrosis factor-alpha expression in microglia and astroglia in the cortex were evaluated by immunofluorescence staining methods. RESULTS: Compared with sham-operated controls, the TBI-induced proprioception inhibition was significantly attenuated by TMX therapy on day 3 after TBI. Using immunofluorescence staining, we found that the TBI-induced neuronal loss, apoptosis, activated microglia, and astrocyte expression and tumor necrosis factor-alpha and ER alpha in the cortex were significantly reduced by TMX therapy. CONCLUSIONS: Our results suggest that the intraperitoneal injection of TMX (1 mg/kg/per day) for 3 days may affect ER alpha expression in neurons and glia, which is accompanied by neuroinflammation and neuronal apoptosis, and it might represent one mechanism by which functional recovery occurs. We consider TMX administration to be a promising strategy for TBI.	[Lim, Sher-Wei] Chia Li Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Nyam, Eric T. T.; Chio, Chung-Ching; Wang, Che-Chuan; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Hu, Cho-Ya; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Gen Educ, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Gen Educ, Tainan, Taiwan.	kuojinnrung@gmail.com					Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dhandapani KM, 2003, ENDOCRINE, V21, P59, DOI 10.1385/ENDO:21:1:59; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; GRILL HJ, 1991, AM J CLIN ONCOL-CANC, V14, pS21; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Lee SH, 2008, MOL CELLS, V26, P285; LIEN EA, 1991, BRIT J CANCER, V63, P641, DOI 10.1038/bjc.1991.147; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu X, 2005, J NEUROSCI RES, V81, P653, DOI 10.1002/jnr.20583; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; Mendez P, 2003, MOL BRAIN RES, V112, P170, DOI 10.1016/S0169-328X(03)00088-3; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; Tang WC, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1457-6; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	46	9	9	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						E278	E287		10.1016/j.wneu.2018.01.036			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700033	29353027				2022-02-06	
J	Meidahl, AC; Eisenried, A; Klukinov, M; Cao, LH; Tzabazis, AZ; Yeomans, DC				Meidahl, Anders C.; Eisenried, Andreas; Klukinov, Michael; Cao, Longhui; Tzabazis, Alexander Z.; Yeomans, David C.			Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury	HEADACHE			English	Article						allodynia; headache; intranasal; pain; traumatic brain injury; trigeminal	POSTTRAUMATIC HEADACHES; OPIOID RECEPTORS; HEAD TRAUMA; SPINAL-CORD; US SOLDIERS; RAT; MODULATION; VASOPRESSIN; ALLODYNIA; ATOSIBAN	Background.-Approximately 1.7 million Americans sustain a traumatic brain injury (TBI) each year and chronic pain is a common complication. Objective.-We studied the effects of intranasally administered oxytocin as a potential treatment for chronic pain in an animal model of mild TBI. Methods.-The lateral fluid percussion model of mild TBI was chosen for this purpose and after exposure to mild TBI the rats (n=12) developed hind paw and facial allodynia compared to sham animals (n=6). Oxytocin or a vehicle was afterwards administered intranasally and reactive pain was assessed by hind paw and facial von Frey testing. Some animals received the oxytocin receptor antagonist, atosiban, in addition to oxytocin/vehicle treatment (n=12). The effect of oxytocin on ongoing and spontaneous pain was examined through conditioned place preference testing. To determine whether the effects of intranasal oxytocin could be attributed to delivery via the peripheral blood stream, some TBI animals received an intravenous injection of the same oxytocin dose that was given intranasally. ELISA immunoassays were carried out (n=6) to measure concentrations of oxytocin in the trigeminal ganglia, pons, spinal cord, and olfactory bulb after intranasal administration and evaluate the most likely route of entry. Results.-These studies confirmed that the fluid percussion model can be used to study post-TBI facial allodynia. Oxytocin attenuated both reactive and spontaneous, ongoing non-reactive pain following mild TBI for at least 3-4 hours after intranasal administration by binding to OT or VA1-receptors most likely by a peri-trigeminal nerve mediated uptake. Conclusions.-Intranasal oxytocin attenuates measures of reactive and non-reactive pain in a model of mild TBI and may represent a novel treatment for chronic pain in TBI patients.	[Meidahl, Anders C.; Eisenried, Andreas; Klukinov, Michael; Cao, Longhui; Tzabazis, Alexander Z.; Yeomans, David C.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA		Yeomans, DC (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	dcyeomans@stanford.edu		Yeomans, David/0000-0002-9389-8539; Meidahl, Anders Christian/0000-0002-8404-4742	Lundbeck FoundationLundbeckfonden; The Danish Cancer SocietyDanish Cancer Society [R101-A6745] Funding Source: researchfish	A.M. received funding from the Lundbeck Foundation.	Alder J., 2011, JOVE-J VIS EXP, V54, P1; Babic S, 2015, J ENDOCRINOL, V225, P9, DOI 10.1530/JOE-14-0560; Barber J, 2011, JAMA-J AM MED ASSOC, V303, P1938; Baribeau DA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00335; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; Breton JD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-19; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crockford C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00068; Davoody L, 2011, J PAIN, V12, P868, DOI 10.1016/j.jpain.2011.01.010; Eisenried A, 2017, PAIN, V158, P2181, DOI 10.1097/j.pain.0000000000001019; Erickson Jay C, 2010, Continuum (Minneap Minn), V16, P55, DOI 10.1212/01.CON.0000391453.37923.83; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gonzalez A., 2017, PAIN, P1; GOODWIN TM, 1995, AM J OBSTET GYNECOL, V173, P913; Grinevich V, 2017, PAIN, V158, P2061, DOI 10.1097/j.pain.0000000000001006; Gu XL, 2007, J PAIN, V8, P85, DOI 10.1016/j.jpain.2006.07.001; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Klenerova V, 2009, NEUROENDOCRINOL LETT, V30, P335; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kubo A, 2017, PAIN, V158, P649, DOI 10.1097/j.pain.0000000000000808; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Louvel D, 1996, GUT, V39, P741, DOI 10.1136/gut.39.5.741; MacDonald E, 2011, PSYCHONEUROENDOCRINO, V36, P1114, DOI 10.1016/j.psyneuen.2011.02.015; Mak P, 2012, J PSYCHOPHARMACOL, V26, P532, DOI 10.1177/0269881111416687; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miranda-Cardenas Y, 2006, PAIN, V122, P182, DOI 10.1016/j.pain.2006.01.029; Myers KM, 2012, NAT PROTOC, V7, P517, DOI 10.1038/nprot.2011.458; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Navratilova E, 2012, P NATL ACAD SCI USA, V109, P20709, DOI 10.1073/pnas.1214605109; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Pagani JH, 2015, GENES BRAIN BEHAV, V14, P167, DOI 10.1111/gbb.12202; Qu CL, 2011, PAIN, V152, P1641, DOI 10.1016/j.pain.2011.03.002; Rash JA, 2014, CLIN J PAIN, V30, P453, DOI 10.1097/AJP.0b013e31829f57df; Reeta K, 2006, REGUL PEPTIDES, V135, P85, DOI 10.1016/j.regpep.2006.04.004; Sack M, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0801-0; Sanu O, 2010, THER CLIN RISK MANAG, V6, P191; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; SWANSON LW, 1979, J COMP NEUROL, V188, P87, DOI 10.1002/cne.901880108; Tappe-Theodor A, 2014, EUR J NEUROSCI, V39, P1881, DOI 10.1111/ejn.12643; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Tracy LM, 2015, NEUROSCI BIOBEHAV R, V55, P53, DOI 10.1016/j.neubiorev.2015.04.013; Tzabazis A, 2015, CEPHALALGIA, V0, P1; Tzabazis A, 2017, HEADACHE, V57, P64, DOI 10.1111/head.13082; Uryvaev YV, 1996, B EXP BIOL MED+, V122, P1071, DOI 10.1007/BF02447648; Veening JG, 2013, NEUROSCI BIOBEHAV R, V37, P1445, DOI 10.1016/j.neubiorev.2013.04.012; Wang YL, 2013, NEUROPEPTIDES, V47, P93, DOI 10.1016/j.npep.2012.12.003	59	9	10	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	APR	2018	58	4					545	558		10.1111/head.13248			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB3YC	WOS:000428995700006	29266199				2022-02-06	
J	Xiang, PC; Ma, K; Li, LJ; Wang, DL; Hu, GY; Long, W				Xiang, Pengcheng; Ma, Ke; Li, Lijuan; Wang, Donglian; Hu, Guoyong; Long, Wei			The protection effect and mechanism of hyperbaric oxygen therapy in rat brain with traumatic injury(1)	ACTA CIRURGICA BRASILEIRA			English	Article						Hyperbaric Oxygenation; Nerve Growth Factors; Brain Injuries; Rats	C-FOS; ION CHANNELS; MODEL; ASTROCYTES; NEUROPROTECTION; ENCEPHALOPATHY; APOPTOSIS; NECROSIS; EDEMA	Purpose: To investigate the effect of hyperbaric oxygen therapy (HBOT) on traumatic brain injury (TBI) outcome. Methods: The modified Marmarou's weight drop device was used to generate non-lethal moderate TBI rat model, and further developed in vitro astrocytes culturing system. Then, we analyzed the expression changes of Interested genes and protein by quantitative PCR and western blot. Results: Multiple HBO treatments significantly reduced the expression of apoptosis promoting genes, such as C-fos, c-jun, Bax and weakened the activation of Caspase-3 in model rats. On the contrary, HBOT alleviated the decrease of anti-apoptosis gene Bcl-2 and promoted the expression of neurotrophic factors (NTFs), such as NGF, BDNF, GDNF and NT-3 in vivo. As a consequent, the neuropathogenesis was remarkably relied with HBOT. Astrocytes from TBI brain or those cultured with 21% O-2 density expressed higher NTFs than that of corresponding controls, from sham brain and cultured with 7% O-2 respectively. The NTFs expression was the highest in astrocytes form TBI brain and cultured with 21% O-2 suggesting a synergistic effect existed between TBI and the following HBO treatment in astrocytes. Conclusion: Our findings provided evidence for the clinical usage of HBO treating brain damages.	[Xiang, Pengcheng; Ma, Ke; Wang, Donglian; Hu, Guoyong] Shanghai Sixth Peoples Hosp East, Dept Emergency, Shanghai 201306, Peoples R China; [Xiang, Pengcheng; Ma, Ke; Wang, Donglian; Hu, Guoyong] Shanghai Sixth Peoples Hosp East, Intens Care Unit, Shanghai 201306, Peoples R China; [Li, Lijuan; Long, Wei] Shanghai Sixth Peoples Hosp East, Dept Geriatr, Shanghai, Peoples R China		Ma, K (corresponding author), Shanghai Sixth Peoples Hosp East, Dept Emergency, Shanghai 201306, Peoples R China.; Ma, K (corresponding author), Shanghai Sixth Peoples Hosp East, Intens Care Unit, Shanghai 201306, Peoples R China.	makewy08@163.com	li, li/AAT-2097-2020		Courtyard Scientific Research Fund of Shanghai Sixth People's Hospital East [2016025]	Courtyard Scientific Research Fund of Shanghai Sixth People's Hospital East (grant numbers 2016025).	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; BOWMAN CL, 1992, BRAIN RES, V584, P272, DOI 10.1016/0006-8993(92)90906-P; Calvert JW, 2003, J APPL PHYSIOL, V95, P2072, DOI 10.1152/japplphysiol.00630.2003; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; Edwards ML, 2010, J VET EMERG CRIT CAR, V20, P289, DOI 10.1111/j.1476-4431.2010.00535_1.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Granacher Jr RP, 2007, TRAUMATIC BRAIN INJU, P32; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Gungor A, 2003, AM J OTOLARYNG, V24, P390, DOI 10.1016/S0196-0709(03)00091-7; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; ISLAS L, 1993, GLIA, V8, P87, DOI 10.1002/glia.440080204; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Kambe Y, 2016, J MOL NEUROSCI, V59, P106, DOI 10.1007/s12031-015-0710-7; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Prat R, 1998, ACT NEUR S, V71, P123; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; SKYHAR MJ, 1986, J BONE JOINT SURG AM, V68A, P1218, DOI 10.2106/00004623-198668080-00011; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Souza DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060282; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang Y, 2014, NAT BIOTECHNOL, P1; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53; Zhang T, 2007, UNDERSEA HYPERBAR M, V34, P335; Zhilyaev S Yu, 2003, Neurosci Behav Physiol, V33, P783, DOI 10.1023/A:1025145331149	44	9	10	1	5	ACTA CIRURGICA BRASILEIRA	SAO PAULO	ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL	0102-8650	1678-2674		ACTA CIR BRAS	Acta Cir. Bras.	APR	2018	33	4					341	353		10.1590/s0102-865020180040000006			13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GG1MA	WOS:000432449900006		gold, Green Published			2022-02-06	
J	Yu, YW; Hsueh, SC; Lai, JH; Chen, YH; Kang, SJ; Chen, KY; Hsieh, TH; Hoffer, BJ; Li, YZ; Greig, NH; Chiang, YH				Yu, Yu-Wen; Hsueh, Shih-Chang; Lai, Jing-Huei; Chen, Yen-Hua; Kang, Shuo-Jhen; Chen, Kai-Yun; Hsieh, Tsung-Hsun; Hoffer, Barry J.; Li, Yazhou; Greig, Nigel H.; Chiang, Yung-Hsiao			Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						glucose-dependent insulinotropic polypeptide; 6-hydroxydopamine; Parkinson's disease; neuroprotection; incretin	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; TRAUMATIC BRAIN-INJURY; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; CENTRAL-NERVOUS-SYSTEM; GIP RECEPTOR AGONIST; DISEASE MOUSE MODEL; RODENT MODELS; INCRETIN; GLP-1	In the present study, the effectiveness of glucose-dependent insulinotropic polypeptide (GIP) was evaluated by behavioral tests in 6-hydroxydopamine (6-OHDA) hemi-parkinsonian (PD) rats. Pharmacokinetic measurements of GIP were carried out at the same dose studied behaviorally, as well as at a lower dose used previously. GIP was delivered by subcutaneous administration (s.c.) using implanted ALZET micro-osmotic pumps. After two days of pre-treatment, male Sprague Dawley rats received a single unilateral injection of 6-OHDA into the medial forebrain bundle (MFB). The neuroprotective effects of GIP were evaluated by apomorphine-induced contralateral rotations, as well as by locomotor and anxiety-like behaviors in open-field tests. Concentrations of human active and total GIP were measured in plasma during a five-day treatment period by ELISA and were found to be within a clinically translatable range. GIP pretreatment reduced behavioral abnormalities induced by the unilateral nigrostriatal dopamine (DA) lesion produced by 6-OHDA, and thus may be a novel target for PD therapeutic development.	[Yu, Yu-Wen; Hsueh, Shih-Chang; Chen, Kai-Yun; Hsieh, Tsung-Hsun; Hoffer, Barry J.; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan; [Yu, Yu-Wen; Hsueh, Shih-Chang; Lai, Jing-Huei; Chen, Yen-Hua; Kang, Shuo-Jhen; Chen, Kai-Yun; Hsieh, Tsung-Hsun; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 11031, Taiwan; [Lai, Jing-Huei; Chen, Yen-Hua; Kang, Shuo-Jhen] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei 11031, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan 33302, Taiwan; [Hoffer, Barry J.; Chiang, Yung-Hsiao] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Li, Yazhou; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 20892 USA; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan		Hoffer, BJ (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan.; Hoffer, BJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA.	yvonneyu524@hotmail.com; d620103001@tmu.edu.tw; m105095006@tmu.edu.tw; swallows3366@gmail.com; terbiun@gmail.com; chenkathryn@hotmail.com; hsiehth@mail.cgu.edu.tw; bjh82@case.edu; yazhou.Li@nih.gov; greign@grc.nia.nih.gov; ychiang@tmu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941; Chen, Kai-Yun/0000-0002-2941-3197; YU, YU-WEN/0000-0002-7279-2532	Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST-101-2632-B-038-001-MY3]; Taipei Medical University [TMU102-AE1-B27, TMU105-AE1-B03]; Intramural Research Program of the National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Department of Neurosurgery, Case Western Reserve University School of Medicine [A-105-055]; National Institute of Neurological Disorders and Stroke, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094152]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333] Funding Source: NIH RePORTER	This study was supported in part by (i) the Ministry of Science and Technology, Grant numbers MOST-101-2632-B-038-001-MY3; (ii) Taipei Medical University TMU102-AE1-B27 and TMU105-AE1-B03; (iii) the Intramural Research Program of the National Institute on Aging, NIH; (iv) Department of Neurosurgery, Case Western Reserve University School of Medicine, Grant A-105-055 and (v) by the National Institute of Neurological Disorders and Stroke, NIH Grant R01NS094152.	Asmar M, 2010, AM J PHYSIOL-ENDOC M, V298, pE614, DOI 10.1152/ajpendo.00639.2009; Athauda D, 2017, NEUROPHARMACOLOGY; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Broen MPG, 2016, MOVEMENT DISORD, V31, P1125, DOI 10.1002/mds.26643; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Figueiredo CP, 2010, BEHAV PHARMACOL, V21, P394, DOI 10.1097/FBP.0b013e32833c8544; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Gault VA, 2008, BIOCHEM PHARMACOL, V75, P2325, DOI 10.1016/j.bcp.2008.03.011; Gault VA, 2008, J NEUROPHYSIOL, V99, P1590, DOI 10.1152/jn.01161.2007; Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Han L, 2016, NEUROREPORT, V27, P23, DOI 10.1097/WNR.0000000000000490; Harkavyi A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-19; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Holscher C, 2014, ALZHEIMERS DEMENT, V10, pS47, DOI 10.1016/j.jalz.2013.12.009; Hsieh TH, 2011, BEHAV BRAIN RES, V222, P1, DOI 10.1016/j.bbr.2011.03.031; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Ji CH, 2016, BRAIN RES, V1634, P1, DOI 10.1016/j.brainres.2015.09.035; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Kim DS, 2017, CELL TRANSPLANT, V26, P1560, DOI 10.1177/0963689717721234; Li YW, 2017, EUR J PHARMACOL, V797, P162, DOI 10.1016/j.ejphar.2016.11.050; Li YW, 2016, REV NEUROSCIENCE, V27, P689, DOI 10.1515/revneuro-2016-0018; Li YW, 2016, NEUROPHARMACOLOGY, V101, P255, DOI 10.1016/j.neuropharm.2015.10.002; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lusis S A, 1997, J Neurosci Nurs, V29, P24; Maetzler W, 2014, NEUROLOGY, V82, P417, DOI 10.1212/WNL.0000000000000095; MARSHALL JF, 1977, EUR J PHARMACOL, V41, P361, DOI 10.1016/0014-2999(77)90256-4; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Mohs Richard C, 2017, Alzheimers Dement (N Y), V3, P651, DOI 10.1016/j.trci.2017.10.005; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; NAUCK MA, 1993, J CLIN ENDOCR METAB, V76, P912, DOI 10.1210/jc.76.4.912; Nauck MA, 2016, LANCET DIABETES ENDO, V4, P525, DOI 10.1016/S2213-8587(15)00482-9; Nyberg J, 2005, J NEUROSCI, V25, P1816, DOI 10.1523/jneurosci.4920-04.2005; Nyberg J, 2007, J NEUROSCI RES, V85, P2099, DOI 10.1002/jnr.21349; Paratore Sabrina, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P210; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rutten S, 2017, PARKINSONISM RELAT D, V43, P49, DOI 10.1016/j.parkreldis.2017.06.024; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Tamargo IA, 2017, EXP NEUROL, V288, P176, DOI 10.1016/j.expneurol.2016.11.005; Tan T, 2013, CURR OPIN PHARMACOL, V13, P996, DOI 10.1016/j.coph.2013.09.005; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Verma MK, 2017, EUR J PHARMACOL, V804, P38, DOI 10.1016/j.ejphar.2017.03.059; Wu TZ, 2016, HANDB EXP PHARMACOL, V233, P137, DOI 10.1007/164_2015_9; Yanagimachi T, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.009; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Yuan ZY, 2017, EUR J PHARMACOL, V812, P82, DOI 10.1016/j.ejphar.2017.06.029; Zeiss CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171790	57	9	9	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2018	19	4							1153	10.3390/ijms19041153			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GJ0XU	WOS:000434978700232	29641447	Green Published, gold, Green Submitted			2022-02-06	
J	Lorente, L; Martin, MM; Perez-Cejas, A; Ramos, L; Argueso, M; Sole-Violan, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Perez-Cejas, Antonia; Ramos, Luis; Argueso, Monica; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Garcia-Marin, Victor			High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality	BMC NEUROLOGY			English	Article						Caspase-cleaved cytokeratin-18; Cerebral infarction; Patients; Mortality	INFLAMMATORY RESPONSE SYNDROME; EPITHELIAL-CELL APOPTOSIS; CHRONIC HEPATITIS-C; ISCHEMIC-STROKE; SEVERE SEPSIS; EXPRESSION; BIOMARKERS; DEATH; HIPPOCAMPUS; PREDICTORS	Background: There have been found apoptotic changes in brain tissue samples from humans after cerebral ischemia. Caspase-cleaved cytokeratin (CCCK)-18 could appears in blood during apoptosis. High circulating levels of CCCK-18 have been associated with a poor prognosis in patients with cerebral process, such as traumatic brain injury and spontaneous cerebral hemorrhage. However, they have not been explored in patients with ischemic stroke. Thus, the aim of this study was to determine whether there is an association between serum CCCK-18 levels and mortality in patients with severe malignant middle cerebral artery infarction (MMCAI). Methods: This was an observational, prospective and multicentre study. We included patients with severe MMCAI. We considered MMCAI as severe when Glasgow Coma Scale (GCS) was lower than 9. We measured serum CCCK-18 levels at the diagnosis moment of the severe MMCAI. Results: We found that non-surviving severe MMCAI patients (n = 33) showed lower GCS and platelet count, and higher serum CCCK-18 levels than survivor ones (n = 33). We found an area under the curve (AUC) of serum CCCK-18 levels to predict 30-day mortality of 82% (95% CI = 71%-91%; p < 0.001). In the multiple logistic regression analysis was found that serum CCCK-18 levels were associated with 30-day mortality (OR = 1.023; 95% CI = 1.010-1. 037; p = 0.001) after to control for platelet count and GCS. Conclusions: To our knowledge, this is the first series reporting data on serum CCCK-18 levels in ischemic stroke patients. The novel findings of our study were that non-surviving severe MMCAI patients had higher serum CCCK-18 levels than surviving patients, and that there is an association between high serum CCCK-18 levels and MMCAI patients mortality.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Perez-Cejas, Antonia] Hosp Univ Canarias, Lab Dept, Ofra S-N, Tenerife 38320, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista de Arriba S-N, Brena Alta 38713, La Palma, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Barranco de la Ballena S-N, Las Palmas De Gran Can 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas De Gran Can 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N, Santa Cruz De Tenerife 38320, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Argueso, Monica/0000-0001-5917-1056; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [INT16/00165]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission; Grupo de Expertos Neurologicos de Canarias (GEN-Canarias. Santa Cruz de Tenerife. Spain)	This study was supported by a grant from Instituto de Salud Carlos III (INT16/00165) (Madrid, Spain) co-financed by Fondo Europeo de Desarrollo Regional (FEDER), and by a grant from Grupo de Expertos Neurologicos de Canarias (GEN-Canarias. Santa Cruz de Tenerife. Spain). Fundings did not influence in the study design, the collection, analysis, and interpretation of data, the manuscript writing, and the decision to submit it for publication.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Akpan N, 2013, NEUROSCIENTIST, V19, P129, DOI 10.1177/1073858412447875; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMra1208623, 10.1056/NEJMc1312359]; Ari F, 2014, CELL PROLIFERAT, V47, P457, DOI 10.1111/cpr.12123; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Boehme AK, 2014, J STROKE CEREBROVASC, V23, pE271, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.022; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chelluboina B, 2014, MOL NEUROBIOL, V49, P50, DOI 10.1007/s12035-013-8486-7; Chen B, 2017, EXP CELL RES, V351, P163, DOI 10.1016/j.yexcr.2016.12.028; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Cho YS, 2015, MOL MED REP, V12, P1796, DOI 10.3892/mmr.2015.3612; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Duan SR, 2010, NEUROSCI LETT, V475, P132, DOI 10.1016/j.neulet.2010.03.058; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Gu SJ, 2016, CLIN CHIM ACTA, V452, P124, DOI 10.1016/j.cca.2015.11.011; Hofer S, 2009, CRIT CARE, V13, DOI 10.1186/cc7923; Kalita J, 2015, J STROKE CEREBROVASC, V24, P1640, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.057; Khoshnam SE, 2017, NEUROL SCI, V38, P1167, DOI 10.1007/s10072-017-2938-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liu DM, 2013, MOL MED REP, V8, P1453, DOI 10.3892/mmr.2013.1671; Lorberboym M, 2006, BRAIN RES, V1103, P13, DOI 10.1016/j.brainres.2006.05.073; Lorente L, 2014, PLOS ONE, P9; Lorente L., 2016, INT J MOL SCI, V17; Lorente L, 2017, CLIN CHEM LAB MED, V55, P1621, DOI 10.1515/cclm-2016-1034; Lorente L, 2015, INT J MOL SCI, V16, P12147, DOI 10.3390/ijms160612147; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125893; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121739; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; Luciani P, 2005, J CLIN ENDOCR METAB, V90, P6156, DOI 10.1210/jc.2005-0633; Mitsios N, 2007, CELL BIOCHEM BIOPHYS, V47, P73, DOI 10.1385/CBB:47:1:73; Moore DJ, 2012, CLIN DRUG INVEST, V32, P179, DOI 10.2165/11598610-000000000-00000; Parfieniuk-Kowerda A, 2014, LIVER INT, V34, P544, DOI 10.1111/liv.12297; Qi JP, 2004, CHINESE MED J-PEKING, V117, P1507; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Rami A, NEUROCHEM INT; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Sgier C, 2010, J VIRAL HEPATITIS, V17, P845, DOI 10.1111/j.1365-2893.2009.01251.x; Sumer S, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10106; TEASDALE G, 1974, LANCET, V2, P81; Ueno T, 2003, EUR J CANCER, V39, P769, DOI 10.1016/S0959-8049(02)00865-1; Xue Yuan-yuan, 2008, Zhonghua Nei Ke Za Zhi, V47, P988; Yuan ZG, 2015, J NEUROL SCI, V359, P298, DOI 10.1016/j.jns.2015.11.020	43	9	9	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	MAR 24	2018	18									10.1186/s12883-018-1038-z			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GA9KW	WOS:000428661100001	29573748	Green Published, gold			2022-02-06	
J	Shommu, NS; Jenne, CN; Blackwood, J; Joffe, AR; Martin, DA; Thompson, GC; Vogel, HJ				Shommu, Nusrat S.; Jenne, Craig N.; Blackwood, Jaime; Joffe, Ari R.; Martin, Dori-Ann; Thompson, Graham C.; Vogel, Hans J.			Metabolomic and inflammatory mediator based biomarker profiling as a potential novel method to aid pediatric appendicitis identification	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; C-REACTIVE PROTEIN; PERFORATED APPENDICITIS; APPENDECTOMY RATE; SEPTIC SHOCK; DIAGNOSIS; CHILDREN; CHEMOMETRICS; SPECTROSCOPY; INFORMATION	Various limitations hinder the timely and accurate diagnosis of appendicitis in pediatric patients. The present study aims to investigate the potential of metabolomics and cytokine profiling for improving the diagnosis of pediatric appendicitis. Serum and plasma samples were collected from pediatric patients for metabolic and inflammatory mediator analyses respectively. Targeted metabolic profiling was performed using Proton Nuclear Magnetic Resonance Spectroscopy and Flow Injection Analysis Mass Spectrometry/Mass Spectrometry and targeted cytokine/chemokine profiling was completed using a multiplex platform to compare children with and without appendicitis. Twenty-three children with appendicitis and 35 control children without appendicitis from the Alberta Sepsis Network pediatric cohorts were included. Metabolomic profiling revealed clear separation between the two groups with very good sensitivity (80%), specificity (97%), and AUROC (0.93 +/- 0.05) values. Inflammatory mediator analysis also distinguished the two groups with high sensitivity (82%), specificity (100%), and AUROC (0.97 +/- 0.02) values. A biopattern comprised of 9 metabolites and 7 inflammatory compounds was detected to be significant for the separation between appendicitis and control groups. Integration of these 16 significant compounds resulted in a combined metabolic and cytokine profile that also demonstrated strong separation between the two groups with 81% sensitivity, 100% specificity and AUROC value of 0.96 +/- 0.03. The study demonstrated that metabolomics and cytokine mediator profiling is capable of distinguishing children with appendicitis from those without. These results suggest a potential new approach for improving the identification of appendicitis in children.	[Shommu, Nusrat S.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Bio NMR Ctr, Calgary, AB, Canada; [Jenne, Craig N.] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Blackwood, Jaime] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Joffe, Ari R.] Univ Alberta, Div Pediat Crit Care Med, Dept Pediat, Edmonton, AB, Canada; [Martin, Dori-Ann; Thompson, Graham C.] Univ Calgary, Dept Pediat & Emergency Med, Calgary, AB, Canada		Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Bio NMR Ctr, Calgary, AB, Canada.	vogel@ucalgary.ca	Thompson, Graham/Y-4180-2019	Thompson, Graham/0000-0002-6781-4186	Alberta Sepsis Network from Alberta Innovates Health Solutions (AIHS) Team Grant	This study was supported by the Alberta Sepsis Network, which in turn received financial support from Alberta Innovates Health Solutions (AIHS) Team Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas MH, 2014, SURG LAPARO ENDO PER, V24, P488, DOI 10.1097/SLE.0000000000000067; Sit M, 2014, Clin Ter, V165, pe148, DOI [10.7471/CT.2014.1688, 10.7471/CT.2014.1669, 10.7471/CT.2014.1699]; Allister L, 2011, J SURG RES, V168, P70, DOI 10.1016/j.jss.2009.10.029; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Andersson M, 2008, WORLD J SURG, V32, P1843, DOI 10.1007/s00268-008-9649-y; Beltran MA, 2007, J PEDIATR SURG, V42, P1208, DOI 10.1016/j.jpedsurg.2007.02.010; Blomqvist PG, 2001, ANN SURG, V233, P455, DOI 10.1097/00000658-200104000-00001; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Bundy DG, 2007, JAMA-J AM MED ASSOC, V298, P438, DOI 10.1001/jama.298.4.438; Eriksson L, 2006, MULTI MEGAVARIATE 2, P307; Eriksson L, 2006, MULTI MEGAVARIATE 1, P425; Euser SM, 2015, J PEDIAT SURG; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Guthery SL, 2004, J PEDIATR-US, V144, P589, DOI 10.1016/j.jpeds.2004.02.029; Hartwich JE, 2013, J SURG RES, V180, P222, DOI 10.1016/j.jss.2012.04.043; Hennelly KE, 2011, CURR OPIN PEDIATR, V23, P281, DOI 10.1097/MOP.0b013e32834604da; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Longo D. L, 2012, HARRISONS PRINCIPLES; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mickiewicz B., 2014, PEDIAT CRIT CARE MED, V15, P146, DOI [10.1097/01.pcc.0000449371.98387.91, DOI 10.1097/01.PCC.0000449371.98387.91]; Mickiewicz B, 2014, METABOLOMIC PROFILIN, P146; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1026-2; Mickiewicz B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0729-0; Mickiewicz B, 2014, CRIT CARE MED, V42, P1140, DOI 10.1097/CCM.0000000000000142; MIKAELSSON C, 1984, ANN CHIR GYNAECOL FE, V73, P281; Milne WK, 2016, ACAD EMERG MED; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Oyetunji TA, 2012, J SURG RES, V173, P16, DOI 10.1016/j.jss.2011.04.046; Paajanen H, 2002, SCAND J CLIN LAB INV, V62, P579, DOI 10.1080/003655102764654312; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; PIEPER R, 1982, ACTA CHIR SCAND, V148, P63; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Roberts DJ, 2013, J NEUROTRAUM, V30, P1717, DOI 10.1089/neu.2012.2841; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Ross MJ, 2014, ACAD EMERG MED, V21, P538, DOI 10.1111/acem.12377; Rothrock SG, 2000, ANN EMERG MED, V36, P39, DOI 10.1067/mem.2000.105658; Samuel M, 2002, J PEDIATR SURG, V37, P877, DOI 10.1053/jpsu.2002.32893; Tang J, 2011, CURR GENOMICS, V12, P391, DOI 10.2174/138920211797248619; Thompson GC, 2015, ACAD EMERG MED, V22, P811, DOI 10.1111/acem.12709; Tintinalli JEK, 2011, EMERGENCY MED COMPRE; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; VELANOVICH V, 1992, AM SURGEON, V58, P264; Vissers RJ, 2010, EMERG MED CLIN N AM, V28, P103, DOI 10.1016/j.emc.2009.09.003; Wangensteen OH, 1937, ARCH SURG-CHICAGO, V34, P496, DOI 10.1001/archsurg.1937.01190090121006; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; ZWEIG MH, 1993, CLIN CHEM, V39, P561	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2018	13	3							e0193563	10.1371/journal.pone.0193563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY9MC	WOS:000427189300025	29529041	Green Published, gold			2022-02-06	
J	Abboud, T; Duhrsen, L; Gibbert, C; Westphal, M; Martens, T				Abboud, Tammam; Duehrsen, Lasse; Gibbert, Christina; Westphal, Manfred; Martens, Tobias			Influence of antithrombotic agents on recurrence rate and clinical outcome in patients operated for chronic subdural hematoma	NEUROCIRUGIA			English	Article						Chronic subdural hematoma; Recurrent hematoma; Antiplatelet drug; Anticoagulant drug; Phenprocoumon	TRAUMATIC BRAIN-INJURY; CLOSED-SYSTEM DRAINAGE; BURR-HOLE; RISK-FACTOR; ANTICOAGULATION; PROPHYLAXIS; MORTALITY	Introduction: Chronic subdural hematoma (cSDH) is a common pathology encountered in neurosurgical practice, especially in elderly patients, who frequently require antithrombotic agents. The aim of this study was to investigate the influence of antithrombotic agents on recurrence rates and clinical outcomes in patients operated for cSDH. Methods: A cohort of patients operated for cSDH at one center during a 5 years period was analyzed retrospectively. Presenting symptoms, coagulation testing, history of antithrombotic agents and comorbidities were obtained from the patient charts. The standard neurosurgical procedure was a single burr hole under local anesthesia with insertion of a subdural drainage. Questionnaires and telephone interviews were used to assess the clinical outcome using the modified Rankin Scale (mRS). Good outcome was defined as mRS 0 to 3 and poor outcome as mRS 4 to 6. Results: 201 patients with cSDH underwent initial surgical treatment and were enrolled in the study. The median follow-up was 81 weeks. 41 patients (20.4%) were on antiplatelet drug and 43 (21.4%) were on phenprocoumon. A recurrent hematoma required surgery in 37 patients (18.4%). A poor outcome was seen in 36 patients (17.9%). Each of older age and administration of phenprocoumon at admission was an independent risk factor predictive of poor outcome, (p = 0.001 and p = 0.031, respectively)) Administration of antithrombotic agents had no impact on hematoma recurrence. Conclusion: Administration of phenprocoumon and older age might increase the risk of poor outcome in patients with cSDH. Neither the administration of phenprocoumon nor antiplatelet drug influenced the recurrence rate of subdural hematoma in our patient cohort. (C) 2017 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Abboud, Tammam] Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany; [Abboud, Tammam; Duehrsen, Lasse; Gibbert, Christina; Westphal, Manfred; Martens, Tobias] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Gibbert, Christina] Med Ctr Eilbek, Dept Spine Surg, Hamburg, Germany		Abboud, T (corresponding author), Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany.; Abboud, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	tammamabboud@gmail.com					Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Beyer-Westendorf J, 2014, BLOOD, V124, P955, DOI 10.1182/blood-2014-03-563577; Borger V, 2012, ACTA NEUROCHIR, V154, P1549, DOI 10.1007/s00701-012-1434-x; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Couldwell WT., 2004, NEUROSURG FOCUS, V17, P1, DOI [10.3171/foc.2004.17.4.1, DOI 10.3171/F0C.2004.17.4.1]; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Foerch C, 2006, STROKE, V37, P2165, DOI 10.1161/01.STR.0000231842.32153.74; Foreman PM, 2014, CLIN NEUROL NEUROSUR, V123, P109, DOI 10.1016/j.clineuro.2014.05.017; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Leroy HA, 2015, J CLIN NEUROSCI; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Nathan S, 2017, NEUROLOGY, V88, P1889, DOI 10.1212/WNL.0000000000003918; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; Pahatouridis D, 2013, NEUROSURG REV, V36, P151, DOI 10.1007/s10143-012-0412-3; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Pilitsis J, 2013, CLIN NEUROL NEUROSUR, V115, P1429, DOI 10.1016/j.clineuro.2013.01.017; Rocchi G, 2007, SURG NEUROL, V67, P374, DOI 10.1016/j.surneu.2006.08.066; Rohde V, 2002, NEUROSURG REV, V25, P89, DOI 10.1007/s101430100182; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Taussky P, 2008, BRIT J NEUROSURG, V22, P279, DOI 10.1080/02688690701818885; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; WAKAI S, 1990, NEUROSURGERY, V26, P771, DOI 10.1227/00006123-199005000-00006; Wang YP, 2016, COLD REG SCI TECHNOL, V126, P10, DOI 10.1016/j.coldregions.2016.02.013	32	9	10	1	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	MAR-APR	2018	29	2					86	92		10.1016/j.neucir.2017.09.006			7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FZ7QJ	WOS:000427795700004	29122534				2022-02-06	
J	Carothers, C; Giancarelli, A; Ibrahim, J; Hobbs, B				Carothers, Chancey; Giancarelli, Amanda; Ibrahim, Joseph; Hobbs, Brandon			Activated prothrombin complex concentrate for warfarin reversal in traumatic intracranial hemorrhage	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic intracranial hemorrhage; Warfarin reversal; Prothrombin complex concentrate; Traumatic brain injury; Anticoagulation reversal	INTRACEREBRAL HEMORRHAGE; HEAD TRAUMA; ANTICOAGULATION; MANAGEMENT	Background: Patients with traumatic intracranial hemorrhage (TIH) anticoagulated with warfarin are at an increased risk of mortality. Fresh frozen plasma (FFP) and vitamin K have been the standard treatment for warfarin reversal; however, guidelines now recommend the use of prothrombin complex concentrate (PCC) for warfarin reversal in patients with life-threatening bleeding. Our protocol uses one vial (w1000 units) of activated PCC (aPCC) for warfarin reversal, regardless of the weight or presenting international normalized ratio (INR). The purpose of this study was to determine the safety and efficacy of using fixed, low-dose aPCC for warfarin reversal in patients with TIH. Methods: This was a retrospective chart review that included patients with an Abbreviated Injury Scale Head score of >= 3, TIH, and initial INR >= 1.5 on warfarin. Patients aged < 18 years and those with no repeat INR were excluded. The primary outcome was to compare the percentage of patients with INR < 1.4 after receiving aPCC versus FFP within 24 hours. Results: Eighty-nine patients were in the FFP group and 31 patients in the aPCC group. The INR was reversed more effectively in the aPCC group compared with the FFP group (90.3% versus 69.7%, P = 0.029). The median time (hours) to reversal was also significantly shorter in the aPCC group compared with the FFP group (3.75 versus 6.75, P = 0.003). However, there was no difference in mortality (35.5% aPCC versus 22.2% control, P = 0.162) or incidences of thrombosis. Conclusion: Fixed, low-dose aPCC is safe and more effective at reversing the effects of warfarin than FFP in patients with TIH. (C) 2017 Elsevier Inc. All rights reserved.	[Carothers, Chancey; Giancarelli, Amanda; Ibrahim, Joseph; Hobbs, Brandon] Orlando Reg Med Ctr Inc, Dept Pharm, 52 W Underwood St, Orlando, FL 32806 USA		Carothers, C (corresponding author), Orlando Reg Med Ctr Inc, Dept Pharm, 52 W Underwood St, Orlando, FL 32806 USA.	william.carothers@orlandohealth.com		Carothers, Chancey/0000-0002-1482-9640			[Anonymous], 1998, Br J Haematol, V101, P374; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Demeyere R, 2010, VOX SANG, V99, P251, DOI 10.1111/j.1423-0410.2010.01339.x; Evans G, 2001, BRIT J HAEMATOL, V115, P998, DOI 10.1046/j.1365-2141.2001.03214.x; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Klein L, 2015, AM J EMERG MED, V33, P1213, DOI 10.1016/j.ajem.2015.05.017; Liotta EM, 2013, J STROKE CEREBROVASC, V22, P1151, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.015; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Wojcik C, 2009, INT J EMERG MED, V2, P217, DOI 10.1007/s12245-009-0125-8; Yasaka M, 2005, THROMB RES, V115, P455, DOI 10.1016/j.thromres.2004.09.002	12	9	9	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2018	223						183	187		10.1016/j.jss.2017.11.008			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FX1XX	WOS:000425850400025	29433872				2022-02-06	
J	Carter, BT; Luke, SG				Carter, Benjamin T.; Luke, Steven G.			Individuals' Eye Movements in Reading are Highly Consistent Across Time and Trial	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-HUMAN PERCEPTION AND PERFORMANCE			English	Article						reading; eye movements; reliability; individual differences; longitudinal	E-Z-READER; FIXATION-RELATED FMRI; STIMULUS ONSET DELAY; SENTENCE COMPREHENSION; COGNITIVE CONTROL; WORD RECOGNITION; LEXICAL QUALITY; POST-CONCUSSION; VISUAL-SEARCH; FREQUENCY	Eye movements are used to study a variety of cognitive phenomena, including attention, perception, memory, language, reading, decision making, and many others, as well as cognitive impairments and individual differences in cognition. These studies assume, with little evidence, that eye movements are stable across time and trials. Eye movement stability must be better characterized to understand the full theoretical and clinical implications of individual differences in eye movement behavior. The present study examined eye movement reliability in normal individuals during reading. Thirty-nine participants completed 2 sessions of a reading task separated by 1 month. Means and standard deviations of fixation duration, saccade amplitude, first fixation duration, gaze duration, total time, go-past time, skipping, refixation and regression probabilities were compared both between sessions and across trials within sessions. All correlations were highly significant, indicating that eye movement behaviors are stable within individuals across several weeks and highly stable across trials within each individual. The different components of the ex-Gaussian distribution of fixation durations were also highly stable over time. Differences in sensitivity to lexical variables (frequency, predictability, length) were also compared, and were also observed to be highly stable across time. Eye movements in reading are therefore suitable for studying cognition and its neural underpinnings, as well as cognitive development and longitudinal change. Theoretical and clinical implications of these findings are discussed.	[Carter, Benjamin T.; Luke, Steven G.] Brigham Young Univ, Dept Psychol, 1062 SWKT, Provo, UT 84602 USA		Luke, SG (corresponding author), Brigham Young Univ, Dept Psychol, 1062 SWKT, Provo, UT 84602 USA.	steven_luke@byu.edu		Carter, Benjamin/0000-0001-6598-2744			Adler SA, 2014, ATTEN PERCEPT PSYCHO, V76, P1590, DOI 10.3758/s13414-014-0667-6; Afflerbach P, 2015, HDB INDIVIDUAL DIFFE, P348, DOI DOI 10.4324/9780203075562.CH25; Anderson T, 2013, J NEUROL NEUROSUR PS, V84, P242, DOI 10.1136/jnnp-2012-304481; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Ashby J, 2005, Q J EXP PSYCHOL-A, V58, P1065, DOI 10.1080/02724980443000476; Au-Yeung Sheena K, 2011, Autism Res Treat, V2011, P657383, DOI 10.1155/2011/657383; Balota DA, 2011, CURR DIR PSYCHOL SCI, V20, P160, DOI 10.1177/0963721411408885; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benson V, 2012, Q J EXP PSYCHOL, V65, P1139, DOI 10.1080/17470218.2011.644305; Boraston Z, 2007, J PHYSIOL-LONDON, V581, P893, DOI 10.1113/jphysiol.2007.133587; Brenner LA, 2007, J AUTISM DEV DISORD, V37, P1289, DOI 10.1007/s10803-006-0277-9; Burrell JR, 2012, NEUROLOGY, V78, P1816, DOI 10.1212/WNL.0b013e318258f75c; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Castelhano MS, 2008, CAN J EXP PSYCHOL, V62, P1, DOI 10.1037/1196-1961.62.1.1; Castellanos FX, 2000, J AM ACAD CHILD PSY, V39, P644, DOI 10.1097/00004583-200005000-00019; Champely S., 2017, pwr: Basic functions for power analysis (Version 1.2.1) [Computer software]; Choi W, 2015, NEUROPSYCHOLOGIA, V75, P109, DOI 10.1016/j.neuropsychologia.2015.05.027; Cop U, 2015, PSYCHON B REV, V22, P1216, DOI 10.3758/s13423-015-0819-2; Crawford TJ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00118; Dambacher M, 2013, J EXP PSYCHOL HUMAN, V39, P1468, DOI 10.1037/a0031647; Davies M, 2009, INT J CORPUS LINGUIS, V14, P159, DOI 10.1075/ijcl.14.2.02dav; Diependaele K, 2013, Q J EXP PSYCHOL, V66, P843, DOI 10.1080/17470218.2012.720994; Dong W, 2013, J NEUROL NEUROSUR PS, V84, P337, DOI 10.1136/jnnp-2012-303926; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Fernald A, 1998, PSYCHOL SCI, V9, P228, DOI 10.1111/1467-9280.00044; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FUKUSHIMA J, 1988, BIOL PSYCHIAT, V23, P670, DOI 10.1016/0006-3223(88)90050-9; Glaholt MG, 2013, ATTEN PERCEPT PSYCHO, V75, P1761, DOI 10.3758/s13414-013-0522-1; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Heathcote A, 2004, BEHAV RES METH INS C, V36, P277, DOI 10.3758/BF03195574; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM, 2008, PSYCHON B REV, V15, P566, DOI 10.3758/PBR.15.3.566; Henderson JM, 2016, NEUROIMAGE, V132, P293, DOI 10.1016/j.neuroimage.2016.02.050; Henderson JM, 2015, NEUROIMAGE, V119, P390, DOI 10.1016/j.neuroimage.2015.06.072; Henderson JM, 2014, J COGNITIVE NEUROSCI, V26, P2880, DOI 10.1162/jocn_a_00668; Henderson JM, 2014, J EXP PSYCHOL HUMAN, V40, P1390, DOI 10.1037/a0036330; Henderson JM, 2014, VIS COGN, V22, P486, DOI 10.1080/13506285.2014.897662; Henderson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064937; Henderson JM, 2013, J EXP PSYCHOL HUMAN, V39, P318, DOI 10.1037/a0031224; Henderson JM, 2012, PSYCHON B REV, V19, P1101, DOI 10.3758/s13423-012-0274-2; Henderson JM, 2009, VIS COGN, V17, P1055, DOI 10.1080/13506280802685552; Hershler O, 2009, ATTEN PERCEPT PSYCHO, V71, P1478, DOI 10.3758/APP.71.7.1478; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; Huestegge L, 2009, VISION RES, V49, P2948, DOI 10.1016/j.visres.2009.09.012; Huettig F, 2015, DYSLEXIA, V21, P97, DOI 10.1002/dys.1497; Hutton SB, 2004, BIOL PSYCHIAT, V56, P553, DOI 10.1016/j.biopsych.2004.07.002; Itti L, 2015, NEURON, V88, P442, DOI 10.1016/j.neuron.2015.10.033; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Kardan O, 2016, J EXP PSYCHOL HUMAN, V42, P1429, DOI 10.1037/xhp0000224; Kardan O, 2015, J EXP PSYCHOL HUMAN, V41, P1502, DOI 10.1037/a0039673; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Kuperman V, 2011, J MEM LANG, V65, P42, DOI 10.1016/j.jml.2011.03.002; Laubrock J, 2006, NEUROSCI BIOBEHAV R, V30, P872, DOI 10.1016/j.neubiorev.2006.06.013; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Lueck KL, 2000, NEUROPSY NEUROPSY BE, V13, P77; Luke SG, 2016, COGNITIVE PSYCHOL, V88, P22, DOI 10.1016/j.cogpsych.2016.06.002; Luke SG, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00257; Luke SG, 2015, J EXP PSYCHOL LEARN, V41, P1675, DOI 10.1037/xlm0000133; Luke SG, 2013, ATTEN PERCEPT PSYCHO, V75, P1230, DOI 10.3758/s13414-013-0482-5; Luke SG, 2013, J EXP PSYCHOL HUMAN, V39, P10, DOI 10.1037/a0030392; Mancheva L, 2015, J COGN PSYCHOL, V27, P657, DOI 10.1080/20445911.2015.1024255; Mani N, 2014, J EXP CHILD PSYCHOL, V126, P264, DOI 10.1016/j.jecp.2014.05.004; Meister MLR, 2016, NEUROBIOL LEARN MEM, V134, P135, DOI 10.1016/j.nlm.2015.12.004; Molitor RJ, 2015, J ALZHEIMERS DIS, V44, P1, DOI 10.3233/JAD-141173; Molitor RJ, 2014, HIPPOCAMPUS, V24, P666, DOI 10.1002/hipo.22256; MORRISON RE, 1984, J EXP PSYCHOL HUMAN, V10, P667, DOI 10.1037/0096-1523.10.5.667; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Nation K, 2003, J EXP CHILD PSYCHOL, V86, P314, DOI 10.1016/j.jecp.2003.09.001; Nuthmann A, 2007, VISION RES, V47, P990, DOI 10.1016/j.visres.2006.11.005; Nuthmann A, 2017, PSYCHON B REV, V24, P370, DOI 10.3758/s13423-016-1124-4; Nuthmann A, 2012, VIS COGN, V20, P457, DOI 10.1080/13506285.2012.670142; Nuthmann A, 2009, VISION RES, V49, P322, DOI 10.1016/j.visres.2008.10.022; Oakes LM, 2012, INFANCY, V17, P1, DOI 10.1111/j.1532-7078.2011.00101.x; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Park H, 2016, COMPUT HUM BEHAV, V63, P796, DOI 10.1016/j.chb.2016.06.016; R Core Team, 2018, R LANGUAGE ENV STAT; Radach R, 2013, Q J EXP PSYCHOL, V66, P429, DOI 10.1080/17470218.2012.750676; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 1996, PERCEPT PSYCHOPHYS, V58, P734, DOI 10.3758/BF03213106; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Rayner K, 2015, CURR OPIN BEHAV SCI, V1, P107, DOI 10.1016/j.cobeha.2014.10.008; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reich ED, 2012, PSYCHOL REV, V119, P155, DOI 10.1037/a0026473; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reichle ED, 2013, J EXP PSYCHOL LEARN, V39, P1311, DOI 10.1037/a0030910; Reichle ED, 2013, DEV REV, V33, P110, DOI 10.1016/j.dr.2013.03.001; Reichle ED, 2010, PSYCHOL SCI, V21, P1300, DOI 10.1177/0956797610378686; Reuter B, 2005, PSYCHIAT RES, V135, P1, DOI 10.1016/j.psychres.2004.12.006; Revelle W., 2015, PSYCH PROCEDURES FOR; Roberts EO, 2013, SCHIZOPHRENIA BULL, V39, P896, DOI 10.1093/schbul/sbr191; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schuster S, 2016, CEREB CORTEX, V26, P3889, DOI 10.1093/cercor/bhw184; Schuster S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12686; Spering M, 2015, TRENDS NEUROSCI, V38, P247, DOI 10.1016/j.tins.2015.02.002; Staub A, 2013, PSYCHON B REV, V20, P1304, DOI 10.3758/s13423-013-0444-x; Swets B, 2007, J EXP PSYCHOL GEN, V136, P64, DOI 10.1037/0096-3445.136.1.64; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Taylor JN, 2016, READ WRIT, V29, P1069, DOI 10.1007/s11145-015-9616-6; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Trueswell JC, 1999, COGNITION, V73, P89, DOI 10.1016/S0010-0277(99)00032-3; Veldre A, 2014, Q J EXP PSYCHOL, V67, P703, DOI 10.1080/17470218.2013.826258; VITU F, 1995, PERCEPT PSYCHOPHYS, V57, P352, DOI 10.3758/BF03213060; Vitu F, 2003, BEHAV BRAIN SCI, V26, P506, DOI 10.1017/S0140525X0351010X; Walshe RC, 2014, VISION RES, V100, P38, DOI 10.1016/j.visres.2014.03.012; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Yang SN, 2001, VISION RES, V41, P3567, DOI 10.1016/S0042-6989(01)00025-6; Yap MJ, 2012, J EXP PSYCHOL HUMAN, V38, P53, DOI 10.1037/a0024177	115	9	11	1	22	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0096-1523	1939-1277		J EXP PSYCHOL HUMAN	J. Exp. Psychol.-Hum. Percept. Perform.	MAR	2018	44	3					482	492		10.1037/xhp0000471			11	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GA5NU	WOS:000428381600010	28816481				2022-02-06	
J	Goedegebuure, WJ; Jonkers, F; Boot, AM; Bakker-van Waarde, WM; van Tellingen, V; Heeg, M; Odink, RJ; van Douveren, F; Besselaar, AT; van der Steen, MC				Goedegebuure, Wesley J.; Jonkers, Frank; Boot, Annemieke M.; Bakker-van Waarde, Willie M.; van Tellingen, Vera; Heeg, Minne; Odink, Roelof J.; van Douveren, Florens; Besselaar, Arnold T.; van der Steen, Marieke C.			Long-term follow-up after bilateral percutaneous epiphysiodesis around the knee to reduce excessive predicted final height	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							CONSTITUTIONALLY TALL CHILDREN; HIGH-DOSE ESTROGEN; ADULT HEIGHT; STATURE; WOMEN; GIRLS; MANAGEMENT; MEN; ADOLESCENCE; FERTILITY	Context Percutaneous epiphysiodesis (PE) around the knee to reduce predicted excessive final height. Studies until now included small numbers of patients and short follow-up periods. Objective and design This Dutch multicentre, longterm, retrospective, follow-up study aimed to assess adult height (AH), complications, knee function and patient satisfaction after PE. The primary hypothesis was that PE around the knee in constitutionally tall boys and girls is an effective treatment for reducing final height with low complication rates and a high level of patient satisfaction. Participants 77 treated adolescents and 60 comparisons. Intervention Percutaneous epiphysiodesis. Outcome AH, complications, knee function, satisfaction. Results In the PE-treated group, final height was 7.0 cm (+/- 6.3 cm) lower than predicted in boys and 5.9 cm (+/- 3.7 cm) lower than predicted in girls. Short-term complications in file search were seen in 5.1% (three infections, one temporary nerve injury), one requiring reoperation. Long-term complications in file search were seen in 2.6% (axis deformity 1.3%, prominent head of fibula 1.3%). No significant difference in knee function was found between treated cases and comparisons. Satisfaction was high in both the comparison and PE groups; most patients in the PE group recommended PE as the treatment for close relatives with tall stature. Conclusion PE is safe and effective in children with predicted excessive AH. There was no difference in patient satisfaction between the PE and comparison group. Careful and detailed counselling is needed before embarking on treatment.	[Goedegebuure, Wesley J.; van Tellingen, Vera; Odink, Roelof J.] Catharina Hosp, Dept Pediat, Eindhoven, Netherlands; [Jonkers, Frank; van Douveren, Florens; Besselaar, Arnold T.] Maxima Med Ctr, Orthopaed Ctr Maxima, Eindhoven, Netherlands; [Boot, Annemieke M.; Bakker-van Waarde, Willie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Endocrinol, Groningen, Netherlands; [Heeg, Minne] Wilhelmina Gasthuis, Dept Orthopaed Surg, Assen, Netherlands; [Odink, Roelof J.] Maxima Med Ctr, Dept Pediat, Eindhoven, Netherlands; [Besselaar, Arnold T.; van der Steen, Marieke C.] Catharina Hosp, Dept Orthopaed Surg, Eindhoven, Netherlands		Goedegebuure, WJ (corresponding author), Erasmus Univ, Med Ctr, Sub Div Endocrinol, Dept Paediat, NL-3015 GJ Rotterdam, Netherlands.	w.goedegebuure@erasmusmc.nl	Kehoe, Clare/ABC-7984-2020	Boot, Annemieke/0000-0002-2426-3222			BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Benyi E, 2014, HORM RES PAEDIAT, V82, P89, DOI 10.1159/000360137; Benyi E, 2010, INT J PEDIATR ENDOCR, DOI 10.1155/2010/740629; Bettendorf M, 1997, EUR J PEDIATR, V156, P911, DOI 10.1007/s004310050741; Binder G, 1997, EUR J PEDIATR, V156, P905, DOI 10.1007/s004310050740; Chu S, 2005, PERS INDIV DIFFER, V38, P1927, DOI 10.1016/j.paid.2004.10.004; Davies JH, 2014, ARCH DIS CHILD, V99, P772, DOI 10.1136/archdischild-2013-304830; deWaal WJ, 1996, J CLIN ENDOCR METAB, V81, P1206, DOI 10.1210/jc.81.3.1206; deWaal WJ, 1996, ACTA PAEDIATR, V85, P889; DEWAAL WJ, 1995, ARCH DIS CHILD, V73, P311, DOI 10.1136/adc.73.4.311; Edmonds EW, 2007, J PEDIATR ORTHOPED, V27, P618, DOI 10.1097/BPO.0b013e31814254b4; FEINGOLD A, 1982, PSYCHOL REP, V50, P810, DOI 10.2466/pr0.1982.50.3.810; GROSS RH, 1978, ORTHOPEDICS, V1, P307; Hendriks AEJ, 2012, J CLIN ENDOCR METAB, V97, P3107, DOI 10.1210/jc.2012-1078; Hendriks AEJ, 2011, J CLIN ENDOCR METAB, V96, P1098, DOI 10.1210/jc.2010-2244; Hendriks AEJ, 2010, J CLIN ENDOCR METAB, V95, P5233, DOI 10.1210/jc.2010-0435; Hermanussen M, 2003, HORM RES, V59, P180, DOI 10.1159/000069321; Horn J, 2013, J CHILD ORTHOP, V7, P295, DOI 10.1007/s11832-013-0502-y; Inan M, 2008, J PEDIATR ORTHOPED, V28, P648, DOI 10.1097/BPO.0b013e3181832475; Iversen MD, 2016, J PEDIATR ORTHOPED, V36, P278, DOI 10.1097/BPO.0000000000000448; JACKSON LA, 1992, J SOC PSYCHOL, V132, P433, DOI 10.1080/00224545.1992.9924723; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; KUH DJL, 1993, BRIT J RHEUMATOL, V32, P911; Odink RJ, 2006, EUR J PEDIATR, V165, P50, DOI 10.1007/s00431-005-1722-z; Ortqvist M, 2014, BRIT J SPORT MED, V48, P1437, DOI 10.1136/bjsports-2013-093164; Pyett P, 2005, SOC SCI MED, V61, P1629, DOI 10.1016/j.socscimed.2005.03.016; PYLE SI, 1971, AM J PHYS ANTHROPOL, V35, P331, DOI 10.1002/ajpa.1330350306; Talma H., 2010, HANDLEIDING BIJ METE; van Dommelen P, 2012, ARCH DIS CHILD, V97, DOI 10.1136/archdischild-2011-301095; Venn A, 2004, LANCET, V364, P1513, DOI 10.1016/S0140-6736(04)17274-7; Verge CF, 2010, ARCH DIS CHILD, V95, P458, DOI 10.1136/adc.2009.157693; Wahlstrom J, 2012, SPINE, V37, P1334, DOI 10.1097/BRS.0b013e31824b5464; WETTENHALL HNB, 1975, J PEDIATR-US, V86, P602	33	9	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	MAR	2018	103	3					219	223		10.1136/archdischild-2017-313295			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GB4CY	WOS:000429009300005	29030385				2022-02-06	
J	Iverson, GL; Terry, DP; Karr, JE; Panenka, WJ; Silverberg, ND				Iverson, Grant L.; Terry, Douglas P.; Karr, Justin E.; Panenka, William J.; Silverberg, Noah D.			Perceived Injustice and Its Correlates after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; mild traumatic brain injury; outcome; perceived injustice	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TEST; CHRONIC PAIN; PERCEPTION QUESTIONNAIRE; EXPERIENCE QUESTIONNAIRE; DEPRESSIVE SYMPTOMS; RESILIENCE SCALE; HEAD-INJURY; OUTCOMES	Perceived injustice is a belief that one has been treated unfairly and disrespectfully, and is suffering unnecessarily as a result of another person's actions. Perceived injustice predicts chronic disability after musculoskeletal injury but to our knowledge has not been empirically studied in people with mild traumatic brain injuries (mTBIs). We examined perceived injustice and its correlates in patients who were slow to recover from mTBI. Patients (n=102) were recruited from four concussion clinics. The sample was on average 41.2 years old (standard deviation [SD]=11.7; range=21-64), 53.9% were women, and patients were evaluated 2-26 weeks post-injury (mean=12.1, SD=6.3). Patients completed measures assessing perceived injustice (Injustice Experience Questionnaire; IEQ), post-concussion symptoms, post-traumatic stress, depression, pain, disability, and neuropsychological performance validity. Patients frequently endorsed items such as "I just want to have my life back" (85.2%) and "people don't understand how severe my condition is" (89.1%), with 23.5% of the sample scoring in the clinically significant range on the IEQ (Total Score >30). Internal consistency was high (Cronbach's =0.91). Patients who failed performance validity testing (Cohen's d=0.48) or were seeking/receiving compensation (d=0.92) reported greater perceived injustice. Greater perceived injustice was associated with greater post-concussion symptoms (r=0.48), traumatic stress (r=0.69), depression (r=0.60), bodily pain (r=0.32), and negative expectations for recovery (r=0.40; all p<0.01). Given that perceived injustice is a belief system that can influence health behaviors, it might be a viable target for psychological treatment.	[Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Home Base, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Boston, MA USA; [Karr, Justin E.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Panenka, William J.] British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Rehabil Res Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), GF Strong Rehabil Ctr, Rehabil Res Program, Vancouver, BC, Canada.	noah.silverberg@vch.ca		Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	Specific Priorities Research Grant from WorkSafeBC [RS2014-SP03]; Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute; Health Professional Investigator award from the Michael Smith Foundation for Health Research	This study was funded by a Specific Priorities Research Grant from WorkSafeBC (# RS2014-SP03). Noah D. Silverberg receives salary support from a Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute and a Health Professional Investigator award from the Michael Smith Foundation for Health Research.	Agtarap S, 2016, REHABIL PSYCHOL, V61, P336, DOI 10.1037/rep0000097; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carriere JS, 2017, EUR J PAIN, V21, P1234, DOI 10.1002/ejp.1023; Carriere JS, 2017, J PAIN RES, V10, DOI 10.2147/JPR.S128184; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Elbers NA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3331-3; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Giummarra MJ, 2017, J OCCUP REHABIL, V27, P173, DOI 10.1007/s10926-016-9642-5; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Green P, 2004, GREENS MED SYMPTOM V; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ioannou LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178894; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kennedy L, 2014, J OCCUP REHABIL, V24, P385, DOI 10.1007/s10926-013-9462-9; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Margiotta F, 2017, PAIN PRACT, V17, P663, DOI 10.1111/papr.12501; Miller MM, 2016, J PAIN, V17, P1217, DOI 10.1016/j.jpain.2016.08.002; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Murgatroyd DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117597; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Rodero B, 2012, J PSYCHOSOM RES, V73, P86, DOI 10.1016/j.jpsychores.2012.05.011; RUTHERFORD WH, 1977, LANCET, V1, P1; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Scott W, 2016, DISABIL REHABIL, V38, P2365, DOI 10.3109/09638288.2015.1129444; Scott W, 2015, CLIN J PAIN, V31, P145, DOI 10.1097/AJP.0000000000000095; Scott W, 2013, J OCCUP REHABIL, V23, P557, DOI 10.1007/s10926-013-9417-1; Scott W, 2013, PAIN, V154, P1691, DOI 10.1016/j.pain.2013.05.015; Scott W, 2012, PAIN RES MANAG, V17, P335, DOI 10.1155/2012/501260; SEEWALD MJ, 1991, ACTA ANAESTH SCAND, V35, P345, DOI 10.1111/j.1399-6576.1991.tb03303.x; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sturgeon JA, 2016, ANN BEHAV MED, V50, P802, DOI 10.1007/s12160-016-9808-6; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sullivan MJL, 2009, PSYCHOL INJ LAW, V2, P238, DOI 10.1007/s12207-009-9055-2; Sullivan MJL, 2009, PAIN, V145, P325, DOI 10.1016/j.pain.2009.06.031; Sullivan MJ., 2008, USER MANUAL INJUSTIC; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Trost Z, 2016, PSYCHOL INJ LAW, V9, P31, DOI 10.1007/s12207-015-9245-z; Trost Z, 2015, REHABIL PSYCHOL, V60, P213, DOI 10.1037/rep0000043; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Yamada K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160567; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	74	9	9	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1156	1166		10.1089/neu.2017.5402		MAR 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000426521000001	29239280				2022-02-06	
J	Jurick, SM; Crocker, LD; Sanderson-Cimino, M; Keller, AV; Trenova, LS; Boyd, BL; Twamley, EW; Rodgers, CS; Schiehser, DM; Aupperle, RL; Jak, AJ				Jurick, Sarah M.; Crocker, Laura D.; Sanderson-Cimino, Mark; Keller, Amber V.; Trenova, Liljana S.; Boyd, Briana L.; Twamley, Elizabeth W.; Rodgers, Carie S.; Schiehser, Dawn M.; Aupperle, Robin L.; Jak, Amy J.			Contributions to Executive Dysfunction in Operation Enduring Freedom/Operation Iraqi Freedom Veterans With Posttraumatic Stress Disorder and History of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attention; cognitive rehabilitation; concussion; executive function; loss of consciousness; mild traumatic brain injury; posttraumatic stress disorder; processing speed	OEF/OIF VETERANS; NEUROPSYCHOLOGICAL OUTCOMES; PROCESSING SPEED; TEST-PERFORMANCE; COMBAT VETERANS; BLAST EXPOSURE; PTSD; TBI; SYMPTOMS	Objective: Posttraumatic stress disorder (PTSD), history of mild traumatic brain injury (mTBI), and executive function (EF) difficulties are prevalent in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans. We evaluated the contributions of injury variables, lower-order cognitive component processes (processing speed/attention), and psychological symptoms to EF. Participants: OEF/OIF Veterans (N = 65) with PTSD and history of mTBI were administered neuropsychological tests of EF and self-report assessments of PTSD and depression. Results: Those impaired on one or more EF measures had higher PTSD and depression symptoms and lower processing speed/attention performance than those with intact performance on all EF measures. Across participants, poorer attention/processing speed performance and higher psychological symptoms were associated with worse performance on specific aspects of EF (eg, inhibition and switching) even after accounting for injury variables. Although direct relationships between EF and injury variables were equivocal, there was an interaction between measures of injury burden and processing speed/attention such that those with greater injury burden exhibited significant and positive relationships between processing speed/attention and inhibition/switching, whereas those with lower injury burden did not. Conclusion: Psychological symptoms as well as lower-order component processes of EF (attention and processing speed) contribute significantly to executive dysfunction in OEF/OIF Veterans with PTSD and history of mTBI. However, there may be equivocal relationships between injury variables and EF that warrant further study. Results provide groundwork for more fully understanding cognitive symptoms in OEF/OIF Veterans with PTSD and history of mTBI that can inform psychological and cognitive interventions in this population.	[Jurick, Sarah M.; Sanderson-Cimino, Mark] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Jurick, Sarah M.; Keller, Amber V.; Trenova, Liljana S.; Boyd, Briana L.] Vet Med Res Fdn, San Diego, CA USA; [Crocker, Laura D.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, 3350 La Jolla Village Dr MC 151B, San Diego, CA 92161 USA; [Twamley, Elizabeth W.; Rodgers, Carie S.; Schiehser, Dawn M.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Schiehser, Dawn M.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Twamley, Elizabeth W.; Schiehser, Dawn M.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Rodgers, Carie S.] PsychArmor Inst, San Diego, CA USA; [Aupperle, Robin L.] Laureate Inst Brain Res, Tulsa, OK USA; [Aupperle, Robin L.] Univ Tulsa, Tulsa, OK 74104 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, Psychol Serv, 3350 La Jolla Village Dr MC 151B, San Diego, CA 92161 USA.	ajak@ucsd.edu	Aupperle, Robin/AAU-8550-2020	Keller, Amber/0000-0002-2972-784X; Sanderson-Cimino, Mark/0000-0002-5872-3186	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]	This work was supported by the Department of Defense grant number W81XWH-11-1-0641 received by Amy J. Jak.	Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Gaines KD, 2016, APPL NEUROPSYCH-ADUL, V23, P115, DOI 10.1080/23279095.2015.1012762; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Hayes AF., CISC VIS NETW IND GL; Heaton R., 2000, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jaycox, 2008, INVISIBLE WOUNDS WAR; Keshavan MS, 2014, AM J PSYCHIAT, V171, P510, DOI 10.1176/appi.ajp.2013.13081075; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Li HJ, 2011, AGEING RES REV, V10, P285, DOI 10.1016/j.arr.2010.11.003; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M., 2008, MILD TRAUMATIC BRAIN; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vinogradov S, 2012, NEUROPSYCHOPHARMACOL, V37, P43, DOI 10.1038/npp.2011.251; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Walter KH, 2010, J TRAUMA STRESS, V23, P292, DOI 10.1002/jts.20506; Weathers F. W., 1993, ANN M INT SOC TRAUMA; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057	50	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E41	E52		10.1097/HTR.0000000000000313			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200005	28520663				2022-02-06	
J	Kim, DS; Li, YTK; Kim, JH; Bergquist, CS; Gerdes, M; Bernbaum, JC; Burnham, N; McDonald-McGinn, DM; Zackai, EH; Nicolson, SC; Spray, TL; Nickerson, DA; Hakonarson, H; Jarvik, GP; Gaynor, JW				Kim, Daniel Seung; Li, Yatong K.; Kim, Jerry H.; Bergquist, Curtis S.; Gerdes, Marsha; Bernbaum, Judy C.; Burnham, Nancy; McDonald-McGinn, Donna M.; Zackai, Elaine H.; Nicolson, Susan C.; Spray, Thomas L.; Nickerson, Deborah A.; Hakonarson, Hakon; Jarvik, Gail P.; Gaynor, J. William			Autosomal dominant mannose-binding lectin deficiency is associated with worse neurodevelopmental outcomes after cardiac surgery in infants	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article						congenital heart disease; neurodevelopment; genetics; MBL2; mannose-binding lectin; gene-by-environment interaction; gene-environment interactions	HYPOTHERMIC CIRCULATORY ARREST; APOLIPOPROTEIN-E GENOTYPE; TRAUMATIC BRAIN-INJURY; HEART-SURGERY; RISK; CHILDREN; DYSFUNCTION; PROTEIN; DEFECT	Objectives: The MBL2 gene is the major genetic determinant of mannose-binding lectin (MBL)-an acute phase reactant. Low MBL levels have been associated with adverse outcomes in preterm infants. The MBL2(Gly54Asp) missense variant causes autosomal dominant MBL deficiency. We tested the hypothesis that MBL2(Gly54Asp) is associated with worse neurodevelopmental outcomes after cardiac surgery in neonates. Methods: This is an analysis of a previously described cohort of patients with nonsyndromic congenital heart disease who underwent cardiac surgery with cardiopulmonary bypass before age 6 months (n = 295). Four-year neurodevelopment was assessed in 3 domains: Full-Scale Intellectual Quotient, the Visual Motor Integration development test, and the Child Behavior Checklist to assess behavior problems. The Child Behavior Checklist measured total behavior problems, pervasive developmental problems, and internalizing/externalizing problems. A multivariable linear regression model, adjusting for confounders, was fit. Results: MBL2(Gly54Asp) was associated with a significantly increased covariate-adjusted pervasive developmental problem score (beta = 3.98; P = .0025). Sensitivity analyses of the interaction between age at first surgery and MBL genotype suggested effect modification for the patients with MBL2(Gly54Asp) (P-interaction = .039), with the poorest neurodevelopment outcomes occurring in children who had surgery earlier in life. Conclusions: We report the novel finding that carriers of MBL2(Gly54Asp) causing autosomal dominant MBL deficiency have increased childhood pervasive developmental problems after cardiac surgery, independent of other covariates. Sensitivity analyses suggest that this effect may be larger in children who underwent surgery at earlier ages. These data support the role of nonsyndromic genetic variation in determining postsurgical neurodevelopment-related outcomes in children with congenital heart disease.	[Kim, Daniel Seung; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Kim, Daniel Seung; Nickerson, Deborah A.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kim, Jerry H.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Kim, Daniel Seung; Li, Yatong K.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Bergquist, Curtis S.] Univ Michigan, Dept Surg, Sect Thorac Surg, Ann Arbor, MI 48109 USA; [Gerdes, Marsha; Bernbaum, Judy C.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Burnham, Nancy; Spray, Thomas L.; Gaynor, J. William] Univ Penn, Childrens Hosp Philadelphia, Div Cardiothorac Surg, Philadelphia, PA 19104 USA; [McDonald-McGinn, Donna M.; Zackai, Elaine H.] Univ Penn, Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Nicolson, Susan C.] Univ Penn, Childrens Hosp Philadelphia, Div Cardiothorac Anesthesiol, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Gaynor, JW (corresponding author), Div Cardiothorac Surg, Rm 8527 Main Bldg,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	gaynor@email.chop.edu	McDonald-McGinn, Donna/L-8643-2019	/0000-0003-4077-250X; Britt, Allison/0000-0001-6601-0453; Kim, Daniel/0000-0003-2971-1909	Fannie E. Rippel Foundation; American Heart AssociationAmerican Heart Association [9950480N]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL071834, 1F31MH101905-01, T32HL007312]; Washington State Life Sciences Discovery Award; American Hospital Association [16POST27250048]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 TR000421]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD086984] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071834, T32HL007312] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH101905] Funding Source: NIH RePORTER	Supported by a grant from the Fannie E. Rippel Foundation, an American Heart Association National Grant-in-Aid (No. 9950480N), National Institutes of Health grant No. HL071834, and a Washington State Life Sciences Discovery Award to the Northwest Institute for Genetic Medicine. Dr D. Kim was supported by National Institutes of Health grants Nos. 1F31MH101905-01 and T32HL007312 and American Hospital Association grant No. 16POST27250048. Dr J. Kim was supported by National Center for Research Resources grant No. KL2 TR000421.	Achenbach T., 2001, ASEBA CHILD BEHAV CH; Auriti C, 2014, PEDIATR RES, V76, P464, DOI 10.1038/pr.2014.118; Beery K., 2010, BEERY BUKTENICA DEV; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Bilgin YM, 2008, TRANSFUSION, V48, P601, DOI 10.1111/j.1537-2995.2007.01585.x; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; Clancy RR, 2000, J THORAC CARDIOV SUR, V119, P347, DOI 10.1016/S0022-5223(00)70191-7; Collard CD, 2007, CIRCULATION, V116, pI106, DOI 10.1161/CIRCULATIONAHA.106.679530; Frakking FNJ, 2006, CLIN EXP IMMUNOL, V145, P5, DOI 10.1111/j.1365-2249.2006.03093.x; Gaynor JW, 2007, J THORAC CARDIOV SUR, V133, P1344, DOI 10.1016/j.jtcvs.2006.10.087; Gaynor JW, 2014, J THORAC CARDIOV SUR, V148, P2560, DOI 10.1016/j.jtcvs.2014.07.052; Gaynor JW, 2009, PEDIATRICS, V124, P241, DOI 10.1542/peds.2008-2281; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Gaynor JW, 2002, EUR J CARDIO-THORAC, V22, P82, DOI 10.1016/S1010-7940(02)00198-7; IKEDA K, 1987, J BIOL CHEM, V262, P7451; Kim DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045936; Kim DS, 2016, J THORAC CARDIOV SUR, V151, P1147, DOI 10.1016/j.jtcvs.2015.09.136; Kim DS, 2014, ANN THORAC SURG, V98, P104, DOI 10.1016/j.athoracsur.2014.03.017; Koroglu OA, 2010, NEONATOLOGY, V98, P305, DOI 10.1159/000291487; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Mazefsky CA, 2011, J PSYCHOPATHOL BEHAV, V33, P31, DOI 10.1007/s10862-010-9198-1; Mogues T, 1996, GLYCOBIOLOGY, V6, P543, DOI 10.1093/glycob/6.5.543; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Speletas M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/478412; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUPER M, 1989, LANCET, V2, P1236; Wechsler D., 2002, WECHSLER PRESCHOOL P; Xue J, 2016, J MATERN-FETAL NEO M, V29, P1425, DOI 10.3109/14767058.2015.1050372; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605	34	9	9	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	MAR	2018	155	3					1139	+		10.1016/j.jtcvs.2017.08.035			11	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	FX2TT	WOS:000425915100085	29452463	Bronze, Green Accepted			2022-02-06	
J	Ma, RC; Rowland, D; Judge, A; Calisto, A; Jayamohan, J; Johnson, D; Richards, P; Magdum, S; Wall, S				Ma, Ruichong; Rowland, David; Judge, Andrew; Calisto, Amedeo; Jayamohan, Jayaratnam; Johnson, David; Richards, Peter; Magdum, Shailendra; Wall, Steven			Complications following intracranial pressure monitoring in children: a 6-year single-center experience	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						ICP monitoring; intracranial pressure; craniosynostosis; trauma; pediatric	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; CRANIOSYNOSTOSIS; HYDROCEPHALUS; SYSTEM	OBJECTIVE Intracranial pressure (ICP) monitoring is an important tool in the neurosurgeon's armamentarium and is used for a wide range of indications. There are many different ICP monitors available, of which fiber-optic intraparen-chymal devices are very popular. Here, the authors document their experience performing ICP monitoring from 2005 to 2015 and specifically complication rates following insertion of the Microsensor ICP monitor. METHODS A retrospective case series review of all patients who underwent ICP monitoring over a 10-year period from 2005 to 2015 was performed. RESULTS There were 385 separate operations with an overall complication rate of 8.3% (32 of 385 cases). Hardware failure occurred in 4.2% of cases, the CSF leakage rate was 3.6%, the postoperative hemorrhage rate was 0.5%, and there was 1 case of infection (0.3% of cases). Only patients with hardware problems required further surgery as a result of their complications, and no patient had any permanent morbidity or mortality from the procedure. Younger patients (p = 0.001) and patients with pathologically high ICP (13% of patients with high ICP vs 6.5% of patients with normal ICP; p = 0.04) were significantly more likely to have complications. There was no significant difference in the complication rates between general neurosurgical patients and craniofacial patients (7.6% vs 8.8%, respectively; p = 0.67). CONCLUSIONS Intraparenchymal ICP monitoring is a safe procedure associated with low complications and morbidity in the pediatric craniofacial and neurosurgical population and should be offered to appropriate patients to assess ICP with the reassurance of the safety record reported in this study.	[Ma, Ruichong; Rowland, David; Calisto, Amedeo; Jayamohan, Jayaratnam; Richards, Peter; Magdum, Shailendra] John Radcliffe Hosp, Dept Neurosurg, Oxford, England; [Judge, Andrew] John Radcliffe Hosp, Oxford Craniofacial Unit, Oxford, England; [Jayamohan, Jayaratnam; Johnson, David; Richards, Peter; Magdum, Shailendra; Wall, Steven] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England		Ma, RC (corresponding author), John Radcliffe Hosp, Oxford, England.	ruichong.ma@gmail.com		Ma, Ruichong/0000-0002-4939-8553			Al-Tamimi YZ, 2009, NEUROSURGERY, V64, P94, DOI 10.1227/01.NEU.0000328392.98602.5A; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Eide PK, 2002, PEDIATR NEUROSURG, V37, P310, DOI 10.1159/000066311; Fernandes HM, 1998, ACT NEUR S, V71, P44; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Khan SH, 1998, ACT NEUR S, V71, P50; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Saehle T, 2015, J NEUROSURG, V122, P1076, DOI 10.3171/2014.12.JNS141029; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841; Tamburrini G, 2005, CHILD NERV SYST, V21, P913, DOI 10.1007/s00381-004-1117-x; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Wall SA, 2014, J NEUROSURG-PEDIATR, V14, P674, DOI 10.3171/2014.8.PEDS1425	21	9	9	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2018	21	3					278	283		10.3171/2017.9.PEDS17360			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FX7VL	WOS:000426299400010	29303458				2022-02-06	
J	MacDonald, J; Patel, N; Young, J; Stuart, E				MacDonald, James; Patel, Neha; Young, Julie; Stuart, Emily			Returning Adolescents to Driving after Sports-Related Concussions: What Influences Physician Decision-Making	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; 4TH INTERNATIONAL-CONFERENCE; AMERICAN MEDICAL SOCIETY; ERROR SCORING SYSTEM; BASE-LINE; CONSENSUS STATEMENT; POSITION STATEMENT; REACTION-TIME; CHILDREN; PERFORMANCE	Objective To determine which data collected on an initial patient clinic visit for a sports-related concussion (SRC) might influence physicians to clear an adolescent to return to drive (RTD) after injury. Study design Retrospective cohort study of 189 adolescents with a SRC referred to a hospital-based concussion clinic between June 1, 2015, and May 31, 2016. Subjects were >= 16 years with a valid driver's license (median age = 16, IQR [16, 17]). Concussion evaluations included Post-Concussion Symptom Scale, modified Balance Error Scoring System, and postinjury computerized neurocognitive testing (CNT). Clearance for RTD was the main outcome. Statistical comparisons were conducted with Mann-Whitney U and chi(2) tests and logistic regression. Results In multivariable analysis, odds of being fully cleared to drive were 5.9-fold greater among patients who were administered CNT. Stated symptoms of "headache" and "sensitivity to light" were statistically significantly associated with RTD clearance. For a subset of 113 individuals undergoing CNT, each additional 10-millisecond decrease in simple reaction time was associated with 9% greater odds of being cleared to drive. Each additional 10-millisecond decrease in choice reaction time was associated with 4% greater odds of being cleared to drive. Conclusions CNT and associated reaction time measures may facilitate a physician's objective decision-making. Making a RTD determination for adolescents recovering from an SRC should be a core component of a physician's assessment.	[MacDonald, James; Young, Julie] Nationwide Childrens Hosp, Div Sports Med, Dept Pediat, Columbus, OH USA; [MacDonald, James; Patel, Neha] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Stuart, Emily] Childrens Hosp Colorado, Sports Med Ctr, Orthoped Inst, Aurora, CO USA; [Stuart, Emily] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA		MacDonald, J (corresponding author), Nationwide Childrens Hosp, 584 Cty Line Rd, West Westerville, OH 43082 USA.	james.macdonald@nationwidechildrens.org		MacDonald, James/0000-0002-0432-0808; Patel, Neha/0000-0002-8884-3197			Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Centers for Disease Control and Prevention, 2015, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention, 2016, HEADS UP HLTH CAR PR; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Dickerson AE, 2011, AM J OCCUP THER, V65, P64, DOI 10.5014/ajot.2011.09052; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Foss RD, 2000, JAMA-J AM MED ASSOC, V283, P1617, DOI 10.1001/jama.283.12.1617; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Powell NB, 1999, LARYNGOSCOPE, V109, P1648, DOI 10.1097/00005537-199910000-00019; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Romer D, 2014, J ADOLESCENT HEALTH, V54, pS6, DOI 10.1016/j.jadohealth.2013.10.202; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Stuart E, 2015, CURR RES, V2, P22; Stuart EADD, 2016, PEDIAT QUAL SAF, V1, P1; World Health Organization, 2016, ROAD TRAFF INJ; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38	44	9	9	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAR	2018	194						177	181		10.1016/j.jpeds.2017.10.032			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	FX9QV	WOS:000426440700037	29198541				2022-02-06	
J	Manderino, L; Gunstad, J				Manderino, Lisa; Gunstad, John			Collegiate Student Athletes With History of ADHD or Academic Difficulties Are More Likely to Produce an Invalid Protocol on Baseline ImPACT Testing	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						ImPACT; neurocognitive testing; baseline testing; ADHD; learning disorder	TEST-RETEST RELIABILITY; NEUROCOGNITIVE TEST-PERFORMANCE; HIGH-SCHOOL; NEUROPSYCHOLOGICAL MEASURES; CONCUSSION ASSESSMENT; TEST BATTERY; SPORTS; PREVALENCE; EPIDEMIOLOGY; STATEMENT	Objective: Attention deficit hyperactivity disorder (ADHD) and other academically-relevant diagnoses have been suggested as modifiers of neurocognitive testing in sport-related concussion, such as Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). These preexisting conditions may suppress ImPACT scores to the extent that they are indistinguishable from low scores because of poor effort. The present study hypothesized that student athletes with history of ADHD or academic difficulties produce lower ImPACT composite scores and are more likely to produce invalid protocols than those without such conditions. Design: Cross-sectional study. Setting: Midsized public university. Participants: Nine hundred forty-nine National College Athletic Association athletes (average age = 19.2 years; 6.8% ADHD, 5.6% Academic Difficulties, 2.0% comorbid ADHD/Academic Difficulties). Independent Variables: Three seasons of baseline ImPACT protocols were analyzed. Student athletes were grouped using self-reported histories of ADHD or academic difficulties taken from ImPACT demographic questions. Dependent Variables: ImPACT composite scores and protocol validity. Results: Student athletes in the academic difficulties and comorbid groups performed worse on ImPACT composite scores (Pillai's Trace - 0.05), though this pattern did not emerge for those with ADHD. Student athletes with comorbid history were more likely to produce an invalid baseline (10.5% invalid) (chi(2) (2) = 11.08, P - 0.004). Those with ADHD were also more likely to produce an invalid protocol (7.7% invalid, compared with 2.6% in student athletes with no history) chi(2) (2) = 10.70, P = 0.005). Conclusions: These findings suggest that student athletes reporting comorbid histories or histories of academic difficulties alone produce lower ImPACT composite scores, and that those with comorbid histories or histories of ADHD alone produce invalid protocol warnings more frequently than student athletes without such histories. Future studies should further examine invalid score thresholds on the ImPACT, especially in student athletes with conditions that may influence test performance.	[Manderino, Lisa; Gunstad, John] Kent State Univ, Dept Psychol Sci, 144 Kent Hall, Kent, OH 44240 USA		Gunstad, J (corresponding author), Kent State Univ, Dept Psychol Sci, 144 Kent Hall, Kent, OH 44240 USA.	jgunstad@kent.edu					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Johnson E, 2014, ARCH CLIN NEUROPSYCH, V29, P590; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lovell M. R., 2016, IMPACT ADM INTERPRET; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	25	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2018	28	2					111	116		10.1097/JSM.0000000000000433			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	GP1HC	WOS:000440564900005	28731886				2022-02-06	
J	Rumalla, K; Letchuman, V; Smith, KA; Arnold, PM				Rumalla, Kavelin; Letchuman, Vijay; Smith, Kyle A.; Arnold, Paul M.			Hydrocephalus in Pediatric Traumatic Brain Injury: National Incidence, Risk Factors, and Outcomes in 124,444 Hospitalized Patients	PEDIATRIC NEUROLOGY			English	Article						post-traumatic hydrocephalus; hydrocephalus; traumatic brain injury; KIDS	POSTERIOR-FOSSA TUMORS; POSTTRAUMATIC HYDROCEPHALUS; VENTRICULOPERITONEAL SHUNTS; CHILDREN; SURGERY	BACKGROUND: Hydrocephalus is a life-threatening sequela of traumatic brain injury (TBI) with poorly defined epidemiology in children. Here, we report the national incidence, risk factors, and outcomes associated with post traumatic hydrocephalus (PTH). METHODS: The Kids Inpatient Database (2003, 2006, 2009, 2012) was queried using the International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes to identify all patients (age 0 to 20) with TBI (850.xx to 854.xx) and noncongenital hydrocephalus (331.3 to 331.5, exclude 742.3). Variables included patient demographics and comorbidities, TBI severity (level of consciousness, injury type), treatment, and outcome-related measures. Risk factors associated with PTH were identified using univariate and multivariable analyses. RESULTS: PTH occurred in 1265 of 124,444 patients (1.0%) hospitalized with TBI and was managed by ventriculoperitoneal shunt (32.7%) and extraventricular drain (10.7%). PTH had the highest rate in shaken baby syndrome (6.7%, n = 19) and firearm injury (3.4%, n = 74). PTH varied by type of TBI: subdural hematoma (2.4%), subarachnoid hemorrhage (1.4%), epidural hematoma (1.0%), cerebral laceration (0.9%), concussion (0.2%). Multivariable risk factors for PTH included age zero to five years old (versus six to 20), Medicaid (versus private), electrolyte disorder, chronic neurological condition, weight loss, subarachnoid hemorrhage, subdural hematoma, open wound, postoperative neurological complication (iatrogenic stroke), and septicemia (P < 0.05). PTH rates are higher among surgically managed patients (6.0% vs 0.5%) unless managed within the first 24 hours (0.8% vs 4.1%) (P < 0.05). PTH was associated with greater length of stay (25 days versus five days) and hospital costs ($86,596 vs $16,791), but lower mortality (1.1% vs 5.4%). CONCLUSIONS: PTH in children is relatively uncommon compared with adults. Risk factors identified here, along with the influence of surgical intervention, warrant further investigation.	[Rumalla, Kavelin; Letchuman, Vijay] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Smith, Kyle A.; Arnold, Paul M.] Univ Kansas, Med Ctr, Dept Neurosurg, 3901 Rainbow Blvd,Delp 5080,Mail Stop 3021, Kansas City, KS 66160 USA		Arnold, PM (corresponding author), Univ Kansas, Med Ctr, Dept Neurosurg, 3901 Rainbow Blvd,Delp 5080,Mail Stop 3021, Kansas City, KS 66160 USA.	parnold@kumc.edu	Kavelin Rumalla, Neurosurgery PGY-1/AAS-6131-2021	Kavelin Rumalla, Neurosurgery PGY-1/0000-0002-2063-9587; Letchuman, Vijay/0000-0001-6594-596X	Stryker Spine; Medtronic Sofamor DanekMedtronic; AOSpine North America; Invivo	Dr. Paul Arnold has commercial relationships with Z-Plasty (stock, stock options, or other ownership interest); Medtronic Sofamor Danek (salary and any payment for services not otherwise identified as salary such as consulting, fees, honoraria, paid authorship, or other payments for services); Stryker Spine (sponsored or reimbursed travel, salary, and any payment for services no otherwise identified as salary such as consulting, fees, honoraria, paid authorship, or other payments for services); AOSpine North America (sponsored or reimbursed travel); Invivo (salary and any payment for series not otherwise identified as salary such as consulting, fees, honoraria, paid authorship, or other payments for services). None of these commercial relationships affected nor provided assistance to this manuscript.	Campbell DJT, 2013, BMC HEALTH SERV RES, P13; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; CULLEY DJ, 1994, NEUROSURGERY, V34, P402, DOI 10.1227/00006123-199403000-00003; de Oliveira FF, 2013, NEUROL SCI, V34, P1009, DOI 10.1007/s10072-012-1161-3; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jorgensen Julianne, 2016, Critical Reviews in Biomedical Engineering, V44, P91, DOI 10.1615/CritRevBiomedEng.2016017149; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kumar V, 1996, BRIT J NEUROSURG, V10, P467, DOI 10.1080/02688699647096; Lam Sandi, 2015, Surg Neurol Int, V6, pS346, DOI 10.4103/2152-7806.161413; LEE M, 1994, PEDIATR NEUROSURG, V20, P240, DOI 10.1159/000120797; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Nor MAM, 2013, MALAYS J MED SCI, V20, P95; Riva-Cambrin J, 2009, J NEUROSURG-PEDIATR, V3, P378, DOI 10.3171/2009.1.PEDS08298; Srinivasan L, 2004, J Matern Fetal Neonatal Med, V16, P67; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478	17	9	9	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAR	2018	80						70	76		10.1016/j.pediatrneurol.2017.11.015			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	GD0AD	WOS:000430159200009	29429778				2022-02-06	
J	Sobue, S; Kawasaki, T; Hasegawa, Y; Shiota, Y; Ota, C; Yoneda, T; Tahara, S; Maki, N; Matsuura, T; Sekiguchi, M; Itoigawa, Y; Tateishi, T; Kaneko, K				Sobue, Shogo; Kawasaki, Takayuki; Hasegawa, Yoshinori; Shiota, Yuki; Ota, Chihiro; Yoneda, Takeshi; Tahara, Shigeyuki; Maki, Nobukazu; Matsuura, Takahiro; Sekiguchi, Masahiro; Itoigawa, Yoshiaki; Tateishi, Tomohiko; Kaneko, Kazuo			Tackler's head position relative to the ball carrier is highly correlated with head and neck injuries in rugby	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							UNION INJURIES; CERVICAL-SPINE; VIDEO ANALYSIS; FOOTBALL; PLAYERS; PREVENTION; STATEMENT; EVENTS; IMPACT	Objectives To characterise the tackler's head position during one-on-one tackling in rugby and to determine the incidence of head, neck and shoulder injuries through analysis of game videos, injury records and a questionnaire completed by the tacklers themselves. Methods We randomly selected 28 game videos featuring two university teams in competitions held in 2015 and 2016. Tackles were categorised according to tackler's head position. The 'pre-contact phase' was defined; its duration and the number of steps taken by the ball carrier prior to a tackle were evaluated. Results In total, 3970 tackles, including 317 (8.0%) with the tackler's head incorrectly positioned (ie, in front of the ball carrier) were examined. Thirty-two head, neck or shoulder injuries occurred for an injury incidence of 0.8% (32/3970). The incidence of injury in tackles with incorrect head positioning was 69.4/1000 tackles; the injury incidence with correct head positioning (ie, behind or to one side of the ball carrier) was 2.7/1000 tackles. Concussions, neck injuries, 'stingers' and nasal fractures occurred significantly more often during tackles with incorrect head positioning than during tackles with correct head positioning. Significantly fewer steps were taken before tackles with incorrect head positioning that resulted in injury than before tackles that did not result in injury. Conclusion Tackling with incorrect head position relative to the ball carrier resulted in a significantly higher incidence of concussions, neck injuries, stingers and nasal fractures than tackling with correct head position. Tackles with shorter duration and distance before contact resulted in more injuries.	[Sobue, Shogo; Kawasaki, Takayuki; Hasegawa, Yoshinori; Shiota, Yuki; Kaneko, Kazuo] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Tokyo, Japan; [Ota, Chihiro; Yoneda, Takeshi; Tahara, Shigeyuki] Keio Univ, Rugby Football Club, Yokohama, Kanagawa, Japan; [Maki, Nobukazu; Matsuura, Takahiro; Sekiguchi, Masahiro] Meiji Univ, Rugby Football Club, Tokyo, Japan; [Itoigawa, Yoshiaki] Juntendo Univ, Urayasu Hosp, Dept Orthoped Surg, Chiba, Japan; [Tateishi, Tomohiko] Doai Mem Hosp, Dept Sports, Tokyo, Japan; [Tateishi, Tomohiko] Doai Mem Hosp, Arthroscopy Ctr, Tokyo, Japan		Kawasaki, T (corresponding author), Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138421, Japan.	k-saki@luck.ocn.ne.jp	t, Kawasaki/AAE-4548-2020	Sobue, Shogo/0000-0002-0480-9494			Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Attwood M, 2017, BRIT J SPORT MED, V51, P1; Australian Rugby, SMART RUGB; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cazzola D, 2015, BRIT J SPORT MED, V49, P541, DOI 10.1136/bjsports-2013-092904; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gerrard DF, 1998, SPORTS MED, V25, P329, DOI 10.2165/00007256-199825050-00004; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hendricks S, 2014, BRIT J SPORT MED, V48, P1115, DOI 10.1136/bjsports-2013-092877; Horsley IG, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-9; Kawasaki T, 2015, AM J SPORT MED, V43, P2809, DOI 10.1177/0363546515597678; Laws of the Game Rugby Union, DANG TACKL HIGH TACK; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; New Zealand Rugby, RUGB SMART; Preatoni E, 2015, BRIT J SPORT MED, V49, P520, DOI 10.1136/bjsports-2013-092938; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; Reboursiere E, 2016, BRIT J SPORT MED; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; Wilson B D, 1999, J Sci Med Sport, V2, P153, DOI 10.1016/S1440-2440(99)80195-9; World Rugby, RUGB READ	30	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2018	52	6					353	358		10.1136/bjsports-2017-098135			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FZ2IO	WOS:000427401500005	29162618	Green Published, hybrid			2022-02-06	
J	Wu, G; Choi, MS; Roh, TH; Jeong, D; Kim, SH				Wu, Guofeng; Choi, Mi Sun; Roh, Tae Hoon; Jeong, Donghwan; Kim, Se-Hyuk			Severe Facial Fracture is Related to Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Facial bones; Fractures; Glasgow Outcome Scale; Traumatic brain injuries	HEAD-INJURY; SCALE	BACKGROUND: Facial fractures frequently occur with traumatic brain injury (TBI). The relationship between facial fractures and brain trauma remains controversial. The objective of this study was to analyze the correlation between facial fracture and TBI. METHODS: Clinical and radiologic data of a total of 206 patients were retrospectively collected from May 2011 to December 2015 in a single institute. Facial fracture was classified by the Facial Injury Severity Scale (FISS). TBI was grouped according to the Glasgow Coma Scale. Outcome was measured with the Glasgow Outcome Scale Extended 3, 6, and 12 months after trauma. - RESULTS: There were 206 TBI patients with concomitant facial fracture including 166 (8.1%) males and 40 (19.4%) females. Mean age of all patients was 46 +/- 19 years. Contusion and brain swelling were more frequent in higher FISS patients. Cranial surgery was done in 63 cases while facial fracture surgery was performed in 89 cases. There were 33 expired cases, including 6 cases due to multi-organ failure. High FISS was significantly associated with severe TBI and less favorable outcome 3 months after trauma. Concomitant surgical treatment for TBI and facial fracture was done in 21 cases without achieving more improved outcome compared with staged operations for 41 cases. CONCLUSION: Severity of facial fracture might be correlated with severity of TBI. Surgical timing of facial fracture with TBI patients does not affect the outcome of TBI.	[Wu, Guofeng; Choi, Mi Sun; Roh, Tae Hoon; Jeong, Donghwan; Kim, Se-Hyuk] Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea		Kim, SH (corresponding author), Ajou Univ, Sch Med, Dept Neurosurg, Suwon, South Korea.	nsksh@ajou.ac.kr		You, Namkyu/0000-0002-8931-4502; Roh, Tae Hoon/0000-0002-1004-9364; Jeong, Donghwan/0000-0002-8258-3187			Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Bagheri SC, 2006, J ORAL MAXIL SURG, V64, P408, DOI 10.1016/j.joms.2005.11.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Martin RCG, 2002, AM SURGEON, V68, P477; Meaney DF, 2011, YOUMANS NEUROL SURG, V337; Medicine AftAoA, 2008, ABBREVIATED INJURY S; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Patil Satishkumar G, 2016, Indian J Dent, V7, P116; Plaisier BR, 2000, J ORAL MAXIL SURG, V58, P708, DOI 10.1053/joms.2000.7250; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Shibuya TY, 2007, J ORAL MAXIL SURG, V65, P1693, DOI 10.1016/j.joms.2006.06.309; Thoren H, 2010, J ORAL MAXIL SURG, V68, P805, DOI 10.1016/j.joms.2009.09.057; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Whitesell RT, 2015, AM J ROENTGENOL, V205, pW4, DOI 10.2214/AJR.14.13589; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	21	9	9	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E47	E52		10.1016/j.wneu.2017.11.166			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700008	29225134				2022-02-06	
J	Kallakuri, S; Pace, E; Lu, HC; Luo, H; Cavanaugh, J; Zhang, JS				Kallakuri, Srinivasu; Pace, Edward; Lu, Huichao; Luo, Hao; Cavanaugh, John; Zhang, Jinsheng			Time course of blast-induced injury in the rat auditory cortex	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; COCHLEAR NUCLEUS; INDUCED TINNITUS; HEARING-LOSS; ACOUSTIC OVERSTIMULATION; EXPOSURE; OVERPRESSURE; DEGENERATION; MODEL	Blast exposure is an increasingly significant health hazard and can have a range of debilitating effects, including auditory dysfunction and traumatic brain injury. To assist in the development of effective treatments, a greater understanding of the mechanisms of blast induced auditory damage and dysfunction, especially in the central nervous system, is critical. To elucidate this area, we subjected rats to a unilateral blast exposure at 22 psi, measured their auditory brainstem responses (ABRs), and histologically processed their brains at 1 day, 1 month, and 3-month survival time points. The left and right auditory cortices was assessed for astrocytic reactivity and axonal degenerative changes using glial fibrillary acidic protein immunoreactivity and a silver impregnation technique, respectively. Although only unilateral hearing loss was induced, astrocytosis was bilaterally elevated at 1 month post-blast exposure compared to shams, and showed a positive trend of elevation at 3 months post-blast. Axonal degeneration, on the other hand, appeared to be more robust at 1 day and 3 months post-blast. Interestingly, while ABR threshold shifts recovered by the 1 and 3-month time-points, a positive correlation was observed between rats' astrocyte counts at 1 month post-blast and their threshold shifts at 1 day post-blast. Taken together, our findings suggest that central auditory damage may have occurred due to biomechanical forces from the blast shockwave, and that different indicators/types of damage may manifest over different timelines.	[Kallakuri, Srinivasu; Lu, Huichao; Cavanaugh, John] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI USA; [Pace, Edward; Luo, Hao; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48202 USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA.; Zhang, JS (corresponding author), Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu		Zhang, Jinsheng/0000-0002-8311-2678	US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the US Department of Defense (grant award W81XWH-11-2-0031).	Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Chang YM, 2004, NEUROREPORT, V15, P1699, DOI 10.1097/01.wnr.0000134584.10207.1a; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Kallakuri S, 2015, J NEUROSCI RURAL PRA, V6, P481, DOI 10.4103/0976-3147.169767; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kim JJ, 2004, J NEUROSCI RES, V77, P829, DOI 10.1002/jnr.20211; Kim JN, 1997, HEARING RES, V103, P169, DOI 10.1016/S0378-5955(96)00173-6; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Licona NE, 2016, ARCH PHYS MED REHABI; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo H., 2016, NEUROSCIENCE; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Nawashiro H, 2002, ACTA NEUROCHIR SUPPL, V81, P269; Nordmann AS, 2000, HEARING RES, V139, P13, DOI 10.1016/S0378-5955(99)00163-X; OUYANG J, 2017, SCI REPORTS, V7, P19374; ROBERTSON D, 1983, HEARING RES, V9, P263, DOI 10.1016/0378-5955(83)90031-X; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith L, 2002, HEARING RES, V169, P1, DOI 10.1016/S0378-5955(02)00461-6; SPOENDLIN H, 1971, ACTA OTO-LARYNGOL, V71, P166, DOI 10.3109/00016487109125346; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193389	10.1371/journal.pone.0193389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	WOS:000426276000069	29489862	gold, Green Published, Green Submitted			2022-02-06	
J	Cusimano, M; Brambilla, E; Capotondo, A; De Feo, D; Tomasso, A; Comi, G; D'Adamo, P; Muzio, L; Martino, G				Cusimano, Melania; Brambilla, Elena; Capotondo, Alessia; De Feo, Donatella; Tomasso, Antonio; Comi, Giancarlo; D'Adamo, Patrizia; Muzio, Luca; Martino, Gianvito			Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Spinal cord injury; Endogenous neural stem cells; Neurotrophic factors; Inflammation	STEM/PROGENITOR CELLS; TRANSGENIC MICE; EPENDYMAL CELLS; TISSUE-DAMAGE; BRAIN; EXPRESSION; REPAIR; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	Background: Spinal cord injury (SCI) is a devastating condition mainly deriving from a traumatic damage of the spinal cord (SC). Immune cells and endogenous SC-neural stem cells (SC-NSCs) play a critical role in wound healing processes, although both are ineffective to completely restore tissue functioning. The role of SC-NSCs in SCI and, in particular, whether such cells can interplay with the immune response are poorly investigated issues, although mechanisms governing such interactions might open new avenues to develop novel therapeutic approaches. Methods: We used two transgenic mouse lines to trace as well as to kill SC-NSCs in mice receiving SCI. We used Nestin CreERT2 mice to trace SC-NSCs descendants in the spinal cord of mice subjected to SCI. While mice carrying the suicide gene thymidine kinase (TK) along with the GFP reporter, under the control of the Nestin promoter regions (Nestin(TK) mice) were used to label and selectively kill SC-NSCs. Results: We found that SC-NSCs are capable to self-activate after SCI. In addition, a significant worsening of clinical and pathological features of SCI was observed in the NestinTK mice, upon selective ablation of SC-NSCs before the injury induction. Finally, mice lacking in SC-NSCs and receiving SCI displayed reduced levels of different neurotrophic factors in the SC and significantly higher number of M1-like myeloid cells. Conclusion: Our data show that SC-NSCs undergo cell proliferation in response to traumatic spinal cord injury. Mice lacking SC-NSCs display overt microglia activation and exaggerate expression of pro-inflammatory cytokines. The absence of SC-NSCs impaired functional recovery as well as neuronal and oligodendrocyte cell survival. Collectively our data indicate that SC-NSCs can interact with microglia/macrophages modulating their activation/responses and that such interaction is importantly involved in mechanisms leading tissue recovery.	[Cusimano, Melania; Brambilla, Elena; Capotondo, Alessia; De Feo, Donatella; Tomasso, Antonio; Muzio, Luca; Martino, Gianvito] Ist Sci San Raffaele, Inst Expt Neurol INSPE, Div Neurosci, Neuroimmunol Unit, Via Olgettina 58, I-20132 Milan, Italy; [Comi, Giancarlo] Univ Vita Salute San Raffaele, Inst Expt Neurol INSPE, Dept Neurol, I-20132 Milan, Italy; [D'Adamo, Patrizia] Ist Sci San Raffaele, Div Neurosci, Mol Genet Intellectual Disabil Unit, Milan, Italy		Muzio, L; Martino, G (corresponding author), Ist Sci San Raffaele, Inst Expt Neurol INSPE, Div Neurosci, Neuroimmunol Unit, Via Olgettina 58, I-20132 Milan, Italy.	muzio.luca@hsr.it; gianvito.martino@hsr.it	BRAMBILLA, ELENA/AAN-3742-2020; D'Adamo, Patrizia/AAN-3919-2020; martino, gianvito/AAL-2682-2020; Muzio, Luca/AAB-2308-2022	BRAMBILLA, ELENA/0000-0003-1399-2128; D'Adamo, Patrizia/0000-0002-0312-5541; martino, gianvito/0000-0003-1295-9131; Muzio, Luca/0000-0002-1068-865X; Tomasso, Antonio/0000-0003-2869-1969; De Feo, Donatella/0000-0003-0121-5364	EUEuropean Commission; Neurokine-ITN; BMW, Italy	This project was supported by EU-FP7 TargetBrain project, Neurokine-ITN and BMW, Italy.	Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Bacigaluppi M, 2016, J NEUROSCI, V36, P10529, DOI 10.1523/JNEUROSCI.1643-16.2016; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butti E, 2012, BRAIN, V135, P3320, DOI 10.1093/brain/aws194; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Doetsch F, 1997, J NEUROSCI, V17, P5046; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Hayakawa K, 2015, J CONTROL RELEASE, V197, P1, DOI 10.1016/j.jconrel.2014.10.027; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Immig K, 2015, GLIA, V63, P611, DOI 10.1002/glia.22771; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597; Li XF, 2016, EBIOMEDICINE, V13, P55, DOI 10.1016/j.ebiom.2016.10.035; Lim DA, 2014, TRENDS NEUROSCI, V37, P563, DOI 10.1016/j.tins.2014.08.006; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Mawhinney LA, 2012, J NEUROPATH EXP NEUR, V71, P180, DOI 10.1097/NEN.0b013e3182479b41; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; North HA, 2015, J NEUROSCI, V35, P3725, DOI 10.1523/JNEUROSCI.4546-14.2015; Pluchino S, 2005, J NEUROL SCI, V233, P117, DOI 10.1016/j.jns.2005.03.026; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	46	9	9	3	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 23	2018	15								58	10.1186/s12974-018-1085-9			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FX3MP	WOS:000425976400002	29475438	Green Published, gold			2022-02-06	
J	Guo, W; Guo, SC; Li, M; Li, LH; Qu, Y				Guo, Wei; Guo, Shao-Chun; Li, Min; Li, Li-Hong; Qu, Yan			Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report	ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL			English	Article						Acinetobacter Baumannii; Multidrug resistance; Polymyxin B; Ventriculitis; Intraventricular therapy	MULTIDRUG-RESISTANT; MENINGITIS; COLISTIN; MANAGEMENT	Background: Acinetobacter baumannii nosocomial ventriculitis/meningitis, especially those due to drug-resistant strains, has substantially increased over recent years. However, limited therapeutic options exist for the Acinetobacter baumannii ventriculitis/meningitis because of the poor penetration rate of most antibiotics through the blood-brain barrier. Case presentation: A 57-year-old male patient developed ventriculitis from an extensively drug-resistant strain of Acinetobacter baumannii after the decompressive craniectomy for severe traumatic brain injury. The patient was successfully treated with intraventricular and intravenous polymyxin B together with intravenous tigecycline. Conclusions: The case illustrates intraventricular polymyxin B can be a therapeutic option against extensively drug-resistant Acinetobacter baumannii ventriculitis.	[Guo, Wei; Guo, Shao-Chun; Li, Min; Li, Li-Hong; Qu, Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Shaanxi, Peoples R China		Qu, Y (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Shaanxi, Peoples R China.	Yanqu0123@icloud.com					Cai YY, 2015, EXPERT REV ANTI-INFE, V13, P1481, DOI 10.1586/14787210.2015.1093933; De Bonis P, 2016, EUR J NEUROL, V23, P68, DOI 10.1111/ene.12789; Hoenigl M, 2013, CAN J INFECT DIS MED, V24, pE88, DOI 10.1155/2013/613865; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Karaiskos I, 2013, INT J ANTIMICROB AG, V41, P499, DOI 10.1016/j.ijantimicag.2013.02.006; Kim BN, 2009, LANCET INFECT DIS, V9, P245, DOI 10.1016/S1473-3099(09)70055-6; Lauretti L, 2016, J NEUROSURG, V19, P1; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Pallotto C, 2014, SCAND J INFECT DIS, V46, P69, DOI 10.3109/00365548.2013.837957; Pankey GA, 2005, J ANTIMICROB CHEMOTH, V56, P470, DOI 10.1093/jac/dki248; Piparsania S, 2012, TURKISH J PEDIATR, V54, P548; Wang KW, 2005, J CLIN NEUROSCI, V12, P647, DOI 10.1016/j.jocn.2004.09.017	12	9	10	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2047-2994			ANTIMICROB RESIST IN	Antimicrob. Resist. Infect. Control	FEB 14	2018	7								22	10.1186/s13756-018-0313-5			4	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Infectious Diseases; Microbiology; Pharmacology & Pharmacy	FW4NJ	WOS:000425290100001	29456841	gold, Green Published			2022-02-06	
J	Hirt, L; Price, M; Mastour, N; Brunet, JF; Barriere, G; Friscourt, F; Badaut, J				Hirt, Lorenz; Price, Melanie; Mastour, Nabil; Brunet, Jean-Francois; Barriere, Gregory; Friscourt, Frederic; Badaut, Jerome			Increase of aquaporin 9 expression in astrocytes participates in astrogliosis	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						water channel; AQP9; transient brain ischemia; mouse; thrombin; preconditioning; brain injury; astrogliosis	TRAUMATIC BRAIN-INJURY; DOWN-REGULATION; WATER CHANNELS; CATECHOLAMINERGIC NEURONS; POSTISCHEMIC EDEMA; CEREBRAL-ISCHEMIA; SCAR FORMATION; C-JUN; THROMBIN; ACTIVATION	Here we assess the potential functional role of increased aquaporin 9 (APQ9) in astrocytes. Increased AQP9 expression was achieved in primary astrocyte cultures by transfection of a plasmid-containing green fluorescent protein fused to either wild-type or mutated human AQP9. Increased AQP9 expression and phosphorylation at Ser222 were associated with a significant change in astrocyte morphology, mainly with a higher number of processes. Similar phenotypic changes are observed in astrogliosis processes after injury. In parallel, we observed that in vivo, thrombin preconditioning before ischemic stroke induced an early increase in AQP9 expression in the male mouse brain. This increased AQP9 expression was also associated with astrocyte morphological changes, especially in the white matter tract. Astrocyte reactivity is debated as being either beneficial or deleterious. As thrombin preconditioning leads to a decrease in lesion size after stroke, our data suggest that the early increase in AQP9 concomitant with astrocyte reactivity leads to a beneficial effect. (c) 2017 Wiley Periodicals, Inc.	[Hirt, Lorenz; Price, Melanie] CHU Vaudois, Dept Neurol, Lausanne, Switzerland; [Hirt, Lorenz; Price, Melanie; Mastour, Nabil; Brunet, Jean-Francois] Univ Lausanne, Lausanne, Switzerland; [Mastour, Nabil; Brunet, Jean-Francois] CHU Vaudois, Neurosurg Res Grp, Lausanne, Switzerland; [Barriere, Gregory; Friscourt, Frederic; Badaut, Jerome] Univ Bordeaux, INCIA, CNRS, UMR 5287, Bordeaux, France		Badaut, J (corresponding author), Bordeaux Univ, CNRS, UMR 5287, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	Jerome.badaut@u-bordeaux.fr	Hirt, Lorenz/G-3553-2010; Friscourt, Frederic/N-8238-2019; Friscourt, Frederic/K-3980-2015	Hirt, Lorenz/0000-0002-2921-5000; Friscourt, Frederic/0000-0002-0749-0861; Barriere, Gregory/0000-0002-0704-508X	Swiss Science FoundationSwiss National Science Foundation (SNSF) [3100AO-112484, 3200-68306.02, 3100AO-108001, 31003A-163465]; Swissheart Foundation; Novartis Science Foundation	This work was supported by Swiss Science Foundation grants 3100AO-112484 (L.H.), 3200-68306.02 (L.H.), 3100AO-108001 (J.B.), and 31003A-163465 (L.H.); Swissheart Foundation (J.B., L.H.); and Novartis Science Foundation (L.H., J.B.). We are grateful to Beatrice Ternon and Delphine Michel-Monigadon for their help with the surgery. We thank Dr. Loitto (Linkoping University, Sweden) for kindly providing the plasmid constructions encoding human AQP9 wild-type cDNA or with mutations.	Amiry-Moghaddam M, 2005, FASEB J, V19, P1459, DOI 10.1096/fj.04-3515com; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arcienega II, 2010, NEUROSCIENCE, V167, P1103, DOI 10.1016/j.neuroscience.2010.02.059; Badaut J, 2008, BRAIN RES, V1188, P17, DOI 10.1016/j.brainres.2007.10.087; Badaut J, 2005, BRAIN RES, V1051, P117, DOI 10.1016/j.brainres.2005.05.063; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Badaut J, 2012, BRAIN RES, V1473, P19, DOI 10.1016/j.brainres.2012.07.041; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Brunet JF, 2004, GLIA, V46, P8, DOI 10.1002/glia.10348; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Granziera C, 2007, BRAIN RES, V1148, P217, DOI 10.1016/j.brainres.2007.02.025; Henrich-Noack P, 2006, J NEUROSCI RES, V83, P469, DOI 10.1002/jnr.20746; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Hoshi A, 2011, EXP NEUROL, V227, P89, DOI 10.1016/j.expneurol.2010.09.016; Kim E, 2007, NEUROSCIENCE, V145, P931, DOI 10.1016/j.neuroscience.2006.12.063; Ko SBH, 1999, BIOCHEM MOL BIOL INT, V47, P309; Li YK, 2012, NEUROPSYCHOPHARMACOL, V37, P1867, DOI 10.1038/npp.2012.34; Loitto VM, 2007, EXP CELL RES, V313, P1295, DOI 10.1016/j.yexcr.2007.01.023; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Mylonakou MN, 2009, J NEUROSCI RES, V87, P1310, DOI 10.1002/jnr.21952; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Price M, 2010, J NEUROSCI RES, V88, P1338, DOI 10.1002/jnr.22299; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Ribeiro MD, 2006, EXP NEUROL, V198, P199, DOI 10.1016/j.expneurol.2005.11.017; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Willis CL, 2010, J CEREBR BLOOD F MET, V30, P1847, DOI 10.1038/jcbfm.2010.119; Xi GH, 1999, STROKE, V30, P1247, DOI 10.1161/01.STR.30.6.1247; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Zhao J, 2007, CELL SIGNAL, V19, P831, DOI 10.1016/j.cellsig.2006.10.006	39	9	10	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2018	96	2					194	206		10.1002/jnr.24061			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FP9IP	WOS:000417961000003	28419510				2022-02-06	
J	Kanagaraj, J; Chen, B; Xiao, S; Cho, M				Kanagaraj, Johnwesly; Chen, Bo; Xiao, Shu; Cho, Michael			Reparative Effects of Poloxamer P188 in Astrocytes Exposed to Controlled Microcavitation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Blast-induced TBI; Microcavitation; Calcium spiking; ROS; Poloxamers; Fluorescence microscopy	TRAUMATIC BRAIN-INJURY; IN-VIVO; CALCIUM; MITOCHONDRIAL; PERTURBATION; INVOLVEMENT; GENERATION; RECOVERY; CELLS	Blast-induced traumatic brain injury (bTBI) is a neurological dysfunction that can result from a sudden exposure to shockwave and lead to adverse health consequences. Currently, there are no preventive measures that specifically target bTBI. Several hypotheses have been formulated to explain such injuries, including the generation of microcavitation (e.g., microbubbles) in the brain that subsequently collapses with high pressure. This study was designed to explore and elucidate potential therapeutic effects of surfactants (poloxamers P188) to partially repair the damaged brain tissue due to bTBI. A controlled electrical discharge system was designed and validated to generate microbubbles of 20-30 mu m in size. Using this system, we tested the hypothesis that the P188 can partially rescue astrocytes exposed to collapsing microbubbles. The immediate impact of the collapse of microbubbles created a crater-like region in which astrocytes detached from the substrate. Of those cells that survived the initial mechanical assault, the poloxamer P188 demonstrated reparative potential by partially restoring calcium spiking and minimizing the production of reactive oxygen species. The FDA-approved P188 may offer a potential therapeutic treatment for those exposed to a blast and suffered bTBI.	[Kanagaraj, Johnwesly; Chen, Bo; Cho, Michael] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Xiao, Shu] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23508 USA; [Chen, Bo; Cho, Michael] Univ Texas Arlington, Dept Bioengn, 500 UTA Blvd,Suite 226, Arlington, TX 76019 USA		Cho, M (corresponding author), Univ Texas Arlington, Dept Bioengn, 500 UTA Blvd,Suite 226, Arlington, TX 76019 USA.	michael.cho@uta.edu		Cho, Myoung Rae/0000-0002-8191-8045	Office of Naval ResearchOffice of Naval Research [N00014-13-1-0404, N00014-16-1-2140]	This work was supported by Grants (N00014-13-1-0404 and N00014-16-1-2140) from the Office of Naval Research.	Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bryant RA, 2015, PSYCHOTHER PSYCHOSOM, V84, P120, DOI 10.1159/000370049; Collins JM, 2007, BBA-BIOMEMBRANES, V1768, P1238, DOI 10.1016/j.bbamem.2007.01.012; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Grant G., 2016, TRANSLATIONAL RES TR; Greenebaum B, 2004, BURNS, V30, P539, DOI 10.1016/j.burns.2004.02.009; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdeman TC, 2009, PSYCHIAT SERV, V60, P273, DOI 10.1176/appi.ps.60.2.273; Jou MJ, 2008, ADV DRUG DELIVER REV, V60, P1512, DOI 10.1016/j.addr.2008.06.004; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kang D, 2014, IEEE T PLASMA SCI, V42, P3231, DOI 10.1109/TPS.2014.2339171; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; Reichert SA, 2001, J NEUROSCI, V21, P6608, DOI 10.1523/JNEUROSCI.21-17-06608.2001; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sakuragi S, 2017, BIOCHEM BIOPH RES CO, V486, P879, DOI 10.1016/j.bbrc.2017.03.096; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Shah AV, 2012, PHARM RES-DORDR, V29, P2817, DOI 10.1007/s11095-012-0704-x; Small DH, 2009, NEUROCHEM RES, V34, P1824, DOI 10.1007/s11064-009-9960-5; Sun S, 2015, J NEUROTRAUM, V32, P1441, DOI 10.1089/neu.2014.3699; Swarnkar S, 2012, ARCH TOXICOL, V86, P1387, DOI 10.1007/s00204-012-0853-z; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wang XH, 2005, NEUROSCI LETT, V376, P127, DOI 10.1016/j.neulet.2004.11.041; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026	34	9	9	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	FEB	2018	46	2					354	364		10.1007/s10439-017-1953-y			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FV9HE	WOS:000424898000014	29110266				2022-02-06	
J	Kim, B; Jeong, H; Kim, J; Kim, T; Kim, K; Lee, H; Ahn, S; Jo, YH; Lee, JH; Hwang, JE				Kim, Byunghyun; Jeong, Hyeonjeong; Kim, Joonghee; Kim, Tackeun; Kim, Kyuseok; Lee, Heeyoung; Ahn, Soyeon; Jo, Yoo Hwan; Lee, Jae Hyuk; Hwang, Ji Eun			Incidence and risk factors of delayed intracranial hemorrhage in the emergency department	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; INTRACEREBRAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; HEAD-INJURY; ASSOCIATION; MANAGEMENT; GUIDELINE; THERAPY	Objectives: This study was performed to identify the risk factors for delayed intracranial hemorrhage and develop a risk stratification system for disposition of head trauma patients with negative initial brain imaging. Methods: The data source was National Health Insurance Service-National Sample Cohort of Korea. We analyzed adult patients presenting to the ER from January 2004 to September 2012, who underwent brain imaging and discharged with or without short-term observation no longer than two days. The primary outcome was defined as any intracranial bleeding within a month defined by a new appearance of any of the diagnostic codes for intracranial hemorrhage accompanied by a new claim for brain imaging(s) within a month of the index visit. We performed amultivariable logistic regression analysis and built a parsimoniousmodel for variable selection to develop a simple scoring system for risk stratification. Results: During the study period, a total of 19,723 head injury cases were identified from the cohort and a total of 149 cases were identified as having delayed intracranial hemorrhage within 30 days. In multivariable logistic regression model, old age, craniofacial fracture, neck injury, diabetes mellitus and hypertension were independent risk factors for delayed intracranial hemorrhage. We constructed the parsimonious model included age, craniofacial fracture and diabetes mellitus. The score showed area under the curve of 0.704 and positive predictive value of the score system was 0.014 when the score >= 2. Conclusions: We found old age, associated craniofacial fracture, any neck injury, diabetes mellitus and hypertension are the independent risk factors of delayed intracranial hemorrhage. (C) 2017 Published by Elsevier Inc.	[Kim, Byunghyun; Jeong, Hyeonjeong; Kim, Joonghee; Kim, Kyuseok; Jo, Yoo Hwan; Lee, Jae Hyuk; Hwang, Ji Eun] Seoul Natl Univ, Bundang Hosp, Dept Emergency Med, 166 Gumi Ro, Seongnam Si 463707, Gyeonggi Do, South Korea; [Kim, Tackeun] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, 166 Gumi Ro, Seongnam Si 463707, Gyeonggi Do, South Korea; [Lee, Heeyoung] Seoul Natl Univ, Bundang Hosp, Dept Prevent Med, 166 Gumi Ro, Seongnam Si 463707, Gyeonggi Do, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, 166 Gumi Ro, Seongnam Si 463707, Gyeonggi Do, South Korea		Kim, J (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Emergency Med, 166 Gumi Ro, Seongnam Si 463707, Gyeonggi Do, South Korea.	joonghee@snubh.org	Lee, Jae Hyuk/W-5616-2018; Kim, Joonghee/C-9811-2014; Kim, Tackeun/N-8436-2019	Lee, Jae Hyuk/0000-0003-2429-4085; Kim, Joonghee/0000-0001-5080-7097; Kim, Tackeun/0000-0002-4375-8095; Kim, Kyuseok/0000-0002-7991-9428	Seoul National University Bundang Hospital (SNUBH) [02-2014-045]	This study was supported by Seoul National University Bundang Hospital (SNUBH) grant 02-2014-045.	Boulanger M, 2016, NEUROLOGY, V87, P870, DOI 10.1212/WNL.0000000000003031; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Shabani S, 2016, WORLD NEUROSURG, V96, P66, DOI 10.1016/j.wneu.2016.08.075; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	21	9	9	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2018	36	2					271	276		10.1016/j.ajem.2017.08.009			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FX1YB	WOS:000425850900018	28811212				2022-02-06	
J	Kuznetsov, NA; Robins, RK; Long, B; Jakiela, JT; Haran, FJ; Ross, SE; Wright, WG; Rhea, CK				Kuznetsov, Nikita A.; Robins, Rebecca K.; Long, Benjamin; Jakiela, Jason T.; Haran, F. Jay; Ross, Scott E.; Wright, W. Geoffrey; Rhea, Christopher K.			Validity and reliability of smartphone orientation measurement to quantify dynamic balance function	PHYSIOLOGICAL MEASUREMENT			English	Article						smartphone sensors; measurement; gait; variability; reliability; validity; intraclass correlation	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; OLDER-ADULTS; HEAD TRAUMA; GAIT; CONCUSSION; WALKING; ENCEPHALOPATHY; INDIVIDUALS; DEFICITS	Objective: Postural control is frequently compromised after sub-concussive and concussive head trauma, and balance testing is an integral part of neuromotor assessment and management. The main objective of this paper is to develop a novel smartphone-based neuromotor assessment protocol for screening of dynamic balance decrements stemming from head trauma. Approach: Experiments 1 and 2 compared Android smartphone orientation detection algorithms to a biomechanics laboratory motion capture system using a pendulum (i.e. non-biological movement) and a human stepping task (i.e. biological movement). Experiment 3 examined the test-retest reliability of a stepping-in-place protocol in three different sensory conditions (eyes open, no-vision, head shake) using temporal and spatial variability metrics extracted from thigh orientation signal in a sample of healthy young adults. Main results: Smartphone sensors provided valid measurements of movement timing and amplitude variables. However, sensor firmware version and Android OS version significantly affected quality of measurement. High test-retest reliability was shown for the temporal and spatial variables of interest during the stepping-in-place task. Significance: Collectively, these experiments show that our smartphone application is a valid and reliable way to measure leg movement characteristics (mean stride time and its variability (CV), Peak Thigh SD, Thigh ROM, and Peak Return Velocity) during dynamic balance activity, which could provide an objective way to assess neuromotor function after head trauma and in other populations with balance dysfunction.	[Kuznetsov, Nikita A.; Long, Benjamin; Jakiela, Jason T.; Haran, F. Jay; Ross, Scott E.; Rhea, Christopher K.] Univ North Carolina Greensboro, Dept Kinesiol, 1400 Spring Garden St, Greensboro, NC 27412 USA; [Kuznetsov, Nikita A.] Louisiana State Univ, Sch Kinesiol, 112 Long Fieldhouse, Baton Rouge, LA 70802 USA; [Robins, Rebecca K.; Wright, W. Geoffrey] Temple Univ, Dept Phys Therapy, 1801 N Broad St, Philadelphia, PA 19122 USA		Rhea, CK (corresponding author), Univ North Carolina Greensboro, Dept Kinesiol, 1400 Spring Garden St, Greensboro, NC 27412 USA.	ckrhea@uncg.edu			US Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0094]	The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. (W81XWH-15-1-0094) to Christopher K. Rhea. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Researchers and/or clinicians interested in obtaining our app and user manual for testing purposes are encouraged to contact the corresponding author.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Buster T, 2013, J NEUROL PHYS THER, V37, P176, DOI 10.1097/NPT.0000000000000022; Carstensen B, 2015, METHCOMP FUNCTIONS A; Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fleiss JL, 1999, DESIGN ANAL CLIN EXP, V73; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Godfrey A, 2007, P ANN INT IEEE EMBS, P4891, DOI 10.1109/IEMBS.2007.4353436; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Grabiner PC, 2001, ARCH PHYS MED REHAB, V82, P31, DOI 10.1053/apmr.2001.18219; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hallemans A, 2009, GAIT POSTURE, V30, P55, DOI 10.1016/j.gaitpost.2009.02.018; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Honaker JA, 2009, J AM ACAD AUDIOL, V20, P311, DOI 10.3766/jaaa.20.5.4; Johnston W, 2016, QJM, V110, P779; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Newell K. M., 2008, ROUTLEDGE HDB BIOMEC, P93; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Peterka R J, 1990, J Vestib Res, V1, P49; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Rhea CK, 2014, GAIT BIOMETRICS BASI; Schatz P, 2015, ASSESSMENT, V22, P405, DOI 10.1177/1073191114566622; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Umek A, 2016, PERS UBIQUIT COMPUT, V20, P657, DOI 10.1007/s00779-016-0946-4; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Wuehr M, 2013, EXP BRAIN RES, V224, P287, DOI 10.1007/s00221-012-3310-6	45	9	9	1	8	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	FEB	2018	39	2							02NT01	10.1088/1361-6579/aaa3c2			12	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering; Physiology	FX7CU	WOS:000426245300001	29271351	Green Published			2022-02-06	
J	Turan, N; Miller, BA; Huie, JR; Heider, RA; Wang, J; Wali, B; Yousuf, S; Ferguson, AR; Sayeed, I; Stein, DG; Pradilla, G				Turan, Nefize; Miller, Brandon A.; Huie, J. Russell; Heider, Robert A.; Wang, Jun; Wali, Bushra; Yousuf, Seema; Ferguson, Adam R.; Sayeed, Iqbal; Stein, Donald G.; Pradilla, Gustavo			Effect of Progesterone on Cerebral Vasospasm and Neurobehavioral Outcomes in a Rodent Model of Subarachnoid Hemorrhage	WORLD NEUROSURGERY			English	Article						Glutamate receptors; Microglia; Neurobehavioral tests; Progesterone; Subarachnoid hemorrhage; Vasospasm	TRAUMATIC BRAIN-INJURY; CORTICOSPINAL TRACT INJURY; RECEPTOR EXPRESSION; OXIDATIVE STRESS; PERMANENT STROKE; CLINICAL-TRIAL; DOSE-RESPONSE; TIME-WINDOW; CELL-DEATH; TNF-ALPHA	BACKGROUND: Subarachnoid hemorrhage (SAH) induces widespread inflammation leading to cellular injury, vasospasm, and ischemia. Evidence suggests that progesterone (PROG) can improve functional recovery in acute brain injury owing to its anti-inflammatory and neuroprotective properties, which could also be beneficial in SAH. We hypothesized that PROG treatment attenuates inflammation-mediated cerebral vasospasm and microglial activation, improves synaptic connectivity, and ameliorates functional recovery after SAH. METHODS: We investigated the effect of PROG in a cisternal SAH model in adult male C57BL/6 mice. Neurobehavioral outcomes were evaluated using rotarod latency and grip strength tests. Basilar artery perimeter, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor 1 (GluR1)/synaptophysin colocalization, and Iba-1 immunoreactivity were quantified histologically. RESULTS: PROG (8 mg/kg) significantly improved rotarod latency at day 6 and grip strength at day 9. PROG-treated mice had significantly reduced basilar artery vasospasm at 24 hours. GluR1/synaptophysin colocalization, indicative of synaptic GluR1, was significantly reduced in the SAH+Vehicle group at 24 hours, and PROG treatment significantly attenuated this reduction. PROG treatment significantly reduced microglial cell activation and proliferation in cerebellum and cortex but not in the brainstem at 10 days. CONCLUSIONS: PROG treatment ameliorated cerebral vasospasm, reduced microglial activation, restored synaptic GluR1 localization, and improved neurobehavioral performance in a murine model of SAH. These results provide a rationale for further translational testing of PROG therapy in SAH.	[Turan, Nefize; Miller, Brandon A.; Heider, Robert A.; Wang, Jun; Pradilla, Gustavo] Emory Univ, Sch Med, Cerebrovasc Res Lab, Atlanta, GA 30322 USA; [Turan, Nefize; Miller, Brandon A.; Heider, Robert A.; Pradilla, Gustavo] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Wang, Jun; Wali, Bushra; Yousuf, Seema; Sayeed, Iqbal; Stein, Donald G.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Huie, J. Russell; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA		Pradilla, G (corresponding author), Emory Univ, Sch Med, Cerebrovasc Res Lab, Atlanta, GA 30322 USA.; Pradilla, G (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.	gpradil@emory.edu	Stein, Donald/AAJ-5139-2020	Pradilla, Gustavo/0000-0002-3661-3269; Ferguson, Adam/0000-0001-7102-1608; Turan, Nefize/0000-0002-4751-1292	Kristen's Legacy of Love Chair of Research; Brain Aneurysm Foundation; Emory Medical Care Foundation; Emory University Department of Neurosurgery departmental funds; Emory University Integrated Cellular Imaging Microscopy Core; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088475] Funding Source: NIH RePORTER	This work was supported by Kristen's Legacy of Love Chair of Research (G.P.) and Karen M. Schurr Memorial Chair of Research (B.A.M.) Grants by the Brain Aneurysm Foundation, Emory Medical Care Foundation (G.P.), Emory University Department of Neurosurgery departmental funds (G.P.) and Emory University Integrated Cellular Imaging Microscopy Core. Along with Emory University, D.G.S. and I.S. hold several patents on the use of progesterone for traumatic brain injury but currently have no licensing, royalty, or payment agreements associated with this intellectual property.	Allen RS, 2015, INVEST OPHTH VIS SCI, V56, P2880, DOI 10.1167/iovs.14-16070; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; Bell JD, 2014, J NEUROSURG, V121, P1424, DOI 10.3171/2014.3.JNS132130; Bendel P, 2006, NEUROLOGY, V67, P575, DOI 10.1212/01.wnl.0000230221.95670.bf; BRANN DW, 1994, FRONT NEUROENDOCRIN, V15, P3, DOI 10.1006/frne.1994.1002; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chang CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/207616; Chen G, 2013, NEURAL REGEN RES, V8, P2693, DOI 10.3969/j.issn.1673-5374.2013.29.001; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute to Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Han SM, 2014, J CEREBR BLOOD F MET, V34, P108, DOI 10.1038/jcbfm.2013.170; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kastrup Y, 1999, NEUROSCI LETT, V275, P85, DOI 10.1016/S0304-3940(99)00753-3; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Ma JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub4; Makino K, 2015, BRAIN RES, V1616, P19, DOI 10.1016/j.brainres.2015.04.048; Miller BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384342; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Pradilla G, 2012, NEUROSURGERY, V70, P747, DOI 10.1227/NEU.0b013e3182363c2f; Qin Y, 2015, J NEUROL SCI, V358, P193, DOI 10.1016/j.jns.2015.08.1536; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schneider U, 2015, ACTA NEUROPATHOL, V130, P215, DOI 10.1007/s00401-015-1440-1; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Turan N, 2017, J CEREBR BLOOD F MET, V37, P3461, DOI 10.1177/0271678X16665623; Turan N, 2016, TRANSL STROKE RES, V7, P12, DOI 10.1007/s12975-015-0434-6; Wali B, 2016, NEUROPHARMACOLOGY, V109, P148, DOI 10.1016/j.neuropharm.2016.05.017; Wali B, 2016, BEHAV BRAIN RES, V305, P46, DOI 10.1016/j.bbr.2016.02.024; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Warembourg M, 2002, J COMP NEUROL, V453, P305, DOI 10.1002/cne.10414; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Yeo SS, 2012, STROKE, V43, P2239, DOI 10.1161/STROKEAHA.112.661116; Yousuf S, 2016, HORM BEHAV, V84, P29, DOI 10.1016/j.yhbeh.2016.06.002; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Zhao YZ, 2011, SYNAPSE, V65, P880, DOI 10.1002/syn.20915	44	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E150	E159		10.1016/j.wneu.2017.10.118			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900023	29097330				2022-02-06	
J	Eghdam, A; Hamidi, U; Bartfai, A; Koch, S				Eghdam, Aboozar; Hamidi, Ulrike; Bartfai, Aniko; Koch, Sabine			Facebook as communication support for persons with potential mild acquired cognitive impairment: A content and social network analysis study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MANAGEMENT; PEOPLE; ADULTS	Introduction Social media has the potential to increase social participation and support for the well-being of individuals with chronic medical conditions. To date, Facebook is the most popular social medium for different types of communication. However, there is a lack of knowledge about the potential use of Facebook as a means of communication for persons with potential Mild Acquired Cognitive Impairment (MACI), a non-progressive mild cognitive impairment after an acquired brain injury. The aim of this study was to explore how persons with potential MACI, specifically persons with perceived brain fatigue after brain injury, communicate through Facebook, to classify the content of the communication and to visualize the frequency and types of interactions. Methods and materials A social network analysis of the interactions between members' and a qualitative content analysis of a whole year's communication of a public Facebook group for Swedish speaking persons (1310 members) with perceived brain fatigue after an illness or injury to the brain were performed. Results The results showed how members use social media technology and Facebook as a means for communication and support for their condition. Individual group members showed very different patterns of communication and interactions. However, for the group as a whole, the most frequent topics in their communication were related to informational support and banter in posts, and socialization in comments. The findings also showed that the majority of members only communicated with few other members and had few direct communications. The most used communication feature of Facebook was likes in form of "thumbs-up". Conclusions This study indicated that social media and in this case Facebook is used for communication and social support by persons with potential MACI, and revealed that their communication behavior is similar to the healthy population. Further studies relating specific cognitive problems of the participants to the use of social media would provide more reliable results for this specific group.	[Eghdam, Aboozar; Hamidi, Ulrike; Koch, Sabine] Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Bartfai, Aniko] Danderyd Hosp, Karolinska Inst, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden		Eghdam, A (corresponding author), Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	aboozar.eghdam@ki.se	Eghdam, Aboozar/D-8561-2013; Eghdam, Aboozar/H-5975-2016	Koch, Sabine/0000-0001-7144-8740; Eghdam, Aboozar/0000-0001-8690-8594	Swedish Research CouncilSwedish Research CouncilEuropean Commission	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet supported this study through funding by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; BRAITHWAITE DO, 1990, INT J INTERCULT REL, V14, P465, DOI 10.1016/0147-1767(90)90031-Q; Braithwaite DO, 1999, HEALTH COMMUN, V11, P123, DOI 10.1207/s15327027hc1102_2; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Bruns A, 2012, INFORM COMMUN SOC, V15, P1323, DOI 10.1080/1369118X.2011.635214; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Combe D., 2010, WEB INTELLIGENCE VIR, P1; Cotten SR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2306; Coursaris CK, 2009, COMPUT HUM BEHAV, V25, P911, DOI 10.1016/j.chb.2009.03.006; CUTRONA CE, 1992, COMMUN RES, V19, P154, DOI 10.1177/009365092019002002; Demir SO, 2006, J REHABIL MED, V38, P68, DOI 10.1080/16501970510041262; Durkheim GS Emile, 2001, CONCEPTS SOCIAL STRA, P36; Eghdam A, 2016, THESIS; Eghdam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159362; Eghdam A, 2012, J MED INTERNET RES, V14, P4, DOI 10.2196/jmir.2275; Eurostat, 2016, DIG EC SOC STAT HOUS; Gattiker UE, SOCIAL MEDIA AUDITS; Gaysynsky A, 2015, AIDS BEHAV, V19, P947, DOI 10.1007/s10461-014-0887-8; Gerolimos M., 2011, D LIB MAGAZINE, V17, P4; Greene JA, 2011, J GEN INTERN MED, V26, P287, DOI 10.1007/s11606-010-1526-3; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jimison HB, 2015, COGNITIVE INFORM BIO, P259; Kahneman D., 2013, THINKING FAST SLOW; Lin F, 2012, RES GERONTOL NURS, V5, P195, DOI 10.3928/19404921-20120605-04; LOMBARDO JP, 1976, J CLIN PSYCHOL, V32, P765, DOI 10.1002/1097-4679(197610)32:4<765::AID-JCLP2270320404>3.0.CO;2-Z; Lopez-Ferrer M, 2012, COLLABORATIVE DISTRI, P209; Loving M, 2011, NEW LIB WORLD, V112, P121, DOI 10.1108/03074801111117023; McGowan BS, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2138; MONTGOMERY JM, 1986, BEHAV PSYCHOTHER, V14, P334, DOI 10.1017/S0141347300014956; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Morley JE, 2015, J AM MED DIRECTORS A; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nygren E., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P1390, DOI 10.1109/PASSAT/SocialCom.2011.83; Rieder Bernhard, 2013, P 5 ANN ACM WEB SCI, P346, DOI [10.1145/2464464.2464475, DOI 10.1145/2464464.2464475]; Robert AH., 2005, INTRO SOCIAL NETWORK; Sayers SL, 2008, ANN BEHAV MED, V35, P70, DOI 10.1007/s12160-007-9003-x; Scott J., 2000, SOCIAL NETWORK ANAL; Sreenivas S., SOCIAL NETWORK ANAL; Statistics Sweden, 2012, SEASONAL ADJUSTMENT; Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242; Thoren EM, 2013, ARCH DIS CHILD-FETAL, V98, pF534, DOI 10.1136/archdischild-2012-303572; Tierney MC, ALZHEIMER DIS ASS DI, V28, P320; Walker KK, 2015, HEALTH COMMUN, V30, P859, DOI 10.1080/10410236.2013.853225; WHO, 2018, TOP 10 CAUS DEATH; Zeng EQ, 2016, BALK MED J, V33, P152, DOI 10.5152/balkanmedj.2016.15701	47	9	9	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2018	13	1							e0191878	10.1371/journal.pone.0191878			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU0AV	WOS:000423514700037	29377930	Green Published, gold, Green Submitted			2022-02-06	
J	Zhang, YL; Chopp, M; Emanuele, M; Zhang, L; Zhang, ZG; Lu, M; Zhang, TL; Mahmood, A; Xiong, Y				Zhang, Yanlu; Chopp, Michael; Emanuele, Martin; Zhang, Li; Zhang, Zheng Gang; Lu, Mei; Zhang, Talan; Mahmood, Asim; Xiong, Ye			Treatment of Traumatic Brain Injury with Vepoloxamer (Purified Poloxamer 188)	JOURNAL OF NEUROTRAUMA			English	Article						functional outcome; neuroinflammation; neuroprotection; traumatic brain injury; vepoloxamer	CONTROLLED CORTICAL IMPACT; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; REACTIVE ASTROCYTES; CEREBRAL-ISCHEMIA; RAT; DAMAGE; MODEL; NEUROPROTECTION; MICROTHROMBOSIS	Vepoloxamer is an amphipathic polymer that has shown potent hemorrheologic, cytoprotective, and anti-inflammatory effects in both pre-clinical and clinical studies. This study was designed to investigate the therapeutic effects of vepoloxamer on sensorimotor and cognitive functional recovery in rats after traumatic brain injury (TBI) induced by controlled cortical impact. Young adult male Wistar rats were randomly divided into the following groups: 1) sham; 2) saline; or 3) vepoloxamer. Vepoloxamer (300mg/kg) or saline was administered over 60min via intravenous infusion into tail veins starting at 2h post-injury. Sensorimotor function and spatial learning were assessed using a modified neurological severity score and foot fault test, and Morris water maze test, respectively. The animals were sacrificed 35 days after injury and their brains were processed for measurement of lesion volume and neuroinflammation. Compared with the saline treatment, vepoloxamer initiated 2h post-injury significantly improved sensorimotor functional recovery (Days 1-35; p<0.0001) and spatial learning (Days 32-35; p<0.0001), reduced cortical lesion volume by 20%, and reduced activation of microglia/macrophages and astrogliosis in many brain regions including injured cortex, corpus callosum, and hippocampus, as well as normalized the bleeding time and reduced brain hemorrhage and microthrombosis formation. In summary, vepoloxamer treatment initiated 2h post-injury provides neuroprotection and anti-inflammation in rats after TBI and improves functional outcome, indicating that vepoloxamer treatment may have potential value for treatment of TBI. Further investigation of the optimal dose and therapeutic window of vepoloxamer treatment for TBI and the mechanisms underlying beneficial effects are warranted.	[Zhang, Yanlu; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Zhang, Li; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei; Zhang, Talan] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Emanuele, Martin] LifeRaft Technol Inc, San Diego, CA USA		Xiong, Y (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, E&R Bldg,Room 3096,2799 West Grand Blvd, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	HFH	This work was supported by internal funding from HFH. The authors would like to thank Susan MacPhee-Gray for editorial assistance.	Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bao HJ, 2016, NEUROSCI LETT, V634, P7, DOI 10.1016/j.neulet.2016.09.052; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BERRY CN, 1994, BRIT J PHARMACOL, V113, P1209, DOI 10.1111/j.1476-5381.1994.tb17126.x; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; COLBASSANI HJ, 1989, STROKE, V20, P1241, DOI 10.1161/01.STR.20.9.1241; Curry DJ, 2004, NEUROSURGERY, V55, P943, DOI 10.1227/01.NEU.0000137890.29862.2C; Dansdill D., 2016, J VASC SURG, VS0741-5214, P31654; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Emanuele M, 2014, DRUGS R&D, V14, P73, DOI 10.1007/s40268-014-0041-0; Emanuele R M, 1998, Expert Opin Investig Drugs, V7, P1193, DOI 10.1517/13543784.7.7.1193; Grindel JM, 2002, J PHARM SCI-US, V91, P1936, DOI 10.1002/jps.10190; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Maeda T, 1997, ACT NEUR S, V70, P102; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Miller BF, 2014, J CEREBR BLOOD F MET, V34, P1347, DOI 10.1038/jcbfm.2014.89; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Schaer GL, 1996, CIRCULATION, V94, P298, DOI 10.1161/01.CIR.94.3.298; Schwarzmaier SM, 2016, J NEUROTRAUM, V33, P1634, DOI 10.1089/neu.2015.4173; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Singh S, 2011, INT J NEUROSCI, V121, P589, DOI 10.3109/00207454.2011.598981; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yildirim T, 2015, INT J NEUROSCI, V125, P941, DOI 10.3109/00207454.2014.979289; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang L, 2001, STROKE, V32, P2926, DOI 10.1161/hs1201.100207; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061	50	9	10	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					661	670		10.1089/neu.2017.5284		JAN 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000419866500001	29121826				2022-02-06	
J	Plummer, SL; Corrigan, F; Thornton, E; Woenig, JA; Vink, R; Cappai, R; Van Den Heuvel, C				Plummer, Stephanie L.; Corrigan, Frances; Thornton, Emma; Woenig, Joshua A.; Vink, Robert; Cappai, Roberto; Van Den Heuvel, Corinna			The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury	PLOS ONE			English	Article							DIFFUSE AXONAL INJURY; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; HEAD-INJURY; BETA-APP; RATS; PATHOPHYSIOLOGY; OPPORTUNITIES; THERAPIES; KNOCKOUT	Following traumatic brain injury (TBI) neurological damage is ongoing through a complex cascade of primary and secondary injury events in the ensuing minutes, days and weeks. The delayed nature of secondary injury provides a valuable window of opportunity to limit the consequences with a timely treatment. Recently, the amyloid precursor protein (APP) and its derivative APP96-110 have shown encouraging neuroprotective activity following TBI following an intracerebroventricular administration. Nevertheless, its broader clinical utility would be enhanced by an intravenous (IV) administration. This study assessed the efficacy of IV APP96-110, where a dose-response for a single dose of 0.005mg/kg +/- 0.5mg/ kg APP96-110 at either 30 minutes or 5 hours following moderate-severe diffuse impactacceleration injury was performed. Male Sprague-Dawley rats were assessed daily for 3 or 7 days on the rotarod to examine motor outcome, with a separate cohort of animals utilised for immunohistochemistry analysis 3 days post-TBI to assess axonal injury and neuroinflammation. Animals treated with 0.05mg/kg or 0.5mg/kg APP96-110 after 30 minutes demonstrated significant improvements in motor outcome. This was accompanied by a reduction in axonal injury and neuroinflammation in the corpus callosum at 3 days post-TBI, whereas 0.005mg/kg had no effect. In contrast, treatment with 0.005m/kg or 0.5mg/kg APP96-110 at 5 hours post-TBI demonstrated significant improvements in motor outcome over 3 days, which was accompanied by a reduction in axonal injury in the corpus callosum. This demonstrates that APP96-110 remains efficacious for up to 5 hours post-TBI when administered IV, and supports its development as a novel therapeutic compound following TBI.	[Plummer, Stephanie L.; Corrigan, Frances; Thornton, Emma; Woenig, Joshua A.; Van Den Heuvel, Corinna] Univ Adelaide, Translat Neuropathol Lab, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Div Hlth Sci, Adelaide, SA, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia		Plummer, SL (corresponding author), Univ Adelaide, Translat Neuropathol Lab, Adelaide, SA, Australia.	Stephanie.plummer@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Plummer, Stephanie/0000-0002-9582-1703; Corrigan, Frances/0000-0001-6150-8893	National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Funding for this project was sought through the National Health and Medical Research Council (NHMRC) of Australia to Corinna Van Den Heuvel. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This study was funded by a grant from the National Health and Medical Research Council of Australia. We thank Jim Manavis for expert technical assistance.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GREENBERG SM, 1995, NEUROSCI LETT, V198, P52, DOI 10.1016/0304-3940(95)11944-R; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; WILLIAMSON TG, 1995, J NEUROCHEM, V65, P2201; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	43	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190449	10.1371/journal.pone.0190449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	WOS:000419689600050	29320530	Green Published, Green Accepted, Green Submitted, gold			2022-02-06	
J	Herold, R; Varga, E; Hajnal, A; Hamvas, E; Berecz, H; Toth, B; Tenyi, T				Herold, Robert; Varga, Eszter; Hajnal, Andras; Hamvas, Edina; Berecz, Hajnalka; Toth, Borbala; Tenyi, Tamas			Altered Neural Activity during Irony Comprehension in Unaffected First-Degree Relatives of Schizophrenia Patients-An fMRI Study	FRONTIERS IN PSYCHOLOGY			English	Article						schizophrenia; irony; theory of mind; social cognition; endophenotype; relatives; functional MRI	TRAUMATIC BRAIN-INJURY; FIGURATIVE LANGUAGE; SOCIAL COGNITION; FUNCTIONAL-ANATOMY; PREFRONTAL CORTEX; EXECUTIVE FUNCTIONS; GENETIC LIABILITY; HIGH-RISK; MIND; METAANALYSIS	Irony is a type of figurative language in which the literal meaning of the expression is the opposite of what the speaker intends to communicate. Even though schizophrenic patients are known as typically impaired in irony comprehension and in the underlying neural functions, to date no one has explored the neural correlates of figurative language comprehension in first-degree relatives of schizophrenic patients. In the present study, we examined the neural correlates of irony understanding in schizophrenic patients and in unaffected first-degree relatives of patients compared to healthy adults with functional MRI. Our aim was to investigate if possible alterations of the neural circuits supporting irony comprehension in first-degree relatives of patients with schizophrenia would fulfill the familiality criterion of an endophenotype. We examined 12 schizophrenic patients, 12 first-degree relatives of schizophrenia patients and 12 healthy controls with functional MRI while they were performing irony and control tasks. Different phases of irony processing were examined, such as context processing and ironic statement comprehension. Patients had significantly more difficulty understanding irony than controls or relatives. Patients also showed markedly different neural activation pattern compared to controls in both stages of irony processing. Although no significant differences were found in the performance of the irony tasks between the control group and the relative group, during the fMRI analysis, the relatives showed stronger brain activity in the left dorsolateral prefrontal cortex during the context processing phase of irony tasks than the control group. However, the controls demonstrated higher activations in the left dorsomedial prefrontal cortex and in the right inferior frontal gyrus during the ironic statement phase of the irony tasks than the relative group. Our results show that despite good task performance, first-degree relatives of schizophrenia patients had alterations in the neural circuits during irony processing. Thus, we suggest that neural alteration of irony comprehension could be a potential endophenotypic marker of schizophrenia.	[Herold, Robert; Varga, Eszter; Hajnal, Andras; Hamvas, Edina; Berecz, Hajnalka; Toth, Borbala; Tenyi, Tamas] Univ Pecs, Med Sch, Dept Psychiat & Psychotherapy, Pecs, Hungary		Varga, E (corresponding author), Univ Pecs, Med Sch, Dept Psychiat & Psychotherapy, Pecs, Hungary.	varga.eszter@pte.hu	Herold, Robert/B-2318-2012		National Brain Research Program [NAP KTIA NAP-A-II/12]; National Excellence Program Kivalosagi Program [NKP_17]; National Brain Research Program 2.0	This research project was supported by the National Brain Research Program Grant No. NAP KTIA NAP-A-II/12. The study was supported by the National Excellence Program Kivalosagi Program NKP_17 and the National Brain Research Program 2.0.	Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andreasen NC, 2008, SCHIZOPHRENIA BULL, V34, P708, DOI 10.1093/schbul/sbn034; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bohrn IC, 2012, NEUROPSYCHOLOGIA, V50, P2669, DOI 10.1016/j.neuropsychologia.2012.07.021; Bosco FM, 2017, PERSP PRAGMAT PHILO, V11, P267, DOI 10.1007/978-3-319-47489-2_11; Bosco FM, 2017, CORTEX, V94, P73, DOI 10.1016/j.cortex.2017.06.010; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00021; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Champagne-Lavau M, 2012, PSYCHIAT RES, V200, P184, DOI 10.1016/j.psychres.2012.06.011; Champagne-Lavau M, 2010, J NEUROLINGUIST, V23, P285, DOI 10.1016/j.jneuroling.2009.08.009; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Colston H. L., 2005, FIGURATIVE LANGUAGE; Crosson B, 1999, CEREB CORTEX, V9, P307, DOI 10.1093/cercor/9.4.307; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dennett D. C., 1989, INTENTIONAL STANCE B; Dodell-Feder D, 2014, SOC COGN AFFECT NEUR, V9, P1914, DOI 10.1093/scan/nst186; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Eviatar Z, 2006, NEUROPSYCHOLOGIA, V44, P2348, DOI 10.1016/j.neuropsychologia.2006.05.007; First M, 2007, STRUCTURED CLIN INTE; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Fruehholz S, 2013, NEUROSCI BIOBEHAV R, V37, P2847, DOI 10.1016/j.neubiorev.2013.10.007; Fussell SR, 1998, SOCIAL AND COGNITIVE APPROACHES TO INTERPERSONAL COMMUNICATION, P113; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Ibanez JMG, 2013, PSICOTHEMA, V25, P440, DOI 10.7334/psicothema2012.357; Gavilan JM, 2011, J NEUROLINGUIST, V24, P54, DOI 10.1016/j.jneuroling.2010.07.006; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Giora R., 2000, METAPHOR SYMBOL, V15, P63, DOI [DOI 10.1080/10926488.2000.9678865, 10.1080/10926488.2000.9678865]; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MJ, 2005, CURR PSYCHIATRY REV, V1, P11, DOI 10.2174/1573400052953529; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Gyori Mikios, 2004, J CULTURAL EVOLUTION, V2, P261, DOI DOI 10.1556/JCEP.2.2004.3-4; Hajnal A, 2016, PSYCHIAT RES, V237, P224, DOI 10.1016/j.psychres.2016.01.036; Hajnal Andras, 2014, Psychiatr Hung, V29, P301; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Hemsley DR, 2005, SCHIZOPHRENIA BULL, V31, P43, DOI 10.1093/schbul/sbi003; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Herold R, 2002, PSYCHOL MED, V32, P1125, DOI 10.1017/S0033291702005433; Herold Robert, 2004, Neuropsychopharmacol Hung, V6, P72; Hoenig K, 2009, NEUROIMAGE, V45, P1009, DOI 10.1016/j.neuroimage.2008.12.044; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Rodrigo MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00060; Kircher TTJ, 2007, NEUROIMAGE, V34, P281, DOI 10.1016/j.neuroimage.2006.08.044; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; KREUZ RJ, 1996, EMPIRICAL APPROACHES, V52, P83; Kronbichler L, 2017, SCHIZOPHRENIA BULL, V43, P1240, DOI 10.1093/schbul/sbx073; Kucharska-Pietura K, 2013, CNS DRUGS, V27, P335, DOI 10.1007/s40263-013-0047-0; Langdon R, 2002, MIND LANG, V17, P68, DOI 10.1111/1468-0017.00189; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Leitman DI, 2006, PSYCHOL MED, V36, P1075, DOI 10.1017/S0033291706007653; Levinson Stephen., 1983, PRAGMATICS; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P1142, DOI 10.1093/schbul/sbn053; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McGeoch PD, 2007, MED HYPOTHESES, V69, P1165, DOI 10.1016/j.mehy.2007.05.017; Mehta UM, 2012, SCHIZOPHR RES, V141, P281, DOI 10.1016/j.schres.2012.07.005; Milanowicz A., 2013, PSYCHOL LANGUAGE COM, V17, P115, DOI DOI 10.2478/PLC-2013-0008; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Nie N.H., 1975, SPSS STAT PACKAGE SO; Obert A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166704; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ORTONY A, 1975, EDUC THEORY, V25, P45, DOI 10.1111/j.1741-5446.1975.tb00666.x; Ozyurek A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0296; Papagno C, 2010, ITAL J LINGUIST, V22, P21; Poppe AB, 2015, SCHIZOPHR RES, V162, P118, DOI 10.1016/j.schres.2014.11.022; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rapp AM, 2010, BRAIN LANG, V113, P1, DOI 10.1016/j.bandl.2009.11.007; Rapp AM, 2014, SCHIZOPHR RES TREAT, V2014, DOI 10.1155/2014/841086; Rapp AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074224; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Reilly JL, 2017, SCHIZOPHRENIA BULL, V43, P397, DOI 10.1093/schbul/sbw081; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; ROBERTS RM, 1994, PSYCHOL SCI, V5, P159, DOI 10.1111/j.1467-9280.1994.tb00653.x; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saban-Bezalel R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00943; Sabb FW, 2010, SCHIZOPHR RES, V116, P173, DOI 10.1016/j.schres.2009.09.042; Salvatore G, 2012, CLIN PSYCHOL PSYCHOT, V19, P247, DOI 10.1002/cpp.746; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schnell Z, 2016, J PRAGMATICS, V92, P74, DOI 10.1016/j.pragma.2015.11.004; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Sela T, 2015, PSYCHIAT RES, V229, P1, DOI 10.1016/j.psychres.2015.07.021; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shibata M, 2010, BRAIN RES, V1308, P114, DOI 10.1016/j.brainres.2009.10.030; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sperber D., 1995, RELEVANCE COMMUNICAT; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Spreng RN, 2012, BRAIN RES, V1428, P43, DOI 10.1016/j.brainres.2010.12.024; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; SULLIVAN K, 1995, BRIT J DEV PSYCHOL, V13, P191, DOI 10.1111/j.2044-835X.1995.tb00673.x; Sullivan SA, 2016, SCHIZOPHR RES, V173, P54, DOI 10.1016/j.schres.2016.03.005; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; Thoma P, 2006, NEUROSCI BIOBEHAV R, V30, P1182, DOI 10.1016/j.neubiorev.2006.09.001; Uchiyama H, 2006, BRAIN RES, V1124, P100, DOI 10.1016/j.brainres.2006.09.088; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; van Ackeren MJ, 2016, SOC COGN AFFECT NEUR, V11, P1402, DOI 10.1093/scan/nsw062; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Varga E, 2014, J NEUROLINGUIST, V29, P1, DOI 10.1016/j.jneuroling.2014.01.001; Varga E, 2013, BRAIN LANG, V126, P231, DOI 10.1016/j.bandl.2013.05.017; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wakusawa K, 2007, NEUROIMAGE, V37, P1417, DOI 10.1016/j.neuroimage.2007.06.013; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Wechsler D., 2007, MEASUREMENT ADULT IN; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; WINNER E, 1991, BRIT J DEV PSYCHOL, V9, P257, DOI 10.1111/j.2044-835X.1991.tb00875.x; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Ziv I, 2011, COGN NEUROPSYCHIATRY, V16, P71, DOI 10.1080/13546805.2010.492693	124	9	9	1	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	JAN 9	2018	8								2309	10.3389/fpsyg.2017.02309			15	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FS2HL	WOS:000419599300001	29375430	Green Published, gold			2022-02-06	
J	Wu, XB; Lau, JTF; Mak, WWS; Gu, J; Mo, PKH; Wang, XD				Wu, Xiaobing; Lau, Joseph T. F.; Mak, Winnie W. S.; Gu, Jing; Mo, Phoenix K. H.; Wang, Xiaodong			How newly diagnosed HIV-positive men who have sex with men look at HIV/AIDS - validation of the Chinese version of the revised illness perception questionnaire	BMC INFECTIOUS DISEASES			English	Article						Illness perception; HIV infections; Men who have sex with men; Factor analysis; China	CONFIRMATORY FACTOR-ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; SELF-REGULATION MODEL; IPQ-R; MYOCARDIAL-INFARCTION; POSTTRAUMATIC GROWTH; COMMON-SENSE; MANAGEMENT; REPRESENTATION	Background: Newly diagnosed HIV-positive men who have sex with men (MSM) are an important subgroup in HIV intervention. How newly diagnosed HIV-positive MSM look at HIV/AIDS is consequential and is potentially associated with their risk behaviors and mental health problems. Illness representation has been used to define patients' beliefs and expectations on an illness, and the revised Illness Perception Questionnaire (IPQ-R) has been developed to measure illness representations. This study aims to examine the psychometric properties of the IPQ-R among newly diagnosed HIV-positive MSM and to investigate their views towards HIV/AIDS. Method: A total of 225 newly diagnosed HIV-positive MSM completed the Chinese version of IPQ-R. Both confirmatory factor analysis (CFA) and exploratory factor analysis (EFA) were applied to examine the factor structure of IPQ-R. Results: CFA showed a poor goodness of fit to the original factor structure of IPQ-R. EFA of the IPQ-R revealed 7 factors, including Emotional Response, Treatment Control, Timeline-acute/chronic, Illness Coherence, Consequence, Personal Control and Helplessness. Cronbach's alpha showed acceptable internal consistency for the derived factors, except the Personal Control (0.61) and Helplessness (0.55). Person correlation coefficients demonstrated that the derived factors of IPQ-R had significant associations with the outcome variables (depression and posttraumatic growth). The scores of the Emotional Response, Consequence, Treatment Control, Personal Control, Timeline-acute/chronic and Illness Coherence were above the midpoint, and the score of the Helplessness was below the midpoint. Conclusion: Both similarities and differences were found when the IPQ-R is applied to newly diagnosed HIV-positive MSM. The IPQ-R can be used with some refinements in future studies. Newly diagnosed HIV-positive MSM have a relatively high level of negative perceptions towards HIV/AIDS in both cognitive and emotional aspects.	[Wu, Xiaobing] Shenzhen Ctr Chron Dis Control, Dept STD Control, 2021 Buxin Rd, Shenzhen, Guangdong, Peoples R China; [Wu, Xiaobing; Lau, Joseph T. F.; Mo, Phoenix K. H.] Chinese Univ Hong Kong, Sch Publ Hlth, Prince Wales Hosp, Ctr Hlth Behav Res,Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Mak, Winnie W. S.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Gu, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaodong] Chengdu Tongle Hlth Counselling Serv Ctr, Chengdu, Sichuan, Peoples R China		Lau, JTF (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth, Prince Wales Hosp, Ctr Hlth Behav Res,Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Mo, Phoenix K.H./K-2853-2013	Mo, Phoenix K.H./0000-0001-9822-5424; Mak, Winnie/0000-0002-9714-7847; Wu, Xiaobing/0000-0002-9289-6822	China-MSD HIV/AIDS Partnership [SC09-3017]; Graduate Division of Public Health; Chinese University of Hong KongChinese University of Hong Kong; Sanming Project of Medicine in Shenzhen [SZSM201611077]	The program was funded by the China-MSD HIV/AIDS Partnership (SC09-3017), the Research Postgraduate Grant from Graduate Division of Public Health, The Chinese University of Hong Kong, and the Sanming Project of Medicine in Shenzhen (SZSM201611077).	[Anonymous], 2015, 2015 CHIN AIDS RESP; Baines T, 2013, J CLIN PSYCHOL MED S, V20, P263, DOI 10.1007/s10880-012-9337-9; Brink E, 2011, SCAND J PSYCHOL, V52, P573, DOI 10.1111/j.1467-9450.2011.00901.x; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Cabassa LJ, 2008, CULT DIVERS ETHN MIN, V14, P377, DOI 10.1037/a0012820; Chen SL, 2008, J ADV NURS, V64, P524, DOI 10.1111/j.1365-2648.2008.04808.x; Chengdu Tongle Health Counseling Service Center, 2011, 2011 CHENGD GAY CAR; Courtenay-Quirk C, 2010, AIDS PATIENT CARE ST, V24, P105, DOI 10.1089/apc.2009.0228; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Giannousi Z, 2010, PSYCHO-ONCOLOGY, V19, P85, DOI 10.1002/pon.1538; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Hagger MS, 2005, PSYCHOL HEALTH, V20, P161, DOI 10.1080/0887044042000334724; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, P37, DOI 10.1089/apc.2010.0192; [胡海洋 Hu Haiyang], 2010, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V30, P467; Hunter MS, 2003, BRIT J HEALTH PSYCH, V8, P319, DOI 10.1348/135910703322370888; Kemppainen J, 2008, J ASSOC NURSE AIDS C, V19, P127, DOI 10.1016/j.jana.2007.08.006; Keogh KM, 2011, AM J MANAG CARE, V17, P105; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; Leventhal H, 1997, PERCEPTIONS HLTH ILL, P19; Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2; Likatavicius G, 2008, SEX TRANSM INFECT, V84, P499, DOI 10.1136/sti.2008.031419; Milam JE, 2004, J APPL SOC PSYCHOL, V34, P2353, DOI 10.1111/j.1559-1816.2004.tb01981.x; Milam J, 2006, J CONSULT CLIN PSYCH, V74, P817, DOI 10.1037/0022-006X.74.5.817; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Newcomb ME, 2014, AIDS BEHAV, V18, P1981, DOI 10.1007/s10461-014-0766-3; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Reynolds NR, 2009, AIDS BEHAV, V13, P258, DOI 10.1007/s10461-007-9297-5; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Sane J, 2014, SEX TRANSM INFECT, V90, P414, DOI 10.1136/sextrans-2013-051420; Sasse A., 2009, Eurosurveillance, V14, P19420; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Sena AC, 2008, AIDS PATIENT CARE ST, V22, P955, DOI 10.1089/apc.2008.0077; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Sterba KR, 2009, PSYCHOL HEALTH, V24, P473, DOI 10.1080/08870440701867788; Surgenor LJ, 2003, EUR EAT DISORD REV, V11, P291, DOI 10.1002/erv.499; UNAIDS, 2016, AIDS NUMB AIDS IS NO; Van Ittersum MW, 2009, PATIENT EDUC COUNS, V74, P53, DOI 10.1016/j.pec.2008.07.041; Watson R, 2006, J ADV NURS, V55, P330, DOI 10.1111/j.1365-2648.2006.03915.x; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wittkowski Anja, 2008, Psychol Health Med, V13, P346, DOI 10.1080/13548500701487697; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019	42	9	10	1	17	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2334			BMC INFECT DIS	BMC Infect. Dis.	JAN 2	2018	18								2	10.1186/s12879-017-2902-y			10	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Infectious Diseases	FR6UU	WOS:000419202300002	29291733	Green Published, gold			2022-02-06	
J	Athanasiou, A; Terzopoulos, N; Pandria, N; Xygonakis, I; Foroglou, N; Polyzoidis, K; Bamidis, PD				Athanasiou, Alkinoos; Terzopoulos, Nikos; Pandria, Niki; Xygonakis, Ioannis; Foroglou, Nicolas; Polyzoidis, Konstantinos; Bamidis, Panagiotis D.			Functional Brain Connectivity during Multiple Motor Imagery Tasks in Spinal Cord Injury	NEURAL PLASTICITY			English	Article							HIGH-RESOLUTION EEG; SCALE NETWORK ANALYSIS; CAUSAL RELATIONS; BCI CONTROL; PATTERNS; REHABILITATION; CLASSIFICATION; REORGANIZATION; RELIABILITY; RECORDINGS	Reciprocal communication of the central and peripheral nervous systems is compromised during spinal cord injury due to neurotrauma of ascending and descending pathways. Changes in brain organization after spinal cord injury have been associated with differences in prognosis. Changes in functional connectivity may also serve as injury biomarkers. Most studies on functional connectivity have focused on chronic complete injury or resting-state condition. In our study, ten right-handed patients with incomplete spinal cord injury and ten age- and gender-matched healthy controls performed multiple visual motor imagery tasks of upper extremities and walking under high-resolution electroencephalography recording. Directed transfer function was used to study connectivity at the cortical source space between sensorimotor nodes. Chronic disruption of reciprocal communication in incomplete injury could result in permanent significant decrease of connectivity in a subset of the sensorimotor network, regardless of positive or negative neurological outcome. Cingulate motor areas consistently contributed the larger outflow (right) and received the higher inflow (left) among all nodes, across all motor imagery categories, in both groups. Injured subjects had higher outflow from left cingulate than healthy subjects and higher inflow in right cingulate than healthy subjects. Alpha networks were less dense, showing less integration and more segregation than beta networks. Spinal cord injury patients showed signs of increased local processing as adaptive mechanism.	[Athanasiou, Alkinoos; Terzopoulos, Nikos; Pandria, Niki; Xygonakis, Ioannis; Bamidis, Panagiotis D.] Aristotle Univ Thessaloniki AUTH, Fac Hlth Sci, Sch Med, Lab Med Phys,BERD Grp, Thessaloniki 54124, Greece; [Athanasiou, Alkinoos; Foroglou, Nicolas; Polyzoidis, Konstantinos] Aristotle Univ Thessaloniki AUTH, AHEPA Univ Gen Hosp, Dept Neurosurg 1, Thessaloniki 54636, Greece		Athanasiou, A (corresponding author), Aristotle Univ Thessaloniki AUTH, Fac Hlth Sci, Sch Med, Lab Med Phys,BERD Grp, Thessaloniki 54124, Greece.; Athanasiou, A (corresponding author), Aristotle Univ Thessaloniki AUTH, AHEPA Univ Gen Hosp, Dept Neurosurg 1, Thessaloniki 54636, Greece.	athalkinoos@auth.gr	Bamidis, Panagiotis/AAK-3556-2020; Foroglou, Nicolaos/AAP-4396-2020; Athanasiou, Alkinoos/C-8418-2016	Bamidis, Panagiotis/0000-0002-9936-5805; Foroglou, Nikolaos/0000-0003-3660-6293; Athanasiou, Alkinoos/0000-0002-0269-4195; Xygonakis, Ioannis/0000-0001-8338-6989; Pandria, Niki/0000-0002-7130-5739	Mario Boni grant from the Cervical Spine Research Society-European Section; "Brihaye" EANS Research Fund Grant from the European Association of Neurosurgical Societies; European UnionEuropean Commission [681120]	Early phases of the study were supported in part by a Mario Boni grant from the Cervical Spine Research Society-European Section, awarded to CSI: Brainwave Project. This study was supported by 2018 "Brihaye" EANS Research Fund Grant from the European Association of Neurosurgical Societies. This work was supported by European Union's Horizon 2020 research and innovation programme under grant agreement No 681120 of the SmokeFreeBrain project (http://smokefreebrain.eu).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Anderson KD, 2011, SPINAL CORD, V49, P880, DOI 10.1038/sc.2011.20; Arfaras G, 2017, COMP MED SY, P440, DOI 10.1109/CBMS.2017.34; Astolfi L, 2007, BRAIN TOPOGR, V19, P107, DOI 10.1007/s10548-007-0018-1; Astolfi L, 2010, J PSYCHOPHYSIOL, V24, P83, DOI 10.1027/0269-8803/a000017; Athanasiou A, 2017, COMP MED SY, P262, DOI 10.1109/CBMS.2017.35; Athanasiou A., 2014, SAN NIHC 2014 M UTR, P64, DOI DOI 10.13140/2.1.3183.3603; Athanasiou A, 2016, NEUROSCIENCE; Athanasiou A, 2017, WIREL COMMUN MOB COM, DOI 10.1155/2017/2986423; Athanasiou A, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00517; Athanasiou A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5708937; Athanasiou A, 2012, ADV HUM-COMPUT INTER, V2012, DOI 10.1155/2012/127627; Avanzini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037534; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Baxter BS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00691; Becker H, 2015, IEEE SIGNAL PROC MAG, V32, P100, DOI 10.1109/MSP.2015.2413711; Belouchrani A, 2000, ELECTRON LETT, V36, P2050, DOI 10.1049/el:20001436; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birbaumer N, 2010, FRONT COLLECT, P155, DOI 10.1007/978-3-642-02091-9_9; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Christ O, 2014, NEUROSCI BIOBEHAV R, V44, P33, DOI 10.1016/j.neubiorev.2014.02.013; Cramer D., 2004, SAGE DICT STAT; Cramer D., 1998, FUNDAMENTAL STAT SOC; Fallani FD, 2007, BRAIN TOPOGR, V19, P125, DOI 10.1007/s10548-007-0019-0; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Doane DP, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889611; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fallani FD, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224014; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Fallani FD, 2013, NEUROIMAGE, V83, P438, DOI 10.1016/j.neuroimage.2013.06.039; Fallani FD, 2011, BRAIN TOPOGR, V23, P344, DOI 10.1007/s10548-010-0152-z; FLORIAN G, 1995, ELECTROEN CLIN NEURO, V95, P393, DOI 10.1016/0013-4694(95)00198-8; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Ginter J, 2005, METHOD INFORM MED, V44, P106, DOI 10.1055/s-0038-1633932; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grosse-Wentrup M., 2009, ADV NEURAL INFORM PR, P561; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hamedi M, 2016, NEURAL COMPUT, V28, P999, DOI 10.1162/NECO_a_00838; Hamedi M, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL AND IMAGE PROCESSING APPLICATIONS (ICSIPA), P269, DOI 10.1109/ICSIPA.2015.7412202; Hansen PC, 2007, NUMER ALGORITHMS, V46, P189, DOI 10.1007/s11075-007-9136-9; Hansen PC, 2007, J COMPUT APPL MATH, V198, P483, DOI 10.1016/j.cam.2005.09.026; Harris JE, 2015, CLIN REHABIL, V29, P1092, DOI 10.1177/0269215514566248; Hawasli AH, 2018, J NEUROTRAUM, V35, P864, DOI 10.1089/neu.2017.5212; He B., 2005, MODELING IMAGING BIO; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hou JM, 2014, NEUROSCIENCE, V277, P446, DOI 10.1016/j.neuroscience.2014.07.045; Hou JM, 2016, HUM BRAIN MAPP, V37, P2195, DOI 10.1002/hbm.23163; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ilvesmaki T, 2017, HUM BRAIN MAPP, V38, P3637, DOI 10.1002/hbm.23619; JANSEN BH, 1981, IEEE T BIO-MED ENG, V28, P836, DOI 10.1109/TBME.1981.324686; Kall LB, 2018, RESTOR NEUROL NEUROS, V36, P73, DOI 10.3233/RNN-170775; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kamousi B, 2005, IEEE T NEUR SYS REH, V13, P166, DOI 10.1109/TNSRE.2005.847386; Kamousi B, 2007, J NEURAL ENG, V4, P17, DOI 10.1088/1741-2560/4/2/002; Kang BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191480; Kaushal M, 2017, BRAIN CONNECT, V7, P413, DOI 10.1089/brain.2016.0468; Kaushal M, 2017, J NEUROTRAUM, V34, P1278, DOI 10.1089/neu.2016.4649; Kim YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190715; Kordjazi N, 2017, BIORXIV; Kraeutner S, 2014, BRAIN RES, V1588, P81, DOI 10.1016/j.brainres.2014.09.001; Kugiumtzis D, 2001, INT J BIFURCAT CHAOS, V11, P1881, DOI 10.1142/S0218127401003061; Kugiumtzis D., 2002, MODELLING FORECASTIN, P267, DOI DOI 10.1007/978-1-4615-0931-8_13; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Luo HW, 2016, 2016 9TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, BIOMEDICAL ENGINEERING AND INFORMATICS (CISP-BMEI 2016), P1521, DOI 10.1109/CISP-BMEI.2016.7852956; Marks D. F., 1995, J MENT IMAG, V19, P153, DOI DOI 10.1177/0963721414532287; Mattia D, 2009, CLIN NEUROPHYSIOL, V120, P181, DOI 10.1016/j.clinph.2008.09.023; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Min YS, 2015, ANN REHABIL MED-ARM, V39, P374, DOI 10.5535/arm.2015.39.3.374; Mizuguchi N, 2017, NEUROSCI LETT, V636, P108, DOI 10.1016/j.neulet.2016.10.064; Mohd Razali N., 2011, J STAT MODEL ANAL, V2, P21; Nardone R, 2015, BRAIN RES, V1619, P139, DOI 10.1016/j.brainres.2014.09.036; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Oni-Orisan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150351; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pan Y, 2017, NEURAL REGEN RES, V12, P2059, DOI 10.4103/1673-5374.221165; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Qin L, 2004, J NEURAL ENG, V1, P135, DOI 10.1088/1741-2560/1/3/002; Rajasekaran V, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-017-0345-8; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sabate M, 2011, NEUROSCIENCE, V189, P236, DOI 10.1016/j.neuroscience.2011.05.011; Sakihara K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00501; Samdin SB, 2014, 2014 IEEE WORKSHOP ON STATISTICAL SIGNAL PROCESSING (SSP), P181, DOI 10.1109/SSP.2014.6884605; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sinatra R, 2009, INT J BIFURCAT CHAOS, V19, P665, DOI 10.1142/S0218127409023020; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O., 2003, NEUROSCIENCE DATABAS, P171, DOI DOI 10.1007/978-1-4615-1079-6_12; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Tung SW, 2013, IEEE ENG MED BIO, P261, DOI 10.1109/EMBC.2013.6609487; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Willemse Ronald B, 2010, Open Neuroimag J, V4, P93, DOI 10.2174/1874440001004010093; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xu L, 2014, NEUROSCIENCE, V261, P184, DOI 10.1016/j.neuroscience.2013.12.005; Yi WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114853; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zheng WM, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4671607	108	9	9	0	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2018	2018								9354207	10.1155/2018/9354207			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF7DZ	WOS:000432129500001	29853852	Green Published, gold			2022-02-06	
J	Brown, RM; Tang, XY; Dreer, LE; Driver, S; Pugh, MJ; Martin, AM; McKenzie-Hartman, T; Shea, T; Silva, MA; Nakase-Richardson, R				Brown, Racine Marcus; Tang, Xinyu; Dreer, Laura E.; Driver, Simon; Pugh, Mary Jo; Martin, Aaron M.; McKenzie-Hartman, Tamara; Shea, Timothy; Silva, Marc A.; Nakase-Richardson, Risa			Change in body mass index within the first-year post-injury: a VA Traumatic Brain Injury (TBI) model systems study	BRAIN INJURY			English	Article						Obesity; weight gain; traumatic brain injury; service members; military; Veterans	QUALITY-OF-LIFE; OBESITY; REHABILITATION; CONSEQUENCES; PREVALENCE; PAIN; DISABILITY; DISORDERS; WEIGHT; IMPACT	Objective: To describe change in body mass index (BMI) and weight classification 1-year post- traumatic brain injury (TBI) among Veterans and service members.Design: Prospective observational cohort study.Setting: VA Polytrauma Rehabilitation Centers.Participants: Veterans and service members (N=84) enrolled in VA Traumatic Brain Injury Model Systems (VA TBIMS) study with BMI scores at enrollment and 1-year post-injury.Interventions: N/A.Main outcome measures: BMI scores from height and weight and weight classifications (underweight, normal weight, overweight, obese classes 1-3) defined by WHO.Results: Twenty per cent were obese at time of injury and 24% were obese at 1-year post-injury. Cross-tab analyses revealed 7% of normal weight and 24% overweight participants at time of injury as obese Class 1 one-year post-injury. Univariate models found BMI and tobacco smoking at time of injury were significant predictors of higher BMI scores 1-year post-TBI. Multivariable models found BMI at time of injury and motor functioning, were significant predictors. Preinjury BMI, tobacco smoking and PTSD symptom severity predicted change in weight category.Conclusion: While obesity among service members and Veterans post-TBI is below national averages, trends in weight gain between time of injury and 1-year follow-up were observed. Implications for health promotion and chronic disease management efforts with regards to rehabilitation for injured military are discussed.List of Abbreviations: BMI, Body mass index; BRFSS, Behavioural Risk Factor Surveillance; GCS, Glasgow Coma Scale; FIM, Functional Independence Measure; NIDILRR, National Institute on Independent Living and Rehabilitation Research; PCL-C, PTSD checklist-civilian; PSTD, Post-traumatic stress disorder; VA, Veterans Affairs; VA PRC, Veterans Affairs Polytrauma Rehabilitation; VA TBIMS, Veterans Affairs TBI Model Systems;	[Brown, Racine Marcus; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA; [Driver, Simon] Baylor Scott & White Hlth Care Syst, Baylor Inst Rehabil, Dallas, TX USA; [Pugh, Mary Jo] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Martin, Aaron M.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [McKenzie-Hartman, Tamara; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL USA; [Shea, Timothy] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Nakase-Richardson, Risa] Univ S Florida, Coll Med, Tampa, FL USA		Brown, RM (corresponding author), James A Haley Vet Hosp, Neuropsychologist Polytrauma, Psychol Serv 117, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Racine.Brown@va.gov	Silva, Marc A./J-1874-2019; Pugh, Mary Jo/K-5336-2019	Silva, Marc A./0000-0002-3879-6054; Pugh, Mary Jo/0000-0003-4196-7763; driver, simon/0000-0003-2356-432X	VHA Central Office VA TBI Model System Program of Research; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0044, 90DP0045-01-0, H133A120086]; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; Department of Veterans Affairs Health Services Research, Center of Innovation on Disability and Rehabilitation ResearchUS Department of Veterans Affairs [1 I50 HX001233-0]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research)	This work was supported by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [grant number W91YTZ-13-C-0015]; the National Institute on Disability, Independent Living, and Rehabilitation Research [grant number 90DP0044 to PI: Novack], [grant number 90DP0045-01-0 to PI: Shafi & Womack], [grant number H133A120086 to Corrigan]; NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). Department of Veterans Affairs Health Services Research, Center of Innovation on Disability and Rehabilitation Research [grant number 1 I50 HX001233-0]. The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, Veterans Affairs, and you should not assume endorsement by the Federal Government, National Institute on Disability, Independent Living, and Rehabilitation Research. The VA TBI Model System conducted at the Polytrauma Rehabilitation Centers is a funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research).	Alpert MA, 2016, J CARDIOPULM REHABIL, V36, P1, DOI 10.1097/HCR.0000000000000147; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Centers for Disease Control and Prevention, 2016, AD BMI CALC; Centers for Disease Control and Prevention, 1999, BEH RISK FACT SURV S; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Chaudhry R, 2017, J NEUROSURG ANESTHES, P1; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crenn P, 2013, CLIN NUTR, V33, P348; Crespo I, 2015, CURR OPIN ENDOCRINOL, V22, P306, DOI 10.1097/MED.0000000000000169; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Driver S, 2018, J HEAD TRAUMA REHAB, V33, pE36, DOI 10.1097/HTR.0000000000000327; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; Ghoorah K, 2016, EUR HEART J-ACUTE CA, V5, P77, DOI 10.1177/2048872614523349; Gibson R., 2005, PRINCIPLES NUTR ASSE, V2nd; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Janke EA, 2007, J REHABIL RES DEV, V44, P245, DOI 10.1682/JRRD.2006.06.0060; Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3; Kanasaki K, 2013, NEPHROL DIAL TRANSPL, V28, P1, DOI 10.1093/ndt/gft098; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Le D, 2015, AM J PHYS MED REHAB, V94, P627, DOI 10.1097/PHM.0000000000000222; Lehman J, 2016, JARNA, V19, P21; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Okifuji A, 2015, J PAIN RES, V8, P399, DOI 10.2147/JPR.S55598; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Pedersen SD, 2013, BEST PRACT RES CL EN, V27, P179, DOI 10.1016/j.beem.2013.02.004; Salim A, 2009, AM SURGEON, V75, P25; Schmidt AM, 2015, ARTERIOSCL THROM VAS, V35, pE19, DOI 10.1161/ATVBAHA.115.305753; Sebastian JC, 2013, BEST PRACT RES CL EN, V27, P157, DOI 10.1016/j.beem.2013.04.014; Sundman M, 2015, FRONT NEUROSCI, V9, P1; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor TR, 2015, J RACIAL ETHN HEALTH, V2, P231, DOI 10.1007/s40615-014-0070-y; TEASDALE G, 1974, LANCET, V2, P81; Weathers F, 1996, MEASUREMENT STRESS T; Weathers F. W., 1994, PCL C FOR DSM 4; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; World Health Organization, OB PREV MAN GLOB EP	61	9	9	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		986	993		10.1080/02699052.2018.1468575			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400005	29701494				2022-02-06	
J	Colon, JM; Gonzalez, PA; Cajigas, A; Maldonado, WI; Torrado, AI; Sandago, JM; Salgado, IK; Miranda, JD				Colon, Jennifer M.; Gonzalez, Pablo A.; Cajigas, Ambar; Maldonado, Wanda I.; Torrado, Aranza I.; Sandago, Jose M.; Salgado, Iris K.; Miranda, Jorge D.			Continuous tamoxifen delivery improves locomotor recovery 6 h after spinal cord injury by neuronal and glial mechanisms in male rats	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Tamoxifen; Therapeutic window; Sex differences; Estrogen receptor alpha; Neuroprotection; Astrogliosis; Myelin spared tissue; Olig-2; Selective estrogen receptor modulator	COUPLED ESTROGEN-RECEPTOR; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; FUNCTIONAL RECOVERY; FEMALE RATS; CELL-DEATH; PHARMACOLOGICAL ACTIONS; INFLAMMATORY RESPONSE; HIPPOCAMPAL-NEURONS; SECONDARY DAMAGE	No treatment is available for patients with spinal cord injury (SCI). Patients often arrive to the hospital hours after SCI suggesting the need of a therapy that can be used on a clinically relevant window. Previous studies showed that Tamoxifen (TAM) treatment 24 h after SCI benefits locomotor recovery in female rats. Tamoxifen exerts beneficial effects in male and female rodents but a gap of knowledge exists on: the therapeutic window of TAM, the spatio-temporal mechanisms activated and if this response is sexually dimorphic. We hypothesized that TAM will favor locomotor recovery when administered up-to 24 h after SCI in male Sprague-Dawley rats. Rats received a thoracic (T10) contusion using the MACSIS impactor followed by placebo or TAM (15 mg/21 days) pellets in a therapeutic window of 0, 6, 12, or 24 h. Animals were sacrificed at 2, 7, 14, 28 or 35 days post injury (DPI) to study the molecular and cellular changes in the acute and chronic stages. Immediate or delayed therapy (t = 6 h) improved locomotor function, increased white matter spared tissue, and neuronal survival. TAM reduced reactive gliosis during chronic stages and increased the expression of Olig-2. A significant difference was observed in estrogen receptor alpha between male and female rodents from 2 to 28 DPI suggesting a sexually dimorphic characteristic that could be related to the behavioral differences observed in the therapeutic window of TAM. This study supports the use of TAM in the SCI setting due to its neuroprotective effects but with a significant sexually dimorphic therapeutic window.	[Colon, Jennifer M.; Gonzalez, Pablo A.; Cajigas, Ambar; Torrado, Aranza I.; Salgado, Iris K.; Miranda, Jorge D.] Univ Puerto Rico, Dept Physiol, Med Sci Campus,POB 365067, San Juan, PR 00936 USA; [Maldonado, Wanda I.; Sandago, Jose M.] Univ Puerto Rico, Neuroregenerat Div, Neurosci Res Lab, Nat Sci Dept, Carolina Campus,POB 4800, Carolina, PR 00984 USA		Miranda, JD (corresponding author), Univ Puerto Rico, Dept Physiol, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.	jennifer.colon10@upr.edu; pablo.gonzalez6@upr.edu; ambar.cajigas@upr.edu; wanda.maldonado3@upr.edu; wanda.maldonado3@upr.edu; jose.santiago13@upr.edu; iris.salgado@upr.edu; jorge.miranda3@upr.edu		Colon-Mercado, Jennifer/0000-0002-2912-554X; Santiago Santana, Jose/0000-0002-0615-5033; Cajigas, Ambar/0000-0001-6436-4450	University of Puerto Rico Carolina Campus [P031S130068]; RISE program; MARC program; National Institutes of health: COBRE program [P20-GM103642]; National Institutes of health: MBRS-RISE Program [R25 GM061838]; National Institutes of health: NIH-MARC program [5T34GM007821-35]; National Institutes of health: RCMI programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5G12MD007600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103642, R25GM061838, T34GM007821] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007600, G12MD007600] Funding Source: NIH RePORTER	This work was supported by the following grants from the National Institutes of health grants: COBRE (P20-GM103642), MBRS-RISE Program (R25 GM061838), NIH-MARC (5T34GM007821-35) and RCMI (5G12MD007600) programs. Experiments from this research project were partially funded by a Cooperative Title V (grant number P031S130068) from the University of Puerto Rico Carolina Campus. JMC was supported by RISE and AC by the MARC programs, respectively.	Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Alexander A, 2017, NEUROPHARMACOLOGY, V113, P652, DOI 10.1016/j.neuropharm.2016.07.003; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Bourque M, 2013, NEUROBIOL AGING, V34, P887, DOI 10.1016/j.neurobiolaging.2012.05.022; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broughton BRS, 2014, STROKE, V45, P835, DOI 10.1161/STROKEAHA.113.001499; Chaovipoch P, 2006, J NEUROTRAUM, V23, P830, DOI 10.1089/neu.2006.23.830; Cheng Q., 2016, BIOSCIENCE REP, P1; Colon JM, 2016, NEURAL REGEN RES, V11, P1208, DOI 10.4103/1673-5374.189164; Colon JM, 2016, J NEUROTRAUM, V33, P1696, DOI 10.1089/neu.2015.4111; Cristante AF, 2012, CLINICS, V67, P1219, DOI 10.6061/clinics/2012(10)16; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Cuzzocrea S, 2008, SHOCK, V29, P362, DOI 10.1097/shk.0b013e31814545dc; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; de la Torre Valdovinos B, 2016, J VET MED, V2016, P1; DonCarlos LL, 2009, PSYCHONEUROENDOCRINO, V34, P113; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; Gupta DS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00028; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Handa RJ, 2012, J NEUROENDOCRINOL, V24, P160, DOI 10.1111/j.1365-2826.2011.02206.x; Hauben E, 2002, EUR J NEUROSCI, V16, P1731, DOI 10.1046/j.1460-9568.2002.02241.x; Hu R, 2012, CRIT CARE MED, V40, P3230, DOI 10.1097/CCM.0b013e3182657560; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Ismailoglu O, 2010, J CLIN NEUROSCI, V17, P1306, DOI 10.1016/j.jocn.2010.01.049; Jadasz JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071814; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; Lemmon VP, 2014, J NEUROTRAUM, V31, P1354, DOI 10.1089/neu.2014.3400; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Lonard DM, 2002, STEROIDS, V67, P15, DOI 10.1016/S0039-128X(01)00133-7; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Nelson ER, 2013, BONE, V53, P42, DOI 10.1016/j.bone.2012.11.011; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; O'Neill K, 2004, EXP NEUROL, V188, P268, DOI 10.1016/j.expneurol.2004.01.014; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Patel SP, 2017, EXP NEUROL, V293, P74, DOI 10.1016/j.expneurol.2017.03.021; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Ritz MF, 2008, BRAIN RES, V1203, P177, DOI 10.1016/j.brainres.2008.01.091; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rosas OR, 2011, DEV NEUROBIOL, V71, P595, DOI 10.1002/dneu.20848; Samantaray S, 2016, J NEUROCHEM, V137, P604, DOI 10.1111/jnc.13610; Samantaray S, 2011, NEUROCHEM RES, V36, P1809, DOI 10.1007/s11064-011-0498-y; Santiago JM, 2009, J NEUROTRAUM, V26, P1783, DOI 10.1089/neu.2007.0502; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Siriphorn A, 2012, J COMP NEUROL, V520, P2630, DOI 10.1002/cne.23056; Sribnick EA, 2006, NEUROSCIENCE, V137, P197, DOI 10.1016/j.neuroscience.2005.08.074; Sribnick EA, 2005, J NEUROSCI RES, V82, P283, DOI 10.1002/jnr.20622; Sribnick EA, 2010, J NEUROSCI RES, V88, P1738, DOI 10.1002/jnr.22337; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Wei HY, 2014, NEUROL SCI, V35, P1763, DOI 10.1007/s10072-014-1828-z; Winterle JS, 2001, ARCH BIOCHEM BIOPHYS, V392, P233, DOI 10.1006/abbi.2001.2431; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	75	9	10	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.		2018	299		A				109	121		10.1016/j.expneurol.2017.10.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR7PD	WOS:000419261500010	29037533	Bronze, Green Accepted			2022-02-06	
J	Cuberos-Urbano, G; Caracuel, A; Valls-Serrano, C; Garcia-Mochon, L; Gracey, F; Verdejo-Garcia, A				Cuberos-Urbano, Gustavo; Caracuel, Alfonso; Valls-Serrano, Carlos; Garcia-Mochon, Leticia; Gracey, Fergus; Verdejo-Garcia, Antonio			A pilot investigation of the potential for incorporating lifelog technology into executive function rehabilitation for enhanced transfer of self-regulation skills to everyday life	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive function; goal management training; lifelog technology; SenseCam; ActiHeart; acquired brain injury	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE ERRANDS TEST; QUALITY-OF-LIFE; AUTOBIOGRAPHICAL MEMORY; ECOLOGICAL VALIDITY; WEARABLE CAMERA; INTERVENTIONS; MANAGEMENT; AWARENESS	The objective of the study was to identify the potential target and effect size of goal management training (GMT) enhanced with life-logging technology compared with standard GMT on a range of possible primary outcomes reflecting cognitive and ecological aspects of executive functioning and quality of life. Sixteen patients with acquired brain injury involving executive dysfunction were randomly allocated to one of the two interventions: seven weeks of GMT (n=8), or seven weeks of GMT+Lifelog (n=8). Outcome measures included a battery of executive function tests, the Dysexecutive Questionnaire (DEX) and the Quality of Life after Brain Injury scale (QOLIBRI), measured pre- and post-interventions. Within-group changes were assessed with related-samples t-tests and estimation of effect sizes. GMT+Lifelog was associated with significant changes, of medium to large effect size, in response inhibition (Stroop), multitasking (Strategy Application and Multiple Errand tests), DEX Intentionality and Positive Affect subscales and QOLIBRI Daily Life and Autonomy, subscales. GMT alone was associated with significant changes of overall quality of life. It was concluded that GMT+Lifelog holds promise to optimise the impact of GMT on executive dysfunction and quality of life.	[Cuberos-Urbano, Gustavo; Valls-Serrano, Carlos; Verdejo-Garcia, Antonio] Univ Granada, Sch Psychol, Dept Clin Psychol, Granada, Spain; [Caracuel, Alfonso] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Caracuel, Alfonso] Univ Granada, Sch Educ, Dept Dev Psychol, Granada, Spain; [Garcia-Mochon, Leticia] Escuela Andaluza Salud Publ, Granada, Spain; [Gracey, Fergus] Cambridgeshire Community Serv NHS Trust, Princess Wales Hosp, Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, Cambs, England; [Gracey, Fergus] Univ East Anglia, Norwich Med Sch, Dept Clin Psychol, Norwich Res Pk, Norwich, Norfolk, England; [Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci F Oloriz, Sch Med, Granada, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Verdejo-Garcia, Antonio] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia		Caracuel, A (corresponding author), Univ Granada, Fac Educ, Campus Cartuja S-N, E-18071 Granada, Spain.	acaracuel@ugr.es	Verdejo-Garcia, Antonio/AAV-1147-2021; Caracuel, Alfonso/V-3695-2019	Verdejo-Garcia, Antonio/0000-0001-8874-9339; Caracuel, Alfonso/0000-0002-9738-8456; Gracey, Fergus/0000-0002-1416-7894	Spanish Ministry of HealthInstituto de Salud Carlos IIISpanish Government [PI09/91008]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; Fondo de Investigacion SanitariaInstituto de Salud Carlos III; National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC)National Institute for Health Research (NIHR); NIHR Flexibility and Sustainability from NHS Cambridgeshire	This study was funded by [grant number PI09/91008] from the Spanish Ministry of Health, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (PI: AVG). FG was supported by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for Cambridgeshire and Peterborough and NIHR Flexibility and Sustainability Funding from NHS Cambridgeshire.	Barker-Collo S, 2006, NEUROPSYCHOL REV, V16, P53, DOI 10.1007/s11065-006-9007-5; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Brindley R, 2011, MEMORY, V19, P745, DOI 10.1080/09658211.2010.493893; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Cuberos-Urbano G, 2013, J CLIN EXP NEUROPSYC, V35, P329, DOI 10.1080/13803395.2013.776011; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Golden CJ., 2002, STROOP COLOR WORD TE; Gracey F., 2012, THE SOCIAL CURE, P273; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam C, 2014, AGING MENT HEALTH, V18, P425, DOI 10.1080/13607863.2013.845871; Haslam C, 2010, PSYCHOL AGING, V25, P157, DOI 10.1037/a0018256; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hodges S, 2011, MEMORY, V19, P685, DOI 10.1080/09658211.2011.605591; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Lancaster Gillian A, 2015, Pilot Feasibility Stud, V1, P1, DOI 10.1186/2055-5784-1-1; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Levine B., 2005, GOAL MANAGEMENT TRAI; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis JA, 1999, STAT MED, V18, P1903, DOI 10.1002/(SICI)1097-0258(19990815)18:15<1903::AID-SIM188>3.3.CO;2-6; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; MARCUS DA, 1989, ARCH NEUROL-CHICAGO, V46, P1129, DOI 10.1001/archneur.1989.00520460125024; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raven J., 2004, MANUAL RAVENS PROGR; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Takken T, 2010, EUR J CLIN NUTR, V64, P1494, DOI 10.1038/ejcn.2010.196; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P47, DOI 10.1017/CBO9780511581083.006; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zelazo P. D., 2003, MONOGRAPHS SOC RES C, V68, P48, DOI DOI 10.1111/j.0037-976X.2003.00263.x	48	9	9	3	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	4					589	601		10.1080/09602011.2016.1187630			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4CA	WOS:000428276000006	27251578	Green Accepted			2022-02-06	
J	DeGutis, J; Chiu, C; Thai, M; Esterman, M; Milberg, W; McGlinchey, R				DeGutis, Joseph; Chiu, Christopher; Thai, Michelle; Esterman, Michael; Milberg, William; McGlinchey, Regina			Trauma Sequelae are Uniquely Associated with Components of Self-Reported Sleep Dysfunction in OEF/OIF/OND Veterans	BEHAVIORAL SLEEP MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEXUAL ASSAULT SURVIVORS; COGNITIVE-BEHAVIORAL THERAPY; ADMINISTERED PTSD SCALE; QUALITY INDEX ADDENDUM; BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; NICOTINE DEPENDENCE; CHRONIC NIGHTMARES; IMAGERY REHEARSAL	While the associations between psychological distress (e.g., posttraumatic stress disorder [PTSD], depression) and sleep dysfunction have been demonstrated in trauma-exposed populations, studies have not fully explored the associations between sleep dysfunction and the wide range of common physical and physiological changes that can occur after trauma exposure (e.g., pain, cardiometabolic risk factors). We aimed to clarify the unique associations of psychological and physical trauma sequelae with different aspects of self-reported sleep dysfunction. A comprehensive psychological and physical examination was administered to 283 combat-deployed trauma-exposed Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) veterans. The Pittsburgh Sleep Quality Index (PSQI) and PSQI Addendum for PSTD (PSQI-A) were administered along with measures of PTSD, depression, anxiety, pain, traumatic brain injury, alcohol use, nicotine dependence, and cardiometabolic symptoms. We first performed a confirmatory factor analysis of the PSQI and then conducted regressions with the separate PSQI factors as well as the PSQI-A to identify unique associations between trauma-related measures and the separate aspects of sleep. We found that the PSQI global score was composed of three factors: Sleep Efficiency (sleep efficiency/sleep duration), Perceived Sleep Quality (sleep quality/sleep latency/sleep medication) and Daily Disturbances (sleep disturbances/daytime dysfunction). Linear regressions demonstrated that PTSD symptoms were uniquely associated with the PSQI global score and all three factors, as well as the PSQI-A. For the other psychological distress variables, anxiety was independently associated with PSQI global as well as Sleep Efficiency, Perceived Sleep Quality, and PSQI-A, whereas depression was uniquely associated with Daily Disturbances and PSQI-A. Notably, cardiometabolic symptoms explained independent variance in PSQI global and Sleep Efficiency. These findings help lay the groundwork for further investigations of the mechanisms of sleep dysfunction in trauma-exposed individuals and may help in the development of more effective, individualized treatments.	[DeGutis, Joseph; Chiu, Christopher; Thai, Michelle; Esterman, Michael] Boston Div VA Healthcare Syst, Boston Attent & Learning Lab, Boston, MA USA; [DeGutis, Joseph; Chiu, Christopher; Thai, Michelle; Esterman, Michael; Milberg, William; McGlinchey, Regina] Boston Div VA Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [DeGutis, Joseph] Harvard Med Sch, Dept Med, Boston, MA USA; [Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Milberg, William; McGlinchey, Regina] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, VA RR&D TBI Ctr Excellence, Boston, MA USA		DeGutis, J (corresponding author), Boston VA Healthcare Syst, GRECC, 150 S Huntington Ave,182-JP, Boston, MA 02130 USA.	degutis@wjh.harvard.edu			Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]; Veterans Affairs Career Development Award II; VA Clinical Science R&D Career Development Award [1IK2CX000706-01A2]; Veterans AffairsUS Department of Veterans Affairs [IK2CX000706] Funding Source: NIH RePORTER	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B9254-C); by a Veterans Affairs Career Development Award II given to JD; and a VA Clinical Science R&D Career Development Award to ME (1IK2CX000706-01A2).	Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 2012, AN VA HLTH CAR UT OP; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Babson KA, 2012, J TRAUMA STRESS, V25, P665, DOI 10.1002/jts.21757; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Bennett LS, 1999, AM J RESP CRIT CARE, V159, P1884, DOI 10.1164/ajrccm.159.6.9808107; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Breslau N, 2004, ARCH GEN PSYCHIAT, V61, P508, DOI 10.1001/archpsyc.61.5.508; Brondel L, 2010, AM J CLIN NUTR, V91, P1550, DOI 10.3945/ajcn.2009.28523; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bulmer MG., 2012, PRINCIPLES STAT; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carney CE, 2014, BEHAV SLEEP MED, V12, P272, DOI 10.1080/15402002.2013.801345; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Casement MD, 2012, SLEEP MED, V13, P752, DOI 10.1016/j.sleep.2012.02.014; Castro JP, 2003, CURR HYPERTENS REP, V5, P393, DOI 10.1007/s11906-003-0085-y; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole JC, 2006, SLEEP, V29, P112, DOI 10.1093/sleep/29.1.112; Davis, 2009, TREATING POSTTRAUMA; de Leon J, 2003, ADDICT BEHAV, V28, P1481, DOI 10.1016/S0306-4603(02)00264-2; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P1, DOI DOI 10.7275/DA8T-4G52; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EVANS JR, 2007, STAT DATA ANAL DECIS; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; GOLDSTEIN G, 1987, AM J PSYCHIAT, V144, P1210; Green P, 2004, GREENS MEDICAL SYMPT; GROSS RT, 1982, BEHAV THER, V13, P112, DOI 10.1016/S0005-7894(82)80054-3; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Hawker G. A., 2011, ARTHRIT CARE RES, V63; Hayes, 2018, INTRO MEDIATION MODE; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HEFEZ A, 1987, AM J PSYCHIAT, V144, P344; Heppner PS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Insana SP, 2013, J TRAUMA STRESS, V26, P192, DOI 10.1002/jts.21793; Jaehne A, 2009, SLEEP MED REV, V13, P363, DOI 10.1016/j.smrv.2008.12.003; Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219; Kaur S. S., 2014, BRAIN IMAGING BEHAV, P1; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Koh HWL, 2015, SLEEP BREATH, V19, P1147, DOI 10.1007/s11325-015-1130-1; Krakow B, 2000, J TRAUMA STRESS, V13, P589, DOI 10.1023/A:1007854015481; Krakow B, 2001, JAMA-J AM MED ASSOC, V286, P537, DOI 10.1001/jama.286.5.537; Krakow B, 2002, J NERV MENT DIS, V190, P442, DOI 10.1097/00005053-200207000-00004; Krakow B, 2002, J ANXIETY DISORD, V16, P175, DOI 10.1016/S0887-6185(02)00093-2; Krakow B, 2000, Crisis, V21, P163, DOI 10.1027//0227-5910.21.4.163; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Lavie P, 2001, NEW ENGL J MED, V345, P1825, DOI 10.1056/NEJMra012893; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lowe B, 2011, J CLIN PSYCHIAT, V72, P304, DOI 10.4088/JCP.09m05290blu; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Magee CA, 2008, SLEEP BIOL RHYTHMS, V6, P222, DOI 10.1111/j.1479-8425.2008.00371.x; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; Mariman A, 2012, J PSYCHOSOM RES, V72, P111, DOI 10.1016/j.jpsychores.2011.11.004; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; Perlis ML, 2010, J SLEEP RES, V19, P31, DOI 10.1111/j.1365-2869.2009.00768.x; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Rasmusson AM, 2010, EXP BIOL MED, V235, P1150, DOI 10.1258/ebm.2010.009334; Redline S, 1998, CLIN CHEST MED, V19, P1, DOI 10.1016/S0272-5231(05)70428-7; ROSEN J, 1991, AM J PSYCHIAT, V148, P62; ROSS RJ, 1989, AM J PSYCHIAT, V146, P697; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sheikh JI, 2003, DEPRESS ANXIETY, V18, P187, DOI 10.1002/da.10066; Sivertsen B, 2012, PSYCHOSOM MED, V74, P758, DOI 10.1097/PSY.0b013e3182648619; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Stewart SH, 1998, ADDICT BEHAV, V23, P797, DOI 10.1016/S0306-4603(98)00070-7; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Talbot LS, 2015, PSYCHOSOM MED, V77, P383, DOI 10.1097/PSY.0000000000000176; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Thomsen DK, 2003, PERS INDIV DIFFER, V34, P1293, DOI 10.1016/S0191-8869(02)00120-4; VANDERKOLK BA, 1980, SLEEP RES, V9, P229; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WOOD JM, 1992, J ABNORM PSYCHOL, V101, P219, DOI 10.1037/0021-843X.101.2.219; Zayfert C, 2004, J TRAUMA STRESS, V17, P69, DOI 10.1023/B:JOTS.0000014679.31799.e7	99	9	9	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-2002	1540-2010		BEHAV SLEEP MED	Behav. Sleep Med.		2018	16	1					38	63		10.1080/15402002.2016.1173550			26	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	FP6IO	WOS:000417729400003	27183394				2022-02-06	
J	Elliott, JE; Opel, RA; Weymann, KB; Chau, AQ; Papesh, MA; Callahan, ML; Storzbach, D; Lim, MM				Elliott, Jonathan E.; Opel, Ryan A.; Weymann, Kris B.; Chau, Alex Q.; Papesh, Melissa A.; Callahan, Megan L.; Storzbach, Daniel; Lim, Miranda M.			Sleep Disturbances in Traumatic Brain Injury: Associations With Sensory Sensitivity	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						autonomic hyperarousal; light sensitivity; neurodegeneration; noise sensitivity; PTSD; Veterans	POSTTRAUMATIC-STRESS-DISORDER; BLAST EXPOSURE; HEAD-INJURY; MILD; SYMPTOMS; WAKE; IMPAIRMENT; VETERANS; OREXIN; QUESTIONNAIRE	Study Objectives: Sleep disturbances following traumatic brain injury (TBI) in Veterans are very common and often persist as chronic sequelae. In addition, sensory sensitivity, ie, discomfort upon exposure to light and noise, is common after TBI. However, the relationship between sleep disturbances and sensory sensitivity in Veterans following TBI has not yet been examined, yet both are established early markers of neurodegeneration. Methods: Veterans (n = 95) in the chronic phase of recovery from TBI at the VA Portland Health Care System completed an overnight polysomnography and provided self-report data on sensory (eg, light and noise) sensitivity, and sleep disturbances. Participants were categorized into four sensory sensitivity groups: (1) "neither," neither light nor noise sensitivity (n = 36); (2) "light," only light sensitivity (n = 12); (3) "noise," only noise sensitivity (n = 24); and (4) "both," light and noise sensitivity (n = 23). Results: Veterans with TBI reported sleep disturbances that were significantly correlated with the severity of their sensory sensitivity and associated with posttraumatic stress disorder (PTSD). Multiple linear regression revealed insomnia severity to be the strongest predictor of the relationship between sleep disturbances and sensory sensitivity. Furthermore, sensory sensitivity was associated with a higher mean heart rate during sleep, even after controlling for PTSD status. Conclusions: These data are the first to report the prevalence and association between sensory sensitivity and sleep disturbances in Veterans with TBI. These data also suggest that the underlying mechanism of the sleep-sensory relationship could be due in part to comorbid PTSD and autonomic nervous system hyperarousal.	[Elliott, Jonathan E.; Opel, Ryan A.; Weymann, Kris B.; Chau, Alex Q.; Papesh, Melissa A.; Callahan, Megan L.; Storzbach, Daniel; Lim, Miranda M.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P3-RD42, Portland, OR 97239 USA; [Elliott, Jonathan E.; Storzbach, Daniel; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Weymann, Kris B.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mailcode P3-RD42, Portland, OR 97239 USA.	lmir@ohsu.edu			VA Career Development Award [IK2 BX002712, IK1RX001820]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT002688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [UL1GM118964] Funding Source: NIH RePORTER	All authors have seen and approved this manuscript. Work for this study was performed at VA Portland Health Care System. This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, VA Career Development Award #IK2 BX002712, NIH EXITO Institutional Core, #UL1GM118964, and the Portland VA Research Foundation to M.M.L.; NIH T32 AT 002688 to J.E.E.; VA OAA Post-doctoral Nursing Research Fellowship to K.B.W.; VA OAA Advanced Research Fellowship in Polytrauma/TBI Rehabilitation and VA Career Development Award IK1RX001820 to M.A.P.. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The authors report no conflicts of interest.	Al-Ozairi A, 2015, J HEAD TRAUMA REHAB, V30, P283, DOI 10.1097/HTR.0000000000000043; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; JONSSON CO, 1967, ACTA NEUROL SCAND, V43, P158, DOI 10.1111/j.1600-0404.1967.tb05725.x; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lavie P, 2001, NEW ENGL J MED, V345, P1825, DOI 10.1056/NEJMra012893; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; McDonald JH., 2014, HDB BIOL STAT; Mellman TA, 2007, J TRAUMA STRESS, V20, P893, DOI 10.1002/jts.20246; Mollayeva T, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0744-z; Morin CM, 1993, INSOMNIA PSYCHOL ASS; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Omachi TA, 2011, ARTHRIT CARE RES, V63, pS287, DOI 10.1002/acr.20544; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Smith M. T., 2003, ARTHRITIS RHEUMATISM, V49, pS184, DOI DOI 10.1002/ART.11409; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Thomasy Hannah E., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P71, DOI 10.1016/j.nbscr.2016.03.001; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Weathers F.W., 1993, 9 ANN C ISTSS; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Weaver TE, 1997, SLEEP, V20, P835; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	57	9	10	0	3	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.		2018	14	7					1177	1186	PII jc-18-00033	10.5664/jcsm.7220			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HH8FA	WOS:000455966100012	29991430	Green Published, Bronze			2022-02-06	
J	Han, XJ; Huang, Q; Liu, L; Sha, XY; Hu, BH; Liu, HS				Han, Xinjia; Huang, Qian; Liu, Lei; Sha, Xiaoyan; Hu, Bihui; Liu, Huishu			Changes in the Expression of AQP4 and AQP9 in the Hippocampus Following Eclampsia-Like Seizure	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						eclampsia; aquaporin 4; aquaporin 9; hippocampus; neuronal death	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; UTERINE PERFUSION; NEURONAL DAMAGE; RAT-BRAIN; ADULT-RAT; AQUAPORIN-4; MODEL; PREECLAMPSIA; EDEMA	Eclampsia is a hypertensive disorder of pregnancy that is defined by the new onset of grand mal seizures on the basis of pre-eclampsia. Until now, the mechanisms underlying eclampsia were poorly understood. Brain edema is considered a leading cause of eclamptic seizures; aquaporins (AQP4 and AQP9), the glial water channel proteins mainly expressed in the nervous system, play an important role in brain edema. We studied AQP4 and AQP9 expression in the hippocampus of pre-eclamptic and eclamptic rats in order to explore the molecular mechanisms involved in brain edema. Using our previous animal models, we found several neuronal deaths in the hippocampal CA1 and CA3 regions after pre-eclampsia and that eclampsia induced more neuronal deaths in both areas by Nissl staining. In the current study, RT-PCR and Western blotting data showed significant upregulation of AQP4 and AQP9 mRNA and protein levels after eclamptic seizures in comparison to pre-eclampsia and at the same time AQP4 and AQP9 immunoreactivity also increased after eclampsia. These findings showed that eclamptic seizures induced cell death and that upregulation of AQP4 and AQP9 may play an important role in this pathophysiological process.	[Han, Xinjia; Huang, Qian; Liu, Lei; Sha, Xiaoyan; Hu, Bihui; Liu, Huishu] Guangzhou Med Univ, Dept Obstet, Guangzhou Women & Childrens Med Ctr, 9 Jinsui Rd, Guangzhou 510623, Guangdong, Peoples R China		Liu, HS (corresponding author), Guangzhou Med Univ, Dept Obstet, Guangzhou Women & Childrens Med Ctr, 9 Jinsui Rd, Guangzhou 510623, Guangdong, Peoples R China.	hanxj.gz@gmail.com; h.qian2018@gmail.com; laurylei618@gmail.com; xy.sha.gz@gmail.com; bihuihu@gmail.com; liuhuishu@gwcmc.org			National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [9681170594, 81701456]; Guangzhou Science and Technology Project [2016A020218002]	We thank Ruheena Javed (a postdoctoral fellow from Guangzhou Women and Children's Medical Center) for her contribution in checking the English language. This project was supported by the National Natural Sciences Foundation of China (9681170594 and 81701456) and the Guangzhou Science and Technology Project (2016A020218002).	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Chatterjee P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041884; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; de Vasconcelos AP, 2002, J CEREBR BLOOD F MET, V22, P196, DOI 10.1097/00004647-200202000-00007; DUDEK FE, 1990, NEUROSCI LETT, V120, P267, DOI 10.1016/0304-3940(90)90056-F; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Filippidis AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010055; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Haram K, 2000, Tidsskr Nor Laegeforen, V120, P1426; Hecht JL, 2017, HYPERTENS PREGNANCY, V36, P259, DOI 10.1080/10641955.2017.1329430; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089333; Hubbard JA, 2016, EXP NEUROL, V283, P85, DOI 10.1016/j.expneurol.2016.05.003; Johnson A.C., 2017, BRAIN BEHAV IMMUN, DOI [10. 1016/j. bbi. 2017. 07. 017 28739514, DOI 10.1016/J.BBI.2017.07.01728739514]; Kim JE, 2009, NEUROSCIENCE, V163, P781, DOI 10.1016/j.neuroscience.2009.07.028; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; LaMarca BBD, 2005, HYPERTENSION, V46, P1022, DOI 10.1161/01.HYP.0000175476.26719.36; Lee TS, 2004, ACTA NEUROPATHOL, V108, P493, DOI 10.1007/s00401-004-0910-7; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Li X., 2016, MOL NEUROBIOL, DOI [10. 1007/s12035-016-0278-4 27878553, DOI 10.1007/S12035-016-0278-427878553]; Li XL, 2016, BRAIN RES, V1642, P487, DOI 10.1016/j.brainres.2016.04.043; Lin TY, 2015, EUR J PHARMACOL, V755, P6, DOI 10.1016/j.ejphar.2015.02.041; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; Liu L, 2016, HYPERTENS RES, V39, P701, DOI 10.1038/hr.2016.53; Pohle W, 1997, SEIZURE-EUR J EPILEP, V6, P467, DOI 10.1016/S1059-1311(97)80022-2; Quick AM, 2005, FASEB J, V19, P170, DOI 10.1096/fj.04-1901hyp; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; Sendrowski K, 2013, PHARMACOL REP, V65, P555, DOI 10.1016/S1734-1140(13)71033-8; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Tchekalarova J, 2017, NEUROBIOL DIS, V104, P1, DOI 10.1016/j.nbd.2017.04.017; Walsh SK, 2009, HYPERTENSION, V54, P345, DOI 10.1161/HYPERTENSIONAHA.109.132191; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P3519, DOI 10.1152/jn.2000.83.6.3519; Yu H., 2016, GENET MOL RES, V15, DOI [10. 4238/gmr. 15039012 27706789, DOI 10.4238/GMR.1503901227706789]; Zeeman GG, 2004, AM J OBSTET GYNECOL, V190, P714, DOI 10.1016/j.ajog.2003.09.015	41	9	9	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2018	19	1							300	10.3390/ijms19010300			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	FV2OI	WOS:000424407200293	29351212	Green Published, gold, Green Submitted			2022-02-06	
J	Hill, JH; Bonner, P; O'Mara, MS; Wood, T; Lieber, M				Hill, Joshua H.; Bonner, Paul; O'Mara, M. Shay; Wood, Teresa; Lieber, Michael			Delayed intracranial hemorrhage in the patient with blunt trauma on anticoagulant or antiplatelet agents: routine repeat head computed tomography is unnecessary	BRAIN INJURY			English	Article						Intracranial hemorrhage; CT Scan; anticoagulation; blunt injury; trauma; neurotrauma	PREINJURY WARFARIN; INJURY; CLOPIDOGREL; PREDICTORS	Objective: We postulate that in patients with blunt trauma on anticoagulant or antiplatelet agents, incidence and complication rate of delayed intracranial hemorrhage (DICH) after an initially negative head CT is low and routine repeat head CT is not warranted.Design: A retrospective, observational study performed from 2008 to 2012.Patients: A total of 338 patients with blunt trauma with pre-admission history of any anticoagulant use, who had an initially negative head CT, followed by a repeat CT within 48hours.Interventions: There were no interventions, this was an observational study only.Measurements and main results: The sample had mean ISS of 8.6 and an average GCS of 15. 55% had obvious head trauma, 27.2% reported LOC. Incidence of DICH was 2.4% (8/338). All patients with DICH were taking aspirin (ASA) either alone or in combination with another anticoagulant. Of the eight patients with DICH, none required medical or surgical intervention and there were no mortalities. We identified no significant predictors of delayed ICH.Conclusions: Routine repeat head CT in patients with blunt trauma taking anticoagulant or antiplatelet agents is unnecessary. Incidence of DICH is low and, when found, DICH was clinically insignificant. We recommend close supervision in this population, especially those taking ASA alone or in combination with another anticoagulant.	[Hill, Joshua H.; O'Mara, M. Shay; Wood, Teresa; Lieber, Michael] OhioHlth Hosp, Grant Med Ctr, Trauma, Columbus, OH USA; [Bonner, Paul] OhioHlth Hosp, Doctors Hosp, PGY Gen Surg 2, Columbus, OH USA		Hill, JH (corresponding author), Grant Med Ctr, 111 South Grant Ave, Columbus, OH 43215 USA.	Joshua7938@gmail.com		Hill, Joshua/0000-0001-7729-0681			Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Muakkassa FF, 2012, J AM COLL SURGEONS, V214, P965, DOI 10.1016/j.jamcollsurg.2012.02.004; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Schuster R, 2005, AM SURGEON, V71, P701; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184	16	9	9	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					735	738		10.1080/02699052.2018.1441442			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200006	29485294				2022-02-06	
J	Iwaskiw, AS; Ott, KA; Armiger, RS; Wickwire, AC; Alphonse, VD; Voo, LM; Carneal, CM; Merkle, AC				Iwaskiw, A. S.; Ott, K. A.; Armiger, R. S.; Wickwire, A. C.; Alphonse, V. D.; Voo, L. M.; Carneal, C. M.; Merkle, A. C.			The measurement of intracranial pressure and brain displacement due to short-duration dynamic overpressure loading	SHOCK WAVES			English	Article						Postmortem human surrogate; Blast-induced traumatic brain injury; Brain motion; Intracranial pressure; Short-duration dynamic overpressure; Dynamic overpressure-induced kinematics; Shock tube	BLAST EXPOSURE; INJURY; MODEL; WAVE	The experimental measurement of biomechanical responses that correlate with blast-induced traumatic brain injury (bTBI) has proven challenging. These data are critical for both the development and validation of computational and physical head models, which are used to quantify the biomechanical response to blast as well as to assess fidelity of injury mitigation strategies, such as personal protective equipment. Therefore, foundational postmortem human surrogate (PMHS) experimental data capturing the biomechanical response are necessary for human model development. Prior studies have measured short-duration pressure transmission to the brain (Kinetic phase), but have failed to reproduce and measure the longer-duration inertial loading that can occur (Kinematic phase). Four fully instrumented PMHS were subjected to short-duration dynamic overpressure in front-facing and rear-facing orientations, where intracranial pressure (ICP), global head kinematics, and brain motion (as measured by high-speed X-ray) with respect to the skull were recorded. Peak ICP results generally increased with increased dose, and a mirrored pressure response was seen when comparing the polarity of frontal bone versus occipital bone ICP sensors. The head kinematics were delayed when compared to the pressure response and showed higher peak angles for front-facing tests as compared to rear-facing. Brain displacements were approximately 2-6 mm, and magnitudes did not change appreciably between front- and rear-facing tests. These data will be used to inform and validate models used to assess bTBI.	[Iwaskiw, A. S.; Ott, K. A.; Armiger, R. S.; Wickwire, A. C.; Alphonse, V. D.; Voo, L. M.; Carneal, C. M.; Merkle, A. C.] Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA		Iwaskiw, AS (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	alexander.iwaskiw@jhuapl.edu		Ott, Kyle/0000-0001-8974-7060; Armiger, Robert/0000-0002-3437-1884	US Army Medical Research and Materiel Command Office of Research Protections [W81XWH-09-2-0168]	This effort was funded by, and in accordance with, the US Army Medical Research and Materiel Command Office of Research Protections, contract # W81XWH-09-2-0168. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. The content included in this work does not necessarily reflect the position or policy of the US government. The authors would like to acknowledge Howard Conner for fabrication support, Brock Wester for testing support, and Joan Murphy and Jill Koehler for editorial contributions.	Anderson R., 1997, P INT IRCOBI C BIOM, P181; Armand M, 2010, J HOPKINS APL TECH D, V28, P214; Armiger RS, 2014, MECH BIOL SYSTEMS MA, V4, P127, DOI DOI 10.1007/978-3-319-00777-9_18; Bailey ZS, 2016, METHODS MOL BIOL, V1462, P119, DOI 10.1007/978-1-4939-3816-2_8; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Bir C., 2011, MEASURING BLAST RELA; Bowen I.G., 1968, ESTIMATE MANS TOLERA, P1; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M, 2010, TRAUMATIC BRAIN INJU; Fournier E., 2007, 2007234 CR; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Ganpule S, 2013, THESIS; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Haladuick T. N., 2012, HEAD KINEMATICS RESU; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Kraft RH, 2011, ARLTR5796; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Merkle A., 2012, PERS ARM SYST S NUR; Merkle AC, 2012, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, PTS A AND B, P663; Merkle AC, 2010, IFMBE PROC, V32, P22, DOI 10.1007/978-3-642-14998-6_6; Merkle AC, 2009, P ASME INT MECH ENG, P91, DOI DOI 10.1115/IMECE2009-11807; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Ott K. A., 2012, ANN C EXP APPL MECH, V1, P139, DOI [10.1007/978-1-4614-4238-7_18, DOI 10.1007/978-1-4614-4238-7_18]; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pratt V., 1987, ACM SIGGRAPH COMPUT, P145, DOI DOI 10.1145/37401.37420; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RICHMOND DR, 1968, ANN NY ACAD SCI, V152, P103, DOI 10.1111/j.1749-6632.1968.tb11970.x; Roberts J.C., 2013, IMECE201364821 ASME, DOI [10.1115/IMECE2013-64821, DOI 10.1115/IMECE2013-64821]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shreiber D. I, 1997, 973335 SAE, DOI [10.4271/973335, DOI 10.4271/973335]; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Sielicki P. W., 2016, EUR C COMP METH APPL; Singh D, 2012, EVALUATION HEAD RESP; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; TAN X, 2011, ASME 2011 INT MECH E, P71, DOI DOI 10.1115/IMECE2011-64331; Tan X.G., 2012, P INT MECH ENG C EXP, P821; Tashman S, 2003, J BIOMECH ENG-T ASME, V125, P238, DOI 10.1115/1.1559896; Walker L., 1973, STAPP CAR CRASH C CO, P525; Ward C., 1980, 801304 SAE, DOI [10.4271/801304, DOI 10.4271/801304]; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yang B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408278; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	57	9	9	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					63	83		10.1007/s00193-017-0759-z			21	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FU0TF	WOS:000423562600006					2022-02-06	
J	Lee, JB; Affeldt, BM; Gamboa, Y; Hamer, M; Dunn, JF; Pardo, AC; Obenaus, A				Lee, Jeong Bin; Affeldt, Bethann M.; Gamboa, Yaritxa; Hamer, Mary; Dunn, Jeff F.; Pardo, Andrea C.; Obenaus, Andre			Repeated Pediatric Concussions Evoke Long-Term Oligodendrocyte and White Matter Microstructural Dysregulation Distant from the Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Diffusion tensor imaging; Magnetic resonance imaging; OLIG2; APC; Mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; ANTERIOR COMMISSURE; CORPUS-CALLOSUM; MOUSE MODEL; ACUTE MILD; LINEAGE PROGRESSION; DIFFUSION; VULNERABILITY; MYELIN	Concussion or mild traumatic brain injury (mTBI) is often accompanied by long-term behavioral and neuropsychological deficits. Emerging data suggest that these deficits can be exacerbated following repeated injuries. However, despite the overwhelming prevalence of mTBI in children due to falls and sports-related activities, the effects of mTBI on white matter (WM) structure and its development in children have not been extensively examined. Moreover, the effect of repeated mTBI (rmTBI) on developing WM has not yet been studied, despite the possibility of exacerbated outcomes with repeat injuries. To address this knowledge gap, we investigated the long-term effects of single (s) mTBI and rmTBI on the WM in the pediatric brain, focusing on the anterior commissure (AC), a WM structure distant to the injury site, using diffusion tensor imaging (DTI) and immunohistochemistry (IHC). We hypothesized that smTBI and rmTBI to the developing mouse brain would lead to abnormalities in microstructural integrity and impaired oligodendrocyte (OL) development. We used a postnatal day 14 Ascl1-CreER: ccGFP mouse closed head injury (CHI) model with a bilateral repeated injury. We demonstrate that smTBI and rmTBI differentially lead to myelin-related diffusion changes in the WM and to abnormal OL development in the AC, which are accompanied by behavioral deficits 2 months after the initial injury. Our results suggest that mTBIs elicit long-term behavioral alterations and OL-associated WM dysregulation in the developing brain. These findings warrant additional research into the development of WM and OL as key components of pediatric TBI pathology and potential therapeutic targets. (C) 2018 S. Karger AG, Basel	[Lee, Jeong Bin; Affeldt, Bethann M.; Gamboa, Yaritxa; Hamer, Mary; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Dunn, Jeff F.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Pardo, Andrea C.] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Obenaus, Andre] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA		Obenaus, A (corresponding author), Univ Calif Irvine, Dept Pediat, Hewitt Hall,Rm 2066, Irvine, CA 92697 USA.	obenausa@uci.edu	; Pardo, Andrea/B-4836-2017	, Andre/0000-0003-0081-6950; Pardo, Andrea/0000-0001-7767-8539	Loma Linda University Department of Pediatrics; Loma Linda University; Brain Canada platform grant	We would like to acknowledge the Loma Linda University Department of Pediatrics for support and Dr. Jane Johnson for generously providing experimental animals. This work was supported by Loma Linda University Grants to Promote Collaborative and Translational Research (GCAT) to A.C.P. and A.O. The Experimental Imaging Centre was supported by a Brain Canada platform grant.	Affeldt BM, 2017, INT J DEV NEUROSCI, V61, P1, DOI 10.1016/j.ijdevneu.2017.05.001; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bolton JL, 2018, BIOL PSYCHIAT, V83, P137, DOI 10.1016/j.biopsych.2017.08.023; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Chang EH, 2017, NEUROIMAGE, V147, P253, DOI 10.1016/j.neuroimage.2016.11.068; Choi H, 2011, SCHIZOPHR RES, V130, P78, DOI 10.1016/j.schres.2011.04.016; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; DEMETER S, 1988, HUM NEUROBIOL, V6, P219; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Di Virgilio G, 1999, EXP BRAIN RES, V124, P1, DOI 10.1007/s002210050593; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; FORAN DR, 1992, J NEUROSCI, V12, P4890; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hernandez A, 2016, J NEUROCHEM, V136, P18, DOI 10.1111/jnc.13402; Huang L, 2016, MED GAS RES, V6, P187, DOI 10.4103/2045-9912.196900; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lotocki G, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2010.0011; Mabrouk OS, 2014, J NEUROSCI METH, V233, P129, DOI 10.1016/j.jneumeth.2014.05.004; MacKenzie-Graham A, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00019; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meier U, 2006, PHARM STAT, V5, P253, DOI 10.1002/pst.210; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nagy B, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001993; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Pastell M., 2016, J OPEN SOURCE SOFTW, V4, pE15, DOI [10.5334/jors.113, DOI 10.5334/JORS.113]; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Peuskens D, 2004, NEUROSURGERY, V55, P1174, DOI 10.1227/01.NEU.0000140843.62311.24; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; STURROCK RR, 1975, J ANAT, V119, P67; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Tsai HH, 2016, SCIENCE, V351, P379, DOI 10.1126/science.aad3839; Wendel KM, 2019, J NEUROTRAUM, V36, P152, DOI 10.1089/neu.2018.5670; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Winter TJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00432; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	89	9	9	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2018	40	4					358	375		10.1159/000494134			18	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	HF3XR	WOS:000454168300007	30466074				2022-02-06	
J	Li, R; Sahu, S; Schachner, M				Li, Rong; Sahu, Sudhanshu; Schachner, Melitta			Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						L1; phenelzine; mouse; spinal cord injury; inflammation; regeneration	AUTOIMMUNE ENCEPHALOMYELITIS EAE; MAO INHIBITOR PHENELZINE; TRAUMATIC BRAIN-INJURY; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; DRUG PHENELZINE; IN-VIVO; MICE; NEUROPROTECTION; EXPRESSION	Background: Neural cell adhesion molecule L1 contributes to nervous system development and maintenance by promoting neuronal survival, neuritogenesis, axonal regrowth/sprouting, myelination, and synapse formation and plasticity. L1 also enhances recovery after spinal cord injury and ameliorates neurodegenerative processes in experimental rodent models. Aiming for clinical translation of L1 into therapy we screened for and functionally characterized in vitro the small organic molecule phenelzine, which mimics characteristic L1 functions. Objective: The present study was designed to evaluate the potential of this compound in vivo in a mouse model of spinal cord injury. Methods and Results: In mice, intraperitoneal injection of phenelzine immediately after severe thoracic compression, and thereafter once daily for 6 weeks, improved hind limb function, reduced astrogliosis and promoted axonal regrowth/sprouting at 4 and 5 weeks after spinal cord injury compared to vehicle control-treated mice. Phenelzine application upregulated Ll expression in the spinal cord and stimulated the cognate L1-mediated intracellular signaling cascades in the spinal cord tissue. Phenelzine-treated mice showed decreased levels of pro-inflammatory cytokines, such as interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in the injured spinal cord during the acute phase of inflammation. Conclusions: This study provides new insights into the role of phenelzine in L1-mediated neural functions and modulation of inflammation. The combined results raise hopes that phenelzine may develop into a therapeutic agent for nervous system injuries.	[Li, Rong; Sahu, Sudhanshu; Schachner, Melitta] Shantou Univ Med Coll, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA		Schachner, M (corresponding author), Shantou Univ Med Coll, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn	Sahu, Sudhanshu Sekhar/M-2678-2019	RONG, LI/0000-0003-1828-5713	Li Kashing Foundation	We are very grateful to Professor Junhui Bian, Dean of Shantou University Medical College, and Dr. Frieda Law, advisor to the Li Kashing Foundation, for support. We thank Dr. StanleyLi Lin for some editing. This work was funded by the Li Kashing Foundation.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; Baker Glen B., 1992, Journal of Psychiatry and Neuroscience, V17, P206; BARBEAU H, 1991, BRAIN RES, V546, P250, DOI 10.1016/0006-8993(91)91489-N; Barbin G, 2004, NEURON GLIA BIOL, V1, P65, DOI [10.1017/S1740925X04000092, 10.1017/s1740925x04000092]; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Benson CA, 2013, BEHAV BRAIN RES, V252, P302, DOI 10.1016/j.bbr.2013.06.019; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Fehlings MG, 2008, J NEUROSURG-SPINE, V8, P205, DOI 10.3171/SPI/2008/8/3/205; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Guo Y, 2011, EXP THER MED, V2, P1133, DOI 10.3892/etm.2011.339; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Hayashi Y, 2010, EXP NEUROL, V221, P68, DOI 10.1016/j.expneurol.2009.10.003; Hofstetter HH, 2005, CLIN EXP IMMUNOL, V142, P39, DOI 10.1111/j.1365-2249.2005.02901.X; Huang WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066613; Irintchev A, 2012, NEUROSCIENTIST, V18, P452, DOI 10.1177/1073858411419047; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; JOHNSON MR, 1995, DRUGS, V49, P328, DOI 10.2165/00003495-199549030-00002; Kataria H, 2016, MOL NEUROBIOL, V53, P4461, DOI 10.1007/s12035-015-9352-6; Lavdas AA, 2011, CURR GENE THER, V11, P90; Lee HJ, 2012, J NEUROTRAUM, V29, P1850, DOI 10.1089/neu.2011.2290; Levesque M, 2013, DIS MODEL MECH, V6, P508, DOI 10.1242/dmm.010371; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Lutz D, 2016, MOL NEUROBIOL, V53, P3360, DOI 10.1007/s12035-015-9277-0; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959; Menzel L, 2016, ACTA NEUROPATHOL, V132, P703, DOI 10.1007/s00401-016-1607-4; Michael-Titus AT, 2000, NEUROSCIENCE, V100, P681, DOI 10.1016/S0306-4522(00)00390-0; Musgrave T, 2011, BRAIN BEHAV IMMUN, V25, P1677, DOI 10.1016/j.bbi.2011.06.011; Pan HC, 2014, NEUROSCIENCE, V277, P356, DOI 10.1016/j.neuroscience.2014.06.069; Parent MB, 2002, BIOCHEM PHARMACOL, V63, P57, DOI 10.1016/S0006-2952(01)00856-5; Paslawski T, 1996, PSYCHOPHARMACOLOGY, V127, P19, DOI 10.1007/BF02805970; Paslawski T, 2001, DRUG DEVELOP RES, V54, P35, DOI 10.1002/ddr.1202; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Poplawski GHD, 2012, MOL CELL NEUROSCI, V50, P169, DOI 10.1016/j.mcn.2012.03.010; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sahu S, 2018, MOL NEUROBIOL, V55, P859, DOI 10.1007/s12035-016-0254-z; Schmid RS, 2000, J NEUROSCI, V20, P4177; Simonini MV, 2010, J NEUROIMMUNE PHARM, V5, P252, DOI 10.1007/s11481-009-9182-2; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Wang Y, 2015, J NEUROCHEM, V133, P828, DOI 10.1111/jnc.13083; Wu B, 2012, EXP NEUROL, V237, P274, DOI 10.1016/j.expneurol.2012.07.016; Yin J, 2006, J NEUROIMMUNOL, V181, P68, DOI 10.1016/j.jneuroim.2006.08.004; Yoo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057415; Zhou SY, 2000, J APPL PHYSIOL, V89, P1528, DOI 10.1152/jappl.2000.89.4.1528	59	9	9	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2018	36	4					469	483		10.3233/RNN-170808			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO0CI	WOS:000439587600003	29889084				2022-02-06	
J	Meng, XG; Li, N; Zhang, Y; Fan, DF; Yang, C; Li, H; Guo, DZ; Pan, SY				Meng, Xiangen; Li, Na; Zhang, Yu; Fan, Danfeng; Yang, Chen; Li, Hang; Guo, Dazhi; Pan, Shuyi			BENEFICIAL EFFECT OF B-ELEMENE ALONE AND IN COMBINATION WITH HYPERBARIC OXYGEN IN TRAUMATIC BRAIN INJURY BY INFLAMMATORY PATHWAY	TRANSLATIONAL NEUROSCIENCE			English	Article						beta-elemene; Hyperbaric oxygen; Traumatic brain injury; Inflammation pathway	CHEMOKINES; ACTIVATION	Background: Present study evaluates the neuroprotective effect of beta-elemene alone and in combination with hyperbaric oxygen (HO) in traumatic brain injury (TBI). Methodology: TBI was induced by dropping a weight from a specific height. All the animals were separated in to five groups (n=20) like control group; TBI group; beta-elemene treated group which receives beta-elemene (100 mg/kg, i.p.) half an hour after the injury; HO group which receives hyperbaric oxygen therapy and beta-elemene + HO group which receives beta-elemene (100 mg/kg, i.p.) half an hour after the injury and hyperbaric oxygen therapy. Neurological function was assessed to evaluate the effect of beta-elemene in TBI rats. Thereafter level of inflammatory cytokines and expression of protein of inflammatory pathway was assessed in the brain tissues of TBI rats. In addition TUNEL assay was also done for the determination apoptosis in neuronal cells. Result: Data of the report reveals that beta-elemene alone and in combination with hyperbaric oxygen (HO) significantly decreases the neurological score Compared to TBI group. Moreover level of inflammatory cytokines and expression of LTR4 and casepase 3 significantly decrease and increase in the expression of IkB in beta-elemene alone and in combination with hyperbaric oxygen (HO) treated group compared to TBI group. Data of TUNEL assay also reveals that beta-elemene treated group shows significant decrease in the TUNEL positive cells and apoptosis index compared to TBI group. Conclusion: Thus present study concludes the neuroprotective effect of beta-elemene against TBI and it shows synergistic effect on TBI when treated with HO.	[Meng, Xiangen; Li, Na; Zhang, Yu; Fan, Danfeng; Yang, Chen; Li, Hang; Guo, Dazhi; Pan, Shuyi] Navy Gen Hosp, Dept Hyperbr Oxygen, Beijing 100048, Peoples R China		Pan, SY (corresponding author), Navy Gen Hosp, Dept Hyperbr Oxygen, Beijing 100048, Peoples R China.	CraigqSmithff@yahoo.com					Fang YY, 2018, FITOTERAPIA, V124, P92, DOI 10.1016/j.fitote.2017.10.015; Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang ZY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00105; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lakshmi S, 2011, INT J MED CHEM, V2011, DOI 10.1155/2011/253962; Liu J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-183; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Zhang RW, 2010, INT IMMUNOPHARMACOL, V10, P738, DOI 10.1016/j.intimp.2010.04.003; Zhang Y, 2013, INT J MOL SCI, V14, P10075, DOI 10.3390/ijms140510075; Zhong Y, 2015, CHIN J NAT MEDICINES, V13, P415, DOI 10.1016/S1875-5364(15)30034-0; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	15	9	9	0	3	DE GRUYTER POLAND SP ZOO	WARSAW	BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2018	9	1					33	37		10.1515/tnsci-2018-0007			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB0MN	WOS:000450707700001	29992051	gold, Green Published			2022-02-06	
J	Odgaard, L; Pedersen, AR; Poulsen, I; Johnsen, SP; Nielsen, JF				Odgaard, L.; Pedersen, A. R.; Poulsen, I.; Johnsen, S. P.; Nielsen, J. F.			Return to work predictors after traumatic brain injury in a welfare state	ACTA NEUROLOGICA SCANDINAVICA			English	Article						competing risk regression; functional abilities; labour market attachment; rehabilitation trajectories; return to work; socio-economic factors; traumatic brain injury	QUALITY-OF-LIFE; AGE INDIVIDUALS; FOLLOW-UP; EMPLOYMENT; MODERATE; REHABILITATION; POPULATION; DISABILITY; STABILITY; DENMARK	ObjectiveTo identify predictors of return to work (RTW) and stable labour market attachment (LMA) after severe traumatic brain injury (TBI) in Denmark. Materials & methodsPatients aged 18-64years, admitted to highly specialized neurorehabilitation after severe TBI 2004-2012 were included and followed up for 6years. Weekly LMA data were retrieved from a national register of public assistance benefits. Weeks without or with supplemental public assistance benefits were defined as LMA weeks. Time of RTW was defined as first week with LMA. Stable LMA was defined as weeks with LMA 75% first year after RTW. Multivariable regressions were used to identify predictors of RTW and stable LMA among preinjury characteristics, injury severity, functional ability and rehabilitation trajectories. ResultsFor the analyses of RTW and stable LMA, 651 and 336 patients were included, respectively. RTW was significantly associated with age (adjusted subhazard ratio 0.98, 95% CI 0.97-0.99), education (1.83, 95% CI 1.16-2.89), supplemental benefits (3.97, 95% CI 2.04-7.71), no benefits (4.86, 95% CI 2.90-8.17), length of stay in acute care (0.77, 95% CI 0.60-0.99) and time period of injury (1.56, 95% CI 1.15-2.10). The only significant predictor of stable LMA was age (adjusted odds ratio 0.97, 95% CI 0.95-0.99). ConclusionRTW after severe TBI was associated with several socio-economic factors, whereas maintaining LMA depended on age only. We suggest that RTW rates could be improved by extensive rehabilitation targeting people that are older and low-educated, as these were less likely to RTW.	[Odgaard, L.; Pedersen, A. R.; Nielsen, J. F.] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Odgaard, L.; Pedersen, A. R.; Nielsen, J. F.] Aarhus Univ, Univ Res Clin, Aarhus, Denmark; [Poulsen, I.] Rigshosp, Dept Neurorehabil, TBI & Res Unit Brain Injury Rehabil RUBRIC, Copenhagen, Denmark; [Johnsen, S. P.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark		Odgaard, L (corresponding author), Hammel Neurorehabil Ctr, Hammel, Denmark.; Odgaard, L (corresponding author), Univ Res Clin, Hammel, Denmark.	lene.odgaard@midt.rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Poulsen, ingrid/AAH-2052-2019; Odgaard, Lene/AAF-1909-2020	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Poulsen, ingrid/0000-0002-0342-017X; Odgaard, Lene/0000-0002-9830-3282			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; ARANGOLASPRILLA. J, 2011, PM R, V3, P1083; ARANGOLASPRILLA. J, 2009, PM R, V1, P41; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Economics A., 2009, EC COST SPINAL CORD, pCanberra; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Ministry of Employment, DAN LAB MARK; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Odgaard L, 2017, BRAIN INJURY, V31, P1298, DOI 10.1080/02699052.2017.1312017; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Stubbs PW, 2014, DISABIL REHABIL, V36, P2278, DOI 10.3109/09638288.2014.904935; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vrangbaek K, 2010, LOCAL GOV STUD, V36, P205, DOI 10.1080/03003930903560562; WHO, INT CLASS DIS ICD	36	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	2018	137	1					44	50		10.1111/ane.12806			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FO7CW	WOS:000417029600008	28758673				2022-02-06	
J	Ritchie, EV; Emery, C; Debert, CT				Ritchie, E. V.; Emery, C.; Debert, C. T.			Analysis of serum cortisol to predict recovery in paediatric sport-related concussion	BRAIN INJURY			English	Article						Fluid biomarkers; neuroendocrine dysfunction; athletes; sport-related concussion; cortisol	TRAUMATIC BRAIN-INJURY; REPETITIVE HEAD TRAUMA; PITUITARY DYSFUNCTION; DIABETES-INSIPIDUS; CHILDREN; HYPOPITUITARISM; BLOOD	Objective: To study the relationship between acute serum cortisol following pediatric sport-related concussion (SRC) and clinical outcome measures of symptom burden and length to return to sport (RTS)Methods: Prospective observational study of ice hockey players ages 11-12 recruited prior to the hockey season. Players sustaining a SRC were assessed by a sports medicine physician completed a child Sport Concussion Assessment Tool-3 (childSCAT-3) and serum cortisol samples.Results: Of 636 ice hockey players enrolled, 41 sustained a SRC. In total, 22 serum cortisol samples were collected, with 14 (63.6%) meeting inclusion criteria. Four players presented with abnormally low cortisol and were more likely to experienced more symptoms (17.8 1.9 vs. 7.5 +/- 6.0) more severe symptoms (28.5 +/- 5.8 vs. 10.2. +/- 8.8) and took longer RTS (23 +/- 13.6 vs. 14.0.7 +/- 7.9.).Conclusion: Paediatric ice hockey players following SRC with abnormally low cortisol may be more susceptible to experiencing increase symptom burden and take longer to return to sport than players with population-based normal cortisol.	[Ritchie, E. V.; Debert, C. T.] Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, Calgary, AB, Canada; [Debert, C. T.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Emery, C.; Debert, C. T.] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada; [Emery, C.] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Debert, CT (corresponding author), Foothills Med Ctr, Special Serv Bldg,Main Floor Room AC 144, Calgary, AB T2N 2T9, Canada.	cdebert@ucalgary.ca	Emery, Carolyn/AAI-2761-2020	Debert, Chantel/0000-0002-2704-0438	Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This study was funded by the Canadian Institute of Health Research (CIHR).	Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Dambinova SA, 2013, MIL MED, V178, P285, DOI 10.7205/MILMED-D-12-00368; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hutchison MG, 2016, J HEAD TRAUMA REHAB, P1; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; Langelier DM, 2017, CLIN J SPORT MED, P1; Maes M, 1997, CLIN ENDOCRINOL, V46, P587, DOI 10.1046/j.1365-2265.1997.1881002.x; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; RICOS C, 1990, ANN CLIN BIOCHEM, V27, P353, DOI 10.1177/000456329002700412; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P811, DOI 10.1007/s00421-012-2503-9; Shahim P, 2016, J NEUROTRAUMA; Shahim P, 2014, JAMA NEUROL, V71, P926, DOI 10.1001/jamaneurol.2014.1160; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586	36	9	9	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					523	528		10.1080/02699052.2018.1429662			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400017	29400570	Green Submitted			2022-02-06	
J	Ross, PE; Di Stefano, M; Charlton, J; Spitz, G; Ponsford, JL				Ross, Pamela E.; Di Stefano, Marilyn; Charlton, Judith; Spitz, Gershon; Ponsford, Jennie L.			Interventions for resuming driving after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Head injury; automobile driving; occupational therapy; on-road training; licence restrictions; driver rehabilitation	DRIVER REHABILITATION; SIMULATOR SICKNESS; FITNESS; RETURN; PERFORMANCE; ISSUES; IMPAIRMENT; CLINICIAN; AWARENESS; CLIENTS	Purpose: To describe the goals, processes, resources and outcomes of on-road training lessons provided to drivers with traumatic brain injury (TBI) who failed an initial occupational therapy (OT) driver assessment. Method: Descriptive cohort study using file audit design of 340 drivers with mild to severe TBI. Measures included; number and goals of on-road training lessons and reassessments, time from injury to independent driving, license restrictions, years licensed, physical/visual impairments and injury severity. Results: Initial OT driver assessment was passed by 72% (n = 246) cases. Of the 28% (n = 94) who failed, 93% (n = 87) resumed driving following on-road training; 42 (45%) with an open licence, 45 (48%) with restricted licence and seven (7%) failed to meet licencing standards. Individuals required, on average, 7.0 driving lessons (14 driving instructor hours), and 2.5 on-road reassessments, (9.8 OT and 3.8 driving instructor hours). Lesson goals were recommended to develop compensatory strategies for cognitive impairments (64%), improve previously learned driving skills (57%), improve confidence (53%), and address physical (26%) or visual impairment (16%). Conclusions: Investment in on-road training lessons addressing individual goals, followed by reassessment and use of restricted licenses, can achieve successful return to driving following TBI.	[Ross, Pamela E.] Epworth HealthCare, Occupat Therapy Dept, Melbourne, Vic, Australia; [Di Stefano, Marilyn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia; [Charlton, Judith] Monash Univ, Monash Univ Accid Res Ctr, Melbourne, Vic, Australia; [Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Spitz, Gershon; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ross, PE (corresponding author), Epworth HealthCare, Occupat Therapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	pam.ross@epworth.org.au	; Spitz, Gershon/H-7755-2014	Charlton, Judith/0000-0002-5990-2151; Spitz, Gershon/0000-0002-7810-1480	RACV Sir Edmond Herring Memorial Scholarship	The corresponding author was awarded an RACV Sir Edmond Herring Memorial Scholarship in 2009.	Akinwuntan AE, 2014, ARCH PHYS MED REHAB, V95, P531, DOI 10.1016/j.apmr.2013.08.294; Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; Austroads, 2012, ASS FITN DRIV COMM P; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Brooks JO, 2010, ACCIDENT ANAL PREV, V42, P788, DOI 10.1016/j.aap.2009.04.013; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Classen S, 2014, OCCUP THER HEALTH CA, V28, P154, DOI 10.3109/07380577.2014.901590; Classen S, 2011, AM J OCCUP THER, V65, P179, DOI 10.5014/ajot.2011.000802; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Devos H, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.1535; Di Stefano M., 2006, DRIVER REHABILITATIO, P297, DOI [10.1016/B978-032302937-7.50019-8, DOI 10.1016/B978-032302937-7.50019-8]; Di Stefano M., 2006, DRIVER REHABILITATIO, P255, DOI DOI 10.1016/B978-032302937-7.50018-6; Di Stefano M, 2012, AUST OCCUP THER J, V59, P37, DOI 10.1111/j.1440-1630.2011.00990.x; Dickerson AE, 2014, OCCUP THER HEALTH CA, V28, P194, DOI 10.3109/07380577.2014.903357; Dickerson AE, 2013, AM J OCCUP THER, V67, P564, DOI 10.5014/ajot.2013.007823; Dobbs AR, 1998, ACCIDENT ANAL PREV, V30, P363, DOI 10.1016/S0001-4575(97)00110-3; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Fleming J, 2014, NEUROREHABILITATION, V34, P157, DOI 10.3233/NRE-131012; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; George S, 2014, COCHRANE DB SYST REV, V2; Gooden JR, 2016, J HEAD TRAUMA REHAB, P13; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; JONES R, 1983, AM J OCCUP THER, V37, P754, DOI 10.5014/ajot.37.11.754; Klavora P, 2000, Can J Occup Ther, V67, P128; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Kreutzer JS, 2009, PM&R, V1, P723, DOI 10.1016/j.pmrj.2009.07.005; Lane A, 2011, OCCUP THER HLTH CARE, V28, P177; Liddle J, 2012, AUST OCCUP THER J, V59, P79, DOI 10.1111/j.1440-1630.2011.00978.x; Liddle J, 2011, DISABIL REHABIL, V33, P2574, DOI 10.3109/09638288.2011.582922; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; Marshall SC, 1999, CAN MED ASSOC J, V160, P1701; Mazer B, 2015, BRIT J OCCUP THER, V78, P369, DOI 10.1177/0308022614562401; Mazer BL, 2004, CRITICAL REV ARCH PH, V16, P291, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V16.I4.40; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; OT-Australia, 1998, COMP STAND OCC THER; Oxley J, 2010, ACCIDENT ANAL PREV, V42, P515, DOI 10.1016/j.aap.2009.09.017; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Ross P, 2015, DISABIL REHABIL, V32, P1; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schultheis MT, 2009, HANDBOOK FOR THE ASSESSMENT OF DRIVING CAPACITY, P1; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Unsworth CA, 2014, ACCIDENT ANAL PREV, V71, P106, DOI 10.1016/j.aap.2014.04.017; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; VicRoads, 2008, GUID OCC THER OT DRI	52	9	9	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	7					757	764		10.1080/09638288.2016.1274341			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5XU	WOS:000426912400003	28129710				2022-02-06	
J	Senior, G; Piovesana, A; Beaumont, P				Senior, Graeme; Piovesana, Adina; Beaumont, Patricia			Discrepancy analysis and Australian norms for the Trail Making Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Discrepancy analysis; Trail Making Test; norms; neuropsychology	TRAUMATIC BRAIN-INJURY; EXECUTIVE CONTROL; CLINICAL UTILITY; NORMATIVE DATA; TEST INDEXES; PART-B; SCORES	Objective: Discrepancy analyses refer to comparison methods that evaluate the relationship or differences between two measures in the same individual. A common type of discrepancy analysis involves the comparison of two trials within a measure, such as, Trails A and B of the Trail Making Test (TMT). The TMT is well-suited to this role as the two measures are highly correlated, assess similar underlying constructs, and most importantly demonstrate differential vulnerability to the impact of pathology. While the inclusion of these types of data in the form of difference scores or ratios has become more frequent, this information has been presented only for demographically adjusted subgroups and has not taken into account the level of performance of the comparison trial, Trails A. Method: The role and advantages of discrepancy analysis with the TMT stratified by level of Trails A performance were demonstrated with an Australian normative sample of 647 participants and a heterogeneous clinical sample consisting of 2,292 Australian and U.S. cases. Results: The ability to differentiate between the influence of slowed visual scanning and/or graphomotor speed, and reduced mental flexibility was demonstrated by applying the normative data to clinical case discrepancies. The importance of accounting for the variability in discrepancy scores associated with the level of performance of Trails A was also highlighted. Conclusion: A simple, efficient, and effective approach to examining the basis for differences between TMT-A and TMT-B performances is provided to examine the relative contributions of perceptual/motor abilities, and mental flexibility.	[Senior, Graeme] Univ Southern Queensland, Ctr Psychol Assessment, Ipswich, Qld, Australia; [Piovesana, Adina] Univ Southern Queensland, Sch Psychol & Counselling, Ipswich, Qld, Australia; [Beaumont, Patricia] Univ Southern Queensland, Sch Psychol & Counselling, Toowoomba, Qld, Australia		Senior, G (corresponding author), Univ Southern Queensland, Ctr Psychol Assessment, Ipswich, Qld, Australia.	Graeme.Senior@usq.edu.au		Piovesana, Adina/0000-0001-8728-711X			Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arbuthnott K, 2000, CAN J EXP PSYCHOL, V54, P33, DOI 10.1037/h0087328; Bezdicek O, 2012, ARCH CLIN NEUROPSYCH, V27, P906, DOI 10.1093/arclin/acs084; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Delis DC., 2001, DELIS KAPLAN EXECUTI; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Golden CJ, 1978, STROOP COLOR WORD TE; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jarvis PE., 1994, HALSTEAD REITAN NEUR; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lange R., 2000, THESIS; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; Nelson H.E., 1982, NATL ADULT READING T; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Psychological Corporation, 2002, WECHSLER INDIVIDUAL; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REISCHIES FM, 1995, J CLIN PSYCHOL, V51, P252, DOI 10.1002/1097-4679(199503)51:2<252::AID-JCLP2270510215>3.0.CO;2-S; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan R., 1979, MANUAL ADM NEUROPSYC; Rey A., 1964, EXAMEN CLIN PSYCHOL; Siegert RJ, 1997, NEW ZEAL J PSYCHOL, V26, P25; Smith A., 1991, SYMBOL DIGIT MODALIT; Spreen O, 1991, COMPENDIUM NEUROPSYC; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1939, MEASUREMENT ADULT IN, DOI [10.1037/10020-000, DOI 10.1037/10020-000]; Wechsler D., 2008, WECHSLER ADULT INTEL	36	9	9	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	3					510	523		10.1080/13854046.2017.1357756			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FZ4KL	WOS:000427561000012	28752789				2022-02-06	
J	Slopien, R; Pluchino, N; Warenik-Szymankiewicz, A; Sajdak, S; Luisi, M; Drakopoulos, P; Genazzani, AR				Slopien, Radoslaw; Pluchino, Nicola; Warenik-Szymankiewicz, Alina; Sajdak, Stefan; Luisi, Michele; Drakopoulos, Panagiotis; Genazzani, Andrea R.			Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause	GYNECOLOGICAL ENDOCRINOLOGY			English	Article						Allopregnanolone; depression; menopause	TRAUMATIC BRAIN-INJURY; FEMALE RATS; SERUM ALLOPREGNANOLONE; NEUROACTIVE STEROIDS; MAJOR DEPRESSION; TEMPORAL CORTEX; MENSTRUAL-CYCLE; RATING-SCALE; NEUROSTEROIDS; PROGESTERONE	Objectives: This observational, cross-sectional study included 140 women with climacteric symptoms. The aim of the study was to evaluate the correlation between the presence and severity of depressive symptoms and allopregnanolone levels in women during late menopausal transition and early postmenopause.Methods: The study group was divided into two groups: 45 women in late menopausal transition and 95 early postmenopausal women. We evaluated Kupperman index, Hamilton scale and serum follicle-stimulating hormone, luteinizing hormone, 17-estradiol, prolactin, total testosterone, dehydroepiandrosterone sulfate and allopregnanolone levels.Results: We found that serum allopregnanolone concentration was lower in early postmenopausal women compared to women in late menopausal transition; that there was a correlation between serum allopregnanolone levels in early postmenopausal women and time since last menstruation, intensity of climacteric symptoms, and intensity of depression symptoms and that there was a correlation between serum allopregnanolone levels and several depression symptoms presence (shallow sleep and symptoms of the digestive tract in women during late menopause transition; feelings of guilt, sleep disorders and general somatic symptoms in early postmenopausal women).Conclusion: We concluded that reproductive aging is characterized by a reduction of allopregnanolone circulating levels that correlate to Hamilton depression index in early postmenopause and presence of specific depressive symptoms during late menopausal transition and early postmenopause.	[Slopien, Radoslaw; Warenik-Szymankiewicz, Alina] Poznan Univ Med Sci, Dept Gynecol Endocrinol, Ul Polna 33, PL-60535 Poznan, Poland; [Pluchino, Nicola] Univ Hosp Geneva, Dept Obstet & Gynecol, Geneva, Switzerland; [Sajdak, Stefan] Poznan Univ Med Sci, Dept Operat Gynecol, Poznan, Poland; [Luisi, Michele; Genazzani, Andrea R.] Univ Pisa, Dept Obstet & Gynecol, Pisa, Italy; [Drakopoulos, Panagiotis] Univ Hosp Brussels, Ctr Reprod Med, Brussels, Belgium		Slopien, R (corresponding author), Poznan Univ Med Sci, Dept Gynecol Endocrinol, Ul Polna 33, PL-60535 Poznan, Poland.	asrs@wp.pl	Drakopoulos, Panagiotis/AAH-4057-2019	Drakopoulos, Panagiotis/0000-0002-9262-785X; Sajdak, Stefan/0000-0002-8641-4188	Polish Committee of Scientific ResearchPolish State Committee for Scientific Research	This work was supported by Polish Committee of Scientific Research.	Andreen L, 2005, PSYCHONEUROENDOCRINO, V30, P212, DOI 10.1016/j.psyneuen.2004.07.003; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; BALLINGER CB, 1975, BRIT MED J, V3, P344, DOI 10.1136/bmj.3.5979.344; Barbaccia ML, 2000, PSYCHONEUROENDOCRINO, V25, P659, DOI 10.1016/S0306-4530(00)00017-2; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; Bernardi F, 2003, GYNECOL ENDOCRINOL, V17, P65, DOI 10.1080/713603176; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bromberger JT, 2010, ARCH GEN PSYCHIAT, V67, P598, DOI 10.1001/archgenpsychiatry.2010.55; Charalampopoulos I, 2008, TRENDS ENDOCRIN MET, V19, P300, DOI 10.1016/j.tem.2008.07.004; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Eser D, 2006, NEUROENDOCRINOLOGY, V84, P244, DOI 10.1159/000097879; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; FRYE CA, 1994, BRAIN RES, V643, P194, DOI 10.1016/0006-8993(94)90025-6; Frye CA, 2010, J SEX MED, V7, P2670, DOI 10.1111/j.1743-6109.2010.01814.x; Genazzani AR, 2005, CNS SPECTRUMS, V10, P449, DOI 10.1017/S1092852900023142; Genazzani AR, 1998, J CLIN ENDOCR METAB, V83, P2099, DOI 10.1210/jc.83.6.2099; GENAZZANI AR, 1995, EUR J ENDOCRINOL, V133, P375, DOI 10.1530/eje.0.1330375; Glantz LA, 2010, SCHIZOPHR RES, V118, P292, DOI 10.1016/j.schres.2009.12.027; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harlow SD, 2012, J CLIN ENDOCR METAB, V97, P1159, DOI 10.1210/jc.2011-3362; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Johansson IM, 2002, BRAIN RES, V934, P125, DOI 10.1016/S0006-8993(02)02414-9; Kehoe P, 2000, DEV BRAIN RES, V124, P133, DOI 10.1016/S0165-3806(00)00106-1; Khisti RT, 1998, NEUROSCI LETT, V251, P85, DOI 10.1016/S0304-3940(98)00479-0; Korneyev A, 1996, HORM BEHAV, V30, P37, DOI 10.1006/hbeh.1996.0006; Kraepelin E., 1921, MANIC DEPRESSIVE INS; KUPPERMAN HS, 1953, J CLIN ENDOCR METAB, V13, P688, DOI 10.1210/jcem-13-6-688; Lancel M, 1997, J PHARMACOL EXP THER, V282, P1213; Maartens LWF, 2002, MATURITAS, V42, P195, DOI 10.1016/S0378-5122(02)00038-5; MELCANGI RC, 1993, ENDOCRINOLOGY, V132, P1252, DOI 10.1210/en.132.3.1252; Miller M N, 2001, Psychopharmacol Bull, V35, P135; MOK WM, 1993, STEROIDS, V58, P112; Nappi RE, 2003, J SEX MARITAL THER, V29, P95, DOI 10.1080/713847135; Nappi RE, 2001, OBSTET GYNECOL, V97, P77, DOI 10.1016/S0029-7844(00)01112-1; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Petralia SM, 2005, PSYCHOPHARMACOLOGY, V178, P174, DOI 10.1007/s00213-004-2001-9; Petratos S, 2000, DEV BRAIN RES, V123, P81, DOI 10.1016/S0165-3806(00)00076-6; Pinna G, 2009, CURR OPIN PHARMACOL, V9, P24, DOI 10.1016/j.coph.2008.12.006; Pisu MG, 2004, LIFE SCI, V74, P3181, DOI 10.1016/j.lfs.2003.12.002; Rapkin AJ, 2006, FERTIL STERIL, V85, P1371, DOI 10.1016/j.fertnstert.2005.10.031; Riedel M, 2010, J PSYCHIATR RES, V44, P1063, DOI 10.1016/j.jpsychires.2010.03.006; ROBEL P, 1994, TRENDS ENDOCRIN MET, V5, P1, DOI 10.1016/1043-2760(94)90114-7; Santoru F, 2014, PSYCHOPHARMACOLOGY, V231, P3351, DOI 10.1007/s00213-014-3539-9; Slopien R, 2003, MATURITAS, V46, P255, DOI 10.1016/S0378-5122(03)00144-0; Slopien R, 2008, MATURITAS, V61, P252, DOI 10.1016/j.maturitas.2008.08.002; Stoffel-Wagner B, 2001, EUR J ENDOCRINOL, V145, P669, DOI 10.1530/eje.0.1450669; Stoffel-Wagner B, 2003, EPILEPSY RES, V54, P11, DOI 10.1016/S0920-1211(03)00036-6; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; Vaccarino Anthony L, 2016, Innov Clin Neurosci, V13, P20; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208	51	9	9	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0951-3590	1473-0766		GYNECOL ENDOCRINOL	Gynecol. Endocrinol.		2018	34	2					144	147		10.1080/09513590.2017.1371129			4	Endocrinology & Metabolism; Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism; Obstetrics & Gynecology	FU2WQ	WOS:000423711100015	28857628				2022-02-06	
J	Stewman, CG; Liebman, C; Fink, L; Sandella, B				Stewman, Chaney G.; Liebman, Catherine; Fink, Laura; Sandella, Brad			Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						ADHD; athletes; NCAA; concussion; pharmacologic treatment	AMERICAN MEDICAL SOCIETY; EXERTIONAL HEAT ILLNESS; TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; HIGH-SCHOOL; CONCUSSION; ADHD; SPORT; STATEMENT; SYMPTOMS	Context: Attention deficit hyperactivity disorder (ADHD) is a common psychiatric condition in the general population, with evidence suggesting that it may be more common among athletes. Evidence Acquisition: Literature searches were performed on PubMed, MEDLINE, and Cochrane databases for the years 2000 to 2016 utilizing the following key search terms: ADHD, ADD, guidelines, diagnosis, athlete, sports, treatment, pharmacotherapy, stimulants, risk, cardiovascular effects, concussion, and traumatic brain injury (TBI). Study Design: Clinical review. Results: ADHD exists among athletes at all levels of play, and symptomatology overlaps significantly with that of concussion. Treatment with stimulants has cardiovascular effects and may not be permitted by the athlete's governing body. An athlete's level of competition and individual cardiovascular risk factors may therefore affect medication choices. Conclusion: ADHD diagnosis and treatment are paramount to optimal quality of life and functioning in affected individuals. Pharmacologic treatment options should not specifically be avoided in athletes; however, stimulant use is an independent risk factor for heat illness. Concussion, a common athletic injury, may have an altered course in those affected by ADHD, specifically with regard to neurocognitive testing and recovery.	[Stewman, Chaney G.] Univ Delaware, Christiana Care Hlth Syst, Newark, DE USA; [Liebman, Catherine] Univ Penn, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA; [Fink, Laura] St Alphonsus Med Grp, Dept Family Med, Boise, ID USA; [Sandella, Brad] Christiana Care Hlth Syst, Associate Lead Musculoskeletal Serv Line, Newark, DE USA		Sandella, B (corresponding author), Christiana Care Hlth Syst, Associate Lead Musculoskeletal Serv Line, 1400 North Washington St, Wilmington, DE 19801 USA.	bsandella@christianacare.org					Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Alosco ML, 2012, INT J ATHL THER TRAI, V17, P22, DOI 10.1123/ijatt.17.5.22; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Biederman J, 2009, PEDIATRICS, V124, P71, DOI 10.1542/peds.2008-3347; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Broshek DK, 2005, CLIN SPORT MED, V24, P663, DOI 10.1016/j.csm.2005.04.005; Conant-Norville DO, 2005, CLIN SPORT MED, V24, P829, DOI 10.1016/j.csm.2005.05.007; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Drezner JA, 2016, CLIN J SPORT MED, V26, P347, DOI [10.1097/JSM.0000000000000382, 10.1136/bjsports-2016-096781]; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gillberg C, 2004, EUR CHILD ADOLES PSY, V13, P80, DOI 10.1007/s00787-004-1008-4; Gokcen C, 2013, INT J PSYCHIAT MED, V46, P169, DOI 10.2190/PM.46.2.d; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howe AS, 2007, AM J SPORT MED, V35, P1384, DOI 10.1177/0363546507305013; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kerr ZY, 2013, AM J PREV MED, V44, P8, DOI 10.1016/j.amepre.2012.09.058; Kiluk BD, 2009, J ATTEN DISORD, V12, P499, DOI 10.1177/1087054708320400; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Kutcher JS, 2011, CURR SPORT MED REP, V10, P32, DOI 10.1249/JSR.0b013e3182091d79; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKune A.J., 2003, S AFR J SPORTS MED, V15, P17, DOI [DOI 10.17159/2078-516X/2003/v15i3a223, 10.17159/2078-516X/2003/v15i3a223]; Meeusen R, 2006, SPORTS MED, V36, P881, DOI 10.2165/00007256-200636100-00006; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Parr JW, 2011, CLIN SPORT MED, V30, P591, DOI 10.1016/j.csm.2011.03.007; Perrin AE, 2014, J FAM PRACTICE, V63, pE1; Perrin JM, 2008, PEDIATRICS, V122, P451, DOI 10.1542/peds.2008-1573; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Roelands B, 2008, MED SCI SPORT EXER, V40, P879, DOI 10.1249/MSS.0b013e3181659c4d; SAWKA MN, 1992, J APPL PHYSIOL, V73, P368, DOI 10.1152/jappl.1992.73.1.368; Seixas M, 2012, J PSYCHOPHARMACOL, V26, P753, DOI 10.1177/0269881111412095; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; Wilens TE, 2006, PEDIATRICS, V118, P1215, DOI 10.1542/peds.2006-0942; Wilens TE, 2006, J PSYCHOPHARMACOL, V20, P580, DOI 10.1177/0269881105058776; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	45	9	10	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2018	10	1					40	46		10.1177/1941738117742906			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FQ4DC	WOS:000418306800006	29144831	Green Published			2022-02-06	
J	Thomas, ML; Brown, GG; Gur, RC; Moore, TM; Patt, VM; Risbrough, VB; Baker, DG				Thomas, Michael L.; Brown, Gregory G.; Gur, Ruben C.; Moore, Tyler M.; Patt, Virginie M.; Risbrough, Victoria B.; Baker, Dewleen G.			A signal detection-item response theory model for evaluating neuropsychological measures	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Assessment; item response theory; neuropsychology; recognition memory; signal detection theory; traumatic brain injury	WORKING-MEMORY; CONSTRUCT-VALIDITY; PERFORMANCE; SCHIZOPHRENIA; ASSOCIATION; VALIDATION; ATTENTION; DEMENTIA; BATTERY; TESTS	Introduction: Models from signal detection theory are commonly used to score neuropsychological test data, especially tests of recognition memory. Here we show that certain item response theory models can be formulated as signal detection theory models, thus linking two complementary but distinct methodologies. We then use the approach to evaluate the validity (construct representation) of commonly used research measures, demonstrate the impact of conditional error on neuropsychological outcomes, and evaluate measurement bias. Method: Signal detection-item response theory (SD-IRT) models were fitted to recognition memory data for words, faces, and objects. The sample consisted of U.S. Infantry Marines and Navy Corpsmen participating in the Marine Resiliency Study. Data comprised item responses to the Penn Face Memory Test (PFMT; N = 1,338), Penn Word Memory Test (PWMT; N = 1,331), and Visual Object Learning Test (VOLT; N = 1,249), and self-report of past head injury with loss of consciousness. Results: SD-IRT models adequately fitted recognition memory item data across all modalities. Error varied systematically with ability estimates, and distributions of residuals from the regression of memory discrimination onto self-report of past head injury were positively skewed towards regions of larger measurement error. Analyses of differential item functioning revealed little evidence of systematic bias by level of education. Conclusions: SD-IRT models benefit from the measurement rigor of item response theory-which permits the modeling of item difficulty and examinee ability-and from signal detection theory-which provides an interpretive framework encompassing the experimentally validated constructs of memory discrimination and response bias. We used this approach to validate the construct representation of commonly used research measures and to demonstrate how non-optimized item parameters can lead to erroneous conclusions when interpreting neuropsychological test data. Future work might include the development of computerized adaptive tests and integration with mixture and random-effects models.	[Thomas, Michael L.; Brown, Gregory G.; Patt, Virginie M.; Risbrough, Victoria B.; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Thomas, Michael L.; Risbrough, Victoria B.; Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA USA; [Brown, Gregory G.] VA San Diego Healthcare Syst, VISN Mental Illness Res Educ & Clin Ctr MIRECC 22, San Diego, CA USA; [Gur, Ruben C.; Moore, Tyler M.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Patt, Virginie M.] San Diego State Univ, Dept Psychol, Univ Calif, San Diego, CA 92182 USA		Thomas, ML (corresponding author), UCSD Dept Psychiat, 9500 Gilman Dr MC, La Jolla, CA 92093 USA.	mlthomas@ucsd.edu	Baker, Dewleen/O-4957-2019; Gur, Ruben/K-1999-2019; Risbrough, Victoria/X-3344-2019	Baker, Dewleen/0000-0002-1736-9838; Gur, Ruben/0000-0002-9657-1996; Moore, Tyler/0000-0002-1384-0151	National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH089983, MH019112, MH096891, MH102420]; Dowshen Program for Neuroscience; Navy Bureau of Medicine and Surgery [N62645-11-C-4037]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RC2MH089983, T32MH019112, P50MH096891, K23MH102420] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institute of Mental Health (NIMH) [grant number MH089983], [grant number MH019112], [grant number MH096891], and [grant number MH102420]; the Dowshen Program for Neuroscience; and the Navy Bureau of Medicine and Surgery [grant number N62645-11-C-4037]	AERA APA and NCME, 2014, STAND ED PSYCH TEST; Basner M, 2015, AEROSP MED HUM PERF, V86, P942, DOI 10.3357/AMHP.4343.2015; Batchelder W.H, 2010, MEASURING PSYCHOL CO, P71, DOI [10.1037/12074-004, DOI 10.1037/12074-004]; Batchelder WH, 2013, PSYCHOL BULL, V139, P1204, DOI 10.1037/a0033894; Brown GG, 2007, J ABNORM PSYCHOL, V116, P741, DOI 10.1037/0021-843X.116.4.741; Brown GG, 2017, CLIN NEUROPSYCHOL, V31, P1047, DOI 10.1080/13854046.2017.1334829; Brown GG, 2016, J CLIN EXP NEUROPSYC, V38, P59, DOI 10.1080/13803395.2015.1087467; Budson AE, 2006, NEUROPSYCHOLOGIA, V44, P2222, DOI 10.1016/j.neuropsychologia.2006.05.024; CAMILLI G, 1994, J EDUC BEHAV STAT, V19, P293, DOI 10.3102/10769986019003293; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chalmers P. R., 2011, J STAT SOFTW, V6, P1; CHAPMAN LJ, 1973, PSYCHOL BULL, V79, P380, DOI 10.1037/h0034541; Cohen AS, 2005, J EDUC MEAS, V42, P133, DOI 10.1111/j.1745-3984.2005.00007; Conners C. K., 1994, CONNERS CONTINUOUS P; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; De Ayala RJ, 2017, J SCHOOL PSYCHOL, V60, P25, DOI 10.1016/j.jsp.2016.01.002; De Ayala RJ., 2009, THEORY PRACTICE ITEM; De Boeck P., 2004, EXPLANATORY ITEM RES, DOI [10.1007/978-1-4757-3990-9, DOI 10.1007/978-1-4757-3990-9]; DeCarlo LT, 2011, J MATH PSYCHOL, V55, P229, DOI 10.1016/j.jmp.2011.01.002; DeCarlo LT, 1998, PSYCHOL METHODS, V3, P186, DOI 10.1037/1082-989X.3.2.186; Delis D.C., 2000, CALIFORNIA VERBAL LE; Embretson S.E., 2013, ITEM RESPONSE THEORY; Embretson SE, 1998, PSYCHOL METHODS, V3, P380, DOI 10.1037/1082-989X.3.3.380; Embretson SE, 1999, NEW RULES MEASUREMEN; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Green D.M., 1966, SOCIETY; Gur RC, 2001, NEUROPSYCHOPHARMACOL, V25, P766, DOI 10.1016/S0893-133X(01)00278-0; Gur RC, 2010, J NEUROSCI METH, V187, P254, DOI 10.1016/j.jneumeth.2009.11.017; Haynes S. N., 2011, SCI FDN CLIN ASSESSM; Irani F, 2012, AM J GERIAT PSYCHIAT, V20, P41, DOI 10.1097/JGP.0b013e3182051a7d; Jahn DR, 2015, J CLIN EXP NEUROPSYC, V37, P229, DOI 10.1080/13803395.2014.1002757; Jez SJ, 2014, RES HIGH EDUC, V55, P710, DOI 10.1007/s11162-014-9332-0; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kenzik KM, 2015, NEUROPSYCHOLOGY, V29, P31, DOI 10.1037/neu0000095; Kim BS, 2017, PSYCHIAT INVEST, V14, P126, DOI 10.4306/pi.2017.14.2.126; Kornbrot DE, 2006, PERCEPT PSYCHOPHYS, V68, P393, DOI 10.3758/BF03193685; Lewandowsky S., 2011, COMPUTATIONAL MODELI, DOI [10.4135/9781483349428, DOI 10.4135/9781483349428]; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Li YL, 2016, ARCH CLIN NEUROPSYCH, V31, P365, DOI 10.1093/arclin/acw017; LOCKHART RS, 1970, PSYCHOL BULL, V74, P100, DOI 10.1037/h0029536; Lord F.M., 1980, APPL ITEM RESPONSE T; Luce R. D., 1963, HDB MATH PSYCHOL, P103; Luce RD, 1959, INDIVIDUAL CHOICE BE, DOI DOI 10.1037/H0043178; Madsen H., 2011, INTRO GEN GEN LINEAR; McDonald R, 1999, TEST THEORY UNIFIED; Millsap R. E., 2011, STAT APPROACHES MEAS; Mislevy RJ, 2008, ADVANCES IN LATENT VARIABLE MIXTURE MODELS, P149; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moore TM, 2015, NEUROPSYCHOLOGY, V29, P235, DOI 10.1037/neu0000093; Mungas D, 2000, STAT MED, V19, P1631, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1631::AID-SIM451>3.0.CO;2-P; Mungas D, 2000, NEUROPSYCHOLOGY, V14, P209, DOI 10.1037//0894-4105.14.2.209; Patt VM, 2018, ARCH CLIN NEUROPSYCH, V33, P79, DOI 10.1093/arclin/acx043; Pazzaglia AM, 2013, PSYCHOL BULL, V139, P1173, DOI 10.1037/a0033044; Pedraza O, 2011, ARCH CLIN NEUROPSYCH, V26, P434, DOI 10.1093/arclin/acr042; Reckase MD, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-89976-3_1; Reise SP, 2009, ANNU REV CLIN PSYCHO, V5, P27, DOI 10.1146/annurev.clinpsy.032408.153553; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Sporns O., 2011, NETWORKS BRAIN; Teresi Jeanne A, 2009, Psychol Sci Q, V51, P148; Thomas M. L., 2018, ADV APPL ITEM UNPUB; Thomas ML, 2017, J ABNORM PSYCHOL, V126, P312, DOI 10.1037/abn0000256; Thomas ML, 2015, J CLIN EXP NEUROPSYC, V37, P653, DOI 10.1080/13803395.2015.1042358; Thomas ML, 2013, J CLIN EXP NEUROPSYC, V35, P225, DOI 10.1080/13803395.2012.762974; van der Maas HLJ, 2011, PSYCHOL REV, V118, P339, DOI 10.1037/a0022749; vansder Linden W. J., 2010, ELEMENTS ADAPTIVE TE; Wang M, 2017, APPL PSYCH MEAS, V41, P17, DOI 10.1177/0146621616668014; WHITELY SE, 1983, PSYCHOL BULL, V93, P179, DOI 10.1037/0033-2909.93.1.179; Wickens TD, 2002, ELEMENTARY SIGNAL DE; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; YEN WM, 1993, J EDUC MEAS, V30, P187, DOI 10.1111/j.1745-3984.1993.tb00423.x	72	9	9	1	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	8					745	760		10.1080/13803395.2018.1427699			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GU2MD	WOS:000445103200001	29402152	Green Accepted			2022-02-06	
J	Vissoci, JRN; Hertz, J; El-Gabri, D; Do Nascimento, JRA; De Oliveira, LP; Mmbaga, BT; Mvungi, M; Staton, CA				Vissoci, Joao Ricardo Nickenig; Hertz, Julian; El-Gabri, Deena; Andrade Do Nascimento, Jose Roberto; De Oliveira, Leonardo Pestillo; Mmbaga, Blandina Theophil; Mvungi, Mark; Staton, Catherine A.			Cross-Cultural Adaptation and Psychometric Properties of the AUDIT and CAGE Questionnaires in Tanzanian Swahili for a Traumatic Brain Injury Population	ALCOHOL AND ALCOHOLISM			English	Article							ALCOHOL-USE-DISORDERS; IDENTIFICATION-TEST AUDIT; PROBLEM DRINKING; SUBSTANCE USE; SCREENING TOOL; SOUTH-AFRICA; HAZARDOUS DRINKING; NORTHERN TANZANIA; TEST RELIABILITY; VALIDATION	Aims: To develop Swahili versions of the Alcohol Use Disorders Identification Test (AUDIT) and CAGE questionnaires and evaluate their psychometric properties in a traumatic brain injury (TBI) population in Tanzania. Methods: Swahili versions of the AUDIT and CAGE were developed through translation and back-translation by a panel of native speakers of both English and Swahili. The translated instruments were administered to a sample of Tanzanian adults from a TBI registry. The validity and reliability were analyzed using standard statistical methods. Results: The translated versions of both the AUDIT and CAGE questionnaires were found to have excellent language clarity and domain coherence. Reliability was acceptable (>0.85) for all tested versions. Confirmatory factor analysis of one, two and three factor solution for the AUDIT and one factor solution for the CAGE showed adequate results. AUDIT and CAGE scores were strongly correlated to each other (R > 0.80), and AUDIT scores were significantly lower in non-drinkers compared to drinkers. Conclusions: This article presents the first Swahili and Tanzanian adaptations of the AUDIT and CAGE instruments as well as the first validation of these questionnaires with TBI patients. Both instruments were found to have acceptable psychometric properties, resulting in two new useful tools for medical and social research in this setting.	[Vissoci, Joao Ricardo Nickenig; Hertz, Julian; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Surg, Duke Div Emergency Med, 2301 Erwin Rd, Durham, NC 27710 USA; [Vissoci, Joao Ricardo Nickenig; El-Gabri, Deena; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, 310 Trent Dr, Durham, NC 27710 USA; [Andrade Do Nascimento, Jose Roberto] Fed Univ Vale do Sao Francisco, Dept Phys Educ, Grad Program Phys Educ, Av Jose de Sa Manicoba, BR-56304917 Petrolina, PE, Brazil; [De Oliveira, Leonardo Pestillo] UNICESUMAR, Dept Hlth & Biol Sci, Grad Program Hlth Promot, Av Guedner 1610, BR-87050900 Maringa, Parana, Brazil; [Mmbaga, Blandina Theophil; Mvungi, Mark] Kilimanjaro Christian Med Ctr, Dept Pediat, Sokoini Rd, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Sokoini Rd, Moshi, Tanzania		Staton, CA (corresponding author), Duke Univ, Med Ctr, Duke Emergency Med, Durham, NC 27710 USA.	catherine.staton@duke.edu	OLIVEIRA, LEONARDO P/L-7300-2018; Oliveira, Leonardo/O-5281-2019; do Nascimento, Jose Roberto Andrade/L-2068-2017; Mmbaga, Blandina Theophil/AAR-8707-2021	OLIVEIRA, LEONARDO P/0000-0001-5278-0676; Oliveira, Leonardo/0000-0001-5278-0676; do Nascimento, Jose Roberto Andrade/0000-0003-3836-6967; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Staton, Catherine/0000-0002-6468-2894; Hertz, Julian/0000-0002-7396-4789	U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [T84HA21123-02]; Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000]; Duke Division of Emergency Medicine; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000] Funding Source: NIH RePORTER	This project was made possible by the Mentored Research Training Program in collaboration with the HRSA-funded KCMC MEPI grant # T84HA21123-02; U.S. National Institutes of Health and the Duke Division of Emergency Medicine. Dr Staton would like to acknowledge salary support provided by the Fogarty International Center of the National Institutes of Health under Award Number K01TW010000 (PI, Staton).	Adewuya AO, 2005, ALCOHOL ALCOHOLISM, V40, P575, DOI 10.1093/alcalc/agh197; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P77, DOI 10.1111/j.1600-0447.1999.tb10698.x; Almarri TSK, 2009, SUBST USE MISUSE, V44, P2001, DOI 10.3109/10826080902848533; de Torres LAP, 2009, EUR J GEN PRACT, V15, P15, DOI 10.1080/13814780902855754; Ao TTH, 2011, AIDS BEHAV, V15, P330, DOI 10.1007/s10461-010-9849-y; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bergman H, 2002, ALCOHOL ALCOHOLISM, V37, P245, DOI 10.1093/alcalc/37.3.245; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryce S, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000091; Carey KB, 2003, J CLIN PSYCHIAT, V64, P767, DOI 10.4088/JCP.v64n0705; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Claassen JN, 1999, S AFR MED J, V89, P976; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cremonte M, 2010, ADDICT BEHAV, V35, P818, DOI 10.1016/j.addbeh.2010.03.021; de Vellis RF, 2003, SCALE DEV THEORY APP, V2nd; Doyle SR, 2007, J STUD ALCOHOL DRUGS, V68, P474, DOI 10.15288/jsad.2007.68.474; Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473; Alvarado ME, 2009, REV MED CHILE, V137, P1463, DOI /S0034-98872009001100008; English Clayton, 2011, Pharm Pract (Granada), V9, P162; Erkut S, 2010, CHILD DEV PERSPECT, V4, P19, DOI 10.1111/j.1750-8606.2009.00111.x; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fekadu A, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0784-y; Ferreira-Borges C, 2016, TROP MED INT HEALTH, V21, P52, DOI 10.1111/tmi.12618; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Francis JM, 2014, TROP MED INT HEALTH, V19, P476, DOI 10.1111/tmi.12267; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Hair J.F., 2005, MULTIVARIATE DATA AN, V6th ed.; Hernandez-Nieto RA, 2002, CONTRIBUTIONS STAT A; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kallmen H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-672; Kanyoni Maurice, 2015, BMC Res Notes, V8, P190, DOI 10.1186/s13104-015-1148-2; Kawada T, 2011, ALCOHOL, V45, P205, DOI 10.1016/j.alcohol.2010.08.012; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P30, DOI 10.1111/j.1600-0447.1999.tb10691.x; Kline R. B, 2012, PRINCIPLES PRACTICE; Kuder GF, 1937, PSYCHOMETRIKA, V2, P151, DOI 10.1007/BF02288391; Kullgren G, 2009, AFR J PSYCHIATRY, V12, P52; Lancaster KE, 2016, INT J DRUG POLICY, V30, P124, DOI 10.1016/j.drugpo.2016.02.020; Lee MK., 1999, KOREAN J, V20, P1152; Leung SF, 2000, INT J NURS STUD, V37, P57, DOI 10.1016/S0020-7489(99)00052-8; Lhachimi SK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3299-z; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Mitsunaga T, 2008, J BIOSOC SCI, V40, P379, DOI 10.1017/S0021932007002441; Molina PE, 2015, ALCOHOL RES-CURR REV, V37, P263; Mongi AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084447; Moretti-Pires RO, 2011, CAD SAUDE PUBLICA, V27, P497, DOI 10.1590/S0102-311X2011000300010; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Nadkarni A, 2016, DRUG ALCOHOL DEPEN, V162, P107, DOI 10.1016/j.drugalcdep.2016.02.039; Namagembe I, 2010, MATERN CHILD HLTH J, V14, P492, DOI 10.1007/s10995-009-0500-3; Nayak MB, 2015, SUBST USE MISUSE, V50, P1579, DOI 10.3109/10826084.2015.1023458; Ogeil RP, 2016, ADDICTION, V111, P626, DOI 10.1111/add.13213; Okulate G T, 2005, Niger Postgrad Med J, V12, P77; OPIO CK, 2013, PAN AFR MED J, V15; Padilla MA, 2016, EDUC PSYCHOL MEAS, V76, P436, DOI 10.1177/0013164415593776; Pal HR, 2004, J STUD ALCOHOL, V65, P794, DOI 10.15288/jsa.2004.65.794; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Pengpid S, 2011, INT J ENV RES PUB HE, V8, P2629, DOI 10.3390/ijerph8072629; Popova S, 2016, ALCOHOL ALCOHOLISM, V51, P367, DOI 10.1093/alcalc/agv117; Pradhan B, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-42; Praud D, 2016, INT J CANCER, V138, P1380, DOI 10.1002/ijc.29890; Rist F, 2009, DRUG ALCOHOL DEPEN, V100, P71, DOI 10.1016/j.drugalcdep.2008.09.008; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schultheis Maria T, 2014, Curr Phys Med Rehabil Rep, V2, P176; Schwitters A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2516-5; Seth P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120850; Siegfried N, 2001, ALCOHOL ALCOHOLISM, V36, P243, DOI 10.1093/alcalc/36.3.243; So K, 2013, KOREAN J FAM MED, V34, P11, DOI 10.4082/kjfm.2013.34.1.11; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Thakarar K, 2016, AIDS BEHAV, V20, P2408, DOI 10.1007/s10461-016-1421-y; Tuliao AP, 2016, J ETHN SUBST ABUSE, V15, P127, DOI 10.1080/15332640.2015.1011731; Unsworth DJ, 2017, J CLIN EXP NEUROPSYC, V39, P547, DOI 10.1080/13803395.2016.1248812; Vissoci J, 2016, EFFECT PREMORBID MEN; Von Der Pahlen B, 2008, J STUD ALCOHOL DRUGS, V69, P616, DOI 10.15288/jsad.2008.69.616; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; Wandera B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126236; Weiss HA, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020153; What is a standard drink, 2017, WHAT IS STANDARD DRI; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organization, 2017, PROC TRANSL AD INSTR; Wu SI, 2008, ALCOHOL ALCOHOLISM, V43, P577, DOI 10.1093/alcalc/agn036; Young C, 2010, J CHILD ADOLESC MENT, V22, P15, DOI 10.2989/17280583.2010.493659; Younossi Z, 2016, GASTROENTEROLOGY, V150, P1778, DOI 10.1053/j.gastro.2016.03.005; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zetola NM, 2012, INT J TUBERC LUNG D, V16, P1529, DOI 10.5588/ijtld.12.0026	88	9	9	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0735-0414	1464-3502		ALCOHOL ALCOHOLISM	Alcohol Alcohol.	JAN	2018	53	1					112	120		10.1093/alcalc/agx058			9	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	FS2CO	WOS:000419586000017	29281046	Bronze, Green Published			2022-02-06	
J	Wang, Y; Guo, ZL; Fan, DH; Lu, HJ; Xie, D; Zhang, DH; Jiang, YT; Li, P; Teng, HJ				Wang, Yan; Guo, Zhiliang; Fan, Dehong; Lu, Haijiang; Xie, Dong; Zhang, Dahai; Jiang, Yongtian; Li, Pei; Teng, Haijun			A Meta-Analysis of the Influencing Factors for Tracheostomy after Cervical Spinal Cord Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							RISK-FACTORS; NEED; MORTALITY; PREDICTS; MODEL	Background. Traumatic cervical spinal cord injury (CSCI) is a common disease that has high complication, disability, and mortality rates and a poor prognosis. Tracheostomy is an important supportive therapy for patients with CSCI. However, a consensus on the predictive factors for tracheostomy after CSCI has not been reached. Objective. This meta-analysis study assessed the influencing factors for tracheostomy after CSCI. Methods. We searched for relevant studies on the influencing factors for tracheostomy after CSCI. The extracted data were analyzed using RevMan 5.3 software. We calculated the odds ratio (OR) or mean difference (MD) and 95% confidence intervals (CIs). Results. Sixteen eligible studies containing 9697 patients with CSCI were selected. The pooled OR (MD) and 95% CI of the influencing factors were as follows: age (mean +/- SD): -0.98 (-4.00 to 2.03), advanced age: 1.93 (0.80 to 4.63), sex (male): 1.29 (1.12 to 1.49), American Spinal Injury Association Impairment Scale (AIS) A grade: 7.79 (5.28 to 11.50), AIS B grade: 1.15 (1.13 to 2.02), AIS C grade: 0.28 (0.20 to 0.41), AIS D grade: 0.04 (0.02 to 0.09), neurological level of injury (upper CSCI): 2.36 (1.51 to 3.68), injury severity score (ISS): 8.97 (8.11 to 9.82), Glasgow Coma Scale (GCS) score <= 8: 6.03 (2.19 to 16.61), thoracic injury: 1.78 (1.55 to 2.04), brain injury: 0.96 (0.55 to 1.69), respiratory complications: 5.97 (4.03 to 8.86), smoking history: 1.45 (0.99 to 2.13), traffic accident injury: 1.27 (0.92 to 1.74), and fall injury: 0.72 (0.52 to 1.01). Conclusions. The current evidence shows that male sex, AIS A grade, AIS B grade, neurological level of injury (upper CSCI), high ISS, GCS <= 8, thoracic injury, and respiratory complications are risk factors for tracheostomy after CSCI, and AIS C grade and AIS D grade are protective factors. This study will allow us to use these factors for tracheostomy decisions and ultimately optimize airway management in patients with CSCI.	[Wang, Yan; Fan, Dehong; Lu, Haijiang] Weifang Med Univ, 288 Shengli St, Weifang 261000, Shandong, Peoples R China; [Guo, Zhiliang; Xie, Dong; Zhang, Dahai; Jiang, Yongtian; Teng, Haijun] 89 Hosp PLA, Dept Spine Surg 2, 256 Beigongxi St, Weifang 261000, Shandong, Peoples R China; [Li, Pei] 89 Hosp PLA, Dept Orthoped Surg, 256 Beigongxi St, Weifang 261000, Shandong, Peoples R China		Teng, HJ (corresponding author), 89 Hosp PLA, Dept Spine Surg 2, 256 Beigongxi St, Weifang 261000, Shandong, Peoples R China.; Li, P (corresponding author), 89 Hosp PLA, Dept Orthoped Surg, 256 Beigongxi St, Weifang 261000, Shandong, Peoples R China.	lipeizrj@163.com; tenghaijun89@163.com					Austin Naola, 2014, Int J Crit Illn Inj Sci, V4, P50, DOI 10.4103/2229-5151.128013; Berney S, 2011, SPINAL CORD, V49, P17, DOI 10.1038/sc.2010.39; Branco BC, 2011, J TRAUMA, V70, P111, DOI 10.1097/TA.0b013e3181d9a559; Childs BR, 2015, SPINE, V40, P1407, DOI 10.1097/BRS.0000000000001008; Dempsey GA, 2016, CRIT CARE MED, V44, P617, DOI 10.1097/CCM.0000000000001382; Durbin CG, 2010, RESP CARE, V55, P1056; Epstein Scott K, 2005, Respir Care, V50, P542; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; Hou YF, 2015, EUR SPINE J, V24, P975, DOI 10.1007/s00586-014-3731-y; Isah Muhammad D, 2017, Niger Postgrad Med J, V24, P1, DOI 10.4103/npmj.npmj_151_16; Jaeger J Michael, 2002, Respir Care, V47, P469; Ji Y. H, 2011, J CLIN EMERGENCY, V12, P309; Lee DS, 2017, EUR SPINE J, V26, P2333, DOI 10.1007/s00586-017-5104-9; Leelapattana P, 2012, J TRAUMA ACUTE CARE, V73, P880, DOI 10.1097/TA.0b013e318251fb34; Leng Yu-xin, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P294, DOI 10.3760/cma.j.issn.2095-4352.2013.05.014; Li Q., 2016, BEIJING MED J, V31, P28; McCully BH, 2014, AM J SURG, V207, P664, DOI 10.1016/j.amjsurg.2014.01.001; Menaker J, 2013, J TRAUMA ACUTE CARE, V75, P629, DOI 10.1097/TA.0b013e3182a12b86; Nakashima H, 2013, EUR SPINE J, V22, P1526, DOI 10.1007/s00586-013-2762-0; Neumann CR, 2009, J TRAUMA, V67, P67, DOI 10.1097/TA.0b013e3181aa63f3; Quesnel A, 2015, ANN PHYS REHABIL MED, V58, P74, DOI 10.1016/j.rehab.2014.12.004; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Roquilly A, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.11.021; Shao J., 2007, ORTHOPEDIC J CHINA, V15, P885; Shi TZ., 2015, J PRACTICAL MED, V31, P3750; Shirawi N, 2006, CRIT CARE, V10, DOI 10.1186/cc3828; Spinal Cord Injury (SCI), 2016, J SPINAL CORD MED, V39, P493, DOI [10.1080/10790268.2016.1210925, DOI 10.1080/10790268.2016.1210925]; Tanaka J, 2016, SPINE, V41, P764, DOI 10.1097/BRS.0000000000001317; [唐辉 Tang Hui], 2016, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V33, P1582; Velmahos GC, 2003, AM SURGEON, V69, P891; Xiao J, 2011, CHINESE MED J-PEKING, V124, P3327, DOI 10.3760/cma.j.issn.0366-6999.2011.20.022; Yugue I, 2012, SPINE, V37, pE1633, DOI 10.1097/BRS.0b013e31827417f1	32	9	9	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2018	2018								5895830	10.1155/2018/5895830			10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	GN7HJ	WOS:000439304000001	30112403	Green Published, Green Submitted, gold			2022-02-06	
J	Weiler, R; van Mechelen, W; Fuller, C; Ahmed, OH; Verhagen, E				Weiler, Richard; van Mechelen, Willem; Fuller, Colin; Ahmed, Osman Hassan; Verhagen, Evert			Do Neurocognitive SCAT3 Baseline Test Scores Differ Between Footballers (Soccer) Living With and Without Disability? A Cross-Sectional Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; neurocognitive testing; SCAT; disability sport	CONCUSSION ASSESSMENT-TOOL; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; REACTION-TIME; STATEMENT; INJURIES; PERFORMANCE; MANAGEMENT; BLINDNESS; CHILDREN	Objective: To determine if baseline Sport Concussion Assessment Tool, third Edition (SCAT3) scores differ between athletes with and without disability. Design: Cross-sectional comparison of preseason baseline SCAT3 scores for a range of England international footballers. Setting: Team doctors and physiotherapists supporting England football teams recorded players' SCAT 3 baseline tests from August 1, 2013 to July 31, 2014. Participants: A convenience sample of 249 England footballers, of whom 185 were players without disability (male: 119; female: 66) and 64 were players with disability (male learning disability: 17; male cerebral palsy: 28; male blind: 10; female deaf: 9). Assessment and Outcome Measures: Between-group comparisons of median SCAT3 total and section scores were made using nonparametric Mann-Whitney-Wilcoxon ranked-sum test. Main Results: All footballers with disability scored higher symptom severity scores compared with male players without disability. Male footballers with learning disability demonstrated no significant difference in the total number of symptoms, but recorded significantly lower scores on immediate memory and delayed recall compared with male players without disability. Male blind footballers' scored significantly higher for total concentration and delayed recall, and male footballers with cerebral palsy scored significantly higher on balance testing and immediate memory, when compared with male players without disability. Female footballers with deafness scored significantly higher for total concentration and balance testing than female footballers without disability. Conclusions: This study suggests that significant differences exist between SCAT3 baseline section scores for footballers with and without disability. Concussion consensus guidelines should recognize these differences and produce guidelines that are specific for the growing number of athletes living with disability.	[Weiler, Richard; van Mechelen, Willem] Vrije Univ Amsterdam, Amsterdam Collaborat Hlth & Safety Sports, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth,Med Ctr, Amsterdam, Netherlands; [Weiler, Richard; Fuller, Colin; Ahmed, Osman Hassan] FA Ctr Disabil Football Res, St Georges Pk, Burton Upon Trent, Staffs, England; [Weiler, Richard] UCL, Hosp NHS Fdn Trust, London, England; [Weiler, Richard] Fortius Clin, 17 Fitzhardinge St, London W1H 6EQ, England; [van Mechelen, Willem] Univ Queensland, Fac Hlth & Behav Sci, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [van Mechelen, Willem] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [van Mechelen, Willem] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med ESSM, Cape Town, South Africa; [Fuller, Colin] Colin Fuller Consultancy Ltd, Loughborough, England; [Ahmed, Osman Hassan] Bournemouth Univ, Fac Hlth & Social Sci, Bournemouth, Dorset, England; [Verhagen, Evert] Federat Univ Australia, Australian Ctr Res Injury Sport & Its Prevent, Ballarat, Vic, Australia		Weiler, R (corresponding author), Fortius Clin, 17 Fitzhardinge St, London W1H 6EQ, England.	rweiler@doctors.org.uk	Verhagen, Evert/A-1502-2013	Verhagen, Evert/0000-0001-9227-8234; van Mechelen, Willem/0000-0001-7136-6382			Ahmed OH, 2015, BRIT J SPORT MED, V49, P566, DOI 10.1136/bjsports-2013-093058; [Anonymous], 2011, WORLD REP DIS; Broglio SP, 2014, J ATHL TRAINING, V7, P7; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Dvorak J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.039362; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Emerson E, IMPROVING HLTH LIVES; English Federation of Disability Sport, PART IND SPORTS ACT; Fernhall Bo, 2008, J Health Hum Serv Adm, V30, P468; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; International Paralympic Committee, 2015, EXPL GUID PAR CLASS; International Paralympic Committee, 2012, LAYM GUID CLASS PAR; King AJ, 2015, CELL TISSUE RES, V361, P295, DOI 10.1007/s00441-015-2175-y; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Konicarova J, 2014, NEUROPSYCH DIS TREAT, V10, P85, DOI 10.2147/NDT.S56017; Majlesi M, 2014, RES DEV DISABIL, V35, P3562, DOI 10.1016/j.ridd.2014.09.001; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mitten MJ, 2002, JOHNS L REV, V76, P5; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Palmer Trish, 2006, Curr Sports Med Rep, V5, P323, DOI 10.1097/01.CSMR.0000306438.21359.13; Pasqualotto A, 2013, BEHAV BRAIN RES, V244, P162, DOI 10.1016/j.bbr.2013.02.005; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Schiftan GS, 2015, J SCI MED SPORT, V18, P238, DOI 10.1016/j.jsams.2014.04.005; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Webborn N., 2006, CLIN SPORTS MED; Webborn N, 2016, PM&R, V8, P545, DOI 10.1016/j.pmrj.2015.09.025; Weiler R, 2016, SPORTS MED, V46, P1141, DOI 10.1007/s40279-016-0478-0; World Health Organization, 2007, INT CLASS FUNCT DIS; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	40	9	9	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2018	28	1					43	50		10.1097/JSM.0000000000000407			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	GB0JM	WOS:000428732000008	28107219	Green Accepted			2022-02-06	
J	Yue, JK; Rick, JW; Morrissey, MR; Taylor, SR; Deng, HS; Suen, CG; Vassar, MJ; Cnossen, MC; Lingsma, HF; Yuh, EL; Mukherjee, P; Gardner, RC; Valadka, AB; Okonkwo, DO; Cage, TA; Manley, GT				Yue, John K.; Rick, Jonathan W.; Morrissey, Molly Rose; Taylor, Sabrina R.; Deng, Hansen; Suen, Catherine G.; Vassar, Mary J.; Cnossen, Maryse C.; Lingsma, Hester F.; Yuh, Esther L.; Mukherjee, Pratik; Gardner, Raquel C.; Valadka, Alex B.; Okonkwo, David O.; Cage, Tene A.; Manley, Geoffrey T.		TRACK-TBI Investigators	Preinjury employment status as a risk factor for symptomatology and disability in mild traumatic brain injury: A TRACK-TBI analysis	NEUROREHABILITATION			English	Article						Common data elements; comorbidities; mild traumatic brain injury; outcome measures; risk factors; unemployment	COMMON DATA ELEMENTS; POST-CONCUSSION SYMPTOMS; GLASGOW OUTCOME SCALE; SOCIOECONOMIC DISPARITIES; UNITED-STATES; HEALTH-CARE; TOBACCO USE; RECOMMENDATIONS; VALIDITY; ACCESS	BACKGROUND: Preinjury employment status may contribute to disparity, injury risk, and recovery patterns following mild traumatic brain injury (MTBI). OBJECTIVE: To characterize associations between preinjury unemployment, prior comorbidities, and outcomes following MTBI. METHODS: MTBI patients from TRACK-TBI Pilot with complete six-month outcomes were extracted. Preinjury unemployment, comorbidities, injury factors, and intracranial pathology were considered. Multivariable regression was performed for employment and outcomes, correcting for demographic and injury factors. Mean-differences (B) and 95% CIs are reported. Statistical significance was assessed at p < 0.05. RESULTS: 162 MTBI patients were aged 39.8 +/- 15.4-years and 24.6%-unemployed. Unemployed patients demonstrated increased psychiatric comorbidities (45.0%-vs.-23.8%;p = 0.010), drug use (52.5%-vs.-21.3%; p < 0.001), smoking (62.5%-vs.-27.0%; p < 0.001), prior TBI (78.4%-vs.-55.0%; p = 0.012), and lower education (15.0%-vs.-45.1% college degree; p = 0.003). On multivariable analysis, unemployment associated with decreased six-month functional outcome (Glasgow Outcome Scale-Extended: B = -0.50, 95% CI [-0.88, -0.11]), increased psychiatric disturbance (Brief Symptom Inventory-18: B = 6.22 [2.33, 10.10]), postconcussional symptoms (Rivermead Questionnaire: B = 4.91 [0.38, 9.44] ), and post-traumatic stress disorder (PTSD Checklist-Civilian: B = 5.99 [0.76, 11.22]). No differences were observed for cognitive measures or satisfaction with life. CONCLUSIONS: Unemployed patients are at risk for preinjury psychosocial comorbidities, poorer six-month functional recovery and increased psychiatric/postconcussional/PTSD symptoms. Resource allocation and return precautions should be implemented to mitigate and/or prevent the decline of at-risk patients.	[Yue, John K.; Rick, Jonathan W.; Morrissey, Molly Rose; Taylor, Sabrina R.; Deng, Hansen; Suen, Catherine G.; Vassar, Mary J.; Cage, Tene A.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Yue, John K.; Rick, Jonathan W.; Morrissey, Molly Rose; Taylor, Sabrina R.; Deng, Hansen; Suen, Catherine G.; Vassar, Mary J.; Yuh, Esther L.; Mukherjee, Pratik; Cage, Tene A.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Cnossen, Maryse C.; Lingsma, Hester F.; Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94110 USA; [Gardner, Raquel C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; [Gardner, Raquel C.] Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	Yue, John/P-1348-2015	Yue, John/0000-0001-9694-7722	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176 (to G.T.M.).	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bregman JA, 2013, J NEUROTRAUM, V30, pA53; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullard SE, 2013, ARCH CLIN NEUROPSYCH, V28, P92, DOI 10.1093/arclin/acs103; Burg JS, 2000, BRAIN INJURY, V14, P513; Butterworth P, 2012, SOC PSYCH PSYCH EPID, V47, P1013, DOI 10.1007/s00127-011-0409-1; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen J, 2016, MED CARE, V54, P140, DOI 10.1097/MLR.0000000000000467; CLOGG CC, 1983, SOC INDIC RES, V12, P117, DOI 10.1007/BF00318232; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Degenhardt L, 2001, Nicotine Tob Res, V3, P225; DeHay T, 2012, J BEHAV MED, V35, P139, DOI 10.1007/s10865-011-9336-6; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Evensen S, 2016, SCHIZOPHRENIA BULL, V42, P476, DOI 10.1093/schbul/sbv141; Fergusson DM, 2014, AUST NZ J PSYCHIAT, V48, P735, DOI 10.1177/0004867414525840; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Howell D. C, 2013, STAT METHODS PSYCHOL; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Licht AS, 2012, AM J PUBLIC HEALTH, V102, P1868, DOI 10.2105/AJPH.2012.300717; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Margerison-Zilko C, 2013, NICOTINE TOB RES, V15, P1161, DOI 10.1093/ntr/nts256; McGee RE, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140451; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Nunn J, 2008, EUR J DENT EDUC, V12, P30, DOI 10.1111/j.1600-0579.2007.00478.x; Olson-Madden JH, 2013, COMMUNITY MENT HLT J, V49, P220, DOI 10.1007/s10597-012-9572-4; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Quinones A. R., 2015, INTERVENTIONS REACH, DOI [10.1007/s40615-014-0078-3, DOI 10.1007/S40615-014-0078-3]; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; STRAIN JJ, 1990, INT J PSYCHIAT MED, V20, P227, DOI 10.2190/J9P9-GP13-HHVP-N5N5; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Weathers F.W., 1993, 9 ANN C ISTSS; Weber M, 2013, ARCH PSYCHIAT NURS, V27, P179, DOI 10.1016/j.apnu.2013.05.001; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	56	9	9	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	2					169	182		10.3233/NRE-172375			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS1MK	WOS:000443290000007	30040754				2022-02-06	
J	Zanin, AC				Zanin, Alaina C.			Structuring bodywork: control and agency in athlete injury discourse	JOURNAL OF APPLIED COMMUNICATION RESEARCH			English	Article						Structuration theory; discourse; resistance; athlete injury	STRUCTURATIONAL DIVERGENCE; ORGANIZATIONAL-COMMUNICATION; IRON CAGE; HEALTH; RESISTANCE; WORK; WORKPLACE; TRANSFORMATION; CONCUSSION; IDENTITY	This qualitative case study employs structuration theory to reveal d/Discourses in tension within athletic injury treatment and rehabilitation (i.e. a National Collegiate Athletic Association Division I football team). A thematic analysis exposed four concurrent discourses: injury heroism, injury recovery, athlete-centered care, and body commodification. These discourses created a structurational divergence nexus that enabled and constrained members. This nexus resulted in unintended consequences for the structuring of both injury disclosure and rehabilitation. Theoretical and practical implications of the findings are discussed as well as suggestions for practitioners in other bodywork and injury-prone organizations.	[Zanin, Alaina C.] Arizona State Univ, Hugh Downs Sch Human Commun, Tempe, AZ 85281 USA		Zanin, AC (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, Tempe, AZ 85281 USA.	alaina.zanin@asu.edu					Alvesson M, 2000, HUM RELAT, V53, P1125, DOI 10.1177/0018726700539002; Ashcraft KL, 2009, ACAD MANAG ANN, V3, P1, DOI 10.1080/19416520903047186; BARKER JR, 1993, ADMIN SCI QUART, V38, P408, DOI 10.2307/2393374; Boden Deirdre., 1994, BUSINESS TALK ORG AC; Brock S.C., 1994, QUAL HEALTH RES, V4, P411, DOI [DOI 10.1177/104973239400400405, 10.1177/104973239400400405]; Brown AD, 2015, ORGAN STUD, V36, P1315, DOI 10.1177/0170840615593594; Burawoy Michael, 1979, MANUFACTURING CONSEN; Carmack H. J., 2010, QUALITATIVE RES REPO, V11, P6, DOI [10.1080/17459430903413432, DOI 10.1080/17459430903413432]; Charmaz, 1991, GOOD DAYS BAD DAYS S; Clair Robin Patric, 1998, ORG SILENCE WORLD PO; CLAIR RP, 1994, WESTERN J COMM, V58, P235, DOI 10.1080/10570319409374499; Coupland C, 2015, ORGANIZATION, V22, P793, DOI 10.1177/1350508413517409; Creswell J.W ., 2007, QUAL INQ; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Davies K, 2003, SOCIOL HEALTH ILL, V25, P720, DOI 10.1046/j.1467-9566.2003.00367.x; Dick R, 2007, J ATHL TRAINING, V42, P173; Ellingson LL, 2009, ROUTLEDGE HANDBOOK OF APPLIED COMMUNICATION RESEARCH, P129; Epstein RM, 2005, SOC SCI MED, V61, P1516, DOI 10.1016/j.socscimed.2005.02.001; Geist-Martin P, 2011, ROUTL COMMUN SER, P117; Giddens A., 1984, CONSTITUTION SOC OUT; GIOIA DA, 1991, STRATEGIC MANAGE J, V12, P433, DOI 10.1002/smj.4250120604; Hartmann D., 2017, OXFORD HDB SPORTS HI, P15; Houston TK, 2011, J HEALTH COMMUN, V16, P686, DOI 10.1080/10810730.2011.551997; Hsieh E, 2016, QUAL HEALTH RES, V26, P1191, DOI 10.1177/1049732315589095; James EP, 2018, MANAGE COMMUN Q, V32, P60, DOI 10.1177/0893318917696990; Kerr S., 1995, ACAD MANAGEMENT EXEC, V9, P7, DOI DOI 10.2307/255378; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lindlof TR, 2017, QUALITATIVE COMMUNIC; Maitlis S, 2007, ACAD MANAGE J, V50, P57; MERRIAM SB, 2009, QUALITATIVE CASE STU, P39; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Michel A, 2011, ADMIN SCI QUART, V56, P325, DOI 10.1177/0001839212437519; Mumby DK, 2017, ORGAN STUD, V38, P1157, DOI 10.1177/0170840617717554; Murphy A. G., 1998, MANAGEMENT COMMUNICA, V11, P499, DOI DOI 10.1177/0893318998114001; National Collegiate Athletic Association, 2017, DAT DRIV DEC; Nicotera AM, 2015, MANAGE COMMUN Q, V29, P493, DOI 10.1177/0893318915585143; Nicotera AM, 2013, MANAGE COMMUN Q, V27, P90, DOI 10.1177/0893318912458214; Nicotera AM, 2010, J APPL COMMUN RES, V38, P362, DOI 10.1080/00909882.2010.514001; Nicotera AM, 2010, HEALTH COMMUN, V25, P32, DOI 10.1080/10410230903473516; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Olufowote JO, 2008, HEALTH COMMUN, V23, P292, DOI 10.1080/10410230802056404; PEIRCE Ch. S., 1979, COLLECTED PAPERS CS, V7-8; Petraglia J, 2007, J HEALTH COMMUN, V12, P493, DOI 10.1080/10810730701441371; Prasad P, 2000, ORGAN SCI, V11, P387, DOI 10.1287/orsc.11.4.387.14597; Putnam LL, 2016, ACAD MANAG ANN, V10, P65, DOI 10.1080/19416520.2016.1162421; Reichertz J., 2014, SAGE HDB QUALITATIVE, P153; Reichertz J., 2007, SAGE HDB GROUNDED TH, P214, DOI DOI 10.4135/9781848607941.N10; Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI [10.1177/1525-822X02239569, DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; SEWELL WH, 1992, AM J SOCIOL, V98, P1, DOI 10.1086/229967; Thornberg R, 2014, SAGE HDB QUALITATIVE, P153; TOMPKINS PK, 1985, ORG COMMUNICATION TR, V13, P179; Tracy S.J., 2013, QUALITATIVE RES METH; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; WANG C, 1992, SOC SCI MED, V35, P1093, DOI 10.1016/0277-9536(92)90221-B; White P.G., 1995, MENS HLTH ILLNESS GE, P158; Wolkowitz C, 2002, WORK EMPLOY SOC, V16, P497, DOI 10.1177/095001702762217452; Young, 2004, SPORTING BODIES DAMA, P59; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; ZOLLER H. M., 2014, SAGE HDB ORG COMMUNI, P595; Zoller HM, 2003, J APPL COMMUN RES, V31, P118, DOI 10.1080/0090988032000064588	63	9	9	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0090-9882	1479-5752		J APPL COMMUN RES	J. Appl. Commun. Res.		2018	46	3					267	290		10.1080/00909882.2018.1465578			24	Communication	Social Science Citation Index (SSCI)	Communication	GH9GN	WOS:000433977600001					2022-02-06	
J	Zhao, J; Huynh, J; Hylin, MJ; O'Malley, JJ; Perez, A; Moore, AN; Dash, PK				Zhao, Jing; Huynh, Jonathan; Hylin, Michael J.; O'Malley, John J.; Perez, Alec; Moore, Anthony N.; Dash, Pramod K.			Mild Traumatic Brain Injury Reduces Spine Density of Projection Neurons in the Medial Prefrontal Cortex and Impairs Extinction of Contextual Fear Memory	JOURNAL OF NEUROTRAUMA			English	Article						concussion; fear extinction; medial prefrontal cortex; post-traumatic stress disorder; PTSD	INFRALIMBIC CORTEX; CONDITIONED FEAR; HIPPOCAMPAL; AMYGDALA; EXPRESSION; ABSENCE	Epidemiology studies have found that a comorbidity exists between traumatic brain injury (TBI) and stress-related disorders. However, the anatomical and cellular bases for this association is poorly understood. An inability to extinguish the memory of a traumatic event lies at the core of many stress-related disorders. Experimental studies have shown that the medial pre-frontal cortex (mPFC), especially the infralimbic (IL) cortex, is required for extinction and for storing the memory of extinction. The output from the central nucleus of amygdala projects to the lateral hypothalamus, paraventricular nucleus, and central gray to regulate heart rate, stress hormone release, and freezing behavior, respectively. Projection neurons of the IL (layers II/III pyramidal neurons) are thought to stimulate GABAergic neurons in the amygdala, which, in turn, inhibit central amygdala output and reduce fear expression. Thus, loss and/or altered morphology of projection neurons of IL as a result of a mild TBI (mTBI) can compromise their ability to effectively inhibit the central amygdala, allowing the original fear memory to drive behavior. Using lateral mild fluid percussion injury (mFPI) in rats, we found that mFPI did not reduce neuronal numbers in the IL, but caused a significant reduction in overall dendritic spine density of both basal and apical dendrites on layer II/III pyramidal neurons. Spine numbers on layer V/VI pyramidal neurons were not significantly changed as a result of mFPI. The reduction in spine density on layer II/III pyramidal neurons we observed may diminish the efficacy of these neurons to inhibit the output of the central amygdala, thereby reducing the ability of the IL to suppress fear responses after extinction training. Consistent with this, mFPI rats display enhanced freezing behavior during and after extinction training as compared to sham-operated controls, although the ability to form contextual fear memories was not impaired. These results may have implications in stress-related disorders associated with mTBI.	[Zhao, Jing; Huynh, Jonathan; Hylin, Michael J.; O'Malley, John J.; Perez, Alec; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX USA		Dash, PK (corresponding author), UTHlth McGovern Med Sch, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Hylin, Michael/U-2878-2019	Dash, Pramod/0000-0001-6746-1002; O'Malley, John/0000-0003-3774-1702	DODUnited States Department of Defense [W81XWH-08-2-0134]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS097149, NS086301]	The authors thank Dr. Bruce Lyeth of University of California, Davis for his invaluable advice on fluid percussion injury. This study was supported by grants from the DOD (W81XWH-08-2-0134) and NIH (NS097149, NS086301).	Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; CASSELL MD, 1989, J COMP NEUROL, V279, P235, DOI 10.1002/cne.902790207; Cho JH, 2013, NEURON, V80, P1491, DOI 10.1016/j.neuron.2013.09.025; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Do-Monte FH, 2015, J NEUROSCI, V35, P3607, DOI 10.1523/JNEUROSCI.3137-14.2015; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ferreira AN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00161; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Goode TD, 2014, ILAR J, V55, P246, DOI 10.1093/ilar/ilu008; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Maren S, 2014, NEUROBIOL LEARN MEM, V108, P88, DOI 10.1016/j.nlm.2013.06.004; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Neumann DL, 2008, BEHAV RES THER, V46, P188, DOI 10.1016/j.brat.2007.12.004; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; Paxinos G, 2000, RAT BRAIN STEREOTAXI; Pinard CR, 2012, NEUROSCIENCE, V205, P112, DOI 10.1016/j.neuroscience.2011.12.036; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	37	9	9	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					149	156		10.1089/neu.2016.4898			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700017	28665166	Green Published			2022-02-06	
J	Pavlou, M; Whitney, SL; Alkathiry, AA; Huett, M; Luxon, LM; Raglan, E; Godfrey, EL; Bamiou, DE				Pavlou, Marousa; Whitney, Susan L.; Alkathiry, Abdulaziz A.; Huett, Marian; Luxon, Linda M.; Raglan, Ewa; Godfrey, Emma L.; Bamiou, Doris-Eva			Visually induced Dizziness in children and Validation of the Pediatric Visually induced Dizziness Questionnaire	FRONTIERS IN NEUROLOGY			English	Article						concussion; migraine; vestibular disorders; motion sickness; environmental dizziness triggers	MOTION SICKNESS SUSCEPTIBILITY; POSTURAL-PERCEPTUAL DIZZINESS; QUALITY-OF-LIFE; DIFFICULTIES QUESTIONNAIRE; VESTIBULAR MIGRAINE; BALANCE DISORDERS; VERTIGO SYMPTOMS; ADOLESCENTS; STRENGTHS; REHABILITATION	Aims: To develop and validate the Pediatric Visually Induced Dizziness Questionnaire (PVID) and quantify the presence and severity of visually induced dizziness (ViD), i.e., symptoms induced by visual motion stimuli including crowds and scrolling computer screens in children. Methods: 169 healthy (female n = 89; recruited from mainstream schools, London, UK) and 114 children with a primary migraine, concussion, or vestibular disorder diagnosis (female n = 62), aged 6-17 years, were included. Children with primary migraine were recruited from mainstream schools while children with concussion or vestibular disorder were recruited from tertiary balance centers in London, UK, and Pittsburgh, PA, USA. Children completed the PVID, which assesses the frequency of dizziness and unsteadiness experienced in specific environmental situations, and Strength and Difficulties Questionnaire (SDQ), a brief behavioral screening instrument. Results: The PVID showed high internal consistency (11 items; alpha = 0.90). A significant between group difference was noted with higher (i.e., worse) PVID scores for patients vs. healthy participants (U = 2,436.5, z = -10.719, p < 0.001); a significant difference was noted between individual patient groups [chi(2)(2) = 11.014, p = 0.004] but post hoc analysis showed no significant pairwise comparisons. The optimal cut-off score for discriminating between individuals with and without abnormal ViD levels was 0.45 out of 3 (sensitivity 83%, specificity 75%). Self-rated emotional (U = 2,730.0, z = -6.169) and hyperactivity (U = 3,445.0, z = -4.506) SDQ subscale as well as informant (U = 188.5, z = -3.916) and self -rated (U = 3,178.5, z = -5.083) total scores were significantly worse for patients compared to healthy participants (p < 0.001). Conclusion: ViD is common in children with a primary concussion, migraine, or vestibular diagnosis. The PVID is a valid measure for identifying the presence of ViD in children and should be used to identify and quantify these symptoms, which require specific management incorporating exposure to optokinetic stimuli.	[Pavlou, Marousa] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Whitney, Susan L.; Alkathiry, Abdulaziz A.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Phys Therapy, Pittsburgh, PA USA; [Alkathiry, Abdulaziz A.] Majmaah Univ, Coll Appl Med Sci, Phys Therapy, Majmaah, Saudi Arabia; [Huett, Marian] Kings Coll London, Dept Physiol, London, England; [Luxon, Linda M.; Bamiou, Doris-Eva] Univ Coll London NHS Hosp Trust, Dept Audiol, Royal Natl Throat Nose & Ear Hosp, London, England; [Raglan, Ewa; Bamiou, Doris-Eva] Great Ormond St Hosp Sick Children, Audiol Med Dept, London, England; [Godfrey, Emma L.] Kings Coll London, Div Hlth & Social Care, London, England; [Bamiou, Doris-Eva] UCL, Ear Inst, London, England		Pavlou, M (corresponding author), Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England.	marousa.pavlou@kcl.ac.uk	Alkathiry, Abdulaziz A/Z-4078-2019; Bamiou, Doris-Eva/M-4082-2017	Alkathiry, Abdulaziz A/0000-0001-7715-6773; Bamiou, Doris-Eva/0000-0001-7486-4264; Pavlou, Marousa/0000-0002-5861-2865; Godfrey, Emma/0000-0001-8995-9653	King's College London	MP wrote the first draft of the manuscript. No honorarium, grant, or other form of payment was given to anyone to produce the manuscript. Open access for this article was funded by King's College London.	Sommerfleck PA, 2016, INT J PEDIATR OTORHI, V87, P148, DOI 10.1016/j.ijporl.2016.06.020; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Bagust J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065321; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; Bell A, 2007, J RES NURS, V12, P461, DOI 10.1177/1744987107079616; Best C, 2009, ANN NY ACAD SCI, V1164, P334, DOI 10.1111/j.1749-6632.2009.03847.x; Bijveld MMC, 2008, AVIAT SPACE ENVIR MD, V79, P661, DOI 10.3357/ASEM.2241.2008; Bisdorff A, 2010, CEPHALALGIA, V30, P815, DOI 10.1177/0333102409353617; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brodsky JR, 2016, INT J PEDIATR OTORHI, V83, P104, DOI 10.1016/j.ijporl.2016.01.027; Brodsky JR, 2016, EUR J PAEDIATR NEURO, V20, P85, DOI 10.1016/j.ejpn.2015.09.011; Bronstein AM, 2016, HAND CLINIC, V137, P57, DOI 10.1016/B978-0-444-63437-5.00004-2; BRONSTEIN AM, 1995, ACTA OTO-LARYNGOL, P45; Bryman A, 1999, GUIDE SOCIAL SCI; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Casselbrant ML, 2005, NEUROL CLIN, V23, P807, DOI 10.1016/j.ncl.2005.03.003; Cousins S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105426; De Vellis R. F., 1991, SCALE DEV THEORY APP, V26; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Dieterich M, 2007, BRAIN, V130, P2108, DOI 10.1093/brain/awm130; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Field A., 2017, DISCOVERING STAT USI, V5th; Geser Rebekka, 2012, Front Neurol, V3, P169, DOI 10.3389/fneur.2012.00169; Gilmore RO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157911; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Henriques IF, 2014, EUR J PEDIATR, V173, P1473, DOI 10.1007/s00431-014-2351-1; Humphriss R, 2011, INT J PEDIATR OTORHI, V75, P106, DOI 10.1016/j.ijporl.2010.10.019; Jackson C., 2000, DESIGNING ANAL QUEST; Jacob R. G., 1989, J ANXIETY DIORD, V3, P117, DOI DOI 10.1016/0887-6185(89)90006-6; Jahn K, 2016, HAND CLINIC, V137, P353, DOI 10.1016/B978-0-444-63437-5.00025-X; Jahn K, 2015, CURR OPIN NEUROL, V28, P78, DOI 10.1097/WCO.0000000000000157; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kleppang AL, 2019, SCAND J PUBLIC HEALT, V47, P166, DOI 10.1177/1403494817716374; Kuhn C, 2017, CHILD PSYCHIAT HUM D, V48, P385, DOI 10.1007/s10578-016-0665-0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lee CH, 2014, OTOL NEUROTOL, V35, pE324, DOI 10.1097/MAO.0000000000000559; Lempert T, 2013, NERVENARZT, V84, P511, DOI 10.1007/s00115-013-3768-x; Lempert T, 2013, SEMIN NEUROL, V33, P212, DOI 10.1055/s-0033-1354596; Li CM, 2016, J PEDIATR-US, V171, P240, DOI 10.1016/j.jpeds.2015.12.002; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Maizels M, 2012, HEADACHE, V52, P1553, DOI 10.1111/j.1526-4610.2012.02209.x; McCaslin DL, 2015, INT J PEDIATR OTORHI, V79, P1662, DOI 10.1016/j.ijporl.2015.07.017; Bittar RSM, 2015, BRAZ J OTORHINOLAR, V81, P276, DOI 10.1016/j.bjorl.2014.08.012; Nind M, 2008, CONDUCTING QUALITATI, P1; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Oztop DB, 2016, J CHILD NEUROL, V31, P837, DOI 10.1177/0883073815623635; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Pavlou M, 2004, J NEUROL, V251, P983, DOI 10.1007/s00415-004-0476-2; Pavlou M, 2012, J VESTIBUL RES-EQUIL, V22, P273, DOI 10.3233/VES-120462; Pavlou M, 2016, J PEDIATR-US, V168, P171, DOI 10.1016/j.jpeds.2015.09.075; Pavlou M, 2015, J NEUROL PHYS THER, V39, P215, DOI 10.1097/NPT.0000000000000105; Petanidou D, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-3; Physicians RCo, 2008, HEARING BALANCE DISO; Raucci U, 2016, CEPHALALGIA, V36, P593, DOI 10.1177/0333102415606078; Reale L, 2011, BRAIN DEV-JPN, V33, P125, DOI 10.1016/j.braindev.2010.03.006; Reavley CM, 2006, AVIAT SPACE ENVIR MD, V77, P1148; Rine RM, 2013, NEUROREHABILITATION, V32, P507, DOI 10.3233/NRE-130873; Rocha PAS, 2014, HEADACHE, V54, P1194, DOI 10.1111/head.12394; Sohsten E, 2016, J VESTIBUL RES-EQUIL, V26, P319, DOI 10.3233/VES-160583; Staab JP, 2014, J PSYCHOSOM RES, V76, P80, DOI 10.1016/j.jpsychores.2013.11.008; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Taehtinen RE, 2014, PREV MED, V67, P128, DOI 10.1016/j.ypmed.2014.07.017; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Torsheim T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-324; Whitney SL, 2016, J VESTIBUL RES-EQUIL, V26, P297, DOI 10.3233/VES-160580; Wiener-Vacher SR, 2008, INT J AUDIOL, V47, P578, DOI 10.1080/14992020802334358; Wood ND, 2015, MARRIAGE FAM REV, V51, P385, DOI 10.1080/01494929.2015.1059785; YARDLEY L, 1990, EUR ARCH OTO-RHINO-L, V247, P300; ZWEIG MH, 1993, CLIN CHEM, V39, P561; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	75	9	13	1	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 5	2017	8								656	10.3389/fneur.2017.00656			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FO7LR	WOS:000417056800001	29259575	Green Published, gold			2022-02-06	
J	Alderman, N; Williams, C; Knight, C; Wood, RL				Alderman, Nick; Williams, Claire; Knight, Caroline; Wood, Rodger Ll.			Measuring Change in Symptoms of Neurobehavioural Disability: Responsiveness of the St Andrew's-Swansea Neurobehavioural Outcome Scale	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; traumatic brain injury; Assessment; Norms/normative studies; Rehabilitation; Practice effects/reliable change; Statistical methods	QUALITY-OF-LIFE; CLINICALLY IMPORTANT DIFFERENCES; MINIMUM DETECTABLE CHANGE; ACQUIRED BRAIN-INJURY; STATISTICAL SIGNIFICANCE; INTRAINDIVIDUAL CHANGES; CHALLENGING BEHAVIOR; COST-BENEFITS; REHABILITATION; PEOPLE	Objective: Neurobehavioural disability (NBD) after acquired brain injury (ABI) is often associated with poor outcome. The "St Andrew's-Swansea Neurobehavioural Outcome Scale" (SASNOS) was developed to measure NBD in a range of applications. Two of the "holy trinity" of psychometric properties, reliability and validity, have been comprehensively mapped, but the extent to which SASNOS meets the third, responsiveness, has not been investigated. Demonstrating responsiveness is essential in instruments employed in repeated measurement scenarios to confirm their ability to discriminate real change from error. However, there is no single agreed method for determining responsiveness. For some instruments, this property remains unexplored. A difference in scores attaining statistical significance for aggregate data is frequently cited as support for this construct, but this approach remains heavily criticized. This study explores responsiveness of SASNOS. Method: Consecutive SASNOS assessments completed over varying times for 145 individuals participating in neurobehavioural rehabilitation, drawn from multiple services, were compiled into a retrospective sample of convenience. Multiple methods were employed to confirm internal responsiveness, including those identifying statistically significant change, minimally detectable change and minimally important change. Results: All methods confirmed responsiveness as a psychometric property of SASNOS; the extent depended on method used and NBD domain investigated. A number of indicators are presented, which equip clinicians and researchers with options to interpret results from repeated assessments, including the individual level in the context of rehabilitation. Conclusions: SASNOS reliably measures change over time in NBD symptoms, further confirming its suitability as an instrument for investigating multidimensional outcomes of ABI.	[Alderman, Nick] Priory Healthcare & Partnerships Care, Brain Injury Serv, Grafton Regis, Northants, England; [Alderman, Nick; Williams, Claire] Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Knight, Caroline] Priory Healthcare & Partnerships Care, Brain Injury Serv, Burton Pk, Melton Mowbray, Leics, England; [Knight, Caroline] Univ Leicester, Sch Psychol, Leicester, Leics, England; [Wood, Rodger Ll.] Swansea Univ, Coll Med, Neuropsychol Clin, Swansea, W Glam, Wales		Alderman, N (corresponding author), Priory Grp & Partnerships Care, Brain Injury Serv, Clin Serv, Grafton Regis NN12 7SS, Northants, England.	nick.alderman@partnershipsincare.co.uk		Alderman, Nick/0000-0002-8523-4142; Williams, Claire/0000-0002-0791-744X			Alderman N., NORMAL SCORES UNPUB; Alderman N, 2013, BRAIN IMPAIR, V14, P5, DOI 10.1017/BrImp.2013.7; Alderman N, 2013, NEUROREHABILITATION, V32, P761, DOI 10.3233/NRE-130900; Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; [Anonymous], 2016, MEDCALC STAT SOFTWAR; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BURKE WH, 1988, INT J REHABIL RES, V11, P235, DOI 10.1097/00004356-198809000-00003; Cohen J., 2013, STAT POWER ANAL BEHA; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Domholft E., 2005, REHABILITATION RES P; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; Eisen SV, 2007, J BEHAV HEALTH SER R, V34, P272, DOI 10.1007/s11414-007-9066-2; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hays RD, 2005, EVAL HEALTH PROF, V28, P160, DOI 10.1177/0163278705275339; Heaton RK, 1991, COMPREHENSIVE NORMS; IBM Corp, 2016, IBM SPSS STAT WINDOW; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Middel Berrie, 1800, Int J Integr Care, V2, pe15; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Rai SK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0658-6; Rehabilitation Institute of Chicago, 2010, REH MEAS DAT; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Stratford P. W., 2004, PHYSIOTHER CAN, V56, P27, DOI [10.2310/6640.2004.15377, DOI 10.2310/6640.2004.15377]; Tate RL, 2010, COMPENDIUM TESTS SCA; Terwee CB, 2003, QUAL LIFE RES, V12, P349, DOI 10.1023/A:1023499322593; Walters S, 2003, HEALTH QUAL LIFE OUT, V11, P1; Walton D, 2011, J ORTHOP SPORT PHYS, V41, P644, DOI 10.2519/jospt.2011.3666; Wood R, OXFORD TXB IN PRESS; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Wyrwich KW, 2005, HEALTH SERV RES, V40, P577, DOI 10.1111/j.1475-6773.2005.0l374.x; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Wyrwich KW, 2000, J EVAL CLIN PRACT, V6, P39, DOI 10.1046/j.1365-2753.2000.00238.x; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	39	9	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2017	32	8					951	962		10.1093/arclin/acx026			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FN7AS	WOS:000416170000004	28383632	Green Accepted, Bronze			2022-02-06	
J	Capron, GK; Voights, MB; Moore, HR; Wall, DB				Capron, Gweniviere Kayla; Voights, Mary Beth; Moore, Henry R., III; Wall, Derek B.			Not every trauma patient with a radiographic head injury requires transfer for neurosurgical evaluation: Application of the brain injury guidelines to patients transferred to a level 1 trauma center	AMERICAN JOURNAL OF SURGERY			English	Article						Traumatic brain injury; Patient transfer; Rural hospital		Background: Patients with radiographically-identified traumatic brain injury are often transferred to our regional trauma center for neurosurgical evaluation, yet few injuries require neurosurgical intervention. Transfer is costly, inconvenient, and potentially risky in inclement weather. We propose that previously-published brain injury guidelines (BIG) 1 can help to determine which patients could avoid mandatory transfer. Methods: Retrospective chart review of patients transferred between January 2012 and December 2013 was performed. Patients were classified as having minor (BIG 1), moderate (BIG 2), or severe (BIG 3) head injuries based on previously-published guidelines. Patient characteristics and outcomes were compared. Results: No BIG 1 patients deteriorated or required surgical intervention. One BIG 2 patient required a non-emergent operation and another was readmitted with a worsened injury. In the BIG 3 group, 11.9% required neurosurgical procedures and 20% died. Conclusions: The BIG classification can help stratify patients for whom transfer is considered. (C) 2017 Elsevier Inc. All rights reserved.	[Capron, Gweniviere Kayla; Voights, Mary Beth; Moore, Henry R., III; Wall, Derek B.] Carle Fdn Hosp, Dept Surg, Div Trauma, Urbana, IL USA		Wall, DB (corresponding author), NorthShore Univ HealthSyst, Div Gastrointestinal & Gen Surg, Dept Surg, 9650 Gross Point Rd,Suite 3900, Skokie, IL 60076 USA.	dwall@northshore.org					Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Newgard CD, 2007, PREHOSP EMERG CARE, V11, P154, DOI 10.1080/10903120701205778	6	9	9	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2017	214	6					1182	1185		10.1016/j.amjsurg.2017.09.002			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FM7XO	WOS:000415294400055	28939250				2022-02-06	
J	Dhawan, PS; Leong, D; Tapsell, L; Starling, AJ; Galetta, SL; Balcer, LJ; Overall, TL; Adler, JS; Halker-Singh, RB; Vargas, BB; Dodick, D				Dhawan, Priya S.; Leong, Danielle; Tapsell, Lisa; Starling, Amaal J.; Galetta, Steven L.; Balcer, Laura J.; Overall, Trenton L.; Adler, Jennifer S.; Halker-Singh, Rashmi B.; Vargas, Bert B.; Dodick, David			King-Devick Test identifies real-time concussion and asymptomatic concussion in youth athletes	NEUROLOGY-CLINICAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; AMATEUR RUGBY UNION; FRONTAL EYE FIELD; CEREBRAL-DYSFUNCTION; HEAD-INJURY; SACCADES; MOVEMENTS; FOOTBALL; PLAYERS	Background: Sports concussion has an annual incidence of approximately 3.8 million. Over half go unreported and a substantial number may be asymptomatic. A rapid, cost-effective, and reliable tool that facilitates diagnosis of concussion is needed. The King-Devick (K-D) test is a vision-based tool of rapid number naming for assessment of concussion. In this study, we evaluated the utility of the K-D test in real time for identification of symptomatic concussion in youth athletes and to determine if similar impairment (subclinical concussion) exists in youth athletes without an obvious head injury or symptoms. Methods: Youth hockey players underwent K-D testing preseason, post-season, and immediately after suspected concussion. Additional testing was performed in a subgroup of nonconcussed athletes immediately before and after a game to determine effects of fatigue on K-D scores. Results: Among 141 players tested, 20 had clinically diagnosed concussion. All 20 had immediate postconcussion K-D times > 5 seconds from base-line (average 7.3 seconds) and all but 2 had worse postseason scores (46.4 seconds vs 52.4 seconds, p < 0.05, Wilcoxon signed rank test). Nonconcussed athletes saw minimal improvement postseason (43.9 seconds vs 42.1 seconds, p < 0.05) and 51 nonconcussed players assessed before and after a game revealed no significant time change as a result of fatigue. Conclusions: Rapid number naming using the K-D test accurately identifies realtime, symptomatic concussion in youth athletes. Scores in concussed players may remain abnormal over time. Athletes should undergo preseason and postseason K-D testing, with additional evaluation real time to inform the assessment of suspected concussion. Classification of Evidence: This study provides Class III evidence that the K-D test accurately identifies real-time concussions in youth athletes.	[Dhawan, Priya S.; Tapsell, Lisa; Starling, Amaal J.; Overall, Trenton L.; Halker-Singh, Rashmi B.; Vargas, Bert B.; Dodick, David] Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA; [Leong, Danielle] King Devick Test Inc, Oak Brook Terrace, IL USA; [Galetta, Steven L.; Balcer, Laura J.] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA; [Galetta, Steven L.; Balcer, Laura J.] NYU, Dept Ophthalmol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY USA; [Galetta, Steven L.; Balcer, Laura J.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Balcer, Laura J.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Adler, Jennifer S.] Univ Arizona, Scottsdale, AZ USA		Dodick, D (corresponding author), Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA.	Dodick.david@mayo.edu					Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Duenas M, 2014, SURG NEUROL INT, V5, P91, DOI DOI 10.4103/2152-7806.134364; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galetta K, 2016, CONCUSSION, V1, P1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2002, PROG BRAIN RES, V140, P433; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ploner CJ, 1999, J NEUROPHYSIOL, V82, P1086; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Spradley B, 2014, SPORT J; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230	35	9	9	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	DEC	2017	7	6					464	473		10.1212/CPJ.0000000000000381			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FT9RO	WOS:000423489400007	29431168	Green Published			2022-02-06	
J	Erba, G; Bianchi, E; Giussani, G; Langfitt, J; Juersivich, A; Beghi, E				Erba, Giuseppe; Bianchi, Elisa; Giussani, Giorgia; Langfitt, John; Juersivich, Adam; Beghi, Ettore			Patients' and caregivers' contributions for differentiating epileptic from psychogenic nonepileptic seizures. Value and limitations of self-reporting questionnaires: A pilot study	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Psychogenic non-epileptic seizures; Epileptic seizures; Questionnaire; Diagnosis; Witnesses	INTERNATIONAL LEAGUE; DIAGNOSIS; MANIFESTATIONS; CONVULSIONS; SEMIOLOGY; ACCURACY; HELPS; VIDEO	Purpose: Questionnaires investigating semiology and comorbidities of psychogenic non-epileptic seizures (PNES) have been used mainly to help physicians expedite referrals to epilepsy centres for confirmation of diagnosis rather than as alternative diagnostic tool when video-EEG monitoring (VEM), the current gold standard, is not available or is inconclusive. Methods: We developed one structured questionnaire for patients, exploring subjective experiences and vulnerabilities and one for eyewitnesses, focused on features observable during typical events to study prospectively 50 consecutive adult patients with PNES or epileptic seizures (ES) admitted for VEM. A list of variables representing specific signs, symptoms and risk factors was obtained from each question. Specificity (SP) and sensitivity (SE) of each variable were calculated analyzing patient's and witness' responses against the final diagnosis. Statistical significance was assessed using the Fisher's exact test. Results: Twenty-eight patients' questionnaires (17 PNES, 11 ES) were eligible for analysis. Seven variables with high SE and SP, of which 5 statistically significant, emerged as diagnostic predictors. They comprised three historical items: head injury, physical abuse and chronic fatigue; two warning signs: heart racing and tingling or numbness; one triggering sign: headache; one postictal symptom: physical pain. Sixteen witness questionnaires (6 PNES, 10 ES) were available. Side-to-side head movements and eyes closed were the statistically significant variables. Conclusion: Pending further refinements, ad hoc questionnaires specifically designed for patients and eyewitnesses, may represent a practical tool for distinguishing ES from PNES in settings without sophisticated facilities or when VEM is inconclusive. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Erba, Giuseppe; Langfitt, John; Juersivich, Adam] Univ Rochester, Dept Neurol, SEC, Rochester, NY USA; [Bianchi, Elisa; Giussani, Giorgia; Beghi, Ettore] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Lab Neurol Disorders, Milan, Italy		Beghi, E (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Lab Neurol Disorders, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	ettore.beghi@marionegri.it	Bianchi, Elisa/ABF-8173-2020; Beghi, Ettore/AAA-7426-2020; Giussani, Giorgia/AAA-8029-2020; Giussani, Giorgia/E-8057-2017	Bianchi, Elisa/0000-0002-0279-0128; Beghi, Ettore/0000-0003-2542-0469; Giussani, Giorgia/0000-0003-2460-3095; Giussani, Giorgia/0000-0003-2460-3095			Alessi R, 2013, EPILEPSY BEHAV, V26, P91, DOI 10.1016/j.yebeh.2012.10.011; An DM, 2010, EPILEPSY BEHAV, V17, P408, DOI 10.1016/j.yebeh.2010.01.003; Asadi-Pooya AA, 2016, J CLIN NEUROSCI, V34, P105, DOI 10.1016/j.jocn.2016.05.037; Asadi-Pooya AA, 2013, J NEUROL SCI, V332, P66, DOI 10.1016/j.jns.2013.06.016; Azar NJ, 2010, EPILEPSY BEHAV, V19, P462, DOI 10.1016/j.yebeh.2010.08.027; Cronje G, 2013, EPILEPSY BEHAV, V29, P581, DOI 10.1016/j.yebeh.2013.09.045; De Paola L, 2016, EPILEPSY BEHAV, V54, P40, DOI 10.1016/j.yebeh.2015.10.025; Erba G, 2016, EPILEPSIA, V57, P777, DOI 10.1111/epi.13351; Farghaly WMA, 2013, SEIZURE-EUR J EPILEP, V22, P611, DOI 10.1016/j.seizure.2013.04.010; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Heo JH, 2008, NEUROLOGIST, V14, P7, DOI 10.1097/NRL.0b013e3181343cb4; Kerr WT, 2017, EPILEPSIA, V58, P1852, DOI 10.1111/epi.13888; Kocalevent RD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-91; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; Moldofsky H, 2016, BJPSYCH OPEN, V2, P359, DOI 10.1192/bjpo.bp.116.003483; Popkirov S, 2017, EPILEPSY BEHAV, V73, P54, DOI 10.1016/j.yebeh.2017.05.027; Reinsberger C, 2012, EPILEPSY BEHAV, V23, P68, DOI 10.1016/j.yebeh.2011.10.008; Reuber M, 2004, J NEUROL NEUROSUR PS, V75, P743, DOI 10.1136/jnnp.2003.013821; Reuber M, 2011, EPILEPSIA, V52, P2028, DOI 10.1111/j.1528-1167.2011.03162.x; Rosemergy I, 2013, EPILEPSY BEHAV, V27, P81, DOI 10.1016/j.yebeh.2012.12.024; Rugg-Gunn FJ, 2001, EPILEPSY RES, V43, P193, DOI 10.1016/S0920-1211(00)00209-6; Sadan O, 2015, ACTA NEUROL SCAND; Sen A, 2007, EPILEPSY RES, V77, P62, DOI 10.1016/j.eplepsyres.2007.07.009; Sharrack S, 2015, NEUROLOGY S14, V84, P5; Syed TU, 2009, NEUROLOGY, V72, P1646, DOI 10.1212/WNL.0b013e3181a55ef7; Syed TU, 2011, ANN NEUROL, V69, P997, DOI 10.1002/ana.22345	26	9	10	0	5	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	DEC	2017	53						66	71		10.1016/j.seizure.2017.11.001			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR3QQ	WOS:000418981600015	29132064	Bronze			2022-02-06	
J	Galili, SF; Bech, BH; Vestergaard, C; Fenger-Gron, M; Christensen, J; Vestergaard, M; Ahrensberg, J				Galili, Stine Fjendbo; Bech, Bodil Hammer; Vestergaard, Claus; Fenger-Gron, Morten; Christensen, Jakob; Vestergaard, Mogens; Ahrensberg, Jette			Use of general practice before and after mild traumatic brain injury: a nationwide population-based cohort study in Denmark	BMJ OPEN			English	Article							YOUNG-PEOPLE; HEAD-INJURY; ASSOCIATION; CONCUSSION; DISABILITY; MANAGEMENT; SYMPTOMS; STRESS; ADULTS	Objectives Traumatic brain injury (TBI) is commonly seen in the emergency department (ED). Approximately 85%-90% of TBIs are mild (mTBI). Some cause symptoms such as headache, dizziness, anxiety, blurred vision, insomnia and concentration difficulties, collectively known as postconcussion syndrome (PCS). Some studies suggest that recovery from mTBI is complete. Others find that symptoms persist for months, even years. The aim of this study was to describe the use of general practice, before and after mTBI, as a proxy for symptoms in a large cohort. Design Nationwide population-based matched cohort study. Setting Danish EDs and general practice. Participants All patients (aged >= 18 years), first-time diagnosed with mTBI in a Danish ED between 1 January 1998 and 31 December 2010 (n=93 517). Ten reference persons per patient with mTBI were randomly matched on gender, age and general practice (n=935 170). Primary outcome Overall use of general practice; consultations relating to mental and physical health. Results We found higher use of general practice during the first year after mTBI for all ages, both genders and all types of contacts. Age 18-40 years: women, incidence rate ratio (IRR) 1.59 (95% CI 1.57 to 1.61); men, IRR 1.82 (95% CI 1.80 to 1.85). Age 41-65 years: women, IRR 1.75 (95% CI 1.72 to 1.78); men, IRR 1.85 (95% CI 1.82 to 1.89). Age 66+ years: women, IRR 1.55 (95% CI 1.52 to 1.58); men, IRR 1.55 (95% CI 1.51 to 1.59). After the first year, the use decreased to the level before mTBI. Individuals with mTBI and higher use of general practice before mTBI had lower socioeconomic status and more comorbidities (P<0.001). Conclusions The use of general practice was higher in the first year after mTBI, specifically in the first 3 months. Patients with mTBI had different healthcare-seeking behaviour several years before diagnosis than their matched reference persons. Pretraumatic morbidity should be considered in the evaluation of PCS.	[Galili, Stine Fjendbo; Vestergaard, Claus; Fenger-Gron, Morten; Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Bech, Bodil Hammer] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Bech, Bodil Hammer] Aarhus Univ, Epidemiol Sect, Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark; [Ahrensberg, Jette] Aarhus Univ Hosp, Dept Clin Med, Res Ctr Emergency Med, Aarhus, Denmark		Galili, SF (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.	s.galili@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Galili, Stine Fjendbo/W-6775-2019	Bech, Bodil Hammer/0000-0002-0287-3687; Vestergaard, Claus Hostrup/0000-0003-2916-1548; Christensen, Jakob/0000-0002-9385-6435; Fenger-Gron, Morten/0000-0002-6354-5871	Program for Clinical Research Infrastructure (PROCRIN); Danish Regions [R155-2014-2647]; Lundbeck Foundation (MEPRICA) [R155-2012-11280]; Danish Epilepsy Association; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF160C0019126]; Lundbeck FoundationLundbeckfonden [R155-2012-11280, R155-2014-2647] Funding Source: researchfish; Novo Nordisk FondenNovo Nordisk Foundation [NNF16OC0019126, NNF14SA0015794, NNF12OC1016030, NNF14OC0009107] Funding Source: researchfish	This work was supported by the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation and administered by the Danish Regions, (grant number: R155-2014-2647) and also supported by an unrestricted grant from the Lundbeck Foundation (MEPRICA) (grant number: R155-2012-11280). JC was supported by the Danish Epilepsy Association and the Novo Nordisk Foundation (grant number NNF160C0019126).	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2019, INT STAT CLASS DIS R; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Eskesen V, 2014, UGESKRIFT LAEGER, V176, P176; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Innocenti F, 2015, INJURY, V46, P902, DOI 10.1016/j.injury.2014.11.033; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kjaersgaard MIS, 2016, CLIN EPIDEMIOL, V8, P273, DOI 10.2147/CLEP.S108307; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nabalamba Alice, 2007, Health Rep, V18, P23; National Center for Health Statistics, ICD ICD 10 CM INT CL; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pedersen CB, 2006, DAN MED BULL, V53, P441; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prior A, 2016, AM J EPIDEMIOL, V184, P199, DOI 10.1093/aje/kwv324; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	40	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2017	7	12							e017735	10.1136/bmjopen-2017-017735			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU4MH	WOS:000423826700074	29248884	Green Published, gold			2022-02-06	
J	Guo, C; Liu, L; Wang, B; Wang, ZG				Guo, Cheng; Liu, Lin; Wang, Bing; Wang, Zhigang			Swirl sign in traumatic acute epidural hematoma: prognostic value and surgical management	NEUROLOGICAL SCIENCES			English	Article						Acute epidural hematoma; Swirl sign; Surgical management	SEVERE HEAD-INJURY	The swirl sign is identified as a small area of low attenuation within an intracranial hyperattenuating clot on non-enhanced computed tomography (CT) scans of the brain, which represents active bleeding. The purpose of this study was to evaluate the incidence of the swirl sign among patients with acute epidural hematoma (AEDH) and to identify its prognostic value and impact on surgical treatment. A retrospective review was performed of patients with a diagnosis of traumatic EDH by CT scan who were surgically treated at the Department of Neurosurgery of the First People's Hospital of Jingmen between January 2010 and January 2014. Patients with combined or open craniocerebral injuries and those who did not undergo surgical treatment were excluded. Of the 147 patients evaluated, 21 (14%) exhibited the swirl sign on non-enhanced CT scans of the brain. Univariate analysis revealed a significant correlation between the occurrence of the swirl sign and preoperative Glasgow coma scale scores, preoperative mydriasis, time from injury to CT scan, and intraoperative hematoma volume. Compared with patients without this sign, those exhibiting the swirl sign had a higher mortality rate (24 vs. 6%, respectively; P = 0.028) and a worse outcome (Glasgow Outcome Scale score ae<currency> 3: 38 vs. 15%, respectively; P = 0.027) at 3 months. An adjusted analysis showed that the occurrence of the swirl sign was an independent predictor of poor outcome (death: odds ratio (OR) = 4.61; 95% confidence interval (CI): 1.34-15.82; P < 0.05; 3-month Glasgow Outcome Scale score ae<currency> 3: OR = 3.47; 95% CI: 1.27-9.49; P < 0.05). In conclusion, the occurrence of the swirl sign on the head CT scan of patients with AEDH was found to be significantly associated with poor outcome. Therefore, early identification of this sign and aggressive management with early surgical evacuation is crucial for improving patient outcome.	[Guo, Cheng; Liu, Lin] Second Peoples Hosp Jingmen, Dept Resp Med, Jingmen, Hubei, Peoples R China; [Wang, Bing] First Peoples Hosp Jingmen, Dept Radiol, Jingmen, Hubei, Peoples R China; [Wang, Zhigang] First Peoples Hosp Jingmen, Dept Neurosurg, Jingmen, Hubei, Peoples R China		Wang, ZG (corresponding author), First Peoples Hosp Jingmen, Dept Neurosurg, Jingmen, Hubei, Peoples R China.	360234044@qq.com					Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Araujo João Luiz Vitorino, 2012, Rev. Col. Bras. Cir., V39, P268; Bezircioglu H, 1996, J TRAUMA, V41, P696, DOI 10.1097/00005373-199610000-00016; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chen H, 2012, EMERG MED INT, V2012, P8; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Selariu E, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-109; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Yilmazlar S, 2005, ACTA NEUROCHIR, V147, P1241, DOI 10.1007/s00701-005-0623-2; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	19	9	10	0	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	DEC	2017	38	12					2111	2116		10.1007/s10072-017-3121-4			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO8WO	WOS:000417169100005	28894943				2022-02-06	
J	Hendricks, S; Sarembock, M; Jones, B; Till, K; Lambert, M				Hendricks, Sharief; Sarembock, Martin; Jones, Ben; Till, Kevin; Lambert, Mike			The tackle in South African youth rugby union - Gap between coaches' knowledge and training behaviour	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Attitudes; injury prevention; rugby football	INJURY PREVENTION; PLAYERS; RISK	In youth rugby union matches, tackle-related injuries account for 60% of all injuries, 62% of concussion injuries and almost 50% of spinal cord injuries (youth and amateur). Because of this high risk of injury, the inclusion of the tackle in youth rugby has been a topic of discussion in the public and a high priority research area for World Rugby. What a coach knows and his/her attitude toward player safety directly impacts the risk and performance profile of a player. The purpose of this study is to describe the tackle knowledge, attitudes and training behaviours of youth rugby coaches. The entire population of Western Province Rugby Union Premier A1 division (highest level of school rugby) under-19 rugby coaches (n=8) completed a knowledge and attitude questionnaire and 96 field-training sessions were observed over four weeks. Coaches rated tackling (mean 3.9, 95% confidence interval 3.3-4.4), rucking (mean 3.8, 95% confidence interval 3.0-4.5) and ball-carrying (mean 3.6, 95% confidence interval 2.6-4.6) as high-risk of injury facets of play (H=30.8, p<0.001). Coaching proper technique was rated as very important for safety (mean 4.6, 95% confidence interval 4.2-5.0) and performance (mean 4.8, 95% confidence interval 4.4-5.0, U=28, p>0.05). Of the 96 observed training sessions, tackle training was recorded 16% of the time (vs. 84% no tackle training, p<0.001). Coaches were aware of the risk of injury in the tackle and rated the coaching of proper technique of utmost importance. These positive knowledge and attitudes did not transfer into their tackle training. The discrepancy between coaches' tackle knowledge and attitudes, and their training of the tackle might be related to how competent they believe themselves to be in delivering tackle training.	[Hendricks, Sharief; Sarembock, Martin; Lambert, Mike] Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Hendricks, Sharief; Jones, Ben; Till, Kevin] Leeds Beckett Univ, Inst Sport Phys Act & Hlth, Leeds, W Yorkshire, England; [Jones, Ben; Till, Kevin] Yorkshire Carnegie Rugby Union Football Club, Leeds, W Yorkshire, England; [Lambert, Mike] Vrije Univ Amsterdam, Dept Publ & Occupat Hlth, Med Ctr, Amsterdam, Netherlands; [Lambert, Mike] Vrije Univ Amsterdam, EMGO Inst, Med Ctr, Amsterdam, Netherlands		Hendricks, S (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, ZA-7725 Newlands, South Africa.	sharief.hendricks01@gmail.com	Hendricks, Sharief/U-3278-2019; Till, Kevin/AAP-7379-2021	Hendricks, Sharief/0000-0002-3416-6266; Jones, Ben/0000-0002-4274-6236			Blair J, 2005, DESIGNING SURVEYS GU; Brown JC, 2016, INT J SPORTS SCI COA, V11, P637, DOI 10.1177/1747954116667100; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Burger N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005556; Carter AF, 2008, J SCI MED SPORT, V11, P167, DOI 10.1016/j.jsams.2007.01.004; Cushion C. J., 2006, INT J SPORTS SCI COA, V1, P247, DOI DOI 10.1260/174795406778604627; Department of Health Republic of South Africa, 2004, ETH HLTH RES PRINC S; Finch CF, 2010, BRIT J SPORT MED, V44, P973, DOI 10.1136/bjsm.2008.056069; Finch CF, 2011, BRIT J SPORT MED, V45, P1253, DOI 10.1136/bjsports-2011-090230; Hendricks S., 2013, South African Journal of Sports Medicine, V25, P8; Hendricks S, 2015, BMJ OPEN SPORT EXERC, V1, DOI DOI 10.1136/BMJSEM-2015-000046; HENDRICKS S, 2012, S AFR J SPORTS MED, V24, P122, DOI DOI 10.7196/SAJSM.357; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hendricks S, 2014, BRIT J SPORT MED, V48, P1115, DOI 10.1136/bjsports-2013-092877; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; Saunders N, 2010, BRIT J SPORT MED, V44, P1128, DOI 10.1136/bjsm.2009.069039; Stoszkowski J, 2016, J SPORT SCI, V34, P794, DOI 10.1080/02640414.2015.1072279; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; Twomey D, 2009, J SCI MED SPORT, V12, P452, DOI 10.1016/j.jsams.2008.04.002; White PE, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091987	24	9	10	0	10	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	DEC	2017	12	6					708	715		10.1177/1747954117738880			8	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FN9MD	WOS:000416360100002					2022-02-06	
J	Nanos, KN; Franco, JM; Larson, D; Mara, K; Laskowski, ER				Nanos, Katherine N.; Franco, John M.; Larson, Dirk; Mara, Kristin; Laskowski, Edward R.			Youth Sport-Related Concussions: Perceived and Measured Baseline Knowledge of Concussions Among Community Coaches, Athletes, and Parents	MAYO CLINIC PROCEEDINGS			English	Article							HOCKEY; PREVENTION	Objective: To assess concussion knowledge of athletes, coaches, and parents/guardians in a community setting and to understand trends/gaps in knowledge among subgroups to tailor efforts toward creating educational interventions. Participants and Methods: This prospective cross-sectional study involved 262 individuals (142 [55%] female): 115 athletes participating in noncontact and contact sports (ages 13-19 years), 15 coaches, and 132 parents. Recruitment occurred from August 30, 2015, through August 30, 2016, at 3 local high schools. Participants completed a questionnaire developed by the investigators to assess concussion experience and basic knowledge. Results: Females, health care employees, and parents showed stronger concern for potential long-term sequelae of concussion, whereas athletes were most concerned about not being able to return to sport. Those with higher perceived concussion knowledge were slightly older (median age, 42.5 vs 33 years), more educated (college or higher: 42 [70%] vs 100 [50%]), and more likely to be health care workers (22 [37.9%] vs 34 [17.7%]) and scored higher on knowledge questions (average correct: 75.5% vs 60%). Most participants could identify potential concussion sequelae, but only 86 (34.3%) identified a concussion as a brain injury. Of the subgroups, coaches scored highest on knowledge questions. Those with a concussion history tended to consider themselves more knowledgeable but were also less concerned about sequelae. Overall, those with a concussion history scored slightly higher on knowledge questions (average correct: 69.8% vs 61.9%). Participants involved in contact sports were more likely to have had a concussion vs those in noncontact sports (57 [26%] vs 4 [10.3%]). Conclusion: Significant differences in perceived and actual concussion knowledge across different subgroups of study participants involved in high school sports were identified. (C) 2017 Mayo Foundation for Medical Education and Research	[Nanos, Katherine N.; Franco, John M.; Laskowski, Edward R.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Laskowski, Edward R.] Mayo Clin, Mayo Clin Sports Med, Rochester, MN USA; [Larson, Dirk; Mara, Kristin] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Nanos, Katherine N.] Emory Univ, Dept Orthoped Sports & Spine, Atlanta, GA 30322 USA		Nanos, KN (corresponding author), High Performance Sports Med, 2300 Yonge St, Toronto, ON M4P 1E4, Canada.	katienanos@gmail.com			Department of Sports Medicine at Mayo Clinic in Rochester, Minnesota	This research received funding from the Department of Sports Medicine at Mayo Clinic in Rochester, Minnesota.	[Anonymous], 2012, HEADS UP HOCK; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15	14	9	9	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	DEC	2017	92	12					1782	1790		10.1016/j.mayocp.2017.10.003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO3SA	WOS:000416752300009	29202937				2022-02-06	
J	Oyegbile, TO; Delasobera, BE; Zecavati, N				Oyegbile, Temitayo Oyefunmike; Delasobera, Bronson Elizabeth; Zecavati, Nassim			Gender differences in sleep symptoms after repeat concussions	SLEEP MEDICINE			English	Article						Gender differences; Repeated concussions; Sleep; Cognitive function; Post-concussive symptoms; Neuropsychological testing	CHRONIC TRAUMATIC ENCEPHALOPATHY; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; HIGH-SCHOOL; NEUROPSYCHOLOGICAL FUNCTION; HEAD IMPACTS; BRAIN-INJURY; HISTORY; IMPAIRMENT; FEMALE	Objectives: There are notable gender differences in concussion as well as sleep. Sleep disturbance is a major symptom of post-concussive syndrome. The interplay between sleep disturbance, concussion, and gender has yet to be examined. The objective of this study was to determine whether sleep disturbance plays a role in the known gender differences associated with concussion. Methods: Males and females (ages 10-35 years) completed a pre-concussion and post-concussion evaluation. Levels of sleep disturbance were assessed at baseline (N = 1284), after first concussion (N = 432) and after repeated concussions (one or more concussions, N = 296). Sleep disturbance levels were also compared among males and females with headaches, mood changes, and cognitive dysfunction. Analyses included group comparisons and correlations of post-concussive symptoms and cognitive dysfunction, respectively. Data was adjusted for age. Results: Compared to males, females reported higher levels of sleep disturbance after a single concussion; however, levels of sleep disturbance equalized after repeated concussions. Females with higher levels of sleep disturbance had more headaches and more mood changes requiring medical treatment, compared to males. In addition, sleep disturbance was more strongly correlated with cognitive dysfunction in females compared to males. Conclusion: Gender differences in concussion recovery after repeat concussions may be primarily due to a difference in sleep disturbance between the genders. This difference in sleep appears to moderate the levels of other post-concussive symptoms. This indicates that sleep disturbance should be closely monitored and treated in females after a concussion. Further studies are required to determine the underlying reasons for these gender differences. (C) 2017 Elsevier B.V. All rights reserved.	[Oyegbile, Temitayo Oyefunmike; Delasobera, Bronson Elizabeth; Zecavati, Nassim] Georgetown Univ, Dept Pediat Neurol Sleep Med & Epilepsy, Washington, DC USA		Oyegbile, TO (corresponding author), MedStar Georgetown Univ Hosp, Pediat Neurol, Sleep Med & Epilepsy, 4200 Wisconsin Ave NW, Washington, DC 20016 USA.	Too3@georgetown.edu					Attarian H., 2016, J SLEEP MED DISORD, V3; Baker M, 2017, JAMA OTOLARYNGOL, P4130; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Basoglu OK, 2017, SLEEP BREATH; Boccabella A, 2017, J CLIN SLEEP MED, V13, P685, DOI 10.5664/jcsm.6584; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Krefting D, 2017, PHYSL MEAS; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oyegbile TO, SLEEP DISTU IN PRESS; Oyegbile TO, POSTCONCUSS IN PRESS; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Tang JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10837-6; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Yamada K, 2017, J PAIN RES, V10, P427, DOI 10.2147/JPR.S125556	42	9	9	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	DEC	2017	40						110	115		10.1016/j.sleep.2017.09.026			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO8SK	WOS:000417157400017	29221773				2022-02-06	
J	Scofield, DE; Proctor, SP; Kardouni, JR; Hill, OT; McKinnon, CJ				Scofield, Dennis E.; Proctor, Susan P.; Kardouni, Joseph R.; Hill, Owen T.; McKinnon, Craig J.			Risk Factors for Mild Traumatic Brain Injury and Subsequent Post-Traumatic Stress Disorder and Mental Health Disorders among United States Army Soldiers	JOURNAL OF NEUROTRAUMA			English	Article						military; mTBI; PTSD	PERSISTENT POSTCONCUSSIVE SYMPTOMS; IRAQ WAR DEPLOYMENT; MILITARY PERSONNEL; PSYCHIATRIC COMORBIDITY; MARINE CORPS; US ARMY; AFGHANISTAN; CARE; PTSD; EPIDEMIOLOGY	The purpose of this study was to determine the association of mild traumatic brain injury (mTBI) with subsequent posttraumatic stress disorder (PTSD) and mental health disorders (MHD), and the intervening role of acute stress disorder (ASD). This matched case-control study utilized the Total Army Injury and Health Outcomes Database (TAIHOD) to analyze soldiers' (n = 1,261,297) medical encounter data between 2002 and 2011. International Classification of Diseases, Ninth Revision (ICD-9) codes were used to identify: mTBI (following Centers for Disease Control [CDC] surveillance definition for mTBI), MHD (ICD-9 codes for depression and anxiety, excluding PTSD), PTSD (ICD-9 309.81), and ASD (ICD-9 308.3). Incident cases of mTBI (n = 79,505), PTSD (n = 71,454), and MHD (n = 285,731) were identified. Overall incidence rates per 1000 soldier years were: mTBI = 17.23, PTSD = 15.37, and MHD= 67.99. mTBI was associated with increased risk for PTSD (risk ratio [RR] 5.09, 95% confidence interval [CI] 4.82-5.37) and MHD (RR 2.94, 95% CI 2.84-3.04). A sub-analysis of the mTBI-only soldiers found that a diagnosis ASD, compared with a diagnosis of no ASD, was associated with greater risk for subsequent PTSD (RR 2.13, 95% CI 1.96-2.32) and MHD (RR 1.90, 95% CI 1.72-2.09) following mTBI. Results indicate that soldiers with previous mTBI have a higher risk for PTSD and MHD, and that ASD may also mediate PTSD and MHD risk subsequent to mTBI. These data may help guide important surveillance and clinical rehabilitation considerations for high-risk populations.	[Scofield, Dennis E.; Proctor, Susan P.; Kardouni, Joseph R.; McKinnon, Craig J.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA 01760 USA; VA Boston Healthcare Syst, Boston, MA USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Hill, Owen T.] MEDCOM AMEDD C&S, HR CoE, Jbsa Ft Sam Houston, TX USA		Scofield, DE (corresponding author), US Army Res Inst Environm Med, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA.	Dennis.scofield@outlook.com	Scofield, Dennis/AAC-6775-2019	Scofield, Dennis/0000-0003-4478-9640			Abram KM, 2007, PSYCHIAT SERV, V58, P1311, DOI 10.1176/appi.ps.58.10.1311; Amoroso P J, 1999, Mil Med, V164, P1; [Anonymous], 1998, NIH Consens Statement, V16, P1; Auxemery Y, 2012, ENCEPHALE, V38, P373, DOI 10.1016/j.encep.2011.12.003; Barr T, 2015, ANNU REV NURS RES-SE, V33, P249, DOI 10.1891/0739-6686.33.249; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Carey PD, 2003, J NERV MENT DIS, V191, P230, DOI 10.1097/00005053-200304000-00003; [Anonymous], 2014, MSMR, V21, P2; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Franklin CL, 2001, J NERV MENT DIS, V189, P548, DOI 10.1097/00005053-200108000-00008; Gahm GA, 2007, J CLIN PSYCHOL, V63, P199, DOI 10.1002/jclp.20330; Garvey-Wilson A. L., 2003, SYLL P 156 ANN M AM, P23; Gray GC, 2002, MIL MED, V167, P483, DOI 10.1093/milmed/167.6.483; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; Hunt E. J., 2016, OCCUP MED LOND; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McMillen C, 2002, COMPR PSYCHIAT, V43, P478, DOI 10.1053/comp.2002.34632; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Center for Injury Prevention and Control, 2015, DOD WORLDW NUMB TBI; Norris JN, 2015, BRAIN INJURY, V29, P898, DOI 10.3109/02699052.2015.1022879; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Packnett ER, 2012, J TRAUMA STRESS, V25, P485, DOI 10.1002/jts.21743; Pavlin Julie A, 2004, MMWR Suppl, V53, P166; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Vasterling JJ, 2016, AM J EPIDEMIOL, V184, P796, DOI 10.1093/aje/kww151; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044; Zhou DY, 2016, NEUROSCI LETT, V610, P154, DOI 10.1016/j.neulet.2015.10.055	51	9	9	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3249	3255		10.1089/neu.2017.5101			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000416341700005	28895451				2022-02-06	
J	Simon-Pimmel, J; Lorton, F; Masson, D; Bouvier, D; Hanf, M; Guen, CGL				Simon-Pimmel, Jeanne; Lorton, Fleur; Masson, Damien; Bouvier, Damien; Hanf, Matthieu; Guen, Christele Gras-Le			Reference ranges for serum S100B neuroprotein specific to infants under four months of age	CLINICAL BIOCHEMISTRY			English	Article						Reference ranges; S100B protein; Head trauma; Children; Infants	PROTEIN; HEAD; CHILDREN; TRAUMA; BLOOD	Background: Minor head traumatisms are a common reason for consultation in paediatric emergency departments. The diagnosis of traumatic brain injuries involves performing a cranial computed tomography (CCT), associated with a risk of cancer due to the radiation. The serum S100B is an effective biomarker used to reduce reliance on CCT. While reference ranges have been determined, the limited number of cases regarding infants less than 4 months of age has not allowed this biomarker to be used with this age group. Our study aimed to determine reference ranges for serum S100B based on a larger number of infants from birth to 4 months of age. Methods: Three centres included infants coming to the hospital for whom blood samples were taken. These samples were analysed to determine the upper reference values based on the 95th percentile. Results: 135 samples were analysed. The upper reference value was 0.51 mu g/L for children aged 0 to 4 months. There was no effect of the gender. Conclusions: This study provides serum S100B reference ranges based on the largest group of neurologically healthy 0 to 4-month-old infants analysed to date. Reliable reference values of S100B for children are now determined. It is the first step towards validation of thresholds for studies integrating S100B into a clinical decision rule for MHT in children.	[Simon-Pimmel, Jeanne; Lorton, Fleur; Guen, Christele Gras-Le] Univ Hosp Nantes, Dept Paediat Emergency, Nantes, France; [Masson, Damien] Univ Hosp Nantes, Dept Biol, Nantes, France; [Bouvier, Damien] Univ Hosp Clermont Ferrand, Dept Biol, Clermont Ferrand, France; [Lorton, Fleur; Hanf, Matthieu; Guen, Christele Gras-Le] Univ Hosp Nantes, Clin Invest Ctr, Nantes, France		Simon-Pimmel, J (corresponding author), CHU Nantes, F-44093 Nantes 01, France.	jeanne.pimmel@chu-nantes.fr		Bouvier, Damien/0000-0002-2707-4320; SIMON-PIMMEL, Jeanne/0000-0003-0699-5793; Hanf, Matthieu/0000-0001-7133-1323; Lorton, Fleur/0000-0003-0921-4622			Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Castellani C, 2008, CLIN CHEM LAB MED, V46, P1296, DOI 10.1515/CCLM.2008.262; CLSI, 2008, EP28A3C CLSI; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 1999, J NEUROL SCI, V170, P32, DOI 10.1016/S0022-510X(99)00194-X; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; R Development Core Team, 2008, R LANG ENV STAT COMP; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schulpis KH, 2006, SCAND J CLIN LAB INV, V66, P733, DOI 10.1080/00365510600977737; Simon-Pimmel J, 2015, SHOCK, V44, P410, DOI 10.1097/SHK.0000000000000442; Wirds J. W., 2003, ARCH DIS CHILD FETAL, V88	15	9	9	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	DEC	2017	50	18					1056	1060		10.1016/j.clinbiochem.2017.08.014			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FN4OT	WOS:000415987300014	28867331				2022-02-06	
J	Yang, Y; Zong, YB; Sun, QW; Jia, YM; Zhao, RQ				Yang, Yang; Zong, Yibo; Sun, Qinwei; Jia, Yimin; Zhao, Ruqian			White light emitting diode suppresses proliferation and induces apoptosis in hippocampal neuron cells through mitochondrial cytochrome c oxydase-mediated IGF-1 and TNF-alpha pathways	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						White LED light; Proliferation; Apoptosis; Cco/ROS; IGF-1; TNF-alpha; Hippocampal neuron cells	NECROSIS-FACTOR-ALPHA; LEVEL LASER THERAPY; IN-VIVO; MEMBRANE PERMEABILIZATION; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; GROWTH-FACTORS; CYCLE ARREST; NITRIC-OXIDE; CANCER CELLS	Light emitting diode (LED) light has been tested to treat traumatic brain injury, neural degenerative diseases and psychiatric disorders. Previous studies indicate that blue LED light affects cell proliferation and apoptosis in photosensitive cells and cancer cells. In this study, we demonstrate that white LED light exposure impaired proliferation and induced apoptosis in HeLa and HT-22 hippocampal neural cells, but not C2C12 cells. Furthermore, the mechanisms underlying the effect of white LED light exposure on HT-22 cells were elucidated. In HeLa and HT-22 cells, white LED light activated mitochondrial cytochrome c oxidase (Cco), in association with enhanced ATP synthase activity and elevated intracellular ATP concentration. Also, reactive oxygen species (ROS) and nitric oxide (NO) production were increased, accompanied by higher calcium concentration and lower mitochondrial membrane potential. HT-22 cells exposed to white LED light for 24 h showed reduced viability, with higher apoptotic rate and a cell cycle arrest at G0/G1 phase. Concurrently, the mRNA expression and the concentration of IGF-1 were decreased, while that of TNF-alpha were increased, in light-exposed cells, which was supported by the luciferase activity of both gene promoters. The down-stream mitogen-activated protein kinase (MAPK), AKT/mTOR pathways were inhibited, in association with an activation of apoptotic caspase 3. N-Acetylcysteine, a ROS scavenger, protected the cells from LED light-induced cellular damage, with rescued cell viability and restored mRNA expression of IGF-1 and TNF-alpha. Our data demonstrate that white LED light suppresses proliferation and induces apoptosis in hippocampal neuron cells through mitochondrial Cco/ROS-mediated IGF-1 and TNF-alpha pathways.	[Yang, Yang; Zong, Yibo; Sun, Qinwei; Jia, Yimin; Zhao, Ruqian] Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing 210095, Jiangsu, Peoples R China; [Zhao, Ruqian] Jiangsu Collaborat Innovat Ctr Meat Prod & Proc Q, Nanjing 210095, Jiangsu, Peoples R China		Zhao, RQ (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol Biochem, Nanjing 210095, Jiangsu, Peoples R China.	zhao.ruqian@gmail.com			National Basic Research Program of ChinaNational Basic Research Program of China [2012CB124703]; Special Fund for Agro-scientific Research in the Public Interest [201003011]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [KYZ201212]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Basic Research Program of China (2012CB124703), the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Fundamental Research Funds for the Central Universities (KYZ201212) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Anderson MF, 2002, DEV BRAIN RES, V134, P115; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bartsch T, 2015, NEUROSCIENCE, V309, P1, DOI 10.1016/j.neuroscience.2015.07.084; Basha AA, 2016, LASER MED SCI, V31, P1803, DOI 10.1007/s10103-016-2054-0; BEAUVOIT B, 1994, BIOPHYS J, V67, P2501, DOI 10.1016/S0006-3495(94)80740-4; Bessis A, 2005, NEUROSCIENTIST, V11, P277, DOI 10.1177/1073858404270905; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chang CC, 2015, CHEM RES TOXICOL, V28, P1574, DOI 10.1021/acs.chemrestox.5b00150; Cui J, 2011, NEUROSCI LETT, V503, P244, DOI 10.1016/j.neulet.2011.08.045; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; del Olmo-Aguado S, 2016, NEUROCHEM RES, V41, P2324, DOI 10.1007/s11064-016-1946-5; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Droge W, 2005, J GERONTOL A-BIOL, V60, P1378, DOI 10.1093/gerona/60.11.1378; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; FRANKLE RT, 1976, AM J CLIN NUTR, V29, P105, DOI 10.1093/ajcn/29.1.105; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hatakeyama T, 2013, ONCOL REP, V29, P911, DOI 10.3892/or.2013.2220; He B, 2016, J CELL PHYSIOL, V231, P233, DOI 10.1002/jcp.25076; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Higuchi M, 2010, OLIGONUCLEOTIDES, V20, P37, DOI 10.1089/oli.2008.0173; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Kim S, 2013, PHOTOMED LASER SURG, V31, P554, DOI 10.1089/pho.2012.3343; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kroft EBM, 2008, J AM ACAD DERMATOL, V59, P1017, DOI 10.1016/j.jaad.2008.07.042; Kuang CY, 2010, BIOCHEM BIOPH RES CO, V398, P315, DOI 10.1016/j.bbrc.2010.06.088; Kuse Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05223; Lamothe B, 1998, FEBS LETT, V426, P381, DOI 10.1016/S0014-5793(98)00377-9; Leal SL, 2015, TRENDS NEUROSCI, V38, P800, DOI 10.1016/j.tins.2015.10.003; Lim W, 2007, LASER SURG MED, V39, P614, DOI 10.1002/lsm.20533; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Moriyama Y, 2009, LASER SURG MED, V41, P227, DOI 10.1002/lsm.20745; Niblock MM, 2000, J NEUROSCI, V20, P4165; Oh PS, 2016, INT J BIOCHEM CELL B, V70, P13, DOI 10.1016/j.biocel.2015.11.004; Oh PS, 2015, J PHOTOCH PHOTOBIO B, V142, P197, DOI 10.1016/j.jphotobiol.2014.12.006; Ozsoy HZ, 2008, J BIOL CHEM, V283, P23419, DOI 10.1074/jbc.M802967200; Pan WH, 1997, NEUROSCI BIOBEHAV R, V21, P603, DOI 10.1016/S0149-7634(96)00047-4; Pardo J, 2016, EUR J NEUROSCI, V44, P2120, DOI 10.1111/ejn.13278; Patel AD, 2014, ANTICANCER RES, V34, P6305; Shan L. L., 2016, SCI REP UK, V6; Shen Y, 2016, EXP EYE RES, V145, P456, DOI 10.1016/j.exer.2015.09.016; Trivedi R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.429; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Xie C, 2014, PHOTOCHEM PHOTOBIOL, V90, P853, DOI 10.1111/php.12250; Yang Y, 2016, INT J BIOCHEM CELL B, V79, P222, DOI 10.1016/j.biocel.2016.08.040; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Zhang SY, 2016, TOXICOL APPL PHARM, V309, P77, DOI 10.1016/j.taap.2016.08.023; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x	53	9	9	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC	2017	113						413	423		10.1016/j.freeradbiomed.2017.10.382			11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	FN2FP	WOS:000415806800038	29106990				2022-02-06	
J	Stephens, JA; Salorio, CE; Gomes, JP; Nebel, MB; Mostofsky, SH; Suskauer, SJ				Stephens, Jaclyn A.; Salorio, Cynthia E.; Gomes, Jerald P.; Nebel, Mary Beth; Mostofsky, Stewart H.; Suskauer, Stacy J.			Response Inhibition Deficits and Altered Motor Network Connectivity in the Chronic Phase of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						functional connectivity; motor network; pediatric TBI; response inhibition	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; INTRASUBJECT VARIABILITY; CHILDREN; FMRI; ADHD; TBI; ADOLESCENTS; IMPAIRMENT; CHILDHOOD; RECOVERY	Poor response inhibition is a hallmark of pediatric traumatic brain injury (TBI). We assessed motor response inhibition by measuring commission error rates on Simple (minimized cognitive demands) and Motivation (monetary reward) Go/No-Go tasks, comparing 17 children with chronic TBI (>1 year post-injury) and 14 matched, uninjured peers. Using resting state functional magnetic resonance imaging (fMRI), we examined between-group differences in whole-brain intrinsic connectivity of the motor network as derived from the averaged time course of bilateral primary motor cortex seeds, to identify regions of interest (ROIs) for brain-behavior correlations. Independent sample t tests compared Go/No-Go performance and connectivity at the ROI level. Pearson correlations examined relationships between intrinsic connectivity at the ROI level and Go/No-Go performance. Adolescents with TBI showed poorer performance on Simple and Motivation Go/No-Go tasks compared with controls. In whole-brain contrasts, adolescents with TBI showed significantly reduced functional connectivity between the motor network and voxels within the left caudate. Furthermore, in ROI analyses, the group with TBI had significantly lower connectivity between the motor network and left caudate and numerically lower connectivity between the motor network and right caudate. In adolescents with TBI, lower motor network to left caudate connectivity correlated with poorer Simple task performance; lower motor network to right caudate connectivity correlated with poorer Simple and Motivation task performance. No significant brain-behavior relationships existed among controls. These results are consistent with previous pediatric TBI literature and suggest that disrupted intrinsic connectivity of a corticostriatal motor network may contribute to response inhibition deficits.	[Stephens, Jaclyn A.; Salorio, Cynthia E.; Gomes, Jerald P.; Nebel, Mary Beth; Mostofsky, Stewart H.; Suskauer, Stacy J.] Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA; [Stephens, Jaclyn A.; Salorio, Cynthia E.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Gomes, Jerald P.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Nebel, Mary Beth; Mostofsky, Stewart H.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Mostofsky, Stewart H.; Suskauer, Stacy J.] Howard Univ, Coll Med, Washington, DC USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA.	Suskauer@kennedykrieger.org	Nebel, Mary Beth/D-3305-2015	Nebel, Mary Beth/0000-0003-0185-3382	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD007414, R01MH078160, R01MH085328, K23HD06161]; National Institute of Health National Center for Research Resources Clinical and Translational Science Awards Program [UL1TR001079-04]; Rehabilitation Research Experience for Medical Students (RREMS) Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123, T32HD007414] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health (J.S. 5T32HD007414), (S.M., R01MH078160 & R01MH085328), (S.S., K23HD06161) the National Institute of Health National Center for Research Resources Clinical and Translational Science Awards Program (S.S., UL1TR001079-04), and the Rehabilitation Research Experience for Medical Students (RREMS) Program (JG).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kriegeskorte N, 2010, J CEREBR BLOOD F MET, V30, P1551, DOI 10.1038/jcbfm.2010.86; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Leunissen I, 2016, HUM BRAIN MAPP, V37, P4706, DOI 10.1002/hbm.23338; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Lindquist MA, 2015, PSYCHOSOM MED, V77, P114, DOI 10.1097/PSY.0000000000000148; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Massat I, 2016, WORLD J BIOL PSYCHIA, P1; Mostofsky SH, 2003, PERCEPT MOTOR SKILL, V97, P1315, DOI 10.2466/PMS.97.8.1315-1331; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Rosch KS, 2015, BIOL PSYCHOL, V110, P12, DOI 10.1016/j.biopsycho.2015.06.010; Rosch KS, 2013, J ABNORM CHILD PSYCH, V41, P485, DOI 10.1007/s10802-012-9690-z; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Stephens J, 2017, J MOTOR BEHAV, V49, P20, DOI 10.1080/00222895.2016.1204267; Suskauer SJ, 2008, J AM ACAD CHILD PSY, V47, P1141, DOI 10.1097/CHI.0b013e3181825b1f; Tlustos SJ, 2015, J PEDIATR REHAB MED, V8, P321, DOI 10.3233/PRM-150350; van Rooij D, 2015, NEUROIMAGE-CLIN, V7, P325, DOI 10.1016/j.nicl.2015.01.004; Wodka EL, 2007, J CLIN EXP NEUROPSYC, V29, P345, DOI 10.1080/13803390600678046; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	39	9	9	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3117	3123		10.1089/neu.2017.5081			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000007	28648110	Green Published			2022-02-06	
J	Mancuso, M; Abbruzzese, L; Canova, S; Landi, G; Rossi, S; Santarnecchi, E				Mancuso, Mauro; Abbruzzese, Laura; Canova, Stefania; Landi, Giulia; Rossi, Simone; Santarnecchi, Emiliano			Transcranial Random Noise Stimulation Does Not Improve Behavioral and Neurophysiological Measures in Patients with Subacute Vegetative-Unresponsive Wakefulness State (VS-UWS)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						non-invasive brain stimulation; disorders of consciousness; transcranial electric stimulation; tRNS; vegetative state	DISORDERS; CONSCIOUSNESS; COMA; NEUROPLASTICITY; PERCEPTION; NETWORKS; RECOVERY; INDEX; TDCS	Background: The absence of efficient treatments capable to promote central nervous system recovery in patients in vegetative state (VS) due to a severe acquired brain injury highlights the need of exploring alternative neuromodulatory treatments that can lead to neurobehavioral gains. Some encouraging preliminary observations suggest that transcranial direct current stimulation could be effective in disorders of consciousness (DoC) patients, especially when applied on the dorsolateral prefrontal cortex (DLPFC) in patients with minimally conscious state (MCS) but not in those with VS. Objective: The primary aim of the present study was to verify if the application of transcranial random noise stimulation (tRNS) on the DLPFC might favor improvements of consciousness recovery in subacute VS-UWS. Methods: Nine patients with DoC due to traumatic brain injury (n = 1), anoxia (n = 3), and vascular damage (n = 5), have undergone a randomized, double-blind, sham-controlled, neuromodulatory trial with tRNS of bilateral DLPFC. All patients were in a post-acute phase and the DoC onset ranged from 30 days to 4 months. The diagnosis of DoC was based on internationally established criteria from the Multi-Society Task Force on PVS, and classified as VS or MCS using the JFK Coma Recovery Scale-Revised scores (CRS-R). We used CRS-R, Synek Scale, Ad-Hoc semi-quantitative scale and the Clinical Global Impression-Improvement scale to measure behavioral and electrophysiological changes during tRNS intervention. All patients were also treated with daily conventional rehabilitation treatment. Results: No significant differences emerged between active and sham groups regarding improvements of level of consciousness, as well as on electroencephalographic data. Only one patient showed emergence from VS-UWS, evolving from VS to MCS after the tRNS stimulation, at a distance of 3 weeks from the enrolment into the study. Conclusion: Repeated applications of tRNS of the DLPFC, even if applied in a subacute phase of VS-UWS state, did not modify behavioral and neurophysiological outcomes differently than sham stimulation.	[Mancuso, Mauro; Abbruzzese, Laura; Canova, Stefania] Tuscany Rehabil Clin, Montevarchi, Italy; [Landi, Giulia; Rossi, Simone; Santarnecchi, Emiliano] Univ Siena, Dept Med Surg & Neurosci, Siena Brain Invest & Neuromodulat Lab, Siena, Italy; [Santarnecchi, Emiliano] Harvard Med Sch, Dept Cognit Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA USA		Mancuso, M (corresponding author), Tuscany Rehabil Clin, Montevarchi, Italy.	m.mancuso62@gmail.com	Abbruzzese, Laura/J-6703-2018; Santarnecchi, Emiliano/H-7528-2017; Rossi, Simone/AAC-6067-2022; Mancuso, Mauro/J-6773-2018	Abbruzzese, Laura/0000-0002-5304-3974; Santarnecchi, Emiliano/0000-0002-6533-7427; Rossi, Simone/0000-0001-6697-9459; Mancuso, Mauro/0000-0002-8451-9277	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) [2014-13121700007]; Beth Israel Deaconess Medical Center (BIDMC) [60182]; Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [HR001117S0030]	ES is partially supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via 2014-13121700007. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the ODNI, IARPA, or the U.S. Government. ES is supported by the Beth Israel Deaconess Medical Center (BIDMC) via the Chief Academic Officer (CAO) grant 2017 (#60182), and the Defense Advanced Research Projects Agency (DARPA) via HR001117S0030.	Ambrus GG, 2010, CLIN NEUROPHYSIOL, V121, P1908, DOI 10.1016/j.clinph.2010.04.020; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bestmann S, 2015, TRENDS COGN SCI, V19, P13, DOI 10.1016/j.tics.2014.10.003; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; CALVET J, 1959, Rev Otoneuroophtalmol, V31, P443; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Guy W., 1976, ASSESSMENT MANUAL PS, P76; JENNETT B, 1972, LANCET, V1, P734; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Kretschmer E, 1940, Z GESAMTE NEUROL PSY, V169, P576, DOI 10.1007/BF02871384; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Moliadze V, 2012, BRAIN STIMUL, V5, P505, DOI 10.1016/j.brs.2011.11.004; Nitsche MA, 2009, J NEUROSCI, V29, P2648, DOI 10.1523/JNEUROSCI.5366-08.2009; Pirulli C, 2013, BRAIN STIMUL, V6, P683, DOI 10.1016/j.brs.2012.12.005; Ragazzoni A, 2017, CLIN NEUROPHYSIOL, V128, P1629, DOI 10.1016/j.clinph.2017.06.037; Ragazzoni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057069; Romanska A, 2015, CEREB CORTEX, V25, P4334, DOI 10.1093/cercor/bhv016; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Santarnecchi E, 2015, CURR OPIN BEHAV SCI, V4, P171, DOI 10.1016/j.cobeha.2015.06.003; Schiff ND, 2014, CURR OPIN NEUROBIOL, V25, P7, DOI 10.1016/j.conb.2013.10.007; Snowball A, 2013, CURR BIOL, V23, P987, DOI 10.1016/j.cub.2013.04.045; Stacey WC, 2000, J NEUROPHYSIOL, V83, P1394, DOI 10.1152/jn.2000.83.3.1394; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488	35	9	9	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 6	2017	11								524	10.3389/fnhum.2017.00524			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	FL7ET	WOS:000414410200001	29163104	Green Published, gold			2022-02-06	
J	Ardesch, DJ; Balbi, M; Murphy, TH				Ardesch, Dirk Jan; Balbi, Matilde; Murphy, Timothy H.			Automated touch sensing in the mouse tapered beam test using Raspberry Pi	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Tapered beam test; Raspberry Pi; Automation; Mouse; Behavior; Stroke	TRAUMATIC BRAIN-INJURY; NEUTROPHIL INFILTRATION; MICROGLIAL ACTIVATION; MICE; RATS; MINOCYCLINE; STROKE; CORTEX	Background: Rodent models of neurological disease such as stroke are often characterized by motor deficits. One of the tests that are used to assess these motor deficits is the tapered beam test, which provides a sensitive measure of bilateral motor function based on foot faults (slips) made by a rodent traversing a gradually narrowing beam. However, manual frame-by-frame scoring of video recordings is necessary to obtain test results, which is time-consuming and prone to human rater bias. New method: We present a cost-effective method for automated touch sensing in the tapered beam test. Capacitive touch sensors detect foot faults onto the beam through a layer of conductive paint, and results are processed and stored on a Raspberry Pi computer. Results: Automated touch sensing using this method achieved high sensitivity (96.2%) as compared to 'gold standard' manual video scoring. Furthermore, it provided a reliable measure of lateralized motor deficits in mice with unilateral photothrombotic stroke: results indicated an increased number of contralesional foot faults for up to 6 days after ischemia. Comparison with existing method: The automated adaptation of the tapered beam test produces results immediately after each trial, without the need for labor-intensive post-hoc video scoring. It also increases objectivity of the data as it requires less experimenter involvement during analysis. Conclusions: Automated touch sensing may provide a useful adaptation to the existing tapered beam test in mice, while the simplicity of the hardware lends itself to potential further adaptations to related behavioral tests. (C) 2017 Elsevier B.V. All rights reserved.	[Ardesch, Dirk Jan; Balbi, Matilde; Murphy, Timothy H.] Univ British Columbia, Kinsmen Lab Neurol Res, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Ardesch, Dirk Jan] Univ Utrecht, Grad Sch Life Sci, Master Program Neurosci & Cognit, Utrecht, Netherlands; [Balbi, Matilde; Murphy, Timothy H.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 1Z3, Canada		Murphy, TH (corresponding author), 2255 Wesbrook Mall,Detwiller Pavil, Vancouver, BC V6T 1Z3, Canada.	thmurphy@mail.ubc.ca	Murphy, Timothy H/I-4982-2014; Balbi, Matilde/ABC-2246-2021; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490; Ardesch, Dirk Jan/0000-0003-0341-5554; Balbi, Matilde/0000-0003-4590-5447	Canadian Institute of Health Research FoundationCanadian Institutes of Health Research (CIHR) [FDN143209]; Brain Canada Neurophotonics Platform; Leducq FoundationLeducq Foundation	This work was supported by the Canadian Institute of Health Research Foundation (FDN143209), the Brain Canada Neurophotonics Platform, and the Leducq Foundation. We thank Luis Bolarios and Jessica Lee for assistance with electronic artwork and video analysis and Jamie Boyd for advice with software and electronics.	Balbi M, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.3.035001; Bolanos F, 2017, J NEUROSCI METH, V276, P79, DOI 10.1016/j.jneumeth.2016.11.011; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Caleo M, 2015, NEUROSCIENCE, V311, P180, DOI 10.1016/j.neuroscience.2015.10.029; Chen CC, 2014, JOVE-J VIS EXP, DOI 10.3791/51238; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Farr TD, 2002, STROKE, V33, P1869, DOI 10.1161/01.STR.0000020714.48349.4E; Fenrich KK, 2015, BEHAV BRAIN RES, V281, P137, DOI 10.1016/j.bbr.2014.11.048; GraphPad Software, 2017, GRAPHPAD PRISM VERS; Lipsanen A, 2011, PHARMACOL BIOCHEM BE, V99, P468, DOI 10.1016/j.pbb.2011.04.019; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mar AC, 2013, NAT PROTOC, V8, P1985, DOI 10.1038/nprot.2013.123; Metz G. A., 2009, JOVE-J VIS EXP, P2; Murphy TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11611; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; R Core Team, 2017, R LANG ENV STAT COMP; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Schallert T, 2000, CONT NEUROS, P131; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Silasi G, 2016, J NEUROSCI METH, V267, P141, DOI 10.1016/j.jneumeth.2016.04.012; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Spanevello MD, 2013, J NEUROTRAUM, V30, P1023, DOI 10.1089/neu.2012.2729; Tarlac V, 2013, CEREBELLUM, V12, P370, DOI 10.1007/s12311-012-0425-z; Tennant KA, 2009, J NEUROSCI METH, V181, P18, DOI 10.1016/j.jneumeth.2009.04.009; Van Rossum G., 1995, PYTHON; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhao CS, 2005, BEHAV BRAIN RES, V156, P85, DOI 10.1016/j.bbr.2004.05.011	30	9	9	0	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	NOV 1	2017	291						221	226		10.1016/j.jneumeth.2017.08.030			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FJ9AP	WOS:000413060100024	28860079				2022-02-06	
J	Brooks, DM; Patel, SA; Wohlgehagen, ED; Semmens, EO; Pearce, A; Sorich, EA; Rau, TF				Brooks, Diane M.; Patel, Sarjubhai A.; Wohlgehagen, Eric D.; Semmens, Erin O.; Pearce, Alan; Sorich, Edmond A.; Rau, Thomas F.			Multiple mild traumatic brain injury in the rat produces persistent pathological alterations in the brain	EXPERIMENTAL NEUROLOGY			English	Article						Repetitive traumatic brain injury; Persistent neuropathology	POSTCONCUSSION SYNDROME; COGNITIVE DEFICITS; MEMORY RETRIEVAL; EYE-MOVEMENTS; HEAD-INJURY; FATIGUE; MODEL; WHITE; NEUROINFLAMMATION; ENCEPHALOPATHY	Multiple mild traumatic brain injury (mmTBI), in certain cases, produces persistent symptoms. However, the molecular mechanisms underlying these symptoms remain unclear. Here, we demonstrate extended pathological changes in the rat brain following mmTBI. Using the lateral fluid percussion (LFP) technique we exposed adult male Wistar rats to a mild TBI (mTBI) once a week for four weeks and compared them to surgical shams. At 90 days following the last TBI or sham procedure the animals were cognitively tested in the Morris Water Maze (MWM), euthanized, and the brains removed for immunohistochemistry. At 90 days following the last mTBI, NRF-2 staining was significantly decreased in the hilus of the hippocampus and cortex on the injured side, but did not significantly differ from shams on the un-injured side. CD68 positive microglia were significantly increased in the ipsilateral corpus callosum, cortex, and internal capsule of injured animals. Reactive astrocytosis, determined by increased GFAP staining, was also evident in the corpus callosum, cortex, internal capsule and thalamus on the injured side. Interestingly, the corpus callosum thickness at the midline was decreased in injured animals and had evident demyelination when compared to sham animals. Despite these findings, there were no significant differences in neurological assessments at 90 days following the last injury. In MWM testing there were not significant differences in the training phase, the time spent in the thigmotaxia zone, or the target quadrant during the probe trial. However, there were significant differences between shams and injured animals in platform zone crossings during the probe trial. These results demonstrate that repetitive head trauma may produce persistent, long-term pathological alterations in brain architecture that may be difficult to detect using standard cognitive and neurological assessments.	[Brooks, Diane M.; Patel, Sarjubhai A.; Wohlgehagen, Eric D.; Rau, Thomas F.] Univ Montana, Neurol Injury Ctr, Skaggs Bldg Rio 478,32 Campus Dr, Missoula, MT 59812 USA; [Pearce, Alan] Univ Melbourne, Melbourne Sch Hlth Sci, Melbourne, Vic 3010, Australia; [Pearce, Alan] Swinburne Univ Technol, Fac Hlth Arts & Design, Hawthorn, Vic 3122, Australia; [Sorich, Edmond A.] GLIA Diagnost, POB 138N, Armadale, Vic 3143, Australia; [Semmens, Erin O.] Univ Montana, Sch Publ & Community Hlth Sci, Missoula, MT 59812 USA		Rau, TF (corresponding author), Univ Montana, Neurol Injury Ctr, Skaggs Bldg Rio 478,32 Campus Dr, Missoula, MT 59812 USA.	Thomas.rau@mso.umt.edu	Pearce, Alan J/W-1195-2018	Pearce, Alan J/0000-0002-9264-9880	Montana University System Research Initiative through the Neural Injury Center at The University of Montana; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1U54GM104944]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104944] Funding Source: NIH RePORTER	This work was funded by the Montana University System Research Initiative through the Neural Injury Center at The University of Montana. Additional support was provided by NIGMS 1U54GM104944.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Baschera D, 2015, J NEUROTRAUM, V32, P557, DOI 10.1089/neu.2014.3604; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Christman SD, 2001, NEUROPSYCHOLOGY, V15, P607, DOI 10.1037//0894-4105.15.4.607; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Guinto G, 2014, WORLD NEUROSURG, V82, P627, DOI 10.1016/j.wneu.2013.10.016; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Johansson R, 2014, PSYCHOL SCI, V25, P236, DOI 10.1177/0956797613498260; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lyle KB, 2008, NEUROPSYCHOLOGY, V22, P523, DOI 10.1037/0894-4105.22.4.523; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Narasimhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051111; Nieuwenhuis S, 2013, BRAIN COGNITION, V81, P52, DOI 10.1016/j.bandc.2012.10.003; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rau TF, 2014, INT J MOL SCI, V15, P1402, DOI 10.3390/ijms15011402; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruth EB, 1935, ANAT REC, V64, P1, DOI 10.1002/ar.1090640102; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	47	9	9	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2017	297						62	72		10.1016/j.expneurol.2017.07.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FJ3GA	WOS:000412617300006	28756201				2022-02-06	
J	Goodson, JT; Helstrom, AW; Marino, EJ; Smith, RV				Goodson, Jason T.; Helstrom, Amy W.; Marino, Emily J.; Smith, Rachel V.			The Impact of Service-Connected Disability and Therapist Experience on Outcomes From Prolonged Exposure Therapy With Veterans	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						Veterans; PTSD; prolonged exposure therapy	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PTSD; IRAQ; COMPENSATION; IMPLEMENTATION; DEPLOYMENT; SEEKING	Objective: Although prolonged exposure therapy (PE) has been shown to be effective in treating posttraumatic stress disorder (PTSD), a sizable minority do not benefit. Examining patient and therapist characteristics that impact treatment outcome may improve treatment delivery and identify individuals who are less likely to respond to treatment or are at risk to prematurely discontinue treatment. The current study uses a sample from a large urban Veterans' Affairs (VA) hospital to build on a previous report that identified correlates of treatment outcome for Veterans who received PE. Method: Two hundred eighty-seven veterans completed measures of PTSD, depression, and quality of life at the beginning and end of treatment. Veterans' service-connected disability rating, therapist experience, benzodiazepine prescription, and traumatic brain injury diagnosis were investigated as predictors of treatment outcome in linear regression analyses. Results: Results showed that Veterans with a service-connected disability for a mental health condition had smaller treatment gains than those without service connection (p < .01). Additionally, results showed that patients treated by certified PE therapists had larger treatment gains than those treated by noncertified PE therapists (p < .01). Finally, younger age and therapist certification were associated with dropout from treatment (p < .05). Conclusion: Veterans treated by PE-certified therapists and Veterans who were not service-connected for a mental health condition fared better in treatment. Results suggest that additional study of both the national effort to train VA clinicians in PE and the impact of service connection on PTSD treatment outcome may be helpful for future research.	[Goodson, Jason T.; Helstrom, Amy W.; Marino, Emily J.; Smith, Rachel V.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Behav Hlth Dept, 3900 Woodland Ave, Philadelphia, PA 19104 USA; [Goodson, Jason T.; Helstrom, Amy W.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA		Goodson, JT (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Behav Hlth Dept, 3900 Woodland Ave, Philadelphia, PA 19104 USA.	jason.goodson@va.gov	Vickers-Smith, Rachel/AAM-1502-2021	Vickers-Smith, Rachel/0000-0002-7224-8916	Veterans Integrated Service Network 4 Mental Illness Research, Education, and Clinical Center; Behavioral Health Department; Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania	This article was prepared with the support of the Veterans Integrated Service Network 4 Mental Illness Research, Education, and Clinical Center, Behavioral Health Department, Corporal Michael J. Crescenz Veterans Affairs Medical Center (formerly Philadelphia Veterans Affairs Medical Center), Philadelphia, Pennsylvania.	Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 2013, STAT POWER ANAL BEHA; Crawford E. F., 2016, J NERVOUS MENTAL DIS; Crits-Christoph P., 1991, PSYCHOTHER RES, V1, P81, DOI DOI 10.1080/10503309112331335511; Department of Veterans Affairs, 2010, DOD CLIN PRACT GUID; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Ehlers A, 2013, BEHAV RES THER, V51, P742, DOI 10.1016/j.brat.2013.08.006; Fontana A, 1998, J NERV MENT DIS, V186, P223, DOI 10.1097/00005053-199804000-00004; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hoge CW, 2008, AM J EPIDEMIOL, V168, P1095, DOI 10.1093/aje/kwn261; Institute of Medicine, 2007, TREATM POSTTR STRESS; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lund BC, 2013, PSYCHIAT SERV, V64, P149, DOI 10.1176/appi.ps.201200267; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Moller Hans-Jurgen, 2011, Dialogues Clin Neurosci, V13, P199; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Mouilso ER, 2016, PSYCHOL SERV, V13, P308, DOI 10.1037/ser0000040; Murdoch M, 2011, ARCH GEN PSYCHIAT, V68, P1072, DOI 10.1001/archgenpsychiatry.2011.105; Otto MW, 2002, CURR PHARM DESIGN, V8, P75, DOI 10.2174/1381612023396726; Rauch SAM, 2012, J REHABIL RES DEV, V49, P679, DOI 10.1682/JRRD.2011.08.0152; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; van Minnen A, 2002, BEHAV RES THER, V40, P439, DOI 10.1016/S0005-7967(01)00024-9; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Weathers F. W., 1993, ANN M INT SOC TRAUMA; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Yoder MS, 2013, INT J PSYCHIAT MED, V45, P111, DOI 10.2190/PM.45.2.b	37	9	9	0	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	NOV	2017	9	6					647	654		10.1037/tra0000260			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	FL5DU	WOS:000414252600003	28182456				2022-02-06	
J	Hanson, E; Ballantyne, J				Hanson, Erin; Ballantyne, Jack			Human Organ Tissue Identification by Targeted RNA Deep Sequencing to Aid the Investigation of Traumatic Injury	GENES			English	Article						massively parallel sequencing; human organ tissue; mRNA; tissue identification; forensic science	BODY-FLUID IDENTIFICATION; SPECTROMETRY-BASED PROTEOMICS; MESSENGER-RNA; MASS-SPECTROMETRY; FORENSIC SAMPLES; DNA METHYLATION; CAPILLARY-ELECTROPHORESIS; EXPRESSION ANALYSIS; MENSTRUAL BLOOD; MARKERS	Molecular analysis of the RNA transcriptome from a putative tissue fragment should permit the assignment of its source to a specific organ, since each will exhibit a unique pattern of gene expression. Determination of the organ source of tissues from crime scenes may aid in shootings and other investigations. We have developed a prototype massively parallel sequencing (MPS) mRNA profiling assay for organ tissue identification that is designed to definitively identify 10 organ/tissue types using a targeted panel of 46 mRNA biomarkers. The identifiable organs and tissues include brain, lung, liver, heart, kidney, intestine, stomach, skeletal muscle, adipose, and trachea. The biomarkers were chosen after iterative specificity testing of numerous candidate genes in various tissue types. The assay is very specific, with little cross-reactivity with non-targeted tissue, and can detect RNA mixtures from different tissues. We also demonstrate the ability of the assay to successful identify the tissue source of origin using a single blind study.	[Hanson, Erin; Ballantyne, Jack] Univ Cent Florida, Natl Ctr Forens Sci, Orlando, FL 32816 USA; [Ballantyne, Jack] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA		Ballantyne, J (corresponding author), Univ Cent Florida, Natl Ctr Forens Sci, Orlando, FL 32816 USA.; Ballantyne, J (corresponding author), Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA.	Erin.Hanson@ucf.edu; Jack.Ballantyne@ucf.edu			National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2014-DN-BX-K019, 2016-DN-BX-0165]	This work was supported by Award No, 2014-DN-BX-K019 and 2016-DN-BX-0165, awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings and conclusions or recommendations in this presentation are those of the authors and do not necessarily reflect those of the Department of Justice.	ALBERTS B, 1994, MOL BIOL CELL, P1; Bauer M, 2003, INT J LEGAL MED, V117, P175, DOI 10.1007/s00414-002-0347-2; Bauer M, 2002, J FORENSIC SCI, V47, P1278; Dammeier S, 2016, J PROTEOME RES, V15, P182, DOI 10.1021/acs.jproteome.5b00704; DiMaio VJ, 2015, GUNSHOT WOUNDS PRACT, P1; Dorum G., 2017, FORENSIC SC IN PRESS; Fleming R. I., 2010, SCI INT GENET, V4, P244, DOI [10.1016/j.fsigen.2009.10.00620457026, DOI 10.1016/J.FSIGEN.2009.10.00620457026]; Frumkin D, 2011, FORENSIC SCI INT-GEN, V5, P517, DOI 10.1016/j.fsigen.2010.12.001; Haas C., 2009, SCI INT GENET, V3, P80, DOI [10.1016/j.fsigen.2008.11.00319215876, DOI 10.1016/J.FSIGEN.2008.11.003]; Haas C, 2012, METHODS MOL BIOL, V830, P169, DOI 10.1007/978-1-61779-461-2_12; Hanson E, 2009, FORENS SCI INT-GEN S, V2, P503, DOI 10.1016/j.fsigss.2009.08.184; Hanson E, 2011, FORENS SCI INT-GEN S, V3, pE305, DOI 10.1016/j.fsigss.2011.09.015; Hanson E, 2012, FORENSIC SCI INT-GEN, V6, P548, DOI 10.1016/j.fsigen.2012.01.004; Hanson E., 2015, SCI INT GENET SUPP S, V5, pe441, DOI [10.1016/j.fsigss.2015.09.175, DOI 10.1016/J.FSIGSS.2015.09.175]; Hanson E K, 2010, Forensic Sci Rev, V22, P145; Hanson E. K., 2017, INT GENET 2 IN PRESS; Hanson EK, 2014, ELECTROPHORESIS, V35, P3087, DOI 10.1002/elps.201400171; Hanson Erin K, 2013, F1000Res, V2, P281, DOI 10.12688/f1000research.2-281.v1; Harteveld J, 2013, SCI JUSTICE, V53, P261, DOI 10.1016/j.scijus.2013.02.001; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Juusola J, 2005, FORENSIC SCI INT, V152, P1, DOI 10.1016/j.forsciint.2005.02.020; Juusola J, 2003, FORENSIC SCI INT, V135, P85, DOI 10.1016/S0379-0738(03)00197-X; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Lee HY, 2012, INT J LEGAL MED, V126, P55, DOI 10.1007/s00414-011-0569-2; Legg KM, 2014, ELECTROPHORESIS, V35, P3069, DOI 10.1002/elps.201400125; Lindenbergh A., 2013, SCI INT GENET, V7, P159, DOI [10.1016/j.fsigen.2012.09.00323036470, DOI 10.1016/J.FSIGEN.2012.09.00323036470]; Lindenbergh A, 2013, INT J LEGAL MED, V127, P891, DOI 10.1007/s00414-013-0895-7; Lindenbergh A, 2012, FORENSIC SCI INT-GEN, V6, P565, DOI 10.1016/j.fsigen.2012.01.009; Madi T, 2012, ELECTROPHORESIS, V33, P1736, DOI 10.1002/elps.201100711; Prahlow J.A., 2012, ATLAS FORENSIC PATHO, P1; Richard MLL, 2012, FORENSIC SCI INT-GEN, V6, P452, DOI 10.1016/j.fsigen.2011.09.007; Roeder AD, 2013, INT J LEGAL MED, V127, P707, DOI 10.1007/s00414-012-0794-3; Sauer E, 2017, FORENSIC SCI INT-GEN, V28, P99, DOI 10.1016/j.fsigen.2017.02.002; Sijen T, 2015, FORENSIC SCI INT-GEN, V18, P21, DOI 10.1016/j.fsigen.2014.11.015; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van den Berge M, 2016, FORENSIC SCI INT-GEN, V21, P81, DOI 10.1016/j.fsigen.2015.12.012; van den Berge M, 2014, FORENSIC SCI INT-GEN, V10, P40, DOI 10.1016/j.fsigen.2014.01.006; van den Berge M, 2016, FORENSIC SCI INT-GEN, V20, P119, DOI 10.1016/j.fsigen.2015.10.011; Van Steendam K, 2013, INT J LEGAL MED, V127, P287, DOI 10.1007/s00414-012-0747-x; Yang HY, 2013, INT J LEGAL MED, V127, P1065, DOI 10.1007/s00414-013-0848-1; Zubakov D, 2008, INT J LEGAL MED, V122, P135, DOI 10.1007/s00414-007-0182-6; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3; Zubakov D, 2009, INT J LEGAL MED, V123, P71, DOI 10.1007/s00414-008-0249-z	43	9	9	2	5	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2073-4425			GENES-BASEL	Genes	NOV	2017	8	11							319	10.3390/genes8110319			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO4GS	WOS:000416800600029	29125589	gold, Green Published, Green Submitted			2022-02-06	
J	Keenan, HT; Bratton, SL; Dixon, RR				Keenan, Heather T.; Bratton, Susan L.; Dixon, Rebecca R.			Pediatricians' Knowledge, Attitudes, and Behaviors to Screening Children After Complicated Mild TBI: A Survey	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attitude; beliefs; knowledge; model; pediatrics; traumatic brain injury	TOOLBOX COGNITION BATTERY; TRAUMATIC BRAIN-INJURY; ACUTE CONCUSSION; INTERVENTION; EXERCISE	Objective: To understand pediatricians' attitudes, knowledge, and behaviors about the care of children with complicated mild traumatic brain injury (TBI). Participants: A total of 3500 pediatricians randomly selected from the American Medical Association Master File. Design: It was a cross-sectional survey. Main Measures: A survey developed to assess pediatricians' attitudes toward following children with complicated mild TBI for cognitive and behavioral sequelae; their knowledge of TBI sequelae; and their usual evaluation and management of children after TBI. Results: There were 576 (16.5%) completed responses. Most pediatricians (51%) see 1 or 2 patients with complicated mild TBI annually. Most do not think that pediatricians are the correct clinician group to be primarily responsible for following children with complicated mild TBI for cognitive (74%) or behavioral sequelae (54%). Pediatricians report difficulty referring children for cognitive (56%) and behavioral (48%) specialty services. Pediatricians have good knowledge of short-term complications of complicated mild TBI. Conclusion: Pediatricians do not think they are the clinicians that should primarily care for children after hospitalization for complicated mild TBI; however, other clinicians are frequently not accessible. Pediatricians need educational and referral support to provide surveillance for injury sequelae in this group of children.	[Keenan, Heather T.; Bratton, Susan L.; Dixon, Rebecca R.] Univ Utah, Dept Pediat, POB 581289, Salt Lake City, UT 84158 USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu	Bratton, Susan L./O-2353-2013	Bratton, Susan L./0000-0002-4605-8078	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984] Funding Source: NIH RePORTER	This project was supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development under award number K24HD072984.	Baek SS, 2016, J EXERC REHABIL, V12, P380, DOI 10.12965/jer.1632808.404; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P133, DOI 10.1111/mono.12039; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Guiney H, 2015, NEUROPSYCHOLOGY, V29, P1, DOI 10.1037/neu0000124; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Prosperini L, 2013, NEUROREHAB NEURAL RE, V27, P516, DOI 10.1177/1545968313478484; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	20	9	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					385	392		10.1097/HTR.0000000000000265			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100094	28489701	Green Accepted			2022-02-06	
J	Maudsley, AA; Govind, V; Saigal, G; Gold, SG; Harris, L; Sheriff, S				Maudsley, Andrew A.; Govind, Varan; Saigal, Gaurav; Gold, Stuart G.; Harris, Leo; Sheriff, Sulaiman			Longitudinal MR Spectroscopy Shows Altered Metabolism in Traumatic Brain Injury	JOURNAL OF NEUROIMAGING			English	Article						MR spectroscopy; longitudinal; z-score image analysis; traumatic brain injury	AXONAL INJURY; DISTRIBUTIONS; GLUTAMATE; MODERATE	BACKGROUND AND PURPOSEBrain trauma is known to result in heterogeneous patterns of tissue damage and altered neuronal and glial metabolism that evolve over time following injury; however, little is known on the longitudinal evolution of these changes. In this study, magnetic resonance spectroscopic imaging (MRSI) was used to map the distributions of altered metabolism in a single subject at five time points over a period of 28 months following injury. METHODSMagnetic resonance imaging and volumetric MRSI data were acquired in a subject that had experienced a moderate traumatic brain injury (Glasgow Coma Scale 13) at five time points, from 7 weeks to 28 months after injury. Maps of N-acetylaspartate (NAA), total choline (Cho), and total creatine signal were generated and differences from normal control values identified using a z-score image analysis method. RESULTSThe z-score metabolite maps revealed areas of significantly reduced NAA and increased Cho, predominately located in frontal and parietal white matter, which evolved over the complete course of the study. A map of the ratio of Cho/NAA showed the greatest sensitivity to change, which indicated additional metabolic changes throughout white matter. The metabolic changes reduced over time following injury, though with abnormal values remaining in periventricular regions. CONCLUSIONSThe use of z-score image analysis for MRSI provides a method for visualizing diffuse changes of tissue metabolism in the brain. This image visualization method is of particularly effective for visualizing widespread and diffuse metabolic changes, such as that due to traumatic injury.	[Maudsley, Andrew A.; Govind, Varan; Saigal, Gaurav; Sheriff, Sulaiman] Univ Miami, Dept Radiol, Sch Med, 1150 NW 14th St,Suite 713, Miami, FL 33136 USA; [Gold, Stuart G.] Hallandale Med Ctr, Div Behav Hlth, Hallandale, FL USA; [Gold, Stuart G.; Harris, Leo] Jackson Mem Hosp, Miami, FL 33136 USA		Maudsley, AA (corresponding author), Univ Miami, Dept Radiol, Sch Med, 1150 NW 14th St,Suite 713, Miami, FL 33136 USA.	AMaudsley@med.miami.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS055107, R01EB000822, R01EB016064]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB016064, R01EB000822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055107] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health research grants R01NS055107, R01EB000822, and R01EB016064.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goryawala MZ, 2016, NMR BIOMED, V29, P1108, DOI 10.1002/nbm.3575; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Mizumura Sunao, 2006, Radiat Med, V24, P545, DOI 10.1007/s11604-006-0056-8; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	23	9	9	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	NOV-DEC	2017	27	6					562	569		10.1111/jon.12463			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FL4CZ	WOS:000414175800002	28736910	Green Accepted			2022-02-06	
J	Shangkuan, WC; Lin, HC; Shih, CP; Cheng, CA; Fan, HC; Chung, CH; Lin, FH; Tsao, CH; Chien, WC				Shangkuan, Wei-Chuan; Lin, Hung-Che; Shih, Cheng-Ping; Cheng, Chun-An; Fan, Hueng-Chuen; Chung, Chi-Hsiang; Lin, Fu-Huang; Tsao, Chang-Huei; Chien, Wu-Chien			Increased long-term risk of hearing loss in patients with traumatic brain injury: A nationwide population-based study	LARYNGOSCOPE			English	Article						Traumatic brain injury; hearing loss; National Health Insurance Research Database	HEAD-INJURY; DYSFUNCTION; FRACTURE; EAR	Objectives/HypothesisWe investigated incidences of hearing loss among patients with traumatic brain injury (TBI) to evaluate whether they had a higher risk of hearing loss than the general population. Study DesignCohort study. MethodsInpatient data from the Taiwan National Health Insurance Research Database from January 1, 2000 to December 31, 2010 were recorded. Patients with TBI and a retrospective comparison cohort were analyzed. Each subject was individually traced from their index date to identify subjects who subsequently received a diagnosis of hearing loss. Cox regression analyses were applied to determine the risk of TBI-related hearing loss. ResultsFollow-up data from the TBI and comparison cohorts were collected over 10 years for 553,286 and 1,106,572 patients, respectively. Multivariate analyses demonstrated that TBI significantly increased the risk of hearing loss (adjusted hazard ratio = 2.125, 95% confidence interval = 2.045-2.546, P = .027). In our subgroup analyses by type of injury, patients with TBI due to traffic injury had the highest associated risk of hearing loss compared with the risk of non-TBI traffic injury patients, followed by patients with crushing/cutting/piercing injuries and falls. ConclusionsOur study shows that TBI led to a higher risk of long-term hearing loss. Traffic injuries were the most common injury related to hearing loss. Prevention, rather than treatment, may be the best policy for preventing hearing loss. Level of Evidence2b. Laryngoscope, 127:2627-2635, 2017	[Shangkuan, Wei-Chuan; Lin, Hung-Che; Shih, Cheng-Ping; Cheng, Chun-An; Fan, Hueng-Chuen; Chung, Chi-Hsiang; Lin, Fu-Huang; Tsao, Chang-Huei; Chien, Wu-Chien] Natl Def Med Ctr, Taipei, Taiwan; [Lin, Hung-Che; Shih, Cheng-Ping] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Natl Def Med Ctr, Taipei, Taiwan; [Cheng, Chun-An] Triserv Gen Hosp, Dept Neurol, Natl Def Med Ctr, Taipei, Taiwan; [Fan, Hueng-Chuen] Tungs Taichung MetroHarbor Hosp, Dept Pediat, Taichung, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, 161,Sect 6,Min Chuan East Rd, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Natl Def Med Ctr, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan		Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, 161,Sect 6,Min Chuan East Rd, Taipei, Taiwan.	chienwu@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	Cheng, Chun-An/0000-0002-0380-7286	Tri-Service General Hospital [TSGH-C105-003, TSGH-C106-002]	This study was supported in part by the Tri-Service General Hospital (TSGH-C105-003, TSGH-C106-002).	Alzahrani M, 2014, INT J PEDIATR OTORHI, V78, P804, DOI 10.1016/j.ijporl.2014.02.018; Atkin G, 2002, BRIT J NEUROSURG, V16, P597; Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Fujii T, 2016, J CLIN NEUROSCI, V31, P152, DOI 10.1016/j.jocn.2016.03.007; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grant JR, 2008, OTOL NEUROTOL, V29, P344, DOI 10.1097/MAO.0b013e3181690792; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; HOUGH JVD, 1968, LARYNGOSCOPE, V78, P899, DOI 10.1288/00005537-196806000-00003; Ilan O, 2016, CLIN OTOLARYNGOL, V41, P627, DOI 10.1111/coa.12572; Khwaja S, 2012, OTOL NEUROTOL, V33, P1328, DOI 10.1097/MAO.0b013e3182659d19; KOCHHAR L K, 1990, Ear Nose and Throat Journal, V69, P537; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lin HC, 2015, QJM-INT J MED, V108, P959, DOI 10.1093/qjmed/hcv079; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Oesterle EC, 2013, HEARING RES, V297, P91, DOI 10.1016/j.heares.2012.11.010; RIZVI SS, 1979, ANN OTO RHINOL LARYN, V88, P741, DOI 10.1177/000348947908800601; ROBINSON DW, 1979, AUDIOLOGY, V18, P320; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Walling AD, 2012, AM FAM PHYSICIAN, V85, P1150	24	9	9	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	NOV	2017	127	11					2627	2635		10.1002/lary.26567			9	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	FK5TW	WOS:000413564900043	28322446				2022-02-06	
J	Sinha, S; Hudgins, E; Schuster, J; Balu, R				Sinha, Saurabh; Hudgins, Eric; Schuster, James; Balu, Ramani			Unraveling the complexities of invasive multimodality neuromonitoring	NEUROSURGICAL FOCUS			English	Article						intracranial pressure; brain oxygen; cerebral blood flow; traumatic brain injury; multimodality monitoring; informatics; precision medicine	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; METABOLIC CRISIS; TISSUE OXYGEN; BLOOD-FLOW; PERIODIC DISCHARGES; CEREBROVASCULAR AUTOREGULATION; INTRACRANIAL HYPERTENSION; SPREADING DEPOLARIZATION	Acute brain injuries are a major cause of death and disability worldwide. Survivors of life-threatening brain injury often face a lifetime of dependent care, and novel approaches that improve outcome are sorely needed. A delayed cascade of brain damage, termed secondary injury, occurs hours to days and even weeks after the initial insult. This delayed phase of injury provides a crucial window for therapeutic interventions that could limit brain damage and improve outcome. A major barrier in the ability to prevent and treat secondary injury is that physicians are often unable to target therapies to patients' unique cerebral physiological disruptions. Invasive neuromonitoring with multiple complementary physiological monitors can provide useful information to enable this tailored, precision approach to care. However, integrating the multiple streams of time-varying data is challenging and often not possible during routine bedside assessment. The authors review and discuss the principles and evidence underlying several widely used invasive neuromonitors. They also provide a framework for integrating data for clinical decision making and discuss future developments in informatics that may allow new treatment paradigms to be developed.	[Sinha, Saurabh; Hudgins, Eric; Schuster, James] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Balu, Ramani] Univ Penn, Dept Neurol, Div Neurocrit Care, Perelman Sch Med, 3W Gates,3600 Spruce St, Philadelphia, PA 19104 USA		Balu, R (corresponding author), Univ Penn, Dept Neurol, Div Neurocrit Care, Perelman Sch Med, 3W Gates,3600 Spruce St, Philadelphia, PA 19104 USA.	ramani.balu@uphs.upenn.edu					Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhatia R, 2006, NEUROSURGERY, V58, P313, DOI 10.1227/01.NEU.0000208963.42378.83; Bohman LE, 2013, NEUROCRIT CARE, V19, P320, DOI 10.1007/s12028-013-9890-6; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chan MTV, 2005, ACT NEUR S, V95, P63; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189; Cohen MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8864; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUILLAUME J, 1951, PRESSE MED, V59, P953; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hocker S, 2016, JAMA NEUROL, V73, P1201, DOI 10.1001/jamaneurol.2016.1572; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; KETY SS, 1948, J CLIN INVEST, V27, P493, DOI 10.1172/JCI101996; King A, 2012, IEEE ENG MED BIO, P166, DOI 10.1109/EMBC.2012.6345897; Ko SB, 2012, ANN NEUROL, V72, P344, DOI 10.1002/ana.23619; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; McLachlan G J, 1992, Stat Methods Med Res, V1, P27, DOI 10.1177/096228029200100103; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Ramakrishna R, 2009, J NEUROSURG, V110, P613, DOI 10.3171/JNS.2008.109.12.1075a; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Siebig S, 2010, J CRIT CARE, V25, P128, DOI 10.1016/j.jcrc.2008.09.001; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tackla R, 2015, NEUROCRIT CARE, V23, P339, DOI 10.1007/s12028-015-0146-5; TAKASU A, 1995, RESUSCITATION, V29, P189, DOI 10.1016/0300-9572(94)00853-8; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Witsch J, 2017, JAMA NEUROL, V74, P299, DOI 10.1001/jamaneurol.2016.5325; Wolf Stefan, 2012, Acta Neurochir Suppl, V114, P187, DOI 10.1007/978-3-7091-0956-4_36; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	75	9	11	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E4	10.3171/2017.8.FOCUS17449			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800016	29088949	gold			2022-02-06	
J	Slasky, SE; Rivaud, Y; Suberlak, M; Tairu, O; Fox, AD; Ohman-Strickland, P; Bilinisky, E				Slasky, Shira E.; Rivaud, Yayone; Suberlak, Matthew; Tairu, Oluwole; Fox, Adam D.; Ohman-Strickland, Pamela; Bilinisky, Esther			Venous Sinus Thrombosis in Blunt Trauma: Incidence and Risk Factors	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						blunt trauma; skull fracture; venous sinus thrombosis	CLOSED-HEAD-INJURY; JUGULAR-VEIN THROMBOSIS; CT VENOGRAPHY; DURAL SINUS; SKULL FRACTURE; SINOVENOUS THROMBOSIS; OBSTRUCTION; CHILDREN; FOSSA	Purpose The aim of our study was to determine the incidence and risk factors of dural venous sinus thrombosis and epidural hemorrhage in the setting of a blunt trauma causing a calvarial fracture crossing a dural venous sinus. Methods A retrospective review of 472 blunt trauma patients with calvarial fracture crossing a dural venous sinus was performed. Two hundred ten patients who underwent computed tomography venography were identified and evaluated for the presence of dural venous sinus thrombosis and/or epidural hemorrhage. Site and displacement of fractures, as well as age, sex, Glasgow Coma Scale (GCS) score, and mechanism of injury, were considered for potential predictive value of thrombosis and/or epidural hemorrhage. Results We found a 23% incidence of dural venous sinus thrombosis in patients with a fracture traversing a dural venous sinus. Significant predictors of thrombosis included temporal fracture (38% incidence) and skull base fracture (31% incidence). Occipital fracture not involving the skull base was associated with a significantly decreased risk of thrombosis, with an incidence of 9%. Decreased GCS score and fall from height greater than 10 feet additionally predicted dural venous sinus thrombosis. Significant predictors of epidural hemorrhage included parietal fractures and displaced fractures, although a large percentage of nondisplaced fractures in other bones demonstrated epidural hemorrhage as well. Conclusions Dural venous sinus thrombosis in the setting of blunt trauma with a calvarial fracture crossing a dural venous sinus has an incidence of 23%. Increased suspicion for thrombosis is warranted in patients with temporal or skull base fractures, low GCS score, and recent fall from great height.	[Slasky, Shira E.; Rivaud, Yayone; Suberlak, Matthew; Tairu, Oluwole; Bilinisky, Esther] Rutgers State Univ, New Jersey Sch Med, Dept Radiol, 150 Bergen St,UH Suite C-318 A, Newark, NJ 07103 USA; [Fox, Adam D.] Rutgers State Univ, New Jersey Sch Med, Dept Trauma Surg, Newark, NJ USA; [Ohman-Strickland, Pamela] RWJ Sch Publ Hlth, Rutgers Sch Publ Hlth, Piscataway, NJ USA		Slasky, SE (corresponding author), Rutgers State Univ, New Jersey Sch Med, Dept Radiol, 150 Bergen St,UH Suite C-318 A, Newark, NJ 07103 USA.	sslasky@gmail.com			New Jersey Medical School Radiology departmental research grant	S.I.S. received a New Jersey Medical School Radiology departmental research grant to pay for statistical analysis for this study. The other authors declare no conflict of interest.	Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Awad Al-Wala, 2014, Surg Neurol Int, V5, P53, DOI 10.4103/2152-7806.130908; Barbati G, 2003, Minerva Anestesiol, V69, P919; Beer-Furlan A, 2013, CHILD NERV SYST, V29, P1231, DOI 10.1007/s00381-013-2184-7; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; Caplan JM, 2008, EMERG MED J, V25, P777, DOI 10.1136/emj.2008.061952; Daligic A, 2008, TURK NEUROSURG, V18, P70; Dobbs TD, 2012, J CLIN NEUROSCI, V19, P1058, DOI 10.1016/j.jocn.2012.01.002; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Fischer C, 2010, J EMERG MED, V38, P140, DOI 10.1016/j.jemermed.2009.08.061; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Georgoulis G, 2014, WORLD NEUROSURG, V81, pE7, DOI 10.1016/j.wneu.2011.11.006; Ghuman Mandeep Singh, 2016, J Emerg Trauma Shock, V9, P37, DOI 10.4103/0974-2700.173865; Holmes G, 1915, Br Med J, V2, P493; Hsu PJ, 2014, NEUROLOGY, V83, pE135, DOI 10.1212/WNL.0000000000000836; Karasu A, 2008, SURG NEUROL, V69, P247, DOI 10.1016/j.surneu.2007.02.024; MARTIN JP, 1955, BRIT MED J, V2, P467, DOI 10.1136/bmj.2.4937.467; Matsushige T, 2009, J TRAUMA, V66, P1599, DOI 10.1097/TA.0b013e3181a3a8e6; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; Nehme J, 2009, INT J PEDIATR OTORHI, V73, P629, DOI 10.1016/j.ijporl.2008.10.025; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Rischall MA, 2016, AM J ROENTGENOL, V207, P852, DOI 10.2214/AJR.15.15972; Rivkin MA, 2014, ACTA NEUROCHIR, V156, P999, DOI 10.1007/s00701-014-2025-9; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Singh S, 2016, PEDIATR RADIOL, V46, P67, DOI 10.1007/s00247-015-3458-x; Sousa J, 2004, BRIT J NEUROSURG, V18, P187, DOI 10.1080/02688690410001681082; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; van Andel HAG, 2009, CLIN NEUROL NEUROSUR, V111, P717, DOI 10.1016/j.clineuro.2009.05.013; Wetzel SG, 1999, AM J NEURORADIOL, V20, P249; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	31	9	10	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	NOV-DEC	2017	41	6					891	897		10.1097/RCT.0000000000000620			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	FN9GQ	WOS:000416338300008	28448419				2022-02-06	
J	Stefanidis, K; Brindley, P; Ramnarine, R; Blaivas, M; Daneshi, M; Sidhu, PS; Alharthy, A; Karakitsos, D				Stefanidis, Konstantinos; Brindley, Peter; Ramnarine, Raymond; Blaivas, Michael; Daneshi, Mohammad; Sidhu, Paul S.; Alharthy, Abdoulrahman; Karakitsos, Dimitrios			Bedside Ultrasound to Facilitate Early Diagnosis and Ease of Follow-Up in Neurogenic Heterotopic Ossification: A Pilot Study From the Intensive Care Unit	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; critical care; intensive care unit; neurogenic heterotopic ossification; NHO; ultrasound	TRAUMATIC BRAIN; INJURY	Objective: To explore the potential role of ultrasound (US) as a bedside tool in intensive care unit patients with presumed neurogenic heterotopic ossification (NHO). Setting: Tertiary university teaching hospitals. Participants: Critical care patients with acquired brain injury. Design: A multicenter prospective study of critical care patients with possible NHO. Main Measures: Following a screening clinical examination, the major joints were evaluated with US, serum laboratory work, and x-ray. Results: A total of 310 patients had decreased range of motion by clinical screen and all received US interrogation. Sonographic signs of NHO were identified in 21 of the 310 patients (6.8%), of which 17/21 (81.0%) showed hyperemia; 9/21 (42.8%) showed the reverse zone phenomenon, and 4/21 patients (19.0%) showed the prezone phenomenon. All 21 patients progressed to the zone phenomenon within 15 weeks. Laboratory parameters were not significantly correlated with US (r = 0.11, r = 0.13; P > .05, respectively), whereas x-rays were associated with a mean diagnostic delay of 2 0.5 weeks (P < .05) compared with US. All 21 sonographic NHO patients survived to intensive care unit discharge. Twelve months after admission, 3/21 had died; 6/21 still had abnormalities by x-ray, US, and clinical examination; and 12/21 had resolution by x-ray, US, and clinical examination. Conclusion: Our pilot study suggests potential benefits for bedside US in NHO, especially when compared with x-ray or laboratory investigations. These include the possibility of earlier diagnosis, consideration of therapy before ossification, and ease of follow-up. Our study also provides insights into the morphologic, sonographic, radiologic, and clinical course of NHO.	[Stefanidis, Konstantinos; Ramnarine, Raymond; Daneshi, Mohammad; Sidhu, Paul S.] Kings Coll Hosp London, Dept Radiol, Denmark Hill, London SE5 9RS, England; [Brindley, Peter] Univ Alberta, Dept Crit Care, Edmonton, AB, Canada; [Blaivas, Michael] Univ South Carolina, Sch Med, Dept Internal Med, Columbia, SC USA; [Alharthy, Abdoulrahman; Karakitsos, Dimitrios] King Saud Med City, Dept Crit Care, Riyadh, Saudi Arabia; [Karakitsos, Dimitrios] USC, Keck Sch Med, Dept Crit Care, Los Angeles, CA USA; [Karakitsos, Dimitrios] Gen State Hosp Athens, Dept Crit Care, Athens, Greece		Stefanidis, K (corresponding author), Kings Coll Hosp London, Dept Radiol, Denmark Hill, London SE5 9RS, England.	kstefanidis@nhs.net	Stefanidis, Konstantinos/AAG-4771-2020	Sidhu, Paul/0000-0003-1928-4077			[Anonymous], 1883, VERH DTSCH GESELLSCH, V12, P93; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Banovac K, 2000, J Spinal Cord Med, V23, P40; Ceillier, 1918, ANN MED, V5, P497; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Falsetti P, 2011, CLIN NEUROL NEUROSUR, V113, P22, DOI 10.1016/j.clineuro.2010.08.012; Falsetti P, 2011, J CLIN ULTRASOUND, V39, P12, DOI 10.1002/jcu.20742; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Pedersen M, 2012, ULTRASCHALL MED, V33, P441, DOI 10.1055/s-0032-1312923; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; THOMAS EA, 1991, CLIN RADIOL, V43, P190, DOI 10.1016/S0009-9260(05)80478-7; URIST MR, 1978, ARCH PATHOL LAB MED, V102, P312; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955; Yeh TS, 2012, J MED ULTRASOUND, V20, P119, DOI 10.1016/j.jmu.2012.04.009	17	9	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E54	E58		10.1097/HTR.0000000000000293			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100007	28195961				2022-02-06	
J	Howe, EI; Langlo, KPS; Terjesen, HCA; Roe, C; Schanke, AK; Soberg, HL; Sveen, U; Aas, E; Enehaug, H; Alves, DE; Klethagen, P; Sagstad, K; Moen, CM; Torsteinsbrend, K; Linnestad, AM; Nordenmark, TH; Rismyhr, BS; Wangen, G; Lu, J; Ponsford, J; Twamley, EW; Ugelstad, H; Spjelkavik, O; Lovstad, M; Andelic, N				Howe, Emilie I.; Langlo, Knut-Petter S.; Terjesen, Hans Christoffer Aargaard; Roe, Cecilie; Schanke, Anne-Kristine; Soberg, Helene L.; Sveen, Unni; Aas, Eline; Enehaug, Heidi; Alves, Daniele E.; Klethagen, Pal; Sagstad, Kjersti; Moen, Christine M.; Torsteinsbrend, Karin; Linnestad, Anne-Margrethe; Nordenmark, Tonje Haug; Rismyhr, Birte Sand; Wangen, Grete; Lu, Juan; Ponsford, Jennie; Twamley, Elizabeth W.; Ugelstad, Helene; Spjelkavik, Oystein; Lovstad, Marianne; Andelic, Nada			Combined cognitive and vocational interventions after mild to moderate traumatic brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Mild traumatic brain injury; Cognitive remediation; Supported employment; Individual Placement and Support (IPS); Five-Step Process; Return to work; Work inclusion; Disability management	POST-CONCUSSION SYMPTOMS; OF-THE-LITERATURE; EMPLOYMENT; WORK; REHABILITATION; RETURN; SEVERITY; SCALE; QUESTIONNAIRE; EXPERIENCES	Background: A considerable proportion of patients with mild to moderate traumatic brain injury (TBI) experience long-lasting somatic, cognitive, and emotional symptoms that may hamper their capacity to return to work (RTW). Although several studies have described medical, psychological, and work-related factors that predict RTW after TBI, well-controlled intervention studies regarding RTW are scarce. Furthermore, there has traditionally been weak collaboration among health-related rehabilitation services, the labor and welfare sector, and workplaces. Methods/design: This study protocol describes an innovative randomized controlled trial in which we will explore the effect of combining manualized cognitive rehabilitation (Compensatory Cognitive Training [CCT]) and supported employment (SE) on RTW and related outcomes for patients with mild to moderate TBI in real-life competitive work settings. The study will be carried out in the southeastern region of Norway and thereby be performed within the Norwegian welfare system. Patients aged 18-60 years with mild to moderate TBI who are employed in a minimum 50% position at the time of injury and sick-listed 50% or more for postconcussive symptoms 2 months postinjury will be included in the study. A comprehensive assessment of neurocognitive function, self-reported symptoms, emotional distress, coping style, and quality of life will be performed at baseline, immediately after CCT (3 months after inclusion), following the end of SE (6 months after inclusion), and 12 months following study inclusion. The primary outcome measures are the proportion of participants who have returned to work at 12-month follow-up and length of time until RTW, in addition to work stability as well as work productivity over the first year following the intervention. Secondary outcomes include changes in self-reported symptoms, emotional and cognitive function, and quality of life. Additionally, a qualitative RTW process evaluation focused on organizational challenges at the workplace will be performed. Discussion: The proposed study will combine cognitive and vocational rehabilitation and explore the efficacy of increased cross-sectoral collaboration between specialized health care services and the labor and welfare system. If the intervention proves effective, the project will describe the cost-effectiveness and utility of the program and thereby provide important information for policy makers. In addition, knowledge about the RTW process for persons with TBI and their workplaces will be provided.	[Howe, Emilie I.; Langlo, Knut-Petter S.; Roe, Cecilie; Soberg, Helene L.; Sveen, Unni; Nordenmark, Tonje Haug; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Howe, Emilie I.; Roe, Cecilie] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Langlo, Knut-Petter S.; Lovstad, Marianne] Univ Oslo, Dept Psychol, Fac Social Sci, Oslo, Norway; [Terjesen, Hans Christoffer Aargaard; Enehaug, Heidi; Alves, Daniele E.; Klethagen, Pal; Spjelkavik, Oystein] Oslo & Akershus Univ Coll Appl Sci, Work Res Inst, Oslo, Norway; [Schanke, Anne-Kristine; Linnestad, Anne-Margrethe; Lovstad, Marianne] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Soberg, Helene L.; Sveen, Unni; Wangen, Grete] Oslo & Akershus Univ Coll Appl Sci, Fac Hlth Sci, Oslo, Norway; [Aas, Eline] Univ Oslo, Inst Hlth & Soc, Dept Hlth Econ, Fac Med, Oslo, Norway; [Sagstad, Kjersti; Moen, Christine M.; Torsteinsbrend, Karin; Ugelstad, Helene] Norwegian Labor & Welf Adm, Dept Vocat Rehabil, Oslo, Norway; [Rismyhr, Birte Sand] Norwegian User Org Personskadeforbundet LTN, Oslo, Norway; [Lu, Juan] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Div Epidemiol, Richmond, VA USA; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Andelic, Nada] Univ Oslo, Fac Med, Inst Hlth & Soc, Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway		Howe, EI (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Howe, EI (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	emilie.howe@medisin.uio.no		Lu, Juan/0000-0002-5389-7603; Andelic, Nada/0000-0002-3719-4406; Alves, Daniele Evelin/0000-0001-7877-3343; Spjelkavik, Oystein/0000-0003-1151-1263	Research Council of Norway (Norges Forskningsrad)Research Council of Norway; NOK [14,887,000, 256689/H10]	The project is funded by the Research Council of Norway (Norges Forskningsrad) with NOK 14,887,000 (project number 256689/H10).	Alderman N., 1996, BADS BEHAV ASSESSMEN; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Bass B.M., 2006, TRANSFORMATIONAL LEA; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bond GR, 1997, PSYCHIATR SERV, V48, P335; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Drake RE, 2012, INDIVIDUAL PLACEMENT; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Franche RL, 2007, J OCCUP REHABIL, V17, P450, DOI 10.1007/s10926-007-9097-9; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Froyland K, 2014, INCLUSION EXPERTISE; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Man DWK, 2013, BRAIN INJURY, V27, P1016, DOI 10.3109/02699052.2013.794969; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marois E, 2009, DISABIL REHABIL, V31, P994, DOI 10.1080/09638280802428374; Noklebye H, 2017, SUPPORTED EMPLOYMENT; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Reme S. E., 2016, EFFEKTEVALUERING IND; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Sveinsdottir V, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0307-7; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Twamley EW, 2012, J CLIN PSYCHIAT, V73, P1212, DOI 10.4088/JCP.12m07686; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wechsler D., 2008, WECHSLER ADULT INTEL; World Health Organization (WHO), 2015, INT CLASS HLTH INT; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]	59	9	9	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	OCT 17	2017	18								483	10.1186/s13063-017-2218-7			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	FK3DS	WOS:000413366000002	29041954	Green Published, gold			2022-02-06	
J	Greenham, M; Anderson, V; Hearps, S; Ditchfield, M; Coleman, L; Mackay, MT; Monagle, P; Gordon, AL				Greenham, Mardee; Anderson, Vicki; Hearps, Stephen; Ditchfield, Michael; Coleman, Lee; Mackay, Mark T.; Monagle, Paul; Gordon, Anne L.			Psychosocial function in the first year after childhood stroke	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							ARTERIAL ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ATTENTION-DEFICIT/HYPERACTIVITY SYMPTOMATOLOGY; PEDIATRIC STROKE; FAMILY ENVIRONMENT; CHILDREN; OUTCOMES; PREDICTORS; SURVIVORS	AimChildhood stroke disrupts brain development and emerging neural networks. Motor, cognitive, and language deficits are well recognized, yet little is known about psychosocial function after childhood stroke. This study aims to describe psychosocial function within the first year after childhood stroke, and to identify factors associated with outcome. MethodThirty-seven children were involved in a prospective, longitudinal study investigating recovery over the first year after childhood stroke. Children's social functioning was assessed at 6-months and 12-months poststroke and psychological function at 12-months poststroke, using standardized measures. ResultsMean social function was poorer at both 6-months and 12-months poststroke, compared to prestroke. Psychological problems were more common than expected, with emotional difficulties and hyperactivity-inattention most significantly affected. Poorer social function was associated with older age at onset, acute neurological impairment, and prestroke social impairment. Social and psychological problems were associated with parent mental health. InterpretationWhile not all children are affected, psychosocial impairment affects a significant minority after childhood stroke. Older age at onset, acute neurological impairment, prestroke social problems, and poorer parent mental health were associated with deficits. Identifying early predictors of poorer outcome will facilitate early intervention. Of particular importance is parent mental health, suggesting support for families may improve child outcome.	[Greenham, Mardee; Anderson, Vicki; Hearps, Stephen; Coleman, Lee; Mackay, Mark T.; Monagle, Paul; Gordon, Anne L.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Greenham, Mardee; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Hlth, Monash Med Ctr, Imaging, Melbourne, Vic, Australia; [Ditchfield, Michael] Monash Univ, Paediat Imaging, Melbourne, Vic, Australia; [Coleman, Lee] Royal Childrens Hosp, Dept Med Imaging, Melbourne, Vic, Australia; [Mackay, Mark T.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Mackay, Mark T.; Monagle, Paul] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Monagle, Paul] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Gordon, Anne L.] Kings Hlth Partners, Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Pediat Neurosci Dept, London, England		Greenham, M (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	mardee.greenham@mcri.edu.au	Greenham, Mardee/AAR-1711-2020; Hearps, Stephen/L-6853-2016	Monagle, Paul/0000-0002-3970-8984; Mackay, Mark/0000-0002-3787-1112; Hearps, Stephen/0000-0003-2984-1172	Murdoch Childrens Research Institute; NHMRCNational Health and Medical Research Council of Australia; Stroke Foundation (Australia); Victorian Government Operational Infrastructure Scheme	This study was supported by Murdoch Childrens Research Institute postgraduate research scholarship (MG), NHMRC senior practitioner fellowship (VA), Stroke Foundation (Australia), and Victorian Government Operational Infrastructure Scheme. The authors have stated that they had no interests which might be perceived as posing a conflict or bias.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Bayley N., 2005, BAYLEY SCALES INFANT; De Schryver ELLM, 2000, DEV MED CHILD NEUROL, V42, P313, DOI 10.1017/S0012162200000554; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Friefeld S, 2004, CNS SPECTRUMS, V9, P465; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; Gomes A, 2014, DEV NEUROPSYCHOL, V39, P9, DOI 10.1080/87565641.2013.827197; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gordon AL, 2002, J CHILD NEUROL, V17, P429, DOI 10.1177/088307380201700606; Gordon AL, 2015, INT J STROKE, V10, P1068, DOI 10.1111/ijs.12489; Greenham M, 2015, DEV NEUROPSYCHOL, V40, P348, DOI 10.1080/87565641.2015.1095191; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Kaufman A. S., 1997, KAUFMAN BRIEF INTELL; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Lo W, 2014, INT J STROKE, V9, P1037, DOI 10.1111/ijs.12222; Mallick AA, 2016, ANN NEUROL, V79, P784, DOI 10.1002/ana.24626; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; Max JE, 2002, J AM ACAD CHILD PSY, V41, P555, DOI 10.1097/00004583-200205000-00013; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mosch SC, 2005, COGN BEHAV NEUROL, V18, P5, DOI 10.1097/01.wnn.0000152207.80819.3c; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; O'Keeffe F, 2012, BRAIN INJURY, V26, P1072, DOI 10.3109/02699052.2012.661117; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Simonetti BG, 2015, NEUROLOGY, V84, P1941, DOI 10.1212/WNL.0000000000001555; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Woods D., 2014, SOC CARE NEURODIS, V5, P145, DOI DOI 10.1108/SCN-03-2013-0006; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	32	9	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	OCT	2017	59	10					1027	1033		10.1111/dmcn.13387			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	FH7JQ	WOS:000411363900014	28121027	Green Published, Bronze			2022-02-06	
J	He, XR; Su, FH; Xie, KL; Taccone, FS; Donadello, K; Vincent, JL				He, Xinrong; Su, Fuhong; Xie, Keliang; Taccone, Fabio Silvio; Donadello, Katia; Vincent, Jean-Louis			Should Hyperoxia Be Avoided During Sepsis? An Experimental Study in Ovine Peritonitis	CRITICAL CARE MEDICINE			English	Article						hemodynamics; hyperoxia; lactate-to-pyruvate ratio; septic shock	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; NORMOBARIC HYPEROXIA; SEPTIC SHOCK; CEREBRAL METABOLISM; 100-PERCENT OXYGEN; INFLAMMATORY RESPONSE; INTRACRANIAL-PRESSURE; FECAL PERITONITIS; OXIDATIVE STRESS	Objectives: Optimizing oxygen delivery is an important part of the hemodynamic resuscitation of septic shock, but concerns have been raised over the potentially deleterious effects of hyperoxia. We evaluated the impact of hyperoxia on hemodynamics, the microcirculation, and cerebral and renal metabolism in an ovine model of septic shock. Design: Randomized animal study. Setting: University hospital animal research laboratory. Subjects: Fourteen adult female sheep. Interventions: After induction of fecal peritonitis, sheep were randomized to ventilation with an Fio(2) of 100% (n = 7) or an Fio(2) adjusted to maintain Pao(2) between 90 and 120 mm Hg (n = 7, control). All animals were fluid resuscitated and observed until death. Measurements and Main Results: In addition to hemodynamic measurements, we assessed the sublingual microcirculation, renal and cerebral microdialysis and microvascular perfusion, and brain tissue oxygen pressure. Hyperoxic animals initially had a higher mean arterial pressure than control animals. After onset of shock, hyperoxia blunted the decrease in stroke volume index observed in the control group. Hyperoxia was associated with a higher sub-lingual microcirculatory flow over time, with higher cerebral perfusion and brain tissue oxygen pressure and with a lower cerebral lactate-to-pyruvate ratio than in control animals. Hyperoxia was also associated with preserved renal microvascular perfusion, lower renal lactate-to-pyruvate ratio, and higher Pao(2)/Fio(2) ratio. Conclusions: In this acute peritonitis model, hyperoxia induced during resuscitation provided better hemodynamics and peripheral microvascular flow and better preserved cerebral metabolism, renal function, and gas exchange. These observations are reassuring with recent concerns about excessive oxygen therapy in acute diseases.	[He, Xinrong; Su, Fuhong; Xie, Keliang; Taccone, Fabio Silvio; Donadello, Katia; Vincent, Jean-Louis] Univ Libre Bruxelles, Dept Intens Care, Erasme Univ Hosp, Brussels, Belgium; [He, Xinrong] Sun Yat Sen Univ, Dept Intens Care, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Donadello, Katia] Univ Verona, AOUI Univ Hosp Integrated Trust Verona, Anesthesia & Intens Care B, Dept Surg Dent Pediat & Gynecol, Verona, Italy		Vincent, JL (corresponding author), Univ Libre Bruxelles, Dept Intens Care, Erasme Univ Hosp, Brussels, Belgium.	jlvincent@intensive.org	DONADELLO, KATIA/R-9442-2018	DONADELLO, KATIA/0000-0002-7053-8434; Vincent, Jean-Louis/0000-0001-6011-6951; He, Xinrong/0000-0003-3426-1420; Su, Fuhong/0000-0003-4962-7907			Atkins JL, 2007, AM J PHYSIOL-HEART C, V292, pH776, DOI 10.1152/ajpheart.00381.2006; Bak Z, 2007, ACTA PHYSIOL, V191, P15, DOI 10.1111/j.1748-1716.2007.01710.x; Barth E, 2008, CRIT CARE MED, V36, P495, DOI 10.1097/01.CCM.0B013E318161FC45; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; BUSING CM, 1981, EXP PATHOL-JENA, V19, P146; Cortes DO, 2015, MICROVASC RES, V98, P23, DOI 10.1016/j.mvr.2014.11.006; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; Dong W, 2015, EXP NEUROL, V272, P181, DOI 10.1016/j.expneurol.2015.04.005; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; ERDMANN AJ, 1983, ANESTHESIOLOGY, V58, P153, DOI 10.1097/00000542-198302000-00009; Farquhar H, 2009, AM HEART J, V158, P371, DOI 10.1016/j.ahj.2009.05.037; Fujita M, 2010, SHOCK, V34, P299, DOI 10.1097/SHK.0b013e3181ceeeec; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Hauser B, 2009, CRIT CARE MED, V37, P2465, DOI 10.1097/CCM.0b013e3181aee8ad; He XR, 2016, CRIT CARE MED, V44, P23, DOI 10.1097/CCM.0000000000001380; He XR, 2012, CRIT CARE MED, V40, P2833, DOI 10.1097/CCM.0b013e31825b88ba; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Hou LC, 2009, SHOCK, V32, P451, DOI 10.1097/SHK.0b013e31819c391a; Jia YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026802; Edul VSK, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0039-3; Knoller E, 2016, CRIT CARE MED, V44, pE264, DOI 10.1097/CCM.0000000000001412; Kopel T, 2008, INTENS CARE MED, V34, P1313, DOI 10.1007/s00134-008-1058-z; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Modun D, 2012, CLIN PHYSIOL FUNCT I, V32, P404, DOI 10.1111/j.1475-097X.2012.01133.x; NEWMAN JH, 1983, J APPL PHYSIOL, V54, P1379, DOI 10.1152/jappl.1983.54.5.1379; Phillips DP, 2012, INT ANESTHESIOL CLIN, V50, P187, DOI 10.1097/AIA.0b013e3182603ec1; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rodriguez-Gonzalez R, 2014, SHOCK, V42, P148, DOI 10.1097/SHK.0000000000000189; Rossi P, 2007, CLIN PHYSIOL FUNCT I, V27, P180, DOI 10.1111/j.1475-097X.2007.00732.x; Seija M, 2012, SHOCK, V38, P403, DOI 10.1097/SHK.0b013e31826660f2; Su FH, 2010, SHOCK, V34, P243, DOI 10.1097/SHK.0b013e3181d75967; Sukhotnik I, 2009, CRIT CARE MED, V37, P1054, DOI 10.1097/CCM.0b013e31819d0f5c; Sutton ADJ, 2014, ANAESTH INTENS CARE, V42, P730, DOI 10.1177/0310057X1404200608; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Verdant CL, 2009, CRIT CARE MED, V37, P2875, DOI 10.1097/CCM.0b013e3181b029c1; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Waisman D, 2012, SHOCK, V37, P95, DOI 10.1097/SHK.0b013e3182356fc3; Xie KL, 2012, SHOCK, V38, P656, DOI 10.1097/SHK.0b013e3182758646	45	9	9	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2017	45	10					E1060	E1067		10.1097/CCM.0000000000002524			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2HQ	WOS:000410960300009	28617696				2022-02-06	
J	Kerrigan, JM; Giza, CC				Kerrigan, Julia Morrow; Giza, Christopher C.			When in doubt, sit it out! Pediatric concussion-an update	CHILDS NERVOUS SYSTEM			English	Article						Pediatric concussion; Sports; TBI	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; SPORT; CHILDREN; EPIDEMIOLOGY; SYMPTOMS	Concussion is a major public health issue that has received much publicity in recent years. Reported concussions are increasing across all ages, including the highest rates in pediatric age ranges. Due to the age-related physiological responses and differential recovery of symptoms after concussion, special consideration must be given to youth concussions. Concussion can affect each child differently and likely affects children differently than adults. Until the past decade, there has been a scarcity of scientifically rigorous studies examining concussions in children. This increasing amount of research and consensus has begun to influence the definition, evaluation, management, return to school and play recommendations, prevention, and education relating to pediatric concussion. The purpose of this article is a review of relevant research published in the last few years (2015-2017) with highlights of these updates summarized for clinical use.	[Kerrigan, Julia Morrow] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Dept Neurosurg, 300 Stein Plaza Driveway,Suite 562, Los Angeles, CA 90095 USA; [Giza, Christopher C.] UCLA, Steve Tisch BrainSPORT Program, Dept Neurosurg & Pediat, 300 Stein Plaza Driveway,Suite 562, Los Angeles, CA 90095 USA		Kerrigan, JM (corresponding author), Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Dept Neurosurg, 300 Stein Plaza Driveway,Suite 562, Los Angeles, CA 90095 USA.	jkerrigan@mednet.ucla.edu			NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS27544]; NCAA; U.S. Dept of Defense; UCLA Brain Injury Research Center; UCLA Faculty Grants Program; UCLA Steve Tisch BrainSPORT program; Avanir; NINDS Neural Analytics SBIR grant [NS092209 2016-2018]	Grants/Research Support: NIH NINDS (R01 NS27544), NCAA, U.S. Dept of Defense, UCLA Brain Injury Research Center, UCLA Faculty Grants Program, UCLA Steve Tisch BrainSPORT program, Avanir (research grant 2017-2018), NINDS Neural Analytics SBIR grant (NS092209 2016-2018)	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P MeeuwisseW, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	31	9	9	0	18	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1669	1675		10.1007/s00381-017-3537-4			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900009	29149392				2022-02-06	
J	Lyu, Q; Zhang, ZB; Fu, SJ; Xiong, LL; Liu, J; Wang, TH				Lyu, Qiang; Zhang, Zi-Bin; Fu, Song-Jun; Xiong, Liu-Lin; Liu, Jing; Wang, Ting-Hua			Microarray Expression Profile of lncRNAs and mRNAs in Rats with Traumatic Brain Injury after A2B5+Cell Transplantation	CELL TRANSPLANTATION			English	Article						A2B5+iPS; transplantation; traumatic brain injury; lncRNA; mRNA	LONG NONCODING RNAS; STEM-CELL TRANSPLANTATION; IPS CELLS; TBI; GENE; GENERATION; THERAPY; IMPACT; MODEL; ROLES	Traumatic brain injury (TBI) may cause neurological damage, but an effective therapy and the associated mechanisms of action have not yet been elucidated. A TBI model was established using the modified Feeney method. A2B5+ cells, an oligodendroglial progenitor, were acquired from induced pluripotent stem cells (iPSCs) by mouse embryonic fibroblasts and were transplanted into the injured site. The neurological severity score (NSS) was recorded on 3 d, 7 d, 11 d, 15 d, and 19 d. Seven days after transplantation, oligodendrocytes 2 (Olig2) and myelin basic protein (MBP) were detected by immunohistochemistry (IHC) and Western blot (WB), and long noncoding RNAs (lncRNAs) and messenger RNAs (mRNAs) were screened by microarray technology. Moreover, we took an intersection of the differentially expressed lncRNAs or mRNAs and scanned 10 kb upstream and downstream of the common lncRNAs. Meanwhile, Gene Ontology (GO) and pathway analysis on mRNAs was performed in the A2B5+ iPSC group. A2B5+ iPSCs survived and migrated around the injury site and differentiated into oligodendrocytes. Meanwhile, the increase in Olig2 and MBP were higher in A2B5+ cell-engrafted rats than that in TBI rats. However, the NSSs in the A2B5+ iPSC group were lower than that in the TBI group. Between the TBI and sham groups, 270 lncRNAs and 1,052 mRNAs were differently expressed (P < 0.05, fold change (FC) > 2), while between the A2B5+ iPSC and TBI groups, 83 lncRNAs and 360 mRNAs were differently expressed (P < 0.05, FC > 2). Meanwhile, 37 lncRNAs and 195 mRNAs were simultaneously changed in the 2 parts. Using bioinformatic analysis, we found the crucial lncRNA and mRNA were ENSRNOT00000052577 and Kif2c in the TBI brain with cell transplantation. This study demonstrated that A2B5+ iPSC grafts effectively improved neurological function, and the mechanism of action was associated with lncRNA and mRNA expression. Therefore, A2B5+ iPSC transplantation could be considered as a new method for the treatment of TBI, and ENSRNOT00000052577 and Kif2c may be new molecular targets or markers for functional improvement.	[Lyu, Qiang; Zhang, Zi-Bin; Xiong, Liu-Lin; Liu, Jing; Wang, Ting-Hua] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr,Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Lyu, Qiang] Sichuan Acad Med Sci, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Lyu, Qiang] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Fu, Song-Jun; Wang, Ting-Hua] Kunming Med Univ, Inistitute Neurosci, Kunming, Yunnan, Peoples R China		Wang, TH (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, 17,Sect 3 South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.; Wang, TH (corresponding author), Sichuan Univ, West China Hosp, Inst Neurol Dis, 17,Sect 3 South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China.	tinghua_neuron@263.net					Aoki J, 2016, BONE MARROW TRANSPL, V51, P604, DOI 10.1038/bmt.2015.297; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; Bohmdorfer G, 2015, TRENDS CELL BIOL, V25, P623, DOI 10.1016/j.tcb.2015.07.002; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Cahu X, 2016, BONE MARROW TRANSPL, V51, P351, DOI 10.1038/bmt.2015.278; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Choi HW, 2014, STEM CELLS, V32, P2596, DOI 10.1002/stem.1757; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Fu XM, 2015, CELL TRANSPLANT, V24, P1533, DOI 10.3727/096368914X679345; Gudenas BL, 2015, BIOINFORM BIOL INSIG, V9, P21, DOI 10.4137/BBI.S29435; Guennewig B, 2014, INT REV NEUROBIOL, V116, P153, DOI 10.1016/B978-0-12-801105-8.00007-2; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Lajiness-O'Neill R, 2011, APPL NEUROPSYCHOL, V18, P298, DOI 10.1080/09084282.2011.595457; Lan X, 2016, HEPATOLOGY, V64, P58, DOI 10.1002/hep.28391; Li YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0343-z; Libin AV, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0061-2; Liu YB, 2014, GENE, V543, P15, DOI 10.1016/j.gene.2014.04.016; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Mills JD, 2015, NEUROGENETICS, V16, P201, DOI 10.1007/s10048-015-0445-1; Ogawa S, 2011, NEUROSCI LETT, V489, P79, DOI 10.1016/j.neulet.2010.11.070; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Ramos-Cejudo J, 2015, STROKE, V46, P221, DOI 10.1161/STROKEAHA.114.006692; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; Shen WB, 2016, CELL TRANSPLANT, V25, P1085, DOI 10.3727/096368915X689550; Shimizu Y, 2013, FEBS J, V280, P1681, DOI 10.1111/febs.12182; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Vausort M, 2014, CIRC RES, V115, P668, DOI 10.1161/CIRCRESAHA.115.303836; Wang K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7779; Wang WY, 2015, J BIOL CHEM, V290, P18721, DOI 10.1074/jbc.M115.646919; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; Welstead G Grant, 2008, J Vis Exp, DOI 10.3791/734; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xu LY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0087-0; Zhao FY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13850; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhou YX, 2013, NEUROLOGY, V80, P1822, DOI 10.1212/WNL.0b013e318292a37d	45	9	9	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	OCT	2017	26	10					1622	1635		10.1177/0963689717723014			14	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	FQ3ZX	WOS:000418298500002	29251113	Green Published, gold			2022-02-06	
J	Mosleh, Y; Sloten, JV; Depreitere, B; Ivens, J				Mosleh, Yasmine; Sloten, Jos Vander; Depreitere, Bart; Ivens, Jan			Novel Composite Foam Concept for Head Protection in Oblique Impacts	ADVANCED ENGINEERING MATERIALS			English	Article							TRAUMATIC BRAIN-INJURY; MODEL; PRIMATE; INERTIA	Rotational acceleration experienced by the head during oblique impacts is known to cause traumatic brain injuries. It is hypothesized that shear properties of a foam layer, used for head protection (e.g., protective helmet liners, headliners in cars) can be related to the extent of rotational acceleration transmitted to the head. Furthermore, it is hypothesized that by introducing anisotropy in a foam layer, rotational acceleration can be mitigated. In this study, an anisotropic composite foam concept is proposed to mitigate head rotational acceleration, hence reducing the risk of traumatic brain injuries. The composite foam concept introduces anisotropy in a foam at the "macro level", combining different densities of foam in layered and quasi-fiber/matrix configurations. The performance of expanded polystyrene (EPS) composite foams in quasi-static compression and combined shear-compression loading and also linear and oblique impact experiments, has been compared with the performance of single layer EPS foam of similar thickness and density. The results of oblique head impact have been analyzed by global head injury criteria such as HIC, HICrot, and HIP. The composite foam concept demonstrates a great potential to be utilized in applications such as protective helmets due to the significant mitigation of brain injury risk.	[Mosleh, Yasmine; Ivens, Jan] Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44 Bus 2450, Leuven, Belgium; [Sloten, Jos Vander] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Celestijnenlaan 300, Leuven, Belgium; [Depreitere, Bart] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurosurg, Leuven, Belgium		Mosleh, Y (corresponding author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44 Bus 2450, Leuven, Belgium.	Yasi.Mosleh@kuleuven.be	Ivens, Jan/A-7922-2015; Ivens, Jan ID/I-4339-2016; Depreitere, Bart/AAA-9846-2020	Ivens, Jan ID/0000-0002-2766-1381; Depreitere, Bart/0000-0002-7458-0648	Flemish research funding agency FWO [G.0C67.13]	Authors wish to thank the Flemish research funding agency FWO for the financial support of this research through the project Levenslijn (G.0C67.13). We would like to express our gratitude to Dr. De Bruijne from Lazer sports to provide us with EPS foam blocks.	Ashby M.F., 1997, CELLULAR SOLIDS; Bosche K. V., 2016, THESIS; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Deck C., 2007, P IRCOBI C MAASTR NE, P185; Depreitere B, 2008, [Protective helmet, Patent], Patent No. [EP1 776 022 B1, 1776022]; Eppinger R., 2000, SUPPLEMENT DEV IMPRO; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harrison T.I., 1996, P INT IRCOBI C DUBL, P49; Holbourn AHS, 1943, LANCET, V2, P438; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Mills NJ, 2007, POLYMER FOAMS HANDBOOK: ENGINEERING AND BIOMECHANICS APPLICATIONS AND DESIGN GUIDE, P1; Newman J A, 2000, Stapp Car Crash J, V44, P215; Otte D., 1999, CONTRIBUTION FINAL R; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault L., 1971, P 15 STAPP CAR CRASH; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Verschueren P., 2009, BIOMECHANICAL ANAL H; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	26	9	9	0	6	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1438-1656	1527-2648		ADV ENG MATER	Adv. Eng. Mater.	OCT	2017	19	10			SI				1700059	10.1002/adem.201700059			12	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FK6BI	WOS:000413587700001		Bronze			2022-02-06	
J	Petkus, V; Preiksaitis, A; Krakauskaite, S; Zubaviciute, E; Rocka, S; Rastenyte, D; Vosylius, S; Ragauskas, A				Petkus, Vytautas; Preiksaitis, Aidanas; Krakauskaite, Solventa; Zubaviciute, Erika; Rocka, Saulius; Rastenyte, Daiva; Vosylius, Saulius; Ragauskas, Arminas			Benefit on optimal cerebral perfusion pressure targeted treatment for traumatic brain injury patients	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Cerebrovascular reactivity; Optimal cerebral perfusion pressure; Cerebrovascular autoregulation	SEVERE HEAD-INJURY; PROTOCOL-DRIVEN THERAPIES; INTRACRANIAL-PRESSURE; CEREBROVASCULAR AUTOREGULATION; VOLUME REGULATION; REACTIVITY; PRINCIPLES; HYPERTENSION; HEMORRHAGE; MANAGEMENT	Purpose: The maintenance of patient-specific optimal cerebral perfusion pressure (CPPopt) is crucial for patients with traumatic brain injury (TBI). The goal of the study was to explore the influence of CPP declination from CPPopt value on the TBI patients' outcome. Methods: The CPP and cerebrovascular autoregulation (CA) monitoring of 52 TBI patients was performed. Patient-specific CPPopt has been identified and the associations between the patients' outcome and complex influence of time of CPP declination from CPPopt value, age, and the duration of CA impairment episodes has been analyzed. Results: The multiple correlation coefficient between the Glasgow outcome scale (GOS), duration of CA impairment events and percentage time, when 0 <Delta CPPopt < 10 mm Hg was r = -0.643 (P < 0.001). The multiple correlation coefficients between GOS, age, and percentage time of Delta CPPopt when 0 <Delta CPPopt < 10 mm Hg was r = -0.587 (P < 0.001). Conclusion: The CPPopt-targeted patient-specific management might be useful for stabilizing CA in TBI patients as well as for improving their outcome. Better outcomes were obtained by maintaining CPP in light hyperperfusion condition (up to 10 mm Hg above CPPopt) when CPPopt is in the range of 60-80 mm Hg, and keeping CPP within the range of CPPopt +/-5 mm Hg when CPPopt is above 80 mm Hg. (C) 2017 Elsevier Inc. All rights reserved.	[Petkus, Vytautas; Preiksaitis, Aidanas; Krakauskaite, Solventa; Ragauskas, Arminas] Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania; [Preiksaitis, Aidanas] Lithuanian Univ Hlth Sci, Acad Med, Dept Neurol, Kaunas, Lithuania; [Preiksaitis, Aidanas; Zubaviciute, Erika; Rocka, Saulius; Vosylius, Saulius] Vilnius Univ, Clin Neurol & Neurosurg, Fac Med, Vilnius, Lithuania; [Preiksaitis, Aidanas; Rocka, Saulius; Vosylius, Saulius] Republ Vilnius Univ Hosp, Dept Neurosurg, Vilnius, Lithuania		Krakauskaite, S (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania.	solventa@mail.com			Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-118/2012, MIP-087/2015]	This research was supported by the Research Council of Lithuania [grants numbers MIP-118/2012 and MIP-087/2015].	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Boeckx S, 2015, INTENSIVE CARE MED E, V3, pA441; Carney N, 2016, GUIDELINES MANAGEMEN, P1; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Friess SH, 2015, J NEUROTRAUM, V32, P237, DOI 10.1089/neu.2014.3468; Fujii T, 2016, J CLIN NEUROSCI, V31, P152, DOI 10.1016/j.jocn.2016.03.007; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Huang SJ, 2007, J CLIN NEUROSCI, V14, P449, DOI 10.1016/j.jocn.2005.12.012; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Liu X, 2016, P 16 INT S INTR PRES, P230; Needham E, 2016, J NEUROTRAUMA; Nordstrom Carl-Henrik, 2003, Neurosurg Focus, V15, pE5; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Petkus V, 2016, MEDICINA-LITHUANIA, V52, P46, DOI 10.1016/j.medici.2016.01.004; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	33	9	9	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	OCT	2017	41						49	55		10.1016/j.jcrc.2017.04.029			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM6YO	WOS:000415210400009	28477510				2022-02-06	
J	Prins, ML				Prins, Mayumi L.			Glucose metabolism in pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Pediatric; Traumatic brain injury; Glucose; Metabolism; Alternative substrates	POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; PENTOSE-PHOSPHATE PATHWAY; INTENSIVE INSULIN THERAPY; FREELY MOVING RATS; TEMPORAL WINDOW; KETOGENIC DIET; CORTICAL HYPOMETABOLISM; COGNITIVE DEFICITS; IN-VIVO	Traumatic brain injury is the number one cause of death and disability among the pediatric population in the USA. The heterogeneity of the pediatric population is reflected by both the normal cerebral maturation and the age differences in the causes of TBI, which generate unique age-related pathophysiology responses and recovery profiles. This review will address the normal changes in cerebral glucose metabolism throughout developmental phases and how TBI alters glucose metabolism. Evidence has shown that TBI disrupts the biochemical processing of glucose to energy. This brings to question, "What is the optimal substrate to manage a pediatric TBI patient?" Issues related to glycemic control and alternative substrate metabolism are addressed specifically in regard to pediatric TBI. Research into pediatric glucose metabolism after TBI is limited, and understanding these age-related differences within the pediatric population have great potential to improve support for the injured younger brain.	[Prins, Mayumi L.] Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 532,POB 957039, Los Angeles, CA 90024 USA		Prins, ML (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 532,POB 957039, Los Angeles, CA 90024 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739			ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BAXTER LR, 1987, PSYCHIAT RES, V21, P237, DOI 10.1016/0165-1781(87)90028-X; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Blanco MMB, 2016, NEUROSURG CLIN N AM, V27, P453, DOI 10.1016/j.nec.2016.05.003; Browne SE, 2001, EXP NEUROL, V170, P36, DOI 10.1006/exnr.2001.7700; Campbell J.N., 2011, J NEUROTRAUMA; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; CHIRON C, 1992, J NUCL MED, V33, P696; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Forbes NC, 2014, INT J GEN MED, V7, P1, DOI 10.2147/IJGM.S55649; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herholz K, 2006, J NEUROL SCI, V245, P9, DOI 10.1016/j.jns.2005.09.012; Hirshberg E, 2008, CHEST, V133, P1328, DOI 10.1378/chest.07-2702; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Institute of Medicine and National Research Council Committee on Sports Related Concussion in Youth, 2014, SPORTS RELATED CONCU; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kim IJ, 2009, ACTA RADIOL, V50, P1169, DOI 10.3109/02841850903258058; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; LEONG SF, 1984, BIOCHEM J, V218, P131, DOI 10.1042/bj2180131; Liu W, 2016, NEURORADIOLOGY; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MAHER F, 1992, BIOCHEM BIOPH RES CO, V182, P703, DOI 10.1016/0006-291X(92)91789-S; Martin A, 2009, CURR NEUROVASC RES, V6, P82, DOI 10.2174/156720209788185650; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; NEHLIG A, 1985, J CEREBR BLOOD F MET, V5, P393, DOI 10.1038/jcbfm.1985.54; NEHLIG A, 1988, J NEUROSCI, V8, P2321; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Okumura Ayumi, 2005, No To Shinkei, V57, P115; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pappius HM, 1995, NEUROCHEM RES, V20, P1311, DOI 10.1007/BF00992506; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Povlishock JT, 1996, ACT NEUR S, V66, P81; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Prins ML, 2011, EPILEPSY RES, V18; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; RODRIGUEZ G, 1988, J CEREBR BLOOD F MET, V8, P783, DOI 10.1038/jcbfm.1988.133; Salim A, 2009, AM SURGEON, V75, P25; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Shan ZYY, 2014, HUM BRAIN MAPP, V35, P2297, DOI 10.1002/hbm.22328; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Trotta N, 2016, HUM BRAIN MAPP, V37, P3017, DOI 10.1002/hbm.23223; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Van Bogaert P, 1998, NEUROIMAGE, V8, P62, DOI 10.1006/nimg.1998.0346; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; WORLEY G, 1995, DEV MED CHILD NEUROL, V37, P213; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yoshizawa H, 2014, PSYCHIAT RES-NEUROIM, V221, P78, DOI 10.1016/j.pscychresns.2013.10.009	83	9	9	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1711	1718		10.1007/s00381-017-3518-7			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900014	29149386				2022-02-06	
J	Van Huizen, AV; Tseng, AS; Beane, WS				Van Huizen, Alanna V.; Tseng, Ai-Sun; Beane, Wendy S.			Methylisothiazolinone toxicity and inhibition of wound healing and regeneration in planaria	AQUATIC TOXICOLOGY			English	Article						Regeneration; Wound healing; Methylisothiazolinone; Planarian flatworm; Toxicity; Epithelial integrity	FRESH-WATER PLANARIANS; CONTACT ALLERGY; KATHON CG; ENVIRONMENTAL WATERS; ACTIVE INGREDIENTS; TAIL REGENERATION; DENDRITIC CELLS; WASTE-WATER; SENSITIZATION; BIOCIDE	Methylisothiazolinone (MIT) is a common biocide used in cosmetic and industrial settings. Studies have demonstrated that MIT is a human sensitizer, to the extent that in 2013 MIT was named allergen of the year. Recently, we showed that MIT exposure in Xenbpus laevis (the African clawed frog) inhibits wound healing and tail regeneration. However, it is unknown whether MIT affects these processes in other animals. Here, we investigated the effects of MIT exposure in planaria non-parasitic freshwater flatworms able to regenerate all tissues after injury. Using a common research Strain of Dugesia japonica, we determined that intact planarians exposed to 15 mu M MIT displayed both neuromuscular and epithelial-integrity defects. Furthermore, regenerating (head and tail) fragments exposed to 15 mu M MIT failed to close wounds or had significantly delayed wound healing. Planarian wounds normally close within 1 h after injury. However, most MIT-exposed animals retained open wounds at 24 h and subsequently died, and those few animals that were able to undergo delayed wound healing without dying exhibited abnormal regeneration. For instance, head regeneration was severely delayed or inhibited, with anterior structures such as eyes failing to form in newly produced tissues. These data suggest that MIT directly affects both wound healing and regeneration in planarians. Next, we investigated the ability of thiol-containing antioxidants to rescue planarian wound closure during MIT exposure. The data reveal both n acetyl cysteine and glutathione were each able to fully rescue MIT inhibition of wound healing. Lastly, we established MIT toxicity levels by determining the LC50 of 5 different planarian species: D. japonica, Schmidtea mediterranea, Girardia tigrina, Girardia dorotocephala, and Phagocata gracilis. Our LC50 data revealed that concentrations as low as 39 mu M (4.5 ppm) are lethal to planarians, with concentrations of just 5 M inhibiting wound healing, and suggest that phylogeny is predictive of species toxicity levels. Together these results indicate MIT may have broad wound healing effects on aquatic species in general and are not limited to X. laevis alone. Future studies should investigate the impact of MIT on wound healing in other organisms, including non-aquatic organisms and mammals.	[Van Huizen, Alanna V.; Beane, Wendy S.] Western Michigan Univ, Dept Biol Sci, 1903 West Michigan Ave,Box 5410, Kalamazoo, MI 49008 USA; [Tseng, Ai-Sun] Univ Nevada, Sch Life Sci, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA		Beane, WS (corresponding author), Western Michigan Univ, Dept Biol Sci, 1903 West Michigan Ave,Box 5410, Kalamazoo, MI 49008 USA.	wendy.beane@wmich.edu			Western Michigan University	We would like to thank the Beane lab and the Tseng lab for comments and suggestions. This work was funded by a start-up grant from Western Michigan University.	Aerts O, 2015, EUR J DERMATOL, V25, P228, DOI 10.1684/ejd.2015.2608; Agata K, 2014, ZOOLOGY, V117, P161, DOI 10.1016/j.zool.2014.04.001; Alvarez-Presas M, 2008, MOL PHYLOGENET EVOL, V47, P555, DOI 10.1016/j.ympev.2008.01.032; Balestrini L, 2017, INT J DEV BIOL, V61, P43, DOI 10.1387/ijdb.160169rb; Baranowska I, 2013, POL J ENVIRON STUD, V22, P1609; Beane WS, 2012, STEM CELLS DEV, V21, P2085, DOI 10.1089/scd.2011.0605; Beane WS, 2013, DEVELOPMENT, V140, P313, DOI 10.1242/dev.086900; Becker D, 2003, J INVEST DERMATOL, V120, P233, DOI 10.1046/j.1523-1747.2003.12026.x; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; BJORKNER B, 1986, CONTACT DERMATITIS, V14, P85, DOI 10.1111/j.1600-0536.1986.tb01166.x; Bottcher I, 2008, IMMUNOLOGY, V123, P139, DOI 10.1111/j.1365-2567.2007.02754.x; Bollmann UE, 2014, WATER RES, V60, P64, DOI 10.1016/j.watres.2014.04.014; Bruchhausen S, 2003, J INVEST DERMATOL, V121, P1039, DOI 10.1046/j.1523-1747.2003.12510.x; BRUZE M, 1987, ACTA DERM-VENEREOL, V67, P315; BRUZE M, 1987, CONTACT DERMATITIS, V16, P183, DOI 10.1111/j.1600-0536.1987.tb01421.x; Buttarelli FR, 2000, COMP BIOCHEM PHYS C, V125, P225, DOI 10.1016/S0742-8413(99)00111-5; Buttarelli FR, 2008, COMP BIOCHEM PHYS C, V147, P399, DOI 10.1016/j.cbpc.2008.01.009; Carbajo JB, 2015, WATER RES, V72, P174, DOI 10.1016/j.watres.2014.12.040; Castanedo-Tardana MP, 2013, DERMATITIS, V24, P2, DOI 10.1097/DER.0b013e31827edc73; COLLIER PJ, 1990, J APPL BACTERIOL, V69, P578, DOI 10.1111/j.1365-2672.1990.tb01551.x; DEGROOT AC, 1985, CONTACT DERMATITIS, V12, P76, DOI 10.1111/j.1600-0536.1985.tb01057.x; Delos Santos N, 2016, AQUAT TOXICOL, V181, P37, DOI 10.1016/j.aquatox.2016.10.016; Du S, 2002, J NEUROSCI, V22, P7408; Finney D.J., 1952, J I ACTUAR, V78, P388, DOI [10.1017/S0020268100052938, DOI 10.1017/S0020268100052938]; GREBE E, 1991, B ENVIRON CONTAM TOX, V46, P866, DOI 10.1007/BF01689731; Hagstrom D, 2016, REGENERATION, V3, P65, DOI 10.1002/reg2.52; Hagstrom D, 2015, TOXICOL SCI, V147, P270, DOI 10.1093/toxsci/kfv129; He K, 2006, J PHARMACOL EXP THER, V317, P1320, DOI 10.1124/jpet.106.103044; Ho DM, 2008, DEV BIOL, V315, P203, DOI 10.1016/j.ydbio.2007.12.031; Horvat T, 2005, AQUAT TOXICOL, V73, P342, DOI 10.1016/j.aquatox.2005.03.023; Leiva-Salinas M, 2014, ACTAS DERMO-SIFILOGR, V105, P840, DOI 10.1016/j.ad.2013.12.010; Lobo D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002481; Lundov MD, 2011, BRIT J DERMATOL, V165, P1178, DOI 10.1111/j.1365-2133.2011.10523.x; Lundov MD, 2011, CONTACT DERMATITIS, V64, P330, DOI 10.1111/j.1600-0536.2011.01901.x; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; National Library of Medicine, 2015, METH; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Oviedo N.J., 2008, PLANARIANS VERSATILE, V2008; Pagan O.R., 2009, J UNDERGRAD NEUROSCI, V7, P48; Passarelli F, 1999, COMP BIOCHEM PHYS C, V124, P51, DOI 10.1016/S0742-8413(99)00048-1; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Pirotte N, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/392476; Pra D, 2005, MUTAT RES-GEN TOX EN, V585, P79, DOI 10.1016/j.mrgentox.2005.04.002; Raffa R.B., 2009, LANDES BIOSCI; Raffa RB, 2001, EUR J PHARMACOL, V430, P143, DOI 10.1016/S0014-2999(01)01358-9; Rafoth A, 2007, J CHROMATOGR A, V1164, P74, DOI 10.1016/j.chroma.2007.07.040; Rawls SM, 2011, DRUG ALCOHOL DEPEN, V118, P274, DOI 10.1016/j.drugalcdep.2011.04.001; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Sakaguchi H, 2007, ARCH DERMATOL RES, V298, P427, DOI 10.1007/s00403-006-0714-9; Sanchez Alvarado A, 1998, Wound Repair Regen, V6, P413; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Thume IS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5792621; Thyssen JP, 2006, CONTACT DERMATITIS, V54, P322, DOI 10.1111/j.0105-1873.2006.00850.x; Umesono Y, 2013, NATURE, V500, P73, DOI 10.1038/nature12359; Uter W, 2013, CONTACT DERMATITIS, V69, P231, DOI 10.1111/cod.12123; VENTURINI G, 1989, NEUROPHARMACOLOGY, V28, P1377, DOI 10.1016/0028-3908(89)90013-0; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Wilford JE, 2017, J CUTAN MED SURG, V21, P207, DOI 10.1177/1203475417690307; Williams T. M., 2007, POWER PLANT CHEM, V9, P14; Wu JP, 2015, NEUROTOXICOLOGY, V47, P72, DOI 10.1016/j.neuro.2015.01.003; Yazar K, 2015, BRIT J DERMATOL, V173, P115, DOI 10.1111/bjd.13751; [No title captured], DOI DOI 10.1111/iwj.12557	65	9	10	7	99	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	OCT	2017	191						226	235		10.1016/j.aquatox.2017.08.013			10	Marine & Freshwater Biology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Toxicology	FI3HN	WOS:000411848700023	28869924				2022-02-06	
J	Young, AMH; Kolias, AG; Hutchinson, PJ				Young, Adam M. H.; Kolias, Angelos G.; Hutchinson, Peter J.			Decompressive craniectomy for traumatic intracranial hypertension: application in children	CHILDS NERVOUS SYSTEM			English	Article						Brain; Injury; Craniectomy; Decompression; Paediatric	SEVERE HEAD-INJURY; CEREBROVASCULAR PRESSURE REACTIVITY; BRAIN-INJURY; COMPLICATIONS; CRANIOTOMY; CRANIOPLASTY; MANAGEMENT; DURAPLASTY; SURGERY; TRIAL	Traumatic brain injury remains prevalent in children, particularly within the adolescent age group. In severe injury, the priority of treatment is to stabilise the patient initially and prevent the evolution of brain swelling and secondary ischaemia using tiers of medical therapy. The final stage of intervention for such patients is a decompressive craniectomy. Here in, we identify the current evidence for performing decompressive crainectomy in children including the results from the RESCUEicp study.	[Young, Adam M. H.; Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Young, Adam M. H.; Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England; [Young, Adam M. H.] Univ Cambridge, Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England		Young, AMH (corresponding author), Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England.; Young, AMH (corresponding author), Univ Cambridge, Cambridge, England.	ay276@cam.ac.uk		Kolias, Angelos/0000-0003-3992-0587	NIHR Academic Clinical Fellowship; Clinical Lectureship, School of Clinical Medicine, University of Cambridge; Research Professorship from the National Institute for Health Research (NIHR); NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); European Union Seventh Framework Program grant (CENTER-TBI) [602150]; Royal College of Surgeons of England; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish	Adam Young is supported by an NIHR Academic Clinical Fellowship. Angelos Kolias is supported by a Clinical Lectureship, School of Clinical Medicine, University of Cambridge. Peter Hutchinson is supported by a Research Professorship from the National Institute for Health Research (NIHR), the NIHR Cambridge Biomedical Research Centre, a European Union Seventh Framework Program grant (CENTER-TBI; grant no. 602150), and the Royal College of Surgeons of England.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agrawal S, 2012, EUR J TRAUMA EMERG S, V38, P75, DOI 10.1007/s00068-011-0093-6; Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Ahmad FU, 2011, WORLD NEUROSURG, V75, P451, DOI 10.1016/j.wneu.2010.12.042; Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; GRANTHAM EG, 1948, J NEUROSURG, V5, P19, DOI 10.3171/jns.1948.5.1.0019; Gurer B, 2013, PEDIATR NEUROSURG, V49, P215, DOI 10.1159/000363193; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Le Roux P, 2015, FRONT NEUROSCI, V57, P315; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; O'Leary R, 2016, NEW ENGL J MED, V374, P1383, DOI 10.1056/NEJMc1600339; Pereyra C, 2012, TRANSPL P, V44, P2181, DOI 10.1016/j.transproceed.2012.07.107; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Walcott BP, 2013, WORLD NEUROSURG, V79, P80, DOI 10.1016/j.wneu.2012.11.014; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817	52	9	9	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1745	1750		10.1007/s00381-017-3534-7			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900018	29149391	Green Published, hybrid			2022-02-06	
J	Wang, YB; Hall, RA; Lee, M; Kamgar-parsi, A; Bi, XN; Baudry, M				Wang, Yubin; Hall, Randy A.; Lee, Moses; Kamgar-parsi, Andysheh; Bi, Xiaoning; Baudry, Michel			The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; NEUTRAL PROTEINASE CALPAIN; CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE; MOLECULAR-MECHANISM; C-ABL; NMDA RECEPTOR; PDZ DOMAIN; ACTIVATION; MODEL	Traumatic brain injury (TBI) increases the risk of Alzheimer's disease (AD). Calpain activation and tau hyperphosphorylation have been implicated in both TBI and AD. However, the link between calpain and tau phosphorylation has not been fully identified. We recently discovered that the two major calpain isoforms in the brain, calpain-1 and calpain-2, play opposite functions in synaptic plasticity and neuronal survival/death, which may be related to their different C-terminal PDZ binding motifs. Here, we identify the tyrosine phosphatase PTPN13 as a key PDZ binding partner of calpain-2. PTPN13 is cleaved by calpain-2, which inactivates its phosphatase activity and generates stable breakdown products (P13BPs). We also found that PTPN13 dephosphorylates and inhibits c-Abl. Following TBI, calpain-2 activation cleaved PTPN13, activated c-Abl and triggered tau tyrosine phosphorylation. The activation of this pathway was responsible for the accumulation of tau oligomers after TBI, as post-TBI injection of a calpain-2 selective inhibitor inhibited c-Abl activation and tau oligomer accumulation. Thus, the calpain-2-PTPN13-c-Abl pathway provides a direct link between calpain-2 activation and abnormal tau aggregation, which may promote tangle formation and accelerate the development of AD pathology after repeated concussions or TBI. This study suggests that P13BPs could be potential biomarkers to diagnose mTBI or AD.	[Wang, Yubin; Lee, Moses; Kamgar-parsi, Andysheh; Baudry, Michel] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA; [Bi, Xiaoning] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Hall, Randy A.] Emory Univ, Sch Med, Atlanta, GA 30303 USA		Baudry, M (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA.	mbaudry@westernu.edu		Wang, Yubin/0000-0002-8836-9632; Hall, Randy/0000-0002-8318-8728	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS045260-01, R01NS057128]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R15MH101703]; Daljit and Elaine Sarkaria Chair; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R15MH101703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090397, P01NS045260, R01NS057128] Funding Source: NIH RePORTER	We thank Liping Mou for technical assistance. This work was supported by grant P01NS045260-01 from NINDS (PI: Dr. C.M. Gall), grant R01NS057128 from NINDS to MB, and grant R15MH101703 from NIMH to XB. XB is also supported by funds from the Daljit and Elaine Sarkaria Chair.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Baudry M., 2016, TRENDS NEUROSCI; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chazot PL, 2004, CURR MED CHEM, V11, P389, DOI 10.2174/0929867043456061; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Freiss G, 2011, ANTI-CANCER AGENT ME, V11, P78, DOI 10.2174/187152011794941262; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; Jin N., 2015, SCI REP, V5; Jin NN, 2015, J BIOL CHEM, V290, P15219, DOI 10.1074/jbc.M115.645507; Jin NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08187; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liu Y, 2016, NEUROPHARMACOLOGY, V105, P471, DOI 10.1016/j.neuropharm.2016.02.022; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Papouin T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0601; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Seinfeld J, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0088-15.2016; SEUBERT P, 1987, SYNAPSE, V1, P20, DOI 10.1002/syn.890010105; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wang Y., 2017, J NEUROTRAUM, DOI DOI 10.1089/neu.2016.4953; Wang YB, 2016, NEUROBIOL DIS, V93, P121, DOI 10.1016/j.nbd.2016.05.007; Wang YB, 2016, CELL REP, V16, P79, DOI 10.1016/j.celrep.2016.05.044; Wang YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4051; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	56	9	9	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 18	2017	7								11771	10.1038/s41598-017-12236-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH1RC	WOS:000410916100029	28924170	Green Published, gold			2022-02-06	
J	Peng, Y; Zhu, HF; Chen, HD; Zhu, ZJ; Zhou, HH; Zhang, SG; Gao, LL; Shi, L; Li, XL; Luo, ZX				Peng, Yuan; Zhu, Haifeng; Chen, Haodong; Zhu, Zijin; Zhou, Huahai; Zhang, Shuguang; Gao, Lili; Shi, Lei; Li, Xiaoliang; Luo, Zhengxiang			Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity	ONCOTARGET			English	Article						dexmedetomidine; propofol; paroxysmal sympathetic hyperactivity; prognosis	TRAUMATIC BRAIN-INJURY; AUTONOMIC INSTABILITY; PHARMACOLOGICAL MANAGEMENT; HEAD-INJURY; DYSAUTONOMIA; DYSTONIA; STORM	We evaluated the curative effect of dexmedetomidine on paroxysmal sympathetic hyperactivity (PSH) in a retrospective study of 72 PSH patients after neurosurgery. Our results showed that dexmedetomidine was superior to propofol for treatment of PSH with respect to: average time needed to reduce paroxysmal hypertension (PH) to < 140/90 mmHg (29.03+/-8.86 vs. 42.0+/-14.77 min), average remission time of PH (3.97+/-1.73 vs. 5.65+/-1.51 min), PH remission rate (61.22+/-10.8% vs. 41.52+/-14.15%), PH duration (9.31+/-2.66 vs. 13.05+/-4.19 days), average time for body temperature to return to normal (10.62+/-4.14 vs. 15.31+/-4.58 days), average time for heartrate to return to normal (11.34+/-3.90 vs. 15.72+/-4.10 days), and average time of respiratory rate below 25 breaths per minute (BPM) (7.00+/-1.74 vs. 15.32+/-5.87 days). Multiple logistic regression analyses showed that dexmedetomidine did not protect against the recurrence of PSH. Age and Glasgow Coma Score were the main factors predicting PSH recurrence. There was no difference in Glasgow Outcome Score (GOS) between the two groups during the 6 months of postoperative follow-up (p>0.05). These data suggest dexmedetomidine effectively controls an acute attack of PSH, but it does not improve the long-term prognosis of patients compared with propofol.	[Peng, Yuan; Zhang, Shuguang; Shi, Lei; Li, Xiaoliang] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Intens Care Unit & Neurosurg, Suzhou 215300, Peoples R China; [Zhu, Haifeng; Gao, Lili] Jiangsu Funing Peoples Hosp, Dept Neurosurg & Med Oncol, Funing 224400, Peoples R China; [Chen, Haodong] Yangzhou Univ, Med Coll, Liuhe Hosp, Dept Neurosurg, Nanjing 211500, Jiangsu, Peoples R China; [Zhu, Zijin] Anhui Prov Wangjiang Hosp, Dept Neurosurg, Anqing 246200, Anhui, Peoples R China; [Zhou, Huahai] Sihong Cty Peoples Hosp, Dept Neurosurg, Suqian 223900, Peoples R China; [Luo, Zhengxiang] Nanjing Med Univ, Dept Neurosurg, Nanjing Brain Hosp, Nanjing 210029, Jiangsu, Peoples R China		Luo, ZX (corresponding author), Nanjing Med Univ, Dept Neurosurg, Nanjing Brain Hosp, Nanjing 210029, Jiangsu, Peoples R China.	zhengxiang_luo@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370062, 81000963]; Jiangsu Province's 333 Talent Program [BRA2011046]; Six talents Peak Project in Jiangsu Province [WSN146]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK2012670]; Medical Research Foundation by Jiangsu Province Health Department [YG201301, Z201215, Z201318]; Medical Research Foundation by Nanjing Commission of Health and Family Planning [YKK14104]; Clinical Technology Development of Jiangsu University [JLY20120053]; Brain Clinic and Basic Research Team Program of the First People's Hospital of Kunshan [KYC004]	This work was supported by the National Natural Science Foundation of China (CN) (81370062 and 81000963), Jiangsu Province's 333 Talent Program (BRA2011046), Six talents Peak Project in Jiangsu Province (WSN146), Jiangsu Province's Natural Science Foundation (BK2012670), Medical Research Foundation by Jiangsu Province Health Department (YG201301, Z201215 and Z201318), Medical Research Foundation by Nanjing Commission of Health and Family Planning (YKK14104), the Clinical Technology Development of Jiangsu University (JLY20120053), and the Brain Clinic and Basic Research Team Program of the First People's Hospital of Kunshan (KYC004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Feng Y, 2015, PEDIATR NEUROSURG, V50, P301, DOI 10.1159/000439282; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Humble SS, 2016, BRAIN INJURY, V30, P1266, DOI 10.1080/02699052.2016.1187289; Ko SB, 2010, NEUROLOGIST, V16, P384, DOI 10.1097/NRL.0b013e3181b1cdff; Letzkus L, 2016, BRAIN INJURY, V30, P1181, DOI 10.1080/02699052.2016.1184757; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; May CC, 2015, PHARMACOTHERAPY, V35, pE27, DOI 10.1002/phar.1568; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Nguyen John, 2016, JBI Database System Rev Implement Rep, V14, P63; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Raithel Deborah S, 2015, J Pediatr Pharmacol Ther, V20, P335, DOI 10.5863/1551-6776-20.4.335; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163	20	9	12	0	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	SEP 15	2017	8	40					69012	69019		10.18632/oncotarget.16920			8	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FG9WL	WOS:000410790500184	28978176	Green Published, gold			2022-02-06	
J	Balasundaram, AP; Athens, J; Schneiders, AG; McCrory, P; Sullivan, SJ				Balasundaram, Arun Prasad; Athens, Josie; Schneiders, Anthony Gerard; McCrory, Paul; Sullivan, Stephen John			Psychological and Lifestyle Factors That Influence the Serial Reporting of Postconcussion-like Symptoms in a Non-concussed Population	PM&R			English	Article							BASE-LINE VALUES; INTERNATIONAL-CONFERENCE; SPORT CONCUSSION; CONSENSUS STATEMENT; DEPRESSION; ANXIETY; STUDENTS; FATIGUE; STRESS; ZURICH	Background: Symptoms related to concussion are generally nonspecific in nature, as they are also reported by non-concussed individuals. What is currently not known is whether the symptoms vary over time, and whether they are also influenced by a multitude of factors. Objective: The aim of this study was to investigate the potential influence of psychological, lifestyle, and situational factors on the change in postconcussion-like symptoms reported over 7 consecutive days in a cohort of normal individuals. Design: This was a longitudinal observational study. Setting: The setting was a real-world context. Participants: A convenience sample of 180 non-concussed university students were enrolled. Of these, 110 participants provided data for the entire period of the study. Methods: An experience-sampling methodology was used to document the symptoms reported over time. Stepwise multivariate linear mixed-effects modeling was performed to identify the predictors contributing to the serially reported symptoms. Independent Variables: Independent variables considered were gender, time of the day, location, primary activity, and type of interactant (person) of the participant, physical activity status, trouble sleeping, alcohol consumption, caffeine consumption, stress, anxiety, depression, mental and physical fatigue, and life stressors. Main Outcome Measures: The key outcome measures were the change in total symptom score (TSSchange) and symptom severity score (SSSchange) reported over 7 consecutive days. Results: The predictors of location at the time of reporting, physical fatigue (estimate: -0.98, P <.001) and mental fatigue (estimate: -0.53, P<. 001) contributed to the TSSchange. Post hoc analysis of the variable of location at the time of reporting revealed that participants reported increased TSSchange when they were at a cafe/restaurant compared to a flat/college or university. Conclusions: A number of factors within the context of daily life influenced the postconcussion-like symptoms reported over time. These findings indicate that clinicians need to be cautious when interpreting the serially assessed symptom scores to track the recovery profile of a concussed athlete to make decisions on return-to-play. Additional investigation is warranted to examine the change in symptom scores reported over time by concussed individuals, considering that this study was conducted in a nonconcussed cohort.	[Balasundaram, Arun Prasad; Sullivan, Stephen John] Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, Dunedin, New Zealand; [Balasundaram, Arun Prasad] Univ Oslo, Forskningsveien 3A, N-0373 Oslo, Norway; [Athens, Josie] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Schneiders, Anthony Gerard] Cent Queensland Univ, Sch Human Hlth & Social Sci, Branyan, Australia; [McCrory, Paul] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia		Balasundaram, AP (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, Dunedin, New Zealand.; Balasundaram, AP (corresponding author), Univ Oslo, Forskningsveien 3A, N-0373 Oslo, Norway.	a.p.balasundaram@medisin.uio.no	McCrory, Paul/Q-8688-2019; Balasundaram, Arun Prasad/D-1270-2017	Balasundaram, Arun Prasad/0000-0001-8256-857X; McCrory, Paul/0000-0003-4850-0568			Amaducci Camila de Moraes, 2010, Rev Esc Enferm USP, V44, P1052; Andrews B, 2004, BRIT J PSYCHOL, V95, P509, DOI 10.1348/0007126042369802; Anthony CA, 2015, CLIN J SPORT MED, V25, P149, DOI 10.1097/JSM.0000000000000115; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Christensen T.C., 2003, J HAPPINESS STUDIES, V4, P53, DOI [DOI 10.1023/A:1023609306024, 10.1023/A:1023609306024]; Cohen J., 2003, APPL MULTIPLE REGRES, V3; COHEN S, 1988, CLAR SYMP, P31; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dillman D., 2008, INTERNET MAIL MIXED; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Gallagher R.P., 2012, NATL SURVEY COLL COU; Heck R. H., 2013, MULTILEVEL LONGITUDI; HORMUTH SE, 1986, J PERS, V54, P262, DOI 10.1111/j.1467-6494.1986.tb00395.x; Hox J.J., 2002, MULTILEVEL ANAL TECH; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; KERNIS MH, 1993, J PERS SOC PSYCHOL, V65, P1190, DOI 10.1037/0022-3514.65.6.1190; Lee H, 2015, BRIT J SPORT MED, V49, P500, DOI 10.1136/bjsports-2013-092930; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mehl M.R., 2011, HDB RES METHODS STUD; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moreno E., 2006, SORT-STAT OPER RES T, V30, P3; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Oginska H, 2006, CHRONOBIOL INT, V23, P1317, DOI 10.1080/07420520601089349; Pennebaker JW., 1982, PSYCHOL PHYS SYMPTOM; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; R Development Core Team, 2012, R LANG ENV STAT COMP; Said D, 2013, SOC PSYCH PSYCH EPID, V48, P935, DOI 10.1007/s00127-012-0574-x; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Scollon C.N., 2003, J HAPPINESS STUD, V4, P5, DOI [10.1023/A:1023605205115, DOI 10.1023/A:1023605205115, 10.1023/a:1023605205115]; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stewart AL, 1992, MEASURING FUNCTIONIN, P55; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Valpiani EM, 2011, PSYCHOL ED, V48, P59; Westfall P, 2003, RESAMPLING BASED MUL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	48	9	9	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					866	873		10.1016/j.pmrj.2017.01.004			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500004	28167303				2022-02-06	
J	Beck, LF; Nguyen, DD				Beck, Laurie F.; Nguyen, Daniel D.			School transportation mode, by distance between home and school, United States, ConsumerStyles 2012	JOURNAL OF SAFETY RESEARCH			English	Article						Motor vehicle; Child passenger safety; Children; Pedestrians; Bicyclists	CRASH INJURY RATES; SAFE ROUTES; START TIMES; TRAVEL MODE; HEAD-INJURY; URBAN FORM; CHILDREN; WALKING; RISK; LAWS	Introduction: Motor-vehicle crashes are a leading cause of death among children in the United States, and almost one-fourth of all trips by school-aged children are trips to and from school. This study sought to determine how children (5-18 years) travel to and from school and, among those living <= 1 mile of school, to explore the role of school bus service eligibility on school travel mode. Methods: We used national 2012 survey data to determine prevalence of usual school travel mode, stratified by distance from school. For those living <= 1 mile of school, multivariable regression was conducted to assess the association between bus service eligibility and walking or bicycling. Results: Almost half (46.6%) of all children rode in passenger vehicles (PV) to school and 41.8% did so for the trip home. Results were similar among those living <= 1 mile (48.1%, PV to school; 41.3%, PV to home). Among those living <= 1 mile, 21.9% and 28.4% of children walked or bicycled to and from school, respectively. Ineligibility for school bus service was strongly associated with walking or bicycling to school [adjusted prevalence ratio (aPR: 536; p < 0.001)] and from school (aPR: 536; p < 0.001). Conclusions: Regardless of distance from school, passenger vehicles were a common mode of travel. For children who live close to school, the role that school bus service eligibility plays in walking or bicycling deserves further consideration. Practical applications: Given the large proportion of children who use passenger vehicles for school travel, effective interventions can be adopted to increase proper child restraint and seat belt use and reduce crash risks among teen drivers. Better understanding of conditions under which bus service is offered to children who live dose to school could inform efforts to improve pedestrian and bicyclist safety for school travel. Published by Elsevier Ltd.	[Beck, Laurie F.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS F62, Atlanta, GA 30341 USA; [Nguyen, Daniel D.] Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA		Beck, LF (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS F62, Atlanta, GA 30341 USA.	LDF8@cdc.gov		Nguyen, Daniel/0000-0001-6748-4677	L. Beck Rollins School of Public Health	We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The Journal of Safety Research has partnered with the Office of the Associate Director for Science, Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control at the CDC in Atlanta, Georgia, USA, to briefly report on some of the latest findings in the research community. This report is the 47th in a series of "From the CDC" articles on injury prevention. Submission declaration: We confirm that no papers have been published or are under review in other journals that are based on similar methods or data. Funding sources: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. CDC provided salary support for L. Beck Rollins School of Public Health provided financial support via a work study program for D. Nguyen.	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P949; [Anonymous], 2008, U0036 US DEP HLTH HU; Arbogast KB, 2009, PEDIATRICS, V124, P1281, DOI 10.1542/peds.2009-0908; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Beck LF, 2007, AM J EPIDEMIOL, V166, P212, DOI 10.1093/aje/kwm064; Beck LF, 2008, J SAFETY RES, V39, P449, DOI 10.1016/j.jsr.2008.07.002; Blomberg R. D., 2008, 811013 DOT HS NAT HI; Carpenter CS, 2008, J HEALTH ECON, V27, P642, DOI 10.1016/j.jhealeco.2007.09.010; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P701; Committee on Injury Violence and Poison Prevention, 2011, Pediatrics, V127, P788, DOI 10.1542/peds.2011-0213; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Danner F, 2008, J CLIN SLEEP MED, V4, P533; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; DiMaggio C, 2013, PEDIATRICS, V131, P290, DOI 10.1542/peds.2012-2182; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Eichelberger AH, 2012, TRAFFIC INJ PREV, V13, P631, DOI 10.1080/15389588.2012.660663; Environmental Protection Agency, 2003, EPA231R03004; Ewing R, 2004, TRANSPORT RES REC, P55, DOI 10.3141/1895-08; Eyler AA, 2008, HEALTH EDUC RES, V23, P963, DOI 10.1093/her/cym061; Federal Highway Administration, 2008, NITIS BRIE NAT HOUS; Goodwin A.H., 2015, 812202 DOT HS; Ham S.A., 2005, PREV CHRONIC DIS, V2, P1; Hu P. S., 2004, SUMMARY TRAVEL TREND; Jones SE, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150573; Lavoie M, 2014, CHRON DIS INJ CAN, V34, P195; Lee BHY, 2005, ACCIDENT ANAL PREV, V37, P93, DOI 10.1016/j.aap.2004.07.001; Lee C, 2013, ANN BEHAV MED, V45, pS55, DOI 10.1007/s12160-012-9432-z; Martin SL, 2007, AM J PREV MED, V33, P98, DOI 10.1016/j.amepre.2007.04.024; Masten S. V., 2015, 812212 DOT HS NAT HI; McCartt Anne T, 2005, Traffic Inj Prev, V6, P120, DOI 10.1080/15389580590931581; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; McDonald NC, 2015, ACCIDENT ANAL PREV, V74, P126, DOI 10.1016/j.aap.2014.10.006; McDonald NC, 2011, AM J PREV MED, V41, P146, DOI 10.1016/j.amepre.2011.04.006; McDonald NC, 2009, J AM PLANN ASSOC, V75, P331, DOI 10.1080/01944360902988794; McMillan TE, 2007, TRANSPORT RES A-POL, V41, P69, DOI 10.1016/j.tra.2006.05.011; McNally DS, 2013, ACCIDENT ANAL PREV, V60, P15, DOI 10.1016/j.aap.2013.07.011; National Highway Traffic Safety Administration, 2016, 812261 DOT HS NAT HI; National Highway Traffic Safety Administration, 2017, 812366 DOT HS NAT HI; National Safe Routes to School Task Force, 2008, SAF ROUT SCH TRANSP; Owens JA, 2014, PEDIATRICS, V134, P642, DOI 10.1542/peds.2014-1697; Pardi Lisa A, 2007, J Trauma Nurs, V14, P84; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Pulugurtha SS, 2015, ACCIDENT ANAL PREV, V76, P34, DOI 10.1016/j.aap.2014.12.020; Ragland, 2007, SAFE ROUTES SCH SAFE; Retting RA, 2003, AM J PUBLIC HEALTH, V93, P1456, DOI 10.2105/AJPH.93.9.1456; Sauber-Schatz EK, 2014, MMWR-MORBID MORTAL W, V63, P113; Schlossberg M, 2006, J AM PLANN ASSOC, V72, P337, DOI 10.1080/01944360608976755; Schuurman N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-233; Shope JT, 2008, AM J PREV MED, V35, pS261, DOI 10.1016/j.amepre.2008.06.022; Teschke K, 2013, CAN J PUBLIC HEALTH, V104, pE75, DOI 10.1007/BF03405659; *TRANSP RES BOARD, 2002, 269 TRANSP RES BOARD; Trapp GSA, 2012, HEALTH EDUC BEHAV, V39, P172, DOI 10.1177/1090198111423272; Vorona RD, 2011, J CLIN SLEEP MED, V7, P145; Weber D, 2012, CONSUMERSTYLES 2012; Wheaton AG, 2016, MMWR-MORBID MORTAL W, V65, P337, DOI 10.15585/mmwr.mm6513a1; WHO, 2013, PED SAF ROAD SAF MAN; Williams AF, 2016, J SAFETY RES, V56, P9, DOI 10.1016/j.jsr.2015.11.006; Yang JZ, 2009, ACCIDENT ANAL PREV, V41, P336, DOI 10.1016/j.aap.2008.12.012; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4; Zhu XM, 2009, J PUBLIC HEALTH POL, V30, pS177, DOI 10.1057/jphp.2008.51; Zients J., 2013, OMB B, V13-01	61	9	10	2	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2017	62						245	251		10.1016/j.jsr.2017.04.001			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	FH9PF	WOS:000411543500026	28882273	Green Accepted			2022-02-06	
J	Brix, KA; Brody, DL; Grimes, JB; Yitzhak, A				Brix, Kelley A.; Brody, David L.; Grimes, Jamie B.; Yitzhak, Avraham			Military Blast Exposure and Chronic Neurodegeneration: Summary of Working Groups and Expert Panel Findings and Recommendations	JOURNAL OF NEUROTRAUMA			English	Article						blast-related injury; chronic traumatic encephalopathy (CTE); traumatic brain injury (TBI)	CHRONIC TRAUMATIC ENCEPHALOPATHY; DISEASE	The potential relationship between chronic traumatic encephalopathy (CTE) and head injuries such as blast-related traumatic brain injury (TBI) is an important area of study, particularly for military and contact sports populations, yet little is known about this relationship. To address this topic, the Department of Defense (DoD) Blast Injury Research Program Coordinating Office organized the 2015 International State-of-the-Science Meeting, which brought together subject matter experts from the DoD, other federal agencies, academia, industry, foreign allies, and the sports community. Over the course of the meeting, this community of experts reached a consensus regarding the current body of knowledge and the future of the field. The overarching finding was that there is insufficient existing scientific evidence to link blast-related TBI with CTE. The meeting's Expert Panel also agreed on 13 additional findings describing research and knowledge gaps, clinical gaps, and research opportunities that, if addressed with focused effort, would further the understanding of the relationship between blast-related TBI and CTE. To this end, the Expert Panel also developed six recommendations for advancing research, each with short- and long-term goals. Among the six recommendations, the Expert Panel identified the first four as highest priority for addressing pressing research needs. These four high-priority recommendations include, in order of priority: (1) more collection and study of clinical neuropathology samples, (2) standardization of clinical diagnostic criteria, (3) development of clinically appropriate and standardized animal models, and (4) development of noninvasive serial assessment strategies (i.e., imaging or biospecimen biomarkers).	[Brix, Kelley A.] Def Hlth Agcy, Falls Church, VA USA; [Brody, David L.] Washington Univ, Sch Med, St Louis, MO USA; [Grimes, Jamie B.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Grimes, Jamie B.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Yitzhak, Avraham] Israeli Def Force, Jerusalem, Israel		Brix, KA (corresponding author), Care of Gupta RK, Med Res & Mat Command, US Dept Def, Blast Injury Res Program Coordinating Off,US Army, 504 Scott St, Ft Detrick, MD 21702 USA.	raj.k.gupta.civ@mail.mil	Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Rosseau, Gail/0000-0002-5392-435X; Dardzinski, Bernard/0000-0001-7098-9131			Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hinds S., 2014, SUBJECT CHRONIC TRAU; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Riley DO, 2015, BRAIN INJURY, V29, P154, DOI 10.3109/02699052.2014.965215; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079	11	9	9	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S18	S25		10.1089/neu.2017.5222			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000004		Bronze			2022-02-06	
J	Chieregato, A; Volpi, A; Gordini, G; Ventura, C; Barozzi, M; Caspani, MLR; Fabbri, A; Ferrari, AM; Ferri, E; Giugni, A; Marino, M; Martino, C; Pizzamiglio, M; Ravaldini, M; Russo, E; Trabucco, L; Trombetti, S; De Palma, R				Chieregato, Arturo; Volpi, Annalisa; Gordini, Giovanni; Ventura, Chiara; Barozzi, Marco; Caspani, Maria Luisa Rita; Fabbri, Andrea; Ferrari, Anna Maria; Ferri, Enrico; Giugni, Aimone; Marino, Massimiliano; Martino, Costanza; Pizzamiglio, Mario; Ravaldini, Maurizio; Russo, Emanuele; Trabucco, Laura; Trombetti, Susanna; De Palma, Rossana			How health service delivery guides the allocation of major trauma patients in the intensive care units of the inclusive (hub and spoke) trauma system of the Emilia Romagna Region (Italy). A cross-sectional study	BMJ OPEN			English	Article							INJURY SEVERITY SCORE; SEVERE HEAD-INJURY; MORTALITY; SCALE; MODERATE; COMA	Objective To evaluate cross-sectional patient distribution and standardised 30-day mortality in the intensive care units (ICU) of an inclusive hub and spoke trauma system. Setting ICUs of the Integrated System for Trauma Patient Care (SIAT) of Emilia-Romagna, an Italian region with a population of approximately 4.5 million. Participants 5300 patients with an Injury Severity Score (ISS) > 15 were admitted to the regional ICUs and recorded in the Regional Severe Trauma Registry between 2007 and 2012. Patients were classified by the Abbreviated Injury Score as follows: (1) traumatic brain injury (2) multiple injuriesand (3) extracranial lesions. The SIATs were divided into those with at least one neurosurgical level II trauma centre (TC) and those with a neurosurgical unit in the level I TC only. Results A higher proportion of patients (out of all SIAT patients) were admitted to the level I TC at the head of the SIAT with no additional neurosurgical facilities (1083/1472, 73.6%) compared with the level I TCs heading SIATs with neurosurgical level II TCs (1905/3815; 49.9%). A similar percentage of patients were admitted to level I TCs (1905/3815; 49.9%) and neurosurgical level II TCs (1702/3815, 44.6%) in the SIATs with neurosurgical level II TCs. Observed versus expected mortality (OE) was not statistically different among the three types of centre with a neurosurgical unit; however, the best mean OE values were observed in the level I TC in the SIAT with no neurosurgical unit. Conclusion The Hub and Spoke concept was fully applied in the SIAT in which neurosurgical facilities were available in the level I TC only. The performance of this system suggests that competition among level I and level II TCs in the same Trauma System reduces performance in both. The density of neurosurgical centres must be considered by public health system governors before implementing trauma systems.	[Chieregato, Arturo] ASST Grande Osped Metropolitano Niguarda, Neurorianimaz, Milan, Italy; [Volpi, Annalisa; Caspani, Maria Luisa Rita] Azienda Osped Univ Parma, Anestesia & Rianimaz 1, Parma, Italy; [Gordini, Giovanni; Ferri, Enrico] AUSL Bologna, Rianimaz & Emergenza Terr 118, Osped Maggiore, Bologna, Italy; [Ventura, Chiara] Direz Gen Cura Persona Salute Welf Assessorato Sa, Serv Strutture Tecnol & Sistemi Informativi, Bologna, Italy; [Ventura, Chiara; Trombetti, Susanna; De Palma, Rossana] Agenzia Sanit & Sociale Reg Emilia Romagna, Area Governo Clin, Bologna, Italy; [Barozzi, Marco] Azienda Osped Univ Modena, Pronto Soccorso & Coordinamento Emergenze Traumat, Modena, Italy; [Fabbri, Andrea] Azienda AUSL Romagna, Osped Forli, Pronto Soccorso & Med Urgenza, Forli, Italy; [Ferrari, Anna Maria; Trabucco, Laura] Azienda Osped Arcispedale Santa Maria Nuova IRCCS, Pronto Soccorso & Med Urgenza, Reggio Emilia, Italy; [Marino, Massimiliano] Azienda USL Reggio Emilia, Governo Clin Direz Sanit, Reggio Emilia, Italy; [Martino, Costanza; Ravaldini, Maurizio; Russo, Emanuele] AUSL Romagna, Osped Cesena, Anestesia & Rianima, Emilia Romagna, Italy; [Pizzamiglio, Mario] Azienda USL Piacenza, Anestesia & Rianima, Piacenza, Italy; [Trombetti, Susanna] AUSL Bologna, Dipartimento Cure Primarie, UOC Cure Primarie & Specialist S Lazzaro, Bologna, Italy; [De Palma, Rossana] Direz Gen Cura Persona Salute Welf Assessorato Sa, Serv Assistenza Osped, Bologna, Italy		Chieregato, A (corresponding author), ASST Grande Osped Metropolitano Niguarda, Neurorianimaz, Milan, Italy.	arturo.chieregato@gmail.com; RDePalma@Regione.Emilia-Romagna.it	Fabbri, Andrea/K-9994-2016; Marino, Massimiliano/K-1515-2016; Russo, Emanuele/AAP-5645-2020; Gordini, Giovanni/AAB-8170-2022	Fabbri, Andrea/0000-0002-9837-4638; Marino, Massimiliano/0000-0003-4005-0646; Russo, Emanuele/0000-0002-6531-5527; Gordini, Giovanni/0000-0003-4518-0204; Chieregato, Arturo/0000-0001-6690-8597			[Anonymous], 2014, ANN 2013 INC STRAD; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chiara O., 2004, SISTEMA INTEGRATO AS; Chiara Osvaldo, 2003, Curr Opin Crit Care, V9, P510, DOI 10.1097/00075198-200312000-00008; Chieregato A, 2014, ANAESTHESIA, V69, P1117, DOI 10.1111/anae.12806; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Di Bartolomeo S, 2008, INJURY, V39, P1001, DOI 10.1016/j.injury.2008.04.009; Di Bartolomeo S, 2014, INJURY, V45, P299, DOI 10.1016/j.injury.2013.02.015; Di Bartolomeo S, 2011, ACCIDENT ANAL PREV, V43, P1955, DOI 10.1016/j.aap.2011.05.013; Di Bartolomeo S, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-26; ETSC (European Transport Safety Council), 2014, ANN PIN REP; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; ROSS SE, 1992, ACCIDENT ANAL PREV, V24, P181, DOI 10.1016/0001-4575(92)90035-H; Servadei F, 2002, BRIT J NEUROSURG, V16, P36, DOI 10.1080/02688690120114255; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Taggi Franco, 2007, QUANTO CI COSTA TRAU, P565; TEASDALE G, 1974, LANCET, V2, P81; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170	24	9	9	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2017	7	9							e016415	10.1136/bmjopen-2017-016415			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ3RY	WOS:000412650700129	28965094	Green Published, gold			2022-02-06	
J	Clark, JF; Ellis, JK; Burns, TM; Childress, JM; Divine, JG				Clark, Joseph F.; Ellis, James K.; Burns, Timothy M.; Childress, John M.; Divine, Jon G.			Analysis of Central and Peripheral Vision Reaction Times in Patients With Postconcussion Visual Dysfunction	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; central vision; peripheral vision; reaction time	POSITION STATEMENT; RELIABILITY; SPORTS	Objective: To determine whether central and peripheral vision reaction times (PVRTs) are prolonged in patients with visual dysfunction after sustaining a concussion. Design: Comparison of Dynavision D2 central and PVRTs in patients with postconcussion visual dysfunction were compared with control data from a normative patient database. Concussion patients without visual dysfunction were not included in this study. Setting: National Collegiate Athletic Association Division 1 college training room and university based, academic health center. Participants: Patients were selected for inclusion based on diagnosis of new visual dysfunction as indicated either by physical examination of the team physician or by patient self-report of symptoms. Patients included college athletes, college students, and concussion patient's presenting to a university based, academic health center. Intervention: Measurement of central and PVRTs using a Dynavision D2 reaction time program were used as the dependent variables. Evaluations were conducted from 3 days to 11 months postconcussion, depending on the temporal development of visual symptoms after the concussion. No intervention was used. Main Outcome Measures: Average central and PVRTs for patients with postconcussion visual symptoms were compared with an asymptomatic control group with no history of concussion. Results: Both central and PVRTs were significantly prolonged in patients with postconcussion visual symptoms compared with patients with no history of concussion. Conclusions: Central and PVRTs are both prolonged in patients with postconcussion visual dysfunction with PVRT being disproportionately prolonged. The percent change from central to PVRT was also increased in patients with postconcussion visual dysfunction.	[Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH 45267 USA; [Ellis, James K.] Univ Cincinnati, Dept Athlet, Sports Med, Cincinnati, OH 45267 USA; [Burns, Timothy M.; Childress, John M.; Divine, Jon G.] Univ Cincinnati, Coll Med, Div Sports Med, Dept Orthoped Surg, Cincinnati, OH 45267 USA		Clark, JF (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, ML 0536, Cincinnati, OH 45267 USA.	Joseph.clark@uc.edu					Abernethy B, 1996, AM J SPORT MED, V24, pS89, DOI 10.1177/036354659602406S24; Bigsby K, 2014, INT J SPORTS PHYS TH, V9, P436; Clark J.F., 2015, OPTOMETRY VISUAL PER, V3, P106; Clark JF., 2015, OPTOM VIS PERFORM, P116; Clark JF, 2014, BRAIN DISORD THER, V3, P131; Clark JF, 2015, JOVE-J VIS EXP, DOI 10.3791/52648; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; COLLINS MW, 2009, AM ORTH SOC SPORTS M; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Flynn DJ, 2013, DAILYCALLER; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kauffman DC, 2015, J SPORT SCI, V33, P1117, DOI 10.1080/02640414.2014.987156; KLAVORA P, 1995, PERCEPT MOTOR SKILL, V80, P607, DOI 10.2466/pms.1995.80.2.607; Solomon J., 2013, AL; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Vesia M, 2008, PERCEPT MOTOR SKILL, V107, P14, DOI 10.2466/PMS.107.1.14-20; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Zupan M, 2011, TRAINING CONDITIONIN, V21, P11	23	9	10	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2017	27	5					457	461		10.1097/JSM.0000000000000381			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	FG2HS	WOS:000409915300011	28107216				2022-02-06	
J	Hart, T; Brockway, A; Maiuro, RD; Vaccaro, M; Fann, JR; Mellick, D; Harrison-Felix, C; Barber, J; Temkin, N				Hart, Tessa; Brockway, Ann; Maiuro, Roland D.; Vaccaro, Monica; Fann, Jesse R.; Mellick, David; Harrison-Felix, Cindy; Barber, Jason; Temkin, Nancy			Anger Self-Management Training for Chronic Moderate to Severe Traumatic Brain Injury: Results of a Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger management; behavioral treatment; irritability; randomized controlled trials; traumatic brain injuries	PROGRAM; INTERVENTIONS; IRRITABILITY; AGGRESSION; PEOPLE; SCALE	Objective: To test efficacy of 8-session, 1:1 treatment, anger self-management training (ASMT), for chronic moderate to severe traumatic brain injury (TBI). Setting: Three US outpatient treatment facilities. Participants: Ninety people with TBI and elevated self-reported anger; 76 significant others (SOs) provided collateral data. Design: Multicenter randomized controlled trial with 2:1 randomization to ASMT or structurally equivalent comparison treatment, personal readjustment and education (PRE). Primary outcome assessment 1 week posttreatment; 8-week follow-up. Primary Outcome: Response to treatment defined as 1 or more standard deviation change in self-reported anger. Secondary Outcomes: SO-rated anger, emotional and behavioral status, satisfaction with life, timing of treatment response, participant and SO-rated global change, and treatment satisfaction. Main Measures: State-Trait Anger Expression Inventory-Revised Trait Anger (TA) and Anger Expression-Out (AX-O) subscales; Brief Anger-Aggression Questionnaire (BAAQ); Likert-type ratings of treatment satisfaction, global changes in anger and well-being. Results: After treatment, ASMT response rate (68%) exceeded that of PRE (47%) on TA but not AX-O or BAAQ; this finding persisted at 8-week follow-up. No significant between-group differences in SO-reported response rates, emotional/behavioral status, or life satisfaction. ASMT participants were more satisfied with treatment and rated global change in anger as significantly better; SO ratings of global change in both anger and well-being were superior for ASMT. Conclusion: ASMT was efficacious and persistent for some aspects of problematic anger. More research is needed to determine optimal dose and essential ingredients of behavioral treatment for anger after TBI.	[Hart, Tessa; Vaccaro, Monica] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Brockway, Ann] Univ Washington, Dept Phys Med & Rehabil, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Barber, Jason; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Maiuro, Roland D.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Mellick, David; Harrison-Felix, Cindy] Craig Hosp, Englewood, CO USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu			National Center for Medical Rehabilitation Research, National Institute of Child Health & Human Development, National Institutes of Health [R01HD061400]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061400] Funding Source: NIH RePORTER	This study was supported by the National Center for Medical Rehabilitation Research, National Institute of Child Health & Human Development, National Institutes of Health, #R01HD061400. We thank Sureyya S. Dikmen, PhD, for guidance and leadership in developing the protocol and Thomas A. Novack, PhD, for his assistance with both protocol development and safety monitoring during the trial. Lenore Hawley, MSW, Donald Gerber, PsyD, Gillian Murray, MSW, Claire McGrath, PhD, Josh Dyer, PhD, and Kevin Alschuler, PhD, provided excellent service as study therapists. We also thank Kelly Bognar, Lauren McLaughlin, Cynthia Braden, MA, CCC-SLP, Jennifer Coker, MPH, Christina Baker-Sparr, MS, Christopher Cusick, MA, and Joanie Machamer, MA, for their contributions to study coordination, recruitment, data collection, and data management.	Aboulafia-Brakha T, 2013, NEUROPSYCHOL REHABIL, V23, P216, DOI 10.1080/09602011.2012.747443; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Burgess P.W., 1997, HAYLING BRIXTON TEST; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deffenbacher JL, 2002, COUNS PSYCHOL, V30, P262, DOI 10.1177/0011000002302004; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DiGiuseppe R, 2003, CLIN PSYCHOL-SCI PR, V10, P70, DOI 10.1093/clipsy/10.1.70; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Laska KM, 2014, PSYCHOTHERAPY, V51, P467, DOI 10.1037/a0034332; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI [10.1177/088626087002002003, DOI 10.1177/088626087002002003]; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; Silver J, 2007, BRAIN INJURY MED PRI, P963; Spielberger CD, 2000, STATE TRAIT ANGER EX; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Wechsler D., 2011, WECHSLER ABBREVIATED; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	46	9	9	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					319	331		10.1097/HTR.0000000000000316			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800012	28520666	Green Accepted			2022-02-06	
J	Hebert-Seropian, B; Boucher, O; Senechal, C; Rouleau, I; Bouthillier, A; Lepore, F; Nguyen, DK				Hebert-Seropian, Benjamin; Boucher, Olivier; Senechal, Carole; Rouleau, Isabelle; Bouthillier, Alain; Lepore, Franco; Dang Khoa Nguyen			Does unilateral insular resection disturb personality? A study with epileptic patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Insula; Personality; Emotion; Epilepsy; Neurosurgery	TRAUMATIC BRAIN-INJURY; VOXEL-BASED LESION; RISK-TAKING; ANXIETY; ACTIVATION; AWARENESS; EMOTION; DAMAGE	The insula is now regarded as a potential site of epileptogenesis in drug-resistant epilepsy, and the advent of microsurgical techniques has allowed insular cortectomy to become a treatment of choice when the insular cortex is involved in the seizure focus. However, considering the evidence of an insular role in socio-emotional processing, it remains unknown whether these cortical resections disturb personality and social behavior as experienced in daily life. We examined such changes in a group of patients (n=19) who underwent epilepsy surgery involving partial or complete resection of the insula, and compared them to a group of patients who underwent standard temporal lobe epilepsy (TLE) surgery (n = 19) as a lesion-control group. Participants were assessed on the Iowa Scales of Personality Change, filled by a close relative at least six months after surgery. While postoperative changes did not significantly differ between groups on any of the ISPC items, insular resections were associated with mild but significant increases in irritability, emotional lability, anxiety, and frugality postoperatively, which, apart from anxiety, were not significant among TLE patients. Our results are congruent with the idea that the insula contributes to emotion processing. To our knowledge, this study is the first to systematically assess personality changes in a consecutive sample of patients with insular resections. (C) 2017 Elsevier Ltd. All rights reserved.	[Hebert-Seropian, Benjamin; Boucher, Olivier; Lepore, Franco] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Senechal, Carole] Univ Ottawa, Fac Educ, Ottawa, ON, Canada; [Rouleau, Isabelle; Bouthillier, Alain; Dang Khoa Nguyen] Ctr Hosp Univ Montreal, Hop Notre Dame, Montreal, PQ, Canada; [Rouleau, Isabelle] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Dang Khoa Nguyen] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada		Nguyen, DK (corresponding author), Ctr Hosp Univ Montreal, Hop Notre Dame, Montreal, PQ, Canada.	d.nguyen@umontreal.ca		Boucher, Olivier/0000-0001-9100-6958			Anderson, 1997, IOWA SCALES PERSONAL; Barrash J, 2011, J CLIN EXP NEUROPSYC, V33, P833, DOI 10.1080/13803395.2011.561300; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Borg C, 2013, NEUROCASE, V19, P592, DOI 10.1080/13554794.2012.713491; Boucher O, 2015, NEUROPSYCHOLOGIA, V71, P1, DOI 10.1016/j.neuropsychologia.2015.03.008; Boucher O, 2015, EPILEPSY BEHAV, V43, P53, DOI 10.1016/j.yebeh.2014.11.016; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Clark L, 2014, P NATL ACAD SCI USA, V111, P6098, DOI 10.1073/pnas.1322295111; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; Engel J., 1993, OUTCOME RESPECT EPIL, P609; Helmstaedter C, 2012, EPILEPSIA, V53, P1765, DOI 10.1111/j.1528-1167.2012.03602.x; Hessen E, 2007, EPILEPSY BEHAV, V10, P449, DOI 10.1016/j.yebeh.2007.01.014; Jenkins LM, 2016, J CLIN NEUROSCI, V29, P128, DOI 10.1016/j.jocn.2015.12.007; Juillerat A.-C., 1998, ADAPTATION FRANCAISE; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Markett S, 2016, NEUROSCI LETT, V619, P172, DOI 10.1016/j.neulet.2016.03.029; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Papagno C, 2016, NEUROPSYCHOLOGIA, V84, P29, DOI 10.1016/j.neuropsychologia.2016.01.036; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Vazquez B, 2003, EPILEPSY BEHAV, V4, pS20, DOI 10.1016/j.yebeh.2003.10.005; Von Siebenthal Z, 2017, SOC COGN AFFECT NEUR, V12, P128, DOI 10.1093/scan/nsw152; Wilson S, 2001, J NEUROL NEUROSUR PS, V70, P649, DOI 10.1136/jnnp.70.5.649	32	9	9	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2017	43						121	125		10.1016/j.jocn.2017.04.001			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE6CN	WOS:000408297700023	28434623				2022-02-06	
J	Hilz, MJ; Wang, RH; Markus, J; Ammon, F; Hosl, KM; Flanagan, SR; Winder, K; Koehn, J				Hilz, Max J.; Wang, Ruihao; Markus, Joerg; Ammon, Fabian; Hoesl, Katharina M.; Flanagan, Steven R.; Winder, Klemens; Koehn, Julia			Severity of traumatic brain injury correlates with long-term cardiovascular autonomic dysfunction	JOURNAL OF NEUROLOGY			English	Article						Orthostatic challenge; Traumatic brain injury; Autonomic dysfunction; Differences in severity	REGRESSIVE SPECTRAL-ANALYSIS; BLOOD-PRESSURE CONTROL; HEART-RATE; BAROREFLEX SENSITIVITY; EXERCISE; DISEASE; RISK; STIMULATION; VARIABILITY; MORTALITY	After traumatic brain injury (TBI), central autonomic dysfunction might contribute to long-term increased mortality rates. Central autonomic dysfunction might depend on initial trauma severity. This study was performed to evaluate differences in autonomic modulation at rest and upon standing between patients with a history of mild TBI (post-mild-TBI patients), moderate or severe TBI (post-moderate-severe-TBI patients), and healthy controls. In 20 post-mild-TBI patients (6-78 months after TBI), age-matched 20 post-moderate-severe-TBI patients (6-94 months after TBI) and 20 controls, we monitored respiration, RR intervals (RRI) and systolic blood pressure (BPsys) at supine rest and upon standing. We determined mainly sympathetic low (LF) and parasympathetic high (HF) frequency powers of RRI fluctuations, sympathetically mediated LF-BPsys powers, LF/HF-RRI ratios, normalized (nu) LF-RRI and HF-RRI powers, and compared data between groups, at rest and upon standing (ANOVA with post hoc testing). We correlated autonomic parameters with initial Glasgow Coma Scale (GCS) scores (Spearman test; significance: p < 0.05). Supine BPsys and LFnu-RRI powers were higher while HFnu-RRI powers were lower in post-moderate-severe-TBI patients than post-mild-TBI patients and controls. LFnu-RRI powers were higher and HFnu-RRI powers were lower in post-mild-TBI patients than controls. Upon standing, only post-mild-TBI patients and controls increased LF-BPsys powers and BPsys and decreased HF-RRI powers. GCS scores correlated positively with LFnu-RRI powers, LF/HF-RRI ratios, and inversely with HFnu-RRI powers, at standing position. More than 6 months after TBI, there is autonomic dysfunction at rest and upon standing which is more pronounced after moderate-severe than mild TBI and in part correlates with initial trauma severity.	[Hilz, Max J.] UCL, Inst Neurol, Clin Dept Auton Neurol, Queen Sq, London WC1N 3BG, England; [Hilz, Max J.] Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England; [Hilz, Max J.; Wang, Ruihao; Markus, Joerg; Ammon, Fabian; Winder, Klemens; Koehn, Julia] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Neurol, Erlangen, Germany; [Hilz, Max J.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Hoesl, Katharina M.] Paracelsus Med Univ, Dept Psychiat & Psychotherapy, Nurnberg, Germany; [Flanagan, Steven R.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA		Hilz, MJ (corresponding author), UCL, Inst Neurol, Clin Dept Auton Neurol, Queen Sq, London WC1N 3BG, England.; Hilz, MJ (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.; Hilz, MJ (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Neurol, Erlangen, Germany.; Hilz, MJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	m.hilz@ucl.ac.uk		Flanagan, Steven/0000-0001-9005-5897; Wang, Ruihao/0000-0003-4792-5572	International Brain Research Foundation, IBRF, Flanders, NJ, USA	The study was partially funded by the International Brain Research Foundation, IBRF, Flanders, NJ, USA.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Aminoff, 2002, NEUROMUSCULAR FUNCTI, P1899; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Camm AJ, 1996, CIRCULATION, V93, P1043; Cencetti S, 1999, HEART, V82, P365, DOI 10.1136/hrt.82.3.365; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Figueroa A, 2007, EUR J APPL PHYSIOL, V100, P437, DOI 10.1007/s00421-007-0446-3; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Hilz MJ, 2015, J NEUROTRAUM, V32, P1796, DOI 10.1089/neu.2014.3842; Hilz MJ, 2014, AUTON NEUROSCI-BASIC, V183, P83, DOI 10.1016/j.autneu.2014.02.004; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Krause M, 2009, PEDIATR DIABETES, V10, P255, DOI 10.1111/j.1399-5448.2008.00447.x; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Laterza MC, 2007, HYPERTENSION, V49, P1298, DOI 10.1161/HYPERTENSIONAHA.106.085548; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liu JL, 2002, J APPL PHYSIOL, V92, P2403, DOI 10.1152/japplphysiol.00039.2002; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Reimann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012187; Rudiger H, 1999, COMPUT METH PROG BIO, V58, P1; Rudiger H, 2001, AUTON NEUROSCI-BASIC, V93, P71, DOI 10.1016/S1566-0702(01)00326-5; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sung CW, 2016, PSYCHOPHYSIOLOGY, V53, P455, DOI 10.1111/psyp.12575; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Timmers HJLM, 1999, CLIN AUTON RES, V9, P317, DOI 10.1007/BF02318378; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wieling W, 1999, AUTONOMIC FAILURE TX, P196; Wieling W, 1997, CLIN AUTONOMIC DISOR, P73; Ziemssen T, 2013, J NEURAL TRANSM, V120, pS27, DOI 10.1007/s00702-013-1054-5	59	9	11	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	SEP	2017	264	9					1956	1967		10.1007/s00415-017-8581-1			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FG1UW	WOS:000409831400014	28770375	Green Published, hybrid			2022-02-06	
J	Jenness, JL; Witt, CE; Quistberg, DA; Johnston, BD; Rowhani-Rahbar, A; Mackelprang, JL; McLaughlin, KA; Vavilala, MS; Rivara, FP				Jenness, Jessica L.; Witt, Cordelie E.; Quistberg, D. Alex; Johnston, Brian D.; Rowhani-Rahbar, Ali; Mackelprang, Jessica L.; McLaughlin, Katie A.; Vavilala, Monica S.; Rivara, Frederick P.			Association of physical injury and mental health: Results from the national comorbidity survey-adolescent supplement	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Trauma; Injuries; Mental disorders; Adolescents; Epidemiologic studies	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DSM-IV DISORDERS; UNINTENTIONAL INJURY; NCS-A; RISK-FACTOR; FUNCTIONAL IMPAIRMENT; DEPRESSIVE SYMPTOMS; BIPOLAR DISORDER; SUBSTANCE USE	Nonfatal injury is common among adolescents in the U.S., but little is known about the bi-directional associations between injury and mental health. Utilizing a nationally representative sample of U.S. adolescents, we examined 1) associations between lifetime mental health history and subsequent injury; 2) concurrent associations between injury and mental health; and 3) associations between injury and subsequent mental disorders. Data were drawn from the National Comorbidity Survey Replication Adolescent Supplement (NCS-A), a national survey of adolescents aged 13 through 17 years (N = 10,123). Twelve-month prevalence of nonfatal injury requiring medical attention was assessed along with lifetime, 12-month, and 30-day prevalence of DSM-IV depressive, anxiety, behavior, substance use, and bipolar disorders. We used Poisson regression to examine associations between 1) lifetime history of mental disorders and 12-month exposure to injury; 2) concurrent associations between 12-month exposure to injury and 12-month prevalence of mental disorders; and 3) 12-month exposure to injury and 30-day prevalence of mental disorders. A total of 11.6% of adolescents experienced an injury requiring medical attention in the year before the survey. Lifetime history of mental disorders was not associated with past-year injury. Behavior and bipolar disorders were concurrently associated with past-year injury. Past-year injury occurrence predicted increased risk for past-month anxiety disorders and decreased risk of past-month depressive disorders. Our findings reveal reciprocal associations between injury and mental disorders and highlight the need for systematic assessment, prevention, and treatment of mental disorders among injured youth. (C) 2017 Elsevier Ltd. All rights reserved.	[Jenness, Jessica L.; Johnston, Brian D.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Witt, Cordelie E.] Univ Washington, Dept Surg, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Quistberg, D. Alex; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Mackelprang, Jessica L.] Seattle Univ, Dept Psychol, Seattle, WA 98122 USA; [McLaughlin, Katie A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA		Jenness, JL (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.	jennessj@uw.edu	Mackelprang, Jessica L./AAT-4283-2021; Quistberg, D Alex/P-3538-2019	Mackelprang, Jessica L./0000-0001-9135-7811; Quistberg, D Alex/0000-0001-9730-2686; Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH103291, K23MH112872] Funding Source: NIH RePORTER	This research was supported by National Institute of Child Health and Human Development T32 HD057822-06 grant. The funding sources had no role in the study design or in the collection, analysis, or interpretation of the data; in writing the report; or in the decision to submit the manuscript.	Asbridge M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-190; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bryant B, 2004, PSYCHOL MED, V34, P335, DOI 10.1017/S0033291703001053; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; Centers for Disease Control and Prevention (CDC), 2020, WEB BAS INJ STAT QUE; Cho H, 2007, ADDICT BEHAV, V32, P1628, DOI 10.1016/j.addbeh.2006.11.017; Crone EA, 2016, J CHILD PSYCHOL PSYC, V57, P353, DOI 10.1111/jcpp.12502; Crump C, 2013, JAMA PSYCHIAT, V70, P931, DOI 10.1001/jamapsychiatry.2013.1394; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Danielson CK, 2010, CHILD MALTREATMENT, V15, P101, DOI 10.1177/1077559509350075; DAVIDSON LL, 1987, J DEV BEHAV PEDIATR, V8, P335; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Dudani A, 2010, J DEV BEHAV PEDIATR, V31, P276, DOI 10.1097/DBP.0b013e3181da7785; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hingson RW, 2000, JAMA-J AM MED ASSOC, V284, P1527, DOI 10.1001/jama.284.12.1527; Johnston C, 2003, PSYCHOL ASSESSMENT, V15, P496, DOI 10.1037/1040-3590.15.4.496; Jokela M, 2009, J CHILD PSYCHOL PSYC, V50, P1541, DOI 10.1111/j.1469-7610.2009.02122.x; Kessler RC, 2012, PSYCHOL MED, V42, P1997, DOI 10.1017/S0033291712000025; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2006, EPIDEMIOL PSICHIAT S, V15, P161, DOI 10.1017/S1121189X00004395; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P381, DOI 10.1001/archgenpsychiatry.2011.1603; Kessler RC, 2009, INT J METH PSYCH RES, V18, P69, DOI 10.1002/mpr.279; Kessler RC, 2009, J AM ACAD CHILD PSY, V48, P380, DOI 10.1097/CHI.0b013e3181999705; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; McLaughlin KA, 2009, J ABNORM PSYCHOL, V118, P659, DOI 10.1037/a0016499; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Merikangas KR, 2009, J AM ACAD CHILD PSY, V48, P367, DOI 10.1097/CHI.0b013e31819996f1; Mo Frank, 2006, Int J Inj Contr Saf Promot, V13, P235, DOI 10.1080/17457300600935122; Momartin S, 2004, J AFFECT DISORDERS, V80, P231, DOI 10.1016/S0165-0327(03)00131-9; Mortensen PB, 2003, J AFFECT DISORDERS, V76, P79, DOI 10.1016/S0165-0327(02)00073-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Patten SB, 2010, CAN J PSYCHIAT, V55, P313, DOI 10.1177/070674371005500507; Reddy LF, 2014, NEUROPSYCHOPHARMACOL, V39, P456, DOI 10.1038/npp.2013.218; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; Schweininger S, 2015, DEPRESS ANXIETY, V32, P64, DOI 10.1002/da.22288; Sobanski E, 2007, EUR ARCH PSY CLIN N, V257, P371, DOI 10.1007/s00406-007-0712-8; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Tiesman HM, 2006, INJURY PREV, V12, P172, DOI 10.1136/ip.2006.011544; Whiteside LK, 2016, J ADOLESCENT HEALTH, V58, P92, DOI 10.1016/j.jadohealth.2015.08.011; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Williams JL, 2015, J TRAUMA STRESS, V28, P41, DOI 10.1002/jts.21983; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; World Health Organization, 2010, INJ VIOL FACTS; Zatzick D, 2006, J PEDIATR PSYCHOL, V31, P377, DOI 10.1093/jpepsy/jsj056; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick D, 2012, J SUBST ABUSE TREAT, V43, P410, DOI 10.1016/j.jsat.2012.08.009; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	52	9	9	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	SEP	2017	92						101	107		10.1016/j.jpsychires.2017.03.022			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EZ4RV	WOS:000404701100013	28414929	Green Accepted			2022-02-06	
J	Jiang, YQ; Zhao, SJ; Ding, Y; Nong, LM; Li, HB; Gao, GM; Zhou, D; Xu, NW				Jiang, Yuqing; Zhao, Shujie; Ding, Yin; Nong, Luming; Li, Haibo; Gao, Gongming; Zhou, Dong; Xu, Nanwei			MicroRNA-21 promotes neurite outgrowth by regulating PDCD4 in a rat model of spinal cord injury	MOLECULAR MEDICINE REPORTS			English	Article						microRNA-21; neurite outgrowth; programmed cell death 4; phosphatase and tensin homolog; spinal cord injury	TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; NERVOUS-SYSTEM; IMPACT; APOPTOSIS; MIR-21; CELLS; RNA	Altered expression levels of microRNA-21 (miRNA-21) have been observed in a series of pathological processes, including cancer and central nervous system injury; however, the involvement of miRNA-21 in the molecular pathophysiology of spinal cord injury (SCI) has not been well documented. The present study examined the expression levels of miRNA-21 and its predicted target genes, programmed cell death 4 (PDCD4) and phosphatase and tensin homolog (PTEN), in rats using quantitative polymerase chain reaction and western blotting to further understand the role of miRNA-21 and the mechanisms underlying repair following SCI. The present study demonstrated that compared with uninjured spinal cords, miRNA-21 expression levels were significantly downregulated in injured spinal cords 4 and 8 h, and 1 day post-SCI, and were significantly upregulated after 3 and 7 days. Conversely, expression levels of PDCD4 and PTEN were significantly decreased at days 3 and 7 post-SCI compared with the control group. miRNA-21 overexpression in monolayer-cultured postnatal rat spinal cord neurons promoted neurite outgrowth and downregulated protein expression levels of PDCD4; however, PTEN protein expression levels were unaltered. To confirm that miRNA-21 directly targets PDCD4, a pRL-CMV luciferase reporter construct was used to detect miRNA-21 interactions with the PDCD4 3' -untranslated region. The results demonstrated that miRNA-21 decreased luciferase activity compared with a rat PDCD4 control reporter. The results of the present study suggested that increased miRNA-21 expression levels following SCI may promote the repair of injured spinal cords by inhibiting the expression of its target gene PDCD4.	[Jiang, Yuqing; Zhao, Shujie; Ding, Yin; Nong, Luming; Li, Haibo; Gao, Gongming; Zhou, Dong; Xu, Nanwei] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Orthoped, 29 Xing Long Rd, Changzhou 213000, Jiangsu, Peoples R China		Zhou, D (corresponding author), Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Orthoped, 29 Xing Long Rd, Changzhou 213000, Jiangsu, Peoples R China.	zhoudong1012@hotmail.com; nanweixu1963@126.com		Zhao, Shujie/0000-0002-2820-2232	H-level Medical Talents Training Project [2016CZBJ033]	The authors would like to thank Dr Hai-bin Xia (Institute of Biological Science, Shaanxi Normal University, Xi'an, China) for his individual support and help with this study. The present study was supported by the H-level Medical Talents Training Project (grant no. 2016CZBJ033).	Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Boltshauser E, 2015, NEUROPEDIATRICS; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dou FF, 2009, J NEUROTRAUM, V26, P2299, DOI 10.1089/neu.2009.0954; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kuzin A, 2007, DEV BIOL, V310, P35, DOI 10.1016/j.ydbio.2007.07.012; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liu G, 2012, EXP NEUROL, V233, P447, DOI 10.1016/j.expneurol.2011.11.018; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Liu XZ, 1997, J NEUROSCI, V17, P5395; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina PP, 2009, NAT METHODS, V6, P37, DOI 10.1038/nmeth0109-37; Montoya-Gacharna Jose V, 2012, Methods Mol Biol, V846, P103, DOI 10.1007/978-1-61779-536-7_10; Polajeva J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-378; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Wong LSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023118; Zai LJ, 2005, BRAIN RES, V1052, P147, DOI 10.1016/j.brainres.2005.05.071	36	9	10	1	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	SEP	2017	16	3					2522	2528		10.3892/mmr.2017.6862			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FD3VX	WOS:000407461600022	28656242	Green Published, hybrid, Green Submitted			2022-02-06	
J	McMillan, LR; Crumbley, D; Freeman, J; Rhodes, M; Kane, M; Napper, J				McMillan, Libba Reed; Crumbley, David; Freeman, Julie; Rhodes, Marilyn; Kane, Michele; Napper, Joy			Caring for the Veteran, military and family member nursing competencies: Strategies for integrating content into nursing school curricula	JOURNAL OF PROFESSIONAL NURSING			English	Article						Competencies; Curricula; Student perception; Nursing education; Veteran health	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; COMBAT VETERANS; HEALTH-CARE	In the United States, one in every 15 persons is a Veteran (U.S. Department of Veterans Affairs, 2016; U.S. News & World Report, 2017). An estimated 27% of these Veterans receive healthcare through the Veteran's Health Administration (VHA), leaving 73% to seek care in civilian hospitals (Bagalman, 2014). Realistically, most nurses in the United States will care for military members, Veterans or family members in a variety of healthcare systems and settings. Nurse educators are positioned to lead efforts in providing nursing students with the knowledge necessary to provide competent care and serve as advocates for our nation's heroes. Recent military deployments and news about the VHA have increased awareness of this population. This article describes competency development resulting from an academic-practice partnership experience between two baccalaureate programs and a national military medical center. Project SERVE, Students' Education Related to the Veteran Experience, utilizes a didactic-experiential model consisting of activities designed to teach students core concepts, including understanding military culture, poly-trauma, traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and issues facing families and care-givers. This article includes competencies, delineating the Knowledge, Sldlls, Attitudes, and resources for the provision of care to the Veteran population. The authors offer strategies to integrate care of Veterans, and military/family members content into nursing programs and replicate similar experiences. Opportunities for future development, challenges, faculty resources for curricular inclusion, and student reflections of the experience are presented. (C) 2017 Elsevier Inc. All rights reserved.	[McMillan, Libba Reed; Crumbley, David] Auburn Univ, Sch Nursing, 221 Miller Hall, Auburn, AL 36849 USA; [Freeman, Julie; Rhodes, Marilyn] Auburn Univ, Auburn, AL USA; [Kane, Michele] US Navy, Bur Med & Surg, Washington, DC USA; [Napper, Joy] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA		McMillan, LR (corresponding author), Auburn Univ, Sch Nursing, 221 Miller Hall, Auburn, AL 36849 USA.	reedreb@auburn.edu			AU; AUM Offices of the Provost and the Daniel Foundation	Project SERVE was supported in part by AU and AUM Offices of the Provost and the Daniel Foundation. The content culminates the work of the authors and does not necessarily represent the official views of WRNMMC. The authors would like to acknowledge the staff of WRNMMC for their work in caring for this special population, for the many ways they welcomed us "into their home," and for modeling teamwork and collaboration in providing care. We wish to express our appreciation for all those military, retired, and civilian personnel who shared their off -duty time to further our understanding of military tradition.	[Anonymous], 2016, J PROF NURS, V32, P78, DOI 10.1016/j.profnurs.2016.02.008; Associated Press, 2017, US NEWS WORLD REPORT; Bagalman E, 2014, NUMBER VETERANS USE; Baines LS, 2012, CASS MIL STUD, P219; Bobrow J., 2012, AM PSYCHOL ASS, V16, P1; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Ellis, 2013, OPEN J NURS, V3, P400, DOI [10.4236/ojn.2013.35054, DOI 10.4236/OJN.2013.35054]; Gleeson TD, 2014, ACAD MED, V89, P1201, DOI 10.1097/ACM.0000000000000368; Hannah Fischer, 2015, GUIDE US MILITARY CA; Harper DC, 2016, NURS OUTLOOK, V64, P424, DOI 10.1016/j.outlook.2016.05.001; Harper DC, 2015, J PROF NURS, V31, P57, DOI 10.1016/j.profnurs.2014.06.004; Hilgeman MM, 2014, J RURAL HEALTH, V30, P153, DOI 10.1111/jrh.12054; Johnson BS, 2013, AM J NURS, V113, P24, DOI 10.1097/01.NAJ.0000431913.50226.83; Liu CF, 2010, HEALTH SERV RES, V45, P1268, DOI 10.1111/j.1475-6773.2010.01123.x; McKenzie G, 2016, CLIN SIMUL NURS, V12, P79, DOI 10.1016/j.ecns.2015.12.011; Military Health System, 2013, MIL HLTH SYST INN RE; Moss JA, 2015, ADV NURS SCI, V38, P306, DOI 10.1097/ANS.0000000000000092; Office of the Under Secretary of Defense for Acquisition Technology and Logistics, 2015, BAS REAL CLOS BRAC D; Olenick M, 2015, ADV MED EDUC PRACT, V6, P635, DOI 10.2147/AMEP.S89479; QSEN Institute, 2014, QSEN COMP; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Shay K, 2013, J AM GERIATR SOC, V61, P632, DOI 10.1111/jgs.12165; Shay K, 2010, GENERATIONS, V34, P20; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; U.S. Department of Veterans Affairs, 2016, VET POP; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004	28	9	9	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	8755-7223	1532-8481		J PROF NURS	J. Prof. Nurs.	SEP-OCT	2017	33	5					378	386		10.1016/j.profnurs.2017.06.002			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	FI7BX	WOS:000412152000010	28931486				2022-02-06	
J	Nagata, K; Browne, KD; Suto, Y; Kumasaka, K; Cognetti, J; Johnson, VE; Marks, J; Smith, DH; Pascual, JL				Nagata, Katsuhiro; Browne, Kevin D.; Suto, Yujin; Kumasaka, Kenichiro; Cognetti, John; Johnson, Victoria E.; Marks, Joshua; Smith, Douglas H.; Pascual, Jose L.			Early heparin administration after traumatic brain injury: Prolonged cognitive recovery associated with reduced cerebral edema and neutrophil sequestration	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Brain edema; heparin; neutrophil; TBI	MOLECULAR-WEIGHT HEPARIN; IN-VIVO; NEUROLOGIC RECOVERY; RAT MODEL; HEMORRHAGE; INFLAMMATION; DYSFUNCTION; ENOXAPARIN; EXPRESSION; BARRIER	BACKGROUND: Early administration of unfractionated heparin (UFH) after traumatic brain injury (TBI) reduces early in vivo circulating leukocytes (LEUs) in peri-injury penumbral brain tissue, enhancing cognitive recovery 2 days after injury. It remains unclear how long this effect lasts and if this is related to persistently accumulating LEUs in penumbral brain tissue. We hypothesized that UFH reduces LEU brain tissue sequestration resulting in prolonged cognitive recovery. METHODS: CD1 male mice underwent either TBI by controlled cortical impact (CCI) or sham craniotomy. Unfractionated heparin (75 or 225 U/kg) or vehicle was repeatedly administered after TBI. Neurologic function (Garcia Neurological Test [maximum score = 18]) and body weight loss ratios were evaluated at 24 hours to 96 hours after TBI. Brain and lung wet-to-dry ratios, hemoglobin levels, and brain LEU sequestration (Ly6G immunohistochemistry) were evaluated 96 hours postmortem. Analysis of variance with Bonferroni correction determined significance (p < 0.05). RESULTS: Compared with untreated CCI animals (24 hours, 14.7 +/- 1.0; 48 hours, 15.5 +/- 0.7; 72 hours, 15.0 +/- 0.8; 96 hours, 16.5 +/- 0.9), UFH75 (24 hours, 16.0 +/- 1.0, p < 0.01; 48 hours, 16.5 +/- 0.7, p < 0.05; 72 hours, 17.1 +/- 0.6, p < 0.01; 96 hours, 17.4 +/- 0.7, p < 0.05) increased cognitive recovery throughout the entire observation period after TBI. At 48 hours, UFH225 significantly worsened body weight loss (10.2 +/- 4.7%) as compared with uninjured animals (5.5 +/- 2.9%, p < 0.05). Both UFH75 (60.8 +/- 40.9 PMNs per high-power field [HPF], p < 0.05) and UFH225 (36.0 +/- 17.6 PMNs/HPF, p < 0.01) significantly decreased brain neutrophil sequestration found in untreated CCI animals (124.2 +/- 44.1 PMNs/HPF) 96 hours after TBI. Compared with untreated CCI animals (78.8 +/- 0.8%), UFH75 (77.3 +/- 0.6%, p = 0.04) reduced cerebral edema to uninjured levels (77.4 +/- 0.6%, p = 0.04 vs. CCI). Only UFH225 (10.6 +/- 1.2 g/dL) resulted in lower hemoglobin than in uninjured animals (13.0 +/- 1.2 g/dL, p < 0.05). CONCLUSIONS: Heparin after TBI reduces tissue LEU sequestration and edema in injured brain for up to 4 days. This is associated with persistent improved cognitive recovery, but only when low-dose UFH is given. Early administration of UFH following TBI may blunt LEU-related cerebral swelling and slow progression of secondary brain injury. (Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.)	[Nagata, Katsuhiro; Suto, Yujin; Pascual, Jose L.] Univ Penn, Ctr Brain Injury & Repair, Div Traumatol Surg Crit Care & Emergency Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nagata, Katsuhiro; Browne, Kevin D.; Suto, Yujin; Cognetti, John; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Tokyo Med Univ, Hachioji Med Ctr, Dept Neurosurg, Tokyo, Japan; [Nagata, Katsuhiro; Suto, Yujin; Kumasaka, Kenichiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan; [Marks, Joshua] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA		Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Perelman Sch Med, 51 N 39th St,Med Off Bldg 1st Floor,Suite 120, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398, R01 NS094003] Funding Source: Medline		Altay O, 2016, ACTA NEUROCHIR SUPPL, V121, P127, DOI 10.1007/978-3-319-18497-5_22; Antonenko D, 2013, AM J SURG, V206, P845; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Kim Luke, 2014, J Emerg Trauma Shock, V7, P141, DOI 10.4103/0974-2700.136846; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Lee JH, 2008, KOREAN J PHYSIOL PHA, V12, P231, DOI 10.4196/kjpp.2008.12.5.231; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P179, DOI 10.1007/978-3-7091-0693-8_30; Miller SJ, 1998, THROMB HAEMOSTASIS, V80, P481; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; RANA MW, 1992, J TRAUMA, V32, P420, DOI 10.1097/00005373-199204000-00003; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Shackford SR, 2004, ANN SURG, V240, P496; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; WANG P, 1990, AM J PHYSIOL, V259, pR645, DOI 10.1152/ajpregu.1990.259.3.R645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Weber JR, 1997, J CEREBR BLOOD F MET, V17, P1221, DOI 10.1097/00004647-199711000-00011; Yanaka K, 1996, J NEUROSURG, V85, P1102, DOI 10.3171/jns.1996.85.6.1102; Zhang ZG, 2013, INT J MOL SCI, V14, P1932, DOI 10.3390/ijms14011932	37	9	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2017	83	3					406	412		10.1097/TA.0000000000001590			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FF0ET	WOS:000408575700009	28538627				2022-02-06	
J	Salmani, F; Mohammadi, E; Rezvani, M; Kazemnezhad, A				Salmani, F.; Mohammadi, E.; Rezvani, M.; Kazemnezhad, A.			The effects of family-centered affective stimulation on brain-injured comatose patients' level of consciousness: A randomized controlled trial	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Traumatic brain injury; Affect; Sensory; Stimulation; Consciousness; Coma	INTENSIVE-CARE-UNIT; SCALE SCORE; ATTENTION; RECOVERY; PROGRAM	Background: Despite the well-defined effects of sensory stimulation, the knowledge of the pure effects of affective stimulation is scarce. Objective: To evaluate the effects of family-centered affective stimulation on the level of consciousness among comatose patients with brain injuries. Design: This study was designed as a three-group double-blinded Randomized Controlled Trial. Methods: Ninety consecutive patients with traumatic brain injuries and a Glasgow Coma Scale score of 5-8 were selected. Patients were randomly allocated to an experimental, a placebo, and a control group using permuted block randomization. Affective stimulation intervention was provided to patients in the experimental group by their family members twice a day during the first seven days of their hospitalization. In the placebo group, a sensory stimulation program was implemented by a fixed trained person who was not familiar with the patients. Patients in the control group solely received sensory stimulation which was routinely provided to all patients. The level of consciousness among the patients using the Glasgow Coma Scale and Coma Recovery Scale-Revised were measured both before and after a family visit. The SPSS software (version 17.0) was used to analyze the data through running the one-way and the repeated measure analyses of variance. Results: Despite an insignificant difference among the groups regarding baseline level of consciousness, the results of the one-way analysis of variance revealed at the seventh day of this study, however, the level of consciousness in the experimental group was significantly higher (9.1 +/- 2.1) than the placebo (7.2 +/- 1.1), the control groups (6.6 +/- 1.7) (P < 0.001), subsequently. Moreover, at the seventh day of the study, the Coma Recovery Scale score in the experimental group (11.9 +/- 3.7) was significantly greater than the placebo (9.0 +/- 2.0) and the control (6.6 +/- 1.6) groups (P < 0.001). Recovery rate and effect size values also confirmed the greater effectiveness of affective stimulation compared with pure sensory stimulation. Conclusion Our findings in this study indicate that early family-centered affective stimulation is more effective than sensory stimulation in improving the level of consciousness among comatose patients with brain injuries. Family-centered affective stimulation is recommended to be integrated into the nursing curricula and routine care plans for comatose trauma patients in intensive care units.	[Salmani, F.; Mohammadi, E.] Tarbiat Modares Univ, Dept Nursing, Fac Med Sci, Tehran, Iran; [Rezvani, M.] Isfahan Univ Med Sci, Fac Med, Esfahan, Iran; [Kazemnezhad, A.] Tarbiat Modares Univ, Dept Biostat, Fac Med Sci, Tehran, Iran		Mohammadi, E (corresponding author), Tarbiat Modares Univ, Dept Nursing, Fac Med Sci, Tehran, Iran.	mohamade@modares.ac.ir	Rezvani, Majid/C-5250-2018; salmani, fatemeh/AAN-3118-2021; Mohammadi, Eesa/I-9004-2018	Rezvani, Majid/0000-0002-9047-4378; Mohammadi, Eesa/0000-0001-6169-9829	Tarbiat Modares University	This study was supported by a grant from Tarbiat Modares University.	Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; Abbate Carlo, 2014, Front Hum Neurosci, V8, P616, DOI 10.3389/fnhum.2014.00616; Bassampoor S., 2007, J NURS MIDWIFERY TEH, V13, P15; Carlson KK, 2009, ADV CRITICAL CARE NU; Davidson JE, 2009, CRIT CARE NURSE, V29, P28, DOI 10.4037/ccn2009611; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Doan N, 2016, INT J PHYS MED REHAB, V4, P120, DOI [10.4172/2329-9096.1000e120, DOI 10.4172/2329-9096.1000e120]; Donahoe L, 2009, AM J CRIT CARE, V18, P58, DOI 10.4037/ajcc2009757; Eysenck M.W., 2001, PSYCHOL A2 LEVEL; Gaugler JE, 2005, AGING MENT HEALTH, V9, P105, DOI 10.1080/13607860412331310245; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Puggina ACG, 2011, J NEUROSCI NURS, V43, pE8, DOI 10.1097/JNN.0b013e3182029778; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gonzalez CE, 2004, AM J CRIT CARE, V13, P194, DOI 10.4037/ajcc2004.13.3.194; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P69, DOI 10.4103/1658-354X.125940; Goudarzi F., 2010, IRAN J NURS, V23, P43; Grafman J, 2015, HDB CLIN NEUROLOGY; Harmon-Jones E, 2013, CURR DIR PSYCHOL SCI, V22, P301, DOI 10.1177/0963721413481353; Hasanzadeh F., 2012, J N KHORASAN U MED S, V4, P121; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hetland B, 2015, HEART LUNG, V44, P416, DOI 10.1016/j.hrtlng.2015.06.010; Hoseini Azizi T., 2016, J URMIA NURS MIDWIFE, V11, P977; Hummel FC, 2005, CURR OPIN NEUROL, V18, P667, DOI 10.1097/01.wco.0000189876.37475.42; Kalani Z, 2016, J BIOL TODAYS WORLD, V5, P86, DOI [10.15412/J.JBTW.01050502, DOI 10.15412/J.JBTW.01050502]; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kavousi-Pour S, 2008, ARCH REHABIL, V8, P21; Khurana I., 2006, TXB MED PHYSL; Kreibig SD, 2013, PSYCHOPHYSIOLOGY, V50, P799, DOI 10.1111/psyp.12064; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lnu M., 2012, INT J HEAD NECK SURG, V3, P137; LOMBARDI F, 2002, COCHRANE LIB; Lotze M, 2011, J REHABIL MED, V43, P230, DOI 10.2340/16501977-0653; Mahmoodi G.R., 2013, J RES DEV NURS MIDWI, V10, P1; Megha M, 2013, BRAIN INJURY, V27, P570, DOI 10.3109/02699052.2013.767937; Mitchell M, 2009, AM J CRIT CARE, V18, P543, DOI 10.4037/ajcc2009226; Moattari M, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.23531; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Olausson H., 2016, AFFECTIVE TOUCH NEUR, P421; Paradiso M.A., 2016, NEUROSCIENCE EXPLORI, P618; Park S, 2016, INT J NURS PRACT, V22, P391, DOI 10.1111/ijn.12448; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Pocock SJ, 2013, CLIN TRIALS PRACTICA; Schneider C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01992; Tavangar H., 2016, ADV BIOMED RES, V4, P106; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Urbenjaphol P, 2009, J NEUROSCI NURSING, V41, pE10, DOI DOI 10.1097/JNN.0B013E3181A23E94; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011	48	9	9	0	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	SEP	2017	74						44	52		10.1016/j.ijnurstu.2017.05.014			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	FN1UN	WOS:000415776800007	28601692				2022-02-06	
J	Singh, N; Hess, E; Guo, G; Sharp, A; Huang, B; Breslin, M; Melnick, E				Singh, Navdeep; Hess, Erik; Guo, George; Sharp, Adam; Huang, Brian; Breslin, Maggie; Melnick, Edward			Tablet-Based Patient-Centered Decision Support for Minor Head Injury in the Emergency Department: Pilot Study	JMIR MHEALTH AND UHEALTH			English	Article						clinical decision support; decision aids; head injury, minor; medical informatics; spiral computed tomography; health services overuse; patient-centered outcomes research	COMPUTED-TOMOGRAPHY USE; VALIDATION; NUMERACY; OVERUSE; SCALE; RULE; INTERVENTIONS; IMPACT; TRUST; CARE	Background: The Concussion or Brain Bleed app is a clinician- and patient-facing electronic tool to guide decisions about head computed tomography (CT) use in patients presenting to the emergency department (ED) with minor head injury. This app integrates a patient decision aid and clinical decision support (using the Canadian CT Head Rule, CCHR) at the bedside on a tablet computer to promote conversations around individualized risk and patients' specific concerns within the ED context. Objective: The objective of this study was to describe the use of the Concussion or Brain Bleed app in a high-volume ED and to establish preliminary efficacy estimates on patient experience, clinician experience, health care utilization, and patient safety. These data will guide the planning of a larger multicenter trial testing the effectiveness of the Concussion or Brain Bleed app. Methods: We conducted a prospective pilot study of adult (age 18-65 years) patients presenting to the ED after minor head injury who were identified by participating clinicians as low risk by the CCHR. The primary outcome was patient knowledge regarding the injury, risks, and CT use. Secondary outcomes included patient satisfaction, decisional conflict, trust in physician, clinician acceptability, system usability, Net Promoter scores, head CT rate, and patient safety at 7 days. Results: We enrolled 41 patients cared for by 29 different clinicians. Patient knowledge increased after the use of the app (questions correct out of 9: pre-encounter, 3.3 vs postencounter, 4.7; mean difference 1.4, 95% CI 0.8-2.0). Patients reported a mean of 11.7 (SD 13.5) on the Decisional Conflict Scale and 92.5 (SD 12.0) in the Trust in Physician Scale (both scales range from 0 to 100). Most patients were satisfied with the app's clarity of information (35, 85%), helpfulness of information (36, 88%), and amount of information (36, 88%). In the 41 encounters, most clinicians thought the information was somewhat or extremely helpful to the patient (35, 85%), would want to use something similar for other decisions (27, 66%), and would recommend the app to other providers (28, 68%). Clinicians reported a mean system usability score of 85.1 (SD 15; scale from 0 to 100 with 85 in the "excellent" acceptability range). The total Net Promoter Score was 36.6 (on a scale from -100 to 100). A total of 7 (17%) patients received a head CT in the ED. No patients had a missed clinically important brain injury at 7 days. Conclusions: An app to help patients assess the utility of CT imaging after head injury in the ED increased patient knowledge. Nearly all clinicians reported the app to be helpful to patients. The high degree of patient satisfaction, clinician acceptability, and system usability support rigorous testing of the app in a larger multicenter trial.	[Singh, Navdeep] Med Coll Georgia, AU UGA Med Partnership, Athens, GA USA; [Singh, Navdeep; Guo, George; Melnick, Edward] Yale Sch Med, Dept Emergency Med, 464 Congress Ave,Suite 260, New Haven, CT 06519 USA; [Hess, Erik] Mayo Clin, Dept Emergency Med, Rochester, MN USA; [Sharp, Adam; Huang, Brian] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA; [Sharp, Adam] Kaiser Permanente Southern Calif, Los Angeles Med Ctr, Dept Emergency Med, Los Angeles, CA USA; [Breslin, Maggie] Sch Visual Arts, New York, NY 10010 USA		Melnick, E (corresponding author), Yale Sch Med, Dept Emergency Med, 464 Congress Ave,Suite 260, New Haven, CT 06519 USA.	edward.melnick@yale.edu		Sharp, Adam/0000-0002-6736-6184; Huang, Brian/0000-0001-8645-5142; Melnick, Edward/0000-0002-6509-9537	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS021271]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER	This project was supported by grant number K08HS021271 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The authors would like to express their gratitude to Kevin Lopez for computer programming of the intervention and Caitlin Johnson for facilitating the IRB process.	American College of Emergency Physicians, CONS REP CHOOS WIS A, DOI [10.1177/0272989X07303824, DOI 10.1177/0272989X07303824]; American College of Emergency Physicians, 2014, 10 THINGS PHYS PAT S; ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091; Bangor A, 2009, J USABILITY STUD, V4, P114; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Gellert GA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j242; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasziou Paul, 2005, Evid Based Nurs, V8, P36, DOI 10.1136/ebn.8.2.36; Hess EP, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6165; Hess EP, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-253; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Koedoot N, 2001, PATIENT EDUC COUNS, V45, P187, DOI 10.1016/S0738-3991(01)00120-3; Korley FK, 2013, ACAD EMERG MED, V20, P463, DOI 10.1111/acem.12136; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kortum PT, 2013, INT J HUM-COMPUT INT, V29, P67, DOI 10.1080/10447318.2012.681221; Mbachu SN, 2018, AM J EMERG MED, V36, P884, DOI 10.1016/j.ajem.2017.09.014; McNaughton C, 2011, ACAD EMERG MED, V18, P1148, DOI 10.1111/j.1553-2712.2011.01210.x; Melnick Edward R, 2017, J Med Internet Res, V19, pe174, DOI 10.2196/jmir.7846; Melnick ER, 2017, ACAD EMERG MED, V24, P391, DOI 10.1111/acem.13084; Melnick ER, 2016, ACAD EMERG MED, V23, P1346, DOI 10.1111/acem.13045; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Melnick ER, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5831; Melnick Edward R, 2015, EGEMS (Wash DC), V3, P1136, DOI 10.13063/2327-9214.1136; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Parma C, 2014, AM SURGEON, V80, P664; Probst MA, 2014, AM J EMERG MED, V32, P645, DOI 10.1016/j.ajem.2014.01.003; Ratanawongsa N, 2016, JAMA INTERN MED, V176, P125, DOI 10.1001/jamainternmed.2015.6186; Reichheld FF, 2003, HARVARD BUS REV, V81, P46; Rogers EM, 1962, DIFFUSION INNOVATION; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010; Zikmund-Fisher BJ, 2007, MED DECIS MAKING, V27, P663, DOI 10.1177/0272989x07303824	43	9	9	0	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	SEP	2017	5	9							e144	10.2196/mhealth.8732			15	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	FM5AJ	WOS:000415041100001	28958987	Green Published, gold			2022-02-06	
J	Stippler, M; Liu, JY; Motiei-Langroudi, R; Voronovich, Z; Yonas, H; Davis, RB				Stippler, Martina; Liu, Jingyi; Motiei-Langroudi, Rouzbeh; Voronovich, Zoya; Yonas, Howard; Davis, Roger B.			Complicated Mild Traumatic Brain Injury and the Need for Imaging Surveillance	WORLD NEUROSURGERY			English	Article						CT scan; Imaging; Mild; Traumatic brain injury	CRANIAL COMPUTED-TOMOGRAPHY; MINIMAL HEAD-INJURY; RISK-FACTORS; CT; UTILITY; PROGRESSION; HEMORRHAGE; RADIATION; RULE	OBJECTIVE: To evaluate the need for repeat head computed tomography (CT) in patients with complicated mild traumatic brain injury (TBI) determined nonoperative after the first head CT. METHODS: A total of 380 patients with mild TBI and a positive head CT not needing surgery were included. Changes between first and second head CT were categorized as decreased, increased, or stable. RESULTS: Three patients required neurosurgical intervention (0.8%) after the second CT. There were no significant differences in demographics including age, gender, alcohol consumption, anticoagulation status, time between first and second CT, Glasgow Coma Scale score at admission and discharge, and incidence of subarachnoid hemorrhage, epidural hematoma, contusion, or skull fractures between the operated and nonoperated groups. All patients in the operated group had subdural hematoma compared with 40.8% in the nonoperated group (P [0.07). All operated patients showed symptoms of neurologic worsening after initial head CT, compared with 2.7% in the nonoperated group (P < 0.001). Moreover, patients who showed neurologic worsening were more likely to show increased intracranial bleeding on repeat head CT, whereas patients who did not show neurologic worsening were more likely to show decreased or stable intracranial bleeding (P [0.04). CONCLUSIONS: Routine repeat head CT in patients with complicated mild TBI is very low yield to predict need for delayed surgical intervention. Instead, serial neurologic examination and observation over the first 8 hours after the injury is recommended. A second CT scan should be obtained only in patients who have neurologic worsening.	[Stippler, Martina; Motiei-Langroudi, Rouzbeh] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Neurosurg Serv, Boston, MA 02115 USA; [Davis, Roger B.] Harvard Med Sch, Div Gen Med & Primary Care, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Liu, Jingyi] Harvard Med Sch, Sch Med, Boston, MA USA; [Voronovich, Zoya; Yonas, Howard] Univ New Mexico, Hlth Sci Ctr, Dept Neurosurg, Albuquerque, NM 87131 USA		Stippler, M (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Neurosurg Serv, Boston, MA 02115 USA.	mstipple@bidmc.harvard.edu					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Innocenti F, 2017, INTERN EMERG MED, V12, P81, DOI 10.1007/s11739-016-1421-y; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; MORAN SG, 1994, AM SURGEON, V60, P533; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pauwels EKJ, 2011, ACTA RADIOL, V52, P767, DOI 10.1258/ar.2011.100496; Seddighi AS, 2013, BRAIN INJURY, V27, P1666, DOI 10.3109/02699052.2013.830333; Shih FY, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0069-2; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	29	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105						265	269		10.1016/j.wneu.2017.05.008			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600036	28502689				2022-02-06	
J	Tai, SSM; Miltenberger, RG				Tai, Sharayah S. M.; Miltenberger, Raymond G.			EVALUATING BEHAVIORAL SKILLS TRAINING TO TEACH SAFE TACKLING SKILLS TO YOUTH FOOTBALL PLAYERS	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						athletic performance; behavioral skills training; coaching; football; tackling	YOUNG-CHILDREN; CONCUSSION; INJURIES	With concussion rates on the rise for football players, there is a need for further research to increase skills and decrease injuries. Behavioral skills training is effective in teaching a wide variety of skills but has yet to be studied in the sports setting. We evaluated behavioral skills training to teach safer tackling techniques to six participants from a Pop Warner football team. Safer tackling techniques increased during practice and generalized to games for the two participants who had opportunities to tackle in games.	[Tai, Sharayah S. M.; Miltenberger, Raymond G.] Univ S Florida, Dept Child & Family Studies, Tampa, FL 33620 USA		Miltenberger, RG (corresponding author), Univ S Florida, MHC2113A, Tampa, FL 33612 USA.	miltenberger@usf.edu					Dickson MJ, 2017, J APPL BEHAV ANAL, V50, P407, DOI 10.1002/jaba.369; Gove J.P., 2012, VAND J ENT TECHNOL L, V14, P649; Harrison AM, 2013, J APPL BEHAV ANAL, V46, P518, DOI 10.1002/jaba.36; Heiner J., 2008, SETON HALL J SPORTS, V18, P255; Himle MB, 2004, J APPL BEHAV ANAL, V37, P1, DOI 10.1901/jaba.2004.37-1; Houvouras AJ, 2014, J APPL BEHAV ANAL, V47, P420, DOI 10.1002/jaba.113; Johnson BM, 2005, J APPL BEHAV ANAL, V38, P67, DOI 10.1901/jaba.2005.26-04; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lerman DC, 2015, J APPL BEHAV ANAL, V48, P233, DOI 10.1002/jaba.196; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Smith SL, 2006, J APPL BEHAV ANAL, V39, P385, DOI 10.1901/jaba.2006.5-06; Speelman RC, 2015, J APPL BEHAV ANAL, V48, P632, DOI 10.1002/jaba.225; Stokes JV, 2010, J APPL BEHAV ANAL, V43, P509, DOI 10.1901/jaba.2010.43-509	15	9	9	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8855	1938-3703		J APPL BEHAV ANAL	J. Appl. Behav. Anal.	FAL	2017	50	4					849	855		10.1002/jaba.412			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FJ6IS	WOS:000412861300014	28940381				2022-02-06	
J	Wang, HF; Zhang, KW; Cao, HS; Zhang, XH; Li, Y; Wei, Q; Zhang, DZ; Jia, Q; Bie, L				Wang, Haifeng; Zhang, Kewei; Cao, Hongshi; Zhang, Xiaohong; Li, Ye; Wei, Qiang; Zhang, Dezhi; Jia, Qian; Bie, Li			Seizure After Cranioplasty: Incidence and Risk Factors	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Complication; cranioplasty; decompressive craniectomy; seizure	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; POSTTRAUMATIC SEIZURES; STATUS EPILEPTICUS; HEAD-INJURY; COMPLICATIONS; GRAFT; MULTICENTER; INFECTION; OUTCOMES	Background: To investigate clinical characteristics of postcranioplasty seizures (PCS) first observed after cranioplasty after decompressive craniectomy (DC) to treat traumatic brain injury and to define factors that increase PCS risk. Methods: This retrospective study, covering the period between January 2008 and July 2015, compared PCS in postcranioplasty patients. Postcranioplasty seizures risk factors included diabetes mellitus, hypertension, time between DC and cranioplasty, duraplasty material, cranioplasty contusion location, electrocautery method, PCS type, and infection. Multivariate logistic regression analysis was performed and confidence intervals (CIs) were calculated (95% CI). Results: Of 270 patients, 32 exhibited initial PCS onset postcranioplasty with 11.9% incidence (32/270). Patients fell into immediate (within 24 hours), early (from 1 to 7 days), and late (after 7 days) PCS groups with frequencies of 12, 5, and 15 patients, respectively. Generalized, partial, and mixed seizure types were observed in 13, 13, and 6 patients, respectively. Multivariate logistic regression analysis showed increased risk with increasing age (>50 years). Cranioplasty contusion location, precranioplasty deficits, duraplasty material, and monopolar electrocautery were predictive of PCS onset (P<0.05). Increased DC to cranioplasty interval increased risk but was not statistically significant (P = 0.062). Conclusions: Understanding risk factors for PCS will benefit the management of cranioplasty patients.	[Wang, Haifeng; Zhang, Kewei; Cao, Hongshi; Zhang, Xiaohong; Li, Ye; Wei, Qiang; Zhang, Dezhi; Jia, Qian; Bie, Li] Jilin Univ, Clin Hosp 1, Dept Neurosurg, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China; [Bie, Li] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA		Bie, L (corresponding author), Jilin Univ, Clin Hosp 1, Dept Neurosurg, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.	bieli@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201980, 81572476]; Natural Science Foundation of Jilin Province, China [20130522028JH]	This work was supported by the National Natural Science Foundation of China (No 81201980 and No 81572476) and Natural Science Foundation of Jilin Province, China (No 20130522028JH).	Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Broughton E, 2014, BRIT J NEUROSURG, V28, P34, DOI 10.3109/02688697.2013.815319; De Reuck J, 2011, CLIN NEUROL NEUROSUR, V113, P469, DOI 10.1016/j.clineuro.2011.02.004; Dhakar MB, 2015, SEIZURE-EUR J EPILEP, V32, P16, DOI 10.1016/j.seizure.2015.08.005; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hefermehl LJ, 2014, BJU INT, V114, P245, DOI 10.1111/bju.12498; HOPKINS A, 1988, LANCET, V1, P721; Huang YH, 2015, SEIZURE-EUR J EPILEP, V25, P150, DOI 10.1016/j.seizure.2014.10.008; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Liang ES, 2016, BRIT J NEUROSURG, V30, P122, DOI 10.3109/02688697.2015.1080216; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Najafi Mohammad Reza, 2015, Adv Biomed Res, V4, P82, DOI 10.4103/2277-9175.156640; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Santana-Cabrera Luciano, 2012, Int J Crit Illn Inj Sci, V2, P186, DOI 10.4103/2229-5151.100937; Sinha S, 2013, J CLIN NEUROSCI, V20, P423, DOI 10.1016/j.jocn.2012.02.050; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Tachibana E, 2002, J NEUROSURG, V96, P280, DOI 10.3171/jns.2002.96.2.0280; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405; Zare MA, 2013, INT J NEUROSCI, V123, P65, DOI 10.3109/00207454.2012.728653	33	9	10	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2017	28	6					E560	E564		10.1097/SCS.0000000000003863			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FO7IW	WOS:000417048300016	28796104				2022-02-06	
J	Debaud, C; Salga, M; Begot, L; Holy, X; Chedik, M; de l'Escalopier, N; Torossian, F; Levesque, JP; Lataillade, JJ; Le Bousse-Kerdiles, MC; Genet, F				Debaud, Charlotte; Salga, Marjorie; Begot, Laurent; Holy, Xavier; Chedik, Malha; de l'Escalopier, Nicolas; Torossian, Frederic; Levesque, Jean-Pierre; Lataillade, Jean-Jacques; Le Bousse-Kerdiles, Marie-Caroline; Genet, Francois			Peripheral denervation participates in heterotopic ossification in a spinal cord injury model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBSTANCE-P; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; BONE-FORMATION; INFLAMMATION; REGENERATION; IMPACT; DEGENERATION; EXPRESSION	We previously reported the development of a new acquired neurogenic HO (NHO) mouse model, combining spinal cord transection (SCI) and chemical muscle injury. Pathological mechanisms responsible for ectopic osteogenesis after central neurological damage are still to be elucidated. In this study, we first hypothesized that peripheral nervous system (PNS) might convey pathological signals from injured spinal cord to muscles in NHO mouse model. Secondly, we sought to determine whether SCI could lead to intramuscular modifications of BMP2 signaling pathways. Twenty one C57Bl6 mice were included in this protocol. Bilateral cardiotoxin (CTX) injection in hamstring muscles was associated with a two-stage surgical procedure, combining thoracic SCI with unilateral peripheral denervation. Volumes of HO (Bone Volume, BV) were measured 28 days after surgery using micro-computed tomography imaging techniques and histological analyses were made to confirm intramuscular osteogenesis. Volume comparisons were conducted between right and left hind limb of each animal, using a Wilcoxon signed rank test. Quantitative polymerase chain reaction (qPCR) was performed to explore intra muscular expression of BMP2, Alk3 and Id1. Nineteen mice survive the complete SCI and peripheral denervation procedure. When CTX injections were done right after surgery (n = 7), bilateral HO were detected in all animals after 28 days. Micro-CT measurements showed significantly increased BV in denervated paws (1.47 mm3 +/- 0.5) compared to contralateral sides (0.56 mm3 +/-0.4), p = 0.03. When peripheral denervation and CTX injections were performed after sham SCI surgery (n = 6), bilateral HO were present in three mice at day 28. Quantitative PCR analyses showed no changes in intra muscular BMP2 expression after SCI as compared to control mice (shamSCI). Peripheral denervation can be reliably added to spinal cord transection in NHO mouse model. This new experimental design confirms that neuro inflammatory mechanisms induced by central or peripheral nervous system injury plays a key role in triggering ectopic osteogenesis.	[Debaud, Charlotte] Hop Europeen Georges Pompidou, APHP, Spine Div, Dept Orthopaed Surg, Paris, France; [Debaud, Charlotte; Salga, Marjorie; Chedik, Malha; Genet, Francois] Univ Versailles St Quentin Yvelines, INSERM, U1179, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Salga, Marjorie; Genet, Francois] Hop Raymond Poincare, APHP, CIC IT 1429, Rehabil Serv, Garches, France; [Begot, Laurent; Holy, Xavier] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [de l'Escalopier, Nicolas] Hop Instruct Armees PERCY, Dept Orthopaed Surg, Clamart, France; [Torossian, Frederic; Le Bousse-Kerdiles, Marie-Caroline] Univ Paris Sud, Hop Paul Brousse, APHP, INSERM,UMR S MD 1197, Villejuif, France; [Levesque, Jean-Pierre] Univ Queensland, Mater Res Inst, Blood & Bone Dis Program, Woolloongabba, Qld, Australia; [Levesque, Jean-Pierre] Univ Queensland, Sch Med, Herston, Qld, Australia; [Lataillade, Jean-Jacques] Univ Paris Sud, Ecole Val de Grace, IRBA CTSA HIA Percy, Unite Mixte Inserm SSA 1197, Clamart, France		Debaud, C (corresponding author), Hop Europeen Georges Pompidou, APHP, Spine Div, Dept Orthopaed Surg, Paris, France.; Debaud, C (corresponding author), Univ Versailles St Quentin Yvelines, INSERM, U1179, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France.	charlotte.debaud@aphp.fr	Levesque, Jean-Pierre/C-5426-2011; Le Bousse-Kerdiles, Marie-Caroline/Q-4029-2018	Levesque, Jean-Pierre/0000-0002-7299-6025; Le Bousse-Kerdiles, Marie-Caroline/0000-0003-0863-5222; de l'Escalopier, Nicolas/0000-0001-6333-7311			Anthonissen J, 2014, ACTA ORTHOP BELG, V80, P2; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; AVELLINO AM, 1995, EXP NEUROL, V136, P183, DOI 10.1006/exnr.1995.1095; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; David S, 2012, INT REV NEUROBIOL, V106, P127, DOI 10.1016/B978-0-12-407178-0.00006-5; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; Genet F, 2015, BRAIN INJURY, V29, P866, DOI 10.3109/02699052.2015.1005133; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; GEPPETTI P, 1995, CAN J PHYSIOL PHARM, V73, P843, DOI 10.1139/y95-115; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Gonda K, 2000, J BONE MINER RES, V15, P1056, DOI 10.1359/jbmr.2000.15.6.1056; Gong LL, 2016, BIOCHEM BIOPH RES CO, V478, P206, DOI 10.1016/j.bbrc.2016.07.067; Han B, CDC42 PROMOTES SCHWA; Hannallah D, 2004, J BONE JOINT SURG AM, V86A, P80, DOI 10.2106/00004623-200401000-00013; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760; Hino K, 2015, P NATL ACAD SCI USA, V112, P15438, DOI 10.1073/pnas.1510540112; Kan LX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/309287; Kan LX, 2011, J CELL BIOCHEM, V112, P2759, DOI 10.1002/jcb.23259; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; Kim KT, 2015, SPINE J, V15, P2055, DOI 10.1016/j.spinee.2015.04.032; Leonard AV, 2014, SPINAL CORD, V52, P17, DOI 10.1038/sc.2013.136; Li XL, 2006, ANN NY ACAD SCI, V1068, P26, DOI 10.1196/annals.1346.006; Liu PT, 2017, DIS MODEL MECH, V10, P53, DOI 10.1242/dmm.026880; Ma CHE, 2011, J NEUROSCI, V31, P18391, DOI 10.1523/JNEUROSCI.4550-11.2011; Ma WH, 2015, BRAZ J MED BIOL RES, V48, P299, DOI 10.1590/1414-431X20144226; Nazarian A, 2008, NEUROSCIENCE, V152, P119, DOI 10.1016/j.neuroscience.2007.11.037; Peng HR, 2001, MOL THER, V4, P95, DOI 10.1006/mthe.2001.0423; Qin J, 2016, NEURAL REGEN RES, V11, P1165, DOI 10.4103/1673-5374.187059; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Sakaguchi S, 2014, INT J BIOCHEM CELL B, V54, P272, DOI 10.1016/j.biocel.2014.05.032; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225; Schwab JM, 2014, EXP NEUROL AOUT, P121; Shehab D, 2002, J NUCL MED, V43, P346; Shono Jun-ichi, 2013, Anim Sci J, V84, P744, DOI 10.1111/asj.12105; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Stangenberg L, 2014, P NATL ACAD SCI USA, V111, P11419, DOI 10.1073/pnas.1410854111; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	53	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2017	12	8							e0182454	10.1371/journal.pone.0182454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF1XX	WOS:000408693600010	28854256	Green Published, gold, Green Submitted			2022-02-06	
J	Sun, YR; Yu, J; Yuan, Q; Wu, X; Wu, XH; Hu, J				Sun, Yirui; Yu, Jian; Yuan, Qiang; Wu, Xing; Wu, Xuehai; Hu, Jin			Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Valproic acid; Seizure; UGT1A6; CYP2C9; Genetic polymorphisms	NONCONVULSIVE STATUS EPILEPTICUS; CONTINUOUS EEG; ELECTROGRAPHIC SEIZURES; MORTALITY PREDICTION; CYP2C9 POLYMORPHISM; PHARMACOKINETICS; PHARMACOGENETICS; METABOLISM; CHINESE; UGT1A6	Background: Seizure is a common complication for severe traumatic brain injury (TBI). Valproic acid (VPA) is a first-line antiepileptic drug, though its metabolism is affected by genetic polymorphisms and varies between individuals. The aim of this study was to investigate such association and to explore its influence on the occurrence of early post-traumatic seizure. Methods: A prospective case control study was conducted from 2012 to 2016 recruiting adult patients with severe TBI. Electroencephalograph (EEG) monitoring was performed approximately 4 h for each patient from day 1 to day 7 after injury. If seizures were detected, EEG monitoring was extended until 12 h after seizures being controlled. Genetic polymorphisms in UGT1A6, UGT2B7, CYP2C9, and CYP2C19 were analyzed in association with daily VPA plasma concentrations, adjusted dosages, and occurrence of seizures. Results: Among the 395 recruited patients, eighty-three (21%) had early post-traumatic seizure, of which 30 (36.14%) were non-convulsive. Most seizures were first detected on day 1 (34.94%) and day 2 (46.99%) after injury. Patients with seizure had longer ICU length of stay and relatively lower VPA plasma concentrations. Patients with UGT1A6_ 19T > G/541A > G/552A > C double heterozygosities or CYP2C9 extensive metabolizers (EMs) initially had lower adjusted VPA plasma concentrations (power > 0.99) and accordingly require higher VPA dosages during later time of treatment (power > 0.99). The odds ratio indicated a higher risk of early post-traumatic seizure occurrence in male patients (OR 1.96, 95% CI 1.01-3.81, p = 0.043), age over 65 (OR 2.13, 95% CI 1.01-4.48), and with UGT1A6_ 19T > G/541A > G/552A > C double heterozygosities (OR 2.38, 95% CI 1.11-5.10, p = 0.02), though the power of the difference was between 0.54 to 0.61. Discussion: Due to limited facility, the actual frequency of non-convulsive seizures is suspected to be higher than identified. There has been discrepancy regarding to genetic polymorphisms and VPA metab olism between this study and some previous reports. This could be related to confounders such as sample size, race, and patient age. Another limitation is that the case numbers of certain genotypes are limited in this study. Conclusions: Continuous EEG monitoring is necessary to detect both convulsive and non-convulsive early post-traumatic seizures in severe TBI patients. UGT1A6/CYP2C9 polymorphisms have influence on VPA metabolism. UGT1A6_ 19T > G/541A > G/552A > C double heterozygositie is associated with occurrence of early post-traumatic seizures in addition to patients' age and gender. Further investigations with larger sample size are required to confirm the difference.	[Sun, Yirui; Yu, Jian; Yuan, Qiang; Wu, Xing; Wu, Xuehai; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Rd, Shanghai 200040, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Rd, Shanghai 200040, Peoples R China.	huashantibi@sohu.com			Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [16411955300]	This work was supported by the Science and Technology Commission of Shanghai Municipality [16411955300].	Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Amini-Shirazi N, 2010, TOXICOL MECH METHOD, V20, P452, DOI 10.3109/15376516.2010.497977; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Association for the Advancement of Automotive Medicine (AAAM), 2005, ABBR INJ SCAL AIS 20; Birnbaum AK, 2007, THER DRUG MONIT, V29, P571, DOI 10.1097/FTD.0b013e31811f3296; Sanchez MB, 2010, SEIZURE-EUR J EPILEP, V19, P93, DOI 10.1016/j.seizure.2009.12.004; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2016, NEUROSURGERY; CHADWICK DW, 1985, CLIN PHARMACOKINET, V10, P155, DOI 10.2165/00003088-198510020-00003; Chatzistefanidis D, 2016, PHARMACOGENOMICS, V17, P827, DOI 10.2217/pgs-2016-0014; Chu XM, 2012, EUR J CLIN PHARMACOL, V68, P1395, DOI 10.1007/s00228-012-1277-7; Chung JY, 2008, CLIN PHARMACOL THER, V83, P595, DOI 10.1038/sj.clpt.6100324; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DeVane C Lindsay, 2003, Psychopharmacol Bull, V37 Suppl 2, P25; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Duncan R, 2006, NEUROLOGY, V66, P1644, DOI 10.1212/01.wnl.0000223320.94812.7a; EBNER T, 1993, DRUG METAB DISPOS, V21, P50; Guo YJ, 2012, DRUG METAB PHARMACOK, V27, P536, DOI 10.2133/dmpk.DMPK-11-NT-144; Hung CC, 2011, PHARMACOGENOMICS, V12, P1107, DOI [10.2217/PGS.11.64, 10.2217/pgs.11.64]; Ibarra M, 2013, J PHARMACOKINET PHAR, V40, P479, DOI 10.1007/s10928-013-9323-3; Innocenti F, 2008, PHARMACOGENET GENOM, V18, P683, DOI 10.1097/FPC.0b013e3283037fe4; Jiang DC, 2009, EUR J CLIN PHARMACOL, V65, P1187, DOI 10.1007/s00228-009-0712-x; JIN CJ, 1993, J PHARMACOL EXP THER, V264, P475; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Kiang TKL, 2006, TOXICOL SCI, V94, P261, DOI 10.1093/toxsci/kfl096; Klotz U, 2007, CLIN PHARMACOKINET, V46, P271, DOI 10.2165/00003088-200746040-00001; Lin GF, 2005, TOXICOL SCI, V85, P502, DOI 10.1093/toxsci/kfi068; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Nagar S, 2004, PHARMACOGENETICS, V14, P487, DOI 10.1097/01.fpc.0000114771.78957.cb; Noai M, 2016, ACTA NEUROL SCAND, V133, P216, DOI 10.1111/ane.12473; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Sutter R, 2016, NAT REV NEUROL, V12, P281, DOI 10.1038/nrneurol.2016.45; Tan L, 2010, CLIN NEUROL NEUROSUR, V112, P320, DOI 10.1016/j.clineuro.2010.01.002; Tankanitlert J, 2007, PHARMACOLOGY, V79, P97, DOI 10.1159/000097908; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; WANG SL, 1995, PHARMACOGENETICS, V5, P37, DOI 10.1097/00008571-199502000-00004; Yang JQ, 2003, FUND CLIN PHARMACOL, V17, P373, DOI 10.1046/j.1472-8206.2003.00148.x; Yi X, 2009, PHARMACOGENOMICS, V10, P741, DOI [10.2217/PGS.09.21, 10.2217/pgs.09.21]; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	44	9	10	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 25	2017	25								85	10.1186/s13049-017-0382-0			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FF1ZG	WOS:000408697100001	28841884	Green Published, gold			2022-02-06	
J	Fernandez, R; Gonzalez, P; Lage, S; Garate, J; Maqueda, A; Marcaida, I; Maguregui, M; Ochoa, B; Rodriguez, FJ; Fernandez, JA				Fernandez, Roberto; Gonzalez, Pau; Lage, Sergio; Garate, Jone; Maqueda, Alfredo; Marcaida, Iker; Maguregui, Maite; Ochoa, Begona; Rodriguez, F. Javier; Fernandez, Jose A.			Influence of the Cation Adducts in the Analysis of Matrix-Assisted Laser Desorption Ionization Imaging Mass Spectrometry Data from Injury Models of Rat Spinal Cord	ANALYTICAL CHEMISTRY			English	Article							BRAIN-TISSUE; ELECTROSPRAY-IONIZATION; FUNCTIONAL RECOVERY; SMALL MOLECULES; LIPIDS; ACID; METABOLITES; XENOGRAFTS; RESOLUTION; SECTIONS	Imaging mass spectrometry (IMS) is quickly becoming a technique of reference to visualize the lipid distribution in tissue sections. Still, many questions remain open, and data analysis has to be optimized to avoid interpretation pitfalls. Here we analyze how the variation on the [Na+/[K+] relative abundance affects the detection of lipids between sections of spinal cord of (uninjured) control rats and of models of spinal cord demyelination and traumatic contusion injury. The [M + Na](+)/[M + K](+) adducts ratio remained approximately constant along transversal and longitudinal sections of spinal cord from control animals, but it strongly changed depending on the type of lesion. A substantial increase in the abundance of [M + Na](+) adducts was observed in samples from spinal cord with demyelination, while the intensity of the [M + K](+) adducts was stronger in those sections from mechanically injured spinal cords. Such changes masked the modifications in the lipid profile due to the injury and only after summing the signal intensity of all adducts and corresponding monoprotonated molecular ions of each detected lipid in a single variable, it was possible to unveil the real changes in the lipid profile due to the lesion. Such lipids included glycerophospholipids (both diacyl and aryl-acyl), sphingolipids, and nonpolar lipids (diacyl and triacylglycerols), which are the main lipid classes detected in positive-ion mode. Furthermore, the results demonstrate the sensitivity of the technique toward modification in tissue homeostasis and that the [M + Na](+)/[M + K](+) ratio may be used to detect alterations in such homeostasis.	[Fernandez, Roberto; Lage, Sergio; Garate, Jone; Fernandez, Jose A.] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Phys Chem, Barrio Sarriena S-N, Leioa 48940, Spain; [Gonzalez, Pau; Maqueda, Alfredo; Rodriguez, F. Javier] HNP, Lab Mol Neurol, Finca Peraleda S-N, Toledo 45071, Spain; [Marcaida, Iker] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Analyt Chem, Barrio Sarriena S-N, Leioa 48940, Spain; [Maguregui, Maite] Univ Basque Country, UPV EHU, Fac Pharm, Dept Analyt Chem, Paseo Univ 7, Vitoria 01006, Spain; [Ochoa, Begona] Univ Basque Country, UPV EHU, Fac Med & Nursing, Dept Physiol, Barrio Sarriena S-N, Leioa 48940, Spain; [Lage, Sergio] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Barrio Sarriena S-N, Leioa 48940, Spain		Fernandez, JA (corresponding author), Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Phys Chem, Barrio Sarriena S-N, Leioa 48940, Spain.	josea.fernandez@ehu.es	Fernandez, Jose A./E-8565-2011; Medina, Sergio Lage/I-2518-2015; Sanchez, Pau Gonzalez/J-2530-2019; Ochoa, Begona/K-9123-2014; Maguregui, Maite/K-5973-2014	Fernandez, Jose A./0000-0002-7315-2326; Medina, Sergio Lage/0000-0002-7029-5428; Sanchez, Pau Gonzalez/0000-0002-8871-8054; Ochoa, Begona/0000-0002-1580-7160; Maqueda Fernandez, Alfredo/0000-0002-0117-5422; Marcaida, Iker/0000-0002-6258-2937; Maguregui, Maite/0000-0001-6011-3590; Fernandez, Roberto Antonio/0000-0002-3424-9758; Rodriguez, Javier/0000-0001-5902-7556	Spanish Ministry of Economy and CompetitivenessSpanish Government [IPT-2011-0742-900000]; Fondo Europeo de Desarrollo regional (FEDER) EUSpanish Government; Basque GovernmentBasque Government [IT971-16]; UPV/EHU	This study was supported by the Spanish Ministry of Economy and Competitiveness, Grant IPT-2011-0742-900000 (INNPACTO program), cofinanced by Fondo Europeo de Desarrollo regional (FEDER) EU, and the Basque Government (Grant IT971-16). Technical and human support provided by the Servicio de Lipidomica of the SGIKER (UPV/EHU, MICINN, GV/EJ, ESF) is gratefully acknowledge. J.G. thanks the UPV/EHU for a predoctoral fellowship.	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Angel PM, 2013, BIOCHEMISTRY-US, V52, P3818, DOI 10.1021/bi301519p; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Astigarraga E, 2008, ANAL CHEM, V80, P9105, DOI 10.1021/ac801662n; Balluff B, 2015, J PATHOL, V235, P3, DOI 10.1002/path.4436; Barcelo-Coblijn G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00003; Benabdellah F, 2009, ANAL CHEM, V81, P5557, DOI 10.1021/ac9005364; Bodzon-Kulakowska A, 2016, MASS SPECTROM REV, V35, P147, DOI 10.1002/mas.21468; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Cha SW, 2007, ANAL CHEM, V79, P2373, DOI 10.1021/ac062251h; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Degaonkar MN, 2002, NMR BIOMED, V15, P293, DOI 10.1002/nbm.771; Dill AL, 2009, J CHROMATOGR B, V877, P2883, DOI 10.1016/j.jchromb.2008.12.058; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Fernandez R, 2016, J AM SOC MASS SPECTR, V27, P244, DOI 10.1007/s13361-015-1268-x; Fernandez R, 2016, ANAL CHEM, V88, P1022, DOI 10.1021/acs.analchem.5b03978; Fernandez R, 2014, J AM SOC MASS SPECTR, V25, P1237, DOI 10.1007/s13361-014-0882-3; Fonville JM, 2013, ANAL CHEM, V85, P1415, DOI 10.1021/ac302330a; Garate J, 2015, ANAL BIOANAL CHEM, V407, P4697, DOI 10.1007/s00216-015-8673-7; Garrett TJ, 2007, INT J MASS SPECTROM, V260, P166, DOI 10.1016/j.ijms.2006.09.019; Girod M, 2010, J AM SOC MASS SPECTR, V21, P1177, DOI 10.1016/j.jasms.2010.03.028; Gonzalez P, 2013, J NEUROTRAUM, V30, P806, DOI 10.1089/neu.2012.2613; Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050793; Groseclose MR, 2013, ANAL CHEM, V85, P10099, DOI 10.1021/ac400892z; Hanada M, 2012, ANAL BIOANAL CHEM, V403, P1873, DOI 10.1007/s00216-012-5900-3; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hanrieder J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05266; Jackson SN, 2007, J MASS SPECTROM, V42, P1093, DOI 10.1002/jms.1245; Jackson SN, 2005, J AM SOC MASS SPECTR, V16, P2052, DOI 10.1016/j.jasms.2005.08.014; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Kompauer M, 2017, NAT METHODS, V14, P90, DOI [10.1038/nmeth.4071, 10.1038/NMETH.4071]; Landgraf RR, 2009, ANAL CHEM, V81, P8488, DOI 10.1021/ac901387u; Liu ZH, 2017, J NEUROTRAUM, V34, P1766, DOI 10.1089/neu.2016.4556; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Ly A, 2016, NAT PROTOC, V11, P1428, DOI 10.1038/nprot.2016.081; Fernandez-Martos CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035594; Fernandez-Martos CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027000; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Muller L, 2015, KIDNEY INT, V88, P186, DOI 10.1038/ki.2015.3; Nemes P, 2010, ANAL CHEM, V82, P982, DOI 10.1021/ac902245p; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; Thomas A, 2013, ANAL CHEM, V85, P2860, DOI 10.1021/ac3034294; Veloso A, 2011, ANAL BIOANAL CHEM, V401, P89, DOI 10.1007/s00216-011-4882-x; Veloso A, 2011, J AM SOC MASS SPECTR, V22, P329, DOI 10.1007/s13361-010-0024-5; Wang HYJ, 2008, INT J MASS SPECTROM, V278, P143, DOI 10.1016/j.ijms.2008.04.005; Wang HYJ, 2005, ANAL CHEM, V77, P6682, DOI 10.1021/ac050868d; Xu DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26427; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769	55	9	9	0	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	AUG 15	2017	89	16					8565	8573		10.1021/acs.analchem.7b02650			9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	FE1OX	WOS:000407988600054	28703574				2022-02-06	
J	Zheng, F; Xia, ZA; Zeng, YF; Luo, JK; Sun, P; Cui, HJ; Wang, Y; Tang, T; Zhou, YT				Zheng, Fei; Xia, Zi-An; Zeng, Yi-Fu; Luo, Jie-Kun; Sun, Peng; Cui, Han-Jin; Wang, Yang; Tang, Tao; Zhou, Yan-Tao			Plasma metabolomics profiles in rats with acute traumatic brain injury	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; AMINO-ACIDS; BETA-HYDROXYBUTYRATE; ARACHIDONIC-ACID; PHOSPHORIC-ACID; LINOLEIC-ACID; BIOMARKER; GALACTOSE; DAMAGE; URINE	Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. We validated the utility of plasma metabolomics analysis in the clinical diagnosis of acute TBI in a rat model of controlled cortical impact (CCI) using gas chromatography/mass spectrometry (GC/MS). Thirty Sprague-Dawley rats were randomly divided into two groups of 15 rats each: the CCI group and sham group. Blood samples were obtained from the rats within the first 24 h after TBI injury. GC/MS measurements were performed to evaluate the profile of acute TBI-induced metabolic changes, resulting in the identification of 45 metabolites in plasma. Principal component analysis, partial least squares-discriminant analysis, orthogonal partial least square discriminant analysis using hierarchical clustering and univariate/multivariate analyses revealed clear differences in the plasma metabolome between the acute CCI group and the sham group. CCI induced distinctive changes in metabolites including linoleic acid metabolism, amino acid metabolism, galactose metabolism, and arachidonic acid metabolism. Specifically, the acute CCI group exhibited significant alterations in proline, phosphoric acid, beta-hydroxybutyric acid, galactose, creatinine, L-valine, linoleic acid and arachidonic acid. A receiver operating characteristic curve analysis showed that the above 8 metabolites in plasma could be used as the potential biomarkers for the diagnosis of acute TBI. Furthermore, this study is the first time to identify the galactose as a biomarker candidate for acute TBI. This comprehensive metabolic analysis complements target screening for potential diagnostic biomarkers of acute TBI and enhances predictive value for the therapeutic intervention of acute TBI.	[Zheng, Fei; Zeng, Yi-Fu; Zhou, Yan-Tao] Hunan Univ, Coll Elect & Informat Engn, Changsha, Hunan, Peoples R China; [Xia, Zi-An; Luo, Jie-Kun; Cui, Han-Jin; Wang, Yang; Tang, Tao] Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha, Hunan, Peoples R China; [Sun, Peng] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan, Shandong, Peoples R China		Zhou, YT (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha, Hunan, Peoples R China.; Wang, Y; Tang, T (corresponding author), Cent S Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha, Hunan, Peoples R China.	wangyang_xy87@163.com; falcontang@126.com; yantao_z@hnu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 61472126, 81473573, 81303074]	This work was supported by the Natural Science Foundation of China (Grant Nos. 81673719, 61472126, 81473573 and 81303074).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Benjamini Y, 2014, BIOSTATISTICS, V15, P13, DOI 10.1093/biostatistics/kxt032; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; de Castro J, 2009, EXP MOL PATHOL, V87, P226, DOI 10.1016/j.yexmp.2009.08.002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Eve DJ, 2016, NEUROPSYCH DIS TREAT, V12, P2689, DOI 10.2147/NDT.S110126; Faul M, 2011, BMJ J, P2002; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Fu SP, 2015, J NEUROENDOCRINOL, V27, P212, DOI 10.1111/jne.12256; Glenn Thomas C, 2013, Acta Neurochir Suppl, V118, P115, DOI 10.1007/978-3-7091-1434-6_20; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Higuchi M, 2015, ALZ DIS ASSOC DIS, V29, P200, DOI 10.1097/WAD.0000000000000082; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kathryn Beauchamp, 2016, METABOLOMICS, V12, P42; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Knerr I, 2015, PEDIATR RES, V78, P272, DOI 10.1038/pr.2015.107; Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Melis GC, 2005, BRIT J NUTR, V94, P19, DOI 10.1079/BJN20051463; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Montero-Barrera D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/615865; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Qin HQ, 2012, CHEM COMMUN, V48, P961, DOI 10.1039/c1cc15222j; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shen DS, 2016, WASTE MANAGE, V51, P65, DOI 10.1016/j.wasman.2016.02.027; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Sun M, 1997, PHYSIOL BEHAV, V61, P433, DOI 10.1016/S0031-9384(9X)00455-8; Thomas MH, 2016, BIOCHIMIE, V130, P168, DOI 10.1016/j.biochi.2016.07.013; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; USUI A, 1989, CLIN CHEM, V35, P1942; Vazquez A, 2014, INT J BIOL SCI, V10, P909, DOI 10.7150/ijbs.9214; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wolahan SM, 2016, NEUROSURG CLIN N AM, V27, P465, DOI 10.1016/j.nec.2016.05.006; Xie GX, 2012, J PROTEOME RES, V11, P3449, DOI 10.1021/pr300318m; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yuan T, 2015, INT J CLIN EXP PATHO, V8, P5044; Zhang W, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006190; Zhang Y. D., 2016, SHOCK VIB, P1, DOI [DOI 10.1155/2016/1317232, 10.1155/2016/3978424, DOI 10.1155/2016/3978424]; Zhao ZL, 2016, J NEUROL SCI, V364, P12, DOI 10.1016/j.jns.2016.03.007; Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088	77	9	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2017	12	8							e0182025	10.1371/journal.pone.0182025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC5AR	WOS:000406853600057	28771528	Green Submitted, gold, Green Published			2022-02-06	
J	Haller, CS				Haller, Chiara S.			The Relatives' Big Five Personality Influences the Trajectories of Recovery of Patients After Severe TBI: A Multilevel Analysis	JOURNAL OF PERSONALITY			English	Article							QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; OLDER-ADULTS; TRAITS; RESILIENCE; STABILITY; MODERATE; CONSCIENTIOUSNESS; NEUROTICISM	This study examines the influence of the personality of relatives on the trajectories of recovery of patients with severe traumatic brain injury (TBI). The present subsample (N5376) of a larger population-based, prospective, 12-month multicenter cohort study in Switzerland (2007-2011) consists of patients with severe TBI (age >= 16) and their relatives. The predictors are the NEO Five-Factor Inventory and time (trajectory of functioning of the patient over time). The outcomes are the patients' (a) neurological functioning; (b) reported emotional, interpersonal, cognitive, and total functioning post-injury; and (c) health-related quality of life (HRQoL). The covariates included Abbreviated Injury Scale score of the head region and age. Results for patients> 50 are (a) relatives' Extraversion influenced patients' total, interpersonal, and cognitive functioning; (b) relatives' Agreeableness influenced patients' interpersonal functioning; and (c) relatives' Conscientiousness influenced patients' physical HRQoL (ps<. 05). Results for patients <= 50 are (a) relatives' Neuroticism influenced patients' neurological and emotional functioning, and (b) relatives' Extraversion influenced patients' emotional functioning and psychological HRQoL (ps<. 05). The personality traits of the relative covary with the functioning of the patient, and psychological adaptation to the loss of function may progress at a later stage after physical health improvements have been achieved. Thus, a biopsychosocial perspective on the rehabilitation process is needed.	[Haller, Chiara S.] Harvard Univ, 33 Kirkland St, Cambridge, MA 02138 USA; [Haller, Chiara S.] Dept Mental Hlth, Cambridge, MA USA		Haller, CS (corresponding author), Harvard Univ, 33 Kirkland St, Cambridge, MA 02138 USA.	haller@fas.harvard.edu					Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bogg T, 2013, ANN BEHAV MED, V45, P278, DOI 10.1007/s12160-012-9454-6; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Chan R, 2000, PERS INDIV DIFFER, V28, P347, DOI 10.1016/S0191-8869(99)00103-8; Chapman B, 2007, J GERONTOL B-PSYCHOL, V62, pP343, DOI 10.1093/geronb/62.6.P343; Claxton A, 2012, J SOC PERS RELAT, V29, P375, DOI 10.1177/0265407511431183; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Costa P. T., 1992, REVISED NEO PERSONAL; Costa P.T., 1990, J PERS DISORD, V4, P362, DOI [10.1521/pedi.1990.4.4.362, DOI 10.1521/PEDI.1990.4.4.362]; Davey M, 2003, J ADOLESCENT RES, V18, P347, DOI 10.1177/0743558403018004002; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Haller C. S., 2015, INFLUENCE MIND UNPUB; Haller C. S., 2015, TRAJECTORY DIS UNPUB; Haller C. S., 2016, SWISS ARCH NEUROLOGY; Hampson SE, 2016, PSYCHOL HEALTH MED, V21, P152, DOI 10.1080/13548506.2015.1061676; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hayes N, 2003, PERS INDIV DIFFER, V34, P723, DOI 10.1016/S0191-8869(02)00057-0; Hill A, 2007, DATA ANAL USING REGR; Hills P, 2001, PERS INDIV DIFFER, V30, P595, DOI 10.1016/S0191-8869(00)00058-1; Hills P, 2001, PERS INDIV DIFFER, V31, P1357, DOI 10.1016/S0191-8869(00)00229-4; Klimstra TA, 2013, J YOUTH ADOLESCENCE, V42, P1661, DOI 10.1007/s10964-012-9862-8; Klonoff PS, 2014, PSYCHOTHERAPY FAMILI, P179; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lamers SMA, 2012, J RES PERS, V46, P517, DOI 10.1016/j.jrp.2012.05.012; Laursen B, 2014, J PERS DISORD, V28, P143, DOI 10.1521/pedi.2014.28.1.143; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Lopes PN, 2003, PERS INDIV DIFFER, V35, P641, DOI 10.1016/S0191-8869(02)00242-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAdams DP., 2015, ART SCI PERSONALITY; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; Mroczek D. K., 2014, HDB PERSONALITY DEV; Mund M, 2014, J PERS SOC PSYCHOL, V107, P352, DOI 10.1037/a0036719; Neyer FJ, 2014, J PERS, V82, P539, DOI 10.1111/jopy.12063; Olsen SO, 2015, SCAND J PSYCHOL, V56, P397, DOI 10.1111/sjop.12220; Ostendorf F., 1993, NEO FUNF FAKTOREN IN; Park J, 2013, J HEALTH PSYCHOL, V18, P226, DOI 10.1177/1359105312439731; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Poppe C, 2012, QUAL LIFE RES, V21, P1337, DOI 10.1007/s11136-011-0048-8; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sebo P, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14072; Skinner E, 2013, EDUC PSYCHOL MEAS, V73, P803, DOI 10.1177/0013164413485241; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Talbot LR, 2014, J MULTIDISCIP HEALTH, V7, P313, DOI 10.2147/JMDH.S64897; Terracciano A, 2014, ALZHEIMERS DEMENT, V10, P179, DOI 10.1016/j.jalz.2013.03.002; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.12149; van Straten A, 2007, QUAL LIFE RES, V16, P1, DOI 10.1007/s11136-006-9124-x; Vollrath ME, 2010, PERS RELATIONSHIP, V17, P27, DOI 10.1111/j.1475-6811.2010.01250.x; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE., 2002, SF 12V2 SCORE VERSIO; White JK, 2004, PERS INDIV DIFFER, V37, P1519, DOI 10.1016/j.paid.2004.02.019; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson J. P., 2013, POSTTRAUMATIC SELF R; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	63	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3506	1467-6494		J PERS	J. Pers.	AUG	2017	85	4					481	493		10.1111/jopy.12254			13	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	FC5HS	WOS:000406873100004	27012583				2022-02-06	
J	Heick, JD; Bay, C; Dompier, TP; McLeod, TCV				Heick, John D.; Bay, Curt; Dompier, Thomas P.; McLeod, Tamara C. Valovich			RELATIONSHIPS AMONG COMMON VISION AND VESTIBULAR TESTS IN HEALTHY RECREATIONAL ATHLETES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Dynamic visual acuity; saccades; vestibulo-ocular reflex	DYNAMIC VISUAL-ACUITY; SENSORY ORGANIZATION TEST; COLLEGIATE FOOTBALL PLAYERS; KING-DEVICK TEST; QUALITY-OF-LIFE; DIZZINESS CHARACTERISTICS; POSTURAL STABILITY; BALANCE DISORDERS; NCAA CONCUSSION; INJURY PATIENTS	Background: Disruption of the visual and vestibular systems is commonly observed following concussion. Researchers have explored the utility of screening tools to identify deficits in these systems in concussed patients, but it is unclear if these tests are measuring similar or distinct phenomena. Purpose: To determine the relationships between common vestibular tests including the King-Devick (K-D) test, Sensory Organization Test (SOT), Head Shake-Sensory Organization Test (HS-SOT), and Dynamic Visual Acuity (DVA) test, when administered contiguously, to healthy recreational athletes aged 14 to 24 years. Study Design: This study used a prospective design to evaluate relationships between the K-D, SOT, HS-SOT, and DVA tests in 60 healthy individuals. Methods: Sixty participants (30 males, 30 females; mean age, 19.9 +/- 3.74 years) completed the four tests in a single testing session. Results: Results did not support a relationship between any pair of the K-D, SOT, HS-SOT, and DVA tests. Pearson correlations between tests were poor, ranging from 0.14 to 0.20. As expected the relationship between condition 2 of the SOT and HS-SOT fixed was strong (ICC = 0.81) as well as condition 5 of the SOT with HS-SOT sway (ICC = 0.78). The test-retest reliability of all 4 tests was evaluated to ensure the relationships of the 4 tests were consistent between test trials and reliability was excellent with intraclass correlations ranging from 0.79 to 0.97. Conclusions: The lack of relationships in these tests is clinically important because it suggests that the tests evaluate different aspects of visual and vestibular function. Further, these results suggest that a comprehensive assessment of visual and vestibular deficits following concussion may require a multifaceted approach.	[Heick, John D.] No Arizona Univ, Flagstaff, AZ USA; [Bay, Curt; McLeod, Tamara C. Valovich] AT Still Univ, Mesa, AZ USA; [Dompier, Thomas P.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA		Heick, JD (corresponding author), No Arizona Univ, Phys Therapy, POB 15105, Flagstaff, AZ 86011 USA.	John.Heick@nau.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Asken BM, 2016, ATHL TRAIN SPORTS HL, V8, P145; Braun PA, 2013, ATHL TRAIN SPORTS HL, V6, P282; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Christy JB, 2014, PEDIATR PHYS THER, V26, P180, DOI 10.1097/PEP.0000000000000039; Clark S, 2008, J ORTHOP SPORT PHYS, V38, P262, DOI 10.2519/jospt.2008.2406; DEMER JL, 1994, AM J OTOL, V15, P340; Dickin DC, 2010, CLIN J SPORT MED, V20, P278, DOI 10.1097/JSM.0b013e3181e8f8b1; Evans MK, 1999, OTOLARYNG HEAD NECK, V120, P164, DOI 10.1016/S0194-5998(99)70401-8; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gloor-Juzi T, 2012, BMC EAR NOSE THROAT, V12, DOI 10.1186/1472-6815-12-7; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; HERDMAN SJ, 1990, PHYS THER, V70, P381, DOI 10.1093/ptj/70.6.381; Herdman SJ, 1998, AM J OTOL, V19, P790; Hirsch MA, 2003, ARCH PHYS MED REHAB, V84, P1109, DOI 10.1016/S0003-9993(03)00046-7; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Honaker JA, 2011, J VESTIBUL RES-EQUIL, V21, P267, DOI 10.3233/VES-2011-0427; Honaker JA, 2009, AM J AUDIOL, V18, P108, DOI 10.1044/1059-0889(2009/09-0012); Honrubia V, 1996, AM J OTOL, V17, P595; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; Mishra A, 2009, AM J AUDIOL, V18, P53, DOI 10.1044/1059-0889(2009/06-0024); NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; O'Neill DE, 1998, AM J OTOL, V19, P797; Pang MYC, 2011, PHYS THER, V91, P246, DOI 10.2522/ptj.20100221; Park MK, 2012, OTOL NEUROTOL, V33, P67, DOI 10.1097/MAO.0b013e318238f75f; Perez N, 2001, ACTA OTO-LARYNGOL, P145; Peters BT, 2012, J VESTIBUL RES-EQUIL, V22, P145, DOI 10.3233/VES-2012-0440; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rine RM, 2012, J REHABIL RES DEV, V49, P209, DOI 10.1682/JRRD.2010.12.0239; Roma Anita Alonte, 2005, J Geriatr Phys Ther, V28, P58; Schubert MC, 2006, JARO-J ASSOC RES OTO, V7, P329, DOI 10.1007/s10162-006-0047-6; Sinaki M, 2002, AM J PHYS MED REHAB, V81, P241, DOI 10.1097/00002060-200204000-00001; Tian JR, 2001, ANN NY ACAD SCI, V942, P501; Tian JR, 2001, EXP BRAIN RES, V137, P309, DOI 10.1007/s002210000671; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Tsang WW, 2004, ARCH PHYS MED REHAB, V85, P129, DOI 10.1016/j.apmr.2003.02.002; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vital D, 2010, ARCH OTOLARYNGOL, V136, P686, DOI 10.1001/archoto.2010.99; Ward BK, 2010, J VESTIBUL RES-EQUIL, V20, P363, DOI 10.3233/VES-2010-0371; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	52	9	10	0	1	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	AUG	2017	12	4					581	591					11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FG9AF	WOS:000410729800009	28900564				2022-02-06	
J	Jackson, TL; Braun, JM; Mello, M; Triche, EW; Buka, SL				Jackson, Tracy L.; Braun, Joseph M.; Mello, Michael; Triche, Elizabeth W.; Buka, Stephen L.			The relationship between early childhood head injury and later life criminal behaviour: a longitudinal cohort study	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; PREVALENCE; CHILDREN; METAANALYSIS; POPULATION; DISORDERS; ADOLESCENCE; PREDICTORS; OFFENDERS; ADULTHOOD	Background Childhood head injury has been associated with the development of behavioural and psychological problems. This study examined the relationship between head injury in young childhood and subsequent criminal behaviour. Methods Data were from the Providence cohort of the Collaborative Perinatal Project, a multicentre longitudinal study aimed at identifying the role of perinatal and prenatal factors on child health. History of head injury between ages 0 and 7 years was ascertained from health records of 2893 children. In total, 120 (4%) of children had a head injury. Propensity score matching was used to match each head injury case to five controls. Negative binomial regression was used to estimate the relationship between head injury and number of arrests, and log binomial regression was used to estimate risk of conduct problems. Results Those who suffered any head injury from ages 0 to 7 years had approximately 1.5 times the rate of arrests and risk of conduct problems compared with uninjured controls, though results did not meet the p<0.05 threshold for statistical significance. Severe head injury was associated with a twofold increased rate of juvenile arrests (incident rate ratio=2.44, 95% CI 0.93 to 6.46) and risk of conduct problems (risk ratio=2.47, 95% CI 0.90 to 6.74) that approached statistical significance. Conclusions Head injury in childhood was associated with increased criminality and conduct problems. Future work should identify mechanisms of this association in order to develop interventions to prevent criminal behaviour resulting from head injury.	[Jackson, Tracy L.; Braun, Joseph M.; Triche, Elizabeth W.; Buka, Stephen L.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02919 USA; [Mello, Michael] Rhode Isl Hosp, Injury Prevent Ctr, Providence, RI USA; [Mello, Michael] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02919 USA; [Triche, Elizabeth W.] Yale Univ, New Haven, CT USA		Jackson, TL (corresponding author), Brown Univ, Dept Epidemiol, 121 South Main St, Providence, RI 02919 USA.	Tracy_Jackson@alumni.brown.edu	Braun, Joseph/H-8649-2014; Buka, Stephen/H-7335-2014	Buka, Stephen/0000-0002-8578-9308			Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Carswell K, 2004, J ADOLESCENCE, V27, P415, DOI 10.1016/j.adolescence.2004.04.003; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Centers for Disease Control and Prevention, 2014, INJ PREV CONTR TRAUM; Donatelli JAL, 2010, AM J PSYCHIAT, V167, P1331, DOI 10.1176/appi.ajp.2010.09020241; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Forrest CB, 2000, PEDIATRICS, V105, P286; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Hulbert E, 2014, SAS MACRO EVALUATE B; Hux D, 1998, BRAIN INJURY, V12, P667; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Klebanoff MA, 2009, PAEDIATR PERINAT EP, V23, P2, DOI 10.1111/j.1365-3016.2008.00984.x; Kosanke J, GMATCH MAYO CLIN; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEWIS DO, 1979, AM J PSYCHIAT, V136, P231; Max JE, J NERV MENT DIS; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, CHILD CARE HLTH DEV; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Paradis AD, 2011, J EPIDEMIOL COMMUN H, V65, P1145, DOI 10.1136/jech.2009.095802; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Scherf KS, 2012, DEV COGN NEUROS-NETH, V2, P199, DOI 10.1016/j.dcn.2011.07.016; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shenassa ED, 2012, ADDICTION, V107, P160, DOI 10.1111/j.1360-0443.2011.03571.x; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wilde EA, 2012, NEUROREHABILITATION, V31, P245, DOI 10.3233/NRE-2012-0794; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	35	9	9	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	AUG	2017	71	8					800	805		10.1136/jech-2016-208582			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FA5HC	WOS:000405472700012	28663442				2022-02-06	
J	Khan, M; O'Keeffe, T; Jehan, F; Kulvatunyou, N; Kattaa, A; Gries, L; Tang, A; Joseph, B				Khan, Muhammad; O'Keeffe, Terence; Jehan, Faisal; Kulvatunyou, Narong; Kattaa, Abdullah; Gries, Lynn; Tang, Andrew; Joseph, Bellal			The impact of Glasgow Coma Scale-age prognosis score on geriatric traumatic brain injury outcomes	JOURNAL OF SURGICAL RESEARCH			English	Article						TBI; Prognostic model; Geriatric population; Outcomes	FUNCTIONAL STATUS EXAMINATION; HEAD-INJURY; SEVERITY SCORE; DISABILITY; DISCHARGE; PATIENT	Background: As the population ages, increasing number of geriatric patients sustain traumatic brain injury (TBI). Communication of accurate prognostic information is crucial for making informed decisions on behalf of such patients. Therefore, the aim of our study was to develop a simple and clinically applicable tool that accurately predicts the prognosis in geriatric TBI patients. Methods: We performed a 1-y (2011) retrospective analysis of isolated geriatric TBI patients (age >= 65 y, head abbreviated injury score [AIS] >= 3, and other body AIS < 3) in the National Trauma Data Bank. We calculated a Glasgow Coma Scale (GCS)-age prognosis (GAP) score (age/GCS score) for all patients. Outcome measures were in-hospital adverse outcomes (mortality and Rehab/skilled nursing facility discharge disposition). Regression analysis and receiver operator characteristic curve analysis were performed to determine the discriminatory power of GAP score. Results: A total of 8750 geriatric patients with TBI were included. Mean age was 77.8 +/- 7.1 y, the median (interquartile range) GCS was 15 (13-15), and the median (interquartile range) head AIS was 4 (3-4). The overall in-hospital mortality rate was 12.7%, and 34.2% of the patients were discharged home. As the GAP score increased, the mortality rate increased and discharge to-home decreased. Receiver operator characteristic curve analysis revealed excellent discriminatory power for mortality (area under the curve: 0.826). Above a GAP score of 12, the mortality rate was >50% and more than 45% of the patients were discharged to Rehab/skilled nursing facility. Conclusions: For geriatric patients with TBI, a simple GAP score reliably predicts outcomes. A score above 12 results in a drastic increase in mortality and an adverse discharge disposition. This simple tool may help clinicians provide accurate prognostic information to patients' families. (C) 2017 Elsevier Inc. All rights reserved.	[Khan, Muhammad; O'Keeffe, Terence; Jehan, Faisal; Kulvatunyou, Narong; Kattaa, Abdullah; Gries, Lynn; Tang, Andrew; Joseph, Bellal] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Khan, Muhammad/0000-0001-5660-8582			BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; Colby S.L., 2015, PROJECTIONS SIZE COM; Control CfD, 2010, CONTR CFD PREV INJ P; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Ditillo M, 2014, J TRAUMA ACUTE CARE, V76, P176, DOI 10.1097/TA.0b013e3182ab0d7c; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, P66; TEASDALE G, 1974, LANCET, V2, P81; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43	24	9	9	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	AUG	2017	216						109	114		10.1016/j.jss.2017.04.026			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FE2JK	WOS:000408042400015	28807194				2022-02-06	
J	Kobata, H				Kobata, Hitoshi			Diagnosis and Treatment of Traumatic Cerebrovascular Injury: Pitfalls in the Management of Neurotrauma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						neurotrauma; traumatic brain injury; traumatic cerebrovascular injury; microneurosurgery; emergency medicine	CAROTID ARTERIAL INJURIES; SEVERE HEAD-INJURY; BLUNT; EMBOLIZATION; ASSOCIATION; HEMORRHAGE; GUIDELINES; ANEURYSM; STROKE	Traumatic cerebrovascular injury (TCVI) is an uncommon clinical entity in traumatic brain injury (TBI), yet it may cause devastating brain injury with high morbidity and mortality. Early recognition and prioritized strategic treatment are of paramount importance. A total of 1966 TBI patients admitted between 1999 and 2015 in our tertiary critical care center were reviewed. Screening of TCVI was based on the Guidelines for the Management of Severe Head Injury in Japan. TCVI was confirmed in 33 (1.7%) patients; 29 blunt and 4 penetrating injuries. The primary location of the injury included 16 cervical, 6 craniofacial, and 11 intracranial lesions. On arrival, 15 patients presented with hemorrhage, 5 of these arrived in shock status with massive hemorrhage. Ten presented with ischemic symptoms. Sixteen patients underwent surgical or endovascular intervention, 13 of whom required immediate treatment upon arrival. Surgical procedures included clipping or trapping for traumatic aneurysms, superficial temporal artery - middle cerebral artery bypass, carotid endarterectomy, and direct suture of the injured vessels. Endovascular intervention was undertaken in 7 patients; embolization with Gelfoam (Pharmacia and Upjohn Company, Kalamazoo, MI, USA) or coil for 6 hemorrhagic lesions and stent placement for 1 lesion causing ischemia. Patients' outcome assessed by the Glasgow Outcome Scale at 3 months were good recovery in 8, moderate disability in 3, severe disability in 9, persistent vegetative state in 1, and death in 12, respectively. In order to rescue potentially salvageable TCVI patients, neurosurgeons in charge should be aware of TCVI and master basic skills of cerebrovascular surgical and endovascular procedures to utilize in an emergency setting.	[Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Dept Neurosurg, 11-1 Minamiakutagawa Cho, Takatsuki, Osaka 5691124, Japan		Kobata, H (corresponding author), Osaka Mishima Emergency Crit Care Ctr, Dept Neurosurg, 11-1 Minamiakutagawa Cho, Takatsuki, Osaka 5691124, Japan.	neu035@osaka-med.ac.jp					[Anonymous], 2013, GUID MAN SEV HEAD IN; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Bynoe RP, 2003, J TRAUMA, V55, P74, DOI 10.1097/01.TA.0000026494.22774.A0; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Fleck SK, 2011, NEUROSURGERY, V69, P615, DOI 10.1227/NEU.0b013e31821a8701; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; Griessenauer CJ, 2013, J NEUROSURG, V118, P397, DOI 10.3171/2012.11.JNS121038; Inoue T, 2005, SURG NEUROL, V64, P450, DOI 10.1016/j.surneu.2004.12.023; Kansagra AP, 2014, J NEUROINTERV SURG, V6, P47, DOI 10.1136/neurintsurg-2012-010605; Komiyama M, 2001, NEUROL MED-CHIR, V41, P264, DOI 10.2176/nmc.41.264; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Onda H, 2013, NEUROL MED-CHIR, V53, P573; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1	17	9	9	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	AUG	2017	57	8					410	417		10.2176/nmc.oa.2017-0056			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FG2OC	WOS:000409948800005	28674346	Green Published, gold			2022-02-06	
J	Meidahl, AC; Klukinov, M; Tzabazis, AZ; Sorensen, JC; Yeomans, DC				Meidahl, A. C.; Klukinov, M.; Tzabazis, A. Z.; Sorensen, J. C.; Yeomans, D. C.			Nasal application of HSV encoding human preproenkephalin blocks craniofacial pain in a rat model of traumatic brain injury	GENE THERAPY			English	Article							INTRANASAL DELIVERY; GENE-THERAPY; VECTOR; DAMAGE	According to Centers for Disease Control and Prevention, each year, an estimated 1.7 million Americans sustain a traumatic brain injury (TBI), which frequently leads to chronic craniofacial pain. In this study we examine a gene therapy approach to the treatment of post-TBI craniofacial neuropathic pain using nasal application of a herpes simplex virus (HSV)-based vector expressing human proenkephalin (SHPE) to target the trigeminal ganglia. Mild TBI was induced in rats by the use of a modified fluid percussion model. Two days after mild TBI, following the development of facial mechanical allodynia, animals received either an intranasal application of vehicle or recombinant HSV encoding human preproenkephalin or lacZ reporter gene encoding control vector (SHZ.1). Compared with baseline response thresholds, mild TBI in SHZ.1 or vehicle-treated animals induced a robust craniofacial allodynia lasting at least 45 days. On the other hand, nasal SHPE application 2 days post-TBI attenuated facial allodynia, reaching significance by day 4-7 and maintaining this effect throughout the duration of the experiment. Immunohistochemical examination revealed strong expression of human proenkephalin in trigeminal ganglia of SHPE, but not SHZ.1-treated rats. This study demonstrates that intranasal administration of HSV-based gene vectors may be a viable, non-invasive means of treating chronic craniofacial pain, including post-TBI pain.	[Meidahl, A. C.; Klukinov, M.; Tzabazis, A. Z.; Yeomans, D. C.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA; [Meidahl, A. C.; Sorensen, J. C.] Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark		Yeomans, DC (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	dcyeomans@stanford.edu		Meidahl, Anders Christian/0000-0002-8404-4742	The Danish Cancer SocietyDanish Cancer Society [R101-A6745] Funding Source: researchfish		Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Braz J, 2001, J NEUROSCI, V21, P7881, DOI 10.1523/JNEUROSCI.21-20-07881.2001; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Erickson Jay C, 2010, Continuum (Minneap Minn), V16, P55, DOI 10.1212/01.CON.0000391453.37923.83; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fink DJ, 2011, ANN NEUROL, V70, P207, DOI 10.1002/ana.22446; Goss JR, 2002, ANN NEUROL, V52, P662, DOI 10.1002/ana.10343; Guedon JMG, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0018-1; Harrow S, 2004, GENE THER, V11, P1648, DOI 10.1038/sj.gt.3302289; Jiang Y, 2012, NEUROSCIENCE, V201, P96, DOI 10.1016/j.neuroscience.2011.10.043; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Lu Y, 2007, MOL THER, V15, P1812, DOI 10.1038/sj.mt.6300228; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Todo T, 2008, FRONT BIOSCI-LANDMRK, V13, P2060, DOI 10.2741/2823; Tralongo P, 2004, ANN ONCOL, V15, P987, DOI 10.1093/annonc/mdh223; Tzabazis AZ, 2014, GENE THER, V21, P422, DOI 10.1038/gt.2014.14; Veening JG, 2013, NEUROSCI BIOBEHAV R, V37, P1445, DOI 10.1016/j.neubiorev.2013.04.012; Wang Q, 1997, GENE THER, V4, P1300, DOI 10.1038/sj.gt.3300535; Wilson SP, 1999, P NATL ACAD SCI USA, V96, P3211, DOI 10.1073/pnas.96.6.3211; Wolfe D, 2012, NEUROSCI LETT, V527, P85, DOI 10.1016/j.neulet.2012.04.047; Yeomans DC, 2009, GENE THER, V16, P502, DOI 10.1038/gt.2009.25; Yeomans DC, 2006, MOL THER, V13, P589, DOI 10.1016/j.ymthe.2005.08.023	27	9	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	AUG	2017	24	8					482	486		10.1038/gt.2017.55			5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FD8TB	WOS:000407795900005	28682314	Bronze			2022-02-06	
J	Price, E; Moore, G; Galway, L; Linden, M				Price, Edward; Moore, George; Galway, Leo; Linden, Mark			Validation of a Smartphone-Based Approach to In Situ Cognitive Fatigue Assessment	JMIR MHEALTH AND UHEALTH			English	Article						mental fatigue; fatigue; acquired brain injury; cognitive tests; assistive technology; smartphone	TRAUMATIC BRAIN-INJURY; MENTAL FATIGUE; SEVERITY SCALE; UNITED-STATES; HEAD-INJURY; RELIABILITY; QUESTIONNAIRE; SYMPTOMS; VALIDITY; MILD	Background: Acquired Brain Injuries (ABIs) can result in multiple detrimental cognitive effects, such as reduced memory capability, concentration, and planning. These effects can lead to cognitive fatigue, which can exacerbate the symptoms of ABIs and hinder management and recovery. Assessing cognitive fatigue is difficult due to the largely subjective nature of the condition and existing assessment approaches. Traditional methods of assessment use self-assessment questionnaires delivered in a medical setting, but recent work has attempted to employ more objective cognitive tests as a way of evaluating cognitive fatigue. However, these tests are still predominantly delivered within a medical environment, limiting their utility and efficacy. Objective: The aim of this research was to investigate how cognitive fatigue can be accurately assessed in situ, during the quotidian activities of life. It was hypothesized that this assessment could be achieved through the use of mobile assistive technology to assess working memory, sustained attention, information processing speed, reaction time, and cognitive throughput. Methods: The study used a bespoke smartphone app to track daily cognitive performance, in order to assess potential levels of cognitive fatigue. Twenty-one participants with no prior reported brain injuries took place in a two-week study, resulting in 81 individual testing instances being collected. The smartphone app delivered three cognitive tests on a daily basis: (1) Spatial Span to measure visuospatial working memory; (2) Psychomotor Vigilance Task (PVT) to measure sustained attention, information processing speed, and reaction time; and (3) a Mental Arithmetic Test to measure cognitive throughput. A smartphone-optimized version of the Mental Fatigue Scale (MFS) self-assessment questionnaire was used as a baseline to assess the validity of the three cognitive tests, as the questionnaire has already been validated in multiple peer-reviewed studies. Results: The most highly correlated results were from the PVT, which showed a positive correlation with those from the prevalidated MFS, measuring 0.342 (P<.008). Scores from the cognitive tests were entered into a regression model and showed that only reaction time in the PVT was a significant predictor of fatigue (P=.016, F=2.682, 95% CI 9.0-84.2). Higher scores on the MFS were related to increases in reaction time during our mobile variant of the PVT. Conclusions: The results show that the PVT mobile cognitive test developed for this study could be used as a valid and reliable method for measuring cognitive fatigue in situ. This test would remove the subjectivity associated with established self-assessment approaches and the need for assessments to be performed in a medical setting. Based on our findings, future work could explore delivering a small set of tests with increased duration to further improve measurement reliability. Moreover, as the smartphone assessment tool can be used as part of everyday life, additional sources of data relating to physiological, psychological, and environmental context could be included within the analysis to improve the nature and precision of the assessment process.	[Price, Edward; Moore, George; Galway, Leo] Ulster Univ, Comp Sci Res Inst, Sch Comp, Jordanstown Campus,Shore Rd, Newtownabbey BT37 0QB, North Ireland; [Linden, Mark] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland		Moore, G (corresponding author), Ulster Univ, Comp Sci Res Inst, Sch Comp, Jordanstown Campus,Shore Rd, Newtownabbey BT37 0QB, North Ireland.	g.moore@ulster.ac.uk	Linden, Mark/L-7754-2019	Linden, Mark/0000-0002-3832-4102; Moore, George/0000-0003-1623-0014	Department of Learning and Employment, Northern Ireland; Smart Environments Research Group, within the Computer Science Research Institute, Ulster University	This research was funded and supported by the Department of Learning and Employment, Northern Ireland. This publication was supported by the Smart Environments Research Group, within the Computer Science Research Institute, Ulster University.	Brooke J., 1996, USABILITY EVALUATION; Drummond SPA, 2005, SLEEP, V28, P1059; Engstrom ALL, 2010, SCAND J OCCUP THER, V17, P233, DOI [10.1080/11038120903191806, 10.3109/11038120903191806]; Ferguson SA, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020171; Gartenberg D, 2012, ADV COGNITIVE ENG NE; Grant DA, 2017, BEHAV RES METHODS, V49, P1020, DOI 10.3758/s13428-016-0763-8; Herlofson K, 2002, EUR J NEUROL, V9, P595, DOI 10.1046/j.1468-1331.2002.00444.x; Johansson B, 2012, BRAIN INJURY FUNCTIO; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kay M, 2013, INT CONF PER COMP, P248, DOI 10.4108/icst.pervasivehealth.2013.252078; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; Reitan R, 1985, HALSTEAD REITAN NEUR; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Shahid A, 2011, STOP 100 OTHER SLEEP, P399, DOI [10.1007/978-1-4419-9893-4_100, DOI 10.1007/978-1-4419-9893-4_100]; Swendeman D, 2015, AIDS BEHAV, V19, P330, DOI 10.1007/s10461-014-0923-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomson AJ, 2009, ANAESTHESIA, V64, P32, DOI 10.1111/j.1365-2044.2008.05683.x; THORNE DR, 1985, NEUROBEH TOXICOL TER, V7, P415; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timmers C, 2014, APPL NEUROPSYCH-ADUL, V21, P136, DOI 10.1080/09084282.2013.778261; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler D., 2008, WECHSLER ADULT INTEL	30	9	9	0	9	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	AUG	2017	5	8							e125	10.2196/mhealth.6333			13	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	FG3HJ	WOS:000410033700003	28818818	gold, Green Published, Green Submitted			2022-02-06	
J	Scheenen, ME; Visser-Keizer, AC; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; Visser-Keizer, Annemarie C.; van der Naalt, Joukje; Spikman, Jacoba M.			Description of an early cognitive behavioral intervention (UPFRONT-intervention) following mild traumatic brain injury to prevent persistent complaints and facilitate return to work	CLINICAL REHABILITATION			English	Article						Intervention; cognitive behavioral therapy; mild traumatic brain injury; coping; return to work	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; POSTTRAUMATIC COMPLAINTS; POSTCONCUSSION SYNDROME; EARLY PREDICTORS; THERAPY; TRIAL; PSYCHOGENESIS; PHYSIOGENESIS; FATIGUE	Purpose: Many patients with mild traumatic brain injury do not fully return to work owing to persistent posttraumatic complaints. Research suggests that preventing chronic complaints might be prevented by giving cognitive behavioral therapy early after injury. Therefore, a new cognitive behavioral intervention (UPFRONT-intervention) was developed to not only prevent chronic complaints but to also establish a more successful return to work. The intervention is currently being evaluated in a multicenter randomized controlled trial design (trial number ISRCTN86191894) in mild traumatic brain injury patients who are at-risk of negative outcomes (patients with high numbers of early complaints). Two case examples are presented to demonstrate the application of the intervention. Rationale: Psychological factors, like cognitive appraisal and coping, play an important role in the persistence of posttraumatic complaints. Some patients are less able to adapt and thus to cope with the injury and its initial consequences than others. Dealing with the injury in a passive, avoidant way, focusing on negative feelings, will hamper recovery and is therefore a valuable target for an intervention. Theory into practice: The UPFRONT intervention is a short cognitive behavioral therapy intervention for patients that are at-risk of developing persistent posttraumatic complaints. Patients will undergo five sessions of cognitive behavioral therapy within 4-10 weeks after trauma. The intervention aims to enhance patients' feeling of competency of dealing with the consequences of mild traumatic brain injury by providing psycho-education, identifying and challenging unrealistic illness perceptions and improving coping style (decreasing maladaptive coping and enhancing adaptive coping).	[Scheenen, Myrthe E.; Visser-Keizer, Annemarie C.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Spikman, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.m.spikman@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation (Hersenstichting Nederland) [Ps2012-06]; Dutch Brain Foundation	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study is funded by the Dutch Brain Foundation (Hersenstichting Nederland, Grant number Ps2012-06). The Dutch Brain Foundation is a charitable foundation that supports projects that promote recovery and quality of life of traumatic brain injury patients in the Netherlands. The funders did not peer review the study, had no role in study design, data collection, decision to publish or preparation of the manuscript.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen E, 2003, INT J EAT DISORDER, V33, P241, DOI 10.1002/eat.10137; Dawson DR, 2006, BRAIN COGNITION, V60, P214; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vereniging voor Gedragstherapie en Cognitieve Therapie, REG COGN GEDR VGCT S; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Zedlitz AMEE, 2011, CLIN REHABIL, V25, P487, DOI 10.1177/0269215510391285; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117	37	9	9	0	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	AUG	2017	31	8					1019	1029		10.1177/0269215516687101			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FB3RS	WOS:000406061000004	28114812	Green Published			2022-02-06	
J	Steenerson, K; Starling, AJ				Steenerson, Kristen; Starling, Amaal Jilani			Pathophysiology of Sports-Related Concussion	NEUROLOGIC CLINICS			English	Article						Concussion; Traumatic brain injury; TBI; Trauma	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; AXONAL INJURY; MICE; RECOVERY; ALPHA	Concussion pathophysiology is complicated and involves numerous mechanisms, including excessive neurotransmitter release, metabolic derangements, neuroinflammation, cerebral blood flow changes, and axonal disruption. The initial biomechanical impact in a concussion results in abnormal function at the cellular level, which initiates a cascade of events that leads to microstructural changes and, in the minority of cases, more persistent, permanent damage.	[Steenerson, Kristen] Barrow Neurol Inst, Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA; [Starling, Amaal Jilani] Mayo Clin, Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA		Starling, AJ (corresponding author), Mayo Clin, Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	starling.amaal@mayo.edu			Eneura; AmgenAmgen; LillyEli Lilly	Dr A.J. Starling has received consulting fees from Eneura, Amgen, and Lilly.	Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GOODMAN JC, 1994, SEMIN NEUROL, V14, P19, DOI 10.1055/s-2008-1041054; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HOVDA DA, 1990, ACT NEUR S, V51, P331; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 1999, J NEUROSCI, V19, P4263; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	31	9	9	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					403	+		10.1016/j.ncl.2017.03.011			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OI	WOS:000406819500003	28673406				2022-02-06	
J	Tremblay, S; Iturria-Medina, Y; Mateos-Perez, JM; Evans, AC; De Beaumont, L				Tremblay, Sebastien; Iturria-Medina, Yasser; Mateos-Perez, Jose Maria; Evans, Alan C.; De Beaumont, Louis			Defining a multimodal signature of remote sports concussions	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						ageing; concussion; diagnosis; machine learning; neuroimaging	TRAUMATIC BRAIN-INJURY; DIFFUSION-WEIGHTED MRI; INTERNATIONAL-CONFERENCE; FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; DEPRESSIVE SYMPTOMS; CONSENSUS STATEMENT; COGNITIVE DECLINE; OLDER-ADULTS; NETWORK	Sports-related concussions lead to persistent anomalies of the brain structure and function that interact with the effects of normal ageing. Although post-mortem investigations have proposed a bio-signature of remote concussions, there is still no clear invivo signature. In the current study, we characterized white matter integrity in retired athletes with a history of remote concussions by conducting a full-brain, diffusion-based connectivity analysis. Next, we combined MRI diffusion markers with MR spectroscopic, MRI volumetric, neurobehavioral and genetic markers to identify a multidimensional invivo signature of remote concussions. Machine learning classifiers trained to detect remote concussions using this signature achieved detection accuracies up to 90% (sensitivity: 93%, specificity: 87%). These automated classifiers identified white matter integrity as the hallmark of remote concussions and could provide, following further validation, a preliminary unbiased detection tool to help medical and legal experts rule out concussion history in patients presenting or complaining about late-life abnormal cognitive decline.	[Tremblay, Sebastien; Iturria-Medina, Yasser; Mateos-Perez, Jose Maria; Evans, Alan C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Iturria-Medina, Yasser; Mateos-Perez, Jose Maria; Evans, Alan C.] McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada; [De Beaumont, Louis] Hop Sacre Coeur Montreal, Ctr Rech, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ H3C 3J7, Canada		De Beaumont, L (corresponding author), Univ Montreal, Dept Surg, Montreal, PQ H3C 3J7, Canada.	louis.de.beaumont@umontreal.ca	Evans, Alan C/B-2373-2013	Evans, Alan C/0000-0003-3841-6098; Tremblay, Sebastien/0000-0001-6251-9797; Iturria Medina, Yasser/0000-0002-9345-0347	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This work was supported by the Canadian Institutes of Health Research (CIHR).	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; [Anonymous], 2000, OB PREV MAN GLOB EP, DOI DOI 10.1007/978-0-387-71799-9_454; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Belson K., 2013, NY TIMES; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2014, HUM BRAIN MAPP, V35, P4944, DOI 10.1002/hbm.22524; CDC, 2015, BEH RISK FACT SURV S; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Duering M, 2012, NEUROLOGY, V79, P2025, DOI 10.1212/WNL.0b013e3182749f39; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Focke NK, 2011, HUM BRAIN MAPP, V32, P1905, DOI 10.1002/hbm.21161; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hastie T, 2009, ELEMENTS STAT LEARNI; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Iturria-Medina Y, 2013, BRAIN CONNECT, V3, P1, DOI 10.1089/brain.2012.0122; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; NCYS, 2008, REP TRENDS PART ORG; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pievani M, 2014, NAT REV NEUROL, V10, P620, DOI 10.1038/nrneurol.2014.178; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Reitan R., 1985, HALSTEAD REITAN NEUR; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvatore C, 2014, J NEUROSCI METH, V222, P230, DOI 10.1016/j.jneumeth.2013.11.016; Schmidt M., 1996, REY AUDITORY VERBAL; Schwartzman A, 2008, ANN APPL STAT, V2, P153, DOI 10.1214/07-AOAS133; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith A., 1973, DIGIT SYMBOL MODALIT; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Taylor L B, 1969, Clin Neurosurg, V16, P269; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Waller, 1850, PHILOS T R SOC LOND, VI, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021]; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	88	9	9	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2017	46	4					1956	1967		10.1111/ejn.13583			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FD6LC	WOS:000407639000003	28512863	Bronze			2022-02-06	
J	Xie, JF; Fan, K; Wang, C; Xie, P; Hou, M; Xin, L; Cui, GF; Wang, LX; Shao, YF; Hou, YP				Xie, Jun-Fan; Fan, Kun; Wang, Can; Xie, Peng; Hou, Min; Xin, Le; Cui, Guang-Fu; Wang, Lin-Xin; Shao, Yu-Feng; Hou, Yi-Ping			Inactivation of the Tuberomammillary Nucleus by GABA(A) Receptor Agonist Promotes Slow Wave Sleep in Freely Moving Rats and Histamine-Treated Rats	NEUROCHEMICAL RESEARCH			English	Article						Histamine; GABA; Tuberomammillary nucleus; Sleep-wake states; EEG power spectral density	VENTROLATERAL PREOPTIC NUCLEUS; TRAUMATIC BRAIN-INJURY; KNOCK-OUT MICE; H-3 RECEPTOR; HYPOTHALAMIC NEURONS; GENERAL-ANESTHESIA; WAKING DISCHARGE; NERVOUS-SYSTEM; WAKEFULNESS; RELEASE	A prominent hypothesis, the "flip-flop switch" model, predicts that histaminergic (HAergic) neurons in the tuberomammillary nucleus (TMN), an important component of the ascending arousal system, are inactivated by GABA mainly from the ventrolateral preoptic nucleus to allow the appearance and maintenance of sleep. However, which sleep state and the band of EEG activity induced by GABAergic inactivation of the TMN are unclear. In this study, alterations of sleep-wake states and cortical EEG power spectral density were investigated following muscimol, a GABA(A)-receptor agonist, microinjected bilaterally into the TMN in freely moving rats and HA pretreated rats, respectively. Muscimol dosed at 0.25 and 0.50 mu g/side into the TMN during dark period dose-dependently increased slow wave sleep (SWS) accompanied by an increase in cortical EEG delta (0.5-4 Hz) and spindle (8.2-12 Hz) activities. In the meanwhile, wakefulness and EEG beta (12.2-30 Hz) activity were decreased significantly, while paradoxical sleep and EEG theta (4.2-8 Hz) activity were not changed. The increase of muscimol-induced SWS was because of prolonged SWS bout duration and not to an increased bout number. Muscimol (0.50 mu g/side) administration 2 h after HA (0.125 mu g/side) treatment during light period reversed the HA-induced wakefulness and EEG beta 2 (20.2-30 Hz) activity into SWS and EEG delta activity. These results demonstrate that the GABAergic inactivation of the TMN in freely moving rats and HA-treated rats promotes SWS and slow activity of cortical EEG, suggesting that the potential function of the GABA(A) receptor in the TMN is to dampen vigilant arousal.	[Xie, Jun-Fan; Fan, Kun; Wang, Can; Xie, Peng; Hou, Min; Xin, Le; Cui, Guang-Fu; Wang, Lin-Xin; Shao, Yu-Feng; Hou, Yi-Ping] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Dept Neurosci Anat Histol & Embryol, 199 Donggang Xi Rd, Lanzhou 730000, Gansu, Peoples R China; [Hou, Min] Gansu Univ Chinese Med, Sch Basic Med Sci, Dept Anat Histol & Embryol, 35 Dingxi Dong Rd, Lanzhou 730000, Gansu, Peoples R China		Shao, YF; Hou, YP (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Dept Neurosci Anat Histol & Embryol, 199 Donggang Xi Rd, Lanzhou 730000, Gansu, Peoples R China.	shaoyf@lzu.edu.cn; houyiping@lzu.edu.cn	Shao, Yu-Feng/AAF-4899-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670677, 81071076, 81171254, 81471347, 31500853]; Fundamental Research Funds for the Central University [lzujbky-2015-167, lzujbky-2015-277]	This work was supported by the National Natural Science Foundation of China (30670677, 81071076, 81171254 and 81471347 to YPH; 31500853 to YFS) and the Fundamental Research Funds for the Central University (lzujbky-2015-167 and lzujbky-2015-277 to YFS). The authors declare no conflicts of interest in this manuscript.	Anaclet C, 2012, J NEUROSCI, V32, P17970, DOI 10.1523/JNEUROSCI.0620-12.2012; Barbara A, 2002, BRAIN RES, V954, P247, DOI 10.1016/S0006-8993(02)03352-8; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Bonaventure P, 2007, BIOCHEM PHARMACOL, V73, P1084, DOI 10.1016/j.bcp.2006.10.031; Chotard C, 2002, J NEURAL TRANSM, V109, P293, DOI 10.1007/s007020200024; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Chouvet G, 1980, Waking Sleeping, V4, P9; Chu M, 2004, NEUROSCI RES, V49, P417, DOI 10.1016/j.neures.2004.05.001; Gradwohl G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125509; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hong ZY, 2005, J NEUROCHEM, V92, P1542, DOI 10.1111/j.1471-4159.2004.02991.x; Huang ZL, 2011, CURR TOP MED CHEM, V11, P1047, DOI 10.2174/156802611795347654; ITOWI N, 1991, PHYSIOL BEHAV, V49, P643, DOI 10.1016/0031-9384(91)90293-W; Korotkova TM, 2005, NEUROPHARMACOLOGY, V49, P129, DOI 10.1016/j.neuropharm.2005.03.001; Kukko-Lukjanov TK, 2003, J CHEM NEUROANAT, V25, P279, DOI 10.1016/S0891-0618(03)00043-7; Lee EY, 2017, BRAIN RES, V1657, P16, DOI 10.1016/j.brainres.2016.11.025; Leung LS, 2014, PROG NEUROBIOL, V122, P24, DOI 10.1016/j.pneurobio.2014.08.001; Lin JS, 1996, J NEUROSCI, V16, P1523; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Lu J, 2008, J COMP NEUROL, V508, P648, DOI 10.1002/cne.21685; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Oishi Y, 2008, P NATL ACAD SCI USA, V105, P19992, DOI 10.1073/pnas.0810926105; OkakuraMochizuki K, 1996, J NEUROCHEM, V67, P171; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; REINER PB, 1994, NEUROSCIENCE, V59, P579, DOI 10.1016/0306-4522(94)90178-3; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sakai K, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00053; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Selbach O, 1997, NEUROPHARMACOLOGY, V36, P1539, DOI 10.1016/S0028-3908(97)00144-5; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SoriaJasso LE, 1997, NEUROSCI LETT, V225, P117, DOI 10.1016/S0304-3940(97)00209-7; Steininger TL, 2001, J COMP NEUROL, V429, P638; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Williams RH, 2014, J NEUROSCI, V34, P6023, DOI 10.1523/JNEUROSCI.4838-13.2014; Xu CQ, 2004, J PHYSIOL-LONDON, V561, P657, DOI 10.1113/jphysiol.2004.071712; Yang QZ, 1997, BRAIN RES, V773, P162, DOI 10.1016/S0006-8993(97)00932-3; Yanovsky Y, 2012, PFLUG ARCH EUR J PHY, V463, P187, DOI 10.1007/s00424-011-0988-4; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009; Zhang X, 2009, NEURAL REGEN RES, V4, P53; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006	49	9	10	3	16	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2017	42	8					2314	2325		10.1007/s11064-017-2247-3			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FB6YI	WOS:000406287900018	28365867				2022-02-06	
J	Reis, M; Boisvert, I; Looi, V; da Cruz, M				Reis, Mariana; Boisvert, Isabelle; Looi, Valerie; da Cruz, Melville			Speech Recognition Outcomes After Cochlear Reimplantation Surgery	TRENDS IN HEARING			English	Article						cochlear implants; revision surgery; CI512; outcomes; reimplantation	TRAUMATIC BRAIN-INJURY; FACIAL-NERVE STIMULATION; OLDER-ADULTS; UNITED-STATES; IMPLANT FAILURES; DEVICE FAILURE; REVISION; PERFORMANCE; OTOSCLEROSIS; EXPERIENCE	This study compares speech recognition outcomes before and after cochlear reimplantation surgery, in relation to clinical factors known before and at time of surgery. Between 2006 and 2015, 2,055 adult cochlear implant surgeries were conducted at this center, of which 87 were reimplantation surgeries (4.2%). Speech recognition scores (SRS) assessed before and after reimplantation were available for 54 adults. Overall, SRS measured after reimplantation were similar to the best SRS obtained by the patient and greater than the last SRS measured before surgery. Additional complications were noted in the clinical files of all patients for which reimplantation was considered unsuccessful (16%).	[Reis, Mariana; Boisvert, Isabelle; Looi, Valerie; da Cruz, Melville] SCIC Cochlear Implant Program, Sydney, NSW, Australia; [Reis, Mariana; Boisvert, Isabelle] Macquarie Univ, Dept Linguist, Sydney, NSW, Australia; [Reis, Mariana; Boisvert, Isabelle] HEARing CRC, Melbourne, Vic, Australia; [da Cruz, Melville] Westmead Hosp, Sydney, NSW, Australia; [da Cruz, Melville] Univ Sydney, Sydney, NSW, Australia		Reis, M (corresponding author), SCIC Cochlear Implant Program, Sydney, NSW, Australia.	mariana.reis@mq.edu.au	Boisvert, Isabelle/AAB-8090-2021; Reis, Mariana/L-2594-2019	Boisvert, Isabelle/0000-0001-7050-3197; Reis, Mariana/0000-0003-3066-2331; looi, valerie/0000-0002-5898-6787	Australian Hearing Hub, an initiative of Macquarie University; Australian GovernmentAustralian GovernmentCGIAR	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Australian Hearing Hub, an initiative of Macquarie University and the Australian Government, provided financial support for the publication of this research article.	Alexiades G, 2001, LARYNGOSCOPE, V111, P1608, DOI 10.1097/00005537-200109000-00022; Battmer R, 2006, OTOL NEUROTOL, V27, P918, DOI 10.1097/01.mao.0000235374.85739.c6; Battmer RD, 2009, OTOL NEUROTOL, V30, P455, DOI 10.1097/MAO.0b013e31819e6206; Carlson Matthew L, 2012, Cochlear Implants Int, V13, P148, DOI 10.1179/1754762811Y.0000000003; Clark GM, 2013, JAMA-J AM MED ASSOC, V310, P1225, DOI 10.1001/jama.2013.278142; Cochlear Ltd, 2012, COCHL NUCL REL REP, V10; Cochlear Ltd, 2011, COCHL NUCL REL REP, V9; Cote M, 2007, LARYNGOSCOPE, V117, P1225, DOI 10.1097/MLG.0b013e31805c9a06; Dillon MT, 2015, JAMA OTOLARYNGOL, V141, P219, DOI 10.1001/jamaoto.2014.3418; Fitzgerald MB, 2008, OTOL NEUROTOL, V29, P168, DOI 10.1097/mao.0b013e31815c4875; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Hildrew DM, 2013, LARYNGOSCOPE, V123, P2829, DOI 10.1002/lary.24149; Lassig AAD, 2005, OTOL NEUROTOL, V26, P624, DOI 10.1097/01.mao.0000178123.35988.96; Lin FR, 2012, ARCH INTERN MED, V172, P369, DOI 10.1001/archinternmed.2011.728; Mahtani S, 2014, OTOL NEUROTOL, V35, P1366, DOI 10.1097/MAO.0000000000000358; Manrique-Huarte R, 2016, EUR ARCH OTO-RHINO-L, V273, P621, DOI 10.1007/s00405-015-3610-0; Masterson L, 2012, J LARYNGOL OTOL, V126, P15, DOI 10.1017/S0022215111002829; Miyamoto RT, 1997, AM J OTOL, V18, pS60; Polak M, 2006, ARCH OTOLARYNGOL, V132, P398, DOI 10.1001/archotol.132.4.398; Rayner MG, 2003, OTOLARYNG HEAD NECK, V129, P475, DOI 10.1016/S0194-5998(03)01444-X; Rivas A, 2008, OTOL NEUROTOL, V29, P639, DOI 10.1097/MAO.0b013e31817e5d31; Roberts C., 2012, UPDATE NUCL CI500 SE; Seyyedi M, 2013, OTOL NEUROTOL, V34, P1603, DOI 10.1097/MAO.0b013e3182979398; Shin SH, 2013, OTOL NEUROTOL, V34, P549, DOI 10.1097/MAO.0b013e31828399da; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; THORNTON AR, 1978, J SPEECH HEAR RES, V21, P507, DOI 10.1044/jshr.2103.507; Toner J, 2004, EAR HEARING, V25, P310, DOI 10.1097/01.AUD.0000134549.48718.53; Wang JT, 2014, LARYNGOSCOPE, V124, P2393, DOI 10.1002/lary.24649	31	9	9	2	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2331-2165			TRENDS HEAR	Trends Hear.	JUL 28	2017	21								2331216517706398	10.1177/2331216517706398			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	FC0WE	WOS:000406558600001	28752810	Green Published, gold			2022-02-06	
J	Cruise, DR; Chagdes, JR; Liddy, JJ; Rietdyk, S; Haddad, JM; Zelaznik, HN; Raman, A				Cruise, Denise R.; Chagdes, James R.; Liddy, Joshua J.; Rietdyk, Shirley; Haddad, Jeffrey M.; Zelaznik, Howard N.; Raman, Arvind			An active balance board system with real-time control of stiffness and time-delay to assess mechanisms of postural stability	JOURNAL OF BIOMECHANICS			English	Article						Human balance control; Balance board; Balance model; Time-delay; Rehabilitation	HUMAN UPRIGHT STANCE; PARKINSONS-DISEASE; INDIVIDUALS; INSTABILITY; PREVENTION; INJURIES; MODEL; SWAY	Increased time-delay in the neuromuscular system caused by neurological disorders, concussions, or advancing age is an important factor contributing to balance loss (Chagdes et al., 2013, 2016a,b). We present the design and fabrication of an active balance board system that allows for a systematic study of stiffness and time-delay induced instabilities in standing posture. Although current commercial balance boards allow for variable stiffness, they do not allow for manipulation of time-delay. Having two controllable parameters can more accurately determine the cause of balance deficiencies, and allows us to induce instabilities even in healthy populations. An inverted pendulum model of human posture on such an active balance board predicts that reduced board rotational stiffness destabilizes upright posture through board tipping, and limit cycle oscillations about the upright position emerge as feedback time-delay is increased. We validate these two mechanisms of instability on the designed balance board, showing that rotational stiffness and board time-delay induced the predicted postural instabilities in healthy, young adults. Although current commercial balance boards utilize control of rotational stiffness, real-time control of both stiffness and time-delay on an active balance board is a novel and innovative manipulation to reveal balance deficiencies and potentially improve individualized balance training by targeting multiple dimensions contributing to standing balance. (C) 2017 Elsevier Ltd. All rights reserved.	[Cruise, Denise R.; Raman, Arvind] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA; [Chagdes, James R.] Miami Univ, Dept Mech & Mfg Engn, 650 East High St, Oxford, OH 45056 USA; [Liddy, Joshua J.; Rietdyk, Shirley; Haddad, Jeffrey M.; Zelaznik, Howard N.] Purdue Univ, Dept Hlth & Kinesiol, 800 West Stadium Ave, W Lafayette, IN 47907 USA		Raman, A (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	raman@purdue.edu	Chagdes, James/R-9241-2019	Chagdes, James/0000-0001-5307-7608; Liddy, Joshua/0000-0002-2081-4648	National Science FoundationNational Science Foundation (NSF) [CMMI-1300632]	The authors are grateful to the National Science Foundation for financial support for this project provided through the Grant CMMI-1300632.	Aaltonen S, 2007, ARCH INTERN MED, V167, P1585, DOI 10.1001/archinte.167.15.1585; Asai H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007371; Balogun J, 1992, PHYS THER CAN, V44, P23; Bisdorff AR, 1996, BRAIN, V119, P1523, DOI 10.1093/brain/119.5.1523; BLOEM BR, 1992, CLIN NEUROL NEUROSUR, V94, pS41; Cameron MH, 2008, SOMATOSENS MOT RES, V25, P113, DOI 10.1080/08990220802131127; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Chagdes JR, 2016, J BIOMECH, V49, P1170, DOI 10.1016/j.jbiomech.2016.03.005; Chagdes JR, 2016, J SPORT HEALTH SCI, V5, P14, DOI 10.1016/j.jshs.2016.01.005; Chagdes JR, 2013, J BIOMECH, V46, P2593, DOI 10.1016/j.jbiomech.2013.08.012; Chen I-Chun, 2002, Chang Gung Med J, V25, P583; Cohen H, 1996, AGE AGEING, V25, P39, DOI 10.1093/ageing/25.1.39; de Bruin Eling D, 2009, BMC Geriatr, V9, P15, DOI 10.1186/1471-2318-9-15; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; DiStefano LJ, 2009, J STRENGTH COND RES, V23, P2718, DOI 10.1519/JSC.0b013e3181c1f7c5; Eckner J.T., 2012, BRIT J SPORT MED, V48, P112; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Engelborghs K., 2001, TW330 KU LEUV DEP CO; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gawthrop P, 2014, BIOL CYBERN, V108, P159, DOI 10.1007/s00422-014-0587-5; Godard M.P., 2004, ACTIVITIES ADAPTATIO, V28, P59; Guckenheimer John, 1983, NONLINEAR OSCILLATIO, V42, DOI 10.1007/978-1-4612-1140-2; Gutierrez EM, 2001, CLIN BIOMECH, V16, P522, DOI 10.1016/S0268-0033(01)00034-1; Hinman, 2002, J GERIATR PHYS THER, V25, P10, DOI DOI 10.1519/00139143-200225030-00003; Hue OA, 2004, AGING CLIN EXP RES, V16, P356; HUGHES MA, 1995, CLIN BIOMECH, V10, P318, DOI 10.1016/0268-0033(94)00001-N; Jordan D.W., 1977, NONLINEAR ORDINARY D; Kowalczyk P, 2012, J R SOC INTERFACE, V9, P234, DOI 10.1098/rsif.2011.0212; Kuznetsov Y. A., 1998, ELEMENTS APPL BIFURC, V2nd; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mergner T, 2003, PROG BRAIN RES, V142, P189; Nordt W E 3rd, 1999, Am J Orthop (Belle Mead NJ), V28, P447; Paterno MV, 2004, J ORTHOP SPORT PHYS, V34, P305, DOI 10.2519/jospt.2004.34.6.305; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Ray CT, 2008, GAIT POSTURE, V28, P58, DOI 10.1016/j.gaitpost.2007.09.010; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Troger H, 1991, NONLINEAR STABILITY; Vette AH, 2010, IEEE T NEUR SYS REH, V18, P86, DOI 10.1109/TNSRE.2009.2037891; Yao W, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021902; Zech A, 2010, J ATHL TRAINING, V45, P392, DOI 10.4085/1062-6050-45.4.392	42	9	9	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUL 26	2017	60						48	56		10.1016/j.jbiomech.2017.06.018			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FE5YN	WOS:000408287300007	28668186				2022-02-06	
J	Sauro, KM; Quan, H; Sikdar, KC; Faris, P; Jette, N				Sauro, Khara M.; Quan, Hude; Sikdar, Khokan C.; Faris, Peter; Jette, Nathalie			Hospital safety among neurologic patients A population-based cohort study of adverse events	NEUROLOGY			English	Article							GLOBAL BURDEN; RISK-FACTORS; DISEASE; CARE; RATES; CODES; FALLS	Objective: To examine the frequency and type of adverse events (AEs) experienced by neurologic patients in hospital. Methods: This population-based, retrospective cohort study used hospital discharge abstract data for children and adults admitted to hospital from 2009 to 2015 with 1 of 9 neurologic conditions (Alzheimer disease and related dementia, brain tumor, epilepsy, motor neuron disease, multiple sclerosis, parkinsonism/Parkinson disease, spinal cord injury, traumatic brain injury, and stroke). Neurologic conditions were identified with ICD-10-CA codes. Eighteen AEs were examined with ICD-10-CA codes. The proportion of AEs was calculated, and regression analysis was used to examine factors and outcomes associated with AEs (age, sex, comorbidity, length of stay, and mortality). Results: The overall proportion of admissions associated with an AE among those with a neurologic condition was 11 per 100 admissions. Those with a spinal cord injury had the highest proportion of AEs (39.4 per 100 admissions). The most common AEs were infections and respiratory complications (32.0% and 16.7%, respectively). Age and the presence of comorbidities were associated with higher odds of an AE, while readmission was associated with lower odds of an AE. Having an AE was associated with increased length of stay and higher odds of mortality. Conclusions: This study demonstrates that neurologic patients have a high proportion of AEs in hospital. The findings provide information on the quality and safety of care for people with neurologic conditions in hospital, which can help inform future quality improvement initiatives.	[Sauro, Khara M.; Quan, Hude; Sikdar, Khokan C.; Jette, Nathalie] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Sauro, Khara M.; Jette, Nathalie] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Sauro, Khara M.; Jette, Nathalie] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Faris, Peter] Alberta Hlth Serv, Calgary, AB, Canada		Jette, N (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.; Jette, N (corresponding author), Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada.; Jette, N (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada.	nathalie.jette@albertahealthservices.ca	Faris, Peter/AAJ-3436-2020	Faris, Peter/0000-0001-5208-817X; Quan, Hude/0000-0002-7848-7256; Sauro, Khara/0000-0002-7658-4351			Baines RJ, 2013, BMJ QUAL SAF, V22, P290, DOI 10.1136/bmjqs-2012-001126; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Borzecki AM, 2011, J AM COLL SURGEONS, V212, P935, DOI 10.1016/j.jamcollsurg.2010.09.034; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Hoonhout LHF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-27; Institute of Medicine, 2001, CROSSING QUALITY CHA, P360; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Kohn LT, 2000, ERR IS HUMAN BUILDIN, P312; LYNN FH, 1980, AM J NURS, V80, P1098, DOI 10.2307/3469974; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mendizabal A, 2016, EPILEPSIA, V57, P1301, DOI 10.1111/epi.13440; Menken M, 2000, ARCH NEUROL-CHICAGO, V57, P418, DOI 10.1001/archneur.57.3.418; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Public Health Agency of Canada, 2015, CAN CHRON DIS SURV S; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Reid AY, 2012, EPILEPSY RES, V102, P173, DOI 10.1016/j.eplepsyres.2012.05.009; Robinson K, 2005, NEUROREHABILITATION, V20, P169; ROHDE JM, 1990, INFECT CONT HOSP EP, V11, P521; Rudzinska M, 2013, NEUROL NEUROCHIR POL, V47, P431, DOI 10.5114/ninp.2013.38223; Southern DA, 2017, MED CARE, V55, P252, DOI 10.1097/MLR.0000000000000649; St Germaine-Smith C, 2012, NEUROLOGY, V79, P1049, DOI 10.1212/WNL.0b013e3182684707; StataCorp, 2011, STAT STAT SOFTW REL; Tu K, 2014, EPILEPSIA, V55, P335, DOI 10.1111/epi.12506; Waters TM, 2013, J AM GERIATR SOC, V61, P2186, DOI 10.1111/jgs.12539; Yoo SH, 2015, J NEUROL SCI, V356, P113, DOI 10.1016/j.jns.2015.06.027; Zegers M, 2011, INT J QUAL HEALTH C, V23, P126, DOI 10.1093/intqhc/mzq086	27	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 18	2017	89	3					284	290		10.1212/WNL.0000000000004111			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FA6KS	WOS:000405552700016	28615436				2022-02-06	
J	Alsherbini, KA; Plancher, JMO; Ficker, DM; Foreman, BP; Adeoye, OM; Ying, J; Privitera, MD				Alsherbini, Khalid A.; Plancher, Joao Mc-O'Neil; Ficker, David M.; Foreman, Brandon P.; Adeoye, Opeolu M.; Ying, Jun; Privitera, Michael D.			Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges in Coma-Incidence and Interrater Reliability of Continuous EEG After a Standard Stimulation Protocol: A Prospective Study	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Continuous EEG monitoring; SIRPIDs; Periodic discharges; Encephalopathy; Coma; Stimulation protocol	LATERALIZED EPILEPTIFORM DISCHARGES; CRITICALLY-ILL; DELTA ACTIVITY; SIRPIDS; TERMINOLOGY	Purpose: Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs) are often seen during continuous electroencephalographic (cEEG) monitoring in coma. Given their uncertain clinical significance, our prospective study evaluated incidence of SIRPIDs in comatose patients in the neuroscience intensive care unit (NSICU) who underwent a standard stimulation protocol and defined interreader reliability for cEEG. Methods: Of 146 patients prospectively screened who underwent cEEG during a 6-month period, 53 patients were included and 93 patients were excluded. Our protocol used a sequence of auditory, mild tactile, and painful stimuli tested in a quiet room. Continuous electroencephalogram were then reviewed offline by blinded experts, with interrater agreement assessed by kappa statistic. By Pearson x2 and Wilcoxon rank-sum tests, we then compared binary and numerical clinical features between those with and without SIRPIDs. Results: Of 53 patients who underwent our protocol, one patient with a corrupt cEEG file was excluded. Traumatic brain injury was the most common diagnosis. Moderate interrater agreement was observed for 66 total stimulations: 20 patients (38.5%) had possible or definite SIRPIDs by minimum one reviewer. For 19 stimulations reviewed by a third reviewer, consensus was reached in 10 cases making the incidence of SIRPIDs 19.3% in our cohort. There was a moderate interrate agreement with kappa of 0.5 (95% confidence interval: 0.1, 0.7). Median intensive care unit stay was 15 days in patients with SIRPIDs versus 6.5 days in those without (P = 0.021). Conclusions: Our prospective study of SIRPIDs in the neuroscience intensive care unit found a 19% incidence by cEEG using a standard stimulation protocol, most often rhythmic delta activity, and showed a moderate interrater agreement.	[Privitera, Michael D.] Univ Cincinnati, Coll Med, Dept Neurol, Epilepsy Ctr, 2348 Stetson, Cincinnati, OH 45221 USA; [Privitera, Michael D.] Univ Cincinnati, Neurocrit Care Program, UC Neurosci Inst, Coll Med, 2348 Stetson, Cincinnati, OH 45221 USA		Privitera, MD (corresponding author), Univ Cincinnati, Coll Med, Dept Neurol, Epilepsy Ctr, 2348 Stetson, Cincinnati, OH 45221 USA.; Privitera, MD (corresponding author), Univ Cincinnati, Neurocrit Care Program, UC Neurosci Inst, Coll Med, 2348 Stetson, Cincinnati, OH 45221 USA.	privitmd@ucmail.uc.edu	Alsherbini, Khalid/AAI-6894-2020	Foreman, Brandon/0000-0002-5418-674X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER		Accolla EA, 2011, CLIN NEUROPHYSIOL, V122, P27, DOI 10.1016/j.clinph.2010.06.005; Alvarez V, 2013, CLIN NEUROPHYSIOL, V124, P204, DOI 10.1016/j.clinph.2012.06.017; Braksick SA, 2016, JAMA NEUROL, V73, P585, DOI 10.1001/jamaneurol.2016.0006; Fluri F, 2008, CLIN NEUROPHYSIOL, V119, P1934, DOI 10.1016/j.clinph.2008.03.028; Gaspard N, 2014, EPILEPSIA, V55, P1366, DOI 10.1111/epi.12653; Gaspard N, 2013, JAMA NEUROL, V70, P1288, DOI 10.1001/jamaneurol.2013.3475; Gross DW, 1998, ELECTROEN CLIN NEURO, V107, P434, DOI 10.1016/S0013-4694(98)00103-5; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x; PohlmannEden B, 1996, J CLIN NEUROPHYSIOL, V13, P519, DOI 10.1097/00004691-199611000-00007; Van Straten AF, 2014, J CLIN NEUROPHYSIOL, V31, P418, DOI 10.1097/WNP.0000000000000094; Watemberg N, 2002, J CLIN NEUROPHYSIOL, V19, P535, DOI 10.1097/00004691-200212000-00006; Zeiler SR, 2011, J CLIN NEUROPHYSIOL, V28, P493, DOI 10.1097/WNP.0b013e318231c00a	13	9	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JUL	2017	34	4					375	380		10.1097/WNP.0000000000000374			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT2CH	WOS:000422945500011	28323659				2022-02-06	
J	Castellano-Tejedor, C; Lusilla-Palacios, P				Castellano-Tejedor, Carmina; Lusilla-Palacios, Pilar			A study of burden of care and its correlates among family members supporting relatives and loved ones with traumatic spinal cord injuries	CLINICAL REHABILITATION			English	Article						Spinal cord injury; caregivers; burden of care; resilience; life satisfaction	QUALITY-OF-LIFE; BRAIN-INJURY; CAREGIVING BURDEN; RESILIENCE; INDIVIDUALS; REHABILITATION; SATISFACTION; PERSPECTIVES; PREDICTORS; OUTCOMES	Objective: To understand and describe in a sample of caregivers of persons with spinal cord injury, their burden of care, resilience and life satisfaction and to explore the relationship between these variables. Design: Cross-sectional design. Setting: One Spinal Cord Injury Acute Inpatient Unit from a general hospital. Subjects: Seventy-five relatives of persons with spinal cord injuries (84% women) with a mean age of 48.55 (SD=12.55)years. Interventions: None. Measures: Demographics (neurological loss and severity according to the American Spinal Injury Association criteria), the Zarit Burden Interview, the Resilience Scale and the Life Satisfaction Checklist. Results: All caregivers experienced feelings of different intensities of burden (52% mild-to-moderate, 43% moderate-to-severe and 5% severe), and none of them expressed little or no burden at the assessment moment. Caregivers' main worries were dependence and the future of the injured. Resilience was medium-to-high (mean=141.93, SD=23.44) for the whole sample with just a minority of them revealing low (15%) or very low resilience (7%). The highest scores were obtained in relation to caregivers' independence and meaning of their lives. Life satisfaction scores were medium-to-high (mean=36.6, SD=6). These scores were not related to demographics or the severity of the injury. Zarit Burden Interview scores were negatively correlated to Resilience Scale (r=-.370, P=.001) and Life Satisfaction Checklist scores (r=-.412, P<.001). Conclusion: More resilient and satisfied caregivers experienced lower burden. Burden is moderate-to-high and mainly related to uncertainty about the future, caregivers' insecurity with caregiving and dependence of the injured.	[Castellano-Tejedor, Carmina; Lusilla-Palacios, Pilar] Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Dept Psychiat, Passeig Vall dHebron 119-129, E-08035 Barcelona, Spain; [Castellano-Tejedor, Carmina; Lusilla-Palacios, Pilar] Vall dHebron Res Inst, Barcelona, Spain		Castellano-Tejedor, C (corresponding author), Autonomous Univ Barcelona, Univ Hosp Vall dHebron, Dept Psychiat, Passeig Vall dHebron 119-129, E-08035 Barcelona, Spain.	ninacastej@yahoo.es			Fundacio La Marato de TV3 [156/U/2011]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Fundacio La Marato de TV3 (grant number 156/U/2011).	Aburn G, 2016, J ADV NURS, V72, P980, DOI 10.1111/jan.12888; Ahern NR, 2006, Compr Child Adoles N, V29, P103, DOI 10.1080/01460860600677643; Alfano D P, 1994, Appl Neuropsychol, V1, P57, DOI 10.1207/s15324826an0101&2_10; American Spinal Injury Association, 2011, INT STAND NEUR CLASS; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P1, DOI 10.3233/NRE-2010-0576; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Blanes L, 2007, SPINAL CORD, V45, P399, DOI 10.1038/sj.sc.3102038; Boschen KA, 2005, REHABIL PSYCHOL, V50, P397, DOI 10.1037/0090-5550.50.4.397; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Charlifue SB, 2016, SPINAL CORD, V54, P732, DOI 10.1038/sc.2016.25; Chou YC, 2011, INT PSYCHOGERIATR, V23, P562, DOI 10.1017/S1041610210001225; Dooley LN, 2017, STRESS HEALTH, DOI [10.1002/smj.2739, DOI 10.1002/SMJ.2739]; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; HAMMELL KRW, 1992, PARAPLEGIA, V30, P317; Hastrup LH, 2011, SCAND J PUBLIC HEALT, V39, P598, DOI 10.1177/1403494811414247; House LA, 2009, SPINAL CORD, V47, P882, DOI 10.1038/sc.2009.64; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Kotliarenco M. A., 1997, ESTADO ARTE RESILIEN; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LaVela SL, 2015, J SPINAL CORD MED, V38, P505, DOI 10.1179/2045772314Y.0000000240; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Lusilla-Palacios P, 2015, J HEALTH PSYCHOL, V20, P1357, DOI 10.1177/1359105313512351; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mancini AD, 2006, J CLIN PSYCHOL, V62, P971, DOI 10.1002/jclp.20283; Martin J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0507-9; Meade MA, 2004, REHABIL PSYCHOL, V49, P150, DOI 10.1037/0090-5550.49.2.150; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Mulud ZA, 2017, ARCH PSYCHIAT NURS, V31, P24, DOI 10.1016/j.apnu.2016.07.019; Nogueira PC, 2016, J NEUROSCI NURS, V48, P28, DOI 10.1097/JNN.0000000000000177; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Rejas J, 2005, MED CLIN-BARCELONA, V124, P165, DOI 10.1157/13071490; Rejas J, 2004, HARMACOECONOMICS SP, V1, P87; Rha SY, 2015, EUR J ONCOL NURS, V19, P174, DOI 10.1016/j.ejon.2014.09.003; Shamsaei Farshid, 2015, Iran J Psychiatry, V10, P239; Tan SB, 2012, J CLIN NURS, V21, P2235, DOI 10.1111/j.1365-2702.2012.04146.x; Tramonti F, 2015, PSYCHOL HEALTH MED, V20, P41, DOI 10.1080/13548506.2014.892627; Wagnild G M, 1993, J Nurs Meas, V1, P165; Weitzenkamp DA, 1997, ARCH PHYS MED REHAB, V78, P822, DOI 10.1016/S0003-9993(97)90194-5; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	42	9	9	0	20	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUL	2017	31	7					948	956		10.1177/0269215517709330			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EY5QP	WOS:000404032700010	28637391				2022-02-06	
J	Dey, S; Gangadharan, J; Deepika, A; Kumar, JK; Christopher, R; Ramesh, SS; Devi, BI; Shukla, DP				Dey, Subir; Gangadharan, Jagathlal; Deepika, Akhil; Kumar, J. Keshav; Christopher, Rita; Ramesh, Shruthi S.; Devi, B. Indira; Shukla, Dhaval P.			Correlation of ubiquitin C terminal hydrolase and S100 beta with cognitive deficits in young adults with mild traumatic brain injury	NEUROLOGY INDIA			English	Article						Mild traumatic brain injury; post-concussion syndrome; S100. neuropsychological outcome; serum biomarkers; traumatic brain injury; ubiquitin C terminal hydrolase-L1	MINOR HEAD-INJURY; NEUROCOGNITIVE PERFORMANCE; SERUM-LEVELS; BIOMARKER; IMPAIRMENT; MANAGEMENT; MARKERS; DAMAGE	Objective: To study the acute phase serum biomarkers in patients with mild traumatic brain injury (mTBI) and to correlate them with short term cognitive deficits. Materials and Methods: This is a prospective observational study conducted at a tertiary care center for neurotrauma. The participants included patients with mTBI (n = 20) and age, gender, and education-status matched healthy controls (n = 20). In both the groups, the serum concentrations of biomarkers ubiquitin C terminal hydrolase (UCH-L1) and S100 calcium-binding protein B (S100.) were measured. Both the groups underwent neuropsychological tests. The serum tests were done in the acute stage after injury and the neuropsychological tests were done 3 months after injury. Results: There was no significant increase in the serum S100B and UCH-L1 levels in patients with mTBI. Patients with mTBI had significant cognitive deficits at 3 months after injury, which was suggestive of involvement of diffuse areas of the brain, in particular, the premotor, prefrontal, and medial inferior frontal lobes and the basitemporal region. The correlation of biomarkers with cognitive deficits in patients with mTBI was found in the following domains: working memory, verbal learning, verbal fluency, and visual memory. Conclusion: The serum biomarkers of mTBI have a correlation with selective domains of neuropsychological outcome.	[Dey, Subir; Gangadharan, Jagathlal; Ramesh, Shruthi S.; Devi, B. Indira; Shukla, Dhaval P.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru 560029, Karnataka, India; [Deepika, Akhil] Natl Inst Mental Hlth & Neurosci, Dept Clin Neurosci, Bengaluru, Karnataka, India; [Kumar, J. Keshav] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bengaluru, Karnataka, India; [Christopher, Rita] Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bengaluru, Karnataka, India		Shukla, DP (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru 560029, Karnataka, India.	neurodhaval@rediffmail.com			"NEUROCON" fund	Subir Dey received a grant for this study from "NEUROCON2011" fund. The other authors report no declarations of interest.	Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Flanagan S, 1999, MT SINAI J MED, V66, P152; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P434; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rao SL, 2004, NIMHANS PUBLICATION; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630	30	9	10	0	4	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JUL-AUG	2017	65	4					761	766		10.4103/neuroindia.NI_884_15			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EZ9ZK	WOS:000405089100017	28681747				2022-02-06	
J	Eaton, J; Grudziak, J; Hanif, AB; Chisenga, WC; Hadar, E; Charles, A				Eaton, Jessica; Grudziak, Joanna; Hanif, Asma Bilal; Chisenga, Wanangwa C.; Hadar, Eldad; Charles, Anthony			The effect of anatomic location of injury on mortality risk in a resource-poor setting	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Traumatic spine injury; Head injury; Mortality; Anatomic location of injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; EPIDEMIOLOGY; AFRICA; PATTERNS; DEATHS	Introduction: Injury is a significant cause of death, with approximately 4.7 million people mortalities each year. By 2030, injury is predicted to be among the top 20 causes of death worldwide. We sought to characterize and compare the mortality probability in trauma patients in a resource-poor setting based on anatomic location of injury. Methods: We performed a retrospective analysis of prospectively collected data using the trauma database at Kamuzu Central Hospital (KCH) in Lilongwe, Malawi. We included all adult trauma patients (>= 16years) admitted between 2011 and 2015. We stratified patients according to anatomic location of injury, and used descriptive statistics to compare characteristics and management of each group. Bivariate analysis by mortality was done to determine covariates for our adjusted model. A Cox proportional hazard model was performed, using upper extremity injury as the baseline comparator. Descriptive statistics were used to describe the trend in incidence and mortality of head and spine injuries over five years. Results: Of the 76,984 trauma patients who presented to KCH from 2011 to 2015, 49,126 (63.8%) were adults, and 8569 (17.4%) were admitted. The most common injury was to the head or spine, seen in 3712 patients (43.6%). The highest unadjusted hazard ratio for mortality was in head and spine injury patients, at 3.685 (95% CI = 2.50-5.44), which increased to 4.501 (95% CI = 2.78-7.30) when adjusted for age, sex, injury severity, transfer status, injury mechanism, and surgical intervention. Abdominal trauma had the second highest adjusted hazard of mortality, at 3.62 (95% CI = 1.92-6.84) followed by thoracic trauma (HR = 1.3621, 95% CI = 0.49-3.56). Conclusion: In our setting, head or spine injury significantly increases the hazard of mortality significantly compared to all other anatomic injury locations. The prioritization of timely operative and non-operative head injury management is imperative. The development of head injury units may help attenuate trauma-related mortality in resource poor settings. (C) 2017 Elsevier Ltd. All rights reserved.	[Eaton, Jessica; Charles, Anthony] UNC Project Malawi, Lilongwe, Malawi; [Eaton, Jessica] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Hanif, Asma Bilal; Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Hanif, Asma Bilal; Chisenga, Wanangwa C.; Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Hadar, Eldad] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC USA		Charles, A (corresponding author), Univ N Carolina, UNC Sch Med, Dept Surg, 4008 Burnett Womack Bldg CB 7228, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu			Fulbright Program; National Institutes of Health Office of the Director, Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC); NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium comprised of the University of North Carolina, John Hopkins, Morehouse and Tulane [R25TW009340]; Office of AIDS Research, National Cancer Center, National Heart, Blood, and Lung Institute	The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper. This work was supported by the Fulbright Program and the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Heart, Blood, and Lung Institute, and the NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium comprised of the University of North Carolina, John Hopkins, Morehouse and Tulane (R25TW009340).	Alexander T, 2009, S AFR J SURG, V47, P120; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; FANISALEK MH, 1999, EMERGEN MED, V11, P155; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janca A, 2006, J NEUROL SCI, V247, P29, DOI 10.1016/j.jns.2006.03.003; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mnguni MN, 2012, INT SURG, V97, P161, DOI 10.9738/CC84.1; Murray CJ, 2015, LANCET, V386, pP2145; Mwita CC, 2016, J NEUROSCI RURAL PRA, V7, P97, DOI 10.4103/0976-3147.165390; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nordberg E, 2000, E AFR MED J, V77, pS1; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thomas Martins Oluwafemi, 2009, Asian Cardiovasc Thorac Ann, V17, P608, DOI 10.1177/0218492309349069; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Tyson Anna F, 2015, J Surg Educ, V72, pe66, DOI 10.1016/j.jsurg.2014.09.010; van Amelsfoort JJC, 2010, TROP DOCT, V40, P74, DOI 10.1258/td.2009.090068; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	31	9	9	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2017	48	7					1432	1438		10.1016/j.injury.2017.05.023			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FB2TW	WOS:000405997100024	28551054	Green Submitted			2022-02-06	
J	Proctor, JL; Mello, KT; Fang, R; Puche, AC; Rosenthal, RE; Fourney, WL; Leiste, UH; Fiskum, G				Proctor, Julie L.; Mello, Kaitlin T.; Fang, Raymond; Puche, Adam C.; Rosenthal, Robert E.; Fourney, William L.; Leiste, Ulrich H.; Fiskum, Gary			Aeromedical evacuation-relevant hypobaria worsens axonal and neurologic injury in rats after underbody blast-induced hyperacceleration	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Axonopathy; balance beam; hypoxia; hyperoxia; normoxia	TRAUMATIC BRAIN-INJURY; HYPEROXIC REPERFUSION; MODEL; EPIDEMIOLOGY; INFLAMMATION; HYPOXIA; CARE	BACKGROUND: Occupants of military vehicles targeted by explosive devices often suffer from traumatic brain injury (TBI) and are typically transported by the aeromedical evacuation (AE) system to a military medical center within a few days. This study tested the hypothesis that exposure of rats to AE-relevant hypobaria worsens cerebral axonal injury and neurologic impairment caused by underbody blasts. METHODS: Anesthetized adultmale ratswere secured within cylinders attached to ametal plate, simulating the hull of an armored vehicle. An explosive located under the plate was detonated, resulting in a peak vertical acceleration force on the plate and occupant rats of 100G. Rats remained under normobaria or were exposed to hypobaria equal to 8,000 feet in an altitude chamber for 6 hours, starting at 6 hours to 6 days after blast. At 7 days, rats were tested for vestibulomotor function using the balance beam walking task and euthanized by perfusion. The brains were then analyzed for axonal fiber injury. RESULTS: The number of internal capsule silver-stained axonal fiberswas greater in animals exposed to 100Gblast than in shams. Animals exposed to hypobaria starting at 6 hours to 6 days after blast exhibited more silver-stained fibers than those not exposed to hypobaria. Rats exposed to 100% oxygen (O-2) during hypobaria at 24 hours postblast displayed greater silver staining and more balance beam foot-faults, in comparison with rats exposed to hypobaria under 21% O-2. CONCLUSION: Exposure of rats to blast-induced acceleration of 100G increases cerebral axonal injury, which is significantly exacerbated by exposure to hypobaria as early as 6 hours and as late as 6 days postblast. Rats exposed to underbody blasts and then to hypobaria under 100% O-2 exhibit increased axonal damage and impairedmotor function compared to those subjected to blast and hypobaria under 21% O2. These findings raise concern about the effects of AE-related hypobaria on TBI victims, the timing of AE after TBI, and whether these effects can be mitigated by supplemental oxygen. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Proctor, Julie L.; Mello, Kaitlin T.; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, 685W Baltimore St,5-34 MSTF, Baltimore, MD 21201 USA; [Fang, Raymond; Rosenthal, Robert E.] Univ Maryland, Med Ctr, Program Trauma, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Fang, Raymond] Univ Maryland, Sch Med, US Air Force Ctr Sustainment Trauma & Readiness S, Baltimore, MD 21201 USA; [Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Rosenthal, Robert E.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Fourney, William L.; Leiste, Ulrich H.] Univ Maryland, Sch Engn, College Pk, MD 20742 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685W Baltimore St,5-34 MSTF, Baltimore, MD 21201 USA.	gfiskum@anes.umm.edu			U.S. Air ForceUnited States Department of Defense [FA8650-11-2-6D04]; U.S. ArmyUnited States Department of Defense [W81XWH-13-1-0016]	There are no financial, consultant, institutional, or relationship conflicts declared by any author. This work was supported by U.S. Air Force grant FA8650-11-2-6D04 and U.S. Army grant U.S. Army W81XWH-13-1-0016. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Air Force, the Department of Defense, or the U.S. Government.	Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1; Blackbourne LH, 2012, J TRAUMA ACUTE CARE, V73, pS378, DOI 10.1097/TA.0b013e3182754900; Butler WP, 2016, AEROSP MED HUM PERF, V87, P352, DOI 10.3357/AMHP.4378.2016; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Galvagno SM, 2014, MIL MED, V179, P612, DOI 10.7205/MILMED-D-13-00474; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hovda DA, 2014, PROG NEUROL SURG, V28, P28, DOI 10.1159/000358749; Johannigman Jay, 2015, J Trauma Acute Care Surg, V79, pS216, DOI 10.1097/TA.0000000000000736; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Proctor Julie L, 2015, J Trauma Acute Care Surg, V79, pS101, DOI 10.1097/TA.0000000000000742; Proctor JL, 2014, J TRAUMA ACUTE CARE, V77, pS83, DOI 10.1097/TA.0000000000000340; Richards EM, 2007, STROKE, V38, P1578, DOI 10.1161/STROKEAHA.106.473967; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scultetus AH, 2016, J TRAUMA ACUTE CARE, V81, P101, DOI 10.1097/TA.0000000000001048; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Tang S, J NEUROTRAUMA; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Tenkova Tatyana I., 2007, V399, P31, DOI 10.1007/978-1-59745-504-6_3; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075	25	9	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2017	83			1			S35	S42		10.1097/TA.0000000000001478			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EY3XA	WOS:000403907300006	28452879				2022-02-06	
J	Boothe, DL; Yu, AB; Kudela, P; Anderson, WS; Vettel, JM; Franaszczuk, PJ				Boothe, David L.; Yu, Alfred B.; Kudela, Pawel; Anderson, William S.; Vettel, Jean M.; Franaszczuk, Piotr J.			Impact of Neuronal Membrane Damage on the Local Field Potential in a Large-Scale Simulation of Cerebral Cortex	FRONTIERS IN NEUROLOGY			English	Article						local field potential; Cerebral Cortex; Modeling and simulation; traumatic brain injury; neuronal network	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; GAP-JUNCTIONS; NEURAL OSCILLATIONS; IN-VITRO; CELL; ELECTROPORATION; SYNCHRONIZATION; MECHANOPORATION; NETWORKS	Within multiscale brain dynamics, the structure-function relationship between cellular changes at a lower scale and coordinated oscillations at a higher scale is not well understood. This relationship may be particularly relevant for understanding functional impairments after a mild traumatic brain injury (mTBI) when current neuroimaging methods do not reveal morphological changes to the brain common in moderate to severe TBI such as diffuse axonal injury or gray matter lesions. Here, we created a physiology-based model of cerebral cortex using a publicly released modeling framework (GEneral NEural SImulation System) to explore the possibility that performance deficits characteristic of blast-induced mTBI may reflect dysfunctional, local network activity influenced by microscale neuronal damage at the cellular level. We operationalized microscale damage to neurons as the formation of pores on the neuronal membrane based on research using blast paradigms, and in our model, pores were simulated by a change in membrane conductance. We then tracked changes in simulated electrical activity. Our model contained 585 simulated neurons, comprised of 14 types of cortical and thalamic neurons each with its own compartmental morphology and electrophysiological properties. Comparing the functional activity of neurons before and after simulated damage, we found that simulated pores in the membrane reduced both action potential generation and local field potential (LFP) power in the 1-40 Hz range of the power spectrum. Furthermore, the location of damage modulated the strength of these effects: pore formation on simulated axons reduced LFP power more strongly than did pore formation on the soma and the dendrites. These results indicate that even small amounts of cellular damage can negatively impact functional activity of larger scale oscillations, and our findings suggest that multiscale modeling provides a promising avenue to elucidate these relationships.	[Boothe, David L.; Yu, Alfred B.; Vettel, Jean M.; Franaszczuk, Piotr J.] US Army, Res Lab, Aberdeen, MD 21005 USA; [Boothe, David L.] Altus Engn, Churchville, MD 21034 USA; [Kudela, Pawel; Anderson, William S.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Kudela, Pawel] Johns Hopkins Inst Clin & Translat Res, Baltimore, MD USA; [Vettel, Jean M.] Univ Calif Santa Barbara, Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Vettel, Jean M.] Univ Penn, Dept Engn, Philadelphia, PA 19104 USA; [Franaszczuk, Piotr J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA		Boothe, DL (corresponding author), US Army, Res Lab, Aberdeen, MD 21005 USA.; Boothe, DL (corresponding author), Altus Engn, Churchville, MD 21034 USA.	david.l.boothe7.civ@mail.mil	Franaszczuk, Piotr/B-6532-2008	Franaszczuk, Piotr/0000-0002-5166-4224; Anderson, William/0000-0003-0958-050X	US Army Research Laboratory (ARL)United States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-12-1-0418, W911NF-14-1-0491]; Johns Hopkins University under ARL's Open Campus framework	We would like to thank Yelena Sliozberg, Tanya Chantawansri, Thuvan Piehler, and Nicole Zander for insightful discussions about this work. Research was sponsored by the US Army Research Laboratory (ARL), including funding from a 3-year Director's Strategic Initiative and contract numbers W911NF-12-1-0418 and W911NF-14-1-0491, and executed in collaboration with Johns Hopkins University under ARL's Open Campus (www.arl.army.mil/opencampus) framework. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the ARL or the US Government.	Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Anderson WS, 2012, EPILEPSY RES, V99, P202, DOI 10.1016/j.eplepsyres.2011.11.006; Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Bower J.M., 2012, BOOK GENESIS EXPLORI; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V902, P360, DOI 10.1016/0005-2736(87)90204-5; Dean P.J., 2013, FRONT HUM NEUROSCI, V12, P7, DOI DOI 10.3389/FNHUM.2013.00030; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; FRANASZCZUK PJ, 1985, BIOL CYBERN, V51, P239, DOI 10.1007/BF00337149; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Insel TR, 2013, SCIENCE, V340, P687, DOI 10.1126/science.1239276; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kudela P, 2015, NEUROMODULATION, V18, P552, DOI 10.1111/ner.12327; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Lifshitz JT, 2015, BRAIN NEUROTRAUMA MO, P1; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; Moran LV, 2011, SCHIZOPHRENIA BULL, V37, P659, DOI 10.1093/schbul/sbr056; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355; Rall W., 2011, COMPREHENSIVE PHYSL; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sliozberg YR, 2016, CHEM PHYS LETT, V651, P39, DOI 10.1016/j.cplett.2016.03.018; Sun S, 2015, J NEUROTRAUM, V32, P1441, DOI 10.1089/neu.2014.3699; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Thatcher RW, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P241, DOI 10.1007/0-387-32565-4_11; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Trevelyan AJ, 2016, TRENDS NEUROSCI, V39, P502, DOI 10.1016/j.tins.2016.06.002; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	55	9	9	0	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 7	2017	8								236	10.3389/fneur.2017.00236			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX6YM	WOS:000403388200001	28638364	Green Published, gold			2022-02-06	
J	Zhang, J; Wei, RL; Peng, GP; Zhou, JJ; Wu, M; He, FP; Pan, G; Gao, J; Luo, BY				Zhang, Jie; Wei, Rui-Li; Peng, Guo-Ping; Zhou, Jia-Jia; Wu, Min; He, Fang-Ping; Pan, Gang; Gao, Jian; Luo, Ben-Yan			Correlations between diffusion tensor imaging and levels of consciousness in patients with traumatic brain injury: a systematic review and meta-analysis	SCIENTIFIC REPORTS			English	Article							GLASGOW COMA SCALE; DEFAULT-MODE NETWORK; CORPUS-CALLOSUM; VEGETATIVE STATE; RECOVERY SCALE; MATTER; CONNECTIVITY; DISORDERS; DIAGNOSIS; PEARSON	Traumatic brain injury (TBI) often leads to impaired consciousness. Recent diffusion tensor imaging studies associated consciousness with imaging metrics including fractional anisotropy (FA) and apparent diffusion coefficient (ADC). We evaluated their correlations and determined the best index in candidate regions. Six databases were searched, including PubMed and Embase, and 16 studies with 701 participants were included. Data from region-of-interest and whole-brain analysis methods were meta-analysed separately. The FA-consciousness correlation was marginal in the whole-brain white matter (r = 0.63, 95% CI [0.47, 0.79], p = 0.000) and the corpus callosum (CC) (r = 0.60, 95% CI [0.48, 0.71], p = 0.000), and moderate in the internal capsule (r = 0.48, 95% CI [0.24, 0.72], p = 0.000). Correlations with ADC trended negative and lacked significance. Further subgroup analysis revealed that consciousness levels correlated strongly with FA in the CC body (r = 0.66, 95% CI [0.43, 0.89]), moderately in the splenium (r = 0.58, 95% CI [0.38, 0.78]), but insignificantly in the genu. In conclusion, FA correlates better with consciousness levels than ADC in TBI. The degree of correlation varies among brain regions. The CC (especially its splenium and body) is a reliable candidate region to quantitatively reflect consciousness levels.	[Zhang, Jie; Wei, Rui-Li; Peng, Guo-Ping; Zhou, Jia-Jia; Wu, Min; He, Fang-Ping; Luo, Ben-Yan] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jie; Wei, Rui-Li; Peng, Guo-Ping; Zhou, Jia-Jia; Wu, Min; He, Fang-Ping; Luo, Ben-Yan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Hangzhou, Zhejiang, Peoples R China; [Pan, Gang] Zhejiang Univ, Dept Comp Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Jian] Hangzhou Hosp Zhejiang CAPR, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Hangzhou, Zhejiang, Peoples R China.	luobenyan@zju.edu.cn		Zhang, Jie/0000-0002-1397-5224	National Key Basic Research Program of ChinaNational Basic Research Program of China [2013CB329504]; General Project Plan of Zhejiang Medical Technology [2014RCA007]; Medical Science and Technology Project; Zhejiang Province [2016152769]; Ministry of Health of China [2016152769]	The preparation of this manuscript received the grants from National Key Basic Research Program of China (2013CB329504), the General Project Plan of Zhejiang Medical Technology (2014RCA007) and the Medical Science and Technology Project co-founded by Zhejiang Province and the Ministry of Health of China (2016152769).	Abe H, 2015, EUR J NEUROL, V22, P405; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Borenstein M., 2009, INTRO METAANALYSIS, V6, P41; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Cavaliere C, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01028; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; de Winter JCF, 2016, PSYCHOL METHODS, V21, P273, DOI 10.1037/met0000079; Deeks JJ., 2009, ASSESSING METHODOLOG; [董景敏 Dong Jingmin], 2011, [实用放射学杂志, The Journal of Practical Radiology], V27, P653; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Eng GK, 2015, NEUROSCI BIOBEHAV R, V52, P233, DOI 10.1016/j.neubiorev.2015.03.002; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fornari E, 2007, NEUROIMAGE, V38, P511, DOI 10.1016/j.neuroimage.2007.07.010; Frieden T.R., 2015, REPORT C TRAUMATIC B; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Laureys S, 2005, LANCET NEUROL, V4, P789, DOI 10.1016/S1474-4422(05)70230-1; Li K, 2015, DEV MED CHILD NEUROL, V57, P328, DOI 10.1111/dmcn.12618; Mitaki S, 2012, J NEUROL SCI, V317, P154, DOI 10.1016/j.jns.2012.02.020; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Rupinski MT, 1996, EDUC PSYCHOL MEAS, V56, P419, DOI 10.1177/0013164496056003004; Schiff ND, 2012, ANN NEUROL, V72, P305, DOI 10.1002/ana.23671; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; SPERRY RW, 1968, AM PSYCHOL, V23, P723, DOI 10.1037/h0026839; Stubbs B., 2017, BMJ, V7, P1, DOI [10.1038/s41467-019-10003-8, 10.1038/s41598-017-07579-w, DOI 10.1136/BMJ.B2535]; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; [王博成 WANG Bo-cheng], 2009, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V29, P1491; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang Shuang-kun, 2005, Chinese Journal of Medical Imaging Technology, V21, P1799; [王双坤 WANG Shuangkun], 2008, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V24, P1715; Whiting P., 2010, UPDATING QUADAS EVID; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wright J, 2000, DISABILITY RATING SC; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; [易亚辉 Yi Yahui], 2015, [中国医学计算机成像杂志, Chinese Computed Medical Imaging], V21, P224; Zhang J. W., 2012, J CHIN MED IMAGING, V23, P229	62	9	9	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 5	2017	7								2793	10.1038/s41598-017-02950-3			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW7LB	WOS:000402690200009	28584256	Green Published, gold			2022-02-06	
J	Graef, F; Seemann, R; Garbe, A; Schmidt-Bleek, K; Schaser, KD; Keller, J; Duda, G; Tsitsilonis, S				Graef, F.; Seemann, R.; Garbe, A.; Schmidt-Bleek, K.; Schaser, K-D.; Keller, J.; Duda, G.; Tsitsilonis, S.			Impaired fracture healing with high non-union rates remains irreversible after traumatic brain injury in leptin-deficient mice	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Fracture Healing; Traumatic Brain Injury; Tbi; Leptin; Ob/ob	CONTROLLED CORTICAL IMPACT; CALLUS FORMATION; BONE-FORMATION; FEMORAL FRACTURE; MODEL; MOUSE; EXPRESSION; DIFFERENTIATION; ABNORMALITIES; OSTEOBLASTS	Patients with traumatic brain injury (TBI) and long-bone fractures can show increased callus formation. This effect has already been reproduced in wild-type (wt) mice. However, the mechanisms remain poorly understood. Leptin is significantly increased following TBI, while its role in bone healing remains unclear. The aim of this study was to evaluate fracture healing in leptin-deficient ob/ob mice and to measure any possible impact of TBI on callus formation. 138 female, 12 weeks old, ob/ob mice were divided into four groups: Control, fracture, TBI and combined trauma. Osteotomies were stabilized with an external fixator; TBI was induced with Controlled Cortical Impact Injury. Callus bridging was weekly evaluated with in vivo micro-CT. Biomechanical testing was performed ex vivo. Micro-CT showed high non-union rates after three and four weeks in the fracture and combined trauma group. No differences were observed in callus volume, density and biomechanical properties at any time point. This study shows that bony bridging is impaired in the present leptin-deficient trauma model. Furthermore, the phenomenon of increased callus formation after TBI could not be reproduced in ob/ob mice, as in wt mice. Our findings suggest that the increased callus formation after TBI may be dependent on leptin signaling.	[Graef, F.; Seemann, R.; Garbe, A.; Keller, J.; Tsitsilonis, S.] Charite, Ctr Musculoskeletal Surg, Augustenburger Pl 1, D-13353 Berlin, Germany; [Schmidt-Bleek, K.; Keller, J.; Duda, G.; Tsitsilonis, S.] Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany; [Schmidt-Bleek, K.; Duda, G.] Charite, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany; [Schaser, K-D.] Univ Hosp Carl Gustav Carus Dresden, Univ Ctr Orthoped & Trauma Surg, Fetscherstr 74, D-01307 Dresden, Germany		Graef, F (corresponding author), Charite, Ctr Musculoskeletal Surg, Augustenburger Pl 1, D-13353 Berlin, Germany.	frank.graef@charite.de	Duda, Georg N/H-2085-2016; Schmidt-Bleek, Katharina/O-9816-2015	Duda, Georg N/0000-0001-7605-3908; Graef, Frank/0000-0002-0435-9059; Seemann, Ricarda/0000-0001-5752-070X	German Research SocietyGerman Research Foundation (DFG) [TS 303/1-1]	The present study has been funded by the German Research Society (DFG, project TS 303/1-1).	Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Beil FT, 2011, J TRAUMA, V70, P857, DOI 10.1097/TA.0b013e3181de3dd9; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brown ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099656; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chaudhary SB, 2008, J AM ACAD ORTHOP SUR, V16, P159, DOI 10.5435/00124635-200803000-00007; Cheung KMC, 2003, J ORTHOP RES, V21, P685, DOI 10.1016/S0736-0266(03)00026-3; CHYUN YS, 1984, ENDOCRINOLOGY, V114, P477, DOI 10.1210/endo-114-2-477; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ealey KN, 2006, REGUL PEPTIDES, V136, P9, DOI 10.1016/j.regpep.2006.04.013; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; GENUTH SM, 1971, ENDOCRINOLOGY, V88, P1230, DOI 10.1210/endo-88-5-1230; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Gordeladze JO, 2002, J CELL BIOCHEM, V85, P825, DOI 10.1002/jcb.10156; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Herold HZ, ISR J MED SCI, V6, P163; Hess R, 2005, J CELL BIOCHEM, V94, P50, DOI 10.1002/jcb.20330; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Histing T, 2009, J ORTHOP RES, V27, P1152, DOI 10.1002/jor.20849; Iwaniec UT, 2007, PEPTIDES, V28, P1012, DOI 10.1016/j.peptides.2007.02.001; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kerimoglu G, 2013, EKLEM HAST CERRAHISI, V24, P102, DOI 10.5606/ehc.2013.23; Khan SN, 2013, J ORTHOP TRAUMA, V27, P656, DOI 10.1097/BOT.0b013e3182847968; Laharrague P, 1998, FASEB J, V12, P747, DOI 10.1096/fasebj.12.9.747; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Liu PC, 2017, MED SCI MONITOR, V23, P258, DOI 10.12659/MSM.899259; Liu XH, 2013, ISRN MATH PHYS, V2013, P1, DOI DOI 10.1016/J.MICR0REL.2012.06.140; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Mehta M, 2010, BONE, V47, P219, DOI 10.1016/j.bone.2010.05.029; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Reimer RA, 2012, J OBES, V2012, DOI 10.1155/2012/650193; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Stallmeyer B, 2001, DIABETOLOGIA, V44, P471, DOI 10.1007/s001250051645; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Thomale UW, 2007, NEUROL RES, V29, P594, DOI 10.1179/016164107X166272; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Yan H, 2013, NEUROL RES, V35, P537, DOI 10.1179/1743132813Y.0000000201; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Zhang Y, NATURE, V372, P425	57	9	9	0	6	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	JUN	2017	17	2					78	85					8	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	FA5SO	WOS:000405504200009	28574414				2022-02-06	
J	Hassan, A; Jokar, TO; Rhee, P; Ibraheem, K; Kulvatunyou, N; Anderson, KT; Gries, L; Roward, ZT; Joseph, B				Hassan, Ahmed; Jokar, Tahereh Orouji; Rhee, Peter; Ibraheem, Kareem; Kulvatunyou, Narong; Anderson, Kathryn Tinsley; Gries, Lynn; Roward, Zachary Thomas; Joseph, Bellal			More Helmets Fewer Deaths: Motorcycle Helmet Legislation Impacts Traumatic Brain Injury Related Mortality in Young Adults	AMERICAN SURGEON			English	Article							LAW; PATTERNS	The aim of our study was to assess the impact of helmet legislations on the incidence and the mortality rate of motorcycle collision (MCC)-related traumatic brain injury (TBI) in young adult trauma patients. A 1-year (2011) retrospective analysis was performed of all patients under 21 years old with trauma-related hospitalization using the Nationwide Inpatient Sample database (representing 20% of all in-patient admissions). Patients with MCC were identified using E-codes. States were classified into three groups based on helmet legislations: universal age helmet legislation, <18 years helmet legislation, and <21 years helmet legislation. Outcome measures were the rates of TBI and mortality. Linear regression analysis was used to assess outcomes among the states. A total of 1,165,150 patients with trauma-related hospitalizations across 29 states were reviewed of which, 587 patients with MCC were included. Ten states had universal age legislation; 13 states had age <18 years legislation, and 6 states had age <21 years legislation. There was a lower incidence in the rate of TBI (P = 0.03) in states with universal helmet legislations compared with states with age-restricted helmet legislation. Universal helmet legislations lowered the rate of MCC-related TBI injures by a factor of 2.15 (beta coefficient: 2.15; 95% confidence interval: 0.91-10.18; P = 0.04). States with age-restricted helmet legislations have a higher rate of traumatic brain injury and mortality compared with states with universal helmet legislations. Establishing universal helmet legislations across the states may provide a potential preventive strategy against traumatic brain injury.	[Hassan, Ahmed; Jokar, Tahereh Orouji; Rhee, Peter; Ibraheem, Kareem; Kulvatunyou, Narong; Anderson, Kathryn Tinsley; Gries, Lynn; Roward, Zachary Thomas; Joseph, Bellal] Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, 1501 North Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, 1501 North Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Hassan, Ahmed/AAB-7241-2019	Anderson, Kathryn/0000-0002-3642-7984			Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Governors Highway Safety Association (GHSA), MOT; Nguyen HT, 2013, INT J INJ CONTROL SA, V20, P192, DOI 10.1080/17457300.2012.706617; Ivers R, 2004, COCHRANE DB SYST REV, P1; Ji M, 2006, ACCIDENT ANAL PREV, V38, P128, DOI 10.1016/j.aap.2005.08.002; Joseph B, 2014, EUR J TRAUMA EMERG S, V40, P729, DOI 10.1007/s00068-014-0453-0; Khalil M, 2015, J TRAUMA ACUTE CARE, V79, P60, DOI 10.1097/TA.0000000000000687; KRAUS JF, 1995, AM J PUBLIC HEALTH, V85, P96, DOI 10.2105/AJPH.85.1.96; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Liu B., 2008, COCHRANE DATABASE SY, V1; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; MCSWAIN NE, 1990, J TRAUMA, V30, P1189, DOI 10.1097/00005373-199010000-00002; National Highway Traffic Safety Administration, FET AN REP SYST FARS; Ouellet James V, 2006, Traffic Inj Prev, V7, P49, DOI 10.1080/15389580500338652; Renga S., MORE JUST LITTER ADV; RIVARA FP, 1985, PEDIATRICS, V75, P456; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; The Insurance Institute for Highway Safety (IIHS), MOT AND ATVS; ULMER RG, 2005, 809849 DOT HS US DEP	20	9	10	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUN	2017	83	6					541	546					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FA2VS	WOS:000405299900016	28637553				2022-02-06	
J	Honeybul, S; Ho, KM; Gillett, GR				Honeybul, S.; Ho, K. M.; Gillett, G. R.			Reconsidering the role of decompressive craniectomy for neurological emergencies	JOURNAL OF CRITICAL CARE			English	Article						Decompressive craniectomy; Outcome; Neurotrauma; Ethics	TRAUMATIC BRAIN-INJURY; MIDDLE-CEREBRAL-ARTERY; SEVERE HEAD-INJURY; ACUTE DISSEMINATED ENCEPHALOMYELITIS; SUBARACHNOID HEMORRHAGE PATIENTS; DURAL SINUS THROMBOSIS; INTRACRANIAL HYPERTENSION; MALIGNANT INFARCTION; BARBITURATE THERAPY; PROGNOSTIC MODELS	Objective: There is little doubt that decompressive craniectomy can reduce mortality. However, there is concern that any reduction in mortality comes at an increase in the number of survivors with severe neurological disability. Method: Over the past decade there have been several randomised controlled trials comparing surgical decompression with standard medical therapy in the context of ischaemic stroke and severe traumatic brain injury. The results of each trial are evaluated. Results: There is now unequivocal evidence that a decompressive craniectomy reduces mortality in the context of "malignant" middle infarction and following severe traumatic brain injury. However, it has only been possible to demonstrate an improvement in outcome by categorizing a mRS of 4 and upper severe disability as favourable outcome. This is contentious and an alternative interpretation is that surgical decompression reduces mortality but exposes a patient to a greater risk of survival with severe disability. Conclusion: It would appear unlikely that further randomised controlled trials will be possible given the significant reduction in mortality achieved by surgical decompression. It may be that observational cohort studies and outcome prediction models may provide data to determine those patients most likely to benefit from surgical decompression. Crown Copyright (C) 2017 Published by Elsevier Inc. All rights reserved.	[Honeybul, S.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, S.] Royal Perth Hosp, Perth, WA, Australia; [Ho, K. M.] Univ Western Australia, Dept Intens Care Med, Nedlands, WA, Australia; [Ho, K. M.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA, Australia; [Gillett, G. R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, G. R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GAAB MR, 1990, ACT NEUR S, V51, P326; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; GREENWOOD J, 1968, JOHNS HOPKINS MED J, V122, P254; HEFFNER JE, 1983, ARCH INTERN MED, V143, P765, DOI 10.1001/archinte.143.4.765; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2016, J NEUROSURG, V125, P775, DOI 10.3171/2016.3.JNS1683; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Honeybul S, 2016, NEUROSURGERY, V79, P231, DOI 10.1227/NEU.0000000000001115; Honeybul S, 2015, STROKE, V46, P2695, DOI 10.1161/STROKEAHA.115.010078; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Honeybul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032375; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Koerner IP, 2006, CURR OPIN ANESTHESIO, V19, P481, DOI 10.1097/01.aco.0000245271.84539.4c; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Larach DR, 2009, NEUROCRIT CARE, V11, P106, DOI 10.1007/s12028-008-9180-x; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Neugebauer H, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-9956-0; Nguyen Ha Son, 2011, Childs Nerv Syst, V27, P657, DOI 10.1007/s00381-010-1285-9; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; RANSOHOFF J, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106-a; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; Refai D, 2005, NEUROSURGERY, V56, P872, DOI 10.1227/01.NEU.0000156201.46473.A8; RENGACHARY SS, 1981, NEUROSURGERY, V8, P321, DOI 10.1227/00006123-198103000-00004; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Sahuquillo J, 2003, CURR PHARM DESIGN, V13, P2310; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; Sekula RF, 2006, J NEUROSURG, V105, P472, DOI 10.3171/jns.2006.105.3.472; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; STULA D, 1992, SCHWEIZ MED WSCHR, V122, P1137; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Wendell LC, 2010, NEUROCRIT CARE, V13, P113, DOI 10.1007/s12028-010-9361-2; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6	65	9	10	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2017	39						185	189		10.1016/j.jcrc.2017.03.006			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW4KR	WOS:000402470900032	28285834				2022-02-06	
J	Hurtubise, JL; Scavone, A; Sagar, S; Erdodi, LA				Hurtubise, Jessica L.; Scavone, Antonette; Sagar, Sanya; Erdodi, Laszlo A.			Psychometric Markers of Genuine and Feigned Neurodevelopmental Disorders in the Context of Applying for Academic Accommodations	PSYCHOLOGICAL INJURY & LAW			English	Article						ADHD; Dyslexia; Feigning; Disability evaluation; Performance validity assessment	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; ADULT INTELLIGENCE SCALE; RECOGNITION MEMORY TEST; CONTINUOUS PERFORMANCE-TEST; MALINGERING CUTOFF SCORES; REY 15-ITEM MEMORIZATION; TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; WORD CHOICE TEST	The article reviews systemic and context-specific challenges of psychoeducational assessment using two case studies: a 19-year-old woman with feigned attention-deficit/hyperactivity disorder and a 50-year-old man with genuine dyslexia. These cases demonstrate that providing a thorough evaluation of performance validity is an essential component of determining eligibility for academic accommodations in both clinical and higher education settings. At the same time, discounting failure on certain performance validity tests may be necessary to protect against false positive errors. In addition, empirically based test selection and interpretation has the potential to enhance the clinical confidence during differential diagnosis. Examining the internal consistency of a given neurocognitive profile provides valuable clinical information to determine both the credibility of the overall presentation and applying established diagnostic criteria. Although clinical research has yet to identify definitive markers of non-credible neurocognitive profiles, a multivariate approach to performance validity assessment that combines empirically validated indicators and sound clinical judgment can improve detection rates while simultaneously protecting against false positive errors.	[Hurtubise, Jessica L.; Scavone, Antonette; Sagar, Sanya; Erdodi, Laszlo A.] Univ Windsor, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada		Erdodi, LA (corresponding author), Univ Windsor, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Sagar, Sanya/0000-0001-7381-0803			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; Arnsten A. F. T., 2001, STIMULANT DRUGS ADHD, P185; Ashtari M, 2005, BIOL PSYCHIAT, V57, P448, DOI 10.1016/j.biopsych.2004.11.047; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Barkley R. A., 1990, ATTENTION DEFICIT HY; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Barrett SP, 2005, CAN J PSYCHIAT, V50, P457, DOI 10.1177/070674370505000805; Baxter P, 2008, QUAL REP, V13, P544; Beneventi H, 2010, INT J NEUROSCI, V120, P51, DOI 10.3109/00207450903275129; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2013, APPL NEUROPSYCH-ADUL, V20, P233, DOI 10.1080/09084282.2012.695757; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bowyer SM, 2010, IFMBE PROC, V28, P346; Bridgeman B, 2004, APPL MEAS EDUC, V17, P25, DOI 10.1207/s15324818ame1701_2; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Caravolas M, 2005, J EXP CHILD PSYCHOL, V92, P107, DOI 10.1016/j.jecp.2005.04.003; Cardillo R, 2017, RES DEV DISABIL, V64, P96, DOI 10.1016/j.ridd.2017.03.011; Carroll JM, 2016, J CHILD PSYCHOL PSYC, V57, P750, DOI 10.1111/jcpp.12488; Casey BJ, 2007, AM J PSYCHIAT, V164, P1729, DOI 10.1176/appi.ajp.2007.06101754; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chang Z, 2013, JAMA PSYCHIAT, V70, P311, DOI 10.1001/jamapsychiatry.2013.287; Coghill DR, 2014, PSYCHOL MED, V44, P1087, DOI 10.1017/S0033291713001761; Conners C. K., 2000, CONNERS CONTINUOUS P; Corbett B, 1999, ARCH CLIN NEUROPSYCH, V14, P373, DOI 10.1016/S0887-6177(98)00037-7; Darki F, 2014, J NEUROSCI, V34, P14455, DOI 10.1523/JNEUROSCI.1216-14.2014; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Diehl JJ, 2014, NEUROIMAGE, V101, P653, DOI 10.1016/j.neuroimage.2014.07.029; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Eicher JD, 2016, BRAIN IMAGING BEHAV, V10, P272, DOI 10.1007/s11682-015-9392-6; Eicher JD, 2013, MOL GENET METAB, V110, P201, DOI 10.1016/j.ymgme.2013.07.001; Elnakib A, 2014, J BIOMED NANOTECHNOL, V10, P2778, DOI 10.1166/jbn.2014.1895; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Erdodi LA, 2010, J ATTEN DISORD, V14, P43, DOI 10.1177/1087054709347199; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Fernandez VG, 2016, BRAIN LANG, V161, P45, DOI 10.1016/j.bandl.2015.07.006; Franquinho F, 2017, CEREB CORTEX, V27, P1732, DOI 10.1093/cercor/bhx023; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Friedmann N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00143; Friedmann N, 2010, CORTEX, V46, P1216, DOI 10.1016/j.cortex.2010.06.012; Gioyagnoli G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01997; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goswami U, 2011, J COGNITIVE NEUROSCI, V23, P325, DOI 10.1162/jocn.2010.21453; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Hadzibeganovic T, 2010, CORTEX, V46, P1312, DOI 10.1016/j.cortex.2010.06.011; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Harrison AG, 2010, CAN FAM PHYSICIAN, V56, P761; Harrison AG, 2010, APPL NEUROPSYCHOL, V17, P135, DOI 10.1080/09084281003715642; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Hopwood CJ, 2007, J PERS ASSESS, V88, P43, DOI 10.1207/s15327752jpa8801_06; Hu W, 2010, BRAIN, V133, P1694, DOI 10.1093/brain/awq106; Johnson DE, 2001, ARCH CLIN NEUROPSYCH, V16, P587; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Julian ER, 2004, ACAD MED, V79, P360, DOI 10.1097/00001888-200404000-00017; Kamradt JM, 2017, DEV PSYCHOPATHOL, V29, P259, DOI 10.1017/S0954579416000195; Kaplan E, 1983, BOSTON NAMING TEST; Kasparek T, 2015, J ATTEN DISORD, V19, P931, DOI 10.1177/1087054713505322; Kazdin A.E., 2017, RES DESIGN CLIN PSYC, V5; Kent KM, 2011, J ABNORM CHILD PSYCH, V39, P451, DOI 10.1007/s10802-010-9472-4; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kirley A, 2004, AM J MED GENET B, V131B, P38, DOI 10.1002/ajmg.b.30072; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Larrabee G. J., 2007, FORENSIC NEUROPSYCHO; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P117; Law JM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00124; Lee A, 2000, CLIN NEUROPSYCHOL, V14, P303, DOI 10.1076/1385-4046(200008)14:3;1-P;FT303; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Linkersdorfer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043122; Liston C, 2011, BIOL PSYCHIAT, V69, P1168, DOI 10.1016/j.biopsych.2011.03.022; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Losier BJ, 1996, J CHILD PSYCHOL PSYC, V37, P971, DOI 10.1111/j.1469-7610.1996.tb01494.x; LOU HC, 1984, ARCH NEUROL-CHICAGO, V41, P825, DOI 10.1001/archneur.1984.04050190031010; LOU HC, 1989, ARCH NEUROL-CHICAGO, V46, P48, DOI 10.1001/archneur.1989.00520370050018; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; MacKeben M, 2004, J VISION, V4, P388, DOI 10.1167/4.5.4; Makris N, 2008, CEREB CORTEX, V18, P1210, DOI 10.1093/cercor/bhm156; Mansour A., 2014, PSYCHOLOGY, V5, P1879, DOI [10.4236/psych.2014.516193, DOI 10.4236/PSYCH.2014.516193]; Martin A, 2016, HUM BRAIN MAPP, V37, P2676, DOI 10.1002/hbm.23202; Mascheretti S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.240; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Morse CL, 2013, CLIN NEUROPSYCHOL, V27, P1395, DOI 10.1080/13854046.2013.832385; Musso MW, 2014, J ATTEN DISORD, V18, P186, DOI 10.1177/1087054712441970; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Norton ES, 2015, CURR OPIN NEUROBIOL, V30, P73, DOI 10.1016/j.conb.2014.09.007; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Olulade OA, 2012, DEV NEUROPSYCHOL, V37, P617, DOI 10.1080/87565641.2012.702826; Ozernov-Palchik O, 2016, WIRES COGN SCI, V7, P156, DOI 10.1002/wcs.1383; Paulesu E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00830; Pearson, 2009, ADV CLIN SOLUTIONS W; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Polner B, 2015, EUR ARCH PSY CLIN N, V265, P689, DOI 10.1007/s00406-014-0531-7; Ramsay J.R., 2008, COGNITIVE BEHAV THER; Reinhart S, 2013, NEUROPSYCHOLOGIA, V51, P1273, DOI 10.1016/j.neuropsychologia.2013.03.006; Rey, 1964, EXAMEN CLINIQUE PSYC; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; Robles L, 2015, J CLIN EXP NEUROPSYC, V37, P614, DOI 10.1080/13803395.2015.1039961; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Ruffino M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00331; Russell Vivienne A, 2006, Behav Brain Funct, V2, P30, DOI 10.1186/1744-9081-2-30; Schatschneider C, 2004, J EDUC PSYCHOL, V96, P265, DOI 10.1037/0022-0663.96.2.265; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; Sjowall D., 2015, CHILD NEUROPSYCHOL, V23, P111, DOI [10.1080/09297049.2015.1063595, DOI 10.1080/09297049.2015.1063595]; Skiba T, 2011, BEHAV GENET, V41, P6, DOI 10.1007/s10519-011-9444-7; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Solanto MV, 2007, J ABNORM CHILD PSYCH, V35, P729, DOI 10.1007/s10802-007-9123-6; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; Specht K, 2009, SCAND J PSYCHOL, V50, P79, DOI 10.1111/j.1467-9450.2008.00688.x; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; SPRINZ DF, 2004, MODELS NUMBERS CASES; Stark R, 2011, NEUROPSYCHOLOGIA, V49, P426, DOI 10.1016/j.neuropsychologia.2010.12.012; Stretch L. S., 2005, PRACTICAL ASSESSMENT, V10, P1; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Suhr JA, 2011, ARCH CLIN NEUROPSYCH, V26, P1, DOI 10.1093/arclin/acq094; SZATMARI P, 1992, CHILD ADOLESC PSYCHI, V1, P361; Tammimies K, 2013, BIOL PSYCHIAT, V73, P583, DOI 10.1016/j.biopsych.2012.08.012; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TUCKER DM, 1984, PSYCHOL REV, V91, P185, DOI 10.1037/0033-295X.91.2.185; Van der Meere J. J., 1996, MONOGRAPHS CHILD ADO, P109; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; van Lieshout M, 2017, J ABNORM CHILD PSYCH, V45, P261, DOI 10.1007/s10802-016-0175-3; Varvara Pamela, 2014, Front Hum Neurosci, V8, P120, DOI 10.3389/fnhum.2014.00120; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; von Karolyi C, 2003, BRAIN LANG, V85, P427, DOI 10.1016/S0093-934X(03)00052-X; Wadsworth SJ, 2010, BEHAV GENET, V40, P751, DOI 10.1007/s10519-010-9349-x; Wang HC, 2015, COGN NEUROPSYCHOL, V32, P58, DOI 10.1080/02643294.2014.1003536; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D., 2008, WAIS IV TECHNICAL IN; Wechsler D., 2009, WMS IV TECHNICAL INT; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Weyandt LL, 2008, DEV DISABIL RES REV, V14, P311, DOI 10.1002/ddrr.38; Wilkinson G. S., 2006, WIDE RANGE ACHIEVMEN; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Williamson KD, 2014, CLIN NEUROPSYCHOL, V28, P1182, DOI 10.1080/13854046.2014.956674; Wolf RC, 2009, HUM BRAIN MAPP, V30, P2252, DOI 10.1002/hbm.20665; Wolf RC, 2010, NEUROPSYCHOLOGIA, V48, P309, DOI 10.1016/j.neuropsychologia.2009.09.020; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406	179	9	9	2	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2017	10	2					121	137		10.1007/s12207-017-9287-5			17	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	FG6NI	WOS:000410497700003					2022-02-06	
J	Minns, RA; Jones, PA; Tandon, A; Fleck, BW; Mulvihill, AO; Minns, FC				Minns, Robert A.; Jones, Patricia A.; Tandon, Anamika; Fleck, Brian W.; Mulvihill, Alan O.; Minns, Fiona C.			Raised intracranial pressure and retinal haemorrhages in childhood encephalopathies	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							INFLICTED BRAIN-INJURY; SHAKEN BABY SYNDROME; HEAD-INJURY; CHILDREN; CLASSIFICATION; HYPERTENSION; HEMATOMAS; PATTERNS; SERIES	AimTo explore the relationship between raised intracranial pressure (RICP) and retinal haemorrhages in traumatic and non-traumatic childhood encephalopathies. MethodA prospective study of 112 children (35 females and 77 males, age range 0.01mo-17y 8.3mo; mean 5y 8.6mo, median 4y 5.6mo) included 57 accidental traumatic brain injuries (ATBIs), 21 inflicted traumatic brain injuries (ITBIs), and 34 non-traumatic encephalopathy cases. Measurements included intracranial pressure (ICP), cerebral perfusion pressure, pressure-time index of ICP, and number, zone, and layer of retinal haemorrhages on retinal imaging. ResultsGroup I had measured elevated ICP (n=42), Group II had clinical and/or radiological signs of RICP (n=21), and Group III had normal ICP (n=49). In the combined Groups I and II, 38% had retinal haemorrhages. Multiple logistic regression confirmed that the presence of retinal haemorrhages was significantly related to the presence of RICP independent of age and aetiology; however, the occurrence and overall numbers were not significantly related to the specific ICP level. The numbers of intraretinal (nerve-fibre layer and dot blot) retinal haemorrhages were significantly greater in those with RICP. The ITBI population was significantly different from the other combined aetiological categories. InterpretationThe study results indicate a complex RICP/retinal haemorrhage relationship. There was no evidence of existing retinal haemorrhages being exacerbated or new retinal haemorrhages developing during periods of confirmed RICP.	[Minns, Robert A.; Jones, Patricia A.] Univ Edinburgh, Dept Child Life & Hlth, Coll Med & Vet Med, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland; [Tandon, Anamika; Fleck, Brian W.; Mulvihill, Alan O.] Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Fleck, Brian W.; Mulvihill, Alan O.] Royal Hosp Sick Children, Edinburgh, Midlothian, Scotland; [Minns, Fiona C.] New Royal Infirm, Dept Radiol, Edinburgh, Midlothian, Scotland		Minns, RA (corresponding author), Univ Edinburgh, Dept Child Life & Hlth, Coll Med & Vet Med, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	Robert.Minns@ed.ac.uk			RS Macdonald Charitable Trust Edinburgh; Royal College of Surgeons Edinburgh (Ophthalmology Grant); Friends of The Sick Kids Foundation, Edinburgh, Scotland	We are grateful to Dr Rob Elton for statistical advice, the medical and nursing staff in the PICU, the neurology ward at RHSC, and the staff of the department of Child Life and Health in University of Edinburgh. We are indebted to the patients and parents/carers for consenting to participate in this study. Funding was obtained from the RS Macdonald Charitable Trust Edinburgh, from the Royal College of Surgeons Edinburgh (Ophthalmology Grant), and from the Friends of The Sick Kids Foundation, Edinburgh, Scotland. The authors have stated that they had no interests which might be perceived as posing a conflict or bias.	Bhardwaj G, 2010, CLIN EXP OPHTHALMOL, V38, P18; Binenbaum G, 2013, PEDIATRICS, V132, pE430, DOI 10.1542/peds.2013-0262; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Cowley R A, 1975, Md State Med J, V24, P37; Fleck BW, 2010, BRIT J OPHTHALMOL, V94, P886, DOI 10.1136/bjo.2009.162271; Forbes BJ, 2008, J AAPOS, V12, P177, DOI 10.1016/j.jaapos.2007.07.009; Jones PA, 2005, ACT NEUR S, V95, P29; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; KIRKPATRICK M, 1989, ARCH DIS CHILD, V64, P124, DOI 10.1136/adc.64.1.124; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Minns RA, 2004, BRIT MED J, V328, P766, DOI 10.1136/bmj.328.7442.766; Minns RA, 1991, CLIN DEV MED; Minns RA, 2012, PEDIATRICS, V130, pE1227, DOI 10.1542/peds.2011-3274; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; Mulvihill AO, 2011, BRIT J OPHTHALMOL, V95, P99, DOI 10.1136/bjo.2009.168153; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Shiau T, 2012, ARCH PEDIAT ADOL MED, V166, P623, DOI 10.1001/archpediatrics.2012.46; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; WEISBERG LA, 1975, MEDICINE, V54, P197, DOI 10.1097/00005792-197505000-00002	21	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JUN	2017	59	6					597	604		10.1111/dmcn.13419			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	ET8UG	WOS:000400577100014	28369828	Bronze, Green Submitted			2022-02-06	
J	Perrin, PB; Stevens, LF; Sutter, M; Lequerica, AH; Krch, D; Kolakowsky-Hayner, SA; Arango-Lasprilla, JC				Perrin, Paul B.; Stevens, Lillian F.; Sutter, Megan; Lequerica, Anthony H.; Krch, Denise; Kolakowsky-Hayner, Stephanie A.; Carlos Arango-Lasprilla, Juan			Reciprocal Causation Between Functional Independence and Mental Health 1 and 2 Years After Traumatic Brain Injury: A Cross-Lagged Panel Structural Equation Model	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Functional Independence; Depression; Anxiety; Life Satisfaction; Causality	DISABILITY RATING-SCALE; PSYCHIATRIC-DISORDERS; LIFE SATISFACTION; TEMPORAL RELATIONSHIP; PUBLIC-HEALTH; UNITED-STATES; HEAD-INJURY; AXIS-I; DEPRESSION; VALIDITY	Objective The research attempting to disentangle the directionality of relationships between mental health and functional outcomes after traumatic brain injury (TBI) is growing but has yielded equivocal findings or focused on isolated predictors or isolated outcomes. The purpose of the current study was to use cross-lagged panel and structural equation modeling (SEM) techniques to examine causality between comprehensive indices of mental health (depression, anxiety, and life satisfaction) and functional independence in a national sample of individuals with TBI over the first 2 years after injury. Design Participants were 4,674 individuals with TBI from the TBI Model Systems Database. Results The SEM, which yielded good fit indices, suggested that individuals with TBI with greater mental health problems at 1 and 2 years after injury had lower functional independence at those same time points. The standardized path loadings for mental health problems and for functional independence over time were large, suggesting a high degree of consistency in mental health and functional independence across 1 and 2 years. In terms of cross-lag, mental health at Time 1 did not exert a unique effect on functional independence at Time 2, but functional independence at Time 1 exerted a statistically significant but quite small unique effect on mental health at Time 2. Conclusions This combination of results suggests that functional independence is only slightly more causal than mental health in the relationship between mental health and functional independence over the first 2 years post-TBI, and that instead, reciprocal causality is a more likely scenario.	[Perrin, Paul B.; Sutter, Megan] Virginia Commonwealth Univ, Richmond, VA USA; [Stevens, Lillian F.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Lequerica, Anthony H.; Krch, Denise] Kessler Fdn, W Orange, NJ USA; [Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp Barakaldo, BioCruces Hlth Res Inst, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao, Spain		Perrin, PB (corresponding author), Virginia Commonwealth Univ, Dept Psychol, 800 West Franklin St,Room 201,POB 842018, Richmond, VA 23284 USA.		Blanco, Leire/O-5114-2017; Kolakowsky-Hayner, Stephanie A./I-9858-2019; Sutter, Megan/L-9770-2019; Arango-Lasprilla, Juan Carlos/AAB-5407-2019; Perrin, Paul/L-5373-2015	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Sutter, Megan/0000-0001-9816-9549; Perrin, Paul/0000-0003-2070-215X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) of the U.S. Department of Human Services	The TBI Model Systems National Database is a multicenter study of the TBI Model Systems Centers Program and is supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) of the U.S. Department of Human Services. However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDILRR, or the U.S. Department of Human Services.	Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bollen K. A., 1989, STRUCTURAL EQUATIONS, DOI 10.1002/9781118619179; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; JONES C, 1979, AM J NURS, V79, P1551; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KENNY DA, 1975, PSYCHOL BULL, V82, P887, DOI 10.1037/0033-2909.82.6.887; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lollar DJ, 2003, ANNU REV PUBL HEALTH, V24, P195, DOI 10.1146/annurev.publhealth.24.100901.140844; LYNESS JM, 1993, AM J PSYCHIAT, V150, P910; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Valk-Kleibeuker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087414; Warren L, 1996, J REHABIL RES DEV, V33, P404; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7	45	9	9	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUN	2017	96	6					374	380		10.1097/PHM.0000000000000644			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EV4DO	WOS:000401708800007	27754999				2022-02-06	
J	Sackheim, AM; Stockwell, D; Villalba, N; Haines, L; Scott, CL; Russell, S; Hammack, SE; Freeman, K				Sackheim, Adrian M.; Stockwell, David; Villalba, Nuria; Haines, Laurel; Scott, Chary L.; Russell, Sheila; Hammack, Sayamwong E.; Freeman, Kalev			Traumatic brain injury impairs sensorimotor function in mice	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Neurologic assessment; Injury severity score; Sensorimotor function; Acoustic startle response	ACOUSTIC STARTLE RESPONSE; MODEL; RATS; PAIN; PATHOPHYSIOLOGY; HABITUATION; BEHAVIOR; IMPACT	Introduction: Understanding the extent to which murine models of traumatic brain injury (TBI) replicate clinically relevant neurologic outcomes is critical for mechanistic and therapeutic studies. We determined sensorimotor outcomes in a mouse model of TBI and validated the use of a standardized neurologic examination scoring system to quantify the extent of injury. Materials and methods: We used a lateral fluid percussion injury model of TBI and compared TBI animals to those that underwent sham surgery. We measured neurobehavioral deficits using a standardized 12-point neurologic examination, magnetic resonance imaging, a rotating rod test, and longitudinal acoustic startle testing. Results: TBI animals had a significantly decreased ability to balance on a rotating rod and a marked reduction in the amplitude of acoustic startle response. The neurologic examination had a high inter-rater reliability (87% agreement) and correlated with latency to fall on a rotating rod (R-s = -0.809). Conclusions: TBI impairs sensorimotor function in mice, and the extent of impairment can be predicted by a standardized neurologic examination. (C) 2017 Elsevier Inc. All rights reserved.	[Sackheim, Adrian M.; Stockwell, David; Villalba, Nuria; Haines, Laurel; Russell, Sheila; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Villalba, Nuria; Scott, Chary L.; Freeman, Kalev] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Hammack, Sayamwong E.] Univ Vermont, Dept Psychol Sci, Burlington, VT 05405 USA		Freeman, K (corresponding author), Univ Vermont, 89 Beaumont Ave,Given Bldg Room E301, Burlington, VT 05405 USA.	Kalev.freeman@uvm.edu			Totman Medical Research Trust; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08-GM-098795, UM1-HL-120877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795] Funding Source: NIH RePORTER	The authors thank the University of Vermont Instrumentation and Model Facility (IMF) for their technical prowess and support with the fluid percussion apparatus. This work was supported by the Totman Medical Research Trust and the National Institute of Health (K08-GM-098795 and UM1-HL-120877).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; DAVIS M, 1969, J COMP PHYSIOL PSYCH, V67, P486, DOI 10.1037/h0027308; Dorsett CR, 2016, J NEUROTRAUMA; EBERT U, 1992, NEUROREPORT, V3, P429, DOI 10.1097/00001756-199205000-00013; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox JH, 2008, BEHAV NEUROSCI, V122, P943, DOI 10.1037/0735-7044.122.4.943; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Hawkins P, 2002, LAB ANIM-UK, V36, P378, DOI 10.1258/002367702320389044; Hinzman JM, 2016, J NEUROTRAUMA; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; KRASE W, 1993, NEUROREPORT, V4, P13, DOI 10.1097/00001756-199301000-00003; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lane ST, 2013, INT J PSYCHOPHYSIOL, V88, P55, DOI 10.1016/j.ijpsycho.2013.01.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Peterson NC, 2004, CONTEMP TOP LAB ANIM, V43, P74; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Thal SC, 2008, J NEUROL SCI, V268, P150, DOI 10.1016/j.jns.2007.12.002; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Williams C, 2012, J CLIN EXP NEUROPSYC, V34, P948, DOI 10.1080/13803395.2012.703641; Wongpakaran N, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-61; Yarnell AM, 2016, CURR PROTOC NEUROSCI, V75	38	9	9	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2017	213						100	109		10.1016/j.jss.2017.02.016			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FA3RV	WOS:000405363000014	28601302	Green Accepted			2022-02-06	
J	Weaver, RH; Roberto, KA				Weaver, Raven H.; Roberto, Karen A.			Home and Community-Based Service Use by Vulnerable Older Adults	GERONTOLOGIST			English	Article						Home and community-based services; Service utilization; Cluster analysis	UNMET NEEDS; CARE; CAREGIVERS; INSTITUTIONALIZATION; BURDEN; ACCESS; IMPACT	Purpose of the Study: The purpose of this study was to identify different types of clients who use home and community-based services. Design and Methods: Enrollment characteristics of 76 clients at risk of nursing home placement and Medicaid spend-down who were enrolled in the Virginia Community Living Program were analyzed. Two-step cluster analysis identified 4 groups of service users. Results: Enabling resources (caregiver relationship to participant, participant living arrangement, and length of time caregiver provided assistance to participant) and disability type (physical, cognitive, traumatic brain injury, or other) differentiated the client groups. Groups differed on average service cost per day and likelihood of nursing home placement if services were not provided. Implications: Findings point to the value of having practitioners assist vulnerable clients in tailoring services to meet different care needs and the need for refining policies guiding home and community-based care.	[Weaver, Raven H.] Virginia Tech, Dept Human Dev, Blacksburg, VA USA; [Weaver, Raven H.; Roberto, Karen A.] Virginia Tech, Ctr Gerontol, 230 Grove Lane 0555, Blacksburg, VA 24061 USA; [Roberto, Karen A.] Virginia Tech, Inst Soc Culture & Environm, Blacksburg, VA USA		Weaver, RH (corresponding author), Virginia Tech, Ctr Gerontol, 230 Grove Lane 0555, Blacksburg, VA 24061 USA.	Raven89@vt.edu	Roberto, Karen A./AAC-1805-2019	Roberto, Karen A./0000-0003-1153-1811	Virginia Department for the Aging and Rehabilitative Services (DARS); Administration on Aging (AoA)	The project described was supported from a contract from the Virginia Department for the Aging and Rehabilitative Services (DARS), formerly known as the Virginia Department for the Aging, to evaluate the Community Living Program, supported by a grant from the Administration on Aging (AoA). The content is solely the responsibility of the authors and does not necessarily represent the official views of DARS or the AoA.	Administration on Aging (AoA), COMM LIV PROGR GRANT; Alkema G., 2013, CURRENT ISSUES POTEN; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Brawijaya Professional Statistical Analysis, 2011, 2 STEP CLUSTER ANAL; Brossoie N., 2012, VIRGINIAS NURSING HO; Caffrey C, 2011, NATL HLTH STAT REPOR, V38; Carlson BL, 2007, HEALTH SERV RES, V42, P467, DOI 10.1111/j.1475-6773.2006.00673.x; Casado BL, 2011, J AGING HEALTH, V23, P529, DOI 10.1177/0898264310387132; Castora-Binkley M, 2011, J AGING SOC POLICY, V23, P19, DOI 10.1080/08959420.2011.532001; Chen YM, 2010, J AGING HEALTH, V22, P267, DOI 10.1177/0898264309356593; Crisp Z., 2003, MONEY FOLLOWS PERSON; Crowley Jeffrey S., 2003, OVERVIEW INDEPENDENC; Family Caregiver Alliance, 2012, SEL CAR STAT; Farber N., 2011, AG PLACE STATE SURVE; Ferris RE, 2016, J APPL GERONTOL, V35, P179, DOI 10.1177/0733464814525504; Fields NL, 2014, J APPL GERONTOL, V33, P130, DOI 10.1177/0733464812443308; Foster L, 2005, GERONTOLOGIST, V45, P474, DOI 10.1093/geront/45.4.474; Gaugler JE, 2005, GERONTOLOGIST, V45, P177, DOI 10.1093/geront/45.2.177; Gaugler JE, 2014, J APPL GERONTOL, V33, P624, DOI 10.1177/0733464812454008; GOINS RT, 2006, THE JOURNAL OF RURAL, V21, P206, DOI DOI 10.1111/J.1748-0361.2005.TB00084.X; Greenfield EA, 2016, GERONTOLOGIST, V56, P651, DOI 10.1093/geront/gnu162; Harrington C, 2012, J AGING SOC POLICY, V24, P169, DOI 10.1080/08959420.2012.659118; Hong SI, 2011, AGEING SOC, V31, P1307, DOI 10.1017/S0144686X10001418; Kaye HS, 2010, HEALTH AFFAIR, V29, P11, DOI 10.1377/hlthaff.2009.0535; Lehning AJ, 2010, J GERONTOL SOC WORK, V53, P43, DOI 10.1080/01634370903361979; Li H, 2005, FAM SOC, V86, P55, DOI 10.1606/1044-3894.1877; Li H, 2006, SOC WORK RES, V30, P109, DOI 10.1093/swr/30.2.109; Noruis M.J., 2004, SPSS 13 0 ADV STAT P, P361; PETERS M, 1992, NEUROPSYCHOLOGIA, V30, P373, DOI 10.1016/0028-3932(92)90110-8; Reaves E. L, 2013, LONG TERM SERV SUPP; Robinson KM, 2013, PUBLIC HEALTH NURS, V30, P501, DOI 10.1111/phn.12041; Robison J, 2012, J AGING SOC POLICY, V24, P251, DOI 10.1080/08959420.2012.676315; Sands Laura P, 2012, Medicare Medicaid Res Rev, V2, DOI 10.5600/mmrr.002.03.a03; Schore J, 2007, HEALTH SERV RES, V42, P446, DOI 10.1111/j.1475-6773.2006.00679.x; Stone R., 2011, LONG TEMR CARE ELDER; Tang Fengyan, 2010, Home Health Care Serv Q, V29, P138, DOI 10.1080/01621424.2010.511518; Weiner J. M., 2013, MED SPEND IMPLICATIO; Wiener JM, 2007, GERONTOLOGIST, V47, P763, DOI 10.1093/geront/47.6.763; [No title captured]	39	9	9	3	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-9013	1758-5341		GERONTOLOGIST	Gerontologist	JUN 1	2017	57	3					540	551		10.1093/geront/gnv149			12	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	EZ1GO	WOS:000404458500018	26608335	Bronze, Green Submitted			2022-02-06	
J	Andrew, RD; Hsieh, YT; Brisson, CD				Andrew, R. David; Hsieh, Yi-Ting; Brisson, C. Devin			Spreading depolarization triggered by elevated potassium is weak or absent in the rodent lower brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Brainstem; ischemia; migraine aura; spreading depolarization; traumatic brain injury	ANOXIC DEPOLARIZATION; DEPRESSION; MECHANISMS; GLUTAMATE; ISCHEMIA; STROKE; DAMAGE; PATHOPHYSIOLOGY; SUSCEPTIBILITY; POPULATION	We examined in live coronal slices from rat and mouse which brain regions generate potassium-triggered spreading depolarization (SDKt). This technique simulates cortical spreading depression, which underlies migraine aura in the intact brain. An SDKt episode was evoked by increasing bath [K+](o) and recorded as a propagating front of elevated light transmittance representing transient neuronal swelling in gray matter of neocortex, hippocampus, striatum, and thalamus. In contrast, SDKt was not imaged in hypothalamic nuclei or brainstem with exception of those nuclei near the dorsal brainstem surface. In rat slices, single neurons were whole-cell current clamped during SDKt. "Higher" neurons depolarized to near zero millivolts indicating SDKt generation. In contrast, seven types of neurons in hypothalamus and brainstem only slowly depolarized without generating SDKt, supporting our imaging findings. Therefore, SDKt is not a default of CNS neurons but rather displays a region-specific susceptibility, similar to anoxic depolarization, which we have proposed is correlated with a region's vulnerability to traumatic brain injury. In the higher brain, SDKt may be a vestigial spreading depolarization that originally evolved to shut down and vasoconstrict gray matter regions more exposed to impact and contusion.	[Andrew, R. David; Hsieh, Yi-Ting; Brisson, C. Devin] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada		Andrew, RD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	andrewd@queensu.ca					Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; ANDREW RD, 1991, J NEUROL SCI, V101, P7, DOI 10.1016/0022-510X(91)90013-W; ANDREW RD, 1989, BRAIN RES, V498, P175, DOI 10.1016/0006-8993(89)90417-4; Andrew RD, 2012, NEUROSCIENCE; Andrew RD, 2011, VAS 2011 11 INT C NE, P311; Andrew RD, 2016, BRAIN FUNCTION RESPO, P119; Armstrong GAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028994; Brisson CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096585; Brisson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079589; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; BURES J, 1981, J NEUROBIOL, V12, P211, DOI 10.1002/neu.480120303; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Eikermann-Haerter K, 2013, REV NEUROSCIENCE, V24, P353, DOI 10.1515/revneuro-2013-0005; Footitt DR, 1998, BRAIN RES, V781, P339, DOI 10.1016/S0006-8993(97)01359-0; Gniel HM, 2013, J NEUROPHYSIOL, V109, P2923, DOI 10.1152/jn.00855.2011; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Holliday R, 2005, BIOGERONTOLOGY, V6, P363, DOI 10.1007/s10522-005-4811-5; Hou N, 2014, J NEUROPHYSIOL, V112, P814, DOI 10.1152/jn.00201.2014; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Loder E, 2002, CEPHALALGIA, V22, P624, DOI 10.1046/j.1468-2982.2002.00437.x; Longstreth WT, 2008, NEUROLOGY GEN MED, P163; MacAulay, 2012, WILEY INTERDISCIP RE, V1, P373, DOI [10.1002/wmts.54, DOI 10.1002/WMTS.54]; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; Ostby I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000272; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Richter F, 2010, EXP NEUROL, V224, P146, DOI 10.1016/j.expneurol.2010.03.004; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; SIEBER FE, 1995, STROKE, V26, P2091, DOI 10.1161/01.STR.26.11.2091; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; SOMJEN GG, 1992, CAN J PHYSIOL PHARM, V70, pS248, DOI 10.1139/y92-268; Somjen GG, 2004, IONS IN THE BRAIN, P268; Spong KE, 2014, J INSECT PHYSIOL, V66, P1, DOI 10.1016/j.jinsphys.2014.05.009; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	49	9	9	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1735	1747		10.1177/0271678X16657344			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200013	27381828	Green Published, Bronze			2022-02-06	
J	Chavez-Valdez, R; O'Connor, M; Perin, J; Reyes, M; Armstrong, J; Parkinson, C; Gilmore, M; Jennings, J; Northington, FJ; Lee, JK				Chavez-Valdez, Raul; O'Connor, Matthew; Perin, Jamie; Reyes, Michael; Armstrong, Jillian; Parkinson, Charlamaine; Gilmore, Maureen; Jennings, Jacky; Northington, Frances J.; Lee, Jennifer K.			Sex-specific associations between cerebrovascular blood pressure autoregulation and cardiopulmonary injury in neonatal encephalopathy and therapeutic hypothermia	PEDIATRIC RESEARCH			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; IMPAIRED CEREBRAL AUTOREGULATION; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; FEMALE RATS; EXPRESSION; CORRELATE; NEWBORNS; OUTCOMES; PIGLETS	BACKGROUND: Cardiopulmonary injury is common in neonatal encephalopathy, but the link with cerebrovascular dysfunction is unknown. We hypothesized that alterations of cerebral autoregulation are associated with cardiopulmonary injury in neonates treated with therapeutic hypothermia (TH) for neonatal encephalopathy. METHODS: The cerebral hemoglobin volume index (HVx) from near-infrared spectroscopy was used to identify the mean arterial blood pressure (MAP) with optimal autoregulatory vasoreactivity (MAP(OPT)). We measured associations between MAP relative to MAP(OPT) and indicators of cardiopulmonary injury (duration of mechanical respiratory support and administration of inhaled nitric oxide (iNO), milrinone, or steroids). RESULTS: We identified associations between cerebrovascular autoregulation and cardiopulmonary injury that were often sex-specific. Greater MAP deviation above MAP(OPT) was associated with shorter duration of intubation in boys but longer ventilatory support in girls. Greater MAP deviation below MAP(OPT). related to longer intensive care stay in boys. Milrinone was associated with greater MAP deviation below MAP(OPT) in girls. CONCLUSION: MAP deviation from MAP(OPT) may relate to cardiopulmonary injury after neonatal encephalopathy, and sex may modulate this relationship. Whereas MAP above MAP(OPT) may protect the brain and lungs in boys, it may be related to cardiopulmonary injury in girls. Future studies are needed to characterize the role of sex in these associations.	[Chavez-Valdez, Raul; O'Connor, Matthew; Gilmore, Maureen; Northington, Frances J.] Johns Hopkins Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA; [Chavez-Valdez, Raul; Parkinson, Charlamaine; Northington, Frances J.; Lee, Jennifer K.] Johns Hopkins Sch Med, Neurosci Intens Care Nursery, Baltimore, MD 21205 USA; [Perin, Jamie; Jennings, Jacky] Johns Hopkins Sch Med, Dept Pediat, Ctr Child & Community Hlth Res CCHR, Baltimore, MD USA; [Reyes, Michael; Armstrong, Jillian; Lee, Jennifer K.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA		Chavez-Valdez, R (corresponding author), Johns Hopkins Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA.; Chavez-Valdez, R (corresponding author), Johns Hopkins Sch Med, Neurosci Intens Care Nursery, Baltimore, MD 21205 USA.	rchavez2@jhmi.edu		jennings, jacky/0000-0002-3789-5122	National Institutes of Health (Bethesda, MD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD070996, R01HD074593, K08N5080984, R21HD072845]; Johns Hopkins University (Baltimore, MD)Johns Hopkins University; American Heart Association (Dallas,TX)American Heart Association; Sutland-Pakula Endowment for Neonatal Research (RC-V); Medtronic (Minneapolis, MN)Medtronic; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD074593, R01HD070996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS080984, K08NS096115] Funding Source: NIH RePORTER	This study is supported by National Institutes of Health (Bethesda, MD) R01HD070996 (F.J.N.), R01HD074593 (F.J.N.), K08N5080984 (J.K.L.), and R21HD072845 (J.K.L.), by Johns Hopkins University (Baltimore, MD) Clinician Scientist Award (J.K.L.), by the American Heart Association (Dallas,TX) Grant-in-Aid (J.K.L.), and the Sutland-Pakula Endowment for Neonatal Research (RC-V). Medtronic (Minneapolis, MN) provided partial funding for this study, but had no involvement in study design, analysis, interpretation and writing of this manuscript.	Ahnstedt H, 2015, J CEREBR BLOOD F MET, V35, P454, DOI 10.1038/jcbfm.2014.217; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Arruza L, 2016, PEDIATR RES, V79, P401, DOI 10.1038/pr.2015.87; Breu M, 2016, DEV NEUROSCI-BASEL, V38, P83, DOI 10.1159/000442943; Burton VJ, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0464-4; Chalak LF, 2016, PEDIATR NEUROL, V55, P30, DOI 10.1016/j.pediatrneurol.2015.11.010; Chavez-Valdez R, 2014, NEUROSCIENCE, V260, P106, DOI 10.1016/j.neuroscience.2013.12.023; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Hankins GDV, 2002, OBSTET GYNECOL, V99, P688, DOI 10.1016/S0029-7844(02)01959-2; Howlett JA, 2013, PEDIATR RES, V74, P525, DOI 10.1038/pr.2013.132; Ibrahim YI, 2012, J PEDIATR-US, V160, P245, DOI 10.1016/j.jpeds.2011.07.040; Jia J, 2016, EXP NEUROL, V279, P75, DOI 10.1016/j.expneurol.2016.02.016; Larson AC, 2013, J APPL PHYSIOL, V115, P1433, DOI 10.1152/japplphysiol.00238.2013; Lee JK, 2014, RESUSCITATION, V85, P1387, DOI 10.1016/j.resuscitation.2014.07.006; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Massaro AN, 2015, J NEUROPHYSIOL, V114, P818, DOI 10.1152/jn.00353.2015; Milerova M, 2016, MOL CELL BIOCHEM, V412, P147, DOI 10.1007/s11010-015-2619-4; Nishuchi M, 2010, NEUROSURGERY, V66, P158, DOI 10.1227/01.NEU.0000363153.62579.FF; Ono M, 2012, BRIT J ANAESTH, V109, P391, DOI 10.1093/bja/aes148; Ono M, 2014, J THORAC CARDIOV SUR, V147, P483, DOI 10.1016/j.jtcvs.2013.07.069; Pappas A, 2011, J PEDIATR-US, V158, P752, DOI 10.1016/j.jpeds.2010.10.019; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, ARCH DIS CHILD-FETAL, V97, pF398, DOI 10.1136/archdischild-2011-301524; Tekes A, 2015, AM J NEURORADIOL, V36, P188, DOI 10.3174/ajnr.A4083; Truong GT, 2014, J PHYSIOL-LONDON, V592, P1785, DOI 10.1113/jphysiol.2013.269340; Xue Q, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129619; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	9	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	MAY	2017	81	5					759	766		10.1038/pr.2017.23			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EU1SN	WOS:000400800600008	28141793	Green Accepted, Bronze			2022-02-06	
J	Coffey, NT; Cassese, J; Cai, XS; Garfinkel, S; Patel, D; Jones, R; Shaewitz, D; Weinstein, AA				Coffey, Nathan T.; Cassese, James; Cai, Xinsheng; Garfinkel, Steven; Patel, Drasti; Jones, Rebecca; Shaewitz, Dahlia; Weinstein, Ali A.			Identifying and Understanding the Health Information Experiences and Preferences of Caregivers of Individuals With Either Traumatic Brain Injury, Spinal Cord Injury, or Burn Injury: A Qualitative Investigation	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						traumatic brain injury; burns; spinal cord injuries; caregivers; health information,consumer; qualitative research	SUPPORTIVE CARE NEEDS; FAMILY CAREGIVERS; CANCER CAREGIVERS; RESOURCE PREFERENCES; SELF-EFFICACY; CHILDREN; INTERVENTION; DEPRESSION; SURVIVORS; PARENTS	Background: In order to meet the challenges of caring for an injured person, caregivers need access to health information. However, caregivers often feel that they lack adequate information. Previous studies of caregivers have primarily focused on either their time and emotional burdens or their health outcomes, but the information needs of caregivers have not been thoroughly investigated. Objective: The purpose of this investigation was to identify the preferred sources of health information for caregivers supporting individuals with injuries and to explore how access to this information could be improved. Methods: A total of 32 caregivers participated in semistructured interviews, which were used in order to develop a more in-depth understanding of these caregivers' information needs. Digital audio recordings of the interviews were used for analysis purposes. These audio recordings were analyzed using a thematic analysis or qualitative content analysis. All of participant's interviews were then coded using the qualitative analysis program, Nvivo 10 for Mac (QSR International). Results: The caregivers endorsed similar behaviors and preferences when seeking and accessing health information. Medical professionals were the preferred source of information, while ease of access made the Internet the most common avenue to obtain information. The challenges faced by participants were frequently a result of limited support. In describing an ideal health system, participants expressed interest in a comprehensive care website offering support network resources, instructive services about the injury and caregiving, and injury-specific materials. Conclusions: According to the participants, an ideal health information system would include a comprehensive care website that offered supportive network resources, instructive services about the injury and caregiving, and materials specific of patient injury.	[Coffey, Nathan T.; Cassese, James; Patel, Drasti; Weinstein, Ali A.] George Mason Univ, Ctr Study Chron Illness & Disabil, 4400 Univ Dr,MSN 5B7, Fairfax, VA 22030 USA; [Cai, Xinsheng; Garfinkel, Steven; Jones, Rebecca; Shaewitz, Dahlia] Amer Inst Res, Washington, DC USA		Weinstein, AA (corresponding author), George Mason Univ, Ctr Study Chron Illness & Disabil, 4400 Univ Dr,MSN 5B7, Fairfax, VA 22030 USA.	aweinst2@gmu.edu		Weinstein, Ali/0000-0002-3371-6086; Cai, Xinsheng "Cindy"/0000-0001-6057-3597; Patel, Drasti/0000-0001-8729-5531	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services	This work was funded by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR).	[Anonymous], 2017, NEUROPSYCHOL REHABIL; [Anonymous], 2017, PSYCHOGERIATRICS; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; CELLA DF, 1988, J PEDIATR PSYCHOL, V13, P87, DOI 10.1093/jpepsy/13.1.87; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Coughlin J., 2010, OUTCOMES INSIGHTS HL, V2, P1; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Dolce MC, 2011, ONCOL NURS FORUM, V38, P353, DOI 10.1188/11.ONF.353-359; Dreer LE, 2007, REHABIL PSYCHOL, V52, P351, DOI 10.1037/0090-5550.52.3.351; Evercare National Alliance for Caregiving, 2006, CAR DECL CLOS LOOK H; Fagnano M, 2012, CLIN PEDIATR, V51, P267, DOI 10.1177/0009922811421413; Fox S, 2012, FAMILY CAREGIVERS; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Girgis A, 2013, PSYCHO-ONCOLOGY, V22, P1557, DOI 10.1002/pon.3166; Greenwood N, 2015, MATURITAS, V82, P162, DOI 10.1016/j.maturitas.2015.07.013; Gulin SL, 2014, FAM SYST HEALTH, V32, P53, DOI 10.1037/a0032623; Hendrix CC, 2016, SUPPORT CARE CANCER, V24, P327, DOI 10.1007/s00520-015-2797-3; Hendrix CC, 2013, WESTERN J NURS RES, V35, P590, DOI 10.1177/0193945911420742; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Longacre ML, 2015, J CANCER EDUC, V30, P786, DOI 10.1007/s13187-015-0814-3; Longacre ML, 2013, J CANCER EDUC, V28, P297, DOI 10.1007/s13187-013-0472-2; National Alliance for Caregiving, 2012, MULT SCLER CAR; National Alliance for Caregiving & AARP, 2009, CAR US 2009; National Spinal Cord Injury Statistical Center (NSCISC), 2014, COMPL PUBL VERS 2014; Reinhard SC., 2012, HOME ALONE FAMILY CA; Ritchie J., 2003, QUALITATIVE RES PRAC; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Sklenarova H, 2015, CANCER-AM CANCER SOC, V121, P1513, DOI 10.1002/cncr.29223; Stajduhar KI, 2013, PALLIATIVE MED, V27, P657, DOI 10.1177/0269216313487765; Tremont G, 2015, ALZHEIMERS DEMENT, V11, P541, DOI 10.1016/j.jalz.2014.05.1752; Wharewera-Mika J, 2016, CLIN CHILD PSYCHOL P, V21, P268, DOI 10.1177/1359104515589636; Willebrand M, 2016, GEN HOSP PSYCHIAT, V38, P105, DOI 10.1016/j.genhosppsych.2015.10.004	35	9	9	0	13	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	MAY	2017	19	5							e159	10.2196/jmir.7027			10	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	EU4OE	WOS:000401008500012	28490418	Green Published, gold			2022-02-06	
J	Hardcastle, TC; Muckart, DJJ; Maier, RV				Hardcastle, Timothy Craig; Muckart, David J. J.; Maier, Ronald V.			Ventilation in Trauma Patients: The First 24 h is Different!	WORLD JOURNAL OF SURGERY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; TIDAL-VOLUME VENTILATION; INDUCED LUNG INJURY; PRESSURE; AIRWAY; TRIAL	Ventilation of major trauma patients is often needed in both the acute (emergency department and early ICU phase) and subsequent phases of trauma care for those who need ICU admission. What is unclear is whether ICU ventilation strategies should be directly extrapolated to the acute phase of treatment. This paper reviews the ARDS.net study, highlights recent developments in ventilation strategies, and provides practical ventilation guidance to the trauma surgeon for acute phase (in the ED or ICU) and the subsequent phase of ICU care. The acute phase of care in the ED and the ICU is different from the subsequent phases of ICU care as the lung is more recruitable and there are other aspects of resuscitation from metabolic acidosis and traumatic brain injury, which require a different ventilation strategy to the traditional ARDS.net approach. The acute phase is different from the subsequent phase of care and there appears to be some inappropriate extrapolation of ICU practice to the acute phase. Application of the proposed ventilation strategies should ensure an optimal outcome. It is important to treat patients as individuals during assessment and treatment.	[Hardcastle, Timothy Craig; Muckart, David J. J.] Inkosi Albert Luthuli Cent Hosp, Trauma Serv, 800 Vusi Mzimela Rd, ZA-4091 Durban, South Africa; [Hardcastle, Timothy Craig; Muckart, David J. J.] Univ KwaZulu Natal, Dept Surg, Durban, South Africa; [Maier, Ronald V.] Univ Washington, Dept Surg, Harborview Med Ctr, Surg Clin, 410 9th Ave,7th Floor, Seattle, WA 98104 USA		Hardcastle, TC (corresponding author), Inkosi Albert Luthuli Cent Hosp, Trauma Serv, 800 Vusi Mzimela Rd, ZA-4091 Durban, South Africa.; Hardcastle, TC (corresponding author), Univ KwaZulu Natal, Dept Surg, Durban, South Africa.	Hardcastle@ukzn.ac.za		Hardcastle, Timothy/0000-0002-3967-0234			Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Bakowitz M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-54; Barbas CSV, 2003, CRIT CARE MED, V31, pS265, DOI 10.1097/01.CCM.0000057902.29449.29; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; Brain Trauma Foundation, 2007, GUID PREH MAN TRAUM; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Cools F, 2015, COCHRANE DB SYST REV, V3; Coppola S, 2014, ANN UPDATE INTENSIVE; Daoud EG, 2012, RESP CARE, V57, P282, DOI 10.4187/respcare.01238; Franco PM, 2015, RESP CARE; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Garnero AJ, 2013, MED INTENSIVA, V37, P292, DOI 10.1016/j.medin.2012.10.007; Gestring M, 2015, ABDOMINAL COMPARTMEN; Gu XL, 2014, CRIT CARE, V18, DOI 10.1186/cc13900; Guldager, 1997, Crit Care, V1, P75, DOI 10.1186/cc107; Hardcastle TC, 2015, AFR J EMERG MED; Harris T, 2012, POSTGRAD MED J, V88, P588, DOI 10.1136/postgradmedj-2010-74245; Hedenstierna G, 2015, BEST PRACT RES-CLIN, V29, P273, DOI 10.1016/j.bpa.2015.08.008; HORMANN C, 1994, EUR J ANAESTH, V11, P37; Jacobs JV, 2015, J TRAUMA ACUTE CARE, V79, P1049, DOI 10.1097/TA.0000000000000790; Karcz Marcin K, 2015, World J Crit Care Med, V4, P47, DOI 10.5492/wjccm.v4.i1.47; Ladeira MT, 2014, COCHRANE DB SYST REV, V5; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Lutge E, 2016, INJURY, V47, P135, DOI 10.1016/j.injury.2015.08.020; Povoa P, 2006, ACTA ANAESTH SCAND, V48, P287; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Recinos G, 2009, INJURY, V40, P856, DOI 10.1016/j.injury.2008.11.001; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Seder DB, 2012, NEUROCRIT CARE, V17, P4, DOI 10.1007/s12028-012-9753-6; Silva PL, 2015, BEST PRACT RES-CLIN, V29, P301, DOI 10.1016/j.bpa.2015.08.004; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Sutherasan Y, 2014, ANN UPDATE INTENSIVE; Treschan TA, 2012, BRIT J ANAESTH, V109, P263, DOI 10.1093/bja/aes140; Trunkey DD, 2008, WORLD J SURG, V32, P1583, DOI 10.1007/s00268-008-9522-z; Welhengama C, 2021, BJA EDUC, V21, P258, DOI 10.1016/j.bjae.2021.02.002; Zonies D., WORLD J SURG	39	9	9	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAY	2017	41	5					1153	1158		10.1007/s00268-016-3530-1			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ES6XG	WOS:000399693400002	27177646				2022-02-06	
J	Huang, TQ; Song, JN; Zheng, FW; Pang, HG; Zhao, YL; Gu, H; Zhao, JJ				Huang, Ting-Qin; Song, Jin-Ning; Zheng, Feng-Wei; Pang, Hong-Gang; Zhao, Yong-Lin; Gu, Hua; Zhao, Jun-Jie			Protection of FK506 against neuronal apoptosis and axonal injury following experimental diffuse axonal injury	MOLECULAR MEDICINE REPORTS			English	Article						FK506; death-associated protein kinase 1; diffuse axonal injury; growth-associated protein-43; neurofilament-H	TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; CEREBRAL-ISCHEMIA; PROTEIN-KINASES; DEATH; RATS; EXPRESSION; NEUROPROTECTION; MECHANISM; GAP-43	Diffuse axonal injury (DAI) is the most common and significant pathological features of traumatic brain injury (TBI). However, there are still no effective drugs to combat the formation and progression of DAI in affected individuals. FK506, also known as tacrolimus, is an immunosuppressive drug, which is widely used in transplantation medicine for the reduction of allograft rejection. Previous studies have identified that FK506 may play an important role in the nerve protective effect of the central nervous system. In the present study, apoptosis of neuronal cells was observed following the induction of experimental DAI. The results demonstrated that it was closely related with the upregulation of death-associated protein kinase 1 (DAPK1). It was hypothesized that FK506 may inhibit the activity of DAPK1 by inhibiting calcineurin activity, which may be primarily involved in anti-apoptosis following DAI induction. Through researching the expression of nerve regeneration associated proteins (NF-H and GAP-43) following DAI, the present study provides novel data to suggest that FK506 promotes axon formation and nerve regeneration following experimental DAI. Therefore, FK506 may be a potent therapeutic for inhibiting nerve injury, as well as promoting the nerve regeneration following DAI.	[Huang, Ting-Qin; Song, Jin-Ning; Pang, Hong-Gang; Zhao, Yong-Lin; Gu, Hua; Zhao, Jun-Jie] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China; [Zheng, Feng-Wei] Lanzhou Univ, Hosp 2, Dept Neurosurg, Lanzhou 730030, Gansu, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	jinningsong@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30471774]; New Century Excellent Talent Support Project of Ministry of Education [NCET-05-0831]	The present study was supported by the National Natural Science Foundation of China (grant no. 30471774) and the New Century Excellent Talent Support Project of Ministry of Education (grant no. NCET-05-0831).	Aberg M, 2011, THROMB RES, V127, P141, DOI 10.1016/j.thromres.2010.11.015; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Baumgartel K, 2012, LEARN MEMORY, V19, P375, DOI 10.1101/lm.027201.112; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Boczek T, 2015, MOL CELL BIOCHEM, V407, P251, DOI 10.1007/s11010-015-2473-4; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Dressler Jan, 2009, Leg Med (Tokyo), V11 Suppl 1, pS54, DOI 10.1016/j.legalmed.2009.02.024; Fontana ACK, 2016, J NEUROTRAUM, V33, P1073, DOI 10.1089/neu.2015.4079; Fujita Y, 2014, APOPTOSIS, V19, P339, DOI 10.1007/s10495-013-0917-4; Gabryel B, 2010, PHARMACOL REP, V62, P814, DOI 10.1016/S1734-1140(10)70342-X; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; He XS, 2010, ACTA NEUROL BELG, V110, P49; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Huang Hai-Ling, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P185; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Jing GJ, 2014, NEURAL REGEN RES, V9, P190, DOI 10.4103/1673-5374.125348; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kato S, 2013, PROG RETIN EYE RES, V37, P13, DOI 10.1016/j.preteyeres.2013.07.004; Kwon HG, 2012, NEURAL REGEN RES, V7, P475, DOI 10.3969/j.issn.1673-5374.2012.06.012; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Li HY, 2002, J VESTIBUL RES-EQUIL, V12, P167; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Mao ZL, 2013, NEURAL REGEN RES, V8, P133, DOI 10.3969/j.issn.1673-5374.2013.02.005; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maroon H, 2002, DEVELOPMENT, V129, P2099; MARSLAND TA, 1954, J NEUROPATH EXP NEUR, V13, P587, DOI 10.1097/00005072-195410000-00005; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Nair S, 2013, INT J MOL SCI, V14, P13858, DOI 10.3390/ijms140713858; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Pei L, 2014, J NEUROSCI, V34, P6546, DOI 10.1523/JNEUROSCI.5119-13.2014; Pelled D, 2002, J BIOL CHEM, V277, P1957, DOI 10.1074/jbc.M104677200; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Schumacher Andrew M, 2002, Expert Opin Ther Targets, V6, P497, DOI 10.1517/14728222.6.4.497; Shamloo M, 2005, J BIOL CHEM, V280, P42290, DOI 10.1074/jbc.M505804200; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shichinohe H, 2004, BRAIN RES, V1001, P51, DOI 10.1016/j.brainres.2003.11.054; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Struffert T, 2003, RADIOLOGE, V43, P1001, DOI 10.1007/s00117-003-0962-z; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tavanti F, 2014, NEURORADIOL J, V27, P397, DOI 10.15274/NRJ-2014-10070; Tian JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095777; Toupalik P, 2000, Soud Lek, V45, P18; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Williams RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118918; Yoo HJ, 2012, CELL SIGNAL, V24, P1471, DOI 10.1016/j.cellsig.2012.03.010; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zhang YM, 2013, CHIN J INTEGR MED, V19, P132, DOI 10.1007/s11655-013-1353-6; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	60	9	11	1	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	MAY	2017	15	5					3001	3010		10.3892/mmr.2017.6350			10	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	EU5JZ	WOS:000401068700078	28339015	Green Published, hybrid, Green Submitted			2022-02-06	
J	Kamp, MA; Sarikaya-Seiwert, S; Petridis, AK; Beez, T; Cornelius, JF; Steiger, HJ; Turowski, B; Slotty, PJ				Kamp, Marcel A.; Sarikaya-Seiwert, Sevgi; Petridis, Athanasios K.; Beez, Thomas; Cornelius, Jan Frederick; Steiger, Hans-Jakob; Turowski, Bernd; Slotty, Philipp J.			Intraoperative Indocyanine Greene-Based Cortical Perfusion Assessment in Patients Suffering from Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Cerebral blood flow; Cerebral perfusion; Decompressive craniectomy; ICG; Indocyanine green; Traumatic brain injury	ARTERIOVENOUS-MALFORMATION SURGERY; DELAYED CEREBRAL-ISCHEMIA; ACUTE SUBDURAL-HEMATOMA; INTRACRANIAL HYPERTENSION; SUBARACHNOID HEMORRHAGE; DECOMPRESSIVE CRANIECTOMY; COMPUTERIZED-TOMOGRAPHY; VIDEO ANGIOGRAPHY; VENOUS SYSTEM; BLOOD-FLOW	OBJECTIVES: The pathophysiology of traumatic brain injury (TBI) largely involves the brains vascular structural integrity. We analyzed the value of an intraoperative cortical indocyanine green (ICG) angiography in patients with severe TBI and acute subdural hematoma who underwent decompressive craniectomy. METHODS: ICG-derived fluorescence curves of cortex and cerebral vessels were recorded by the use of software integrated into a surgical microscope in 10 patients. The maximum intensity, rise time (RT), time to peak, and residual fluorescence intensity (FI) were estimated from cortical arteries, the parenchyma, and veins. RESULTS: ICG-derived fluorescence parameters were correlated with the short-term outcome 3 months after discharge. Five patients had a favorable and 5 an unfavorable outcome. Patients with a favorable outcome showed a significant longer RT in the arteries and a trend towards a significant longer RT in the veins. Overall mean residual FI was 47.5 +/- 6.8% for the arteries, 45.0 +/- 7% for the parenchyma and 57.6 +/- 6% for the veins. The residual FI of the parenchyma and the veins was significantly greater in patients with an unfavorable clinical outcome. CONCLUSIONS: Patients with an unfavorable clinical outcome showed an altered shape of the ICG-derived fluorescence curve, a shorter increase of the ICG-derived fluorescence intensity in the cortical arteries, and significantly greater residual fluorescence intensity. These observations are likely a correlate of an increased intracranial pressure, a capillary leak, and venous congestion. Intraoperative quantification of the ICG-derived fluorescence might help to appreciate the clinical outcome in patients with severe TBI.	[Kamp, Marcel A.; Sarikaya-Seiwert, Sevgi; Petridis, Athanasios K.; Beez, Thomas; Cornelius, Jan Frederick; Steiger, Hans-Jakob; Slotty, Philipp J.] Heinrich Heine Univ, Med Fac, Dept Neurosurg, Dusseldorf, Germany; [Turowski, Bernd] Heinrich Heine Univ, Med Fac, Inst Diagnost & Intervent Radiol, Dusseldorf, Germany		Kamp, MA (corresponding author), Heinrich Heine Univ, Med Fac, Dept Neurosurg, Dusseldorf, Germany.	MarcelAlexander.Kamp@med.uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021; Beez, Thomas/ABG-7004-2021; Sarikaya-Seiwert, Sevgi/AAH-4859-2020	Steiger, Hans-Jakob/0000-0002-8249-2998; Beez, Thomas/0000-0002-8715-5237; Kamp, Marcel/0000-0002-1252-2944			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Balamurugan S, 2011, Asian J Neurosurg, V6, P88, DOI 10.4103/1793-5482.92168; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Beseoglu Kerim, 2015, Acta Neurochir Suppl, V120, P35, DOI 10.1007/978-3-319-04981-6_6; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; CHAMBERS R, 1948, NATURE, V162, P835, DOI 10.1038/162835a0; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Etminan N, 2013, STROKE, V44, P1260, DOI 10.1161/STROKEAHA.111.675975; Ewelt C, 2015, J PHOTOCH PHOTOBIO B, V148, P302, DOI 10.1016/j.jphotobiol.2015.05.002; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Feletti A, 2017, WORLD NEUROSURG, V99, P572, DOI 10.1016/j.wneu.2016.12.070; Fukuda K, 2015, WORLD NEUROSURG, V83, P203, DOI 10.1016/j.wneu.2014.07.012; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hanggi D, 2010, NEUROSURGERY, V67, P1094, DOI 10.1227/NEU.0b013e3181eb5049; Holling M, 2013, NEUROSURGERY, V73, P93, DOI 10.1227/NEU.0b013e31828772a4; Imizu S, 2008, MINIM INVAS NEUROSUR, V51, P199, DOI 10.1055/s-2008-1080916; JENNETT B, 1975, LANCET, V1, P480; Kamp Marcel A, 2012, Acta Neurochir Suppl, V114, P329, DOI 10.1007/978-3-7091-0956-4_63; Kamp MA, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822f7d7c; Kato Y, 2011, NEUROL INDIA, V59, P829, DOI 10.4103/0028-3886.91359; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Killory BD, 2011, NEUROSURGERY, V68, P781, DOI 10.1227/NEU.0b013e318207ac3b; Killory BD, 2009, NEUROSURGERY, V65, P456, DOI 10.1227/01.NEU.0000346649.48114.3A; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; LANGFITT TW, 1965, NEUROLOGY, V15, P761, DOI 10.1212/WNL.15.8.761; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Prinz V, 2014, OPER NEUROSURG, V10, P231, DOI 10.1227/NEU.0000000000000277; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Raabe A, 2003, NEUROSURGERY, V52, P132, DOI 10.1097/00006123-200301000-00017; RANKIN J, 1957, Scott Med J, V2, P254; RANKIN J, 1957, Scott Med J, V2, P200; RANKIN J, 1957, Scott Med J, V2, P127; Roberts I, 2000, COCHRANE DB SYST REV; Roberts I., 2000, COCHRANE DB SYST REV, V12; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schubert GA, 2012, NEUROSURGERY, V71, P260, DOI 10.1227/NEU.0b013e318265a3fb; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Si Z, 2008, EUR J MED RES, V13, P121; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Turowski B, 2007, ROFO-FORTSCHR RONTG, V179, P847, DOI 10.1055/s-2007-963197; Turowski B, 2007, ROFO-FORTSCHR RONTG, V179, P525, DOI 10.1055/s-2007-962853; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wittsack HJ, 2008, COMPUT MED IMAG GRAP, V32, P67, DOI 10.1016/j.compmedimag.2007.09.004; Woitzik J, 2005, J NEUROSURG, V102, P692, DOI 10.3171/jns.2005.102.4.0692; Woitzik J, 2006, STROKE, V37, P1549, DOI 10.1161/01.STR.0000221671.94521.51	55	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2017	101						431	443		10.1016/j.wneu.2017.01.054			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7CR	WOS:000401932500056	28137550				2022-02-06	
J	Monti, S; Cocozza, S; Borrelli, P; Straub, S; Ladd, ME; Salvatore, M; Tedeschi, E; Palma, G				Monti, Serena; Cocozza, Sirio; Borrelli, Pasquale; Straub, Sina; Ladd, Mark E.; Salvatore, Marco; Tedeschi, Enrico; Palma, Giuseppe			MAVEN: An Algorithm for Multi-Parametric Automated Segmentation of Brain Veins From Gradient Echo Acquisitions	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Brain veins; vesselness; segmentation; MRI	DEEP MEDULLARY VEINS; VENOUS HEMODYNAMICS; MR VENOGRAPHY; SUSCEPTIBILITY; SYSTEM; LEUKOARAIOSIS; SCLEROSIS; MODEL; SWI	Cerebral vein analysis provides a chance to study, from an unusual viewpoint, an entire class of brain diseases, including neurodegenerative disorders and traumatic brain injuries. Manual segmentation approaches can be used to assess vascular anatomy, but they are observer-dependent and time-consuming; therefore, automated approaches are desirable, as they also improve reproducibility. In this paper, a new, fully automated algorithm, based on structural, morphological, and relaxometric information, is proposed to segment the entire cerebral venous system from MR images. The algorithm formulti-parametric automated segmentation of brain VEiNs (MAVEN) is based on a combined investigation of multi-parametric information that allows for rejection of false positives and detection of thin vessels. The method is tested on gradient echo brain data sets acquired at 1.5, 3, and 7 T. It is compared to previous methods against manual segmentation, and its inter-scan reproducibility is assessed. The achieved accuracy and reproducibility are good, meaning that MAVEN outperforms previous methods on both quantitative and qualitative analyses. It is usable at all the field strengths explored, showing comparable accuracy scores, with no need for algorithm parameter adjustments, and thus, it is a promising candidate for the characterization of the venous tree topology.	[Monti, Serena; Borrelli, Pasquale; Salvatore, Marco] IRCCS SDN, I-80143 Naples, Italy; [Monti, Serena] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Cocozza, Sirio; Tedeschi, Enrico] Univ Federico II, Dept Adv Biomed Sci, I-80131 Naples, Italy; [Straub, Sina; Ladd, Mark E.] German Canc Res Ctr, Dept Med Phys Radiol, D-69120 Heidelberg, Germany; [Palma, Giuseppe] CNR, Inst Biostruct & Bioimaging, I-80145 Naples, Italy		Monti, S (corresponding author), IRCCS SDN, I-80143 Naples, Italy.	serena.monti@polimi.it	Tedeschi, Enrico/AAN-7112-2020; Cocozza, Sirio/ABD-1161-2020; Borrelli, Pasquale/N-4880-2019; Borrelli, Pasquale/H-7493-2016; Straub, Sina/ABA-7211-2021; Palma, Giuseppe/AAX-1413-2020; Monti, Serena/C-1062-2015; Salvatore, Marco/K-8083-2016	Tedeschi, Enrico/0000-0002-0511-0132; Cocozza, Sirio/0000-0002-0300-5160; Borrelli, Pasquale/0000-0002-9299-9661; Borrelli, Pasquale/0000-0002-9299-9661; Straub, Sina/0000-0002-9167-8778; Monti, Serena/0000-0002-8777-7837; PALMA, GIUSEPPE/0000-0002-0210-268X; Salvatore, Marco/0000-0001-9734-7702	Italian Minister of Health [RRC-2015-2360454]	This work was supported by the Italian Minister of Health under Grant RRC-2015-2360454. Asterisk indicates corresponding author.	ADAMS CWM, 1987, NEUROPATH APPL NEURO, V13, P141, DOI 10.1111/j.1365-2990.1987.tb00177.x; Arrigoni F, 2011, AM J NEURORADIOL, V32, P2030, DOI 10.3174/ajnr.A2687; Bateman GA, 2008, AM J NEURORADIOL, V29, P198, DOI 10.3174/ajnr.A0739; Beggs CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-142; Beriault S, 2015, IEEE T MED IMAGING, V34, P2478, DOI 10.1109/TMI.2015.2442236; Beriault S, 2014, J NEUROSURG, V121, P131, DOI 10.3171/2014.3.JNS131860; Beriault S, 2014, LECT NOTES COMPUT SC, V8361, P39, DOI 10.1007/978-3-319-05666-1_6; Borrelli P, 2014, IEEE T ACOUST SPEECH, P1230; Borrelli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126835; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chen S, 2015, EXP NEUROL, V272, P4, DOI 10.1016/j.expneurol.2015.03.007; Coutinho JM, 2014, STROKE, V45, P1836, DOI 10.1161/STROKEAHA.113.004414; Cusack R, 2002, NEUROIMAGE, V16, P754, DOI 10.1006/nimg.2002.1092; De Simone R, 2012, CURR PAIN HEADACHE R, V16, P261, DOI 10.1007/s11916-012-0254-2; Dubuisson M. P., 1994, P 12 INT C PATT REC, V1, P566, DOI DOI 10.1109/ICPR.1994.576361; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Gaitan MI, 2013, NEUROLOGY, V80, P145, DOI 10.1212/WNL.0b013e31827b916f; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke E.M., 2014, SUSCEPTIBILITY WEIGH; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Kau T, 2013, EUR RADIOL, V23, P1956, DOI 10.1007/s00330-013-2791-4; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Koopmans PJ, 2008, MAGN RESON MATER PHY, V21, P149, DOI 10.1007/s10334-007-0101-3; Kudo K., 2015, J CEREBRAL BLOOD FLO, V36; Kuijf HJ, 2016, EUR RADIOL, V26, P3412, DOI 10.1007/s00330-016-4220-y; Kuijf HJ, 2015, PROC SPIE, V9413, DOI 10.1117/12.2080952; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Li W, 2015, NEUROIMAGE, V108, P111, DOI 10.1016/j.neuroimage.2014.12.043; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Manniesing R, 2006, MED IMAGE ANAL, V10, P815, DOI 10.1016/j.media.2006.06.003; Monti S, 2015, IEEE ENG MED BIO, P3041, DOI 10.1109/EMBC.2015.7319033; Monti S., 2016, P INT SOC MAG RESON, P1906; MOODY DM, 1995, RADIOLOGY, V194, P469, DOI 10.1148/radiology.194.2.7824728; Muller LO, 2014, INT J NUMER METH BIO, V30, P681, DOI 10.1002/cnm.2622; Nowinski WL, 2009, NEUROINFORMATICS, V7, P23, DOI 10.1007/s12021-008-9028-8; Palma G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134963; Palma G, 2013, FED CONF COMPUT SCI, P495; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Toro EF, 2016, APPL MATH COMPUT, V272, P542, DOI 10.1016/j.amc.2015.06.066; Tsai FY, 2007, CARDIOVASC INTER RAD, V30, P675, DOI 10.1007/s00270-007-9046-1; Xu X., 2012, P 6 INT C INT COMP S, P107; Xu YB, 2006, MAGN RESON IMAGING, V24, P155, DOI 10.1016/j.mri.2005.10.030; Yan SQ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00144; Zivadinov R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-128	48	9	9	0	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	MAY	2017	36	5					1054	1065		10.1109/TMI.2016.2645286			12	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	EU2OV	WOS:000400869700002	28237923				2022-02-06	
J	Rothlind, J; Dukarm, P; Kraybill, M				Rothlind, Johannes; Dukarm, Paul; Kraybill, Matthew			Assessment of Self-Awareness of Cognitive Function: Correlations of Self-Ratings with Actual Performance Ranks for Tests of Processing Speed, Memory and Executive Function in Non-Clinical Samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Meta cognition	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; DEFICIT AWARENESS; SYMPTOMS; ADULTS; REHABILITATION; SCHIZOPHRENIA; UNAWARENESS; DEPRESSION	Objective: For individuals with neurologic disorders, self-awareness of cognitive impairment is associated with improved treatment course and clinical outcome. However, methods for assessment of levels of self-awareness are limited, and most require collateral information, which may not be readily available. Although distortions in self-awareness are most often associated with low cognitive ability, the frequently mixed pattern of cognitive strengths and deficits in individuals with neurologic disorders complicates assessment. The present study explores relationships between actual test performance and self-ratings, utilizing a brief probe administered during testing. The "common-metric" approach solicits self-appraisal ratings in percentile equivalents and capitalizes on available normative data for specific standardized neuropsychological tests to allow direct comparisons. Method: A convenience sample of 199 adults recruited from community sources participated in this study, including healthy adults and neuropsychologically "at-risk" volunteers who were HIV positive and/or endorsing heavy current alcohol consumption. Immediately following completion of standardized neuropsychological tests, participants estimated their own percentile ranking. Results: Across study groups, participant's estimates of their own percentile rank were modestly correlated with actual performance ranking. Highest correlations were obtained for tests of learning, memory and conceptual reasoning, and executive function, with smaller correlations for simple tests of motor and psychomotor speed. Conclusions: The study reveals normal biases affecting the self-appraisal during standardized testing, and suggests that a common-metric approach for assessing self-appraisal may play a role in establishing clinical thresholds and identifying and quantifying reductions in insight in persons with neuropsychological deficits	[Rothlind, Johannes] San Francisco VA Med Ctr, Psychol Serv, San Francisco, CA USA; [Dukarm, Paul] Alaska Neuropsychol & Behav Hlth LLC, Neuropsychol, Fairbanks, AK USA; [Kraybill, Matthew] Ross Univ, Sch Med, Behav Sci, Roseau, Dominica		Rothlind, J (corresponding author), San Francisco VA Med Ctr, Psychol Serv 116B, 4150 Clement St, San Francisco, CA 94121 USA.	johannes.rothlind@va.gov			NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [PO1 11493]	This research was supported by NIAAA PO1 11493 (M.W. Weiner, PI).	ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Barba Gianfranco Dalla, 1995, Neuropsychologia, V33, P247, DOI 10.1016/0028-3932(94)00091-3; Beck AT, 1987, BECK DEPRESSION INVE; Benedict H. B, 1997, PSYCHOL ASSESSMENT R; Blackstone K, 2012, J INT NEUROPSYCH SOC, V18, P79, DOI 10.1017/S135561771100141X; Chin J, 2014, INT PSYCHOGERIATR, V26, P573, DOI 10.1017/S104161021300241X; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P177, DOI 10.1348/014466504323088042; Cosentino S, 2011, INT J ALZHEIMERS DIS; Cotrell V, 1999, ALZ DIS ASSOC DIS, V13, P151, DOI 10.1097/00002093-199907000-00007; Delis DC, 1987, CALIFORNIA VERBAL LE; Denman S. B., 1984, MANUAL DENMAN NEUROP; Duke LM, 2002, NEUROPSYCHOLOGY, V16, P359, DOI 10.1037//0894-4105.16.3.359; Ecklund-Johnson E, 2005, NEUROPSYCHOL REV, V15, P147, DOI 10.1007/s11065-005-9026-7; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming JM, 1996, BRAIN INJURY, V10, P1; Graham DP, 2005, COGNITIVE BRAIN RES, V25, P144, DOI 10.1016/j.cogbrainres.2005.05.001; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Hamsher K., 1994, MULTILINGUAL APHASIA; Heaton RK, 1991, COMPREHENSIVE NORMS; Kedia G, 2013, NEUROREPORT, V24, P259, DOI 10.1097/WNR.0b013e32835f2069; Krueger CE, 2011, CLIN NEUROPSYCHOL, V25, P741, DOI 10.1080/13854046.2011.569759; LaBuda J, 1999, CLIN NEUROPSYCHOL, V13, P258, DOI 10.1076/clin.13.3.258.1741; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Lehrner J, 2014, INT PSYCHOGERIATR, V26, P463, DOI 10.1017/S1041610213002263; LYSAKER P, 1994, PSYCHIATRY, V57, P307; Matthews CG., 1964, INSTRUCTION MANUAL A; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCGLYNN SM, 1991, J COGNITIVE NEUROSCI, V3, P183, DOI 10.1162/jocn.1991.3.2.183; Moore MT, 2012, CLIN PSYCHOL REV, V32, P496, DOI 10.1016/j.cpr.2012.05.004; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rosen HJ, 2010, NEUROIMAGE, V49, P3358, DOI 10.1016/j.neuroimage.2009.11.041; Rothlind JC, 2005, J INT NEUROPSYCH SOC, V11, P70, DOI 10.1017/S1355617705050095; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Seltzer B, 1997, GERONTOLOGIST, V37, P20, DOI 10.1093/geront/37.1.20; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Smith, 1973, SYMBOL DIGIT MODALIT; Smith TE, 1999, J NERV MENT DIS, V187, P102, DOI 10.1097/00005053-199902000-00006; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vogel A, 2010, J NEUROPSYCH CLIN N, V22, P93, DOI 10.1176/appi.neuropsych.22.1.93; Williamson C, 2010, J NEUROL NEUROSUR PS, V81, P140, DOI 10.1136/jnnp.2008.166041; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628; [No title captured]	49	9	10	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					316	327		10.1093/arclin/acw109			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700007	28034850	Bronze, Green Published			2022-02-06	
J	Rush, B; Wormsbecker, A; Berger, L; Wiskar, K; Sekhon, MS; Griesdale, DE				Rush, Barret; Wormsbecker, Andrew; Berger, Landon; Wiskar, Katie; Sekhon, Mypinder S.; Griesdale, Donald E.			Optic nerve sheath diameter on computed tomography not predictive of neurological status post-cardiac arrest	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						cardiac arrest; optic nerve sheath diameter; prognosis	TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; INTRACRANIAL HYPERTENSION; PRESSURE; PATIENT	Objective: Optic nerve sheath diameter (ONSD) measured on a head computed tomography (CT) has been suggested as a potential prognostic factor for poor neurological outcome after cardiac arrest. We performed a single centre retrospective cohort analysis to further investigate this relationship. Methods: All patients >18 years of age admitted to St. Paul's Hospital in Vancouver, Canada who survived a cardiac arrest and had a CT scan of the head within 48 hours were included in the analysis. Results: A total of 72 patients met inclusion criteria for the study; 54 (75.0%) of the patients had a poor neurological outcome, whereas 18 (25.0%) patients were discharged from the hospital with a good outcome. A CT head was obtained for patients in the good outcome group in a mean time of 9.3 hours (SD 10.0) compared to 10.2 hours (SD 11.2) for the poor outcome group (p = 0.75). There was no difference in average ONSD observed between the two outcome groups (6.66mm SD 0.78 v. 6.60mm SD 0.82, p = 0.77). Multiple logistic regression failed to show any association between ONSD and neurological outcome when adjusted for all other covariates (OR 1.32 95% CI 0.40-4.34, p = 0.65). Setting an ONSD threshold of >8mm (OR 2.32, 95% CI 0.14-39.40, p = 0.55) or >7mm (OR 0.28, 95% CI 0.03-2.77, p = 0.28) also failed to show any association on neurological outcome. Conclusion: There was no observed difference in ONSD between those with a good neurological outcome and those with a poor outcome. ONSD was not an independent predictor of poor neurological outcome.	[Rush, Barret; Wormsbecker, Andrew; Berger, Landon; Wiskar, Katie; Sekhon, Mypinder S.; Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Div Crit Care, Dept Med, Vancouver, BC, Canada; [Berger, Landon; Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC, Canada; [Rush, Barret] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Griesdale, Donald E.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Rush, B (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	bar890@mail.harvard.edu	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624; Rush, Barret/0000-0001-9201-8352	VGH & UBC Hospital Foundation Best of Health Fund	The VGH & UBC Hospital Foundation Best of Health Fund supported this research.	Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2006.0209; Finelli PF, 2006, NEUROCRIT CARE, V4, P119, DOI 10.1385/NCC:4:2:119; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Iida K, 1997, CRIT CARE MED, V25, P971, DOI 10.1097/00003246-199706000-00013; Kim YH, 2014, ACAD EMERG MED, V21, P1121, DOI 10.1111/acem.12477; Launey Y, 2014, J NEUROTRAUM, V31, P984, DOI 10.1089/neu.2012.2829; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; Naples R, 2009, AM J EMERG MED, V27, P63, DOI 10.1016/j.ajem.2008.01.014; Samaniego EA, 2011, NEUROCRIT CARE, V15, P113, DOI 10.1007/s12028-010-9412-8; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Topcuoglu MA, 2009, INTERNAL MED, V48, P1635, DOI 10.2169/internalmedicine.48.2091; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd	16	9	10	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	MAY	2017	19	3					181	185		10.1017/cem.2016.348			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EV5XK	WOS:000401842000003	27514585	Bronze			2022-02-06	
J	Carteron, L; Taccone, FS; Oddo, M				Carteron, Laurent; Taccone, Fabio S.; Oddo, Mauro			How to manage blood pressure after brain injury?	MINERVA ANESTESIOLOGICA			English	Article						Blood pressure; Arterial pressure; Brain injuries; Critical care; Transcranial Doppler ultrasonography	CEREBRAL PERFUSION-PRESSURE; ACUTE INTRACEREBRAL HEMORRHAGE; SEVERE HEAD-INJURY; ASSOCIATION/AMERICAN STROKE ASSOCIATION; IMPAIRED CEREBROVASCULAR AUTOREGULATION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEALTH-CARE PROFESSIONALS; INTRACRANIAL-PRESSURE; INDUCED HYPERTENSION; PERIHEMATOMAL EDEMA	Manipulation of blood pressure (BP) is a mainstay of therapy in patients with acute brain injury (ABI). In the early emergent phase (first hours from injury), depending on intracranial pathology, BP manipulation aims to: 1) limit the progression of parenchymal hematomas or hemorrhagic transformation (in patients with ischemic/hemorrhagic stroke and aneurysmal subarachnoid hemorrhage [SAH]), and 2) attenuate hypoperfusion and secondary cerebral ischemic insults (in patients with traumatic brain injury [TBI]). During the intensive care unit (ICU) phase, BP management is primarily focused at identifying the so-called "optimal" BP/cerebral perfusion pressure (CPP), i. e. the threshold of mean arterial pressure (MAP)/CPP to prevent secondary cerebral ischemia. BP augmentation is also an essential component of the medical management of delayed cerebral ischemia following SAH. Increasing clinical data support the use of surrogate monitoring modalities of cerebral perfusion (including trans-cranial Doppler and brain tissue oximetry) to indentify BP/ CPP targets in ABI patients. We reviewed herein the actual evidence regarding BP control in the early phase after ABI and recent clinical investigations using multimodal monitoring to optimize CPP and BP in severe ABI patients. The main purpose of this review is to provide a pragmatic approach of BP management, taking into account the timing of injury and differences in brain pathologies.	[Carteron, Laurent] Besancon Univ Hosp, Dept Anesthesiol & Intens Care Med, Besancon, France; [Carteron, Laurent] Univ Franche Comte, Besancon, France; [Taccone, Fabio S.] Free Univ Brussels, Erasme Hosp, Dept Intens Care Med, Brussels, Belgium; [Oddo, Mauro] CHU Vaudois, Lausanne Univ Hosp, Dept Intens Care Med, Rue Bugnon 46,BH 08-623, CH-1011 Lausanne, Switzerland		Oddo, M (corresponding author), CHU Vaudois, Lausanne Univ Hosp, Dept Intens Care Med, Rue Bugnon 46,BH 08-623, CH-1011 Lausanne, Switzerland.	mauro.oddo@chuv.ch					Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Anderson CS, 2015, STROKE, V46, P291, DOI 10.1161/STROKEAHA.114.006321; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Anderson CS, 2010, STROKE, V41, P307, DOI 10.1161/STROKEAHA.109.561795; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Butcher KS, 2013, STROKE, V44, P620, DOI 10.1161/STROKEAHA.111.000188; Carney N, 2016, NEUROSURGERY; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Gathier CS, 2015, STROKE, V46, P3277, DOI 10.1161/STROKEAHA.115.010537; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Gould B, 2014, STROKE, V45, P2894, DOI 10.1161/STROKEAHA.114.005614; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2013, NEUROCRIT CARE, V19, P69, DOI 10.1007/s12028-013-9857-7; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kate MP, 2014, J CEREBR BLOOD F MET, V34, P81, DOI 10.1038/jcbfm.2013.164; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Lazaridis C, 2016, ACTA NEUROCHIR SUPPL, V122, P117, DOI 10.1007/978-3-319-22533-3_23; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Leonard Anne D, 2002, Neurology, V59, pE1; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; McCourt R, 2014, STROKE, V45, P1292, DOI 10.1161/STROKEAHA.113.003194; Mignini MA, 2006, CRIT CARE, V10, DOI 10.1186/cc4852; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Needham E, 2016, J NEUROTRAUMA; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Ohwaki K, 2004, STROKE, V35, P1364, DOI 10.1161/01.STR.0000128795.38283.4b; Powers WJ, 2015, STROKE, DOI DOI 10.1161/STR.0000000000000074; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Raabe A, 2005, J NEUROSURG, V103, P974, DOI 10.3171/jns.2005.103.6.0974; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Thomas E, 2015, BRIT J ANAESTH, V115, P487, DOI 10.1093/bja/aev233; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	64	9	10	0	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	APR	2017	83	4					412	421		10.23736/S0375-9393.16.11696-7			10	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	ES1UZ	WOS:000399313800012	27982555				2022-02-06	
J	Haller, CS; Bosma, CM; Kapur, K; Zafonte, R; Langer, EJ				Haller, Chiara S.; Bosma, Colin M.; Kapur, Kush; Zafonte, Ross; Langer, Ellen J.			Mindful creativity matters: trajectories of reported functioning after severe traumatic brain injury as a function of mindful creativity in patients' relatives: a multilevel analysis	QUALITY OF LIFE RESEARCH			English	Article						Mindfulness; Creativity; Severe traumatic brain injury; Functioning of the patient; Association with the relative	SELF; DEPRESSION; FAMILY; PERSONALITY; COMPETENCE; PREDICTORS; THERAPY; STYLE; CARE	The objective of the present investigation was to examine the association of mindful creativity with the trajectory of recovery (emotional, interpersonal, cognitive, and total functioning) of patients with severe TBI. This was drawn from a subsample of an adult prospective cohort study on severe TBI in Switzerland; patients and their relatives were assessed at 3, 6, and 12 months (patients N = 176, relatives N = 176). Predictor measures were assessed using Mindful Creativity Scale-short form and time (trajectory of functioning of the patient over time). Outcome measures were assessed using Patient Competency Rating Scale for Neuro-rehabilitation (PCRS-NR; measuring emotional, interpersonal, cognitive, and total functioning post-injury). All measures were assessed at each time point. Mixed linear models were run separately for ages > 50 and ae<currency>50 (i.e., bimodal distribution). Patients' mindful creativity showed no significant association with patients' functioning across time in any of the models. In all age groups, interpersonal functioning decreased across time (slope(> 50) = -4.66, p = .037; slope(ae<currency>50) = -7.19, p = .007). Interestingly, in age group ae<currency>50, interpersonal functioning increased when looking at relative mindful creativity by time (slope = 1.69, p = .005). Additionally, relatives mindful creativity was significantly associated with patients' functioning in age group ae<currency>50: (a) patients' total functioning (slope = 0.18, p = .03) and (b) cognitive functioning (slope = 0.72, p = .020). Relatives' mindful creativity was significantly associated with patients' functioning after severe TBI. Implications for treatment and future research are discussed.	[Haller, Chiara S.; Bosma, Colin M.; Langer, Ellen J.] Harvard Univ, Dept Psychol, 33 Kirland St, Cambridge, MA 02138 USA; [Haller, Chiara S.] Massachusetts Mental Hlth Ctr, Div Publ Psychiat, 75 Fenwood Rd, Boston, MA 02115 USA; [Kapur, Kush] Harvard Med Sch, Boston, MA 02115 USA; [Kapur, Kush] Boston Childrens Hosp, Clin Res Ctr, 21 Autumn St, Boston, MA 02115 USA; [Kapur, Kush] Boston Childrens Hosp, Dept Neurol, 21 Autumn St, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Cambridge, MA USA		Haller, CS (corresponding author), Harvard Univ, Dept Psychol, 33 Kirland St, Cambridge, MA 02138 USA.; Haller, CS (corresponding author), Massachusetts Mental Hlth Ctr, Div Publ Psychiat, 75 Fenwood Rd, Boston, MA 02115 USA.	haller@fas.harvard.edu	Kapur, Kush/AAQ-3437-2020	Kapur, Kush/0000-0001-9022-913X; Bosma, Colin/0000-0002-4828-6023	PEBITA team	Many thanks to the PEBITA team for their passion and support (www.pebita.ch). Profound thanks to all the participants.	Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Association AP., 2013, DIAGN STAT MAN MENT, V5th; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Baron-Cohen S., 1994, CHILDRENS EARLY UNDE; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; Bodner T. E., 2001, 13 ANN AM PSYCH SOC; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Bombardier C. H., 2014, J NEUROPSYCHIATRY CL, V8, P501; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; Dick WF, 1999, RESUSCITATION, V42, P81, DOI 10.1016/S0300-9572(99)00102-1; Duff Diane, 2006, Axone, V27, P9; Farin A., 2004, LESSONS EPIDEMIOLOGI; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gelrnan A, 2007, DATA ANAL USING REGR; Haller CS, 2015, BRAIN INJURY, V29, P517, DOI 10.3109/02699052.2014.989906; Haller CS, 2011, CREATIVITY RES J, V23, P99, DOI 10.1080/10400419.2011.571182; Haller CS, 2010, PSYCHOL AESTHET CREA, V4, P149, DOI 10.1037/a0017084; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hughes DJ, 2013, THINK SKILLS CREAT, V9, P76, DOI 10.1016/j.tsc.2012.10.001; Ie A, 2012, COMPUT HUM BEHAV, V28, P1526, DOI 10.1016/j.chb.2012.03.022; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; Klonoff P. S, 2014, PSYCHOTHERAPY FAMILI, P115; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Langer E., 1997, POWER MINDFUL LEARNI; Langer EJ, 2000, J SOC ISSUES, V56, P1, DOI 10.1111/0022-4537.00148; Langer EJ., 1989, MINDFULNESS; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; McDonald S., 2013, SOCIAL COMMUNICATION, P119; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Nicol JJ, 1996, CREATIVITY RES J, V9, P1, DOI 10.1207/s15326934crj0901_1; Rosenzweig S, 2010, J PSYCHOSOM RES, V68, P29, DOI 10.1016/j.jpsychores.2009.03.010; Runco M. A., 2007, CREATIVITY HDB TEACH; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Singh N., 2014, LEARNING COMMUNITY I, V5, P23; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Talbot LR, 2014, J MULTIDISCIP HEALTH, V7, P313, DOI 10.2147/JMDH.S64897; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Wiart L., 2012, Annals of Physical and Rehabilitation Medicine, V55, P375, DOI 10.1016/j.rehab.2012.04.002; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	53	9	9	0	17	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	APR	2017	26	4					893	902		10.1007/s11136-016-1416-1			10	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EN5RL	WOS:000396063100009	27663903				2022-02-06	
J	Jonsdottir, GM; Lund, SH; Snorradottir, B; Karason, S; Olafsson, IH; Reynisson, K; Mogensen, B; Sigvaldason, K				Jonsdottir, G. M.; Lund, S. H.; Snorradottir, B.; Karason, S.; Olafsson, I. H.; Reynisson, K.; Mogensen, B.; Sigvaldason, K.			A population-based study on epidemiology of intensive care unit treated traumatic brain injury in Iceland	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; SEVERITY SCORE; CLASSIFICATION; PREDICTION; PATTERN; TRISS; TRIAL; SCALE	BackgroundTraumatic brain injury is a worldwide health issue and a significant cause of preventable deaths and disabilities. We aimed to describe population-based data on intensive care treated traumatic brain injury in Iceland over 15 years period. MethodsRetrospective review of all intensive care unit admissions due to traumatic brain injury at The National University Hospital of Iceland 1999-2013. Data were collected on demographics, mechanism of injury, alcohol consumption, glasgow come scale upon admission, Injury Severity Scoring, acute physiology and chronic health evaluation II score, length of stay, interventions and mortality (defined as glasgow outcome score one). All computerized tomography scans were reviewed for Marshall score classification. ResultsIntensive care unit admissions due to traumatic brain injury were 583. The incidence decreased significantly from 14/100.000/year to 12/100.000/year. Males were 72% and the mean age was 41 year. Majority of patients (42%) had severe traumatic brain injury. The most common mechanism of injury was a fall from low heights (36.3%). The mortality was 18.2%. Increasing age, injury severity score, Marshall score and acute physiology and chronic health evaluation II score are all independent risk factors for death. Glasgow coma scale was not an independent prognostic factor for outcome. ConclusionsIncidence decreased with a shift in injury mechanism from road traffic accidents to falls and an increased rate of traumatic brain injury in older patients following a fall from standing or low heights. Mortality was higher in older patients falling from low heights than in younger patients suffering multiple injuries in road traffic accidents. Age, injury severity score, acute physiology and chronic health evaluation II score and Marshall score are good prognostic factors for outcome. Traumatic brain injury continues to be a considerable problem and the increase in severe traumatic brain injury in the middle age and older age groups after a seemingly innocent accident needs a special attention.	[Jonsdottir, G. M.; Snorradottir, B.; Karason, S.; Sigvaldason, K.] Natl Univ Hosp Iceland, Dept Anesthesia & Intens Care Med, Reykjavik, Iceland; [Lund, S. H.] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Karason, S.; Olafsson, I. H.; Mogensen, B.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Olafsson, I. H.] Natl Univ Hosp Iceland, Dept Neurosurg, Reykjavik, Iceland; [Reynisson, K.] Natl Univ Hosp Iceland, Dept Radiol, Reykjavik, Iceland; [Mogensen, B.] Natl Univ Hosp Iceland, Dept Emergency, Reykjavik, Iceland		Jonsdottir, GM (corresponding author), Natl Univ Hosp Iceland, Dept Anesthesia & Intens Care Med, Reykjavik, Iceland.	gudmarjo@landspitali.is	Lund, Sigrun Helga/K-9144-2015; Lund, Sigrun Helga/AAG-6042-2019	Lund, Sigrun Helga/0000-0002-3806-2296; Lund, Sigrun Helga/0000-0002-3806-2296; Mogensen, Brynjolfur/0000-0002-7583-0661	Landspitali University Hospital Research Fund, Reykjavik, Iceland	The authors thank Elin Helga Sanko for special assistance. This work was financially supported by Landspitali University Hospital Research Fund, Reykjavik, Iceland. Authors report no conflict of interest.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chieregato A, 2010, ACTA ANAESTH SCAND, V54, P696, DOI 10.1111/j.1399-6576.2010.02234.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Einarsson A, 2000, Laeknabladid, V86, P25; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gisladottir EH, 2014, LAEKNABLADID, V100, P331, DOI 10.17992/lbl.2014.06.547; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Gudmundsson K, 1987, ICELANDIC MED J, V73, P113; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Jonsdottir GM, 2017, ACTA ANAESTHESIOLOGI; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Livingston BM, 2000, CRIT CARE MED, V28, P1820, DOI 10.1097/00003246-200006000-00023; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; R Core Team, 2016, R PROJECT STAT COMPU; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Reiter A, 2004, J TRAUMA, V57, P375, DOI 10.1097/01.TA.0000104016.78539.94; ROCCA B, 1989, J TRAUMA, V29, P299, DOI 10.1097/00005373-198903000-00004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Statistics Iceland, 2015, NAT ACC PUBL FIN; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Surgeons, 2007, J NEUROSURG S, V24, pS1, DOI DOI 10.1089/NEU.2007.9990; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Ulvik A, 2007, ACTA ANAESTH SCAND, V51, P171, DOI 10.1111/j.1399-6576.2006.01207.x; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017; Wang JW, 2016, J CLIN NEUROSCI, V27, P1, DOI 10.1016/j.jocn.2015.06.037	43	9	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	2017	61	4					408	417		10.1111/aas.12869			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EM5VU	WOS:000395382600009	28194757				2022-02-06	
J	Julien, J; Alsideiri, G; Marcoux, J; Hasen, M; Correa, JA; Feyz, M; Maleki, M; de Guise, E				Julien, Jessica; Alsideiri, Ghusn; Marcoux, Judith; Hasen, Mohammed; Correa, Jose A.; Feyz, Mitra; Maleki, Mohammed; de Guise, Elaine			Antithrombotic agents intake prior to injury does not affect outcome after a traumatic brain injury in hospitalized elderly patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Older age; Aging; Level 1 trauma center; Outcome	PREINJURY WARFARIN USE; HEAD-INJURY; INDUCED COAGULOPATHY; ATRIAL-FIBRILLATION; ANTICOAGULATION; METAANALYSIS; MORTALITY; THERAPY; MECHANISMS; HEMORRHAGE	Background: The purpose of this study is to investigate the effect of risk factors including International Normalized Ratio (INR) as well as the Partial Thromboplastin Time (PTT) scores on several outcomes, including hospital length of stay (LOS) and The Extended Glasgow Outcome Scale (GOSE) following TBI in the elderly population. Methods: Data were retrospectively collected on patients (n = 982) aged 65 and above who were admitted post TBI to the McGill University Health Centre-Montreal General Hospital from 2000 to 2011. Age, Injury Severity Score (ISS), Glasgow Coma Scale score (GCS), type of trauma (isolated TBI vs polytrauma including TBI), initial CT scan results according to the Marshall Classification and the INR and PTT scores and prescriptions of antiplatelet or anticoagulant agents (AP/AC) were collected. Results: Results also indicated that age, ISS and GSC score have an effect on the GOSE score. We also found that taking AC/AP has an effect on GOSE outcome, but that this effects depends on PTT, with lower odds of a worse outcome for those taking AC/AP agents as the PTT value goes up. However, this effect only becomes significant as the PTT value reaches 60 and above. Conclusion: Age and injury severity rather than antithrombotic agent intake are associated with adverse acute outcome such as GOSE in hospitalized elderly TBI patients. (C) 2017 Elsevier Ltd. All rights reserved.	[Julien, Jessica; de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Julien, Jessica; de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Alsideiri, Ghusn] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2T5, Canada; [Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Neurol & Neurosurg Dept, Montreal, PQ H3A 2T5, Canada; [Hasen, Mohammed] Univ Dammam, Dammam, Saudi Arabia; [Correa, Jose A.] McGill Univ, Dept Math & Stat, Montreal, PQ H3A 2T5, Canada; [Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3A 2T5, Canada; [de Guise, Elaine] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3A 2T5, Canada		de Guise, E (corresponding author), Univ Montreal, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca			Research-Institute of the McGill University Health Center	We thank the Research-Institute of the McGill University Health Center for their support.	Brock GN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-144; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Canada S, 2011, GEN CAN AG SEX 2011; Cardenas JC, 2014, CURR OPIN HEMATOL, V21, P404, DOI 10.1097/MOH.0000000000000063; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Cull JD, 2015, AM SURGEON, V81, P128; Davenport R, 2014, CRIT CARE, V18, DOI 10.1186/cc13923; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Epstein DS, 2016, J CLIN NEUROSCI, V29, P64, DOI 10.1016/j.jocn.2015.11.024; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Labuz-Roszak B, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-98; Latouche A, 2013, J CLIN EPIDEMIOL, V66, P648, DOI 10.1016/j.jclinepi.2012.09.017; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Marshall LF, 1999, J NEUROSURG S1, V75, pS14; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Parachute, 2014, FALL PREV; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Sachdev GP, 1999, AM J HEALTH-SYST PH, V56, P1505, DOI 10.1093/ajhp/56.15.1505; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; White NJ, 2013, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2013.1.660; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	32	9	9	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2017	38						122	125		10.1016/j.jocn.2016.12.032			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP4UT	WOS:000397376100028	28110930				2022-02-06	
J	Narad, ME; Yeates, KO; Taylor, HG; Stancin, T; Wade, SL				Narad, Megan E.; Yeates, Keith O.; Taylor, H. Gerry; Stancin, Terry; Wade, Shari L.			Maternal and Paternal Distress and Coping Over Time Following Pediatric Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						accidents and injuries; children; coping; parent stress	OF-THE-LITERATURE; EARLY-CHILDHOOD; FAMILY BURDEN; PSYCHOLOGICAL ADJUSTMENT; FUNCTIONAL RECOVERY; PARENTAL STRESS; INITIAL YEAR; CHILDREN; PREDICTORS; STRATEGIES	Objective Examine differences in maternal and paternal coping and distress following traumatic brain injury (TBI) and orthopedic injuries (OI). Method Concurrent cohort/prospective design with five assessments between 1 and an average of 7 years after injury of children aged 3-6 years hospitalized for TBI (n = 87) or OI (n = 119). Mixed models analyses were used to examine hypotheses. Results Overall, fathers reported greater depression and general distress than mothers 18 months after injury, but not at long-term follow-up. Active and acceptance coping were unrelated to parental sex, injury factors, or time since injury. A group x rater x time interaction was noted for Denial coping. Following severe TBI, fathers reported greater denial at 18 months, whereas mothers reported greater denial at the long-term follow-up. Denial coping did not differ between mothers and fathers following OI and moderate TBI. Conclusions Parental response to early TBI is complex and may warrant clinical intervention even years after injury.	[Narad, Megan E.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Yeates, Keith O.] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst,Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729, F32HD088011] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	This publication was supported by grant R01 HD42729 from the National Institute of Child Health and Human Development and Trauma Research grants from the State of Ohio Emergency Medical Services. Additional support was provided through Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of National Institutes of Health.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Baker JP, 2007, COGNITION EMOTION, V21, P95, DOI 10.1080/02699930600562276; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; BILLINGS AG, 1984, J PERS SOC PSYCHOL, V46, P877, DOI 10.1037/0022-3514.46.4.877; BUCHANAN CM, 1990, J YOUTH ADOLESCENCE, V19, P363, DOI 10.1007/BF01537078; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Compas BE, 2001, J DEV BEHAV PEDIATR, V22, P323, DOI 10.1097/00004703-200110000-00007; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Derogatis LR, 1993, SCL 90 R ADM SCORING; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; FELTON BJ, 1984, J CONSULT CLIN PSYCH, V52, P343, DOI 10.1037/0022-006X.52.3.343; FELTON BJ, 1984, SOC SCI MED, V18, P889, DOI 10.1016/0277-9536(84)90158-8; Folkman S., 1984, STRESS; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; HOLAHAN CJ, 1987, J PERS SOC PSYCHOL, V52, P946, DOI 10.1037/0022-3514.52.5.946; Holmbeck GN, 1997, J PEDIATR PSYCHOL, V22, P167; KOHN PM, 1991, J PERS SOC PSYCHOL, V61, P478, DOI 10.1037/0022-3514.61.3.478; Lamb ME., 2013, FATHERS ROLE CROSS C; Laursen B, 1998, CHILD DEV, V69, P817, DOI 10.1111/j.1467-8624.1998.00817.x; Macias MM, 2007, CHILD HEALTH CARE, V36, P99, DOI 10.1080/02739610701334558; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Pasley K., 1984, ANNU REV PSYCHOL, V39, P583; Pearlin L.I., 1979, COMMUNITY MENT HLT J, V1, P217; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; Petranovich C., IN PRESS; Phares V, 2005, J PEDIATR PSYCHOL, V30, P631, DOI 10.1093/jpepsy/jsi050; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Sloper P, 2000, J PEDIATR PSYCHOL, V25, P79, DOI 10.1093/jpepsy/25.2.79; SMALL SA, 1988, J YOUTH ADOLESCENCE, V17, P377, DOI 10.1007/BF01537880; SMALL SA, 1983, 91 ANN M AM PSYCH AS; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor SE, 1991, HLTH PSYCHOL; Thurman D. J., 2016, J CHILD NEUROL, V31, P20, DOI DOI 10.1177/0883073814544363; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WEINRAUB M, 1983, CHILD DEV, V54, P1297, DOI 10.2307/1129683	51	9	9	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2017	42	3					304	314		10.1093/jpepsy/jsw079			11	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	EQ3HY	WOS:000397963800007	27633324	Green Published, Bronze			2022-02-06	
J	Post, A; Hoshizaki, TB; Gilchrist, MD; Koncan, D; Dawson, L; Chen, W; Ledoux, AA; Zemek, R				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Koncan, David; Dawson, Lauren; Chen, Wesley; Ledoux, Andree-Anne; Zemek, Roger		Pediat Emergency Res Canada	A comparison in a youth population between those with and without a history of concussion using biomechanical reconstruction	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; history; biomechanics; youth; trauma	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HEAD CIRCUMFERENCE; ACCIDENT RECONSTRUCTIONS; MULTIBODY DYNAMICS; SUBDURAL-HEMATOMA; TEMPORAL WINDOW; TISSUE; IMPACTS; FALLS	OBJECTIVE Concussion is a common topic of research as a result of the short-and long-term effects it can have on the affected individual. Of particular interest is whether previous concussions can lead to a biomechanical susceptibility, or vulnerability, to incurring further head injuries, particularly for youth populations. The purpose of this research was to compare the impact biomechanics of a concussive event in terms of acceleration and brain strains of 2 groups of youths: those who had incurred a previous concussion and those who had not. It was hypothesized that the youths with a history of concussion would have lower-magnitude biomechanical impact measures than those who had never suffered a previous concussion. METHODS Youths who had suffered a concussion were recruited from emergency departments across Canada. This pool of patients was then separated into 2 categories based on their history of concussion: those who had incurred 1 or more previous concussions, and those who had never suffered a concussion. The impact event that resulted in the brain injury was reconstructed biomechanically using computational, physical, and finite element modeling techniques. The output of the events was measured in biomechanical parameters such as energy, force, acceleration, and brain tissue strain to determine if those patients who had a previous concussion sustained a brain injury at lower magnitudes than those who had no previously reported concussion. RESULTS The results demonstrated that there was no biomechanical variable that could distinguish between the concussion groups with a history of concussion versus no history of concussion. CONCLUSIONS The results suggest that there is no measureable biomechanical vulnerability to head impact related to a history of concussions in this youth population. This may be a reflection of the long time between the previous concussion and the one reconstructed in the laboratory, where such a long period has been associated with recovery from injury.	[Post, Andrew; Ledoux, Andree-Anne; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, 200 Lees Ave,Rm A106, Ottawa, ON K1H 8L1, Canada; [Post, Andrew; Hoshizaki, T. Blaine; Koncan, David; Dawson, Lauren; Chen, Wesley] Univ Ottawa, Human Kinet, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 200 Lees Ave,Rm A106, Ottawa, ON K1H 8L1, Canada.	apost@uottawa.ca	Barlow, Karen/C-1323-2014; Zemek, Roger/H-1039-2018; Barlow, Karen/I-6492-2019; Mikrogianakis, Angelo/AAW-5929-2021; Richer, Lawrence/D-3622-2009	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Mikrogianakis, Angelo/0000-0002-8854-0620; Richer, Lawrence/0000-0002-6897-8668; Klassen, Terry/0000-0002-5309-7091; Craig, William/0000-0002-4804-194X	Canadian Institutes of Health Research Operating Grant (TM1) [127047]; Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant [126197]	This study was funded by a Canadian Institutes of Health Research Operating Grant (TM1, no. 127047) and Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant (no. 126197).	Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dawson L, 2016, THESIS; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Effgen G.B., 2016, J NEUROTRAUMA; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giza CC, 2001, J ATHL TRAINING, V36, P228; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Horgan TJ, 2004, INT J CRASH, V9, P401; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mennes M, 2014, NEUROIMAGE, V98, P513, DOI 10.1016/j.neuroimage.2014.04.030; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller R, 1990, P 42 STAPP CAR CRASH, P155; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nguyen AKD, 2012, INT J MORPHOL, V30, P1474, DOI 10.4067/S0717-95022012000400033; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau P., 2014, THESIS; Ruan J, 1994, THESIS; Ruan SJ, 2012, ZHONGGUO SHENGWU YIX, V31, P1; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; SCHREIBER DI, 1997, P 41 STAPP CAR CRASH, P277; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; THOMAS LM, 1966, J NEUROL NEUROSUR PS, V29, P404, DOI 10.1136/jnnp.29.5.404; Uchiyama HT, 2013, BRAIN DEV-JPN, V35, P228, DOI 10.1016/j.braindev.2012.04.005; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van Hoof Jack, 2003, Stapp Car Crash J, V47, P401; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Willinger R, 1995, P IRCOBI, V23, P245; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C., 1995, P STAPP CAR CRASH J, P121; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569	65	9	9	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2017	19	4					502	510		10.3171/2016.10.PEDS16449			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EP4MQ	WOS:000397355000016	28128703	Bronze			2022-02-06	
J	Roquilly, A; David, G; Cinotti, R; Vourc'h, M; Morin, H; Rozec, B; Retiere, C; Asehnoune, K				Roquilly, Antoine; David, Gaelle; Cinotti, Raphael; Vourc'h, Mickael; Morin, Helene; Rozec, Bertrand; Retiere, Christelle; Asehnoune, Karim			Role of IL-12 in overcoming the low responsiveness of NK cells to missing self after traumatic brain injury	CLINICAL IMMUNOLOGY			English	Article						Traumatic brain injury; NK cells; Monocytes; HLA class I; IL-12; Immune suppression; KIR	NATURAL-KILLER-CELLS; INTERFERON-GAMMA PRODUCTION; CLASS-I; EXPRESSION; REPERTOIRE; ACTIVATION; CYTOMEGALOVIRUS; INTERLEUKIN-10; POPULATION; RECEPTORS	Blood samples from 32 patients with severe Traumatic brain injury (TBI) were studied and compared with 11 cardiac surgery patients, and 29 healthy controls. A dramatic decreased expression of HLA class I molecules on monocytes was associated with increased KIR+ NK cell frequency in TBI patients. Overall, the phenotype of TBI NK cells marked by KIR and CD57 expression and lower level of NKp46 and DNAM-1 reflected a differentiated state. The NK-cell response to missing self was marked by lower degranulation and lower IFN-gamma production after stimulation with HLA class I deficient cell line. In contrast, the NK-cell ADCC was not altered. IL-12 was able to restore both IFN-gamma production and the cytotoxicity capacities of NM cells. This study provides the first extensive description of the phenotype and functions of NM cells in TBI patients. Further evaluation of IL-12 treatment to overcome immunosuppression-induced nosocomial infections is warranted. (C) 2015 Elsevier Inc. All rights reserved.	[Roquilly, Antoine; David, Gaelle; Cinotti, Raphael; Vourc'h, Mickael; Asehnoune, Karim] Univ Hosp Nantes, Hotel Dieu HME, Intens Care Unit, Anesthesia & Crit Care Dept, Nantes, France; [David, Gaelle; Cinotti, Raphael; Vourc'h, Mickael; Asehnoune, Karim] Univ Nantes, Fac Med Therapeut Clin & Expt Infect, EA 3826, Nantes, France; [David, Gaelle; Retiere, Christelle] Etab Francais Sang, Nantes, France; [David, Gaelle; Retiere, Christelle] Univ Nantes, ImmunoVirol & Polymorphisme Genet, Equipe Accueil 4271, Nantes, France; [Morin, Helene; Rozec, Bertrand] Univ Hosp Nantes, Intens Care Unit, Anesthesia & Crit Care Dept, Nantes, France		Asehnoune, K (corresponding author), Univ Nantes, Anesthesia & Crit Care Dept, Fac Med Therapeut Clin & Expt Infect,EA 3826, Univ Hosp Nantes,Intens Care Unit,Hotel Dieu HME, Nantes, France.	karim.asehnoune@chu-nantes.fr	Roquilly, Antoine/P-9826-2017; RETIERE, Christelle/L-5709-2015; Rozec, Bertrand/AAA-8152-2021	RETIERE, Christelle/0000-0001-5943-6990; Rozec, Bertrand/0000-0002-2226-3982; VOURC'H, Mickael/0000-0002-1576-7728			Adib-Conquy M, 2002, J BIOL CHEM, V277, P27927, DOI 10.1074/jbc.M200705200; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Asehnoune K., 2014, LANCET RESP MED; Athie-Morales V, 2008, J IMMUNOL, V180, P4082, DOI 10.4049/jimmunol.180.6.4082; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Broquet A., 2014, CRIT CARE MED, V1; Chiche L, 2012, CRIT CARE MED, V40, P3162, DOI 10.1097/CCM.0b013e318260c90e; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; Dehoux MS, 2000, CRIT CARE MED, V28, P1721, DOI 10.1097/00003246-200006000-00004; Deknuydt F, 2013, CRIT CARE MED, V41, P245, DOI 10.1097/CCM.0b013e3182676052; Djaoud Z, 2013, J IMMUNOL, V191, P2708, DOI 10.4049/jimmunol.1301138; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Feriazzo Guido, 2008, V415, P197, DOI 10.1007/978-1-59745-570-1_12; Forel JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050446; Gagne K, 2013, EUR J IMMUNOL, V43, P1085, DOI 10.1002/eji.201243007; Guerra N, 2013, CLIN IMMUNOL, V149, P432, DOI 10.1016/j.clim.2013.09.003; Hasan M, 2015, CLIN IMMUNOL, V157, P261, DOI 10.1016/j.clim.2014.12.008; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lehmann D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087131; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Morvan M, 2009, J IMMUNOL, V182, P6727, DOI 10.4049/jimmunol.0900212; Morvan M, 2008, EUR J IMMUNOL, V38, P3474, DOI 10.1002/eji.200838407; Narni-Mancinelli E, 2013, CURR OPIN IMMUNOL, V25, P53, DOI 10.1016/j.coi.2012.11.005; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Roquilly A., 2014, CRIT CARE MED; Roquilly A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071639; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Seki S, 1998, INFECT IMMUN, V66, P5286, DOI 10.1128/IAI.66.11.5286-5294.1998; Sleiman M, 2014, J IMMUNOL, V192, P2602, DOI 10.4049/jimmunol.1302843; Souza-Fonseca-Guimaraes F., 2011, MOL MED; Souza-Fonseca-Guimaraes F, 2012, CRIT CARE, V16, DOI 10.1186/cc11838; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yajima T, 2001, EUR J IMMUNOL, V31, P757, DOI 10.1002/1521-4141(200103)31:3<757::AID-IMMU757>3.0.CO;2-Q	40	9	9	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	APR	2017	177						87	94		10.1016/j.clim.2015.08.006			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EX6WX	WOS:000403383900011	26387630				2022-02-06	
J	Shaker, M; Erdogmus, D; Dy, J; Bouix, S				Shaker, Matineh; Erdogmus, Deniz; Dy, Jennifer; Bouix, Sylvain			Subject-specific abnormal region detection in traumatic brain injury using sparse model selection on high dimensional diffusion data	MEDICAL IMAGE ANALYSIS			English	Article						Sparse learning; Graphical lasso; TBI; DTI	CONNECTIVITY; WHITE	We present a method to estimate a multivariate Gaussian distribution of diffusion tensor features in a set of brain regions based on a small sample of healthy individuals, and use this distribution to identify imaging abnormalities in subjects with mild traumatic brain injury. The multivariate model receives apriori knowledge in the form of a neighborhood graph imposed on the precision matrix, which models brain region interactions, and an additional L-1 sparsity constraint. The model is then estimated using the graphical LASSO algorithm and the Mahalanobis distance of healthy and TBI subjects to the distribution mean is used to evaluate the discriminatory power of the model. Our experiments show that the addition of the apriori neighborhood graph results in significant improvements in classification performance compared to a model which does not take into account the brain region interactions or one which uses a fully connected prior graph. In addition, we describe a method, using our model, to detect the regions that contribute the most to the overall abnormality of the DTI profile of a subject's brain. (C)2017 Elsevier B.V. All rights reserved.	[Shaker, Matineh; Erdogmus, Deniz; Dy, Jennifer] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Shaker, Matineh; Bouix, Sylvain] Brigham & Womens Hosp, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA		Bouix, S (corresponding author), Brigham & Womens Hosp, Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA.	shaker@ece.neu.edu; erdogmus@ece.neu.edu; jdy@ece.neu.edu; sylvain@bwh.harvard.edu		Bouix, Sylvain/0000-0003-1326-6054	CIMIT Soldier in Medicine Award; NSFNational Science Foundation (NSF) [CCF 1442728, IIS-1149570, IIS-1118061]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, RO1HL089856]; DoDUnited States Department of Defense [W81XWH-08-2-0159]; Veterans Administration Merit Review AwardUS Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD090641] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL089856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337] Funding Source: NIH RePORTER	This work was supported in part by a CIMIT Soldier in Medicine Award; NSF grants CCF 1442728, IIS-1149570, and IIS-1118061; NIH grants R01 NS 078337 and RO1HL089856; DoD grants W81XWH-08-2-0159; and a Veterans Administration Merit Review Award.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Koch K, 2013, CORTEX, V49, P722, DOI 10.1016/j.cortex.2012.02.001; Lauritzen S.L., 1996, GRAPH MODELS, V17; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Liu XY, 2014, MAGN RESON IMAGING, V32, P1, DOI 10.1016/j.mri.2013.08.004; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Miyata J, 2009, SCHIZOPHR RES, V111, P78, DOI 10.1016/j.schres.2009.03.010; Planetta PJ, 2016, BRAIN, V139, P495, DOI 10.1093/brain/awv361; Ruscio J, 2008, J MOD APPL STAT METH, V7, P416; Savadjiev P, 2014, MED IMAGE ANAL, V18, P1349, DOI 10.1016/j.media.2014.06.013; Sun Y., 2011, J COMPUT GRAPH STAT, V20, P156; Vergara V. M., 2016, J NEUROTRAUMA; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Yoldemir Burak, 2015, Inf Process Med Imaging, V24, P770, DOI 10.1007/978-3-319-19992-4_61; Zhu D, 2012, CEREB CORTEX; Zhu Dajiang, 2013, Inf Process Med Imaging, V23, P13, DOI 10.1007/978-3-642-38868-2_2	30	9	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1361-8415	1361-8423		MED IMAGE ANAL	Med. Image Anal.	APR	2017	37						56	65		10.1016/j.media.2017.01.005			10	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Radiology, Nuclear Medicine & Medical Imaging	EP7IM	WOS:000397551500005	28160691	Green Submitted, Green Accepted, Bronze			2022-02-06	
J	Zhang, HS; Dai, R; Qin, PM; Tang, WJ; Hu, J; Weng, XC; Wu, X; Mao, Y; Wu, XH; Northoff, G				Zhang, Haosu; Dai, Rui; Qin, Pengmin; Tang, Weijun; Hu, Jin; Weng, Xuchu; Wu, Xing; Mao, Ying; Wu, Xuehai; Northoff, Georg			Posterior cingulate cross-hemispheric functional connectivity predicts the level of consciousness in traumatic brain injury	SCIENTIFIC REPORTS			English	Article							DEFAULT-MODE NETWORK; RESTING-STATE; DISORDERS; CORTEX; SELF; SYNCHRONIZATION; ANESTHESIA; RECOVERY; DISEASE; REGIONS	Previous studies have demonstrated that altered states of consciousness are related to changes in resting state activity in the default-mode network (DMN). Anatomically, the DMN can be divided into anterior and posterior regions. The anterior DMN includes the perigenual anterior cingulate cortex and other medial prefrontal cortical regions, whereas the posterior DMN includes regions such as the posterior cingulate cortex (PCC) and the temporal parietal junction (TPJ). Although differential roles have been attributed to the anterior and posterior DMN regions, their exact contributions to consciousness levels remain unclear. To investigate the specific role of the posterior DMN in consciousness levels, we investigated 20 healthy controls (7 females, mean age = 33.6 years old) and 20 traumatic brain injury (TBI) patients (5 females, mean age = 43 years old) whose brain lesions were mainly restricted to the bilateral frontal cortex but retained a well-preserved posterior DMN (e.g., the PCC and the TPJ) and who exhibited varying levels of consciousness. We investigated the intra- and cross-functional connectivity strengths (FCSs) between the right/left PCC and the right/left TPJ and their correlation with consciousness levels. Significant reductions in both the intra-and cross-hemispheric FCSs were observed in patients compared with controls. A significant correlation with consciousness levels was observed only for the cross-hemispheric PCC-TPJ FCS but not for the intra-hemispheric PCC-TPJ FCS. Taken together, our results show that the cross-hemispheric posterior DMN is related to consciousness levels in a specific group of patients without posterior structural lesions. We therefore propose that the PCC may be central in maintaining consciousness through its cross-hemispheric FC with the TPJ.	[Zhang, Haosu; Tang, Weijun; Hu, Jin; Wu, Xing; Mao, Ying; Wu, Xuehai] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Mid Rd, Shanghai 200040, Peoples R China; [Weng, Xuchu; Northoff, Georg] Hangzhou Normal Univ, CCBD, 19 3 Shuyuan,58 Haishu Rd, Hangzhou 310000, Zhejiang, Peoples R China; [Weng, Xuchu; Northoff, Georg] Univ Ottawa, Inst Mental Hlth Res, 1145 Carling Ave,Room 6435, Ottawa, ON K1Z 7K4, Canada; [Dai, Rui] South China Normal Univ, Sch Life Sci, Key Lab Ecol & Environm Sci Higher Educ Guangdong, Guangzhou 510631, Guangdong, Peoples R China; [Qin, Pengmin] South China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Guangdong, Peoples R China; [Qin, Pengmin] South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China; [Qin, Pengmin] South China Normal Univ, Sch Psychol, Guangzhou 510631, Guangdong, Peoples R China		Wu, XH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Mid Rd, Shanghai 200040, Peoples R China.; Northoff, G (corresponding author), Hangzhou Normal Univ, CCBD, 19 3 Shuyuan,58 Haishu Rd, Hangzhou 310000, Zhejiang, Peoples R China.; Northoff, G (corresponding author), Univ Ottawa, Inst Mental Hlth Res, 1145 Carling Ave,Room 6435, Ottawa, ON K1Z 7K4, Canada.	wuxuehai2013@163.com; georg.northoff@theroyal.ca		Mao, Ying/0000-0001-8055-115X	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571025]; National 863 projectNational High Technology Research and Development Program of China [2015AA020501]; Shanghai Natural Science FoundationNatural Science Foundation of Shanghai [10ZR1405400]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [200809EJL-194083-CECA-179644]; Michael Smith Foundation (EJLB-CIHR) [EJL-94190]; Thousand Talents Program from the Federal Government of China; National Science Foundation for Distinguished Young Scholars of ChinaNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81025013]; Project for National 985 Engineering of China [985III-YFX0102]; "Dawn Tracking" Program of Shanghai Education Commission [10GG01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020501] Funding Source: NIH RePORTER	This work was sponsored by grants to Xuehai Wu from Natural Science Foundation of China (Grants 81571025 to Xuehai Wu), National 863 project (No. 2015AA020501 to Xuehai Wu) and the Shanghai Natural Science Foundation (grant numbers: 10ZR1405400 to Xuehai Wu). And this study was also supported by GN from the Canadian Institutes of Health Research (CIHR) (No. 200809EJL-194083-CECA-179644), the Michael Smith Foundation (EJLB-CIHR) (No. EJL-94190) and a chair to GN sponsored by the Thousand Talents Program from the Federal Government of China. The study received supports from by the National Science Foundation for Distinguished Young Scholars of China (No. 81025013 to Y.M.), the Project for National 985 Engineering of China (No. 985III-YFX0102 to Y.M.), the "Dawn Tracking" Program of Shanghai Education Commission (No. 10GG01 to Y.M.).	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Crone JS, 2015, NEUROIMAGE, V110, P101, DOI 10.1016/j.neuroimage.2015.01.037; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Huang ZR, 2016, NEUROIMAGE, V124, P693, DOI 10.1016/j.neuroimage.2015.08.062; Huang ZR, 2014, HUM BRAIN MAPP, V35, P5368, DOI 10.1002/hbm.22556; Huang ZR, 2014, HUM BRAIN MAPP, V35, P1997, DOI 10.1002/hbm.22308; Jiang HD, 2017, CEREB CORTEX, V27, P4083, DOI 10.1093/cercor/bhw220; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; Northoff G, 2004, TRENDS COGN SCI, V8, P484, DOI 10.1016/j.tics.2004.09.003; Northoff G, 2008, TRENDS COGN SCI, V12, P259, DOI 10.1016/j.tics.2008.04.007; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Qin PM, 2015, HUM BRAIN MAPP, V36, P3867, DOI 10.1002/hbm.22883; Qin PM, 2011, NEUROIMAGE, V57, P1221, DOI 10.1016/j.neuroimage.2011.05.028; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Razlighi QR, 2014, BRAIN BEHAV, V4, P143, DOI 10.1002/brb3.202; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Saenger VM, 2012, NEUROPSYCHOLOGIA, V50, P1308, DOI 10.1016/j.neuropsychologia.2012.02.014; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tsai YH, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00956; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vassena E, 2014, NEUROPSYCHOLOGIA, V59, P112, DOI 10.1016/j.neuropsychologia.2014.04.019; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	43	9	9	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 24	2017	7								387	10.1038/s41598-017-00392-5			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP3JN	WOS:000397278700005	28341824	gold, Green Published			2022-02-06	
J	Corrigan, F; Arulsamy, A; Teng, J; Collins-Praino, LE				Corrigan, Frances; Arulsamy, Alina; Teng, Jason; Collins-Praino, Lyndsey E.			Pumping the Brakes: Neurotrophic Factors for the Prevention of Cognitive Impairment and Dementia after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; growth factors; inflammation; neurodegenerative disorders; secondary insult	COLONY-STIMULATING FACTOR; NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; FACTOR G-CSF; PROMOTES FUNCTIONAL RECOVERY; CEREBRAL-ARTERY OCCLUSION; LONG-TERM ACCUMULATION; DIFFUSE AXONAL INJURY; CORD BLOOD-CELL; ALZHEIMERS-DISEASE	Traumatic brain injury (TBI) is the leading cause of disability and death worldwide, affecting as many as 54,000,000-60,000,000 people annually. TBI is associated with significant impairments in brain function, impacting cognitive, emotional, behavioral, and physical functioning. Although much previous research has focused on the impairment immediately following injury, TBI may have much longer-lasting consequences, including neuropsychiatric disorders and cognitive impairment. TBI, even mild brain injury, has also been recognized as a significant risk factor for the later development of dementia and Alzheimer's disease. Although the link between TBI and dementia is currently unknown, several proposed mechanisms have been put forward, including alterations in glucose metabolism, excitotoxicity, calcium influx, mitochondrial dysfunction, oxidative stress, and neuroinflammation. A treatment for the devastating long-term consequences of TBI is desperately needed. Unfortunately, however, no such treatment is currently available, making this a major area of unmet medical need. Increasing the level of neurotrophic factor expression in key brain areas may be one potential therapeutic strategy. Of the neurotrophic factors, granulocyte-colony stimulating factor (G-CSF) may be particularly effective for preventing the emergence of long-term complications of TBI, including dementia, because of its ability to reduce apoptosis, stimulate neurogenesis, and increase neuroplasticity.	[Corrigan, Frances; Arulsamy, Alina; Teng, Jason; Collins-Praino, Lyndsey E.] Univ Adelaide, Sch Med, Discipline Anat & Pathol, Translat Neuropathol Lab, Adelaide, SA, Australia		Collins-Praino, LE (corresponding author), Univ Adelaide, Sch Med, Discipline Anat & Pathol, Neurodegenerat Dis Grp,Translat Neuropathol Lab, Adelaide, SA 5005, Australia.	lyndsey.collins-praino@adelaide.edu.au	Arulsamy, Alina/AAU-9166-2021; Collins-Praino, Lyndsey/AAB-3318-2019	Arulsamy, Alina/0000-0003-0993-5622; Collins-Praino, Lyndsey/0000-0002-4380-7600; Corrigan, Frances/0000-0001-6150-8893	Neurosurgical Research Foundation	This work was supported by a grant from the Neurosurgical Research Foundation.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Ando K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005917; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; DAVIES SW, 1992, NEUROSCI LETT, V140, P161, DOI 10.1016/0304-3940(92)90092-L; De La Pena I, 2015, CELL TRANSPLANT, V24, P447, DOI 10.3727/096368915X686913; de la Pena I, 2014, REGEN MED, V9, P409, DOI [10.2217/RME.14.32, 10.2217/rme.14.32]; Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ferenz KB, 2012, BRAIN RES, V1448, P20, DOI 10.1016/j.brainres.2012.02.016; Feuillette S, 2010, J NEUROCHEM, V113, P895, DOI 10.1111/j.1471-4159.2010.06663.x; FIBIGER HC, 1991, TRENDS NEUROSCI, V14, P220, DOI 10.1016/0166-2236(91)90117-D; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Freyer G, 2013, ANTICANCER RES, V33, P301; Gamberger D, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0183-0; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gerson J. E., 2016, J NEUROTRAUMA; Ghalaut P S, 2008, J Assoc Physicians India, V56, P942; Ghribi O, 2001, NEUROBIOL DIS, V8, P764, DOI 10.1006/nbdi.2001.0429; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Giza CC, 2001, J ATHL TRAINING, V36, P228; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hill JM, 2005, J AM COLL CARDIOL, V46, P1643, DOI 10.1016/j.jacc.2005.01.067; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Holm PC, 2002, J NEUROCHEM, V81, P1318, DOI 10.1046/j.1471-4159.2002.00926.x; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jiang H, 2010, J INT MED RES, V38, P1305, DOI 10.1177/147323001003800412; Jiang YJ, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/372423; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Konishi Y, 2014, J NEUROSCI, V34, P13127, DOI 10.1523/JNEUROSCI.2582-13.2014; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kumar Rajeev, 2009, Indian J Psychiatry, V51 Suppl 1, pS35; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Laske C, 2009, J ALZHEIMERS DIS, V17, P115, DOI 10.3233/JAD-2009-1017; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Lee HJ, 2012, CELL TRANSPLANT, V21, P2487, DOI 10.3727/096368912X638964; Lee JS, 2012, SPINE, V37, P10, DOI 10.1097/BRS.0b013e31823b0440; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005424; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Li YK, 2003, J NEUROSCI, V23, P1605; Liang ZH, 2009, J ALZHEIMERS DIS, V17, P531, DOI 10.3233/JAD-2009-1069; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Liu GX, 2014, INT IMMUNOPHARMACOL, V19, P145, DOI 10.1016/j.intimp.2014.01.008; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; Makar TK, 2009, J NEUROIMMUNOL, V210, P40, DOI 10.1016/j.jneuroim.2009.02.017; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McDonald JW, 2002, NEUROSCIENCE, V115, P931, DOI 10.1016/S0306-4522(02)00342-1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Miyasaka T, 2010, FEBS LETT, V584, P3227, DOI 10.1016/j.febslet.2010.06.014; Monastero R, 2014, IMMUN AGEING, V11, DOI 10.1186/s12979-014-0026-4; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; MORSTYN G, 1988, LANCET, V1, P667, DOI 10.1016/S0140-6736(88)91475-4; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murray John, 2014, Adv J Mol Imaging, V4, P15; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; OLSON L, 1992, J NEURAL TRANSM-PARK, V4, P79, DOI 10.1007/BF02257624; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; PECHAN PA, 1995, NEUROREPORT, V6, P669, DOI 10.1097/00001756-199503000-00021; Perez M, 2007, J NEUROCHEM, V103, P1447, DOI 10.1111/j.1471-4159.2007.04834.x; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Povlishock J T, 2000, Clin Neurosurg, V46, P113; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 1996, ACT NEUR S, V66, P81; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sanchez-Ramos J, 2012, J ALZHEIMERS DIS, V31, P843, DOI 10.3233/JAD-2012-120196; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sehara Y, 2007, J NEUROSCI RES, V85, P2167, DOI 10.1002/jnr.21341; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sikoglu EM, 2014, BEHAV BRAIN RES, V259, P354, DOI 10.1016/j.bbr.2013.11.008; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stranahan AM, 2012, CURR ALZHEIMER RES, V9, P86; Straten G, 2009, J ALZHEIMERS DIS, V18, P331, DOI 10.3233/JAD-2009-1146; Sudduth TL, 2013, NEUROBIOL AGING, V34, P1051, DOI 10.1016/j.neurobiolaging.2012.09.012; Sultana R, 2009, ACTA NEUROPATHOL, V118, P131, DOI 10.1007/s00401-009-0517-0; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; TEASDALE G, 1974, LANCET, V2, P81; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; Tuszynski MH, 2015, JAMA NEUROL, V72, P1139, DOI 10.1001/jamaneurol.2015.1807; Uryu K, 2004, NEUROBIOL AGING, V25, pS303, DOI 10.1016/S0197-4580(04)80996-5; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang Y, 1997, J NEUROSCI, V17, P4341; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Won SJ, 2000, NEUROBIOL DIS, V7, P251, DOI 10.1006/nbdi.2000.0284; Wong LF, 2005, MOL THER, V11, P89, DOI 10.1016/j.ymthe.2004.08.026; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiao N, 2016, ARCH IMMUNOL THER EX, V64, P89, DOI 10.1007/s00005-015-0376-4; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang WR, 1999, BRAIN RES, V842, P211, DOI 10.1016/S0006-8993(99)01818-1; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001; Zumkehr J, 2015, NEUROBIOL AGING, V36, P2260, DOI 10.1016/j.neurobiolaging.2015.04.005	278	9	9	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					971	986		10.1089/neu.2016.4589			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200002	27630018				2022-02-06	
J	Merchant-Borna, K; Jones, CMC; Janigro, M; Wasserman, EB; Clark, RA; Bazarian, JJ				Merchant-Borna, Kian; Jones, Courtney Marie Cora; Janigro, Mattia; Wasserman, Erin B.; Clark, Ross A.; Bazarian, Jeffrey J.			Evaluation of Nintendo Wii Balance Board as a Tool for Measuring Postural Stability After Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; athletes; balance; recovery; return-to-play guidelines; neurocognitive testing	ERROR SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; RELIABILITY; RECOVERY; ASSOCIATION; ASSESSMENTS; IMPACT	Context: Recent changes to postconcussion guidelines indicate that postural-stability assessment may augment traditional neurocognitive testing when making return-to-participation decisions. The Balance Error Scoring System (BESS) has been proposed as 1 measure of balance assessment. A new, freely available software program to accompany the Nintendo Wii Balance Board (WBB) system has recently been developed but has not been tested in concussed patients. Objective: To evaluate the feasibility of using the WBB to assess postural stability across 3 time points (baseline and postconcussion days 3 and 7) and to assess concurrent and convergent validity of the WBB with other traditional measures (BESS and Immediate Post-Concussion Assessment and Cognitive Test [ImPACT] battery) of assessing concussion recovery. Design: Cohort study. Setting: Athletic training room and collegiate sports arena. Patients or Other Participants: We collected preseason baseline data from 403 National Collegiate Athletic Association Division I and III student-athletes participating in contact sports and studied 19 participants (age = 19.2 +/- 1.2 years, height = 177.7 +/- 8.0 cm, mass = 75.3 +/- 16.6 kg, time from baseline to day 3 postconcussion = 27.1 +/- 36.6 weeks) who sustained concussions. Main Outcome Measure(s): We assessed balance using single-legged and double-legged stances for both the BESS and WBB, focusing on the double-legged, eyes-closed stance for the WBB, and used ImPACT to assess neurocognition at 3 time points. Descriptive statistics were used to characterize the sample. Mean differences and Spearman rank correlation coefficients were used to determine differences within and between metrics over the 3 time points. Individual-level changes over time were also assessed graphically. Results: The WBB demonstrated mean changes between baseline and day 3 postconcussion and between days 3 and 7 postconcussion. It was correlated with the BESS and ImPACT for several measures and identified 2 cases of abnormal balance postconcussion that would not have been identified via the BESS. Conclusions: When accompanied by the appropriate analytic software, the WBB may be an alternative for assessing postural stability in concussed student-athletes and may provide additional information to that obtained via the BESS and ImPACT. However, verification among independent samples is required.	[Merchant-Borna, Kian; Jones, Courtney Marie Cora; Janigro, Mattia; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, 601 Elmwood Ave,Box 655, Rochester, NY 14642 USA; [Jones, Courtney Marie Cora; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY 14627 USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Neurol Neurosurg & Phys Med & Rehabil, Rochester, NY 14627 USA; [Wasserman, Erin B.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Clark, Ross A.] Australian Catholic Univ, Sch Exercise Sci, Fitzroy, Vic, Australia		Merchant-Borna, K (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, 601 Elmwood Ave,Box 655, Rochester, NY 14642 USA.	Kian_Merchant-Borna@urmc.rochester.edu	Clark, Ross/K-7613-2019; Clark, Ross A/R-5664-2018	Clark, Ross/0000-0002-7291-8553; Clark, Ross A/0000-0002-7291-8553; Wasserman, Erin/0000-0001-5957-5878			[Anonymous], 1995, GAIT POSTURE; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Clark RA, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0006-8; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Onate JA, 2007, J ATHL TRAINING, V42, P446; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Rhine TD, 2016, CLIN J SPORT MED, V26, P221, DOI 10.1097/JSM.0000000000000234; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51	30	9	9	0	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2017	52	3					245	255		10.4085/1062-6050-52.1.13			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ES0NE	WOS:000399222500010	28387551	Green Published, Bronze, Green Submitted			2022-02-06	
J	Mihaljcic, T; Haines, TP; Ponsford, JL; Stolwyk, RJ				Mihaljcic, Tijana; Haines, Terry P.; Ponsford, Jennie L.; Stolwyk, Renerus J.			Investigating the relationship between reduced self-awareness of falls risk, rehabilitation engagement and falls in older adults	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Falls; Rehabilitation; Engagement; Self-awareness; Motivation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; PREVENTION INTERVENTIONS; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; CAREGIVER BURDEN; PEOPLES VIEWS; EXERCISE; DEFICITS; RELIABILITY	The present study aimed to investigate whether self-awareness of falls risk is associated with rehabilitation engagement, motivation for rehabilitation, and number of falls after hospital discharge. The sample comprised 91 older adults (M-age = 77.97, SD = 8.04) undergoing inpatient rehabilitation. The Self-Awareness of Falls Risk Measure (SAFRM) was used to measure different aspects of self-awareness. The treating physiotherapist and occupational therapist rated the patient's engagement in rehabilitation and the patient reported his/her motivation for treatment. Falls information was collected from the patient and significant other once a month for three months following hospital discharge. Significant correlations were found between physiotherapist-rated engagement and intellectual (r(s) = -0.22, p < 0.05) and anticipatory awareness (r(s) = -0.24, p < 0.05). Occupational therapist-rated engagement and patient-reported motivation for rehabilitation was correlated with emergent awareness (r(s) = -0.38 and -0.31, p < 0.05, respectively) and overall self-awareness (r(s) = -0.31 and -0.26, p < 0.05, respectively). Regression analyses indicated that overall self-awareness provided a unique contribution to occupational therapist-rated engagement when controlling for age, gender, cognition and functional ability. Falls were reported by 29.9% of participants, however, self-awareness did not differ significantly between fallers and nonfallers. The findings suggest that self-awareness of falls risk is associated with rehabilitation engagement and motivation. Therefore, improving patient self-awareness of falls risk may increase engagement in therapy leading to better patient outcomes. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Mihaljcic, Tijana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Wellington Rd, Clayton, Vic 3800, Australia; [Haines, Terry P.] Monash Univ, Dept Physiotherapy, McMahons Rd, Frankston, Vic 3199, Australia; [Haines, Terry P.] Monash Hlth, Allied Hlth Res Unit, Warrigal Rd, Cheltenham, Vic 3192, Australia; [Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Suite 1-7,173 Lennox St, Richmond, Vic 3121, Australia		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Wellington Rd, Clayton, Vic 3800, Australia.	Rene.Stolwyk@monash.edu	Haines, Terrence/E-9372-2015	Haines, Terrence/0000-0003-3150-6154	Monash University Strategic Grant SchemeMonash University [ECD013]	This work was supported by Monash University Strategic Grant Scheme (ECD013). The study sponsors were not involved in any aspect of the study design, data collection, data analysis, interpretation, or writing and submission of the manuscript.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Braun BL, 1998, PHYS THER, V78, P1262, DOI 10.1093/ptj/78.12.1262; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Clare L, 2004, J CLIN EXP NEUROPSYC, V26, P215, DOI 10.1076/jcen.26.2.215.28088; Cohen J., 1988, SET CORRELATION MULT; Conn VS, 1998, NURS RES, V47, P180, DOI 10.1097/00006199-199805000-00009; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Delbaere K, 2010, BMJ-BRIT MED J, V341, P4165, DOI [DOI 10.1136/BMJ.C4165, DOI 10.1136/BMJ.ABSTRACT]; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Haines T. P., 2012, HLTH EXPECTATIONS; Haines T, 2009, MED CARE, V47, P448, DOI 10.1097/MLR.0b013e318190ccc0; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hill AM, 2011, ARCH PHYS MED REHAB, V92, P1395, DOI 10.1016/j.apmr.2011.04.009; Horne M, 2009, AGE AGEING, V38, P68, DOI 10.1093/ageing/afn237; Hughes K, 2008, AM J PUBLIC HEALTH, V98, P351, DOI 10.2105/AJPH.2007.115055; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Lafargue G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051218; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Lucas SE, 2005, AUSTR OCCUPATIONAL T, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Mihaljcic T, 2015, ARCH PHYS MED REHAB, V96, P2145, DOI 10.1016/j.apmr.2015.08.414; Mihaljcic T, 2014, ARCH GERONTOL GERIAT, V59, P249, DOI 10.1016/j.archger.2014.06.001; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Robinovitch SN, 1999, J GERONTOL A-BIOL, V54, pB124, DOI 10.1093/gerona/54.3.B124; Rymer S, 2002, ALZ DIS ASSOC DIS, V16, P248, DOI 10.1097/00002093-200210000-00006; Sakurai R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-44; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Seltzer B, 1997, GERONTOLOGIST, V37, P20, DOI 10.1093/geront/37.1.20; Sherer M., 2014, HDB NEUROPSYCHOLOGY, P233, DOI [10.1007/978-1-4939-0784-7_12, DOI 10.1007/978-1-4939-0784-7_12]; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; World Health Organization, 2007, WHO GLOB REP FALLP; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	47	9	10	2	45	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	MAR-APR	2017	69						38	44		10.1016/j.archger.2016.11.003			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	EF6NY	WOS:000390449000006	27886565				2022-02-06	
J	Paradells-Navarro, S; Benlloch-Navarro, MS; Frias, MIA; Garcia-Esparza, MA; Broccoli, V; Miranda, M; Soria, JM				Paradells-Navarro, Sara; Soledad Benlloch-Navarro, Maria; Almansa Frias, Maria Inmaculada; Angeles Garcia-Esparza, Ma; Broccoli, Vania; Miranda, Maria; Miguel Soria, Jose			Neuroprotection of Brain Cells by Lipoic Acid Treatment after Cellular Stress	ACS CHEMICAL NEUROSCIENCE			English	Article						Brain; lipoic acid; oxidative stress; glutathione; malondialdehyde; antioxidants	LIPID-PEROXIDATION; OXIDATIVE STRESS; TRAUMATIC BRAIN; ALZHEIMERS-DISEASE; FREE-RADICALS; IN-VITRO; GLUTATHIONE; ANTIOXIDANT; CURCUMIN; RATS	We have previously observed that in vivo lipoic acid (LA) treatment induced a protective effect onto primary cortical neurons after brain injury. In an effort to better understand LA action mechanism in the brain, in the present study, we stressed brain cells in vitro and ex vivo and then analyzed by inmmunocytochemistry and biochemical assays, the changes induced by LA on cell survival and on the concentration of oxidative stress markers, such as glutathione (GSH), oxidized glutathione (GSSG), and malondialdehyde (MDA). The stressors used were lipopolysaccharide (LPS), dopamine, and Lbuthionine-S,R-sulfoximine (BSO). Our results showed that LA decreased cell death and increased GSH/GSSG ratio in cells stressed by LPS + dopamine, suggesting that the mechanism underlying LA action is regeneration of GSSG to GSH. When cells were stressed by BSO, LA diminished cell death and decreased GSH/GSSG ratio. In this case, it could be concluded that, due to the low GSH basal levels, GSSG reduction is not possible and therefore it might be thought that cell death prevention might be mediated through other mechanisms. Finally, we induced chemical oxidative damage in brain homogenate. After LA treatment, GSH and GSH/GSSG ratio increased and MDA concentration decreased, demonstrating again that LA was not able to increase de novo GSH synthesis but is able to increase GSSG conversion to GSH.	[Paradells-Navarro, Sara; Soledad Benlloch-Navarro, Maria; Almansa Frias, Maria Inmaculada; Miranda, Maria; Miguel Soria, Jose] Univ CEU Cardenal Herrera, Dept Ciencias Biomed, Valencia 46113, Spain; [Paradells-Navarro, Sara; Soledad Benlloch-Navarro, Maria; Miranda, Maria; Miguel Soria, Jose] Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia 46113, Spain; [Angeles Garcia-Esparza, Ma] Univ CEU Cardenal Herrera, Dept Farm, Valencia 46113, Spain; [Broccoli, Vania] Hosp San Raffaele, I-20132 Milan, Italy		Miranda, M; Soria, JM (corresponding author), Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Dept Ciencias Biomed, Moncada Avda Seminario S-N, Valencia 46113, Spain.	mmiranda@uchceu.es; jose.soria@uch.ceu.es	Miranda, Maria/L-3471-2014; Almansa, Inmaculada/F-4183-2016; Broccoli, Vania/K-3464-2016; Lopez, Jose Miguel Soria/M-5266-2017; Miranda, Maria/ABG-5343-2020; Esparza, M. Angeles Garcia/AAH-2495-2019	Miranda, Maria/0000-0002-3738-367X; Almansa, Inmaculada/0000-0001-8085-3377; Broccoli, Vania/0000-0003-4050-0926; Lopez, Jose Miguel Soria/0000-0001-9144-5096; Miranda, Maria/0000-0002-3738-367X; Esparza, M. Angeles Garcia/0000-0001-6510-0879	Cardenal Herrera University	This work was partially supported by grants from Cardenal Herrera University: J.M.S., Programa de ayudas a grupos consolidados UCHCEU 2015/16; M.M., Proyecto Precompetitivo Banco Santander UCHCEU 2015/16.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Akpinar D, 2007, INT J NEUROSCI, V117, P1691, DOI 10.1080/00207450601050287; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; CHIRICO S, 1994, METHOD ENZYMOL, V233, P314; Dadhania VP, 2010, CHEM-BIOL INTERACT, V183, P85, DOI 10.1016/j.cbi.2009.10.020; Dalazen GR, 2014, METAB BRAIN DIS, V29, P175, DOI 10.1007/s11011-013-9466-3; De Araujo DP, 2011, INT J NEUROSCI, V121, P51, DOI 10.3109/00207454.2010.535934; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Escobar L, 2010, VITAE-COLUMBIA, V17, P67; FRAGA CG, 1988, BIOCHEM J, V252, P893, DOI 10.1042/bj2520893; FRANKEL EN, 1983, PROG LIPID RES, V22, P1, DOI 10.1016/0163-7827(83)90002-4; Freitas RM, 2009, NEUROSCI LETT, V455, P140, DOI 10.1016/j.neulet.2009.03.065; Geerts H, 2016, ALZHEIMERS DEMENT, V12, P1014, DOI 10.1016/j.jalz.2016.04.008; Golbidi S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00069; Goozee KG, 2016, BRIT J NUTR, V115, P449, DOI 10.1017/S0007114515004687; Goraca A, 2009, ARCH IMMUNOL THER EX, V57, P141, DOI 10.1007/s00005-009-0015-z; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; HALLIWELL B, 1995, FOOD CHEM TOXICOL, V33, P601, DOI 10.1016/0278-6915(95)00024-V; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Han D, 1997, BIOFACTORS, V6, P321, DOI 10.1002/biof.5520060303; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Hsieh R J, 1989, Adv Food Nutr Res, V33, P233, DOI 10.1016/S1043-4526(08)60129-1; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Khanna S, 2015, ANTIOXID REDOX SIGN, V22, P175, DOI 10.1089/ars.2014.6106; Kim HG, 2003, MOL CELLS, V16, P278; Kim J, 2015, VASC HEALTH RISK MAN, V11, P601, DOI 10.2147/VHRM.S77571; Larghero P, 2007, CARCINOGENESIS, V28, P1008, DOI 10.1093/carcin/bgl233; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Lee HS, 2007, PHARMAZIE, V62, P937, DOI 10.1691/ph.2007.12.7563; Liao TT, 2011, J ENVIRON SCI HEAL A, V46, P1769, DOI 10.1080/10934529.2011.624016; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch MA, 2001, NUTR NEUROSCI, V4, P419, DOI 10.1080/1028415X.2001.11747378; May JM, 1998, J BIOL CHEM, V273, P23039, DOI 10.1074/jbc.273.36.23039; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MINOTTI G, 1987, CHEM PHYS LIPIDS, V44, P191, DOI 10.1016/0009-3084(87)90050-8; Miranda M, 2010, FREE RADICAL BIO MED, V48, P216, DOI 10.1016/j.freeradbiomed.2009.10.042; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Oboh G, 2014, J OLEO SCI, V63, P373, DOI 10.5650/jos.ess13166; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozbal S, 2015, BIOTECH HISTOCHEM, V90, P206, DOI 10.3109/10520295.2014.977950; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Paradells S, 2015, BRAIN INJURY, V29, P380, DOI 10.3109/02699052.2014.973448; Prince MJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000176; Rankine EL, 2006, EUR J NEUROSCI, V24, P77, DOI 10.1111/j.1460-9568.2006.04891.x; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; REES S, 1987, ACTA BIOCHIM BIOPHYS, V22, P241; RICHARD MJ, 1992, J CHROMATOGR-BIOMED, V577, P9, DOI 10.1016/0378-4347(92)80593-F; Rocamonde B, 2012, NEUROSCIENCE, V224, P102, DOI 10.1016/j.neuroscience.2012.08.028; Rocamonde B, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/521939; Rochette L, 2013, MOL NUTR FOOD RES, V57, P114, DOI 10.1002/mnfr.201200608; Romero MJ, 1998, FREE RADICAL BIO MED, V25, P993, DOI 10.1016/S0891-5849(98)00118-X; ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7; Sanchez-Vallejo V, 2015, PHARMACOL RES, V99, P276, DOI 10.1016/j.phrs.2015.06.019; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shoichet Molly S., 2008, P221; Steele ML, 2013, REDOX BIOL, V1, P441, DOI 10.1016/j.redox.2013.08.006; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Tomassoni D, 2013, INT J MOL SCI, V14, P4580, DOI 10.3390/ijms14034580; Yamada T, 2011, NEUROCHEM INT, V59, P1003, DOI 10.1016/j.neuint.2011.09.005; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931	69	9	10	0	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	MAR	2017	8	3					569	577		10.1021/acschemneuro.6b00306			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	EO6MT	WOS:000396807900018	27935686				2022-02-06	
J	van der Horn, HJ; Kok, JG; de Koning, ME; Scheenen, ME; Leemans, A; Spikman, JM; van der Naalt, J				van der Horn, Harm Jan; Kok, Jelmer G.; de Koning, Myrthe E.; Scheenen, Myrthe E.; Leemans, Alexander; Spikman, Jacoba M.; van der Naalt, Joukje			Altered Wiring of the Human Structural Connectome in Adults with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; diffusion MRI; graph theory; mTBI; networks; post-traumatic complaints; tractography	TENSOR IMAGING FINDINGS; DIFFUSION MRI; GEOMETRICALLY ACCURATE; MENTAL FATIGUE; NETWORK HUBS; SEGMENTATION; CONNECTIVITY; COMPLAINTS; IMPAIRMENT; CHILDREN	In this study, structural connectivity after mild traumatic brain injury (mTBI) was examined from a network perspective, with a particular focus on post-traumatic complaints. Fifty-three patients with and without self-reported complaints at 2 weeks after uncomplicated mTBI were included, in addition to 20 matched healthy controls. Diffusion weighted imaging was performed at 4 weeks post-injury, and neuropsychological tests measuring processing speed and verbal memory were administered at 3 months post-injury to determine cognitive outcome. Structural connectivity was investigated using whole brain tractography and subsequent graph theory analysis. In patients with mTBI, eigenvector centrality within the left temporal pole was lower than in healthy controls. In patients without complaints, global and mean local efficiency were lower than in patients with complaints, although no differences were found between either subgroup and the group of healthy controls. Neuropsychological test scores were similar for patients with mTBI and healthy controls. However, patients with complaints showed higher processing speed than patients without complaints. Within the total mTBI group, a trend was found toward a correlation between lower network clustering and higher processing speed. Additionally, significant correlations were found between higher betweenness centrality values of language areas and lower verbal memory scores in patients with mTBI. In conclusion, our findings may indicate that global graph measures of the structural connectome are associated with pre- and/or non-injury-related factors that determine the susceptibility to developing (persistent) complaints after mTBI. Further, correlations between graph measures and neuropsychological test scores could suggest early compensatory mechanisms to maintain adequate cognitive performance.	[van der Horn, Harm Jan; Kok, Jelmer G.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl	Leemans, Alexander/A-1784-2011	Leemans, Alexander/0000-0002-9306-6126; Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation [Ps2012-06]	This study was funded by the Dutch Brain Foundation (grant no. Ps2012-06). The authors thank Dr. Jan Cees de Groot for his assistance in assessing clinical MRI sequences, and Robert Harris for proofreading the manuscript.	Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Filippi M, 2013, LANCET NEUROL, V12, P12, DOI 10.1016/S1474-4422(12)70288-0; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hammes J. G. W., 1971, STROOP KLEUR WOORD T; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK., 2010, IMAGING MED, V2, P341, DOI 10.2217/iim.10.21; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Liu K, 2016, BRAIN IMAGING BEHAV, V10, P857, DOI 10.1007/s11682-015-9492-3; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Reitan R., 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schmand B., 1999, AMSTERDAMSE KORTE TE; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wechsler D., 2001, WECHSLER ADULT INTEL; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	78	9	9	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1035	1044		10.1089/neu.2016.4659			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200008	27627836	Green Submitted			2022-02-06	
J	Jung, SH; Kim, SH; Kim, TS; Joo, SP				Jung, Seung-Hoon; Kim, Sung-Hyun; Kim, Tae-Sun; Joo, Sung-Pil			Surgical Treatment of Traumatic Intracranial Aneurysms: Experiences at a Single Center over 30 Years	WORLD NEUROSURGERY			English	Article						Delayed intracerebral hemorrhage; Intracranial aneurysm; Trauma	INTERNAL CAROTID-ARTERY; CEREBRAL-ARTERY; VERTEBRAL ARTERY; BRAIN INJURY; CHILDHOOD; INFANCY	OBJECTIVE: Traumatic intracranial aneurysm (tIA) is rare and is associated with high rates of morbidity and mortality. We describe our experiences with tIA at our institution. METHODS: We retrospectively reviewed records from patients who underwent treatment for tIA between January 1986 and December 2015. RESULTS: Data from 5532 patients with cerebral aneurysms between January 1986 and December 2015 were reviewed. Of these, 13 cases (0.23%) were tIA. Most occurred after blunt brain trauma (12/13; 92%). The most common location was the distal anterior cerebral artery (7/13; 53%) followed by the internal carotid artery (5/13; 38%). One patient had a tIA in the distal middle cerebral artery. Delayed intracerebral hemorrhage was the major presentation at the time of aneurysmal rupture (70%). Most patients underwent surgical treatment (10/12; 83.3%), which included clipping (5/10), trapping (3/10), aneurysmal excision and bypass (1/10), and aneurysmal excision and coagulation (1/10). In 2 cases, tIA located in the internal carotid artery was treated with coil embolization and detachable balloon occlusion, respectively. Most patients had good recovery (5/12; 41.7%); 3 patients and 1 patient had moderate and severe disability, respectively; 1 patient was in a vegetative state; and 2 patients died. CONCLUSIONS: tIA is an uncommon complication of head trauma. tIA should be considered when unexpected new symptoms develop in patients with head trauma. Early diagnosis and prompt treatment could help to improve final clinical outcomes.	[Jung, Seung-Hoon; Kim, Sung-Hyun; Kim, Tae-Sun; Joo, Sung-Pil] Chonnam Natl Univ Hosp & Med Sch, Dept Neurosurg, Gwangju, South Korea		Joo, SP (corresponding author), Chonnam Natl Univ Hosp & Med Sch, Dept Neurosurg, Gwangju, South Korea.	nsjsp@jnu.ac.kr			Chonnam National University Hospital Biomedical Research Institute [CRI16040-21]	This study was supported by a grant from Chonnam National University Hospital Biomedical Research Institute (CRI16040-21).	Allison JW, 1998, PEDIATR RADIOL, V28, P223, DOI 10.1007/s002470050336; Amenta Peter S, 2012, Surg Neurol Int, V3, P160, DOI 10.4103/2152-7806.105099; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; Bavinzski G, 1997, ACTA NEUROCHIR, V139, P37, DOI 10.1007/BF01850866; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; Chedid MK, 2001, J NEUROSURG, V94, P637, DOI 10.3171/jns.2001.94.4.0637; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; ENDO S, 1980, CHILD BRAIN, V6, P131; GEORGE B, 1987, NEUROSURGERY, V20, P821; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lath R, 2002, J CLIN NEUROSCI, V9, P466, DOI 10.1054/jocn.2001.1050; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; Martin E M, 1986, J Neurosci Nurs, V18, P89; Murakami M, 2003, NEUROL MED-CHIR, V43, P130, DOI 10.2176/nmc.43.130; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; Norris JS, 1998, NEUROSURG CLIN N AM, V9, P557; OBrien D, 1997, ARCH PHYS MED REHAB, V78, P883, DOI 10.1016/S0003-9993(97)90205-7; PARKINSON D, 1985, SURG NEUROL, V23, P453, DOI 10.1016/0090-3019(85)90236-8; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; Scholtes F, 2015, J NEUROL SURG PART A, V76, P72, DOI 10.1055/s-0033-1354748; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Sui MX, 2015, INT J CLIN EXP MED, V8, P1598; Tan TC, 2001, BRIT J NEUROSURG, V15, P137; Tureyen K, 2001, BRIT J NEUROSURG, V15, P429, DOI 10.1080/02688690120082440; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5; Wang X, 2008, NEUROL INDIA, V56, P47, DOI 10.4103/0028-3886.39312; WIENER I, 1984, J TRAUMA, V24, P346, DOI 10.1097/00005373-198404000-00012; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294; YOKOTA H, 1983, Neurological Surgery, V11, P521	39	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2017	98						243	250		10.1016/j.wneu.2016.11.005			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO9SL	WOS:000397028300023	27836703				2022-02-06	
J	Smith, JL; Mattick, RP; Sufani, C				Smith, Janette L.; Mattick, Richard P.; Sufani, Christopher			Error detection and behavioural inhibition in young heavy drinkers	DRUG AND ALCOHOL DEPENDENCE			English	Article						Response inhibition; Error processing; Performance monitoring; Alcohol; Cognitive control	TRAUMATIC BRAIN-INJURY; SUBSTANCE USE; RESPONSE-INHIBITION; ALCOHOL-USE; NEUROIMAGING EVIDENCE; SUSTAINED ATTENTION; CINGULATE CORTEX; DRUG-ADDICTION; FRONTAL-CORTEX; BINGE DRINKERS	Background: Increases in inhibitory errors in heavy drinkers are established; less well-studied is whether heavy drinkers are aware of these errors in performance. Reductions in error detection and awareness limit the possibility for remedial action to be taken, and have implications for substance abusers seeking to control use: failure to monitor and/or adjust ongoing behaviour may be linked to using more or more often than intended, and failing to adjust behaviour after a slip. Here we report the first study of both inhibitory control and error awareness in young heavy drinkers, using behavioural and psychophysiological measures. Methods: Heavy drinkers (n = 25) and light- or non-drinking controls (n = 35) completed a difficult inhibitory task which required signaling the awareness of inhibitory errors on the subsequent trial, while brain electrical activity was recorded. Results: Heavy drinkers made more inhibitory errors than controls, but we observed no difference in error awareness, both via overt signaling and with equivalent amplitude of the error positivity (Pe), indexing conscious error detection. Similarly, controls and heavy drinkers showed no difference in amplitude or latency of the error-related negativity (ERN), indexing early pre-conscious error detection. Conclusions: This research suggests no significant difference in detection of errors in heavy drinkers, even as they are more prone to make these errors, a result seen in dependent drinkers reported elsewhere. Future research with larger sample sizes, and a more difficult task producing sufficient errors, should determine whether heavy drinkers employ sufficient post-error remedial action. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Smith, Janette L.; Mattick, Richard P.] Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Sufani, Christopher] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia		Smith, JL (corresponding author), Univ New South Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	janette.smith@unsw.edu.au	Smith, Janette L/C-2833-2008	Smith, Janette L/0000-0001-8896-1188	Australian Rotary Health Postdoctoral Research Fellowship; Australian Government NHMRC Principal Research FellowshipNational Health and Medical Research Council of Australia [APP 1045318]; Australian GovernmentAustralian GovernmentCGIAR	This study was funded by an Australian Rotary Health Postdoctoral Research Fellowship to JS. RM is supported by an Australian Government NHMRC Principal Research Fellowship (2013-2017, APP 1045318). The National Drug and Alcohol Research Centre at the University of NSW is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund. Funding sources had no role in the study design, collection, analysis or interpretation of data, in the decision to publish, or in the writing of the report.	AIHW, 2014, DRUG STAT SER, V28; Allom V, 2016, HEALTH PSYCHOL REV, V10, P168, DOI 10.1080/17437199.2015.1051078; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Bailey NW, 2015, BIOL PSYCHOL, V106, P1, DOI 10.1016/j.biopsycho.2015.01.011; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bednarski SR, 2012, ALCOHOL CLIN EXP RES, V36, P768, DOI 10.1111/j.1530-0277.2011.01672.x; Benikos N, 2013, INT J PSYCHOPHYSIOL, V87, P262, DOI 10.1016/j.ijpsycho.2012.08.005; Berman AH, 2007, J SUBST ABUSE TREAT, V32, P357, DOI 10.1016/j.jsat.2006.10.001; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Fiehler K, 2005, PSYCHOPHYSIOLOGY, V42, P72, DOI 10.1111/j.1469-8986.2005.00265.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Hajcak G, 2008, BRAIN COGNITION, V68, P15, DOI 10.1016/j.bandc.2008.02.118; HALPERIN JM, 1991, DEV NEUROPSYCHOL, V7, P207, DOI 10.1080/87565649109540488; Henges AL, 2012, ADDICT BEHAV, V37, P217, DOI 10.1016/j.addbeh.2011.09.013; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Hester R, 2007, NEUROPSYCHOPHARMACOL, V32, P1974, DOI 10.1038/sj.npp.1301326; Hester R, 2010, CURR TOP BEHAV NEURO, V3, P301, DOI 10.1007/7854_2009_28; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Jentsch JD, 2014, NEUROPHARMACOLOGY, V76, P479, DOI 10.1016/j.neuropharm.2013.05.022; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Jones A, 2016, APPETITE, V97, P16, DOI 10.1016/j.appet.2015.11.013; Jongenelis MI, 2016, PSYCHOL ADDICT BEHAV, V30, P639, DOI 10.1037/adb0000194; Logan DM, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00397, 10.3389/fnhum.2015.00397]; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Lopez-Caneda E, 2012, ADDICTION, V107, P1796, DOI 10.1111/j.1360-0443.2012.03908.x; Luijten M, 2014, J PSYCHIATR NEUROSCI, V39, P149, DOI 10.1503/jpn.130052; Mahmood OM, 2013, ADDICT BEHAV, V38, P1435, DOI 10.1016/j.addbeh.2012.07.012; Maurage P, 2009, J PSYCHIATR NEUROSCI, V34, P111; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Moreno M, 2012, DRUG ALCOHOL DEPEN, V124, P355, DOI 10.1016/j.drugalcdep.2012.02.011; Murphy PR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00065; Nederkoorn C, 2009, PHARMACOL BIOCHEM BE, V93, P331, DOI 10.1016/j.pbb.2009.04.015; NHMRC, 2009, AUSTR GUID RED HLTH; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Papachristou H, 2012, PSYCHOPHARMACOLOGY, V219, P511, DOI 10.1007/s00213-011-2240-5; Pontifex MB, 2010, PSYCHOPHYSIOLOGY, V47, P767, DOI 10.1111/j.1469-8986.2010.00974.x; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubio G, 2008, ALCOHOL CLIN EXP RES, V32, P1681, DOI 10.1111/j.1530-0277.2008.00746.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shalgi S, 2007, EXP BRAIN RES, V182, P119, DOI 10.1007/s00221-007-1054-5; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Simons RF, 2010, PSYCHOPHYSIOLOGY, V47, P1, DOI 10.1111/j.1469-8986.2009.00929.x; Skinner H.A., 1977, LIFETIME DRINKING HI; Smith JL, 2016, PSYCHIAT RES-NEUROIM, V254, P103, DOI 10.1016/j.pscychresns.2016.06.012; Smith JL, 2015, PSYCHIAT RES-NEUROIM, V233, P424, DOI 10.1016/j.pscychresns.2015.07.014; Smith JL, 2014, DRUG ALCOHOL DEPEN, V145, P1, DOI 10.1016/j.drugalcdep.2014.08.009; Steele VR, 2016, NEUROIMAGE, V132, P247, DOI 10.1016/j.neuroimage.2016.02.046; Stevens L, 2014, J SUBST ABUSE TREAT, V47, P58, DOI 10.1016/j.jsat.2014.01.008; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Van der Borght L, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02051; Wessel JR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00088; Yucel M, 2007, DRUG ALCOHOL REV, V26, P33, DOI 10.1080/09595230601036978	71	9	9	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	FEB 1	2017	171						20	30		10.1016/j.drugalcdep.2016.11.016			11	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	EK0QA	WOS:000393630700004	28012428				2022-02-06	
J	Yamamoto, K; Sato, K; Yukita, M; Yasuda, M; Omodaka, K; Ryu, M; Fujita, K; Nishiguchi, KM; Machida, S; Nakazawa, T				Yamamoto, Kotaro; Sato, Kota; Yukita, Masayoshi; Yasuda, Masayuki; Omodaka, Kazuko; Ryu, Morin; Fujita, Kosuke; Nishiguchi, Koji M.; Machida, Shigeki; Nakazawa, Toru			The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection	JOURNAL OF NEUROCHEMISTRY			English	Article						calpain; glaucoma; klotho; latanoprost	RETINAL GANGLION-CELLS; SCOTOPIC THRESHOLD RESPONSE; TRAUMATIC BRAIN-INJURY; IN-VIVO; OXIDATIVE STRESS; PROSTAGLANDIN ANALOGS; EXPERIMENTAL GLAUCOMA; CALPASTATIN SYSTEM; HORMONE KLOTHO; TRPV5 CHANNEL	Latanoprost was first developed for use in glaucoma therapy as an ocular hypotensive agent targeting the prostaglandin F2 alpha (FP) receptor. Subsequently, latanoprost showed a neuroprotective effect, an additional pharmacological action. However, although it is well-known that latanoprost exerts an ocular hypotensive effect via the FP receptor, it is not known whether this is also true of its neuroprotective effect. Klotho was firstly identified as the gene linked to the suppression of aging phenotype: the defect of klotho gene in mice results aging phenotype such as hypokinesis, arteriosclerosis, and short lifespan. After that, the function of klotho was also reported to maintain calcium homeostasis and to exert a neuroprotective effect in various models of neurodegenerative disease. However, the function of klotho in eyes including retina is still poorly understood. Here, we show that klotho is a key factor underlying the neuroprotective effect of latanoprost during post-axotomy retinal ganglion cell (RGC) degeneration. Importantly, a quantitative RT-PCR gene expression analysis of klotho in sorted rat retinal cells revealed that the highest expression level of klotho in the retina was in the RGCs. Latanoprost acid, the biologically active form of latanoprost, inhibits post-traumatic calpain activation and concomitantly facilitates the expression and shedding of klotho in axotomized RGCs. This expression profile is a good match with the localization, not of the FP receptor, but of organic anion transporting polypeptide 2B1, known as a prostaglandin transporter, in the ocular tissue. Furthermore, an organic anion transporting polypeptide 2B1 inhibitor suppressed latanoprost acid-mediated klotho shedding exvivo, whereas an FP receptor antagonist did not. The klotho fragments shed from the RGCs reduced the intracellular level of reactive oxygen species, and a specific klotho inhibitor accelerated and increased RGC death after axotomy. We conclude that the shed klotho fragments might contribute to the attenuation of axonal injury-induced calpain activation and oxidative stress, thereby protecting RGCs from post-traumatic neuronal degeneration.	[Yamamoto, Kotaro; Sato, Kota; Yukita, Masayoshi; Yasuda, Masayuki; Omodaka, Kazuko; Ryu, Morin; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Sato, Kota; Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi 980, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 980, Japan; [Machida, Shigeki] Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, Koshigaya, Saitama, Japan; [Machida, Shigeki] Iwate Med Univ, Dept Ophthalmol, Sch Med, Morioka, Iwate, Japan		Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, 1-1 Seiryo, Sendai, Miyagi 9808574, Japan.	ntoru@oph.med.tohoku.ac.jp			Pfizer, Inc.Pfizer [WS2252097]; Ministry of Education, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [26893019, 15K20247, 15H06041, 25462749, 22689045, 26670751]	This study was supported by grants from Pfizer, Inc. (WS2252097) and by a Grant-in-Aid from the Ministry of Education, Science and Technology of Japan (K.S. 26893019 and 15K20247, K.O. 15H06041, M.R. 25462749, T.N. 22689045 and 26670751). There is a conflict of interest. We thank Mr. Tim Hilts for reviewing and editing the language of the manuscript, Ms. Natsumi Konno, Ms. Junko Sato, and Ms. Kanako Sakai for the technical assistance. We also thank the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support. Authors thank Dr. Jun Kosaka (Okayama University) for gift of C38 antibody. All experiments were conducted in compliance with the ARRIVE guidelines.	Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Drago F, 2001, EXP EYE RES, V72, P479, DOI 10.1006/exer.2000.0975; Emre S, 2009, EXP ANIM TOKYO, V58, P505, DOI 10.1538/expanim.58.505; Farinelli Pietro, 2013, J Neurochem, V127, P868, DOI 10.1111/jnc.12353; Frishman LJ, 1996, INVEST OPHTH VIS SCI, V37, P125; Gao B, 2005, EXP EYE RES, V80, P61, DOI 10.1016/j.exer.2004.08.013; Gao B, 2015, PFLUG ARCH EUR J PHY, V467, P1481, DOI 10.1007/s00424-014-1596-x; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Huang W, 2010, INVEST OPHTH VIS SCI, V51, P3049, DOI 10.1167/iovs.09-4364; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105; Kanamori A, 2009, EXP EYE RES, V88, P535, DOI 10.1016/j.exer.2008.11.012; Kawasaki H, 1996, MOL MEMBR BIOL, V13, P217, DOI 10.3109/09687689609160599; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Kokkinaki M, 2013, J NEUROSCI, V33, P16346, DOI 10.1523/JNEUROSCI.0402-13.2013; Kraft ME, 2010, INVEST OPHTH VIS SCI, V51, P2504, DOI 10.1167/iovs.09-4290; Kudo H, 2006, GRAEF ARCH CLIN EXP, V244, P1003, DOI 10.1007/s00417-005-0215-0; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Liu S, 2014, BRAIN INJURY, V28, P133, DOI 10.3109/02699052.2013.860479; Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200; MELLONI E, 1992, BIOCHIMIE, V74, P217, DOI 10.1016/0300-9084(92)90120-4; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nakanishi Y, 2006, EXP EYE RES, V83, P1108, DOI 10.1016/j.exer.2006.05.018; Nakazawa T, 2002, J NEUROSCI RES, V68, P668, DOI 10.1002/jnr.10259; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nakazawa T, 2009, J NEUROSCI RES, V87, P1412, DOI 10.1002/jnr.21953; Ocklind A, 1997, PROSTAG LEUKOTR ESS, V57, P527, DOI 10.1016/S0952-3278(97)90555-X; Ota T, 2005, INVEST OPHTH VIS SCI, V46, P4159, DOI 10.1167/iovs.05-0494; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Ryu M, 2012, J NEUROSCI RES, V90, P802, DOI 10.1002/jnr.22800; Sales KJ, 2007, ENDOCRINOLOGY, V148, P3635, DOI 10.1210/en.2006-1517; Sharif NA, 2003, J OCUL PHARMACOL TH, V19, P501, DOI 10.1089/108076803322660422; SIEVING PA, 1986, J NEUROPHYSIOL, V56, P1049, DOI 10.1152/jn.1986.56.4.1049; SIEVING PA, 1988, INVEST OPHTH VIS SCI, V29, P1608; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Yamamoto K, 2014, INVEST OPHTH VIS SCI, V55, P7126, DOI 10.1167/iovs.13-13842; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yokoyama Y, 2014, BIOCHEM BIOPH RES CO, V451, P510, DOI 10.1016/j.bbrc.2014.08.009; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zheng J, 2011, CELL MOL NEUROBIOL, V31, P597, DOI 10.1007/s10571-011-9653-x	49	9	11	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	2017	140	3					495	508		10.1111/jnc.13902			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EL5DG	WOS:000394641200013	27859240	Green Published, hybrid			2022-02-06	
J	Fleming, J; Ownsworth, T; Doig, E; Hutton, L; Griffin, J; Kendall, M; Shum, DHK				Fleming, Jennifer; Ownsworth, Tamara; Doig, Emmah; Hutton, Lauren; Griffin, Janelle; Kendall, Melissa; Shum, David H. K.			The efficacy of prospective memory rehabilitation plus metacognitive skills training for adults with traumatic brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Brain injury; Prospective memory; Self-awareness; Rehabilitation; Randomized controlled trial	ASSESSING SUPPORT NEEDS; SELF-AWARENESS; SCALE; INDIVIDUALS; PERFORMANCE; DEFICITS; PEOPLE; AIDS; CARE	Background: Impairment of prospective memory (PM) is common following traumatic brain injury (TBI) and negatively impacts on independent living. Compensatory approaches to PM rehabilitation have been found to minimize the impact of PM impairment in adults with TBI; however, poor self-awareness after TBI poses a major barrier to the generalization of compensatory strategies in daily life. Metacognitive skills training (MST) is a cognitive rehabilitation approach that aims to facilitate the development of self-awareness in adults with TBI. This paper describes the protocol of a study that aims to evaluate the efficacy of a MST approach to compensatory PM rehabilitation for improving everyday PM performance and psychosocial outcomes after TBI. Methods/design: This randomized controlled trial has three treatment groups: compensatory training plus metacognitive skills training (COMP-MST), compensatory training only (COMP), and waitlist control. Participants in the COMP-MST and COMP groups will complete a 6-week intervention consisting of six 2-h weekly training sessions. Each 1.5-h session will involve compensatory strategy training and 0.5 h will incorporate either MST (COMP-MST group) or filler activity as an active control (COMP group). Participants in the waitlist group receive care as usual for 6 weeks, followed by the COMP-MST intervention. Based on the sample size estimate, 90 participants with moderate to severe TBI will be randomized into the three groups using a stratified sampling approach. The primary outcomes include measures of PM performance in everyday life and level of psychosocial reintegration. Secondary outcomes include measures of PM function on psychometric testing, strategy use, self-awareness, and level of support needs following TBI. Blinded assessments will be conducted pre and post intervention, and at 3-month and 6-month follow-ups. Discussion: This study seeks to determine the efficacy of COMP-MST for improving and maintaining everyday PM performance and level of psychosocial integration in adults with moderate to severe TBI. The findings will advance theoretical understanding of the role of self-awareness in compensatory PM rehabilitation and skills generalization. COMP-MST has the potential to reduce the cost of rehabilitation and lifestyle support following TBI because the intervention could enhance generalization success and lifelong application of PM compensatory strategies.	[Fleming, Jennifer; Doig, Emmah] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Ownsworth, Tamara; Hutton, Lauren; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia; [Ownsworth, Tamara; Hutton, Lauren; Shum, David H. K.] Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol, Mt Gravatt, Qld, Australia; [Fleming, Jennifer; Griffin, Janelle] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Kendall, Melissa] Princess Alexandra Hosp, Metro South Hosp & Hlth Serv, Acquired Brain Injury Outreach Serv, Woolloongabba, Qld, Australia; [Kendall, Melissa] Griffith Univ, Menzies Hlth Inst Queensland, Meadowbrook, Qld, Australia; [Kendall, Melissa] Griffith Univ, Sch Human Serv & Social Work, Meadowbrook, Qld, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.; Shum, DHK (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia.; Shum, DHK (corresponding author), Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol, Mt Gravatt, Qld, Australia.	j.fleming@uq.edu.au; d.shum@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Doig, Emmah/AAG-6674-2021; Shum, David H. K./A-3914-2008	Ownsworth, Tamara/0000-0003-1835-7094; Doig, Emmah/0000-0002-7020-053X; Shum, David H. K./0000-0002-4810-9262; Fleming, Jennifer/0000-0002-5603-2410	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1083064]	The project outlined in this study is funded by the National Health and Medical Research Council (NHMRC). Project Grant APP1083064.	Boman IL, 2010, SCAND J OCCUP THER, V17, P140, DOI 10.3109/11038120902875144; Borrelli B, 2011, J PUBLIC HEALTH DENT, V71, pS52, DOI 10.1111/j.1752-7325.2011.00233.x; Canty A. L., 2014, UNDERSTANDING TRAUMA; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; de Joode E, 2012, DISABIL REHABIL-ASSI, V7, P389, DOI 10.3109/17483107.2011.644623; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Fleming JM, 1996, BRAIN INJURY, V10, P1; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kirsch NL, 2004, BRAIN INJURY, V18, P725, DOI 10.1080/02699050310001646161; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; Manly T, 2014, UNDERSTANDING TRAUMA, P215; Maylor EA, 2002, LIFESPAN DEVELOPMENT OF HUMAN MEMORY, P235; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Piras F, 2011, EUR J PHYS REHAB MED, V47, P149; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1997, ARCH CLIN NEUROPSYCH, V12, P403, DOI 10.1093/arclin/12.4.403a; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; Soo C, 2010, ARCH PHYS MED REHAB, V91, P905, DOI 10.1016/j.apmr.2009.11.033; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate R, 2012, AUST PSYCHOL, V47, P20, DOI 10.1111/j.1742-9544.2011.00060.x; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Winograd E, 1998, PRACTICAL ASPECTS ME, P348	48	9	9	0	22	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	JAN 5	2017	18								3	10.1186/s13063-016-1758-6			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	EG9XC	WOS:000391412600002	28057075	Green Published, gold			2022-02-06	
J	Agtarap, S; Boals, A; Holtz, P; Roden-Foreman, K; Rainey, EE; Ruggero, C; Warren, AM				Agtarap, Stephanie; Boals, Adriel; Holtz, Pamela; Roden-Foreman, Kenleigh; Rainey, Evan E.; Ruggero, Camilo; Warren, Ann Marie			The effect of depressive symptoms on social support one year following traumatic injury	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Depression; Social support; Traumatic injury; Recovery; Outcomes	POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; HEALTH; OUTCOMES; IMPAIRMENT; DISABILITY; RECOVERY; ILLNESS; FAMILY; INTERVENTIONS	Background: Depression is a common mental health outcome after traumatic injury, negatively impacting physical outcomes and increasing the cost of care. Research shows that the presence and quality of support is leading protective factor against depression post-injury; however, research is vague on the directional effects of both factors over the course of recovery. Methods: 130 patients admitted to a Level I Trauma Center were recruited to a prospective study examining overall outcomes one-year after injury. Effects of social support and depression at baseline and 12-months post injury were examined using correlational and cross-lagged path model analyses. Additional follow-up analyser were conducted for depression on specific types of social support. Results: Findings replicated previous research suggesting depression and social support were inversely related. Initial depression at time of traumatic injury was predictive of social support 12-months after their injury, but initial social support levels did not significantly predict depression at 12-months. Additionally, initial depression significantly predicted attachment, social integration, reassurance of worth, and guidance 12-months later. Limitations: Findings of the analyses are limited by lack of experimentation and inability to control for other related variables. Conclusions: Findings of the present study support the notion that initial depression predicts poorer socia support in recovery, in lieu of prevailing theory (i.e., initial support buffers against later depression) in a sample of trauma patients. These findings highlight the need for medical staff to target specific factors during inpatien stay, such as addressing depressive symptoms and preparing family members and caregivers prior to discharge.	[Agtarap, Stephanie; Boals, Adriel; Holtz, Pamela; Ruggero, Camilo] Univ North Texas, Denton, TX 76203 USA; [Roden-Foreman, Kenleigh; Warren, Ann Marie] Baylor Univ, Med Ctr, Dallas, TX USA; [Rainey, Evan E.] Baylor Res Inst, Dallas, TX USA		Agtarap, S (corresponding author), Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	StephanieAgtarap@my.unt.edu		Warren, Ann Marie/0000-0002-3753-5573; Agtarap, Stephanie/0000-0002-1188-0897; McShan, Evan Elizabeth/0000-0002-9250-3240			American College of Surgeon Committee on Trauma, 2014, RES OPT CAR INJ PAT; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Archer KR, 2012, J TRAUMA ACUTE CARE, V72, P1068, DOI 10.1097/TA.0b013e3182452df5; BARNETT PA, 1988, PSYCHOL BULL, V104, P97, DOI 10.1037/0033-2909.104.1.97; Beedie A, 2002, J CLIN PSYCHOL MED S, V9, P227, DOI 10.1023/A:1016003428370; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Caron J, 2013, SANTE MENT QUE, V38, P297, DOI 10.7202/1019198ar; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Corrigan PW, 2014, PSYCHOL SCI PUBL INT, V15, P37, DOI 10.1177/1529100614531398; Crichlow RJ, 2006, J BONE JOINT SURG AM, V88A, P1927, DOI 10.2106/JBJS.D.02604; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Druss BG, 2000, AM J PSYCHIAT, V157, P1274, DOI 10.1176/appi.ajp.157.8.1274; Ebrahimzadeh Mohammad Hosein, 2014, Iran J Psychiatry, V9, P133; ELLIOTT TR, 1992, PSYCHOL HEALTH, V7, P55, DOI 10.1080/08870449208404295; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Frasure-Smith N, 2000, CIRCULATION, V101, P1919, DOI 10.1161/01.CIR.101.16.1919; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hinrichsen GA, 2005, CLIN PSYCHOL-SCI PR, V12, P264, DOI 10.1093/clipsy/bpi027; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Jackson JC, 2011, J TRAUMA, V71, P860, DOI 10.1097/TA.0b013e3182151961; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lenze EJ, 2004, INT J GERIATR PSYCH, V19, P472, DOI 10.1002/gps.1116; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Luppa M, 2007, J AFFECT DISORDERS, V98, P29, DOI 10.1016/j.jad.2006.07.017; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Martire LM, 2007, CURR DIR PSYCHOL SCI, V16, P90, DOI 10.1111/j.1467-8721.2007.00482.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muthen L. K., 2013, MPLUS USERS GUIDE VE; Nota SPFT, 2015, INJURY, V46, P207, DOI 10.1016/j.injury.2014.06.012; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Park M, 2014, COGNITIVE THER RES, V38, P600, DOI 10.1007/s10608-014-9630-z; Perera H.N., 2015, CONSTRUCT VALIDITY S, P1; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Powers MB, 2014, J ANXIETY DISORD, V28, P301, DOI 10.1016/j.janxdis.2014.01.003; Prang KH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0291-8; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Steptoe A, 2009, J PERS, V77, P1747, DOI 10.1111/j.1467-6494.2009.00599.x; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Trew JL, 2009, COGNITIVE THER RES, V33, P432, DOI 10.1007/s10608-008-9196-8; Trost Z, 2015, REHABIL PSYCHOL, V60, P213, DOI 10.1037/rep0000043; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Uchino BN, 2012, SOC SCI MED, V74, P949, DOI 10.1016/j.socscimed.2011.11.023; van der Sluis CK, 1998, INJURY, V29, P281, DOI 10.1016/S0020-1383(97)00199-X; Vranceanu Ana-Maria, 2014, J Bone Joint Surg Am, V96, pe20, DOI 10.2106/JBJS.L.00479; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080; Warren AM, 2016, J TRAUMA ACUTE CARE, V80, P318, DOI 10.1097/TA.0000000000000898; Warren AM, 2014, J TRAUMA ACUTE CARE, V76, P517, DOI 10.1097/TA.0000000000000110; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Zatzick DF, 2003, PSYCHOSOMATICS, V44, P479, DOI 10.1176/appi.psy.44.6.479	68	9	9	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 1	2017	207						398	405		10.1016/j.jad.2016.08.067			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	ED7YM	WOS:000389088600056	27770732				2022-02-06	
J	Allison, DJ; Josse, AR; Gabriel, DA; Klentrou, P; Ditor, DS				Allison, D. J.; Josse, A. R.; Gabriel, D. A.; Klentrou, P.; Ditor, D. S.			Targeting inflammation to influence cognitive function following spinal cord injury: a randomized clinical trial	SPINAL CORD			English	Article							VERBAL-LEARNING TEST; CLOSED HEAD-INJURY; EXTRACELLULAR GLUTAMATE; MEMORY; KYNURENINE; AUTOANTIBODIES; DYSFUNCTION; PARAPLEGIA; IMPAIRMENT; METABOLISM	Study design: This study was a randomized, parallel-group, controlled clinical trial. Objectives: The purpose of this study was to examine the efficacy of targeting inflammation as a means of improving cognitive function in individuals with spinal cord injury. Setting: Participants were recruited from the Niagara region of Ontario Canada and all testing occurred on-site at Brock University. Methods: Indices of memory and verbal learning were assessed by means of the California Verbal Learning Test (CVLT). Inflammation and concentrations of neuroactive compounds related to the kynurenine pathway were assessed via a number of pro-and anti-inflammatory cytokines, as well as tryptophan, kynurenine and several large neutral amino acids. All assessments were performed at baseline as well as at 1 month and 3 months during a 3-month intervention by means of an anti-inflammatory diet. Results: Despite a reduction in inflammation, all measures of the CVLT, including list A, trial 1 (P=0.48), learning slope (P=0.46), long delay free recall (P=0.83), intrusions (P=0.61) and repetitions (P=0.07), showed no significant group x time interaction. Conclusion: It may be possible that the reduction in inflammation achieved in the current study was insufficient to induce substantial changes in indices of verbal learning and memory. Alternatively, as these participants likely underwent years of previous chronic inflammation, the underlying hippocampal damage may have negated potential improvements induced by acute reductions in inflammation.	[Allison, D. J.; Josse, A. R.; Gabriel, D. A.; Klentrou, P.; Ditor, D. S.] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada; [Allison, D. J.; Ditor, D. S.] Brock Niagara Ctr Hlth & Well Being, St Catharines, ON, Canada		Allison, DJ (corresponding author), Brock Univ, Fac Appl Hlth Sci, Dept Kinesiol, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	dallison@brocku.ca		Josse, Andrea/0000-0002-7247-9466	Ontario Neurotrauma Foundation	This study was supported by the Ontario Neurotrauma Foundation. We thank Now, CanPrev, AOR and Progressive for providing the supplements utilized in the dietary intervention.	Allison DJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0425-2; Allison DJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0151-1; BENDER DA, 1985, BIOCHEM SOC T, V13, P441, DOI 10.1042/bst0130441; Braidy N, 2010, FEBS J, V277, P368, DOI 10.1111/j.1742-4658.2009.07487.x; Chess AC, 2007, SCHIZOPHRENIA BULL, V33, P797, DOI 10.1093/schbul/sbl033; Chess AC, 2006, BEHAV BRAIN RES, V170, P326, DOI 10.1016/j.bbr.2006.03.006; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Gibson AE, 2008, SPINAL CORD, V46, P616, DOI 10.1038/sc.2008.32; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Kalmijn S, 2004, NEUROLOGY, V62, P275, DOI 10.1212/01.WNL.0000103860.75218.A5; Kato A, 2010, HEMODIAL INT, V14, P418, DOI 10.1111/j.1542-4758.2010.00464.x; LEVINE AM, 1992, PARAPLEGIA, V30, P880, DOI 10.1038/sc.1992.165; Manns PJ, 2005, ARCH PHYS MED REHAB, V86, P1176, DOI 10.1016/j.apmr.2004.11.020; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Nisapakultorn K, 2009, J PERIODONTOL, V80, P114, DOI [10.1902/jop.2009.080315, 10.1902/jop.2009.080315 ]; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Okuda S, 1998, J NEUROCHEM, V70, P299; Oxenkrug GF, 2010, ISR J PSYCHIATR REL, V47, P56; Panza F, 2004, PUBLIC HEALTH NUTR, V7, P959, DOI 10.1079/PHN2004561; Papanicolaou AC, 2002, LEARN MEMORY, V9, P99, DOI 10.1101/lm.44302; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Spencer JPE, 2010, BRIT J NUTR, V104, pS40, DOI 10.1017/S0007114510003934; Stegen S, 2010, CLIN NEUROPSYCHOL, V24, P189, DOI 10.1080/13854040903266910; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Wecht JM, 2012, CLIN AUTON RES, V22, P25, DOI 10.1007/s10286-011-0139-1; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Wu HQ, 2010, J MOL NEUROSCI, V40, P204, DOI 10.1007/s12031-009-9235-2; Zmarowski A, 2009, EUR J NEUROSCI, V29, P529, DOI 10.1111/j.1460-9568.2008.06594.x	39	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2017	55	1					26	32		10.1038/sc.2016.96			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EK9XA	WOS:000394276000005	27324320	Bronze			2022-02-06	
J	Browning, JR; Whiteman, AC; Leung, LY; Lu, XCM; Shear, DA				Browning, Jenny R.; Whiteman, Ashley C.; Leung, Lai Yee; Lu, Xi-Chun May; Shear, Deborah A.			Air-puff induced vocalizations: A novel approach to detecting negative affective state following concussion in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Ultrasonic vocalizations; Concussion; 22kHz vocalizations; Negative affect; Projectile concussive impact model	TRAUMATIC BRAIN-INJURY; ULTRASONIC VOCALIZATIONS; BEHAVIORAL IMPAIRMENTS; AGGRESSIVE ENCOUNTERS; RATTUS-NORVEGICUS; OPIOID RECEPTORS; LABORATORY RATS; COCAINE BINGES; ANIMAL-MODEL; ALARM CRIES	Background: Negative emotional states resulting from concussion are of increasing concern. In the current study, we developed a model to investigate negative affect following concussion in the projectile concussive impact (PCI) model. High frequency ultrasonic vocalizations (22 kHz USVs) are associated with negative affective stimuli in rats. Changes in negative affective state were examined following PCI using a mild air-puff stimulus to elicit 22 kHz USVs. New method: Forty-eight hours post-injury, animals were placed into a clean acrylic box lined with bedding. A 5 min baseline recording was followed by 15 air puffs (55 psi) spaced 15 s apart aimed at the upper back and neck. Results: Injured animals produced on average 153.5 +/- 55.13 more vocalizations than shams, vocalizing on average 4 min longer than shams. Additionally, concussed animals vocalized to fewer air-puffs, exhibiting a 1.5 fold lower threshold for the expression of negative affect. Comparison with existing methods: Studies currently used to test negative affective states following concussion in animals, such as the elevated plus maze and forced swim task have, as of yet, been unsuccessful in demonstrating injury effects in the PCI model. While the air-puff test has been applied in other fields, to our knowledge it has not been utilized to study traumatic brain injury. Conclusion: The current study demonstrates that the air-puff vocalization test may be a valuable tool in assessing negative mood states following concussion in rat models and may be used to evaluate novel therapies following brain injury for the treatment of mood dysfunction. Published by Elsevier B.V.	[Browning, Jenny R.; Whiteman, Ashley C.; Leung, Lai Yee; Lu, Xi-Chun May; Shear, Deborah A.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA		Browning, JR (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	jenny.browning@gmail.com		Whiteman, Ashley/0000-0003-1240-9404	Combat Casualty Care Research ProgramUnited States Department of Defense; Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-12-2-0134]	d The authors declare that there are no conflicts of interest in this study. This research is funded by Combat Casualty Care Research Program and Congressionally Directed Medical Research Program (Contract #: W81XWH-12-2-0134).	Barros HMT, 1996, PSYCHOPHARMACOLOGY, V125, P379; Berger AL, 2013, NEUROPSYCHOPHARMACOL, V38, P647, DOI 10.1038/npp.2012.229; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; BRUDZYNSKI SM, 1993, PHYSIOL BEHAV, V54, P215, DOI 10.1016/0031-9384(93)90102-L; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Calvino B, 1996, NEUROREPORT, V7, P581, DOI 10.1097/00001756-199601310-00049; Choi JS, 2003, J NEUROSCI, V23, P8713; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Han JS, 2005, J NEUROSCI METH, V141, P261, DOI 10.1016/j.jneumeth.2004.07.005; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; JOURDAN D, 1995, PAIN, V63, P237, DOI 10.1016/0304-3959(95)00049-X; Kissler JL, 2014, BIOL PSYCHIAT, V75, P774, DOI 10.1016/j.biopsych.2013.03.014; Knapp DJ, 1995, J NEUROSCI METH, V62, P1, DOI 10.1016/0165-0270(95)00044-5; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Leo P, 2016, TRANSLATIONAL RES TR; Leung LY, 2014, ANN BIOMED ENG, V42, P1618, DOI 10.1007/s10439-014-1014-8; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mutschler NH, 1998, PSYCHOPHARMACOLOGY, V136, P402, DOI 10.1007/s002130050584; Mutschler NH, 1998, PSYCHOPHARMACOLOGY, V135, P161, DOI 10.1007/s002130050497; Mutschler NH, 2001, PSYCHOPHARMACOLOGY, V154, P292, DOI 10.1007/s002130000646; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; TAKAHASHI LK, 1983, J COMP PSYCHOL, V97, P207, DOI 10.1037/0735-7036.97.3.207; THOMAS DA, 1983, J COMP PSYCHOL, V97, P201, DOI 10.1037/0735-7036.97.3.201; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; VIVIAN JA, 1994, PSYCHOPHARMACOLOGY, V114, P101, DOI 10.1007/BF02245450; VIVIAN JA, 1991, PSYCHOPHARMACOLOGY, V104, P187, DOI 10.1007/BF02244177; Williams AM, 2012, PSYCHOPHARMACOLOGY, V223, P75, DOI 10.1007/s00213-012-2691-3; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Wohr M, 2005, NEUROBIOL LEARN MEM, V84, P228, DOI 10.1016/j.nlm.2005.07.004; Yee N, 2012, J PSYCHIATR RES, V46, P1199, DOI 10.1016/j.jpsychires.2012.05.010	41	9	9	0	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 1	2017	275						45	49		10.1016/j.jneumeth.2016.10.017			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EF9CC	WOS:000390627300006	27984100				2022-02-06	
J	Arango-Lasprilla, JC; Olabarrieta-Landa, L; Ertl, MM; Stevens, LF; Morlett-Paredes, A; Andelic, N; Zasler, N				Carlos Arango-Lasprilla, Juan; Olabarrieta-Landa, Laiene; Ertl, Melissa M.; Stevens, Lillian Flores; Morlett-Paredes, Alejandra; Andelic, Nada; Zasler, Nathan			Provider perceptions of the assessment and rehabilitation of sexual functioning after Traumatic Brain Injury	BRAIN INJURY			English	Article						Traumatic brain injury; sexuality; assessment; treatment	UNITED-STATES; HEALTH; INDIVIDUALS; MULTICENTER; DYSFUNCTION; PARTNERS; IMPACT; ISSUES; VIEWS; NEEDS	Objective: To explore how health care professionals who work with individuals with TBI address issues related to the assessment and treatment of sexuality after TBI.Methods: A survey composed of 53 questions was developed to evaluate professional training, assessment of sexuality in individuals with TBI and attitudes towards sexuality. The sample consisted of 324 self-identified TBI health care professionals.Results: Ninety seven per cent of participants believed that sexuality should be discussed during rehabilitation; however, 36% reported talking about it. Seventy nine per cent reported that their patients have asked about sexuality after TBI, with 60% feeling calm and competent addressing the topic. The main reason for not discussing the topic was that patients do not ask for information (42%). Assessment (87%) and treatment of sexuality (82%) in individuals with TBI are considered a part of their professional responsibility.Conclusion: Despite recognition of the importance of addressing the topic and the belief of it being their professional responsibility, many professionals reported lack of training. Working to increase comfort with the topic and providing comprehensive education on treating sexuality may be beneficial.	[Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp, BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Olabarrieta-Landa, Laiene] Univ Deusto, Psychol & Educ Fac, Bilbao, Bizkaia, Spain; [Ertl, Melissa M.] SUNY Albany, Div Counseling Psychol, Albany, NY 12222 USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Stevens, Lillian Flores; Morlett-Paredes, Alejandra] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Morlett-Paredes, Alejandra] Virginia Commonwealth Univ, Dept Phys Med, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Morlett-Paredes, Alejandra] Virginia Commonwealth Univ, Dept Rehabil, Box 2018, Richmond, VA 23284 USA; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Oslo, Norway; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan] Int Brain Injury Assoc, Alexandria, VA USA		Arango-Lasprilla, JC (corresponding author), Cruces Univ Hosp, IKERBASQUE Basque Fdn Sci, BioCruces Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com	Blanco, Leire/O-5114-2017; Arango-Lasprilla, Juan Carlos/AAB-5407-2019; Landa, Laiene Olabarrieta/V-6207-2017	Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Landa, Laiene Olabarrieta/0000-0002-8305-8720; Ertl, Melissa/0000-0002-1022-1777; Andelic, Nada/0000-0002-3719-4406			Akinci AC, 2011, SEX DISABIL, V29, P239, DOI 10.1007/s11195-011-9208-6; Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni A, 2003, SEXUAL DIFFICULTIES; Aloni R, 2007, SEX DISABIL, V25, P125, DOI 10.1007/s11195-007-9047-7; Aloni Ronit, 2009, Harefuah, V148, P615; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; Bivona U, 2016, BRAIN INJURY, V30, P1082, DOI 10.3109/02699052.2016.1165867; Chan S., 2004, THESIS; Connell KM, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.130189; Crowe SF, 1999, BRAIN INJURY, V13, P347; Downing M, 2018, NEUROPSYCHOL REHABIL, V28, P1028, DOI 10.1080/09602011.2016.1236732; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2013, J SEX MED, V10, P2658, DOI 10.1111/j.1743-6109.2012.02856.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IBM Corporation, 2015, IBM SPSS STAT VERS 2; International Brain Injury Association, 2016, BRAIN INJ FACTS; Julien Jerelyn O, 2010, Oncol Nurs Forum, V37, pE186, DOI 10.1188/10.ONF.E186-E190; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Magnan Morris A, 2005, Medsurg Nurs, V14, P282; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; Mellor RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078802; Miller SA, 2012, ARCH SEX BEHAV, V41, P1041, DOI 10.1007/s10508-011-9877-3; Moreno A, 2015, NEUROREHABILITATION, V37, P99, DOI 10.3233/NRE-151243; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Sandel ME, 2007, SEXUALITY REPROD NEU; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Ussher JM, 2013, PSYCHOL HEALTH, V28, P1370, DOI 10.1080/08870446.2013.811242; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778	41	9	9	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1605	1611		10.1080/02699052.2017.1332784			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200006	28699795				2022-02-06	
J	Donnelly, KZ; Linnea, K; Grant, DA; Lichtenstein, J				Donnelly, Kyla Z.; Linnea, Kate; Grant, Daya Alexander; Lichtenstein, Jonathan			The feasibility and impact of a yoga pilot programme on the quality-of-life of adults with acquired brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; rehabilitation; community based rehabilitation; mindfulness; community integration	RANDOMIZED CONTROLLED-TRIAL; COMMUNITY INTEGRATION; 1ST YEAR; EXERCISE INTERVENTION; STRESS REDUCTION; MINDFULNESS; PEOPLE; PARTICIPATION; INDIVIDUALS; HEALTH	Objective: This pilot study measured the feasibility and impact of an 8-week yoga programme on the quality-of-life of adults with acquired brain injury (ABI).Methods: Thirty-one adults with ABI were allocated to yoga (n = 16) or control (n = 15) groups. Participants completed the Quality of Life After Brain Injury (QOLIBRI) measure pre- and post-intervention; individuals in the yoga group also rated programme satisfaction. Mann-Whitney/Wilcoxon and the Wilcoxon Signed Rank tests were used to evaluate between- and within-group differences for the total and sub-scale QOLIBRI scores, respectively.Results: No significant differences emerged between groups on the QOLIBRI pre- or post-intervention. However, there were significant improvements on overall quality-of-life and on Emotions and Feeling sub-scales for the intervention group only. The overall QOLIBRI score improved from 1.93 (SD = 0.27) to 2.15 (SD = 0.34, p = 0.01). The mean Emotions sub-scale increased from 1.69 (SD = 0.40) to 2.01 (SD = 0.52, p = 0.01), and the mean Feeling sub-scale from 2.1 (SD = 0.34) to 2.42 (SD = 0.39, p = 0.01).Conclusion: Adults with ABI experienced improvements in overall quality-of-life following an 8-week yoga programme. Specific improvements in self-perception and negative emotions also emerged. High attendance and satisfaction ratings support the feasibility of this type of intervention for people with brain injury.	[Donnelly, Kyla Z.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy, Lebanon, NH 03766 USA; [Linnea, Kate; Lichtenstein, Jonathan] Geisel Sch Med Dartmouth, Lebanon, NH USA		Donnelly, KZ (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	kyla.z.donnelly@dartmouth.edu			LoveYourBrain Foundation	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: KD and DG have done consultancy for the LoveYourBrain Foundation and have received financial support for business travel; KD is married to the Executive Director of the LoveYourBrain Foundation; JL and KL have no relationships or activities that could appear to have influenced the submitted work. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bellon K, 2015, BRAIN INJURY, V29, P313, DOI 10.3109/02699052.2014.974670; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bussing A, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI [10.1155/2012/219402, 10.1155/2012/165410]; Buffart LM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-559; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Cramer H, 2014, INT J CARDIOL, V173, P170, DOI 10.1016/j.ijcard.2014.02.017; Cramer H, 2013, DEPRESS ANXIETY, V30, P1068, DOI 10.1002/da.22166; Desveaux L, 2015, MED CARE, V53, P653, DOI 10.1097/MLR.0000000000000372; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Garrett R, 2011, DISABIL REHABIL, V33, P2404, DOI 10.3109/09638288.2011.573058; Gerber GJ, 2015, BRAIN INJURY, V29, P722, DOI 10.3109/02699052.2015.1004745; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Guillamondegui OD, 2011, COMP EFFECTIVENESS R, V25; Hughes DC, 2015, PHYSIOTHER THEOR PR, V31, P451, DOI 10.3109/09593985.2015.1037409; Immink MA, 2014, TOP STROKE REHABIL, V21, P256, DOI 10.1310/tsr2103-256; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Mak WWS, 2011, J COUNS PSYCHOL, V58, P610, DOI 10.1037/a0025195; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McCall MC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/945895; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McHugh L, 2013, BRAIN INJURY, V27, P1595, DOI 10.3109/02699052.2013.834379; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Hospital Discharge Survey (NHDS) NHAMCSN, 2010, ALL DAT SOURC MAINT; Nelson Michelle L A, 2015, J Comorb, V5, P1, DOI 10.15256/joc.2015.5.47; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Parvaneh S, 2012, AUST OCCUP THER J, V59, P131, DOI 10.1111/j.1440-1630.2012.01001.x; Perna R, 2012, APPL NEUROPSYCH-ADUL, V19, P263, DOI 10.1080/09084282.2012.670147; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schmalzl L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00235; Schmid AA, 2016, DISABIL REHABIL, V38, P914, DOI 10.3109/09638288.2015.1062927; Schmid AA, 2014, COMPLEMENT THER MED, V22, P994, DOI 10.1016/j.ctim.2014.09.005; Schmid AA, 2012, STROKE, V43, P2402, DOI 10.1161/STROKEAHA.112.658211; Schneider William N, 2011, Continuum (Minneap Minn), V17, P462, DOI 10.1212/01.CON.0000399067.69567.f2; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Sharma M, 2014, J EVID-BASED INTEGR, V19, P271, DOI 10.1177/2156587214543143; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Verri A, 1999, J INTELL DISABIL RES, V43, P513, DOI 10.1046/j.1365-2788.1999.00241.x; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wells RE, 2010, J NEUROL, V257, P1822, DOI 10.1007/s00415-010-5616-2	60	9	9	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					208	214		10.1080/02699052.2016.1225988			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500008	27936953				2022-02-06	
J	Durand, E; Watier, L; Lecu, A; Fix, M; Weiss, JJ; Chevignard, M; Pradat-Diehl, P				Durand, Eric; Watier, Laurence; Lecu, Anne; Fix, Michel; Weiss, Jean-Jacques; Chevignard, Mathilde; Pradat-Diehl, Pascale			Traumatic brain injury among female offenders in a prison population: results of the FleuryTBI study	BRAIN AND BEHAVIOR			English	Article						female prisoners; head injury; inmates; neuropsychology; traumatic brain injury	HEAD-INJURY; AGGRESSIVE-BEHAVIOR; SALIVARY CORTISOL; CRIMINAL BEHAVIOR; SUBSTANCE-ABUSE; UNITED-STATES; SEXUAL-ABUSE; PARIS-TBI; PREVALENCE; EPIDEMIOLOGY	AimThe study was designed to estimate the prevalence of traumatic brain injury (TBI) in a French prison population of female offenders, study the variables known to be associated with TBI, and compare our results with those obtained among male offenders as described in a previous paper. ParticipantsAll female offenders (adults and juveniles) consecutively admitted to Fleury-Merogis prison over a 3-month period were included in the study. MethodDuring the admission procedure, female offenders were interviewed by healthcare staff using a self-reported questionnaire. ResultsIn all, 100 female offenders were included. The rate of self-reported TBI was high, with a prevalence of 21%. The first cause of TBI was violence related (35%) and a majority of female offenders with a history of TBI reported having sustained more than one TBI. When compared with those who did not report a TBI, epilepsy and use of alcohol were higher among female offenders with a history of TBI. Perceived health was significantly worse for women who reported a TBI. ConclusionsThis study findings provide additional evidence that TBI among offender populations is serious and that specific actions need to be developed and implemented in correctional settings such as screening for TBI upon arrival.	[Durand, Eric; Chevignard, Mathilde; Pradat-Diehl, Pascale] UPMC Univ Paris 06, Sorbonne Univ, LIB, CNRS,UMR 7371,INSERM,UMR S 1146, Paris, France; [Durand, Eric] Fdn St Marie, Serv MPR, Paris, France; [Watier, Laurence] INSERM, U 657, Paris, France; [Watier, Laurence] Inst Pasteur, PhEMI, Paris, France; [Watier, Laurence] Univ Versailles St Quentin Versailles St Quentin, EA 4499, Fac Med Paris Ile France Ouest, Versailles, France; [Fix, Michel] UCSA Maisons Arret Fleury Merogis, St Genevieve Des Bois, France; [Weiss, Jean-Jacques] Ctr Ressources Francilien Traumatisme Cranien, Paris, France; [Chevignard, Mathilde] Hop St Maurice, Serv Reeducat Pathol Neurol Acquises Enfant, St Maurice, France; [Pradat-Diehl, Pascale] Hop Univ Pitie Salpetriere Charles Foix, Hop Pitie Salpetriere, APHP, Dept Med Phys & Readaptat, Paris, France		Durand, E (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, LIB, CNRS,UMR 7371,INSERM,UMR S 1146, Paris, France.	edurand@fhsm.fr	WATIER, Laurence/K-8213-2013	WATIER, Laurence/0000-0002-4057-1102	Fondation des Gueules Cassees; Centre Ressources du Traumatisme Cranien Ile de France; Sorbonne Univ Paris [UMR 7371, UMR S 1146]; Laboratoire d'Imagerie Biomedicale, Paris, France	This study was funded by the "Fondation des Gueules Cassees" and has been supported by the "Centre Ressources du Traumatisme Cranien Ile de France" and Sorbonne Univ Paris 06, UMR 7371, UMR S 1146, Laboratoire d'Imagerie Biomedicale, F-75005, Paris, France.	Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chodorge G, 1993, RAPPORT AMELIORATION; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Durand E, 2016, BRAIN INJURY, V30, P363, DOI 10.3109/02699052.2015.1131848; Durand E, 2001, REV NEUROL-FRANCE, V157, P87; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; GODIN-BLANDEAU E., 2013, B EPIDEMIOLOGIQUE HE, V35-36, P434; Gunter TD, 2009, BEHAV SCI LAW, V27, P695, DOI 10.1002/bsl.887; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; Hux D, 1998, BRAIN INJURY, V12, P667; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C., 2015, 30 C SOFMER 8 10 OCT; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MOUQUET MC, 1999, SANTE ENTREE PRISON; Mouquet MC., 2005, SANTE PERSONNES ENTR; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Watson R, 2004, INT J NURS STUD, V41, P119, DOI 10.1016/S0020-7489(03)00128-7; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	55	9	9	0	15	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2017	7	1							e00535	10.1002/brb3.535			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	EK9XE	WOS:000394276400001	28127505	Green Published, gold			2022-02-06	
J	Dutil, E; Bottari, C; Auger, C				Dutil, Elisabeth; Bottari, Carolina; Auger, Claudine			Test-Retest Reliability of a Measure of Independence in Everyday Activities: The ADL Profile	OCCUPATIONAL THERAPY INTERNATIONAL			English	Article							STROKE; ENVIRONMENT; AGREEMENT	Background. Very few performance-based measures used in occupational therapy have established test-retest reliability coefficients. Objectives of Study. This study presents the test-retest reliability of the task and operation scores of a performance-based measure of independence in everyday activities called the ADL Profile. Methods. 20 adults with severe traumatic brain injury (mean age 28.4 years; SD 9.9) were tested on two occasions with the 17 tasks (personal care, home, and community) of the ADL Profile. Kappa coefficients were calculated on both task and operation scores (formulating goal, planning, executing, and goal attainment). Findings. Test-retest reliability was moderate to almost perfect on task and operation scores of all 17 tasks. The three tasks with only moderate agreement were more novel and complex (e.g., making a budget) for the participants. Relevance to Clinical Practice. Use of measures that are stable over time is essential for treatment planning and research. Repeat testing is crucial with clients that require long periods of treatment (acute care, rehabilitation, and community integration) and multiple measurements of ADL independence. Limitations. The small sample size is a limit of the study. Recommendations for Further Research. Alternate versions of the three tasks with only moderate agreement would need to be developed and other psychometric properties established.	[Dutil, Elisabeth; Bottari, Carolina; Auger, Claudine] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Dutil, Elisabeth; Bottari, Carolina; Auger, Claudine] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada		Dutil, E (corresponding author), Univ Montreal, Sch Rehabil, Montreal, PQ, Canada.; Dutil, E (corresponding author), Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada.	elisabeth.dutil@umontreal.ca		Dutil, Elisabeth/0000-0001-7346-033X	Fonds de Recherche du Quebec-Sante (FRQS) [901383]; Fonds de Recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec	This work is supported by Grant 901383 (Dutil) and Salary Support (Auger) from the Fonds de Recherche du Quebec-Sante (FRQS). The authors wish to thank the Fonds de Recherche du Quebec-Sante for having funded this study as well as persons with TBI and their families for their participation. Also, they gratefully acknowledge the contribution of the occupational therapists who participated as raters, research assistants, and graduate students throughout this project.	Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DUTIL E, 1990, Occupational Therapy in Health Care, V7, P7, DOI 10.1080/J003v07n01_03; Fisher A. G., 2010, ASSESSMENT MOTOR PRO, V1; Fisher A. G., 2010, ASSESSMENT MOTOR PRO, V2; Green J, 2001, DISABIL REHABIL, V23, P670, DOI 10.1080/09638280110045382; Ku J, 2009, AM J PHYS MED REHAB, V88, P702, DOI 10.1097/PHM.0b013e3181aa427d; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWTON MP, 1983, GERONTOLOGIST, V23, P349, DOI 10.1093/geront/23.4.349; Luria A. R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN INTRO; Poulin V, 2013, AUST OCCUP THER J, V60, P3, DOI 10.1111/1440-1630.12024; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; Rousseau J., 1994, CANADIAN J OCCUPATIO, V61, P149, DOI DOI 10.1177/000841749406100304; ROUSSEAU J, 1994, CANADIAN J OCCUPATIO, V61, P159, DOI DOI 10.1177/000841749406100305; Sakzewski L, 2016, SCANDINAVIAN J OCCUP, P1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Streiner DL, 2014, HLTH MEASUREMENT SCA, V4th	18	9	9	2	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND	0966-7903	1557-0703		OCCUP THER INT	Occup. Ther. Int.		2017									3014579	10.1155/2017/3014579			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK7XP	WOS:000394138800001	29097964	gold, Green Published, Green Submitted			2022-02-06	
J	Ekinci, O; Okuyaz, C; Gunes, S; Ekinci, N; Orekeci, G; Teke, H; Direk, MC				Ekinci, Ozalp; Okuyaz, Cetin; Gunes, Serkan; Ekinci, Nuran; Orekeci, Gulhan; Teke, Halenur; Direk, Meltem Cobanogullari			Sleep and quality of life in children with traumatic brain injury and ADHD: A comparison with primary ADHD	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						traumatic brain injury; children; attention deficit hyperactivity disorder; sleep; quality of life	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PSYCHOMETRIC PROPERTIES; HEAD-INJURY; DISTURBANCES; IMPACT; ADOLESCENTS; REHABILITATION; QUESTIONNAIRE; DIFFICULTIES; PREVALENCE	Objective: Attention problems are common in children who sustain a traumatic brain injury (TBI). The differential features of TBI-related Attention Deficit Hyperactivity Disorder (ADHD) and primary ADHD are largely unknown. This study aimed to compare sleep problems and quality of life between children with TBI and ADHD and children with primary ADHD. Methods: Twenty children with TBI (mean age = 12.7 +/- 3.1 years) who had clinically significant ADHD symptoms according to the structured diagnostic interview and rating scales and a control group with primary ADHD (n = 20) were included. Parents completed Children's Sleep Habits Questionnaire (CSHQ) and Kinder Lebensqualitatsfragebogen: Children's Quality of Life Questionnaire-revised (KINDL-R). Neurology clinic charts were reviewed for TBI-related variables. Results: When compared to children with primary ADHD, the Total Score and Sleep Onset Delay, Daytime Sleepiness, Parasomnias, and Sleep Disordered Breathing subscores of CSHQ were found to be higher in children with TBI and ADHD. The Total Score and Emotional Well-Being and Self-Esteem subscores of the KINDL-R were found to be low (poorer) in children with TBI and ADHD. The Total Score and certain subscores of KINDL-R were found to be lower in TBI patients with a CSHQ > 56 (corresponds to significant sleep problems) when compared to those with a CSHQ < 56. CSHQ Total Score was negatively correlated with age. Conclusion: Children with TBI and ADHD symptoms were found to have a poorer sleep quality and quality of life than children with primary ADHD. ADHD in TBI may be considered as a highly impairing condition which must be early diagnosed and treated.	[Ekinci, Ozalp; Gunes, Serkan; Ekinci, Nuran; Teke, Halenur] Mersin Univ, Fac Med, Dept Child & Adolescent Psychiat, Mersin, Turkey; [Okuyaz, Cetin; Direk, Meltem Cobanogullari] Mersin Univ, Fac Med, Dept Pediat Neurol, Mersin, Turkey; [Orekeci, Gulhan] Mersin Univ, Fac Med, Dept Biostat & Med Informat, Mersin, Turkey		Ekinci, O (corresponding author), Mersin Univ, Dept Child & Adolescent Psychiat, Sch Med, Mersin, Turkey.	ozalpekinci@yahoo.com	COBANOGULLARI DIREK, Meltem/ABC-7551-2021	Gunes, Serkan/0000-0002-8247-2145			Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Brenner LA, 2007, J HEAD TRAUMA REHAB, V22, P56, DOI 10.1097/00001199-200701000-00007; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Clarke E, 1990, SCHOOL PSYCHOL INT, V11, P227; Corkum P, 1999, J AM ACAD CHILD PSY, V38, P1285, DOI 10.1097/00004583-199910000-00018; Danckaerts M, 2010, EUR CHILD ADOLES PSY, V19, P83, DOI 10.1007/s00787-009-0046-3; Dereboy C, 2007, TURK PSIKIYATR DERG, V18, P48; Eme R, 2012, EXPERT REV NEUROTHER, V12, P475, DOI [10.1586/ERN.12.15, 10.1586/ern.12.15]; Eser E, 2008, TURK PSIKIYATR DERG, V19, P409; Fi NP, 2010, ANADOLU PSIKIYATR DE, V11, P151; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gormez V, 2015, INT J PSYCHIAT MED, V49, P19, DOI 10.2190/PM.49.1.b; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Hargrave TM, 2015, INT J PSYCHIAT MED, V50, P60, DOI 10.1177/0091217415592358; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Morley CP, 2010, INT J PSYCHIAT MED, V40, P383, DOI 10.2190/PM.40.4.b; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Owens JA, 2000, SLEEP, V23, P1043; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Sener S., 1995, J CHILD ADOLESCENT M, V2, P131; Sikora DM, 2012, PEDIATRICS, V130, pS83, DOI 10.1542/peds.2012-0900F; Stores G, 2013, DEV MED CHILD NEUROL, V55, P797, DOI 10.1111/dmcn.12163; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Wassenberg R, 2004, BRAIN INJURY, V18, P377, DOI 10.1080/02699050310001617325; Weed ED, 2016, INT J PSYCHIAT MED, V51, P120, DOI 10.1177/0091217416636561; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012	42	9	9	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2174	1541-3527		INT J PSYCHIAT MED	Int. J. Psychiatr. Med.	JAN	2017	52	1					72	87		10.1177/0091217417703288			16	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EU7WP	WOS:000401247100006	28486878				2022-02-06	
J	Flygt, J; Clausen, F; Marklund, N				Flygt, Johanna; Clausen, Fredrik; Marklund, Niklas			Diffuse traumatic brain injury in the mouse induces a transient proliferation of oligodendrocyte progenitor cells in injured white matter tracts	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; axonal injury; proliferation; EdU; oligodendrocyte progenitor cells; white matter; myelin; fluid percussion	CENTRAL-NERVOUS-SYSTEM; AXONAL INJURY; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; CORPUS-CALLOSUM; PRECURSOR CELLS; ADULT CNS; REMYELINATION; MYELIN; RATS	Background: Injury to the white matter may lead to impaired neuronal signaling and is commonly observed following traumatic brain injury (TBI). Although endogenous repair of TBI-induced white matter pathology is limited, oligodendrocyte progenitor cells (OPCs) may be stimulated to proliferate and regenerate functionally myelinating oligodendrocytes. Even though OPCs are present throughout the adult brain, little is known about their proliferative activity following axonal injury caused by TBI. Objective: We hypothesized that central fluid percussion injury (cFPI) in mice, a TBI model causing wide- spread axonal injury, results in OPC proliferation. Methods: Proliferation of OPCs was evaluated in 27 cFPI mice using 5-ethynyl- 2 '- deoxyuridine (EdU) labeling and a cell proliferation assay at 2 (n= 9), 7 (n = 8) and 21 (n = 10) days post injury (dpi). Sham-injured mice (n = 14) were used as controls. OPC proliferation was quantified by immunohistochemistry using the OPC markers NG2 and Olig2 in several white matter loci including the corpus callosum, external capsule, fimbriae, the internal capsule and cerebral peduncle. Results: The number of EdU/DAPI/Olig2-positive cells were increased in the cFPI group compared to sham-injured animals at 7 days post-injury (dpi; p <= 0.05) in the majority of white matter regions. The OPC proliferation had subsided by 21 dpi. The number of EdU/DAPI/NG2 cells was also increase at 7 dpi in the external capsule and fimbriae. Conclusion: These results suggest that traumatic axonal injury in the mouse induces a transient proliferative response of residing OPCs. These proliferating OPCs may replace dead oligodendrocytes and contribute to remyelination, which needs evaluation in future studies.	[Flygt, Johanna; Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden.	Niklas.marklund@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417; Marklund, Niklas/0000-0002-9797-5626	Swedish Brain Foundation; Uppsala University ALF funds; Swedish Research CouncilSwedish Research CouncilEuropean Commission	The study was supported by the Swedish Brain Foundation, Uppsala University ALF funds and the Swedish Research Council under the framework of EU-ERA-NET NEURON CnsAFlame. The authors wish to acknowledge support with the confocal and super-resolution imaging by Drs. Matyas Molnar and Dirk Pacholsky at Biological Visualization (BioVis), Uppsala University.	Abdel Baki SG, 2010, PLOS ONE, V5; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; Borgens RB, 2012, Q REV BIOL, V87, P89, DOI DOI 10.1086/665457; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Chamberlain KA, 2015, NEUROPHARMACOLOGY; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Ekmark-Lewen S, 2010, J NEUROTRAUM, V27, P1643, DOI 10.1089/neu.2009.0953; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grigoriadis N, 2004, CLIN NEUROL NEUROSUR, V106, P211, DOI 10.1016/j.clineuro.2004.02.017; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kaiser CL, 2009, LARYNGOSCOPE, V119, P1770, DOI 10.1002/lary.20557; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maki T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00275; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Steelman AJ, 2016, NEUROBIOL DIS, V91, P336, DOI 10.1016/j.nbd.2016.03.023; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wegner M, 2001, MICROSC RES TECHNIQ, V52, P746, DOI 10.1002/jemt.1059; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zambonin JL, 2011, BRAIN, V134, P1901, DOI 10.1093/brain/awr110; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092; Zheng YW, 2011, EXP BRAIN RES, V210, P477, DOI 10.1007/s00221-010-2491-0	64	9	9	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2017	35	2					251	263		10.3233/RNN-160675			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ5OG	WOS:000398131700009	27768001				2022-02-06	
J	Furlan, JC; Gulasingam, S; Craven, BC				Furlan, Julio C.; Gulasingam, Sivakumar; Craven, B. Catharine			The Health Economics of the spinal cord injury or disease among veterans of war: A systematic review	JOURNAL OF SPINAL CORD MEDICINE			English	Article; Proceedings Paper	7th National Spinal Cord Injury Conference	NOV 09-11, 2017	Niagara Falls, CANADA			Spinal cord injury; Neurotrauma; Military; veterans; War; Health economics	COST-EFFECTIVENESS; CARE COSTS; PRESSURE ULCERS; RECOMMENDATIONS; EMPLOYMENT; MEDICINE; BURDEN	Context: Information on health-care utilization and the economic burden of disease are essential to understanding service demands, service accessibility, and practice patterns. This information may also be used to enhance the quality of care through altered resource allocation. Thus, a systematic review of literature on the economic impact of caring for SCI/D veterans would be of great value. Objective: To systematically review and critically appraise the literature on the economics of the management of veterans with SCI/D. Methods: Medline, EMBASE and PsycINFO databases were searched for articles on economic impact of management of SCI/D veterans, published from 1946 to September/2016. The STROBE statement was used to determine publication quality. Results: The search identified 1,573 publications of which 13 articles fulfilled the inclusion/exclusion criteria with 12 articles focused on costs of management of SCI/D veterans; and, one cost-effectiveness analysis. Overall, the health care costs for the management of SCI/D veterans are substantial ($30,770 to $62,563 in 2016 USD per year) and, generally, greater than the costs of caring for patients with other chronic diseases. The most significant determinants of the higher total healthcare costs are cervical level injury, complete injury, time period (i.e. first year post-injury and end-oflife year), and presence of pressure ulcers. Conclusions: There is growing evidence for the economic burden of SCI/D and its determinants among veterans, whereas there is a paucity of comparative studies on interventions including cost-effectiveness analyses. Further investigations are needed to fulfill significant knowledge gaps on the economics of caring for veterans with SCI/D.	[Furlan, Julio C.; Gulasingam, Sivakumar; Craven, B. Catharine] Univ Toronto, Div Phys Med & Rehabil, Dept Med, Toronto, ON, Canada; [Furlan, Julio C.; Gulasingam, Sivakumar; Craven, B. Catharine] Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, Toronto, ON, Canada		Furlan, JC (corresponding author), 520 Sutherland Dr,Room 205, Toronto, ON M4G 3V9, Canada.	jcfurlan@gmail.com	Craven, Beverley/D-5001-2015; Furlan, Julio/Q-8290-2018	Craven, Beverley/0000-0001-8234-6803; Furlan, Julio/0000-0002-2038-0018; Gulasingam, Sivakumar/0000-0003-4588-8341	Wings for Life [WFL-CA-0916]	This work was supported by Wings for Life [WFL-CA-0916].	[Affairs UDoV US-VA], 2009, FACT SHEET VA SPIN C, P1; [Affairs UDoV US-VA], 2016, HLTH BEN; [Affairs UDoV US-VA], 2016, 2017 BUDG 2018 ADV A; Brem H, 2010, AM J SURG, V200, P473, DOI 10.1016/j.amjsurg.2009.12.021; Bridle C, 2004, HEALTH TECHNOL ASSES, V8, P1; Chan BC, 2013, INT WOUND J, V10, P431, DOI 10.1111/j.1742-481X.2012.01002.x; Chandra B. P., 2014, SPINAL CORD INJURY R, P1; CIHI, 2007, BURD NEUR DIS DIS IN; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Furlan J, 2014, SPINAL CORD INJURY R, P1; Furlan JC, COMMUNICATION; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Ghosh Dipankar, 2003, J Health Care Finance, V30, P41; Halfhill TR, TOMS INFLATION CALCU; Hedrick B, 2006, J REHABIL RES DEV, V43, P185, DOI 10.1682/JRRD.2005.03.0062; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Mahabaleshwarkar R, 2014, SPINAL CORD, V52, P139, DOI 10.1038/sc.2013.144; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; New PW, 2010, SPINE, V35, P796, DOI 10.1097/BRS.0b013e3181be76f5; Petersen LA, 2007, AM J MANAG CARE, V13, P513; Roski Richard A, 2004, Clin Neurosurg, V51, P43; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Russo CA, 2008, HCUP STAT BRIEF, V2017, P1; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Sinnott PL, 2014, ARCH PHYS MED REHAB, V95, P1254, DOI 10.1016/j.apmr.2014.01.010; Smith MW, 2012, INT J TELEMED APPL, V2012, P1; St. Andre JR, 2011, TOP SPINAL CORD INJ, V16, P27; Stroupe K., 2011, TOP SPINAL CORD INJU, V16, P62, DOI [10.1310/sci1604-62, DOI 10.1310/SCI1604-62, DOI 10.1310/SCI1604]; Theobald K, 2009, GMS GERMAN MED SCI, V7, P1; US-BLS, 2016, CONS PRIC IND ALL UR; van den Berg MEE, 2012, ARCH PHYS MED REHAB, V93, P325, DOI 10.1016/j.apmr.2011.08.027; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yoon J, 2014, MED CARE, V52, pS31, DOI 10.1097/MLR.0000000000000061; Young-Hughes S, 2011, REHABIL NURS, V36, P153, DOI 10.1002/j.2048-7940.2011.tb00083.x; Yu W, 2004, AM J MANAG CARE, V10, P909; Yu W, 2003, MED CARE RES REV, V60, p40S, DOI 10.1177/1077558703256724; Yu W, 2008, J REHABIL RES DEV, V45, P831, DOI 10.1682/JRRD.2006.08.0102; Yu Wei, 2004, J Med Syst, V28, P271, DOI 10.1023/B:JOMS.0000032844.26308.95; Zakrasek EC, 2015, SPINAL CORD, V53, P7, DOI 10.1038/sc.2014.179; Zhao Y, 2009, HCUP STAT BRIEF	46	9	9	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2017	40	6			SI		649	664		10.1080/10790268.2017.1368267			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	FO2JZ	WOS:000416604400005	28874099	Green Published			2022-02-06	
J	Garcia-Barrera, MA; Karr, JE; Trujillo-Orrego, N; Trujillo-Orrego, S; Pineda, DA				Garcia-Barrera, Mauricio A.; Karr, Justin E.; Trujillo-Orrego, Natalia; Trujillo-Orrego, Sandra; Pineda, David A.			Evaluating Empathy in Colombian Ex-Combatants: Examination of the Internal Structure of the Interpersonal Reactivity Index (IRI) in Spanish	PSYCHOLOGICAL ASSESSMENT			English	Article						empathy; Interpersonal Reactivity Index; civil war; Colombia; cross-cultural validation	TRAUMATIC BRAIN-INJURY; GOODNESS-OF-FIT; VALIDATION; CONFLICT; VETERANS	The Republic of Colombia has a long-standing history of internal armed conflict, further complicated by the ideological assumptions underlying their war. In recent years, its government designed the Program for Reincorporation to Civilian Life (Programa para la Reincorporacion a la Vida Civil, PRVC), aiming demobilization of thousands of insurgents who were involved in guerilla and paramilitary forces. One PRVC goal involves the psychological characterization of its reincorporated members, aiming the informed design of effective and efficacious interventions to improve their adjustment. We are interested in the examination of empathy in this population. Empathy refers to the ability to predict, understand, and experience other's feelings. Empathy appears to have an effect on level of aggressive behavior. The Interpersonal Reactivity Index (IRI; Davis, 1980, 1983) is a well-established 28-item self-report tool for the assessment of empathy, including 4 scales: Perspective Taking, Fantasy, Empathic Concern, and Personal Distress. Versions in Spanish were validated in Spain and Chile, but no norms for Colombians exist. We examined the factorial structure of the IRI in a sample of 548 (83.4% males) members of the PRVC. Ten items with low factor loadings were eliminated following a series of confirmatory factor analyses (CFA). The final 4-factor model (Model 2) reached an acceptable fit (e.g., CFI = .898). A second-order CFA demonstrated that empathic concern correlated too high with a common "empathy" latent factor. With these results at hand, our 18-item IRI version in Spanish achieved a factorial structure comparable to that previously validated for Spanish speakers from other countries.	[Garcia-Barrera, Mauricio A.; Karr, Justin E.] Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada; [Trujillo-Orrego, Natalia] Univ Antioquia, Sch Publ Hlth, Medellin, Colombia; [Trujillo-Orrego, Sandra] Univ Antioquia, Neurosci Grp, Medellin, Colombia; [Pineda, David A.] Univ Antioquia, Dept Neurol, Medellin, Colombia		Garcia-Barrera, MA (corresponding author), Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.	mgarcia@uvic.ca	Garcia-Barrera, Mauricio A./AAO-9757-2021; Pineda, David/AAE-4785-2020; Garcia-Barrera, Mauricio A/H-3850-2016	Garcia-Barrera, Mauricio A./0000-0002-4302-4964; Garcia-Barrera, Mauricio A/0000-0002-4302-4964; Trujillo, Sandra/0000-0003-3100-0102; Pineda, David A/0000-0002-1080-4796	Colombian Department of Science, Technology, and Innovation (COLCIENCIAS) [455-2009]	Data collection was funded by the Colombian Department of Science, Technology, and Innovation (COLCIENCIAS; Grant 455-2009 awarded to David A. Pineda [Principal Investigator]; Mauricio A. Garcia-Barrera served as coapplicant).	Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bjorkqvist K, 2000, AGGRESS VIOLENT BEH, V5, P191, DOI 10.1016/S1359-1789(98)00029-9; Carter CS, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P169; Centro Nacional de Memoria Historica, 2013, INF GEN BAST YA MEM; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cliffordson C, 2002, SCAND J PSYCHOL, V43, P49, DOI 10.1111/1467-9450.00268; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; French BF, 2006, STRUCT EQU MODELING, V13, P378, DOI 10.1207/s15328007sem1303_3; Garcia-Barrera M. A., 2014, REHABILITACION COGNI, P165; Garcia-Barrera MA, 2015, PSYCHOL ASSESSMENT, V27, P1349, DOI 10.1037/pas0000117; Gilet AL, 2013, CAN J BEHAV SCI, V45, P42, DOI 10.1037/a0030425; Gray VJ, 2008, LAT AM POLIT SOC, V50, P63, DOI 10.1111/j.1548-2456.2008.00022.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kashdan TB, 2010, BEHAV THER, V41, P350, DOI 10.1016/j.beth.2009.09.003; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Fernandez AM, 2011, EUR J PSYCHOL ASSESS, V27, P179, DOI 10.1027/1015-5759/a000065; Mestre-Escriva V, 2004, PSICOTHEMA, V16, P255; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Muthen L, 2011, MPLUS; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nezlek JB, 2001, J RES PERS, V35, P401, DOI 10.1006/jrpe.2001.2332; Patino Orozco R. A., 2012, PSICOLOGIA SOC, V24, P517; Perez-Albeniz A, 2003, PSICOTHEMA, V15, P267; Pineda David A, 2013, rev.colomb.psiquiatr., V42, P9, DOI 10.1016/S0034-7450(14)60084-6; Restrepo JA, 2006, J PEACE RES, V43, P99, DOI 10.1177/0022343306059924; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; Taft CT, 2007, J TRAUMA STRESS, V20, P135, DOI 10.1002/jts.20197; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.2307/1130296; Vargas JF, 2012, DEFENCE PEACE ECON, V23, P203, DOI 10.1080/10242694.2011.597234; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Yu CY, 2002, EVALUATING CUTOFF CR	41	9	10	1	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JAN	2017	29	1					116	122		10.1037/pas0000331			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	EI1DF	WOS:000392215300011	27111730				2022-02-06	
J	Gilligan, J; Reilly, P; Pearce, A; Taylor, D				Gilligan, John; Reilly, Peter; Pearce, Andrew; Taylor, Danielle			Management of acute traumatic intracranial haematoma in rural and remote areas of Australia	ANZ JOURNAL OF SURGERY			English	Article						aircraft transport; craniocerebral trauma; emergency burr hole; epidural haematoma; rural location; subdural	INJURY SEVERITY SCORE; EXTRADURAL HEMATOMA; WESTERN-AUSTRALIA; MAJOR TRAUMA; EMERGENCY; NEUROTRAUMA; CARE	IntroductionOutcomes are reviewed with traumatic brain injury (TBI) involving intracranial haematomata (ICH) with patients in rural and remote areas of South Australia and adjacent states. Patients were referred to the Royal Adelaide Hospital (RAH), a level 1 trauma centre with a major neurosurgical service. MethodFrom 2000 to 2013, 1107 multiple trauma cases included 162 with severe TBI. Local medical officers (LMOs) phoned a specific number to access resuscitative and neurosurgical advice. Onsite neurosurgical support was provided when requested. Specialist teams later retrieved these patients to RAH. Locations were coded according to the Accessibility/Remoteness Index of Australia (ARIA+). Injuries were coded using ICD 9 and 10. ResultsGeneral surgeon LMOs drained nine clinically progressive ICHs. Neurosurgical attendance was provided in four instances. Eight patients survived. The remaining 153 patients had other injuries involving thoraco-abdominal organs, spine, pelvis and limbs. The overall mortality was 30%. Twenty-six had ICHs requiring surgical drainage later at the RAH, with 46% mortality. Average Injury Severity Score was 30 (range 9-66). Male/female ratio was 76/24. Motor vehicular accidents predominated (60%), followed by falls (26%) and assaults (10%). Those under 30 years were overrepresented. Patients were transported a mean distance of 283km (maximum distance 2600km). Conclusion LMOs in remote locations may consider immediate drainage of deteriorating traumatic ICH. Adequate support from a distant major trauma centre can help achieve acceptable outcomes. Effective communications are vital. The Royal Australasian College of Surgeons and Neurosurgical Society of Australasia guidelines based on the Early Management of Severe Trauma protocols can assist LMOs in making the decision to undertake emergency craniotomy.	[Gilligan, John] Royal Flying Doctor Serv Cent Operat, Hlth Advisory Comm, 71 Henley Beach Rd, Adelaide, SA 5031, Australia; [Reilly, Peter] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Pearce, Andrew] Royal Adelaide Hosp, ED Trauma, Adelaide, SA, Australia; [Pearce, Andrew] SA Ambulance Serv, MedSTAR, Adelaide, SA, Australia; [Taylor, Danielle] Univ Adelaide, Australian Populat & Migrat Res Ctr, Adelaide, SA, Australia		Gilligan, J (corresponding author), Royal Flying Doctor Serv Cent Operat, Hlth Advisory Comm, 71 Henley Beach Rd, Adelaide, SA 5031, Australia.	fgilliga@adam.com.au	Taylor, Danielle/V-9216-2019	Taylor, Danielle/0000-0003-0692-7889; Reilly, Peter/0000-0003-3173-0666			Australian Bureau of Statistics, THE AUSTRALIAN STAND; Australian Population and Migration Research Centre, ARIA ACCESSIBILITY R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bishop CV, 2006, ANZ J SURG, V76, P53, DOI 10.1111/j.1445-2197.2006.03642.x; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; CareFlight, CAREFLIGHT NORTHERN; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Department of Infrastructure Transport Regional Development and Local Government, 2009, ROAD DEATHS AUSTRALI; Die Johanniter, EMERGENCY MED SYSTEM; Fatovich DM, 2013, J TRAUMA ACUTE CARE, V74, P647, DOI 10.1097/TA.0b013e3182788065; Fatovich DM, 2011, J TRAUMA, V71, P1816, DOI 10.1097/TA.0b013e318238bd4c; GILLIGAN JE, 1977, MED J AUSTRALIA, V2, P849, DOI 10.5694/j.1326-5377.1977.tb107714.x; Hinkelbein J, 2008, J TRAUMA, V64, P204, DOI 10.1097/01.ta.0000239256.28393.e2; IndexMundi, NORWAY AREA; JENNETT B, 1975, LANCET, V1, P480; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; Marion DW, 2006, NEUROSURGERY, V58, P655; Mendelow AD, 1979, BMJ-BRIT MED J, V12, P1240; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Royal Australasian College of Surgeons, EMST OVERVIEW; Treacy PJ, 2005, ANZ J SURG, V75, P852, DOI 10.1111/j.1445-2197.2005.03549.x; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Wilson MH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-24; World Health Organization, 2004, INT STAT CLASSIFICAT	28	9	9	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JAN-FEB	2017	87	1-2					80	85		10.1111/ans.13583			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EL7FS	WOS:000394787100020	27145070				2022-02-06	
J	Gregory, E; West, TA; Cole, WR; Bailie, JM; McCulloch, KL; Ettenhofer, ML; Cecchini, A; Qashu, FM				Gregory, Emma; West, Therese A.; Cole, Wesley R.; Bailie, Jason M.; McCulloch, Karen L.; Ettenhofer, Mark L.; Cecchini, Amy; Qashu, Felicia M.			Use of a multi-level mixed methods approach to study the effectiveness of a primary care progressive return to activity protocol after acute mild traumatic brain injury/concussion in the military	CONTEMPORARY CLINICAL TRIALS			English	Article						Clinical study methodology; Outcomes research; Traumatic brain injury; Concussion; Knowledge translation; Military	CONCUSSION; SYMPTOMS; IMPACT; INJURY; REST; RECOMMENDATIONS; INTERVENTION; STATEMENT; EDUCATION	The large number of U.S. service members diagnosed with concussion/mild traumatic brain injury each year underscores the necessity for clear and effective clinical guidance for managing concussion. Relevant research continues to emerge supporting a gradual return to pre-injury activity levels without aggravating symptoms; however, available guidance does not provide detailed standards for this return to activity process. To fill this gap, the Defense and Veterans Brain Injury Center released a recommendation for primary care providers detailing a step-wise return to unrestricted activity during the acute phase of concussion. This guidance was developed in collaboration with an interdisciplinary group of clinical, military, and academic subject matter experts using an evidence-based approach. Systematic evaluation of the guidance is critical to ensure positive patient outcomes, to discover barriers to implementation by providers, and to identify ways to improve the recommendation. Here we describe a multi-level, mixed-methods approach to evaluate the recommendation incorporating outcomes from both patients and providers. Procedures were developed to implement the study within complex but ecologically-valid settings at multiple military treatment facilities and operational medical units. Special consideration was given to anticipated challenges such as the frequent movement of military personnel, selection of appropriate design and measures, study implementation at multiple sites, and involvement of multiple service branches (Army, Navy, and Marine Corps). We conclude by emphasizing the need to consider contemporary approaches for evaluating the effectiveness of clinical guidance. (C) 2016 Elsevier Inc. All rights reserved.	[Gregory, Emma; Cole, Wesley R.; Bailie, Jason M.; Ettenhofer, Mark L.; Cecchini, Amy; Qashu, Felicia M.] Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA; [Gregory, Emma; Cole, Wesley R.; Bailie, Jason M.] Gen Dynam Hlth Solut, 8601 Georgia Ave Ste 900, Silver Spring, MD 20910 USA; [West, Therese A.] US Army Med Res & Mat Command, Combat Casualty Care Res Program, 722 Doughten St, Ft Detrick, MD 21792 USA; [Cole, Wesley R.] Womack Army Med Ctr, MIXC TBI 2817 Reilly Rd, Ft Bragg, NC 28310 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, 33 Area,Mental Hlth Bldg 33305, Camp Pendleton, CA 92055 USA; [McCulloch, Karen L.] Univ North Carolina Chapel Hill, 321 S Columbia St,Bondurant Hall Ste 3024, Chapel Hill, NC 27599 USA; [McCulloch, Karen L.; Cecchini, Amy] Venesco LLC, 14801 Murdock St Suite 125, Chantilly, VA 20151 USA; [Ettenhofer, Mark L.] Naval Med Ctr San Diego, Dept Phys Med & Rehabil, 34730 Bob Wilson Dr Ste 201 Bldg 3, San Diego, CA 92134 USA; [Ettenhofer, Mark L.] Amer Hosp Serv Grp LLC, 1 E Uwchlan Ave,Suite 407, Exton, PA 19341 USA		Gregory, E (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA.	emma.d.gregory2.ctr@mail.mil	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	Defense Health Program [6.7]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by the Defense Health Program 6.7 and the Defense and Veterans Brain Injury Center.	Cabana MD, 2014, HEALTH EDUC BEHAV, V41, P509, DOI 10.1177/1090198114547510; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, PROGR RET ACT FOLL M; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; IOM, 2011, CLIN PRACTICE GUIDEL; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lutz Robert H, 2010, J Spec Oper Med, V10, P23; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Ontario Neurotrauma Foundation, GUID CONC MILD TRAUM; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; The Management of Concussion/mTBI Work Group, VA DOD CLIN PRACT GU; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031	31	9	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2017	52						95	100		10.1016/j.cct.2016.11.005			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	EI5VZ	WOS:000392565700013	27836507	Green Submitted			2022-02-06	
J	Hart, T; Vaccaro, MJ				Hart, Tessa; Vaccaro, Monica J.			Goal intention reminding in traumatic brain injury: A feasibility study using implementation intentions and text messaging	BRAIN INJURY			English	Article						Brain injuries; goal management training; implementation intentions; rehabilitation technology	PROSPECTIVE MEMORY PERFORMANCE; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE REHABILITATION; HEALTH-CARE; INTERVENTIONS	Objective: To examine feasibility of participant-created implementation intentions, delivered as text message reminders, to enhance goal-related activity in persons with chronic, moderate/severe traumatic brain, injury (TBI). Design: Pilot randomized controlled trial on effects of 8 weeks receiving goal-related implementation intentions (GI) compared to control condition, educational review regarding goals (GR). Participants: Eight persons with moderate/severe TBI nearing discharge from intensive outpatient brain injury treatment. Measures: Neuropsychological tests to characterize cognitive status; Participation with. Recombined Tools-Objective (PART-O) assessing community activity, social relations and productivity; Brief Symptom Inventory-18 (BSI-18) assessing depression, anxiety and overall distress; Goal Attainment Scales (GAS). PART-O, BSI-18 and GAS were completed at baseline and 8 weeks; significant others provided ratings on PART-O and GAS. Results: Participants replied to SMS messages at high rates. Statistically significant group x time interactions with medium-to-large effect sizes favouring the GI group were observed on PART-O community activity and social relations. Neither BSI-18 nor GAS revealed differences or trends by group. Qualitative results suggested overall acceptance and success of SMS reminders. Conclusions: Given positive preliminary findings, implementation intentions delivered by text holds promise as a simple, low-cost intervention to help people with moderate/severe TBI to implement goal-relevant behaviours.	[Hart, Tessa; Vaccaro, Monica J.] Moss Rehabil Res Inst, Elkins Pk, PA USA		Hart, T (corresponding author), MRRI, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu			Pennsylvania Department of Health (SAP) [4100054839]	This research was funded by a grant from the Pennsylvania Department of Health (SAP #4100054839) to the first author. The authors alone are responsible for the content and writing of the paper.	Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Latimer AE, 2006, REHABIL PSYCHOL, V51, P273, DOI 10.1037/0090-5550.51.4.273; Lengfelder A, 2001, NEUROPSYCHOLOGY, V15, P80, DOI 10.1037//0894-4105.15.1.80; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; McFarland CP, 2011, AGING NEUROPSYCHOL C, V18, P633, DOI 10.1080/13825585.2011.613449; Mioni G, 2015, J INT NEUROPSYCH SOC, V21, P305, DOI 10.1017/S1355617715000211; Prestwich A, 2009, PSYCHOL HEALTH, V24, P677, DOI 10.1080/08870440802040715; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rockwood K, 2003, J CLIN EPIDEMIOL, V56, P736, DOI 10.1016/S0895-4356(03)00132-X; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Vacha-Haase T, 2004, J COUNS PSYCHOL, V51, P473, DOI 10.1037/0022-0167.51.4.473; Wechsler D., 2011, WECHSLER ABBREVIATED; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	29	9	9	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					297	303		10.1080/02699052.2016.1251612			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900003	28102697				2022-02-06	
B	Horswill, MS		Fisher, DL; Caird, JK; Horrey, WJ; Trick, LM		Horswill, Mark S.			Hazard Perception Tests	HANDBOOK OF TEEN AND NOVICE DRIVERS: RESEARCH, PRACTICE, POLICY, AND DIRECTIONS			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DRIVING EXPERIENCE; EYE-MOVEMENTS; CRASH INVOLVEMENT; OLDER DRIVERS; RISK-TAKING; ROAD; AWARENESS; SIMULATOR; ABILITY	It is now 50 years since the publication of the first known study involving a hazard perception test for drivers (Spicer, 1964), and hazard perception tests are being increasingly used as part of driver licensing procedures around the world. They typically involve drivers watching images of traffic situations and indicating their awareness of potentially dangerous events, on the assumption that a greater awareness of such events has implications for an individual's crash liability while driving. Consistent with this assumption, test scores have been found to be associated with crash risk, on-road driver ratings, and key factors linked with crash risk (such as distraction, fatigue, alcohol, and speed choice), as well as differentiating between high- and low-risk driver groups. This chapter will discuss our current understanding of hazard perception tests, including their validity, issues surrounding test content, alternative test implementations, and what high scorers might be doing that low scorers are not.	[Horswill, Mark S.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia		Horswill, MS (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.		Horswill, Mark/J-9029-2019	Horswill, Mark/0000-0002-0286-6292			Anstey KJ, 2012, ACCIDENT ANAL PREV, V45, P766, DOI 10.1016/j.aap.2011.10.006; Borowsky A., 2014, P HUM FACT ERG SOC A; Borowsky A, 2015, TRAFFIC INJ PREV, V16, P133, DOI 10.1080/15389588.2014.909593; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Borowsky A, 2009, TRANSPORT RES F-TRAF, V12, P277, DOI 10.1016/j.trf.2009.02.001; Boufous S, 2011, TRAFFIC INJ PREV, V12, P475, DOI 10.1080/15389588.2011.591856; Chapman PR, 1998, PERCEPTION, V27, P951, DOI 10.1068/p270951; Cheng ASK, 2011, ACCIDENT ANAL PREV, V43, P1464, DOI 10.1016/j.aap.2011.02.024; Congdon P., 1999, VICROADS HAZARD PERC; Coyne P, 2007, ROADCRAFT POLICE DRI; Crundall D, 2003, J EXP PSYCHOL-APPL, V9, P163, DOI 10.1037/1076-898X.9.3.163; Crundall D, 2012, ACCIDENT ANAL PREV, V45, P600, DOI 10.1016/j.aap.2011.09.049; Darby P, 2009, SAFETY SCI, V47, P436, DOI 10.1016/j.ssci.2008.05.004; Deery HA, 1996, ADDICTION, V91, P815, DOI 10.1046/j.1360-0443.1996.9168158.x; Driver and Vehicle Standards Agency, 2014, HAZ PERC TEST WINS R; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Farrand P., 2001, TRANSP RES F, V4, P201, DOI [DOI 10.1016/S1369-8478(01)00024-9, 10.1016/S1369-8478(01)00024-9]; Fisher Donald L, 2014, Ann Adv Automot Med, V58, P33; Grayson G, 2003, RISK HAZARD PERCEPTI; Grayson G.B., 2002, DEV HAZARD PERCEPTIO; Groeger J.A., 2000, UNDERSTANDING DRIVIN; Hamid M., 2014, TRANSP RES BOARD 93; Horswill M. S., 2004, COGNITIVE APPROACH S, P155; Horswill MS, 2008, J GERONTOL B-PSYCHOL, V63, pP212, DOI 10.1093/geronb/63.4.P212; Horswill MS, 2015, ACCIDENT ANAL PREV, V82, P213, DOI 10.1016/j.aap.2015.05.019; Horswill MS, 2013, ACCIDENT ANAL PREV, V50, P130, DOI 10.1016/j.aap.2012.04.001; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Horswill MS, 1999, BRIT J PSYCHOL, V90, P189, DOI 10.1348/000712699161341; Jackson L, 2009, ERGONOMICS, V52, P154, DOI 10.1080/00140130802030714; Lee SE, 2008, TRANSPORT RES REC, P26, DOI 10.3141/2078-04; McDonald CC, 2012, TRANSPORT RES REC, P73, DOI 10.3141/2321-10; McGehee DV, 2007, J SAFETY RES, V38, P215, DOI 10.1016/j.jsr.2007.02.009; McGowan A.M., 2004, COGNITIVE APPROACH S, P176; McKenna F. P., 1999, BEHAV RES ROAD SAFET; McKenna F.P., 1999, J INT ASS TRAFFIC SA, V23, P26; McKenna F.P., 1991, HAZARD PERCEPTION DR; McKenna FP, 2006, J EXP PSYCHOL-APPL, V12, P1, DOI 10.1037/1076-898X.12.1.1; MILLS KL, 1998, EFFECTS HAZARD PERCE; Pelz D.C., 1974, ACCIDENT ANAL PREV, V6, P45, DOI [10.1016/0001-4575(74)90015-3., DOI 10.1016/0001-4575(74)90015-3]; Pollatsek A, 2006, HUM FACTORS, V48, P447, DOI 10.1518/001872006778606787; Pradhan AK, 2009, ERGONOMICS, V52, P657, DOI 10.1080/00140130802550232; Pradhan AK, 2005, HUM FACTORS, V47, P840, DOI 10.1518/001872005775570961; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Quimby A., 1981, HUMAN FACTORS DRIVIN; QUIMBY AR, 1986, PERCEPTUAL ABILITIES; Renge K., 2005, TRAFFIC TRANSPORT PS, P91; Rosenbloom T, 2011, ACCIDENT ANAL PREV, V43, P601, DOI 10.1016/j.aap.2010.08.005; Ross R. W, 2013, 7 INT DRIV S HUM FAC; Rowe R. M., 1997, ANTICIPATION SKILLED; Sagberg F, 2006, ACCIDENT ANAL PREV, V38, P407, DOI 10.1016/j.aap.2005.10.014; Savage SW, 2013, TRANSPORT RES F-TRAF, V17, P52, DOI 10.1016/j.trf.2012.10.002; Scialfa CT, 2014, ACCIDENT ANAL PREV, V73, P41, DOI 10.1016/j.aap.2014.08.007; Scialfa CT, 2012, ACCIDENT ANAL PREV, V45, P547, DOI 10.1016/j.aap.2011.09.005; Scialfa CT, 2011, ACCIDENT ANAL PREV, V43, P204, DOI 10.1016/j.aap.2010.08.010; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Spicer R. A, 1964, HUMAN FACTORS TRAFFI; Taylor T, 2013, ACCIDENT ANAL PREV, V58, P175, DOI 10.1016/j.aap.2013.02.008; Transport and Road Research Laboratory, 1979, HAZ PERC TEST DRIV; Underwood G, 2011, TRANSPORT RES F-TRAF, V14, P435, DOI 10.1016/j.trf.2011.04.008; Vlakveld WP, 2014, TRANSPORT RES F-TRAF, V22, P218, DOI 10.1016/j.trf.2013.12.013; Wallis TSA, 2007, ACCIDENT ANAL PREV, V39, P1177, DOI 10.1016/j.aap.2007.03.003; Watts G., 1979, DESIGN VALIDATION DR; Wells P, 2008, COHORT; WEST R, 1993, ADDICTION, V88, P527, DOI 10.1111/j.1360-0443.1993.tb02059.x; Wetton MA, 2010, ACCIDENT ANAL PREV, V42, P1232, DOI 10.1016/j.aap.2010.01.017; Wetton MA, 2011, ACCIDENT ANAL PREV, V43, P1759, DOI 10.1016/j.aap.2011.04.007; Wood JM, 2002, HUM FACTORS, V44, P482, DOI 10.1518/0018720024497664; Wood JM, 2013, ACCIDENT ANAL PREV, V50, P1161, DOI 10.1016/j.aap.2012.09.009	69	9	9	1	2	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA			978-1-4665-8702-1; 978-1-4665-8700-7				2017							439	450					12	Transportation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Transportation	BI0GD	WOS:000404759300028					2022-02-06	
J	Hubbard, WB; Greenberg, S; Norris, C; Eck, J; Lavik, E; VandeVord, P				Hubbard, W. Brad; Greenberg, Shaylen; Norris, Carly; Eck, Joseph; Lavik, Erin; VandeVord, Pamela			Research Article Distinguishing the Unique Neuropathological Profile of Blast Polytrauma	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							BLOOD-BRAIN-BARRIER; PRESSURE RESPONSE; OXIDATIVE STRESS; BOMB EXPLOSION; RODENT MODEL; LUNG INJURY; OPEN-FIELD; RAT MODEL; MILD; EXPOSURE	Traumatic brain injury sustained after blast exposure (blast-induced TBI) has recently been documented as a growing issue for military personnel. Incidence of injury to organs such as the lungs has decreased, though current epidemiology still causes a great public health burden. In addition, unprotected civilians sustain primary blast lung injury (PBLI) at alarming rates. Often, mild-to-moderate cases of PBLI are survivable with medical intervention, which creates a growing population of survivors of blast-induced polytrauma (BPT) with symptoms from blast-induced mild TBI (mTBI). Currently, there is a lack of preclinical models simulating BPT, which is crucial to identifying unique injury mechanisms of BPT and its management. To meet this need, our group characterized a rodent model of BPT and compared results to a blast-induced mTBI model. Open field (OF) performance trials were performed on rodents at 7 days after injury. Immunohistochemistry was performed to evaluate cellular outcome at day seven following BPT. Levels of reactive astrocytes (GFAP), apoptosis (cleaved caspase-3 expression), and vascular damage (SMI-71) were significantly elevated in BPT compared to blast-induced mTBI. Downstream markers of hypoxia (HIF-1 alpha and VEGF) were higher only after BPT. This study highlights the need for unique therapeutics and prehospital management when handling BPT.	[Hubbard, W. Brad; Norris, Carly; Eck, Joseph; VandeVord, Pamela] Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Greenberg, Shaylen] Virginia Tech, Translat Biol Med & Hlth, Blacksburg, VA 24061 USA; [Lavik, Erin] Univ Maryland Baltimore Cty, Dept Chem Biochem & Environm Engn, Baltimore, MD 21250 USA; [VandeVord, Pamela] Salem VAMC, Res Serv, Salem, VA 24153 USA		VandeVord, P (corresponding author), Virginia Tech, Biomed Engn & Mech, Blacksburg, VA 24061 USA.; VandeVord, P (corresponding author), Salem VAMC, Res Serv, Salem, VA 24153 USA.	pvord@vt.edu		VandeVord, Pamela/0000-0003-3422-2704; Norris, Carly/0000-0002-0654-0214	DOD CDMRP Program [W81XWH11- 1-0014]	The authors would like to thank Dr. Michael Urban, Zachary Bailey, Bryce Dunn, and Ryan Brady for their technical assistance during blast testing. They would like to acknowledge funding support by the DOD CDMRP Program W81XWH11- 1-0014.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; CDC, 2006, BOMB INJ PATT CAR BL; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Darwish H, 2014, BRAIN INJURY, V28, P211, DOI 10.3109/02699052.2013.862737; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Gean A. D., 2014, BRAIN INJURY APPL WA; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; Hampton Carolyn E, 2012, Biomed Sci Instrum, V48, P157; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; HIRSCH M, 1969, Clinical Radiology, V20, P362, DOI 10.1016/S0009-9260(69)80087-5; Huang E, 2013, BRAIN RES, V1529, P125, DOI 10.1016/j.brainres.2013.06.042; Hubbard WB, 2015, ACS MACRO LETT, V4, P387, DOI 10.1021/acsmacrolett.5b00061; Hubbard William Brad, 2014, Biomed Sci Instrum, V50, P92; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kirkman E, 2011, PHILOS T R SOC B, V366, P286, DOI 10.1098/rstb.2010.0249; Kovesdi E., 2012, FRONT NEUROL, V3; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Liao G. P., 2017, NEUROTRAUMA MANAGEME, P51; Lin BW, 2000, BRAIN RES, V865, P237, DOI 10.1016/S0006-8993(00)02228-9; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mohaddes G, 2017, EXP PHYSIOL, V102, P376, DOI 10.1113/EP086068; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Neigh GN, 2010, J CEREBR BLOOD F MET, V30, P1100, DOI 10.1038/jcbfm.2010.46; Ogunshola OO, 2012, HIGH ALT MED BIOL, V13, P153, DOI 10.1089/ham.2012.1052; Okada S, 1998, RADIAT RES, V150, P304, DOI 10.2307/3579980; Pelz J, 2013, EUR J HISTOCHEM, V57, P255, DOI 10.4081/ejh.2013.e38; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Pizov R, 1999, CHEST, V115, P165, DOI 10.1378/chest.115.1.165; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rajkowska G, 2013, BIOL PSYCHIAT, V73, P613, DOI 10.1016/j.biopsych.2012.09.024; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Thelin E. P., 2016, FRONTIERS NEUROLOGY, V7; Toyinbo PA, 2017, AM J EPIDEMIOL, V185, P135, DOI 10.1093/aje/kww074; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Westin JE, 2006, J NEUROSCI, V26, P9448, DOI 10.1523/JNEUROSCI.0944-06.2006; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhang HT, 2017, MOL MED REP, V15, P57, DOI 10.3892/mmr.2016.5974	72	9	10	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2017	2017									10.1155/2017/5175249			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EQ7GE	WOS:000398251700001	28424745	Green Submitted, Green Published, gold			2022-02-06	
J	Katyal, N; Sarwal, A; George, P; Banik, B; Newey, CR				Katyal, Nakul; Sarwal, Aarti; George, Pravin; Banik, Biswajit; Newey, Christopher R.			The Relationship of Triphasic Waves with Intracranial Pressure as a Possible Prognostic Marker in Traumatic Brain Injury	CASE REPORTS IN NEUROLOGICAL MEDICINE			English	Article							CONTINUOUS ELECTROENCEPHALOGRAPHY; HEPATIC-ENCEPHALOPATHY; PLATEAU WAVES; PATTERNS; EEG	Background. Continuous electroencephalography (CEEG) monitoring is used for detection of convulsive and nonconvulsive seizures and assessing the degree of encephalopathy in critically ill patients. A commonly seen encephalopathic pattern on CEEG is generalized periodic discharges with triphasic wave (TW) morphology. The underlying role and prognostic significance of TW in relationship to intracranial pressure (ICP) remain unknown. We present a case highlighting the relationship of TW with ICP in a case with severe traumatic brain injury (TBI). Method. Case report. Results. A patient with severe TBI and no underlying metabolic abnormalities was admitted to the neurocritical care unit. TW were seen on CEEG. The TW diminished during episodes of intracranial hypertension but reappeared with reduction of the intracranial pressure. Conclusion. This study highlights a possible favorable prognostic marker of finding TW in a patient with intracranial hypertension. We have proposed a preliminary understanding of the relationship between TW and intracranial hypertension, which may be helpful in formulating future studies involving larger cohorts.	[Katyal, Nakul; Banik, Biswajit; Newey, Christopher R.] Univ Missouri, Dept Neurol, 5 Hosp Dr,CE 540, Columbia, MO 65211 USA; [Sarwal, Aarti] Wake Forest Univ, Bowman Gray Sch Med, Neurol & Crit Care Anesthesia, Reynolds M,Med Ctr Blvd, Winston Salem, NC 27157 USA; [George, Pravin; Newey, Christopher R.] Cleveland Clin, Cerebrovasc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA		Newey, CR (corresponding author), Univ Missouri, Dept Neurol, 5 Hosp Dr,CE 540, Columbia, MO 65211 USA.; Newey, CR (corresponding author), Cleveland Clin, Cerebrovasc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	neweyc@ccf.org	Sarwal, A./I-2139-2019	Katyal, Nakul/0000-0003-0249-1707			Ahboucha S, 2004, METAB BRAIN DIS, V19, P331, DOI 10.1023/B:MEBR.0000043979.58915.41; Bermeo-Ovalle A, 2017, EPILEPSY CURR, V17, P40, DOI 10.5698/1535-7511-17.1.40; BICKFORD RG, 1955, J CLIN INVEST, V34, P790, DOI 10.1172/JCI103134; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; EVANS BM, 1976, J NEUROL NEUROSUR PS, V39, P392, DOI 10.1136/jnnp.39.4.392; Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kamel H, 2013, NEUROCRIT CARE, V19, P336, DOI 10.1007/s12028-012-9736-7; KARNAZE DS, 1984, ELECTROEN CLIN NEURO, V57, P193, DOI 10.1016/0013-4694(84)90120-2; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; McGrail KM, 1996, NEUROSURG CLIN N AM, V7, P685; Newey CR, 2013, NEUROCRIT CARE, V18, P261, DOI 10.1007/s12028-011-9650-4; O'Rourke D, 2016, NEUROCRIT CARE, V24, P233, DOI 10.1007/s12028-015-0151-8; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Rosner M. J., 1986, VASODILATORY CASCADE; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Schneider A. L., 2005, AM J ELECTRONEUROD T, V45, P102; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Sutter R, 2013, CLIN NEUROPHYSIOL, V124, P1952, DOI 10.1016/j.clinph.2013.03.031	20	9	9	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-6668	2090-6676		CASE REP NEUROL MED	Case Rep. Neurol. Med.		2017	2017								4742026	10.1155/2017/4742026			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FO0ST	WOS:000416459200001	29318067	Green Submitted, Green Published, gold			2022-02-06	
J	Kesinger, MR; Kumar, RG; Ritter, AC; Sperry, JL; Wagner, AK				Kesinger, Matthew Ryan; Kumar, Raj Gopalan; Ritter, Anne Connelly; Sperry, Jason Lee; Wagner, Amy Kathleen			Probabilistic Matching Approach to Link Deidentified Data from a Trauma Registry and a Traumatic Brain Injury Model System Center	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Probabilistic Linkage; TBI; Trauma; Rehabilitation; Trauma Registry; TBI Model System	RECORD LINKAGE; HEALTH; BIRTH; TOOL	Objective: There is no civilian traumatic brain injury database that captures patients in all settings of the care continuum. The linkage of such databases would yield valuable insight into possible care interventions. Thus, the objective of this article is to describe the creation of an algorithm used to link the Traumatic Brain Injury Model System (TBIMS) to trauma data in state and national trauma databases. Design: The TBIMS data from a single center was randomly divided into two sets. One subset was used to generate a probabilistic linking algorithm to link the TBIMS data to the center's trauma registry. The other subset was used to validate the algorithm. Medical record numbers were obtained and used as unique identifiers to measure the quality of the linkage. Novel methods were used to maximize the positive predictive value. Results: The algorithmgeneration subset had 121 patients. It had a sensitivity of 88% and a positive predictive value of 99%. The validation subset consisted of 120 patients and had a sensitivity of 83% and a positive predictive value of 99%. Conclusions: The probabilistic linkage algorithm can accurately link TBIMS data across systems of trauma care. Future studies can use this database to answer meaningful research questions regarding the long-term impact of the acute trauma complex on health care utilization and recovery across the care continuum in traumatic brain injury populations.	[Kesinger, Matthew Ryan; Sperry, Jason Lee] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Kumar, Raj Gopalan; Ritter, Anne Connelly; Wagner, Amy Kathleen] Univ Penn, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Kumar, Raj Gopalan; Ritter, Anne Connelly] Univ Penn, Dept Epidemiol, Philadelphia, PA 19104 USA; [Wagner, Amy Kathleen] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Wagner, Amy Kathleen] Univ Penn, Safar Ctr Resuscitat Res, Philadelphia, PA 19104 USA		Wagner, AK (corresponding author), Univ Pittsburgh, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15237 USA.; Sperry, JL (corresponding author), Univ Pittsburgh, Med Ctr, 200 Lothrop St,Suite F1268 PUH, Pittsburgh, PA 15213 USA.				NIDILRRUnited States Department of Health & Human Services [90DP0041-02-01, TL1TR000005]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23GM093032, 2R25 MH054318]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH054318] Funding Source: NIH RePORTER	Supported in part by NIDILRR 90DP0041-02-01 (primary investigator: A.K. Wagner), TL1TR000005, NIH K23GM093032, and NIH 2R25 MH054318.	Bentley JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-149; Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246; Clark D E, 1993, Proc Annu Symp Comput Appl Med Care, P654; Dean JM, 2001, ANN EMERG MED, V37, P616, DOI 10.1067/mem.2001.115214; Fair M, 2000, Chronic Dis Can, V21, P8; FERRANTE AM, 1993, ACCIDENT ANAL PREV, V25, P659, DOI 10.1016/0001-4575(93)90031-Q; Grannis Shaun J, 2003, AMIA Annu Symp Proc, P259; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Herman AA, 1997, PAEDIATR PERINAT EP, V11, P5, DOI 10.1046/j.1365-3016.11.s1.11.x; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Mann NC, 2006, ACAD EMERG MED, V13, P946, DOI 10.1197/j.aem.2006.04.019; Mason CA, 2008, BIRTH DEFECTS RES A, V82, P812, DOI 10.1002/bdra.20510; Meray N, 2007, J CLIN EPIDEMIOL, V60, P883, DOI 10.1016/j.jclinepi.2006.11.021; Patterson L, 1996, Am J Med Qual, V11, pS73; Sayers A, 2016, INT J EPIDEMIOL, V45, P954, DOI 10.1093/ije/dyv322; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Zhang YJ, 2012, MATERN CHILD HLTH J, V16, P1703, DOI 10.1007/s10995-011-0877-7	22	9	9	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2017	96	1					17	24		10.1097/PHM.0000000000000513			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EG0CR	WOS:000390699000008	27088479	Green Accepted			2022-02-06	
J	Koshida, S; Ishii, T; Matsuda, T; Hashimoto, T				Koshida, Sentaro; Ishii, Takanori; Matsuda, Tadamitsu; Hashimoto, Toshihiko			Kinematics of judo breakfall for osoto-gari: Considerations for head injury prevention	JOURNAL OF SPORTS SCIENCES			English	Article						Judo; martial arts; head concussion; motion analysis; injury prevention	BIOMECHANICAL ANALYSIS; ICE HOCKEY; CONCUSSION; SPORT; FALL; STATEMENT; SEVERITY; STRENGTH; PLAYERS; TRAUMA	Previous studies suggest that increasing the skill level of judokas will decrease the number of head injuries sustained during judo. However, the kinematics are poorly understood, making it difficult to establish an effective breakfall teaching programme. Therefore, we studied the kinematic parameters of breakfall for osoto-gari to identify the risk of judo-related head injuries by comparing experienced and novice judokas. This information will provide insight into developing a better prevention plan for judo-related head injuries. A total of 10 experienced and 12 novice judokas volunteered to participate in this study. The kinematic data of the breakfall motion for osoto-gari were collected using a three-dimensional motion analysis technique (200 Hz). We observed a significantly higher peak neck extension momentum in the novice group than in the experienced group. This suggests that neck extension momentum during breakfall is associated with the risk of head injuries during judo. In addition, the novice judokas demonstrated a significantly greater flexed pattern in the trunk and hip movement than the experienced judokas (P < 0.05). The results suggest that the trunk and lower extremity motion are important kinematic parameters that determine the skill level in performing the breakfall for osoto-gari.	[Koshida, Sentaro; Hashimoto, Toshihiko] Ryotokuji Univ, Fac Hlth Sci, 5-8-1 Akemi, Urayasu, Chiba 2798567, Japan; [Ishii, Takanori] Ryotokuji Univ, Ctr Liberal Arts, Urayasu, Chiba, Japan; [Ishii, Takanori] Univ Tsukuba, Doctoral Program Phys Educ Hlth & Sport Sci, Urayasu, Chiba, Japan; [Matsuda, Tadamitsu] Uekusa Gakuen Univ, Fac Hlth Sci, Wakaba Ku, Chiba, Chiba, Japan		Koshida, S (corresponding author), Ryotokuji Univ, Fac Hlth Sci, 5-8-1 Akemi, Urayasu, Chiba 2798567, Japan.	koshida@ryotokuji-u.ac.jp	Koshida, Sentaro/AAP-2471-2020; Koshida, Sentaro/ABA-6877-2020	Koshida, Sentaro/0000-0003-3592-1742; Ishii, Takanori/0000-0002-6626-9294			Ae, 1996, J SPORTS SCI, V15, P155; Aiba K., 2012, T JAPAN SOC MECH ENG, V78, P30; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Cohen J., 2013, STAT POWER ANAL BEHA; Groen BE, 2007, J BIOMECH, V40, P458, DOI 10.1016/j.jbiomech.2005.12.014; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hashimoto T, 2015, J SPORT SCI, V33, P1356, DOI 10.1080/02640414.2014.990482; Hitosugi M, 2014, BIOMED RES-TOKYO, V35, P339, DOI 10.2220/biomedres.35.339; Imamura Rodney, 2003, Sports Biomech, V2, P191, DOI 10.1080/14763140308522817; Ishii T., 2012, P 30 INT C BIOM SPOR, P193; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Kano J., 1994, KODOKAN JUDO ESSENTI; Koshida S., 2016, 21 ANN C EUR COLL SP; Koshida S, 2014, ARCH BUDO, V10, P187; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; Kurabayashi J., 2003, J SOC BIOMECH, V27, P29, DOI [DOI 10.3951/S0BIM.27.29, 10.3951/sobim.27.29, DOI 10.3951/SOBIM.27.29]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Miyazaki S, 2012, TOKAI J SPORTS MED S, V24, P173; Murayama H, 2014, NEUROL MED-CHIR, V54, P374, DOI 10.2176/nmc.oa.2013-0227; Murayama H, 2013, NEUROL MED-CHIR, V53, P580; Nagahiro Shinji, 2011, No Shinkei Geka, V39, P1139; Nambu S, 2014, CURR SPORT MED REP, V13, P11, DOI 10.1249/JSR.0000000000000024; Nishimura K, 1988, Neurol Med Chir (Tokyo), V28, P991, DOI 10.2176/nmc.28.991; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Robinovitch SN, 2004, J BIOMECH, V37, P1329, DOI 10.1016/j.jbiomech.2003.12.015; Sandler R, 2001, J BIOMECH ENG-T ASME, V123, P590, DOI 10.1115/1.1408940; Souza M, 2006, SCI SPORT, V21, P280, DOI 10.1016/j.scispo.2006.06.002; Suzuki Y, 2014, SPORT BIOMECH, V13, P144, DOI 10.1080/14763141.2014.910264; Tangi H. P., 1995, JAPAN J PHYS ED, V40, P161; van der Zijden AM, 2012, J BIOMECH, V45, P1650, DOI 10.1016/j.jbiomech.2012.03.024	32	9	9	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2017	35	11					1059	1065		10.1080/02640414.2016.1210194			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EO5YV	WOS:000396769800005	27444196				2022-02-06	
J	Leveille, E; Guay, S; Blais, C; Scherzer, P; De Beaumont, L				Leveille, Edith; Guay, Samuel; Blais, Caroline; Scherzer, Peter; De Beaumont, Louis			Sex-Related Differences in Emotion Recognition in Multi-concussed Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Sport; Concussion; Emotional facial expression; Gender differences; Anxiety; Depression	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; PROFESSIONAL FOOTBALL PLAYERS; BILATERAL AMYGDALA DAMAGE; II PSYCHIATRIC-DISORDERS; MEDIAL TEMPORAL-LOBE; STATES HIGH-SCHOOL; FACIAL EXPRESSIONS; LONG-TERM; RECURRENT CONCUSSION	Objectives: Concussion is defined as a complex pathophysiological process affecting the brain. Although the cumulative and long-term effects of multiple concussions are now well documented on cognitive and motor function, little is known about their effects on emotion recognition. Recent studies have suggested that concussion can result in emotional sequelae, particularly in females and multi-concussed athletes. The objective of this study was to investigate sex-related differences in emotion recognition in asymptomatic male and female multi-concussed athletes. Methods: We tested 28 control athletes (15 males) and 22 multi-concussed athletes (10 males) more than a year since the last concussion. Participants completed the Post-Concussion Symptom Scale, the Beck Depression Inventory-II, the Beck Anxiety Inventory, a neuropsychological test battery and a morphed emotion recognition task. Pictures of a male face expressing basic emotions (anger, disgust, fear, happiness, sadness, surprise) morphed with another emotion were randomly presented. After each face presentation, participants were asked to indicate the emotion expressed by the face. Results: Results revealed significant sex by group interactions in accuracy and intensity threshold for negative emotions, together with significant main effects of emotion and group. Conclusions: Male concussed athletes were significantly impaired in recognizing negative emotions and needed more emotional intensity to correctly identify these emotions, compared to same-sex controls. In contrast, female concussed athletes performed similarly to same-sex controls. These findings suggest that sex significantly modulates concussion effects on emotional facial expression recognition.	[Leveille, Edith; Scherzer, Peter] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Leveille, Edith; De Beaumont, Louis] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Guay, Samuel; De Beaumont, Louis] Univ Quebec Trois Rivieres, Dept Psychol, CP 5000, Trois Rivieres, PQ G9A 5H7, Canada; [Blais, Caroline] Univ Quebec Outaouais, Dept Psychoeduc & Psychol, Gatineau, PQ, Canada		De Beaumont, L (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, CP 5000, Trois Rivieres, PQ G9A 5H7, Canada.	louis.debeaumont@uqtr.ca		Guay, Samuel/0000-0001-6990-839X	Fonds de recherche du Quebec	The authors declare no conflict of interests. This work was supported by the Fonds de recherche du Quebec awarded to EL and LDB. The authors thank Andre Achim and Jean Begin for their advices on statistical analyses.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 1999, NEUROSCIENTIST, V5, P125, DOI 10.1177/107385849900500216; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Beck A., 1996, BECK DEPRESSION INVE; Beck AT, 1993, BECK ANXIETY INVENTO; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bishop SJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00152; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Campbell R, 2002, NEUROPSYCHOLOGIA, V40, P575, DOI 10.1016/S0028-3932(01)00164-6; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chayer C, 2001, Curr Neurol Neurosci Rep, V1, P547, DOI 10.1007/s11910-001-0060-4; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Derntl B, 2008, PSYCHONEUROENDOCRINO, V33, P1031, DOI 10.1016/j.psyneuen.2008.04.014; Derntl B, 2008, HORM BEHAV, V53, P90, DOI 10.1016/j.yhbeh.2007.09.006; Deschenes A., 2015, J VISION, V15, P1383, DOI DOI 10.1167/15.12.1383; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Guapo VG, 2009, PSYCHONEUROENDOCRINO, V34, P1087, DOI 10.1016/j.psyneuen.2009.02.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Harmer CJ, 2002, BIOL PSYCHIAT, V51, P298, DOI 10.1016/S0006-3223(01)01249-5; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kosaka B., 2006, BRIT COLOMBIA MEDICA, V48, P447; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Larson-Dupuis C, 2015, BRAIN INJURY, V29, P963, DOI 10.3109/02699052.2015.1016452; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mareckova K, 2014, SOC COGN AFFECT NEUR, V9, P191, DOI 10.1093/scan/nss128; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Pearson R, 2005, HORM BEHAV, V47, P267, DOI 10.1016/j.yhbeh.2004.11.003; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rahman Q, 2004, BRAIN COGNITION, V54, P179, DOI 10.1016/j.bandc.2004.01.002; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Richards A, 2002, EMOTION, V2, P273, DOI 10.1037/1528-3542.2.3.273; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stuss D. T., 1997, CONT BEHAV NEUROLOGY, V16, P348; Tardif J., 2014, J VISION, V14, P1444; Tardif J., 2014, SLEEP A, V89; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Trojian T, 2016, BRIT J SPORT MED, V50, P137, DOI 10.1136/bjsports-2015-095582; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	130	9	9	0	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2017	23	1					65	77		10.1017/S1355617716001004			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	EL4GS	WOS:000394580300007	27974074				2022-02-06	
J	Meireles, ALF; Marques, MR; Segabinazi, E; Spindler, C; Piazza, FV; Salvalaggio, GS; Augustin, OA; Achaval, M; Marcuzzo, S				Meireles, Andre L. F.; Marques, Marilia R.; Segabinazi, Ethiane; Spindler, Christiano; Piazza, Francele V.; Salvalaggio, Gabriela S.; Augustin, Otavio A.; Achaval, Matilde; Marcuzzo, Simone			Association of environmental enrichment and locomotor stimulation in a rodent model of cerebral palsy: Insights of biological mechanisms	BRAIN RESEARCH BULLETIN			English	Article						Functional recovery; Early stimulation; Bone analysis; Immunohistochemistry; Treadmill walking; Muscle assays	MEDIATED FUNCTIONAL IMPROVEMENT; TRAUMATIC BRAIN-INJURY; BONE-MINERAL DENSITY; GROSS MOTOR FUNCTION; CHILDREN; RATS; GAIT; INTERVENTION; SENSORIMOTOR; WALKING	Several physiotherapy approaches are used with different aims in the treatment of cerebral palsy (CP), such as the early stimulation and the locomotor training, but their biological effects, isolated or combined, are not completely known. In animals models, these strategies can be compared, with due translational restrictions, to the environmental enrichment (EE), that involves the enhancement of animal's physical and social environment, and locomotor stimulation (LS), that can be performed using the treadmill adapted for rats. This study was designed to describe which biological and functional mechanisms underlying rehabilitative process in clinical practice. Male rat pups were initially divided in two groups: control (healthy) and submitted to a CP model. Then, pups were divided in eight groups: CP, CPEE, CPLS, CPEELS and its respectively control groups. Functional outcomes were assessed at the postnatal day (P) 31 and P52. The tibialis anterior and soleus muscles, tibia bone parameters, the expression of synaptophysin in the primary motor cortex (M1) and ventral horn (VH) of the spinal cord, were evaluated. The association of therapies was able to improve the functional assessments and musculoskeletal parameters. Isolated therapies presented complementary benefits in CP, but the association of therapies proved to be a fundamental and effective strategy to functional recovery, besides alter positively all biological tissues evaluated in this study. (C) 2016 Published by Elsevier Inc.	[Meireles, Andre L. F.; Marques, Marilia R.; Segabinazi, Ethiane; Spindler, Christiano; Piazza, Francele V.; Achaval, Matilde; Marcuzzo, Simone] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Neurociencias, Porto Alegre, RS, Brazil; [Meireles, Andre L. F.; Marques, Marilia R.; Segabinazi, Ethiane; Spindler, Christiano; Piazza, Francele V.; Salvalaggio, Gabriela S.; Augustin, Otavio A.; Achaval, Matilde; Marcuzzo, Simone] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Ciencias Morfol, Lab Histofisiol Comparada, Porto Alegre, RS, Brazil		Marcuzzo, S (corresponding author), 134 Univ Fed Rio Grande Sul, Inst Ciencias Basicas Saude, Lab Histofisiol Comparada, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.	simone.marcuzzo@ufrgs.br	Segabinazi, Ethiane/AAA-1004-2021; de Meireles, Andre Luis Ferreira/O-5579-2019; Segabinazi, Ethiane/AAA-1480-2021	Segabinazi, Ethiane/0000-0003-0834-9728; de Meireles, Andre Luis Ferreira/0000-0002-1751-5022; spindler, christiano/0000-0002-4901-656X	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPERGSFundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [002097-2552/13-6-1]	We are very grateful to PhD Matilde Achaval, founder of the Laboratorio Histofisiologia Comparada, for the laboratory's structure. We also thank Maria Augusta Timmen for the graphical abstract assistance. This work was supported by the Brazilian funding agencies: CNPq, CAPES and FAPERGS (002097-2552/13-6-1). A.L.F. Meireles is supported by a scholarship from CNPq and M. Achaval is a CNPq investigator.	Aisen ML, 2011, LANCET NEUROL, V10, P844, DOI 10.1016/S1474-4422(11)70176-4; Blauw-Hospers CH, 2005, DEV MED CHILD NEUROL, V47, P421, DOI 10.1017/S0012162205000824; Callaghan M. E., 2011, OBSTET GYNECOLOGY, V118, P576; Caulton JM, 2004, ARCH DIS CHILD, V89, P131, DOI 10.1136/adc.2002.009316; Cherng RJ, 2007, AM J PHYS MED REHAB, V86, P548, DOI 10.1097/PHM.0b013e31806dc302; Cho C, 2016, TOHOKU J EXP MED, V238, P213, DOI 10.1620/tjem.238.213; Clowry GJ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00258; Damiano DL, 2006, PHYS THER, V86, P1534, DOI 10.2522/ptj.20050397; Girard S., 2008, NEUROSCIENCE, V2008, P673; Graham HK, 2003, J BONE JOINT SURG BR, V85B, P157, DOI 10.1302/0301620X.85B2.14066; Hadder-Algra M., 2001, NEURAL PLAS, V31; Herskind A, 2015, DEV MED CHILD NEUROL, V57, P29, DOI 10.1111/dmcn.12531; Hoeger H, 2000, LIFE SCI, V66, P947, DOI 10.1016/S0024-3205(99)00678-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Jansen EM, 1996, BEHAV BRAIN RES, V78, P189, DOI 10.1016/0166-4328(95)00248-0; Keogh JM, 2006, CURR OPIN NEUROL, V19, P129, DOI 10.1097/01.wco.0000218227.35560.0d; Kline AE, 2010, J NEUROTRAUM, V12, P289; Krigger KW, 2006, AM FAM PHYSICIAN, V73, P91; Li JY, 2014, J NEUROPHYSIOL, V111, P2061, DOI 10.1152/jn.00475.2013; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Majnemer A, 2002, CHILD CARE HLTH DEV, V28, P29, DOI 10.1046/j.1365-2214.2002.00237.x; Marcuzzo S, 2008, BRAIN RES, V1222, P129, DOI 10.1016/j.brainres.2008.05.042; Marques MR, 2014, BEHAV BRAIN RES, V263, P149, DOI 10.1016/j.bbr.2014.01.007; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Metz G. A., 2009, JOVE-J VIS EXP, V12, P28; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Patel Dilip R., 2005, Indian Journal of Pediatrics, V72, P979, DOI 10.1007/BF02731676; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Piazza F, 2014, METAB BRAIN DIS, V29, P93, DOI 10.1007/s11011-013-9467-2; Plane JM, 2008, EXP NEUROL, V214, P125, DOI 10.1016/j.expneurol.2008.08.006; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Stark C, 2010, J MUSCULOSKEL NEURON, V10, P151; Stigger F, 2011, INT J DEV NEUROSCI, V29, P833, DOI 10.1016/j.ijdevneu.2011.09.002; Stigger F, 2011, EXP NEUROL, V228, P183, DOI 10.1016/j.expneurol.2011.01.001; Swe N. N., 2015, CLIN REHABIL, P1; Willerslev-Olsen M, 2015, BRAIN, V138, P589, DOI 10.1093/brain/awu399; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002	40	9	9	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JAN	2017	128						58	67		10.1016/j.brainresbull.2016.12.001			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI2XU	WOS:000392354000009	27940102				2022-02-06	
J	Moreno, A; Laoch, A; Zasler, ND				Moreno, Alexander; Laoch, Ari; Zasler, Nathan D.			Changing the culture of neurodisability through language and sensitivity of providers: Creating a safe place for LGBTQIA plus people	NEUROREHABILITATION			English	Article						Neurosexuality; LGBTQIA; LGBT; neurodisability; sexual diversity; gender identity; sexual orientation	GENDER DYSPHORIA; INTELLECTUAL DISABILITIES; SEXUAL ORIENTATION; LESBIAN WOMEN; YOUNG-PEOPLE; GAY; HEALTH; CARE; DEMENTIA; ATTITUDES	BACKGROUND: There is an increasing interest in sexual and gender diversity in neurorehabilitation. Healthcare professionals wanting to improve their practice know the importance of understanding the needs and expectations of specific communities. OBJECTIVE: To critically review the literature about neurological disorders in people who identify as lesbian, gay, bisexual, transgender, queer, intersex, asexual, and people with other sexual orientations and forms of gender expression (LGBTQIA+). METHODS: Systematic search in electronic databases (CINAHL, EMBASE, Medline, PsycINFO, Scopus, and Web of Science) and identification of relevant studies. RESULTS: Quantitative and qualitative findings are summarized and reported by neurological disorders: a) neurodisability/epilepsy (17.7%), b) intellectual disability/autism spectrum disorders (19.6%), c) dementia/HIV-related dementia (39.2%), d) spinal cord injury (7.8%), and e) traumatic brain injury/stroke (15.7%). CONCLUSIONS: LGBTQIA+ people with neurodisabilities and their partners/families of choice can conceal their sexual orientation or gender identity for fear of diminished quality of care. Their invisibility translates into health disparities, lack of policies and services that meet their unique needs. Dementia is the most common neurodisability documented in LGBTQLA+ people. We provide recommendations to increase LGBTQIA+ cultural competency for clinical practice, research, and policy to help different stakeholders to promote a positive change in the culture of neurodisability.	[Moreno, Alexander] Univ Quebec Montreal, Dept Sexol, Fac Human Sci, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada; [Moreno, Alexander] Ctr Interdisciplinary Res Rehabil Greater Montreal, Montreal, PQ, Canada; [Laoch, Ari] Virginia Commonwealth Univ, Richmond, VA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Henrico, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Henrico, VA USA		Moreno, A (corresponding author), Univ Quebec Montreal, Dept Sexol, Fac Human Sci, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	moreno.jhon_alexander@uqam.ca					ACLU, 2017, NOND LAWS STAT STAT; Anetzberger G. J., 2004, CLIN GERONTOLOGIST, V28, P43; [Anonymous], 2016, Nurs Stand, V30, P11, DOI 10.7748/ns.30.35.11.s12; Archibald C., 2006, J DEMENTIA CARE, V14, P21; Bailey JM, 2016, PSYCHOL SCI PUBL INT, V17, P45, DOI 10.1177/1529100616637616; Baird AD, 2007, J NEUROL NEUROSUR PS, V78, P1042, DOI 10.1136/jnnp.2006.107193; Banja J. D., 1993, J HEAD TRAUMA REHAB, V8, P116; Banks ME, 2003, WOMEN THER, V26, pXXIII; Bariola E, 2015, AM J PUBLIC HEALTH, V105, P2108, DOI 10.2105/AJPH.2015.302763; Barrett C, 2015, AUSTRALAS J AGEING, V34, P34, DOI 10.1111/ajag.12271; Barrett M., 1990, PERSPECTIVES DISABIL, P328; Bartos SE, 2014, J SEX RES, V51, P363, DOI 10.1080/00224499.2013.871625; Bashe Patricia Romanowski, 2012, Narrat Inq Bioeth, V2, P183, DOI 10.1353/nib.2012.0055; Bauer G., 2012, WHAT DIFFERENCE SEX, P59; Bel Bruno Ron, 2009, Newsweek, V153, P16; BOAST N, 1994, BRIT J PSYCHIAT, V164, P842, DOI 10.1192/bjp.164.6.842; Burch A., 2005, HLTH CARE PROVIDERS; Burch A, 2008, PHYS THER, V88, P191, DOI 10.2522/ptj.20060188; Casteel C, 2008, INJURY PREV, V14, P87, DOI 10.1136/ip.2007.016451; Cheasty M, 2002, INT J GERIATR PSYCH, V17, P87, DOI 10.1002/gps.518; Clinical digest, 2005, NURSING STANDARD, V19, P18; Colin O, 2015, JAMA NEUROL, V72, P1209, DOI 10.1001/jamaneurol.2015.2128; DeHope E., 2006, CASE STUDIES SEXUAL, P44; Dorsen C, 2016, J CLIN NURS, V25, P3716, DOI 10.1111/jocn.13464; Dworkin S. H., 2012, CASEBOOK COUNSELING; El-Ghoroury Nabil Hassan, 2012, Narrat Inq Bioeth, V2, P189, DOI 10.1353/nib.2012.0056; Elk, 2015, CANC LGBT COMMUNITY; Esmail S, 2010, DISABIL REHABIL, V32, P1148, DOI 10.3109/09638280903419277; Farace D., 2010, GREY LIT LIB INFORM; Glidden Derek, 2016, Sex Med Rev, V4, P3, DOI 10.1016/j.sxmr.2015.10.003; Goldberg A.E., 2013, LGBT PARENT FAMILIES; Harley D. A, 2016, HDB LGBT ELDERS I IN, DOI [10.1007/978-3-319-03623-6, DOI 10.1007/978-3-319-03623-6]; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgs R, 2000, J MED ETHICS, V26, P61, DOI 10.1136/jme.26.1.61; HUNTER R, 1967, J NEUROL SCI, V4, P357, DOI 10.1016/0022-510X(67)90114-1; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; International panel of experts, 2007, YOG PRINC PRINC APPL; IPsyNet, 2017, INT PSYCH NETW LESB; Jacobs LA, 2014, LGBT HEALTH, V1, P277, DOI 10.1089/lgbt.2013.0045; Jawad S, 2009, J NEUROPSYCH CLIN N, V21, P353, DOI 10.1176/appi.neuropsych.21.3.353; Knocker S., 2006, J DEMENTIA CARE, V14, P22; Lapinski J, 2014, J AM OSTEOPATH ASSOC, V114, P788, DOI 10.7556/jaoa.2014.153; Levounis P., 2012, THE LGBT CASE BOOK; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; Marshall Z, 2012, J EMPIR RES HUM RES, V7, P20, DOI 10.1525/jer.2012.7.4.20; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; McCann E, 2016, RES DEV DISABIL, V57, P39, DOI 10.1016/j.ridd.2016.06.013; McClelland A, 2012, J HOMOSEXUAL, V59, P808, DOI 10.1080/00918369.2012.694760; McGovern J, 2014, J GERONTOL SOC WORK, V57, P845, DOI 10.1080/01634372.2014.900161; Meadows J, 1999, AIDS PATIENT CARE ST, V13, P47, DOI 10.1089/apc.1999.13.47; Meyer I. H., 2014, PSYCHOL SEX ORIENTAT, V1, P348, DOI DOI 10.1037/SGD0000070; Meyer IH, 2007, HLTH SEXUAL MINORITI; Miller E., 2004, SCI PSYCHOSOCIAL PRO, V17, P126; Miracle A. W., 2009, SEXUALITY LATE ADULT, V3rd, P409; Moore WR, 2002, J GAY LESBIAN SOCIAL, V14, P23, DOI DOI 10.1300/J041V14N03_; Moorley C, 2016, J CLIN NURS, V25, P3413, DOI 10.1111/jocn.13596; Moreno A., 2016, PSYCHOL SEXUALITIES, V7, P11; Moreno JA, 2015, J CROSS-CULT GERONTO, V30, P393, DOI 10.1007/s10823-015-9270-0; Moriarty J., 2003, DEMENTIA, V2, P133; Morris C, 2013, DEV MED CHILD NEUROL, V55, P1103, DOI 10.1111/dmcn.12218; Munson S, 2016, J CLIN NURS, V25, P3497, DOI 10.1111/jocn.13364; Murphy TF, 2003, HASTINGS CENT REP, V33, P15, DOI 10.2307/3528631; Newman R, 2005, PSYCHIATR BULL, V29, P266, DOI 10.1192/pb.29.7.266; Newsom Cassandra R, 2012, Narrat Inq Bioeth, V2, P199, DOI 10.1353/nib.2012.0057; Nosek MA, 2001, SEX DISABIL, V19, P5, DOI 10.1023/A:1010716820677; O'Dell M. W., 2001, BRAIN INJ SOURCE, V5, P22; Parkinson J, 2015, AUSTRALAS PSYCHIATRY, V23, P166, DOI 10.1177/1039856214568223; Parsi Kayhan, 2012, Narrat Inq Bioeth, V2, P207, DOI 10.1353/nib.2012.0058; Price E., 2003, J DEMENTIA CARE, V11, P38; Price E, 2008, BRIT J SOC WORK, V38, P1337, DOI 10.1093/bjsw/bcm027; Price E, 2012, AGEING SOC, V32, P516, DOI 10.1017/S0144686X11000560; Price E, 2011, BRIT J SOC WORK, V41, P1288, DOI 10.1093/bjsw/bcr015; Price E, 2010, HEALTH SOC CARE COMM, V18, P160, DOI 10.1111/j.1365-2524.2009.00884.x; Rosendale N, 2015, JAMA NEUROL, V72, P855, DOI 10.1001/jamaneurol.2015.0226; Sabin JA, 2015, AM J PUBLIC HEALTH, V105, P1831, DOI 10.2105/AJPH.2015.302631; Sandel ME, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P915; Sare G, 2007, SEIZURE-EUR J EPILEP, V16, P384, DOI 10.1016/j.seizure.2007.02.007; Saxe A, 2014, SEX DISABIL, V32, P45, DOI 10.1007/s11195-013-9314-8; Skagerberg E, 2015, J AUTISM DEV DISORD, V45, P2628, DOI 10.1007/s10803-015-2413-x; Stotzer RebeccaL., 2014, HDB LGBT COMMUNITIES, P45; Strang JF, 2018, J CLIN CHILD ADOLESC, V47, P105, DOI 10.1080/15374416.2016.1228462; Tallentire L, 2020, J APPL RES INTELLECT, V33, DOI 10.1111/jar.12281; THOMAS PR, 1995, J INTELL DISABIL RES, V39, P454, DOI 10.1111/j.1365-2788.1995.tb00552.x; Umberson D, 2016, J HEALTH SOC BEHAV, V57, P517, DOI 10.1177/0022146516671570; Van der Miesen AIR, 2016, INT REV PSYCHIATR, V28, P70, DOI 10.3109/09540261.2015.1111199; Ward R, 2005, DEMENTIA, P49, DOI DOI 10.1177/1471301205049190; Ward R., 2000, J DEMENTIA CARE, V8, P24; Ward Richard, 2012, LESBIAN GAY BISEXUAL; Williams AR, 2012, J GAY LESBIAN MENT H, V16, P56, DOI 10.1080/19359705.2011.613301; Willis P, 2011, BRIT J SOC WORK, V41, P1304, DOI 10.1093/bjsw/bcr114; Witten TM, 2014, LGBT HEALTH, V1, P24, DOI 10.1089/lgbt.2013.0017; Yarns BC, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0697-y; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P397; 문영래, 2014, [Journal of the Korean Fracture Society, 대한골절학회지], V27, P237	94	9	9	6	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	41	2					375	393		10.3233/NRE-172187			19	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK2DU	WOS:000413293600009	28946588	Bronze			2022-02-06	
B	Pitkanen, A; Kyyriainen, J; Andrade, P; Pasanen, L; Ndode-Ekane, XE		Pitkanen, A; Buckmaster, PS; Galanopoulou, AS; Moshe, SL		Pitkanen, Asla; Kyyriainen, Jenni; Andrade, Pedro; Pasanen, Lotta; Ndode-Ekane, Xavier Ekolle			Epilepsy After Traumatic Brain Injury	MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION			English	Article; Book Chapter							FLUID PERCUSSION INJURY; CONTROLLED CORTICAL IMPACT; HIPPOCAMPAL CELL LOSS; POSTTRAUMATIC EPILEPSY; SEIZURE SUSCEPTIBILITY; HEAD-INJURY; UNPROVOKED SEIZURES; EXPERIMENTAL-MODELS; RECEPTOR SUBUNITS; OXIDATIVE STRESS		[Pitkanen, Asla; Kyyriainen, Jenni; Andrade, Pedro; Pasanen, Lotta; Ndode-Ekane, Xavier Ekolle] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland.		Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341			Alder J., 2011, JOVE-J VIS EXP, V54, P1; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Andrade P., 2016, J NEUROTRAUMA; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bolkvadze T, 2016, EPILEPSY BEHAV, V60, P187, DOI 10.1016/j.yebeh.2016.04.038; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOW RS, 1962, ELECTROEN CLIN NEURO, V14, P399, DOI 10.1016/0013-4694(62)90116-5; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Eakin K, 2015, BRAIN NEUROTRAUMA MO; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gonzalez-Martinez J., 2016, J NEUROTRAUM, V9, P1; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Gurkoff GG, 2009, NEUROSCIENCE, V164, P862, DOI 10.1016/j.neuroscience.2009.08.021; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Johnson V.E., 2015, ANIMAL MODELS TRAUMA, V127; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; KOPELOFF N, 1950, ELECTROEN CLIN NEURO, V2, P163, DOI 10.1016/0013-4694(50)90029-0; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; LEVASSEUR JE, 1993, J NEUROSURG, V78, P610, DOI 10.3171/jns.1993.78.4.0610; Lidster K, 2016, J NEUROSCI METH, V260, P2, DOI 10.1016/j.jneumeth.2015.09.007; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Saraiva ALL, 2012, BRAIN RES BULL, V87, P180, DOI 10.1016/j.brainresbull.2011.10.010; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Marion D W, 1999, Clin Neurosurg, V45, P184; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ping X., 2016, PLOS ONE, V11, P1; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Schwartzkroin PA, 2010, EPILEPSY RES, V92, P74, DOI 10.1016/j.eplepsyres.2010.08.009; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tai PC, 2004, CAN J NEUROL SCI, V31, P394, DOI 10.1017/S0317167100003516; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wang X, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P5, DOI 10.1145/2983323.2983701; Wang X, 2016, EPILEPSY RES, V128, P35, DOI 10.1016/j.eplepsyres.2016.10.002; Watson NF, 2004, EPILEPSIA, V45, P690, DOI 10.1111/j.0013-9580.2004.59403.x; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Young NH, 2011, NEUROCRIT CARE, V15, P623, DOI 10.1007/s12028-011-9550-7	117	9	9	0	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-804067-6; 978-0-12-804066-9				2017							661	681		10.1016/B978-0-12-804066-9.00046-8			21	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BK5XW	WOS:000439737400047					2022-02-06	
J	Pollandt, S; Ouyang, BC; Bleck, TP; Busl, KM				Pollandt, Sebastian; Ouyang, Bichun; Bleck, Thomas P.; Busl, Katharina M.			Seizures and Epileptiform Discharges in Patients With Acute Subdural Hematoma	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Subdural hematoma; EEG; Seizures; Status epilepticus; Adult; Epileptiform discharges	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; POSTTRAUMATIC SEIZURES; RISK-FACTORS; LEVETIRACETAM; PROPHYLAXIS; PHENYTOIN; PREVALENCE; HEMORRHAGE; EVACUATION	Purpose: Subdural hematomas (SDH) are associated with seizures and epileptiform discharges, but little is known about the prevalence and impact of seizures, status epilepticus (SE), and epileptiform discharges on outcomes in patients with isolated acute SDH (aSDH). Methods: Continuous EEG reports from 76 adult patients admitted to Rush University Medical Center with aSDH between January 2009 and March 2012 were reviewed. Clinical and radiographic findings, comorbidities, treatment, and outcome parameters, such as mortality, discharge destination, need for tracheostomy/percutaneous endoscopic gastrostomy placement, and length of stay (LOS), were assessed. Univariate and multivariate analyses were performed to assess the impact of clinical seizures, SE, and epileptiform EEG on outcomes. Results: Of 76 patients with aSDH who underwent EEG monitoring, 74 (97.4%) received antiseizure prophylaxis. Thirty-two (41.1%) patients had seizures, most of which were clinical seizures. Twenty-four (32%) patients had epileptiform EEG findings. Clinical or nonconvulsive SE was diagnosed in 12 (16%) patients. Clinical seizures were not associated with outcome parameters. Epileptiform EEG findings were independently associated with longer hospital LOS (13 vs. 8 days, P = 0.04) and intensive care unit LOS (10 vs. 4 days, P = 0.002). The SE also predicted longer intensive care unit LOS (10 vs. 4 days, P =0.002). Neither epileptiform EEG nor SE was significantly related to mortality, discharge destination, or need for tracheostomy/ percutaneous endoscopic gastrostomy placement. Conclusions: Seizures and epileptiform EEG findings are very common in patients with aSDH despite antiseizure prophylaxis. While clinical seizures did not affect outcomes, the presence of epileptiform EEG findings and SE was independently associated with longer intensive care unit LOS and hospital LOS.	[Pollandt, Sebastian; Busl, Katharina M.] Rush Univ, Med Ctr, Dept Neurol Sci, Sect Neurocrit Care, 1725 West Harrison St,POB Suite 1106, Chicago, IL 60612 USA; [Ouyang, Bichun; Bleck, Thomas P.] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Bleck, Thomas P.] Rush Univ, Med Ctr, Dept Anesthesiol, Chicago, IL 60612 USA		Pollandt, S (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Sect Neurocrit Care, 1725 West Harrison St,POB Suite 1106, Chicago, IL 60612 USA.	sebastian_pollandt@rush.edu	Bleck, Thomas/R-2286-2019; Pollandt, Sebastian/I-8055-2019; Bleck, Thomas/D-3772-2009	Bleck, Thomas/0000-0002-8267-9787; Pollandt, Sebastian/0000-0003-1540-7439; 			Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Battaglia F, 2012, NEUROCHIRURGIE, V58, P230, DOI 10.1016/j.neuchi.2012.04.002; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Chen CW, 2004, J CLIN NEUROSCI, V11, P706, DOI 10.1016/j.jocn.2004.03.019; CHU NS, 1979, CLIN ELECTROENCEPHAL, V10, P145, DOI 10.1177/155005947901000303; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; D'Amato L, 2007, J Neurosurg Sci, V51, P107; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Hamasaki T, 2013, CLIN NEUROL NEUROSUR, V115, P2336, DOI 10.1016/j.clineuro.2013.08.016; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kondziella D, 2015, NEUROCRIT CARE, V22, P450, DOI 10.1007/s12028-014-0068-7; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Kurtz P, 2014, INTENS CARE MED, V40, P228, DOI 10.1007/s00134-013-3149-8; Mehryar G R, 1975, Bull Los Angeles Neurol Soc, V40, P8; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; Sawauchi S, 2008, ACTA NEUROCHIR, V150, P531, DOI 10.1007/s00701-007-1497-2; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Sutter R, 2016, J CLIN NEUROPHYSIOL, V33, P25, DOI 10.1097/WNP.0000000000000216; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P147, DOI 10.1097/WNP.0000000000000157; Szaflarski JP, 2007, NEUROCRIT CARE, V7, P140, DOI 10.1007/s12028-007-0042-8; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Westmoreland BF, 2001, J CLIN NEUROPHYSIOL, V18, P20, DOI 10.1097/00004691-200101000-00005; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	35	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JAN	2017	34	1					55	60		10.1097/WNP.0000000000000311			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG2EU	WOS:000390856800009	27748723				2022-02-06	
J	Singleton, MD				Singleton, Michael D.			Differential protective effects of motorcycle helmets against head injury	TRAFFIC INJURY PREVENTION			English	Article						Motor vehicle crash; probabilistic record linkage; traumatic brain injury; concussion; skull fracture	BIOMECHANICS; LINKAGE; IMPACT; ACCURACY; VALIDITY; CRASHES; TRAUMA	Background: Although numerous observational studies have demonstrated a protective effect of motorcycle helmets against head injury, the degree of protection against specific head injury types remains unclear. Experimental biomechanics studies involving cadavers, animals, and computer models have established that head injuries have varying etiologies. This retrospective cross-sectional study compared helmet protection against skull fracture, cerebral contusion, intracranial hemorrhage, and cerebral concussion in a consecutive series of motorcycle operators involved in recent traffic crashes in Kentucky.Methods: Police collision reports linked to hospital inpatient and emergency department (ED) claims were analyzed for the period 2008 to 2012. Motorcycle operators with known helmet use who were not killed at the crash scene were included in the study. Helmet use was ascertained from the police report. Skull fracture, cerebral contusion, intracranial hemorrhage, and cerebral concussion were identified from International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes on the claims records. The relative risks of each type of head injury for helmeted versus unprotected operators were estimated using generalized estimating equations.Results: Helmets offer substantial protection against skull fracture (relative risk [RR] = 0.31, 95% confidence interval [CI], 0.23, 0.34), cerebral contusion (RR = 0.29, 95% CI, 0.16, 0.53), and intracranial hemorrhage (RR = 0.47, 95% CI, 0.35, 0.63). The findings pertaining to uncomplicated concussion (RR = 0.80, 95% CI, 0.64, 1.01) were inconclusive. A modest protective effect (20% risk reduction) was suggested by the relative risk estimate, but the 95% confidence interval included the null value.Conclusions: Motorcycle helmets were associated with a 69% reduction in skull fractures, 71% reduction in cerebral contusion, and 53% reduction in intracranial hemorrhage. This study finds that current motorcycle helmets do not protect equally against all types of head injury. Efforts to improve rotational acceleration management in motorcycle helmets should be considered.	[Singleton, Michael D.] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA; [Singleton, Michael D.] Univ Kentucky, Coll Publ Hlth, Kentucky Injury Prevent & Res Ctr, Lexington, KY USA		Singleton, MD (corresponding author), Kentucky Injury Prevent & Res Ctr, 333 Waller Ave,Suite 242, Lexington, KY 40504 USA.	msingle@email.uky.edu			National Highway Traffic Safety Administration [DTNH22-08-H-00302]	This research was partially funded by the National Highway Traffic Safety Administration, cooperative agreement number DTNH22-08-H-00302 (Crash Outcome Data Evaluation System).	Agent K, 2013, KTC138KSP1121F LEX U; Babu ML, 2005, JK SCI, V7, P205; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carter RE, 2009, J DATA SCI, V7, P397; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P429; Clark DE, 2004, INJURY PREV, V10, P186, DOI 10.1136/ip.2003.004580; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; King A. I., 2003, IRCOBI C LISB PORT; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; MacLeod JBA, 2010, J TRAUMA, V69, P1101, DOI 10.1097/TA.0b013e3181f8a9cc; McGlincy MH, 2004, ASA P JOINT STAT M, P4001; McIntosh AS, 2013, J AUSTRALAS COLL ROA, V24, P11; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P835, DOI 10.1080/15389588.2013.774083; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; NEWCOMBE HB, 1959, SCIENCE, V130, P954, DOI 10.1126/science.130.3381.954; PAUL M, 1955, Ann R Coll Surg Engl, V17, P69; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; R Core Team, 2018, R LANGUAGE ENV STAT; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Thibault L., 1971, P 15 STAPP CAR CRASH; Thomas AM, 2012, TRAFFIC INJ PREV, V13, P348, DOI 10.1080/15389588.2012.658480; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; US Department of Transportation NHTSA, 2015, CRASH OUTC DAT EV SY; Viano DC, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P124; Wilson SJ, 2012, ACCIDENT ANAL PREV, V49, P30, DOI 10.1016/j.aap.2011.03.007; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659	41	9	10	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2017	18	4					387	392		10.1080/15389588.2016.1211271			6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	ES2LI	WOS:000399359600009	27585909				2022-02-06	
J	Soltani, Z; Shahrokhi, N; Karamouzian, S; Khaksari, M; Mofid, B; Nakhaee, N; Reihani, H				Soltani, Zahra; Shahrokhi, Nader; Karamouzian, Saeed; Khaksari, Mohammad; Mofid, Behshad; Nakhaee, Nouzar; Reihani, Hamed			Does progesterone improve outcome in diffuse axonal injury?	BRAIN INJURY			English	Article						Diffuse axonal injury; Glasgow coma scale; mortality; progesterone	TRAUMATIC BRAIN-INJURY; SEX STEROID-HORMONES; CLINICAL-TRIAL; DOSE-RESPONSE; INTRACRANIAL-PRESSURE; CEREBRAL-ISCHEMIA; STROKE; EDEMA; EPIDEMIOLOGY; PROTECTS	Background and objective: The benefits of progesterone have been demonstrated in the animal models of-traumatic brain injury (TBI). However, the results of clinical studies are conflicting. Considering the heterogenic nature of TBI, the effect of progesterone in patients with diffuse axonal injury (DAI) was investigated in a clinical trial. Methods: In this study, 48 patients with DAI and Glasgow Coma Scale of 3-12, admitted within 4 hours after injury, were randomly assigned to the progesterone or control group. The dose of progesterone administration was 1 mg kg(-1) per 12 hours for 5 days. The effect of progesterone was investigated using extended-Glasgow Outcome Scale (GOS-E), functional independence measure (FIM) scores and also mortality within the follow-up period. Results: The progesterone group exhibited higher GOS-E and FIM. scores in comparison to the control group at 6 months post-injury (p < 0.01 and p < 0.05, respectively). Mortality was also found in the control group (p < 0.05). The adverse events attributed to the progesterone administration were not found throughout the study. Conclusions: Findings of this study suggest that progesterone may be neuroprotective in patients-with DAI. However, large clinical trials are needed to assess progesterone as a promising drug in DAI.	[Soltani, Zahra] Kerman Univ Med Sci, Afzalipour Sch Med, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Shahrokhi, Nader; Nakhaee, Nouzar] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Karamouzian, Saeed; Mofid, Behshad; Reihani, Hamed] Kerman Univ Med Sci, Dept Neurosurg, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran		Shahrokhi, N (corresponding author), Kerman Univ Med Sci, 22 Bahman Blvd, Kerman 7616914115, Iran.	nshahrokhi@kmu.ac.ir	Nakhaee, Nouzar/AAZ-2677-2020; karamouzian, saeid/ABD-1538-2020; Shahrokhi, Nader/AAV-3747-2020; Soltani, Zahra/AAC-1350-2019; Haddad, Mohammad Khaksari/AAB-9025-2019	Nakhaee, Nouzar/0000-0001-5808-6503; Shahrokhi, Nader/0000-0002-0149-7819; Soltani, Zahra/0000-0002-8423-6189; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Karamouzian, Saeid/0000-0001-6256-0941			ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Faul M, 2010, TRAUMATIC BRAIN INJU; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Goldfien A, 1998, BASIC CLIN PHARM, V4, P493; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; JENNETT B, 1975, LANCET, V305, P480; Johnson V, 2014, HDB CLIN NEUROLOGY, V127, P115; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mungenast AE, 2012, NEURODEGENER DIS, V10, P191, DOI 10.1159/000334602; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schumacher M, 1996, DEV NEUROSCIENCE, V18, P14; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; Stein D., 2014, HDB CLIN NEUROL, V127, P433; Stein DG, 2016, FUTUR NEUROL, V11, P9, DOI 10.2217/fnl.15.49; Stein DG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P162; UNICEF, ROAD TRAFF INJ IR TH; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; ZARROW MX, 1954, J CLIN ENDOCR METAB, V14, P645, DOI 10.1210/jcem-14-6-645	47	9	10	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					16	23		10.1080/02699052.2016.1213421			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600003	27819489				2022-02-06	
B	Stein, DG		Auger, AP; Auger, CJ; Pfaff, DW; Joels, M		Stein, Donald G.			Effects of Sex Steroids on Damaged Neural Systems	HORMONES, BRAIN AND BEHAVIOR, VOL 5: DEVELOPMENT OF HORMONE-BEHAVIOR RELATIONSHIPS, 3RD EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; PROGESTERONE-RECEPTOR ISOFORMS; NEUROTROPHIC FACTOR EXPRESSION; BINDING-PROTEIN 25-DX; MYELIN BASIC-PROTEIN; LONG-TERM OUTCOMES; SPINAL-CORD TRAUMA; INFLAMMATORY RESPONSE		[Stein, Donald G.] Emory Univ, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Atlanta, GA 30322 USA.		Stein, Donald/AAJ-5139-2020				Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Aksoy AN, 2014, INDIAN J PHARMACOL, V46, P622, DOI 10.4103/0253-7613.144922; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Allitt BJ, 2016, J NEUROTRAUM, V33, P375, DOI 10.1089/neu.2015.3946; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Auger CJ, 2002, J NEUROENDOCRINOL, V14, P561, DOI 10.1046/j.1365-2826.2002.00809.x; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; BAULIEU EE, 1997, HORM RES, V52, P1; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; BETZ AL, 1990, ACT NEUR S, V51, P256; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Blaustein JD, 2003, ANN NY ACAD SCI, V1007, P238, DOI 10.1196/annals.1286.023; Bousser MG, 1999, CIRCULATION, V99, P463, DOI 10.1161/01.CIR.99.4.463; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broderick JP, 2015, STROKE, V46, P3416, DOI 10.1161/STROKEAHA.115.011397; Broomall E, 2014, ANN NEUROL, V76, P911, DOI 10.1002/ana.24295; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Bullock R, 1995, GUIDELINES MANAGEMEN; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Cargill RS, 1999, J NEUROTRAUM, V16, P983; Carreira B. P., 2015, CELL LONGEV, V2015, P451; Carswell HVO, 1999, HYPERTENSION, V33, P681, DOI 10.1161/01.HYP.33.2.681; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Cekic M., 2012, RESTOR NEUROL NEUROS, V28, P1; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Cermenati G, 2010, J NEUROSCI, V30, P11896, DOI 10.1523/JNEUROSCI.1898-10.2010; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Chisholm N. C., 2015, NEUROBIOL DIS, V85; Chung LS, 2016, J STROKE CEREBROVASC, V25, P565, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.014; Clua-Espuny JL, 2015, CEREBROVASC DIS EXTR, V5, P95, DOI 10.1159/000440734; Cnossen MC, 2015, J NEUROTRAUMA; Coca-Prados M, 2003, J STEROID BIOCHEM, V86, P207, DOI 10.1016/j.jsbmb.2003.08.001; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Coronel MF, 2011, J PAIN, V12, P71, DOI 10.1016/j.jpain.2010.04.013; Coughlan T, 2005, J NEUROCHEM, V93, P932, DOI 10.1111/j.1471-4159.2005.03068.x; Cubeddu A, 2011, PSYCHONEUROENDOCRINO, V36, P523, DOI 10.1016/j.psyneuen.2010.08.006; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; De Nicola AF, 2013, CNS NEUROL DISORD-DR, V12, P1205; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Deniselle MCG, 2005, EXP NEUROL, V195, P518, DOI 10.1016/j.expneurol.2005.06.015; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Dhir A, 2015, LIFE SCI, V143, P202, DOI 10.1016/j.lfs.2015.09.008; Dietrich W.D., 2015, BRAIN RES; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Dufourny L, 2003, NEUROENDOCRINOLOGY, V77, P51, DOI 10.1159/000068333; Ehring GR, 1998, J EXP MED, V188, P1593, DOI 10.1084/jem.188.9.1593; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Etgen AM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1121; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Fischer H., 2015, MILITARY CASUALTY ST; French J., 2009, NATL GUIDEL CIGH; Fulop Z., 1992, 22 ANN M SOC NEUR AN, P178; Gaignard P, 2016, J CEREBR BLOOD F MET, V36, P562, DOI 10.1177/0271678X15610338; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Ovejero D, 2014, J NEUROTRAUM, V31, P857, DOI 10.1089/neu.2013.3162; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Giatti S, 2012, J NEUROENDOCRINOL, V24, P851, DOI 10.1111/j.1365-2826.2012.02284.x; Giatti S, 2015, STEROIDS, V103, P23, DOI 10.1016/j.steroids.2015.03.014; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2016, J CEREBR BLOOD F MET, V36, P487, DOI 10.1177/0271678X15616782; GIROUD M, 1991, INT J EPIDEMIOL, V20, P892, DOI 10.1093/ije/20.4.892; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Gruber CJ, 2003, MATURITAS, V46, pS71, DOI 10.1016/j.maturitas.2003.09.021; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Guerra-Araiza C, 2002, BRAIN RES BULL, V59, P105, DOI 10.1016/S0361-9230(02)00845-6; Gulinello M, 2003, EUR J NEUROSCI, V17, P641, DOI 10.1046/j.1460-9568.2003.02479.x; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hagedorn KA, 2007, HYPERTENSION, V49, P328, DOI 10.1161/01.HYP.0000253478.51950.27; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; He L, 2014, NEUROCHEM RES, V39, P2251, DOI 10.1007/s11064-014-1427-7; Herzog AG, 2015, SEIZURE-EUR J EPILEP, V28, P18, DOI 10.1016/j.seizure.2015.02.024; Herzog AG, 2015, EPILEPSIA, V56, pE58, DOI 10.1111/epi.12969; Herzog AG, 2014, NEUROLOGY, V83, P345, DOI 10.1212/WNL.0000000000000623; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Hoffmann S, 2015, J MOL NEUROSCI, V56, P12, DOI 10.1007/s12031-014-0462-9; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hoppeler H, 2005, J EXP BIOL, V208, P1573, DOI 10.1242/jeb.01630; Hovakimyan M, 2013, NEUROSCIENCE, V252, P201, DOI 10.1016/j.neuroscience.2013.08.001; Hovakimyan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028418; Howard R. B., 2015, J NEUROTRAUM; Hsieh J. T., 2015, NEUROENDOCRINOLOGY; Hunt JS, 1997, J REPROD IMMUNOL, V35, P87, DOI 10.1016/S0165-0378(97)00060-0; Inoue T, 2002, J CLIN ENDOCR METAB, V87, P5325, DOI 10.1210/jc.2002-012096; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Irwin RW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00203; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jarahi M, 2014, NEUROSCIENCE, V256, P403, DOI 10.1016/j.neuroscience.2013.10.043; Jiang C., 2016, MOL NEUROBIOL; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jickling GC, 2015, METAB BRAIN DIS, V30, P461, DOI 10.1007/s11011-014-9499-2; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Jung-Testas I, 1998, J STEROID BIOCHEM, V65, P243, DOI 10.1016/S0960-0760(97)00191-X; JUNGTESTAS I, 1994, J STEROID BIOCHEM, V48, P145, DOI 10.1016/0960-0760(94)90261-5; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kelly RW, 1997, BIOCHEM BIOPH RES CO, V239, P557, DOI 10.1006/bbrc.1997.7502; Kilts JD, 2010, PAIN MED, V11, P1469, DOI 10.1111/j.1526-4637.2010.00927.x; Kipp M., 2015, NEUROSCI BIOBEHAV RE; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Kuebler JF, 2003, CRIT CARE MED, V31, P1786, DOI 10.1097/01.CCM.0000063441.41446.23; Kumar P, 2014, EUR J PHARMACOL, V723, P38, DOI 10.1016/j.ejphar.2013.11.036; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumasaka K, 2014, AM J SURG, V208, P961, DOI 10.1016/j.amjsurg.2014.08.004; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2015, J STEROID BIOCHEM, V154, P274, DOI 10.1016/j.jsbmb.2015.09.011; Labombarda F, 2013, NEUROPHARMACOLOGY, V71, P46, DOI 10.1016/j.neuropharm.2013.03.010; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Lammerding L., 2015, NEUROENDOCRINOLOGY; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Lei B., 2015, NEUROENDOCRINOLOGY; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li H, 2005, ANN NEUROL, V58, P317, DOI 10.1002/ana.20538; Li M, 2015, MEDICINE, V94; LI XJ, 2015, CLIN EXP MED, V8, P18831; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; LIEB K, 1995, EXP NEUROL, V134, P222, DOI 10.1006/exnr.1995.1052; Lin CB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001298; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Liu XM, 2014, J STEROID BIOCHEM, V143, P130, DOI 10.1016/j.jsbmb.2014.02.017; Lombardi C, 2013, J SLEEP RES, V22, P322, DOI 10.1111/jsr.12012; Lonstein JS, 2004, J NEUROENDOCRINOL, V16, P534, DOI 10.1111/j.1365-2826.2004.01198.x; Maass F, 2015, J NEUROSCI RES, V93, P433, DOI 10.1002/jnr.23509; Mahfouz A, 2016, P NATL ACAD SCI USA, V113, P2738, DOI 10.1073/pnas.1520376113; Malcolm Shannon G., 2000, Journal of Neurotrauma, V17, P967; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Manolagas, 1995, CIBA F SYMP, V191, P106; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Maurice T, 2001, BRIT J PHARMACOL, V134, P1731, DOI 10.1038/sj.bjp.0704355; McCullough LD, 2003, J NEUROSCI, V23, P8701; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Melcangi RC, 2015, NEUROSCI BIOBEHAV RE; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Melcangi RC, 2014, PROG NEUROBIOL, V113, P1, DOI 10.1016/j.pneurobio.2013.09.005; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Mitro N, 2014, J STEROID BIOCHEM, V143, P115, DOI 10.1016/j.jsbmb.2014.02.015; Mitro N, 2012, NEUROCHEM INT, V60, P616, DOI 10.1016/j.neuint.2012.02.025; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Mokin M, 2016, NAT REV NEUROL, V12, P86, DOI 10.1038/nrneurol.2015.240; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; National Institutes of Health and Northwestern University, NIH TOOLB; Nilsen J, 2002, BRAIN RES, V930, P216, DOI 10.1016/S0006-8993(02)02254-0; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ockene JK, 2005, JAMA-J AM MED ASSOC, V294, P183, DOI 10.1001/jama.294.2.183; Oral E, 2015, GEN HOSP PSYCHIAT, V37, P266, DOI 10.1016/j.genhosppsych.2015.03.001; Ou L. C., 1994, J APPL PHYSIOL, V77, P427; OU LC, 1984, P SOC EXP BIOL MED, V177, P308; Ozawa Hitoshi, 2005, Journal of Nippon Medical School, V72, P316, DOI 10.1272/jnms.72.316; Palaniswami M, 2015, INTERV NEUROL, V4, P18, DOI 10.1159/000438774; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; PATERSON G D, 1963, Br J Ophthalmol, V47, P129, DOI 10.1136/bjo.47.3.129; Patte-Mensah C, 2014, PROG NEUROBIOL, V113, P70, DOI 10.1016/j.pneurobio.2013.07.004; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; PIVA F, 1995, J STEROID BIOCHEM, V53, P343, DOI 10.1016/0960-0760(95)00072-8; Pluchino N, 2006, J STEROID BIOCHEM, V102, P205, DOI 10.1016/j.jsbmb.2006.09.023; POSTHUMUS RG, 1952, OPHTHALMOLOGICA, V124, P17, DOI 10.1159/000301245; Prasad V, 2016, EUR J CANCER, V52, P197, DOI 10.1016/j.ejca.2015.08.024; Qian XW, 2015, INT J CLIN EXP MED, V8, P13610; Qin YB, 2015, J STEROID BIOCHEM, V154, P302, DOI 10.1016/j.jsbmb.2015.01.002; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Quadros PS, 2002, J NEUROBIOL, V51, P24, DOI 10.1002/neu.10040; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Ramanujam B, 2016, EPILEPTIC DISORD, V18, P101, DOI 10.1684/epd.2016.0792; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Remus EW, 2015, EXP NEUROL, V271, P401, DOI 10.1016/j.expneurol.2015.07.010; Robert R, 1997, NITRIC OXIDE-BIOL CH, V1, P453, DOI 10.1006/niox.1997.0157; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 1997, NEUROTRAUMA, V14, P760; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; Sakamoto H, 2003, NEUROSCI LETT, V343, P163, DOI 10.1016/S0304-9340(03)000362-8; Salinsky M, 2016, EPILEPSY BEHAV, V57, P141, DOI 10.1016/j.yebeh.2016.02.003; Sameni H, 2011, CELL J, V13, P31; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schmidl D, 2015, CURR EYE RES, V40, P201, DOI 10.3109/02713683.2014.906625; Schumacher, 1997, Stress, V2, P65; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 1995, CIBA F SYMP, V191, P90; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Shimamura K, 1995, J REPROD FERTIL, V105, P253, DOI 10.1530/jrf.0.1050253; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Singh M, 2013, NEUROSCIENCE, V239, P84, DOI 10.1016/j.neuroscience.2012.09.056; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Smith SS, 2005, J PHYSIOL-LONDON, V564, P421, DOI 10.1113/jphysiol.2004.077297; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Soares HD, 1995, J NEUROSCI, V15, P8223; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Spratt NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107752; Stein D. G., 2016, SCIENCE; Stein D. G., 2016, FUTURE NEUROL, V11, P9; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stoffel EC, 2004, PHYSIOL BEHAV, V83, P505, DOI 10.1016/j.physbeh.2004.08.033; SUBRAMANIAN M, 1993, NEUROSCI LETT, V155, P151, DOI 10.1016/0304-3940(93)90695-H; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tenovuo O, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P40; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Toung TK, 2000, STROKE, V31, P2701, DOI 10.1161/01.STR.31.11.2701; Turan N, 2016, TRANSL STROKE RES, V7, P12, DOI 10.1007/s12975-015-0434-6; Tyagi E, 2014, EXP NEUROL, V253, P41, DOI 10.1016/j.expneurol.2013.12.004; Van Meervenne SAE, 2015, J VET INTERN MED, V29, P251, DOI 10.1111/jvim.12505; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Vedder H, 1999, J NEUROCHEM, V72, P2531, DOI 10.1046/j.1471-4159.1999.0722531.x; Verdi J, 2013, EUR J PHARMACOL, V699, P207, DOI 10.1016/j.ejphar.2012.11.052; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Wali B, 2014, BRAIN, V137, P486, DOI 10.1093/brain/awt319; Wang JP, 2011, MOL MED REP, V4, P319, DOI 10.3892/mmr.2011.418; WARDLAW SL, 1982, J CLIN ENDOCR METAB, V55, P877, DOI 10.1210/jcem-55-5-877; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yablon SA, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P636; YAMORI Y, 1976, STROKE, V7, P120, DOI 10.1161/01.STR.7.2.120; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yepes M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00304, 10.3389/fncel.2015.00304]; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Yuan XH, 2016, J STEROID BIOCHEM, V155, P104, DOI 10.1016/j.jsbmb.2015.09.029; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624; Zhang L, 2003, NEUROSCI LETT, V337, P65, DOI 10.1016/S0304-3940(02)01179-5; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267; Zhao WJ, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0045-7; Zhao YZ, 2015, NEURAL REGEN RES, V10, P1076, DOI 10.4103/1673-5374.160097	319	9	9	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-803592-4				2017							411	441		10.1016/B978-0-12-803592-4.00110-3			31	Behavioral Sciences; Endocrinology & Metabolism; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Endocrinology & Metabolism; Neurosciences & Neurology	BJ4XY	WOS:000425589300020					2022-02-06	
J	Stein, E; Howard, W; Rowhani-Rahbar, A; Rivara, FP; Zatzick, D; McCarty, CA				Stein, Elizabeth; Howard, Waylon; Rowhani-Rahbar, Ali; Rivara, Frederick P.; Zatzick, Douglas; McCarty, Carolyn A.			Longitudinal trajectories of post-concussive and depressive symptoms in adolescents with prolonged recovery from concussion	BRAIN INJURY			English	Article						concussion; pediatric; post-concussive symptoms; depression; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; CHILDREN; DISORDER; OUTCOMES; QUALITY; ANXIETY; HEALTH; TRIAL	Primary Objective: To investigate the symptom trajectories of depressive and post-concussive symptoms (PCS) in slow-to-recover adolescents to understand how the two sets of symptoms are related.& para;& para;Research Design: We used data from a randomized clinical trial of a collaborative care intervention for post-concussive symptoms to better understand how these two sets of symptoms change in parallel over 6 months.& para;& para;Methods and Procedure: PCS and depressive symptom scores for 49 adolescents (ages 11-17) were measured at enrolment and after 1, 3, and 6 months. Latent growth curve modelling for parallel processes was used to simultaneously examine change In PCS and depressive symptoms over time and to evaluate the Influence of one change process on the other.& para;& para;Main Outcomes and Results: On average, patients enrolled 66 days following injury (Interquartile range (IQR) 43.5, 88.5). PCS and depressive symptoms were significantly associated at enrolment and over time, and both decreased over the course of 6 months. Higher PCS at enrolment predicted a greater decrease in depressive symptoms over time.& para;& para;Conclusions: Our results suggest that clinicians should screen for and treat depressive symptoms In patients with high post-concussive symptoms one month following injury.	[Stein, Elizabeth; Howard, Waylon; Rivara, Frederick P.; McCarty, Carolyn A.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,Suite 400,Mailstop CW8-5A, Seattle, WA 98145 USA; [Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali; Rivara, Frederick P.; Zatzick, Douglas] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.; McCarty, Carolyn A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Zatzick, Douglas] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Stein, E (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,Suite 400,Mailstop CW8-5A, Seattle, WA 98145 USA.	lizstein@me.com	; Howard, Waylon/C-1176-2015	Rowhani-Rahbar, Ali/0000-0002-2705-4485; Howard, Waylon/0000-0002-0355-2244; Stein, Elizabeth/0000-0002-1820-3821	National Center For Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR002319]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002319, UL1TR000423] Funding Source: NIH RePORTER	This study was supported by a legacy gift from the Satterberg Foundation. Study data were collected and managed using REDCap electronic data capture tools hosted at the Institute of Translational Health Sciences. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies, providing: 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources. REDCap at ITHS is supported by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number UL1 TR002319.	Association A.P, 2013, DIAGN STAT MAN MENT; Avenevoli S., 2008, HDB DEPRESSION CHILD, P6; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown TA, 2012, CONFIRMATORY FACTOR; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Enders C. K., 2010, APPL MISSING DATA AN; Enders CK, 2011, MULTIVAR APPL SER, P357; Enders CK, 2011, STRUCT EQU MODELING, V18, P35, DOI 10.1080/10705511.2011.532695; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fisher E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011118.pub2; Hopkins K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h824; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Institute of Medicine (IOM) and National Research Council (NRC), 2013, SPORTS RELATED CONCU; Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Little T.D, 2013, LONGITUDINAL STRUCTU, V1st, P386; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; MUTHEN BO, 1989, PSYCHOMETRIKA, V54, P557, DOI 10.1007/BF02296397; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Preacher K., 2010, REV GUIDE QUANTITATI, P185; Preacher K.J., 2008, LATENT GROWTH CURVE; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	47	9	9	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1736	1744		10.1080/02699052.2017.1380843			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500005	29115868	Green Accepted			2022-02-06	
J	Veeramuthu, V; Narayanan, V; Ramli, N; Hernowo, A; Waran, V; Bondi, MW; Delano-Wood, L; Ganesan, D				Veeramuthu, Vigneswaran; Narayanan, Vairavan; Ramli, Norlisah; Hernowo, Aditya; Waran, Vicknes; Bondi, Mark W.; Delano-Wood, Lisa; Ganesan, Dharmendra			Neuropsychological Outcomes in Patients with Complicated Versus Uncomplicated Mild Traumatic Brain Injury: 6-Month Follow-Up	WORLD NEUROSURGERY			English	Article						Complicated versus uncomplicated; Early neuropsychological impairment; Mild traumatic brain injury	HEAD-INJURY; COGNITIVE DYSFUNCTION; PERSISTENT SYMPTOMS; CT-SCAN; CONCUSSION; RECOVERY; REHABILITATION; PREDICTION; SEVERITY; LESIONS	OBJECTIVE: To compare the extent of persistent neuropsychological impairment in patients with complicated mild traumatic brain injury (mTBI) and those with uncomplicated mTBI. METHODS: Sixty-one patients with mTBI (Glasgow Coma Scale score 13-15) were recruited prospectively, categorized according to baseline computed tomography findings, and subjected to neuropsychological assessment at initial admission (n = 61) as well as at a 6-month follow-up (n = 30). The paired t test, Cohen's d effect size calculation, and repeated-measures analysis of variance were used to establish the differences between the 2 groups in terms of neuropsychological performance. RESULTS: A trend toward poorer neuropsychological performance among the patients with complicated mTBI was observed during admission; however, performance in this group improved over time. In contrast, the uncomplicated mTBI group showed slower recovery, especially in tasks of memory, visuospatial processing, and executive functions, at follow-up. CONCLUSIONS: Our findings suggest that despite the broad umbrella designation of mTBI, the current classification schemes of injury severity for mild neurotrauma should be revisited. They also raise questions about the clinical relevance of both traumatic focal lesions and the absence of visible traumatic lesions on brain imaging studies in patients with milder forms of head trauma.	[Veeramuthu, Vigneswaran; Narayanan, Vairavan; Hernowo, Aditya; Waran, Vicknes; Ganesan, Dharmendra] Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Malaysia; [Ramli, Norlisah] Univ Malaya, Res Imaging Ctr, Kuala Lumpur, Malaysia; [Bondi, Mark W.; Delano-Wood, Lisa] VA San Diego Healthcare Syst, San Diego, CA USA; [Bondi, Mark W.; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Narayanan, V (corresponding author), Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Malaysia.	nvairavan@um.edu.my	GANESAN, DHARMENDRA/B-8437-2010; RAMLI, NORLISAH MOHD/G-5209-2010; Mathaneswaran, Vickneswaran/E-5180-2010; NARAYANAN, VAIRAVAN/B-9191-2010; Veeramuthu, Vigneswaran/F-2220-2015; Hernowo, Aditya T/M-9651-2015; Hernowo, Aditya/M-9316-2017	RAMLI, NORLISAH MOHD/0000-0001-7497-8093; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; Veeramuthu, Vigneswaran/0000-0003-2052-0858; Hernowo, Aditya T/0000-0002-9212-6705; 	University Malaya Research Grant (UMRG) [RG 447/12HTM]; University of MalayaUniversiti Malaya [UM.C/625/1/HIR-MOHE/12]	This research was partially funded by University Malaya Research Grant (UMRG) RG 447/12HTM and University of Malaya High-Impact Research Grant UM.C/625/1/HIR-MOHE/12. The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chua KSG, 2010, J REHABIL MED, V42, P27, DOI 10.2340/16501977-0476; Chung P, 2013, J NEUROL NEUROPHYSIO, V5, P182; Cowie CJA, 2014, THESIS; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jeng TC, 2008, MALAYS J MED SCI, V15, P56; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Peden M, 2004, WORLD REPORT ROAD TR, P31; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Price CJ, 2001, J COGNITIVE NEUROSCI, V13, P419, DOI 10.1162/08989290152001853; Proto D, 2009, NEUROREHABILITATION, V24, P145, DOI 10.3233/NRE-2009-0463; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Veeramuthu V, 2014, NEUROL ASIA, V19, P69; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	68	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						416	423		10.1016/j.wneu.2016.10.041			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400056	27751922				2022-02-06	
J	Viano, DC; Parenteau, CS; Xu, LK; Faul, A				Viano, David C.; Parenteau, Chantal S.; Xu, Likang; Faul, Andmark			Head injuries (TBI) to adults and children in motor vehicle crashes	TRAFFIC INJURY PREVENTION			English	Article						Head injury; TBI; motor vehicle crashes; emergency department visits; adult and children injury	TRAUMATIC BRAIN-INJURY; SURVEILLANCE; DEATH; DISEASE; CODES	Purpose: This is a descriptive study. It determined the annual, national incidence of head injuries (traumatic brain injury, TBI) to adults and children in motor vehicle crashes. It evaluated NASS-CDS for exposure and incidence of various head injuries in towaway crashes. It evaluated 3 health databases for emergency department (ED) visits, hospitalizations, and deaths due to TBI in motor vehicle occupants. Methods: Four databases were evaluated using 1997-2010 data on adult (15+ years old) and child (0-14 years old) occupants in motor vehicle crashes: (1) NASS-CDS estimated the annual incidence of various head injuries and outcomes in towaway crashes, (2) National Hospital Ambulatory Medical Care Survey (NHAMCS)-estimated ED visits for TBI, (3) National Hospital Discharge Survey (NHDS) estimated hospitalizations for TBI, and (4) National Vital Statistics System (NVSS) estimated TBI deaths. The 4 databases provide annual national totals for TBI related injury and death in motor vehicle crashes based on differing definitions with TBI coded by the Abbreviated Injury Scale (AIS) in NASS-CDS and by International Classification of Diseases (ICD) in the health data. Results: Adults: NASS-CDS had 16,980 +/- 2,411 (risk = 0.43 +/- 0.06%) with severe head injury (AIS 4+) out of 3,930,543 exposed adults in towaway crashes annually. There were 49,881 +/- 9,729 (risk = 1.27 +/- 0.25%) hospitalized with AIS 2+ head injury, without death. There were 6,753 +/- 882 (risk = 0.17 +/- 0.02%) fatalities with a head injury cause. The public health data had 89,331 +/- 6,870 ED visits, 33,598 +/- 1,052 hospitalizations, and 6,682 +/- 22 deaths with TBI. NASS-CDS estimated 48% more hospitalized with AIS 2+ head injury without death than NHDS occupants hospitalized with TBI. NASS-CDS estimated 29% more deaths with AIS 3+ head injury than NVSS occupant TBI deaths but only 1% more deaths with a head injury cause. Children: NASS-CDS had 1,453 +/- 318 (risk = 0.32 +/- 0.07%) with severe head injury (AIS 4+) out of 454,973 exposed children annually. There were 2,581 +/- 683 (risk = 0.57 +/- 0.15%) hospitalized with AIS 2+ head injury, without death. There were 466 +/- 132 (risk = 0.10 +/- 0.03%) fatalities with a head injury cause. The public health data had 19,251 +/- 2,803 ED visits, 3,363 +/- 255 hospitalizations, and 488 +/- 6 deaths with TBI. NASS-CDS estimated 24% fewer hospitalized children with AIS 2+ head injury without death than NHDS hospitalization with TBI. NASS-CDS estimated 31% more deaths with AIS 3+ head injury than NVSS child deaths but 5% fewer deaths with a head injury cause. Conclusions: The annual national incidence of motor vehicle-related head injury (TBI) was estimated using 1997-2010 NASS-CDS from the Department of Transportation and NHAMCS (ED visits), NHDS (hospitalizations), and NVSS (deaths) from the Department of Health and Human Services. The transportation and health databases use different definitions and coding, which complicates direct comparisons. Future work is needed where ICD to AIS translators are used if comparisons of serious head injuries in NASS and health data sets are to be made.	[Viano, David C.; Parenteau, Chantal S.] ProBiomechan LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA; [Xu, Likang; Faul, Andmark] Ctr Dis Control & Prevent, Atlanta, GA USA		Viano, DC (corresponding author), ProBiomechan LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net		Faul, Mark/0000-0002-7683-0348	Intramural CDC HHS [CC999999] Funding Source: Medline		Atkinson T, 2004, 2004010328 SAE; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barrett ML., 2011, HEALTHCARE COST UTIL; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Betz ME, 2008, J AM GERIATR SOC, V56, P2267, DOI 10.1111/j.1532-5415.2008.02001.x; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Centers for Disease Control and Prevention, 2011, NAT CTR INJ PREV CON; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2011, REC FRAM E COD GROUP; Centers for Disease Control and Prevention, MORT DAT MULT CAUS O; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Ermenc B, 1999, MED SCI LAW, V39, P287, DOI 10.1177/002580249903900404; Faul M, 2010, TRAUMATIC BRAIN INJU; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gujral IB., 2007, PROQUEST; Hallman JJ, 2011, STAPP J, P147; Haskins AE, 2013, AM J EPIDEMIOL, V177, P380, DOI 10.1093/aje/kws242; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Loftis KL, 2016, TRAFFIC INJ PREV, V17, P1, DOI 10.1080/15389588.2016.1191069; National Center for Health Statistics, 2013, NAT HOSP DISCH SURV; National Center for Health Statistics, 2013, NAT AMB MED CAR SURV; NHTSA, 2014, 812067 DOT HS; NHTSA, 2010, 811402 DOT HS; *NHTSA, 1997, NAT AUT SAMPL SYST C; NHTSA, 2009, NAT AUT SAMPL SYST C; Peng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134821; Rodriguez SR, 2006, PUBLIC HEALTH REP, V121, P282, DOI 10.1177/003335490612100310; SAS Institute Inc, 2013, SAS STAT US GUID VER; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Weaver Ashley A, 2013, Ann Adv Automot Med, V57, P235	34	9	10	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2017	18	6					616	622		10.1080/15389588.2017.1285023			7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	FC9OQ	WOS:000407171400009	28112983	Green Accepted			2022-02-06	
J	Wei, G; Chen, BJ; Lin, QJ; Li, YS; Luo, LQ; He, HF; Fu, HD				Wei, Guan; Chen, Bingji; Lin, Qingjiang; Li, Yasong; Luo, Liangqin; He, Hefan; Fu, Huangde			Tetrahydrocurcumin Provides Neuroprotection in Experimental Traumatic Brain Injury and the Nrf2 Signaling Pathway as a Potential Mechanism	NEUROIMMUNOMODULATION			English	Article						Traumatic brain injury; Tetrahydrocurcumin; NFE2-related factor 2; Apoptosis	REDUCES OXIDATIVE STRESS; RATS; APOPTOSIS; AUTOPHAGY; MICE; MODELS; ACID	The protective effect of tetrahydrocurcumin (THC) after experimental traumatic brain injury (TBI) has been demonstrated, as demonstrated by the inhibition of oxidative stress, mitochondrial dysfunction, and apoptosis. However, the mechanisms underlying this effect are still not well understood. This study was to investigate the neuroprotective effects of THC, and its potential mechanisms, in a rat model of TBI. To this end, rats were divided into 4 groups: the sham group, the TBI group, the TBI + vehicle (V) group, and the TBI + THC group. THC or V was administered via intraperitoneal injection to rats in the TBI + V and TBI + THC groups 30 min after TBI. After euthanasia (24 h after TBI), neurological scores, brain water content, and neuronal cell death in the cerebral cortex were recorded. Brain samples were collected after neurological scoring for further analysis. THC treatment alleviated brain edema, attenuated TBI-induced neuronal cell apoptosis, and improved neurobehavioral function. In addition, NFE2-related factor 2 (Nrf2) expression was upregulated following TBI. These results suggest that THC improves neurological outcome after TBI, possibly by activating the Nrf2 signaling pathway. (C) 2018 S. Karger AG, Basel	[Wei, Guan; Chen, Bingji; Lin, Qingjiang] Fujian Med Univ, Affiliated Hosp 2, Emergency Dept, Quanzhou, Peoples R China; [Li, Yasong; Luo, Liangqin] Fujian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Quanzhou, Peoples R China; [He, Hefan] Fujian Med Univ, Affiliated Hosp 2, Dept Anesthesia, Quanzhou 362000, Fujian, Peoples R China; [Fu, Huangde] YouJiang Med Univ Nationalities, Dept Neurosurg, Affiliated Hosp, Baise 533000, Guangxi, Peoples R China		He, HF (corresponding author), Fujian Med Univ, Affiliated Hosp 2, Dept Anesthesia, Quanzhou 362000, Fujian, Peoples R China.; Fu, HD (corresponding author), YouJiang Med Univ Nationalities, Dept Neurosurg, Affiliated Hosp, Baise 533000, Guangxi, Peoples R China.	15860905262@163.com; qzhuangdefu@126.com			Fujian Province Natural Science FoundationNatural Science Foundation of Fujian Province [2016J1517]	This work was supported by grants from the Fujian Province Natural Science Foundation (2016J1517).	Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116007; Bello M, 2017, INT J BIOL MACROMOL, V105, P981, DOI 10.1016/j.ijbiomac.2017.07.117; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong N, 2017, EXP THER MED, V13, P3183, DOI 10.3892/etm.2017.4411; Gao YY, 2017, AM J TRANSL RES, V9, P887; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Gupta V, 2017, ENVIRON SCI POLLUT R, V24, P23915, DOI 10.1007/s11356-017-0057-4; Jia JX, 2017, J TOXICOL ENV HEAL A, V80, P1206, DOI 10.1080/15287394.2017.1367139; Ledbetter C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00825; Li X, 2016, AM J TRANSL RES, V8, P3558; Li XL, 2017, MOL NEUROBIOL, V54, P7938, DOI 10.1007/s12035-016-0278-4; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Mishra S, 2011, NEUROREPORT, V22, P23, DOI 10.1097/WNR.0b013e328341e141; Moreira S, 2017, EXP NEUROL, V295, P77, DOI 10.1016/j.expneurol.2017.05.009; Ramakrishnan R, 2017, APPL BIOCHEM BIOTECH, V183, P51, DOI 10.1007/s12010-017-2430-7; Sangartit W, 2016, VASC PHARMACOL, V87, P199, DOI 10.1016/j.vph.2016.10.001; Sobeh M, 2017, PHYTOMEDICINE, V33, P36, DOI [10.1016/j.phymed.2017.0, 10.1016/j.phymed.2017.07.003]; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Wan PX, 2017, CLIN SCI, V131, P2363, DOI 10.1042/CS20171182; Wang SD, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.410; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xiang L, 2011, AGING-US, V3, P1098, DOI 10.18632/aging.100396; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu X, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1655-x; Ye XL, 2017, EXP THER MED, V13, P1725, DOI 10.3892/etm.2017.4197	26	9	9	1	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2017	24	6					348	355		10.1159/000487998			8	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	GH9ES	WOS:000433972600007	29669346				2022-02-06	
S	Wijdicks, EFM		Wijdicks, EFM; Kramer, AH		Wijdicks, E. F. M.			The history of neurocritical care	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							MEDICAL INTENSIVE-CARE; SEVERE HEAD-INJURY; MULTIDISCIPLINARY CONSENSUS CONFERENCE; NEUROLOGIC SUBSPECIALTIES GUIDELINES; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CLASSIFICATION-SYSTEM; UNITED COUNCIL; MANAGEMENT; COMA	Critical care medicine came into sharp focus in the second part of the 20th century. The care of acutely ill neurologic patients in the USA may have originated in postoperative neurosurgical units, but for many years patients with neurocritical illness were admitted to intensive care units next to patients with general medical or surgical conditions. Neurologists may have had their first exposure to the complexity of neurocritical care during the poliomyelitis epidemics, but few were interested. Much later, the development of neurocritical care as a legitimate subspecialty was possible as a result of a new cadre of neurologists, with support by departments of neurosurgery and anesthesia, who appreciated their added knowledge and expertise in care of acute neurologic illness. Fellowship programs have matured in the US and training programs in certain European countries. Certification in the USA is possible through the American Academy of Neurology United Council of Neurologic Specialties. Most neurointensivists had a formal neurology training. This chapter is a brief analysis of the development of the specialty critical care neurology and how it gained strength, what it is to be a neurointensivist, what the future of care of these patients may hold, and what it takes for neurointensivists to stay exemplary. This chapter revisits some of the earlier known and previously unknown landmarks in the history of neurocritical care.	[Wijdicks, E. F. M.] Mayo Clin, Div Crit Care Neurol, Rochester, MN USA; [Wijdicks, E. F. M.] St Marys Hosp, Neurosci Intens Care Unit, Mayo Clin Campus, Rochester, MN USA		Wijdicks, EFM (corresponding author), Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA.	wijde@mayo.edu					ANDERSEN EW, 1954, BMJ-BRIT MED J, V1, P786, DOI 10.1136/bmj.1.4865.786; Weil Max Harry, 2011, J Crit Care, V26, P439; BAKER AB, 1957, NEUROLOGY, V7, P743, DOI 10.1212/WNL.7.11.743; BAKER AB, 1954, NEUROLOGY, V4, P379, DOI 10.1212/WNL.4.5.379; BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; Berthelsen PG, 2003, ACTA ANAESTH SCAND, V47, P1190, DOI 10.1046/j.1399-6576.2003.00256.x; Bleck TP, 2009, CRIT CARE CLIN, V25, P153, DOI 10.1016/j.ccc.2008.12.004; BLECK TP, 1986, MED CLIN N AM, V70, P1167, DOI 10.1016/S0025-7125(16)30918-X; Bliss M., 2005, HARVEY CUSHING LIFE; BODMAN RI, 1955, LANCET, V2, P230; Borel C, 1985, Crit Care Clin, V1, P223; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; BROWN J R, 1947, J Am Med Assoc, V134, P757; Bryan-Brown CW, 2007, AM J CRIT CARE, V16, P12, DOI 10.4037/ajcc2007.16.1.12; Brydges R, 2015, ACAD MED, V90, P246, DOI 10.1097/ACM.0000000000000549; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Calvin JE, 1997, CRIT CARE CLIN, V13, P363, DOI 10.1016/S0749-0704(05)70315-8; Carson SS, 1996, JAMA-J AM MED ASSOC, V276, P322, DOI 10.1001/jama.276.4.322; CULLEN DJ, 1976, NEW ENGL J MED, V294, P982, DOI 10.1056/NEJM197604292941805; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; GOLDSTEIN RL, 1986, CRIT CARE MED, V14, P783, DOI 10.1097/00003246-198609000-00005; GRENVIK A, 1981, CRIT CARE MED, V9, P117, DOI 10.1097/00003246-198102000-00012; Guttmann L, 1967, Paraplegia, V5, P115; Hilberman M, 1975, Crit Care Med, V3, P159; Hocker S, 2015, ANN NEUROL, V78, P337, DOI 10.1002/ana.24473; IBSEN B, 1954, P ROY SOC MED, V47, P72, DOI 10.1177/003591575404700120; JENNETT B, 1990, J NEUROSURG, V73, P479; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1980, J NEUROL NEUROSUR PS, V43, P289, DOI 10.1136/jnnp.43.4.289; JENNETT B, 1976, LANCET, V1, P1031; Kelly FE, 2014, CLIN MED, V14, P376, DOI 10.7861/clinmedicine.14-4-376; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lanier WL, 2012, J NEUROSURG ANESTH, V24, P281, DOI 10.1097/ANA.0b013e3182697743; LASSEN HCA, 1953, LANCET, V264, P37; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; MARSHALL J, 1961, POSTGRAD MED J, V37, P26, DOI 10.1136/pgmj.37.423.26; Mashour GA, 2012, ANESTH ANALG, V114, P715, DOI 10.1213/ANE.0b013e3182455c96; Mayer SA, 2006, NEUROCRIT CARE, V5, P159, DOI 10.1385/NCC:5:2:159; Mayer SA, 2006, NEUROCRIT CARE, V5, P166, DOI 10.1385/NCC:5:2:166; Multz AS, 1998, AM J RESP CRIT CARE, V157, P1468, DOI 10.1164/ajrccm.157.5.9708039; MUNRO D, 1954, NEW ENGL J MED, V250, P4, DOI 10.1056/NEJM195401072500102; Murphy SA, 2015, NEUROCRIT CARE, V23, P149, DOI 10.1007/s12028-015-0120-2; PLUM F, 1956, NEW ENGL J MED, V254, P193, DOI 10.1056/NEJM195602022540501; PLUM F, 1951, JAMA-J AM MED ASSOC, V146, P442, DOI 10.1001/jama.1951.03670050024005; Plum F, 1966, DIAGNOSIS STUPOR COM; PRYSROBERTS C, 1969, LANCET, V1, P542; Reisner-Senelar L, 2011, INTENS CARE MED, V37, P1084, DOI 10.1007/s00134-011-2235-z; RELMAN AS, 1980, NEW ENGL J MED, V302, P965, DOI 10.1056/NEJM198004243021711; Reynolds LA, 2011, WELLCOME WITNESSES T; ROPPER AH, 1980, ANN NEUROL, V8, P141, DOI 10.1002/ana.410080203; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P725, DOI 10.1001/archneur.1984.04050180047016; ROPPER AH, 1982, NEUROLOGY, V32, P1288, DOI 10.1212/WNL.32.11.1288; ROPPER AH, 1985, NEUROLOGY, V35, P1662, DOI 10.1212/WNL.35.11.1662; ROPPER AH, 1983, NEUROLOGICAL NEUROSU; Rosengart MR, 2006, SURG CLIN N AM, V86, P1305, DOI 10.1016/j.suc.2006.09.004; RUSSELL WR, 1953, LANCET, V265, P707; SAFAR P, 1986, CIRCULATION, V74, P138; SAFAR P, 1971, CHEST, V59, P535, DOI 10.1378/chest.59.5.535; SHOEMAKER WC, 1984, SOC CRITICAL CARE ME; Smith WS, 2012, NEUROCRIT CARE, V17, P1, DOI 10.1007/s12028-012-9741-x; SPALDING JMK, 1963, CLIN PRACTICE PHYSL; TERES D, 1982, CRIT CARE MED, V10, P86, DOI 10.1097/00003246-198202000-00004; Weil M H, 1973, Crit Care Med, V1, P1, DOI 10.1097/00003246-197301000-00001; WIJDICKS E, 2000, NEUROLOGIC CATASTROP; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2006, NEUROCRIT CARE, V5, P81, DOI 10.1385/NCC:5:2:81; Wijdicks EFM, 2016, SEMIN NEUROL, V36, P483, DOI 10.1055/s-0036-1592108; Wijdicks EFM, 2016, NEUROLOGY, V87, P1167, DOI 10.1212/WNL.0000000000003098; Wijdicks EFM, 2011, MAYO CLIN PROC, V86, P903, DOI 10.4065/mcp.2010.0815; Wijdicks EFM, 2011, NEUROSURGERY, V68, P1695, DOI 10.1227/NEU.0b013e318212babf; WIJDICKS EF, 1997, CLIN PRACTICE CRITIC; Wijdicks EFM, 2004, NEUROCRIT CARE, V1; Wijdicks EFM, 1995, CONT NEUROLOGY SERIE	77	9	9	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						3	14		10.1016/B978-0-444-63600-3.00001-5			12	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500003	28187805				2022-02-06	
S	Young, GB; Mantia, J		Wijdicks, EFM; Kramer, AH		Young, G. B.; Mantia, J.			Continuous EEG monitoring in the intensive care unit	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL; SEIZURES; DISCHARGES; COMA; ICU	The purpose and indications for continuous electroencephalography monitoring (CEEG) in intensive care unit (ICU) patients include seizure detection, monitoring the effects of treatment (including depth of sedation), grading and classification of EEG abnormalities, ischemia detection and prognostication. Practical considerations of ICU CEEG include: choice of montages (patterns of electrode placement and connections), EEG electrodes, recognition of artifacts, and the use of automated or computerized analysis. These aspects are reviewed, along with an identifcation of current advances and challenges for the future of CEEG in the ICU.	[Young, G. B.] Western Univ, Dept Clin Neurol Sci, London, ON, Canada; [Young, G. B.] Western Univ, Dep Med Crit Care, London, ON, Canada; [Mantia, J.] Sunnybrook Hlth Sci Ctr, Clin Neurophysiol Unit, Toronto, ON, Canada		Young, GB (corresponding author), Western Univ, Dept Clin Neurol Sci, London, ON, Canada.; Young, GB (corresponding author), Western Univ, Dep Med Crit Care, London, ON, Canada.	bryan.young@lhsc.on.ca					ACNS, 2016, GUID CONS STAT; Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; BOGOUSSLAVSKY J, 1992, ARCH NEUROL-CHICAGO, V49, P385, DOI 10.1001/archneur.1992.00530280073025; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Claassen J, 2009, NEUROCRIT CARE, V11, P437, DOI 10.1007/s12028-009-9295-8; DeGiorgio CM, 1996, EPILEPSIA, V37, P606, DOI 10.1111/j.1528-1157.1996.tb00623.x; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KRUMHOLZ A, 1995, NEUROLOGY, V45, P1499, DOI 10.1212/WNL.45.8.1499; LOTHMAN E, 1990, NEUROLOGY, V40, P13; Ocak H, 2009, EXPERT SYST APPL, V36, P2027, DOI 10.1016/j.eswa.2007.12.065; Perks A, 2012, BRIT J ANAESTH, V108, P562, DOI 10.1093/bja/aes027; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Sackellares JC, 2011, EPILEPSY BEHAV, V22, pS69, DOI 10.1016/j.yebeh.2011.08.028; Savard M, 2009, J CLIN NEUROPHYSIOL, V26, P21, DOI 10.1097/WNP.0b013e3181960453; Scholtes FB, 1996, J NEUROL NEUROSUR PS, V61, P93, DOI 10.1136/jnnp.61.1.93; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Thenayan EAL, 2010, J CRIT CARE, V25, P300, DOI 10.1016/j.jcrc.2009.06.049; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; TREIMAN DM, 1981, NEUROLOGY, V31, P109; Tzallas AT, 2007, COMPUT INTELL NEUROS, V5; Tzvetanov P, 2005, NEUROSCI LETT, V380, P99, DOI 10.1016/j.neulet.2005.01.023; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WASTERLAIN CG, 1993, EPILEPSIA, V34, pS37, DOI 10.1111/j.1528-1157.1993.tb05905.x; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2009, NEUROCRIT CARE, V11, P411, DOI 10.1007/s12028-009-9248-2; Young GB, 2005, NEUROCRIT CARE, V2, P5, DOI 10.1385/NCC:2:1:005; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Young GB, 1999, J CLIN NEUROPHYSIOL, V16, P40, DOI 10.1097/00004691-199901000-00003; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f	38	9	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						107	116		10.1016/B978-0-444-63600-3.00007-6			10	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500009	28187794				2022-02-06	
J	Vavilala, MS; Lujan, SB; Qiu, Q; Petroni, GJ; Ballarini, NM; Guadagnoli, N; Depetris, MA; Faguaga, GA; Baggio, GM; Busso, LO; Garcia, ME; Carrillo, OR; Medici, PL; Saenz, SS; Vanella, EE; Fabio, A; Bell, MJ				Vavilala, Monica S.; Lujan, Silvia B.; Qiu, Qian; Petroni, Gustavo J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria; Faguaga, Gabriela A.; Baggio, Gloria M.; Busso, Leonardo O.; Garcia, Mirta E.; Gonzalez Carrillo, Osvaldo R.; Medici, Paula L.; Saenz, Silvia S.; Vanella, Elida E.; Fabio, Anthony; Bell, Michael J.			Benchmarking Prehospital and Emergency Department Care for Argentine Children with Traumatic Brain Injury: For the South American Guideline Adherence Group	PLOS ONE			English	Article							SYSTEM-DEVELOPMENT; OUTCOMES; PERFORMANCE; MORTALITY	Objective There is little information on the type of early care provided to children with traumatic brain injury (TBI) in low middle income countries. We benchmarked early prehospital [PH] and emergency department [ED] pediatric TBI care in Argentina. Methods We conducted a secondary analysis of data from patients previously enrolled in a prospective seven center study of children with TBI. Eligible participants were patients 0-18 years, and had diagnosis of TBI (admission Glasgow Coma scale score [GCS] < 13 or with GCS 14-15 and abnormal head CT scan within 48 hours of admission, and head AIS > 0). Outcomes were transport type, transport time, PH and ED adherence to best practice, and discharge Pediatric Cerebral Performance Category Scale (PCPC) and Pediatric Overall Performance category Scale (POPC). Results Of the 366 children, mean age was 8.7 (5.0) years, 58% were male, 90% had isolated TBI and 45.4% were transported by private vehicle. 50 (34.7%) of the 144 children with severe TBI (39.3% of all TBI patients) were transported by private vehicle. Most (267; 73%) patients received initial TBI care at an index hospital prior to study center admission, including children with severe (81.9%) TBI. Transport times were shorter for those patients who were directly transported by ambulance to study center than for the whole cohort (1.4 vs.5.5 hours). Ambulance blood pressure data were recorded in 30.9%. ED guideline adherence rate was higher than PH guideline adherence rate (84.8% vs. 26.4%). For patients directly transferred from scene to study trauma centers, longer transport time was associated with worse discharge outcome (PCPC aOR 1.10 [1.04, 1.18] and (POPC aOR 1.10 [1.04, 1.18]). There was no relationship between PH or ED TBI guideline adherence rate and discharge POPC and PCPC. Conclusion This study benchmarks early pediatric TBI care in Argentina and shows that many critically injured children with TBI do not receive timely or best practice PH care, that PH guideline adherence rate is low and that longer transport time was associated with poor discharge outcomes for patients with direct transfer status. There is an urgent need to improve the early care of children with TBI in Argentina, especially timely transportation to a hospital.	[Vavilala, Monica S.; Qiu, Qian] Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Lujan, Silvia B.; Petroni, Gustavo J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria] Ctr Informat Invest Clin, Rosario, Santa Fe, Argentina; [Lujan, Silvia B.; Petroni, Gustavo J.] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Faguaga, Gabriela A.; Baggio, Gloria M.] Hosp Ninos Victor J Vilela, Rosario, Santa Fe, Argentina; [Busso, Leonardo O.] Hosp El Cruce Ezpeleta Oeste, Buenos Aires, DF, Argentina; [Garcia, Mirta E.] Hosp Ninos Sor Maria Ludov, La Plata, Buenos Aires, Argentina; [Gonzalez Carrillo, Osvaldo R.] Hosp Ninos Dr Orlando Alassia, Santa Fe, Santa Fe, Argentina; [Medici, Paula L.] Hosp Interzonal Especializado Materno Infantil Dr, Mar Del Plata, Buenos Aires, Argentina; [Saenz, Silvia S.] Hosp Ninos Santisima Trinidad Cordoba, Cordoba, Argentina; [Vanella, Elida E.] Hosp Pediatr Dr Humberto Notti, Mendoza, Argentina; [Fabio, Anthony] Univ Pittsburgh, Epidemiol Data Coordinating Ctr, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Neurol Surg & Pediat Crit Care Med, Pittsburgh, PA 15260 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA.	vavilala@uw.edu		Fabio, Anthony/0000-0002-6808-4939; Ballarini, Nicolas/0000-0002-3432-8931	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-06, NS081041]	National Institute of Neurological Disorders and Stroke (NINDS) R01 NS072308-06 (Vavilala) and NS081041 (Bell, Vavilala, Fabio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CATEGORIZACION CTR A; Burton A., 2016, LANCET NEUROL; Callese TE, 2015, J SURG RES, V193, P300, DOI 10.1016/j.jss.2014.09.040; Carney NA, 2016, PEDIAT CRIT CARE MED; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Emmanuel G, 1998, QUAL HEALTH CARE, V7, P12; Freeman C, 2002, QUAL SAF HEALTH CARE, V11, P239, DOI 10.1136/qhc.11.3.239; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kannan N, TIMELY HEMODYNAMIC R; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mock C, 2005, J TRAUMA, V59, P1243, DOI 10.1097/01.ta.0000197290.02807.de; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; Stewart BT, 2016, J VASC SURG; Tansley G, 2016, PREHOSP EMERG CARE, V13, P1; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; World Health Organization, 2015, VIOL INJ PREV INJ VI; World Health Organization, 2009, GUID TRAUM QUAL IMPR	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166478	10.1371/journal.pone.0166478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	WOS:000392843200007	28005912	Green Published, gold, Green Submitted			2022-02-06	
J	Vipin, A; Thow, XY; Mir, H; Kortelainen, J; Manivannan, J; Al-Nashash, H; All, AH				Vipin, Ashwati; Thow, Xin Yuan; Mir, Hasan; Kortelainen, Jukka; Manivannan, Janani; Al-Nashash, Hasan; All, Angelo H.			Natural Progression of Spinal Cord Transection Injury and Reorganization of Neural Pathways	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; neuroplasticity; traumatic spinal cord injury	SOMATOSENSORY-EVOKED POTENTIALS; FUNCTIONAL REORGANIZATION; MACAQUE MONKEYS; MOTOR CORTEX; PLASTICITY; RATS; HEMISECTION; RECOVERY; OUTCOMES; BRAIN	The spinal cord injury (SCI) transection model accurately represents traumatic laceration and has been widely used to study the natural history and reorganization of neuropathways and plasticity in the central nervous system (CNS). This model is highly reproducible, which makes it ideal for studying the progression of injury as well as endogenous recovery and plasticity in the CNS. Five experimental groups of transection injury were designed: left hemitransection; right hemitransection; double hemitransection; complete transection injuries; and laminectomy-only control. We used somatosensory evoked potentials (SSEPs) as an objective electrophysiological assessment tool and motor behavior testing (Basso, Beattie, and Bresnahan [BBB] scoring) to functionally assess the neural pathways post-injury. Histological examinations were carried out to investigate the extent of injury and spinal cord morphological changes. Significant (p<0.05) electrophysiological changes were observed and were verified by an increase in SSEP amplitude in somatosensory cortices for all four injury groups during days 4 and 7 post-injury. Degree of plasticity among the groups was distinguished by changes in SSEP amplitude and BBB scores. Our results support our previous published findings (using a contusive model of SCI), which shows that the reorganization of neuropathways and plasticity persist in time and are not transient phenomena. SSEPs are a reliable tool to assess the functionality of neural pathways and their projections to higher CNS structures such as the cortices. They enable us to determine residual function and the changes within the CNS post-injury and consistently track these events over time. The results from our study provide supporting evidence for the presence of neuronal network reorganization and plasticity in the CNS after transection SCI.	[Vipin, Ashwati; Thow, Xin Yuan] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore; [Mir, Hasan; Al-Nashash, Hasan] Amer Univ Sharjah, Dept Elect Engn, Sharjah, U Arab Emirates; [Kortelainen, Jukka] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland; [Manivannan, Janani; All, Angelo H.] Natl Univ Singapore, Dept Orthoped Surg, Singapore, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [All, Angelo H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [All, Angelo H.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA		All, AH (corresponding author), Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Dept Orthoped Surg,Yong Loo Lin Sch Med, 1E Kent Ridge Rd,Tower Block,Level 11, Singapore 119228, Singapore.	angelo.all@nuhs.edu.sg	Mir, Hasan/AAH-5477-2021; Kortelainen, Jukka/P-5512-2014	Mir, Hasan/0000-0002-6863-3002; Kortelainen, Jukka/0000-0003-2585-2376; Manivannan, Janani/0000-0003-0062-1416; Al-Nashash, Hasan/0000-0002-9685-4937	National University of Singapore (NUS)National University of Singapore [R-175-000-122-112, R-175-000-121-133, R-175-000-121-733]; NUHS Clinician Research Grant [FY2014, R-175-000-133-733]; National University of SingaporeNational University of Singapore; Maryland stem cell research fund [2013-MSCRFII-0109-00]	This work was supported by National University of Singapore (NUS) grants R-175-000-122-112 (Tier 1; principal investigator [PI]: A. All), R-175-000-121-133 (Departmental Start-Up Fund; PI: A. All), and R-175-000-121-733 (Singapore Institute for Neurotechnology Seed Fund; PI: A. All) and NUHS Clinician Research Grant FY2014 (PI: A. All; R-175-000-133-733), National University of Singapore. It was also supported by a Maryland stem cell research fund grant proposal (2013-MSCRFII-0109-00; PI: A. All).	Agrawal G, 2010, J CLIN NEUROSCI, V17, P1159, DOI 10.1016/j.jocn.2010.02.005; Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Agrawal G, 2009, J CLIN NEUROSCI, V16, P1052, DOI 10.1016/j.jocn.2008.08.009; Agrawal G, 2008, IEEE ENG MED BIO, P4688, DOI 10.1109/IEMBS.2008.4650259; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Al-Nashash H, 2009, IEEE T BIO-MED ENG, V56, P1971, DOI 10.1109/TBME.2009.2018296; All AH, 2010, NEUROL SCI, V31, P595, DOI 10.1007/s10072-010-0329-y; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bazley FA, 2014, IEEE T NEUR SYS REH, V22, P953, DOI 10.1109/TNSRE.2014.2319313; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bazley FA, 2011, IEEE ENG MED BIO, P2005, DOI 10.1109/IEMBS.2011.6090564; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Chisholm AE, 2015, PHYS THER, V95, P257, DOI 10.2522/ptj.20130522; DePaul M. A., 2015, PLOS ONE, V10; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Isa T, 2014, NEUROSCI RES, V78, P3, DOI 10.1016/j.neures.2013.10.008; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kortelainen J, 2014, IEEE ENG MED BIO, P4286, DOI 10.1109/EMBC.2014.6944572; Mir H, 2010, IEEE ENG MED BIO, P4942, DOI 10.1109/IEMBS.2010.5627238; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; Murata Y, 2015, J NEUROSCI, V35, P84, DOI 10.1523/JNEUROSCI.1737-14.2015; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Onifer SM, 2011, NEUROTHERAPEUTICS, V8, P283, DOI 10.1007/s13311-011-0034-4; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sherman DL, 2010, J NEUROSCI METH, V193, P90, DOI 10.1016/j.jneumeth.2010.07.035; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; Yague JG, 2011, EXP NEUROL, V227, P252, DOI 10.1016/j.expneurol.2010.11.011; Yague JG, 2014, EXP NEUROL, V257, P19, DOI 10.1016/j.expneurol.2014.03.015	34	9	9	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2016	33	24					2191	2201		10.1089/neu.2015.4383			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF3RU	WOS:000390242900004	27159651				2022-02-06	
J	Chasle, V; Riffaud, L; Longuet, R; Martineau-Curt, M; Collet, Y; Le Fournier, L; Pladys, P				Chasle, Veronique; Riffaud, Laurent; Longuet, Romain; Martineau-Curt, Marie; Collet, Yann; Le Fournier, Luc; Pladys, Patrick			Mild head injury and attention deficit hyperactivity disorder in children	CHILDS NERVOUS SYSTEM			English	Article						Attention deficit hyperactivity disorder; Cognitive impairment; Mild head injury; Controlled study	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; OUTCOMES; EPIDEMIOLOGY; CHILDHOOD	Post-concussion syndrome is a well-described complication following moderate and severe head trauma but whether it occurs after mild head injury in children remains unclear. The aim of this study was to evaluate whether exposure to mild head injury with potential additional risk factors (non-surgical lesion on computed tomographic, high kinetic trauma, or Glasgow Coma Scale < 15) is associated with attention deficit hyperactivity disorder (ADHD) after the head trauma. This study was performed in an emergency department on children admitted between 2009 and 2013. It compared victims of mild head injury aged 6-16 years with matched children presenting isolated non-surgical forearm fracture (ratio1/2). ADHD was assessed using Conners' Global Index-Parent short version 3-40 months after the trauma. The patients were compared using chi-square test or Fisher's exact test, t test or u-test as appropriate with a p value set at 0.05. During the study period, 676 patients were admitted for mild head injury. Among them, 34 (5 %) fulfilled the inclusion criteria and were compared with 64 matched patients admitted for a forearm fracture. The groups were comparable. ADHD was observed in both groups (18 % in the mild head injury group, 11 % in the control group) with no significant differences between groups. The prevalence was high when compared to an expected frequency of 3.5-5.6 % in children aged 6-12 years in the general population. These results suggest that pre-existing ADHD may have contributed to injury proneness in both groups and does not argue for a specific risk of ADHD induced by mild head injury. The diagnosis of ADHD should be evoked at admission of children aged 6-16 years presenting with a trauma.	[Chasle, Veronique; Longuet, Romain; Collet, Yann; Pladys, Patrick] Rennes Univ Hosp, Dept Pediat & Emergency Med, Rennes, France; [Riffaud, Laurent; Le Fournier, Luc] Rennes Univ Hosp, Dept Pediat Neurosurg, Rennes, France; [Riffaud, Laurent; Pladys, Patrick] Univ Rennes 1, INSERM, UMR LTSI 1099, Rennes, France; [Martineau-Curt, Marie] Rennes Univ Hosp, Dept Phys Med & Rehabil, Rennes, France		Riffaud, L (corresponding author), Rennes Univ Hosp, Dept Pediat Neurosurg, Rennes, France.; Riffaud, L (corresponding author), Univ Rennes 1, INSERM, UMR LTSI 1099, Rennes, France.	laurent.riffaud@chu-rennes.fr	RIFFAUD, Laurent/ABC-6349-2020	RIFFAUD, Laurent/0000-0003-3570-8132			Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Faul M, 2010, TRAUMATIC BRAIN INJU; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hawley C, 2013, INJURY, V44, P1855, DOI 10.1016/j.injury.2013.07.021; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Hsiang John N K, 2005, J Long Term Eff Med Implants, V15, P153, DOI 10.1615/JLongTermEffMedImplants.v15.i2.40; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lecendreux M, 2011, J ATTEN DISORD, V15, P516, DOI 10.1177/1087054710372491; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Mayo Clinic Staff, POSTC SYNDR SYMPT; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nolin P., 2000, Annales de Readaptation et de Medecine Physique, V43, P236, DOI 10.1016/S0168-6054(00)89087-X; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21	25	9	9	1	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2016	32	12					2357	2361		10.1007/s00381-016-3230-z			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	EE5GL	WOS:000389633500016	27568372				2022-02-06	
